PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, S; Matsunaga, S; Lin, YF; Sishc, B; Shang, Z; Sui, J; Shih, HY; Zhao, Y; Foreman, O; Story, MD; Chen, DJ; Chen, BPC				Zhang, S.; Matsunaga, S.; Lin, Y-F; Sishc, B.; Shang, Z.; Sui, J.; Shih, H-Y; Zhao, Y.; Foreman, O.; Story, M. D.; Chen, D. J.; Chen, B. P. C.			Spontaneous tumor development in bone marrow-rescued DNA-PKcs(3A/3A) mice due to dysfunction of telomere leading strand deprotection	ONCOGENE			English	Article							DEPENDENT PROTEIN-KINASE; HUMAN SOMATIC-CELLS; DNA-PKCS; CATALYTIC SUBUNIT; BREAK REPAIR; DYSKERATOSIS-CONGENITA; CANCER-CELLS; AUTOPHOSPHORYLATION; OVERHANG; DAMAGE	Phosphorylation of the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) at the Thr2609 cluster is essential for its complete function in DNA repair and tissue stem cell homeostasis. This phenomenon is demonstrated by congenital bone marrow failure occurring in DNA-PKcs(3A/3A) mutant mice, which require bone marrow transplantation (BMT) to prevent early mortality. Surprisingly, an increased incidence of spontaneous tumors, especially skin cancer, was observed in adult BMT-rescued DNA-PKcs(3A/3A) mice. Upon further investigation, we found that spontaneous yH2AX foci occurred in DNA-PKcs(3A/3A) skin biopsies and primary keratinocytes and that these foci overlapped with telomeres during mitosis, indicating impairment of telomere replication and maturation. Consistently, we observed significantly elevated frequencies of telomere fusion events in DNA-PKcs3A/3A cells as compared with wild-type and DNA-PKcs-knockout cells. In addition, a previously identified DNA-PKcs Thr2609Pro mutation, found in breast cancer, also induces a similar impairment of telomere leading-end maturation. Taken together, our current analyses indicate that the functional DNA-PKcs T2609 cluster is required to facilitate telomere leading strand maturation and prevention of genomic instability and cancer development.	[Zhang, S.; Matsunaga, S.; Lin, Y-F; Sishc, B.; Shang, Z.; Sui, J.; Shih, H-Y; Story, M. D.; Chen, D. J.; Chen, B. P. C.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, 2201 Inwood Rd,Room NC7-206, Dallas, TX 75390 USA; [Zhang, S.] Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu 610041, Peoples R China; [Matsunaga, S.] Tottori Univ, Dept Pathophysiol & Therapeut Sci, Div Mol Pharmacol, Yonago, Tottori, Japan; [Zhao, Y.] Sun Yat Sen Univ, Sch Life Sci, Cooperat Innovat Ctr High Performance Comp, Key Lab Gene Engn,Minist Educ, Guangzhou, Guangdong, Peoples R China; [Foreman, O.] Jackson Lab, Sacramento, CA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Tottori University; Sun Yat Sen University; Jackson Laboratory	Zhang, S; Chen, BPC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, 2201 Inwood Rd,Room NC7-206, Dallas, TX 75390 USA.; Zhang, S (corresponding author), Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu 610041, Peoples R China.	zhangsc65@hotmail.com; benjamin.chen@utsouthwestern.edu	Story, Michael/AAX-2864-2021; Sishc, Brock James/ABE-4487-2021; Sui, Jiang-Dong/AAU-6005-2021	Story, Michael/0000-0001-6522-4169; 	National Institutes of Health [CA166677]; Cancer Prevention Research Institute of Texas [RP110465]; NATIONAL CANCER INSTITUTE [R01CA166677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (CA166677) and the Cancer Prevention Research Institute of Texas (RP110465) to BPC. We thank Dr Titia de Lange for kindly providing anti-TRF1 antibody, and Dr Damiana Chiavolini for critical reading and editing of the manuscript.	Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Bombarde O, 2010, EMBO J, V29, P1573, DOI 10.1038/emboj.2010.49; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chow TT, 2012, GENE DEV, V26, P1167, DOI 10.1101/gad.187211.112; Convery E, 2005, P NATL ACAD SCI USA, V102, P1345, DOI 10.1073/pnas.0406466102; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; He H, 2009, MOL CELL BIOL, V29, P229, DOI 10.1128/MCB.01400-08; Heijink AM, 2013, MUTAT RES-FUND MOL M, V750, P45, DOI 10.1016/j.mrfmmm.2013.07.003; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Hsu FM, 2012, TRANSL CANCER RES, V1, P22, DOI 10.3978/j.issn.2218-676X.2012.04.01; Hultdin M, 1998, NUCLEIC ACIDS RES, V26, P3651, DOI 10.1093/nar/26.16.3651; Ishii-Ohba H, 2007, MUTAT RES-FUND MOL M, V619, P124, DOI 10.1016/j.mrfmmm.2007.02.028; Jiang WX, 2015, MOL CELL, V58, P172, DOI 10.1016/j.molcel.2015.02.024; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Khadka P, 2014, BIOCHEM J, V463, P19, DOI 10.1042/BJ20131395; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Mirchandani KD, 2006, EXP CELL RES, V312, P2647, DOI 10.1016/j.yexcr.2006.06.014; Nishio N, 2010, INT J HEMATOL, V92, P419, DOI 10.1007/s12185-010-0695-5; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Poon Steven S S, 2001, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1804s12; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Reddy YVR, 2004, J BIOL CHEM, V279, P39408, DOI 10.1074/jbc.M406432200; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Sui JD, 2015, NUCLEIC ACIDS RES, V43, P5971, DOI 10.1093/nar/gkv539; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang XS, 2008, CANCER RES, V68, P971, DOI 10.1158/0008-5472.CAN-07-6272; Wang YB, 2009, P NATL ACAD SCI USA, V106, P12430, DOI 10.1073/pnas.0903362106; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Wu P, 2010, MOL CELL, V39, P606, DOI 10.1016/j.molcel.2010.06.031; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; YU H, 1993, BLOOD, V81, P373; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026	49	13	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 28	2016	35	30					3909	3918		10.1038/onc.2015.459	http://dx.doi.org/10.1038/onc.2015.459			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8DJ	26616856	Green Accepted			2022-12-26	WOS:000381013100003
J	Fenyk, S; Dixon, CH; Gittens, WH; Townsend, PD; Sharples, GJ; Palsson, LO; Takken, FLW; Cann, MJ				Fenyk, Stepan; Dixon, Christopher H.; Gittens, William H.; Townsend, Philip D.; Sharples, Gary J.; Palsson, Lars-Olof; Takken, Frank L. W.; Cann, Martin J.			The Tomato Nucleotide-binding Leucine-rich Repeat Immune Receptor I-2 Couples DNA-binding to Nucleotide-binding Domain Nucleotide Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; REPLICATION ORIGIN RECOGNITION; PROTEIN-STRUCTURE PREDICTION; NB-ARC DOMAIN; RESISTANCE PROTEIN; NUCLEAR ACCUMULATION; DISEASE-RESISTANCE; DEFENSE REGULATORS; ATPASE ACTIVITY; GENE-PRODUCTS	Plant nucleotide-binding leucine-rich repeat (NLR) proteins enable plants to recognize and respond to pathogen attack. Previously, we demonstrated that the Rx1 NLR of potato is able to bind and bend DNA in vitro. DNA binding in situ requires its genuine activation following pathogen perception. However, it is unknown whether other NLR proteins are also able to bind DNA. Nor is it known how DNA binding relates to the ATPase activity intrinsic to NLR switch function required to immune activation. Here we investigate these issues using a recombinant protein corresponding to the N-terminal coiled-coil and nucleotide- binding domain regions of the I-2 NLR of tomato. Wild type I-2 protein bound nucleic acids with a preference of ssDNA approximate to dsDNA > ssRNA, which is distinct from Rx1. I-2 induced bending and melting of DNA. Notably, ATP enhanced DNA binding relative to ADP in the wild type protein, the null P-loop mutant K207R, and the autoactive mutant S233F. DNA binding was found to activate the intrinsic ATPase activity of I-2. Because DNA binding by I-2 was decreased in the presence of ADP when compared with ATP, a cyclic mechanism emerges; activated ATP-associated I-2 binds to DNA, which enhances ATP hydrolysis, releasing ADP-bound I-2 from the DNA. Thus DNA binding is a general property of at least a subset of NLR proteins, and NLR activation is directly linked to its activity at DNA.	[Fenyk, Stepan; Dixon, Christopher H.; Gittens, William H.; Townsend, Philip D.; Sharples, Gary J.; Cann, Martin J.] Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England; [Fenyk, Stepan; Dixon, Christopher H.; Gittens, William H.; Townsend, Philip D.; Sharples, Gary J.; Cann, Martin J.] Univ Durham, Biophys Sci Inst, Durham DH1 3LE, England; [Palsson, Lars-Olof] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Takken, Frank L. W.] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Plant Pathol, NL-1098 XH Amsterdam, Netherlands	Durham University; Durham University; Durham University; University of Amsterdam	Cann, MJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	m.j.cann@durham.ac.uk	Pålsson, Lars-Olof A/F-3877-2012; Townsend, Phiip/J-3761-2018; Sharples, Gary/B-8638-2016; Takken, Frank/C-8051-2012	Pålsson, Lars-Olof A/0000-0003-3592-8506; Townsend, Phiip/0000-0001-9235-3492; Sharples, Gary/0000-0003-2495-0062; Gittens, William/0000-0002-3830-1218; Takken, Frank/0000-0003-2655-3108	Biotechnology and Biological Sciences Research Council [BB/M007405/1]; European Union; BBSRC [BB/M007405/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1220464] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/M007405/1 (to M.J.C., G.J.S., and L.-O.P.) and European Union-funded Integrated Project BIOEXPLOIT (to F.L.W.T.). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht M, 2006, BIOCHEM BIOPH RES CO, V339, P459, DOI 10.1016/j.bbrc.2005.10.074; Bai SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002752; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Edelman LM, 2003, BIOPHYS J, V84, P1131, DOI 10.1016/S0006-3495(03)74929-7; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Fenyk S, 2015, J BIOL CHEM, V290, P24945, DOI 10.1074/jbc.M115.672121; Fenyk S, 2012, J BIOL CHEM, V287, P4023, DOI 10.1074/jbc.M111.314450; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; FUJIMOTO M, 1974, AGR BIOL CHEM TOKYO, V38, P777, DOI 10.1080/00021369.1974.10861230; Gabriels SHEJ, 2007, PLANT J, V50, P14, DOI 10.1111/j.1365-313X.2007.03027.x; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Gaudreault M, 2009, METHODS MOL BIOL, V543, P15, DOI 10.1007/978-1-60327-015-1_2; GOHLKE C, 1994, P NATL ACAD SCI USA, V91, P11660, DOI 10.1073/pnas.91.24.11660; Grainge I, 2006, J MOL BIOL, V363, P355, DOI 10.1016/j.jmb.2006.07.076; Green V, 2013, MOL MICROBIOL, V89, P1240, DOI 10.1111/mmi.12343; Griebel T, 2014, TRENDS IMMUNOL, V35, P562, DOI 10.1016/j.it.2014.09.005; GRINVALD A, 1974, ANAL BIOCHEM, V59, P583, DOI 10.1016/0003-2697(74)90312-1; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Lee DG, 2000, EMBO J, V19, P4774, DOI 10.1093/emboj/19.17.4774; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Ma Lisong, 2013, Front Plant Sci, V4, P94, DOI 10.3389/fpls.2013.00094; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Maqbool A, 2015, ELIFE, V4, DOI 10.7554/eLife.08709; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nishimura MT, 2015, CELL, V161, P957, DOI 10.1016/j.cell.2015.05.017; PARKHURST KM, 1995, BIOCHEMISTRY-US, V34, P285, DOI 10.1021/bi00001a035; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Vamosi G, 1996, BIOPHYS J, V71, P972, DOI 10.1016/S0006-3495(96)79300-1; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wiermer M, 2010, NUCLEUS-PHILA, V1, P332, DOI 10.4161/nucl.1.4.12109; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Yokoyama H, 2003, J BIOL CHEM, V278, P2767, DOI 10.1074/jbc.M210899200; Zhu ZH, 2010, P NATL ACAD SCI USA, V107, P13960, DOI 10.1073/pnas.1002828107	66	16	16	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1137	1147		10.1074/jbc.M115.698589	http://dx.doi.org/10.1074/jbc.M115.698589			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26601946	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000368068300010
J	Le, SN; Porebski, BT; McCoey, J; Fodor, J; Riley, B; Godlewska, M; Gora, M; Czarnocka, B; Banga, JP; Hoke, DE; Kass, I; Buckle, AM				Le, Sarah N.; Porebski, Benjamin T.; McCoey, Julia; Fodor, James; Riley, Blake; Godlewska, Marlena; Gora, Monika; Czarnocka, Barbara; Banga, J. Paul; Hoke, David E.; Kass, Itamar; Buckle, Ashley M.			Modelling of Thyroid Peroxidase Reveals Insights into Its Enzyme Function and Autoantigenicity	PLOS ONE			English	Article							AUTOANTIBODY IMMUNODOMINANT REGION; HASHIMOTOS-THYROIDITIS; MOLECULAR-DYNAMICS; AUTOIMMUNE-DISEASE; CRYSTAL-STRUCTURE; THYROGLOBULIN MOLECULES; COMPLEMENT ACTIVATION; HUMAN THYROPEROXIDASE; HUMAN MYELOPEROXIDASE; 3-DIMENSIONAL MODEL	Thyroid peroxidase (TPO) catalyses the biosynthesis of thyroid hormones and is a major autoantigen in Hashimoto's disease-the most common organ-specific autoimmune disease. Epitope mapping studies have shown that the autoimmune response to TPO is directed mainly at two surface regions on the molecule: immunodominant regions A and B (IDR-A, and IDR-B). TPO has been a major target for structural studies for over 20 years; however, to date, the structure of TPO remains to be determined. We have used a molecular modelling approach to investigate plausible modes of TPO structure and dimer organisation. Sequence features of the C-terminus are consistent with a coiled-coil dimerization motif that most likely anchors the TPO dimer in the apical membrane of thyroid follicular cells. Two contrasting models of TPO were produced, differing in the orientation and exposure of their active sites relative to the membrane. Both models are equally plausible based upon the known enzymatic function of TPO. The "trans" model places IDR-B on the membrane-facing side of the myeloperoxidase (MPO)-like domain, potentially hindering access of autoantibodies, necessitating considerable conformational change, and perhaps even dissociation of the dimer into monomers. IDR-A spans MPO- and CCP-like domains and is relatively fragmented compared to IDR-B, therefore most likely requiring domain rearrangements in order to coalesce into one compact epitope. Less epitope fragmentation and higher solvent accessibility of the "cis" model favours it slightly over the "trans" model. Here, IDR-B clusters towards the surface of the MPO-like domain facing the thyroid follicular lumen preventing steric hindrance of autoantibodies. However, conformational rearrangements may still be necessary to allow full engagement with autoantibodies, with IDR-B on both models being close to the dimer interface. Taken together, the modelling highlights the need to consider the oligomeric state of TPO, its conformational properties, and its proximity to the membrane, when interpreting epitope-mapping data.	[Le, Sarah N.; Porebski, Benjamin T.; McCoey, Julia; Fodor, James; Riley, Blake; Hoke, David E.; Kass, Itamar; Buckle, Ashley M.] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia; [Le, Sarah N.; Porebski, Benjamin T.; McCoey, Julia; Fodor, James; Riley, Blake; Hoke, David E.; Kass, Itamar; Buckle, Ashley M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Godlewska, Marlena; Czarnocka, Barbara] Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Gora, Monika] Polish Acad Sci, Inst Biochem & Biophys, Dept Genet, Warsaw, Poland; [Banga, J. Paul] Kings Coll London, Sch Med, Div Diabet & Nutr Sci, London WC2R 2LS, England	Monash University; Monash University; Centre of Postgraduate Medical Education - Poland; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of London; King's College London	Kass, I (corresponding author), Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia.	itamar.kass@gmail.com; ashley.buckle@monash.edu	Buckle, Ashley/P-8366-2016; Kass, Itamar/P-5724-2014; Riley, Blake T./ABD-8129-2020; Gora, Monika/AAB-9577-2020; Czarnocka, Barbara/V-1048-2019; Godlewska, Marlena/J-9540-2019	Buckle, Ashley/0000-0003-2943-9044; Kass, Itamar/0000-0002-5368-937X; Riley, Blake T./0000-0003-2176-0503; Gora, Monika/0000-0002-8554-663X; Czarnocka, Barbara/0000-0001-7701-760X; Godlewska, Marlena/0000-0003-2337-6724; McCoey, Julia/0000-0002-2768-3409	National Health and Medical Research Council [1043418]; Victorian Life Sciences Computation Initiative (VLSCI), an initiative of the Victorian Government, Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative (VLSCI), an initiative of the Victorian Government, Australia	AMB is a National Health and Medical Research Senior Research Fellow (1022688). This work was supported by the National Health and Medical Research Council (Project Grant 1043418), and the Victorian Life Sciences Computation Initiative (VLSCI), an initiative of the Victorian Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PYMOL MOL GRAPHICS S; BAKER JR, 1994, THYROID, V4, P173, DOI 10.1089/thy.1994.4.173; Banga JP, 1998, CURR OPINION ENDOCRI, V5, P275; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; BERG G, 1980, MOL CELL ENDOCRINOL, V20, P87, DOI 10.1016/0303-7207(80)90096-9; BERG G, 1975, J ULTRA MOL STRUCT R, V53, P113, DOI 10.1016/S0022-5320(75)80090-6; BERG G, 1975, BIOCHIM BIOPHYS ACTA, V386, P422, DOI 10.1016/0005-2795(75)90285-8; Blanchin S, 2003, ENDOCRINOLOGY, V144, P5422, DOI 10.1210/en.2003-0918; BOGNER U, 1990, ACTA ENDOCRINOL-COP, V123, P431, DOI 10.1530/acta.0.1230431; Bresson D, 2003, J BIOL CHEM, V278, P9560, DOI 10.1074/jbc.M211930200; Case DA, 2014, AMBER 14 REFERENCE M, DOI DOI 10.1038/srep42717; Chacko S, 1996, J BIOL CHEM, V271, P12191, DOI 10.1074/jbc.271.21.12191; CHAZENBALK GD, 1993, J CLIN INVEST, V92, P62, DOI 10.1172/JCI116600; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YJ, 2003, MAMM GENOME, V14, P859, DOI 10.1007/s00335-003-2296-6; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; CHIOVATO L, 1993, J CLIN ENDOCR METAB, V77, P1700, DOI 10.1210/jc.77.6.1700; Czarnocka B, 1997, J CLIN ENDOCR METAB, V82, P2639, DOI 10.1210/jc.82.8.2639; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Estienne V, 2002, FASEB J, V16, P1087, DOI 10.1096/fj.01-0998hyp; Estienne V, 1999, J BIOL CHEM, V274, P35313, DOI 10.1074/jbc.274.50.35313; FENNA R, 1995, ARCH BIOCHEM BIOPHYS, V316, P653, DOI 10.1006/abbi.1995.1086; Ferrand M, 2003, J BIOL CHEM, V278, P3793, DOI 10.1074/jbc.M209513200; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Gardas A, 1997, BIOCHEM BIOPH RES CO, V234, P366, DOI 10.1006/bbrc.1997.6600; Godlewska M, 2014, THYROID, V24, P371, DOI 10.1089/thy.2013.0127; Gora M, 2004, BIOCHEM BIOPH RES CO, V320, P795, DOI 10.1016/j.bbrc.2004.06.028; Guo J, 2002, J BIOL CHEM, V277, P40189, DOI 10.1074/jbc.M205524200; HAMADA N, 1985, J CLIN ENDOCR METAB, V61, P120, DOI 10.1210/jcem-61-1-120; Hendry E, 1999, J ENDOCRINOL, V160, pR13, DOI 10.1677/joe.0.160R013; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hobby P, 2000, ENDOCRINOLOGY, V141, P2018, DOI 10.1210/en.141.6.2018; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Jones FG, 1999, AUTOIMMUNITY, V30, P157, DOI 10.3109/08916939908993850; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KAJITA Y, 1985, FEBS LETT, V187, P334, DOI 10.1016/0014-5793(85)81271-0; Kass I, 2005, STRUCTURE, V13, P1789, DOI 10.1016/j.str.2005.08.022; KAUFMAN KD, 1989, J CLIN INVEST, V84, P394, DOI 10.1172/JCI114179; Kessler J, 2008, THYROID, V18, P769, DOI 10.1089/thy.2007.0310; KIMURA S, 1987, P NATL ACAD SCI USA, V84, P5555, DOI 10.1073/pnas.84.16.5555; KIMURA S, 1988, PROTEINS, V3, P113, DOI 10.1002/prot.340030206; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; KRINSKY MM, 1971, J BIOL CHEM, V246, P4755; Le Fourn V, 2005, J BIOL CHEM, V280, P4568, DOI 10.1074/jbc.M408042200; Lee J, 2009, J BIOL CHEM, V284, P12752, DOI 10.1074/jbc.M806898200; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; LIBERT F, 1987, EMBO J, V6, P4193, DOI 10.1002/j.1460-2075.1987.tb02766.x; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; McDonald DO, 2009, J MOL MED, V87, P971, DOI 10.1007/s00109-009-0511-y; Nishikawa T, 1996, ENDOCRINOLOGY, V137, P1000, DOI 10.1210/en.137.3.1000; NISHIKAWA T, 1994, J CLIN ENDOCR METAB, V79, P1648, DOI 10.1210/jc.79.6.1648; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PORTOLANO S, 1992, J CLIN INVEST, V90, P720, DOI 10.1172/JCI115943; Quaratino S, 2004, NAT MED, V10, P920, DOI 10.1038/nm1092; Rapoport B, 2001, J CLIN INVEST, V108, P1253, DOI 10.1172/JCI14321; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; RUF J, 1989, ENDOCRINOLOGY, V125, P1211, DOI 10.1210/endo-125-3-1211; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; TAKAGI Y, 1991, FEBS LETT, V282, P17, DOI 10.1016/0014-5793(91)80435-6; Taurog A, 1996, ARCH BIOCHEM BIOPHYS, V330, P24, DOI 10.1006/abbi.1996.0222; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Wiles AP, 1997, J MOL BIOL, V272, P253, DOI 10.1006/jmbi.1997.1241; Xiong ZG, 2001, THYROID, V11, P227, DOI 10.1089/105072501750159598; YOKOYAMA N, 1988, MOL ENDOCRINOL, V2, P838, DOI 10.1210/mend-2-9-838	71	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0142615	10.1371/journal.pone.0142615	http://dx.doi.org/10.1371/journal.pone.0142615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26623656	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600009
J	Iavicoli, I; Fontana, L; Corbi, M; Leso, V; Marinaccio, A; Leopold, K; Schindl, R; Sgambato, A				Iavicoli, Ivo; Fontana, Luca; Corbi, Maddalena; Leso, Veruscka; Marinaccio, Alessandro; Leopold, Kerstin; Schindl, Roland; Sgambato, Alessandro			Exposure to Palladium Nanoparticles Affects Serum Levels of Cytokines in Female Wistar Rats	PLOS ONE			English	Article							PLATINUM-GROUP ELEMENTS; BLOOD MONONUCLEAR-CELLS; AIRBORNE PLATINUM; RHODIUM CONCENTRATIONS; ORAL-EXPOSURE; TRAM DRIVERS; RELEASE; NANOMATERIALS; EMISSIONS; CITY	Background Information currently available on the impact of palladium on the immune system mainly derives from studies assessing the biological effects of palladium salts. However, in the last years, there has been a notable increase in occupational and environmental levels of fine and ultrafine palladium particles released from automobile catalytic converters, which may play a role in palladium sensitization. In this context, the evaluation of the possible effects exerted by palladium nanoparticles (Pd-NPs) on the immune system is essential to comprehensively assess palladium immunotoxic potential. Aim Therefore, the aim of this study was to investigate the effects of Pd-NPs on the immune system of female Wistar rats exposed to this xenobiotic for 14 days, by assessing possible quantitative changes in a number of cytokines: IL-1 alpha, IL-2, IL-4, IL-6, IL-10, IL-12, GM-CSF, INF-gamma and TNF-alpha. Methods Twenty rats were randomly divided into four exposure groups and one of control. Animals were given a single tail vein injection of vehicle (control group) and different concentrations of Pd-NPs (0.012, 0.12, 1.2 and 12 mu g/kg). A multiplex biometric enzyme linked immunosorbent assay was used to evaluate cytokine serum levels. Results The mean serum concentrations of all cytokines decreased after the administration of 0.012 mu g/kg of Pd-NPs, whereas exceeded the control levels at higher exposure doses.The highest concentration of Pd-NPs (12 mu g/kg) induced a significant increase of IL-1 alpha, IL-4, IL-6, IL-10, IL-12, GM-CSF and INF-gamma compared to controls. Discussion and Conclusions These results demonstrated that Pd-NP exposure can affect the immune response of rats inducing a stimulatory action that becomes significant at the highest administered dose. Our findings did not show an imbalance between cytokines produced by CD4(+) T helper (Th) cells 1 and 2, thus suggesting a generalized stimulation of the immune system with a simultaneous activation and polarization of the naive T cells towards Th1 and Th2 phenotype.	[Iavicoli, Ivo; Fontana, Luca; Leso, Veruscka] Univ Cattolica Sacro Cuore, Sect Occupat Med, Inst Publ Hlth, I-00168 Rome, Italy; [Corbi, Maddalena; Sgambato, Alessandro] Univ Cattolica Sacro Cuore, Inst Gen Pathol, I-00168 Rome, Italy; [Marinaccio, Alessandro] Italian Workers Compensat Author INAIL, Div Res, Dept Occupat Med, Epidemiol Unit, I-00198 Rome, Italy; [Leopold, Kerstin; Schindl, Roland] Univ Ulm, Inst Analyt & Bioanalyt Chem, D-89081 Ulm, Germany	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Ulm University	Iavicoli, I (corresponding author), Univ Cattolica Sacro Cuore, Sect Occupat Med, Inst Publ Hlth, Largo Francesco Vito 1, I-00168 Rome, Italy.	iavicoli.ivo@rm.unicatt.it	Leopold, Kerstin/GON-5246-2022; Leso, Veruscka/J-8946-2018; Iavicoli, Ivo/K-9062-2016; Leopold, Kerstin/AAU-1996-2021; Sgambato, Alessandro/K-7266-2016	Leopold, Kerstin/0000-0003-0586-7239; Leso, Veruscka/0000-0002-3039-2856; Iavicoli, Ivo/0000-0003-0444-3792; Sgambato, Alessandro/0000-0002-9487-4563; fontana, Luca/0000-0002-4621-7374				Acker H, 2005, PHILOS T R SOC B, V360, P2201, DOI 10.1098/rstb.2005.1760; Artelt S, 1999, ATMOS ENVIRON, V33, P3559, DOI 10.1016/S1352-2310(99)00109-0; Bencs L, 2003, SPECTROCHIM ACTA B, V58, P1723, DOI 10.1016/S0584-8547(03)00162-9; Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; Borm PJA, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-11; Boscolo P, 2004, ANN CLIN LAB SCI, V34, P299; Boscolo P, 2010, J BIOL REG HOMEOS AG, V24, P207; Brasch J, 1997, CONTACT DERMATITIS, V37, P286, DOI 10.1111/j.1600-0536.1997.tb02466.x; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P249, DOI 10.1177/0960327109363973; Calabrese EJ, 2009, ARCH TOXICOL, V83, P227, DOI 10.1007/s00204-009-0411-5; Chang C, 2010, J AUTOIMMUN, V34, pJ234, DOI 10.1016/j.jaut.2009.11.009; Chen BA, 2010, INT J NANOMED, V5, P593; Choi B, 2005, JSME INT J B-FLUID T, V48, P874, DOI 10.1299/jsmeb.48.874; CLAUSE BT, 1993, J HIST BIOL, V26, P329, DOI 10.1007/BF01061973; Cosmi L, 2014, CYTOM PART A, V85A, P36, DOI 10.1002/cyto.a.22348; Cristaudo A, 2007, ANAL LETT, V40, P3343, DOI 10.1080/00032710701689099; Descotes J, 2003, AN INTRODUCTION TO I; Dongarra G, 2003, APPL GEOCHEM, V18, P109, DOI 10.1016/S0883-2927(02)00051-3; Dubiella-Jackowska A, 2009, REV ENVIRON CONTAM T, V199, P111, DOI 10.1007/978-0-387-09808-1_3; Durosaro O, 2009, DERMATITIS, V20, P208, DOI 10.2310/6620.2009.08108; Faurschou A, 2011, CONTACT DERMATITIS, V64, P185, DOI 10.1111/j.1600-0536.2011.01878.x; Fontana L, 2015, NANOTOXICOLOGY, V9, P843, DOI 10.3109/17435390.2014.980759; Franco R, 2009, MUTAT RES-GEN TOX EN, V674, P3, DOI 10.1016/j.mrgentox.2008.11.012; Gaillet S, 2015, FOOD CHEM TOXICOL, V77, P58, DOI 10.1016/j.fct.2014.12.019; Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040; Iavicoli I, 2006, Int J Immunopathol Pharmacol, V19, P21; Iavicoli I, 2008, HUM EXP TOXICOL, V27, P493, DOI 10.1177/0960327108090489; Iavicoli I, 2009, J TOXICOL ENV HEAL A, V72, P88, DOI 10.1080/15287390802477387; Iavicoli I, 2008, J OCCUP ENVIRON MED, V50, P1158, DOI 10.1097/JOM.0b013e31818226a1; Iavicoli I, 2007, INT ARCH OCC ENV HEA, V81, P109, DOI 10.1007/s00420-007-0195-y; Iavicoli I, 2014, SCI TOTAL ENVIRON, V487, P361, DOI 10.1016/j.scitotenv.2014.04.023; Iavicoli I, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2302-9; Iavicoli I, 2013, INT J MOL SCI, V14, P16732, DOI 10.3390/ijms140816732; Iavicoli I, 2010, TOXICOL IND HEALTH, V26, P183, DOI 10.1177/0748233710362383; Kacew S, 1999, CELOEM, V5, P201; Kalavrouziotis IK, 2009, WATER AIR SOIL POLL, V196, P393, DOI 10.1007/s11270-008-9786-9; Kamala CT, 2015, ARCH ENVIRON CON TOX, V68, P421, DOI 10.1007/s00244-014-0114-7; Larese Filon Francesca, 2003, Am J Contact Dermat, V14, P78; Mathur R, 2011, ENVIRON EARTH SCI, V62, P1085, DOI 10.1007/s12665-010-0597-0; Medina-Reyes EI, 2015, ENVIRON RES, V136, P424, DOI 10.1016/j.envres.2014.10.016; Merget R, 2001, SCI TOTAL ENVIRON, V270, P165, DOI 10.1016/S0048-9697(00)00788-9; Mitzukami F, 1991, CATALYSIS AUTOMOTIVE, P557; Morawska L, 2008, ATMOS ENVIRON, V42, P8113, DOI 10.1016/j.atmosenv.2008.07.050; Muris J, 2015, CONTACT DERMATITIS, V72, P11, DOI 10.1111/cod.12295; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Palacios M, 2000, SCI TOTAL ENVIRON, V257, P1, DOI 10.1016/S0048-9697(00)00464-2; Park EJ, 2010, TOXICOLOGY, V275, P65, DOI 10.1016/j.tox.2010.06.002; Raphael I, 2015, CYTOKINE, V74, P5, DOI 10.1016/j.cyto.2014.09.011; Rauch S, 2002, SCI TOTAL ENVIRON, V286, P243, DOI 10.1016/S0048-9697(01)00988-3; Ravindra K, 2004, SCI TOTAL ENVIRON, V318, P1, DOI 10.1016/S0048-9697(03)00372-3; Reale M, 2011, J OCCUP ENVIRON MED, V53, P1054, DOI 10.1097/JOM.0b013e318228115e; RICHTERREICHHELM HB, 1995, REGUL TOXICOL PHARM, V22, P54, DOI 10.1006/rtph.1995.1068; Schmalz G, 2000, EUR J ORAL SCI, V108, P442, DOI 10.1034/j.1600-0722.2000.108005442.x; Schmalz G, 1998, BIOMATERIALS, V19, P1689, DOI 10.1016/S0142-9612(98)00075-1; Schmitt N, 2015, CURR OPIN IMMUNOL, V34, P130, DOI 10.1016/j.coi.2015.03.007; Shi JP, 1999, SCI TOTAL ENVIRON, V235, P51, DOI 10.1016/S0048-9697(99)00189-8; Sobrova P, 2012, CENT EUR J CHEM, V10, P1369, DOI 10.2478/s11532-012-0073-7; Tsuji JS, 2006, TOXICOL SCI, V89, P42, DOI 10.1093/toxsci/kfi339; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; *WHO, 2002, ENV HLTH; Wilkinson KE, 2011, ACS NANO, V5, P5312, DOI 10.1021/nn1032664; Wohrl S, 2003, PEDIATR DERMATOL, V20, P119, DOI 10.1046/j.1525-1470.2003.20204.x; Zereini F, 2007, ENVIRON SCI TECHNOL, V41, P451, DOI 10.1021/es061453s	63	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143801	10.1371/journal.pone.0143801	http://dx.doi.org/10.1371/journal.pone.0143801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618704	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800073
J	Padhukasahasram, B; Reddy, CK; Levin, AM; Burchard, EG; Williams, LK				Padhukasahasram, Badri; Reddy, Chandan K.; Levin, Albert M.; Burchard, Esteban G.; Williams, L. Keoki			Powerful Tests for Multi-Marker Association Analysis Using Ensemble Learning	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ASTHMA; RARE	Multi-marker approaches have received a lot of attention recently in genome wide association studies and can enhance power to detect new associations under certain conditions. Gene-, gene-set- and pathway-based association tests are increasingly being viewed as useful supplements to the more widely used single marker association analysis which have successfully uncovered numerous disease variants. A major drawback of single-marker based methods is that they do not look at the joint effects of multiple genetic variants which individually may have weak or moderate signals. Here, we describe novel tests for multi-marker association analyses that are based on phenotype predictions obtained from machine learning algorithms. Instead of assuming a linear or logistic regression model, we propose the use of ensembles of diverse machine learning algorithms for prediction. We show that phenotype predictions obtained from ensemble learning algorithms provide a new framework for multi-marker association analysis. They can be used for constructing tests for the joint association of multiple variants, adjusting for covariates and testing for the presence of interactions. To demonstrate the power and utility of this new approach, we first apply our method to simulated SNP datasets. We show that the proposed method has the correct Type-1 error rates and can be considerably more powerful than alternative approaches in some situations. Then, we apply our method to previously studied asthma-related genes in 2 independent asthma cohorts to conduct association tests.	[Padhukasahasram, Badri; Williams, L. Keoki] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI 48202 USA; [Reddy, Chandan K.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Levin, Albert M.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Williams, L. Keoki] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University; Henry Ford Health System; Henry Ford Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Henry Ford Health System; Henry Ford Hospital	Padhukasahasram, B (corresponding author), Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI 48202 USA.	bpadhuk1@hfhs.org		Reddy, Chandan/0000-0003-2839-3662	American Asthma Foundation; Fund for Henry Ford Hospital; National Science Foundation [IIS-1231742, IIS-1242304]; Flight Attendant Medical Research Institute; RWJF Amos Medical Faculty Development Award; Sandler Foundation; National Institutes of Health: National Cancer Institute [R21CA175974, R25CA113710]; National Heart Lung and Blood Institute [R01HL088133, R01HL078885, R01HL004464, R01HL104608, R01HL079055, R01HL117004, HLR01HL118267]; National Institute of Allergy and Infectious Diseases [U19AI077439, R01AI061774, R01AI079139]; National Institute of Diabetes and Digestive and Kidney diseases [R01DK064695]; National Institute of Environmental Health Sciences [R01ES015794]; National Institute of General Medical Sciences [T32GM007546]; National Institute on Minority Health and Health Disparities [P60MD006902]; NATIONAL CANCER INSTITUTE [R25CA113710, R21CA175974] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078885, R01HL118267, R01HL079055, R01HL104608, K23HL004464, R01HL117004, R01HL088133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079139, R01AI061774, U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007546] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1231742] Funding Source: National Science Foundation	American Asthma Foundation; Fund for Henry Ford Hospital; National Science Foundation(National Science Foundation (NSF)); Flight Attendant Medical Research Institute; RWJF Amos Medical Faculty Development Award; Sandler Foundation; National Institutes of Health: National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by grants from the American Asthma Foundation (LKW), the Fund for Henry Ford Hospital (LKW), the National Science Foundation (IIS-1231742 and IIS-1242304 to CKR), the Flight Attendant Medical Research Institute (EGB), RWJF Amos Medical Faculty Development Award (EGB), the Sandler Foundation (EGB), and the following institutes of the National Institutes of Health: National Cancer Institute (R21CA175974 to CKR; R25CA113710 to EGB), National Heart Lung and Blood Institute (R01HL088133, R01HL078885, R01HL004464, R01HL104608 and R01HL117004 to EGB; R01HL079055 and HLR01HL118267 to LKW), National Institute of Allergy and Infectious Diseases (U19AI077439 to EGB; R01AI061774 and R01AI079139 to LKW), National Institute of Diabetes and Digestive and Kidney diseases (R01DK064695 to LKW), National Institute of Environmental Health Sciences (R01ES015794 to EGB), National Institute of General Medical Sciences (T32GM007546 to EGB), and the National Institute on Minority Health and Health Disparities (P60MD006902 to EGB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RM, 2007, COMMUNICATION; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, MACH LEARN, P24; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Drucker H, 1997, ADV NEUR IN, V9, P155; Fisher RA, STAT METHODS RES WOR; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moskvina V, 2012, EUR J HUM GENET, V20, P890, DOI 10.1038/ejhg.2012.8; Padhukasahasram B, 2014, PHARMACOGENOMICS J; Pang H, 2006, BIOINFORMATICS, V22, P2028, DOI 10.1093/bioinformatics/btl344; Sill J., 2009, ARXIV09110460; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Toscher A, 2009, COMMUNICATION; van der Sluis S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003235; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002	27	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143489	10.1371/journal.pone.0143489	http://dx.doi.org/10.1371/journal.pone.0143489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619286	gold, Green Published, Green Submitted			2022-12-26	WOS:000365889800041
J	Seo, JH; Kuzhikandathil, EV				Seo, Joon H.; Kuzhikandathil, Eldo V.			Dopamine D3 Receptor Mediates Preadolescent Stress-Induced Adult Psychiatric Disorders	PLOS ONE			English	Article							D-3 RECEPTOR; HOUSEHOLD DYSFUNCTION; CHILDHOOD ABUSE; MOUSE; RISK; RAT; INNERVATION; AMYGDALA; MICE; SENSITIVITY	Several studies have shown that repeated stressful experiences during childhood increases the likelihood of developing depression-and anxiety-related disorders in adulthood; however, the underlying mechanisms are not well understood. We subjected drd3-EGFP and drd3-null mice to daily, two hour restraint stress episodes over a five day period during preadolescence (postnatal day 35 to 39), followed by social isolation. When these mice reached adulthood (post-natal day > 90), we assessed locomotor behavior in a novel environment, and assessed depression-related behavior in the Porsolt Forced Swim test. We also measured the expression and function of dopamine D3 receptor in limbic brain areas such as hippocampus, nucleus accumbens and amygdala in control and stressed drd3-EGFP mice in adulthood. Adult male mice subjected to restraint stress during preadolescence exhibited both anxiety-and depression-related behaviors; however, adult female mice subjected to preadolescent restraint stress exhibited only depression-related behaviors. The development of preadolescent stress-derived psychiatric disorders was blocked by D3 receptor selective antagonist, SB 277011-A, and absent in D3 receptor null mice. Adult male mice that experienced stress during preadolescence exhibited a loss of D3 receptor expression and function in the amygdala but not in hippocampus or nucleus accumbens. In contrast, adult female mice that experienced preadolescent stress exhibited increased D3 receptor expression in the nucleus accumbens but not in amygdala or hippocampus. Our results suggest that the dopamine D3 receptor is centrally involved in the etiology of adult anxiety-and depression-related behaviors that arise from repeated stressful experiences during childhood.	[Seo, Joon H.; Kuzhikandathil, Eldo V.] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kuzhikandathil, EV (corresponding author), Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA.	kuzhikev@njms.rutgers.edu			F.M. Kirby Foundation	F.M. Kirby Foundation	The work was supported by a grant from the F.M. Kirby Foundation to EVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolanos CA, 2003, BIOL PSYCHIAT, V54, P1317, DOI 10.1016/S0006-3223(03)00570-5; Bruce J, 2013, PREV SCI, V14, P247, DOI 10.1007/s11121-012-0354-6; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Cote SR, 2014, NEUROPHARMACOLOGY, V79, P359, DOI 10.1016/j.neuropharm.2013.11.023; Diaz MR, 2011, NEUROPSYCHOPHARMACOL, V36, P1090, DOI 10.1038/npp.2010.246; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Hasue RH, 2002, J COMP NEUROL, V454, P15, DOI 10.1002/cne.10420; Hostinar CE, 2012, P NATL ACAD SCI USA, V109, P17208, DOI 10.1073/pnas.1121246109; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; Koshibu K, 2004, NEUROIMAGE, V22, P1636, DOI 10.1016/j.neuroimage.2004.03.051; Laviola G, 1999, NEUROSCI BIOBEHAV R, V23, P993, DOI 10.1016/S0149-7634(99)00032-9; Leggio GM, 2008, EUR NEUROPSYCHOPHARM, V18, P271, DOI 10.1016/j.euroneuro.2007.07.003; Leggio GM, 2013, EUR J PHARMACOL, V719, P25, DOI 10.1016/j.ejphar.2013.07.022; Lereya ST, 2015, LANCET PSYCHIAT, V2, P524, DOI 10.1016/S2215-0366(15)00165-0; Li Y, 2012, BRAIN STRUCT FUNCT, V217, P809, DOI 10.1007/s00429-012-0383-8; Middlebrooks JS., 2008, EFFECTS CHILDHOOD ST; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; O'Donnell P, 2010, NEUROTOX RES, V18, P306, DOI 10.1007/s12640-010-9157-3; Pinard CR, 2008, NEUROSCIENCE, V157, P850, DOI 10.1016/j.neuroscience.2008.09.043; Pollak SD, 2010, CHILD DEV, V81, P224, DOI 10.1111/j.1467-8624.2009.01391.x; Pritchard LM, 2003, NEUROPSYCHOPHARMACOL, V28, P100, DOI 10.1038/sj.npp.1300018; Rogers DC, 2000, PSYCHOPHARMACOLOGY, V151, P91, DOI 10.1007/s002130000485; Rogoz Z, 2004, POL J PHARMACOL, V56, P519; Rubinow MJ, 2009, NEUROBIOL AGING, V30, P137, DOI 10.1016/j.neurobiolaging.2007.05.006; Rubinow MJ, 2009, J COMP NEUROL, V512, P717, DOI 10.1002/cne.21924; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Southam E, 2007, BRAIN RES, V1149, P50, DOI 10.1016/j.brainres.2007.02.051; Steiner H, 1997, PHYSIOL BEHAV, V63, P137, DOI 10.1016/S0031-9384(97)00430-7; Suri D, 2015, NEUROPSYCHOPHARMACOL, V40, P88, DOI 10.1038/npp.2014.231; Xing B, 2013, BEHAV BRAIN RES, V243, P261, DOI 10.1016/j.bbr.2013.01.019; Xu M, 1997, NEURON, V19, P837, DOI 10.1016/S0896-6273(00)80965-4; Zarate CA, 2004, BIOL PSYCHIAT, V56, P54, DOI 10.1016/j.biopsych.2004.03.013	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143908	10.1371/journal.pone.0143908	http://dx.doi.org/10.1371/journal.pone.0143908			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619275	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800086
J	Tayabali, AF; Coleman, G; Nguyen, KC				Tayabali, Azam F.; Coleman, Gordon; Nguyen, Kathy C.			Virulence Attributes and Host Response Assays for Determining Pathogenic Potential of Pseudomonas Strains Used in Biotechnology	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; AERUGINOSA LUNG INFECTION; BLOOD-STREAM INFECTION; IMMUNE-RESPONSES; FLUORESCENS; DEFENSE; IDENTIFICATION; BIOSYNTHESIS; SECONDARY; OUTBREAK	Pseudomonas species are opportunistically pathogenic to humans, yet closely related species are used in biotechnology applications. In order to screen for the pathogenic potential of strains considered for biotechnology applications, several Pseudomonas strains (P. aeruginosa (Pa), P. fluorescens (Pf), P. putida (Pp), P. stutzeri (Ps)) were compared using functional virulence and toxicity assays. Most Pa strains and Ps grew at temperatures between 28 degrees C and 42 degrees C. However, Pf and Pp strains were the most antibiotic resistant, with ciprofloxacin and colistin being the most effective of those tested. No strain was haemolytic on sheep blood agar. Almost all Pa, but not other test strains, produced a pyocyanin-like chromophore, and caused cytotoxicity towards cultured human HT29 cells. Murine endotracheal exposures indicated that the laboratory reference strain, PAO1, was most persistent in the lungs. Only Pa strains induced pro-inflammatory and inflammatory responses, as measured by elevated cytokines and pulmonary Gr-1 -positive cells. Serum amyloid A was elevated at >= 48 h post-exposure by only some Pa strains. No relationship was observed between strains and levels of peripheral leukocytes. The species designation or isolation source may not accurately reflect pathogenic potential, since the clinical strain Pa10752 was relatively nonvirulent, but the industrial strain Pa31480 showed comparable virulence to PAO1. Functional assays involving microbial growth, cytotoxicity and murine immunological responses may be most useful for identifying problematic Pseudomonas strains being considered for biotechnology applications.	[Tayabali, Azam F.; Coleman, Gordon; Nguyen, Kathy C.] Hlth Canada, Ctr Environm Hlth, Hlth Environm & Consumer Safety Branch, Biotechnol Lab,Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada	Health Canada	Tayabali, AF (corresponding author), Hlth Canada, Ctr Environm Hlth, Hlth Environm & Consumer Safety Branch, Biotechnol Lab,Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.	azam.tayabali@hc-sc.gc.ca			Canadian Regulatory System for Biotechnology (CRSB)	Canadian Regulatory System for Biotechnology (CRSB)	Financial support for this research was provided by Canadian Regulatory System for Biotechnology (CRSB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Benito N, 2012, J HOSP INFECT, V82, P286, DOI 10.1016/j.jhin.2012.09.008; Carpenter RJ, 2008, J INFECTION, V56, P234, DOI 10.1016/j.jinf.2008.01.004; Cheung DOY, 2000, INFECT IMMUN, V68, P4585, DOI 10.1128/IAI.68.8.4585-4592.2000; D'Ovidio C, 2011, BRIT DENT J, V211, P205, DOI 10.1038/sj.bdj.2011.723; Deredjian A, 2011, RES MICROBIOL, V162, P689, DOI 10.1016/j.resmic.2011.06.007; Donnarumma G, 2010, INT J IMMUNOPATH PH, V23, P227, DOI 10.1177/039463201002300120; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Erol S, 2014, CLIN LAB, V60, P615, DOI 10.7754/Clin.Lab.2013.130325; Flores Ribeiro Angela, 2014, Sci Total Environ, V490, P370, DOI 10.1016/j.scitotenv.2014.05.012; Fothergill JL, 2007, WIDESPREAD PYOCYANIN, V7; Gharabaghi MA, 2012, COMMUNITY ACQUIRED P; Hatchette TF, 2000, CLIN INFECT DIS, V31, P1349, DOI 10.1086/317486; Jayaseelan S, 2014, WORLD J MICROB BIOT, V30, P1159, DOI 10.1007/s11274-013-1552-5; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Kaszab E, 2010, MICROB ECOL, V59, P37, DOI 10.1007/s00248-009-9551-7; Kunimasa K, 2012, INTERNAL MED, V51, P2473, DOI 10.2169/internalmedicine.51.7596; LaBauve AE, 2012, GROWTH LAB MAINTENAN; LATIFI A, 1995, MOL MICROBIOL, V17, P333, DOI 10.1111/j.1365-2958.1995.mmi_17020333.x; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Le Berre R, 2011, CRIT CARE MED, V39, P2113, DOI 10.1097/CCM.0b013e31821e899f; Lindholm DA, 2013, MIL MED, V178, P963; Liu YM, 2014, INT J INFECT DIS, V23, P105, DOI 10.1016/j.ijid.2014.02.013; Mayansky AN, 2012, MOL GENET MICROBIOL+, V27, P1, DOI 10.3103/S0891416812010053; MEYER JM, 1978, J GEN MICROBIOL, V107, P319, DOI 10.1099/00221287-107-2-319; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Okamoto M, 2012, INTERNAL MED, V51, P2809, DOI 10.2169/internalmedicine.51.7921; Park SY, 2013, J ULTRAS MED, V32, P2013, DOI 10.7863/ultra.32.11.2013; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; Schalk IJ, 2013, ENVIRON MICROBIOL, V15, P1661, DOI 10.1111/1462-2920.12013; Schmidt A, 2014, NEUTROPHIL ELASTASE; Scotta C, 2012, EUR J CLIN MICROBIOL, V31, P2133, DOI 10.1007/s10096-012-1547-4; Seligy VL, 1999, J IND MICROBIOL BIOT, V22, P565, DOI 10.1038/sj.jim.2900625; Sharma G, 2014, BIOLOGICALS, V42, P1, DOI 10.1016/j.biologicals.2013.11.001; Singhal Sameer, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P83, DOI 10.1016/S2221-1691(11)60075-0; Spiers AJ, 2000, MICROBIOL-SGM, V146, P2345, DOI 10.1099/00221287-146-10-2345; Tayabali AF, 1997, ECOTOX ENVIRON SAFE, V37, P152, DOI 10.1006/eesa.1997.1525; Tayabali AF, 2000, ENVIRON HEALTH PERSP, V108, P919, DOI 10.2307/3435049; Tayabali AF, 2012, COMP VIRULENCE POTEN, V7; Tayabali AF, 2011, TOXICOL ENVIRON CHEM, V93, P314, DOI 10.1080/02772248.2010.526784; Thomas BS, 2013, LETHAL CASE PSEUDOMO, V21, pe13; Uhlar CM, 1997, J IMMUNOL METHODS, V203, P123, DOI 10.1016/S0022-1759(96)00220-7; Wasi S, 2013, ENVIRON MONIT ASSESS, V185, P8147, DOI 10.1007/s10661-013-3163-x; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Wolbeling F, 2010, RESPIRATION, V80, P340, DOI 10.1159/000319442; Wong V, 2011, J CLIN MICROBIOL, V49, P2093, DOI 10.1128/JCM.02559-10; Wu H, 2004, J ANTIMICROB CHEMOTH, V53, P1054, DOI 10.1093/jac/dkh223; Xu XL, 2014, INT J CLIN EXP MED, V7, P809; Xu YY, 2013, J PURE APPL MICROBIO, V7, P2003; Yamada T, 1999, AMYLOID, V6, P199, DOI 10.3109/13506129909007327; Yoshino Y, 2011, J INFECT CHEMOTHER, V17, P278, DOI 10.1007/s10156-010-0114-0; Zuberbuhler B, 2012, INFECTION, V40, P579, DOI 10.1007/s15010-012-0248-3	52	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143604	10.1371/journal.pone.0143604	http://dx.doi.org/10.1371/journal.pone.0143604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619347	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800051
J	Chuang, SC; Wu, GJ; Lu, YS; Lin, CH; Hsiung, CA				Chuang, Shu-Chun; Wu, Guo-Jie; Lu, Yen-Shen; Lin, Ching-Hung; Hsiung, Chao Agnes			Associations between Medical Conditions and Breast Cancer Risk in Asians: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							YOUNG-WOMEN; ESTROGEN-RECEPTORS; METABOLIC SYNDROME; THYROID-CARCINOMA; HUMAN-DISEASE; METAANALYSIS; HISTORY; ENDOMETRIOSIS; MORTALITY; HORMONES	Background The breast cancer incidence in Asia is rising. To explore whether the etiology of breast cancer is different from the known risk factors from studies in Western countries, we conducted a nested case-control study using data from the Taiwan National Health Insurance Research Database (NHIRD). Methods All medical conditions based on the first three digits of the ICD-9 and a list of medical conditions based on literature review were retrieved for each case and control. The odds ratios (OR) and 95% confidence intervals (CI) of the associations between medical conditions and breast cancer risks were estimated using conditional logistic regression and adjusted for occupation, number of breast cancer screening, and the average number of outpatient visits prior the diagnosis. The associations were also estimated for younger (<50 years old) and older subjects separately. Results The analyses included 4,884 breast cancer cases and 19,536 age-matched controls. Prior breast diseases (OR, 95% CI: 2.47, 2.26-2.71), obesity (1.43, 1.04-1.96), endometriosis (1.44, 1.15-1.80), uterine leiomyoma (1.20, 1.03-1.40), hypertensive diseases (1.14, 1.05-1.25), and disorders in lipid metabolism (1.13, 1.04-1.24) were associated with increased breast cancer risk. No heterogeneity was observed between age groups (<50 and >= 50 years old). Conclusions In addition to benign breast diseases, obesity, endometriosis, uterine leiomyoma, hypertensive diseases, and disorders of lipid metabolism were associated with a subsequent breast cancer risk.	[Chuang, Shu-Chun; Wu, Guo-Jie; Hsiung, Chao Agnes] Inst Populat Hlth Sci, Natl Hlth Res Inst, Miaoli, Taiwan; [Lu, Yen-Shen; Lin, Ching-Hung] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Lu, Yen-Shen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chuang, SC (corresponding author), Inst Populat Hlth Sci, Natl Hlth Res Inst, Miaoli, Taiwan.	scchuang@nhri.org.tw; hsiung@nhri.org.tw		LIN, CHING-HUNG/0000-0003-2403-4056; Lu, Yen-Shen/0000-0001-7461-1291	National Health Research Institutes [PH-104-PP-15]	National Health Research Institutes(National Health Research Institutes, Japan)	The study is supported by the National Health Research Institutes (PH-104-PP-15). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study is supported by the National Health Research Institutes PH-104-PP-15. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GLOBAL STATUS REPORT; [Anonymous], 2012, NATL HLTH INTERVIEW; Axelrod D, 2008, J AM COLL SURGEONS, V206, P1193, DOI 10.1016/j.jamcollsurg.2007.12.026; Bhoo-Pathy N, 2013, EUR J CANCER, V49, P703, DOI 10.1016/j.ejca.2012.09.014; Bjorge T, 2010, CANCER EPIDEM BIOMAR, V19, P1737, DOI 10.1158/1055-9965.EPI-10-0230; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Burns KA, 2012, ARCH TOXICOL, V86, P1491, DOI 10.1007/s00204-012-0868-5; Chen AY, 2001, CANCER-AM CANCER SOC, V92, P225, DOI 10.1002/1097-0142(20010715)92:2<225::AID-CNCR1313>3.0.CO;2-B; Chen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067420; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chuang SC, 2006, CANCER LETT, V238, P42, DOI 10.1016/j.canlet.2005.06.015; Degnim AC, 2007, J CLIN ONCOL, V25, P2671, DOI 10.1200/JCO.2006.09.0217; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; FRANCESCHI S, 1990, EUR J CANCER, V26, P781, DOI 10.1016/0277-5379(90)90151-I; Gaikwad NW, 2009, BREAST CANCER-BASIC, V3, P1; Gong ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072619; Hardefeldt PJ, 2012, BREAST CANCER RES TR, V133, P1169, DOI 10.1007/s10549-012-2019-3; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill DA, 2002, CANCER CAUSE CONTROL, V13, P711, DOI 10.1023/A:1020201106117; Johansen C, 1996, GUT, V39, P439, DOI 10.1136/gut.39.3.439; Jung Sun Jae, 2013, J Prev Med Public Health, V46, P346, DOI 10.3961/jpmph.2013.46.6.346; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kok VC, 2015, INT J GYNECOL CANCER, V25, P968, DOI 10.1097/IGC.0000000000000454; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin CH, 2012, INT J CANCER, V130, P2629, DOI 10.1002/ijc.26249; Lin CH, 2009, CANCER EPIDEM BIOMAR, V18, P1807, DOI 10.1158/1055-9965.EPI-09-0096; LOWENFELS AB, 1982, GASTROENTEROLOGY, V83, P672; MOSESON M, 1993, INT J EPIDEMIOL, V22, P1000, DOI 10.1093/ije/22.6.1000; Munksgaard PS, 2011, GYNECOL ONCOL, V123, P157, DOI 10.1016/j.ygyno.2011.06.017; Schairer C, 1997, INT J CANCER, V70, P150, DOI 10.1002/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Simon MS, 2002, CANCER EPIDEM BIOMAR, V11, P1574; Talamini R, 1997, BRIT J CANCER, V75, P1699, DOI 10.1038/bjc.1997.289; Hieu TT, 2012, ENDOCR-RELAT CANCER, V19, P645, DOI 10.1530/ERC-12-0176; Tseng CH, 2013, CLIN ORAL INVEST, V17, P1357, DOI 10.1007/s00784-012-0820-3; Vassilopoulou-Sellin R, 1999, CANCER, V85, P696, DOI 10.1002/(SICI)1097-0142(19990201)85:3<696::AID-CNCR20>3.0.CO;2-4; Veli EM, 1999, COMMON ENV RISK FACT, P213; Weiss HA, 1999, INT J EPIDEMIOL, V28, P816, DOI 10.1093/ije/28.5.816; Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007; Zahid M, 2013, INT J CANCER, V133, P2642, DOI 10.1002/ijc.28275	44	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143410	10.1371/journal.pone.0143410	http://dx.doi.org/10.1371/journal.pone.0143410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605792	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300063
J	Ilmarinen, T; Hiidenmaa, H; Koobi, P; Nymark, S; Sorkio, A; Wang, JH; Stanzel, BV; Thieltges, F; Alajuuma, P; Oksala, O; Kataja, M; Uusitalo, H; Skottman, H				Ilmarinen, Tanja; Hiidenmaa, Hanna; Koobi, Peeter; Nymark, Soile; Sorkio, Anni; Wang, Jing-Huan; Stanzel, Boris V.; Thieltges, Fabian; Alajuuma, Palvi; Oksala, Olli; Kataja, Marko; Uusitalo, Hannu; Skottman, Heli			Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium	PLOS ONE			English	Article							MACULAR DEGENERATION; RAT MODEL; SURVIVAL; IMPLANTATION; SCAFFOLDS; THERAPIES; DELIVERY; BEHAVIOR; SHEETS; REPAIR	In this study, we investigated the suitability of ultrathin and porous polyimide (PI) membrane as a carrier for subretinal transplantation of human embryonic stem cell (hESC) -derived retinal pigment epithelial (RPE) cells in rabbits. The in vivo effects of hESC-RPE cells were analyzed by subretinal suspension injection into Royal College of Surgeons (RCS) rats. Rat eyes were analyzed with electroretinography (ERG) and histology. After analyzing the surface and permeability properties of PI, subretinal PI membrane transplantations with and without hESC-RPE were performed in rabbits. The rabbits were followed for three months and eyes analyzed with fundus photography, ERG, optical coherence tomography (OCT), and histology. Animals were immunosuppressed with cyclosporine the entire follow-up time. In dystrophic RCS rats, ERG and outer nuclear layer (ONL) thickness showed some rescue after hESC-RPE injection. Cells positive for human antigen were found in clusters under the retina 41 days post-injection but not anymore after 105 days. In rabbits, OCT showed good placement of the PI. However, there was loss of pigmentation on the hESC-RPE-PI over time. In the eyes with PI alone, no obvious signs of inflammation or retinal atrophy were observed. In the presence of hESC-RPE, mononuclear cell infiltration and retinal atrophy were observed around the membranes. The porous ultrathin PI membrane was well-tolerated in the subretinal space and is a promising scaffold for RPE transplantation. However, the rejection of the transplanted cells seems to be a major problem and the given immunosuppression was insufficient for reduction of xenograft induced inflammation.	[Ilmarinen, Tanja; Hiidenmaa, Hanna; Sorkio, Anni; Skottman, Heli] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland; [Koobi, Peeter; Wang, Jing-Huan; Uusitalo, Hannu] Univ Tampere, Dept Ophthalmol, SILK, FIN-33101 Tampere, Finland; [Koobi, Peeter; Wang, Jing-Huan; Kataja, Marko; Uusitalo, Hannu] Tays Eye Ctr, Tampere, Finland; [Nymark, Soile] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Nymark, Soile] Tampere Univ Technol, BioMediTech, FIN-33101 Tampere, Finland; [Stanzel, Boris V.; Thieltges, Fabian] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Alajuuma, Palvi; Oksala, Olli] Santen Oy, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University; University of Bonn	Ilmarinen, T (corresponding author), Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland.	tanja.ilmarinen@uta.fi	Stanzel, Boris/ADP-9221-2022; Stanzel, Boris/AAG-7010-2022; Nymark, Soile/M-9453-2016	Stanzel, Boris/0000-0002-4316-1539; Stanzel, Boris/0000-0002-4316-1539; Nymark, Soile/0000-0002-9274-0123; Skottman, Heli/0000-0002-4127-8792; Moro, Anni/0000-0002-0301-4745; Ilmarinen, Tanja/0000-0002-4609-8897	Paivikki and Sakari Sohlberg Foundation; Finnish funding agency of innovation [866/31/2009, 549/31/2011]; Academy of Finland [218050, 133879, 260375]; Finnish Cultural Foundation [130858]; Tampere Graduate Program in Biomedicine and Biotechnology; BONFOR/Gerok Scholarship [O-137.0019]; Emil Aaltonen Foundation	Paivikki and Sakari Sohlberg Foundation; Finnish funding agency of innovation; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Tampere Graduate Program in Biomedicine and Biotechnology; BONFOR/Gerok Scholarship; Emil Aaltonen Foundation	Santen Oy provided support in the form of salaries for authors [PA OO]. The specific roles of these authors are articulated in the 'author contributions' section. In addition, Santen Oy paid the animal costs and part of reagent costs. Santen Oy did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Paivikki and Sakari Sohlberg Foundation, (www.pss-saatio.fi) (HS); The Finnish funding agency of innovation, (www.tekes.fi), grant numbers 866/31/2009 and 549/31/2011 (HS); the Academy of Finland, (www.aka.fi), grant numbers 218050 (HS), 133879 (TI), and 260375 (SN); the Finnish Cultural Foundation, (www.skr.fi), grant number 130858 (AS); Tampere Graduate Program in Biomedicine and Biotechnology, (www.uta.fi/bmt/doctoral_programme.html) (HH); BONFOR/Gerok Scholarship, (www.ukb.uni-bonn.de/quick2web/internet/internet.nsf/vwUNIDLookup/B72A5EAAF5CFF627C1257658002584DA), grant number O-137.0019 (BS and FT); the Emil Aaltonen Foundation, (www.emilaaltonen.fi), (SN). None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TISSUE ENG A; Besch D, 2008, BRIT J OPHTHALMOL, V92, P1361, DOI 10.1136/bjo.2007.131961; Bharti K, 2014, INVEST OPHTH VIS SCI, V55, P1191, DOI 10.1167/iovs.13-13481; Boochoon KS, 2014, J BIOMECH, V47, P3237, DOI 10.1016/j.jbiomech.2014.06.021; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Dang YL, 2015, CLIN INTERV AGING, V10, P255, DOI 10.2147/CIA.S73705; Del Priore LV, 1998, ARCH OPHTHALMOL-CHIC, V116, P335, DOI 10.1001/archopht.116.3.335; Del Priore LV, 2004, INVEST OPHTH VIS SCI, V45, P985, DOI 10.1167/iovs.03-0662; Diniz B, 2013, INVEST OPHTH VIS SCI, V54, P5087, DOI 10.1167/iovs.12-11239; Forest DL, 2015, DIS MODEL MECH, V8, P421, DOI 10.1242/dmm.017236; Gullapalli VK, 2005, EXP EYE RES, V80, P235, DOI 10.1016/j.exer.2004.09.006; Heller JP, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.4.4; Hu YT, 2012, OPHTHALMIC RES, V48, P186, DOI 10.1159/000338749; Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7; Inoue Y, 2007, EXP EYE RES, V85, P234, DOI 10.1016/j.exer.2007.04.007; Jian Q, 2015, EXP EYE RES, V132, P34, DOI 10.1016/j.exer.2015.01.008; Julien S, 2011, BIOMATERIALS, V32, P3890, DOI 10.1016/j.biomaterials.2011.02.016; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Kane FE, 2008, EXPERT OPIN DRUG DEL, V5, P1039, DOI [10.1517/17425247.5.9.1039, 10.1517/17425247.5.9.1039 ]; Kanemura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085336; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; LaVail M M, 2001, Prog Brain Res, V131, P617; Liu ZP, 2014, BIOMATERIALS, V35, P2837, DOI 10.1016/j.biomaterials.2013.12.069; Lu B, 2010, EXP EYE RES, V91, P449, DOI 10.1016/j.exer.2010.06.024; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Montezuma SR, 2006, INVEST OPHTH VIS SCI, V47, P3514, DOI 10.1167/iovs.06-0106; Ninomiya H, 2008, J VET MED SCI, V70, P887, DOI 10.1292/jvms.70.887; Nistor G, 2010, J NEUROSCI METH, V190, P63, DOI 10.1016/j.jneumeth.2010.04.025; Peng SM, 2011, INVEST OPHTH VIS SCI, V52, P1392, DOI 10.1167/iovs.10-5984; PFEFFER BA, 1986, INVEST OPHTH VIS SCI, V27, P1031; Rowland TJ, 2012, J CELL PHYSIOL, V227, P457, DOI 10.1002/jcp.22814; Sakamoto N, 2007, BLOOD, V110, P501, DOI 10.1182/blood-2007-01-066522; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Skottman H, 2010, IN VITRO CELL DEV-AN, V46, P206, DOI 10.1007/s11626-010-9286-2; Sohn EH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11791; Song WK, 2015, STEM CELL REP, V4, P860, DOI 10.1016/j.stemcr.2015.04.005; Sorkio AE, 2015, BIOMATERIALS, V51, P257, DOI 10.1016/j.biomaterials.2015.02.005; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Stanzel BV, 2014, STEM CELL REP, V2, P64, DOI 10.1016/j.stemcr.2013.11.005; Stanzel BV, 2012, INVEST OPHTH VIS SCI, V53, P490, DOI 10.1167/iovs.11-8260; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Subrizi A, 2012, BIOMATERIALS, V33, P8047, DOI 10.1016/j.biomaterials.2012.07.033; SUGAHARA K, 1984, J CELL BIOL, V99, P1541, DOI 10.1083/jcb.99.4.1541; Sugino IK, 2011, INVEST OPHTH VIS SCI, V52, P9598, DOI 10.1167/iovs.11-8400; Sugino IK, 2011, INVEST OPHTH VIS SCI, V52, P4979, DOI 10.1167/iovs.10-5386; Thumann G, 2009, BIOMATERIALS, V30, P287, DOI 10.1016/j.biomaterials.2008.09.039; Tzameret A, 2014, EXP EYE RES, V118, P135, DOI 10.1016/j.exer.2013.10.023; Vaajasaari H, 2011, MOL VIS, V17, P558; Xian BK, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0167-1; Zakrzewski JL, 2014, NAT BIOTECHNOL, V32, P786, DOI 10.1038/nbt.2960; Zhao TB, 2015, CELL STEM CELL, V17, P353, DOI 10.1016/j.stem.2015.07.021; Zhou Ru, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-3	54	39	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143669	10.1371/journal.pone.0143669	http://dx.doi.org/10.1371/journal.pone.0143669			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606532	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300099
J	Mishima, E; Jinno, D; Akiyama, Y; Itoh, K; Nankumo, S; Shima, H; Kikuchi, K; Takeuchi, Y; Elkordy, A; Suzuki, T; Niizuma, K; Ito, S; Tomioka, Y; Abe, T				Mishima, Eikan; Jinno, Daisuke; Akiyama, Yasutoshi; Itoh, Kunihiko; Nankumo, Shinnosuke; Shima, Hisato; Kikuchi, Koichi; Takeuchi, Yoichi; Elkordy, Alaa; Suzuki, Takehiro; Niizuma, Kuniyasu; Ito, Sadayoshi; Tomioka, Yoshihisa; Abe, Takaaki			Immuno-Northern Blotting: Detection of RNA Modifications by Using Antibodies against Modified Nucleosides	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; CANCER-PATIENTS; ACID; 1-METHYLADENOSINE; DEFICIENCY; DISEASE; CELLS	The biological roles of RNA modifications are still largely not understood. Thus, developing a method for detecting RNA modifications is important for further clarification. We developed a method for detecting RNA modifications called immuno-northern blotting (INB) analysis and herein introduce its various capabilities. This method involves the separation of RNAs using either polyacrylamide or agarose gel electrophoresis, followed by transfer onto a nylon membrane and subsequent immunoblotting using antibodies against modified nucleosides for the detection of specific modifications. We confirmed that INB with the antibodies for 1-methyladenosine (m1A), N6-methyladenosine (m6A), pseudouridine, and 5-methylcytidine (m(5)C) showed different modifications in a variety of RNAs from various species and organelles. INB with the anti-m(5)C antibody revealed that the antibody cross-reacted with another modification on DNA, suggesting the application of this method for characterization of the antibody for modified nucleosides. Additionally, using INB with the antibody for m1A, which is a highly specific modification in eukaryotic tRNA, we detected tRNA-derived fragments known as tiRNAs under the cellular stress response, suggesting the application for tracking target RNA containing specific modifications. INB with the anti-m(6)A antibody confirmed the demethylation of m(6)A by the specific demethylases fat mass and obesity-associated protein (FTO) and ALKBH5, suggesting its application for quantifying target modifications in separated RNAs. Furthermore, INB demonstrated that the knockdown of FTO and ALKBH5 increased the m(6)A modification in small RNAs as well as in mRNA. The INB method has high specificity, sensitivity, and quantitative capability, and it can be employed with conventional experimental apparatus. Therefore, this method would be useful for research on RNA modifications and metabolism.	[Mishima, Eikan; Akiyama, Yasutoshi; Shima, Hisato; Kikuchi, Koichi; Takeuchi, Yoichi; Suzuki, Takehiro; Ito, Sadayoshi; Abe, Takaaki] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan; [Mishima, Eikan; Akiyama, Yasutoshi] Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Jinno, Daisuke; Nankumo, Shinnosuke; Tomioka, Yoshihisa] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Oncol Pharm Practice & Sci, Sendai, Miyagi 980, Japan; [Itoh, Kunihiko] Univ Shizuoka, Sch Pharmaceut Sci, Dept Clin Pharmacol & Genet, Shizuoka 4228526, Japan; [Elkordy, Alaa; Niizuma, Kuniyasu] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan; [Abe, Takaaki] Tohoku Univ, Grad Sch Biomed Engn, Dept Med Sci, Sendai, Miyagi 980, Japan; [Abe, Takaaki] Tohoku Univ, Grad Sch Med, Dept Clin Biol & Hormonal Regulat, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; University of Shizuoka; Tohoku University; Tohoku University; Tohoku University	Abe, T (corresponding author), Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan.	takaabe@med.tohoku.ac.jp	Ito, Sadayoshi/A-3933-2015; Suzuki, Takehiro/AAE-2210-2019	Ito, Sadayoshi/0000-0002-5092-3626; Niizuma, Kuniyasu/0000-0001-9282-6499; Akiyama, Yasutoshi/0000-0002-0211-7793; Mishima, Eikan/0000-0002-3706-2745	JSPS KAKENHI [26860624, 23390033, 26305007]; Grants-in-Aid for Scientific Research [26860624] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by JSPS KAKENHI Grant Number 26860624 to EM, JSPS KAKENHI Grant Number 23390033 to TA, and JSPS KAKENHI Grant Number 26305007 to TA.	BRINGMANN P, 1987, FEBS LETT, V213, P309, DOI 10.1016/0014-5793(87)81512-0; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; ERLANGER BF, 1964, P NATL ACAD SCI USA, V52, P68, DOI 10.1073/pnas.52.1.68; Ge JH, 2013, TRENDS BIOCHEM SCI, V38, P210, DOI 10.1016/j.tibs.2013.01.002; ITOH K, 1988, JPN J CANCER RES, V79, P1130, DOI 10.1111/j.1349-7006.1988.tb01536.x; ITOH K, 1989, CLIN CHIM ACTA, V181, P305, DOI 10.1016/0009-8981(89)90236-2; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V126, P8, DOI 10.1016/0003-9861(68)90553-5; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kikusato M, 2015, BRIT POULTRY SCI, V56, P225, DOI 10.1080/00071668.2014.996529; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Klungland A, 2014, CURR OPIN GENET DEV, V26, P47, DOI 10.1016/j.gde.2014.05.006; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mishima E, 2015, J AM SOC NEPHROL, V26, P1787, DOI 10.1681/ASN.2014060530; Mishima E, 2014, J AM SOC NEPHROL, V25, P2316, DOI 10.1681/ASN.2013091001; Mizugaki M, 1996, BIOL PHARM BULL, V19, P1537; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; Ohtsuki T, 2007, IUBMB LIFE, V59, P68, DOI 10.1080/15216540701218722; Russell SP, 2013, J CHROMATOGR B, V923, P74, DOI 10.1016/j.jchromb.2013.02.010; Saigusa D, 2010, ANAL CHIM ACTA, V677, P169, DOI 10.1016/j.aca.2010.08.005; Saikia M, 2010, RNA, V16, P1317, DOI 10.1261/rna.2057810; Sakurai M, 2005, NUCLEIC ACIDS RES, V33, P1653, DOI 10.1093/nar/gki309; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	28	53	55	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143756	10.1371/journal.pone.0143756	http://dx.doi.org/10.1371/journal.pone.0143756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606401	Green Published, gold			2022-12-26	WOS:000365865300108
J	Yan, C; Zhang, BB; Hua, H; Li, B; Zhang, B; Yu, Q; Li, XY; Liu, Y; Pan, W; Liu, XY; Tang, RX; Zheng, KY				Yan, Chao; Zhang, Bei-Bei; Hua, Hui; Li, Bo; Zhang, Bo; Yu, Qian; Li, Xiang-Yang; Liu, Ying; Pan, Wei; Liu, Xiang-Ye; Tang, Ren-Xian; Zheng, Kui-Yang			The Dynamics of Treg/Th17 and the Imbalance of Treg/Th17 in Clonorchis sinensis-Infected Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; ROR-GAMMA-T; TGF-BETA; LIVER FIBROSIS; B-CELLS; GM-CSF; INDUCTION; EXPRESSION; CYTOKINE; PATHWAY	Clonorchiasis, caused by the liver fluke Clonorchis sinensis, is a chronic parasitic infection regulated by T cell subsets. An imbalance of CD4+CD25+Foxp3+ regulatory T (Treg) and interleukin (IL)-17-secreting T cells (Th17) may control inflammation and play an important role in the pathogenesis of immune evasion. In the present study, we assessed the dynamics of Treg/Th17 and determined whether the Treg/Th17 ratio is altered in C. sinensis infected mice. The results showed that the percentages of splenic Treg cells in CD4+ T cells were suppressed on day 14 post-infection (PI) but increased on day 56 PI, while Th17 cells were increased on day 56 PI compared with normal control (NC) mice. The Treg/Th17 ratio steadily increased from day 28 to day 56 PI. The hepatic levels of their specific transcription factors (Foxp3 for Treg and ROR gamma t for Th17) were increased in C. sinensis-infected mice from day 14 to 56 PI, and significantly higher than those in NC mice. Meanwhile, serum levels of IL-2 and IL-17 were profoundly increased in C. sinensis-infected mice throughout the experiment; while the concentrations of IL-6 and transforming growth factor beta(1) (TGF-beta(1)) peaked on day 14 PI, but then decreased on day 28 and 56 PI. Our results provide the first evidence of an increased Treg/Th17 ratio in C. sinensis-infected mice, suggesting that a Treg/Th17 imbalance may play a role in disease outcomes of clonorchiasis.	[Yan, Chao; Zhang, Bei-Bei; Hua, Hui; Li, Bo; Zhang, Bo; Yu, Qian; Li, Xiang-Yang; Liu, Ying; Pan, Wei; Liu, Xiang-Ye; Tang, Ren-Xian; Zheng, Kui-Yang] Xuzhou Med Coll, Dept Pathogen Biol & Immunol, Lab Infect & Immun, Xuzhou 221004, Jiangsu, Peoples R China	Xuzhou Medical University	Zheng, KY (corresponding author), Xuzhou Med Coll, Dept Pathogen Biol & Immunol, Lab Infect & Immun, Xuzhou 221004, Jiangsu, Peoples R China.	Tangrenxian-t@163.com; ZKY02@163.com	Yan, Chao/AAA-9403-2021		National Natural Science Foundation of China [81171590, 31302077, 81572019]; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences [SKLVEB2013KFKT005]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Starting Foundation for Talents of Xuzhou Medical College [53591317]; Science Foundation of Xuzhou Medical College [2014KJ08, 2014KJ10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Starting Foundation for Talents of Xuzhou Medical College; Science Foundation of Xuzhou Medical College	Project support was provided in part by the National Natural Science Foundation of China (Grant Nos. 81171590, 31302077 and 81572019), the Open Funds of the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Grant No. SKLVEB2013KFKT005), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Starting Foundation for Talents of Xuzhou Medical College (Grant No. 53591317), and the Science Foundation of Xuzhou Medical College (Grant Nos. 2014KJ08 and 2014KJ10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalid-Peralta L, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/981468; Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; ATTWOOD HD, 1978, PATHOLOGY, V10, P153, DOI 10.3109/00313027809063494; Baumgart M, 2006, J IMMUNOL, V176, P5374, DOI 10.4049/jimmunol.176.9.5374; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Chen DH, 2013, IMMUNOLOGY, V139, P523, DOI 10.1111/imm.12105; Chen J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-152; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; D'Elia R, 2009, J IMMUNOL, V182, P2340, DOI 10.4049/jimmunol.0802767; Fang Yue-Yi, 2008, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V26, P99; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fu LinLin, 2008, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V3, P46; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kara EE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003905; Keswani T, 2014, EXP PARASITOL, V141, P82, DOI 10.1016/j.exppara.2014.03.003; Kim EM, 2012, PARASITOL INT, V61, P124, DOI 10.1016/j.parint.2011.07.001; Kim Jong In, 1992, Korean Journal of Parasitology, V30, P169, DOI 10.3347/kjp.1992.30.3.169; Kim TI, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001414; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039307; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martinez NE, 2014, J NEUROIMMUNOL, V276, P142, DOI 10.1016/j.jneuroim.2014.09.006; Mbow M, 2013, J INFECT DIS, V207, P186, DOI 10.1093/infdis/jis654; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Pang NN, 2014, INT IMMUNOPHARMACOL, V20, P248, DOI 10.1016/j.intimp.2014.02.038; Rouse BT, 2004, J IMMUNOL, V173, P2211, DOI 10.4049/jimmunol.173.4.2211; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shainheit MG, 2011, J IMMUNOL, V187, P5328, DOI 10.4049/jimmunol.1101445; Shen JQ, 2015, PARASITOL RES, V114, P1661, DOI 10.1007/s00436-015-4347-9; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Shin MH, 2003, INT ARCH ALLERGY IMM, V132, P48, DOI 10.1159/000073264; Smith KA, 2014, EUR J IMMUNOL, V44, P150, DOI 10.1002/eji.201343746; Sun XF, 2014, WORLD J GASTROENTERO, V20, P2062, DOI 10.3748/wjg.v20.i8.2062; Turaga PSD, 2000, INFECT IMMUN, V68, P1905, DOI 10.1128/IAI.68.4.1905-1911.2000; Tuxun T, 2012, PARASITE IMMUNOL, V34, P520, DOI 10.1111/j.1365-3024.2012.01383.x; Uddin MH, 2012, PARASITOL INT, V61, P118, DOI 10.1016/j.parint.2011.07.002; Wang XY, 2009, PARASITOL RES, V106, P15, DOI 10.1007/s00436-009-1622-7; Yan C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0675-y; Zhang HX, 2012, AM J REPROD IMMUNOL, V67, P112, DOI 10.1111/j.1600-0897.2011.01065.x; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213	52	13	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143217	10.1371/journal.pone.0143217	http://dx.doi.org/10.1371/journal.pone.0143217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599407	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900078
J	Shi, JX; He, Y; Hewett, SJ; Hewett, JA				Shi, Jingxue; He, Yan; Hewett, Sandra J.; Hewett, James A.			Interleukin 1 beta Regulation of the System x(c)(-), Substrate-specific Subunit, xCT, in Primary Mouse Astrocytes Involves the RNA-binding Protein HuR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTINE TRANSPORT ACTIVITY; HUMAN BREAST-CANCER; MESSENGER-RNA; EXTRACELLULAR GLUTAMATE; CYSTINE/GLUTAMATE TRANSPORTER; HUMAN-FIBROBLASTS; OXIDATIVE STRESS; NITRIC-OXIDE; EXPRESSION; INDUCTION	System x(c)(-) is a heteromeric amino acid cystine/glutamate antiporter that is constitutively expressed by cells of the CNS, where it functions in the maintenance of intracellular glutathione and extracellular glutamate levels. We recently determined that the cytokine, IL -1 beta, increases the activity of system x(c)(-) in CNS astrocytes secondary to an up -regulation of its substrate specific light chain, xCT, and that this occurs, in part, at the level of transcription. However, an in silica analysis of the murine xCT 3'-UTR identified numerous copies of adenine- and uridine-rich elements, raising the possibility that undefined transacting factors governing mRNA stability and translation may also contribute to xCT expression. Here we show that IL-1p increases the level of mRNA encoding xCT in primary cultures of astrocytes isolated from mouse cortex in association with an increase in xCT mRNA halt -life. Additionally, IL-113 induces HuR translocation from the nucleus to the cytoplasm. RNA immunoprecipitation analysis reveals that HuR binds directly to the 3'-UTR of xCT in an IL-1 beta-dependent manner. Knockdown of endogenous HuR protein abrogates the IL-1 beta-mediated increase in xCT mRNA half-life, whereas overexpression of HuR in unstimulated primary mouse astrocytes doubles the half-life of constitutive xCT mRNA. This latter effect is accompanied by an increase in xCT protein levels, as well as a functional increase in system x(c)(-) activity. Altogether, these data support a critical role for HuR in mediating the IL-1-induced stabilization of astrocyte xCT mRNA.	[Hewett, James A.] Syracuse Univ, Dept Biol, 107 Coll Ple, Syracuse, NY 13244 USA; [Hewett, James A.] Syracuse Univ, Program Neurosci, 107 Coll Ple, Syracuse, NY 13244 USA	Syracuse University; Syracuse University	Hewett, JA (corresponding author), Syracuse Univ, Dept Biol, 107 Coll Ple, Syracuse, NY 13244 USA.; Hewett, JA (corresponding author), Syracuse Univ, Program Neurosci, 107 Coll Ple, Syracuse, NY 13244 USA.	jhewett@syr.edu			National Institutes of Health [R01NS051445]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS051445 (to S. J. H. and J. A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; Baker DA, 2002, AMINO ACIDS, V23, P161, DOI 10.1007/s00726-001-0122-6; Baker DA, 2002, J NEUROSCI, V22, P9134; Baker DA, 2008, NEUROPSYCHOPHARMACOL, V33, P1760, DOI 10.1038/sj.npp.1301532; BANNAI S, 1989, J BIOL CHEM, V264, P18480; BANNAI S, 1984, J BIOL CHEM, V259, P2435; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; Bentea E, 2015, PROG NEURO-PSYCHOPH, V59, P49, DOI 10.1016/j.pnpbp.2015.01.010; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bridges CC, 2001, INVEST OPHTH VIS SCI, V42, P47; Bridges R, 2012, PHARMACOL REV, V64, P780, DOI 10.1124/pr.110.003889; Chintala S, 2005, P NATL ACAD SCI USA, V102, P10964, DOI 10.1073/pnas.0502856102; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; De Bundel D, 2011, J NEUROSCI, V31, P5792, DOI 10.1523/JNEUROSCI.5465-10.2011; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; Domingues AMD, 2010, NEUROCHEM INT, V57, P359, DOI 10.1016/j.neuint.2010.03.024; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Dun Y, 2006, CELL TISSUE RES, V324, P189, DOI 10.1007/s00441-005-0116-x; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Featherstone DE, 2008, NEUROSCIENTIST, V14, P171, DOI 10.1177/1073858407308518; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Grosjean Y, 2008, NAT NEUROSCI, V11, P54, DOI 10.1038/nn2019; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Habib E, 2015, REDOX BIOL, V5, P33, DOI 10.1016/j.redox.2015.03.003; Hamby ME, 2006, J NEUROSCI METH, V150, P128, DOI 10.1016/j.jneumeth.2005.06.016; He Y, 2015, GLIA, V63, P1568, DOI 10.1002/glia.22828; Hewett JA, 1999, J NEUROSCI RES, V56, P189, DOI 10.1002/(SICI)1097-4547(19990415)56:2<189::AID-JNR8>3.3.CO;2-2; Hewett Sandra J, 2012, Eur J Neurodegener Dis, V1, P195; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jackman NA, 2012, ASN NEURO, V4, P23, DOI 10.1042/AN20110030; Jackman NA, 2010, GLIA, V58, P1806, DOI 10.1002/glia.21050; Jin SH, 2007, EUR J PHARMACOL, V558, P14, DOI 10.1016/j.ejphar.2006.11.060; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Lewerenz J, 2014, ANTIOXID REDOX SIGN, V20, P2907, DOI 10.1089/ars.2013.5455; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lewerenz J, 2012, AMINO ACIDS, V42, P171, DOI 10.1007/s00726-011-0862-x; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Lin XH, 2013, J BIOL CHEM, V288, P14815, DOI 10.1074/jbc.M113.466565; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; Martin L, 2015, ONCOGENE, V34, P4211, DOI 10.1038/onc.2014.352; Massie A, 2015, J NEUROCHEM, V135, P1062, DOI 10.1111/jnc.13348; Massie A, 2011, FASEB J, V25, P1359, DOI 10.1096/fj.10-177212; Melendez RI, 2005, J PHARMACOL EXP THER, V314, P139, DOI 10.1124/jpet.104.081521; MIURA K, 1992, AM J PHYSIOL, V262, pC50, DOI 10.1152/ajpcell.1992.262.1.C50; Moran MM, 2005, J NEUROSCI, V25, P6389, DOI 10.1523/JNEUROSCI.1007-05.2005; Mysona B, 2009, CELL TISSUE RES, V335, P477, DOI 10.1007/s00441-008-0742-1; Okamura M, 2015, GENES-BASEL, V6, P124, DOI 10.3390/genes6010124; Okano HJ, 1997, J NEUROSCI, V17, P3024; Sakakura Y, 2007, J LEUKOCYTE BIOL, V81, P974, DOI 10.1189/jlb.0606385; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; SATO H, 1995, BIOCHEM J, V310, P547, DOI 10.1042/bj3100547; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Sato H, 2001, J BIOL CHEM, V276, P10407, DOI 10.1074/jbc.M007216200; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shih AY, 2001, BIOCHEM BIOPH RES CO, V282, P1132, DOI 10.1006/bbrc.2001.4703; TAKADA A, 1984, J BIOL CHEM, V259, P2441; Tomi M, 2003, GLIA, V43, P208, DOI 10.1002/glia.10253; Uliasz TF, 2012, METHODS MOL BIOL, V814, P61, DOI 10.1007/978-1-61779-452-0_5; Untergasser A., 2008, TITRATION ADENOVIRAL; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Warr O, 1999, J PHYSIOL-LONDON, V514, P783, DOI 10.1111/j.1469-7793.1999.783ad.x; WATANABE H, 1987, J EXP MED, V165, P628, DOI 10.1084/jem.165.3.628	71	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1643	1651		10.1074/jbc.M115.697821	http://dx.doi.org/10.1074/jbc.M115.697821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601945	hybrid, Green Published			2022-12-26	WOS:000368620700009
J	Byun, MS; Kim, SE; Park, J; Yi, D; Choe, YM; Sohn, BK; Choi, HJ; Baek, H; Han, JY; Woo, JI; Lee, DY				Byun, Min Soo; Kim, Song E.; Park, Jinsick; Yi, Dahyun; Choe, Young Min; Sohn, Bo Kyung; Choi, Hyo Jung; Baek, Hyewon; Han, Ji Young; Woo, Jong Inn; Lee, Dong Young		Alzheimer's Dis Neuroimaging	Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer's Disease	PLOS ONE			English	Article							NEUROIMAGING INITIATIVE ADNI; NEUROPSYCHOLOGICAL ASSESSMENT BATTERY; NATIONAL INSTITUTE; GRAY-MATTER; DIAGNOSTIC GUIDELINES; HYPOTHETICAL MODEL; DEFINED SUBTYPES; COMPOSITE SCORE; DEMENTIA; MRI	We aimed to identify and characterize subtypes of Alzheimer's disease (AD) exhibiting different patterns of regional brain atrophy on MRI using age-and gender-specific norms of regional brain volumes. AD subjects included in the Alzheimer's Disease Neuroimaging Initiative study were classified into subtypes based on standardized values (Z-scores) of hippocampal and regional cortical volumes on MRI with reference to age- and gender-specific norms obtained from 222 cognitively normal (CN) subjects. Baseline and longitudinal changes of clinical characteristics over 2 years were compared across subtypes. Whole-brain-level gray matter (GM) atrophy pattern using voxel-based morphometry (VBM) and cerebrospinal fluid (CSF) biomarkers of the subtypes were also investigated. Of 163 AD subjects, 58.9% were classified as the "both impaired" subtype with the typical hippocampal and cortical atrophy pattern, whereas 41.1% were classified as the subtypes with atypical atrophy patterns: "hippocampal atrophy only" (19.0%), "cortical atrophy only" (11.7%), and "both spared" (10.4%). Voxel-based morphometric analysis demonstrated whole-brain-level differences in overall GM atrophy across the subtypes. These subtypes showed different progression rates over 2 years; and all subtypes had significantly lower CSF amyloid-beta(1-42) levels compared to CN. In conclusion, we identified four AD subtypes exhibiting heterogeneous atrophy patterns on MRI with different progression rates after controlling the effects of aging and gender on atrophy with normative information. CSF biomarker analysis suggests the presence of A beta neuropathology irrespective of subtypes. Such heterogeneity of MRI-based neuronal injury biomarker and related heterogeneous progression patterns should be considered in clinical trials and practice with AD patients.	[Byun, Min Soo; Kim, Song E.; Yi, Dahyun; Choi, Hyo Jung; Baek, Hyewon; Han, Ji Young; Lee, Dong Young] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea; [Park, Jinsick] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Choe, Young Min] Ulsan Univ Hosp, Dept Neuropsychiat, Ulsan, South Korea; [Sohn, Bo Kyung] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Neuropsychiat, Seoul, South Korea; [Woo, Jong Inn] Seoul Natl Univ, Med Res Ctr, Neurosci Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Hanyang University; University of Ulsan; Ulsan University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, DY (corresponding author), Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea.	selfpsy@snu.ac.kr	Byun, Min Soo/GLS-1324-2022		Ministry of Science, ICT and Future Planning [NRF-2014M3C7A1046042]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Study design, data analysis, and preparation of the manuscript in this study were supported by a grant from Ministry of Science, ICT and Future Planning (Grant No: NRF-2014M3C7A1046042). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkour A, 2013, NEUROIMAGE, V76, P332, DOI 10.1016/j.neuroimage.2013.02.059; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bradford A, 2009, ALZ DIS ASSOC DIS, V23, P306, DOI 10.1097/WAD.0b013e3181a6bebc; Brewer JB, 2009, BEHAV NEUROL, V21, P21, DOI [10.3233/BEN-2009-0226, 10.1155/2009/616581]; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Caban-Holt A, 2012, CLIN NEUROPSYCHOL, V26, P751, DOI 10.1080/13854046.2012.690451; Cash David M, 2014, Alzheimers Res Ther, V6, P87, DOI 10.1186/s13195-014-0087-9; Crane PK, 2012, BRAIN IMAGING BEHAV, V6, P502, DOI 10.1007/s11682-012-9186-z; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2011, J NEUROL NEUROSUR PS, V82, P45, DOI 10.1136/jnnp.2009.199505; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Duara R., 2013, ADV ALZHEIMERS DIS, V2, P135, DOI [10.4236/aad.2013.24019, DOI 10.4236/AAD.2013.24019]; Fillenbaum GG, 2011, CLIN NEUROPSYCHOL, V25, P1345, DOI 10.1080/13854046.2011.614962; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gibbons LE, 2012, BRAIN IMAGING BEHAV, V6, P517, DOI 10.1007/s11682-012-9176-1; Hake A, 2015, ALZHEIMERS DEMENT, V11, P986, DOI 10.1016/j.jalz.2015.03.002; Han JY, 2014, INT PSYCHOGERIATR, V26, P1897, DOI 10.1017/S1041610214001379; HANSEN LA, 1993, J NEUROPATH EXP NEUR, V52, P648, DOI 10.1097/00005072-199311000-00012; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heister D, 2011, NEUROLOGY, V77, P1619, DOI 10.1212/WNL.0b013e3182343314; Ivnik R.J., 1990, PSYCHOL ASSESS, V2, P304, DOI [10.1037/1040-3590.2.3.304, DOI 10.1037/1040-3590.2.3.304]; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; JACK CR, 1992, NEUROLOGY, V42, P183, DOI 10.1212/WNL.42.1.183; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; La Joie R, 2014, NEURON, V81, P1417, DOI 10.1016/j.neuron.2014.01.026; Lee DY, 2004, J INT NEUROPSYCH SOC, V10, P72, DOI 10.1017/s1355617704101094; Lehmann M, 2013, BRAIN, V136, P844, DOI 10.1093/brain/aws327; Li QX, 2015, J ALZHEIMERS DIS, V48, P175, DOI 10.3233/JAD-150247; Lowe VJ, 2013, NEUROLOGY, V80, P2130, DOI 10.1212/WNL.0b013e318295d6cf; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; Noh Y, 2014, NEUROLOGY, V83, P1936, DOI 10.1212/WNL.0000000000001003; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; PAUKER JD, 1988, J CLIN PSYCHOL, V44, P930, DOI 10.1002/1097-4679(198811)44:6<930::AID-JCLP2270440613>3.0.CO;2-H; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Seo EH, 2008, INT J GERIATR PSYCH, V23, P1020, DOI 10.1002/gps.2027; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Shiino A, 2006, NEUROIMAGE, V33, P17, DOI 10.1016/j.neuroimage.2006.06.010; Taki Y, 2013, HUM BRAIN MAPP, V34, P2292, DOI 10.1002/hbm.22067; Teipel SJ, 2013, MED CLIN N AM, V97, P399, DOI 10.1016/j.mcna.2012.12.013; TERRY RD, 1987, J NEUROPATH EXP NEUR, V46, P262, DOI 10.1097/00005072-198705000-00003; Thompson PM, 2003, J NEUROSCI, V23, P994; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Visser PJ, 1999, J NEUROL, V246, P477, DOI 10.1007/s004150050387; Whitwell JL, 2008, NEUROLOGY, V70, P512, DOI 10.1212/01.wnl.0000280575.77437.a2; Whitwell JL, 2012, LANCET NEUROL, V11, P868, DOI 10.1016/S1474-4422(12)70200-4; Yavuz BB, 2007, INT PSYCHOGERIATR, V19, P767, DOI 10.1017/S1041610206004303	55	58	62	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0142756	10.1371/journal.pone.0142756	http://dx.doi.org/10.1371/journal.pone.0142756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618360	Green Submitted, gold, Green Published			2022-12-26	WOS:000365889800016
J	Infarinato, F; Rahman, A; Del Percio, C; Lamberty, Y; Bordet, R; Richardson, JC; Forloni, G; Drinkenburg, W; Lopez, S; Aujard, F; Babiloni, C; Pifferi, F				Infarinato, Francesco; Rahman, Anisur; Del Percio, Claudio; Lamberty, Yves; Bordet, Regis; Richardson, Jill C.; Forloni, Gianluigi; Drinkenburg, Wilhelmus; Lopez, Susanna; Aujard, Fabienne; Babiloni, Claudio; Pifferi, Fabien		IMI Project PharmaCog Consortium	On-Going Frontal Alpha Rhythms Are Dominant in Passive State and Desynchronize in Active State in Adult Gray Mouse Lemurs	PLOS ONE			English	Article							ELECTROCORTICOGRAPHIC SPECTRAL-ANALYSIS; DELTA OSCILLATORY RESPONSES; MILD COGNITIVE IMPAIRMENT; HUMAN SENSORIMOTOR CORTEX; BALANCE PERFORMANCE; ALZHEIMERS-DISEASE; SLEEP-DEPRIVATION; SYNCHRONIZATION; RESVERATROL; TUMORS	The gray mouse lemur (Microcebus murinus) is considered a useful primate model for translational research. In the framework of IMI PharmaCog project (Grant Agreement no 115009, www.pharmacog.org), we tested the hypothesis that spectral electroencephalographic (EEG) markers of motor and locomotor activity in gray mouse lemurs reflect typical movement-related desynchronization of alpha rhythms (about 8-12 Hz) in humans. To this aim, EEG (bipolar electrodes in frontal cortex) and electromyographic (EMG; bipolar electrodes sutured in neck muscles) data were recorded in 13 male adult (about 3 years) lemurs. Artifact-free EEG segments during active state (gross movements, exploratory movements or locomotor activity) and awake passive state (no sleep) were selected on the basis of instrumental measures of animal behavior, and were used as an input for EEG power density analysis. Results showed a clear peak of EEG power density at alpha range (7-9 Hz) during passive state. During active state, there was a reduction in alpha power density (8-12 Hz) and an increase of power density at slow frequencies (1-4 Hz). Relative EMG activity was related to EEG power density at 2-4 Hz (positive correlation) and at 8-12 Hz (negative correlation). These results suggest for the first time that the primate gray mouse lemurs and humans may share basic neurophysiologic mechanisms of synchronization of frontal alpha rhythms in awake passive state and their desynchronization during motor and locomotor activity. These EEG markers may be an ideal experimental model for translational basic (motor science) and applied (pharmacological and non-pharmacological interventions) research in Neurophysiology.	[Infarinato, Francesco; Babiloni, Claudio] IRCCS San Raffaele Pisana, Rome, Italy; [Rahman, Anisur; Aujard, Fabienne; Pifferi, Fabien] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France; [Del Percio, Claudio] IRCCS SDN, Naples, Italy; [Lamberty, Yves] UCB Pharma Sa, Neurosci Therapeut Area, Braine Lalleud, Belgium; [Bordet, Regis] Univ Lille 2, Lille, France; [Richardson, Jill C.] GlaxoSmithKline R&D, Neurosci Therapeut Area Unit, Stevenage, Herts, England; [Forloni, Gianluigi] Mario Negri Inst Pharmacol Res, Dept Neurodegenerat, Milan, Italy; [Drinkenburg, Wilhelmus] Janssen Res & Dev, Beerse, Belgium; [Lopez, Susanna; Babiloni, Claudio] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy	IRCCS San Raffaele Pisana; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); UCB Pharma SA; Universite de Lille - ISITE; Universite de Lille; GlaxoSmithKline; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Johnson & Johnson; Janssen Pharmaceuticals; Sapienza University Rome	Babiloni, C (corresponding author), IRCCS San Raffaele Pisana, Rome, Italy.	claudio.babiloni@uniroma1.it	Lopez, Susanna/AAD-2365-2020; Lopez, Susanna/AAB-9716-2019; Infarinato, Francesco/K-8843-2016; Babiloni, Claudio/AAC-5324-2022; Forloni, Gianluigi/AAB-2115-2020	Lopez, Susanna/0000-0002-3568-2668; Infarinato, Francesco/0000-0002-5570-8490; Babiloni, Claudio/0000-0002-5245-9839; Forloni, Gianluigi/0000-0001-5374-3914; Richardson, Jill/0000-0001-6564-3187; Drinkenburg, Wilhelmus/0000-0002-1095-7995; Pifferi, Fabien/0000-0001-9316-1935	European Community [115009]	European Community(European Commission)	The activity leading to the present study has received funding from the Seventh Framework Programme of European Community (FP7/2007-2013) for the Innovative Medicine Initiative under Grant Agreement No. 115009 (www.pharmacog.org) (title of the project: "Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development"; acronym: PharmaCog). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2009, BEHAV BRAIN RES, V198, P13, DOI 10.1016/j.bbr.2008.10.046; Achilefu S, 2004, TECHNOL CANCER RES T, V3, P393, DOI 10.1177/153303460400300410; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Babiloni C, 2015, CLIN NEUROPHYSIOL; Babiloni C, 2013, CLIN NEUROPHYSIOL, V124, P437, DOI 10.1016/j.clinph.2012.07.023; Babiloni C, 2011, J ALZHEIMERS DIS, V26, P201, DOI 10.3233/JAD-2011-0051; Babiloni C, 2010, J ALZHEIMERS DIS, V22, P1047, DOI 10.3233/JAD-2010-100798; Basar E, 2013, PREFACE SUPPL CLIN N, V62, pv; Basar E., 1980, EEG BRAIN DYNAMICS R; Basar E, 2011, BRAIN-BODY-MIND IN THE NEBULOUS CARTESIAN SYSTEM: A HOLISTIC APPROACH BY OSCILLATIONS, P1, DOI 10.1007/978-1-4419-6136-5; Becker A, 2001, NAT BIOTECHNOL, V19, P327, DOI 10.1038/86707; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bons N, 1998, BRAIN RES BULL, V46, P1; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chin J, 2007, INT C ALZH DIS CHIC; Coude G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0415; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Del Percio C, 2010, CLIN NEUROPHYSIOL, V121, P482, DOI 10.1016/j.clinph.2009.12.004; Dhenain M, 2000, NEUROBIOL AGING, V21, P81, DOI 10.1016/S0197-4580(00)00098-1; GASTAUT H, 1952, Mars Med, V89, P296; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Kaas JH, 2013, AM J PRIMATOL, V75, P407, DOI 10.1002/ajp.22065; Kaushal N, 2012, BRAIN RES, V1454, P65, DOI 10.1016/j.brainres.2012.03.019; Kurt P, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/268967; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Liu JJV, 2013, NEUROIMAGE, V78, P186, DOI 10.1016/j.neuroimage.2013.03.038; Mestre-Frances N, 2000, NEUROBIOL DIS, V7, P1, DOI 10.1006/nbdi.1999.0270; Miller KJ, 2007, NEUROIMAGE, V37, P504, DOI 10.1016/j.neuroimage.2007.05.029; Nemoz-Bertholet F, 2004, EXP GERONTOL, V39, P841, DOI 10.1016/j.exger.2004.01.010; Nemoz-Bertolet F, 2003, EXP GERONTOL, V38, P407, DOI 10.1016/S0531-5565(02)00244-9; Perret M, 2006, M S-MED SCI, V22, P279, DOI 10.1051/medsci/2006223279; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pifferi F, 2012, CHRONOBIOL INT, V29, P261, DOI 10.3109/07420528.2011.654019; Pifferi F, 2011, J BIOL RHYTHM, V26, P271, DOI 10.1177/0748730411401788; Presacco A, 2011, J NEUROPHYSIOL, V106, P1875, DOI 10.1152/jn.00104.2011; Rahman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064493; Rubio SE, 2012, FASEB J, V26, P4458, DOI 10.1096/fj.12-208413; SALMELIN R, 1994, ELECTROEN CLIN NEURO, V91, P237, DOI 10.1016/0013-4694(94)90187-2; Smucny J, 2014, TRENDS PHARMACOL SCI, V35, P397, DOI 10.1016/j.tips.2014.05.001; SOMERS D, 1993, BIOL CYBERN, V68, P393, DOI 10.1007/BF00198772; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Wither RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035396; Yener G, 2008, EUR J NEUROL, V15, P540, DOI 10.1111/j.1468-1331.2008.02100.x; Yener GG, 2012, BEHAV NEUROL, V25, P3, DOI [10.3233/BEN-2012-0344, 10.1155/2012/810173]; Yener GG, 2013, J ALZHEIMERS DIS, V37, P759, DOI 10.3233/JAD-130569	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143719	10.1371/journal.pone.0143719	http://dx.doi.org/10.1371/journal.pone.0143719			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618512	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800062
J	Magombedze, G; Eda, S; Stabel, J				Magombedze, Gesham; Eda, Shigetoshi; Stabel, Judy			Predicting the Role of IL-10 in the Regulation of the Adaptive Immune Responses in Mycobacterium avium Subsp paratuberculosis Infections Using Mathematical Models	PLOS ONE			English	Article							CD4(+) T-CELLS; CYTOKINE GENE-EXPRESSION; BLOOD MONONUCLEAR-CELLS; INTERFERON-GAMMA; IFN-GAMMA; PERIPHERAL-BLOOD; LONG-TERM; INNATE RESISTANCE; HUMAN MACROPHAGES; CLINICAL-DISEASE	Mycobacterium avium subsp. paratuberculosis (MAP) is an intracellular bacterial pathogen that causes Johne's disease (JD) in cattle and other animals. The hallmark of MAP infection in the early stages is a strong protective cell-mediated immune response (Th1-type), characterized by antigen-specific gamma-interferon (IFN-gamma). The Th1 response wanes with disease progression and is supplanted by a non-protective humoral immune response (Th2-type). Interleukin-10 (IL-10) is believed to play a critical role in the regulation of host immune responses to MAP infection and potentially orchestrate the reversal of Th1/Th2 immune dominance during disease progression. However, how its role correlates with MAP infection remains to be completely deciphered. We developed mathematical models to explain probable mechanisms for IL-10 involvement in MAP infection. We tested our models with IL-4, IL-10, IFN-gamma, and MAP fecal shedding data collected from calves that were experimentally infected and followed over a period of 360 days in the study of Stabel and Robbe-Austerman (2011). Our models predicted that IL-10 can have different roles during MAP infection, (i) it can suppress the Th1 expression, (ii) can enhance Th2 (IL-4) expression, and (iii) can suppress the Th1 expression in synergy with IL-4. In these predicted roles, suppression of Th1 responses was correlated with increased number of MAP. We also predicted that Th1-mediated responses (IFN-gamma) can lead to high expression of IL-10 and that infection burden regulates Th2 suppression by the Th1 response. Our models highlight areas where more experimental data is required to refine our model assumptions, and further test and investigate the role of IL-10 in MAP infection.	[Magombedze, Gesham] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA; [Magombedze, Gesham] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Eda, Shigetoshi] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA; [Stabel, Judy] USDA ARS, Natl Anim Dis, Ames, IA 50010 USA	University of Tennessee System; University of Tennessee Knoxville; Imperial College London; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of Agriculture (USDA)	Magombedze, G (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA.	gmagombedze@nimbios.org		Magombedze, Gesham/0000-0003-2745-3475	National Institute for Mathematical and Biological Synthesis (NIMBioS) - National Science Foundation [EF-0832858]; University of Tennessee, Knoxville; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Institute for Mathematical and Biological Synthesis (NIMBioS) - National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); University of Tennessee, Knoxville; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge the support of the National Institute for Mathematical and Biological Synthesis (NIMBioS), an Institute sponsored by the National Science Foundation through NSF Award #EF-0832858, with additional support from The University of Tennessee, Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendano N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/908348; Begg DJ, 2011, IMMUNOBIOLOGY, V216, P840, DOI 10.1016/j.imbio.2010.12.004; Begg DJ, 2005, VACCINE, V23, P4999, DOI 10.1016/j.vaccine.2005.05.031; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; Buergelt C. D., 2004, International Journal of Applied Research in Veterinary Medicine, V2, P126; Burrells C, 1999, VET IMMUNOL IMMUNOP, V68, P139, DOI 10.1016/S0165-2427(99)00022-7; Buza JJ, 2004, INFECT IMMUN, V72, P2425, DOI 10.1128/IAI.72.4.2425-2428.2004; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Coussens PM, 2012, COMP IMMUNOL MICROB, V35, P233, DOI 10.1016/j.cimid.2012.01.004; de Almeida DE, 2008, VET IMMUNOL IMMUNOP, V125, P234, DOI 10.1016/j.vetimm.2008.05.019; de Silva K, 2013, PREV VET MED, V112, P203, DOI 10.1016/j.prevetmed.2013.08.006; de Silva K, 2011, VET IMMUNOL IMMUNOP, V139, P10, DOI 10.1016/j.vetimm.2010.07.022; de Silva K, 2010, IMMUNOBIOLOGY, V215, P12, DOI 10.1016/j.imbio.2009.01.014; Elguezabal N, 2011, APPL ENVIRON MICROB, V77, P8615, DOI 10.1128/AEM.05818-11; Flores RR, 2007, J IMMUNOL, V178, P211, DOI 10.4049/jimmunol.178.1.211; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hostetter J, 2005, CLIN DIAGN LAB IMMUN, V12, P793, DOI 10.1128/CDLI.12.6.793-796.2005; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jacysyn JF, 2003, IMMUNOL CELL BIOL, V81, P424, DOI 10.1046/j.1440-1711.2003.01194.x; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Karcher EL, 2008, VET IMMUNOL IMMUNOP, V123, P277, DOI 10.1016/j.vetimm.2008.02.006; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Koets A, 2002, INFECT IMMUN, V70, P3856, DOI 10.1128/IAI.70.7.3856-3864.2002; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Liu LM, 1998, INT IMMUNOL, V10, P1017, DOI 10.1093/intimm/10.8.1017; Liu XS, 2009, J IMMUNOL, V183, P51, DOI 10.4049/jimmunol.0802047; Magombedze G, 2011, JOURNAL OF THEORETIC; Magombedze G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076636; Magombedze G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003414; Magombedze G, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00206; Magombedze G, 2013, INFECT GENET EVOL, V13, P267, DOI 10.1016/j.meegid.2012.09.017; Mentula S, 2005, APPL ENVIRON MICROB, V71, P4169, DOI 10.1128/AEM.71.8.4169-4175.2005; Mocellin S, 2004, CYTOKINE GROWTH F R, V15, P61, DOI 10.1016/j.cytogfr.2003.11.001; MOMOTANI E, 1988, VET PATHOL, V25, P131, DOI 10.1177/030098588802500205; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; O'Garra A, 2000, CURR BIOL, V10, pR492, DOI 10.1016/S0960-9822(00)00556-X; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Paludan SR, 1998, SCAND J IMMUNOL, V48, P459; Ponnusamy D, 2013, RES VET SCI, V94, P306, DOI 10.1016/j.rvsc.2012.09.023; Rincon M, 1997, CURR BIOL, V7, pR729, DOI 10.1016/S0960-9822(06)00368-X; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i03; Specht S, 2004, INFECT IMMUN, V72, P6287, DOI 10.1128/IAI.72.11.6287-6293.2004; Stabel JR, 2011, CLIN VACCINE IMMUNOL, V18, P393, DOI 10.1128/CVI.00359-10; Stabel JR, 2000, AM J VET RES, V61, P754, DOI 10.2460/ajvr.2000.61.754; Stabel JR, 1996, J VET DIAGN INVEST, V8, P345, DOI 10.1177/104063879600800311; Stewart DJ, 2006, VET MICROBIOL, V113, P13, DOI 10.1016/j.vetmic.2005.09.015; Stewart DJ, 2004, VET MICROBIOL, V104, P165, DOI 10.1016/j.vetmic.2004.09.007; Subharat S, 2012, VET IMMUNOL IMMUNOP, V149, P225, DOI 10.1016/j.vetimm.2012.07.005; Sweeney RW, 1998, AM J VET RES, V59, P842; Tanaka S, 2005, VET PATHOL, V42, P579, DOI 10.1354/vp.42-5-579; Taut K, 2008, AM J RESP CELL MOL, V38, P105, DOI 10.1165/rcmb.2007-0132OC; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; van Roon JAG, 2001, ARTHRITIS RHEUM-US, V44, P3, DOI 10.1002/1529-0131(200101)44:1<3::AID-ANR2>3.0.CO;2-U; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203	66	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0141539	10.1371/journal.pone.0141539	http://dx.doi.org/10.1371/journal.pone.0141539			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619346	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800006
J	Schwarb, H; Watson, PD; Campbell, K; Shander, CL; Monti, JM; Cooke, GE; Wang, JX; Kramer, AF; Cohen, NJ				Schwarb, Hillary; Watson, Patrick D.; Campbell, Kelsey; Shander, Christopher L.; Monti, Jim M.; Cooke, Gillian E.; Wang, Jane X.; Kramer, Arthur F.; Cohen, Neal J.			Competition and Cooperation among Relational Memory Representations	PLOS ONE			English	Article							PREFRONTAL CORTEX; COGNITIVE CONTROL; WORKING-MEMORY; HIPPOCAMPAL; RECOGNITION; RETRIEVAL; AMNESIA; FRAMEWORK; SUPPORTS; BINDING	Mnemonic processing engages multiple systems that cooperate and compete to support task performance. Exploring these systems' interaction requires memory tasks that produce rich data with multiple patterns of performance sensitive to different processing sub-components. Here we present a novel context-dependent relational memory paradigm designed to engage multiple learning and memory systems. In this task, participants learned unique face-room associations in two distinct contexts (i.e., different colored buildings). Faces occupied rooms as determined by an implicit gender-by-side rule structure (e.g., male faces on the left and female faces on the right) and all faces were seen in both contexts. In two experiments, we use behavioral and eye-tracking measures to investigate interactions among different memory representations in both younger and older adult populations; furthermore we link these representations to volumetric variations in hippocampus and ventromedial PFC among older adults. Overall, performance was very accurate. Successful face placement into a studied room systematically varied with hippocampal volume. Selecting the studied room in the wrong context was the most typical error. The proportion of these errors to correct responses positively correlated with ventromedial prefrontal volume. This novel task provides a powerful tool for investigating both the unique and interacting contributions of these systems in support of relational memory.	[Schwarb, Hillary; Watson, Patrick D.; Campbell, Kelsey; Shander, Christopher L.; Monti, Jim M.; Cooke, Gillian E.; Kramer, Arthur F.; Cohen, Neal J.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Wang, Jane X.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Feinberg School of Medicine	Schwarb, H (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	schwarb2@illinois.edu	Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	National Institutes of Health Silvio Conte Center [MH094263]; National Institutes of Health, National Institute of Mental Health [MH062500-12]; National Institutes of Health, National Institute on Aging [AG036682-03]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062500, P50MH094263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036682] Funding Source: NIH RePORTER	National Institutes of Health Silvio Conte Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by a National Institutes of Health (http://www.nih.gov/) Silvio Conte Center award MH094263, National Institute of Mental Health (http://www.nimh.nih.gov/) RO1 award MH062500-12, and National Institute on Aging (https://www.nia.nih.gov/) RO1 award AG036682-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban MW, 2012, MEM COGNITION, V40, P681, DOI 10.3758/s13421-012-0185-5; Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Atkinson R. C., 1968, PSYCHOL LEARN MOTIVA, V2, P89, DOI 10.1016/S0079-7421(08)60422-3; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Brewer W. F., 1984, HDB SOCIAL COGNITION, P119; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Cohen J., 2003, APPL MULTIPLE REGRES; Cohen N. J., 1984, NEUROPSYCHOLOGY MEMO, P83; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Danckert SL, 2011, MEM COGNITION, V39, P1374, DOI 10.3758/s13421-011-0117-9; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Davachi L, 2015, TRENDS COGN SCI, V19, P92, DOI 10.1016/j.tics.2014.12.004; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Eichenbaum H, 2014, NEURON, V83, P764, DOI 10.1016/j.neuron.2014.07.032; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Hannula DE, 2008, J NEUROSCI, V28, P116, DOI 10.1523/JNEUROSCI.3086-07.2008; Hannula DE, 2006, J NEUROSCI, V26, P8352, DOI 10.1523/JNEUROSCI.5222-05.2006; Hannula DE, 2007, J COGNITIVE NEUROSCI, V19, P1690, DOI 10.1162/jocn.2007.19.10.1690; HASHER L, 1991, J EXP PSYCHOL LEARN, V17, P163, DOI 10.1037/0278-7393.17.1.163; Head D, 2008, NEUROPSYCHOLOGY, V22, P491, DOI 10.1037/0894-4105.22.4.491; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; Jacoby LL, 2005, J EXP PSYCHOL GEN, V134, P131, DOI 10.1037/0096-3445.134.2.131; JACOBY LL, 1989, J PERS SOC PSYCHOL, V56, P326, DOI 10.1037/0022-3514.56.3.326; Jacoby LL, 2005, PSYCHON B REV, V12, P852, DOI 10.3758/BF03196776; Jacoby LL, 2005, J MEM LANG, V52, P493, DOI 10.1016/j.jml.2005.01.007; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Konkel A, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.015.2008; Koscik TR, 2012, J COGNITIVE NEUROSCI, V24, P1191, DOI 10.1162/jocn_a_00203; Lustig C., 2007, INHIBITION COGNITION, P145, DOI [DOI 10.1037/11587-008, 10.1037/11587-008]; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mickes L, 2007, PSYCHON B REV, V14, P858, DOI 10.3758/BF03194112; Mitchell KJ, 2009, PSYCHOL BULL, V135, P638, DOI 10.1037/a0015849; Monsell S., 1996, UNSOLVED MYSTERIES M, P93; Olson IR, 2006, J NEUROSCI, V26, P4596, DOI 10.1523/JNEUROSCI.1923-05.2006; Pertzov Y, 2013, BRAIN, V136, P2474, DOI 10.1093/brain/awt129; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Ranganath C, 2010, HIPPOCAMPUS, V20, P1263, DOI 10.1002/hipo.20852; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Ryan JD, 2007, MEMORY, V15, P508, DOI 10.1080/09658210701391022; Schacter D., 1994, MEMORY SYSTEMS; Schumacher EH, 2010, BRAIN RES, V1329, P113, DOI 10.1016/j.brainres.2010.03.015; Seymour TL, 2009, COGN AFFECT BEHAV NE, V9, P71, DOI 10.3758/CABN.9.1.71; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Voss JL, 2011, NAT NEUROSCI, V14, P115, DOI 10.1038/nn.2693; Warren DE, 2012, HIPPOCAMPUS, V22, P1577, DOI 10.1002/hipo.21000; Watson PD, 2013, HIPPOCAMPUS, V23, P570, DOI 10.1002/hipo.22115; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Yonelinas AP, 2013, BEHAV BRAIN RES, V254, P34, DOI 10.1016/j.bbr.2013.05.030; Zeithamova D, 2012, NEURON, V75, P168, DOI 10.1016/j.neuron.2012.05.010; Zeithamova D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00070	58	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143832	10.1371/journal.pone.0143832	http://dx.doi.org/10.1371/journal.pone.0143832			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619203	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800077
J	Choi, HW; Tian, MY; Manohar, M; Harraz, MM; Park, SW; Schroeder, FC; Snyder, SH; Klessig, DF				Choi, Hyong Woo; Tian, Miaoying; Manohar, Murli; Harraz, Maged M.; Park, Sang-Wook; Schroeder, Frank C.; Snyder, Solomon H.; Klessig, Daniel F.			Human GAPDH Is a Target of Aspirin's Primary Metabolite Salicylic Acid and Its Derivatives	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INFLAMMATORY BOWEL-DISEASE; BUSHY-STUNT-VIRUS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; 5-AMINOSALICYLIC ACID; NATURAL-PRODUCTS; GENOMIC RNA; KAPPA-B; APOPTOSIS; GLYCYRRHIZIN	The plant hormone salicylic acid (SA) controls several physiological processes and is a key regulator of multiple levels of plant immunity. To decipher the mechanisms through which SA's multiple physiological effects are mediated, particularly in immunity, two high-throughput screens were developed to identify SA-binding proteins (SABPs). Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) from plants (Arabidopsis thaliana) was identified in these screens. Similar screens and subsequent analyses using SA analogs, in conjunction with either a photoaffinity labeling technique or surface plasmon resonance-based technology, established that human GAPDH (HsGAPDH) also binds SA. In addition to its central role in glycolysis, HsGAPDH participates in several pathological processes, including viral replication and neuronal cell death. The anti-Parkinson's drug deprenyl has been shown to suppress nuclear translocation of HsGAPDH, an early step in cell death and the resulting cell death induced by the DNA alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine. Here, we demonstrate that SA, which is the primary metabolite of aspirin (acetyl SA) and is likely responsible for many of its pharmacological effects, also suppresses nuclear translocation of HsGAPDH and cell death. Analysis of two synthetic SA derivatives and two classes of compounds from the Chinese medicinal herb Glycyrrhiza foetida (licorice), glycyrrhizin and the SA-derivatives amorfrutins, revealed that they not only appear to bind HsGAPDH more tightly than SA, but also exhibit a greater ability to suppress translocation of HsGAPDH to the nucleus and cell death.	[Choi, Hyong Woo; Tian, Miaoying; Manohar, Murli; Park, Sang-Wook; Schroeder, Frank C.; Klessig, Daniel F.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Harraz, Maged M.; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Klessig, Daniel F.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Johns Hopkins University; Cornell University	Klessig, DF (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, 533 Tower Rd, Ithaca, NY 14853 USA.	dfk8@cornell.edu	Choi, Hyong Woo/W-7213-2019	Choi, Hyong Woo/0000-0003-4089-7548; Choi, Hyong Woo/0000-0001-6049-4426; Harraz, Maged/0000-0003-4353-4216; Schroeder, Frank/0000-0002-4420-0237; Manohar, Murli/0000-0003-1622-0369; Tian, Miaoying/0000-0001-8900-6414	Arabidopsis Initiative of the US National Science Foundation [IOS-0820405]; US Public Health Service [MH18501]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER	Arabidopsis Initiative of the US National Science Foundation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Arabidopsis 2010 Initiative of the US National Science Foundation (IOS-0820405 to D.F.K.) and US Public Health Service (MH18501 to S.H.S. and M.M.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashfaq UA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-112; Bellosillo B, 1998, BLOOD, V92, P1406, DOI 10.1182/blood.V92.4.1406.416k17_1406_1414; Choi HW, 2015, MOL MED, V21, P526, DOI 10.2119/molmed.2015.00148; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Derouet M, 2006, J IMMUNOL, V176, P957, DOI 10.4049/jimmunol.176.2.957; Ekinci D, 2011, EXPERT OPIN THER PAT, V21, P1831, DOI 10.1517/13543776.2011.636354; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; Kiss K, 2004, J BIOCHEM BIOPH METH, V61, P229, DOI 10.1016/j.jbbm.2004.06.003; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; Lee EJ, 2003, INT J ONCOL, V23, P503; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Manohar M, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00777; McKenzie SM, 1999, GUT, V44, P180, DOI 10.1136/gut.44.2.180; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Petrik J, 1999, J GEN VIROL, V80, P3109, DOI 10.1099/0022-1317-80-12-3109; PROOST JH, 1983, PHARM WEEKBLAD, V5, P22, DOI 10.1007/BF01959647; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; ROWLAND M, 1967, NATURE, V215, P413, DOI 10.1038/215413a0; Sato H, 1996, ANTIVIR RES, V30, P171, DOI 10.1016/0166-3542(96)00942-4; TAMAI H, 1991, BIOCHEM PHARMACOL, V41, P1001, DOI 10.1016/0006-2952(91)90207-L; Tian MY, 2015, MOL PLANT MICROBE IN, V28, P379, DOI 10.1094/MPMI-09-14-0259-R; Tian MY, 2012, PLANT J, V72, P1027, DOI 10.1111/tpj.12016; Van Rossum TGJ, 1998, ALIMENT PHARM THER, V12, P199; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang RYL, 2008, CELL HOST MICROBE, V3, P178, DOI 10.1016/j.chom.2008.02.005; Weidner C, 2012, P NATL ACAD SCI USA, V109, P7257, DOI 10.1073/pnas.1116971109; WEISSMANN G, 1991, SCI AM, V264, P84, DOI 10.1038/scientificamerican0191-84; WILLIAMS JG, 1989, BIOCHEM PHARMACOL, V38, P149, DOI 10.1016/0006-2952(89)90161-5; Wu KK, 2000, CIRCULATION, V102, P2022, DOI 10.1161/01.CIR.102.17.2022; Yi MY, 2000, J VIROL, V74, P6459, DOI 10.1128/JVI.74.14.6459-6468.2000; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zang WQ, 1998, VIROLOGY, V248, P46, DOI 10.1006/viro.1998.9255; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	39	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143447	10.1371/journal.pone.0143447	http://dx.doi.org/10.1371/journal.pone.0143447			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606248	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300067
J	Huang, JX; Wang, JF; Li, ZJ; Wang, Y; Lai, SJ; Yang, WZ				Huang, Ji-Xia; Wang, Jin-Feng; Li, Zhong-Jie; Wang, Yan; Lai, Sheng-Jie; Yang, Wei-Zhong			Visualized Exploratory Spatiotemporal Analysis of Hand-Foot-Mouth Disease in Southern China	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; BRUCELLOSIS MODEL; INFECTION	Objectives In epidemiological research, major studies have focused on theoretical models; however, few methods of visual analysis have been used to display the patterns of disease distribution. Design For this study, a method combining the space-time cube (STC) with space-time scan statistics (STSS) was used to analyze the pattern of incidence of hand-foot-mouth disease (HFMD) in Guangdong Province from May 2008 to March 2009. In this research, STC was used to display the spatiotemporal pattern of incidence of HFMD, and STSS were used to detect the local aggregations of the disease. Setting The hand-foot-mouth disease data were obtained from Guangdong Province from May 2008 to March 2009, with a total of 68,130 cases. Results The STC analysis revealed a differential pattern of HFMD incidence among different months and cities and also showed that the population density and average precipitation are correlated with the incidence of HFMD. The STSS analysis revealed that the most likely aggregation includes the Shenzhen, Foshan and Dongguan populations, which are the most developed regions in Guangdong Province. Conclusion Both STC and STSS are efficient tools for the exploratory data analysis of disease transmission. STC clearly displays the spatiotemporal patterns of disease. Using the maximum likelihood ratio, the STSS model precisely locates the most likely aggregation.	[Huang, Ji-Xia] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Huang, Ji-Xia] Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China; [Huang, Ji-Xia; Wang, Jin-Feng] Chinese Acad Sci, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Li, Zhong-Jie; Lai, Sheng-Jie; Yang, Wei-Zhong] Chinese Ctr Dis Control & Prevent, Key Lab Infect Dis Surveillance & Early Warning, Beijing, Peoples R China; [Wang, Yan] Beijing Res Inst Water Affair Automat, Beijing, Peoples R China	Beijing Forestry University; Beijing Normal University; Chinese Academy of Sciences; Chinese Center for Disease Control & Prevention	Huang, JX (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	huangjx@bjfu.edu.cn; wangjf@lreis.ac.cn	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Wang, Jinfeng/0000-0002-6687-9420	National Natural Science Foundation of China [41501426]; Open Fund of State Key Laboratory of Remote Sensing Science [OFSLRSS201513]; MOST [2012CB955503, 201202006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of State Key Laboratory of Remote Sensing Science; MOST	This study was supported by National Natural Science Foundation of China (No. 41501426), Open Fund of State Key Laboratory of Remote Sensing Science (No. OFSLRSS201513) and MOST (2012CB955503; 201202006).	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Boscoe FP, 2003, HEALTH PLACE, V9, P273, DOI 10.1016/S1353-8292(02)00060-6; Cao ZD, 2010, CHINESE SCI BULL, V55, P1142, DOI 10.1007/s11434-010-0144-0; Gatalsky P, 2004, IEEE INFOR VIS, P145, DOI 10.1109/IV.2004.1320137; Hagerstraand T., 1970, PAPERS REGIONAL SCI, V24, P7, DOI [DOI 10.1111/J.1435-5597.1970.TB01464.X, 10.1007/BF01936872]; Hardisty F, 2011, INT J GEOGR INF SCI, V25, P191, DOI 10.1080/13658810903214203; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu M, 2012, PLOS ONE, V6; Huang JX, 2014, INT J ENV RES PUB HE, V11, P3407, DOI 10.3390/ijerph110303407; Jung I, 2010, STAT MED, V29, P1910, DOI 10.1002/sim.3951; Kraak M.-J., 2003, PROC 21 INT CARTOGRA, P1988; Kraak MJ, 2005, DEVELOPMENTS IN SPATIAL DATA HANDLING, P189, DOI 10.1007/3-540-26772-7_15; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; Li MT, 2014, MATH BIOSCI ENG, V11, P1115, DOI 10.3934/mbe.2014.11.1115; Li X, 2011, ACTA ECOLOGICA SINIC, V31, P31, DOI DOI 10.1002/SIM.4341; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; MacEachren AM, 1998, ENVIRON PLANN A, V30, P1547, DOI 10.1068/a301547; MacEachren AM, 1990, CARTOGRAPHIC PERSPEC, V4, P32; National Bureau of Statistics of China, 2009, CHIN CIT STAT YB 200; Nie J, 2014, J BIOL SYST, V22, P533, DOI 10.1142/S021833901450020X; OLAP Council, 1995, OLAP COUNCIL OLAP OL; Openshaw S, 1987, INT J GEOGR INF SYST, V1, P335, DOI DOI 10.1080/02693798708927821; PEUQUET DJ, 1994, ANN ASSOC AM GEOGR, V84, P441, DOI 10.1111/j.1467-8306.1994.tb01869.x; Reis Ben Y, 2003, BMC Med Inform Decis Mak, V3, P2, DOI 10.1186/1472-6947-3-2; Shekhar S, 2002, IEEE 5TH INTERNATIONAL CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, PROCEEDINGS, P674, DOI 10.1109/ITSC.2002.1041299; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006; TURNBULL BW, 1990, AM J EPIDEMIOL, V132, pS136; Wang JF, 2013, GEOSPATIAL HEALTH, V7, P381, DOI 10.4081/gh.2013.95; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; WHO, HAND FOOT MOUTH DIS; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108592; Zhang J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04846; Zhou H, 2008, COMPUT GRAPH FORUM, V27, P1047, DOI 10.1111/j.1467-8659.2008.01241.x	38	14	16	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143411	10.1371/journal.pone.0143411	http://dx.doi.org/10.1371/journal.pone.0143411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605919	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000365865300064
J	Loschky, LC; Larson, AM; Magliano, JP; Smith, TJ				Loschky, Lester C.; Larson, Adam M.; Magliano, Joseph P.; Smith, Tim J.			What Would Jaws Do? The Tyranny of Film and the Relationship between Gaze and Higher-Level Narrative Film Comprehension	PLOS ONE			English	Article							EYE-MOVEMENT CONTROL; SITUATION MODELS; PERCEPTION; SEGMENTATION; INFERENCES; CONTINUITY; ATTENTION; BLINDNESS; SALIENCE; VIEWERS	What is the relationship between film viewers' eye movements and their film comprehension? Typical Hollywood movies induce strong attentional synchrony-most viewers look at the same things at the same time. Thus, we asked whether film viewers' eye movements would differ based on their understanding-the mental model hypothesis-or whether any such differences would be overwhelmed by viewers' attentional synchrony-the tyranny of film hypothesis. To investigate this question, we manipulated the presence/absence of prior film context and measured resulting differences in film comprehension and eye movements. Viewers watched a 12-second James Bond movie clip, ending just as a critical predictive inference should be drawn that Bond's nemesis, "Jaws," would fall from the sky onto a circus tent. The No-context condition saw only the 12-second clip, but the Context condition also saw the preceding 2.5 minutes of the movie before seeing the critical 12-second portion. Importantly, the Context condition viewers were more likely to draw the critical inference and were more likely to perceive coherence across the entire 6 shot sequence (as shown by event segmentation), indicating greater comprehension. Viewers' eye movements showed strong attentional synchrony in both conditions as compared to a chance level baseline, but smaller differences between conditions. Specifically, the Context condition viewers showed slightly, but significantly, greater attentional synchrony and lower cognitive load (as shown by fixation probability) during the critical first circus tent shot. Thus, overall, the results were more consistent with the tyranny of film hypothesis than the mental model hypothesis. These results suggest the need for a theory that encompasses processes from the perception to the comprehension of film.	[Loschky, Lester C.] Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA; [Larson, Adam M.] Univ Findlay, Dept Psychol, Findlay, OH USA; [Magliano, Joseph P.] No Illinois Univ, Dept Psychol, De Kalb, IL 60115 USA; [Smith, Tim J.] Birkbeck Univ London, Dept Psychol, London, England	Kansas State University; University of Findlay; Northern Illinois University; University of London; Birkbeck University London	Loschky, LC (corresponding author), Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA.	loschky@ksu.edu		Smith, Tim/0000-0002-2808-9401	Center for the Interdisciplinary Studies of Language and Literacy	Center for the Interdisciplinary Studies of Language and Literacy	Research by JM was funded by the Center for the Interdisciplinary Studies of Language and Literacy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DIGITAL MOBILE TV DO; BAGGETT P, 1979, J VERB LEARN VERB BE, V18, P333, DOI 10.1016/S0022-5371(79)90191-9; Bartlett F. C., 1932, REMEMBERING; Bordwell D, 2002, FILM QUART, V55, P16, DOI 10.1525/fq.2002.55.3.16; Bordwell David, 1985, NARRATION FICTION FI; Broccoli A. R. P, 1979, MOONRAKER; Carmi R, 2006, VISION RES, V46, P4333, DOI 10.1016/j.visres.2006.08.019; Chan HS, 1998, ERGONOMICS, V41, P1433, DOI 10.1080/001401398186199; Copeland DE, 2006, COGNITIVE SYSTEMS: HUMAN COGNITIVE MODELS IN SYSTEMS DESIGN, P37; Cutting JE, 2011, I-PERCEPTION, V2, P569, DOI 10.1068/i0441aap; DeAngelus M, 2009, VIS COGN, V17, P790, DOI 10.1080/13506280902793843; Dorr M, 2010, J VISION, V10, DOI 10.1167/10.10.28; Ehinger KA, 2009, VIS COGN, V17, P945, DOI 10.1080/13506280902834720; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Foulsham T, 2007, PERCEPTION, V36, P1123, DOI 10.1068/p5659; Freeland C, 2012, PROJECTIONS J MOVIES, V6, P34, DOI DOI 10.3167/PROJ.2012.060102A; Gernsbacher M. A., 1990, LANGUAGE COMPREHENSI; Goldstein RB, 2007, COMPUT BIOL MED, V37, P957, DOI 10.1016/j.compbiomed.2006.08.018; GRAESSER AC, 1994, PSYCHOL REV, V101, P371, DOI 10.1037/0033-295X.101.3.371; Grice Paul., 1989, STUDIES WAY WORDS; Hard BM, 2006, MEM COGNITION, V34, P1221, DOI 10.3758/BF03193267; Hasson U, 2008, PROJECTIONS, V2, P1, DOI 10.3167/proj.2008.020102; Henderson J. M., 2005, REAL WORLD SCENE PER; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; HORNSHOJMOLLER S, 1992, HIST J FILM RADIO TV, V12, P41, DOI 10.1080/01439689200260021; Hutson J, 2014, J VISION, V14, P760; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kaakinen JK, 2011, Q J EXP PSYCHOL, V64, P1372, DOI 10.1080/17470218.2010.548872; Kurby CA, 2008, TRENDS COGN SCI, V12, P72, DOI 10.1016/j.tics.2007.11.004; Le Meur O, 2013, BEHAV RES METHODS, V45, P251, DOI 10.3758/s13428-012-0226-9; Levin DT, 1997, PSYCHON B REV, V4, P501, DOI 10.3758/BF03214339; Magliano JP, 2011, COGNITIVE SCI, V35, P1489, DOI 10.1111/j.1551-6709.2011.01202.x; Magliano Joseph P., 2013, UNRAVELING BEHAV NEU, P78; Magliano JP, 1996, DISCOURSE PROCESS, V22, P199, DOI 10.1080/01638539609544973; Magliano JP, 2001, APPL COGNITIVE PSYCH, V15, P533, DOI 10.1002/acp.724; MCKOON G, 1992, PSYCHOL REV, V99, P440, DOI 10.1037/0033-295X.99.3.440; Memmert D, 2006, CONSCIOUS COGN, V15, P620, DOI 10.1016/j.concog.2006.01.001; Mital PK, 2011, COGN COMPUT, V3, P5, DOI 10.1007/s12559-010-9074-z; Munoz B, 2006, BEHAV RES METHODS, V38, P211, DOI 10.3758/BF03192771; Murch W., 2001, BLINK EYE; NEWTSON D, 1973, J PERS SOC PSYCHOL, V28, P28, DOI 10.1037/h0035584; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Parkhurst DJ, 2003, SPATIAL VISION, V16, P125, DOI 10.1163/15685680360511645; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Reichle ED, 2010, PSYCHOL SCI, V21, P1300, DOI 10.1177/0956797610378686; Reilly RG, 2006, COGN SYST RES, V7, P34, DOI 10.1016/j.cogsys.2005.07.006; Reingold E.M., 2000, READING PERCEPTUAL P, P119, DOI [10.1016/B978-008043642-5/50008-5, DOI 10.1016/B978-008043642-5/50008-5]; Reingold EM, 2002, J COGNITIVE NEUROSCI, V14, P371, DOI 10.1162/089892902317361903; Rentschler Eric, 1996, MINISTRY ILLUSION NA; Rosenholtz R, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00013; Schwan S, 2010, PSYCHOL SCI, V21, P970, DOI 10.1177/0956797610372632; Shepherd SV, 2010, CURR BIOL, V20, P649, DOI 10.1016/j.cub.2010.02.032; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Smith T., 2008, J EYE MOVEMENT RES, V2, p[6, 1], DOI DOI 10.16910/JEMR.2.2.6; Smith TJ, 2012, PROJECTIONS, V6, P1, DOI 10.3167/proj.2012.060102; Smith TJ, 2013, J VISION, V13, DOI 10.1167/13.8.16; Smith TJ, 2012, PERCEPTION, V41, P489, DOI 10.1068/p7092; Smith TJ, 2012, CURR DIR PSYCHOL SCI, V21, P107, DOI 10.1177/0963721412437407; Stirk JA, 2007, J VISION, V7, DOI 10.1167/7.10.3; Taya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071371; Taya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039060; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Tosi V, 1997, INT J NEUROSCI, V92, P47, DOI 10.3109/00207459708986388; Triesch J, 2003, J VISION, V3, P86, DOI 10.1167/3.1.9; VITU F, 1995, PERCEPT PSYCHOPHYS, V57, P352, DOI 10.3758/BF03213060; Wang HX, 2012, J VISION, V12, DOI [10.1167/12.1.16, 10.1167/12.6.26]; Welles Orson, 1958, TOUCH OF EVIL; Yang SN, 2001, VISION RES, V41, P3567, DOI 10.1016/S0042-6989(01)00025-6; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Zacks JM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00168; Zacks JM, 2009, J EXP PSYCHOL GEN, V138, P307, DOI 10.1037/a0015305; Zacks JM, 2001, PSYCHOL BULL, V127, P3, DOI 10.1037//0033-2909.127.1.3; ZWAAN RA, 1995, PSYCHOL SCI, V6, P292, DOI 10.1111/j.1467-9280.1995.tb00513.x; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	76	66	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142474	10.1371/journal.pone.0142474	http://dx.doi.org/10.1371/journal.pone.0142474			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CX7ES	26606606	Green Published, gold, Green Accepted			2022-12-26	WOS:000365865300020
J	Macas, J; Novak, P; Pellicer, J; Cizkova, J; Koblizkova, A; Neumann, P; Fukova, I; Dolezel, J; Kelly, LJ; Leitch, IJ				Macas, Jiri; Novak, Petr; Pellicer, Jaume; Cizkova, Jana; Koblizkova, Andrea; Neumann, Pavel; Fukova, Iva; Dolezel, Jaroslav; Kelly, Laura J.; Leitch, Ilia J.			In Depth Characterization of Repetitive DNA in 23 Plant Genomes Reveals Sources of Genome Size Variation in the Legume Tribe Fabeae	PLOS ONE			English	Article							GENERATION SEQUENCING REVEALS; TRANSPOSABLE ELEMENTS; C-VALUE; EVOLUTION; EXPANSION; DYNAMICS; AMPLIFICATION; RETROTRANSPOSONS; DATABASE; LINEAGE	The differential accumulation and elimination of repetitive DNA are key drivers of genome size variation in flowering plants, yet there have been few studies which have analysed how different types of repeats in related species contribute to genome size evolution within a phylogenetic context. This question is addressed here by conducting large-scale comparative analysis of repeats in 23 species from four genera of the monophyletic legume tribe Fabeae, representing a 7.6-fold variation in genome size. Phylogenetic analysis and genome size reconstruction revealed that this diversity arose from genome size expansions and contractions in different lineages during the evolution of Fabeae. Employing a combination of low-pass genome sequencing with novel bioinformatic approaches resulted in identification and quantification of repeats making up 55-83% of the investigated genomes. In turn, this enabled an analysis of how each major repeat type contributed to the genome size variation encountered. Differential accumulation of repetitive DNA was found to account for 85% of the genome size differences between the species, and most (57%) of this variation was found to be driven by a single lineage of Ty3/gypsy LTR-retrotransposons, the Ogre elements. Although the amounts of several other lineages of LTR-retrotransposons and the total amount of satellite DNA were also positively correlated with genome size, their contributions to genome size variation were much smaller (up to 6%). Repeat analysis within a phylogenetic framework also revealed profound differences in the extent of sequence conservation between different repeat types across Fabeae. In addition to these findings, the study has provided a proof of concept for the approach combining recent developments in sequencing and bioinformatics to perform comparative analyses of repetitive DNAs in a large number of non-model species without the need to assemble their genomes.	[Macas, Jiri; Novak, Petr; Koblizkova, Andrea; Neumann, Pavel; Fukova, Iva] Acad Sci Czech Republ, Inst Plant Mol Biol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Pellicer, Jaume; Leitch, Ilia J.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Cizkova, Jana; Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic; [Kelly, Laura J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Royal Botanic Gardens, Kew; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of London; Queen Mary University London	Macas, J (corresponding author), Acad Sci Czech Republ, Inst Plant Mol Biol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic.	macas@umbr.cas.cz	Leitch, Ilia J/D-6052-2011; Neumann, Pavel/H-7345-2013; Pellicer, Jaume/L-3048-2015; Leitch, Ilia J/X-5449-2019; Macas, Jiri/G-8618-2014; Vrbova, Iva/G-9415-2014; Novak, Petr/A-3059-2013; Dolezel, Jaroslav/B-7716-2008; Pellicer, Jaume/AAA-3065-2022	Leitch, Ilia J/0000-0002-3837-8186; Neumann, Pavel/0000-0001-6711-6639; Pellicer, Jaume/0000-0001-7632-9775; Leitch, Ilia J/0000-0002-3837-8186; Macas, Jiri/0000-0003-0829-1570; Vrbova, Iva/0000-0002-2472-0665; Novak, Petr/0000-0002-5068-9681; Dolezel, Jaroslav/0000-0002-6263-0492; Pellicer, Jaume/0000-0001-7632-9775; Cizkova, Jana/0000-0001-7787-1849	Czech Science Foundation [GBP501/12/G090]; Czech Academy of Sciences [RVO:60077344]; National Program of Sustainability I. [LO1204]; Czech National Grid Infrastructure MetaCentrum [LM2010005]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences); National Program of Sustainability I.; Czech National Grid Infrastructure MetaCentrum	This work was supported by grants from the Czech Science Foundation [GBP501/12/G090] and the Czech Academy of Sciences [RVO:60077344] to JM and from the National Program of Sustainability I. [LO1204] to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Genbank of the Leibniz Institute of Plant Genetics and Crop Plant Research (Gatersleben, Germany) and Petr Smykal (Palacky University, Olomouc, Czech Republic) for providing seeds of some Fabeae species, and V. Tetourova and J. Latalova for excellent technical assistance. Access to computing and storage facilities owned by parties and projects contributing to the Czech National Grid Infrastructure MetaCentrum, provided under the program " Projects of Large Infrastructure for Research, Development, and Innovations" [LM2010005], is greatly appreciated.	Agren JA, 2015, EVOLUTION, V69, P1053, DOI 10.1111/evo.12627; Agren JA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-602; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennett MD, 2012, PLANT DNA C VALUES D; Bennetzen JL, 2014, ANNU REV PLANT BIOL, V65, P505, DOI 10.1146/annurev-arplant-050213-035811; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Cai ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1025; Camacho JPM, 2015, CHROMOSOMA, V124, P263, DOI 10.1007/s00412-014-0499-0; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; DOLEZEL J, 1994, BIOL PLANTARUM, V36, P351, DOI 10.1007/BF02920930; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; El Baidouri M, 2013, GENOME BIOL EVOL, V5, P954, DOI 10.1093/gbe/evt025; Estep MC, 2013, HEREDITY, V110, P194, DOI 10.1038/hdy.2012.99; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; Fleischmann A, 2014, ANN BOT-LONDON, V114, P1651, DOI 10.1093/aob/mcu189; Garcia G, 2015, GENETICA, V143, P353, DOI 10.1007/s10709-015-9834-5; Gong ZY, 2012, PLANT CELL, V24, P3559, DOI 10.1105/tpc.112.100511; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Greilhuber J, 2005, ANN BOT-LONDON, V95, P255, DOI 10.1093/aob/mci019; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hawkins JS, 2009, P NATL ACAD SCI USA, V106, P17811, DOI 10.1073/pnas.0904339106; Hemleben V, 2007, SYST BIODIVERS, V5, P277, DOI 10.1017/S147720000700240X; INGHAM LD, 1993, MOL GEN GENET, V238, P350, DOI 10.1007/BF00291993; Istvanek J, 2014, AM J BOT, V101, P327, DOI 10.3732/ajb.1300340; Kejnovsky E, 2012, PLANT GENOME DIVERSI, V1, P17; Kelly LJ, 2015, NEW PHYTOL, V208, P596, DOI 10.1111/nph.13471; Kelly LJ, 2012, PLANT ECOL DIVERS, V5, P415, DOI 10.1080/17550874.2012.716868; Kelly LJ, 2011, CHROMOSOME RES, V19, P939, DOI 10.1007/s10577-011-9246-z; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Klemme S, 2013, NEW PHYTOL, V199, P550, DOI 10.1111/nph.12289; Linquist S, 2013, BIOL REV, V88, P573, DOI 10.1111/brv.12017; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Lockton S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-10; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lysak MA, 1998, CARYOLOGIA, V51, P123, DOI 10.1080/00087114.1998.10589127; Macas J, 2000, MOL GEN GENET, V263, P741, DOI 10.1007/s004380000245; Macas J, 2003, CHROMOSOMA, V112, P152, DOI 10.1007/s00412-003-0255-3; Macas J, 2002, BIOINFORMATICS, V18, P28, DOI 10.1093/bioinformatics/18.1.28; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2007, GENE, V390, P108, DOI 10.1016/j.gene.2006.08.007; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Michael TP, 2014, BRIEF FUNCT GENOMICS, V13, P308, DOI 10.1093/bfgp/elu005; Navratilova A, 2003, ANN BOT-LONDON, V91, P921, DOI 10.1093/aob/mcg099; Neumann P, 2006, GENETICS, V173, P1047, DOI 10.1534/genetics.106.056259; Neumann P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002777; Nouzova M, 2001, PLANT MOL BIOL, V45, P229, DOI 10.1023/A:1006408119740; Novak P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098918; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Nylander JAA, 2004, MRMODELTEST 2 0; Oliver KR, 2013, GENOME BIOL EVOL, V5, P1886, DOI 10.1093/gbe/evt141; Oliver KR, 2009, BIOESSAYS, V31, P703, DOI 10.1002/bies.200800219; Otto F, 1990, Methods Cell Biol, V33, P105; Pagan HJT, 2012, GENOME BIOL EVOL, V4, P575, DOI 10.1093/gbe/evs038; Pellicer J, 2014, NEW PHYTOL, V201, P1484, DOI 10.1111/nph.12617; Pellicer J, 2010, BOT J LINN SOC, V164, P10, DOI 10.1111/j.1095-8339.2010.01072.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Piednoel M, 2012, MOL BIOL EVOL, V29, P3601, DOI 10.1093/molbev/mss168; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Renny-Byfield S, 2011, MOL BIOL EVOL, V28, P2843, DOI 10.1093/molbev/msr112; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schaefer H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-250; Smykal P, 2009, HEREDITY, V103, P157, DOI 10.1038/hdy.2009.45; Steinbauerova V, 2008, MOL GENET GENOMICS, V280, P427, DOI 10.1007/s00438-008-0376-8; Steinbauerova V, 2011, GENETICA, V139, P1543, DOI 10.1007/s10709-012-9654-9; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; THOMAS CA, 1971, ANNU REV GENET, V5, P237, DOI 10.1146/annurev.ge.05.120171.001321; Travnicek P, 2010, PRESLIA, V82, P149; Weiss-Schneeweiss H., 2015, NEXT GENERATION SEQU; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152; Zuccolo A, 2015, GENE, V568, P89, DOI 10.1016/j.gene.2015.05.028	76	110	111	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143424	10.1371/journal.pone.0143424	http://dx.doi.org/10.1371/journal.pone.0143424			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606051	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300065
J	Chen, MC; Chen, YL; Lee, CF; Hung, CH; Chou, TC				Chen, Meng-Chuan; Chen, Yen-Lin; Lee, Chi-Feng; Hung, Chih-Huang; Chou, Tz-Chong			Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1	PLOS ONE			English	Article							GROWTH-FACTOR-I; MYOSTATIN; CACHEXIA; HYPERTROPHY; INTERLEUKIN-6; INHIBITION; EXPRESSION; PATHWAYS; PROTEIN; CELLS	Skeletal muscle atrophy, the most prominent phenotypic feature of cancer cachexia, is often observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from Magnolia officinalis exhibits several pharmacological effects including anti-inflammatory and anticancer activities. In this study, we investigated whether magnolol supplementation protects against the development of cachexia symptoms in bladder cancer-bearing mice undergoing chemotherapy. Combined treatment of magnolol with chemotherapeutic drugs, such as gemcitabine and cisplatin (TGCM) or gemcitabine (TGM), markedly attenuates the body weight loss and skeletal muscle atrophy compared with conventional chemotherapy (TGC). The antiatrophic effect of magnolol may be associated with inhibition of myostatin and activin A formation, as well as FoxO3 transcriptional activity resulting from Akt activation, thereby suppressing ubiquitin ligases MuRF-1 and MAFbx/atrogin-1 expression, as well as proteasomal enzyme activity. Notably, magnolol-induced insulin-like growth factor 1 (IGF-1) production and related protein synthesis may also contribute to its protective effects. The decreased food intake, and intestinal injury and dysfunction observed in the mice of TGC group were significantly improved in the TGCM and TGM groups. Moreover, the increased inflammatory responses evidenced by elevation of proinflammatory cytokine formation and NF-kappa B activation occurred in the atrophying muscle of TGC group were markedly inhibited in mice of combined treatment with magnolol. In summary, these findings support that magnolol is a promising chemopreventive supplement for preventing chemotherapy-induced skeletal muscle atrophy associated with cancer cachexia by suppressing muscle protein degradation, and inflammatory responses, as well as increasing IGF-1-mediated protein synthesis.	[Chen, Meng-Chuan; Chou, Tz-Chong] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chen, Yen-Lin] Cardinal Tien Hosp, Dept Pathol, New Taipei, Taiwan; [Chen, Yen-Lin] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Lee, Chi-Feng] Natl Def Med Ctr, Inst Prevent Med, Div Biopharmaceut, Taipei, Taiwan; [Hung, Chih-Huang; Chou, Tz-Chong] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chou, Tz-Chong] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chou, Tz-Chong] China Med Univ, China Med Univ Hosp, Taichung, Taiwan	National Defense Medical Center; Fu Jen Catholic University; National Defense Medical Center; Tzu Chi University; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chou, TC (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	tcchou48@mail.tcu.edu.tw			Tzu-Chi General Hospital [TDRD103-40]	Tzu-Chi General Hospital	This study was supported by a grant from Tzu-Chi General Hospital (TDRD103-40). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P2036, DOI 10.1016/j.biocel.2005.03.014; Aversa Z, 2012, ANN SURG ONCOL, V19, P1350, DOI 10.1245/s10434-011-1720-5; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Braun TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106489; Chen MC, 2013, BIOCHEM PHARMACOL, V85, P1278, DOI 10.1016/j.bcp.2013.02.009; Cohen MH, 2001, J CLIN ONCOL, V19, P1229, DOI 10.1200/JCO.2001.19.4.1229; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; de Palma L, 2008, JOINT BONE SPINE, V75, P53, DOI 10.1016/j.jbspin.2007.04.019; Donohoe CL, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/601434; Ebner N, 2014, CURR OPIN SUPPORT PA, V8, P15, DOI 10.1097/SPC.0000000000000030; Eley HL, 2007, BIOCHEM J, V407, P113, DOI 10.1042/BJ20070651; Elkina Y, 2011, J CACHEXIA SARCOPENI, V2, P143, DOI 10.1007/s13539-011-0035-5; Fanzani A, 2011, TOXICOL APPL PHARM, V250, P312, DOI 10.1016/j.taap.2010.11.003; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Ge XM, 2013, MOL CELL ENDOCRINOL, V372, P23, DOI 10.1016/j.mce.2013.03.017; Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019; LAZARUS DD, 1993, LYMPHOKINE CYTOK RES, V12, P219; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; MacDonald V, 2009, CAN VET J, V50, P665; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Narsale AA, 2014, CURR OPIN SUPPORT PA, V8, P321, DOI 10.1097/SPC.0000000000000091; Onesti JK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/168407; Rhoads MG, 2010, EUR J CANCER, V46, P191, DOI 10.1016/j.ejca.2009.10.008; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Soares PMG, 2008, CANCER CHEMOTH PHARM, V63, P91, DOI 10.1007/s00280-008-0715-9; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Strucksberg KH, 2010, ANAL BIOCHEM, V399, P225, DOI 10.1016/j.ab.2009.12.026; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wing SS, 2011, CRIT REV CL LAB SCI, V48, P49, DOI 10.3109/10408363.2011.586171; Yamamoto H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/276186; Yu DS, 2007, J UROLOGY, V177, P738, DOI 10.1016/j.juro.2006.09.074; Zheng ZY, 2013, INT J MED SCI, V10, P653, DOI 10.7150/ijms.6050; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	39	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143594	10.1371/journal.pone.0143594	http://dx.doi.org/10.1371/journal.pone.0143594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600425	Green Submitted, gold, Green Published			2022-12-26	WOS:000365862600091
J	Wang, Y; Ding, JT; Yang, HM; Yan, ZJ; Cao, W; Li, YB				Wang, Ying; Ding, Jia-tong; Yang, Hai-ming; Yan, Zheng-jie; Cao, Wei; Li, Yang-bai			Analysis of Pigeon (Columba) Ovary Transcriptomes to Identify Genes Involved in Blue Light Regulation	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; ACTIVATED PROTEIN-KINASE; RNA-SEQ DATA; CIRCADIAN CLOCK; FOLLICULAR DEVELOPMENT; MONOCHROMATIC LIGHT; MEIOTIC MATURATION; ESTROGEN-RECEPTOR; IMMUNE-RESPONSE; JAPANESE-QUAIL	Monochromatic light is widely applied to promote poultry reproductive performance, yet little is currently known regarding the mechanism by which light wavelengths affect pigeon reproduction. Recently, high-throughput sequencing technologies have been used to provide genomic information for solving this problem. In this study, we employed Illumina Hiseq 2000 to identify differentially expressed genes in ovary tissue from pigeons under blue and white light conditions and de novo transcriptome assembly to construct a comprehensive sequence database containing information on the mechanisms of follicle development. A total of 157,774 unigenes (mean length: 790 bp) were obtained by the Trinity program, and 35.83% of these unigenes were matched to genes in a non-redundant protein database. Gene description, gene ontology, and the clustering of orthologous group terms were performed to annotate the transcriptome assembly. Differentially expressed genes between blue and white light conditions included those related to oocyte maturation, hormone biosynthesis, and circadian rhythm. Furthermore, 17,574 SSRs and 533,887 potential SNPs were identified in this transcriptome assembly. This work is the first transcriptome analysis of the Columba ovary using Illumina technology, and the resulting transcriptome and differentially expressed gene data can facilitate further investigations into the molecular mechanism of the effect of blue light on follicle development and reproduction in pigeons and other bird species.	[Wang, Ying; Ding, Jia-tong; Yang, Hai-ming; Yan, Zheng-jie; Cao, Wei; Li, Yang-bai] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University	Ding, JT (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China.	jtding@yzu.edu.cn; hmyang@yzu.edu.cn			Priority Academic Program Development of Jiangsu Higher Education Institutions; Cultivate Funding of Six Kinds of High-level Personnel Selection in Jiangsu Province [2014 - NY - 036]	Priority Academic Program Development of Jiangsu Higher Education Institutions; Cultivate Funding of Six Kinds of High-level Personnel Selection in Jiangsu Province	This research was funded by grants from A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and The Cultivate Funding of Six Kinds of High-level Personnel Selection in Jiangsu Province (2014 - NY - 036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHOFF J, 1966, ECOLOGY, V47, P657, DOI 10.2307/1933949; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Campbell CL, 2015, POULTRY SCI; Choi TS, 1996, P NATL ACAD SCI USA, V93, P7032, DOI 10.1073/pnas.93.14.7032; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; FOSS DC, 1983, POULTRY SCI, V62, P1424; Gieffers C, 2001, MOL CELL, V7, P907, DOI 10.1016/S1097-2765(01)00234-9; Goerlich VC, 2010, J EXP ZOOL PART A, V313A, P328, DOI 10.1002/jez.600; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu HC, 2004, ENCY PIGEON BREEDING, P2; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Halevy O, 2006, AM J PHYSIOL-REG I, V290, pR1062, DOI 10.1152/ajpregu.00378.2005; HORSEMAN ND, 1995, ANNU REV NUTR, V15, P213; Hoshino Y, 2004, MOL REPROD DEV, V69, P77, DOI 10.1002/mrd.20150; Hussein TS, 2006, DEV BIOL, V296, P514, DOI 10.1016/j.ydbio.2006.06.026; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kunstner A, 2010, MOL ECOL, V19, P266, DOI 10.1111/j.1365-294X.2009.04487.x; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lewis PD, 2000, WORLD POULTRY SCI J, V56, P189, DOI 10.1079/WPS20000015; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Liu WJ, 2010, ANAT REC, V293, P1315, DOI 10.1002/ar.21174; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Maurer G, 2011, J AVIAN BIOL, V42, P494, DOI 10.1111/j.1600-048X.2011.05368.x; McGinnis J, 1967, PACIFIC POULTRYMAN, P24; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullis PE, 1997, J CLIN ENDOCR METAB, V82, P1739, DOI 10.1210/jc.82.6.1739; Nakao N, 2007, ENDOCRINOLOGY, V148, P3031, DOI 10.1210/en.2007-0044; NEBERT DW, 1987, DNA-J MOLEC CELL BIO, V6, P1, DOI 10.1089/dna.1987.6.1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; RIDDLE OSCAR, 1963, ANIMAL BEHAVIOUR, V11, P419, DOI 10.1016/0003-3472(63)90256-2; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Sadrzadeh A, 2011, AFR J BIOTECHNOL, V10, P9528; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; Schmitt A, 2002, J CELL SCI, V115, P2457; SILVER R, 1984, J EXP ZOOL, V232, P617, DOI 10.1002/jez.1402320330; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Thomas P, 2006, STEROIDS, V71, P310, DOI 10.1016/j.steroids.2005.09.015; Wang Y, 2015, POULTRY SCI; WASSERMAN WJ, 1982, DEV BIOL, V89, P152, DOI 10.1016/0012-1606(82)90303-7; WOODARD AE, 1969, POULTRY SCI, V48, P118, DOI 10.3382/ps.0480118; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Wunderer F, 2013, ENDOCRINOLOGY, V154, P2046, DOI 10.1210/en.2012-2274; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Xie D, 2008, POULTRY SCI, V87, P1535, DOI 10.3382/ps.2007-00317; Xu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055496; Yadav S, 2015, PHYSIOL BEHAV, V147, P163, DOI 10.1016/j.physbeh.2015.04.036; Yamamura K, 2014, MOL CELL ENDOCRINOL, V382, P131, DOI 10.1016/j.mce.2013.09.014; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshino O, 2006, P NATL ACAD SCI USA, V103, P10678, DOI 10.1073/pnas.0600507103; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zhang H, 2014, GENET MOL RES, V13, P1926, DOI 10.4238/2014.March.17.20; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhao WL, 1993, PRODUCTION SPECIAL E, P12	65	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143568	10.1371/journal.pone.0143568	http://dx.doi.org/10.1371/journal.pone.0143568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599806	Green Submitted, gold, Green Published			2022-12-26	WOS:000365862600087
J	Maruyama, Y; Yokoyama, K; Yokoo, T; Shigematsu, T; Iseki, K; Tsubakihara, Y				Maruyama, Yukio; Yokoyama, Keitaro; Yokoo, Takashi; Shigematsu, Takashi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu			The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ERYTHROPOIETIN REQUIREMENTS; RECEIVING HEMODIALYSIS; ANEMIA MANAGEMENT; PRACTICE PATTERNS; RISK-FACTORS; DOUBLE-BLIND; IRON; HEMOGLOBIN; METAANALYSIS	Background/Aims Monitoring of serum ferritin levels is widely recommended in the management of anemia among patients on dialysis. However, associations between serum ferritin and mortality are unclear and there have been no investigations among patients undergoing peritoneal dialysis (PD). Methods Baseline data of 191,902 patients on dialysis (age, 65 +/- 13 years; male, 61.1%; median dialysis duration, 62 months) were extracted from a nationwide dialysis registry in Japan at the end of 2007. Outcomes, such as one-year mortality, were then evaluated using the registry at the end of 2008. Results Within one year, a total of 15,284 (8.0%) patients had died, including 6,210 (3.2%) cardiovascular and 2,707 (1.4%) infection-related causes. Higher baseline serum ferritin levels were associated with higher mortality rates among patients undergoing hemodialysis (HD). In contrast, there were no clear associations between serum ferritin levels and mortality among PD patients. Multivariate Cox regression analysis of HD patients showed that those in the highest serum ferritin decile group had higher rates of all-cause and cardiovascular mortality than those in the lowest decile group (hazard ratio [HR], 1.54; 95% confidence interval [CI], 1.31-1.81 and HR, 1.44; 95% CI, 1.13-1.84, respectively), whereas associations with infection-related mortality became non-significant (HR, 1.14; 95% CI, 0.79-1.65). Conclusions Using Japanese nationwide dialysis registry, higher serum ferritin values were associated with mortality not in PD patients but in HD patients.	[Maruyama, Yukio; Yokoyama, Keitaro; Yokoo, Takashi] Jikei Univ, Sch Med, Div Nephrol & Hypertens, Tokyo, Japan; [Shigematsu, Takashi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan	Jikei University	Maruyama, Y (corresponding author), Jikei Univ, Sch Med, Div Nephrol & Hypertens, Tokyo, Japan.	maruyama@td5.so-net.ne.jp						Akizawa T, 2014, THER APHER DIAL, V18, P24, DOI 10.1111/1744-9987.12202; [Anonymous], 2004, NEPHROL DIAL TRANSPL, V19, pii1; Bailie GR, 2013, NEPHROL DIAL TRANSPL, V28, P2570, DOI 10.1093/ndt/gft062; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Coronel F, 2003, J NEPHROL, V16, P697; Coyne DW, 2011, KIDNEY INT, V80, P240, DOI 10.1038/ki.2011.141; Cuevas X, 2012, BLOOD PURIFICAT, V33, P21, DOI 10.1159/000332395; Galic G, 2011, COLLEGIUM ANTROPOL, V35, P93; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hasuike Y, 2010, CLIN EXP NEPHROL, V14, P349, DOI 10.1007/s10157-010-0288-x; House AA, 1998, NEPHROL DIAL TRANSPL, V13, P1763, DOI 10.1093/ndt/13.7.1763; Ichii H, 2012, AM J NEPHROL, V36, P50, DOI 10.1159/000339285; Ishida JH, 2014, SEMIN DIALYSIS, V27, P26, DOI 10.1111/sdi.12168; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; Kalantar-Zadeh K, 2006, CLIN J AM SOC NEPHRO, V1, pS9, DOI 10.2215/CJN.01390406; Kuragano T, 2014, KIDNEY INT, V86, P845, DOI 10.1038/ki.2014.114; Langston RD, 2003, KIDNEY INT, V64, P1398, DOI 10.1046/j.1523-1755.2003.00200.x; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Li SL, 2004, KIDNEY INT, V65, P1864, DOI 10.1111/j.1523-1755.2004.00584.x; Litton E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4822; Maruyama Y, 2012, CLIN NEPHROL, V78, P281, DOI 10.5414/CN107424; McFarlane PA, 2010, KIDNEY INT, V78, P215, DOI 10.1038/ki.2010.108; Molnar MZ, 2011, CLIN J AM SOC NEPHRO, V6, P1973, DOI 10.2215/CJN.01050211; Nakai S, 2009, THER APHER DIAL, V13, P457, DOI 10.1111/j.1744-9987.2009.00789.x; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Pollak VE, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-6; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Wetmore JB, 2015, AM J NEPHROL, V41, P354, DOI 10.1159/000431335	30	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143430	10.1371/journal.pone.0143430	http://dx.doi.org/10.1371/journal.pone.0143430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599216	Green Submitted, gold, Green Published			2022-12-26	WOS:000365853900119
J	Yun, D; Jeong, D; Cho, E; Jung, S				Yun, Deokgyu; Jeong, Daham; Cho, Eunae; Jung, Seunho			Colorimetric Detection of Some Highly Hydrophobic Flavonoids Using Polydiacetylene Liposomes Containing Pentacosa-10,12-diynoyl Succinoglycan Monomers	PLOS ONE			English	Article							SINORHIZOBIUM-MELILOTI; SOLUBILITY ENHANCEMENT; MOLECULAR RECOGNITION; PLANT INTERACTIONS; BETA-CYCLODEXTRIN; COMPLEXATION; ACID; TRANSITION; SEPARATION; BACTERIA	Flavonoids are a group of plant secondary metabolites including polyphenolic molecules, and they are well known for antioxidant, anti-allergic, anti-inflammatory and anti-viral propertied. In general, flavonoids are detected with various non-colorimetric detection methods such as column liquid chromatography, thin-layer chromatography, and electrochemical analysis. For the first time, we developed a straightforward colorimetric detection system allowing recognition of some highly hydrophobic flavonoids such as alpha-naphthoflavone and beta-naphthoflavone, visually using 10,12-pentacosadiynoic acid (PCDA) derivatized with succinoglycan monomers isolated from Sinorhizobium meliloti. Besides changes in visible spectrum, we also demonstrate fluorescence changes using our detection system in the presence of those flavonoids. The succinoglycan monomers attached to PCDA molecules may function as an unstructured molecular capturer for some highly hydrophobic flavonoids by hydrophobic interactions, and transmit their molecular interactions as a color change throughout the PCDA liposome.	[Yun, Deokgyu; Jeong, Daham; Jung, Seunho] Konkuk Univ, Dept Biosci & Biotechnol, MCRB, Seoul, South Korea; [Yun, Deokgyu; Jeong, Daham; Cho, Eunae; Jung, Seunho] Konkuk Univ, Ctr Biotechnol Res UBITA CBRU, Seoul, South Korea; [Cho, Eunae] Konkuk Univ, Inst Ubiquitous Informat Technol & Applicat UBITA, Seoul, South Korea	Konkuk University; Konkuk University; Konkuk University	Jung, S (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, MCRB, Seoul, South Korea.	shjung@konkuk.ac.kr	Jung, Seunho/D-4555-2011	cho, eunae/0000-0002-5422-9463	Konkuk University; SDG	Konkuk University; SDG	This paper was supported by Konkuk University in 2014.; This paper was supported by Konkuk University in 2014. SDG.	Ahmad N, 2004, J INVEST DERMATOL, V123, P417, DOI 10.1111/j.0022-202X.2004.23307.x; Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637; Brady B., 2000, ORG SYNTH, V77, P220, DOI DOI 10.15227/ORGSYN.077.0220; Brencic A, 2005, MICROBIOL MOL BIOL R, V69, P155, DOI 10.1128/MMBR.69.1.155-194.2005; Charych D, 1996, CHEM BIOL, V3, P113, DOI 10.1016/S1074-5521(96)90287-2; CHARYCH DH, 1993, SCIENCE, V261, P585, DOI 10.1126/science.8342021; Cheng Q, 1997, ADV MATER, V9, P481, DOI 10.1002/adma.19970090605; Cheng Q, 1998, LANGMUIR, V14, P1974, DOI 10.1021/la980185b; Cho E, 2014, J INCL PHENOM MACRO, V80, P427, DOI 10.1007/s10847-014-0431-5; Cho E, 2014, CARBOHYD RES, V389, P141, DOI 10.1016/j.carres.2013.12.015; Cho E, 2013, J INCL PHENOM MACRO, V76, P133, DOI 10.1007/s10847-012-0182-0; Choi JM, 2012, B KOREAN CHEM SOC, V33, P2091, DOI 10.5012/bkcs.2012.33.6.2091; Cote GL, 1995, KIRK OTHMER ENCY CHE; Datta A, 2015, CANCER LETT, V362, P25, DOI 10.1016/j.canlet.2015.03.009; de Rijke E, 2006, J CHROMATOGR A, V1112, P31, DOI 10.1016/j.chroma.2006.01.019; Ficarra R, 2002, J PHARMACEUT BIOMED, V29, P1005, DOI 10.1016/S0731-7085(02)00141-3; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Ji EK, 2003, B KOR CHEM SOC, V24, P667; Kim K, 2014, CARBOHYD POLYM, V106, P101, DOI 10.1016/j.carbpol.2014.02.017; Kolusheva S, 2001, J AM CHEM SOC, V123, P417, DOI 10.1021/ja0034139; Kumar S, 2013, SCI WORLD J, V2013; Kwon C, 2011, CARBOHYD RES, V346, P2308, DOI 10.1016/j.carres.2011.07.023; Kwon C, 2009, CARBOHYD RES, V344, P1347, DOI 10.1016/j.carres.2009.05.018; Kwon C, 2008, ELECTROPHORESIS, V29, P4284, DOI 10.1002/elps.200800127; Lee DC, 2002, MACROMOLECULES, V35, P4347, DOI 10.1021/ma011860i; Lee HY, 2011, SOFT MATTER, V7, P3273, DOI 10.1039/c0sm01243b; Lee J, 2008, J AM CHEM SOC, V130, P5010, DOI 10.1021/ja709996c; Lee J, 2009, ADV MATER, V21, P3674, DOI 10.1002/adma.200900639; Matsumoto K, 1998, INORG CHIM ACTA, V272, P162, DOI 10.1016/S0020-1693(97)06065-9; Mierziak J, 2014, MOLECULES, V19, P16240, DOI 10.3390/molecules191016240; Morris VJ, 1991, FOOD HYDROCOLLOID, V5, P185, DOI 10.1016/S0268-005X(09)80312-3; OLMSTED J, 1983, J PHYS CHEM-US, V87, P4790, DOI 10.1021/j150642a006; Pan JJ, 1997, LANGMUIR, V13, P1365, DOI 10.1021/la9602675; Rothwell JA, 2005, J AGR FOOD CHEM, V53, P4355, DOI 10.1021/jf0483669; Saenger WR, 1998, CHEM REV, V98, P1787, DOI 10.1021/cr9700181; Seo S, 2013, MACROMOL RAPID COMM, V34, P743, DOI 10.1002/marc.201200819; Sutherland IW, 1998, TRENDS BIOTECHNOL, V16, P41, DOI 10.1016/S0167-7799(97)01139-6; Thongmalai W, 2011, J MATER CHEM, V21, P16391, DOI 10.1039/c1jm12795k; Tommasini S, 2004, J PHARMACEUT BIOMED, V35, P379, DOI 10.1016/S0731-7085(03)00647-2; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Wang CG, 2005, ANAL BIOANAL CHEM, V382, P1708, DOI 10.1007/s00216-005-3345-7; Wang LX, 1999, J BACTERIOL, V181, P6788, DOI 10.1128/JB.181.21.6788-6796.1999	42	11	11	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143454	10.1371/journal.pone.0143454	http://dx.doi.org/10.1371/journal.pone.0143454			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600071	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900125
J	Lee, CC; Julian, MC; Tiller, KE; Meng, FL; DuConge, SE; Akter, R; Raleigh, DP; Tessier, PM				Lee, Christine C.; Julian, Mark C.; Tiller, Kathryn E.; Meng, Fanling; DuConge, Sarah E.; Akter, Rehana; Raleigh, Daniel P.; Tessier, Peter M.			Design and Optimization of Anti-amyloid Domain Antibodies Specific for beta-Amyloid and Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; PRION PROTEIN; PHAGE DISPLAY; FIBRILLAR OLIGOMERS; ALZHEIMERS-DISEASE; CHARGED MUTATIONS; AGGREGATION; CONFORMATION; GENERATION; INHIBITION	Antibodies with conformational specificity are important for detecting and interfering with polypeptide aggregation linked to several human disorders. We are developing a motif-grafting approach for designing lead antibody candidates specific for amyloid-forming polypeptides such as the Alzheimer peptide (A beta). This approach involves grafting amyloidogenic peptide segments into the complementarity-determining regions (CDRs) of single-domain (V-H) antibodies. Here we have investigated the impact of polar mutations inserted at the edges of a large hydrophobic A beta 42 peptide segment (A beta residues 17-42) in CDR3 on the solubility and conformational specificity of the corresponding V-H domains. We find that V-H expression and solubility are strongly enhanced by introducing multiple negatively charged or asparagine residues at the edges of CDR3, whereas other polar mutations are less effective (glutamine and serine) or ineffective (threonine, lysine, and arginine). Moreover, A beta V-H domains with negatively charged CDR3 mutations show significant preference for recognizing A beta fibrils relative to A beta monomers, whereas the same V-H domains with other polar CDR3 mutations recognize both A beta conformers. We observe similar behavior for a V-H domain grafted with a large hydrophobic peptide from islet amyloid polypeptide (residues 8-37) that contains negatively charged mutations at the edges of CDR3. These findings highlight the sensitivity of antibody binding and solubility to residues at the edges of CDRs, and provide guidelines for designing other grafted antibody fragments with hydrophobic binding loops.	[Lee, Christine C.; Julian, Mark C.; Tiller, Kathryn E.; Meng, Fanling; DuConge, Sarah E.; Tessier, Peter M.] Rensselaer Polytech Inst, Isermann Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Akter, Rehana; Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tessier, PM (corresponding author), Rensselaer Polytech Inst, Isermann Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	tessier@rpi.edu	Tessier, Peter/GPP-3396-2022		National Institutes of Health [R01GM104130, R01GM078114]; National Science Foundation [0954450, 1159943]; Pew Charitable Trust; New York Capital Region Research Alliance; Richard Baruch M.D. Chair; MedImmune; Eli Lilly; Bristol-Myers Squibb; Janssen; Merck; Genentech; Amgen; Pfizer; Adimab; Abbvie; Roche; Boehringer Ingelheim; Bayer; Abbott; DuPont; Schrodinger; Novo Nordisk; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104130, R01GM078114] Funding Source: NIH RePORTER; Directorate For Engineering [1159943, 0954450] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Pew Charitable Trust; New York Capital Region Research Alliance; Richard Baruch M.D. Chair; MedImmune(AstraZenecaMedimmune); Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Genentech(Roche HoldingGenentech); Amgen(Amgen); Pfizer(Pfizer); Adimab; Abbvie(AbbVie); Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Bayer(Bayer AG); Abbott(Abbott Laboratories); DuPont; Schrodinger(Austrian Science Fund (FWF)); Novo Nordisk(Novo Nordisk); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM104130 (to P. M. T.) and R01GM078114 (to D. P. R.), National Science Foundation CBET Grants 0954450 and 1159943 (to P. M. T.), grants from the Pew Charitable Trust (Pew Scholars Award in Biomedical Sciences (to P. M. T.), New York Capital Region Research Alliance (to P. M. T.), and Richard Baruch M.D. Chair (to P. M. T). P. M. T. has received consulting fees and/or honorariums for presentations of this and/or related research findings at MedImmune, Eli Lilly, Bristol-Myers Squibb, Janssen, Merck, Genentech, Amgen, Pfizer, Adimab, Abbvie, Roche, Boehringer Ingelheim, Bayer, Abbott, DuPont, Schrodinger, and Novo Nordisk. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Barkhordarian H, 2006, PROTEIN ENG DES SEL, V19, P497, DOI 10.1093/protein/gzl036; Baumketner A, 2008, P NATL ACAD SCI USA, V105, P6027, DOI 10.1073/pnas.0708193105; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Bond CJ, 2003, J MOL BIOL, V332, P643, DOI 10.1016/S0022-2836(03)00967-7; Brannstrom K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090857; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Chabry J, 1999, J VIROL, V73, P6245, DOI 10.1128/JVI.73.8.6245-6250.1999; Chan JCC, 2012, TOP CURR CHEM, V306, P47, DOI 10.1007/128_2011_154; Chang HJ, 2014, STRUCTURE, V22, P9, DOI 10.1016/j.str.2013.10.005; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Colvin MT, 2015, J AM CHEM SOC, V137, P7509, DOI 10.1021/jacs.5b03997; Droste P, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0146-8; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; GLENNER GG, 1988, BIOCHEM BIOPH RES CO, V155, P608, DOI 10.1016/S0006-291X(88)80538-2; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Julian MC, 2015, PROTEIN ENG DES SEL, V28, P339, DOI 10.1093/protein/gzv050; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Klooster Rinse, 2012, Methods Mol Biol, V911, P241, DOI 10.1007/978-1-61779-968-6_15; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Ladiwala ARA, 2012, P NATL ACAD SCI USA, V109, P19965, DOI 10.1073/pnas.1208797109; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lambert MP, 2009, CNS NEUROL DISORD-DR, V8, P65, DOI 10.2174/187152709787601876; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lu XM, 2014, J PEPT SCI, V20, P860, DOI 10.1002/psc.2677; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Miklos AE, 2012, CHEM BIOL, V19, P449, DOI 10.1016/j.chembiol.2012.01.018; Morgado I, 2012, P NATL ACAD SCI USA, V109, P12503, DOI 10.1073/pnas.1206433109; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Perchiacca JM, 2014, PROTEIN ENG DES SEL, V27, P29, DOI 10.1093/protein/gzt058; Perchiacca JM, 2012, PROTEIN ENG DES SEL, V25, P591, DOI 10.1093/protein/gzs042; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Perchiacca JM, 2011, PROTEINS, V79, P2637, DOI 10.1002/prot.23085; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shivaprasad S, 2006, J BIOL CHEM, V281, P993, DOI 10.1074/jbc.M505091200; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Solomon B, 2005, VACCINE, V23, P2327, DOI 10.1016/j.vaccine.2005.01.034; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Trevino SR, 2007, J MOL BIOL, V366, P449, DOI 10.1016/j.jmb.2006.10.026; Tycko R, 2000, CURR OPIN CHEM BIOL, V4, P500, DOI 10.1016/S1367-5931(00)00123-X; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Vaikath NN, 2015, NEUROBIOL DIS, V79, P81, DOI 10.1016/j.nbd.2015.04.009; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Vasilevko V, 2010, NEUROBIOL DIS, V39, P301, DOI 10.1016/j.nbd.2010.04.014; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wang XP, 2009, FEBS LETT, V583, P579, DOI 10.1016/j.febslet.2008.12.064; Wasmer C, 2009, J MOL BIOL, V394, P119, DOI 10.1016/j.jmb.2009.09.015; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Williams SM, 2015, JOVE-J VIS EXP, DOI 10.3791/52584; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Wilson DR, 1998, CAN J MICROBIOL, V44, P313, DOI 10.1139/cjm-44-4-313; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yamamoto N, 2004, J NEUROCHEM, V90, P62, DOI 10.1111/j.1471-4159.2004.02459.x; Yoshihara T, 2008, J BIOCHEM, V143, P475, DOI 10.1093/jb/mvm239; Yuan ZN, 2013, NEURAL REGEN RES, V8, P3107, DOI 10.3969/j.issn.1673-5374.2013.33.004; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	78	31	31	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2858	2873		10.1074/jbc.M115.682336	http://dx.doi.org/10.1074/jbc.M115.682336			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26601942	Green Published, hybrid			2022-12-26	WOS:000369626900025
J	Ott, AK; Locher, L; Koch, M; Deuerling, E				Ott, Ann-Kathrin; Locher, Lisa; Koch, Miriam; Deuerling, Elke			Functional Dissection of the Nascent Polypeptide-Associated Complex in Saccharomyces cerevisiae	PLOS ONE			English	Article							RIBOSOMAL-SUBUNIT BIOGENESIS; CRYSTAL-STRUCTURE; GENE DISRUPTION; BETA-NAC; PROTEIN; YEAST; CHAPERONES; REVEALS; DOMAIN; PROTEOSTASIS	Both the yeast nascent polypeptide-associated complex (NAC) and the Hsp40/70-based chaperone system RAC-Ssb are systems tethered to the ribosome to assist cotranslational processes such as folding of nascent polypeptides. While loss of NAC does not cause phenotypic changes in yeast, the simultaneous deletion of genes coding for NAC and the chaperone Ssb (nac Delta ssb Delta) leads to strongly aggravated defects compared to cells lacking only Ssb, including impaired growth on plates containing L-canavanine or hygromycin B, aggregation of newly synthesized proteins and a reduced translational activity due to ribosome biogenesis defects. In this study, we dissected the functional properties of the individual NAC-subunits (alpha-NAC, beta-NAC and beta'-NAC) and of different NAC heterodimers found in yeast (alpha beta-NAC and alpha beta'-NAC) by analyzing their capability to complement the pleiotropic phenotype of nac Delta ssb Delta cells. We show that the abundant heterodimer alpha beta-NAC but not its paralogue alpha beta'-NAC is able to suppress all phenotypic defects of nac Delta ssb Delta cells including global protein aggregation as well as translation and growth deficiencies. This suggests that alpha beta-NAC and alpha beta'-NAC are functionally distinct from each other. The function of alpha beta-NAC strictly depends on its ribosome association and on its high level of expression. Expression of individual beta-NAC, beta'-NAC or alpha-NAC subunits as well as alpha beta'-NAC ameliorated protein aggregation in nac Delta ssb Delta cells to different extents while only beta-NAC was able to restore growth defects suggesting chaperoning activities for beta-NAC sufficient to decrease the sensitivity of nac Delta ssb Delta cells against L-canavanine or hygromycin B. Interestingly, deletion of the ubiquitin-associated (UBA)-domain of the alpha-NAC subunit strongly enhanced the aggregation preventing activity of alpha beta-NAC pointing to a negative regulatory role of this domain for the NAC chaperone activity in vivo.	[Ott, Ann-Kathrin; Locher, Lisa; Koch, Miriam; Deuerling, Elke] Univ Konstanz, Dept Biol, Mol Microbiol, D-78457 Constance, Germany; [Ott, Ann-Kathrin; Locher, Lisa; Koch, Miriam] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany	University of Konstanz; University of Konstanz	Deuerling, E (corresponding author), Univ Konstanz, Dept Biol, Mol Microbiol, D-78457 Constance, Germany.	Elke.Deuerling@uni-konstanz.de			German Science Foundation (DFG) [SFB969/A01]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a research grant from the German Science Foundation (DFG; SFB969/A01) to ED.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; Brachmann CB, 1998, YEAST, V14, P115; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Demoinet E, 2007, RNA, V13, P1570, DOI 10.1261/rna.585007; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franke J, 2001, J CELL SCI, V114, P2641; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gamerdinger M, 2015, SCIENCE, V348, P201, DOI 10.1126/science.aaa5335; George R, 1998, P NATL ACAD SCI USA, V95, P2296, DOI 10.1073/pnas.95.5.2296; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GORENSTEIN C, 1976, P NATL ACAD SCI USA, V73, P1547, DOI 10.1073/pnas.73.5.1547; Hartmann-Petersen R, 2003, INT J BIOCHEM CELL B, V35, P629, DOI 10.1016/S1357-2725(02)00393-X; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Liu YW, 2010, BIOCHEMISTRY-US, V49, P2890, DOI 10.1021/bi902050p; Lopez N, 1999, J BACTERIOL, V181, P3136, DOI 10.1128/JB.181.10.3136-3143.1999; Markesich DC, 2000, DEVELOPMENT, V127, P559; Meyer AE, 2007, P NATL ACAD SCI USA, V104, P1558, DOI 10.1073/pnas.0610704104; Nyathi Y, 2015, J CELL BIOL, V210, P287, DOI 10.1083/jcb.201410086; Pech Markus, 2010, J Biol Chem, V285, P19679, DOI 10.1074/jbc.M109.092536; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; Spreter T, 2005, J BIOL CHEM, V280, P15849, DOI 10.1074/jbc.M500160200; Sydorskyy Y, 2003, MOL CELL BIOL, V23, P2042, DOI 10.1128/MCB.23.6.2042-2054.2003; Wang LF, 2010, PROTEIN CELL, V1, P406, DOI 10.1007/s13238-010-0049-3; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; Wessa P., 2015, FREE STAT SOFTWARE; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Wiedmann B, 1999, FEBS LETT, V458, P51, DOI 10.1016/S0014-5793(99)01118-7	35	19	20	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143457	10.1371/journal.pone.0143457	http://dx.doi.org/10.1371/journal.pone.0143457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618777	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800037
J	Dobb, KS; Kaye, SJ; Beckmann, N; Thain, JL; Stateva, L; Birch, M; Oliver, JD				Dobb, Katharine S.; Kaye, Sarah J.; Beckmann, Nicola; Thain, John L.; Stateva, Lubomira; Birch, Mike; Oliver, Jason D.			Characterisation of the Candida albicans Phosphopantetheinyl Transferase Ppt2 as a Potential Antifungal Drug Target	PLOS ONE			English	Article							ALPHA-AMINOADIPATE REDUCTASE; DIRECTED MUTATIONAL ANALYSIS; SACCHAROMYCES-CEREVISIAE; LYSINE BIOSYNTHESIS; GENE DISRUPTION; SYSTEM; MANIPULATION; INFECTIONS; INHIBITORS; MECHANISM	Antifungal drugs acting via new mechanisms of action are urgently needed to combat the increasing numbers of severe fungal infections caused by pathogens such as Candida albicans. The phosphopantetheinyl transferase of Aspergillus fumigatus, encoded by the essential gene pptB, has previously been identified as a potential antifungal target. This study investigated the function of its orthologue in C. albicans, PPT2/C1_09480W by placing one allele under the control of the regulatable MET3 promoter, and deleting the remaining allele. The phenotypes of this conditional null mutant showed that, as in A. fumigatus, the gene PPT2 is essential for growth in C. albicans, thus fulfilling one aspect of an efficient antifungal target. The catalytic activity of Ppt2 as a phosphopantetheinyl transferase and the acyl carrier protein Acp1 as a substrate were demonstrated in a fluorescence transfer assay, using recombinant Ppt2 and Acp1 produced and purified from E. coli. A fluorescence polarisation assay amenable to high-throughput screening was also developed. Therefore we have identified Ppt2 as a broad-spectrum novel antifungal target and developed tools to identify inhibitors as potentially new antifungal compounds.	[Dobb, Katharine S.; Kaye, Sarah J.; Beckmann, Nicola; Thain, John L.; Birch, Mike; Oliver, Jason D.] F2G Ltd, Manchester M30 0LX, Lancs, England; [Stateva, Lubomira] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Oliver, JD (corresponding author), F2G Ltd, Lankro Way, Manchester M30 0LX, Lancs, England.	joliver@f2g.com		Beckmann, Nicola/0000-0003-4010-4384	European Commission 7th Framework programme; Marie Curie Initial Training network FINSysB [PITNGA-2008-214004]; NOFUN project [HEALTH-F3-2013-601963]	European Commission 7th Framework programme(European Commission); Marie Curie Initial Training network FINSysB; NOFUN project	Funding for this work, including salaries and research materials, was supplied by a combination of the following: European Commission 7th Framework programme (http://ec.europa.eu/research/fp7/index_en.cfm), Marie Curie Initial Training network FINSysB PITNGA-2008-214004 (KSD, MB, JDO) programme, and NOFUN project HEALTH-F3-2013-601963 (NB, MB, JDO); F2G Ltd (http://www.f2g.com/)-NB, MB, JDO are current employees; KSD, SJK, JLT were employed by F2G when they carried out the work included in this paper. The funders provided support in the form of salaries for authors KSD, SJK, NB, JLT, MB and JDO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2011, FUNGAL GENET BIOL, V48, P456, DOI 10.1016/j.fgb.2010.12.006; Baughman BM, 2012, ACS CHEM BIOL, V7, P526, DOI 10.1021/cb200439z; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Carr PD, 2010, EUKARYOT CELL, V9, P438, DOI 10.1128/EC.00324-09; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Duckworth BP, 2010, ANAL BIOCHEM, V403, P13, DOI 10.1016/j.ab.2010.04.009; Ehmann DE, 1999, BIOCHEMISTRY-US, V38, P6171, DOI 10.1021/bi9829940; Firon A, 2002, TRENDS MICROBIOL, V10, P456, DOI 10.1016/S0966-842X(02)02442-3; Garber G, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161001-00001; Glockner A, 2011, MYCOSES, V54, P420, DOI 10.1111/j.1439-0507.2010.01885.x; Guo SJ, 2003, FEMS MICROBIOL LETT, V224, P261, DOI 10.1016/S0378-1097(03)00455-5; Guo SJ, 2001, J BACTERIOL, V183, P7120, DOI 10.1128/JB.183.24.7120-7125.2001; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; Kosa NM, 2014, J ANTIBIOT, V67, P113, DOI 10.1038/ja.2013.106; Kuwayama H, 2002, BIOTECHNOL LETT, V24, P1307, DOI 10.1023/A:1019817203917; La Clair JJ, 2004, CHEM BIOL, V11, P195, DOI 10.1016/j.chembiol.2004.02.010; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Liu MP, 2006, EUKARYOT CELL, V5, P638, DOI 10.1128/EC.5.4.638-649.2006; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0; Oliver JD, 2010, Antifungal Target, Patent No. [WO 2010139952, 2010139952]; SIKORSKI RS, 1989, GENETICS, V122, P19; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	29	7	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143770	10.1371/journal.pone.0143770	http://dx.doi.org/10.1371/journal.pone.0143770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606674	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300110
J	Fehres, CM; Bruijns, SCM; Sotthewes, BN; Kalay, H; Schaffer, L; Head, SR; de Gruijl, TD; Garcia-Vallejo, JJ; van Kooyk, Y				Fehres, Cynthia. M.; Bruijns, Sven C. M.; Sotthewes, Brigit N.; Kalay, Hakan; Schaffer, Lana; Head, Steven R.; de Gruijl, Tanja D.; Garcia-Vallejo, Juan J.; van Kooyk, Yvette			Phenotypic and Functional Properties of Human Steady State CD14(+) and CD1a(+) Antigen Presenting Cells and Epidermal Langerhans Cells	PLOS ONE			English	Article							DERMAL DENDRITIC CELLS; CD8(+) T-CELLS; CUTTING EDGE; CROSS-PRESENTATION; SKIN; ACTIVATION; EFFICIENT; DISTINCT; SUBSETS; MOUSE	Cutaneous antigen presenting cells (APCs) are critical for the induction and regulation of skin immune responses. The human skin contains phenotypically and functionally distinct APCs subsets that are present at two separated locations. While CD1a(high) LCs form a dense network in the epidermis, the CD14(+) and CD1a(+) APCs reside in the dermal compartment. A better understanding of the biology of human skin APC subsets is necessary for the improvement of vaccine strategies that use the skin as administration route. In particular, progress in the characterization of uptake and activatory receptors will certainly improve APC-targeting strategies in vaccination. Here we performed a detailed analysis of the expression and function of glycan-binding and pattern-recognition receptors in skin APC subsets. The results demonstrate that under steady state conditions human CD1a(+) dermal dendritic cells (DCs) were phenotypically most mature as measured by the expression of CD83 and CD86, whereas the CD14(+) cells showed a higher expression of the CLRs DC-SIGN, mannose receptor and DCIR and had potent antigen uptake capacity. Furthermore, steady state LCs showed superior antigen cross-presentation as compared to the dermal APC subsets. Our results also demonstrate that the TLR3 ligand polyribosinic-polyribocytidylic acid (pI:C) was the most potent stimulator of cytokine production by both LCs and dDCs. These studies warrant further exploration of human CD1a(+) dDCs and LCs as target cells for cancer vaccination to induce anti-tumor immune responses.	[Fehres, Cynthia. M.; Bruijns, Sven C. M.; Sotthewes, Brigit N.; Kalay, Hakan; Garcia-Vallejo, Juan J.; van Kooyk, Yvette] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Schaffer, Lana; Head, Steven R.] Scripps Res Inst, DNA Array Core Facil, La Jolla, CA 92037 USA; [de Gruijl, Tanja D.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Scripps Research Institute; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Kooyk, Y (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	y.vankooyk@vumc.nl	Vallejo, Juan Garcia/AAA-3765-2020	Van Kooyk, Yvette/0000-0001-5997-3665	KWF kankerbestrijding [VU2009-2598]; European Research Council [ERCAdvanced339977]	KWF kankerbestrijding(KWF Kankerbestrijding); European Research Council(European Research Council (ERC)European Commission)	This work was supported by KWF kankerbestrijding VU2009-2598 (CMF YvK) and European Research Council ERCAdvanced339977 (YvK JJGV HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel CE, 2006, J IMMUNOL, V176, P5730, DOI 10.4049/jimmunol.176.10.5730; Artyomov MN, 2015, J EXP MED, V212, P743, DOI 10.1084/jem.20131675; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Boltjes A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00131; Bond E, 2009, J IMMUNOL METHODS, V348, P42, DOI 10.1016/j.jim.2009.06.012; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; de Aguero MG, 2012, J CLIN INVEST, V122, P1700, DOI 10.1172/JCI59725; de Gruijl TD, 2006, J IMMUNOL, V176, P7232, DOI 10.4049/jimmunol.176.12.7232; de Jong MAWP, 2010, METHODS MOL BIOL, V595, P55, DOI 10.1007/978-1-60761-421-0_4; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Engering AJ, 1997, ADV EXP MED BIOL, V417, P183; Fehres CM, 2015, J INVEST DERMATOL; Fehres CM, 2015, J CONTROL RELEASE, V203, P67, DOI 10.1016/j.jconrel.2015.01.040; Fehres CM, 2014, EUR J IMMUNOL, V44, P2415, DOI 10.1002/eji.201344094; Fehres CM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00149; Flacher V, 2006, J IMMUNOL, V177, P7959, DOI 10.4049/jimmunol.177.11.7959; Furio L, 2010, J INVEST DERMATOL, V130, P1345, DOI 10.1038/jid.2009.424; Garcia-Vallejo JJ, 2004, ANAL BIOCHEM, V329, P293, DOI 10.1016/j.ab.2004.02.037; Guttman-Yassky E, 2007, J ALLERGY CLIN IMMUN, V119, P1210, DOI 10.1016/j.jaci.2007.03.006; Haniffa M, 2015, J DERMATOL SCI, V77, P85, DOI 10.1016/j.jdermsci.2014.08.012; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Liard C, 2012, J INVEST DERMATOL, V132, P615, DOI 10.1038/jid.2011.346; Lindenberg JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070237; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Oosterhoff D, 2013, J IMMUNOL, V190, P3338, DOI 10.4049/jimmunol.1200598; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Polak ME, 2014, J INVEST DERMATOL, V134, P695, DOI 10.1038/jid.2013.375; Polak ME, 2012, J INVEST DERMATOL, V132, P1636, DOI 10.1038/jid.2012.26; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santegoets SJAM, 2008, J LEUKOCYTE BIOL, V84, P143, DOI 10.1189/jlb.1107750; Schaft N, 2003, J IMMUNOL, V170, P2186, DOI 10.4049/jimmunol.170.4.2186; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Sparber F, 2010, IMMUNOBIOLOGY, V215, P770, DOI 10.1016/j.imbio.2010.05.014; van der Aar AMG, 2007, J IMMUNOL, V178, P1986, DOI 10.4049/jimmunol.178.4.1986; van der Aar AMG, 2011, J IMMUNOL, V187, P3488, DOI 10.4049/jimmunol.1101105; van der Aar AMG, 2011, J ALLERGY CLIN IMMUN, V127, P1532, DOI 10.1016/j.jaci.2011.01.068; van der Vlist M, 2011, EUR J IMMUNOL, V41, P2619, DOI 10.1002/eji.201041305; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360	46	12	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143519	10.1371/journal.pone.0143519	http://dx.doi.org/10.1371/journal.pone.0143519			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605924	gold, Green Submitted, Green Published			2022-12-26	WOS:000365865300074
J	Goel, P; Singh, AK				Goel, Parul; Singh, Anil Kumar			Abiotic Stresses Downregulate Key Genes Involved in Nitrogen Uptake and Assimilation in Brassica juncea L.	PLOS ONE			English	Article							CYTOSOLIC GLUTAMINE-SYNTHETASE; AFFINITY NITRATE TRANSPORTER; HIGH-TEMPERATURE STRESS; SALT STRESS; ENHANCED TOLERANCE; DURUM-WHEAT; GROWTH; DEHYDROGENASE; EXPRESSION; REDUCTASE	Abiotic stresses such as salinity, drought and extreme temperatures affect nitrogen (N) uptake and assimilation in plants. However, little is known about the regulation of N pathway genes at transcriptional level under abiotic stress conditions in Brassica juncea. In the present work, genes encoding nitrate transporters (NRT), ammonium transporters (AMT), nitrate reductase (NR), nitrite reductase (NiR), glutamine synthetase (GS), glutamate synthase (GOGAT), glutamate dehydrogenase (GDH), asparagines synthetase (ASN) were cloned from Brassica juncea L. var. Varuna. The deduced protein sequences were analyzed to predict their subcellular localization, which confirmed localization of all the proteins in their respective cellular organelles. The protein sequences were also subjected to conserved domain identification, which confirmed presence of characteristic domains in all the proteins, indicating their putative functions. Moreover, expression of these genes was studied after 1h and 24h of salt (150 mM NaCl), osmotic (250 mM Mannitol), cold (4 degrees C) and heat (42 degrees C) stresses. Most of the genes encoding nitrate transporters and enzymes responsible for N assimilation and remobilization were found to be downregulated under abiotic stresses. The expression of BjAMT1.2, BjAMT2, BjGS1.1, BjGDH1 and BjASN2 was downregulated after 1hr, while expression of BjNRT1.1, BjNRT2.1, BjNiR1, BjAMT2, BjGDH1 and BjASN2 was downregulated after 24h of all the stress treatments. However, expression of BjNRT1.1, BjNRT1.5 and BjGDH2 was upregulated after 1h of all stress treatments, while no gene was found to be upregulated after 24h of stress treatments, commonly. These observations indicate that expression of most of the genes is adversely affected under abiotic stress conditions, particularly under prolonged stress exposure (24h), which may be one of the reasons of reduction in plant growth and development under abiotic stresses.	[Goel, Parul; Singh, Anil Kumar] CSIR Inst Himalayan Bioresource Technol, Palampur 176061, Himachal Prades, India; [Goel, Parul; Singh, Anil Kumar] Acad Sci & Innovat Res, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Academy of Scientific & Innovative Research (AcSIR)	Singh, AK (corresponding author), CSIR Inst Himalayan Bioresource Technol, Palampur 176061, Himachal Prades, India.	anil@ihbt.res.in		Singh, Anil/0000-0002-3569-5207				Abd-El Baki GK, 2000, PLANT CELL ENVIRON, V23, P515, DOI 10.1046/j.1365-3040.2000.00568.x; Angadi SV, 2000, CAN J PLANT SCI, V80, P693, DOI 10.4141/P99-152; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072126; Herrera-Rodriguez MB, 2006, J PLANT PHYSIOL, V163, P1061, DOI 10.1016/j.jplph.2005.10.012; Betti Marco, 2012, Cells, V1, P1089, DOI 10.3390/cells1041089; Bu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083111; Cai HM, 2009, PLANT CELL REP, V28, P527, DOI 10.1007/s00299-008-0665-z; CAMMAERTS D, 1985, PLANTA, V163, P517, DOI 10.1007/BF00392709; Carillo P, 2005, FUNCT PLANT BIOL, V32, P209, DOI 10.1071/FP04184; Chakrabarti N, 2003, BIOL PLANTARUM, V46, P63, DOI 10.1023/A:1022358016487; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chauhan JS, 2007, PLANT BREEDING, V126, P399, DOI 10.1111/j.1439-0523.2007.01394.x; Chauhan J.S., P 16 AUSTR RES ASSEM, P91; Chen CZ, 2012, PLANT PHYSIOL, V159, P1582, DOI 10.1104/pp.112.199257; Chevalier C, 1996, PLANT J, V9, P1, DOI 10.1046/j.1365-313X.1996.09010001.x; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Cordovilla MD, 1999, APPL SOIL ECOL, V11, P1; Cordovilla MDP, 1999, PLANT SCI, V140, P127, DOI 10.1016/S0168-9452(98)00201-5; CRAMER GR, 1986, PLANT PHYSIOL, V81, P792, DOI 10.1104/pp.81.3.792; Crawford NM, 1998, TRENDS PLANT SCI, V3, P389, DOI 10.1016/S1360-1385(98)01311-9; da Silveira Joaquim Albenisio Gomes, 1999, Revista Brasileira de Fisiologia Vegetal, V11, P77; DALLING MJ, 1972, BIOCHIM BIOPHYS ACTA, V283, P505, DOI 10.1016/0005-2728(72)90266-6; Debouba M, 2007, ANN BOT-LONDON, V99, P1143, DOI 10.1093/aob/mcm050; Debouba M, 2006, J PLANT PHYSIOL, V163, P1247, DOI 10.1016/j.jplph.2005.09.012; Debouba M, 2013, J PLANT PHYSIOL, V170, P155, DOI 10.1016/j.jplph.2012.09.011; El-Khatib RT, 2004, TREE PHYSIOL, V24, P729, DOI 10.1093/treephys/24.7.729; El-Shora HM, 2001, PLANT SCI, V161, P1047, DOI 10.1016/S0168-9452(01)00463-0; Ercoli L, 2010, CEREAL RES COMMUN, V38, P294, DOI 10.1556/CRC.38.2010.2.16; Ferrario-Mery S, 1998, PLANT PHYSIOL, V117, P293, DOI 10.1104/pp.117.1.293; Flores P, 2004, CAN J BOT, V82, P207, DOI [10.1139/b03-152, 10.1139/B03-152]; FUKUTOKU Y, 1984, PHYSIOL PLANTARUM, V61, P622, DOI 10.1111/j.1399-3054.1984.tb05180.x; Ghawana Sanjay, 2011, BMC Res Notes, V4, P85, DOI 10.1186/1756-0500-4-85; Gilbert GA, 1998, J EXP BOT, V49, P107, DOI 10.1093/jexbot/49.318.107; Gunasekera CP, 2006, EUR J AGRON, V25, P1, DOI 10.1016/j.eja.2005.08.002; Hayat Shamsul, 2009, Braz. J. Plant Physiol., V21, P187, DOI 10.1590/S1677-04202009000300003; Hernandez LE, 1997, PLANT SOIL, V189, P97, DOI 10.1023/A:1004252816355; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hoshida H, 2000, PLANT MOL BIOL, V43, P103, DOI 10.1023/A:1006408712416; Howitt SM, 2000, BBA-BIOMEMBRANES, V1465, P152, DOI 10.1016/S0005-2736(00)00136-X; Hu TZ, 2006, ACTA BIOCH BIOPH SIN, V38, P795, DOI 10.1111/j.1745-7270.2006.00225.x; Huez-Lopez M. A., 2011, Tropical and Subtropical Agroecosystems, V14, P137; Ito S, 2009, J AGRON CROP SCI, V195, P368, DOI 10.1111/j.1439-037X.2009.00376.x; Khan MG, 1998, BIOL PLANTARUM, V41, P93, DOI 10.1023/A:1001768601359; Kirda C, 2001, FIELD CROP RES, V71, P113, DOI 10.1016/S0378-4290(01)00153-8; Klimenko S. B., 2006, Journal of Stress Physiology & Biochemistry, V2, P50; Kolbert Z, 2010, J PLANT PHYSIOL, V167, P77, DOI 10.1016/j.jplph.2009.08.013; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Krouk G, 2006, PLANT PHYSIOL, V142, P1075, DOI 10.1104/pp.106.087510; Kumar RG, 2000, PLANT SCI, V156, P23, DOI 10.1016/S0168-9452(00)00224-7; LEA PJ, 1974, NATURE, V251, P614, DOI 10.1038/251614a0; Lea PJ, 1990, INTERMEDIARY NITROGE, V16, P121, DOI [10.1016/B978-0-08-092616-2.50010-3, DOI 10.1016/B978-0-08-092616-2.50010-3]; Lee HJ, 2013, PLANT CELL REP, V32, P1521, DOI 10.1007/s00299-013-1464-8; Li JY, 2010, PLANT CELL, V22, P1633, DOI 10.1105/tpc.110.075242; Li WB, 2007, PLANT PHYSIOL, V143, P425, DOI 10.1104/pp.106.091223; Lightfoot DA, 2007, EUPHYTICA, V156, P103, DOI 10.1007/s10681-007-9357-y; Lin SH, 2008, PLANT CELL, V20, P2514, DOI 10.1105/tpc.108.060244; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; LOULAKAKIS CA, 1990, J EXP BOT, V41, P1223, DOI 10.1093/jxb/41.10.1223; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Meyer C, 2001, PLANT NITROGEN, P37; Mungur R, 2006, PLANT GROWTH REGUL, V50, P231, DOI 10.1007/s10725-006-9140-4; Mungur R, 2005, J BIOMED BIOTECHNOL, V2, P198, DOI DOI 10.1016/J.CHEMOLAB.2010.04.010; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nathawat NS, 2005, J PLANT NUTR, V28, P1089, DOI 10.1081/PLN-200058911; Omarov RT, 1998, J EXP BOT, V49, P897, DOI 10.1093/jexbot/49.322.897; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; Parvaiz Ahmad, 2012, African Journal of Biotechnology, V11, P2694, DOI 10.5897/AJB11.3203; PRUNKARD DE, 1986, PLANT PHYSIOL, V81, P349, DOI 10.1104/pp.81.2.349; Rachmilevitch S, 2006, NEW PHYTOL, V170, P479, DOI 10.1111/j.1469-8137.2006.01684.x; Rana NK, 2008, BIOL PLANTARUM, V52, P361, DOI 10.1007/s10535-008-0075-7; RAO GU, 1992, ANN BOT-LONDON, V69, P193, DOI 10.1093/oxfordjournals.aob.a088329; Robredo A, 2011, ENVIRON EXP BOT, V71, P399, DOI 10.1016/j.envexpbot.2011.02.011; Santa-Cruz A, 1999, PLANT PHYSIOL BIOCH, V37, P65, DOI 10.1016/S0981-9428(99)80068-0; Siddiqui MH, 2009, J PLANT INTERACT, V4, P67, DOI 10.1080/17429140802227992; SIECIECHOWICZ KA, 1988, PHYTOCHEMISTRY, V27, P663, DOI 10.1016/0031-9422(88)84071-8; Singh M, 2009, 16 AUSTR RES ASS BRA, P1; Skopelitis DS, 2007, PLANT PHYSIOL, V145, P1726, DOI 10.1104/pp.107.107813; SMIRNOFF N, 1985, PHYSIOL PLANTARUM, V64, P133, DOI 10.1111/j.1399-3054.1985.tb02326.x; Soussi M, 1998, J EXP BOT, V49, P1329, DOI 10.1093/jexbot/49.325.1329; Stitt M, 1999, PR PHYT SOC, V42, P275; Tahir ISA, 2005, J AGRON CROP SCI, V191, P106, DOI 10.1111/j.1439-037X.2004.00127.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teixeira J, 2009, PLANT PHYSIOL BIOCH, V47, P807, DOI 10.1016/j.plaphy.2009.05.002; Wong HK, 2004, PLANT PHYSIOL, V134, P332, DOI 10.1104/pp.103.033126; You-Cai X, 2006, PLANTA, V224, P710, DOI 10.1007/s00425-006-0252-x; Yaneva IA, 2002, PHYSIOL PLANTARUM, V114, P65, DOI 10.1034/j.1399-3054.2002.1140110.x; Yao J, 2008, RUSS J PLANT PHYSL+, V55, P232, DOI 10.1134/S1021443708020106	88	72	75	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143645	10.1371/journal.pone.0143645	http://dx.doi.org/10.1371/journal.pone.0143645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605918	gold, Green Submitted, Green Published			2022-12-26	WOS:000365865300094
J	Niermann, CYN; Kremers, SPJ; Renner, B; Woll, A				Niermann, Christina Y. N.; Kremers, Stef P. J.; Renner, Britta; Woll, Alexander			Family Health Climate and Adolescents' Physical Activity and Healthy Eating: A Cross-Sectional Study with Mother-Father-Adolescent Triads	PLOS ONE			English	Article							BALANCE-RELATED BEHAVIORS; SELF-DETERMINATION THEORY; AUTONOMOUS MOTIVATION; SEDENTARY BEHAVIOR; PARENTING STYLES; DIETARY BEHAVIOR; SOCIAL SUPPORT; PRIMARY-CARE; CHILDREN; YOUTH	Introduction The importance of the family environment for children's and adolescents' health behavior has been demonstrated, the underlying mechanisms of this influence remain unclear. Therefore, the aim of the study was to investigate the relationship between family environmental and individual determinants. It was hypothesized that the Family Health Climate (FHC) is associated with adolescents' physical activity and dietary behavior and that intrinsic motivation mediates this association. Methods Cross-sectional data were collected from 198 families (mother, father, and child) using questionnaires. Perceptions of FHC of mothers, fathers, and their children were assessed using the FHC-scales for physical activity (FHC-PA) and nutrition (FHC-NU). The adolescents also rated their intrinsic motivation for exercise and healthy eating, their physical activity and consumption of healthful food. A structural equation model was analyzed and a bootstrapping procedure was used to test direct and indirect effects. Results The FHC-PA was related to the amount of weekly physical activity and the FHC-NU to the consumption of fruit, vegetables and salad. These effects were mediated by adolescents' intrinsic motivation; the indirect effects were significant for both behaviors. Discussion These results emphasize the importance of the FHC in shaping adolescents' physical activity and dietary behavior. Individual motivational factors are potential mediators of family and parental influences. Considering family-level variables and their interaction with individual factors contributes to the understanding of adolescents' health behavior.	[Niermann, Christina Y. N.; Woll, Alexander] Karlsruhe Inst Technol, Inst Sports & Sports Sci, D-76021 Karlsruhe, Germany; [Kremers, Stef P. J.] Maastricht Univ, Dept Hlth Promot, NL-6200 MD Maastricht, Netherlands; [Renner, Britta] Univ Konstanz, Dept Psychol, Psychol Assessment & Hlth Psychol, Constance, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Maastricht University; University of Konstanz	Niermann, CYN (corresponding author), Karlsruhe Inst Technol, Inst Sports & Sports Sci, D-76021 Karlsruhe, Germany.	christina.niermann@kit.edu	Niermann, Christina/AAS-8931-2020; Renner, Britta/AAW-1895-2020	Niermann, Christina/0000-0002-2087-5328; Renner, Britta/0000-0001-8385-2839	Federal Ministry of Education and Research, Germany [0315671]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Karlsruhe Institute of Technology	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology	This study is part of the research project 'EATMOTIVE' which is funded by the Federal Ministry of Education and Research, Germany (Grant 0315671). We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the participants and project staff who took part in and supported the authors during this study, Dr. Miriam Reiner and Fabian Krapf for their support during the data collection and PD Dr. Annegret Mundermann for proof-reading the manuscript. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology.	BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; BARANOWSKI T, 1997, HDB HLTH BEHAV RES, V1, P179; Bauer KW, 2011, INT J BEHAV NUTR PHY, V8, P1; Berge JM, 2012, FAM SYST HEALTH, V30, P344, DOI 10.1037/a0030660; Bogels SM, 2004, PERS INDIV DIFFER, V37, P1583, DOI 10.1016/j.paid.2004.02.014; Boutelle KN, 2007, PUBLIC HEALTH NUTR, V10, P16, DOI 10.1017/S136898000721794X; Brustad R.J., 2012, OXFORD HDB EXERCISE, P385; Campbell TL., 2000, FAMILIE SYSTEM GESUN, P225; Colineau N, 2011, USER MODEL USER-ADAP, V21, P341, DOI 10.1007/s11257-010-9089-x; Cox MJ, 2003, CURR DIR PSYCHOL SCI, V12, P193, DOI 10.1111/1467-8721.01259; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; De Bourdeaudhuij I, 1997, J Health Psychol, V2, P45, DOI 10.1177/135910539700200105; Deci E. L., 2012, OXFORD LIB PSYCHOL, P85, DOI DOI 10.1093/OXFORDHB/9780195399820.013.0006; Deutsche Forschungsgemeinschaft (DFG), INF GEIST UND SOZ IN; Edwardson CL, 2010, PSYCHOL SPORT EXERC, V11, P522, DOI 10.1016/j.psychsport.2010.05.001; Ekvall G., 1996, EUR J WORK ORGAN PSY, V5, P105, DOI DOI 10.1080/13594329608414845; Friend S, 2015, J FAM PSYCHOL, V29, P136, DOI 10.1037/fam0000046; George M, 2013, J APPL SOC PSYCHOL, V43, P1333, DOI 10.1111/jasp.12142; Golan M, 2004, NUTR REV, V62, P39, DOI 10.1111/j.1753-4887.2004.tb00005.x; Grolnick WS., 1997, PARENTING CHILDRENS, P135, DOI DOI 10.1016/J.APPDEV.2009.02.001; Gustafson SL, 2006, SPORTS MED, V36, P79, DOI 10.2165/00007256-200636010-00006; Hagger M, 2009, PSYCHOL HEALTH, V24, P689, DOI 10.1080/08870440801956192; Hagger MS, 2006, PERS SOC PSYCHOL B, V32, P131, DOI 10.1177/0146167205279905; Hammons AJ, 2011, PEDIATRICS, V127, pE1565, DOI 10.1542/peds.2010-1440; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hofstetter H, 2014, PREV MED, V67, P141, DOI 10.1016/j.ypmed.2014.07.007; Jacka FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024805; Janssen I, 2012, OXFORD HDB EXERCISE, P9; Johnson L, 2008, AM J CLIN NUTR, V87, P846, DOI 10.1093/ajcn/87.4.846; Johnson L, 2011, BRIT J NUTR, V105, P950, DOI 10.1017/S0007114510004484; Joussemet M, 2008, CAN PSYCHOL, V49, P194, DOI 10.1037/a0012754; Kitzman-Ulrich H, 2010, CLIN CHILD FAM PSYCH, V13, P231, DOI 10.1007/s10567-010-0073-0; Kitzmann KA, 2010, HEALTH PSYCHOL, V29, P91, DOI 10.1037/a0017437; Kremers SP, 2003, APPETITE, V41, P43, DOI 10.1016/S0195-6663(03)00038-2; Kremers SPJ, 2004, PSYCHOL HEALTH, V19, P595, DOI 10.1080/08870440412331279630; Kremers SPJ, 2010, PATIENT EDUC COUNS, V79, P291, DOI 10.1016/j.pec.2010.03.002; Lam CB, 2015, J FAM PSYCHOL, V29, P100, DOI 10.1037/fam0000049; Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4; Lim C, 2012, INT J SPORT EXERC PS, V10, P211, DOI 10.1080/1612197X.2012.672006; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; LYTLE LA, 1995, HEALTH EDUC RES, V10, P133, DOI 10.1093/her/10.2.133; Maitland C, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-99; Markland D, 2004, J SPORT EXERCISE PSY, V26, P191, DOI 10.1123/jsep.26.2.191; Mata J, 2009, HEALTH PSYCHOL, V28, P709, DOI 10.1037/a0016764; Morrison SA, 2013, NURSING RES REV, P3; Nader P.R., 1988, HLTH BEHAV, P107; Nielsen Samara Joy, 2014, NCHS Data Brief, P1; Niermann C, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-30; Pearson N, 2010, PUBLIC HEALTH NUTR, V13, P1245, DOI 10.1017/S1368980009992217; Pelletier LG, 2004, MOTIV EMOTION, V28, P245, DOI 10.1023/B:MOEM.0000040154.40922.14; Pelletier LG, 2007, J SOC CLIN PSYCHOL, V26, P303, DOI 10.1521/jscp.2007.26.3.303; Peterson MS, 2013, HEALTH PSYCHOL, V32, P666, DOI 10.1037/a0029129; Pinquart M, 2014, J PEDIATR PSYCHOL, V39, P381, DOI 10.1093/jpepsy/jst144; Prochaska JJ, 2001, ARCH PEDIAT ADOL MED, V155, P554, DOI 10.1001/archpedi.155.5.554; Pugliese J, 2007, J FAM PSYCHOL, V21, P331, DOI 10.1037/0893-3200.21.3.331; Rodenburg G, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-36; Rutten C, 2013, PEDIATR EXERC SCI, V25, P273, DOI 10.1123/pes.25.2.273; Rutten GM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0086-z; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Schaefbauer C, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P1045, DOI 10.1145/2675133.2675180; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Statistisches Bundesamt, ZAHL FAKT BILD; Sting S., 2007, HDB FAMILIE, P480, DOI DOI 10.1007/978-3-531-90675-1_26; Teixeira PJ, 2011, NUTR BULL, V36, P102, DOI 10.1111/j.1467-3010.2010.01876.x; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; Vallerand R. J., 2002, HDB DELF DETERMINATI, P37; Vallerand R. J., 2007, HDB SPORT PSYCHOL, V3, P59, DOI DOI 10.1002/9781118270011.CH3; van der Horst K, 2007, HEALTH EDUC RES, V22, P295, DOI 10.1093/her/cyl080; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; Vansteenkiste M, 2009, J EDUC PSYCHOL, V101, P671, DOI 10.1037/a0015083; Vollmer RL, 2013, APPETITE, V71, P232, DOI 10.1016/j.appet.2013.08.015; Walther Julia, 2014, Int J Adolesc Med Health, V26, P377, DOI 10.1515/ijamh-2013-0310; Welk GJ, 2003, PEDIATR EXERC SCI, V15, P19, DOI 10.1123/pes.15.1.19; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Winkler G, 1998, Z ERNAHRUNGSWISS, V37, P234, DOI 10.1007/s003940050022	76	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143599	10.1371/journal.pone.0143599	http://dx.doi.org/10.1371/journal.pone.0143599			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7ES	26606157	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300086
J	Paiva, C; Godbersen, JC; Soderquist, RS; Rowland, T; Kilmarx, S; Spurgeon, SE; Brown, JR; Srinivasa, SP; Danilov, AV				Paiva, Cody; Godbersen, J. Claire; Soderquist, Ryan S.; Rowland, Taylor; Kilmarx, Sumner; Spurgeon, Stephen E.; Brown, Jennifer R.; Srinivasa, Sreesha P.; Danilov, Alexey V.			Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; ACTIVATION; FLAVOPIRIDOL; DINACICLIB; RESISTANCE; CANCER; POTENT; MECHANISM; PROTEINS	CDK (cyclin-dependent kinase) inhibitors have shown remarkable activity in CLL, where its efficacy has been linked to inhibition of the transcriptional CDKs (7 and 9) and deregulation of RNA polymerase and short-lived pro-survival proteins such as MCL1. Furthermore, ER (endoplasmic reticulum) stress has been implicated in CDK inhibition in CLL. Here we conducted a pre-clinical study of a novel orally active kinase inhibitor P1446A in CLL B-cells. P1446A inhibited CDKs at nanomolar concentrations and induced rapid apoptosis of CLL cells in vitro, irrespective of chromosomal abnormalities or IGHV mutational status. Apoptosis preceded inactivation of RNA polymerase, and was accompanied by phosphorylation of stress kinases JNK (c-Jun N-terminal kinase) and p38 MAPK (mitogen-activated protein kinase). Pharmacologic inhibitors of JNK/p38 MAPK conferred protection from P1446A-mediated apoptosis. Treatment with P1446A led to a dramatic induction of NOXA in a JNKdependent manner, and sensitized CLL cells to ABT-737, a BH3-mimetic. We observed concurrent activation of apoptosis stress-inducing kinase 1 (ASK1) and its interaction with inositol-requiring enzyme 1 (IRE1) and tumor necrosis factor receptor-associated factor 2 (TRAF2) in CLL cells treated with P1446A, providing insights into upstream regulation of JNK in this setting. Consistent with previous reports on limited functionality of ER stress mechanism in CLL cells, treatment with P1446A failed to induce an extensive unfolded protein response. This study provides rationale for additional investigations of P1446A in CLL.	[Paiva, Cody; Rowland, Taylor; Spurgeon, Stephen E.; Danilov, Alexey V.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Godbersen, J. Claire; Kilmarx, Sumner] Dartmouth Coll, Hanover, NH 03755 USA; [Soderquist, Ryan S.] Duke Univ, Durham, NC USA; [Brown, Jennifer R.] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA; [Srinivasa, Sreesha P.] Piramal Healthcare Ltd, Bombay, Maharashtra, India	Oregon Health & Science University; Dartmouth College; Duke University; Harvard University; Dana-Farber Cancer Institute	Danilov, AV (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.	danilov@ohsu.edu			Piramal Healthcare Ltd.; Lymphoma Research Foundation; Leukemia Lymphoma Society; American Cancer Society	Piramal Healthcare Ltd.; Lymphoma Research Foundation; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society)	This study was in part funded by Piramal Healthcare Ltd., which provided salary support for Sreesha Srinivasa, a co-author on this study, as well as research materials. In addition, Alexey V. Danilov's salary was in part paid by the Lymphoma Research Foundation Clinical Investigator Career development award. JRB is supported by the Leukemia Lymphoma Society and the American Cancer Society and is a Scholar in Clinical Research of the Leukemia and Lymphoma Society. The above funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Bates DJP, 2015, BRIT J CLIN PHARMACO, V80, P493, DOI 10.1111/bcp.12624; Bates DJP, 2013, MOL CANCER THER, V12, P1504, DOI 10.1158/1535-7163.MCT-12-1197; Brenner H, 2008, BLOOD, V111, P6; Byrd JC, 1998, BLOOD, V92, P12; Byrd JC, 2015, BLOOD, V125, P2497, DOI 10.1182/blood-2014-10-606038; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; Cosimo E, 2013, CLIN CANCER RES, V19, P2393, DOI 10.1158/1078-0432.CCR-12-2170; Danilov AV, 2013, EXPERT REV ANTICANC, V13, P1009, DOI 10.1586/14737140.2013.825424; Davids MS, 2012, BLOOD, V120, P3501, DOI 10.1182/blood-2012-02-414060; Denning DP, 2014, NAT CELL BIOL, V16, P741, DOI 10.1038/ncb3012; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Fisher RP, 2012, GENES CANC, V3, P7; Fiskus W, 2014, CANCER RES, V74, P2520, DOI 10.1158/0008-5472.CAN-13-2033; Flynn J, 2015, LEUKEMIA, V29, P1524, DOI 10.1038/leu.2015.31; Godbersen JC, 2014, CLIN CANCER RES, V20, P1576, DOI 10.1158/1078-0432.CCR-13-0987; Godbersen JC, 2013, AM SOC HEM ANN M NEW; Gupta S, 2012, ASCO ANN M; Hahntow IN, 2004, LEUKEMIA, V18, P747, DOI 10.1038/sj.leu.2403295; Hao D, 2012, ASCO ANN M; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Humphries LA, 2013, BRIT J HAEMATOL, V163, P590, DOI 10.1111/bjh.12580; Johnson AJ, 2012, LEUKEMIA, V26, P2554, DOI 10.1038/leu.2012.144; Jones JA, 2014, BLOOD, V123, P1455, DOI 10.1182/blood-2013-09-453092; Joshi K, 2012, AACR ANN M 2012 CHIC; Kawauchi T, 2014, DEV GROWTH DIFFER, V56, P335, DOI 10.1111/dgd.12138; Keeton EK, 2014, BLOOD, V123, P905, DOI 10.1182/blood-2013-04-495366; Kitada S, 2000, BLOOD, V96, P393; Krysov S, 2014, BLOOD, V124, P3101, DOI 10.1182/blood-2014-04-567198; Lin TS, 2009, J CLIN ONCOL, V27, P6012, DOI 10.1200/JCO.2009.22.6944; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu XR, 2012, INT J CANCER, V130, P1216, DOI 10.1002/ijc.26127; Lowman XH, 2010, MOL CELL, V40, P823, DOI 10.1016/j.molcel.2010.11.035; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Mahoney E, 2012, BLOOD, V120, P1262, DOI 10.1182/blood-2011-12-400184; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI200523409; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Nekhai S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/964964; Neron S, 2006, INT IMMUNOL, V18, P375, DOI 10.1093/intimm/dxh377; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Pietkiewicz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061438; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sendoel A, 2014, NAT CELL BIOL, V16, P812, DOI 10.1038/ncb3010; Shindiapina P, 2014, BRIT J HAEMATOL, V167, P149, DOI 10.1111/bjh.13042; Soderquist R, 2013, LEUKEMIA, V27, P2262, DOI 10.1038/leu.2013.138; Sun KH, 2009, MOL BIOL CELL, V20, P4611, DOI 10.1091/mbc.E09-05-0433; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walsby EP G, 2014, ONCOTARGET, V5, P10; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Xu C, 2009, CELL CYCLE, V8, P7	60	29	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143685	10.1371/journal.pone.0143685	http://dx.doi.org/10.1371/journal.pone.0143685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606677	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300100
J	Scaccabarozzi, L; Leoni, L; Ballarini, A; Barberio, A; Locatelli, C; Casula, A; Bronzo, V; Pisoni, G; Jousson, O; Morandi, S; Rapetti, L; Garcia-Fernandez, A; Moroni, P				Scaccabarozzi, Licia; Leoni, Livia; Ballarini, Annalisa; Barberio, Antonio; Locatelli, Clara; Casula, Antonio; Bronzo, Valerio; Pisoni, Giuliano; Jousson, Olivier; Morandi, Stefano; Rapetti, Luca; Garcia-Fernandez, Aurora; Moroni, Paolo			Pseudomonas aeruginosa in Dairy Goats: Genotypic and Phenotypic Comparison of Intramammary and Environmental Isolates	PLOS ONE			English	Article							MASTITIS OUTBREAKS; BETA-LACTAMASE; ANTIMICROBIAL RESISTANCE; IDENTIFICATION; EMERGENCE; VIRULENCE; MOTILITY; SHEEP	Following the identification of a case of severe clinical mastitis in a Saanen dairy goat (goat A), an average of 26 lactating goats in the herd was monitored over a period of 11 months. Milk microbiological analysis revealed the presence of Pseudomonas aeruginosa in 7 of the goats. Among these 7 does, only goat A showed clinical signs of mastitis. The 7 P. aeruginosa isolates from the goat milk and 26 P. aeruginosa isolates from environmental samples were clustered by RAPD-PCR and PFGE analyses in 3 genotypes (G1, G2, G3) and 4 clusters (A, B, C, D), respectively. PFGE clusters A and B correlated with the G1 genotype and included the 7 milk isolates. Although it was not possible to identify the infection source, these results strongly suggest a spreading of the infection from goat A. Clusters C and D overlapped with genotypes G2 and G3, respectively, and included only environmental isolates. The outcome of the antimicrobial susceptibility test performed on the isolates revealed 2 main patterns of multiple resistance to beta-lactam antibiotics and macrolides. Virulence related phenotypes were analyzed, such as swarming and swimming motility, production of biofilm and production of secreted virulence factors. The isolates had distinct phenotypic profiles, corresponding to genotypes G1, G2 and G3. Overall, correlation analysis showed a strong correlation between sampling source, RAPD genotype, PFGE clusters, and phenotypic clusters. The comparison of the levels of virulence related phenotypes did not indicate a higher pathogenic potential in the milk isolates as compared to the environmental isolates.	[Scaccabarozzi, Licia; Barberio, Antonio; Locatelli, Clara; Casula, Antonio; Bronzo, Valerio; Pisoni, Giuliano; Moroni, Paolo] Univ Milan, Dipartimento Sci Vet Salute Prod Anim & Sicurezza, Milan, Italy; [Leoni, Livia] Univ Roma Roma Tre, Dipartimento Sci, Rome, Italy; [Ballarini, Annalisa; Jousson, Olivier] Univ Trento, Ctr Integrat Biol CIBIO, Trento, Italy; [Barberio, Antonio] Ist Zooprofilatt Sperimentale Venezie, Sez Terr Vicenza, Vicenza, Italy; [Morandi, Stefano] Italian Natl Res Council, Inst Sci Food Prod, Milan, Italy; [Rapetti, Luca] Univ Milan, Dipartimento Sci Agr & Ambientali Prod, Milan, Italy; [Garcia-Fernandez, Aurora] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy; [Moroni, Paolo] Cornell Univ, Anim Hlth Diagnost Ctr, Qual Milk Prod Serv, Ithaca, NY USA	University of Milan; Roma Tre University; University of Trento; IZS delle Venezie; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR); University of Milan; Istituto Superiore di Sanita (ISS); Cornell University	Moroni, P (corresponding author), Univ Milan, Dipartimento Sci Vet Salute Prod Anim & Sicurezza, Milan, Italy.	paolo.moroni@unimi.it	Moroni, Paolo/M-1527-2017; Jousson, Olivier/S-4397-2019; Morandi, Stefano/F-5979-2013; Barberio, Antonio/ABF-2297-2021; García-Fernández, Aurora/K-2560-2016; Bronzo, Bronzo VB/M-1515-2017	Moroni, Paolo/0000-0002-0974-3084; Jousson, Olivier/0000-0003-3344-7194; Morandi, Stefano/0000-0001-5755-300X; Barberio, Antonio/0000-0002-3108-8354; García-Fernández, Aurora/0000-0002-5070-6154; Bronzo, Bronzo VB/0000-0003-4250-0823				Ballarini A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-152; Bannerman DD, 2005, VET IMMUNOL IMMUNOP, V107, P201, DOI 10.1016/j.vetimm.2005.04.012; Bergonier D, 2003, LIVEST PROD SCI, V79, P1, DOI 10.1016/S0301-6226(02)00145-8; Bergonier D, 2003, VET RES, V34, P689, DOI 10.1051/vetres:2003030; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Clinical and Laboratory Standards Institute (CLSI), 2020, PERFORMANCE STANDARD, V5th; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; CLSI, 2013, VET01S2 CLSI; Contreras A, 1997, J DAIRY SCI, V80, P2815, DOI 10.3168/jds.S0022-0302(97)76245-3; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Daly M, 1999, APPL ENVIRON MICROB, V65, P2723; Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001; Docquier JD, 2001, EMERG INFECT DIS, V7, P910; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fournier D, 2013, J CLIN MICROBIOL, V51, P3846, DOI 10.1128/JCM.01299-13; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Gales AC, 2001, CLIN INFECT DIS, V32, pS146, DOI 10.1086/320186; KIRK JH, 1984, J DAIRY SCI, V67, P441, DOI 10.3168/jds.S0022-0302(84)81322-3; Kurachi M., 1958, B I CHEM RES KYOTO U, V36, P174; Las Heras A, 1999, VET REC, V145, P111, DOI 10.1136/vr.145.4.111; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Lee Y, 2012, INT J ANTIMICROB AG, V40, P168, DOI 10.1016/j.ijantimicag.2012.04.004; Leitner G, 2007, VET IMMUNOL IMMUNOP, V119, P198, DOI 10.1016/j.vetimm.2007.05.007; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Longo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069554; Mena KD, 2009, REV ENVIRON CONTAM T, V201, P71, DOI 10.1007/978-1-4419-0032-6_3; Migliavacca R, 2002, J CLIN MICROBIOL, V40, P4388, DOI 10.1128/JCM.40.11.4388-4390.2002; National Mastitis Council, 1999, LAB HDB BOVINE MASTI; NICHOLLS TJ, 1981, VET REC, V108, P93, DOI 10.1136/vr.108.5.93; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ohnishi M, 2011, VET MICROBIOL, V154, P202, DOI 10.1016/j.vetmic.2011.06.023; Olechnowicz J, 2014, MED WETER, V70, P67; Oliver SP, 2012, VET CLIN N AM-FOOD A, V28, P165, DOI 10.1016/j.cvfa.2012.03.005; OSBORNE AD, 1981, CAN VET J, V22, P215; Persson Y, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-15; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Radostits O., 2000, VET MED-US, V9, P1450; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sajben E, 2011, MICROBIOL RES, V166, P255, DOI 10.1016/j.micres.2010.05.002; Sela S, 2007, J DAIRY RES, V74, P425, DOI 10.1017/S0022029907002610; Song KP, 2000, MOL CELL PROBE, V14, P199, DOI 10.1006/mcpr.2000.0306; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tremblay J, 2008, J BASIC MICROB, V48, P509, DOI 10.1002/jobm.200800030; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Vives-Florez M, 2006, INT MICROBIOL, V9, P247; Vogel Liesbeth, 1999, Clin Microbiol Infect, V5, P270, DOI 10.1111/j.1469-0691.1999.tb00140.x; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weldhagen GF, 2004, INT J ANTIMICROB AG, V24, P35, DOI 10.1016/j.ijantimicag.2003.12.012; White E, 2007, P NMC 46 ANN M NAT M, P119; Workentine ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060225; Wright EA, 2015, VET MICROBIOL, V175, P105, DOI 10.1016/j.vetmic.2014.11.011; Yeruham I, 2005, BERL MUNCH TIERARZTL, V118, P220; Yum HK, 2014, TUBERC RESPIR DIS, V77, P172, DOI 10.4046/trd.2014.77.4.172; Zhu H, 2004, INVEST OPHTH VIS SCI, V45, P1897, DOI 10.1167/iovs.03-0980	58	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142973	10.1371/journal.pone.0142973	http://dx.doi.org/10.1371/journal.pone.0142973			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606430	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300038
J	Liang, QS; Anderson, WD; Jones, ST; Souza, CS; Hosoume, JM; Treptow, W; Covarrubias, M				Liang, Qiansheng; Anderson, Warren D.; Jones, Shelly T.; Souza, Caio S.; Hosoume, Juliana M.; Treptow, Werner; Covarrubias, Manuel			Positive Allosteric Modulation of Kv Channels by Sevoflurane: Insights into the Structural Basis of Inhaled Anesthetic Action	PLOS ONE			English	Article							GATED K+ CHANNELS; INTRACELLULAR T1-T1 INTERFACE; SHAKER POTASSIUM CHANNELS; MOLECULAR-DYNAMICS; VOLTAGE SENSOR; SODIUM-CHANNELS; ION CHANNELS; T1 DOMAIN; WILD-TYPE; ACTIVATION	Inhalational general anesthesia results from the poorly understood interactions of haloethers with multiple protein targets, which prominently includes ion channels in the nervous system. Previously, we reported that the commonly used inhaled anesthetic sevoflurane potentiates the activity of voltage-gated K+ (Kv) channels, specifically, several mammalian Kv1 channels and the Drosophila K-Shaw2 channel. Also, previous work suggested that the S4-S5 linker of K-Shaw2 plays a role in the inhibition of this Kv channel by n-alcohols and inhaled anesthetics. Here, we hypothesized that the S4-S5 linker is also a determinant of the potentiation of Kv1.2 and K-Shaw2 by sevoflurane. Following functional expression of these Kv channels in Xenopus oocytes, we found that converse mutations in Kv1.2 (G329T) and K-Shaw2 (T330G) dramatically enhance and inhibit the potentiation of the corresponding conductances by sevoflurane, respectively. Additionally, Kv1.2-G329T impairs voltage-dependent gating, which suggests that Kv1.2 modulation by sevoflurane is tied to gating in a state-dependent manner. Toward creating a minimal Kv1.2 structural model displaying the putative sevoflurane binding sites, we also found that the positive modulations of Kv1.2 and Kv1.2-G329T by sevoflurane and other general anesthetics are T1-independent. In contrast, the positive sevoflurane modulation of K-Shaw2 is T1-dependent. In silico docking and molecular dynamics-based free-energy calculations suggest that sevoflurane occupies distinct sites near the S4-S5 linker, the pore domain and around the external selectivity filter. We conclude that the positive allosteric modulation of the Kv channels by sevoflurane involves separable processes and multiple sites within regions intimately involved in channel gating.	[Liang, Qiansheng; Anderson, Warren D.; Jones, Shelly T.; Covarrubias, Manuel] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Neurosci, Philadelphia, PA 19107 USA; [Covarrubias, Manuel] Thomas Jefferson Univ, Farber Inst Neurosci, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Souza, Caio S.; Hosoume, Juliana M.; Treptow, Werner] Univ Brasilia, Dept Biol Celular, Lab Biol Teor & Computac, Brasilia, DF, Brazil	Jefferson University; Jefferson University; Universidade de Brasilia	Covarrubias, M (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Neurosci, Philadelphia, PA 19107 USA.	Manuel.Covarrubias@jefferson.edu	Treptow, Werner/AAZ-5170-2020	Covarrubias, Manuel/0000-0002-0881-4143; Souza, Caio/0000-0003-2770-3315	National Institutes of Health [GM055876]; National Council of Technological and Scientific Development [470406/2011-9]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Council of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: National Institutes of Health, http://www.nih.gov/, GM055876, Dr. Roderic Eckenhoff (University of Pennsylvania); and the National Council of Technological and Scientific Development, http://www.cnpq.br/web/guest/geral, 470406/2011-9, Dr. Werner Treptow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2009, ANESTHESIOLOGY, V110, P766, DOI 10.1097/ALN.0b013e31819c461c; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; Barber AF, 2014, P NATL ACAD SCI USA, V111, P6726, DOI 10.1073/pnas.1405768111; Barber AF, 2012, J BIOL CHEM, V287, P40425, DOI 10.1074/jbc.M112.405787; Barber AF, 2011, BIOPHYS J, V101, P1613, DOI 10.1016/j.bpj.2011.08.026; Bhattacharji A, 2010, BRIT J PHARMACOL, V159, P1475, DOI 10.1111/j.1476-5381.2010.00642.x; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Chowdhury S, 2014, J GEN PHYSIOL, V144, P457, DOI 10.1085/jgp.201411185; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Delemotte L, 2011, P NATL ACAD SCI USA, V108, P6109, DOI 10.1073/pnas.1102724108; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Hemmings HC, 2009, BRIT J ANAESTH, V103, P61, DOI 10.1093/bja/aep144; Herold KE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00050; Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Li JC, 2001, AM J PHYSIOL-CELL PH, V280, pC1130, DOI 10.1152/ajpcell.2001.280.5.C1130; Lioudyno MI, 2013, J NEUROSCI, V33, P16310, DOI 10.1523/JNEUROSCI.0344-13.2013; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lugli AK, 2009, EUR J ANAESTH, V26, P807, DOI 10.1097/EJA.0b013e32832d6b0f; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robbins CA, 2012, EPILEPSIA, V53, P134, DOI 10.1111/j.1528-1167.2012.03484.x; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Treptow W, 2006, BIOPHYS J, V90, pL64, DOI 10.1529/biophysj.106.080754; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang GY, 2007, J BIOL CHEM, V282, P13637, DOI 10.1074/jbc.M609182200; Wang GY, 2006, J GEN PHYSIOL, V127, P391, DOI 10.1085/jgp.200509442; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	38	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143363	10.1371/journal.pone.0143363	http://dx.doi.org/10.1371/journal.pone.0143363			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599217	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600057
J	Zhao, Y; Li, GL; Sun, CY; Li, C; Wang, XC; Liu, HC; Zhang, PP; Zhao, XQ; Wang, XR; Jiang, Y; Yang, RF; Wan, KL; Zhou, L				Zhao, Yong; Li, Guilian; Sun, Chongyun; Li, Chao; Wang, Xiaochen; Liu, Haican; Zhang, Pingping; Zhao, Xiuqin; Wang, Xinrui; Jiang, Yi; Yang, Ruifu; Wan, Kanglin; Zhou, Lei			Locked Nucleic Acid Probe-Based Real-Time PCR Assay for the Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis	PLOS ONE			English	Article							MOLECULAR-DETECTION; DRUG-RESISTANCE; RPOB MUTATIONS; DIAGNOSTICS; IDENTIFICATION	Drug-resistant Mycobacterium tuberculosis can be rapidly diagnosed through nucleic acid amplification techniques by analyzing the variations in the associated gene sequences. In the present study, a locked nucleic acid (LNA) probe-based real-time PCR assay was developed to identify the mutations in the rpoB gene associated with rifampin (RFP) resistance in M. tuberculosis. Six LNA probes with the discrimination capability of one-base mismatch were designed to monitor the 23 most frequent rpoB mutations. The target mutations were identified using the probes in a "probe dropout" manner (quantification cycle = 0); thus, the proposed technique exhibited superiority in mutation detection. The LNA probe-based real-time PCR assay was developed in a two-tube format with three LNA probes and one internal amplification control probe in each tube. The assay showed excellent specificity to M. tuberculosis with or without RFP resistance by evaluating 12 strains of common non-tuberculosis mycobacteria. The limit of detection of M. tuberculosis was 10 genomic equivalents (GE)/reaction by further introducing a nested PCR method. In a blind validation of 154 clinical mycobacterium isolates, 142/142 (100%) were correctly detected through the assay. Of these isolates, 88/88 (100%) were determined as RFP susceptible and 52/54 (96.3%) were characterized as RFP resistant. Two unrecognized RFP-resistant strains were sequenced and were found to contain mutations outside the range of the 23 mutation targets. In conclusion, this study established a sensitive, accurate, and low-cost LNA probe-based assay suitable for a four-multiplexing real-time PCR instrument. The proposed method can be used to diagnose RFP-resistant tuberculosis in clinical laboratories.	[Zhao, Yong; Sun, Chongyun; Wang, Xiaochen; Zhang, Pingping; Wang, Xinrui; Yang, Ruifu; Zhou, Lei] Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Zhao, Yong; Sun, Chongyun; Wang, Xiaochen; Zhang, Pingping; Wang, Xinrui; Yang, Ruifu; Zhou, Lei] Beijing Key Lab POCT Bioemergency & Clin BZ0329, Beijing 100071, Peoples R China; [Li, Guilian; Li, Chao; Liu, Haican; Zhao, Xiuqin; Jiang, Yi; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China; [Sun, Chongyun] Chinese Peoples Liberat Army, Dept Clin Lab, Gen Hosp, Beijing, Peoples R China; [Wang, Xiaochen] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun 130118, Peoples R China; [Wang, Xinrui] Inst Plague Prevent & Control Hebei Prov, Zhangjiakou 075000, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Chinese People's Liberation Army General Hospital; Jilin Agricultural University	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China.	wankanglin@icdc.cn; ammszhoulei@aliyun.com	Yang, Ruifu/A-2273-2011	Yang, Ruifu/0000-0003-3219-7269	National High Technology Research and Development Program of China [2013AA032205]; Major National Science and Technology Programs of China [2011ZX10004, 2012ZX1004801-002-004, 2012ZX1004801-004-015]; Beijing Nova Program of China [Z151100000315086]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major National Science and Technology Programs of China; Beijing Nova Program of China(Beijing Municipal Science & Technology Commission)	This study was supported by the National High Technology Research and Development Program of China (No. 2013AA032205), the Major National Science and Technology Programs of China (Grant Nos. 2011ZX10004, 2012ZX1004801-002-004, and 2012ZX1004801-004-015) and Beijing Nova Program of China (No. Z151100000315086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chakravorty S, 2012, J CLIN MICROBIOL, V50, P2194, DOI 10.1128/JCM.00143-12; Chen XY, 2014, J CLIN MICROBIOL, V52, P1540, DOI 10.1128/JCM.00065-14; de Freitas FAD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104100; El-Hajj HH, 2001, J CLIN MICROBIOL, V39, P4131, DOI 10.1128/JCM.39.11.4131-4137.2001; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hoek KGP, 2011, MOL DIAGN THER, V15, P189, DOI 10.2165/11593780-000000000-00000; Huang HR, 2002, TUBERCULOSIS, V82, P79, DOI 10.1054/tube.2002.0326; Johnson MP, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh046; Josefsen MH, 2009, MOL CELL PROBE, V23, P201, DOI 10.1016/j.mcp.2009.02.003; Lis P, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0225-4; Liu QY, 2013, J ANTIMICROB CHEMOTH, V68, P1097, DOI 10.1093/jac/dks509; Luo T, 2011, J CLIN MICROBIOL, V49, P3132, DOI 10.1128/JCM.02046-10; Mboowa G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-481; McNerney R, 2015, INT J INFECT DIS, V32, P81, DOI 10.1016/j.ijid.2015.01.012; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Noor KM, 2015, PATHOLOGY, V47, P250, DOI 10.1097/PAT.0000000000000232; Palomino JC, 2009, FEMS IMMUNOL MED MIC, V56, P103, DOI 10.1111/j.1574-695X.2009.00555.x; Roh SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126257; Salvi S, 2008, J AGR FOOD CHEM, V56, P4320, DOI 10.1021/jf800149j; Somerville W, 2005, J CLIN MICROBIOL, V43, P2996, DOI 10.1128/JCM.43.6.2996-2997.2005; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Wada T, 2004, J CLIN MICROBIOL, V42, P5277, DOI 10.1128/JCM.42.11.5277-5285.2004; Wang Q, 2012, EXP THER MED, V3, P503, DOI 10.3892/etm.2011.442; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; Wilson ML, 2011, CLIN INFECT DIS, V52, P1350, DOI 10.1093/cid/cir146; Zaczek A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-10; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	29	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143444	10.1371/journal.pone.0143444	http://dx.doi.org/10.1371/journal.pone.0143444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599667	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600066
J	Cecchinato, F; Agha, NA; Martinez-Sanchez, AH; Luthringer, BJC; Feyerabend, F; Jimbo, R; Willumeit-Romer, R; Wennerberg, A				Cecchinato, Francesca; Agha, Nezha Ahmad; Martinez-Sanchez, Adela Helvia; Luthringer, Berengere Julie Christine; Feyerabend, Frank; Jimbo, Ryo; Willumeit-Roemer, Regine; Wennerberg, Ann			Influence of Magnesium Alloy Degradation on Undifferentiated Human Cells	PLOS ONE			English	Article							IN-VITRO CORROSION; RARE-EARTH; ANTIBODY-PRODUCTION; BONE; RESISTANCE; GROWTH; PH; BIOCOMPATIBILITY; METABOLISM; SCAFFOLDS	Background Magnesium alloys are of particular interest in medical science since they provide compatible mechanical properties with those of the cortical bone and, depending on the alloying elements, they have the capability to tailor the degradation rate in physiological conditions, providing alternative bioresorbable materials for bone applications. The present study investigates the in vitro short-term response of human undifferentiated cells on three magnesium alloys and high-purity magnesium (Mg). Materials and Methods The degradation parameters of magnesium-silver (Mg2Ag), magnesium-gadolinium (Mg10Gd) and magnesium-rare-earth (Mg4Y3RE) alloys were analysed after 1, 2, and 3 days of incubation in cell culture medium under cell culture condition. Changes in cell viability and cell adhesion were evaluated by culturing human umbilical cord perivascular cells on corroded Mg materials to examine how the degradation influences the cellular development. Results and Conclusions The pH and osmolality of the medium increased with increasing degradation rate and it was found to be most pronounced for Mg4Y3RE alloy. The biological observations showed that HUCPV exhibited a more homogeneous cell growth on Mg alloys compared to high-purity Mg, where they showed a clustered morphology. Moreover, cells exhibited a slightly higher density on Mg2Ag and Mg10Gd in comparison to Mg4Y3RE, due to the lower alkalinisation and osmolality of the incubation medium. However, cells grown on Mg10Gd and Mg4Y3RE generated more developed and healthy cellular structures that allowed them to better adhere to the surface. This can be attributable to a more stable and homogeneous degradation of the outer surface with respect to the incubation time.	[Cecchinato, Francesca; Jimbo, Ryo; Wennerberg, Ann] Fac Odontol, Dept Prosthodont, Malmo, Sweden; [Agha, Nezha Ahmad; Martinez-Sanchez, Adela Helvia; Luthringer, Berengere Julie Christine; Feyerabend, Frank; Willumeit-Roemer, Regine] Helmholtz Zentrum Geesthacht, D-21502 Geesthacht, Germany	Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Cecchinato, F (corresponding author), Fac Odontol, Dept Prosthodont, Malmo, Sweden.	francesca.cecchinato@mah.se	Feyerabend, Frank/A-1124-2010; Willumeit, Regine/I-8029-2013; Luthringer, Bérengère/G-9039-2017	Feyerabend, Frank/0000-0001-9532-0207; Willumeit, Regine/0000-0002-6004-6946; Luthringer, Bérengère/0000-0002-8248-6715	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant [n289163]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement non289163.	AHMAD Z, 1993, J MATER ENG PERFORM, V2, P739, DOI 10.1007/BF02650065; Ardelean H, 2001, MATER CORROS, V52, P889, DOI 10.1002/1521-4176(200112)52:12<889::AID-MACO889>3.0.CO;2-0; Banczek EP, 2009, J ALLOY COMPD, V479, P342, DOI 10.1016/j.jallcom.2008.12.075; Beaumont KG, 2012, CHEM BIOL, V19, P711, DOI 10.1016/j.chembiol.2012.04.016; BRUCE DW, 1963, TOXICOL APPL PHARM, V5, P750, DOI 10.1016/0041-008X(63)90067-X; Carey SP, 2011, STUD MECHANOBIOL TIS, V4, P29, DOI 10.1007/8415_2010_22; De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; deZengotita VM, 1998, CYTOTECHNOLOGY, V28, P213, DOI 10.1023/A:1008010605287; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Elias CN, 2008, JOM-US, V60, P46, DOI 10.1007/s11837-008-0031-1; ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B; Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024; Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0; HALEY TJ, 1961, BRIT J PHARM CHEMOTH, V17, P526, DOI 10.1111/j.1476-5381.1961.tb01139.x; Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006; Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010; Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037; Kajimura M, 1997, J PHYSIOL-LONDON, V503, P413, DOI 10.1111/j.1469-7793.1997.413bh.x; Kohn DH, 2002, J BIOMED MATER RES, V60, P292, DOI 10.1002/jbm.10050; Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008; Li N, 2013, J MATER SCI TECHNOL, V29, P489, DOI 10.1016/j.jmst.2013.02.005; Lin X, 2015, Open Biomed Eng J, V9, P56, DOI 10.2174/1874120701509010056; MACKENZIE C, 1961, J BIOPHYS BIOCHEM CY, V9, P141, DOI 10.1083/jcb.9.1.141; Ou CW, 2013, INT J ELECTROCHEM SC, V8, P9518; OZTURK SS, 1991, BIOTECHNOL BIOENG, V37, P989, DOI 10.1002/bit.260371015; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; Seuss F, 2011, J BIOMED MATER RES B, V99B, P276, DOI 10.1002/jbm.b.31896; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Nguyen TY, 2012, IEEE ENG MED BIO, P723, DOI 10.1109/EMBC.2012.6346033; Tie D, 2013, EUR CELLS MATER, V25, P284, DOI 10.22203/eCM.v025a20; Wang Y, 2009, MAT SCI ENG C-BIO S, V29, P1311, DOI 10.1016/j.msec.2008.09.051; Wei ZL, 2001, RARE METAL MAT ENG, V30, P147; Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331; Williams D, 1991, Med Device Technol, V2, P44; Willumeit R, 2011, ACTA BIOMATER, V7, P2704, DOI 10.1016/j.actbio.2011.03.004; Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293; Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028; Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001; Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015; Ye CH, 2012, APPL SURF SCI, V258, P3420, DOI 10.1016/j.apsusc.2011.11.087; Ye CH, 2013, T NONFERR METAL SOC, V23, P996, DOI 10.1016/S1003-6326(13)62558-3	46	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142117	10.1371/journal.pone.0142117	http://dx.doi.org/10.1371/journal.pone.0142117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600388	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900020
J	Er, F; Yuksel, D; Hellmich, M; Gassanov, N				Er, Fikret; Yueksel, Dilek; Hellmich, Martin; Gassanov, Natig			Comparison of Conventional versus Steerable-Catheter Guided Coronary Sinus Lead Positioning in Patients Undergoing Cardiac Resynchronization Device Implantation	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; THERAPY; DEFIBRILLATOR; PREVENTION	Objectives The aim of this study was to compare conventional versus steerable catheter guided coronary sinus (CS) cannulation in patients with advanced heart failure undergoing cardiac resynchronization therapy (CRT). Background Steerable catheter guided coronary sinus cannulation could reduce fluoroscopy time and contrast medium use during CRT implantation. Methods 176 consecutive patients with ischemic and non-ischemic heart failure undergoing CRT implantation from January 2008 to December 2012 at the University Hospital of Cologne were identified. During the study period two concurrent CS cannulation techniques were used: standard CS cannulation technique (standard-group, n = 113) and CS cannulation using a steerable electrophysiology (EP) catheter (EPCath-group, n = 63). Propensity-score matched pairs of conventional and EP-catheter guided CS cannulation made up the study population (n = 59 pairs). Primary endpoints were total fluoroscopy time and contrast medium amount used during procedure. Results The total fluoroscopy time was 30.9 min (interquartile range (IQR), 19.9-44.0 min) in the standard-group and 23.4 min (IQR, 14.2-34-2 min) in the EPCath-group (p = 0.011). More contrast medium was used in the standard-group (60.0 ml, IQR, 30.0-100 ml) compared to 25.0 ml (IQR, 20.0-50.0 ml) in the EPCath-group (P<0.001). Conclusions Use of steerable EP catheter was associated with significant reduction of fluoroscopy time and contrast medium use in patients undergoing CRT implantation.	[Er, Fikret; Yueksel, Dilek; Gassanov, Natig] Univ Hosp Munster, Klinikum Gutersloh, Dept Internal Med 1, Gutersloh, Germany; [Hellmich, Martin] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany	University of Cologne	Er, F (corresponding author), Univ Hosp Munster, Klinikum Gutersloh, Dept Internal Med 1, Gutersloh, Germany.	Fikret.Er@klinikum-guetersloh.de		Hellmich, Martin/0000-0001-5174-928X				Ando G, 2013, CATHETER CARDIO INTE, V82, P878, DOI 10.1002/ccd.25023; Bax JJ, 2005, J AM COLL CARDIOL, V46, P2168, DOI 10.1016/j.jacc.2005.09.020; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Capodanno D, 2016, J CARDIOVASC MED, V17, P524, DOI 10.2459/JCM.0000000000000215; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Er F, 2012, CIRCULATION, V126, P296, DOI 10.1161/CIRCULATIONAHA.112.096370; Gregoratos G, 2005, AM FAM PHYSICIAN, V71, P1563; Kennergren C, 1996, AM J CARDIOL, V78, P15, DOI 10.1016/S0002-9149(96)00497-3; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Niazi I, 2014, J INTERV CARD ELECTR, V41, P147, DOI 10.1007/s10840-014-9932-9; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Thibault B, 2015, PACE, V38, P63, DOI 10.1111/pace.12522; Wang LW, 2014, SCAND CARDIOVASC J, V48, P41, DOI 10.3109/14017431.2013.875623	14	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143292	10.1371/journal.pone.0143292	http://dx.doi.org/10.1371/journal.pone.0143292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599637	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900088
J	Figueroa, RI; Dapena, C; Bravo, I; Cuadrado, A				Figueroa, Rosa I.; Dapena, Carlos; Bravo, Isabel; Cuadrado, Angeles			The Hidden Sexuality of Alexandrium Minutum: An Example of Overlooked Sex in Dinoflagellates	PLOS ONE			English	Article							LIFE-CYCLES; GONYAULAX-TAMARENSIS; GENUS ALEXANDRIUM; CYST FORMATION; CELL-CYCLE; DINOPHYCEAE; DNA; REPRODUCTION; ORGANIZATION; SEGREGATION	Dinoflagellates are haploid eukaryotic microalgae in which rapid proliferation causes dense blooms, with harmful health and economic effects to humans. The proliferation mode is mainly asexual, as the sexual cycle is believed to be rare and restricted to stressful environmental conditions. However, sexuality is key to explaining the recurrence of many dinoflagellate blooms because in many species the fate of the planktonic zygotes (planozygotes) is the formation of resistant cysts in the seabed (encystment). Nevertheless, recent research has shown that individually isolated planozygotes in the lab can enter other routes besides encystment, a behavior of which the relevance has not been explored at the population level. In this study, using imaging flow cytometry, cell sorting, and Fluorescence In Situ Hybridization (FISH), we followed DNA content and nuclear changes in a population of the toxic dinoflagellate Alexandrium minutum that was induced to encystment. Our results first show that planozygotes behave like a population with an "encystment-independent" division cycle, which is light-controlled and follows the same Light: Dark (L:D) pattern as the cycle governing the haploid mitosis. Resting cyst formation was the fate of just a small fraction of the planozygotes formed and was restricted to a period of strongly limited nutrient conditions. The diploid-haploid turnover between L:D cycles was consistent with two-step meiosis. However, the diel and morphological division pattern of the planozygote division also suggests mitosis, which would imply that this species is not haplontic, as previously considered, but biphasic, because individuals could undergo mitotic divisions in both the sexual (diploid) and the asexual (haploid) phases. We also report incomplete genome duplication processes. Our work calls for a reconsideration of the dogma of rare sex in dinoflagellates.	[Figueroa, Rosa I.] Lund Univ, Aquat Ecol, S-22362 Lund, Sweden; [Figueroa, Rosa I.; Dapena, Carlos; Bravo, Isabel] IEO, Vigo 36390, Spain; [Cuadrado, Angeles] Univ Alcala UAH, Dept Biomed & Biotecnol, Alcala De Henares 28801, Spain	Lund University; Spanish Institute of Oceanography; Universidad de Alcala	Figueroa, RI (corresponding author), Lund Univ, Aquat Ecol, Biol Bldg, S-22362 Lund, Sweden.	rosa.figueroa@biol.lu.se	Bravo, Isabel/D-3147-2012; Cuadrado, Angeles/H-3470-2015; Figueroa, Rosa Isabel/M-7598-2015	Cuadrado, Angeles/0000-0003-0089-5249; Figueroa, Rosa Isabel/0000-0001-9944-7993; Bravo, Isabel/0000-0003-3764-745X	FORMAS (Sweden) [Formas 215-2010-824]; Spanish National Project CICAN [CGL2013-40671-R]; CCVIEO project	FORMAS (Sweden)(Swedish Research Council Formas); Spanish National Project CICAN; CCVIEO project	The present work was funded by a FORMAS (Sweden) project to RF (Formas 215-2010-824), the Spanish National Project CICAN (CGL2013-40671-R) to IB and RF and the CCVIEO project.; The present work was funded by a FORMAS (Sweden) project to RF (Formas 215-2010-824), the Spanish National Project CICAN (CGL2013-40671-R) to IB and RF and the CCVIEO project. We thank Isabel Ramilo for technical support.	ADAMICH M, 1976, PLANTA, V130, P1, DOI 10.1007/BF00390837; Alpermann TJ, 2010, J PHYCOL, V46, P18, DOI 10.1111/j.1529-8817.2009.00767.x; Alverca E, 2007, CYTOGENET GENOME RES, V116, P224, DOI 10.1159/000098191; Anderson D.M., 1998, PHYSL ECOLOGY HARMFU, V41, P29; ANDERSON DM, 1985, J PHYCOL, V21, P200; ANDERSON DM, 1985, J EXP MAR BIOL ECOL, V86, P1, DOI 10.1016/0022-0981(85)90039-5; ANDERSON DM, 1984, J PHYCOL, V20, P418, DOI 10.1111/j.0022-3646.1984.00418.x; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; Bell G, 1982, MASTERPIECE NATURE E; BHAUD Y, 1988, J CELL SCI, V89, P197; BIECHELER B., 1952, B BIOL             S, V36, P1; Blackburn SI, 2001, PHYCOLOGIA, V40, P78, DOI 10.2216/i0031-8884-40-1-78.1; Bouligand Y, 2001, BIOCHIMIE, V83, P187, DOI 10.1016/S0300-9084(00)01211-6; Bravo Isabel, 2014, Microorganisms, V2, P11; Brosnahan ML, 2014, DEEP-SEA RES PT II, V103, P185, DOI 10.1016/j.dsr2.2013.05.034; Chow MH, 2010, EUKARYOT CELL, V9, P1577, DOI 10.1128/EC.00026-10; D'Souza TG, 2010, J HERED, V101, pS34, DOI 10.1093/jhered/esq005; Dapena C, 2015, PROTIST, V166, P146, DOI 10.1016/j.protis.2015.01.001; Davis L, 2001, P NATL ACAD SCI USA, V98, P8395, DOI 10.1073/pnas.121005598; Dia A, 2014, MOL ECOL, V23, P549, DOI 10.1111/mec.12617; Erdner DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022965; Figueroa RI, 2006, J PHYCOL, V42, P350, DOI 10.1111/j.1529-8817.2006.00191.x; Figueroa RI, 2006, J PHYCOL, V42, P67, DOI 10.1111/j.1529-8817.2006.00181.x; Figueroa RI, 2005, PHYCOLOGIA, V44, P658, DOI 10.2216/0031-8884(2005)44[658:EONFAD]2.0.CO;2; Figueroa RI, 2007, J PHYCOL, V43, P1039, DOI 10.1111/j.1529-8817.2007.00393.x; GAO XP, 1989, BRIT PHYCOL J, V24, P153; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Gerstein AC, 2009, J HERED, V100, P571, DOI 10.1093/jhered/esp057; Goodenough U, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016154; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hackett JD, 2004, AM J BOT, V91, P1523, DOI 10.3732/ajb.91.10.1523; HIMES M, 1975, P NATL ACAD SCI USA, V72, P4546, DOI 10.1073/pnas.72.11.4546; HURST LD, 1992, TRENDS ECOL EVOL, V7, P144, DOI 10.1016/0169-5347(92)90205-P; Figueroa RI, 2006, J PHYCOL, V42, P1028, DOI 10.1111/j.1529-8817.2006.00262.x; Figueroa RI, 2014, PROTIST, V165, P343, DOI 10.1016/j.protis.2014.04.001; Figueroa RI, 2010, DEEP-SEA RES PT II, V57, P190, DOI 10.1016/j.dsr2.2009.09.016; KONDRASHOV AS, 1994, NATURE, V370, P213, DOI 10.1038/370213a0; Kremp A, 2013, MICROPALEAEONTOLOGIC, P197; Larkins BA, 2001, J EXP BOT, V52, P183, DOI 10.1093/jexbot/52.355.183; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; LEVASSEUR M, 1993, J PHYCOL, V29, P587, DOI 10.1111/j.0022-3646.1993.00587.x; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; LOPER CL, 1980, T AM MICROSC SOC, V99, P343, DOI 10.2307/3226012; Mable BK, 1998, BIOESSAYS, V20, P453, DOI 10.1002/(SICI)1521-1878(199806)20:6<453::AID-BIES3>3.0.CO;2-N; Marangon I, 2012, NANO LETT, V12, P4830, DOI 10.1021/nl302273p; Nagai Satoshi, 2004, Plankton Biology and Ecology, V51, P103; Pfiester L.A., 1984, P181; Pfiester L.A., 1987, Botanical Monographs (Oxford), V21, P611; PFIESTER LA, 1976, J PHYCOL, V12, P234; PFIESTER LA, 1975, J PHYCOL, V11, P259, DOI 10.1111/j.1529-8817.1975.tb02776.x; PFIESTER LA, 1984, AM J BOT, V71, P1121, DOI 10.2307/2443388; Pfiester LA, 1989, INT REV CYTOL, V114, P249; Pouchet G., 1883, J ANATOMIE PHYSL, V19, P399; Raberg L, 2014, ECOL EVOL, V4, P4775, DOI 10.1002/ece3.1314; RAIKOV IB, 1995, EUR J PROTISTOL, V31, P1, DOI 10.1016/S0932-4739(11)80349-4; RILL RL, 1989, CHROMOSOMA, V98, P280, DOI 10.1007/BF00327314; Roy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034340; SILVA ES, 1995, PHYCOLOGIA, V34, P396, DOI 10.2216/i0031-8884-34-5-396.1; Stosch H.A. von., 1973, British phycol J, V8, P105; TaroncherOldenburg G, 1997, LIMNOL OCEANOGR, V42, P1178, DOI 10.4319/lo.1997.42.5_part_2.1178; Tillmann U, 2013, J PHYCOL, V49, P298, DOI 10.1111/jpy.12037; Uchida Takuji, 1996, Phycological Research, V44, P119, DOI 10.1111/j.1440-1835.1996.tb00040.x; von Stosch H. A., 1972, B SOC BOT FR S1, P201, DOI DOI 10.1080/00378941.1972.10839089; Wisecaver JH, 2011, ANNU REV MICROBIOL, V65, P369, DOI 10.1146/annurev-micro-090110-102841	64	29	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142667	10.1371/journal.pone.0142667	http://dx.doi.org/10.1371/journal.pone.0142667			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599692	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900035
J	Kannel, K; Alnek, K; Vahter, L; Gross-Paju, K; Uibo, R; Kisand, KV				Kannel, Karin; Alnek, Kristi; Vahter, Liina; Gross-Paju, Katrin; Uibo, Raivo; Kisand, Kalle V.			Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome	PLOS ONE			English	Article							LYMPHOCYTE STIMULATOR BLYS; NEUROMYELITIS-OPTICA; CEREBROSPINAL-FLUID; SERUM BAFF; EXPRESSION; APRIL; CXCL13; CSF; NEUTROPHILS; DISTINCT	Multiple sclerosis (MS) is mediated primarily by autoreactive T cells. However, evidence suggesting the involvement of humoral immunity in brain diseases has increased interest in the role of B cells and their products during MS pathogenesis. The major survival factor for B cells, BAFF has been shown to play a role in several autoimmune conditions. Elevated BAFF levels have been reported in MS animal model and during MS relapse in patients. Moreover, disease-modifying treatments (DMT) reportedly influence blood BAFF levels in MS patients, but the significance of these changes remains unclear. The present study addresses how blood BAFF levels are associated with the clinical course of relapsing-remitting MS and the effectiveness of DMT and short-term steroid treatment. During a prospective longitudinal follow-up of 2.3 years, BAFF was measured in the blood of 170 MS patients in the stable phase and within 186 relapses. BAFF levels were significantly higher in MS patients compared to healthy controls. However, stable MS patients without relapses exhibited significantly higher BAFF levels than relapsing patients. Treatment with interferon-beta and immunosuppressants raised BAFF blood levels. Interestingly, a similar effect was not seen in patients treated with glatiramer acetate. Short-term treatment with high doses of intravenous methylprednisolone did not significantly alter plasma BAFF levels in 65% of relapsing-remitting MS patients. BAFF were correlated weakly but significantly with monocyte and basophil counts, but not with other blood cell types (neutrophils, lymphocytes, or eosinophils) or inflammatory biomarkers. To our knowledge, this is the first report demonstrating that higher blood BAFF levels may reflect a more stable and effective MS treatment outcome. These results challenge hypotheses suggesting that elevated blood BAFF levels are associated with more severe disease presentation and could explain the recent failure of pharmaceutical trials targeting BAFF with soluble receptor for MS treatment.	[Kannel, Karin; Vahter, Liina; Gross-Paju, Katrin] West Tallinn Cent Hosp MS Ctr, Tallinn, Estonia; [Alnek, Kristi; Uibo, Raivo; Kisand, Kalle V.] Univ Tartu, Inst Biomed & Translat Med, Dept Immunol, EE-50090 Tartu, Estonia; [Gross-Paju, Katrin] Tallinn Univ Technol, Inst Clin Med, EE-19086 Tallinn, Estonia; [Vahter, Liina] Tallinn Univ, Inst Psychol, EE-10120 Tallinn, Estonia	University of Tartu; Tallinn University of Technology; Tallinn University	Kisand, KV (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Immunol, Ulikooli 18, EE-50090 Tartu, Estonia.	kalle.kisand@ut.ee	Kisand, Kalle/AAZ-2563-2020; Kisand, Kalle/S-5958-2016; Alnek, Kristi/E-3847-2019	Kisand, Kalle/0000-0002-7789-5565; Kisand, Kalle/0000-0002-7789-5565; Uibo, Raivo/0000-0002-2298-1300	Estonian Research Council [IUT20-43]; European Union Regional Development Fund	Estonian Research Council(Estonian Research Council); European Union Regional Development Fund(European Commission)	Funding provided by Estonian Research Council: grant no. IUT20-43 (RU) - http://www.etag.ee/teadusagentuur/ and European Union Regional Development Fund (RU) - http://ec.europa.eu/regional_policy/index.cfm/en/funding/erdf/.	Comabella M, 2014, LANCET NEUROL, V13, P113, DOI 10.1016/S1474-4422(13)70233-3; Frota ERC, 2009, NEUROSCI LETT, V460, P130, DOI 10.1016/j.neulet.2009.05.057; Deiss A, 2013, EXPERT REV NEUROTHER, V13, P313, DOI [10.1586/ERN.13.17, 10.1586/ern.13.17]; Franciotta D, 2011, J NEUROIMMUNOL, V230, P160, DOI 10.1016/j.jneuroim.2010.10.027; Fuhlhuber V, 2009, J NEUROIMMUNOL, V210, P87, DOI 10.1016/j.jneuroim.2009.03.006; Goodin DS, 2008, NEUROLOGY, V71, pS8, DOI 10.1212/WNL.0b013e31818f3d8b; Graber JJ, 2010, CLIN NEUROL NEUROSUR, V112, P583, DOI 10.1016/j.clineuro.2010.05.002; Gran B, 2001, Curr Neurol Neurosci Rep, V1, P263, DOI 10.1007/s11910-001-0029-3; Hamzaoui K, 2008, CLIN EXP RHEUMATOL, V26, pS64; Hedegaard CJ, 2011, MULT SCLER J, V17, P567, DOI 10.1177/1352458510393771; Hirst CL, 2012, MULT SCLER J, V18, P1152, DOI 10.1177/1352458511433919; Huntington ND, 2006, INT IMMUNOL, V18, P1473, DOI 10.1093/intimm/dxl080; Jin XZ, 2013, EXPERT OPIN BIOL TH, V13, P315, DOI 10.1517/14712598.2012.758248; Kappos L, 2014, LANCET NEUROL, V13, P353, DOI 10.1016/S1474-4422(14)70028-6; Kim JY, 2008, J NEUROIMMUNOL, V199, P151, DOI 10.1016/j.jneuroim.2008.05.010; Kowarik MC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-93; Kreuzaler M, 2012, J IMMUNOL, V188, P497, DOI 10.4049/jimmunol.1102321; Krumbholz M, 2008, BRAIN, V131, P1455, DOI 10.1093/brain/awn077; Krumbholz M, 2005, J AUTOIMMUN, V25, P298, DOI 10.1016/j.jaut.2005.08.004; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lehmann-Horn K, 2013, THER ADV NEUROL DISO, V6, P161, DOI 10.1177/1756285612474333; Liu X, 2013, AEROSP MANUF TECHNOL, V1, P1, DOI DOI 10.1109/TNNLS.2013.2287275; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Meinl E, 2011, J NEUROL SCI, V306, P180, DOI 10.1016/j.jns.2010.08.009; Nagai M, 2011, NEPHRON CLIN PRACT, V118, pC339, DOI 10.1159/000323393; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Nikolov NP, 2009, CURR OPIN RHEUMATOL, V21, P465, DOI 10.1097/BOR.0b013e32832eba21; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Quan C, 2013, MULT SCLER J, V19, P289, DOI 10.1177/1352458512454771; R Core Team, 2013, R LANG ENV STAT COMP; Ragheb S, 2011, MULT SCLER J, V17, P819, DOI 10.1177/1352458511398887; Scapini P, 2005, BLOOD, V105, P830, DOI 10.1182/blood-2004-02-0564; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Scapini P, 2008, IMMUNOL LETT, V116, P1, DOI 10.1016/j.imlet.2007.11.009; Sellebjerg F, 2011, EUR HDB NEUROLOGICAL, V1; Stohl William, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P351; Thangarajh M, 2004, J NEUROIMMUNOL, V152, P183, DOI 10.1016/j.jneuroim.2004.03.017; Thompson SAJ, 2010, J CLIN IMMUNOL, V30, P99, DOI 10.1007/s10875-009-9327-3; Tremlett H, 2008, J NEUROL NEUROSUR PS, V79, P1368, DOI 10.1136/jnnp.2008.145805; Tremlett H, 2009, NEUROLOGY, V73, P1616, DOI 10.1212/WNL.0b013e3181c1e44f; Vaknin-Dembinsky A, 2010, MULT SCLER, V16, P1453, DOI 10.1177/1352458510380416; Vannucchi G, 2012, J CLIN ENDOCR METAB, V97, pE755, DOI 10.1210/jc.2011-2614; Vincent FB, 2014, NAT REV RHEUMATOL, V10, P365, DOI 10.1038/nrrheum.2014.33; Wang HH, 2012, J CLIN IMMUNOL, V32, P1007, DOI 10.1007/s10875-012-9709-9; Xin G, 2013, NEPHROLOGY, V18, P209, DOI 10.1111/nep.12032	46	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143393	10.1371/journal.pone.0143393	http://dx.doi.org/10.1371/journal.pone.0143393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600308	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900105
J	Wiencek, JR; Hirbawi, J; Yee, VC; Kalafatis, M				Wiencek, Joesph R.; Hirbawi, Jamila; Yee, Vivien C.; Kalafatis, Michael			The Dual Regulatory Role of Amino Acids Leu(480) and Gln(481) of Prothrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VA HEAVY-CHAIN; THROMBIN-CATALYZED ACTIVATION; COAGULATION FACTOR XA; HUMAN ALPHA-THROMBIN; PROTEIN-C; CRYSTAL-STRUCTURE; STRUCTURAL REQUIREMENTS; BINDING-SITE; PROEXOSITE-I; FACTOR-VIII	Prothrombin (FII) is activated to alpha-thrombin (IIa) by prothrombinase. Prothrombinase is composed of a catalytic subunit, factor Xa (fXa), and a regulatory subunit, factor Va (fVa), assembled on a membrane surface in the presence of divalent metal ions. We constructed, expressed, and purified several mutated recombinant FII (rFII) molecules within the previously determined fVa-dependent binding site for fXa (amino acid region 473-487 of FII). rFII molecules bearing overlapping deletions within this significant region first established the minimal stretch of amino acids required for the fVa-dependent recognition exosite for fXa in prothrombinase within the amino acid sequence Ser(478)-Val(479)-Leu(480)-Gln(481)-Val(482). Single, double, and triple point mutations within this stretch of rFII allowed for the identification of Leu(480) and Gln(481) as the two essential amino acids responsible for the enhanced activation of FII by prothrombinase. Unanticipated results demonstrated that although recombinant wild type alpha-thrombin and rIIa(S478A) were able to induce clotting and activate factor V and factor VIII with rates similar to the plasma-derived molecule, rIIa(SLQ -> 3AAA) with mutations S478A/L480A/Q481A was deficient in clotting activity and unable to efficiently activate the pro-cofactors. This molecule was also impaired in protein C activation. Similar results were obtained with rIIa(Delta SLQ) (where rIIa(Delta SLQ) is recombinant human alpha-thrombin with amino acids Ser(478)/Leu(480)/Gln(481) deleted). These data provide new evidence demonstrating that amino acid sequence Leu(480)-Gln(481): 1) is crucial for proper recognition of the fVa-dependent site(s) for fXa within prothrombinase on FII, required for efficient initial cleavage of FII at Arg(320); and 2) is compulsory for appropriate tethering of fV, fVIII, and protein C required for their timely activation by IIa.	[Wiencek, Joesph R.; Hirbawi, Jamila; Kalafatis, Michael] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Wiencek, Joesph R.; Hirbawi, Jamila; Kalafatis, Michael] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Yee, Vivien C.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Kalafatis, Michael] Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Kalafatis, Michael] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Wiencek, Joesph R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 1301 Med Ctr Dr, Nashville, TN 37232 USA; [Kalafatis, Michael] Cleveland State Univ, Sci & Res Ctr SR 370, Dept Chem, 2351 Euclid Ave, Cleveland, OH 44115 USA	Cleveland State University; Cleveland State University; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Vanderbilt University; Cleveland State University	Kalafatis, M (corresponding author), Cleveland State Univ, Sci & Res Ctr SR 370, Dept Chem, 2351 Euclid Ave, Cleveland, OH 44115 USA.	m.kalafatis@csuohio.edu			Doctoral Dissertation Research Expense Award and Fellowship Program; Molecular Medicine Graduate Program Fellowship; Center for Gene Regulation in Health and Disease at Cleveland State University; Division of Research and Graduate Studies at Cleveland State University	Doctoral Dissertation Research Expense Award and Fellowship Program; Molecular Medicine Graduate Program Fellowship; Center for Gene Regulation in Health and Disease at Cleveland State University; Division of Research and Graduate Studies at Cleveland State University	This work was supported in part by Doctoral Dissertation Research Expense Award and Fellowship Program (to J. R. W.), by a Molecular Medicine Graduate Program Fellowship (to J. R. W.), by funds from the Center for Gene Regulation in Health and Disease at Cleveland State University (to M. K.), and funds from the Division of Research and Graduate Studies at Cleveland State University (to M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	ACKERS GK, 1985, ANNU REV BIOCHEM, V54, P597, DOI 10.1146/annurev.bi.54.070185.003121; Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; BAJAJ SP, 1975, J BIOL CHEM, V250, P2150; Barhoover MA, 2008, BIOCHEMISTRY-US, V47, P6840, DOI 10.1021/bi800057r; Beck DO, 2004, J BIOL CHEM, V279, P3084, DOI 10.1074/jbc.M306850200; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Blostein MD, 2000, J BIOL CHEM, V275, P38120, DOI 10.1074/jbc.M007174200; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Bukys MA, 2005, J BIOL CHEM, V280, P27393, DOI 10.1074/jbc.M503435200; Bukys MA, 2008, THROMB HAEMOSTASIS, V99, P511, DOI 10.1160/TH07-08-0532; Bukys MA, 2006, J BIOL CHEM, V281, P18569, DOI 10.1074/jbc.M600752200; Bukys MA, 2006, J BIOL CHEM, V281, P39194, DOI 10.1074/jbc.M604482200; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; BUTKOWSKI RJ, 1977, J BIOL CHEM, V252, P4942; Chen L, 2003, J BIOL CHEM, V278, P27564, DOI 10.1074/jbc.M302707200; COTE HCF, 1994, J BIOL CHEM, V269, P11374; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P6165, DOI 10.1021/bi00393a033; Deguchi H, 1997, BIOCHEM J, V321, P729, DOI 10.1042/bj3210729; DOWNING MR, 1975, J BIOL CHEM, V250, P8897; DOYLE MF, 1993, METHOD ENZYMOL, V222, P299; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESMON CT, 1974, J BIOL CHEM, V249, P8045; ESMON CT, 1973, BIOCHIM BIOPHYS ACTA, V310, P289, DOI 10.1016/0005-2795(73)90034-2; ESMON CT, 1974, J BIOL CHEM, V249, P7782; ESMON CT, 1974, J BIOL CHEM, V249, P606; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; FAY PJ, 1992, J BIOL CHEM, V267, P13246; Figueiredo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034354; Gale AJ, 2000, BLOOD, V96, P585; Guinto E. R., 1984, J BIOL CHEM, V259, P13986; HELDEBRANT CM, 1973, J BIOL CHEM, V248, P7149; Hirbawi J, 2008, BIOCHEMISTRY-US, V47, P7963, DOI 10.1021/bi800593k; Hirbawi J, 2010, BIOCHEMISTRY-US, V49, P8520, DOI 10.1021/bi101097t; KALAFATIS M, 1993, METHOD ENZYMOL, V222, P224; KALAFATIS M, 1993, J BIOL CHEM, V268, P27246; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; Kalafatis M, 2002, BIOCHEMISTRY-US, V41, P12715, DOI 10.1021/bi026208+; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; Kalafatis M, 1997, CRIT REV EUKAR GENE, V7, P241, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.40; KELLER FG, 1995, BIOCHEMISTRY-US, V34, P4118, DOI 10.1021/bi00012a030; Koike H, 2003, J BIOL CHEM, V278, P15015, DOI 10.1074/jbc.M208220200; KOTKOW KJ, 1995, J BIOL CHEM, V270, P4551, DOI 10.1074/jbc.270.9.4551; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lechtenberg BC, 2013, BLOOD, V122, P2777, DOI 10.1182/blood-2013-06-511733; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LICATA VJ, 1995, BIOCHEMISTRY-US, V34, P3133, DOI 10.1021/bi00010a001; Mann K G, 1981, Ann N Y Acad Sci, V370, P378, DOI 10.1111/j.1749-6632.1981.tb29750.x; MANN K G, 1973, Series Haematologica, V6, P479; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; MANN KG, 1981, BIOCHEMISTRY-US, V20, P28, DOI 10.1021/bi00504a005; MESTERS RM, 1993, PROTEIN SCI, V2, P1482, DOI 10.1002/pro.5560020912; MILDVAN AS, 1992, ARCH BIOCHEM BIOPHYS, V294, P327, DOI 10.1016/0003-9861(92)90692-P; MILETICH JP, 1990, J BIOL CHEM, V265, P11397; Monteiro RQ, 2002, THROMB HAEMOSTASIS, V87, P288; MORITA T, 1981, METHOD ENZYMOL, V80, P303; Myles T, 2002, BLOOD, V100, P2820, DOI 10.1182/blood-2002-03-0843; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; NESHEIM ME, 1983, J BIOL CHEM, V258, P5386; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Orban T, 2005, BIOCHEMISTRY-US, V44, P13082, DOI 10.1021/bi050891t; Orfeo T, 2004, J BIOL CHEM, V279, P19580, DOI 10.1074/jbc.M400727200; OWEN WG, 1974, J BIOL CHEM, V249, P594; Pozzi N, 2014, P NATL ACAD SCI USA, V111, P7630, DOI 10.1073/pnas.1403779111; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; PRZYSIECKI CT, 1987, P NATL ACAD SCI USA, V84, P7856, DOI 10.1073/pnas.84.22.7856; Rezaie AR, 1998, PROTEIN SCI, V7, P349; ROSING J, 1980, J BIOL CHEM, V255, P274; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Schuijt TJ, 2013, CIRCULATION, V128, P254, DOI 10.1161/CIRCULATIONAHA.113.003191; Shim JY, 2015, BIOPHYS CHEM, V199, P46, DOI 10.1016/j.bpc.2015.02.003; Simioni P, 1996, BLOOD, V88, P2101, DOI 10.1182/blood.V88.6.2101.bloodjournal8862101; Singh LS, 2003, J BIOL CHEM, V278, P28335, DOI 10.1074/jbc.M300233200; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; TOOLE JJ, 1986, P NATL ACAD SCI USA, V83, P5939, DOI 10.1073/pnas.83.16.5939; Toso R, 2006, J BIOL CHEM, V281, P8773, DOI 10.1074/jbc.M511419200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRACY PB, 1982, BLOOD, V60, P59; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Wiencek JR, 2013, J BIOL CHEM, V288, P37026, DOI 10.1074/jbc.M113.462374; WITTING JI, 1987, THROMB RES, V46, P567, DOI 10.1016/0049-3848(87)90157-5; Yegneswaran S, 2002, CHEM BIOL, V9, P485, DOI 10.1016/S1074-5521(02)00132-1; Yegneswaran S, 2004, J BIOL CHEM, V279, P49019, DOI 10.1074/jbc.M406645200; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	91	1	1	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1565	1581		10.1074/jbc.M115.691956	http://dx.doi.org/10.1074/jbc.M115.691956			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601957	Green Published, hybrid			2022-12-26	WOS:000368620700002
J	Maletzki, C; Huehns, M; Knapp, P; Waukosin, N; Klar, E; Prall, F; Linnebacher, M				Maletzki, Claudia; Huehns, Maja; Knapp, Patrick; Waukosin, Nancy; Klar, Ernst; Prall, Friedrich; Linnebacher, Michael			Functional Characterization and Drug Response of Freshly Established Patient-Derived Tumor Models with CpG Island Methylator Phenotype	PLOS ONE			English	Article							COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; BRAF MUTATION; CELL-LINES; IDENTIFICATION; ASSOCIATIONS; TARGET; GENES	Patient-individual tumor models constitute a powerful platform for basic and translational analyses both in vitro and in vivo. However, due to the labor-intensive and highly time-consuming process, only few well-characterized patient-derived cell lines and/or corresponding xenografts exist. In this study, we describe successful generation and functional analysis of novel tumor models from patients with sporadic primary colorectal carcinomas (CRC) showing CpG island methylator phenotype (CIMP). Initial DNA fingerprint analysis confirmed identity with the patient in all four cases. These freshly established cells showed characteristic features associated with the CIMP-phenotype (HROC40: APC(wt), TP53(mut), KRAS(mut); 3/8 marker methylated; HROC43: APC(mut), TP53(mut), KRAS(mut); 4/8 marker methylated; HROC60: APC(wt), TP53(mut), KRAS(wt); 4/8 marker methylated; HROC183: APC(mut), TP53(mut), KRAS(mut); 6/8 marker methylated). Cell lines were of epithelial origin (EpCAM(+)) with distinct morphology and growth kinetics. Response to chemotherapeutics was quite individual between cells, with stage I-derived cell line HROC60 being most susceptible towards standard clinically approved chemotherapeutics (e.g. 5-FU, Irinotecan). Of note, most cell lines were sensitive towards "non-classical" CRC standard drugs (sensitivity: Gemcitabin > Rapamycin > Nilotinib). This comprehensive analysis of tumor biology, genetic alterations and assessment of chemosensitivity towards a broad range of (chemo-) therapeutics helps bringing forward the concept of personalized tumor therapy.	[Maletzki, Claudia; Knapp, Patrick; Waukosin, Nancy; Linnebacher, Michael] Univ Rostock, Mol Oncol & Immunotherapy, D-18055 Rostock, Germany; [Huehns, Maja; Prall, Friedrich] Univ Rostock, Inst Pathol, D-18055 Rostock, Germany; [Klar, Ernst] Univ Rostock, Dept Gen Surg, D-18055 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Linnebacher, M (corresponding author), Univ Rostock, Mol Oncol & Immunotherapy, D-18055 Rostock, Germany.	michael.linnebacher@med.uni-rostock.de	Linnebacher, Michael/AAT-3763-2021	Linnebacher, Michael/0000-0001-8054-1402				Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Atreya CE, 2012, INVEST NEW DRUG, V30, P2219, DOI 10.1007/s10637-012-9793-y; Cai ZR, 2014, ANN SURG ONCOL, V21, P179, DOI 10.1245/s10434-013-3146-8; Curtin Karen, 2011, Patholog Res Int, V2011, P902674, DOI 10.4061/2011/902674; FIELDING LP, 1991, J GASTROEN HEPATOL, V6, P325, DOI 10.1111/j.1440-1746.1991.tb00867.x; Francipane MG, 2014, ONCOTARGET, V5, P49, DOI 10.18632/oncotarget.1548; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hua VY, 1997, P NATL ACAD SCI USA, V94, P9614, DOI 10.1073/pnas.94.18.9614; Imamura Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-135; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jabbour E, 2014, AM J HEMATOL, V89, P547, DOI 10.1002/ajh.23691; JEN J, 1994, CANCER RES, V54, P5523; Jover R, 2011, GASTROENTEROLOGY, V140, P1174, DOI 10.1053/j.gastro.2010.12.035; Juo YY, 2014, ANN ONCOL, V25, P2314, DOI 10.1093/annonc/mdu149; Kaneda A, 2011, CANCER SCI, V102, P18, DOI 10.1111/j.1349-7006.2010.01712.x; Leroy C, 2010, ABSTRACT EJC S, V8; Maletzki C, 2015, WORLD J GASTROENTERO, V21, P164, DOI 10.3748/wjg.v21.i1.164; Maletzki C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052485; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Moon JW, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-4; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ostwald C, 2009, INT J ONCOL, V35, P321, DOI 10.3892/ijo_00000343; Palena C, 2012, FUTURE ONCOL, V8, P713, DOI [10.2217/FON.12.59, 10.2217/fon.12.59]; Pytel D, 2009, ANTI-CANCER AGENT ME, V9, P66, DOI 10.2174/187152009787047752; Rosfjord E, 2014, BIOCHEM PHARMACOL, V91, P135, DOI 10.1016/j.bcp.2014.06.008; Sun J, 2010, CANCER IMMUNOL IMMUN, V59, P1163, DOI 10.1007/s00262-010-0841-1; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; van Rijnsoever M, 2003, CLIN CANCER RES, V9, P2898; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wilding JL, 2014, CANCER RES, V74, P2377, DOI 10.1158/0008-5472.CAN-13-2971; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yamamoto E, 2012, AM J PATHOL, V181, P1847, DOI 10.1016/j.ajpath.2012.08.007	35	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143194	10.1371/journal.pone.0143194	http://dx.doi.org/10.1371/journal.pone.0143194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618628	Green Published, gold			2022-12-26	WOS:000365889800027
J	Masoumik, SM; Abdul-Rashid, SH; Olugu, EU				Masoumik, S. Maryam; Abdul-Rashid, Salwa Hanim; Olugu, Ezutah Udoncy			The Development of a Strategic Prioritisation Method for Green Supply Chain Initiatives	PLOS ONE			English	Article							MEDIUM-SIZED SUPPLIERS; RESOURCE-BASED VIEW; MANAGEMENT-PRACTICES; INSTITUTIONAL PRESSURES; DRIVERS; PERFORMANCE; COMPETITIVENESS; CERTIFICATION; CAPABILITIES; INDUSTRY	To maintain a competitive position, companies are increasingly required to integrate their proactive environmental strategies into their business strategies. The shift from reactive and compliance-based to proactive and strategic environmental management has driven companies to consider the strategic factors while identifying the areas in which they should focus their green initiatives. In previous studies little attention was given to providing the managers with a basis from which they could strategically prioritise these green initiatives across their companies' supply chains. Considering this lacuna in the literature, we present a decision-making method for prioritising green supply chain initiatives aligned with the preferred green strategies alternatives for the manufacturing companies. To develop this method, the study considered a position between determinism and the voluntarism orientation of environmental management involving both external pressures and internal competitive drivers and key resources as decision factors. This decision-making method was developed using the analytic network process (ANP) technique. The elements of the decision model were derived from the literature. The causal relationships among the multiple decision variables were validated based on the results of structural equation modelling (SEM) using a dataset collected from a survey of the ISO 14001-certified manufacturers in Malaysia. A portion of the relative weights required for computation in ANP was also calculated using the SEM results. A case study is presented to demonstrate the applicability of the method.	[Masoumik, S. Maryam; Abdul-Rashid, Salwa Hanim; Olugu, Ezutah Udoncy] Univ Malaya, Fac Engn, Dept Mech Engn, CPDM, Kuala Lumpur, Malaysia	Universiti Malaya	Abdul-Rashid, SH (corresponding author), Univ Malaya, Fac Engn, Dept Mech Engn, CPDM, Kuala Lumpur, Malaysia.	salwa_hanim@um.edu.my	Abdul-Rashid, Salwa Hanim/B-9683-2010; OLUGU, EZUTAH U./B-6781-2012	Abdul-Rashid, Salwa Hanim/0000-0001-7554-0149; 	University of Malaya [RP033B-15AET]	University of Malaya(Universiti Malaya)	This work was supported by University of Malaya Research Grant RP033B-15AET (http://umresearch.um.edu.my/index.php) to SHA-R.	Analytic Network Process Team, 2015, SUP DEC SOFTW; Ann GE, 2006, MANAG ENVIRON QUAL, V17, P73, DOI 10.1108/14777830610639459; Azzone G, 1997, LONG RANGE PLANN, V30, P562, DOI 10.1016/S0024-6301(97)00035-6; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Bai CG, 2010, J CLEAN PROD, V18, P1200, DOI 10.1016/j.jclepro.2010.01.016; Banerjee SB, 2001, MANAGE DECIS, V39, P36, DOI DOI 10.1108/EUM0000000005405; Borchardt M, 2012, INT J IND ENG-THEORY, V19, P330; Buyukozkan G, 2012, PROD PLAN CONTROL, V23, P405, DOI 10.1080/09537287.2011.561814; Buyukozkan G, 2011, EXPERT SYST APPL, V38, P13731, DOI 10.1016/j.eswa.2011.04.171; Chen CC, 2012, COMPUT MATH APPL, V64, P2544, DOI 10.1016/j.camwa.2012.06.013; Chien MK, 2007, INT J ENVIRON SCI TE, V4, P383; Comas Marti JM, 2012, BUSINESS STRATEGY EN; Corbett CJ, 2006, M&SOM-MANUF SERV OP, V8, P5, DOI 10.1287/msom.1060.0095; Darnall N, 2006, STRATEGIC MANAGE J, V27, P301, DOI 10.1002/smj.518; Delmas M., 2004, BUSINESS STRATEGY EN, V13, P209, DOI [10.1002/bse.409, DOI 10.1002/BSE.409]; Diabat A, 2011, RESOUR CONSERV RECY, V55, P659, DOI 10.1016/j.resconrec.2010.12.002; DIMAGGIO PJ, 1983, AM SOCIOL REV, V48, P147, DOI 10.2307/2095101; Eltayeb TK, 2011, RESOUR CONSERV RECY, V55, P495, DOI 10.1016/j.resconrec.2010.09.003; Eltayeb TK, 2009, OPER SUPPLY CHAIN MA, V2, P93; Erol I, 2010, SUPPLY CHAIN MANAG, V15, P43, DOI 10.1108/13598541011018111; Esty D., 2009, GREEN GOLD SMART CO; Federation of Malaysian Manufacturers, 2013, FMM DIR 2013; FORNELL C, 1981, J MARKETING RES, V18, P382, DOI 10.2307/3150980; Gavronski I, 2011, TRANSPORT RES E-LOG, V47, P872, DOI 10.1016/j.tre.2011.05.018; Gefen D., 2000, COMMUN ASSOC INF SYS, V4, DOI [10.17705/1cais.00407, DOI 10.17705/1CAIS.00407, 10.17705/1CAIS.00407]; Gonzalez P, 2008, INT J OPER PROD MAN, V28, P1021, DOI 10.1108/01443570810910179; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Hair J.F., 2017, PRIMER PARTIAL LEAST, V2nd ed.; Hair JF, 2012, LONG RANGE PLANN, V45, P320, DOI 10.1016/j.lrp.2012.09.008; Handfield R, 2005, BUSINESS STRATEGY EN, V14, P1, DOI [10.1002/cb.210, DOI 10.1002/CB.210, DOI 10.1002/BSE.422]; Harper B. D., 1993, P 1 ANN MID HUM FACT, P224; Hart SL, 2003, ACAD MANAGE EXEC, V17, P56, DOI 10.5465/AME.2003.10025194; HART SL, 1995, ACAD MANAGE REV, V20, P986, DOI 10.2307/258963; Hart SL, 2011, J MANAGE, V37, P1464, DOI 10.1177/0149206310390219; Hsu CC, 2013, INT J OPER PROD MAN, V33, P656, DOI 10.1108/IJOPM-10-2011-0401; KIRAKOWSKI J, 1993, BRIT J EDUC TECHNOL, V24, P210, DOI 10.1111/j.1467-8535.1993.tb00076.x; Lambert DM, 2000, IND MARKET MANAG, V29, P65, DOI 10.1016/S0019-8501(99)00113-3; Large RO, 2011, J PURCH SUPPLY MANAG, V17, P176, DOI 10.1016/j.pursup.2011.04.006; Lee SY, 2007, MANAGE DECIS, V45, P196, DOI 10.1108/00251740710727241; Lee SY, 2008, PROD OPER MANAG, V17, P573, DOI 10.3401/poms.1080.0063; Lee SY, 2008, SUPPLY CHAIN MANAG, V13, P185, DOI 10.1108/13598540810871235; LEWIS JR, 1995, INT J HUM-COMPUT INT, V7, P57, DOI 10.1080/10447319509526110; Linton JD, 2007, J OPER MANAG, V25, P1075, DOI 10.1016/j.jom.2007.01.012; Luthra S, 2013, J IND ENG MANAG-JIEM, V6, P930, DOI 10.3926/jiem.693; Ministry of International Trade and Industry, 2013, MITI WEEKL B, V228; Oliver C, 1997, STRATEGIC MANAGE J, V18, P697, DOI 10.1002/(SICI)1097-0266(199710)18:9<697::AID-SMJ909>3.0.CO;2-C; Petter S, 2007, MIS QUART, V31, P623; PORTER ME, 1995, HARVARD BUS REV, V73, P120; Porter ME, 2006, HARVARD BUS REV, V84, P78; Rao P, 2005, INT J OPER PROD MAN, V25, P898, DOI 10.1108/01443570510613956; Rao P, 2009, BUS STRATEG ENVIRON, V18, P14, DOI 10.1002/bse.555; Ringle C.M., 2005, SMARTPLS, V2; Saaty T.L, 1999, DECISION MAKING LEAD; Saaty TL, 2006, INT SER OPER RES MAN, V95, P1; Saaty TL., 1980, ANAL HIERARCHY PROCE; Sarkis J, 2003, J CLEAN PROD, V11, P397, DOI 10.1016/S0959-6526(02)00062-8; Sarkis J, 1998, EUR J OPER RES, V107, P159, DOI 10.1016/S0377-2217(97)00160-4; Sarkis J, 2011, INT J PROD ECON, V130, P1, DOI 10.1016/j.ijpe.2010.11.010; Sarmiento R, 2010, BENCHMARKING, V17, P452, DOI 10.1108/14635771011049399; Seuring S, 2013, DECIS SUPPORT SYST, V54, P1513, DOI 10.1016/j.dss.2012.05.053; Sharma S, 1998, STRATEGIC MANAGE J, V19, P729, DOI 10.1002/(SICI)1097-0266(199808)19:8<729::AID-SMJ967>3.0.CO;2-4; Simpson D, 2012, INT J PROD ECON, V139, P330, DOI 10.1016/j.ijpe.2012.05.020; Slack N., 1994, International Journal of Operations & Production Management, V14, P59, DOI 10.1108/01443579410056803; Sroufe R, 2003, PROD OPER MANAG, V12, P416, DOI 10.1111/j.1937-5956.2003.tb00212.x; Testa F, 2010, J CLEAN PROD, V18, P953, DOI 10.1016/j.jclepro.2010.03.005; Thun JH, 2010, BUS STRATEG ENVIRON, V19, P119, DOI 10.1002/bse.642; Tseng ML, 2014, EXPERT SYST APPL, V41, P3250, DOI 10.1016/j.eswa.2013.10.062; Walker Helen, 2008, Journal of Purchasing and Supply Management, V14, P69, DOI 10.1016/j.pursup.2008.01.007; Wey WM, 2005, KNOWL-BASED SYST, V18, P267, DOI 10.1016/j.knosys.2005.03.004; Wu GC, 2012, INT J PROD ECON, V135, P618, DOI 10.1016/j.ijpe.2011.05.023; Yang CS, 2013, TRANSPORT RES E-LOG, V55, P55, DOI 10.1016/j.tre.2013.03.005; Zailani SHM, 2012, INT J OPER PROD MAN, V32, P721, DOI 10.1108/01443571211230943; Zhu QH, 2005, INT J OPER PROD MAN, V25, P449, DOI 10.1108/01443570510593148; Zhu Q, 2007, INT J PROD RES, V45, P4333, DOI 10.1080/00207540701440345; Zhu QH, 2007, J CLEAN PROD, V15, P1041, DOI 10.1016/j.jclepro.2006.05.021	75	9	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143115	10.1371/journal.pone.0143115	http://dx.doi.org/10.1371/journal.pone.0143115			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7NW	26618353	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800025
J	Rogers, SW; Gahring, LC				Rogers, Scott W.; Gahring, Lorise C.			Upregulation of Nicotinic Acetylcholine Receptor alph4+beta2 through a Ligand-Independent PI3Kbeta Mechanism That Is Enhanced by TNFalpha and the Jak2/p38Mapk Pathways	PLOS ONE			English	Article							IA PHOSPHATIDYLINOSITOL 3-KINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; PROTEIN-KINASE B; SELECTIVE-INHIBITION; BINDING-SITES; RAT-BRAIN; CHOLINERGIC-RECEPTOR; SIGNALING PATHWAYS; ANNEXIN-II; CELLS	High affinity nicotine-binding sites in the mammalian brain are neuronal nicotinic acetylcholine receptors (nAChR) assembled from at least alpha4 and beta2 subunits into pentameric ion channels. When exposed to ligands such as nicotine, these receptors respond by undergoing upregulation, a correlate of nicotine addiction. Upregulation can be measured using HEK293 (293) cells that stably express alpha4 and beta2 subunits using quantification of [H-3]epibatidine ([H-3]Eb) binding to measure mature receptors. Treatment of these cells with choline also produces upregulation through a hemicholinium3 (HC3)-sensitive (choline kinase) and an HC3-insensitive pathway which are both independent of the mechanism used by nicotine for upregulation. In both cases, upregulation is significantly enhanced by the pro-inflammatory cytokine tumor necrosis factor alpha (TNF alpha) which signals through its receptor Tnfr1 to activate p38Mapk. Here we report that the inhibition of class1 phosphoinositide 3-kinases isoform PI3Kbeta using the selective antagonist PI828 is alone sufficient to produce upregulation and enhance both nicotine and choline HC3-sensitive mediated upregulation. Further, these processes are impacted upon by an AG-490 sensitive Jak2-associated pathway. Both PI3Kbeta (negative) and Jak2 (positive) modulation of upregulation converge through p38Mapk and both overlap with TNFalpha enhancement of this process. Upregulation through the PI3Kbeta pathway did not require Akt. Collectively these findings support upregulation of endogenous alpha4beta2 as a balance among cellular signaling networks that are highly responsive to multiple environmental, inflammatory and metabolic agents. The findings also suggest how illness and metabolic stress could alter the expression of this important nicotinic receptor and novel avenues to intercede in modifying its expression.	[Rogers, Scott W.; Gahring, Lorise C.] Salt Lake City Vet Adm Geriatr Res Educ & Clin Ct, Salt Lake City, UT 84148 USA; [Rogers, Scott W.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Gahring, Lorise C.] Univ Utah, Sch Med, Div Geriatr, Dept Internal Med, Salt Lake City, UT 84132 USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rogers, SW (corresponding author), Salt Lake City Vet Adm Geriatr Res Educ & Clin Ct, Salt Lake City, UT 84148 USA.	Scott.Rogers@hsc.utah.edu			Veterans Administration Merit Grant [1BX001798]; National Institutes of Health [R01DA025057]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001798] Funding Source: NIH RePORTER	Veterans Administration Merit Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Administration Merit Grant 1BX001798 and National Institutes of Health Grant R01DA025057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 1999, J BIOL CHEM, V274, P5333, DOI 10.1074/jbc.274.9.5333; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Barrantes FJ, 2010, FEBS LETT, V584, P1856, DOI 10.1016/j.febslet.2009.11.036; Bharadwaj A, 2013, INT J MOL SCI, V14, P6259, DOI 10.3390/ijms14036259; Brown GR, 2000, BIOORG MED CHEM LETT, V10, P575, DOI 10.1016/S0960-894X(00)00051-2; Cescon DW, 2015, CANCER CELL, V27, P5, DOI 10.1016/j.ccell.2014.12.003; ChasserotGolaz S, 1996, J CELL BIOL, V133, P1217, DOI 10.1083/jcb.133.6.1217; Chiarini F, 2009, CANCER RES, V69, P3520, DOI 10.1158/0008-5472.CAN-08-4884; Chua BT, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-131; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Dou ZX, 2010, J CELL BIOL, V191, P827, DOI 10.1083/jcb.201006056; Flores CM, 1997, J NEUROCHEM, V69, P2216; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Gahring LC, 2008, J BIOL CHEM, V283, P693, DOI 10.1074/jbc.M707330200; Gahring LC, 2010, J BIOL CHEM, V285, P26049, DOI 10.1074/jbc.M110.105346; Gahring LC, 2010, J BIOL CHEM, V285, P19793, DOI 10.1074/jbc.M110.108803; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Govind AP, 2012, J NEUROSCI, V32, P2227, DOI 10.1523/JNEUROSCI.5438-11.2012; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Guo DQ, 1996, J BIOL CHEM, V271, P615, DOI 10.1074/jbc.271.2.615; Heerding DA, 2008, J MED CHEM, V51, P5663, DOI 10.1021/jm8004527; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Hong BS, 2010, J BIOL CHEM, V285, P16330, DOI 10.1074/jbc.M109.039024; Hosur V, 2011, MOL PHARMACOL, V79, P167, DOI 10.1124/mol.110.066381; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Katayama K, 2007, MAMM GENOME, V18, P246, DOI 10.1007/s00335-007-9015-7; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Liu NS, 2013, MOL CANCER THER, V12, P2319, DOI 10.1158/1535-7163.MCT-12-0993-T; Lundin VF, 2008, DEV BIOL, V313, P320, DOI 10.1016/j.ydbio.2007.10.022; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Muthu K, 2015, CELL SIGNAL, V27, P739, DOI 10.1016/j.cellsig.2014.11.036; Nefedova Y, 2005, CANCER RES, V65, P9525, DOI 10.1158/0008-5472.CAN-05-0529; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; OSHEROV N, 1993, J BIOL CHEM, V268, P11134; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Peng XD, 2010, J PHARMACOL EXP THER, V332, P46, DOI 10.1124/jpet.109.153494; Perry DC, 2007, J PHARMACOL EXP THER, V322, P306, DOI 10.1124/jpet.107.121228; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Pincheira R, 2008, J IMMUNOL, V181, P1288, DOI 10.4049/jimmunol.181.2.1288; Redondo-Munoz J, 2015, MOL CELL BIOL, V35, P249, DOI 10.1128/MCB.01184-14; Ridgway ND, 2013, CRIT REV BIOCHEM MOL, V48, P20, DOI 10.3109/10409238.2012.735643; ROGERS SW, 1992, J NEUROSCI, V12, P4611; Sagot I, 1997, FEBS LETT, V410, P229, DOI 10.1016/S0014-5793(97)00594-2; SANCHEZMARGALET V, 1994, BIOCHEM BIOPH RES CO, V204, P446, DOI 10.1006/bbrc.1994.2480; Sandberg EM, 2005, J MED CHEM, V48, P2526, DOI 10.1021/jm049470k; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Walsh H, 2008, J BIOL CHEM, V283, P6022, DOI 10.1074/jbc.M703432200; Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200; Weinberg I, 2012, AM J HEMATOL, V87, P5, DOI 10.1002/ajh.22180; Xiao YX, 2004, BIOORG MED CHEM LETT, V14, P1845, DOI 10.1016/j.bmcl.2003.09.105; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Yalcin A, 2010, ONCOGENE, V29, P139, DOI 10.1038/onc.2009.317; Ye T, 2013, DEV COMP IMMUNOL, V41, P491, DOI 10.1016/j.dci.2013.07.015; ZIMMERMAN UJP, 1995, BIOCHEM MOL BIOL INT, V35, P307	63	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143319	10.1371/journal.pone.0143319	http://dx.doi.org/10.1371/journal.pone.0143319			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619345	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800033
J	Turner, HC; Shuryak, I; Weber, W; Doyle-Eisele, M; Melo, D; Guilmette, R; Amundson, SA; Brenner, DJ				Turner, Helen C.; Shuryak, Igor; Weber, Waylon; Doyle-Eisele, Melanie; Melo, Dunstana; Guilmette, Raymond; Amundson, Sally A.; Brenner, David J.			gamma-H2AX Kinetic Profile in Mouse Lymphocytes Exposed to the Internal Emitters Cesium-137 and Strontium-90	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DOSE-RATE; COMPARATIVE METABOLISM; RADIATION-EXPOSURE; CANCER-MORTALITY; BIOKINETIC MODEL; HISTONE H2AX; DNA-DAMAGE; REPAIR; PHOSPHORYLATION	In the event of a dirty bomb scenario or an industrial nuclear accident, a significant dose of volatile radionuclides such as Cs-137 and Sr-90 may be dispersed into the atmosphere as a component of fallout and inhaled or ingested by hundreds and thousands of people. To study the effects of prolonged exposure to ingested radionuclides, we have performed long-term (30 day) internal-emitter mouse irradiations using soluble-injected (CsCl)-Cs-137 and (SrCl2)-Sr-90 radioisotopes. The effect of ionizing radiation on the induction and repair of DNA double strand breaks (DSBs) in peripheral mouse lymphocytes in vivo was determined using the gamma-H2AX biodosimetry marker. Using a serial sacrifice experimental design, whole-body radiation absorbed doses for Cs-137 (0 to 10 Gy) and Sr-90 (0 to 49 Gy) were delivered over 30 days following exposure to each radionuclide. The committed absorbed doses of the two internal emitters as a function of time post exposure were calculated based on their retention parameters and their derived dose coefficients for each specific sacrifice time. In order to measure the kinetic profile for gamma-H2AX, peripheral blood samples were drawn at 5 specific timed dose points over the 30-day study period and the total gamma-H2AX nuclear fluorescence per lymphocyte was determined using image analysis software. A key finding was that a significant gamma-H2AX signal was observed in vivo several weeks after a single radionuclide exposure. A mechanistically-motivated model was used to analyze the temporal kinetics of gamma-H2AX fluorescence. Exposure to either radionuclide showed two peaks of gamma-H2AX: one within the first week, which may represent the death of mature, differentiated lymphocytes, and the second at approximately three weeks, which may represent the production of new lymphocytes from damaged progenitor cells. The complexity of the observed responses to internal irradiation is likely caused by the interplay between continual production and repair of DNA damage, cell cycle effects and apoptosis.	[Turner, Helen C.; Shuryak, Igor; Amundson, Sally A.; Brenner, David J.] Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA; [Weber, Waylon; Doyle-Eisele, Melanie; Melo, Dunstana; Guilmette, Raymond] Lovelace Resp Res Inst, Albuquerque, NM USA	Columbia University; Lovelace Respiratory Research Institute	Turner, HC (corresponding author), Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA.	ht2231@cumc.columbia.edu			Center for High-Throughput Minimally-Invasive Radiation Biodosimetry, National Institute of Allergy and Infectious Diseases [U19AI067773]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	Center for High-Throughput Minimally-Invasive Radiation Biodosimetry, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Center for High-Throughput Minimally-Invasive Radiation Biodosimetry, National Institute of Allergy and Infectious Diseases grant number U19AI067773. The PI is DJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RE, 1977, AM J PATHOL, V89, P367; Baskaya H, 2014, J ENVIRON RADIOACTIV, V134, P61, DOI 10.1016/j.jenvrad.2014.02.023; Beck HL, 2002, HEALTH PHYS, V82, P591, DOI 10.1097/00004032-200205000-00007; Berberan-Santos MN, 2005, CHEM PHYS, V315, P171, DOI 10.1016/j.chemphys.2005.04.006; Bertho JM, 2010, RADIAT ENVIRON BIOPH, V49, P239, DOI 10.1007/s00411-010-0267-3; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Busby C, 2013, ASPECTS DNA DAMAGE I; Fujikawa K, 2000, J RADIAT RES, V41, P113, DOI 10.1269/jrr.41.113; FUJITA M, 1966, HEALTH PHYS, V12, P1237, DOI 10.1097/00004032-196609000-00003; Ghandhi SA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1774-z; Goudarzi M., 2014, J PROTEOME RES; Goudarzi M, 2014, RADIAT RES, V181, P54, DOI 10.1667/RR13479.1; Harrison J, 2008, J RADIOL PROT, V28, P137, DOI 10.1088/0952-4746/28/2/R01; Harrison J, 2009, J RADIOL PROT, V29, pA81, DOI 10.1088/0952-4746/29/2A/S06; Homeland Security Council, 2006, NAT PLANN SCEN FIN V; ICRP, 1993, ICRP PUBL, V67; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Krestinina LY, 2013, BRIT J CANCER, V109, P2886, DOI 10.1038/bjc.2013.614; Krestinina LY, 2005, RADIAT RES, V164, P602, DOI 10.1667/RR3452.1; LAnnunziata M.F., 2003, HDB RADIOACTIVITY AN; Leggett RW, 2003, SCI TOTAL ENVIRON, V317, P235, DOI 10.1016/S0048-9697(03)00333-4; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; Melo DR, 1997, HEALTH PHYS, V73, P320, DOI 10.1097/00004032-199708000-00004; Moysich KB, 2002, LANCET ONCOL, V3, P269, DOI 10.1016/S1470-2045(02)00727-1; Paul S, 2014, RADIAT RES, V182, P380, DOI 10.1667/RR13466.1; Pecaut MJ, 2001, IN VIVO, V15, P195; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Redon CE, 2012, BBA-GENE REGUL MECH, V1819, P743, DOI 10.1016/j.bbagrm.2012.02.021; Redon CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015544; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265; Schonfeld SJ, 2013, RADIAT RES, V179, P183, DOI 10.1667/RR2932.1; Seo J, 2012, NUCLEIC ACIDS RES, V40, P5965, DOI 10.1093/nar/gks287; Smith LE, 2003, HEALTH PHYS, V85, P23, DOI 10.1097/00004032-200307000-00006; Solovjeva LV, 2007, CHROMOSOME RES, V15, P787, DOI 10.1007/s10577-007-1162-x; Stabin MG, 2006, J NUCL MED, V47, P655; STARA J F, 1963, Fission Prod Inhal Proj, V84, P1; STARA JF, 1971, HEALTH PHYS, V20, P113, DOI 10.1097/00004032-197102000-00001; Stather JW, 2000, MED J AUSTRALIA, V172, P352, DOI 10.5694/j.1326-5377.2000.tb124000.x; Steinhausler F, 2005, HEALTH PHYS, V89, P566, DOI 10.1097/01.HP.0000178545.02726.21; Turner HC, 2015, RADIAT RES, V183, P315, DOI 10.1667/RR13860.1; Turner HC, 2014, RAD ENV BIOPHYS; Turner HC, 2011, RADIAT RES, V175, P282, DOI 10.1667/RR2125.1; VARGA LP, 1994, INT J RADIAT BIOL, V66, P399, DOI 10.1080/09553009414551351; Vignard J, 2013, RADIOTHER ONCOL, V108, P362, DOI 10.1016/j.radonc.2013.06.013; WHICKER FW, 1983, RADIAT RES, V94, P135, DOI 10.2307/3575869	48	14	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143815	10.1371/journal.pone.0143815	http://dx.doi.org/10.1371/journal.pone.0143815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618801	Green Submitted, gold, Green Published			2022-12-26	WOS:000365889800074
J	Lance, RM; Capehart, B; Kadro, O; Bass, CR				Lance, Rachel M.; Capehart, Bruce; Kadro, Omar; Bass, Cameron R.			Human Injury Criteria for Underwater Blasts	PLOS ONE			English	Article							RISK-ASSESSMENT; DURATION BLASTS; WATER EXPLOSION; SHOCK-WAVES; ABDOMEN; PRESSURE; CHARGES; CHEST	Underwater blasts propagate further and injure more readily than equivalent air blasts. Development of effective personal protection and countermeasures, however, requires knowledge of the currently unknown human tolerance to underwater blast. Current guidelines for prevention of underwater blast injury are not based on any organized injury risk assessment, human data or experimental data. The goal of this study was to derive injury risk assessments for underwater blast using well-characterized human underwater blast exposures in the open literature. The human injury dataset was compiled using 34 case reports on underwater blast exposure to 475 personnel, dating as early as 1916. Using severity ratings, computational reconstructions of the blasts, and survival information from a final set of 262 human exposures, injury risk models were developed for both injury severity and risk of fatality as functions of blast impulse and blast peak overpressure. Based on these human data, we found that the 50% risk of fatality from underwater blast occurred at 302 +/- 16 kPa-ms impulse. Conservatively, there is a 20% risk of pulmonary injury at a kilometer from a 20 kg charge. From a clinical point of view, this new injury risk model emphasizes the large distances possible for potential pulmonary and gut injuries in water compared with air. This risk value is the first impulse-based fatality risk calculated from human data. The large-scale inconsistency between the blast exposures in the case reports and the guidelines available in the literature prior to this study further underscored the need for this new guideline derived from the unique dataset of actual injuries in this study.	[Lance, Rachel M.] Code E15 Underwater Syst Dev & Acquisit, Naval Surface Warfare Ctr Panama City Div, Panama City, FL USA; [Lance, Rachel M.; Bass, Cameron R.] Duke Univ, Pratt Sch Engn, Durham, NC USA; [Capehart, Bruce] Vet Adm Med Ctr, Durham, NC USA; [Capehart, Bruce] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Kadro, Omar] William Beaumont Hosp, Royal Oak, MI 48072 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Beaumont Health	Lance, RM (corresponding author), Code E15 Underwater Syst Dev & Acquisit, Naval Surface Warfare Ctr Panama City Div, Panama City, FL USA.	rachel.lance@duke.edu		Lance, Rachel/0000-0003-3103-533X	Naval Surface Warfare Center Panama City Division, Underwater Systems Development and Acquisition [E15]; SMART Scholarship; US Army MURI Program [W911NF-10-1-0526]	Naval Surface Warfare Center Panama City Division, Underwater Systems Development and Acquisition; SMART Scholarship; US Army MURI Program	General labor costs for Rachel Lance were funded by Naval Surface Warfare Center Panama City Division, Underwater Systems Development and Acquisition Code E15 and the SMART Scholarship. The US Army MURI Program (U Penn prime W911NF-10-1-0526) partially supported the labor of Cameron R. Bass and Bruce Capehart. None of these sources funded this work specifically. There are no current funding sources for this study.; We would like to thank Reid McKeown and Greg Harris of NSWC Indian Head Explosive Ordnance Disposal Technology Division, Weapon Effects and Analysis Branch Code E31, for their invaluable discussions, which enabled the successful use of the DYSMAS Hydrocode. We would also like to thank Robert Womble, Senior Chief, Explosive Ordnance Disposal, Ret., for providing his technical expertise on underwater explosives. Finally, we would like to acknowledge the professional support of Naval Surface Warfare Center Panama City Division, Underwater Systems Development and Acquisition Code E15.	Abu-Zidan FM, 2001, J TRAUMA, V50, P169, DOI 10.1097/00005373-200101000-00037; Adler J., 1981, MED B US ARM EUR, V7, P33; ANDERSEN P, 1968, ACTA PHYSIOL SCAND, V72, P6, DOI 10.1111/j.1748-1716.1968.tb03820.x; ARONS AB, 1954, J ACOUST SOC AM, V26, P343, DOI 10.1121/1.1907339; Auster LS, 1943, J AMER MED ASSOC, V121, P995, DOI 10.1001/jama.1943.02840130009003; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bebb AH, 1954, UNDERWATER EXPLOSION; Bebb AH., 1951, UNDERWATER BLAST INJ; Bebb AH, 1981, UNDERWATER BLAST EXP; BLAIK M, 1965, J ACOUST SOC AM, V38, P50, DOI 10.1121/1.1909613; Bowen IG., 1968, ESTIMATE MANS TOLERA, P35; Breden NP, 1942, BMJ-BRIT MED J, V1942, P144, DOI 10.1136/bmj.1.4230.144; Bulson PS., 2002, EXPLOSIVE LOADING EN; Cameron GR, 1943, BRIT J SURG, V31, P51, DOI 10.1002/bjs.18003112108; Cameron GR, 1942, BRIT J SURG, V30, P49, DOI 10.1002/bjs.18003011708; Christian EA, 1974, SWIMMER SAFE STANDOF; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Cole R.H., 1948, UNDERWATER EXPLOSION; COREY E L, 1946, U S Nav Med Bull, V46, P623; Cripps NPJ, 1996, J TRAUMA, V40, pS206, DOI 10.1097/00005373-199603001-00045; Cudahy E, 2001, EFFECTS UNDERWATER B; DRAEGER RH, 1946, JAMA-J AM MED ASSOC, V132, P762, DOI 10.1001/jama.1946.02870480008004; Ecklund A. M., 1943, U S NAVAL MED BULL, V41, P19; Ellis FP, 1944, PRESENT POSITION OUR; Ferencz RM, 2008, PARADYN IMPLEMENTATI; Fothergill DM, 2002, RECREATIONAL DIVER R; Friedell MT, 1943, US NAV M B, V41, P353; Gage EL, 1945, US NAVAL MED B, V44, P225; GALANTER E, 1973, PERCEPT PSYCHOPHYS, V14, P301, DOI 10.3758/BF03212395; GASPIN JB, 1979, J ACOUST SOC AM, V66, P1453, DOI 10.1121/1.383539; Gibson JJ, 1950, PERCEPTION VISUAL WO; Gill WG, 1943, BRIT J SURG, V31, P67, DOI 10.1002/bjs.18003112109; Goligher JC, 1943, LANCET, V2, P119; Gordon-Taylor G, 1942, BRIT J SURG, V30, P89, DOI 10.1002/bjs.18003011802; Greaves FC, 1943, US NAVAL MED B, V41, P339; Green JB, 1859, DIVING ARMORE CONTAI; Hamlin H., 1943, U S NAVAL MED BULL, V41, P26; HARMON JW, 1983, MIL MED, V148, P586; Heinke JW, 1856, P I CIVIL ENG; HIRSCH M, 1969, Clinical Radiology, V20, P362, DOI 10.1016/S0009-9260(69)80087-5; HULLER T, 1970, ARCH SURG-CHICAGO, V100, P24; Kedrinskii V, 1972, FIZ GOREN VZRYVA, V8, P115; Lampton DR, 1995, P HUM FACT ERG SOC 3; Lance RM, 2015, DIVING HYPERBARIC ME; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069201; Mair HU, 1999, SHOCK VIB, V6, P81, DOI 10.1155/1999/587105; Martin PGC, 1943, LANCET, V2, P336; Mathew WE, 1917, J R NAV MED SERV, V4, P108; McKeown R, 2004, DEV EVALUATIONS DYSM; Miller ST, 2013, COMPUT FLUIDS, V87, P132, DOI 10.1016/j.compfluid.2013.04.002; MOORE EE, 1990, J TRAUMA, V30, P1427, DOI 10.1097/00005373-199011000-00035; Moore T, 1944, BRIT MED J, V1944, P626, DOI 10.1136/bmj.2.4375.626; Nakahara M, 2008, JPN J APPL PHYS, V47, P3510, DOI 10.1143/JJAP.47.3510; ODaniel J.L., 2011, UNDERWATER EXPLOSION; Palma J., 1943, U S NAVAL MED BULL, V41, P3; Panzer M, 2012, J TRAUMA, V72, P565; Petri NM, 2001, AM J FOREN MED PATH, V22, P383, DOI 10.1097/00000433-200112000-00009; Pinnock DD, 1943, BMJ-BRIT MED J, V1943, P537; Pugh H, 1943, AM J SURG, V60, P429; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Rafaels KA, 2010, J TRAUMA, V69, P368, DOI 10.1097/TA.0b013e3181e88122; Richardson WJ, 1991, EFFECTS NOISE MARINE, P480; Richmond D.R., 1973, FAR FIELD UNDERWATER; Richmond DR, 1976, UND HYP MED SOC INC; Richmond DR, 1977, P 5 INT S MIL APPL B; RIDAH S, 1988, J APPL PHYS, V64, P152, DOI 10.1063/1.341448; ROGERS PH, 1977, J ACOUST SOC AM, V62, P1412, DOI 10.1121/1.381674; Ross JAS, 2007, OCCUP MED-OXFORD, V57, P254, DOI 10.1093/occmed/kqm005; Rusca F, 1915, Z CHIR, V132, P315; Shin YS, 2004, COMPUT STRUCT, V82, P2211, DOI 10.1016/j.compstruc.2004.03.075; Slifko JF, 1959, 6634 NAVORD; Stuhmiller J, 2012, MILITARY QUANTITIATI, P267; Sun HJ, 2004, PERCEPTION, V33, P49, DOI 10.1068/p5145; Theobald X, 1977, EFFECTS UNDERWATER E, P381; Turner GS, 1917, BATTLE FIRE TRAINING; USN, 2011, US NAV DIV MAN REV 6; Wardlaw A., 1998, COUPLED HYDROCODE PR; Wardlaw AB, 2003, GEMINI EULER SOLVER; Webster DR, 1943, CAN MED ASSOC J, V49, P1; WEILERRAVELL D, 1975, ISRAEL J MED SCI, V11, P268; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Williams E, 1944, WAR MED, V5, P296; Williams ERP, 1942, BRIT J SURG, V30, P38, DOI 10.1002/bjs.18003011707; Wood GW, 2013, INJURY PREV, V19, P19, DOI 10.1136/injuryprev-2011-040277; Wright H, 1950, EFFECTS UNDERWATER E; Wright HC, 1947, SUBJECTIVE EFFECTS D; Wright R., 1995, VIRTUAL REALITY PSYC; Yaguda A, 1945, US NAV M B, V44, P232; Yelverton J., 1981, J ACOUT SOC AM, V70, P84; Zuckerman S, 1969, TXB AIR ARMAMENT MIN	91	4	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143485	10.1371/journal.pone.0143485	http://dx.doi.org/10.1371/journal.pone.0143485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606655	gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300070
J	Ma, C; Hao, ZY; Huysmans, G; Lesiuk, A; Bullough, P; Wang, YY; Bartlam, M; Phillips, SE; Young, JD; Goldman, A; Baldwin, SA; Postis, VLG				Ma, Cheng; Hao, Zhenyu; Huysmans, Gerard; Lesiuk, Amelia; Bullough, Per; Wang, Yingying; Bartlam, Mark; Phillips, Simon E.; Young, James D.; Goldman, Adrian; Baldwin, Stephen A.; Postis, Vincent L. G.			A Versatile Strategy for Production of Membrane Proteins with Diverse Topologies: Application to Investigation of Bacterial Homologues of Human Divalent Metal Ion and Nucleoside Transporters	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE ANALYSES; ESCHERICHIA-COLI; TRANSMEMBRANE TOPOLOGY; STRUCTURAL GENOMICS; ZINC-TRANSPORTER; IN-VIVO; EXPRESSION; GENE; OVEREXPRESSION	Membrane proteins play key roles in many biological processes, from acquisition of nutrients to neurotransmission, and are targets for more than 50% of current therapeutic drugs. However, their investigation is hampered by difficulties in their production and purification on a scale suitable for structural studies. In particular, the nature and location of affinity tags introduced for the purification of recombinant membrane proteins can greatly influence their expression levels by affecting their membrane insertion. The extent of such effects typically depends on the transmembrane topologies of the proteins, which for proteins of unknown structure are usually uncertain. For example, attachment of oligohistidine tags to the periplasmic termini of membrane proteins often interferes with folding and drastically impairs expression in Escherichia coli. To circumvent this problem we have employed a novel strategy to enable the rapid production of constructs bearing a range of different affinity tags compatible with either cytoplasmic or periplasmic attachment. Tags include conventional oligohistidine tags compatible with cytoplasmic attachment and, for attachment to proteins with a periplasmic terminus, either tandem Strep-tag II sequences or oligohistidine tags fused to maltose binding protein and a signal sequence. Inclusion of cleavage sites for TEV or HRV-3C protease enables tag removal prior to crystallisation trials or a second step of purification. Together with the use of bioinformatic approaches to identify members of membrane protein families with topologies favourable to cytoplasmic tagging, this has enabled us to express and purify multiple bacterial membrane transporters. To illustrate this strategy, we describe here its use to purify bacterial homologues of human membrane proteins from the Nramp and ZIP families of divalent metal cation transporters and from the concentrative nucleoside transporter family. The proteins are expressed in E. coli in a correctly folded, functional state and can be purified in amounts suitable for structural investigations.	[Hao, Zhenyu; Wang, Yingying] Nankai Univ, Key Lab Pollut Proc & Environm Criteria, Minist Educ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China; [Ma, Cheng; Hao, Zhenyu; Huysmans, Gerard; Lesiuk, Amelia; Bartlam, Mark; Goldman, Adrian; Baldwin, Stephen A.; Postis, Vincent L. G.] Univ Leeds, Sch Biomed Sci, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Bullough, Per] Univ Sheffield, Dept Mol Biol & Biotechnol, Krebs Inst Biomol Res, Sheffield S10 2TN, S Yorkshire, England; [Bartlam, Mark; Goldman, Adrian] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Bartlam, Mark] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Phillips, Simon E.] Harwell Sci & Innovat Campus, Res Complex Harwell, Didcot, Oxon, England; [Young, James D.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Goldman, Adrian] Univ Helsinki, Div Biochem, Dept Biosci, Helsinki, Finland; [Postis, Vincent L. G.] Leeds Beckett Univ, Fac Hlth & Social Sci, Biomed Res Grp, Leeds LS1 3HE, W Yorkshire, England	Nankai University; University of Leeds; University of Sheffield; Nankai University; Nankai University; University of Alberta; University of Helsinki; Leeds Beckett University	Postis, VLG (corresponding author), Univ Leeds, Sch Biomed Sci, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	v.l.g.postis@leeds.ac.uk	Ma, Cheng/AGY-8424-2022; wang, yingying/GRS-3058-2022; HAO, ZHENYU/AAF-3810-2019; Postis, Vincent/D-7736-2013; Huysmans, Gerard/AAJ-6285-2020; wang, yan/GSE-6489-2022	Postis, Vincent/0000-0001-9251-4567; Bullough, Per/0000-0001-8147-1127; Bartlam, Mark/0000-0001-5173-5080; Phillips, Simon/0000-0001-8922-0250; Goldman, Adrian/0000-0001-8032-9700	Wellcome Trust [019322/7/10/Z, 094232]; University of Leeds; China Scholarship Council; National Natural Science Foundation of China [31450110071]; SAFEA High-End Foreign Expert Project [GDW20131200049]; Royal Society Wolfson Research Merit Award; Canadian Cancer Society Research Institute; Alberta Cancer Foundation; Canadian Institutes of Health Research; MRC [MC_EX_G0901251] Funding Source: UKRI; Medical Research Council [MC_EX_G0901251] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); University of Leeds; China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SAFEA High-End Foreign Expert Project; Royal Society Wolfson Research Merit Award(Royal Society of London); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust (ref. 019322/7/10/Z) to SP, PB, JY, AG and SB. The Circular Dichroism facility was supported by the Wellcome Trust (ref 094232). CM was in receipt of a China Scholarship Council award and funding from the University of Leeds, while ZH was funded by an award from the China Scholarship Council. YW and MB were funded by the National Natural Science Foundation of China (ref. 31450110071) and MB received funding from the SAFEA High-End Foreign Expert Project (ref. GDW20131200049). AG is funded by a Royal Society Wolfson Research Merit Award. JY is supported by the Canadian Cancer Society Research Institute, the Alberta Cancer Foundation, and the Canadian Institutes of Health Research. JY is a Senior Investigator of the Alberta Heritage Foundation for Medical Research.	Abrantes MC, 2013, INFECT IMMUN, V81, P935, DOI 10.1128/IAI.06377-11; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Bin BH, 2011, J BIOL CHEM, V286, P40255, DOI 10.1074/jbc.M111.256784; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Busby M, 2010, BIOPHYS CHEM, V152, P170, DOI 10.1016/j.bpc.2010.09.005; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Courville P, 2004, J BIOL CHEM, V279, P3318, DOI 10.1074/jbc.M309913200; CRAIG JE, 1994, MOL MICROBIOL, V11, P1159, DOI 10.1111/j.1365-2958.1994.tb00392.x; Deacon SE, 2008, MOL MEMBR BIOL, V25, P588, DOI 10.1080/09687680802511774; Fagerberg L, 2010, PROTEOMICS, V10, P1141, DOI 10.1002/pmic.200900258; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Glover CAP, 2011, J STRUCT BIOL, V176, P419, DOI 10.1016/j.jsb.2011.09.005; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hsieh JM, 2010, PROTEIN SCI, V19, P868, DOI 10.1002/pro.365; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kang HJ, 2013, INT J BIOCHEM CELL B, V45, P636, DOI 10.1016/j.biocel.2012.12.018; Kauko A, 2010, J MOL BIOL, V397, P190, DOI 10.1016/j.jmb.2010.01.042; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Lopez PJ, 1999, MOL MICROBIOL, V33, P188, DOI 10.1046/j.1365-2958.1999.01465.x; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Montalbetti N, 2013, MOL ASPECTS MED, V34, P270, DOI 10.1016/j.mam.2013.01.002; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Quick M, 2002, P NATL ACAD SCI USA, V99, P8597, DOI 10.1073/pnas.132266599; Rahman M, 2007, MOL MEMBR BIOL, V24, P407, DOI 10.1080/09687860701243998; Raran-Kurussi S, 2013, ANAL BIOCHEM, V436, P142, DOI 10.1016/j.ab.2013.01.031; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Richer E, 2003, J MOL EVOL, V57, P363, DOI 10.1007/s00239-003-2472-z; Schlegel S, 2012, J MOL BIOL, V423, P648, DOI 10.1016/j.jmb.2012.07.019; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Surade S, 2006, PROTEIN SCI, V15, P2178, DOI 10.1110/ps.062312706; Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wallace BA, 2001, CURR OPIN CHEM BIOL, V5, P567, DOI 10.1016/S1367-5931(00)00243-X; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Xie H, 2004, MOL MEMBR BIOL, V21, P323, DOI 10.1080/09687860400003941; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007	54	13	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143010	10.1371/journal.pone.0143010	http://dx.doi.org/10.1371/journal.pone.0143010			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606682	Green Accepted, Green Published, gold			2022-12-26	WOS:000365865300040
J	Mohn, KGI; Cox, RJ; Tunheim, G; Berdal, JE; Hauge, AG; Jul-Larsen, A; Peters, B; Oftung, F; Jonassen, CM; Mjaaland, S				Mohn, Kristin G-I.; Cox, Rebecca Jane; Tunheim, Gro; Berdal, Jan Erik; Hauge, Anna Germundsson; Jul-Larsen, Asne; Peters, Bjoern; Oftung, Fredrik; Jonassen, Christine Monceyron; Mjaaland, Siri		Norwegian Pandemic Group	Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway	PLOS ONE			English	Article							CD4 T-CELLS; H1N1 INFLUENZA; VIRUS-INFECTION; A H1N1; RISK-FACTOR; PROTECTION; VACCINATION; A(H1N1); CHALLENGE; SIGNATURE	Increased understanding of immune responses influencing clinical severity during pandemic influenza infection is important for improved treatment and vaccine development. In this study we recruited 46 adult patients during the 2009 influenza pandemic and characterized humoral and cellular immune responses. Those included were either acute hospitalized or convalescent patients with different disease severities (mild, moderate or severe). In general, protective antibody responses increased with enhanced disease severity. In the acute patients, we found higher levels of TNF-alpha single-producing CD4(+) T-cells in the severely ill as compared to patients with moderate disease. Stimulation of peripheral blood mononuclear cells (PBMC) from a subset of acute patients with peptide T-cell epitopes showed significantly lower frequencies of influenza specific CD8(+) compared with CD4(+) IFN. T-cells in acute patients. Both T-cell subsets were predominantly directed against the envelope antigens (HA and NA). However, in the convalescent patients we found high levels of both CD4(+) and CD8(+) T-cells directed against conserved core antigens (NP, PA, PB, and M). The results indicate that the antigen targets recognized by the T-cell subsets may vary according to the phase of infection. The apparent low levels of cross-reactive CD8(+) T-cells recognizing internal antigens in acute hospitalized patients suggest an important role for this T-cell subset in protective immunity against influenza.	[Mohn, Kristin G-I.; Cox, Rebecca Jane; Jul-Larsen, Asne] Univ Bergen, Dept Clin Sci, Influenza Ctr, Bergen, Norway; [Mohn, Kristin G-I.] Haukeland Hosp, Dept Internal Med, Infect Dis Unit, N-5021 Bergen, Norway; [Cox, Rebecca Jane] Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway; [Tunheim, Gro; Oftung, Fredrik; Mjaaland, Siri] Norwegian Inst Publ Hlth, Div Infect Dis Control, Dept Bacteriol & Immunol, Oslo, Norway; [Mohn, Kristin G-I.; Cox, Rebecca Jane; Tunheim, Gro; Oftung, Fredrik; Mjaaland, Siri] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Influenza Vaccine Res, Bergen, Norway; [Mohn, Kristin G-I.; Cox, Rebecca Jane; Tunheim, Gro; Oftung, Fredrik; Mjaaland, Siri] Norwegian Inst Publ Hlth, Oslo, Norway; [Berdal, Jan Erik] Akershus Univ Hosp, Dept Infect Dis, Nordbyhagen, Norway; [Hauge, Anna Germundsson] Norwegian Vet Inst, Virol Sect, Dept Lab Serv, Oslo, Norway; [Hauge, Anna Germundsson] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; [Peters, Bjoern] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Jonassen, Christine Monceyron] Akershus Univ Hosp, Dept Multidisciplinary Lab Med & Med Biochem, Genet Unit, Nordbyhagen, Norway; [Jonassen, Christine Monceyron] Ostfold Hosp Trust, Genet Unit, Ctr Lab Med, Fredrikstad, Norway; [Jonassen, Christine Monceyron] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Norwegian Institute of Public Health (NIPH); University of Bergen; Norwegian Institute of Public Health (NIPH); University of Oslo; Norwegian Veterinary Institute; Norwegian Institute of Public Health (NIPH); La Jolla Institute for Immunology; University of Oslo; Norwegian University of Life Sciences	Mohn, KGI (corresponding author), Univ Bergen, Dept Clin Sci, Influenza Ctr, Bergen, Norway.	Kristin.Mohn@uib.no; Siri.Mjaaland@fhi.no		Skrede, Steinar/0000-0003-1615-4453; Mjaaland, Siri/0000-0002-3870-5861; Dembinski, Jennifer/0000-0001-9259-9572	Influenza Centre at the University of Bergen; Akershus University Hospital; Norwegian Institute of Public Health; Bergen Clinical Vaccine Consortium; Ministry of Health and Care Services, Norway; Norwegian Research Council [220670]; Research Counsil Norway Bio bank [221122]; European Union, Helse Vest [Univax 601738, Unisec 602012, EU IMI115672 FLUCOP]; K.G. Jebsen Centre for Research on Influenza Vaccines	Influenza Centre at the University of Bergen; Akershus University Hospital; Norwegian Institute of Public Health; Bergen Clinical Vaccine Consortium; Ministry of Health and Care Services, Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission); Research Counsil Norway Bio bank; European Union, Helse Vest; K.G. Jebsen Centre for Research on Influenza Vaccines	The study was funded intramurally by the Influenza Centre at the University of Bergen, the Akershus University Hospital, and the Norwegian Institute of Public Health. Funding was received from the Bergen Clinical Vaccine Consortium and by the Ministry of Health and Care Services, Norway, the Norwegian Research Council Globvac program (220670), the Research Counsil Norway Bio bank (221122), the European Union (Univax 601738, Unisec 602012 and EU IMI115672 FLUCOP), Helse Vest and the K.G. Jebsen Centre for Research on Influenza Vaccines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg AF, 2015, VACCINE, V33, P500, DOI 10.1016/j.vaccine.2014.11.054; Baldanti F, 2011, CLIN MICROBIOL INFEC, V17, P1166, DOI 10.1111/j.1469-0691.2010.03403.x; Berdal JE, 2011, J INFECTION, V63, P308, DOI 10.1016/j.jinf.2011.07.004; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Bogoch II, 2013, VIRULENCE, V4, P82, DOI 10.4161/viru.22466; Bonduelle O, 2014, J CLIN INVEST, V124, P3129, DOI 10.1172/JCI74565; Brandsaeter BJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-75; Broadbent AJ, 2011, CURR OPIN VIROL, V1, P254, DOI 10.1016/j.coviro.2011.08.002; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Chiu C, 2015, NAT IMMUNOL, V16, P18, DOI 10.1038/ni.3056; Choi SM, 2012, J INFECT DIS, V206, P1872, DOI 10.1093/infdis/jis610; Cui W, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-145; de Blasio BF, 2012, PLOS ONE, V7, P327, DOI 10.1371/journal.pone.0030018; Dembinski JL, 2014, J VIROL METHODS, V207, P232, DOI 10.1016/j.jviromet.2014.07.003; Departement DfsobDNPH, 2010, RAP NEW INFL A H1N1, V11, P46; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Guidotti LG, 2000, VIROLOGY, V273, P221, DOI 10.1006/viro.2000.0442; Haran JP, 2014, J CLIN VIROL, V60, P367, DOI 10.1016/j.jcv.2014.04.017; Hayward AC, 2015, AM J RESP CRIT CARE; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Louie JK, 2010, ARCH PEDIAT ADOL MED, V164, P1023, DOI 10.1001/archpediatrics.2010.203; Madhun AS, 2010, VACCINE, V29, P266, DOI 10.1016/j.vaccine.2010.10.038; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Mohn KG, 2014, J INFECT DIS; Mohn KG-l, 2013, VACCINES VACCINATION, V4; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; NPH NPHDF, 2010, 2009 INFL PAND SURV; Ortiz JR, 2013, CRIT CARE MED, V41, P1345, DOI 10.1097/CCM.0b013e3182771386; Oughton M, 2011, DIAGN MICR INFEC DIS, V70, P213, DOI 10.1016/j.diagmicrobio.2010.12.013; Pedersen G, 2011, SCAND J IMMUNOL, V74, P210, DOI 10.1111/j.1365-3083.2011.02561.x; Peiris JSM, 2009, EUR J IMMUNOL, V39, P2946, DOI 10.1002/eji.200939911; Rykkvin R, 2013, EURO SURVEILL, V18; Samdal HH, 2005, HUM VACCINES, V1, P85, DOI 10.4161/hv.1.2.1718; Savic MD, 2015, IMMUNOLOGY IN PRESS; Slifka MK, 2000, J MOL MED, V78, P74, DOI 10.1007/s001090000086; Sridhar S, 2012, EUR J IMMUNOL, V42, P2913, DOI 10.1002/eji.201242504; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Vita R, 2014, NUCL ACIDS RES; Wagar LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028063; Weaver JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057275; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Yang JB, 2013, INT IMMUNOL, V25, P447, DOI 10.1093/intimm/dxt005; Zhao Y, 2012, AM J RESP CRIT CARE, V186, P1292, DOI 10.1164/rccm.201207-1245OC; [No title captured]	57	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143281	10.1371/journal.pone.0143281	http://dx.doi.org/10.1371/journal.pone.0143281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606759	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000365865300051
J	Duffy, JE; Ziegler, SL; Campbell, JE; Bippus, PM; Lefcheck, JS				Duffy, J. Emmett; Ziegler, Shelby L.; Campbell, Justin E.; Bippus, Paige M.; Lefcheck, Jonathan S.			Squidpops: A Simple Tool to Crowdsource a Global Map of Marine Predation Intensity	PLOS ONE			English	Article							GRAZING INTENSITY; TERRESTRIAL; ABUNDANCE; PATTERNS; FISH; LIMITATION; TEMPERATE; GRADIENTS; NITROGEN; EELGRASS	We present a simple, standardized assay, the squidpop, for measuring the relative feeding intensity of generalist predators in aquatic systems. The assay consists of a 1.3-cm diameter disk of dried squid mantle tethered to a rod, which is either inserted in the sediment in soft-bottom habitats or secured to existing structure. Each replicate squidpop is scored as present or absent after 1 and 24 hours, and the data for analysis are proportions of replicate units consumed at each time. Tests in several habitats of the temperate southeastern USA (Virginia and North Carolina) and tropical Central America (Belize) confirmed the assay's utility for measuring variation in predation intensity among habitats, among seasons, and along environmental gradients. In Belize, predation intensity varied strongly among habitats, with reef > seagrass = mangrove > unvegetated bare sand. Quantitative visual surveys confirmed that assayed feeding intensity increased with abundance and species richness of fishes across sites, with fish abundance and richness explaining up to 45% and 70% of the variation in bait loss respectively. In the southeastern USA, predation intensity varied seasonally, being highest during summer and declining in late autumn. Deployments in marsh habitats generally revealed a decline in mean predation intensity from fully marine to tidal freshwater sites. The simplicity, economy, and standardization of the squidpop assay should facilitate engagement of scientists and citizens alike, with the goal of constructing high-resolution maps of how top-down control varies through space and time in aquatic ecosystems, and addressing a broad array of long-standing hypotheses in macro-and community ecology.	[Duffy, J. Emmett] Smithsonian Inst, Tennenbaum Marine Observ Network, Washington, DC 20560 USA; [Duffy, J. Emmett; Ziegler, Shelby L.; Lefcheck, Jonathan S.] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA USA; [Campbell, Justin E.] Smithsonian Marine Stn, Ft Pierce, FL USA; [Bippus, Paige M.] Coll Charleston, Charleston, SC 29401 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; William & Mary; Virginia Institute of Marine Science; Smithsonian Institution; Smithsonian National Museum of Natural History; College of Charleston	Duffy, JE (corresponding author), Smithsonian Inst, Tennenbaum Marine Observ Network, Washington, DC 20560 USA.	duffye@si.edu	Lefcheck, Jonathan/H-8768-2019; Duffy, J. Emmett/ABF-9200-2020	Lefcheck, Jonathan/0000-0002-8787-1786; Duffy, J. Emmett/0000-0001-8595-6391; Ziegler, Shelby/0000-0001-7218-0811	National Science Foundation [OCE-1336206]; Smithsonian Institution's Caribbean Coral Reef Ecosystem Program; Tennenbaum Marine Observatories Network; National Science Foundation's Research Experiences for Undergraduates program [OCE-062882]	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution's Caribbean Coral Reef Ecosystem Program; Tennenbaum Marine Observatories Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); National Science Foundation's Research Experiences for Undergraduates program	This work was supported by the National Science Foundation (award OCE-1336206 to JED), and the Smithsonian Institution's Caribbean Coral Reef Ecosystem Program and Tennenbaum Marine Observatories Network. PB was also supported by the National Science Foundation's Research Experiences for Undergraduates program (award OCE-062882 to Drs. Linda Schaffner and Rochelle Seitz, VIMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson RB, 1987, PALEOBIOLOGY; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Douglass JG, 2010, LIMNOL OCEANOGR, V55, P1499, DOI 10.4319/lo.2010.55.4.1499; DUFFY JE, 1994, ECOLOGY, V75, P1304, DOI 10.2307/1937456; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V137, P195, DOI 10.1016/0022-0981(90)90185-F; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; HAY ME, 1984, ECOLOGY, V65, P446, DOI 10.2307/1941407; HAY ME, 1981, AM NAT, V118, P520, DOI 10.1086/283845; HAY ME, 1981, AQUAT BOT, V11, P97, DOI 10.1016/0304-3770(81)90051-6; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Madin EMP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00014; Manyak-Davis A, 2013, AM NAT, V182, P347, DOI 10.1086/671170; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Meyer ST, 2015, TRENDS ECOL EVOL, V30, P390, DOI 10.1016/j.tree.2015.04.006; Moles AT, 2013, IDEAS ECOL EVOL, V6, P1, DOI 10.4033/iee.2013.6.1.c; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; OGDEN JC, 1973, SCIENCE, V182, P715, DOI 10.1126/science.182.4113.715; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Peterson BJ, 2001, MAR ECOL PROG SER, V224, P77, DOI 10.3354/meps224077; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Rotjan RD, 2006, J EXP MAR BIOL ECOL, V335, P292, DOI 10.1016/j.jembe.2006.03.015; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Thompson RM, 2012, TRENDS ECOL EVOL, V27, P689, DOI 10.1016/j.tree.2012.08.005; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; WILSON KA, 1987, FISH B-NOAA, V85, P53; Wood SA, 2010, ECOL LETT, V13, P1160, DOI 10.1111/j.1461-0248.2010.01508.x	39	34	34	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142994	10.1371/journal.pone.0142994	http://dx.doi.org/10.1371/journal.pone.0142994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599815	gold, Green Published, Green Submitted			2022-12-26	WOS:000365862600024
J	Park, SH; Gong, JH; Choi, YJ; Kang, MK; Kim, YH; Kang, YH				Park, Sin-Hye; Gong, Ju-Hyun; Choi, Yean-Jung; Kang, Min-Kyung; Kim, Yun-Ho; Kang, Young-Hee			Kaempferol Inhibits Endoplasmic Reticulum Stress-Associated Mucus Hypersecretion in Airway Epithelial Cells And Ovalbumin-Sensitized Mice	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MUC5AC GENE-EXPRESSION; HUMAN HEALTH; ER STRESS; ASTHMA; INFLAMMATION; LUNG; DISEASE; COPD; MECHANISM	Mucus hypersecretion is an important pathological feature of chronic airway diseases, such as asthma and pulmonary diseases. MUC5AC is a major component of the mucus matrix forming family of mucins in the airways. The initiation of endoplasmic reticulum (ER)-mediated stress responses contributes to the pathogenesis of airway diseases. The present study investigated that ER stress was responsible for airway mucus production and this effect was blocked by the flavonoid kaempferol. Oral administration of >= 10 mg/kg kaempferol suppressed mucus secretion and goblet cell hyperplasia observed in the bronchial airway and lung of BALB/c mice sensitized with ovalbumin (OVA). TGF-beta and tunicamycin promoted MUC5AC induction after 72 h in human bronchial airway epithelial BEAS-2B cells, which was dampened by 20 mu M kaempferol. Kaempferol inhibited tunicamycin-induced ER stress of airway epithelial cells through disturbing the activation of the ER trans-membrane sensor ATF6 and IRE1 alpha. Additionally, this compound demoted the induction of ER chaperones such as GRP78 and HSP70 and the splicing of XBP-1 mRNA by tunicamycin. The in vivo study further revealed that kaempferol attenuated the induction of XBP-1 and IRE1 alpha in epithelial tissues of OVA-challenged mice. TGF-beta and tunicamycin induced TRAF2 with JNK activation and such induction was deterred by kaempferol. The inhibition of JNK activation encumbered the XBP-1 mRNA splicing and MUC5AC induction by tunicamycin and TGF-beta. These results demonstrate that kaempferol alleviated asthmatic mucus hypersecretion through blocking bronchial epithelial ER stress via the inhibition of IRE1 alpha-TRAF2-JNK activation. Therefore, kaempferol may be a potential therapeutic agent targeting mucus hypersecretion-associated pulmonary diseases.	[Park, Sin-Hye; Gong, Ju-Hyun; Choi, Yean-Jung; Kang, Min-Kyung; Kim, Yun-Ho; Kang, Young-Hee] Hallym Univ, Dept Food & Nutr, Chunchon, South Korea	Hallym University	Kang, YH (corresponding author), Hallym Univ, Dept Food & Nutr, Chunchon, South Korea.	yhkang@hallym.ac.kr			Hallym University [HRF-2013-00]; National Research Foundation of Korea [2015R1A2A2A01006666]	Hallym University; National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by Hallym University Research Fund, 2013 (HRF-2013-00), and the National Research Foundation of Korea (2015R1A2A2A01006666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2000, J BIOMATER APPL, V14, P243, DOI 10.1106/9D4B-L6PP-7CTF-BY8G; Bosse Y, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-66; Bravo R, 2013, INT REV CEL MOL BIO, V301, P215, DOI 10.1016/B978-0-12-407704-1.00005-1; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chen AY, 2013, FOOD CHEM, V138, P2099, DOI 10.1016/j.foodchem.2012.11.139; Danahay H, 2015, CELL REP, V10, P239, DOI 10.1016/j.celrep.2014.12.017; Goh FY, 2012, EUR J PHARMACOL, V679, P109, DOI 10.1016/j.ejphar.2012.01.002; Gong JH, 2014, LAB INVEST, V94, P297, DOI 10.1038/labinvest.2013.137; Gong JH, 2012, J NUTR, V142, P47, DOI 10.3945/jn.111.150748; Gosens R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-73; Gras D, 2013, PHARMACOL THERAPEUT, V140, P290, DOI 10.1016/j.pharmthera.2013.07.008; Groneberg DA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-18; Hannum SM, 2004, CRIT REV FOOD SCI, V44, P1, DOI 10.1080/10408690490263756; Hasnain SZ, 2013, GASTROENTEROLOGY, V144, P357, DOI 10.1053/j.gastro.2012.10.043; Hauber Hans-Peter, 2008, Inflammation & Allergy Drug Targets, V7, P30, DOI 10.2174/187152808784165153; Hoffman SM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-141; Izuhara K, 2009, CURR MED CHEM, V16, P2867, DOI 10.2174/092986709788803196; Kim HJ, 2008, J NUTR BIOCHEM, V19, P536, DOI 10.1016/j.jnutbio.2007.06.010; Kim JH, 2009, AM J RHINOL ALLERGY, V23, P385, DOI 10.2500/ajra.2009.23.3337; Kim SR, 2015, ALLERGY ASTHMA IMMUN, V7, P106, DOI 10.4168/aair.2015.7.2.106; Kim Suil, 2004, Treat Respir Med, V3, P147, DOI 10.2165/00151829-200403030-00003; Kim V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116108; Kim WD, 1997, EUR RESPIR J, V10, P1914, DOI 10.1183/09031936.97.10081914; Kitaguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038038; Lai H, 2010, J AEROSOL MED PULM D, V23, P219, DOI 10.1089/jamp.2009.0802; Lea S, 2014, EUR RESPIR J, V43, P409, DOI 10.1183/09031936.00187812; Makhija L, 2014, AM J RESP CELL MOL, V50, P923, DOI 10.1165/rcmb.2013-0320OC; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; Martino MB, 2013, MUCOSAL IMMUNOL, V6, P639, DOI 10.1038/mi.2012.105; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; Munakata Mitsuru, 2006, Allergol Int, V55, P235, DOI 10.2332/allergolint.55.235; Ribeiro CMP, 2012, CURR MOL MED, V12, P872; Schroeder BW, 2012, AM J RESP CELL MOL, V47, P178, DOI 10.1165/rcmb.2011-0421OC; Shale DJ, 2004, EUR RESPIR J, V23, P797, DOI 10.1183/09031936.0.00018404; Shinkai M, 2008, PHARMACOL THERAPEUT, V117, P393, DOI 10.1016/j.pharmthera.2007.11.001; Soltys BJ, 1996, J CELL SCI, V109, P1909; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vandewynckel YP, 2013, ANTICANCER RES, V33, P4683; Wang GQ, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-21; Yamauchi Kohei, 2007, Allergol Int, V56, P321, DOI 10.2332/allergolint.R-07-151; Yang T, 2012, INT IMMUNOPHARMACOL, V13, P73, DOI 10.1016/j.intimp.2012.03.006; Yang YC, 2012, ALLERGY, V67, P1193, DOI 10.1111/j.1398-9995.2012.02880.x	42	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143526	10.1371/journal.pone.0143526	http://dx.doi.org/10.1371/journal.pone.0143526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599511	Green Published, gold			2022-12-26	WOS:000365862600079
J	Benziger, CP; Bernabe-Ortiz, A; Gilman, RH; Checkley, W; Smeeth, L; Malaga, G; Miranda, JJ				Benziger, Catherine P.; Bernabe-Ortiz, Antonio; Gilman, Robert H.; Checkley, William; Smeeth, Liam; Malaga, German; Miranda, J. Jaime		CRONICAS Cohort Study Grp	Metabolic Abnormalities Are Common among South American Hispanics Subjects with Normal Weight or Excess Body Weight: The CRONICAS Cohort Study	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; MASS INDEX; CARDIOVASCULAR-DISEASE; HEALTHY OBESITY; COLLABORATIVE ANALYSIS; POOLED ANALYSIS; RISK-FACTORS; OVERWEIGHT; PREVALENCE; POPULATION	Objective We aimed to characterize metabolic status by body mass index (BMI) status. Methods The CRONICAS longitudinal study was performed in an age-and-sex stratified random sample of participants aged 35 years or older in four Peruvian settings: Lima (Peru's capital, costal urban, highly urbanized), urban and rural Puno (both high-altitude), and Tumbes (costal semirural). Data from the baseline study, conducted in 2010, was used. Individuals were classified by BMI as normal weight (18.5-24.9 kg/m(2)), overweight (25.0-29.9 kg/m(2)), and obese (>= 30 kg/m(2)), and as metabolically healthy (0-1 metabolic abnormality) or metabolically unhealthy (>= 2 abnormalities). Abnormalities included individual components of the metabolic syndrome, high-sensitivity C-reactive protein, and insulin resistance. Results A total of 3088 (age 55.6 +/- 12.6 years, 51.3% females) had all measurements. Of these, 890 (28.8%), 1361 (44.1%) and 837 (27.1%) were normal weight, overweight and obese, respectively. Overall, 19.0% of normal weight in contrast to 54.9% of overweight and 77.7% of obese individuals had >= 3 risk factors (p<0.001). Among normal weight individuals, 43.1% were metabolically unhealthy, and age >= 65 years, female, and highest socioeconomic groups were more likely to have this pattern. In contrast, only 16.4% of overweight and 3.9% of obese individuals were metabolically healthy and, compared to Lima, the rural and urban sites in Puno were more likely to have a metabolically healthier profile. Conclusions Most Peruvians with overweight and obesity have additional risk factors for cardiovascular disease, as well as a majority of those with a healthy weight. Prevention programs aimed at individuals with a normal BMI, and those who are overweight and obese, are urgently needed, such as screening for elevated fasting cholesterol and glucose.	[Benziger, Catherine P.; Bernabe-Ortiz, Antonio; Malaga, German; Miranda, J. Jaime] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Benziger, Catherine P.] Univ Washington, Div Cardiol, Seattle, WA 98195 USA; [Gilman, Robert H.; Checkley, William] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Program Global Dis Epidemiol & Control, Baltimore, MD USA; [Gilman, Robert H.] Asociac Benef PRISMA, Lima, Peru; [Checkley, William] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, Baltimore, MD USA; [Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Malaga, German; Miranda, J. Jaime] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia	Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	jaime.miranda@upch.pe	Benziger, Catherine/AAN-3344-2021; Smeeth, Liam/X-5862-2018	Benziger, Catherine/0000-0002-8992-6197; Miranda, J. Jaime/0000-0002-4738-5468; Smeeth, Liam/0000-0002-9168-6022; Huicho, Luis/0000-0002-5272-5885; Montori, Victor/0000-0003-0595-2898; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Leon-Velarde Servetto, Fabiola/0000-0001-8398-2406; Wise, Robert/0000-0002-8353-2349; Checkley, William/0000-0003-1106-8812; Malaga, German/0000-0002-7828-300X; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]; National Institutes of Health; Fogarty International Center through the International Clinical Research Fellows Program at Vanderbilt University [R24 TW007988]; Wellcome Trust; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K24ES021098] Funding Source: NIH RePORTER	United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center through the International Clinical Research Fellows Program at Vanderbilt University; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project and authors ABO, RHG, WC, and JJM have been funded with Federal funds from the United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN268200900033C. CPB was supported by the National Institutes of Health and Fogarty International Center through the International Clinical Research Fellows Program at Vanderbilt University (R24 TW007988). LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay LR, 2013, NUTR REV, V71, P168, DOI 10.1111/j.1753-4887.2012.00533.x; Bernabe-Ortiz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035127; Bobbioni-Harsch E, 2012, OBESITY, V20, P2063, DOI 10.1038/oby.2012.69; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Cerhan JR, 2014, MAYO CLIN PROC, V89, P335, DOI 10.1016/j.mayocp.2013.11.011; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conus F, 2004, J CLIN ENDOCR METAB, V89, P5013, DOI 10.1210/jc.2004-0265; Daeppen JB, 2000, ALCOHOL CLIN EXP RES, V24, P659, DOI 10.1097/00000374-200005000-00010; Dalleck LC, 2014, DIABET METAB SYND OB, V7, P369, DOI 10.2147/DMSO.S67441; Durward CM, 2012, J OBES, V2012, DOI 10.1155/2012/460321; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS259, DOI 10.1123/jpah.7.s2.s259; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Jacoby E, 2003, PREV MED, V37, P396, DOI 10.1016/S0091-7435(03)00159-2; Miranda JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054056; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; de Mola CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092550; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Medina-Lezama J, 2010, DIABETES CARE, V33, P1385, DOI 10.2337/dc09-2353; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Miranda J Jaime, 2012, BMJ Open, V2, pe000610, DOI 10.1136/bmjopen-2011-000610; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Muller MJ, 2012, OBES REV, V13, P6, DOI 10.1111/j.1467-789X.2012.01033.x; Pajunen P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-754; Pataky Z, 2011, INT J OBESITY, V35, P1208, DOI 10.1038/ijo.2010.264; Popkin BM, 2013, OBES REV, V14, P11, DOI 10.1111/obr.12102; Poterico JA, 2012, OBESITY, V20, P2283, DOI 10.1038/oby.2011.288; Shea JL, 2011, OBESITY, V19, P624, DOI 10.1038/oby.2010.174; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Soriguer F, 2013, J CLIN ENDOCR METAB, V98, P2318, DOI 10.1210/jc.2012-4253; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; Webber L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039589; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0	42	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0138968	10.1371/journal.pone.0138968	http://dx.doi.org/10.1371/journal.pone.0138968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599322	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000365853900002
J	Mkenda, P; Mwanauta, R; Stevenson, PC; Ndakidemi, P; Mtei, K; Belmain, SR				Mkenda, Prisila; Mwanauta, Regina; Stevenson, Philip C.; Ndakidemi, Patrick; Mtei, Kelvin; Belmain, Steven R.			Extracts from Field Margin Weeds Provide Economically Viable and Environmentally Benign Pest Control Compared to Synthetic Pesticides	PLOS ONE			English	Article							TITHONIA-DIVERSIFOLIA; TEPHROSIA-VOGELII; LIPPIA-JAVANICA; ECOLOGICAL INTENSIFICATION; BOTANICAL INSECTICIDES; SESQUITERPENE LACTONES; ANTIFEEDANT; YIELD; EFFICACY; PLANTS	Plants with pesticidal properties have been investigated for decades as alternatives to synthetics, but most progress has been shown in the laboratory. Consequently, research on pesticidal plants is failing to address gaps in our knowledge that constrain their uptake. Some of these gaps are their evaluation of their efficacy under field conditions, their economic viability and impact on beneficial organisms. Extracts made from four abundant weed species found in northern Tanzania, Tithonia diversifolia, Tephrosia vogelii, Vernonia amygdalina and Lippia javanica offered effective control of key pest species on common bean plants (Phaseolus vulgaris) that was comparable to the pyrethroid synthetic, Karate. The plant pesticide treatments had significantly lower effects on natural enemies (lady beetles and spiders). Plant pesticide treatments were more cost effective to use than the synthetic pesticide where the marginal rate of return for the synthetic was no different from the untreated control, around 4USD/ha, compared to a rate of return of around 5.50USD/ha for plant pesticide treatments. Chemical analysis confirmed the presence of known insecticidal compounds in water extracts of T. vogelii (the rotenoid deguelin) and T. diversifolia (the sesquiterpene lactone tagitinin A). Sesquiterpene lactones and the saponin vernonioside C were also identified in organic extracts of V. amygdalina but only the saponin was recorded in water extracts which are similar to those used in the field trial. Pesticidal plants were better able to facilitate ecosystem services whilst effectively managing pests. The labour costs of collecting and processing abundant plants near farm land were less than the cost of purchasing synthetic pesticides.	[Mkenda, Prisila; Mwanauta, Regina; Ndakidemi, Patrick; Mtei, Kelvin] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania; [Stevenson, Philip C.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Stevenson, Philip C.; Belmain, Steven R.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England	Nelson Mandela African Institution of Science & Technology; Royal Botanic Gardens, Kew; University of Greenwich	Belmain, SR (corresponding author), Univ Greenwich, Nat Resources Inst, Chatham, Kent, England.	s.r.belmain@gre.ac.uk	stevenson, philip c/E-8741-2013; Belmain, Steven R/F-7758-2012; Stevenson, Philip C/E-8822-2013; MKENDA, PRISILA ANDREA/ABE-1774-2020	stevenson, philip c/0000-0002-0736-3619; Belmain, Steven R/0000-0002-5590-7545; Stevenson, Philip C/0000-0002-0736-3619; 	McKnight Foundation grant [13-335]; European Union 9th European Development Fund grant from the African Caribbean and Pacific Science and Technology Programme [FED/2013/329-272]	McKnight Foundation grant; European Union 9th European Development Fund grant from the African Caribbean and Pacific Science and Technology Programme	This research was funded by a McKnight Foundation grant (Grant No: 13-335) https://www.mcknight.org/grant-programs/international/collaborative-crop-research and a European Union 9th European Development Fund grant from the African Caribbean and Pacific Science and Technology Programme (FED/2013/329-272), http://www.acp-st.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate T, 1996, ANNU REV ENTOMOL, V41, P45, DOI 10.1146/annurev.en.41.010196.000401; Adedire CO, 2004, ANN APPL BIOL, V144, P185, DOI 10.1111/j.1744-7348.2004.tb00332.x; Adeniyi SA, 2010, INT J PHYS SCI, V5, P753; Akhtar Y., 2008, Phytochemistry Reviews, V7, P77, DOI 10.1007/s11101-006-9048-7; Ambrsio SR, 2008, PHYTOCHEMISTRY, V69, P2052, DOI 10.1016/j.phytochem.2008.03.019; Amoabeng BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078651; Asawalam EF, 2008, AFR J BIOTECHNOL, V7, P2957; Bagnarello G, 2009, REV BIOL TROP, V57, P1201; Belmain S., 2001, Pesticide Outlook, V12, P233, DOI 10.1039/b110542f; Belmain SR, 2012, J AGR FOOD CHEM, V60, P10055, DOI 10.1021/jf3032217; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Brown PR, 2005, CROP PROT, V24, P101, DOI 10.1016/j.cropro.2004.06.012; Cassida JE, 2012, PYRETHRUM NATURAL IN; Chagas-Paula DA, 2012, CHEM BIODIVERS, V9, P210, DOI 10.1002/cbdv.201100019; Chukwujekwu JC, 2009, S AFR J BOT, V75, P176, DOI 10.1016/j.sajb.2008.10.001; De la Fuente M, 2012, FOOD TECHNOL BIOTECH, V50, P315; Gadzirayi CT, 2009, AFR J BIOTECHNOL, V8, P4134; GANJIAN I, 1983, PHYTOCHEMISTRY, V22, P2525, DOI 10.1016/0031-9422(83)80154-X; Grobbelaar E, 2008, AFR ENTOMOL, V16, P7, DOI 10.4001/1021-3589-16.1.7; Grzywacz D, 2014, FOOD SECUR, V6, P71, DOI 10.1007/s12571-013-0313-5; Gu JQ, 2002, J NAT PROD, V65, P532, DOI 10.1021/np010545m; HILL D.S., 2008, PESTS CROPS WARMER C; Hillocks RJ, 2006, EUPHYTICA, V150, P215, DOI 10.1007/s10681-006-9112-9; Ibarra-Perez FJ, 1999, CROP SCI, V39, P428, DOI 10.2135/cropsci1999.0011183X0039000200022x; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Isman MB, 2008, PEST MANAG SCI, V64, P8, DOI 10.1002/ps.1470; Isman MB, 2014, TRENDS PLANT SCI, V19, P140, DOI 10.1016/j.tplants.2013.11.005; JISAKA M, 1992, TETRAHEDRON, V48, P625, DOI 10.1016/S0040-4020(01)88123-0; Juarez ZN, 2014, NAT PROD COMMUN, V9, P895; Kasina JM, 2009, J ECON ENTOMOL, V102, P467, DOI 10.1603/029.102.0201; Kawuki RS, 2005, CROP PROT, V24, P473, DOI 10.1016/j.cropro.2004.09.017; Madzimure J, 2011, TROP ANIM HEALTH PRO, V43, P481, DOI 10.1007/s11250-010-9720-1; Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s; Miranda MAFM, 2015, J NAT PROD, V78, P1083, DOI 10.1021/acs.jnatprod.5b00040; Mkenda PA, 2015, INT J TROP INSECT SC, V35, P172, DOI 10.1017/S174275841500017X; Mujovo SF, 2008, NAT PROD RES, V22, P1047, DOI 10.1080/14786410802250037; Ndakidemi PA, 2006, AUST J EXP AGR, V46, P571, DOI 10.1071/EA03157; Nyirenda SP, 2011, AFRICAN J AGR RES, V6; Oyewole IO, 2008, J MED PLANTS RES, V2, P171; Pereira PS, 1997, PHYTOCHEMISTRY, V45, P1445, DOI 10.1016/S0031-9422(97)00142-8; Pretty J, 2011, INT J AGR SUSTAIN, V9, P5, DOI 10.3763/ijas.2010.0583; Rabe T, 2002, J ETHNOPHARMACOL, V80, P91, DOI 10.1016/S0378-8741(02)00010-7; Rubia EG, 1996, CROP PROT, V15, P335, DOI 10.1016/0261-2194(95)00102-6; Singh P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104377; Stark J.D., 2004, NEEM TODAY NEW MILLE, DOI [10.1007/1-4020-2596-3_6, DOI 10.1007/1-4020-2596-3_6]; Stevenson PC, 2012, PHYTOCHEMISTRY, V78, P135, DOI 10.1016/j.phytochem.2012.02.025; Stevenson PC, 2009, J AGR FOOD CHEM, V57, P8860, DOI 10.1021/jf901599j; Tittonell P, 2013, FIELD CROP RES, V143, P76, DOI 10.1016/j.fcr.2012.10.007; Viljoen AM, 2005, J ETHNOPHARMACOL, V96, P271, DOI 10.1016/j.jep.2004.09.017	49	51	53	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143530	10.1371/journal.pone.0143530	http://dx.doi.org/10.1371/journal.pone.0143530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599609	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000365853900137
J	Romes, EM; Sobhany, M; Stanley, RE				Romes, Erin M.; Sobhany, Mack; Stanley, Robin E.			The Crystal Structure of the Ubiquitin-like Domain of Ribosome Assembly Factor Ytm1 and Characterization of Its Interaction with the AAA-ATPase Midasin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WD-REPEAT PROTEIN; NUCLEOLAR LOCALIZATION; BIOGENESIS FACTORS; ER-ALPHA; PES1; COMPLEX; EXPRESSION; MATURATION; CANCER; WDR12	The synthesis of eukaryotic ribosomes is a complex, energetically demanding process requiring the aid of numerous non-ribosomal factors, such as the PeBoW complex. The mammalian PeBoW complex, composed of Pes1, Bop1, and WDR12, is essential for the processing of the 32S preribosomal RNA. Previous work in Saccharomyces cerevisiae has shown that release of the homologous proteins in this complex (Nop7, Erb1, and Ytm1, respectively) from preribosomal particles requires Rea1 (midasin or MDN1 in humans), a large dynein-like protein. Midasin contains a C-terminal metal ion-dependent adhesion site (MIDAS) domain that interacts with the N-terminal ubiquitin- like (UBL) domain of Ytm1/WDR12 as well as the UBL domain of Rsa4/Nle1 in a later step in the ribosome maturation pathway. Here we present the crystal structure of the UBL domain of the WDR12 homologue from S. cerevisiae at 1.7 angstrom resolution and demonstrate that human midasin binds to WDR12 as well as Nle1 through their respective UBL domains. Midasin contains a well conserved extension region upstream of the MIDAS domain required for binding WDR12 and Nle1, and the interaction is dependent upon metal ion coordination because removal of the metal or mutation of residues that coordinate the metal ion diminishes the interaction. Mammalian WDR12 displays prominent nucleolar localization that is dependent upon active ribosomal RNA transcription. Based upon these results, we propose that release of the PeBoW complex and subsequent release of Nle1 by midasin is a well conserved step in the ribosome maturation pathway in both yeast and mammalian cells.	[Romes, Erin M.; Sobhany, Mack; Stanley, Robin E.] NIEHS, Signal Transduct Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Stanley, RE (corresponding author), NIEHS, Signal Transduct Labo, NIH, Bldg 101,Rm F378,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	robin.stanley@nih.gov	Stanley, Robin/M-3008-2019; Stanley, Robin E/C-7128-2019	Stanley, Robin/0000-0002-2106-3102; Stanley, Robin E/0000-0002-2106-3102	NIEHS, National Institutes of Health; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103247] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in whole or in part by the Intramural Research Program of NIEHS, National Institutes of Health. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams NBP, 2013, J BIOL CHEM, V288, P28727, DOI 10.1074/jbc.M113.477943; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bassler J, 2014, J CELL BIOL, V207, P481, DOI 10.1083/jcb.201408111; Bassler J, 2010, MOL CELL, V38, P712, DOI 10.1016/j.molcel.2010.05.024; Beck-Cormier S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098507; Bursac S, 2014, BBA-MOL BASIS DIS, V1842, P817, DOI 10.1016/j.bbadis.2013.08.014; Castle CD, 2012, MOL BIOL CELL, V23, P716, DOI 10.1091/mbc.E11-06-0530; Chantha SC, 2007, PLANTA, V225, P1107, DOI 10.1007/s00425-006-0420-z; Cheng L, 2012, J CLIN INVEST, V122, P2857, DOI 10.1172/JCI62676; Chung KY, 2011, HEPATOLOGY, V54, P307, DOI 10.1002/hep.24372; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Galani K, 2004, J BIOL CHEM, V279, P55411, DOI 10.1074/jbc.M406876200; Garbarino JE, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-18; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Golomb L, 2014, FEBS LETT, V588, P2571, DOI 10.1016/j.febslet.2014.04.014; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Killian A, 2006, GENE CHROMOSOME CANC, V45, P874, DOI 10.1002/gcc.20351; Kressler D, 2012, BBA-MOL CELL RES, V1823, P92, DOI 10.1016/j.bbamcr.2011.06.017; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Li JP, 2013, IUBMB LIFE, V65, P1017, DOI 10.1002/iub.1228; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; Miles TD, 2005, MOL CELL BIOL, V25, P10419, DOI 10.1128/MCB.25.23.10419-10432.2005; Moilanen AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124907; Morita E, 2007, CELL HOST MICROBE, V2, P41, DOI 10.1016/j.chom.2007.06.003; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Nakaguro M, 2015, CANCER SCI, V106, P237, DOI 10.1111/cas.12598; Nal B, 2002, GENOMICS, V79, P77, DOI 10.1006/geno.2001.6682; Quin JE, 2014, BBA-MOL BASIS DIS, V1842, P802, DOI 10.1016/j.bbadis.2013.12.009; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Royet J, 1998, EMBO J, V17, P7351, DOI 10.1093/emboj/17.24.7351; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Stedman A, 2015, CELL DEATH DIFFER, V22, P1865, DOI 10.1038/cdd.2015.57; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tang L, 2008, MOL BIOL CELL, V19, P2844, DOI 10.1091/mbc.E07-12-1281; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Wegrecki Marcin, 2015, Nucleic Acids Res, V43, P11017, DOI 10.1093/nar/gkv1043; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woods SJ, 2015, BBA-GENE REGUL MECH, V1849, P821, DOI 10.1016/j.bbagrm.2014.10.007; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Xie W, 2013, BIOCHEM BIOPH RES CO, V431, P460, DOI 10.1016/j.bbrc.2012.12.145; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042253; Zabalza M, 2015, REV ESP CARDIOL, V68, P869, DOI [10.1016/j.rec.2014.10.023, 10.1016/j.recesp.2014.10.023]; Zhang JH, 2009, ACTA BIOCH BIOPH SIN, V41, P991, DOI 10.1093/abbs/gmp096; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	56	23	26	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					882	893		10.1074/jbc.M115.693259	http://dx.doi.org/10.1074/jbc.M115.693259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26601951	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000367830500034
J	Paterson, EK; Fielder, TJ; MacGregor, GR; Ito, S; Wakamatsu, K; Gillen, DL; Eby, V; Boissy, RE; Ganesan, AK				Paterson, Elyse K.; Fielder, Thomas J.; MacGregor, Grant R.; Ito, Shosuke; Wakamatsu, Kazumasa; Gillen, Daniel L.; Eby, Victoria; Boissy, Raymond E.; Ganesan, Anand K.			Tyrosinase Depletion Prevents the Maturation of Melanosomes in the Mouse Hair Follicle	PLOS ONE			English	Article							HUMAN SKIN; CHEMICAL-CHARACTERIZATION; MULTIVESICULAR BODIES; TRANSGENIC MICE; HUMAN EPIDERMIS; ALBINO LOCUS; COAT COLOR; MELANOCYTES; MELANIN; GENE	The mechanisms that lead to variation in human skin and hair color are not fully understood. To better understand the molecular control of skin and hair color variation, we modulated the expression of Tyrosinase (Tyr), which controls the rate-limiting step of melanogenesis, by expressing a single-copy, tetracycline-inducible shRNA against Tyr in mice. Moderate depletion of TYR was sufficient to alter the appearance of the mouse coat in black, agouti, and yellow coat color backgrounds, even though TYR depletion did not significantly inhibit accumulation of melanin within the mouse hair. Ultra-structural studies revealed that the reduction of Tyr inhibited the accumulation of terminal melanosomes, and inhibited the expression of genes that regulate melanogenesis. These results indicate that color in skin and hair is determined not only by the total amount of melanin within the hair, but also by the relative accumulation of mature melanosomes.	[Paterson, Elyse K.; Ganesan, Anand K.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Fielder, Thomas J.] Univ Calif Irvine, Transgen Mouse Facil, Univ Lab Anim Resources, Res Off, Irvine, CA 92717 USA; [MacGregor, Grant R.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Ito, Shosuke; Wakamatsu, Kazumasa] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Toyoake, Aichi 4701192, Japan; [Gillen, Daniel L.] Univ Calif Irvine, Dept Stat, Irvine, CA USA; [Eby, Victoria; Boissy, Raymond E.] Univ Cincinnati, Dept Dermatol, Cincinnati, OH USA; [Ganesan, Anand K.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Fujita Health University; University of California System; University of California Irvine; University System of Ohio; University of Cincinnati; University of California System; University of California Irvine	Ganesan, AK (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA.	aganesan@uci.edu	Wakamatsu, Kazumasa/AAZ-5877-2020	Wakamatsu, Kazumasa/0000-0003-1748-9001; Ito, Shosuke/0000-0001-9182-5144	National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR063116-01A1]; Chao Family Comprehensive Cancer Center Support Grant from the National Cancer Institute [P30CA062203]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063116] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Chao Family Comprehensive Cancer Center Support Grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded 1R01AR063116-01A1 to AKG entitled "Phosphoinositide Signaling Regulates Melanogenesis. The TMF, GHTF and BSR Shared Resources are funded in part by the Chao Family Comprehensive Cancer Center Support Grant (P30CA062203) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong B K, 1997, Australas J Dermatol, V38 Suppl 1, pS1; Basrur V, 2003, J PROTEOME RES, V2, P69, DOI 10.1021/pr025562r; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; BEERMANN F, 1995, EXP EYE RES, V61, P599, DOI 10.1016/S0014-4835(05)80053-3; Beermann F, 2004, MAMM GENOME, V15, P749, DOI 10.1007/s00335-004-4002-8; BEERMANN F, 1990, EMBO J, V9, P2819, DOI 10.1002/j.1460-2075.1990.tb07470.x; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Boissy RE, 2003, EXP DERMATOL, V12, P5, DOI 10.1034/j.1600-0625.12.s2.1.x; BOUCHARD B, 1989, J EXP MED, V169, P2029, DOI 10.1084/jem.169.6.2029; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; BURCHILL SA, 1986, J ENDOCRINOL, V109, P15, DOI 10.1677/joe.0.1090015; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Eliason CM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1505; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Ganesan AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000298; Gloster HM, 1996, DERMATOL SURG, V22, P217, DOI 10.1111/j.1524-4725.1996.tb00312.x; GREEN MC, 1961, J HERED, V52, P73, DOI 10.1093/oxfordjournals.jhered.a107028; HALABAN R, 1988, P NATL ACAD SCI USA, V85, P7241, DOI 10.1073/pnas.85.19.7241; HALABAN R, 1983, J CELL BIOL, V97, P480, DOI 10.1083/jcb.97.2.480; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; Hearing VJ, 2000, PIGM CELL RES, V13, P23, DOI 10.1034/j.1600-0749.13.s8.7.x; Ho H, 2011, PIGM CELL MELANOMA R, V24, P595, DOI 10.1111/j.1755-148X.2011.00889.x; Ho HA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200543; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; IMOKAWA G, 1988, J INVEST DERMATOL, V91, P106, DOI 10.1111/1523-1747.ep12464093; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Jablonski NG, 2004, ANNU REV ANTHROPOL, V33, P585, DOI 10.1146/annurev.anthro.33.070203.143955; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; JIMBOW K, 1979, J INVEST DERMATOL, V73, P278, DOI 10.1111/1523-1747.ep12531650; Kobayashi N, 1998, J INVEST DERMATOL, V110, P806, DOI 10.1046/j.1523-1747.1998.00178.x; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; KWON BS, 1989, J INVEST DERMATOL, V93, P589, DOI 10.1111/1523-1747.ep12319693; Lamoreux ML, 2001, PIGM CELL RES, V14, P23, DOI 10.1034/j.1600-0749.2001.140105.x; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Liu Y, 2003, PIGM CELL RES, V16, P355, DOI 10.1034/j.1600-0749.2003.00059.x; LOOMIS WF, 1967, SCIENCE, V157, P501, DOI 10.1126/science.157.3788.501; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Matts PJ, 2007, BRIT J DERMATOL, V156, P620, DOI 10.1111/j.1365-2133.2006.07706.x; Morris JK, 1965, J CELL BIOL, V27, P137; ORLOW SJ, 1993, J INVEST DERMATOL, V100, P55, DOI 10.1111/1523-1747.ep12354138; Ozeki H, 1996, PIGM CELL RES, V9, P51, DOI 10.1111/j.1600-0749.1996.tb00088.x; Ozeki H, 1996, PIGM CELL RES, V9, P265, DOI 10.1111/j.1600-0749.1996.tb00116.x; Ozeki H, 1997, BBA-GEN SUBJECTS, V1336, P539, DOI 10.1016/S0304-4165(97)00068-8; Ozeki H, 1995, CHEM CHARACTERIZATIO; Paterson EK, 2013, EXP DERMATOL, V22, P202, DOI 10.1111/exd.12099; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Prota G, 2000, PIGM CELL RES, V13, P283, DOI 10.1034/j.1600-0749.2000.130412.x; Provance DW, 1996, P NATL ACAD SCI USA, V93, P14554, DOI 10.1073/pnas.93.25.14554; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Sarna T, 2006, PIGMENTARY SYSTEM PH, P311; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEIJI M, 1963, NATURE, V197, P1082, DOI 10.1038/1971082a0; SEIJI M, 1963, ANN NY ACAD SCI, V100, P497, DOI 10.1111/j.1749-6632.1963.tb42911.x; SILVERS WK (ED), 1979, COAT COLORS MICE MOD; Simmen T, 1999, J CELL SCI, V112, P45; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Szabo G, 1969, Nature, V222, P1081, DOI 10.1038/2221081a0; Takiguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054009; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Thong HY, 2003, BRIT J DERMATOL, V149, P498, DOI 10.1046/j.1365-2133.2003.05473.x; TODA K, 1972, NATURE-NEW BIOL, V236, P143, DOI 10.1038/newbio236143a0; Toyofuku K, 2001, FASEB J, V15, P2149, DOI 10.1096/fj.01-0216com; TURNER WA, 1975, J ULTRA MOL STRUCT R, V51, P16, DOI 10.1016/S0022-5320(75)80004-9; URABE K, 1994, BBA-MOL CELL RES, V1221, P272, DOI 10.1016/0167-4889(94)90250-X; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x	73	19	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143702	10.1371/journal.pone.0143702	http://dx.doi.org/10.1371/journal.pone.0143702			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619124	Green Published, gold			2022-12-26	WOS:000365889800058
J	Xiang, LL; Liu, XF; Li, X; Yin, XR; Grierson, D; Li, F; Chen, KS				Xiang, Li-li; Liu, Xiao-fen; Li, Xue; Yin, Xue-ren; Grierson, Donald; Li, Fang; Chen, Kun-song			A Novel bHLH Transcription Factor Involved in Regulating Anthocyanin Biosynthesis in Chrysanthemums (Chrysanthemum morifolium Ramat.)	PLOS ONE			English	Article							CHILLING INJURY; GENES; EXPRESSION; PIGMENTATION; BIOCHEMISTRY; GENETICS; PROTEIN; LIGNIFICATION; ACCUMULATION; ACTIVATORS	Chrysanthemums (Chrysanthemum morifolium Ramat.) exhibit a variety of flower colors due to their differing abilities to accumulate anthocyanins. One MYB member, CmMYB6, has been verified as a transcription regulator of chrysanthemum genes involved in anthocyanin biosynthesis; however, the co-regulators for CmMYB6 remain unclear in chrysanthemum. Here, the expression pattern of CmbHLH2, which is clustered in the IIIf bHLH subgroup, was shown to be positively correlated with the anthocyanin content of cultivars with red, pink and yellow flower colors, respectively. CmbHLH2 significantly upregulated the CmDFR promoter and triggered anthocyanin accumulation when co-expressed with CmMYB6. Yeast one-hybrid analyses indicated that CmbHLH2 was able to bind directly to the CmDFR promoter. Moreover, yeast two-hybrid assays indicated protein-protein interaction between CmbHLH2 and CmMYB6. These results suggest that CmbHLH2 is the essential partner for CmMYB6 in regulating anthocyanin biosynthesis in chrysanthemum.	[Xiang, Li-li; Liu, Xiao-fen; Li, Xue; Yin, Xue-ren; Grierson, Donald; Li, Fang; Chen, Kun-song] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China; [Xiang, Li-li; Liu, Xiao-fen; Yin, Xue-ren; Li, Fang; Chen, Kun-song] Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Xiang, Li-li; Liu, Xiao-fen; Yin, Xue-ren; Chen, Kun-song] Zhejiang Univ, State Agr Minist Lab Hort Plant Growth Dev & Qual, Hangzhou 310058, Zhejiang, Peoples R China; [Grierson, Donald] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England	Zhejiang University; Zhejiang University; Zhejiang University; University of Nottingham	Yin, XR (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.	xuerenyin@zju.edu.cn	Yin, Xue-ren/B-3893-2008	Yin, Xue-ren/0000-0002-1282-4432	National High Technology Research and Development Program of China [2013AA102700]; National Natural Science Foundation of China [31401909]; China Postdoctoral Science Foundation [2014M551758]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by the National High Technology Research and Development Program of China (2013AA102700), the National Natural Science Foundation of China (31401909), and the China Postdoctoral Science Foundation (2014M551758).	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; Anderson NO, 2006, FLOWER BREEDING AND GENETICS: ISSUES, CHALLENGES AND OPPORTUNITIES FOR THE 21ST CENTURY, P389; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Brugliera F, 2013, PLANT CELL PHYSIOL, V54, P1696, DOI 10.1093/pcp/pct110; CHANDLER VL, 1989, PLANT CELL, V1, P1175, DOI 10.1105/tpc.1.12.1175; Chen SM, 2009, PLANT MOL BIOL REP, V27, P503, DOI 10.1007/s11105-009-0103-6; Elomaa P, 2003, PLANT PHYSIOL, V133, P1831, DOI 10.1104/pp.103.026039; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hong Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1428-1; Hong Y, 2015, J AM SOC HORTIC SCI, V140, P68, DOI 10.21273/JASHS.140.1.68; Hsu CC, 2015, PLANT PHYSIOL, V168, P175, DOI 10.1104/pp.114.254599; Huang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074395; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li HM, 2007, PLANT MOL BIOL, V65, P655, DOI 10.1007/s11103-007-9230-3; Liu XF, 2015, SCI HORTIC-AMSTERDAM, V194, P278, DOI 10.1016/j.scienta.2015.08.018; Liu XF, 2013, PLANT CELL TISS ORG, V115, P285, DOI 10.1007/s11240-013-0361-8; Morohashi K, 2007, PLANT PHYSIOL, V145, P736, DOI 10.1104/pp.107.104521; Nakatsuka A, 2009, SCI HORTIC-AMSTERDAM, V121, P84, DOI 10.1016/j.scienta.2009.01.008; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Noda N, 2013, PLANT CELL PHYSIOL, V54, P1684, DOI 10.1093/pcp/pct111; Ohno S, 2013, PLANTA, V238, P331, DOI 10.1007/s00425-013-1897-x; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; Sung SY, 2013, MOL BIOL REP, V40, P5177, DOI 10.1007/s11033-013-2620-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Wang T, 2014, BIOCHEM SYST ECOL, V55, P79, DOI 10.1016/j.bse.2014.02.023; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xu Q, 2014, J EXP BOT, V65, P4349, DOI 10.1093/jxb/eru208; Xu WJ, 2015, TRENDS PLANT SCI, V20, P176, DOI 10.1016/j.tplants.2014.12.001; Yin XR, 2009, POSTHARVEST BIOL TEC, V52, P9, DOI 10.1016/j.postharvbio.2008.09.016; Zeng JK, 2015, PLANT BIOTECHNOL J, V13, P1325, DOI 10.1111/pbi.12351; Zhao M., 2014, SCI REP, V4; Zhu LH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054028, 10.1371/journal.pone.0065680]	38	47	57	8	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143892	10.1371/journal.pone.0143892	http://dx.doi.org/10.1371/journal.pone.0143892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619181	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800085
J	Altizer, S; Hobson, KA; Davis, AK; De Roode, JC; Wassenaar, LI				Altizer, Sonia; Hobson, Keith A.; Davis, Andrew K.; De Roode, Jacobus C.; Wassenaar, Leonard I.			Do Healthy Monarchs Migrate Farther? Tracking Natal Origins of Parasitized vs. Uninfected Monarch Butterflies Overwintering in Mexico	PLOS ONE			English	Article							DANAUS-PLEXIPPUS; PROTOZOAN PARASITE; HOST MIGRATION; TRANSMISSION; LEPIDOPTERA; POPULATIONS; INFLUENZA; INFECTION; BEHAVIOR; SITE	Long-distance migration can lower parasite prevalence if strenuous journeys remove infected animals from wild populations. We examined wild monarch butterflies (Danaus plexippus) to investigate the potential costs of the protozoan Ophryocystis elektroscirrha on migratory success. We collected monarchs from two wintering sites in central Mexico to compare infection status with hydrogen isotope (delta H-2) measurements as an indicator of latitude of origin at the start of fall migration. On average, uninfected monarchs had lower delta H-2 values than parasitized butterflies, indicating that uninfected butterflies originated from more northerly latitudes and travelled farther distances to reach Mexico. Within the infected class, monarchs with higher quantitative spore loads originated from more southerly latitudes, indicating that heavily infected monarchs originating from farther north are less likely to reach Mexico. We ruled out the alternative explanation that lower latitudes give rise to more infected monarchs prior to the onset of migration using citizen science data to examine regional differences in parasite prevalence during the summer breeding season. We also found a positive association between monarch wing area and estimated distance flown. Collectively, these results emphasize that seasonal migrations can help lower infection levels in wild animal populations. Our findings, combined with recent declines in the numbers of migratory monarchs wintering in Mexico and observations of sedentary ( winter breeding) monarch populations in the southern U.S., suggest that shifts from migratory to sedentary behavior will likely lead to greater infection prevalence for North American monarchs.	[Altizer, Sonia; Davis, Andrew K.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Hobson, Keith A.; Wassenaar, Leonard I.] Environm Canada, Saskatoon, SK, Canada; [Hobson, Keith A.] Univ Western Ontario, Dept Biol, London, ON, Canada; [De Roode, Jacobus C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University System of Georgia; University of Georgia; Environment & Climate Change Canada; Western University (University of Western Ontario); Emory University	Altizer, S (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	saltizer@uga.edu	Hobson, Keith/Q-9306-2019; Wassenaar, Leonard/AAY-7081-2020	Wassenaar, Leonard/0000-0001-5532-0771	National Science Foundation [DEB-0643831]; Environment Canada	National Science Foundation(National Science Foundation (NSF)); Environment Canada(CGIAR)	This work was supported by a National Science Foundation (www.nsf.gov) grant (DEB-0643831) to SA and Environment Canada (www.ec.gc.ca/financement-funding/) operating grants to LIW and KAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery PR, 1984, MILKWEED BUTTERFLIES; AlonsoMejia A, 1997, ECOL APPL, V7, P934; Altizer SM, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P203; Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Altizer S, 2010, EVOLUTION, V64, P1018, DOI 10.1111/j.1558-5646.2010.00946.x; Bartel RA, 2011, ECOLOGY, V92, P342, DOI 10.1890/10-0489.1; Batalden R.V., 2015, MONARCHS CHANGING WO; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Beall G., 1946, Transactions of the Royal Entomological Society of London, V97, P337; Becker-Asano C, 2008, WASABI AFFECT SIMULA; Borland J, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P97; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; Brower L, 2004, CONSERVATION MIGRATO; Brower LP, 2012, INSECT CONSERV DIVER, V5, P95, DOI 10.1111/j.1752-4598.2011.00142.x; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; BROWER LP, 1991, AM ZOOL, V31, P265; Brower LP, 1996, J EXP BIOL, V199, P93; Calmaestra RG, 2001, ARDEA, V89, P407; CALVERT W H, 1986, Journal of the Lepidopterists' Society, V40, P164; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Cornelius EA, 2014, PHYSIOL BIOCHEM ZOOL, V87, P719, DOI 10.1086/677541; Davis A.K., 2009, PSYCHE, V2009, P705780, DOI [10.1155/2009/705780, DOI 10.1155/2009/705780]; Davis AK, 2005, J THERM BIOL, V30, P410, DOI 10.1016/j.jtherbio.2005.04.003; Davis AK, 2009, PLOS ONE, V7; de Roode JC, 2007, PARASITOLOGY, V134, P657, DOI 10.1017/S0031182006002009; de Roode JC, 2008, P NATL ACAD SCI USA, V105, P7489, DOI 10.1073/pnas.0710909105; de Roode JC, 2009, OECOLOGIA, V161, P67, DOI 10.1007/s00442-009-1361-6; Dingle H, 2014, MIGRATION: THE BIOLOGY OF LIFE ON THE MOVE, 2ND EDITION, P1, DOI 10.1093/acprof:oso/9780199640386.001.0001; DINGLE H, 1980, EVOLUTION, V34, P371, DOI 10.1111/j.1558-5646.1980.tb04825.x; Dingle H., 1981, P57; Dockx C, 2004, ECOL APPL, V14, P1106, DOI 10.1890/03-5128; Dockx C, 2007, BIOL J LINN SOC, V92, P605, DOI 10.1111/j.1095-8312.2007.00886.x; Figuerola J, 2000, EVOL ECOL, V14, P143, DOI 10.1023/A:1011009419264; Flockhart DTT, 2015, J ANIM ECOL, V84, P155, DOI 10.1111/1365-2656.12253; Flockhart DTT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1087; Gibo David L., 1993, Journal of the Lepidopterists' Society, V47, P154; Gunnarsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035679; Hall RJ, 2014, J ANIM ECOL, V83, P1068, DOI 10.1111/1365-2656.12204; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Hobson KA, 2009, J FIELD ORNITHOL, V85, P237; Hobson KA, 2008, HDB TERRESTRIAL ECOL; Howard E, 2010, PSYCHE; Howard Elizabeth, 2012, Journal of Research on the Lepidoptera, V45, P49; IBM Corp, 2010, SPSS STAT WIND VERS; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Kleijn D, 2010, P ROY SOC B-BIOL SCI, V277, P2041, DOI 10.1098/rspb.2010.0026; Knight A, 2009, J CHEM ECOL, V35, P816, DOI 10.1007/s10886-009-9655-z; Krkosek M, 2007, P R SOC B, V274, P3141, DOI 10.1098/rspb.2007.1122; Leong KLH, 1997, PAN-PAC ENTOMOL, V73, P49; Lyons JI, 2012, MOL ECOL, V21, P3433, DOI 10.1111/j.1365-294X.2012.05613.x; Malcolm S. B., 1993, BIOL CONSERVATION MO; McCord John W., 2012, Journal of Research on the Lepidoptera, V45, P1; McCord JW, 2010, J INSECT BEHAV, V23, P405, DOI 10.1007/s10905-010-9224-x; MCLAUGHLIN RE, 1970, J PROTOZOOL, V17, P300, DOI 10.1111/j.1550-7408.1970.tb02375.x; Miller NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031891; MONKKONEN M, 1995, EVOL ECOL, V9, P520, DOI 10.1007/BF01237833; Nagano Nagano C.D., 1993, BIOL CONSERVATION MO; Pierce AA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2230; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Satterfield DA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1734; SIMMONS AM, 1991, J ENTOMOL SCI, V26, P136, DOI 10.18474/0749-8004-26.1.136; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; URQUHART FA, 1976, NATL GEOGR, V150, P161; URQUHART FA, 1978, CAN J ZOOL, V56, P1759, DOI 10.1139/z78-240; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Vidal O, 2014, BIOL CONSERV, V180, P165, DOI 10.1016/j.biocon.2014.09.041; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Wassenaar LI, 2006, RAPID COMMUN MASS SP, V20, P2505, DOI 10.1002/rcm.2626; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Zhan S, 2014, NATURE, V514, P317, DOI 10.1038/nature13812	76	55	56	1	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0141371	10.1371/journal.pone.0141371	http://dx.doi.org/10.1371/journal.pone.0141371			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606389	gold, Green Submitted, Green Published			2022-12-26	WOS:000365865300008
J	Polo, G; Labruna, MB; Ferreira, F				Polo, Gina; Labruna, Marcelo Bahia; Ferreira, Fernando			Satellite Hyperspectral Imagery to Support Tick-Borne Infectious Diseases Surveillance	PLOS ONE			English	Article							CAPYBARAS HYDROCHOERUS-HYDROCHAERIS; LYME-DISEASE; RICKETTSIA-RICKETTSII; PRINCIPAL COMPONENTS; AMBLYOMMA-CAJENNENSE; BORRELIA-BURGDORFERI; SPOTTED-FEVER; PUBLIC-HEALTH; LANDSAT TM; AREA	This study proposed the use of satellite hyperspectral imagery to support tick-borne infectious diseases surveillance based on monitoring the variation in amplifier hosts food sources. To verify this strategy, we used the data of the human rickettsiosis occurrences in southeastern Brazil, region in which the emergence of this disease is associated with the rising capybara population. Spatio-temporal analysis based on Monte Carlo simulations was used to identify risk areas of human rickettsiosis and hyperspectral moderate-resolution imagery was used to identify the increment and expansion of sugarcane crops, main food source of capybaras. In general, a pixel abundance associated with increment of sugarcane crops was detected in risk areas of human rickettsiosis. Thus, the hypothesis that there is a spatio-temporal relationship between the occurrence of human rickettsiosis and the sugarcane crops increment was verified. Therefore, due to the difficulty of monitoring locally the distribution of infectious agents, vectors and animal host's, satellite hyperspectral imagery can be used as a complementary tool for the surveillance of tick-borne infectious diseases and potentially of other vector-borne diseases.	[Polo, Gina; Ferreira, Fernando] Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Lab Epidemiol & Biostat, Sao Paulo, Brazil; [Labruna, Marcelo Bahia] Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Parasit Dis Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Polo, G (corresponding author), Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Lab Epidemiol & Biostat, Sao Paulo, Brazil.	gina@vps.fmvz.usp.br	Ferreira, Fernando/C-9038-2013; Labruna, Marcelo B/B-6241-2013	Ferreira, Fernando/0000-0002-9160-7355; Labruna, Marcelo B/0000-0002-9675-3132; Polo, Gina/0000-0001-5569-7392	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/12213-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grant number: 2014/12213-1 (GP), (http://bvs.fapesp.br/en/pesquisador/673996/gina-paola-polo-infante/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt Geir, 2006, Int J Health Geogr, V5, P15, DOI 10.1186/1476-072X-5-15; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Allman E, 2004, MATHEMATICAL MODELS, P371; Beck LR, 1997, AM J TROP MED HYG, V56, P99, DOI 10.4269/ajtmh.1997.56.99; Biradar CM, 2011, INT J REMOTE SENS, V32, P367, DOI 10.1080/01431160903464179; BURGDORFER W., 1988, BIOL RICKETTSIAL DIS, V1, P33; Cousens S, 2001, LANCET, V357, P1002, DOI 10.1016/S0140-6736(00)04236-7; CVE-SES. Centro de Vigilancia Epidemiologica, 2013, DISTRIBUICAO DOS CAS; Ferraz KMPMD, 2007, J BIOGEOGR, V34, P223, DOI 10.1111/j.1365-2699.2006.01568.x; Del Fiol FD, 2010, REV PANAM SALUD PUBL, V27, P461, DOI 10.1590/S1020-49892010000600008; Estrada-Pena A, 2002, ENVIRON HEALTH PERSP, V110, P635, DOI 10.1289/ehp.02110635; Fang HL, 1998, INT J REMOTE SENS, V19, P521, DOI 10.1080/014311698216134; Felix GA, 2014, BRAZ J BIOL, V74, P779, DOI 10.1590/1519-6984.02113; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; Garni R, 2014, INFECT GENET EVOL, V28, P725, DOI 10.1016/j.meegid.2014.09.036; Gaudart Jean, 2005, BMC Med Res Methodol, V5, P22, DOI 10.1186/1471-2288-5-22; GLASS GE, 1994, AM J TROP MED HYG, V51, P538, DOI 10.4269/ajtmh.1994.51.538; GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001; IBGE, 2010, BRAZILIAN INSTITUTE; INPE. Instituto de Pesquisas Espaciais, 2013, CANASAT MONITORAMENT; Jain M, 2013, REMOTE SENS ENVIRON, V134, P210, DOI 10.1016/j.rse.2013.02.029; James MC, 2013, PARASITOLOGY, V140, P237, DOI 10.1017/S003118201200145X; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Keshava N, 2002, IEEE SIGNAL PROC MAG, V19, P44, DOI 10.1109/79.974727; Krawczak FS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-7; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Labruna MB, 2009, ANN NY ACAD SCI, V1166, P156, DOI 10.1111/j.1749-6632.2009.04516.x; Labruna MB., 2013, CAPYBARA BIOL USE CO, P371; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; LEE JB, 1990, IEEE T GEOSCI REMOTE, V28, P295, DOI 10.1109/36.54356; Liu H, 2012, REMOTE SENS ENVIRON, V117, P57, DOI 10.1016/j.rse.2011.06.023; Martinez-Casasnovas JA, 2005, EUR J AGRON, V23, P159, DOI 10.1016/j.eja.2004.11.004; Moreira JR, 2013, CAPYBARA BIOL USE CO, P3, DOI [10.1007/978-1-4614-4000-0_1, DOI 10.1007/978-1-4614-4000-0_1]; Mostashari F, 2003, EMERG INFECT DIS, V9, P641; NASA. National Aeronautics and Space Administration, 2014, MODERATE RESOLUTION; Niebylski ML, 1999, APPL ENVIRON MICROB, V65, P773; Ojasti J., 1973, ESTUDIO BIOLOGICO DE; Patil GP, 2003, STAT SCI, V18, P457, DOI 10.1214/ss/1081443229; Pinter A, 2011, VEPA SUPLEMENTO, V8, P19; Polo G, 2013, PREVENTIVE VETERINAR; Polo G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119190; QUARMBY NA, 1992, INT J REMOTE SENS, V13, P415, DOI 10.1080/01431169208904046; Rodarmel C., 2002, SURV LAND INF SCI, V62, P115; Sao-Paulo, 2013, DISTRIBUICAO DOS CAS; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; SINGH A, 1985, INT J REMOTE SENS, V6, P883, DOI 10.1080/01431168508948511; Small C, 2012, REMOTE SENS ENVIRON, V124, P793, DOI 10.1016/j.rse.2012.05.031; Soares JF, 2012, MED VET ENTOMOL, V26, P139, DOI 10.1111/j.1365-2915.2011.00982.x; Souza CE, 2009, VET PARASITOL, V161, P116, DOI 10.1016/j.vetpar.2008.12.010; Tatem AJ, 2004, REMOTE SENS ENVIRON, V93, P42, DOI 10.1016/j.rse.2004.06.014; Thenkabail PS, 2012, HYPERSPECTRAL REMOTE SENSING OF VEGETATION, P1; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; Rudorff BFT, 2010, REMOTE SENS-BASEL, V2, P1057, DOI 10.3390/rs2041057; Vicente LE, 2012, PESQUI AGROPECU BRAS, V47, P1337, DOI 10.1590/S0100-204X2012000900019; Winters AM, 2008, AM J TROP MED HYG, V79, P581, DOI 10.4269/ajtmh.2008.79.581; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Wood CL, 2013, TRENDS ECOL EVOL, V28, P239, DOI 10.1016/j.tree.2012.10.011; Xiao XM, 2005, REMOTE SENS ENVIRON, V95, P480, DOI 10.1016/j.rse.2004.12.009	58	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143736	10.1371/journal.pone.0143736	http://dx.doi.org/10.1371/journal.pone.0143736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599337	gold, Green Submitted, Green Published			2022-12-26	WOS:000365862600112
J	Smith, AN; Creighton, JC; Belk, MC				Smith, Ashlee N.; Creighton, J. Curtis; Belk, Mark C.			Differences in Patterns of Reproductive Allocation between the Sexes in Nicrophorus orbicollis	PLOS ONE			English	Article							BIPARENTAL BURYING BEETLE; PARENTAL CARE; BROOD SIZE; CALLOSOBRUCHUS-MACULATUS; COSTS; BENEFITS; LONGEVITY; BEHAVIOR; LIFE; VESPILLOIDES	Organisms are selected to maximize lifetime reproductive success by balancing the costs of current reproduction with costs to future survival and fecundity. Males and females typically face different reproductive costs, which makes comparisons of their reproductive strategies difficult. Burying beetles provide a unique system that allows us to compare the costs of reproduction between the sexes because males and females are capable of raising offspring together or alone and carcass preparation and offspring care represent the majority of reproductive costs for both sexes. Because both sexes perform the same functions of carcass preparation and offspring care, we predict that they would experience similar costs and have similar life history patterns. In this study we assess the cost of reproduction in male Nicrophorus orbicollis and compare to patterns observed in females. We compare the reproductive strategies of single males and females that provided pre- and post-hatching parental care. There is a cost to reproduction for both males and females, but the sexes respond to these costs differently. Females match brood size with carcass size, and thus maximize the lifetime number of offspring on a given size carcass. Males cull proportionately more offspring on all carcass sizes, and thus have a lower lifetime number of offspring compared to females. Females exhibit an adaptive reproductive strategy based on resource availability, but male reproductive strategies are not adaptive in relation to resource availability.	[Smith, Ashlee N.; Creighton, J. Curtis] Purdue Univ Calumet, Dept Biol Sci, Hammond, IN USA; [Smith, Ashlee N.; Belk, Mark C.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Purdue University System; Purdue University; Brigham Young University	Smith, AN (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	ashlee.n.smith@gmail.com		Smith, Ashlee/0000-0001-8941-8574	Purdue University Calumet; Biology Department	Purdue University Calumet; Biology Department	This research was funded in part by a graduate research grant from Purdue University Calumet and funds from the Biology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT J, 1987, BEHAV ECOL SOCIOBIOL, V21, P179, DOI 10.1007/BF00303208; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Benowitz KM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1124; Billman EJ, 2014, BEHAV ECOL, V25, P813, DOI 10.1093/beheco/aru051; Castrejon F, 2012, SW ENTOMOLOGIST, V3, P103; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Creighton JC, 2009, AM NAT, V174, P673, DOI 10.1086/605963; Creighton JC, 2005, BEHAV ECOL, V16, P1031, DOI 10.1093/beheco/ari084; EGGERT AK, 1992, BEHAV ECOL, V3, P243, DOI 10.1093/beheco/3.3.243; Eggert AK, 1997, SOCIAL BEHAV INSECTS, P216; Eggert AK, 2011, ANIM BEHAV, V82, P1227, DOI 10.1016/j.anbehav.2011.09.001; FETHERSTON IA, 1990, ETHOLOGY, V85, P177, DOI 10.1111/j.1439-0310.1990.tb00398.x; Field J, 2007, P ROY SOC B-BIOL SCI, V274, P445, DOI 10.1098/rspb.2006.3745; Gilbert JDJ, 2010, ECOL ENTOMOL, V35, P639, DOI 10.1111/j.1365-2311.2010.01221.x; Gilg MR, 2003, AM MIDL NAT, V149, P306, DOI 10.1674/0003-0031(2003)149[0306:RDLSIT]2.0.CO;2; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Houston AI, 2013, ANIM BEHAV, V86, P667, DOI 10.1016/j.anbehav.2013.08.001; Hunt J, 2002, J EVOLUTION BIOL, V15, P57, DOI 10.1046/j.1420-9101.2002.00374.x; Kolliker M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1489, DOI 10.1007/s00265-007-0381-7; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Kotiaho JS, 2003, J INSECT PHYSIOL, V49, P817, DOI 10.1016/S0022-1910(03)00117-3; Messina FJ, 2003, J EVOLUTION BIOL, V16, P501, DOI 10.1046/j.1420-9101.2003.00535.x; Muller JK, 2007, BEHAV ECOL, V18, P196, DOI 10.1093/beheco/arl073; MULLER JK, 1990, J INSECT BEHAV, V3, P265, DOI 10.1007/BF01417917; MULLER JK, 1990, BEHAV ECOL SOCIOBIOL, V27, P11, DOI 10.1007/BF00183307; Ohgushi T, 1996, OECOLOGIA, V106, P345, DOI 10.1007/BF00334562; Paukku S, 2005, J INSECT PHYSIOL, V51, P1220, DOI 10.1016/j.jinsphys.2005.06.012; Prowse N, 1997, J INSECT PHYSIOL, V43, P501, DOI 10.1016/S0022-1910(97)00014-0; Rauter CM, 2004, ANIM BEHAV, V68, P695, DOI 10.1016/j.anbehav.2003.09.018; Rauter CM, 1999, P ROY SOC B-BIOL SCI, V266, P1691, DOI 10.1098/rspb.1999.0833; Roff Derek A., 1992; Rosenheim JA, 1999, EVOL ECOL, V13, P141, DOI 10.1023/A:1006612519265; Sakaluk SK, 2008, J INSECT BEHAV, V21, P153, DOI 10.1007/s10905-007-9115-y; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; SCOTT MP, 1990, ANIM BEHAV, V39, P274, DOI 10.1016/S0003-3472(05)80871-1; SCOTT MP, 1990, BEHAV ECOL SOCIOBIOL, V26, P31, DOI 10.1007/BF00174022; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRUMBO ST, 1991, BEHAVIOUR, V117, P82, DOI 10.1163/156853991X00139; Trumbo ST, 1995, ETHOL ECOL EVOL, V7, P313, DOI 10.1080/08927014.1995.9522939; Trumbo ST, 2006, ANIM BEHAV, V72, P1159, DOI 10.1016/j.anbehav.2006.05.004; Walling CA, 2008, P NATL ACAD SCI USA, V105, P18430, DOI 10.1073/pnas.0803146105; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Zink AG, 2003, BEHAV ECOL, V14, P687, DOI 10.1093/beheco/arg044	44	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143762	10.1371/journal.pone.0143762	http://dx.doi.org/10.1371/journal.pone.0143762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600016	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600118
J	Becerra-Artiles, A; Dominguez-Amorocho, O; Stern, LJ; Calvo-Calle, JM				Becerra-Artiles, Aniuska; Dominguez-Amorocho, Omar; Stern, Lawrence J.; Calvo-Calle, J. Mauricio			A Simple Proteomics-Based Approach to Identification of Immunodominant Antigens from a Complex Pathogen: Application to the CD4 T Cell Response against Human Herpesvirus 6B	PLOS ONE			English	Article							SDS-POLYACRYLAMIDE-GELS; MULV-INDUCED TUMORS; HOUSE-DUST MITE; HLA-DR; NITROCELLULOSE IMMUNOBLOTS; DERMATOPHAGOIDES-FARINAE; TRANSPLANT RECIPIENTS; HUMAN CYTOMEGALOVIRUS; MULTIPLE-SCLEROSIS; VIRAL-INFECTIONS	Most of humanity is chronically infected with human herpesvirus 6 (HHV-6), with viral replication controlled at least in part by a poorly characterized CD4 T cell response. Identification of viral epitopes recognized by CD4 T cells is complicated by the large size of the herpesvirus genome and a low frequency of circulating T cells responding to the virus. Here, we present an alternative to classical epitope mapping approaches used to identify major targets of the T cell response to a complex pathogen like HHV-6B. In the approach presented here, extracellular virus preparations or virus-infected cells are fractionated by SDS-PAGE, and eluted fractions are used as source of antigens to study cytokine responses in direct ex vivo T cell activation studies. Fractions inducing significant cytokine responses are analyzed by mass spectrometry to identify viral proteins, and a subset of peptides from these proteins corresponding to predicted HLA-DR binders is tested for IFN-gamma production in seropositive donors with diverse HLA haplotypes. Ten HHV-6B viral proteins were identified as immunodominant antigens. The epitope-specific response to HHV-6B virus was complex and variable between individuals. We identified 107 peptides, each recognized by at least one donor, with each donor having a distinctive footprint. Fourteen peptides showed responses in the majority of donors. Responses to these epitopes were validated using in vitro expanded cells and naturally expressed viral proteins. Predicted peptide binding affinities for the eight HLA-DRB1 alleles investigated here correlated only modestly with the observed CD4 T cell responses. Overall, the response to the virus was dominated by peptides from the major capsid protein U57 and major antigenic protein U11, but responses to other proteins including glycoprotein H (U48) and tegument proteins U54 and U14 also were observed. These results provide a means to follow and potentially modulate the CD4 T-cell immune response to HHV-6B.	[Becerra-Artiles, Aniuska; Dominguez-Amorocho, Omar; Stern, Lawrence J.; Calvo-Calle, J. Mauricio] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Stern, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	lawrence.stern@umassmed.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases [U19-AI057319, U19-AI109858, HHSN27220140046C]; NIH [U19-AI057319, U19-AI109858, HHSN27220140046C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319, U19AI109858] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx) grants U19-AI057319 (to JMCC), U19-AI109858 (to LJS), and HHSN27220140046C (to LJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by NIH grants U19-AI057319, U19-AI109858, and HHSN27220140046C. We acknowledge advice and assistance provided by James Evans and Karin Green at the University of Massachusetts Medical School Proteomics and Mass Spectrometry Facility, and we thank blood donors for their cooperation. The authors declare no commercial or financial conflict of interest.	Agut H, 2015, CLIN MICROBIOL REV, V28, P313, DOI 10.1128/CMR.00122-14; AHITUV A, 1982, CANCER IMMUNOL IMMUN, V14, P16; ANDERSEN P, 1993, J IMMUNOL METHODS, V161, P29, DOI 10.1016/0022-1759(93)90195-D; Aoki J, 2015, BIOL BLOOD MARROW TR, V21, P2017, DOI 10.1016/j.bbmt.2015.07.022; Becerra A, 2014, CURR OPIN VIROL, V9, P154, DOI 10.1016/j.coviro.2014.10.001; Beckhove P, 2010, J CLIN INVEST, V120, P2230, DOI 10.1172/JCI37646; Bhaskar S, 2000, J IMMUNOASSAY, V21, P355, DOI 10.1080/01971520009349542; Cacoub P, 2011, AM J MED, V124, P588, DOI 10.1016/j.amjmed.2011.01.017; Calvo-Calle JM, 2007, PLOS PATHOG, V3, P1511, DOI 10.1371/journal.ppat.0030144; Calvo-Calle JM, 2014, HUMAN HERPESVIRUSES, P235; Chiozzini C, 2014, AIDS, V28, P2189, DOI 10.1097/QAD.0000000000000389; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Dulery R, 2012, BIOL BLOOD MARROW TR, V18, P1080, DOI 10.1016/j.bbmt.2011.12.579; Emery VC, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P875; Fernandez-Ponce C, 2014, PLOS ONE, DOI [10.1371/journal.pone.008519, DOI 10.1371/J0URNAL.P0NE.008519]; Fuhrmann S, 2008, J INFECT DIS, V197, P1455, DOI 10.1086/587692; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Gamvrellis A, 2004, IMMUNOL CELL BIOL, V82, P506, DOI 10.1111/j.0818-9641.2004.01271.x; Gerdemann U, 2013, BLOOD, V121, P207, DOI 10.1182/blood-2012-05-430413; Glosson NL, 2007, VIROLOGY, V365, P125, DOI 10.1016/j.virol.2007.03.048; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; GULLE H, 1990, J IMMUNOL METHODS, V133, P253, DOI 10.1016/0022-1759(90)90366-4; Haberthur K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002367; Halawi M, 2015, IMMUN INFLAMM DIS, V3, P118, DOI 10.1002/iid3.55; Hata A, 2002, NEW ENGL J MED, V347, P26, DOI 10.1056/NEJMoa013441; Iampietro M, 2014, EUR J IMMUNOL, V44, P3573, DOI 10.1002/eji.201444931; Jing LC, 2013, J VIROL, V87, P2617, DOI 10.1128/JVI.03047-12; Jing LC, 2009, J IMMUNOL METHODS, V347, P36, DOI 10.1016/j.jim.2009.05.011; Johnson DC, 2002, CURR TOP MICROBIOL, V269, P101; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; KIRKLAND TN, 1991, INFECT IMMUN, V59, P3952, DOI 10.1128/IAI.59.11.3952-3961.1991; KLEIN BY, 1980, J IMMUNOL METHODS, V38, P325, DOI 10.1016/0022-1759(80)90281-1; Kurien BT, 2003, J IMMUNOL METHODS, V274, P1, DOI 10.1016/S0022-1759(02)00523-9; Laing KJ, 2015, J INFECT DIS, V212, P1022, DOI 10.1093/infdis/jiv164; LAMB JR, 1988, J IMMUNOL METHODS, V110, P1, DOI 10.1016/0022-1759(88)90076-2; Leen AM, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1318; Martin LK, 2012, EUR J IMMUNOL, V42, P2901, DOI 10.1002/eji.201242439; Mohan JF, 2013, MOL IMMUNOL, V55, P166, DOI 10.1016/j.molimm.2012.10.024; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; Mori Y, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P833; Nastke MD, 2012, J VIROL, V86, P4776, DOI 10.1128/JVI.06573-11; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Ogata M, 2015, BONE MARROW TRANSPL, V50, P1030, DOI 10.1038/bmt.2015.76; OHEHIR R, 1989, INT ARCH ALLER A IMM, V88, P170, DOI 10.1159/000234775; OHEHIR RE, 1987, IMMUNOLOGY, V62, P635; OSULLIVAN D, 1991, J IMMUNOL, V147, P2663; Papadopoulou A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008825; PHAM BN, 1989, CLIN EXP IMMUNOL, V77, P168; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Romanets-Korbut O, 2016, CELL MOL IMMUNOL, V13, P828, DOI 10.1038/cmi.2015.55; Sant AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00340; Sebelin-Wulf K, 2007, TRANSPL IMMUNOL, V17, P203, DOI 10.1016/j.trim.2006.10.006; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; SHARON R, 1984, CANCER IMMUNOL IMMUN, V18, P203; Southwood S, 1998, J IMMUNOL, V160, P3363; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tejada-Simon MV, 2003, ANN NEUROL, V53, P189, DOI 10.1002/ana.10425; Tel J, 2010, J IMMUNOL, V184, P4276, DOI 10.4049/jimmunol.0903286; Tosato Giovanna, 2007, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0722s76; Tu WW, 2004, J IMMUNOL, V172, P3260, DOI 10.4049/jimmunol.172.5.3260; Verhoeven DHJ, 2015, PEDIATR INFECT DIS J, V34, P1118, DOI 10.1097/INF.0000000000000824; Verweij MC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004743; Virtanen JO, 2012, CNS NEUROL DISORD-DR, V11, P528; Walton S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00105; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; YAKUSHIJIN Y, 1992, J VIROL, V66, P2773, DOI 10.1128/JVI.66.5.2773-2779.1992; Yao K, 2010, J MED VIROL, V82, P1669, DOI 10.1002/jmv.21861; Yin Liusong, 2014, Curr Protoc Immunol, V106, DOI 10.1002/0471142735.im0510s106; Yin LS, 2012, J IMMUNOL, V189, P3983, DOI 10.4049/jimmunol.1200626; Yoshikawa T, 2002, J INFECT DIS, V185, P847, DOI 10.1086/339411; Yoshikawa T, 2011, J CLIN VIROL, V50, P65, DOI 10.1016/j.jcv.2010.09.017; Yoshikawa Tetsushi, 2010, Brain and Nerve (Tokyo), V62, P869; YOUNG DB, 1986, IMMUNOLOGY, V59, P167; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	77	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142871	10.1371/journal.pone.0142871	http://dx.doi.org/10.1371/journal.pone.0142871			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599878	gold, Green Submitted, Green Published			2022-12-26	WOS:000365853900044
J	Behrens, M; Huwel, S; Galla, HJ; Humpf, HU				Behrens, Matthias; Huewel, Sabine; Galla, Hans-Joachim; Humpf, Hans-Ulrich			Blood-Brain Barrier Effects of the Fusarium Mycotoxins Deoxynivalenol, 3 Acetyldeoxynivalenol, and Moniliformin and Their Transfer to the Brain	PLOS ONE			English	Article							IN-VITRO; ENDOTHELIAL-CELLS; JUNCTION PROTEINS; PRIMARY CULTURES; ORAL TOXICITY; TRANSPORT; MODEL; PERMEABILITY; METABOLISM; EXPOSURE	Background Secondary metabolites produced by Fusarium fungi frequently contaminate food and feed and have adverse effects on human and animal health. Fusarium mycotoxins exhibit a wide structural and biosynthetic diversity leading to different toxicokinetics and toxicodynamics. Several studies investigated the toxicity of mycotoxins, focusing on very specific targets, like the brain. However, it still remains unclear how fast mycotoxins reach the brain and if they impair the integrity of the blood-brain barrier. This study investigated and compared the effects of the Fusarium mycotoxins deoxynivalenol, 3-acetyldeoxynivalenol and moniliformin on the blood-brain barrier. Furthermore, the transfer properties to the brain were analyzed, which are required for risk assessment, including potential neurotoxic effects. Methods Primary porcine brain capillary endothelial cells were cultivated to study the effects of the examined mycotoxins on the blood-brain barrier in vitro. The barrier integrity was monitored by cellular impedance spectroscopy and C-14 radiolabeled sucrose permeability measurements. The distribution of the applied toxins between blood and brain compartments of the cell monolayer was analyzed by high performance liquid chromatography-mass spectrometry to calculate transfer rates and permeability coefficients. Results Deoxynivalenol reduced the barrier integrity and caused cytotoxic effects at 10 mu M concentrations. Slight alterations of the barrier integrity were also detected for 3-acetyldeoxynivalenol. The latter was transferred very quickly across the barrier and additionally cleaved to deoxynivalenol. The transfer of deoxynivalenol and moniliformin was slower, but clearly exceeded the permeability of the negative control. None of the compounds was enriched in one of the compartments, indicating that no efflux transport protein is involved in their transport.	[Behrens, Matthias; Humpf, Hans-Ulrich] Univ Munster, Inst Food Chem, Corrensstr 45, D-48149 Munster, Germany; [Huewel, Sabine; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster; University of Munster	Humpf, HU (corresponding author), Univ Munster, Inst Food Chem, Corrensstr 45, D-48149 Munster, Germany.	humpf@wwu.de	Humpf, Hans-Ulrich/AAV-4845-2020	Humpf, Hans-Ulrich/0000-0003-3296-3058; Behrens, Matthias/0000-0001-5425-8144				Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alassane-Kpembi I, 2015, ARCH TOXICOL, V89, P1337, DOI 10.1007/s00204-014-1309-4; Alassane-Kpembi I, 2013, TOXICOL APPL PHARM, V272, P191, DOI 10.1016/j.taap.2013.05.023; ALTPETER F, 1994, APPL MICROBIOL BIOT, V41, P384, DOI [10.1007/s002530050161, 10.1007/BF00212246]; Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5; Beuckmann CT, 1997, CYTOTECHNOLOGY, V24, P11, DOI 10.1023/A:1007936323956; Beyer Marita, 2009, Mycotoxin Res, V25, P41, DOI 10.1007/s12550-009-0006-2; Bonnet MS, 2012, TOXINS, V4, P1120, DOI 10.3390/toxins4111120; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Eriksen GS, 2003, ARCH ANIM NUTR, V57, P335, DOI 10.1080/00039420310001607699; Ficheux AS, 2013, TOXICON, V71, P1, DOI 10.1016/j.toxicon.2013.04.024; Franke H, 1999, BRAIN RES, V818, P65, DOI 10.1016/S0006-8993(98)01282-7; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Gerding J, 2015, MYCOTOXIN RES, V31, P127, DOI 10.1007/s12550-015-0223-9; Gerding J, 2014, MOL NUTR FOOD RES, V58, P2358, DOI 10.1002/mnfr.201400406; Goyarts T, 2006, TOXICOL LETT, V163, P171, DOI 10.1016/j.toxlet.2005.10.007; Hoheisel D, 1998, BIOCHEM BIOPH RES CO, V244, P312, DOI 10.1006/bbrc.1997.8051; Jestoi M, 2008, CRIT REV FOOD SCI, V48, P21, DOI 10.1080/10408390601062021; Jonsson M, 2015, TOXICOL LETT, V233, P38, DOI 10.1016/j.toxlet.2014.11.006; Jonsson M, 2013, FOOD CHEM TOXICOL, V53, P27, DOI 10.1016/j.fct.2012.11.023; Kim JA, 2006, J CEREBR BLOOD F MET, V26, P209, DOI 10.1038/sj.jcbfm.9600181; Knasmuller S, 1997, MUTAT RES-GEN TOX EN, V391, P39, DOI 10.1016/S0165-1218(97)00030-X; Lohmann C, 2002, J DRUG TARGET, V10, P263, DOI 10.1080/10611860290031903; Lohrey L, 2011, SYNLETT, P2242, DOI 10.1055/s-0030-1261189; Maresca M, 2013, TOXINS, V5, P784, DOI 10.3390/toxins5040784; Mulac D, 2012, MOL NUTR FOOD RES, V56, P475, DOI 10.1002/mnfr.201100431; Naik P, 2012, J PHARM SCI-US, V101, P1337, DOI 10.1002/jps.23022; Ohtsuki S, 2013, MOL PHARMACEUT, V10, P289, DOI 10.1021/mp3004308; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pinton P, 2012, TOXICOL SCI, V130, P180, DOI 10.1093/toxsci/kfs239; Pinton P, 2010, J NUTR, V140, P1956, DOI 10.3945/jn.110.123919; PRELUSKY DB, 1990, J ENVIRON SCI HEAL B, V25, P395, DOI 10.1080/03601239009372697; PRELUSKY DB, 1988, FUND APPL TOXICOL, V10, P276, DOI 10.1016/0272-0590(88)90312-0; RABIE CJ, 1982, APPL ENVIRON MICROB, V43, P517, DOI 10.1128/AEM.43.3.517-521.1982; Razafimanjato H, 2011, GLIA, V59, P1672, DOI 10.1002/glia.21214; Sarkanj B, 2013, FOOD CHEM TOXICOL, V62, P231, DOI 10.1016/j.fct.2013.08.043; Schothorst RC, 2004, TOXICOL LETT, V153, P133, DOI 10.1016/j.toxlet.2004.04.045; Schrot S, 2005, BIOPHYS J, V89, P3904, DOI 10.1529/biophysj.104.058750; Scientific Committee on Food, 1999, OPIN FUS TOX 1; Sergent T, 2006, TOXICOL LETT, V164, P167, DOI 10.1016/j.toxlet.2005.12.006; Thanabalasundaram G, 2011, METHODS MOL BIOL, V686, P379, DOI 10.1007/978-1-60761-938-3_19; THIEL PG, 1978, BIOCHEM PHARMACOL, V27, P483, DOI 10.1016/0006-2952(78)90381-7; Videmann B, 2007, FOOD CHEM TOXICOL, V45, P1938, DOI 10.1016/j.fct.2007.04.011; von Bargen KW, 2012, J AGR FOOD CHEM, V60, P3586, DOI 10.1021/jf300323d; Warth B, 2012, TOXICOL LETT, V211, P85, DOI 10.1016/j.toxlet.2012.02.023; Weidner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060484; Weidner M, 2013, CHEM RES TOXICOL, V26, P347, DOI 10.1021/tx3004664; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; WHO, 2011, WHO TECH REP SER, V959, P1	51	36	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143640	10.1371/journal.pone.0143640	http://dx.doi.org/10.1371/journal.pone.0143640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600019	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900150
J	Chen, HL; Yang, B; Liu, DY; Liu, WB; Liu, YL; Zhang, XH; Hu, LF				Chen, Huiling; Yang, Bo; Liu, Dayou; Liu, Wenbin; Liu, Yanlong; Zhang, Xiuhua; Hu, Lufeng			Using Blood Indexes to Predict Overweight Statuses: An Extreme Learning Machine-Based Approach	PLOS ONE			English	Article							BODY-MASS INDEX; FEEDFORWARD NETWORKS; LOGISTIC-REGRESSION; GLUCOSE-TOLERANCE; OBESITY; CLASSIFICATION; DISEASE; NUMBER; RISK	The number of the overweight people continues to rise across the world. Studies have shown that being overweight can increase health risks, such as high blood pressure, diabetes mellitus, coronary heart disease, and certain forms of cancer. Therefore, identifying the overweight status in people is critical to prevent and decrease health risks. This study explores a new technique that uses blood and biochemical measurements to recognize the overweight condition. A new machine learning technique, an extreme learning machine, was developed to accurately detect the overweight status from a pool of 225 overweight and 251 healthy subjects. The group included 179 males and 297 females. The detection method was rigorously evaluated against the real-life dataset for accuracy, sensitivity, specificity, and AUC (area under the receiver operating characteristic (ROC) curve) criterion. Additionally, the feature selection was investigated to identify correlating factors for the overweight status. The results demonstrate that there are significant differences in blood and biochemical indexes between healthy and overweight people (p-value < 0.01). According to the feature selection, the most important correlated indexes are creatinine, hemoglobin, hematokrit, uric Acid, red blood cells, high density lipoprotein, alanine transaminase, triglyceride, and. gamma-glutamyl transpeptidase. These are consistent with the results of Spearman test analysis. The proposed method holds promise as a new, accurate method for identifying the overweight status in subjects.	[Chen, Huiling; Liu, Wenbin] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou, Peoples R China; [Yang, Bo; Liu, Dayou] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [Chen, Huiling; Yang, Bo; Liu, Dayou] Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China; [Liu, Yanlong] Wenzhou Med Univ, Coll Pharmaceut Sci, Wenzhou, Peoples R China; [Zhang, Xiuhua; Hu, Lufeng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pharmaceut, Wenzhou, Peoples R China	Wenzhou University; Jilin University; Jilin University; Wenzhou Medical University; Wenzhou Medical University	Zhang, XH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Pharmaceut, Wenzhou, Peoples R China.	wzxiuhuazhang@163.com; hulufeng79@sina.com	chen, huiling/J-2477-2013; liu, wen/HGE-3071-2022; Chen, Huiling/N-8510-2019; liu, yan/HGV-1365-2022	Chen, Huiling/0000-0002-7714-9693; 	National Natural Science Foundation of China (NSFC) [61303113, 61133011, 61373053, 61272018, 61402337, 61572226, 61572367, 81300311]; key construction academic subject (medical innovation) of Zhejiang Province [11-CX26]; Zhejiang Provincial Natural Science Foundation of China [R1110261, LQ13G010007, LQ13F020011, LY14F020035]; young talents project of the First Affiliated Hospital of Wenzhou Medical University [qnyc 043]; open project program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University [93K172013K01]; Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences; Jilin Province Natural Science Foundation [20150101052JC]; Science and Technology Plan Project of Wenzhou, China [G20140048]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); key construction academic subject (medical innovation) of Zhejiang Province; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); young talents project of the First Affiliated Hospital of Wenzhou Medical University; open project program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University; Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences; Jilin Province Natural Science Foundation; Science and Technology Plan Project of Wenzhou, China	This research is supported by the National Natural Science Foundation of China (NSFC) (61303113, 61133011, 61373053, 61272018 and 61402337). This work is also supported by the key construction academic subject (medical innovation) of Zhejiang Province (11-CX26), Zhejiang Provincial Natural Science Foundation of China (R1110261, LQ13G010007, LQ13F020011, LY14F020035), and the young talents project of the First Affiliated Hospital of Wenzhou Medical University (qnyc 043), the open project program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University under Grant No. 93K172013K01, the Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by the National Natural Science Foundation of China (NSFC) (61303113, 61133011, 61572226, 61572367, 61373053, 61272018, 81300311 and 61402337). This work is also supported by the key construction academic subject (medical innovation) of Zhejiang Province (11-CX26), Zhejiang Provincial Natural Science Foundation of China (R1110261, LQ13G010007, LQ13F020011, LY14F020035), and the young talents project of the First Affiliated Hospital of Wenzhou Medical University (qnyc 043), Jilin Province Natural Science Foundation under grants 20150101052JC, the Science and Technology Plan Project of Wenzhou, China (G20140048), the open project program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University under Grant No. 93K172013K01, the Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences.	Almoosawi S, 2012, FOOD FUNCT, V3, P1035, DOI 10.1039/c2fo30060e; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Duda R.O., 2000, PATTERN CLASSIFICATI; Ergun U, 2009, J MED SYST, V33, P67, DOI 10.1007/s10916-008-9165-5; Evans EM, 2006, INT J OBESITY, V30, P837, DOI 10.1038/sj.ijo.0803208; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferenci T, 2010, IEEE ENG MED BIO, P3883, DOI 10.1109/IEMBS.2010.5627672; Hardalac Firat, 2004, J Med Syst, V28, P129, DOI 10.1023/B:JOMS.0000023296.42481.a1; Heydari ST, 2012, J MED SYST, V36, P2449, DOI 10.1007/s10916-011-9711-4; Hsu CW, 2003, TECHNICAL REPORT, P1; Hu LF, 2015, COMPUT BIOL MED, V59, P116, DOI 10.1016/j.compbiomed.2015.02.003; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2003, IEEE T NEURAL NETWOR, V14, P274, DOI 10.1109/TNN.2003.809401; Huang GB, 1998, IEEE T NEURAL NETWOR, V9, P224, DOI 10.1109/72.655045; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Hyska J, 2014, J COMMUN HEALTH, V39, P828, DOI 10.1007/s10900-014-9888-9; Kong APS, 2008, ACTA PAEDIATR, V97, P1738, DOI 10.1111/j.1651-2227.2008.01056.x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lee BJ, 2013, ARTIF INTELL MED, V58, P51, DOI 10.1016/j.artmed.2013.02.001; Lee MF, 2013, GENET TEST MOL BIOMA, V17, P40, DOI 10.1089/gtmb.2012.0231; Liu T, 2015, INT J SYST SCI, V46, P919, DOI 10.1080/00207721.2013.801096; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mohammed AA, 2011, PATTERN RECOGN, V44, P2588, DOI 10.1016/j.patcog.2011.03.013; Moreno R, 2014, NEUROCOMPUTING, V128, P207, DOI 10.1016/j.neucom.2013.03.057; Pal M, 2009, INT J REMOTE SENS, V30, P3835, DOI 10.1080/01431160902788636; Rolandsson O, 2001, J INTERN MED, V249, P279, DOI 10.1046/j.1365-2796.2001.00813.x; Sabah Khandker Md Nurus, 2014, BMC Res Notes, V7, P246, DOI 10.1186/1756-0500-7-246; Salzberg SL, 1997, DATA MIN KNOWL DISC, V1, P317, DOI 10.1023/A:1009752403260; Seo DC, 2014, INT J BEHAV MED, V21, P682, DOI 10.1007/s12529-013-9322-1; Suresh S, 2009, APPL SOFT COMPUT, V9, P541, DOI 10.1016/j.asoc.2008.07.005; Valavanis IK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-453; Van Pelt RE, 2001, INT J OBESITY, V25, P1183, DOI 10.1038/sj.ijo.0801640; Vikoren LA, 2013, BRIT J NUTR, V109, P648, DOI 10.1017/S0007114512001717; Yan WL, 2015, ETHNIC HEALTH, V20, P365, DOI 10.1080/13557858.2014.921894; Zhang RX, 2007, IEEE ACM T COMPUT BI, V4, P485, DOI 10.1109/TCBB.2007.1012; Zheng RD, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/362147	39	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143003	10.1371/journal.pone.0143003	http://dx.doi.org/10.1371/journal.pone.0143003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600199	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900056
J	Chu, C; Belavy, DL; Armbrecht, G; Bansmann, M; Felsenberg, D; Zheng, GY				Chu, Chengwen; Belavy, Daniel L.; Armbrecht, Gabriele; Bansmann, Martin; Felsenberg, Dieter; Zheng, Guoyan			Fully Automatic Localization and Segmentation of 3D Vertebral Bodies from CT/MR Images via a Learning-Based Method	PLOS ONE			English	Article							CT	In this paper, we address the problems of fully automatic localization and segmentation of 3D vertebral bodies from CT/MR images. We propose a learning-based, unified random forest regression and classification framework to tackle these two problems. More specifically, in the first stage, the localization of 3D vertebral bodies is solved with random forest regression where we aggregate the votes from a set of randomly sampled image patches to get a probability map of the center of a target vertebral body in a given image. The resultant probability map is then further regularized by Hidden Markov Model (HMM) to eliminate potential ambiguity caused by the neighboring vertebral bodies. The output from the first stage allows us to define a region of interest (ROI) for the segmentation step, where we use random forest classification to estimate the likelihood of a voxel in the ROI being foreground or background. The estimated likelihood is combined with the prior probability, which is learned from a set of training data, to get the posterior probability of the voxel. The segmentation of the target vertebral body is then done by a binary thresholding of the estimated probability. We evaluated the present approach on two openly available datasets: 1) 3D T2-weighted spine MR images from 23 patients and 2) 3D spine CT images from 10 patients. Taking manual segmentation as the ground truth (each MR image contains at least 7 vertebral bodies from T11 to L5 and each CT image contains 5 vertebral bodies from L1 to L5), we evaluated the present approach with leave-one-out experiments. Specifically, for the T2-weighted MR images, we achieved for localization a mean error of 1.6 mm, and for segmentation a mean Dice metric of 88.7% and a mean surface distance of 1.5 mm, respectively. For the CT images we achieved for localization a mean error of 1.9 mm, and for segmentation a mean Dice metric of 91.0% and a mean surface distance of 0.9 mm, respectively.	[Chu, Chengwen; Zheng, Guoyan] Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland; [Belavy, Daniel L.] Free Univ Berlin, Ctr Muscle & Bone Res, Charite Univ Med Berlin, D-12200 Berlin, Germany; [Belavy, Daniel L.] Humboldt Univ, D-12200 Berlin, Germany; [Belavy, Daniel L.; Armbrecht, Gabriele; Felsenberg, Dieter] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia; [Bansmann, Martin] Krankenhaus Porz Rhein gGmbH, Inst Diagnost & Intervent Radiol, D-51149 Cologne, Germany	University of Bern; Humboldt University of Berlin; Deakin University	Zheng, GY (corresponding author), Stauffacherstr 78, CH-3014 Bern, Switzerland.	guoyan.zheng@istb.unibe.ch	Belavy, Daniel/P-4947-2016; Zheng, Guoyan/C-8079-2014; , Guoyan/M-3617-2018	Belavy, Daniel/0000-0002-9307-832X; , Guoyan/0000-0003-4173-0379; Armbrecht, Gabriele/0000-0002-6578-338X	Swiss National Science Foundation [205321_157207/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation (http://www.snf.ch/en/Pages/default.aspx) with the grant no. 205321_157207/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the Swiss National Science Foundation with Project No. 205321_157207/1.	Ali AM, 2014, COMPUT MED IMAG GRAP, V38, P586, DOI 10.1016/j.compmedimag.2014.04.009; Aslan M. S., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3951, DOI 10.1109/ICPR.2010.961; Ben Ayed I, 2012, LECT NOTES COMPUT SC, V7510, P520, DOI 10.1007/978-3-642-33415-3_64; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carballido-Gamio J, 2004, IEEE T MED IMAGING, V23, P36, DOI 10.1109/TMI.2003.819929; Chen C, 2014, LECT NOTES COMPUT SC, V8679, P50, DOI 10.1007/978-3-319-10581-9_7; Chu CW, 2015, ANN BIOMED ENG, V43, P1247, DOI 10.1007/s10439-014-1176-4; Criminisi A, 2011, LECT NOTES COMPUT SC, V6533, P106, DOI 10.1007/978-3-642-18421-5_11; Cuingnet R, 2012, LECT NOTES COMPUT SC, V7512, P66, DOI 10.1007/978-3-642-33454-2_9; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Egger J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031064; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Glocker B, 2012, LECT NOTES COMPUT SC, V7512, P590, DOI 10.1007/978-3-642-33454-2_73; Huang SH, 2009, IEEE T MED IMAGING, V28, P1595, DOI 10.1109/TMI.2009.2023362; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Ibragimov B, 2014, IEEE T MED IMAGING, V33, P861, DOI 10.1109/TMI.2013.2296976; Jaeger F, 2011, NORMALIZATION MAGNET; Jager F, 2009, IEEE T MED IMAGING, V28, P137, DOI 10.1109/TMI.2008.2004429; Klinder T, 2008, LECT NOTES COMPUT SC, V5241, P227, DOI 10.1007/978-3-540-85988-8_28; Klinder T, 2009, MED IMAGE ANAL, V13, P471, DOI 10.1016/j.media.2009.02.004; Kolmogorov V, 2004, IEEE T PATTERN ANAL, V26, P147, DOI 10.1109/TPAMI.2004.1262177; Li CM, 2014, MAGN RESON IMAGING, V32, P913, DOI 10.1016/j.mri.2014.03.010; Li K, 2006, IEEE T PATTERN ANAL, V28, P119, DOI 10.1109/TPAMI.2006.19; Lindner C, 2013, IEEE T MED IMAGING, V32, P1462, DOI 10.1109/TMI.2013.2258030; Lootus M, 2013, LNCVB, V17, P219; Ma J, 2013, COMPUT VIS IMAGE UND, V117, P1072, DOI 10.1016/j.cviu.2012.11.016; Miao J, 2013, EUR SPINE J, V22, P425, DOI 10.1007/s00586-012-2428-3; Oktay A, 2011, LNCS, V6893, P159; Schmidt S, 2007, LECT NOTES COMPUT SC, V4584, P122; Schwarzenberg R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093389; Song Q, 2013, IEEE T MED IMAGING, V32, P376, DOI 10.1109/TMI.2012.2227120; Stern D, 2011, PHYS MED BIOL, V56, P7505, DOI 10.1088/0031-9155/56/23/011; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Yang C., 2005, ADV NEURAL INFORM PR, V17, P1561; Yao JH, 2006, I S BIOMED IMAGING, P390; Zhan YQ, 2012, LECT NOTES COMPUT SC, V7510, P141, DOI 10.1007/978-3-642-33415-3_18; Zukic D, 2012, VISION MODELING VISU, P135, DOI DOI 10.2312/PE/VMV/VMV12/135-142; Zukic D, 2014, COMPUT GRAPH FORUM, V33, P190, DOI 10.1111/cgf.12343	40	43	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143327	10.1371/journal.pone.0143327	http://dx.doi.org/10.1371/journal.pone.0143327			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599505	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900094
J	Daudigeos-Dubus, E; Le Dret, L; Lanvers-Kaminsky, C; Bawa, O; Opolon, P; Vievard, A; Villa, I; Pages, M; Bosq, J; Vassal, G; Zopf, D; Geoerger, B				Daudigeos-Dubus, Estelle; Le Dret, Ludivine; Lanvers-Kaminsky, Claudia; Bawa, Olivia; Opolon, Paule; Vievard, Albane; Villa, Irene; Pages, Melanie; Bosq, Jacques; Vassal, Gilles; Zopf, Dieter; Geoerger, Birgit			Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SIMIAN SARCOMA-VIRUS; HIGH-GRADE GLIOMAS; COLORECTAL-CANCER; PHASE-II; HUMAN NEUROBLASTOMA; METASTATIC-DISEASE; ANGIOGENIC FACTORS; INHIBITS GROWTH; SOLID TUMORS	The multikinase inhibitor regorafenib (BAY 73-4506) exerts both anti-angiogenic and anti-tumorigenic activity in adult solid malignancies mainly advanced colorectal cancer and gastrointestinal stromal tumors. We intended to explore preclinically the potential of regorafenib against solid pediatric malignancies alone and in combination with anticancer agents to guide the pediatric development plan. In vitro effects on cell proliferation were screened against 33 solid tumor cell lines of the Innovative Therapies for Children with Cancer (ITCC) panel covering five pediatric solid malignancies. Regorafenib inhibited cell proliferation with a mean half maximal growth inhibition of 12.5 mu mol/L (range 0.7 mu mol/L to 28 mu mol/L). In vivo, regorafenib was evaluated alone at 10 or 30 mg/kg/d or in combination with radiation, irinotecan or the mitogen-activated protein kinase kinase (MEK) inhibitor refametinib against various tumor types, including patient-derived brain tumor models with an amplified platelet-derived growth factor receptor A (PDGFRA) gene. Regorafenib alone significantly inhibited tumor growth in all xenografts derived from nervous system and connective tissue tumors. Enhanced effects were observed when regorafenib was combined with irradiation and irinotecan against PDGFRA amplified IGRG93 glioma and IGRM57 medulloblastoma respectively, resulting in 100% tumor regressions. Antitumor activity was associated with decreased tumor vascularization, inhibition of PDGFR signaling, and induction of apoptotic cell death. Our work demonstrates that regorafenib exhibits significant antitumor activity in a wide spectrum of preclinical pediatric models through inhibition of angiogenesis and induction of apoptosis. Furthermore, radio- and chemosensitizing effects were observed with DNA damaging agents in PDGFR amplified tumors.	[Daudigeos-Dubus, Estelle; Le Dret, Ludivine; Vassal, Gilles; Geoerger, Birgit] Univ Paris 11, UMR 8203, Vectorol & Anticanc Therapeut, Villejuif, France; [Daudigeos-Dubus, Estelle; Le Dret, Ludivine; Vassal, Gilles; Geoerger, Birgit] CNRS, UMR 8203, Vectorol & Anticanc Therapeut, F-91405 Orsay, France; [Daudigeos-Dubus, Estelle; Le Dret, Ludivine; Vassal, Gilles; Geoerger, Birgit] Gustave Roussy, UMR 8203, Vectorol & Anticanc Therapeut, Villejuif, France; [Lanvers-Kaminsky, Claudia] Univ Childrens Hosp, Dept Pediat Hematol & Oncol, Munster, Germany; [Bawa, Olivia; Opolon, Paule] Gustave Roussy, PFEP Plateforme Evaluat Preclin, Villejuif, France; [Vievard, Albane] Tribvn, Chatillon, France; [Villa, Irene; Bosq, Jacques] Gustave Roussy, Pathol Lab, Villejuif, France; [Pages, Melanie] St Annes Hosp, Dept Neuropathol, Paris, France; [Pages, Melanie] Paris Descartes Univ, Paris, France; [Zopf, Dieter] Bayer Pharma Aktiengesell, Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Bayer AG; Bayer Healthcare Pharmaceuticals	Geoerger, B (corresponding author), Univ Paris 11, UMR 8203, Vectorol & Anticanc Therapeut, Villejuif, France.	birgit.geoerger@gustaveroussy.fr	Pages, Melanie/S-1875-2019; Lanvers-Kaminsky, Claudia/AAY-2071-2021		Bayer Pharma Aktiengesellschaft; Enfants et Sante; Societe Francaise des Cancers de l'Enfant; Tribvn	Bayer Pharma Aktiengesellschaft; Enfants et Sante; Societe Francaise des Cancers de l'Enfant; Tribvn	This preclinical evaluation was supported by: Bayer Pharma Aktiengesellschaft, (BG), 'Enfants et Sante' and the 'Societe Francaise des Cancers de l'Enfant'. Bayer Pharma Aktiengesellschaft provided support in the form of salaries for authors [DZ] and had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Tribvn provided support in the form of salaries for authors [AV] and had a collaborative role in data analysis and preparation of the manuscript without financial support. The specific roles of these authors are articulated in the 'author contributions' section.	Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; [Anonymous], 2013, ONCOL WILLISTON PARK, V27, P164; [Anonymous], 2012, ONCOL WILLISTON PARK, V26, P896; Aprile G, 2013, BIODRUGS, V27, P213, DOI 10.1007/s40259-013-0014-9; Bruix J, 2013, EUR J CANCER, V49, P3412, DOI 10.1016/j.ejca.2013.05.028; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carr BI, 2013, J CELL PHYSIOL, V228, P1344, DOI 10.1002/jcp.24291; Cassinelli G, 2013, BIOCHEM PHARMACOL, V85, P1424, DOI 10.1016/j.bcp.2013.02.023; Chan ASY, 1998, AM J SURG PATHOL, V22, P816, DOI 10.1097/00000478-199807000-00004; Crose LES, 2012, CLIN CANCER RES, V18, P3780, DOI 10.1158/1078-0432.CCR-10-3063; D'Alessandro R, 2013, CANCER CHEMOTH PHARM, V72, P869, DOI 10.1007/s00280-013-2269-8; Daudigeos-Dubus E, 2014, IN VIVO, V28, P425; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Demoulin JB, 2014, CYTOKINE GROWTH F R, V25, P273, DOI 10.1016/j.cytogfr.2014.03.003; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Fakhari M, 2002, J PEDIATR SURG, V37, P582, DOI 10.1053/jpsu.2002.31614; Geoerger B, 2002, CANCER RES, V62, P764; George S, 2012, J CLIN ONCOL, V30, P2401, DOI 10.1200/JCO.2011.39.9394; Grill J, 2013, NEURO-ONCOLOGY, V15, P1236, DOI 10.1093/neuonc/not097; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Gururangan S, 2010, J CLIN ONCOL, V28, P3069, DOI 10.1200/JCO.2009.26.8789; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hinson ARP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00183; Jeong YK, 2013, TUMORI, V99, P176, DOI 10.1700/1283.14189; Keles GE, 1995, ONCOL RES, V7, P493; Komuro H, 2001, J CANCER RES CLIN, V127, P739; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Miyagami Mitsusuke, 2005, Medical Molecular Morphology, V38, P36, DOI 10.1007/s00795-004-0273-0; Mross K, 2012, CLIN CANCER RES, V18, P2658, DOI 10.1158/1078-0432.CCR-11-1900; Narayana A, 2010, NEURO-ONCOLOGY, V12, P985, DOI 10.1093/neuonc/noq033; Paugh BS, 2013, CANCER RES, V73, P6219, DOI 10.1158/0008-5472.CAN-13-1491; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; PETER M, 1995, BRIT J CANCER, V72, P96, DOI 10.1038/bjc.1995.283; Peter M, 2001, LAB INVEST, V81, P905, DOI 10.1038/labinvest.3780299; Phillips JJ, 2013, BRAIN PATHOL, V23, P565, DOI 10.1111/bpa.12043; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Rechsteiner M, 2015, ANN ONCOL, V26, P246, DOI 10.1093/annonc/mdu471; Rossler J, 2011, INT J CANCER, V128, P2748, DOI 10.1002/ijc.25611; Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679; Sajithlal GB, 2013, MOL PHARMACOL, V84, P562, DOI 10.1124/mol.113.088005; Sanceau J, 2002, ONCOGENE, V21, P7700, DOI 10.1038/sj.onc.1205881; Schiavetti A, 2012, PEDIATR BLOOD CANCER, V59, P627, DOI 10.1002/pbc.24072; Schmieder R, 2014, INT J CANCER, V135, P1487, DOI 10.1002/ijc.28669; Schultheis B, 2013, ANN ONCOL, V24, P1560, DOI 10.1093/annonc/mdt056; Serra M, 2001, MODERN PATHOL, V14, P710, DOI 10.1038/modpathol.3880377; Sherman JH, 2014, J CLIN NEUROSCI, V21, P131, DOI 10.1016/j.jocn.2013.04.010; Sie M, 2014, CRIT REV ONCOL HEMAT, V89, P418, DOI 10.1016/j.critrevonc.2013.09.005; Skorski T, 2002, NAT REV CANCER, V2, P351, DOI 10.1038/nrc799; Spaniol K, 2011, ANTI-CANCER DRUG, V22, P531, DOI 10.1097/CAD.0b013e3283454526; Taylor M, 2009, CLIN CANCER RES, V15, P4561, DOI 10.1158/1078-0432.CCR-08-2363; van Limpt V, 2004, ONCOGENE, V23, P9280, DOI 10.1038/sj.onc.1208157; Vassal G, 1996, INT J CANCER, V69, P146, DOI 10.1002/(SICI)1097-0215(19960422)69:2<146::AID-IJC14>3.0.CO;2-7; Virag J, 2014, PATHOL ONCOL RES, V20, P417, DOI 10.1007/s12253-013-9711-4; Waha A, 2003, J NEUROPATH EXP NEUR, V62, P1192, DOI 10.1093/jnen/62.11.1192; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Wohrle S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077652; Zopf D, 2010, AACR 101 ANN M ONL P; Zwerner JP, 2002, ONCOGENE, V21, P3847, DOI 10.1038/sj.onc.1205486	60	32	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142612	10.1371/journal.pone.0142612	http://dx.doi.org/10.1371/journal.pone.0142612			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599335	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900031
J	Lim, S; Nash, D; Hollod, L; Harris, TG; Lennon, MC; Thorpe, LE				Lim, Sungwoo; Nash, Denis; Hollod, Laura; Harris, Tiffany G.; Lennon, Mary Clare; Thorpe, Lorna E.			Influence of Jail Incarceration and Homelessness Patterns on Engagement in HIV Care and HIV Viral Suppression among New York City Adults Living with HIV/AIDS	PLOS ONE			English	Article							OUTCOMES	Objectives Both homelessness and incarceration are associated with housing instability, which in turn can disrupt continuity of HIV medical care. Yet, their impacts have not been systematically assessed among people living with HIV/AIDS (PLWHA). Methods We studied a retrospective cohort of 1,698 New York City PLWHA with both jail incarceration and homelessness during 2001-05 to evaluate whether frequent transitions between jail incarceration and homelessness were associated with a lower likelihood of continuity of HIV care during a subsequent one-year follow-up period. Using matched jail, single-adult homeless shelter, and HIV registry data, we performed sequence analysis to identify trajectories of these events and assessed their influence on engagement in HIV care and HIV viral suppression via marginal structural modeling. Results Sequence analysis identified four trajectories; 72% of the cohort had sporadic experiences of both brief incarceration and homelessness, whereas others experienced more consistent incarceration or homelessness during early or late months. Trajectories were not associated with differential engagement in HIV care during follow-up. However, compared with PLWHA experiencing early bouts of homelessness and later minimal incarceration/homelessness events, we observed a lower prevalence of viral suppression among PLWHA with two other trajectories: those with sporadic, brief occurrences of incarceration/homelessness (0.67, 95% CI = 0.50,0.90) and those with extensive incarceration experiences (0.62, 95% CI = 0.43,0.88). Conclusions Housing instability due to frequent jail incarceration and homelessness or extensive incarceration may exert negative influences on viral suppression. Policies and services that support housing stability should be strengthened among incarcerated and sheltered PLWHA to reduce risk of adverse health conditions.	[Lim, Sungwoo; Harris, Tiffany G.] New York City Dept Hlth & Mental Hyg, Bur Epidemiol Serv, Queens, NY 10013 USA; [Nash, Denis; Lennon, Mary Clare; Thorpe, Lorna E.] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Hollod, Laura] Johnson & Johnson, Monitoring & Evaluat, Corp Contribut, New Brunswick, NJ USA; [Harris, Tiffany G.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Lennon, Mary Clare] CUNY, Grad Ctr, PhD Program Sociol, New York, NY USA	New York City Department of Health & Mental Hygiene; City University of New York (CUNY) System; Johnson & Johnson; Johnson & Johnson USA; Columbia University; City University of New York (CUNY) System	Lim, S (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Epidemiol Serv, Queens, NY 10013 USA.	slim1@health.nyc.gov	Nash, Denis/AFI-7485-2022	Lim, Sungwoo/0000-0002-4890-0396; Harris, Tiffany/0000-0003-2212-0874; Nash, Denis/0000-0002-3280-5386	NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER; NIMH NIH HHS [P30 MH043520] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aidala AA, 2007, AIDS BEHAV, V11, pS101, DOI 10.1007/s10461-007-9276-x; Aidala AA, 2007, AIDS BEHAV, V11, pS1, DOI 10.1007/s10461-007-9302-z; Althoff AL, 2013, AIDS BEHAV, V17, P156, DOI 10.1007/s10461-012-0372-1; Berg KM, 2004, J GEN INTERN MED, V19, P1111, DOI 10.1111/j.1525-1497.2004.30445.x; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Johnson MO, 2003, AIDS PATIENT CARE ST, V17, P645, DOI 10.1089/108729103771928708; Jordan AO, 2013, AIDS BEHAV, V17, P212, DOI 10.1007/s10461-012-0352-5; Leaver CA, 2007, AIDS BEHAV, V11, pS85, DOI 10.1007/s10461-007-9246-3; Lim S, 2015, AM J EPIDEMIOL, V181, P261, DOI 10.1093/aje/kwu313; Lim S, 2012, AM J EPIDEMIOL, V175, P519, DOI 10.1093/aje/kwr327; Meyer JP, 2014, LANCET HIV, V1, pE77, DOI 10.1016/S2352-3018(14)70022-0; Meyer JP, 2014, JAMA INTERN MED, V174, P721, DOI 10.1001/jamainternmed.2014.601; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Rich JD, 2011, NEW ENGL J MED, V364, P2081, DOI 10.1056/NEJMp1102385; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; RUBIN DB, 1980, J AM STAT ASSOC, V75, P591, DOI 10.2307/2287653; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Springer SA, 2007, HIV CLIN TRIALS, V8, P205, DOI 10.1310/hct0804-205; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P42, DOI 10.1097/EDE.0b013e3181f74493; Wiewel EW, 2015, JAIDS-J ACQ IMM DEF, V68, P217, DOI 10.1097/QAI.0000000000000424	25	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141912	10.1371/journal.pone.0141912	http://dx.doi.org/10.1371/journal.pone.0141912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599877	Green Published, gold			2022-12-26	WOS:000365853900017
J	Porth, I; Klapste, J; McKown, AD; La Mantia, J; Guy, RD; Ingvarsson, PK; Hamelin, R; Mansfield, SD; Ehlting, J; Douglas, CJ; El-Kassaby, YA				Porth, Ilga; Klapste, Jaroslav; McKown, Athena D.; La Mantia, Jonathan; Guy, Robert D.; Ingvarsson, Par K.; Hamelin, Richard; Mansfield, Shawn D.; Ehlting, Juergen; Douglas, Carl J.; El-Kassaby, Yousry A.			Evolutionary Quantitative Genomics of Populus trichocarpa	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SPRUCE PICEA-SITCHENSIS; LOCAL ADAPTATION; TRAIT VARIATION; GENE FLOW; ARABIDOPSIS-THALIANA; POPULATION-STRUCTURE; NATURAL-POPULATIONS; BLACK COTTONWOOD; CLIMATE-CHANGE	Forest trees generally show high levels of local adaptation and efforts focusing on understanding adaptation to climate will be crucial for species survival and management. Here, we address fundamental questions regarding the molecular basis of adaptation in undomesticated forest tree populations to past climatic environments by employing an integrative quantitative genetics and landscape genomics approach. Using this comprehensive approach, we studied the molecular basis of climate adaptation in 433 Populus trichocarpa (black cottonwood) genotypes originating across western North America. Variation in 74 field-assessed traits (growth, ecophysiology, phenology, leaf stomata, wood, and disease resistance) was investigated for signatures of selection (comparing Q(ST)-F-ST) using clustering of individuals by climate of origin (temperature and precipitation). 29,354 SNPs were investigated employing three different outlier detection methods and marker-inferred relatedness was estimated to obtain the narrow-sense estimate of population differentiation in wild populations. In addition, we compared our results with previously assessed selection of candidate SNPs using the 25 topographical units (drainages) across the P. trichocarpa sampling range as population groupings. Narrow-sense QST for 53% of distinct field traits was significantly divergent from expectations of neutrality (indicating adaptive trait variation); 2,855 SNPs showed signals of diversifying selection and of these, 118 SNPs (within 81 genes) were associated with adaptive traits (based on significant QST). Many SNPs were putatively pleiotropic for functionally uncorrelated adaptive traits, such as autumn phenology, height, and disease resistance. Evolutionary quantitative genomics in P. trichocarpa provides an enhanced understanding regarding the molecular basis of climate-driven selection in forest trees and we highlight that important loci underlying adaptive trait variation also show relationship to climate of origin. We consider our approach the most comprehensive, as it uncovers the molecular mechanisms of adaptation using multiple methods and tests. We also provide a detailed outline of the required analyses for studying adaptation to the environment in a population genomics context to better understand the species' potential adaptive capacity to future climatic scenarios.	[Porth, Ilga; Klapste, Jaroslav; McKown, Athena D.; La Mantia, Jonathan; Guy, Robert D.; Hamelin, Richard; El-Kassaby, Yousry A.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada; [Porth, Ilga] Univ Laval, Fac Foresterie Geog & Geomat, Dept Sci Bois & Foret, Quebec City, PQ G1V 0A6, Canada; [Klapste, Jaroslav] Czech Univ Life Sci, Dept Genet & Physiol Forest Trees, Prague 16521, Czech Republic; [La Mantia, Jonathan] USDA, Corn Soybean & Wheat Qual Res Unit, Wooster, OH 44691 USA; [Ingvarsson, Par K.] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden; [Mansfield, Shawn D.] Univ British Columbia, Dept Wood Sci, Vancouver, BC V6T 1Z4, Canada; [Ehlting, Juergen] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada; [Ehlting, Juergen] Univ Victoria, Ctr Forest Biol, Victoria, BC V8W 3N5, Canada; [Douglas, Carl J.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; Laval University; Czech University of Life Sciences Prague; United States Department of Agriculture (USDA); Umea University; University of British Columbia; University of Victoria; University of Victoria; University of British Columbia	El-Kassaby, YA (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada.	y.el-kassaby@ubc.ca	Guy, Robert/GPX-8421-2022; Ingvarsson, Pär/G-2748-2010; El-Kassaby, Yousry A/K-9856-2016; Porth, Ilga M/N-4862-2015; Klapste, Jaroslav/B-6668-2016; Hamelin, Richard/F-7006-2010	El-Kassaby, Yousry A/0000-0002-4887-8977; Porth, Ilga M/0000-0002-9344-6348; Klapste, Jaroslav/0000-0001-5504-3735; McKown, Athena/0000-0002-7402-9952; Mansfield, Shawn/0000-0002-0175-554X; Hamelin, Richard/0000-0003-4006-532X; Ehlting, Jurgen/0000-0003-2302-696X; Ingvarsson, Par/0000-0001-9225-7521	Genome British Columbia Applied Genomics Innovation Program [103BIO]; Genome Canada Large-Scale Applied Research Project [168BIO]	Genome British Columbia Applied Genomics Innovation Program; Genome Canada Large-Scale Applied Research Project(Genome Canada)	This work was supported by Genome British Columbia Applied Genomics Innovation Program (Project 103BIO) and Genome Canada Large-Scale Applied Research Project (Project 168BIO), funds to RDG, RCH, JE, SDM, CJD, and YE-K.	Aitken S. N., 2013, ANNU REV ECOL EVOL S, V44, P367, DOI DOI 10.1146/annurev-ecolsys-110512-135747; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Anderson JT, 2011, TRENDS GENET, V27, P258, DOI 10.1016/j.tig.2011.04.001; [Anonymous], 2010, NAT GENET, V42, P551, DOI 10.1038/ng0710-551; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072126; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bivand R, 2014, SPDEP SPATIAL DEPEND; Black BL, 2002, TREE PHYSIOL, V22, P717, DOI 10.1093/treephys/22.10.717; Camanes G, 2012, PLANT PHYSIOL, V158, P1054, DOI 10.1104/pp.111.184424; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; CHANDRASHEKAR M, 1981, PHYTOPATHOLOGY, V71, P421, DOI 10.1094/Phyto-71-421; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Cronk QCB, 2005, NEW PHYTOL, V166, P39, DOI 10.1111/j.1469-8137.2005.01369.x; Di Giuseppe E, 2013, THEOR APPL CLIMATOL, V114, P39, DOI 10.1007/s00704-012-0801-0; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Eckenwalder J.E, 1996, SYSTEMATICS EVOLUTIO; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Endler J.A., 1977, Monographs in Population Biology, pi; Epperson B. K., 2003, GEOGRAPHICAL GENETIC; Evans LM, 2014, NAT GENET, V46, P1089, DOI 10.1038/ng.3075; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Fabbrini F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-47; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Fracheboud Y, 2009, PLANT PHYSIOL, V149, P1982, DOI 10.1104/pp.108.133249; Frentiu FD, 2008, P R SOC B, V275, P639, DOI 10.1098/rspb.2007.1032; Geraldes A, 2013, MOL ECOL RESOUR, V13, P306, DOI 10.1111/1755-0998.12056; Geraldes A, 2014, EVOLUTION, V68, P3260, DOI 10.1111/evo.12497; Geraldes A, 2011, MOL ECOL RESOUR, V11, P81, DOI 10.1111/j.1755-0998.2010.02960.x; Gilmour A. R., 2002, ASREML USER GUIDE RE; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hanninen H, 2011, TRENDS PLANT SCI, V16, P412, DOI 10.1016/j.tplants.2011.05.001; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hemani G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003295; Henderson C. R, 1984, APPL LINEAR MODELS A; Holliday JA, 2008, NEW PHYTOL, V178, P103, DOI 10.1111/j.1469-8137.2007.02346.x; Holliday JA, 2012, P ROY SOC B-BIOL SCI, V279, P1675, DOI 10.1098/rspb.2011.1805; HOWE GT, 1995, PHYSIOL PLANTARUM, V93, P695, DOI 10.1111/j.1399-3054.1995.tb05119.x; Jannink JL, 2007, GENETICS, V176, P553, DOI 10.1534/genetics.106.062992; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Kalcsits LA, 2009, TREES-STRUCT FUNCT, V23, P971, DOI 10.1007/s00468-009-0339-7; Keller SR, 2012, MOL BIOL EVOL, V29, P3143, DOI 10.1093/molbev/mss121; Kremer A, 2012, HEREDITY, V108, P375, DOI 10.1038/hdy.2011.81; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; La Mantia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078423; Larisch C, 2012, PLANT PHYSIOL, V160, P1515, DOI 10.1104/pp.112.202291; Le Corre V, 2012, MOL ECOL, V21, P1548, DOI 10.1111/j.1365-294X.2012.05479.x; Lefevre F, 2013, ANN FOREST SCI, P1; LEWONTIN RC, 1973, GENETICS, V74, P175; Lexer C, 2012, NEW PHYTOL, V196, P652, DOI 10.1111/j.1469-8137.2012.04362.x; Lind MI, 2011, EVOLUTION, V65, P684, DOI 10.1111/j.1558-5646.2010.01122.x; Lippert C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01815; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luquez V, 2008, TREE GENET GENOMES, V4, P279, DOI 10.1007/s11295-007-0108-y; Lynch M., 1998, GENETICS ANAL QUANTI; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; McKown AD, 2014, MOL ECOL, V23, P5771, DOI 10.1111/mec.12969; McKown AD, 2014, NEW PHYTOL, V203, P535, DOI 10.1111/nph.12815; McKown AD, 2014, NEW PHYTOL, V201, P1263, DOI 10.1111/nph.12601; McKown AD, 2013, OECOLOGIA, V172, P653, DOI 10.1007/s00442-012-2531-5; Mimura M, 2007, HEREDITY, V99, P224, DOI 10.1038/sj.hdy.6800987; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Petterle A, 2013, CURR OPIN PLANT BIOL, V16, P301, DOI 10.1016/j.pbi.2013.02.006; Porth I., 2014, Diversity, V6, P283, DOI 10.3390/d6020283; Porth I, 2015, BIOTECHNOL J, V10, P510, DOI 10.1002/biot.201400194; Porth I, 2013, NEW PHYTOL, V200, P710, DOI 10.1111/nph.12422; Porth I, 2013, NEW PHYTOL, V197, P777, DOI 10.1111/nph.12014; Prunier J, 2011, MOL ECOL, V20, P1702, DOI 10.1111/j.1365-294X.2011.05045.x; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Ritland K, 1996, EVOLUTION, V50, P1074, DOI 10.1111/j.1558-5646.1996.tb02348.x; Rohde A, 2011, TREE PHYSIOL, V31, P472, DOI 10.1093/treephys/tpr038; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Saether SA, 2007, J EVOLUTION BIOL, V20, P1563, DOI 10.1111/j.1420-9101.2007.01328.x; Sannigrahi P, 2010, BIOFUEL BIOPROD BIOR, V4, P209, DOI 10.1002/bbb.206; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; SCHNEE FB, 1984, EVOLUTION, V38, P42, DOI 10.1111/j.1558-5646.1984.tb00258.x; Schnute Jon T., 2004, Canadian Technical Report of Fisheries and Aquatic Sciences, V2549, P1; Slavov GT, 2010, HEREDITY, V105, P348, DOI 10.1038/hdy.2010.73; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Slavov GT, 2010, PLANT GENET GENOMICS, V8, P15, DOI 10.1007/978-1-4419-1541-2_2; Soolanayakanahally RY, 2013, PLANT CELL ENVIRON, V36, P116, DOI 10.1111/j.1365-3040.2012.02560.x; Sork VL, 2013, TREE GENET GENOMES, P1; Stanton BJ, 2010, PLANT GENET GENOMICS, V8, P309, DOI 10.1007/978-1-4419-1541-2_14; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Tsumura Y, 2012, HEREDITY, V109, P349, DOI 10.1038/hdy.2012.50; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Wang YY, 2011, PLANT CELL, V23, P1945, DOI 10.1105/tpc.111.083618; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Whitlock MC, 2009, GENETICS, V183, P1055, DOI 10.1534/genetics.108.099812; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Xie CY, 2009, CAN J FOREST RES, V39, P519, DOI 10.1139/X08-190; Yang WY, 2012, NAT GENET, V44, P725, DOI 10.1038/ng.2285; Yeaman S, 2013, P NATL ACAD SCI USA, V110, pE1743, DOI 10.1073/pnas.1219381110	99	17	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142864	10.1371/journal.pone.0142864	http://dx.doi.org/10.1371/journal.pone.0142864			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599762	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900043
J	Wen, JH; Ye, F; Li, SJ; Huang, XJ; Yang, L; Xiao, XS; Xie, XM				Wen, Jiahuai; Ye, Feng; Li, Shuaijie; Huang, Xiaojia; Yang, Lu; Xiao, Xiangsheng; Xie, Xiaoming			The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I-III Breast Cancer Patients Undergoing Surgical Treatment	PLOS ONE			English	Article							AXILLARY NODES; CHOLESTEROL; EXPRESSION; SURVIVAL; LUNG; INFLAMMATION; FIBRINOGEN; INHIBITORS; OBESITY; WOMEN	Background Previous studies have indicated the prognostic value of various laboratory parameters in cancer patients. This study was to establish a prognostic index (PI) model for breast cancer patients based on the potential prognostic factors. Methods A retrospective study of 1661 breast cancer patients who underwent surgical treatment between January 2002 and December 2008 at Sun Yat-sen University Cancer Center was conducted. Multivariate analysis (Cox regression model) was performed to determine the independent prognostic factors and a prognostic index (PI) model was devised based on these factors. Survival analyses were used to estimate the prognostic value of PI, and the discriminatory ability of PI was compared with Nottingham Prognostic Index (NPI) by evaluating the area under the receiver operating characteristics curves (AUC). Results The mean survival time of all participants was 123.6 months. The preoperative globulin >30.0g/L, triglyceride >1.10mmol/L and fibrinogen >2.83g/L were identified as risk factors for shorter cancer-specific survival. The novel prognostic index model was established and enrolled patients were classified as low- (1168 patients, 70.3%), moderate- (410 patients, 24.7%) and high-risk groups (83 patients, 5.0%), respectively. Compared with the low-risk group, higher risks of poor clinical outcome were indicated in the moderate-risk group [Hazard ratio (HR): 1.513, 95% confidence interval (CI): 1.169-1.959, p = 0.002] and high-risk group (HR: 2.481, 95% CI: 1.653-3.724, p< 0.001). Conclusions The prognostic index based on three laboratory parameters was a novel and practicable prognostic tool. It may serve as complement to help predict postoperative survival in breast cancer patients.	[Wen, Jiahuai; Ye, Feng; Li, Shuaijie; Huang, Xiaojia; Yang, Lu; Xiao, Xiangsheng; Xie, Xiaoming] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Breast Oncol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Xie, XM (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Breast Oncol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	xiexm@sysucc.org.cn	xiao, xiang/GWU-6035-2022		National Natural Science Foundation of China [81472575, 81272514, 81372133]; Key Programme of the National Natural Science Foundation of China [31030061]; Science and Technology Planning Project of Guangdong and Guangzhou [2013B060300009, 2014J4100169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Programme of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong and Guangzhou	This work was supported by funds from the National Natural Science Foundation of China (81472575, 81272514, 81372133), the Key Programme of the National Natural Science Foundation of China (31030061), and the Science and Technology Planning Project of Guangdong and Guangzhou (2013B060300009, 2014J4100169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1982, SCAND J IMMUNOL, V15, P109, DOI 10.1111/j.1365-3083.1982.tb00628.x; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Alli PM, 2005, ONCOGENE, V24, P39, DOI 10.1038/sj.onc.1208174; Amaral BB, 2007, SEMIN ROENTGENOL, V42, P253, DOI 10.1053/j.ro.2007.07.002; Azab B, 2013, INT J COLORECTAL DIS, V28, P1629, DOI 10.1007/s00384-013-1748-z; Bala Dinavahi V, 2001, Asian Pac J Cancer Prev, V2, P123; Berra E, 2000, BIOCHEM PHARMACOL, V60, P1171, DOI 10.1016/S0006-2952(00)00423-8; Berthold D, 2010, ANN ONCOL, V21, DOI 10.1093/annonc/mdp556; Bureau F, 2002, BLOOD, V99, P3683, DOI 10.1182/blood.V99.10.3683; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carlson RW, 2012, J NATL COMPR CANC NE, V10, P821, DOI 10.6004/jnccn.2012.0086; COHEN MH, 1981, CANCER TREAT REP, V65, P187; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di Leo A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt337; DVORAK HF, 1992, ANN NY ACAD SCI, V667, P101, DOI 10.1111/j.1749-6632.1992.tb51603.x; Fedele P, 2015, CRIT REV ONCOL HEMAT; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gong Y, 2014, EUR REV MED PHARMACO, V18, P2808; Guo QQ, 2009, PANCREAS, V38, pE75, DOI 10.1097/MPA.0b013e3181987d86; HIGASHIYAMA M, 1992, BRIT J CANCER, V65, P300, DOI 10.1038/bjc.1992.60; Jung HA, 2015, TUMOR BIOL, V36, P1073, DOI 10.1007/s13277-014-2730-2; Kang M, 2015, PLOS ONE, V10; Kapil U, 2013, J BREAST CANCER, V16, P129, DOI 10.4048/jbc.2013.16.1.129; Kataoka H, 1999, AM J PATHOL, V154, P457, DOI 10.1016/S0002-9440(10)65292-3; Kollias J, 1999, EUR J CANCER, V35, P908, DOI 10.1016/S0959-8049(99)00056-8; Lee AHS, 2008, PATHOL ONCOL RES, V14, P113, DOI 10.1007/s12253-008-9067-3; Liu XA, 2015, CARCINOGENESIS, V36, P243, DOI 10.1093/carcin/bgu247; Nieswandt B, 1999, CANCER RES, V59, P1295; Orucevic A, 2015, BREAST J, V21, P147, DOI 10.1111/tbj.12367; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; PIERCE JH, 1991, ONCOGENE, V6, P1189; Polterauer S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.008; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Ray G, 2001, CLIN BIOCHEM, V34, P71, DOI 10.1016/S0009-9120(00)00200-9; Schoppmann SF, 2006, BREAST CANCER RES TR, V99, P135, DOI 10.1007/s10549-006-9190-3; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sok M, 2009, WIEN KLIN WOCHENSCHR, V121, P314, DOI 10.1007/s00508-009-1169-8; TARTTER PI, 1981, CANCER, V47, P2222, DOI 10.1002/1097-0142(19810501)47:9<2222::AID-CNCR2820470919>3.0.CO;2-5; Ulmer H, 2009, BRIT J CANCER, V101, P1202, DOI 10.1038/sj.bjc.6605264; Vinh-Hung V, 2003, INT J ONCOL, V22, P697; Yamashita H, 2009, WORLD J SURG, V33, P1298, DOI 10.1007/s00268-009-9992-7	46	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143537	10.1371/journal.pone.0143537	http://dx.doi.org/10.1371/journal.pone.0143537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600129	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900140
J	Yasuda, K; Takahashi, M; Mori, N				Yasuda, Kunihiko; Takahashi, Mayumi; Mori, Nozomu			Mdm20 Modulates Actin Remodeling through the mTORC2 Pathway via Its Effect on Rictor Expression	PLOS ONE			English	Article							N-TERMINAL ACETYLTRANSFERASES; TRANSCRIPTION FACTOR FKHR; COFILIN PHOSPHORYLATION; KINASE 1; PROTEIN; YEAST; COMPLEX; GROWTH; IDENTIFICATION; ACETYLATION	NatB is an N-terminal acetyltransferase consisting of a catalytic Nat5 subunit and an auxiliary Mdm20 subunit. In yeast, NatB acetylates N-terminal methionines of proteins during de novo protein synthesis and also regulates actin remodeling through N-terminal acetylation of tropomyosin (Trpm), which stabilizes the actin cytoskeleton by interacting with actin. However, in mammalian cells, the biological functions of the Mdm20 and Nat5 subunits are not well understood. In the present study, we show for the first time that Mdm20-knockdown (KD), but not Nat5-KD, in HEK293 and HeLa cells suppresses not only cell growth, but also cellular motility. Although stress fibers were formed in Mdm20-KD cells, and not in control or Nat5-KD cells, the localization of Trpm did not coincide with the formation of stress fibers in Mdm20-KD cells. Notably, knockdown of Mdm20 reduced the expression of Rictor, an mTORC2 complex component, through post-translational regulation. Additionally, PKC alpha(S657) phosphorylation, which regulates the organization of the actin cytoskeleton, was also reduced in Mdm20-KD cells. Our data also suggest that FoxO1 phosphorylation is regulated by the Mdm20-mTORC2-Akt pathway in response to serum starvation and insulin stimulation. Taken together, the present findings suggest that Mdm20 acts as a novel regulator of Rictor, thereby controlling mTORC2 activity, and leading to the activation of PKC alpha(S657) and FoxO1.	[Yasuda, Kunihiko; Takahashi, Mayumi; Mori, Nozomu] Nagasaki Univ, Sch Med, Dept Anat & Neurobiol, Nagasaki 852, Japan	Nagasaki University	Yasuda, K (corresponding author), Tokai Gakuin Univ, Fac Hlth & Welf, Dept Registered Dietitians, Gifu, Japan.	kyasuda@tokaigakuin-u.ac.jp; morinosm@nagasaki-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, KY, https://kaken.nii.ac.jp/d/p/26430072.en.html. The work was also supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, NM, https://kaken.nii.ac.jp/d/p/22300121.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Caesar R, 2004, J BIOL CHEM, V279, P38532, DOI 10.1074/jbc.M402939200; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; HERMANN GJ, 1997, J CELL BIOL, V137, P141, DOI 10.1083/jcb.137.1.141; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Hung CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008771; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kim JH, 2011, GENE DEV, V25, P730, DOI 10.1101/gad.2028611; Lee JW, 2011, J BIOL CHEM, V286, P6423, DOI 10.1074/jbc.M110.180661; LIU HP, 1992, J CELL BIOL, V118, P285, DOI 10.1083/jcb.118.2.285; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ohyama K, 2012, GENE EXPR PATTERNS, V12, P36, DOI 10.1016/j.gep.2011.11.001; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Taylor R.C., 2011, COLD SPRING HARB PER, V3; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Van Damme P, 2012, P NATL ACAD SCI USA, V109, P12449, DOI 10.1073/pnas.1210303109; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yasuda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082523; Yu Jae-Ran, 1998, Korean Journal of Parasitology, V36, P227, DOI 10.3347/kjp.1998.36.4.227; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142943	10.1371/journal.pone.0142943	http://dx.doi.org/10.1371/journal.pone.0142943			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600389	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900047
J	Debruyne, DN; Bhatnagar, N; Sharma, B; Luther, W; Moore, NF; Cheung, K; Gray, NS; George, RE				Debruyne, D. N.; Bhatnagar, N.; Sharma, B.; Luther, W.; Moore, N. F.; Cheung, K.; Gray, N. S.; George, R. E.			ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT	ONCOGENE			English	Article							GENE-EXPRESSION SIGNATURE; CANCER-CELLS; THERAPEUTIC TARGET; KINASE INHIBITOR; LUNG-CANCER; RECEPTOR; MUTATIONS; GROWTH; EGFR; MYCN	The crizotinib-resistant ALK(F1174L) mutation arises de novo in neuroblastoma (NB) and is acquired in ALK translocation-driven cancers, lending impetus to the development of novel anaplastic lymphoma kinase (ALK) inhibitors with different modes of action. The diaminopyrimidine TAE684 and its derivative ceritinib (LDK378), which are structurally distinct from crizotinib, are active against NB cells expressing ALK(F1174L). Here we demonstrate acquired resistance to TAE684 and LDK378 in ALK(F1174L)-driven human NB cells that is linked to overexpression and activation of the AXL tyrosine kinase and epithelial-to-mesenchymal transition (EMT). AXL phosphorylation conferred TAE684 resistance to NB cells through upregulated extracellular signal-regulated kinase (ERK) signaling. Inhibition of AXL partly rescued TAE684 resistance, resensitizing these cells to this compound. AXL activation in resistant cells was mediated through increased expression of the active form of its ligand, GAS6, that also served to stabilize the AXL protein. Although ectopic expression of AXL and TWIST2 individually in TAE684-sensitive parental cells led to the elevated expression of mesenchymal markers and invasive capacity, only AXL overexpression induced resistance to TAE684 as well. TAE684-resistant cells showed greater sensitivity to HSP90 inhibition than did their parental counterparts, with downregulation of AXL and AXL-mediated ERK signaling. Our studies indicate that aberrant AXL signaling and development of an EMT phenotype underlie resistance of ALK(F1174L)-driven NB cells to TAE684 and its derivatives. We suggest that the combination of ALK and AXL or HSP90 inhibitors be considered to delay the emergence of such resistance.	[Debruyne, D. N.; Bhatnagar, N.; Sharma, B.; Luther, W.; Moore, N. F.; George, R. E.] Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; [Debruyne, D. N.; Bhatnagar, N.; Sharma, B.; Luther, W.; Moore, N. F.; George, R. E.] Boston Childrens Hosp, Boston, MA USA; [Cheung, K.] Mem Sloan Kettering Canc Ctr, Dept Pediat Oncol, 1275 York Ave, New York, NY 10021 USA; [Gray, N. S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gray, N. S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [George, R. E.] Harvard Med Sch, Dept Pediat, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	George, RE (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Dana 640E,450 Brookline Ave, Boston, MA 02215 USA.	rani_george@dfci.harvard.edu	George, Rani/AAG-7635-2019		NIH/NCI [R01 CA148688]; Friends for Life Neuroblastoma Fellowship; Ruth L Kirschstein NRSA [F32CA183566]; NATIONAL CANCER INSTITUTE [R01CA148688, P30CA008748] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Friends for Life Neuroblastoma Fellowship; Ruth L Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH/NCI R01 CA148688 (to REG), Friends for Life Neuroblastoma Fellowship (to DND) and a Ruth L Kirschstein NRSA F32CA183566 (to NFM).	Anastassiou D, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-529; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chen JY, 2013, J MED CHEM, V56, P5673, DOI 10.1021/jm401005u; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Duijkers FAM, 2013, GENE, V521, P62, DOI 10.1016/j.gene.2013.03.029; Eleveld TF, 2015, NAT GENET, V47, P864, DOI 10.1038/ng.3333; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Gainor JF, 2013, J CLIN ONCOL, V31, P3987, DOI 10.1200/JCO.2012.45.2029; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Giles KM, 2013, MOL CANCER THER, V12, P2541, DOI 10.1158/1535-7163.MCT-13-0170; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Goruppi S, 1997, FEBS LETT, V415, P59, DOI 10.1016/S0014-5793(97)01093-4; GRECO WR, 1995, PHARMACOL REV, V47, P331; Heuckmann JM, 2011, CLIN CANCER RES, V17, P7394, DOI 10.1158/1078-0432.CCR-11-1648; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hong J, 2013, CANCER RES, V73, P331, DOI 10.1158/0008-5472.CAN-12-3151; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kim HR, 2013, MOL ONCOL, V7, P1093, DOI 10.1016/j.molonc.2013.08.001; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Korshunov VA, 2012, CLIN SCI, V122, P361, DOI 10.1042/CS20110411; Krishnamoorthy GP, 2013, J BIOL CHEM, V288, P17481, DOI 10.1074/jbc.M112.439422; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Mark MR, 1996, J BIOL CHEM, V271, P9785, DOI 10.1074/jbc.271.16.9785; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Mudduluru G, 2008, BIOSCIENCE REP, V28, P161, DOI 10.1042/BSR20080046; Normant E, 2011, ONCOGENE, V30, P2581, DOI 10.1038/onc.2010.625; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wilson C, 2014, CANCER RES, V74, P5878, DOI 10.1158/0008-5472.CAN-14-1009; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	47	69	73	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 14	2016	35	28					3681	3691		10.1038/onc.2015.434	http://dx.doi.org/10.1038/onc.2015.434			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UQ	26616860	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000379622800007
J	Baiady, N; Padala, P; Mashahreh, B; Cohen-Kfir, E; Todd, EA; Du Pont, KE; Berndsen, CE; Wiener, R				Baiady, Nardeen; Padala, Prasanth; Mashahreh, Bayan; Cohen-Kfir, Einav; Todd, Emily A.; Du Pont, Kelly E.; Berndsen, Christopher E.; Wiener, Reuven			The Vps27/Hrs/STAM (VHS) Domain of the Signal-transducing Adaptor Molecule (STAM) Directs Associated Molecule with the SH3 Domain of STAM (AMSH) Specificity to Longer Ubiquitin Chains and Dictates the Position of Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYMES; RECEPTOR DEGRADATION; POLYUBIQUITIN CHAINS; CONJUGATING ENZYMES; STRUCTURAL BASIS; BINDING; PROTEIN; ISOPEPTIDASE; TRAFFICKING; DIUBIQUITIN	The deubiquitinating enzyme associated molecule with the SH3 domain of STAM (AMSH) is crucial for the removal of ubiquitin molecules during receptor-mediated endocytosis and lysosomal receptor sorting. AMSH interacts with signal transducing adapter molecule (STAM) 1 or 2, which enhances the activity of AMSH through an unknown mechanism. This stimulation is dependent on the ubiquitin-interacting motif of STAM. Here we investigate the specific mechanism of AMSH stimulation by STAM proteins and the role of the STAMV ps27/Hrs/STAM domain. We show that, in the presence of STAM, the length of the ubiquitin chains affects the apparent cleavage rate. Through measurement of the chain cleavage kinetics, we found that, although the k(cat) of Lys(63)-linked ubiquitin chain cleavage was comparable for di-and tri-ubiquitin, the K-m value was lower for tri-ubiquitin. This increased affinity for longer chains was dependent on the Vps27/Hrs/STAM domain of STAM and required that the substrate ubiquitin chain contain homogenous Lys(63)-linkages. In addition, STAM directed AMSH cleavage toward the distal isopeptide bond in tri-ubiquitin chains. Finally, we generated a structural model of AMSH-STAM to show how the complex binds Lys(63)-linked ubiquitin chains and cleaves at the distal end. These data show how a deubiquitinating enzyme-interacting protein dictates the efficiency and specificity of substrate cleavage.	[Baiady, Nardeen; Padala, Prasanth; Mashahreh, Bayan; Cohen-Kfir, Einav; Wiener, Reuven] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel; [Todd, Emily A.; Du Pont, Kelly E.; Berndsen, Christopher E.] James Madison Univ, Dept Chem & Biochem, Harrisonburg, VA 22807 USA	Hebrew University of Jerusalem; James Madison University	Wiener, R (corresponding author), Hebrew Univ Campus Ein Karem, Dept Biochem & Mol Biol, Sch Med, Botnar Bldg,Rm 119 1st Floor, IL-91120 Jerusalem, Israel.	reuvenw@ekmd.huji.ac.il		Zuccaro, Kelly E/0000-0001-8904-5106; Berndsen, Christopher/0000-0002-4285-4341	United States-Israel Binational Science Foundation [2013261]; National Science Foundation Research Experience for Undergraduates Grant [CHE-1461175]; Marie Curie Career Integration Grant [PCIG13-GA-2013-630755]; Direct For Mathematical & Physical Scien [1461175] Funding Source: National Science Foundation	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Science Foundation Research Experience for Undergraduates Grant; Marie Curie Career Integration Grant; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by United States-Israel Binational Science Foundation Grant 2013261, National Science Foundation Research Experience for Undergraduates Grant CHE-1461175, and Marie Curie Career Integration Grant PCIG13-GA-2013-630755. The authors declare that they have no conflicts of interest with the contents of this article.	Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Bekes M, 2013, CELL REP, V5, P826, DOI 10.1016/j.celrep.2013.10.008; Berndsen CE, 2013, NAT CHEM BIOL, V9, P154, DOI [10.1038/NCHEMBIO.1159, 10.1038/nchembio.1159]; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; Davies CW, 2013, BIOCHEMISTRY-US, V52, P7818, DOI 10.1021/bi401106b; Davies CW, 2011, J MOL BIOL, V413, P416, DOI 10.1016/j.jmb.2011.08.029; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Frey P. A., 2007, ENZYMATIC REACTION M, P314; Huang FT, 2013, P NATL ACAD SCI USA, V110, P15722, DOI 10.1073/pnas.1308014110; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kaneko T, 2003, J BIOL CHEM, V278, P48162, DOI 10.1074/jbc.M306677200; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Kim MS, 2006, BIOCHEM BIOPH RES CO, V351, P612, DOI 10.1016/j.bbrc.2006.10.068; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lange A, 2012, J BIOL CHEM, V287, P18687, DOI 10.1074/jbc.M111.324954; Lawrence Ann-Marie, 2009, J Vis Exp, DOI 10.3791/1350; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sierra MI, 2010, J BIOL CHEM, V285, P13990, DOI 10.1074/jbc.M109.061309; Steen H, 2002, J BIOL CHEM, V277, P1031, DOI 10.1074/jbc.M109992200; Trempe JF, 2010, ACTA CRYSTALLOGR F, V66, P994, DOI 10.1107/S1744309110027600; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200	48	7	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					2033	2042		10.1074/jbc.M115.689869	http://dx.doi.org/10.1074/jbc.M115.689869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601948	Green Published, hybrid			2022-12-26	WOS:000368620700038
J	Mistry, RK; Murray, TVA; Prysyazhna, O; Martin, D; Burgoyne, JR; Santos, C; Eaton, P; Shah, AM; Brewer, AC				Mistry, Rajesh K.; Murray, Thomas V. A.; Prysyazhna, Oleksandra; Martin, Daniel; Burgoyne, Joseph R.; Santos, Celio; Eaton, Philip; Shah, Ajay M.; Brewer, Alison C.			Transcriptional Regulation of Cystathionine-gamma-Lyase in Endothelial Cells by NADPH Oxidase 4-Dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE; NITRIC-OXIDE; OXIDATIVE STRESS; SUBUNIT NOX4; REDOX; TRANSLATION; KINASE; GENE; EXPRESSION; SYNTHASE	The gasotransmitter, hydrogen sulfide (H2S) is recognized as an important mediator of endothelial cell homeostasis and function that impacts upon vascular tone and blood pressure. Cystathionine-gamma-lyase (CSE) is the predominant endothelial generator of H2S, and recent evidence suggests that its transcriptional expression is regulated by the reactive oxygen species, H2O2. However, the cellular source of H2O2 and the redox-dependent molecular signaling pathway that modulates this is not known. We aimed to investigate the role of Nox4, an endothelial generator of H2O2, in the regulation of CSE in endothelial cells. Both gain- and loss-of-function experiments in human endothelial cells in vitro demonstrated Nox4 to be a positive regulator of CSE transcription and protein expression. We demonstrate that this is dependent upon a heme-regulated inhibitor kinase/eIF2 alpha/activating transcription factor 4 (ATF4) signaling module. ATF4 was further demonstrated to bind directly to cis-regulatory sequences within the first intron of CSE to activate transcription. Furthermore, CSE expression was also increased in cardiac microvascular endothelial cells, isolated from endothelial-specific Nox4 transgenic mice, compared with wild-type littermate controls. Using wire myography we demonstrate that endothelial-specific Nox4 transgenic mice exhibit a hypo-contractile phenotype in response to phenylephrine that was abolished when vessels were incubated with a CSE inhibitor, propargylglycine. We, therefore, conclude that Nox4 is a positive transcriptional regulator of CSE in endothelial cells and propose that it may in turn contribute to the regulation of vascular tone via the modulation of H2S production.	[Mistry, Rajesh K.; Murray, Thomas V. A.; Martin, Daniel; Santos, Celio; Shah, Ajay M.; Brewer, Alison C.] Kings Coll London British Heart Fdn Ctr, Cardiovasc Div, 125 Coldharbour Lane, London SES 9NU, England; [Prysyazhna, Oleksandra; Burgoyne, Joseph R.; Eaton, Philip] St Thomas Hosp, Rayne Inst, Kings Coll London British Heart Fdn Ctr, Cardiovasc Div, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Brewer, AC (corresponding author), Kings Coll London British Heart Fdn Ctr Res Excel, James Black Ctr, Cardiovasc Div, London SE5 9NU, England.	alison.brewer@kcl.ac.uk	; Eaton, Philip/I-5444-2015	Murray, Thomas/0000-0003-3019-2739; Eaton, Philip/0000-0003-0748-2367; Brewer, Alison/0000-0002-1021-9888; Shah, Ajay/0000-0002-6547-0631; Prysyazhna, Oleksandra/0000-0002-0394-7000; Burgoyne, Joseph/0000-0001-7325-7382	British Heart Foundation (BHF) [FS/11/80/29330, RG/13/11/30384]; BHF Centre of Excellence Award [RE/13/2/30182]; MRC [MR/L009684/1, G0600785, G0700320, G1000458, MR/K003232/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C503646/1] Funding Source: researchfish; British Heart Foundation [PG/11/124/29318, RG/12/12/29872, PG/10/98/28655, PG/13/13/30018, PG/15/26/31373, FS/14/1/30551, FS/11/45/28859, RG/13/11/30384] Funding Source: researchfish; Medical Research Council [MR/L009684/1, MR/K003232/1, G1000458, G0600785, G0700320, 998501] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); BHF Centre of Excellence Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a 4-year British Heart Foundation (BHF) Master of Research/Ph.D. studentship (FS/11/80/29330), a BHF program grant RG/13/11/30384, and a BHF Centre of Excellence Award-RE/13/2/30182. The authors declare that they have no conflicts of interest with the contents of this article.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Brandes RP, 2014, J MOL CELL CARDIOL, V73, P70, DOI 10.1016/j.yjmcc.2014.02.006; Brewer AC, 2011, FREE RADICAL BIO MED, V51, P205, DOI 10.1016/j.freeradbiomed.2011.04.022; BROWN SB, 1978, BIOCHEM J, V174, P901, DOI 10.1042/bj1740901; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; CHEN PF, 1994, J BIOL CHEM, V269, P25062; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775; Datla SR, 2007, ARTERIOSCL THROM VAS, V27, P2319, DOI 10.1161/ATVBAHA.107.149450; Dickhout JG, 2012, J BIOL CHEM, V287, P7603, DOI 10.1074/jbc.M111.304576; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; ENVER T, 1988, MOL CELL BIOL, V8, P1301, DOI 10.1128/MCB.8.3.1301; Flora SJS, 2008, INDIAN J MED RES, V128, P501; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hassan MI, 2012, BRIT J PHARMACOL, V166, P2231, DOI 10.1111/j.1476-5381.2012.01949.x; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hughes MN, 2009, FREE RADICAL BIO MED, V47, P1346, DOI 10.1016/j.freeradbiomed.2009.09.018; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Kolluru GK, 2013, REDOX BIOL, V1, P313, DOI 10.1016/j.redox.2013.05.001; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lassot I, 2005, J BIOL CHEM, V280, P41537, DOI 10.1074/jbc.M505294200; Leffler CW, 2006, J APPL PHYSIOL, V100, P1065, DOI 10.1152/japplphysiol.00793.2005; Lin VS, 2013, P NATL ACAD SCI USA, V110, P7131, DOI 10.1073/pnas.1302193110; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Murray TVA, 2013, J BIOL CHEM, V288, P15745, DOI 10.1074/jbc.M112.439844; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Pare G, 2009, CIRC-CARDIOVASC GENE, V2, P142, DOI 10.1161/CIRCGENETICS.108.829804; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Ray R, 2011, ARTERIOSCL THROM VAS, V31, P1368, DOI 10.1161/ATVBAHA.110.219238; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Sciarretta S, 2014, AUTOPHAGY, V10, P699, DOI 10.4161/auto.27955; Sciarretta S, 2013, CIRC RES, V113, P1253, DOI 10.1161/CIRCRESAHA.113.301787; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shimokawa H, 2010, PFLUG ARCH EUR J PHY, V459, P915, DOI 10.1007/s00424-010-0790-8; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang MX, 2012, GENE EXPRESSION, V15, P235, DOI 10.3727/105221613X13571653093286; Wind S, 2010, HYPERTENSION, V56, P490, DOI 10.1161/HYPERTENSIONAHA.109.149187; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107	54	39	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1774	1788		10.1074/jbc.M115.685578	http://dx.doi.org/10.1074/jbc.M115.685578			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26620565	Green Published, hybrid			2022-12-26	WOS:000368620700019
J	Marubashi, S; Shimada, H; Fukuda, M; Ohbayashi, N				Marubashi, Soujiro; Shimada, Hikaru; Fukuda, Mitsunori; Ohbayashi, Norihiko			RUTBC1 Functions as a GTPase-activating Protein for Rab32/38 and Regulates Melanogenic Enzyme Trafficking in Melanocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOME-RELATED ORGANELLES; HERMANSKY-PUDLAK-SYNDROME; RAB GTPASES; MELANOSOME TRANSPORT; BINDING-SPECIFICITY; COMPLEX-3 BLOC-3; DOMAIN; GOLGI; SLAC2-A/MELANOPHILIN; IDENTIFICATION	Two cell type-specific Rab proteins, Rab32 and Rab38 (Rab32/38), have been proposed as regulating the trafficking of melanogenic enzymes, including tyrosinase and tyrosinase-related protein 1 (Tyrp1), to melanosomes in melanocytes. Like other GTPases, Rab32/38 function as switch molecules that cycle between a GDP-bound inactive form and a GTP-bound active form; the cycle is thought to be regulated by an activating enzyme, guanine nucleotide exchange factor (GEF), and an inactivating enzyme, GTPase-activating protein (GAP), which stimulates the GTPase activity of Rab32/38. Although BLOC-3 has already been identified as a Rab32/38-specific GEF that regulates the trafficking of tyrosinase and Tyrp1, no physiological GAP for Rab32/38 in melanocytes has ever been identified, and it has remained unclear whether Rab32/38 is involved in the trafficking of dopachrome tautomerase, another melanogenic enzyme, in mouse melanocytes. In this study we investigated RUTBC1, which was originally characterized as a Rab9-binding protein and GAP for Rab32 and Rab33B in vitro, and the results demonstrated that RUTBC1 functions as a physiological GAP for Rab32/38 in the trafficking of all three melanogenic enzymes in mouse melanocytes. The results of this study also demonstrated the involvement of Rab9A in the regulation of the RUTBC1 localization and in the trafficking of all three melanogenic enzymes. We discovered that either excess activation or inactivation of Rab32/38 achieved by manipulating RUTBC1 inhibits the trafficking of all three melanogenic enzymes. These results collectively indicate that proper spatiotemporal regulation of Rab32/38 is essential for the trafficking of all three melanogenic enzymes in mouse melanocytes.	[Marubashi, Soujiro; Shimada, Hikaru; Fukuda, Mitsunori; Ohbayashi, Norihiko] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ohbayashi, Norihiko] Univ Tsukuba, Fac Med, Dept Physiol Chem, Tsukuba, Ibaraki 3058575, Japan; [Ohbayashi, Norihiko] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan	Tohoku University; University of Tsukuba; University of Tsukuba	Fukuda, M (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp; nohbayashi@md.tsukuba.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853; marubashi, soujiro/0000-0003-4729-5339	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan [15K07039, 15H04367, 15H01198]; Toray Science Foundation; Kao Melanin Workshop; Grants-in-Aid for Scientific Research [15K07039] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.); Kao Melanin Workshop; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 15K07039 (to N.O.) and 15H04367 and 15H01198 (to M.F.) from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan, a grant from the Toray Science Foundation (to M.F.), and a grant from the Kao Melanin Workshop (to N.O.). The authors declare that they have no conflicts of interest with the contents of this article.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Beaumont KA, 2011, TRAFFIC, V12, P627, DOI 10.1111/j.1600-0854.2011.01172.x; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dennis MK, 2015, J CELL BIOL, V209, P563, DOI 10.1083/jcb.201410026; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Ho HA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200543; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ishida M, 2014, J BIOL CHEM, V289, P11059, DOI 10.1074/jbc.M114.552281; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Kloer DP, 2010, J BIOL CHEM, V285, P7794, DOI 10.1074/jbc.M109.069088; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Mahanty S, 2016, PIGM CELL MELANOMA R, V29, P43, DOI 10.1111/pcmr.12434; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; Nazarian R, 2003, P NATL ACAD SCI USA, V100, P8770, DOI 10.1073/pnas.1532040100; Nottingham RM, 2011, J BIOL CHEM, V286, P33213, DOI 10.1074/jbc.M111.261115; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Valsdottir R, 2001, FEBS LETT, V508, P201, DOI 10.1016/S0014-5793(01)02993-3; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051; Yatsu A, 2013, J INVEST DERMATOL, V133, P2237, DOI 10.1038/jid.2013.156; Zhang Z, 2014, STRUCTURE, V22, P1408, DOI 10.1016/j.str.2014.08.005; Zheng JY, 1998, J CELL SCI, V111, P1061	40	28	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1427	1440		10.1074/jbc.M115.684043	http://dx.doi.org/10.1074/jbc.M115.684043			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26620560	Green Published, hybrid			2022-12-26	WOS:000368068300033
J	Liao, QY; Yuan, J; Lau, EHY; Chen, GY; Yang, ZC; Ma, XW; Chen, JD; Liu, YH; Wang, C; Tang, XP; Liu, YF; Zhuo, L; Leung, GM; Zhang, W; Cowling, BJ; Wang, M; Fielding, R				Liao, Qiuyan; Yuan, Jun; Lau, Eric H. Y.; Chen, Guang Yan; Yang, Zhi Cong; Ma, Xiao Wei; Chen, Jian Dong; Liu, Yan Hui; Wang, Chang; Tang, Xiao Ping; Liu, Yu Fei; Zhuo, Li; Leung, Gabriel M.; Zhang, Wei; Cowling, Benjamin J.; Wang, Ming; Fielding, Richard			Live Bird Exposure among the General Public, Guangzhou, China, May 2013	PLOS ONE			English	Article							INFLUENZA-A H7N9; TO-PERSON TRANSMISSION; AVIAN INFLUENZA; POULTRY MARKETS; HONG-KONG; VIRUS; RISK; INFECTION; A(H7N9); PERCEPTION	Background A novel avian-origin influenza A(H7N9) caused a major outbreak in Mainland China in early 2013. Exposure to live poultry was believed to be the major route of infection. There are limited data on how the general public changes their practices regarding live poultry exposure in response to the early outbreak of this novel influenza and the frequency of population exposure to live poultry in different areas of China. Methodology This study investigated population exposures to live birds from various sources during the outbreak of H7N9 in Guangzhou city, China in 2013 and compared them with those observed during the 2006 influenza A(H5N1) outbreak. Adults were telephone-interviewed using two-stage sampling, stratified by three residential areas of Guangzhou: urban areas and two semi-rural areas in one of which (Zengcheng) A(H7N9) virus was detected in a chicken from wet markets. Logistic regression models were built to describe practices protecting against avian influenza, weighted by age and gender, and then compare these practices across residential areas in 2013 with those from a comparable 2006 survey. Principal Findings Of 1196 respondents, 45% visited wet markets at least daily and 22.0% reported buying live birds from wet markets at least weekly in April-May, 2013, after the H7N9 epidemic was officially declared in late March 2013. Of those buying live birds, 32.3% reported touching birds when buying and 13.7% would slaughter the poultry at home. Although only 10.1% of the respondents reported raising backyard birds, 92.1% of those who did so had physical contact with the birds they raised. Zengcheng respondents were less likely to report buying live birds from wet markets, but more likely to buy from other sources when compared to urban respondents. Compared with the 2006 survey, the prevalence of buying live birds from wet markets, touching when buying and slaughtering birds at home had substantially declined in the 2013 survey. Conclusion/Significance Although population exposures to live poultry were substantially fewer in 2013 compared to 2006, wet markets and backyard poultry remained the two major sources of live bird exposures for the public in Guangzhou in 2013. Zengcheng residents seemed to have reduced buying live birds from wet markets but not from other sources in response to the detection of H7N9 virus in wet markets.	[Liao, Qiuyan; Lau, Eric H. Y.; Leung, Gabriel M.; Cowling, Benjamin J.; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Yuan, Jun; Yang, Zhi Cong; Ma, Xiao Wei; Chen, Jian Dong; Liu, Yan Hui; Wang, Chang; Liu, Yu Fei; Wang, Ming] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Chen, Guang Yan] Panyu Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Tang, Xiao Ping; Zhuo, Li] Eighth Peoples Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China; [Zhang, Wei] Guangdong Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China	University of Hong Kong	Yang, ZC (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	yangzc@gzcdc.org.cn	Lau, Eric/AAJ-6588-2021; Cowling, Benjamin John/C-4263-2009	Lau, Eric/0000-0002-6688-9637; Cowling, Benjamin John/0000-0002-6297-7154; Leung, Gabriel/0000-0002-2503-6283; Liao, Qiuyan/0000-0002-1105-6857	National Science and Technology Major Projects of China [2012ZX10004213-005]; Science and Technology Planning Project of Guangdong Province, China [2013B021800029]; Key Medical Science and Technology Research Projects of Guangzhou Municipality [201102A212006]; Science and Technology Program of Guangzhou [2014Y2-00063]; Area of Excellence Scheme of the University Grants Committee, Hong Kong SAR Government [AoE/M-12/06]	National Science and Technology Major Projects of China; Science and Technology Planning Project of Guangdong Province, China; Key Medical Science and Technology Research Projects of Guangzhou Municipality; Science and Technology Program of Guangzhou; Area of Excellence Scheme of the University Grants Committee, Hong Kong SAR Government	This work was supported by grants from the National Science and Technology Major Projects of China (No. 2012ZX10004213-005), Science and Technology Planning Project of Guangdong Province, China (No. 2013B021800029), Key Medical Science and Technology Research Projects of Guangzhou Municipality (No. 201102A212006), Science and Technology Program of Guangzhou (No. 2014Y2-00063), and the Area of Excellence Scheme of the University Grants Committee (AoE/M-12/06), Hong Kong SAR Government.	Campbell MJ, 2007, MED STAT TXB HLTH SC; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Fielding R, 2007, HEALTH EDUC, V107, P437, DOI 10.1108/09654280710778574; Fielding R, 2007, EMERG INFECT DIS, V13, P1065, DOI 10.3201/eid1307.061031; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; iJET, 2014, OFF REP NEW AV INFL; Lam WWT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044022; Larson C, 2013, SCIENCE, V342, P1031, DOI 10.1126/science.342.6162.1031; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liao QY, 2009, J PUBLIC HEALTH-UK, V31, P573, DOI 10.1093/pubmed/fdp043; Liao QY, 2014, J INFECT DEV COUNTR, V8, P526, DOI 10.3855/jidc.3545; Liao QY, 2011, EMERG INFECT DIS, V17, P2379, DOI 10.3201/eid1712.110298; Liao QY, 2009, EPIDEMICS-NETH, V1, P207, DOI 10.1016/j.epidem.2009.09.002; Liao QY, 2009, RISK ANAL, V29, P416, DOI 10.1111/j.1539-6924.2008.01157.x; Ma XW, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0554-8; Muller C. R., 2014, PROC INT C INTEGR PO, P1, DOI DOI 10.2175/193864714816196871; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Sims LD, 2003, AVIAN DIS, V47, P832, DOI 10.1637/0005-2086-47.s3.832; Statistics Bureau of Guangzhou, 2010, 6 NAT POP CENS; Statistics Bureau of Guangzhou, 2012, GUANGZH EC SOC DEV S; Vong S, 2014, EARLY RESPONSE EMERG; Wang LP, 2014, EMERG INFECT DIS, V20, P1296, DOI 10.3201/eid2008.131821; WANG Y, 2013, PLOS ONE, V2013; WHO, H5N1 AV INFL TIM MAJ; Xu JG, 2013, LANCET, V381, P1815, DOI 10.1016/S0140-6736(13)60950-2; Yang JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119792; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yuan J, 2009, EPIDEMIOL INFECT, V137, P988, DOI 10.1017/S0950268809002726; Yuan J, 2014, AM J INFECT CONTROL, V42, P1322, DOI 10.1016/j.ajic.2014.08.010; Yuan J, 2014, EMERG INFECT DIS, V20, P1238, DOI 10.3201/eid2007.131155; Zhang J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04846	33	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143582	10.1371/journal.pone.0143582	http://dx.doi.org/10.1371/journal.pone.0143582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26623646	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600036
J	Liu, ZM; Wang, XZ; Luo, Z; Huo, MX; Wu, JH; Huo, HL; Yang, W				Liu, Zhongmou; Wang, Xianze; Luo, Zhen; Huo, Mingxin; Wu, Jinghui; Huo, Hongliang; Yang, Wu			Removing of Disinfection By-Product Precursors from Surface Water by Using Magnetic Graphene Oxide	PLOS ONE			English	Article							NATURAL ORGANIC-MATTER; DRINKING-WATER; ION-EXCHANGE; AQUEOUS-SOLUTION; WASTE-WATER; ADSORPTION; NANOSHEETS; OZONATION; OXIDATION; ENRICHMENT	The magnetic graphene oxide (MGO) was successfully synthesised by the in situ chemical co-precipitation method with Fe3+, Fe2+ and graphene oxide (GO) in laboratory and, was used as an adsorbent for disinfection by-product (DBP) precursors removing from four natural surface water samples. The results indicate that various DBPs formation significantly decreased by 7-19% to 78-98% for the four samples after MGO treatment and, the treatment process was rapidly reached equilibrium within 20 minutes. The DBP precursors removal efficiency decreased with the increasing pH value from 4 to 10. Hydrophobic compounds (humic acid and fulvic acid) are more sensitive to MGO, whereas hydrophilic and nitrogenous compounds (aromatic proteins) are more insensitive. MGO could be regenerated by using 20% (v/v) ethanol and, the DBP precursors removal efficiency can stay stable after five cycles. These results indicate that MGO can be utilized as a promising adsorbent for the removal of DBP precursors from natural surface water.	[Liu, Zhongmou; Wang, Xianze; Luo, Zhen; Huo, Mingxin; Huo, Hongliang; Yang, Wu] NE Normal Univ, Sch Environm, Changchun 130117, Peoples R China; [Huo, Mingxin; Yang, Wu] Jilin Engn Res Ctr Municipal Wastewater Treatment, Changchun 130117, Peoples R China; [Luo, Zhen] Wuxi Xindu Environm Protect Technol Co Ltd, Wuxi 214215, Peoples R China; [Wu, Jinghui] Environm Monitoring Ctr Jilin Prov, Sci Res Management Dept, Changchun 13011, Peoples R China	Northeast Normal University - China	Huo, HL (corresponding author), NE Normal Univ, Sch Environm, Changchun 130117, Peoples R China.	huohl001@163.com; yangw104@nenu.edu.cn		Liu, Zhongmou/0000-0002-3319-7781	National Natural Science Foundation of China [51238001]; Fundamental Research Funds for the Central Universities [2412015KJ025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (No. 51238001) and the Fundamental Research Funds for the Central Universities (2412015KJ025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2013, J HAZARD MATER, V256, P33, DOI 10.1016/j.jhazmat.2013.03.064; Bao CL, 2012, J MATER CHEM, V22, P6088, DOI 10.1039/c2jm16203b; Barrott L, 2004, J WATER SUPPLY RES T, V53, P381, DOI 10.2166/aqua.2004.0030; Bond T, 2011, ENVIRON TECHNOL, V32, P1, DOI 10.1080/09593330.2010.495138; Boyer TH, 2006, WATER RES, V40, P2865, DOI 10.1016/j.watres.2006.05.022; Chen D, 2012, CHEM REV, V112, P6027, DOI 10.1021/cr300115g; Comstock SEH, 2014, CHEM ENG J, V241, P366, DOI 10.1016/j.cej.2013.10.073; Deng JH, 2013, CHEM ENG J, V226, P189, DOI 10.1016/j.cej.2013.04.045; Gao Y, 2012, J COLLOID INTERF SCI, V368, P540, DOI 10.1016/j.jcis.2011.11.015; Goncalves M, 2011, ENVIRON SCI TECHNOL, V45, P10605, DOI 10.1021/es203093v; Hartono T, 2009, J COLLOID INTERF SCI, V333, P114, DOI 10.1016/j.jcis.2009.02.005; Hong HC, 2013, J HYDROL, V476, P274, DOI 10.1016/j.jhydrol.2012.10.040; Hu XJ, 2013, SEP PURIF TECHNOL, V108, P189, DOI 10.1016/j.seppur.2013.02.011; Hua GH, 2013, WATER RES, V47, P4322, DOI 10.1016/j.watres.2013.04.057; Huang XH, 2008, WATER RES, V42, P1142, DOI 10.1016/j.watres.2007.08.030; Kim D, 2003, DESALINATION, V151, P11, DOI 10.1016/S0011-9164(02)00968-2; Kingsbury RS, 2013, WATER RES, V47, P1060, DOI 10.1016/j.watres.2012.11.015; Kristiana I, 2011, CHEMOSPHERE, V83, P661, DOI 10.1016/j.chemosphere.2011.02.017; Lamsal R, 2012, DESALINATION, V303, P12, DOI 10.1016/j.desal.2012.06.025; Li J, 2012, ACS APPL MATER INTER, V4, P4991, DOI 10.1021/am301358b; Liang L, 2003, ENVIRON SCI TECHNOL, V37, P2920, DOI 10.1021/es026230q; Lin YX, 2013, CHEM ENG J, V225, P679, DOI 10.1016/j.cej.2013.03.104; Liu HJ, 2012, SEP PURIF TECHNOL, V84, P41, DOI 10.1016/j.seppur.2011.07.009; Liu MC, 2011, J PHYS CHEM C, V115, P25234, DOI 10.1021/jp208575m; Liu S, 2008, ENVIRON SCI TECHNOL, V42, P6218, DOI 10.1021/es800887s; Liu SB, 2011, ACS NANO, V5, P6971, DOI 10.1021/nn202451x; Lu CY, 2007, SEP PURIF TECHNOL, V58, P113, DOI 10.1016/j.seppur.2007.07.036; Matilainen A, 2010, ADV COLLOID INTERFAC, V159, P189, DOI 10.1016/j.cis.2010.06.007; Moslemi M, 2014, SEP PURIF TECHNOL, V125, P202, DOI 10.1016/j.seppur.2014.01.054; Pavagadhi S, 2013, WATER RES, V47, P4621, DOI 10.1016/j.watres.2013.04.033; Qi S, 2008, WATER RES, V42, P3353, DOI 10.1016/j.watres.2008.04.016; Sarathy S, 2010, WATER RES, V44, P4087, DOI 10.1016/j.watres.2010.05.025; Sitko R, 2013, TRAC-TREND ANAL CHEM, V51, P33, DOI 10.1016/j.trac.2013.05.011; Sitko R, 2013, DALTON T, V42, P5682, DOI 10.1039/c3dt33097d; Tang WW, 2012, CHEM ENG J, V211, P470, DOI 10.1016/j.cej.2012.09.102; Velten S, 2011, WATER RES, V45, P3951, DOI 10.1016/j.watres.2011.04.047; Villanueva CM, 2004, EPIDEMIOLOGY, V15, P357, DOI 10.1097/01.ede.0000121380.02594.fc; Wang HT, 2011, J HAZARD MATER, V194, P156, DOI 10.1016/j.jhazmat.2011.07.093; Wang J, 2014, ENVIRON SCI TECHNOL, V48, P4817, DOI 10.1021/es405227u; Wang XY, 2015, TALANTA, V132, P753, DOI 10.1016/j.talanta.2014.10.014; Yang W, 2014, CHEMOSPHERE, V101, P34, DOI 10.1016/j.chemosphere.2013.11.018; Yang X, 2012, RSC ADV, V2, P8821, DOI 10.1039/c2ra20885g; Zeng SL, 2013, CHEM ENG J, V218, P108, DOI 10.1016/j.cej.2012.12.030; Zhang MM, 2003, ENVIRON SCI TECHNOL, V37, P1663, DOI 10.1021/es0260418; Zhao GX, 2011, ENVIRON SCI TECHNOL, V45, P10454, DOI 10.1021/es203439v	45	8	8	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143819	10.1371/journal.pone.0143819	http://dx.doi.org/10.1371/journal.pone.0143819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26623652	Green Submitted, gold, Green Published			2022-12-26	WOS:000365891600054
J	Frazao, A; da Silva, HR; Russo, CAD				Frazao, Annelise; da Silva, Helio Ricardo; de Moraes Russo, Claudia Augusta			The Gondwana Breakup and the History of the Atlantic and Indian Oceans Unveils Two New Clades for Early Neobatrachian Diversification	PLOS ONE			English	Article							PHYLOGENETIC ANALYSES; MAXIMUM-LIKELIHOOD; SEQUENCE ALIGNMENT; GEOGRAPHIC RANGE; EVOLUTION; BIOGEOGRAPHY; INFERENCE; DISPERSAL; PATTERNS; ORIGIN	The largest anuran diversity belongs to the Neobatrachia, which harbor more than five thousand extant species. Here, we propose a new hypothesis for the historical aspects of the neobatrachian evolution with a formal biogeographical analysis. We selected 12 genes for 144 neobatrachian genera and four archaeobatrachian outgroups and performed a phylogenetic analysis using a maximum likelihood algorithm with the rapid bootstrap test. We also estimated divergence times for major lineages using a relaxed uncorrelated clock method. According to our time scale, the diversification of crown Neobatrachia began around the end of the Early Cretaceous. Our phylogenetic tree suggests that the first split of Neobatrachia is related to the geological events in the Atlantic and Indian Oceans. Hence, we propose names for these clades that indicate this connection, i. e., Atlanticanura and Indianura. The Atlanticanura is composed of three major neobatrachian lineages: Heleophrynidae, Australobatrachia and Nobleobatrachia. On the other hand, the Indianura consists of two major lineages: Sooglossoidea and Ranoides. The biogeographical analysis indicates that many neobatrachian splits occurred as a result of geological events such as the separation between South America and Africa, between India and the Seychelles, and between Australia and South America.	[Frazao, Annelise; de Moraes Russo, Claudia Augusta] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Rio De Janeiro, Rio De Janeiro, Brazil; [da Silva, Helio Ricardo] Univ Fed Rural Rio de Janeiro, Dept Biol Anim, Inst Biol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Russo, CAD (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Rio De Janeiro, Rio De Janeiro, Brazil.	claudia@biologia.ufrj.br	Russo, Claudia/R-7432-2019; Russo, Claudia A M/I-1217-2012; Frazão, Annelise/G-9373-2016; Russo, Claudia/N-8063-2019; de Moraes Russo, Claudia Augusta/N-6361-2019	Russo, Claudia/0000-0002-1252-9206; Russo, Claudia A M/0000-0002-1252-9206; Frazão, Annelise/0000-0001-5784-6830; 	FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro) [E-26/102.879/2011]; FAPERJ "Prioridade Rio" grant [110.933/2010]; CNPq (Brazilian National Council for Scientific and Technological Development) [304134/2012-0, 309011/2012-4]	FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ "Prioridade Rio" grant(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq (Brazilian National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study has been funded by a FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro) Master degree fellowship E-26/102.879/2011 to AF; a FAPERJ "Prioridade Rio" grant (110.933/2010) to CAMR; and CNPq (Brazilian National Council for Scientific and Technological Development) fellowships to CAMR (304134/2012-0) and to HRS (309011/2012-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida EAB, 2012, J BIOGEOGR, V39, P526, DOI 10.1111/j.1365-2699.2011.02624.x; BAEZ A M, 1989, Anais da Academia Brasileira de Ciencias, V61, P447; Baez AM, 2009, CRETACEOUS RES, V30, P829, DOI 10.1016/j.cretres.2009.01.002; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Bossuyt F, 2001, SCIENCE, V292, P93, DOI 10.1126/science.1058875; Bossuyt F, 2006, SYST BIOL, V55, P579, DOI 10.1080/10635150600812551; Bossuyt Franky, 2009, P357; Boulenger GA, 1882, CATALOGUE OF THE BAT; Broin de F., 1974, CR HEBD ACAD SCI, V279, P469; Brusatte SL, 2008, J SYST PALAEONTOL, V6, P155, DOI 10.1017/S1477201907002404; Buerki S, 2011, J BIOGEOGR, V38, P531, DOI 10.1111/j.1365-2699.2010.02432.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chatterjee S, 2013, GONDWANA RES, V23, P238, DOI 10.1016/j.gr.2012.07.001; de Oliveira Felipe Bandoni, 2009, P55, DOI 10.1007/978-0-387-78705-3_3; de Sa RO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-241; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Drummond A., 2010, FIGTREE; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duellman W.E., 1975, OCCAS PAP MUS NAT HI, V42, P1; Duellman WE, 1986, BIOLOGY OF AMPHIBIAN; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Frost DR., 2015, AMPHIBIAN SPECIES OF; Galazzo FB, 2013, PALAEOGEOGR PALAEOCL, V378, P22, DOI 10.1016/j.palaeo.2013.03.018; Gomez-Mestre I, 2012, EVOLUTION, V66, P3687, DOI 10.1111/j.1558-5646.2012.01715.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Haywood AM, 2004, CRETACEOUS RES, V25, P303, DOI 10.1016/j.cretres.2004.01.005; Henrici AC, 1998, J VERTEBR PALEONTOL, V18, P321, DOI 10.1080/02724634.1998.10011060; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Irisarri I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-626; Izquierdo-Carrasco F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-470; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kominz MA, 2008, BASIN RES, V20, P211, DOI 10.1111/j.1365-2117.2008.00354.x; Laloy F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074874; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Leal MEC, 2006, PALEONTOLOGIA VERTEB, P145; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Li ZX, 2001, EARTH-SCI REV, V53, P237, DOI 10.1016/S0012-8252(00)00021-0; Martin C, 2010, LISANFOS KMS VERSION; McKenna M.C., 1983, STRUCTURE DEV GREENL, P351, DOI DOI 10.1007/978-1-4613-3485-9_19; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Mello B, 2012, ECOL EVOL, V2, P493, DOI 10.1002/ece3.94; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Miller M, 2009, CIPRES; NOBLE G. K., 1930, AMER MUS NOVITATES, V401, P1; Parsiegla N, 2008, GEOPHYS J INT, V174, P336, DOI 10.1111/j.1365-246X.2008.03808.x; POINAR GO, 1987, SCIENCE, V237, P1215, DOI 10.1126/science.237.4819.1215; Pramuk JB, 2008, GLOBAL ECOL BIOGEOGR, V17, P72, DOI 10.1111/j.1466-8238.2007.00348.x; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; RAGE J-C, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P1; Rambaut A, 2013, TRACER VERSION 1 6; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ree RH, 2009, J BIOGEOGR, V36, P1211, DOI 10.1111/j.1365-2699.2008.02068.x; Renner SS, 2000, SYST BIOL, V49, P579, DOI 10.1080/10635159950127402; Robovska-Havelkova P, 2010, ZOOMORPHOLOGY, V129, P121, DOI 10.1007/s00435-010-0105-9; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; Saether O. A., 2003, CIMBEBASIA, V19, P123; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; Sanderson MJ, 2008, SYST BIOL, V57, P335, DOI 10.1080/10635150802158688; Savage J.M., 1973, EVOLUTIONARY BIOL AN, P351; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Selvatti AP, 2015, MOL PHYLOGENET EVOL, V88, P1, DOI 10.1016/j.ympev.2015.03.018; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sige B, 2009, GEOBIOS-LYON, V42, P813, DOI 10.1016/j.geobios.2009.08.001; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Van Bocxlaer I, 2010, SCIENCE, V327, P679, DOI 10.1126/science.1181707; Van der Meijden A, 2007, BIOL J LINN SOC, V91, P347, DOI 10.1111/j.1095-8312.2007.00800.x; Vidal N, 2008, BIOL LETTERS, V4, P115, DOI 10.1098/rsbl.2007.0531; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Woodburne Michael O., 1996, Journal of Mammalian Evolution, V3, P121, DOI 10.1007/BF01454359; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091	81	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143926	10.1371/journal.pone.0143926	http://dx.doi.org/10.1371/journal.pone.0143926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618546	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800090
J	Hoffmann, K; Schott, F; Donati, M; Di Francesco, A; Hassig, M; Wanninger, S; Sidler, X; Borel, N				Hoffmann, Karolin; Schott, Franziska; Donati, Manuela; Di Francesco, Antonietta; Haessig, Michael; Wanninger, Sabrina; Sidler, Xaver; Borel, Nicole			Prevalence of Chlamydial Infections in Fattening Pigs and Their Influencing Factors	PLOS ONE			English	Article							MICROARRAY-BASED DETECTION; SUS-SCROFA; GASTROINTESTINAL-TRACT; CHLAMYDOPHILA-ABORTUS; INTESTINAL CHLAMYDIA; REPRODUCTIVE FAILURE; GNOTOBIOTIC PIGS; SUIS INFECTION; LUNG-FUNCTION; SWINE	Chlamydial infections in pigs are associated with respiratory disease, diarrhea, conjunctivitis and other pathologies. The aim of this study was to define the prevalence of Chlamydiaceae in Swiss fattening pigs by applying sensitive and specific detection methods and to correlate prior antibiotic treatment and farm related factors with differences in prevalence. Conjunctival and fecal swabs were collected from 636 pigs in 29 Swiss fattening pig farms with and without antibiotic treatment, at the beginning and the end of the fattening period. The swabs were screened by real-time PCR for Chlamydiaceae. For the chlamydial detection and species-identification, a DNA-microarray analysis was performed. All farms were positive for Chlamydiaceae with 94.3 and 92.0% prevalence in fecal swabs as well as 45.9 and 32.6% in conjunctival swabs at the first and second time points, respectively. Antibiotic treatment could not clear the infection on herd level. Potential contact with wild boars was a significant risk factor, while hygiene criteria did not influence chlamydial prevalence. A correlation of chlamydial positivity to diarrhea, but not to conjunctivitis was evident. Chlamydia suis was the predominant species. Mixed infections with C. suis and C. pecorum were common, with a substantial increase in C. pecorum positivity at the end of the fattening period, and this finding was associated with ruminant contact. C. abortus was detected in one conjunctival swab. In this study, C. suis inhabited the intestinal tract of nearly all examined pigs, implying a long-term infection. C. pecorum was also common and might be transmitted to pigs by ruminants.	[Hoffmann, Karolin; Wanninger, Sabrina; Borel, Nicole] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland; [Hoffmann, Karolin; Wanninger, Sabrina] Univ Zurich, Vetsuisse Fac, Ctr Clin Studies, Zurich, Switzerland; [Schott, Franziska; Sidler, Xaver] Univ Zurich, Vetsuisse Fac, Div Swine Med, Dept Farm Anim, Zurich, Switzerland; [Donati, Manuela] Univ Bologna, DIMES, Microbiol, Bologna, Italy; [Di Francesco, Antonietta] Univ Bologna, Dept Vet Med Sci, Ozzano Dell Emilia, BO, Italy; [Haessig, Michael] Univ Zurich, Vetsuisse Fac, Sect Herd Hlth, Dept Farm Anim, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; University of Bologna; University of Bologna; University of Zurich	Borel, N (corresponding author), Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, Zurich, Switzerland.	n.borel@access.uzh.ch	Borel, Nicole/GPP-1073-2022; Borel, Nicole/M-6204-2016	Borel, Nicole/0000-0002-1556-9262; Borel, Nicole/0000-0002-1556-9262	Swiss Federal Food Safety and Veterinary Office [1.13.03]	Swiss Federal Food Safety and Veterinary Office	This study was funded by the Swiss Federal Food Safety and Veterinary Office (grant 1.13.03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN DG, 1994, PRACTICAL STAT MED R; Baumgartner W, 2005, CLIN PROPAEDEUTICS I, P76; Becker A, 2007, J VET MED A, V54, P307, DOI 10.1111/j.1439-0442.2007.00963.x; Blumer C, 2007, VET PATHOL, V44, P144, DOI 10.1354/vp.44-2-144; Blumer S, 2011, VET MICROBIOL, V152, P385, DOI 10.1016/j.vetmic.2011.05.024; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; Borel N, 2008, MOL CELL PROBE, V22, P55, DOI 10.1016/j.mcp.2007.06.003; Callaway T. R., 2006, Current Issues in Intestinal Microbiology, V7, P65; Camenisch U, 2004, VET REC, V155, P593, DOI 10.1136/vr.155.19.593; DAVIDSON HJ, 1994, AM J VET RES, V55, P949; De Puysseleyr K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0560-x; De Puysseleyr K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096704; Dean D, 2013, EMERG INFECT DIS, V19, P1948, DOI 10.3201/eid1912.130656; Di Francesco A, 2008, VET REC, V163, P253, DOI 10.1136/vr.163.8.251; Di Francesco A, 2006, VET REC, V159, P849; Di Francesco A, 2013, VET ITAL, V49, P119; Di Francesco A, 2011, J WILDLIFE DIS, V47, P709, DOI 10.7589/0090-3558-47.3.709; Done S, 2012, DIS SWINE, P301; Dugan J, 2004, ANTIMICROB AGENTS CH, V48, P3989, DOI 10.1128/AAC.48.10.3989-3995.2004; Eggemann G, 2000, DEUT TIERARZTL WOCH, V107, P3; Englund S, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-9; Guscetti F, 2009, VET MICROBIOL, V135, P157, DOI 10.1016/j.vetmic.2008.09.038; Hoelzle LE, 2000, EPIDEMIOL INFECT, V125, P427, DOI 10.1017/S0950268899004446; Hotzel H, 2004, VET MICROBIOL, V103, P121, DOI 10.1016/j.vetmic.2004.06.009; Kauffold J, 2006, THERIOGENOLOGY, V65, P1750, DOI 10.1016/j.theriogenology.2005.10.010; Kauffold J, 2006, THERIOGENOLOGY, V66, P1816, DOI 10.1016/j.theriogenology.2006.04.042; Khafipour E, 2014, J ANIM SCI, V92, P2017, DOI 10.2527/jas.2013-7043; Lenart J, 2001, ANTIMICROB AGENTS CH, V45, P2198, DOI 10.1128/AAC.45.8.2198-2203.2001; Longbottom D, 2004, VET J, V168, P9, DOI 10.1016/S1090-0233(03)00106-0; Mohamad KY, 2010, VET RES, V41, DOI 10.1051/vetres/2009075; Montagnaro S, 2010, J WILDLIFE DIS, V46, P316, DOI 10.7589/0090-3558-46.1.316; Muntener CR, 2013, SCHWEIZ ARCH TIERH, V155, P365, DOI 10.1024/0036-7281/a000472; Nietfeld JC, 1997, AM J VET RES, V58, P260; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; Polkinghorne A, 2009, VET MICROBIOL, V135, P142, DOI 10.1016/j.vetmic.2008.09.034; Pollmann M., 2006, THESIS; POSPISCHIL A, 1987, VET PATHOL, V24, P568, DOI 10.1177/030098588702400617; Pospischil A, 2009, VET MICROBIOL, V135, P147, DOI 10.1016/j.vetmic.2008.09.035; Rank RG, 2014, INFECT IMMUN, V82, P1362, DOI 10.1128/IAI.01244-13; Regenscheit N, 2012, VET J, V193, P589, DOI 10.1016/j.tvjl.2012.02.016; Regula G, 2009, J ANTIMICROB CHEMOTH, V63, P805, DOI 10.1093/jac/dkp009; Reinhold P, 2005, VET RES COMMUN, V29, P125, DOI 10.1007/s11259-005-0843-1; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; Reinhold P, 2011, VET J, V187, P405, DOI 10.1016/j.tvjl.2010.01.008; Reinhold P, 2008, VET RES, V39, DOI 10.1051/vetres:2008012; Risco D, 2013, J ZOO WILDLIFE MED, V44, P159, DOI 10.1638/1042-7260-44.1.159; Rodolakis A, 2010, VET MICROBIOL, V140, P382, DOI 10.1016/j.vetmic.2009.03.014; Rogers DG, 1996, J VET DIAGN INVEST, V8, P433, DOI 10.1177/104063879600800405; Rogers DG, 1999, J VET DIAGN INVEST, V11, P341, DOI 10.1177/104063879901100408; Sachse K, 2005, MOL CELL PROBE, V19, P41, DOI 10.1016/j.mcp.2004.09.005; Salinas J, 2009, VET MICROBIOL, V135, P46, DOI 10.1016/j.vetmic.2008.10.001; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; Schautteet K, 2010, VET REC, V166, P329, DOI 10.1136/vr.b4714; Schautteet K, 2013, J MED MICROBIOL, V62, P331, DOI 10.1099/jmm.0.042861-0; Schautteet K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-29; Schiller I, 1997, J VET MED B, V44, P185, DOI 10.1111/j.1439-0450.1997.tb00963.x; Schiller I, 1997, VET MICROBIOL, V58, P251, DOI 10.1016/S0378-1135(97)00154-5; Schnee C, 2015, METHODS MOL BIOL, V1247, P193, DOI 10.1007/978-1-4939-2004-4_15; Swiss Farmers' Union, AGR FLEISCHB; Swiss Federal Statistical Office, LANDW BETR NUTZT LAN; Szeredi L, 1996, VET PATHOL, V33, P369, DOI 10.1177/030098589603300401; Szymanska-Czerwinska M, 2013, ANN AGR ENV MED, V20, P682; Teankum K, 2007, THERIOGENOLOGY, V67, P303, DOI 10.1016/j.theriogenology.2006.07.012; Vanrompay D, 2004, VET MICROBIOL, V99, P59, DOI 10.1016/j.vetmic.2003.08.014; Yeruva L, 2013, ANTIMICROB AGENTS CH, V57, P6290, DOI 10.1128/AAC.01405-13; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052; ZAHN I, 1995, J VET MED B, V42, P266, DOI 10.1111/j.1439-0450.1995.tb00710.x	67	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143576	10.1371/journal.pone.0143576	http://dx.doi.org/10.1371/journal.pone.0143576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619187	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800049
J	Marsicano, EO; Fernandes, NS; Colugnati, FAB; Fernandes, NMS; De Geest, S; Sanders-Pinheiro, H				Marsicano, Elisa Oliveira; Fernandes, Neimar Silva; Basile Colugnati, Fernando Antonio; Silva Fernandes, Natalia Maria; De Geest, Sabina; Sanders-Pinheiro, Helady			Multilevel Correlates of Non-Adherence in Kidney Transplant Patients Benefitting from Full Cost Coverage for Immunosuppressives: A Cross-Sectional Study	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; RISK-FACTORS; MEDICATION; ADHERENCE; NONCOMPLIANCE; CONSEQUENCES; PREVALENCE; DRUGS	Background Adherence is the result of the interaction of the macro, meso, micro, and patient level factors. The macro level includes full coverage of immunosuppressive medications as is the case in Brazil. We studied the correlates of immunosuppressive non-adherence in post kidney transplant patients in the Brazilian health care system. Methods Using a cross-sectional design, adherence to immunosuppressives was assessed in a sample of 100 kidney transplant patients using a composite non-adherence score consisting of three methods (self-report [i.e., The Basel Adherence Scale for Assessment of Immunossupressives-BAASIS], collateral report, and immunosuppressive blood levels). Multilevel correlations of non-adherence were assessed (macro, meso, micro and patient level). Univariate and multivariate logistic regression was applied to assess the correlates of non-adherence. Results Our sample consisted primarily of male (65%), Caucasians (72%) with a mean age of 45.0 +/- 13.5 years old, who received grafts from a living donor (89%), with a mean time after transplantation of 72.3 +/- 44.4 months. Prevalence of non-adherence was 51%. Family income higher than five reference wages (21.6 vs. 4%; OR 6.46 [1.35-30.89], p = 0.009; patient level), and having access to private health insurance (35.3% vs. 18.4%; OR 2.42 [0.96-6.10], p = 0.04; meso level) were associated with non-adherence in univariate analysis. Only the higher family income variable was retained in the multiple logistic regression model (OR 5.0; IC: 1.01-25.14; p = 0.04). Conclusions Higher family income was the only factor that was associated with immunosuppressive non-adherence. In Brazil, lower income recipients benefit from better access to care and coverage of health care costs after transplantation. This is supposed to result in a better immunosuppressive adherence compared to high-income patients who have experienced these benefits continuously.	[Marsicano, Elisa Oliveira; Basile Colugnati, Fernando Antonio; Silva Fernandes, Natalia Maria; Sanders-Pinheiro, Helady] Univ Fed Juiz de Fora, Sch Hosp, Div Nephrol, Renal Transplantat Unit, Juiz De Fora, MG, Brazil; [Marsicano, Elisa Oliveira; Basile Colugnati, Fernando Antonio; Silva Fernandes, Natalia Maria; Sanders-Pinheiro, Helady] Nucleo Interdisciplinar Estudos & Pesquisas Nefro, Juiz De Fora, MG, Brazil; [Fernandes, Neimar Silva] Univ Fed Juiz de Fora, Ctr Publ Policy & Educ Evaluat CAED, Juiz De Fora, MG, Brazil; [De Geest, Sabina] Univ Basel, Inst Nursing Sci, Basel, Switzerland; [De Geest, Sabina] Katholieke Univ Leuven, Fac Med, Dept Publ Hlth & Primary Care, Louvain, Belgium	Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; University of Basel; KU Leuven	Sanders-Pinheiro, H (corresponding author), Univ Fed Juiz de Fora, Sch Hosp, Div Nephrol, Renal Transplantat Unit, Juiz De Fora, MG, Brazil.	heladysanders@gmail.com	Fernandes, Natalia M S/J-1307-2016; Colugnati, Fernando/AAQ-9237-2020; SANDERS-PINHEIRO, HELADY/A-7042-2013; Colugnati, Fernando A. B./G-1892-2012	Fernandes, Natalia M S/0000-0001-8728-7937; Colugnati, Fernando/0000-0002-8288-203X; De Geest, Sabina/0000-0001-6596-7237	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Instituto Mineiro de Estudos e Pesquisas em Nefrologia (IMEPEN); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG) [PRI-00862-15]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Instituto Mineiro de Estudos e Pesquisas em Nefrologia (IMEPEN); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The study was supported by a grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Instituto Mineiro de Estudos e Pesquisas em Nefrologia (IMEPEN) and by Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG, number PRI-00862-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaubrun AC, 2012, J HEALTH CARE POOR U, V23, P20, DOI 10.1353/hpu.2012.0021; Berben L, 2015, J ADV NURS, V71, P642, DOI 10.1111/jan.12519; Berben L, 2012, WESTERN J NURS RES, V34, P635, DOI 10.1177/0193945911434518; BITTAR AE, 1992, TRANSPLANT P, V24, P2720; Brahm MMT, 2012, TRANSPL P, V44, P2391, DOI 10.1016/j.transproceed.2012.08.001; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Butler JA, 2004, TRANSPLANTATION, V77, P786, DOI 10.1097/01.TP.0000110412.20050.36; Butler JA, 2004, TRANSPLANTATION, V77, P769, DOI 10.1097/01.TP.0000110408.83054.88; Couzi L, 2013, TRANSPLANTATION, V95, P326, DOI 10.1097/TP.0b013e318271d7c1; De Geest S, 2012, AM J TRANSPLANT, V12, P27, DOI [10.1111/j.1600-6143.2012.04112.x, DOI 10.1111/J.1600-6143.2012.04112.X]; De Geest S, 2011, INT TRANSPLANTATION, P63; Denhaerynck K, 2007, AM J TRANSPLANT, V7, P108, DOI 10.1111/j.1600-6143.2006.01611.x; Denhaerynck K, 2005, TRANSPL INT, V18, P1121, DOI 10.1111/j.1432-2277.2005.00176.x; Denhaerynck K, 2014, INT J TRANSPLANT MED, V5, P7; Denhaerynck K, 2009, TRANSPL INT, V22, P441, DOI 10.1111/j.1432-2277.2008.00820.x; Dew MA, 2007, TRANSPLANTATION, V83, P858, DOI 10.1097/01.tp.0000258599.65257.a6; Dobbels F, 2010, TRANSPLANTATION, V90, P205, DOI 10.1097/TP.0b013e3181e346cd; DONABEDIAN A, 1990, ARCH PATHOL LAB MED, V114, P1115; Fine RN, 2009, AM J TRANSPLANT, V9, P35, DOI 10.1111/j.1600-6143.2008.02495.x; Goldfarb-Rumyantzev AS, 2011, NEPHRON CLIN PRACT, V117, pC33, DOI 10.1159/000319645; Marsicano EO, 2013, BMC NEPHROL, V14, P3, DOI [10.1186/1471-2369-14-3, DOI 10.1186/1471-2369-14-3]; Mauss M, 1950, SOCIOLOGIE ANTHR, P1923; Medina-Pestana JO, 2006, TRANSPLANTATION, V81, P1510, DOI 10.1097/01.tp.0000214934.48677.e2; Michelon TF, 2002, TRANSPLANT P, V34, P2768, DOI 10.1016/S0041-1345(02)03403-6; Neipp M, 2009, LANGENBECK ARCH SURG, V394, P1, DOI 10.1007/s00423-008-0335-1; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pinsky BW, 2009, AM J TRANSPLANT, V9, P2597, DOI 10.1111/j.1600-6143.2009.02798.x; Schafer-Keller P, 2008, AM J TRANSPLANT, V8, P616, DOI 10.1111/j.1600-6143.2007.02127.x; Schmid-Mohler G, 2010, CLIN TRANSPLANT, V24, P213, DOI 10.1111/j.1399-0012.2009.01056.x; Silva HT, 2011, AM J TRANSPLANT, V11, P1368, DOI 10.1111/j.1600-6143.2011.03564.x; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; Vlaminck H, 2004, AM J TRANSPLANT, V4, P1509, DOI 10.1111/j.1600-6143.2004.00537.x; World Health Organisation, 2003, ADHERENCE LONG TERM; Yach D, 2002, INNOVATIVE CARE CHRO, P99	34	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0138869	10.1371/journal.pone.0138869	http://dx.doi.org/10.1371/journal.pone.0138869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7NW	26619070	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800003
J	Sarma, RR; Munsi, M; Ananthram, AN				Sarma, Roshmi Rekha; Munsi, Madhushree; Ananthram, Aravind Neelavara			Effect of Climate Change on Invasion Risk of Giant African Snail (Achatina fulica Ferussac, 1821: Achatinidae) in India	PLOS ONE			English	Article							POTENTIAL DISTRIBUTION; ECOLOGICAL NICHE; SPECIES DISTRIBUTIONS; CONSEQUENCES; PREDICTION; SCENARIOS; IMPACTS; PLANTS	The Giant African Snail (Achatina fulica) is considered to be one the world's 100 worst invasive alien species. The snail has an impact on native biodiversity, and on agricultural and horticultural crops. In India, it is known to feed on more than fifty species of native plants and agricultural crops and also outcompetes the native snails. It was introduced into India in 1847 and since then it has spread all across the country. In this paper, we use ecological niche modeling (ENM) to assess the distribution pattern of Giant African Snail (GAS) under different climate change scenarios. The niche modeling results indicate that under the current climate scenario, Eastern India, peninsular India and the Andaman and Nicobar Islands are at high risk of invasion. The three different future climate scenarios show that there is no significant change in the geographical distribution of invasion prone areas. However, certain currently invaded areas will be more prone to invasion in the future. These regions include parts of Bihar, Southern Karnataka, parts of Gujarat and Assam. The Andaman and Nicobar and Lakshadweep Islands are highly vulnerable to invasion under changed climate. The Central Indian region is at low risk due to high temperature and low rainfall. An understanding of the invasion pattern can help in better management of this invasive species and also in formulating policies for its control.	[Sarma, Roshmi Rekha; Munsi, Madhushree; Ananthram, Aravind Neelavara] Royal Enclave, ATREE, Suri Sehgal Ctr Biodivers & Conservat, Bangalore 560064, Karnataka, India; [Sarma, Roshmi Rekha; Munsi, Madhushree] Manipal Univ, Manipal 576104, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Ananthram, AN (corresponding author), Royal Enclave, ATREE, Suri Sehgal Ctr Biodivers & Conservat, Jakkur PO, Bangalore 560064, Karnataka, India.	aravind@atree.org		Sarma, Roshmi Rekha/0000-0003-3389-6416	Dept. of Science and Technology, Govt. of India [SR/SO/AS/89-2012]	Dept. of Science and Technology, Govt. of India(Department of Science & Technology (India))	This work was funded by the Dept. of Science and Technology, Govt. of India (Ref no: SR/SO/AS/89-2012).	Albuquerque FS, 2008, BRAZ J BIOL, V68, P837, DOI 10.1590/S1519-69842008000400020; ALICATA JE, 1991, PARASITOL TODAY, V7, P151, DOI 10.1016/0169-4758(91)90285-V; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2011, ECOLOGICAL NICHES GE; Aravind N.A., 2005, Records of the Western Australian Museum Supplement, V68, P31; Aravind NA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0675; Aravind NA, 2008, ZOOSYMPOSIA, V1, P281, DOI 10.11646/zoosymposia.1.1.17; Barik SK, 2012, CABI INVASIVE SERIES; Bellard C, 2013, GLOBAL CHANGE BIOL, V19, P3740, DOI 10.1111/gcb.12344; Bentlage B, 2013, GLOBAL ECOL BIOGEOGR, V22, P952, DOI 10.1111/geb.12049; Bernie D, 2010, AVWS2D1R11 AVOID; Blanford WT, 1868, ANN MAGAZINE NATURAL, V1, P110; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Budha PB., 2008, MALACOLOGIST, V50, P19; Chitale VS, 2012, CURR SCI INDIA, V102, P1126; Cowie RH, 2003, BIOL CONSERV, V110, P55, DOI 10.1016/S0006-3207(02)00176-3; Davis M. A., 2009, INVASION BIOL; De Meyer M, 2010, B ENTOMOL RES, V100, P35, DOI 10.1017/S0007485309006713; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Evangelista PH, 2011, FOREST ECOL MANAG, V262, P307, DOI 10.1016/j.foreco.2011.03.036; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fontanilla IKC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105151; Garcia-Valdes R, 2013, J ECOL, V101, P441, DOI 10.1111/1365-2745.12049; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Godwin-Austen H. H., 1908, Proceedings of the Malacological Society of London, V8; Gopalakrishnan R, 2011, CURR SCI INDIA, V101, P348; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOLT RD, 1990, TRENDS ECOL EVOL, V5, P311, DOI 10.1016/0169-5347(90)90088-U; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jav Aregowda, 2004, Pest Management and Economic Zoology, V12, P221; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Kumar S, 2014, COMPUT ELECTRON AGR, V103, P55, DOI 10.1016/j.compag.2014.02.007; Larson ER, 2012, GLOBAL ECOL BIOGEOGR, V21, P1114, DOI 10.1111/j.1466-8238.2012.00758.x; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Lowe S., 2000, ENCY BIOL INVASIONS; Mainka SA, 2010, INTEGR ZOOL, V5, P102, DOI 10.1111/j.1749-4877.2010.00193.x; Masters G., 2010, CLIMATE CHANGE INVAS; Mead AR, 1979, EC MALACOLOGY PARTIC; Mead AR., 1961, GIANT AFRICAN SNAIL; Mendoza-Gonzalez G, 2013, GLOBAL CHANGE BIOL, V19, P2524, DOI 10.1111/gcb.12236; Mika AM, 2008, GLOBAL CHANGE BIOL, V14, P1721, DOI 10.1111/j.1365-2486.2008.01620.x; Moore BA, 2005, FBS8E FOR HLTH BIOS; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Muniappan R, 1973, ALAFUA AGR B, V8, P13; Naggs Fred, 1997, Archives of Natural History, V24, P37, DOI 10.3366/anh.1997.24.1.37; Naylor R, 1996, AMBIO, V25, P443; New York Sea Grant, 1994, POL ISS DREISS POL I; Nori J, 2011, BIODIVERS CONSERV, V20, P1125, DOI 10.1007/s10531-011-0014-3; O'Donnell J, 2012, GLOBAL CHANGE BIOL, V18, P617, DOI 10.1111/j.1365-2486.2011.02537.x; Pallewatta N, 2003, PREVENTION MANAGEMEN; Parsa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047675; Pathak H, 2012, CLIMATE CHANGE IMPAC; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pimentel D, 2011, BIOLOGICAL INVASIONS: ECONOMIC AND ENVIRONMENTAL COSTS OF ALIEN PLANT, ANIMAL, AND MICROBE SPECIES, 2ND EDITION, P1, DOI 10.1201/b10938; Poucher C, 1975, ANN M FLA STATE HORT, V88, P523; Prociv P, 2000, INT J PARASITOL, V30, P1295, DOI 10.1016/S0020-7519(00)00133-8; Pyke CR, 2008, CONSERV BIOL, V22, P585, DOI 10.1111/j.1523-1739.2008.00956.x; Pyron RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002931; RAUT S K, 1991, Malacological Review, V24, P79; RAUT SK, 1984, ZOOLOGICAL SURVEY IN, V11, P151; Raut SK, 2002, MOLLUSCS CROP PESTS, P55; Reddy KB, 2006, ACHATINA FULICA BOWD, P17; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Sajeev TV, 2011, APFISN WORKSH FOR HL; Shree M. P., 2002, Bulletin of Indian Academy of Sericulture, V6, P50; Simberloff D, 2000, SCI TOTAL ENVIRON, V262, P253, DOI 10.1016/S0048-9697(00)00527-1; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Smith AL, 2012, ENVIRON REV, V20, P1, DOI [10.1139/A11-020, 10.1139/a11-020]; Sridhar V., 2014, Pest Management in Horticultural Ecosystems, V20, P14; Sridhar V., 2012, Pest Management in Horticultural Ecosystems, V18, P228; Srivastava PD, 1985, GIANT AFRICAN SNAIL; Srivastava PD, 1992, PROBLEM LAND SNAIL P; Sujay Y.H., 2010, Karnataka Journal of Agricultural Sciences, V23, P26; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taylor S, 2012, WEED RES, V52, P391, DOI 10.1111/j.1365-3180.2012.00930.x; Thakur S, 1999, MANAGEMENT GIA UNPUB; Thakur S, 1988, J ECOBIOLOGY, V10, P103; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2007, BIOL INVASIONS; Tillier S., 1982, Haliotis, V12, P111; Turner GI, 1967, MYCOL RES, V50, P251; TURNER GJ, 1964, NATURE, V202, P1133, DOI 10.1038/2021133a0; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; Vanitha K, 2008, ANN PLANT PROTECT SC, V16, P203; Veeresh GK, 1979, CURRENT RES, V8, P202; Vijayshankar PS, 2014, INDIAS AGR DEV REGIO; Vila M, 2007, TERRESTRIAL ECOSYSTE; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1	93	35	40	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143724	10.1371/journal.pone.0143724	http://dx.doi.org/10.1371/journal.pone.0143724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618637	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800063
J	Chang, DC; Piaggi, P; Hanson, RL; Knowler, WC; Bucci, J; Thio, G; Hohenadel, MG; Bogardus, C; Krakoff, J				Chang, Douglas C.; Piaggi, Paolo; Hanson, Robert L.; Knowler, William C.; Bucci, John; Thio, Guene; Hohenadel, Maximilian G.; Bogardus, Clifton; Krakoff, Jonathan			Use of a High-Density Protein Microarray to Identify Autoantibodies in Subjects with Type 2 Diabetes Mellitus and an HLA Background Associated with Reduced Insulin Secretion	PLOS ONE			English	Article							T-CELL RESPONSES; PIMA-INDIANS; IDENTIFICATION; PATHOGENESIS; OBESITY; RESISTANCE; GAMMA; POLYMORPHISMS; AUTOANTIGENS; AUTOIMMUNITY	New biomarkers for type 2 diabetes mellitus (T2DM) may aid diagnosis, drug development or clinical treatment. Evidence is increasing for the adaptive immune system's role in T2DM and suggests the presence of unidentified autoantibodies. While high-density protein microarrays have emerged as a useful technology to identify possible novel autoantigens in autoimmune diseases, its application in T2DM has lagged. In Pima Indians, the HLA haplotype (HLA-DRB1*02) is protective against T2DM and, when studied when they have normal glucose tolerance, subjects with this HLA haplotype have higher insulin secretion compared to those without the protective haplotype. Possible autoantibody biomarkers were identified using microarrays containing 9480 proteins in plasma from Pima Indians with T2DM without the protective haplotype (n = 7) compared with those with normal glucose regulation (NGR) with the protective haplotype (n = 11). A subsequent validation phase involving 45 cases and 45 controls, matched by age, sex and specimen storage time, evaluated 77 proteins. Eleven autoantigens had higher antibody signals among T2DM subjects with the lower insulin-secretion HLA background compared with NGR subjects with the higher insulin-secretion HLA background (p<0.05, adjusted for multiple comparisons). PPARG2 and UBE2M had lowest p-values (adjusted p = 0.023) while PPARG2 and RGS17 had highest case-to-control antibody signal ratios (1.7). A multi-protein classifier involving the 11 autoantigens had sensitivity, specificity, and area under the receiver operating characteristics curve of 0.73, 0.80, and 0.83 (95% CI 0.74-0.91, p = 3.4x10(-8)), respectively. This study identified 11 novel autoantigens which were associated with T2DM and an HLA background associated with reduced insulin secretion. While further studies are needed to distinguish whether these antibodies are associated with insulin secretion via the HLA background, T2DM more broadly, or a combination of the two, this study may aid the search for autoantibody biomarkers by narrowing the list of protein targets.	[Chang, Douglas C.; Piaggi, Paolo; Hanson, Robert L.; Knowler, William C.; Hohenadel, Maximilian G.; Bogardus, Clifton; Krakoff, Jonathan] NIDDK, Phoenix Epidemiol & Clin Res Branch, NIH, Phoenix, AZ USA; [Bucci, John; Thio, Guene] Life Technol, Carlsbad, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Thermo Fisher Scientific	Chang, DC (corresponding author), NIDDK, Phoenix Epidemiol & Clin Res Branch, NIH, Phoenix, AZ USA.	changdc@mail.nih.gov	Piaggi, Paolo/E-2539-2011	Piaggi, Paolo/0000-0003-2774-9161	Intramural Research Program of NIH, NIDDK; Life Technologies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069028, ZIADK069015, ZIADK069000] Funding Source: NIH RePORTER	Intramural Research Program of NIH, NIDDK; Life Technologies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was solely funded by the Intramural Research Program of NIH, NIDDK. The funder provided support in the form of salaries for authors D.C.C., P.P, R.L.H., W.C.K., M.G.H., C.B, and J.K. The authors J.B. and G.T. are employed by Life Technologies, a commercial company. Life Technologies provided support in the form of salaries for authors J.B. and G.T, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aghdam SY, 2013, BIOCHEM BIOPH RES CO, V432, P339, DOI 10.1016/j.bbrc.2013.01.101; Aprile M, 2014, PPAR RES, V2014, DOI 10.1155/2014/537865; Arvan P, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007658; Auger I, 2009, ANN RHEUM DIS, V68, P591, DOI 10.1136/ard.2008.096917; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bian L, 2013, HUM MOL GENET, V22, P4438, DOI 10.1093/hmg/ddt291; Bouchard L, 2009, OBESITY, V17, P1466, DOI 10.1038/oby.2009.71; Bram Yaron, 2014, Sci Rep, V4, P4267, DOI 10.1038/srep04267; Brooks-Worrell B, 2013, DIABETES OBES METAB, V15, P137, DOI 10.1111/dom.12167; Brooks-Worrell BM, 2013, CLIN EXP IMMUNOL, V171, P164, DOI 10.1111/cei.12012; Brooks-Worrell BM, 2013, DIABETES CARE, V36, P4098, DOI 10.2337/dc12-2328; Brooks-Worrell BM, 2011, DIABETES CARE, V34, P168, DOI 10.2337/dc10-0579; Bunt JC, 2007, DIABETES-METAB RES, V23, P304, DOI 10.1002/dmrr.686; Costes S, 2011, DIABETES, V60, P227, DOI 10.2337/db10-0522; Fosgerau K, 2010, J ENDOCRINOL, V204, P265, DOI 10.1677/JOE-09-0413; Genuth S, 2003, DIABETES CARE, V26, P3160; Goel A, 2007, DIABETES, V56, P2110, DOI 10.2337/db06-0552; Gupta D, 2014, J CLIN INVEST, V124, P3292, DOI 10.1172/JCI77506; Han SH, 2013, AM J TRANSL RES, V5, P379; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Hempel P, 2009, SCAND J IMMUNOL, V70, P159, DOI 10.1111/j.1365-3083.2009.02280.x; Hu S, 2011, PROTEOMICS, V11, P1499, DOI 10.1002/pmic.201000206; Hudson ME, 2007, P NATL ACAD SCI USA, V104, P17494, DOI 10.1073/pnas.0708572104; Jaisson S, 2014, DIABETOLOGIA, V57, P1517, DOI 10.1007/s00125-014-3257-1; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; KNOWLER WC, 1979, DIABETOLOGIA, V17, P161, DOI 10.1007/BF01219743; Koo BK, 2014, DIABETES, V63, P3022, DOI 10.2337/db13-1566; Lalive PH, 2006, NEUROLOGY, V67, P176, DOI 10.1212/01.wnl.0000223346.09426.34; Lindsay RS, 2001, DIABETES, V50, P1598, DOI 10.2337/diabetes.50.7.1598; Muller YL, 2003, DIABETES, V52, P1864, DOI 10.2337/diabetes.52.7.1864; Odegaard JI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007724; Pei H, 2011, CELL DEATH DIFFER, V18, P315, DOI 10.1038/cdd.2010.100; Predki P.F., 2007, FUNCTIONAL PROTEIN M; Qian H, 1998, BIOCHEM BIOPH RES CO, V246, P660, DOI 10.1006/bbrc.1998.8680; Roep BO, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007781; Ross JS, 2004, MOL CELL PROTEOMICS, V3, P379, DOI 10.1074/mcp.R400001-MCP200; Sboner A, 2009, J PROTEOME RES, V8, P5451, DOI 10.1021/pr900412k; Takano M, 2014, BRAIN RES, V1542, P186, DOI 10.1016/j.brainres.2013.10.034; Tashiro E, 2013, J BIOL CHEM, V288, P19958, DOI 10.1074/jbc.M113.477984; Tsai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00321; Velloso LA, 2013, NAT REV ENDOCRINOL, V9, P750, DOI 10.1038/nrendo.2013.131; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Wamelink M, 2008, J INHERIT METAB DIS, V31, P703, DOI 10.1007/s10545-008-1015-6; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Williams KT, 2012, DIABETES-METAB RES, V28, P123, DOI 10.1002/dmrr.1281; Williams RC, 2011, DIABETOLOGIA, V54, P1684, DOI 10.1007/s00125-011-2122-8; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Zhang Y, 2012, BIOCHEM BIOPH RES CO, V417, P1, DOI 10.1016/j.bbrc.2011.11.158; Zimering MB, 2009, J CLIN ENDOCR METAB, V94, P2171, DOI 10.1210/jc.2008-2354	50	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143551	10.1371/journal.pone.0143551	http://dx.doi.org/10.1371/journal.pone.0143551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606528	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300079
J	Dalla-Riva, J; Lagerstedt, JO; Petrlova, J				Dalla-Riva, Jonathan; Lagerstedt, Jens O.; Petrlova, Jitka			Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; PARAMAGNETIC-RESONANCE SPECTROSCOPY; ABCA1-MEDIATED CHOLESTEROL EFFLUX; A-I; APOA-I; ENDOTHELIAL-CELLS; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; OXIDATIVE STRESS	Apolipoprotein A-I (apoA-I) is the main protein involved in the formation of high-density lipoprotein (HDL), it is the principal mediator of the reverse cholesterol transfer (RCT) pathway and provides cardio-protection. In addition to functional wild-type apoA-I, several variants have been shown to associate with hereditary amyloidosis. In this study we have performed biophysical and biochemical analyses of the structure and functional properties of the A164S variant of apoA-I (1:500 in the Danish general population), which is the first known mutation of apoA-I that leads to an increased risk of ischaemic heart disease (IHD), myocardial infarction and mortality without associated low HDL cholesterol levels. Despite the fact that epidemiologically IHD is associated with low plasma levels of HDL, the A164S mutation is linked to normal plasma levels of lipids, HDL and apoA-I, suggesting impaired functionality of this variant. Using biophysical techniques (e.g., circular dichroism spectroscopy and electron microscopy) to determine secondary structure, stability and pro-amyloidogenic property of the lipid free A164S apoA-I variant, our observations suggest similarity in structural properties between apoA-I WT and apoA-I A164S. However, the A164S apoA-I variant exhibits lower binding affinity to lipids but forms similar sized HDL particles to those produced by WT.	[Dalla-Riva, Jonathan; Lagerstedt, Jens O.; Petrlova, Jitka] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Lagerstedt, JO (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	jens.lagerstedt@med.lu.se	Lagerstedt, Jens/AAF-9567-2021	Lagerstedt, Jens/0000-0002-4313-2666	Swedish Research Council [K2014-54X-22426-01-3]; Royal Physiographic Society in Lund; Greta and Johan Kocks foundation; Craaford foundation; Tage Blucher foundation; Gyllenstierna Krapperup's foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; Greta and Johan Kocks foundation; Craaford foundation; Tage Blucher foundation; Gyllenstierna Krapperup's foundation	The authors acknowledge support from the Swedish Research Council (K2014-54X-22426-01-3), from the Royal Physiographic Society in Lund, the Greta and Johan Kocks foundation, the Craaford foundation, the Tage Blucher foundation and the Gyllenstierna Krapperup's foundation.	Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; ASSMANN G, 1993, CIRCULATION, V87, P28; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; Baker PW, 1999, J LIPID RES, V40, P345; Brubaker G, 2006, BBA-MOL CELL BIOL L, V1761, P64, DOI 10.1016/j.bbalip.2006.01.007; Chetty PS, 2012, BIOCHEMISTRY-US, V51, P8993, DOI 10.1021/bi300926j; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Chroni A, 2005, BIOCHEMISTRY-US, V44, P14353, DOI 10.1021/bi050962o; Dalla-Riva J, 2013, J LIPID RES, V54, P1275, DOI 10.1194/jlr.M032904; de Sousa MM, 2000, AM J PATHOL, V156, P1911, DOI 10.1016/S0002-9440(10)65064-X; de Souza JA, 2010, J CELL MOL MED, V14, P608, DOI 10.1111/j.1582-4934.2009.00713.x; Drew BG, 2012, NAT REV ENDOCRINOL, V8, P237, DOI 10.1038/nrendo.2011.235; FRANCESCHINI G, 1980, J CLIN INVEST, V66, P892, DOI 10.1172/JCI109956; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Haase CL, 2011, J INTERN MED, V270, P136, DOI 10.1111/j.1365-2796.2011.02381.x; Haase CL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003063; Hamidi Asl K, 1999, BIOCHEM BIOPH RES CO, V257, P584, DOI DOI 10.1006/BBRC.1999.0518; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Kontush A, 2006, NAT CLIN PRACT CARD, V3, P144, DOI 10.1038/ncpcardio0500; Kontush A, 2003, ARTERIOSCL THROM VAS, V23, P1881, DOI 10.1161/01.ATV.0000091338.93223.E8; Lagerstedt JO, 2007, BIOCHEMISTRY-US, V46, P9693, DOI 10.1021/bi7005493; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; Lagerstedt JO, 2012, BBA-MOL CELL BIOL L, V1821, P448, DOI 10.1016/j.bbalip.2011.12.010; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; Moore RE, 2005, CIRC RES, V97, P763, DOI 10.1161/01.RES.0000185320.82962.F7; Moriyama K, 1996, J Atheroscler Thromb, V3, P12; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Oda MN, 2013, FEBS J, V280, P3416, DOI 10.1111/febs.12334; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Petrlova J, 2012, J LIPID RES, V53, P390, DOI 10.1194/jlr.M020883; Ramella NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043755; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; Rye KA, 2014, CIRC RES, V114, P143, DOI 10.1161/CIRCRESAHA.114.300632; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; Segrest JP, 2014, BIOCHEMISTRY-US, V53, P7625, DOI 10.1021/bi501111j; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; Sirtori CR, 2001, CIRCULATION, V103, P1949; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; Sriram R, 2011, NMR BIOMED, V24, P916, DOI 10.1002/nbm.1650; Stenkula KG, 2014, DIABETOLOGIA, V57, P797, DOI 10.1007/s00125-014-3162-7; Tabet F, 2009, CLIN SCI, V116, P87, DOI 10.1042/CS20080106; Van Linthout S, 2010, ATHEROSCLEROSIS, V210, P438, DOI 10.1016/j.atherosclerosis.2010.01.001; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; VONECKARDSTEIN A, 1990, J BIOL CHEM, V265, P8610; Yancey PG, 2004, J LIPID RES, V45, P337, DOI 10.1194/jlr.M300231-JLR200; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; Zhu WY, 2013, BBA-PROTEINS PROTEOM, V1834, P593, DOI 10.1016/j.bbapap.2012.11.010	52	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143915	10.1371/journal.pone.0143915	http://dx.doi.org/10.1371/journal.pone.0143915			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605794	Green Published, gold			2022-12-26	WOS:000365865300123
J	Gozzard, P; Chapman, C; Vincent, A; Lang, B; Maddison, P				Gozzard, Paul; Chapman, Caroline; Vincent, Angela; Lang, Bethan; Maddison, Paul			Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study	PLOS ONE			English	Article							EATON MYASTHENIC SYNDROME; PARANEOPLASTIC ENCEPHALOMYELITIS; ACQUIRED NEUROMYOTONIA; FAVORABLE PROGNOSIS; TUMOR-ANTIGEN; CANCER; ANTIBODIES; HU; TISSUES; EXPRESSION	Purpose Favourable small cell lung carcinoma (SCLC) survival outcomes have been reported in patients with paraneoplastic neurological disorders (PNDs) associated with neuronal antibodies (Neur-Abs), but the presence of a PND might have expedited diagnosis. Our aim was to establish whether neuronal antibodies, independent of clinical neurological features, correlate with SCLC survival. Experimental Design 262 consecutive SCLC patients were examined: of these, 24 with neurological disease were excluded from this study. The remaining 238 were tested for a broad array of Neur-Abs at the time of cancer diagnosis; survival time was established from follow-up clinical data. Results Median survival of the non-PND cohort (n = 238) was 9.5 months. 103 patients (43%) had one or more antigen-defined Neur-Abs. We found significantly longer median survival in 23 patients (10%) with HuD/anti-neuronal nuclear antibody type 1 (ANNA-1, 13.0 months P = 0.037), but not with any of the other antigen-defined antibodies, including the PND-related SOX2 (n = 56, 24%). An additional 28 patients (12%) had uncharacterised anti-neuronal nuclear antibodies (ANNA-U); their median survival time was longer still (15.0 months, P = 0.0048), contrasting with the survival time in patients with non-neuronal anti-nuclear antibodies (detected using HEp-2 cells, n = 23 (10%), 9.25 months). In multivariate analyses, both ANNA-1 and ANNA-U independently reduced the mortality hazard by a ratio of 0.532 (P = 0.01) and 0.430 (P<0.001) respectively. Conclusions ANNAs, including the newly described ANNA-U, may be key components of the SCLC immunome and have a potential role in predicting SCLC survival; screening for them could add prognostic value that is similar in magnitude to that of limited staging at diagnosis.	[Gozzard, Paul; Vincent, Angela; Lang, Bethan] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Chapman, Caroline] Univ Nottingham, Royal Derby Hosp, Div Med Sci & Grad Entry Med, Derby, England; [Maddison, Paul] Univ Nottingham, Queens Med Ctr, Div Clin Neurosci, Nottingham NG7 2RD, England	University of Oxford; University of Nottingham; University of Nottingham	Gozzard, P (corresponding author), Royal Hallamshire Hosp, Dept Neurol, Sheffield S10 2JF, S Yorkshire, England.	p.gozzard@nhs.net	Vincent, Angela/AAE-7310-2019		Myaware (Myasthenia Gravis Association)	Myaware (Myasthenia Gravis Association)	The study was funded by a grant from Myaware (Myasthenia Gravis Association [http://myaware.org/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DJ, 1982, J IMMUNOL, V129, P452; Bjorling E, 2008, MOL CELL PROTEOMICS, V7, P825, DOI 10.1074/mcp.M700411-MCP200; CHALK CH, 1990, NEUROLOGY, V40, P1552, DOI 10.1212/WNL.40.10.1552; Chan KH, 2001, ANN NEUROL, V50, P301, DOI 10.1002/ana.1127; Chapman CJ, 2008, THORAX, V63, P228, DOI 10.1136/thx.2007.083592; Chow S, 2005, ELECTRON NOTES THEOR, V134, P3, DOI 10.1016/j.entcs.2005.02.017; DALMAU J, 1990, ANN NEUROL, V27, P544, DOI 10.1002/ana.410270515; DALMAU J, 1992, AM J PATHOL, V141, P881; DARNELL RB, 1993, LANCET, V341, P21, DOI 10.1016/0140-6736(93)92485-C; Derbinski J, 2010, CURR OPIN IMMUNOL, V22, P592, DOI 10.1016/j.coi.2010.08.003; DORFMAN LJ, 1972, ACTA NEUROL SCAND, V48, P556, DOI 10.1111/j.1600-0404.1972.tb07576.x; Eerola AK, 2000, CLIN CANCER RES, V6, P1875; Flieder DB, 2002, CURR OPIN PULM MED, V8, P275, DOI 10.1097/00063198-200207000-00006; Gnjatic S, 2006, ADV CANCER RES, V95, P1, DOI 10.1016/S0065-230X(06)95001-5; Gozzard P, 2015, NEUROLOGY, V85, P235, DOI 10.1212/WNL.0000000000001721; Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447; Graus F, 1997, J CLIN ONCOL, V15, P2866, DOI 10.1200/JCO.1997.15.8.2866; HARDY JD, 1981, ANN SURG, V193, P539, DOI 10.1097/00000658-198105000-00002; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; KATO Y, 1969, CANCER, V23, P517, DOI 10.1002/1097-0142(196903)23:3<517::AID-CNCR2820230301>3.0.CO;2-L; Katz-Levy Y, 1999, J CLIN INVEST, V104, P599, DOI 10.1172/JCI7292; Keime-Guibert F, 1999, NEUROLOGY, V53, P1719, DOI 10.1212/WNL.53.8.1719; Lally BE, 2007, ONCOLOGIST, V12, P1096, DOI 10.1634/theoncologist.12-9-1096; LAMPSON LA, 1984, P NATL ACAD SCI-BIOL, V81, P6476, DOI 10.1073/pnas.81.20.6476; Maddison P, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(05)76153-5; Monstad SE, 2004, J CLIN ONCOL, V22, P795, DOI 10.1200/JCO.2004.01.028; MOTOMURA M, 1995, J NEUROL NEUROSUR PS, V58, P85, DOI 10.1136/jnnp.58.1.85; Office for National Statistics, 2009, CANC STAT REG REG CA; ONEILL JH, 1988, BRAIN, V111, P577, DOI 10.1093/brain/111.3.577; ROBERTS A, 1985, NATURE, V317, P737, DOI 10.1038/317737a0; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SHILLITO P, 1995, ANN NEUROL, V38, P714, DOI 10.1002/ana.410380505; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; Titulaer MJ, 2009, J CLIN ONCOL, V27, P4260, DOI 10.1200/JCO.2008.20.6169; Yu P, 2003, J EXP MED, V197, P985, DOI 10.1084/jem.20021804	38	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143558	10.1371/journal.pone.0143558	http://dx.doi.org/10.1371/journal.pone.0143558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606748	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300081
J	Skindersoe, ME; Krogfelt, KA; Blom, A; Jiang, GW; Prestwich, GD; Mansell, JP				Skindersoe, Mette Elena; Krogfelt, Karen A.; Blom, Ashley; Jiang, Guowei; Prestwich, Glenn D.; Mansell, Jason Peter			Dual Action of Lysophosphatidate-Functionalised Titanium: Interactions with Human (MG63) Osteoblasts and Methicillin Resistant Staphylococcus aureus	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; TEICHOIC-ACIDS; GROWTH-FACTOR; MATURATION; SURFACE; LPA; CALCITRIOL; MONOLAYERS; AGONIST; MG-63	Titanium (Ti) is a widely used material for surgical implants; total joint replacements (TJRs), screws and plates for fixing bones and dental implants are forged from Ti. Whilst Ti integrates well into host tissue approximately 10% of TJRs will fail in the lifetime of the patient through a process known as aseptic loosening. These failures necessitate revision arthroplasties which are more complicated and costly than the initial procedure. Finding ways of enhancing early (osseo) integration of TJRs is therefore highly desirable and continues to represent a research priority in current biomaterial design. One way of realising improvements in implant quality is to coat the Ti surface with small biological agents known to support human osteoblast formation and maturation at Ti surfaces. Lysophosphatidic acid (LPA) and certain LPA analogues offer potential solutions as Ti coatings in reducing aseptic loosening. Herein we present evidence for the successful bio-functionalisation of Ti using LPA. This modified Ti surface heightened the maturation of human osteoblasts, as supported by increased expression of alkaline phosphatase. These functionalised surfaces also deterred the attachment and growth of Staphylococcus aureus, a bacterium often associated with implant failures through sepsis. Collectively we provide evidence for the fabrication of a dual-action Ti surface finish, a highly desirable feature towards the development of next-generation implantable devices.	[Skindersoe, Mette Elena] Tech Univ Denmark, Dept Syst Biol, Lyngby, Denmark; [Skindersoe, Mette Elena; Krogfelt, Karen A.] Statens Serum Inst, Dept Infect & Microbiol Control, DK-2300 Copenhagen S, Denmark; [Blom, Ashley] Univ Bristol, Southmead Hosp, Musculoskeletal Res Unit, Bristol BS10 5NB, Avon, England; [Jiang, Guowei; Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA; [Mansell, Jason Peter] Univ W England, Dept Biol Biomed & Analyt Sci, Bristol BS16 1QY, Avon, England	Technical University of Denmark; Statens Serum Institut; Southmead Hospital; University of Bristol; Utah System of Higher Education; University of Utah; University of West England	Mansell, JP (corresponding author), Univ W England, Dept Biol Biomed & Analyt Sci, Frenchay Campus, Bristol BS16 1QY, Avon, England.	jason.mansell@uwe.ac.uk	Krogfelt, Karen Angeliki/P-2430-2018; Krogfelt, Karen Angeliki A/O-8145-2016	Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Blom, Ashley/0000-0002-9940-1095; Skindersoe, Mette/0000-0001-9695-2767	Danish Council for Strategic Research [09-067075]; Orthopaedic Research UK [496]; Noth Bristol NHS Trust (Southmead Hospital); Carlsberg Foundation [2012_01_0659]; Bristol Orthopaedic Trust	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Orthopaedic Research UK; Noth Bristol NHS Trust (Southmead Hospital); Carlsberg Foundation(Carlsberg Foundation); Bristol Orthopaedic Trust	This work was supported by the Danish Council for Strategic Research to the Danish Centre for Antibiotic Research and Development, grant number: 09-067075 (http://ufm.dk/en/research-and-innovation/councils-and-commissions/former-councils-and-commissions/the-danish-council-for-strategic-research); Orthopaedic Research UK, grant number: 496 (http://www.oruk.org/funding-research/introduction/); Noth Bristol NHS Trust (Southmead Hospital) (http://www.nbt.nhs.uk/research-and-innovation); The Carlsberg Foundation to MES, grant number: 2012_01_0659, (http://www.carlsberggroup.com/Company/Foundations/CARLSBERGFOUNDATION/Pages/Default.aspx); and The Bristol Orthopaedic Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn J, 2012, BONE, V50, P756, DOI 10.1016/j.bone.2011.12.002; BONEWALD LF, 1992, J BIOL CHEM, V267, P8943; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0; Cohen PS, 2002, Phospholipids having antimicrobial activity with the presence of antimicrobials, Patent No. [EP1051180, 1051180]; Gidley J, 2006, PROSTAG OTH LIPID M, V80, P46, DOI 10.1016/j.prostaglandins.2006.04.001; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; HEPTINSTALL S, 1970, NATURE, V225, P519, DOI 10.1038/225519a0; Krogfelt KA, 2000, J ANTIMICROB CHEMOTH, V46, P377, DOI 10.1093/jac/46.3.377; Lambert RJW, 2004, J APPL MICROBIOL, V96, P244, DOI 10.1046/j.1365-2672.2004.02135.x; Lancaster S, 2013, CLIN LIPIDOL, V8, P123, DOI 10.2217/CLP.12.86; Lancaster ST, 2014, STEROIDS, V83, P52, DOI 10.1016/j.steroids.2014.01.010; Laux DC, 2002, MICROBIOL-SGM, V148, P1709, DOI 10.1099/00221287-148-6-1709; Lundberg CV, 2013, INT J ANTIMICROB AG, V42, P272, DOI 10.1016/j.ijantimicag.2013.05.008; Mansell JP, 2012, EUR CELLS MATER, V23, P348, DOI 10.22203/eCM.v023a27; Mansell JP, 2013, BBA-MOL CELL BIOL L, V1831, P105, DOI 10.1016/j.bbalip.2012.04.005; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Paramonov PB, 2008, CHEM MATER, V20, P5131, DOI 10.1021/cm8014622; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Paz YR, 2011, BEILSTEIN J NANOTECH, V2, P845, DOI 10.3762/bjnano.2.94; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Qian L, 2003, J MED CHEM, V46, P5575, DOI 10.1021/jm034207p; Queffelec C, 2012, CHEM REV, V112, P3777, DOI 10.1021/cr2004212; Saga H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093230; Tokumura A, 2009, INT J MED SCI, V6, P168; WEISER R, 1968, NATURE, V219, P1365, DOI 10.1038/2191365a0; Whyte MP, 2010, ANN NY ACAD SCI, V1192, P190, DOI 10.1111/j.1749-6632.2010.05387.x; Yarram SJ, 2004, MOL CELL ENDOCRINOL, V220, P9, DOI 10.1016/j.mce.2004.04.005	30	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143509	10.1371/journal.pone.0143509	http://dx.doi.org/10.1371/journal.pone.0143509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605796	Green Published, gold			2022-12-26	WOS:000365865300073
J	Yin, SJ; Rao, GX; Wang, J; Luo, LY; He, GH; Wang, CY; Ma, CY; Luo, XX; Hou, Z; Xu, GL				Yin, Sunjun; Rao, Gaoxiong; Wang, Jin; Luo, Liyang; He, Gonghao; Wang, Chengying; Ma, Chaoyu; Luo, Xiaoxing; Hou, Zheng; Xu, Guili			Roemerine Improves the Survival Rate of Septicemic BALB/c Mice by Increasing the Cell Membrane Permeability of Staphylococcus aureus	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY; PHOTODYNAMIC THERAPY; IN-VITRO; RESISTANCE; BACTEREMIA; THANATIN; VIVO	Staphylococcus aureus is one of the most frequently occurring hospital-and communityassociated pathogenic bacteria featuring high morbidity and mortality. The occurrence of methicillin-resistant S. aureus (MRSA) has increased persistently over the years. Therefore, developing novel anti-MRSA drugs to circumvent drug resistance of S. aureus is highly important. Roemerine, an aporphine alkaloid, has previously been reported to exhibit antibacterial activity. The present study aimed to investigate whether roemerine can maintain these activities against S. aureus in vivo and further explore the underlying mechanism. We found that roemerine is effective in vitro against four S. aureus strains as well as in vivo against MRSA insepticemic BALB/c mice. Furthermore, roemerine was found to increase cell membrane permeability in a concentration-dependent manner. These findings suggest that roemerine may be developed as a promising compound for treating S. aureus, especially methicillin-resistant strains of these bacteria.	[Yin, Sunjun; He, Gonghao; Xu, Guili] Kunming Gen Hosp Chengdu Mil Reg, Dept Pharm, Kunming 650500, Yunnan, Peoples R China; [Rao, Gaoxiong; Wang, Chengying] Yunnan Univ Tradit Chinese Med, Kunming 650500, Yunnan, Peoples R China; [Wang, Jin; Luo, Liyang; Luo, Xiaoxing; Hou, Zheng] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Shaanxi, Peoples R China; [Ma, Chaoyu] Kunming Med Univ, Kunming 650500, Yunnan, Peoples R China	Kunming General Hospital; Yunnan University of Chinese Medicine; Air Force Military Medical University; Kunming Medical University	Hou, Z (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Shaanxi, Peoples R China.	hzh_0001@163.com; kmxuguili@126.com	Hou, Zheng/AAE-5173-2020	/0000-0002-0358-7869	National Natural Science Foundation of China [81173643, 81460560, 81471997]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81173643, No. 81460560 and No. 81471997) (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LY, 2012, ARCH GERONTOL GERIAT, V55, P152, DOI 10.1016/j.archger.2011.07.003; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304; Espadinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059960; Gasch O, 2013, J ANTIMICROB CHEMOTH, V68, P1423, DOI 10.1093/jac/dkt016; Hogberg LD, 2010, TRENDS PHARMACOL SCI, V31, P509, DOI 10.1016/j.tips.2010.08.002; Hou Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep13637; Hou Z, 2013, ANTIMICROB AGENTS CH, V57, P5045, DOI 10.1128/AAC.00504-13; Hou Z, 2011, J INFECT DIS, V203, P273, DOI 10.1093/infdis/jiq029; Huang E, 2014, APPL ENVIRON MICROB, V80, P2700, DOI 10.1128/AEM.03775-13; Kharkwal GB, 2011, LASER SURG MED, V43, P755, DOI 10.1002/lsm.21080; Liu YQ, 2014, J CHROMATOGR B, V969, P249, DOI 10.1016/j.jchromb.2014.08.031; Ma CY, 2015, MOLECULES, V20, P17913, DOI 10.3390/molecules201017913; OZTEKIN A, 1985, PLANTA MED, V51, P431, DOI 10.1055/s-2007-969540; Piddock LJV, 2012, LANCET INFECT DIS, V12, P249, DOI 10.1016/S1473-3099(11)70316-4; Rossi F, 2014, NEW ENGL J MED, V370, P1524, DOI 10.1056/NEJMoa1303359; Sapp AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108868; Sette IMF, 2000, PHARM BIOL, V38, P318, DOI 10.1076/1388-0209(200009)3841-AFT318; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Tadros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075171; Theuretzbacher U, 2012, INT J ANTIMICROB AG, V39, P295, DOI 10.1016/j.ijantimicag.2011.12.006; TSAI I-L, 1989, Kaohsiung Journal of Medical Sciences, V5, P132; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; YOU M, 1995, J NAT PRODUCTS, V58, P598, DOI 10.1021/np50118a021	23	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143863	10.1371/journal.pone.0143863	http://dx.doi.org/10.1371/journal.pone.0143863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606133	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300116
J	Hepping, AM; Ploegmakers, JJW; Geertzen, JHB; Bulstra, SK; Stevens, M				Hepping, Ann M.; Ploegmakers, Joris J. W.; Geertzen, Jan H. B.; Bulstra, Sjoerd K.; Stevens, Martin			The Influence of Hand Preference on Grip Strength in Children and Adolescents; A Cross-Sectional Study of 2284 Children and Adolescents	PLOS ONE			English	Article							PINCH STRENGTH; LEFT-HANDEDNESS; 19-YEAR-OLDS; RELIABILITY; PERFORMANCE; SELECTION; VALIDITY; DOMINANT; VALUES; NORMS	Introduction In adults the preferred hand is often considered to be around 10% stronger than the non-preferred hand. Whether the same is true for children and adolescents remains unclear. The objective of this study is therefore to determine whether there is a difference in grip strength between the preferred and non-preferred hand in developing children, to establish whether this difference is similar for children of a different gender or hand preference, and whether there is a difference in grip strength of the preferred hand of left-preferent (LP) and right-preferent (RP) children. Design Cross-sectional study. Participants Participants were recruited from schools in the northern provinces of the Netherlands. The study included healthy children and adolescents in the age range of 4-17 years. Outcome Measures Each child was allowed a total of four attempts using the JAMAR hand dynamometer, two attempts with each hand. All individual attempts were scored. Hand preference was determined by asking which hand was used to write, or in the case of 4- and 5-year-olds, which hand was used to draw a shape. Results The study population comprised 2284 children and adolescents. RP boys and girls scored significantly higher with their preferred hand, the difference amounting to 9.5 and 10.1% respectively. LP girls scored significantly higher with their preferred hand, but this difference was only 3.0%. For LP boys no significant difference was found in favor of either hand. LP children score higher with the non-preferred hand and tie scores on both hands more often than RP children. Conclusion The 10% rule of hand preference is applicable to RP children ranging in age between 4 and 17 years, but not to LP children. In contrast to LP boys, LP girls are generally significantly stronger with their preferred hand.	[Hepping, Ann M.; Geertzen, Jan H. B.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Ploegmakers, Joris J. W.; Bulstra, Sjoerd K.; Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands	University of Groningen; University of Groningen	Hepping, AM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.	a.m.hepping@umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894				AGER CL, 1984, AM J OCCUP THER, V38, P107, DOI 10.5014/ajot.38.2.107; American Medical Association, 1993, GUIDES EVALUATION PE; American Society of Hand Therapists, 1992, CLIN ASSESSMENT RECO; ANNETT M, 1967, Q J EXP PSYCHOL, V19, P327, DOI 10.1080/14640746708400109; Armstrong CA, 1999, J HAND SURG-BRIT EUR, V24B, P421, DOI 10.1054/jhsb.1999.0236; BALOGUN JA, 1991, ARCH PHYS MED REHAB, V72, P280; Bear-Lehman Jane, 2002, J Hand Ther, V15, P340; BECHTOL CO, 1954, J BONE JOINT SURG AM, V36-A, P820, DOI 10.2106/00004623-195436040-00013; BEUKELAAR LJ, 1986, NEUROPSYCHOLOGIA, V24, P301, DOI 10.1016/0028-3932(86)90066-7; Bohannon RW, 2003, PERCEPT MOTOR SKILL, V96, P728, DOI 10.2466/PMS.96.3.728-730; Burmeister LF, 1974, SIZE STRENGTH DEV HA; Butterfield SA, 2009, PERCEPT MOTOR SKILL, V109, P362, DOI 10.2466/PMS.109.2.362-370; CARLIER M, 1993, NEUROPSYCHOLOGIA, V31, P233, DOI 10.1016/0028-3932(93)90087-G; Clerke A, 2001, AM J OCCUP THER, V55, P206, DOI 10.5014/ajot.55.2.206; CROSBY CA, 1994, J HAND SURG-AM, V19A, P665, DOI 10.1016/0363-5023(94)90280-1; Dassonville P, 1997, P NATL ACAD SCI USA, V94, P14015, DOI 10.1073/pnas.94.25.14015; De Smet L, 2001, J PEDIATR ORTHOP B, V10, P352, DOI 10.1097/00009957-200110000-00017; Fess EE., 1992, CLIN ASSESSMENT RECO, P41; Incel Nurgul Arinci, 2002, SMJ Singapore Medical Journal, V43, P234; Innes E, 1999, AUST OCCUP THER J, V46, P120, DOI DOI 10.1046/J.1440-1630.1999.00182.X; MATHIOWETZ V, 1986, AM J OCCUP THER, V40, P705, DOI 10.5014/ajot.40.10.705; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; Molenaar HM, 2008, J BONE JOINT SURG AM, V90A, P1053, DOI 10.2106/JBJS.G.00469; Molenaar HM, 2010, CLIN ORTHOP RELAT R, V468, P217, DOI 10.1007/s11999-009-0881-z; NEWMAN DG, 1984, ARCH DIS CHILD, V59, P453, DOI 10.1136/adc.59.5.453; PETERSEN P, 1989, AM J OCCUP THER, V43, P444, DOI 10.5014/ajot.43.7.444; Ploegmakers JJW, 2013, J PHYSIOTHER, V59, P255, DOI 10.1016/S1836-9553(13)70202-9; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; ROSZKOWSKI M J, 1981, Journal of Clinical Neuropsychology, V3, P199, DOI 10.1080/01688638108403126; ROSZKOWSKI MJ, 1982, INT J CLIN NEUROPSYC, V4, P35; Scharoun SM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00082; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; van den Beld WA, 2006, DISABIL REHABIL, V28, P1303, DOI 10.1080/09638280600631047; Vingerhoets G, 2012, HUM BRAIN MAPP, V33, P763, DOI 10.1002/hbm.21247; Yahagi S, 1999, NEUROSCI LETT, V276, P185, DOI 10.1016/S0304-3940(99)00823-X	36	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143476	10.1371/journal.pone.0143476	http://dx.doi.org/10.1371/journal.pone.0143476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599429	Green Submitted, gold, Green Published			2022-12-26	WOS:000365853900131
J	Kumagai, K; Tabu, K; Sasaki, F; Takami, Y; Morinaga, Y; Mawatari, S; Hashimoto, S; Tanoue, S; Kanmura, S; Tamai, T; Moriuchi, A; Uto, H; Tsubouchi, H; Ido, A				Kumagai, Kotaro; Tabu, Kazuaki; Sasaki, Fumisato; Takami, Yoichiro; Morinaga, Yuko; Mawatari, Seiichi; Hashimoto, Shinichi; Tanoue, Shiroh; Kanmura, Shuji; Tamai, Tsutomu; Moriuchi, Akihiro; Uto, Hirofumi; Tsubouchi, Hirohito; Ido, Akio			Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; DC-HIL; ENDOTHELIAL-CELLS; TISSUE-REPAIR; OSTEOACTIVIN; REGENERATION; EXPRESSION; ACTIVATION; RATS; DEPLETION	Background and aims Glycoprotein nonmetastatic melanoma B (Gpnmb), a transmembrane glycoprotein that is expressed in macrophages, negatively regulates inflammation. We have reported that Gpnmb is strongly expressed in the livers of rats fed a choline-deficient, L-amino acid-defined (CDAA) diet. However, the role of macrophage-expressed Gpnmb in liver injury is still unknown. This study aimed to clarify the characteristics of infiltrating macrophages that express Gpnmb, and the involvement of Gpnmb in the repair process in response to liver injury. Methods C57BL/6J, DBA/2J [DBA] and DBA/2J-Gpnmb(+) [DBA-g+] mice were treated with a single intraperitoneal injection of carbon tetrachloride (CCl4) at a dose of 1.0 mL/kg body weight. Mice were sacrificed at predetermined time points, followed by measurement of serum alanine aminotransferase (ALT) levels and histological examination. Expression of Gpnmb, pro-/anti-inflammatory cytokines, and profibrotic/antifibrotic factors were examined by quantitative RT-PCR and/or Western blotting. Immunohistochemistry, fluorescent immunostaining and flow cytometry were used to determine the expression of Gpnmb, CD68, CD11b and alpha-SMA, phagocytic activity, and the presence of apoptotic bodies. We used quantitative RT-PCR and ELISA to examine TGF-beta and MMP-13 expression and the concentrations and supernatants of isolated infiltrating hepatic macrophages transfected with siGpnmb. Results In C57BL/6J mice, serum ALT levels increased at two days after CCl4 injection and decreased at four days. Gpnmb expression in the liver was stimulated four days after CCl4 injection. Histological examination and flow cytometry showed that Gpnmb-positive cells were almost positive for CD68-positive macrophages, contained engulfed apoptotic bodies and exhibited enhanced phagocytic activity. Isolated infiltrating hepatic macrophages transfected with siGpnmb showed high MMP-13 secretion. There was no significant difference in the magnitude of CCl4-induced liver injury between DBA-g+ and DBA mice. However, hepatic MMP-13 expression, as well as alpha-SMA expression and collagen production, increased significantly in DBA-g+ compared with DBA mice. Conclusions Gpnmb-positive macrophages infiltrate the liver during the recovery phase of CCl4-induced acute liver injury and contribute to the balance between fibrosis and fibrolysis in the repair process following acute liver injury.	[Kumagai, Kotaro; Tabu, Kazuaki; Sasaki, Fumisato; Morinaga, Yuko; Mawatari, Seiichi; Hashimoto, Shinichi; Tanoue, Shiroh; Kanmura, Shuji; Tamai, Tsutomu; Moriuchi, Akihiro; Uto, Hirofumi; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima 890, Japan; [Takami, Yoichiro] Shujitsu Univ, Sch Pharm, Pharmaceut Care & Hlth Sci, Okayama, Japan; [Uto, Hirofumi] Miyazaki Med Ctr Hosp, Ctr Digest & Liver Dis, Miyazaki, Japan; [Tsubouchi, Hirohito] Kagoshima City Hosp, Kagoshima, Japan	Kagoshima University; Kagoshima City Hospital	Kumagai, K (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima 890, Japan.	kumakou@m2.kufm.kagoshima-u.ac.jp	Sasaki, Fumisato/AAQ-6470-2020	Sasaki, Fumisato/0000-0003-4824-4154	Ministry of Education, Culture, Sports, Science and Technology of Japan [22590742, 26461013]; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid for Scientific Research (#22590742, AI, https://kaken.nii.ac.jp/d/p/22590742.ja.html and #26461013, AI, https://kaken.nii.ac.jp/d/p/26461013.ja.html) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and for the Intractable Hepato-Biliary Diseases Study Group of Japan from the Ministry of Health, Labour and Welfare of Japan.	Abe H, 2007, BIOCHEM BIOPH RES CO, V356, P610, DOI 10.1016/j.bbrc.2007.03.035; Ahn JH, 2002, BLOOD, V100, P1742, DOI 10.1182/blood.V100.5.1742.h81702001742_1742_1754; Alber A, 2012, INT J EXP PATHOL, V93, P243, DOI 10.1111/j.1365-2613.2012.00833.x; Bachner Dietmar, 2002, Brain Res Gene Expr Patterns, V1, P159; Bohm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085; Bourbonnais E, 2012, GASTROENTEROLOGY, V142, P130, DOI 10.1053/j.gastro.2011.09.033; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Chung JS, 2007, BLOOD, V109, P4320, DOI 10.1182/blood-2006-11-053769; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Dechene A, 2010, HEPATOLOGY, V52, P1008, DOI 10.1002/hep.23754; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Haralanova-Ilieva B, 2005, J HEPATOL, V42, P565, DOI 10.1016/j.jhep.2004.12.021; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Hu SL, 2009, EUR J PHARMACOL, V616, P287, DOI 10.1016/j.ejphar.2009.06.044; Imamura M, 2005, GASTROENTEROLOGY, V128, P138, DOI 10.1053/j.gastro.2004.10.005; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mo JS, 2003, J EXP MED, V197, P1335, DOI 10.1084/jem.20022041; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1152/ajpcell.00565.2004; Onaga M, 2003, J HEPATOL, V39, P779, DOI 10.1016/S0168-8278(03)00361-1; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Possamai LA, 2014, J HEPATOL, V61, P439, DOI 10.1016/j.jhep.2014.03.031; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042596; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369	44	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143413	10.1371/journal.pone.0143413	http://dx.doi.org/10.1371/journal.pone.0143413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599547	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900113
J	Novgorodov, SA; Riley, CL; Keffler, JA; Yu, J; Kindy, MS; Macklin, WB; Lombard, DB; Gudz, TI				Novgorodov, Sergei A.; Riley, Christopher L.; Keffler, Jarryd A.; Yu, Jin; Kindy, Mark S.; Macklin, Wendy B.; Lombard, David B.; Gudz, Tatyana I.			SIRT3 Deacetylates Ceramide Synthases IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; MANGANESE SUPEROXIDE-DISMUTASE; PERMEABILITY TRANSITION PORE; RADIATION-INDUCED APOPTOSIS; OXYGEN SPECIES GENERATION; REACTIVE OXYGEN; CYCLOPHILIN-D; CELL-DEATH; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID BIOSYNTHESIS	Experimental evidence supports the role of mitochondrial ceramide accumulation as a cause of mitochondrial dysfunction and brain injury after stroke. Herein, we report that SIRT3 regulates mitochondrial ceramide biosynthesis via deacetylation of ceramide synthase (CerS) 1, 2, and 6. Reciprocal immunoprecipitation experiments revealed that CerS1, CerS2, and CerS6, but not CerS4, are associated with SIRT3 in cerebral mitochondria. Furthermore, CerS1, -2, and -6 are hyperacetylated in the mitochondria of SIRT3-null mice, and SIRT3 directly deacetylates the ceramide synthases in aNAD(+)-dependent manner that increases enzyme activity. Investigation of the SIRT3 role in mitochondrial response to brain ischemia/reperfusion (IR) showed that SIRT3-mediated deacetylation of ceramide synthases increased enzyme activity and ceramide accumulation after IR. Functional studies demonstrated that absence of SIRT3 rescued the IR-induced blockade of the electron transport chain at the level of complex III, attenuated mitochondrial outer membrane permeabilization, and decreased reactive oxygen species generation and protein carbonyls in mitochondria. Importantly, Sirt3 gene ablation reduced the brain injury after IR. These data support the hypothesis that IR triggers SIRT3-dependent deacetylation of ceramide synthases and the elevation of ceramide, which could inhibit complex III, leading to increased reactive oxygen species generation and brain injury. The results of these studies highlight a novel mechanism of SIRT3 involvement in modulating mitochondrial ceramide biosynthesis and suggest an important role of SIRT3 in mitochondrial dysfunction and brain injury after experimental stroke.	[Riley, Christopher L.; Kindy, Mark S.; Gudz, Tatyana I.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Novgorodov, Sergei A.; Keffler, Jarryd A.; Yu, Jin; Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci Med, Charleston, SC 29425 USA; [Macklin, Wendy B.] Univ Colorado, Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Lombard, David B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lombard, David B.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gudz, TI (corresponding author), 114 Doughty St, Charleston, SC 29425 USA.	gudz@musc.edu		Lombard, David/0000-0002-4292-0185	National Institutes of Health [R01NS083544, R01GM101171, P30 GM103339]; Veterans Affairs Merit Award [I01BX001104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101171, P30GM103339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083544] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001104, I01BX002991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants R01NS083544 (to T. I. G.), R01GM101171 (to D. B. L.), and P30 GM103339 (to Lipidomics Core Facility. Medical University of South Carolina) and Veterans Affairs Merit Award I01BX001104 (to T. I. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Anderson MF, 1999, J NEUROCHEM, V73, P1189, DOI 10.1046/j.1471-4159.1999.0731189.x; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Chan PH, 2004, STROKE, V35, P2748, DOI 10.1161/01.STR.0000143325.25610.ac; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; DIRNAGL U, 1995, J CEREBR BLOOD F MET, V15, P929, DOI 10.1038/jcbfm.1995.118; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; Gillies LA, 2015, MOL BIOL CELL, V26, P339, DOI 10.1091/mbc.E13-11-0638; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Herr I, 1999, BRAIN RES, V826, P210, DOI 10.1016/S0006-8993(99)01288-3; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Hirschey MD, 2011, AGING-US, V3, P635, DOI 10.18632/aging.100339; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Keller JN, 1998, J NEUROSCI, V18, P687; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Kincaid B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00048; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kurek K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/980815; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Li C, 2011, DIABETES RES CLIN PR, V93, P77, DOI 10.1016/j.diabres.2011.03.017; Li Y, 1998, J NEUROL SCI, V156, P119, DOI 10.1016/S0022-510X(98)00036-7; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mori T, 1999, BRAIN RES, V816, P350, DOI 10.1016/S0006-8993(98)01124-X; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Novgorodov S. A., 2011, INT J BIOCH MOL BIOL, V2, P34; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Novgorodov SA, 2014, J BIOL CHEM, V289, P13142, DOI 10.1074/jbc.M113.530311; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Ohtani R, 2004, BRAIN RES, V1023, P31, DOI 10.1016/j.brainres.2004.07.024; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Park TS, 2008, PHARMACOL RES, V58, P45, DOI 10.1016/j.phrs.2008.06.005; Patwardhan GA, 2016, J BIOENERG BIOMEMBR, V48, P153, DOI 10.1007/s10863-015-9602-3; Pillai VB, 2010, CARDIOVASC RES, V88, P250, DOI 10.1093/cvr/cvq250; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Shulga N, 2010, J CELL SCI, V123, P4117, DOI 10.1242/jcs.073502; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Shulyakova N, 2014, BRAIN RES, V1587, P40, DOI 10.1016/j.brainres.2014.08.066; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Volkmann N, 2014, CELL DEATH DIFFER, V21, P206, DOI 10.1038/cdd.2013.153; Watts LT, 2013, BRAIN SCI, V3, P540, DOI 10.3390/brainsci3020540; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85	81	48	51	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1957	1973		10.1074/jbc.M115.668228	http://dx.doi.org/10.1074/jbc.M115.668228			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26620563	Green Published, hybrid			2022-12-26	WOS:000368620700033
J	Nakano, M; Fukami, T; Gotoh, S; Takamiya, M; Aoki, Y; Nakajima, M				Nakano, Masataka; Fukami, Tatsuki; Gotoh, Saki; Takamiya, Masataka; Aoki, Yasuhiro; Nakajima, Miki			RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-INOSINE RNA; ADENOSINE DEAMINASES; HEPATOCELLULAR-CARCINOMA; HUMAN TRANSCRIPTOME; ADAR DEAMINASES; LIVER FIBROSIS; 2 FORMS; CELLS; BINDING; CANCER	Adenosine to inosine (A-to-I) RNA editing is the most frequent type of post-transcriptional nucleotide conversion in humans, and it is catalyzed by adenosine deaminase acting on RNA(ADAR) enzymes. In this study we investigated the effect of RNA editing on human aryl hydrocarbon receptor (AhR) expression because the AhR transcript potentially forms double-stranded structures, which are targets of ADAR enzymes. In human hepatocellular carcinoma-derived Huh-7 cells, the ADAR1 knockdown reduced the RNA editing levels in the 3'-untranslated region (3'-UTR) of the AhR transcript and increased the AhR protein levels. The ADAR1 knockdown enhanced the ligand-mediated induction of CYP1A1, a gene downstream of AhR. We investigated the possibility that A-to-I RNA editing creates miRNA targeting sites in the AhR mRNA and found that the miR-378-dependent down-regulation of AhR was abolished by ADAR1 knockdown. These results indicated that the ADAR1-mediated down-regulation of AhR could be attributed to the creation of a miR-378 recognition site in the AhR3'-UTR. The interindividual differences in the RNA editing levels within the AhR 3'-UTR in a panel of 32 human liver samples were relatively small, whereas the differences in ADAR1 expression were large (220-fold). In the human liver samples a significant inverse association was observed between the miR378 and AhR protein levels, suggesting that the RNA-editing dependent down-regulation of AhR by miR-378 contributes to the variability in the constitutive hepatic expression of AhR. In conclusion, this study uncovered for the first time that A-to-I RNA editing modulates the potency of xenobiotic metabolism in the human liver.	[Nakano, Masataka; Fukami, Tatsuki; Gotoh, Saki; Nakajima, Miki] Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan; [Takamiya, Masataka; Aoki, Yasuhiro] Iwate Med Univ, Sch Med, Dept Legal Med, Morioka, Iwate 0208505, Japan	Kanazawa University; Iwate Medical University	Nakajima, M (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	nmiki@p.kanazawa-u.ac.jp	Nakajima, Miki/C-3990-2015	Fukami, Tatsuki/0000-0003-2416-5988	Japan Society for the Promotion of Science [15H04663]; Smoking Research Foundation in Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation in Japan	This work was supported by Japan Society for the Promotion of Science Grant-in-aid for Scientific Research (B) 15H04663 and a grant from the Smoking Research Foundation in Japan. The authors declare that they have no conflicts of interest with contents of this article.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 1997, RNA, V3, P947; Bazak L, 2014, NUCLEIC ACIDS RES, V42, P6876, DOI 10.1093/nar/gku414; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Gerber A, 1997, RNA, V3, P453; HAYASHI S, 1994, CARCINOGENESIS, V15, P801, DOI 10.1093/carcin/15.5.801; Iwanari M, 2002, ARCH TOXICOL, V76, P287, DOI 10.1007/s00204-002-0340-z; Jeon TI, 2013, MOL NUTR FOOD RES, V57, P1931, DOI 10.1002/mnfr.201300071; Kallman AM, 2003, NUCLEIC ACIDS RES, V31, P4874, DOI 10.1093/nar/gkg681; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kurtz CL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12911; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Liang H, 2007, RNA, V13, P463, DOI 10.1261/rna.296407; Ma JC, 2014, CELL PHYSIOL BIOCHEM, V34, P2266, DOI 10.1159/000369669; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Mohri T, 2010, BIOCHEM PHARMACOL, V79, P1045, DOI 10.1016/j.bcp.2009.11.015; Nakano M, 2015, DRUG METAB DISPOS, V43, P1450, DOI 10.1124/dmd.115.065664; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Paschen W, 1996, J CEREBR BLOOD F MET, V16, P548, DOI 10.1097/00004647-199607000-00004; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pierre S, 2014, TOXICOL SCI, V137, P114, DOI 10.1093/toxsci/kft236; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; Ramadoss Preeti, 2005, Expert Opin Drug Metab Toxicol, V1, P9, DOI 10.1517/17425255.1.1.9; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Tsuchiya Y, 2004, CANCER RES, V64, P3119, DOI 10.1158/0008-5472.CAN-04-0166; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang Qiong, 2013, RNA, V19, P1525, DOI 10.1261/rna.041533.113; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	42	34	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					894	903		10.1074/jbc.M115.699363	http://dx.doi.org/10.1074/jbc.M115.699363			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26601943	Green Published, hybrid			2022-12-26	WOS:000367830500035
J	Peng, XR; Wu, HB; Peng, XM; Jin, CZ; Wu, NP				Peng, Xiaorong; Wu, Haibo; Peng, Xiuming; Jin, Changzhong; Wu, Nanping			Heterogeneous Evolution of HIV-1 CRF01_AE in Men Who Have Sex with Men (MSM) and Other Populations in China	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; INFERENCE; EPIDEMIC; SUBTYPES; ENVELOPE	Introduction The HIV epidemic in men who have sex with men (MSM) continues to grow in most countries. However, the phylodynamic and virological differences among HIV-1 strains circulating in MSM and other populations are not well characterized. Methods Nearly full-length genomes (NFLGs) of the HIV-1 CRF01_AE were obtained from the Los Alamos HIV database. Phylogenetic analyses were conducted using the NFLG, gag, pol and env genes, using the maximum likelihood method. Selection pressure analyses at the codon level were performed for each gene in the phylogenetic clusters using PAML. Results Sequences isolated from MSM in China clustered in Clusters 1 (92.5%) and 2 (85.71%). The major risk factor for Cluster 3 was heterosexual transmission (62.16%). The ratio of non-synonymous to synonymous substitutions in the env gene (0.7-0.75) was higher than the gag (0.26-0.34) or pol (0.21-0.26) genes. In env gene, Cluster 1 (4.56x10-3subs/site/year) and 2 (6.01x10-3subs/site/year) had higher evolutionary rates than Cluster 3 (1.14x10-3subs/site/year). Positive selection affected 4.2-6.58% of the amino acid sites in the env gene. Two sites (HXB2: 136 and 316) evolved similarly in Clusters 1 and 2, but not Cluster 3. Conclusion The HIV-1 CRF01_AE in MSM is evolving differently than in other populations.	[Peng, Xiaorong; Wu, Haibo; Peng, Xiuming; Jin, Changzhong; Wu, Nanping] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Affiliated Hosp 1,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Wu, NP (corresponding author), Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Affiliated Hosp 1,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	flwnp2013@163.com	peng, xiaorong/F-5442-2015	peng, xiaorong/0000-0001-7833-4885	Mega-Project for National Science and Technology Development under "12th, Five-Year Plan of China" [2013ZX10004-904]	Mega-Project for National Science and Technology Development under "12th, Five-Year Plan of China"	This study was supported in part by grants from the Mega-Project for National Science and Technology Development under the "12th, Five-Year Plan of China" (2013ZX10004-904).	Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Birrell PJ, 2013, LANCET INFECT DIS, V13, P313, DOI 10.1016/S1473-3099(12)70341-9; China. MoHotPsRo, 2010, CHIN 2010 UNGASS COU; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Han XX, 2013, JAIDS-J ACQ IMM DEF, V64, P16, DOI 10.1097/QAI.0b013e3182932210; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rangel HR, 2003, J VIROL, V77, P9069, DOI 10.1128/JVI.77.16.9069-9073.2003; Sergei L KPA, 2007, FROST ESTIMATING SEL, V2007; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1	21	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143699	10.1371/journal.pone.0143699	http://dx.doi.org/10.1371/journal.pone.0143699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26623642	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600045
J	Le Bourvellec, C; Bureau, S; Renard, CMGC; Plenet, D; Gautier, H; Touloumet, L; Girard, T; Simon, S				Le Bourvellec, Carine; Bureau, Sylvie; Renard, Catherine M. G. C.; Plenet, Daniel; Gautier, Helene; Touloumet, Line; Girard, Thierry; Simon, Sylvaine			Cultivar and Year Rather than Agricultural Practices Affect Primary and Secondary Metabolites in Apple Fruit	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITIES; GOLDEN DELICIOUS APPLES; MALUS X DOMESTICA; CROP LOAD; POLYPHENOL COMPOSITION; ANTIOXIDANT ACTIVITY; PRODUCTION SYSTEMS; PHENOLIC-COMPOUNDS; CHLOROGENIC ACID; ORGANIC-ACIDS	Many biotic and abiotic parameters affect the metabolites involved in the organoleptic and health value of fruits. It is therefore important to understand how the growers' decisions for cultivar and orchard management can affect the fruit composition. Practices, cultivars and/or year all might participate to determine fruit composition. To hierarchize these factors, fruit weight, dry matter, soluble solids contents, titratable acidity, individual sugars and organics acids, and phenolics were measured in three apple cultivars ('Ariane', 'Melrose' and 'Smoothee') managed under organic, low-input and conventional management. Apples were harvested at commercial maturity in the orchards of the cropping system experiment BioREco at INRA Gotheron (Drome, 26) over the course of three years (2011, 2012 and 2013). The main factors affecting primary and secondary metabolites, in both apple skin and flesh, were by far the cultivar and the yearly conditions, while the management system had a very limited effect. When considering the three cultivars and the year 2011 to investigate the effect of the management system per se, only few compounds differed significantly between the three systems and in particular the total phenolic content did not differ significantly between systems. Finally, when considering orchards grown in the same pedoclimatic conditions and of the same age, instead of the usual organic vs. conventional comparison, the effect of the management system on the apple fruit quality (Fruit weight, dry matter, soluble solids content, titratable acidity, individual sugars, organic acids, and phenolics) was very limited to non-significant. The main factors of variation were the cultivar and the year of cropping rather than the cropping system. More generally, as each management system (e.g. conventional, organic...) encompasses a great variability of practices, this highlights the importance of accurately documenting orchard practices and design beside the generic type of management in such studies.	[Le Bourvellec, Carine; Bureau, Sylvie; Renard, Catherine M. G. C.; Plenet, Daniel; Gautier, Helene; Touloumet, Line; Girard, Thierry; Simon, Sylvaine] INRA, Secur & Qual Prod Origine Vegetale UMR408, Avignon, France; [Le Bourvellec, Carine; Bureau, Sylvie; Renard, Catherine M. G. C.; Touloumet, Line] Univ Avignon & Pays Vaucluse, Secur & Qual Prod Origine Vegetale UMR, Avignon, France; [Plenet, Daniel; Gautier, Helene] INRA, Plantes & Syst Culture Horticoles UR1115, Avignon, France; [Girard, Thierry; Simon, Sylvaine] INRA, Domaine Gotheron, Rech Integrees UE695, St Marcel, France	INRAE; Avignon Universite; INRAE; INRAE	Le Bourvellec, C (corresponding author), INRA, Secur & Qual Prod Origine Vegetale UMR408, Avignon, France.	carine.lebourvellec@avignon.inra.fr	Renard, Catherine M.G.C./F-1137-2015; Renard, Catherine/AAH-4723-2019	Renard, Catherine M.G.C./0000-0002-8904-5517; Renard, Catherine/0000-0002-8904-5517; Le Bourvellec, Carine/0000-0003-3434-4082; BUREAU, Sylvie/0000-0002-9335-5091				Awad MA, 2001, SCI HORTIC-AMSTERDAM, V91, P227, DOI 10.1016/S0304-4238(01)00266-7; Brat P, 2006, J NUTR, V136, P2368, DOI 10.1093/jn/136.9.2368; Bureau S, 2013, ANAL CHEM, V85, P11312, DOI 10.1021/ac402428s; Bureau S, 2012, J AGR FOOD CHEM, V60, P3551, DOI 10.1021/jf204785w; Chaves N, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P267; Chinnici F, 2004, J AGR FOOD CHEM, V52, P4684, DOI 10.1021/jf049770a; Cordella CBY, 2014, TRAC-TREND ANAL CHEM, V54, P75, DOI 10.1016/j.trac.2013.10.009; Debaeke P, 2009, AGRON SUSTAIN DEV, V29, P73, DOI [10.1051/agro:2008050, 10.1007/978-90-481-2666-8_43]; DEBERARDINIS E, 1994, ECOL MODEL, V72, P115, DOI 10.1016/0304-3800(94)90147-3; Eisele TA, 2005, J FOOD COMPOS ANAL, V18, P213, DOI 10.1016/j.jfca.2004.01.002; Fauriel J., 2007, Improving sustainability in organic and low input food production systems. Proceedings of the 3rd International Congress of the European Integrated Project Quality Low Input Food (QLIF), University of Hohenheim, Germany, 20-23 March, 2007, P122; Fiche Technique Pomme, 2014, LE PORTAIL DE LAGROA; Giorgi A, 2009, FOOD CHEM, V114, P204, DOI 10.1016/j.foodchem.2008.09.039; Guyot S, 2002, LEBENSM-WISS TECHNOL, V35, P289, DOI 10.1006/fstl.2001.0843; Guyot S, 2001, J AGR FOOD CHEM, V49, P14, DOI 10.1021/jf000814z; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Jakopic J, 2012, FRUITS, V67, P377, DOI 10.1051/fruits/2012032; Khanizadeh S, 2008, J FOOD COMPOS ANAL, V21, P396, DOI 10.1016/j.jfca.2008.03.004; Knekt P, 1996, BRIT MED J, V312, P478, DOI 10.1136/bmj.312.7029.478; Kviklys D, 2014, PLANT SOIL ENVIRON, V60, P234, DOI 10.17221/71/2014-PSE; Lamperi L, 2008, J AGR FOOD CHEM, V56, P6536, DOI 10.1021/jf801378m; Le Bourvellec C, 2011, J FOOD COMPOS ANAL, V24, P537, DOI 10.1016/j.jfca.2010.12.012; Marks SC, 2007, J SCI FOOD AGR, V87, P719, DOI 10.1002/jsfa.2778; Martinez-Palou A, EUROSTAT STATISTICS; Mikulic-Petkovsek M, 2010, J SCI FOOD AGR, V90, P2366, DOI 10.1002/jsfa.4093; Mikulic-Petkovsek M, 2007, SCI HORTIC-AMSTERDAM, V114, P37, DOI 10.1016/j.scienta.2007.05.004; Plenet D, 2010, INNOVATIONS AGRONOMI, V9, P85; Renard CMGC, 2007, PHYTOCHEMISTRY, V68, P1128, DOI 10.1016/j.phytochem.2007.02.012; Roth E, 2007, POSTHARVEST BIOL TEC, V45, P11, DOI 10.1016/j.postharvbio.2007.01.006; Roussos PA, 2009, SCI HORTIC-AMSTERDAM, V123, P247, DOI 10.1016/j.scienta.2009.09.011; Sanoner P, 1999, J AGR FOOD CHEM, V47, P4847, DOI 10.1021/jf990563y; Savakin K, 2014, JOURNAL OF FOOD COMP, V35, P101; Simon S, 2015, PROCEEDING 5TH INTER, P411; Simon S, 2011, AGRON SUSTAIN DEV, V31, P541, DOI 10.1007/s13593-011-0003-7; Stopar M, 2002, J AGR FOOD CHEM, V50, P1643, DOI 10.1021/jf011018b; Stracke BA, 2009, J AGR FOOD CHEM, V57, P4598, DOI 10.1021/jf803961f; do Amarante CVT, 2008, PESQUI AGROPECU BRAS, V43, P333, DOI 10.1590/S0100-204X2008000300007; Tomas-Barberan F, 2001, J SCI FOOD AGR, V81, P853, DOI 10.1002/jsfa.885; Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298; Unuk T, 2006, ACTA HORTIC, P173, DOI 10.17660/ActaHortic.2006.721.22; Valavanidis A, 2009, INT J FOOD SCI TECH, V44, P1167, DOI 10.1111/j.1365-2621.2009.01937.x; Veberic R, 2005, J SCI FOOD AGR, V85, P1687, DOI 10.1002/jsfa.2113; Volz RK, 2011, J AGR FOOD CHEM, V59, P11509, DOI 10.1021/jf202680h; Vrhovsek U, 2004, J AGR FOOD CHEM, V52, P6532, DOI 10.1021/jf049317z; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wojdylo A, 2008, J AGR FOOD CHEM, V56, P6520, DOI 10.1021/jf800510j; Xia GH, 2009, J AM SOC HORTIC SCI, V134, P126, DOI 10.21273/JASHS.134.1.126; Yuri AJ, 2012, JOURNAL OF FOOD AGRI, V10, P207	48	17	17	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0141916	10.1371/journal.pone.0141916	http://dx.doi.org/10.1371/journal.pone.0141916			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618711	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800010
J	Savage-McGlynn, E; Redshaw, M; Heron, J; Stein, A; Quigley, MA; Evans, J; Ramchandani, P; Gray, R				Savage-McGlynn, Emily; Redshaw, Maggie; Heron, Jon; Stein, Alan; Quigley, Maria A.; Evans, Jonathan; Ramchandani, Paul; Gray, Ron			Mechanisms of Resilience in Children of Mothers Who Self-Report with Depressive Symptoms in the First Postnatal Year	PLOS ONE			English	Article							MATERNAL DEPRESSION; BEHAVIOR; INFANTS; FAMILY; RISK; INTERVENTIONS; POSTPARTUM; ATTACHMENT; PREGNANCY; STRENGTHS	Background Symptoms of maternal postnatal depression are associated with an increased risk of adverse effects on child development. However, some children exposed to postnatal depression have outcomes similar to unexposed children, and can be referred to as resilient. This study aimed to determine the mechanisms of resilience in children exposed to depressive symptoms postnatally. Method Data are from a prospective cohort study, the Avon Longitudinal Study of Parents and Children. Self-report questionnaire data were collected during pregnancy and the child's first 2 years regarding maternal views of parenting and her perception of the child. The Edinburgh Postnatal Depression Scale (EPDS) was completed postnatally at 8 months and the Strengths and Difficulties Questionnaire (SDQ) at age 11 years. Exposed children who scored above the median score of non-exposed children were defined as resilient. Structural equation modeling was used to investigate the development of resilience. Results From the core ALSPAC cohort, 1,009 children (6.9%) were exposed to maternal depression at 8 months postnatally. The SDQ total difficulties scores at 11 years of age indicated that 325 (32.2%) were resilient, 684 were non-resilient. Maternal positive feelings about parenting and child non-verbal communication at 15 months increased the likelihood of later resilience. Conclusions In this study, resilience was associated with two factors: the child's nonverbal communication at 15 months and by maternal positive feelings about parenting. Early intervention to support mother-child interaction and foster child development in women identified with postnatal depressive symptoms may benefit later child resilience.	[Savage-McGlynn, Emily; Redshaw, Maggie; Quigley, Maria A.; Gray, Ron] Univ Oxford, Natl Perinatal Epidemiol Unit, Policy Res Unit Maternal Hlth & Care, Oxford, England; [Heron, Jon] Univ Bristol, Fac Med & Dent, Sch Social & Community Med, Bristol, Avon, England; [Stein, Alan] Univ Oxford, Dept Psychiat, Oxford, England; [Evans, Jonathan] Univ Bristol, Ctr Acad Mental Hlth, Bristol, Avon, England; [Ramchandani, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	University of Oxford; University of Bristol; University of Oxford; University of Bristol; Imperial College London	Redshaw, M (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Policy Res Unit Maternal Hlth & Care, Oxford, England.	maggie.redshaw@npeu.ox.ac.uk	Heron, Jon/D-5884-2011; Ramchandani, Paul/O-5340-2014	Heron, Jon/0000-0001-6199-5644; Evans, Jonathan/0000-0003-3171-640X; Ramchandani, Paul/0000-0003-3646-2410; Stein, Alan/0000-0001-8207-2822; Quigley, Maria/0000-0002-8058-6181	Wellcome Trust [092731]; Policy Research Programme in the Department of Health, England [108/0001]; UK Medical Research Council; University of Bristol; Medical Research Council [MC_PC_15018] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Policy Research Programme in the Department of Health, England; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council, the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. This paper reports on an independent study which was funded by the Policy Research Programme in the Department of Health, England (Grant 108/0001).	[Anonymous], 2011, STAT STAT SOFTW REL; [Anonymous], [No title captured]; Appelbaum M, 1999, DEV PSYCHOL, V35, P1297; Asparouhov T., 2010, MPLUS TECHNICAL APPE; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Barker ED, 2012, BRIT J PSYCHIAT, V200, P124, DOI 10.1192/bjp.bp.111.092346; Beardslee WR, 2003, PEDIATRICS, V112, pE119, DOI 10.1542/peds.112.2.e119; Beeghly M, 2011, CURR PROB PEDIATR AD, V41, P197, DOI 10.1016/j.cppeds.2011.02.005; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brennan PA, 2003, J AM ACAD CHILD PSY, V42, P1469, DOI 10.1097/00004583-200312000-00014; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Caldwell B., 1984, HOME OBSERVATION MEA; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; De Haan L, 2002, AM J FAM THER, V30, P275, DOI 10.1080/01926180290033439; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Fenson L., 1991, TECHNICAL MANUAL MAC; Fergusson DM, 1996, PAEDIATR PERINAT EP, V10, P279, DOI 10.1111/j.1365-3016.1996.tb00051.x; FIELD T, 1990, DEV PSYCHOL, V26, P7, DOI 10.1037/0012-1649.26.1.7; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; FONAGY P, 1994, J CHILD PSYCHOL PSYC, V35, P231, DOI 10.1111/j.1469-7610.1994.tb01160.x; Fraser A, 2012, INT J EPIDEMIOLOGY; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; GELFAND DM, 1990, CLIN PSYCHOL REV, V10, P329, DOI 10.1016/0272-7358(90)90065-I; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Grace S L, 2003, Arch Womens Ment Health, V6, P263, DOI 10.1007/s00737-003-0024-6; HARRIS B, 1989, BRIT J PSYCHIAT, V154, P813, DOI 10.1192/bjp.154.6.813; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Hewitt CE, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13360; Hill M., 2007, PARENTING RESILIENCE; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hutman T, 2012, INFANT BEHAV DEV, V35, P561, DOI 10.1016/j.infbeh.2012.05.007; Jaffee SR, 2007, CHILD ABUSE NEGLECT, V31, P231, DOI 10.1016/j.chiabu.2006.03.011; Jones E., 2013, FAMILY STRESSORS CHI; Kabir K, 2008, PEDIATRICS, V122, pE696, DOI 10.1542/peds.2007-1759; Kim G, 2010, INFANT BEHAV DEV, V33, P189, DOI 10.1016/j.infbeh.2009.12.009; Letourneau N, 1997, INFANT YOUNG CHILD, V9, P36, DOI 10.1097/00001163-199701000-00006; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Luthar S.S., 2003, RESILIENCE VULNERABI, P510, DOI [DOI 10.1017/CBO9780511615788, 10.1017/CBO9780511615788]; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Luthar SS, 2000, DEV PSYCHOPATHOL, V12, P857, DOI 10.1017/S0954579400004156; Martins C, 2000, J CHILD PSYCHOL PSYC, V41, P737, DOI 10.1111/1469-7610.00661; Masten A. S., 2006, ENCY EARLY CHILDHOOD, P1, DOI DOI 10.1146/ANNUREV.PSYCH.60.110707.163612; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Maughan A, 2007, J ABNORM CHILD PSYCH, V35, P685, DOI 10.1007/s10802-007-9129-0; McDonald RP, 1999, TEST THEORY UNIFIED; Murray L, 1997, ARCH DIS CHILD, V77, P99, DOI 10.1136/adc.77.2.99; Murray L., 2010, HDB INFANT DEV, V2; Murray L, 2011, J AM ACAD CHILD PSY, V50, P460, DOI 10.1016/j.jaac.2011.02.001; Murray L, 2010, J CHILD PSYCHOL PSYC, V51, P1150, DOI 10.1111/j.1469-7610.2010.02259.x; Muthen L.K., 2012, SOFTWARE MPLUS VERSI; Poole Helen, 2006, Community Pract, V79, P363; Ramchandani PG, 2013, BRIT J PSYCHIAT, V202, P84, DOI 10.1192/bjp.bp.112.115659; RICHTERS JE, 1992, PSYCHOL BULL, V112, P485, DOI 10.1037/0033-2909.112.3.485; RUTTER M, 1993, J ADOLESCENT HEALTH, V14, P626, DOI 10.1016/1054-139X(93)90196-V; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Sassi Roberto B, 2013, J Am Acad Child Adolesc Psychiatry, V52, P1, DOI 10.1016/j.jaac.2012.10.014; Shakespeare J, 2003, BRIT J GEN PRACT, V53, P614; Sokolowski MB, 2013, NEW SCI, V217, P28, DOI 10.1016/S0262-4079(13)60228-6; Solantaus T, 2010, EUR CHILD ADOLES PSY, V19, P883, DOI 10.1007/s00787-010-0135-3; Stamp GE, 1996, BIRTH-ISS PERINAT C, V23, P218, DOI 10.1111/j.1523-536X.1996.tb00498.x; Stein A, 2012, J ABNORM PSYCHOL, V121, P795, DOI 10.1037/a0026847; Stein A, 2009, PSYCHOPATHOLOGY, V42, P11, DOI 10.1159/000173699; Sutter-Dallay AL, 2003, INFANCY, V4, P589, DOI 10.1207/S15327078IN0404_10; TETI DM, 1991, CHILD DEV, V62, P918, DOI 10.2307/1131143; Whitton A, 1996, INT REV PSYCHIATR, V8, P73, DOI 10.3109/09540269609037819	70	15	15	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0142898	10.1371/journal.pone.0142898	http://dx.doi.org/10.1371/journal.pone.0142898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7NW	26618860	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800020
J	Amanzada, A; Reinhardt, L; Fey, D; Zeisberg, EM; Mihm, S				Amanzada, Ahmad; Reinhardt, Lars; Fey, Dorothea; Zeisberg, Elisabeth M.; Mihm, Sabine			Hepatic Interferon-lambda 3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LAMBDA-S; IL28B; CLEARANCE; GENOTYPE; VIRUS	Genetic polymorphisms in the region of the interferon-lambda genes (IFNL) associate with clearance of hepatitis C virus (HCV) infection. One of these polymorphisms, IFNL4 rs368234815, determines loss or gain of function of the IFNL4 gene by frameshift variation. The very same and a second one, IFNL3 rs4803217, are supposed to impact the expression of IFNL3: while IFNL4 rs368234815 is suggested to modulate IFNL3 transcription, IFNL3 rs4803217 is thought to alter IFNL3 mRNA stability. The latter process is believed to be partially driven by an HCV-induced ectopic expression of myosin heavy chain genes 7B and 7 and their coexpressed microRNAs mir499 and mir208B. These ideas are evidenced by functional investigations on peripheral blood mononuclear and hepatoma cells in culture. Our study aimed at exploring IFNL3 gene expression in clinical samples, i.e., in ex vivo derived liver tissue from patients with chronic hepatitis C (n = 57) and various other diseases (n = 56). By applying an assay designed to specifically quantify IFNL3 and discriminating paralogous IFNL2 transcripts, IFNL3 mRNA expression was not found to differ significantly between chronic hepatitis C and control samples. Among patients with chronic HCV infection, moreover, IFNL3 rs4803217 or IFNL4 rs368234815 minor alleles did not associate with reduced IFNL3 gene expression. Finally, myosin heavy chain genes 7B and 7 and corresponding microRNAs mir499 and mir208B were not found activated in liver in chronic HCV infection. Of note, detectability of MYH7 mRNA related to the procedure of liver biopsy sampling, as tissue obtained by direct punctation of the liver during laparoscopic inspection was less likely to contain MYH7 transcripts than samples acquired by percutaneous punctation. In conclusion, data on ex vivo derived liver tissue samples argue against an attenuating impact of IFNL3 rs4803217 or IFNL4 rs368234815 minor alleles on hepatic IFNL3 gene expression in vivo.	[Amanzada, Ahmad; Reinhardt, Lars; Fey, Dorothea; Mihm, Sabine] Univ Gottingen, Univ Med Ctr, Dept Gastroenterol & Gastrointestinal Oncol, D-37073 Gottingen, Germany; [Zeisberg, Elisabeth M.] Univ Gottingen, Univ Med Ctr, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany; [Zeisberg, Elisabeth M.] DZHK German Ctr Cardiovasc Res, Gottingen, Germany	University of Gottingen; University of Gottingen; German Centre for Cardiovascular Research	Mihm, S (corresponding author), Univ Gottingen, Univ Med Ctr, Dept Gastroenterol & Gastrointestinal Oncol, D-37073 Gottingen, Germany.	smihm@med.uni-goettingen.de	Zeisberg, Elisabeth/ABG-4970-2021		Deutsche Forschungsgemeinschaft (DFG) [MI 474/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) to SM [grant number MI 474/1-1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084026; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Chu TW, 2012, GASTROENTEROLOGY, V142, P790, DOI 10.1053/j.gastro.2011.12.057; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Matsuura K, 2014, J GASTROEN HEPATOL, V29, P241, DOI 10.1111/jgh.12475; McFarland AP, 2014, NAT IMMUNOL, V15, P72, DOI 10.1038/ni.2758; Mihm S, 2004, LAB INVEST, V84, P1148, DOI 10.1038/labinvest.3700135; Mihm S, 2015, J INNATE IMMUN, V7, P251, DOI 10.1159/000369973; Noureddin M, 2015, GENES IMMUN, V16, P321, DOI 10.1038/gene.2015.11; O'Brien TR, 2014, J INTERF CYTOK RES, V34, P829, DOI 10.1089/jir.2013.0136; O'Brien TR, 2015, J HEPATOL; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Savan R, 2014, J INTERF CYTOK RES, V34, P318, DOI 10.1089/jir.2013.0117; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143783	10.1371/journal.pone.0143783	http://dx.doi.org/10.1371/journal.pone.0143783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606750	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300111
J	Shi, YY; Lenzi, M; An, RP				Shi, Yuyan; Lenzi, Michela; An, Ruopeng			Cannabis Liberalization and Adolescent Cannabis Use: A Cross-National Study in 38 Countries	PLOS ONE			English	Article							MEDICAL MARIJUANA LAWS; SUBJECTIVE HEALTH COMPLAINTS; FAMILY AFFLUENCE; COSTS OUTWEIGH; POLICY DEBATE; MENTAL-HEALTH; DUTCH SURVEY; SCHOOL; LEGALIZATION; WASHINGTON	Aims To assess the associations between types of cannabis control policies at country level and prevalence of adolescent cannabis use. Setting, Participants and Design Multilevel logistic regressions were performed on 172,894 adolescents 15 year of age who participated in the 2001/2002, 2005/2006, or 2009/2010 cross-sectional Health Behaviour in School-Aged Children (HBSC) survey in 38 European and North American countries. Measures Self-reported cannabis use status was classified into ever use in life time, use in past year, and regular use. Country-level cannabis control policies were categorized into a dichotomous measure (whether or not liberalized) as well as 4 detailed types (full prohibition, depenalization, decriminalization, and partial prohibition). Control variables included individual-level sociodemographic characteristics and country-level economic characteristics. Findings Considerable intra-class correlations (.15-.19) were found at country level. With respect to the dichotomized cannabis control policy, adolescents were more likely to ever use cannabis (odds ratio (OR) = 1.10, p=.001), use in past year (OR = 1.09, p=.007), and use regularly (OR = 1.26, p=.004). Although boys were substantially more likely to use cannabis, the correlation between cannabis liberalization and cannabis use was smaller in boys than in girls. With respect to detailed types of policies, depenalization was associated with higher odds of past-year use (OR = 1.14, p=.013) and regular use (OR = 1.23, p=.038), and partial prohibition was associated with higher odds of regular use (OR = 2.39, p=.016). The correlation between cannabis liberalization and regular use was only significant after the policy had been introduced for more than 5 years. Conclusions Cannabis liberalization with depenalization and partial prohibition policies was associated with higher levels of regular cannabis use among adolescents. The correlations were heterogeneous between genders and between short- and long-terms.	[Shi, Yuyan] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Lenzi, Michela] Univ Padua, Dept Dev & Social Psychol, Padua, Italy; [An, Ruopeng] Univ Illinois, Dept Kinesiol & Community Hlth, Champaign, IL USA	University of California System; University of California San Diego; University of Padua; University of Illinois System; University of Illinois Urbana-Champaign	Shi, YY (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.	yus001@ucsd.edu		Lenzi, Michela/0000-0001-7721-2448				[Anonymous], 2000, WORLD DRUG REP; [Anonymous], BANK TW GDP CAP CURR; [Anonymous], EMCDDA COUNTR LEG PR; Bendtsen P, 2014, ADDICTION, V109, P1857, DOI 10.1111/add.12681; Cerda M, 2012, DRUG ALCOHOL DEPEN, V120, P22, DOI 10.1016/j.drugalcdep.2011.06.011; Choo EK, 2014, J ADOLESCENT HEALTH, V55, P160, DOI 10.1016/j.jadohealth.2014.02.018; Currie C, 2012, REGIONAL OFFICE EURO; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Drummond C, 2002, BRIT MED J, V324, P107; Gorman DA, 2007, INT J DRUG POLICY, V18, P160, DOI 10.1016/j.drugpo.2006.10.001; Hall W, 1997, ADDICTION, V92, P1109; Hall W, 2000, CAN MED ASSOC J, V162, P1690; Hall W, 2001, DRUG ALCOHOL DEPEN, V62, P163, DOI 10.1016/S0376-8716(00)00171-X; Hall W, 2014, DRUG TEST ANAL, V6, P39, DOI 10.1002/dta.1506; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hall W, 2009, CURR OPIN PSYCHIATR, V22, P258, DOI 10.1097/YCO.0b013e3283298f36; Harper S, 2012, ANN EPIDEMIOL, V22, P207, DOI 10.1016/j.annepidem.2011.12.002; Hasin DS, 2015, LANCET PSYCHIAT, V2, P601, DOI 10.1016/S2215-0366(15)00217-5; Haugland S, 2001, J ADOLESCENCE, V24, P611, DOI 10.1006/jado.2000.0393; Haugland S, 2001, EUR J PUBLIC HEALTH, V11, P4, DOI 10.1093/eurpub/11.1.4; Hublet A, 2009, ADDICTION, V104, P1918, DOI 10.1111/j.1360-0443.2009.02686.x; Joffe A, 2004, PEDIATRICS, V113, pE632, DOI 10.1542/peds.113.6.e632; Lynne-Landsman SD, 2013, AM J PUBLIC HEALTH, V103, P1500, DOI 10.2105/AJPH.2012.301117; MacCoun R, 2001, BRIT J PSYCHIAT, V178, P123, DOI 10.1192/bjp.178.2.123; McDonald D, 1994, LEGISLATIVE OPTIONS; Monshouwer K, 2006, BRIT J PSYCHIAT, V188, P148, DOI 10.1192/bjp.188.2.148; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Nations U, 1977, SINGLE CONVENTION NA; Pardo B, 2014, INT J DRUG POLICY, V25, P727, DOI 10.1016/j.drugpo.2014.05.010; Reinarman C, 2004, AM J PUBLIC HEALTH, V94, P836, DOI 10.2105/AJPH.94.5.836; Roberts C, 2009, INT J PUBLIC HEALTH, V54, P140, DOI 10.1007/s00038-009-5405-9; Room R., 2010, CANNABIS POLICY MOVI; Room R, 2014, ADDICTION, V109, P345, DOI 10.1111/add.12355; Shi Y., 2014, IMPACTS STATE MED MA; Simons-Morton B, 2010, INT J DRUG POLICY, V21, P64, DOI 10.1016/j.drugpo.2009.02.003; Tang ZQ, 2009, SUBST USE MISUSE, V44, P195, DOI 10.1080/10826080802347636; ter Bogt T, 2006, ADDICTION, V101, P241, DOI 10.1111/j.1360-0443.2006.01309.x; ter Bogt TFM, 2014, ADDICTION, V109, P273, DOI 10.1111/add.12373; THIES CF, 1993, SOC SCI J, V30, P385, DOI 10.1016/0362-3319(93)90016-O; van Gastel WA, 2012, ADDICTION, V107, P381, DOI 10.1111/j.1360-0443.2011.03626.x; Vieno A, 2007, AM J COMMUN PSYCHOL, V39, P177, DOI 10.1007/s10464-007-9095-2; Wang T, 2008, CAN MED ASSOC J, V178, P1669, DOI 10.1503/cmaj.071178; Williams J, 2004, HEALTH ECON, V13, P123, DOI 10.1002/hec.796; Williams J, 2014, J HEALTH ECON, V36, P20, DOI 10.1016/j.jhealeco.2014.03.006; Wodak A, 2002, BRIT MED J, V324, P105, DOI 10.1136/bmj.324.7329.105; Zeese K.B., 1999, INT J DRUG POLICY, V10, P319, DOI [10.1016/ S0955-3959(99)00031-6, DOI 10.1016/S0955-3959(99)00031-6]	46	42	43	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143562	10.1371/journal.pone.0143562	http://dx.doi.org/10.1371/journal.pone.0143562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7ES	26605550	gold, Green Submitted, Green Published			2022-12-26	WOS:000365865300082
J	Beileke, S; Claassen, H; Wagner, W; Matthies, C; Ruf, C; Hartmann, A; Garreis, F; Paulsen, F; Schicht, M; Brauer, L				Beileke, Stephanie; Claassen, Horst; Wagner, Walter; Matthies, Cord; Ruf, Christian; Hartmann, Arndt; Garreis, Fabian; Paulsen, Friedrich; Schicht, Martin; Braeuer, Lars			Expression and Localization of Lung Surfactant Proteins in Human Testis	PLOS ONE			English	Article							PULMONARY SURFACTANT; CHRONIC RHINOSINUSITIS; MUCOSA	Background Surfactant proteins (SPs) have been described in various tissues and fluids including tissues of the nasolacrimal apparatus, airways and digestive tract. Human testis have a glandular function as a part of the reproductive and the endocrine system, but no data are available on SPs in human testis and prostate under healthy and pathologic conditions. Objective The aim of the study was the detection and characterization of the surfactant proteins A, B, C and D (SP-A, SP-B, SP-C, SP-D) in human testis. Additionally tissue samples affected by testicular cancer were investigated. Results Surfactant proteins A, B, C and D were detected using RT-PCR in healthy testis. By means of Western blot analysis, these SPs were detected at the protein level in normal testis, seminoma and seminal fluid, but not in spermatozoa. Expression of SPs was weaker in seminoma compared to normal testicular tissue. SPs were localized in combination with vimentin immunohistochemically in cells of Sertoli and Leydig. Conclusion Surfactant proteins seem to be inherent part of the human testis. By means of physicochemical properties the proteins appear to play a role during immunological and rheological process of the testicular tissue. The presence of SP-B and SP-C in cells of Sertoli correlates with their function of fluid secretion and may support transportation of spermatozoa. In seminoma the expression of all SP's was generally weaker compared to normal germ cells. This could lead to a reduction of immunomodulatory and rheology processes in the germ cell tumor.	[Beileke, Stephanie; Garreis, Fabian; Paulsen, Friedrich; Schicht, Martin; Braeuer, Lars] Univ Erlangen Nurnberg, Inst Anat 2, D-91054 Erlangen, Germany; [Claassen, Horst] Univ Halle Wittenberg, Inst Anat & Cell Biol, D-06108 Halle, Saale, Germany; [Wagner, Walter; Matthies, Cord; Ruf, Christian] Fed Armed Forces Hosp Hamburg, Dept Urol, Hamburg, Germany; [Hartmann, Arndt] Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany	University of Erlangen Nuremberg; Martin Luther University Halle Wittenberg; University of Erlangen Nuremberg	Brauer, L (corresponding author), Univ Erlangen Nurnberg, Inst Anat 2, D-91054 Erlangen, Germany.	lars.braeuer@anatomie2.med.uni-erlangen.de		Schicht, Martin/0000-0001-5155-5477; Paulsen, Friedrich/0000-0002-0527-0953	German Research Foundation (DFG) [1329/12-1 BR, BR 3681/2-1]; Wilhelm Roux Program, Halle, Germany [FKZ 17/20]	German Research Foundation (DFG)(German Research Foundation (DFG)); Wilhelm Roux Program, Halle, Germany	This study was supported by the German Research Foundation (DFG, Program Grants 1329/12-1 BR and BR 3681/2-1) and the Wilhelm Roux Program, Halle, Germany (Program Grants FKZ 17/20).	Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Bourbon JR, 2001, COMP BIOCHEM PHYS A, V129, P151, DOI 10.1016/S1095-6433(01)00312-9; Brauer L, 2007, CURR EYE RES, V32, P931, DOI 10.1080/02713680701694369; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Brauer L, 2009, HISTOCHEM CELL BIOL, V132, P331, DOI 10.1007/s00418-009-0609-x; Brauer L, 2012, BIOMED TECH, V2011, P0113; Castano JP, 1997, AM J PHYSIOL-ENDOC M, V272, pE390, DOI 10.1152/ajpendo.1997.272.3.E390; CURSTEDT T, 1988, EUR J BIOCHEM, V172, P521, DOI 10.1111/j.1432-1033.1988.tb13918.x; Davidoff MS, 1996, BIOMED REV, V6, P11; Ferguson JS, 1999, J IMMUNOL, V163, P312; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Glowina A, 2011, ATEMWEGS LUNGENKRA S, V31, P1; Hartshorn Kevan L, 2010, Front Biosci (Schol Ed), V2, P527; Holstein A F, 1996, Int J Urol, V3, P165; Holstein Adolf-Friedrich, 2003, Reprod Biol Endocrinol, V1, P107, DOI 10.1186/1477-7827-1-107; Holstein AF, 1981, DERMATOL PRAXIS, P503; Holstein AF, 2003, MANNLICHE GESCHLECHT, P799; Holstein AF, 1977, UROLOGE            B, VB 17, P1; Kankavi O, 2014, RENAL FAILURE, V36, P258, DOI 10.3109/0886022X.2013.846831; Kim JK, 2007, AM J PHYSIOL-LUNG C, V292, pL879, DOI 10.1152/ajplung.00156.2006; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Krege S, 2008, EUR UROL, V53, P478, DOI 10.1016/j.eururo.2007.12.024; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Liu J, 2015, SHOCK, V43, P31, DOI 10.1097/SHK.0000000000000270; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; NOTTER RH, 1987, CHEM PHYS LIPIDS, V44, P1, DOI 10.1016/0009-3084(87)90002-8; Oberley RE, 2005, PROSTATE, V65, P241, DOI 10.1002/pros.20292; Ooi EH, 2007, LARYNGOSCOPE, V117, P51, DOI 10.1097/01.mlg.0000243196.75418.6f; Paananen R, 2001, AM J PHYSIOL-LUNG C, V280, pL214, DOI 10.1152/ajplung.2001.280.2.L214; Paulsen F, 2004, CELL TISSUE RES, V316, P167, DOI 10.1007/s00441-004-0877-7; Ruf CG, 2013, J UROLOGY, V190, P1046, DOI 10.1016/j.juro.2013.04.022; Salari R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002644; Schicht M, 2013, AM J RHINOL ALLERGY, V27, P24, DOI 10.2500/ajra.2013.27.3838; Schlosser RJ, 2006, ANN OTO RHINOL LARYN, V115, P40; Schob S, 2013, PLOS ONE, V8, DOI [10.1371/annotation/920eb90c-4f7f-4468-ae9c-1198b7b952fc, DOI 10.1371/ANNOTATION/920EB90C-4F7F-4468-AE9C-1198B7B952FC]; van de Wetering JK, 2004, EUR J BIOCHEM, V271, P1229, DOI 10.1111/j.1432-1033.2004.04040.x; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Von Neergaard K., 1929, Z GES EXP MED, V66, P373; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; WHITSETT JA, 1986, PEDIATR RES, V20, P744, DOI 10.1203/00006450-198608000-00009; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; YU SH, 1990, BIOCHIM BIOPHYS ACTA, V1046, P233, DOI 10.1016/0005-2760(90)90236-Q	45	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143058	10.1371/journal.pone.0143058	http://dx.doi.org/10.1371/journal.pone.0143058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599233	gold, Green Published, Green Submitted			2022-12-26	WOS:000365862600027
J	Tang, YJ; Dong, W; Wan, KY; Zhang, LG; Li, C; Zhang, LL; Liu, N				Tang, Yanjun; Dong, Wei; Wan, Keyu; Zhang, Ligang; Li, Chun; Zhang, Lili; Liu, Ning			Exopolysaccharide Produced by Lactobacillus Plantarum Induces Maturation of Dendritic Cells in BALB/c Mice	PLOS ONE			English	Article							FERMENTED MILK; NITRIC-OXIDE; PEYERS PATCH; BACTERIA; IMMUNITY; SIGNALS; RANTES; ENCEPHALOMYELITIS; DIFFERENTIATION; PROLIFERATION	Lactobacillus plantarum (L. plantarum) exopolysaccharide (EPS) is an important bioactive component in fermented functional foods. However, there is a lack of data concerning the effects of L. plantarum EPS on maturation of mouse dendritic cells (DCs). In this study, we purified L. plantarum EPS and examined its effects on cytokines production by dendritic cells in serum and intestinal fluid of BALB/c mice, then investigated its effects on phenotypic and functional maturation of mouse bone marrow-derived dendritic cells (BMDCs). Cytokines (nitric oxide, IL-12p70, IL-10 and RANTES) in serum and intestinal fluid were analyzed by enzyme linked immunosorbent assay (ELISA) after the mice received EPS for 2, 5 and 7 days, respectively. DCs derived from bone marrow of BALB/c mouse were treated with EPS, then the phenotypic maturation of BMDCs was analyzed using flow cytometer and the functional maturation of BMDCs was analyzed by ELISA, and, lastly, mixed lymphocyte proliferation was performed. We found the molecular weight of purified EPS was approximately 2.4x10(6) Da and it was composed of ribose, rhamnose, arabinose, xylose, mannose, glucose and galactose in a molar ratio of 2:1:1:10:4:205:215. We observed that L. plantarum EPS enriched production of nitric oxide, IL-12p70 and RANTES, and decreased the secretion of IL-10 in the serum or intestinal fluid as well as in the supernatant of DCs treated with the EPS. The EPS also up-regulated the expression of MHC II and CD86 on DCs surface and promoted T cells to proliferate in vitro. Our data provide direct evidence to suggest that L. plantarum EPS can effectively induce maturation of DCs in mice.	[Tang, Yanjun; Dong, Wei; Wan, Keyu; Zhang, Ligang; Li, Chun; Zhang, Lili; Liu, Ning] Northeast Agr Univ, Coll Food Sci, Minist Educ, Key Lab Dairy Sci, Harbin, Peoples R China; [Liu, Ning] Natl Dairy Engn & Res Ctr, Harbin, Peoples R China; [Tang, Yanjun; Zhang, Ligang; Li, Chun; Zhang, Lili; Liu, Ning] Synerget Innovat Ctr Food Safety & Nutr, Harbin, Peoples R China; [Tang, Yanjun] Heilongjiang Bayi Agr Univ, Coll Food Sci, Daqing, Peoples R China	Northeast Agricultural University - China; Heilongjiang Bayi Agricultural University	Li, C (corresponding author), Northeast Agr Univ, Coll Food Sci, Minist Educ, Key Lab Dairy Sci, Harbin, Peoples R China.	spxylch@126.com; ningliuneau@outlook.com		Zhang, Lili/0000-0002-1053-292X	Ministry of Education of the People's Republic of China [IRT-0959-202]; Science & Technology Bureau of Harbin [2011RFXXN042]; Education Department of Heilongjiang Province [YJSCX2012-043HLJ]	Ministry of Education of the People's Republic of China(Ministry of Education, China); Science & Technology Bureau of Harbin; Education Department of Heilongjiang Province	NL received the funding "Program for Changjiang Scholars and Innovative Research Team in University (IRT-0959-202)" supported by Ministry of Education of the People's Republic of China (http://www.moe.gov.cn/) for the study design, data collection and analysis, decision to publish. NL received the funding "Project of Special Funds for Harbin Technological Innovation Talent (2011RFXXN042)" supported by Science & Technology Bureau of Harbin (http://www.hrbinfo.gov.cn/) for data collection and analysis. YJT received the funding "Postgraduate Innovative Research Projects of Heilongjiang Province Office of Education (YJSCX2012-043HLJ)" supported by the Education Department of Heilongjiang Province (http://www.hlje.net/) for preparation of the manuscript.	Adams S, 2005, J CLIN IMMUNOL, V25, P87, DOI 10.1007/s10875-005-2814-2; Adikari SB, 2005, CYTOKINE MODULATED D; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blaschitz C, 2010, J CLIN IMMUNOL, V30, P196, DOI 10.1007/s10875-010-9368-7; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; de LeBlanc AD, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-27; de St Groth BF, 1998, IMMUNOL TODAY, V19, P448, DOI 10.1016/S0167-5699(98)01328-0; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Gaizka GI, 2010, BIORESOURCE TECHNOL, V101, P9254, DOI 10.1016/j.biortech.2010.07.050; Georgieva R, 2009, INT DAIRY J, V19, P696, DOI 10.1016/j.idairyj.2009.06.006; HERSHKOVIZ R, 1995, J AUTOIMMUN, V8, P741, DOI 10.1006/jaut.1995.0055; Huang SY, 2013, FERTIL STERIL, V100, P234, DOI 10.1016/j.fertnstert.2013.02.052; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ismail B, 2010, ARCH MICROBIOL, V192, P1049, DOI 10.1007/s00203-010-0636-y; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Khanna A, 2000, J IMMUNOL, V164, P1346, DOI 10.4049/jimmunol.164.3.1346; Kim Y, 2009, BIOCHEM BIOPH RES CO, V379, P324, DOI 10.1016/j.bbrc.2008.12.053; Lee M, 2000, J KOREAN MED SCI, V15, P217, DOI 10.3346/jkms.2000.15.2.217; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Liu CH, 2010, BIORESOURCE TECHNOL, V101, P5528, DOI 10.1016/j.biortech.2010.01.151; Lu LN, 1997, J IMMUNOL, V158, P5676; Maddur MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5092; Galdeano CM, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-64; Mathara JM, 2008, CURR MICROBIOL, V56, P315, DOI 10.1007/s00284-007-9084-6; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Nichols CM, 2005, MICROB ECOL, V49, P578, DOI 10.1007/s00248-004-0093-8; Nicoletti C, 2010, GUT MICROBES, V1, P131, DOI 10.4161/gmic.1.3.11711; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Pan DD, 2010, CARBOHYD POLYM, V80, P908, DOI 10.1016/j.carbpol.2010.01.005; Pieters J, 1997, CURR OPIN IMMUNOL, V9, P89, DOI 10.1016/S0952-7915(97)80164-1; Reid SD, 2000, CURR OPIN IMMUNOL, V12, P114, DOI 10.1016/S0952-7915(99)00059-X; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Serafini B, 2000, AM J PATHOL, V157, P1991, DOI 10.1016/S0002-9440(10)64838-9; Sheu SC, 2013, PROCESS BIOCHEM, V48, P1402, DOI 10.1016/j.procbio.2013.06.012; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Vila-Coro AJ, 1999, J IMMUNOL, V163, P3037; Welman AD, 2003, TRENDS BIOTECHNOL, V21, P269, DOI 10.1016/S0167-7799(03)00107-0; WU L, 1995, EUR J IMMUNOL, V25, P418, DOI 10.1002/eji.1830250217; Zhu J, 2007, CELL BIOL INT, V31, P615, DOI 10.1016/j.cellbi.2006.12.002	45	24	28	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143743	10.1371/journal.pone.0143743	http://dx.doi.org/10.1371/journal.pone.0143743			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599612	gold, Green Submitted, Green Published			2022-12-26	WOS:000365862600115
J	Vonghia, L; Magrone, T; Verrijken, A; Michielsen, P; Van Gaal, L; Jirillo, E; Francque, S				Vonghia, Luisa; Magrone, Thea; Verrijken, An; Michielsen, Peter; Van Gaal, Luc; Jirillo, Emilio; Francque, Sven			Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features	PLOS ONE			English	Article							AMINOPYRINE BREATH TEST; REGULATORY T-CELLS; PORTAL-HYPERTENSION; INSULIN-RESISTANCE; INDEPENDENT PREDICTORS; RAT MODEL; STEATOHEPATITIS; FIBROSIS; OBESITY; NAFLD	Background Haemodynamic impairment, inflammatory mediators and glucose metabolism disturbances have been implicated in the pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD). Aim To investigate the cytokine profile in NAFLD patients in peripheral (P) and hepatic venous (HV) blood and to compare with histology, haemodynamic and metabolic parameters. Methods 40 obese patients with an indication for a transjugular liver biopsy were enrolled. Besides an extended liver and metabolic work-up, interleukin (IL) 1B, IL4, IL6, IL10, IL23, tumour necrosis factor (TNF) a and interferon (INF). were measured in plasma obtained from P and HV blood by means of multiplex immunoassay. The T helper (Th) 1/Th2, the macrophage M1/M2 and the IL10/IL17a ratios were calculated. Results A decrease of the P-IL10/IL17-ratio and an increase of the P-M1/M2-ratio (p<0.05) were observed in NASH versus no-NASH patients. A P-M1/M2-ratio increase was detected also in patients with portal hypertension in comparison with patients without it (p<0.05). Moreover diabetic patients showed an increase of the P-Th1/Th2-ratio in comparison with non-diabetic ones (p<0.05). The P-M1/M2 ratio positively correlated with steatosis grade (r = 0.39, p = 0.02) and insulin (r = 0.47, p = 0.003). The HV-M1/M2 ratio positively correlated with fasting insulin and Hepatic Venous Pressure Gradient (r = 0.47, p = 0.003). IL6 correlated with the visceral fat amount (r = 0.36, p = 0.02). The P- and HV-IL10/IL17 ratios negatively correlated with fasting insulin (respectively r = -0.4, p = 0.005 and r = 0.4, p = 0.01). Conclusions A proinflammatory cytokine state is associated with more disturbed metabolic, histological, and haemodynamic features in NAFLD obese patients. An increase of the M1/M2 ratio and a decrease of the IL10/IL17 ratio play a key role in this process.	[Vonghia, Luisa; Magrone, Thea; Michielsen, Peter; Jirillo, Emilio; Francque, Sven] Univ Bari, Dept Basic Med Sci Neurosci & Sensory Organs, Bari, Italy; [Vonghia, Luisa] Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium; [Verrijken, An; Van Gaal, Luc] Univ Antwerp Hosp, Dept Endocrinol Diabet & Metab Dis, Antwerp, Belgium; [Verrijken, An; Michielsen, Peter; Van Gaal, Luc; Francque, Sven] Univ Antwerp, Lab Expt Med & Paediat, Div Gastroenterol, B-2020 Antwerp, Belgium	Universita degli Studi di Bari Aldo Moro; University of Antwerp; University of Antwerp; University of Antwerp	Vonghia, L (corresponding author), Univ Bari, Dept Basic Med Sci Neurosci & Sensory Organs, Bari, Italy.	luisa.vonghia@uza.be	Magrone, Thea/AAG-3444-2019; Vonghia, Luisa/ABC-4169-2020; Michielsen, Peter/D-7088-2017	Magrone, Thea/0000-0002-0503-9110; Vonghia, Luisa/0000-0002-3999-9259; Michielsen, Peter/0000-0001-7232-8927				Abbas AE, 2013, J AM SOC ECHOCARDIOG, V26, P1170, DOI 10.1016/j.echo.2013.06.003; Aller MA, 2013, WORLD J GASTROENTERO, V19, P7992, DOI 10.3748/wjg.v19.i44.7992; ANDUS T, 1991, HEPATOLOGY, V13, P364, DOI 10.1016/0270-9139(91)92454-G; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Asrani Sumeet K, 2013, Curr Gastroenterol Rep, V15, P308, DOI 10.1007/s11894-012-0308-y; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Bosch J, 2006, SEMIN LIVER DIS, V26, P348, DOI 10.1055/s-2006-951603; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chang YH, 2012, INT J OBESITY, V36, P993, DOI 10.1038/ijo.2011.168; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Francque S, 2011, INT J OBESITY, V35, P270, DOI 10.1038/ijo.2010.134; Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019; Francque S, 2012, LAB INVEST, V92, P1428, DOI 10.1038/labinvest.2012.103; Francque S, 2010, EUR J GASTROEN HEPAT, V22, P1449, DOI 10.1097/MEG.0b013e32833f14a1; Francque S, 2010, LIVER INT, V30, P365, DOI 10.1111/j.1478-3231.2009.02136.x; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Groszmann Roberto, 2006, Clin Liver Dis, V10, P499, DOI 10.1016/j.cld.2006.08.005; Guo Y, 2013, HEPATO-GASTROENTEROL, V60, P581, DOI 10.5754/hge11381; Hebel K, 2011, J IMMUNOL, V187, P5627, DOI 10.4049/jimmunol.1003998; Kalambokis G, 2007, J HEPATOL, V47, P284, DOI 10.1016/j.jhep.2007.05.001; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; LEBREC D, 1982, GASTROENTEROLOGY, V83, P338; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lim S, 2015, INT J CARDIOL, V201, P408, DOI 10.1016/j.ijcard.2015.08.107; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Madhumitha H, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-1; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; MERKEL C, 1992, GUT, V33, P836, DOI 10.1136/gut.33.6.836; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Pasarin M, 2011, J HEPATOL, V55, P1095, DOI 10.1016/j.jhep.2011.01.053; PERRI F, 1994, DIGEST DIS SCI, V39, P2445, DOI 10.1007/BF02087664; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Tang Y, 2011, CLIN EXP IMMUNOL, V166, P281, DOI 10.1111/j.1365-2249.2011.04471.x; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tsochatzis EA, 2009, SCAND J GASTROENTERO, V44, P6, DOI 10.1080/00365520802273058; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Vonghia L, 2013, INT J MOL SCI, V14, P19867, DOI 10.3390/ijms141019867; Waidmann O, 2013, J HEPATOL, V58, P956, DOI 10.1016/j.jhep.2013.01.005; Wiest R, 2011, CYTOKINE, V53, P178, DOI 10.1016/j.cyto.2010.06.013; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	53	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143380	10.1371/journal.pone.0143380	http://dx.doi.org/10.1371/journal.pone.0143380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599575	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600058
J	Bales, MB; Schier, LA; Blonde, GD; Spector, AC				Bales, Michelle B.; Schier, Lindsey A.; Blonde, Ginger D.; Spector, Alan C.			Extensive Gustatory Cortex Lesions Significantly Impair Taste Sensitivity to KCl and Quinine but Not to Sucrose in Rats	PLOS ONE			English	Article							INSULAR CORTEX; CORTICAL-NEURONS; AVERSION; RESPONSES; AVOIDANCE; AMYGDALA; HYPOTHALAMUS; PROJECTIONS; NEOCORTEX; REPRESENTATION	Recently, we reported that large bilateral gustatory cortex (GC) lesions significantly impair taste sensitivity to salts in rats. Here we extended the tastants examined to include sucrose and quinine in rats with ibotenic acid-induced lesions in GC (GCX) and in sham-operated controls (SHAM). Presurgically, immediately after drinking NaCl, rats received a LiCl or saline injection (i.p.), but postsurgical tests indicated a weak conditioned taste aversion (CTA) even in controls. The rats were then trained and tested in gustometers to discriminate a tastant from water in a two-response operant taste detection task. Psychometric functions were derived for sucrose, KCl, and quinine. Our mapping system was used to determine placement, size, and symmetry of the lesions (similar to 91% GC damage on average). For KCl, there was a significant rightward shift (Delta EC50 = 0.57 log(10) units; p < 0.001) in the GCX psychometric function relative to SHAM, replicating our prior work. There was also a significant lesion-induced impairment (Delta EC50 = 0.41 log(10) units; p = 0.006) in quinine sensitivity. Surprisingly, taste sensitivity to sucrose was unaffected by the extensive lesions and was comparable between GCX and SHAM rats. The fact that such large bilateral GC lesions did not shift sucrose psychometric functions relative to SHAM, but did significantly compromise quinine and KCl sensitivity suggests that the neural circuits responsible for the detection of specific taste stimuli are partially dissociable. Lesion-induced impairments were observed in expression of a postsurgical CTA to a maltodextrin solution as assessed in a taste-oriented brief-access test, but were not reflected in a longer term 46-h two-bottle test. Thus, deficits observed in rats after extensive damage to the GC are also dependent on the test used to assess taste function. In conclusion, the degree to which the GC is necessary for the maintenance of normal taste detectability apparently depends on the chemical andor perceptual features of the stimulus.	[Spector, Alan C.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Spector, AC (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	spector@psy.fsu.edu	Spector, Alan/W-2925-2019		National Institute on Deafness and Other Communication Disorders [R01-DC-DC009821, T32 DC000044]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC000044] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by a research grant from the National Institute on Deafness and Other Communication Disorders (R01-DC-DC009821 (ACS)) and an FSU Chemical Senses Training (CTP) Grant Award (T32 DC000044 (MBB)) from the National Institute on Deafness and Other Communication Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; BENJAMIN RM, 1959, J COMP NEUROL, V111, P231, DOI 10.1002/cne.901110203; BENJAMIN RM, 1955, J COMP PHYSIOL PSYCH, V48, P119, DOI 10.1037/h0041257; BENJAMIN RM, 1955, J NEUROPHYSIOL, V18, P56, DOI 10.1152/jn.1955.18.1.56; Bermudez-Rattoni F, 2004, NAT REV NEUROSCI, V5, P209, DOI 10.1038/nrn1344; BERMUDEZRATTONI F, 1991, BRAIN RES, V549, P165, DOI 10.1016/0006-8993(91)90616-4; Blonde GD, 2006, BEHAV NEUROSCI, V120, P580, DOI 10.1037/0735-7044.120.3.580; Blonde GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117515; BRAUN JJ, 1981, EXP NEUROL, V72, P711, DOI 10.1016/0014-4886(81)90020-0; BRAUN JJ, 1972, PHYSIOL BEHAV, V9, P637; BRAUN JJ, 1982, PHYSIOL PSYCHOL, V10, P13; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Cubero I, 1999, BRAIN RES, V839, P323, DOI 10.1016/S0006-8993(99)01745-X; DUNN LT, 1988, BEHAV NEUROSCI, V102, P3, DOI 10.1037/0735-7044.102.1.3; Fontanini A, 2006, J NEUROPHYSIOL, V96, P3183, DOI 10.1152/jn.00804.2006; Fresquet N, 2004, BEHAV BRAIN RES, V153, P357, DOI 10.1016/j.bbr.2003.12.011; Gardner MPH, 2014, J NEUROSCI, V34, P13000, DOI 10.1523/JNEUROSCI.1820-14.2014; Geddes RI, 2008, BEHAV NEUROSCI, V122, P1038, DOI 10.1037/a0012748; Hanamori T, 1998, J NEUROPHYSIOL, V79, P2535, DOI 10.1152/jn.1998.79.5.2535; Hashimoto K, 2014, CHEM SENSES, V39, P57, DOI 10.1093/chemse/bjt054; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Kida I, 2011, NEUROIMAGE, V56, P1520, DOI 10.1016/j.neuroimage.2011.03.007; KIEFER SW, 1984, BEHAV NEUROSCI, V98, P590; KIEFER SW, 1992, BEHAV NEUROSCI, V106, P140, DOI 10.1037/0735-7044.106.1.140; King CT, 2015, BRAIN RES, V1599, P9, DOI 10.1016/j.brainres.2014.12.035; KOSAR E, 1986, BRAIN RES, V379, P342, DOI 10.1016/0006-8993(86)90788-2; KOSAR E, 1986, BRAIN RES, V379, P329, DOI 10.1016/0006-8993(86)90787-0; Kusumoto-Yoshida I, 2015, P NATL ACAD SCI USA, V112, P1190, DOI 10.1073/pnas.1416573112; Lin JY, 2009, BRAIN RES, V1292, P52, DOI 10.1016/j.brainres.2009.07.033; Lin JY, 2009, BEHAV NEUROSCI, V123, P810, DOI 10.1037/a0016460; LORDEN JF, 1976, J COMP PHYSIOL PSYCH, V90, P665, DOI 10.1037/h0077237; Lundy RF, 2004, J NEUROPHYSIOL, V91, P1143, DOI 10.1152/jn.00840.2003; MacDonald CJ, 2012, J PHYSIOL-LONDON, V590, P3169, DOI 10.1113/jphysiol.2012.233486; Maier JX, 2013, J NEUROPHYSIOL, V109, P2108, DOI 10.1152/jn.00917.2012; Naor C, 1996, BEHAV BRAIN RES, V79, P61, DOI 10.1016/0166-4328(95)00262-6; Nerad L, 1996, NEUROBIOL LEARN MEM, V66, P44, DOI 10.1006/nlme.1996.0042; NISSENBAUM JW, 1987, NEUROSCI BIOBEHAV R, V11, P187, DOI 10.1016/S0149-7634(87)80025-8; NORGREN R, 1975, BRAIN RES, V92, P123, DOI 10.1016/0006-8993(75)90531-4; OGAWA H, 1990, NEUROSCI RES, V9, P196, DOI 10.1016/0168-0102(90)90004-X; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PFAFFMANN C, 1977, ANN NY ACAD SCI, V290, P18, DOI 10.1111/j.1749-6632.1977.tb39713.x; Reynolds SM, 2005, J NEUROSCI, V25, P11757, DOI 10.1523/JNEUROSCI.3432-05.2005; Roman C, 2007, EUR J NEUROSCI, V26, P2627, DOI 10.1111/j.1460-9568.2007.05872.x; Roman C, 2006, BEHAV NEUROSCI, V120, P1257, DOI 10.1037/0735-7044.120.6.1257; Rosenblum K, 1997, J NEUROSCI, V17, P5129; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sakai N, 1999, NEUROSCI RES, V35, P53, DOI 10.1016/S0168-0102(99)00067-X; Schier LA, 2016, J COMP NEUROL, V524, P54, DOI 10.1002/cne.23822; Schier LA, 2014, P NATL ACAD SCI USA, V111, P1162, DOI 10.1073/pnas.1315624111; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Spector A. C., 2003, Handbook of olfaction and gustation, P861; SPECTOR AC, 1988, BEHAV NEUROSCI, V102, P942, DOI 10.1037/0735-7044.102.6.942; Spector AC, 2000, NEUROSCI BIOBEHAV R, V24, P391, DOI 10.1016/S0149-7634(00)00013-0; Spector AC, 2015, CHEM SENSES, V40, P187, DOI 10.1093/chemse/bju072; Stapleton JR, 2006, J NEUROSCI, V26, P4126, DOI 10.1523/JNEUROSCI.0092-06.2006; Stehberg J, 2011, NEUROBIOL LEARN MEM, V95, P14, DOI 10.1016/j.nlm.2010.10.002; VANDERKOOY D, 1984, J COMP NEUROL, V224, P1, DOI 10.1002/cne.902240102; YAMAMOTO T, 1980, J NEUROPHYSIOL, V44, P440, DOI 10.1152/jn.1980.44.3.440; YAMAMOTO T, 1984, J NEUROPHYSIOL, V51, P616, DOI 10.1152/jn.1984.51.4.616; YAMAMOTO T, 1989, J NEUROPHYSIOL, V61, P1244, DOI 10.1152/jn.1989.61.6.1244	62	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143419	10.1371/journal.pone.0143419	http://dx.doi.org/10.1371/journal.pone.0143419			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599914	gold, Green Published			2022-12-26	WOS:000365853900114
J	Zhang, XL; Zhai, LM; Rong, CZ; Qin, X; Li, S				Zhang, Xiaolian; Zhai, Limin; Rong, Chengzhi; Qin, Xue; Li, Shan			Association of Ghrelin Gene Polymorphisms and Serum Ghrelin Levels with the Risk of Hepatitis B Virus-Related Liver Diseases in a Chinese Population	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ENDOTHELIAL-CELLS; CANCER RISK; TNF-ALPHA; RATS; HBV; PROGRESSION; INFECTION; INJURY; ACTIVATION	Background The functions of ghrelin (GHRL) include anti-inflammatory effects, reduction of the fibrogenic response, protection of liver tissue, and regulation of cell proliferation. Genetic variations in the GHRL gene may play an important role in the development of chronic hepatitis B (CHB), liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Therefore, we investigated whether GHRL gene polymorphisms and its serum levels are associated with hepatitis B virus (HBV)-related diseases risk in a Chinese population. Methods 176 patients with CHB, 106 patients with HBV-related LC, 151 patients with HBV-related HCC, and 167 healthy controls were recruited in the study. Genotyping of GHRL rs26311, rs27647, rs696217, and rs34911341 polymorphisms were determined with the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing. The serum GHRL concentrations were determined using enzyme-linked immunosorbent assay (ELISA). Results Binary logistic regression analyses adjusting for gender and age revealed that a significant increased risk of LC was found in the GHRL rs26311 GC genotype and combined GC+CC genotypes when compared with the GG genotype (GC vs. GG: OR = 1.671, 95% CI = 1.013-2.757, P = 0.044; GC+CC vs. GG: OR = 1.674, 95% CI = 1.040-2.696, P = 0.034). In subgroup analysis by gender, binary logistic regression analyses adjusting for age showed that the GHRL rs26311 C allele and combined GC+CC genotypes were associated with a significantly increased risk to LC in males (C vs. G OR = 1.416, 95% CI = 1.017-1.972, P = 0.040; GC+CC vs. GG: OR = 1.729, 95% CI = 1.019-2.933, P = 0.042). In addition, we found significant decreased serum GHRL levels in LC patients compared with the healthy controls. However, there was no significant association of the GHRL rs26311 polymorphism with serum GHRL levels in LC patients. Conclusions These observations suggest that the GHRL rs26311 polymorphism is associated with an increased risk to HBV-related LC, especially in men. We also found an inverse association of serum GHRL levels with LC.	[Zhang, Xiaolian; Zhai, Limin; Rong, Chengzhi; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Qin, X (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; lis8858@126.com						Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Ataseven H, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/78380; Camacho S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07919; Campa D, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-112; Carey William D, 2009, Cleve Clin J Med, V76 Suppl 3, pS2, DOI 10.3949/ccjm.76.s3.01; Chang L, 2003, ACTA PHARMACOL SIN, V24, P45; Chopin LK, 2012, ENDOCR REV, V33, P849, DOI 10.1210/er.2011-1007; Delporte C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/518909; Deng B, 2015, INT J CLIN EXP MED, V8, P579; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dossus L, 2008, CARCINOGENESIS, V29, P1360, DOI 10.1093/carcin/bgn083; Granado M, 2005, AM J PHYSIOL-ENDOC M, V288, pE486, DOI 10.1152/ajpendo.00196.2004; Harkisoen S, 2012, ANN HEPATOL, V11, P164, DOI 10.1016/S1665-2681(19)31020-8; Iseri SO, 2008, REGUL PEPTIDES, V146, P73, DOI 10.1016/j.regpep.2007.08.014; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Li WG, 2004, CIRCULATION, V109, P2221, DOI 10.1161/01.CIR.0000127956.43874.F2; Li Y, 2013, ENDOCRINE, V43, P376, DOI 10.1007/s12020-012-9761-5; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Liang XF, 2013, VACCINE, V31, pJ21, DOI 10.1016/j.vaccine.2013.08.012; Liao N, 2013, GENE, V517, P179, DOI 10.1016/j.gene.2012.12.094; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110061; Majchrzak K, 2012, POL J VET SCI, V15, P189, DOI 10.2478/v10181-011-0133-5; Moreno M, 2010, HEPATOLOGY, V51, P974, DOI 10.1002/hep.23421; Motawi TK, 2013, GENE, V527, P516, DOI 10.1016/j.gene.2013.06.053; Qin Y, 2014, LIVER INT, V34, P567, DOI 10.1111/liv.12286; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sato T, 2012, J BIOCHEM, V151, P119, DOI 10.1093/jb/mvr134; Tacke F, 2003, J HEPATOL, V38, P447, DOI 10.1016/S0168-8278(02)00438-5; Takezawa J, 2009, OBES RES CLIN PRACT, V3, P179, DOI 10.1016/j.orcp.2009.04.003; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Ukkola O, 2002, OBES RES, V10, P782, DOI 10.1038/oby.2002.106; Ukkola O, 2001, J CLIN ENDOCR METAB, V86, P3996, DOI 10.1210/jc.86.8.3996; Wajnrajch MP., 2000, J ENDOCR GENET, V1, P231, DOI [10.1515/ijdhd.2000.1.4.231, DOI 10.1515/IJD-HD.2000.1.4.231, DOI 10.1515/IJDHD.2000.1.4.231]; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Xu LL, 2008, BIOMED ENVIRON SCI, V21, P188, DOI 10.1016/S0895-3988(08)60027-6; Yamawaki H, 2015, J NEUROGASTROENTEROL, V21, P93, DOI 10.5056/jnm14086; Yang YF, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-11; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Zeng Z, 2014, WORLD J GASTROENTERO, V20, P7696, DOI 10.3748/wjg.v20.i24.7696; Zhou P, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000730	40	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143069	10.1371/journal.pone.0143069	http://dx.doi.org/10.1371/journal.pone.0143069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599409	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900061
J	Chu, PC; Yang, MC; Kulp, SK; Salunke, SB; Himmel, LE; Fang, CS; Jadhav, AM; Shan, YS; Lee, CT; Lai, MD; Shirley, LA; Bekaii-Saab, T; Chen, CS				Chu, P-C; Yang, M-C; Kulp, S. K.; Salunke, S. B.; Himmel, L. E.; Fang, C-S; Jadhav, A. M.; Shan, Y-S; Lee, C-T; Lai, M-D; Shirley, L. A.; Bekaii-Saab, T.; Chen, C-S			Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; K-RAS; DUCTAL ADENOCARCINOMA; GENE-EXPRESSION; HNRNP A1; EGF RECEPTOR; KINASE; TRANSCRIPTION; PROTEIN; MYC	Integrin-linked kinase (ILK) is a mediator of aggressive phenotype in pancreatic cancer. On the basis of our finding that knockdown of either KRAS or ILK has a reciprocal effect on the other's expression, we hypothesized the presence of an ILK-KRAS regulatory loop that enables pancreatic cancer cells to regulate KRAS expression. This study aimed to elucidate the mechanism by which this regulatory circuitry is regulated and to investigate the translational potential of targeting ILK to suppress oncogenic KRAS signaling in pancreatic cancer. Interplay between KRAS and ILK and the roles of E2F1, c-Myc and heterogeneous nuclear ribonucleoprotein as intermediary effectors in this feedback loop was interrogated by genetic manipulations through small interfering RNA/short hairpin RNA knockdown and ectopic expression, western blotting, PCR, promoter-luciferase reporter assays, chromatin immunoprecipitation and pull-down analyses. In vivo efficacy of ILK inhibition was evaluated in two murine xenograft models. Our data show that KRAS regulated the expression of ILK through E2F1-mediated transcriptional activation, which, in turn, controlled KRAS gene expression via hnRNPA1-mediated destabilization of the G-quadruplex on the KRAS promoter. Moreover, ILK inhibition blocked KRAS-driven epithelial-mesenchymal transition and growth factor-stimulated KRAS expression. The knockdown or pharmacological inhibition of ILK suppressed pancreatic tumor growth, in part, by suppressing KRAS signaling. These studies suggest that this KRAS-E2F1-ILK-hnRNPA1 regulatory loop enables pancreatic cancer cells to promote oncogenic KRAS signaling and to interact with the tumor microenvironment to promote aggressive phenotypes. This regulatory loop provides a mechanistic rationale for targeting ILK to suppress oncogenic KRAS signaling, which might foster new therapeutic strategies for pancreatic cancer.	[Chu, P-C; Yang, M-C; Kulp, S. K.; Salunke, S. B.; Himmel, L. E.; Fang, C-S; Jadhav, A. M.; Chen, C-S] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500W 12th Ave, Columbus, OH 43201 USA; [Chu, P-C; Lai, M-D; Chen, C-S] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Chu, P-C; Chen, C-S] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Himmel, L. E.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH USA; [Shan, Y-S] Natl Cheng Kung Univ, Coll Med, Dept Surg, Tainan, Taiwan; [Lee, C-T] Natl Cheng Kung Univ, Coll Med, Dept Pathol, Tainan, Taiwan; [Shirley, L. A.] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH USA; [Bekaii-Saab, T.] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH USA	University System of Ohio; Ohio State University; National Cheng Kung University; Academia Sinica - Taiwan; University System of Ohio; Ohio State University; National Cheng Kung University; National Cheng Kung University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500W 12th Ave, Columbus, OH 43201 USA.	chen.844@osu.edu	Lai, Ming-Derg/M-8028-2014; Jadhav, Appaso/ABC-8338-2020	Jadhav, Appaso/0000-0002-4892-0792; Bekaii-Saab, Tanios/0000-0001-7721-1699	Lucius A Wing Endowed Chair Fund; Ministry of Science and Technology [MOST 103-2320-B-001-017]; National Cheng Kung University College of Medicine; Ohio State University Wexner Medical Center; Comprehensive Cancer Center; National Institutes of Health [P30 CA016058]; Comparative Pathology and Mouse Phenotyping Shared Resource at The Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	Lucius A Wing Endowed Chair Fund; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Cheng Kung University College of Medicine; Ohio State University Wexner Medical Center; Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comparative Pathology and Mouse Phenotyping Shared Resource at The Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Lucius A Wing Endowed Chair Fund (CSC), Ministry of Science and Technology grant MOST 103-2320-B-001-017 (PCC), Bi-institutional Collaborative Pancreatic Cancer Research grants from National Cheng Kung University College of Medicine (CSC) and The Ohio State University Wexner Medical Center and Comprehensive Cancer Center (TBS) and National Institutes of Health grant P30 CA016058, which supports, in part, the Comparative Pathology and Mouse Phenotyping Shared Resource at The Ohio State University Comprehensive Cancer Center.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Bommert KS, 2013, LEUKEMIA, V27, P441, DOI 10.1038/leu.2012.185; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Cogoi S, 2010, J BIOL CHEM, V285, P22003, DOI 10.1074/jbc.M110.101923; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hsu EC, 2015, NEOPLASIA, V17, P497, DOI 10.1016/j.neo.2015.06.001; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Kalra J, 2010, ONCOGENE, V29, P6343, DOI 10.1038/onc.2010.366; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Lee SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067149; Lee SL, 2011, J MED CHEM, V54, P6364, DOI 10.1021/jm2007744; Liu TM, 2015, BLOOD, V125, P284, DOI 10.1182/blood-2014-06-583518; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Meng P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.326; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Paramasivam M, 2009, NUCLEIC ACIDS RES, V37, P2841, DOI 10.1093/nar/gkp138; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Sawai H, 2006, ONCOGENE, V25, P3237, DOI 10.1038/sj.onc.1209356; Schaeffer DF, 2010, VIRCHOWS ARCH, V456, P261, DOI 10.1007/s00428-009-0866-z; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Serrano I, 2013, ONCOGENE, V32, P50, DOI 10.1038/onc.2012.30; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Stolzenberg-Solomon RZ, 2005, JAMA-J AM MED ASSOC, V294, P2872, DOI 10.1001/jama.294.22.2872; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Wang ZW, 2013, J CELL PHYSIOL, V228, P556, DOI 10.1002/jcp.24162; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yau CYF, 2005, CANCER RES, V65, P1497, DOI 10.1158/0008-5472.CAN-04-2940; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Zhou ZJ, 2013, INT J CANCER, V132, P1080, DOI 10.1002/ijc.27742	47	28	29	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 28	2016	35	30					3897	3908		10.1038/onc.2015.458	http://dx.doi.org/10.1038/onc.2015.458			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8DJ	26616862				2022-12-26	WOS:000381013100002
J	Chang, CH; Lin, CY; Liu, FH; Chen, MHC; Lin, CP; Ho, HN; Liao, YS				Chang, Chih-Hao; Lin, Chih-Yang; Liu, Fwu-Hsing; Chen, Mark Hung-Chih; Lin, Chun-Pin; Ho, Hong-Nerng; Liao, Yunn-Shiuan			3D Printing Bioceramic Porous Scaffolds with Good Mechanical Property and Cell Affinity	PLOS ONE			English	Article							BONE TISSUE REGENERATION; BIOACTIVE GLASS SCAFFOLDS; BIOLOGICAL-PROPERTIES; IN-VITRO; WOLLASTONITE; CERAMICS; STRENGTH; ABILITY; DESIGN; POWDER	Artificial bone grafting is widely used in current orthopedic surgery for bone defect problems. Unfortunately, surgeons remain unsatisfied with the current commercially available products. One of the major complaints is that these products cannot provide sufficient mechanical strength to support the human skeletal structure. In this study, we aimed to develop a bone scaffold with better mechanical property and good cell affinity by 3D printing (3DP) techniques. A self-developed 3D printer with laser-aided gelling (LAG) process was used to fabricate bioceramic scaffolds with inter-porous structures. To improve the mechanical property of the bioceramic parts after heating, CaCO3 was added to the silica ceramic slurry. CaCO3 was blended into a homogenous SiO2-sol dispersion at weight ratios varying from 0/100 to 5/95 to 9/91 (w/w). Bi-component CaCO3/SiO2-sol was prepared as a biocomposite for the 3DP scaffold. The well-mixed biocomposite was used to fabricate the bioceramic green part using the LAG method. The varied scaffolds were sintered at different temperatures ranging from 900 to 1500 degrees C, and the mechanical property was subsequently analyzed. The scaffolds showed good property with the composite ratio of 5:95 CaCO3:SiO2 at a sintering temperature of 1300 degrees C. The compressive strength was 47 MPa, and the porosity was 34%. The topography of the sintered 3DP bioceramic scaffold was examined by SEM, EDS and XRD. The silica bioceramic presented no cytotoxicity and good MG-63 osteoblast-like cell affinity, demonstrating good biocompatibility. Therefore, the new silica biocomposite is viable for fabricating 3DP bone bioceramics with improved mechanical property and good cell affinity.	[Chang, Chih-Hao; Chen, Mark Hung-Chih] Natl Taiwan Univ Hosp, Dept Orthoped, Taipei, Taiwan; [Chang, Chih-Hao; Chen, Mark Hung-Chih; Ho, Hong-Nerng] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Lin, Chih-Yang; Liao, Yunn-Shiuan] Natl Taiwan Univ, Dept Mech Engn, Taipei 10764, Taiwan; [Liu, Fwu-Hsing] LungHwa Univ Sci & Technol, Dept Mech Engn, Taoyuan, Taiwan; [Lin, Chun-Pin] Natl Taiwan Univ Hosp, Sch Dent, Dept Dent, Taipei, Taiwan; [Lin, Chun-Pin] Natl Taiwan Univ, Taipei 10764, Taiwan; [Ho, Hong-Nerng] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Liao, YS (corresponding author), Natl Taiwan Univ, Dept Mech Engn, Taipei 10764, Taiwan.	liaoys@ntu.edu.tw	NTU, Ref07/AAX-7890-2021	CHANG, CHIH-HAO/0000-0001-9794-0610; Ho, Hong-Nerng/0000-0002-7207-0089	Ministry of Science and Technology [MOST 103-2221-E262-005]; National Taiwan University [NTU-CESRP-103R104941]; National Taiwan University Hospital [UN104-063, 104C101-31]; National Taiwan University College of Medicine	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University(National Taiwan University); National Taiwan University Hospital(National Taiwan University); National Taiwan University College of Medicine(National Taiwan University)	Y.-S. Liao gratefully acknowledges financial support from the Ministry of Science and Technology (MOST 103-2221-E262-005), National Taiwan University (NTU-CESRP-103R104941), and National Taiwan University Hospital (UN104-063). This work is further supported by the excellent translational medicine research projects of National Taiwan University College of Medicine and National Taiwan University Hospital (104C101-31) for H.-N. Ho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulQader ST, 2013, CERAM INT, V39, P2375, DOI 10.1016/j.ceramint.2012.08.089; Baino F, 2014, MATER LETT, V118, P27, DOI 10.1016/j.matlet.2013.12.037; CHAKLADER ACD, 1961, J AM CERAM SOC, V44, P35, DOI 10.1111/j.1151-2916.1961.tb15344.x; Chang CH, 2010, J BIOACT COMPAT POL, V25, P465, DOI 10.1177/0883911510372284; Chen XF, 2009, J NON-CRYST SOLIDS, V355, P791, DOI 10.1016/j.jnoncrysol.2009.02.005; Cheng YL, 2009, RAPID PROTOTYPING J, V15, P29, DOI 10.1108/13552540910925045; Erol M, 2012, J EUR CERAM SOC, V32, P2747, DOI 10.1016/j.jeurceramsoc.2012.01.015; Fielding GA, 2012, DENT MATER, V28, P113, DOI 10.1016/j.dental.2011.09.010; Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019; Huang YH, 2014, ACS APPL MATER INTER, V6, P20324, DOI 10.1021/am5057213; Ko YG, 2010, J BIOACT COMPAT POL, V25, P360, DOI 10.1177/0883911510370002; Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9; Lei B, 2014, J BIOMED MATER RES B, V102, P1528, DOI 10.1002/jbm.b.33133; Liu FH, 2014, APPL SURF SCI, V297, P1, DOI 10.1016/j.apsusc.2013.12.130; Liu FH, 2012, INT J PRECIS ENG MAN, V13, P439, DOI 10.1007/s12541-012-0056-9; Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024; Long LH, 2006, CERAM INT, V32, P457, DOI 10.1016/j.ceramint.2005.03.023; Long LH, 2006, J EUR CERAM SOC, V26, P1701, DOI 10.1016/j.jeurceramsoc.2005.03.247; Niu LN, 2014, J DENT, V42, P517, DOI 10.1016/j.jdent.2013.12.015; Nour WMN, 2008, CERAM INT, V34, P101, DOI 10.1016/j.ceramint.2006.08.019; Pach L, 1998, MATER RES BULL, V33, P1653, DOI 10.1016/S0025-5408(98)00159-7; Padmanabhan SK, 2013, CERAM INT, V39, P619, DOI 10.1016/j.ceramint.2012.06.073; Santos CFL, 2012, MAT SCI ENG C-MATER, V32, P1293, DOI 10.1016/j.msec.2012.04.010; Singh NB, 2006, PROG CRYST GROWTH CH, V52, P77, DOI 10.1016/j.pcrysgrow.2006.03.011; Torres AL, 2013, MAT SCI ENG C-MATER, V33, P4460, DOI 10.1016/j.msec.2013.07.003; Venkatesan J, 2012, INT J BIOL MACROMOL, V50, P393, DOI 10.1016/j.ijbiomac.2011.12.032; Vichaphund S, 2011, J EUR CERAM SOC, V31, P2435, DOI 10.1016/j.jeurceramsoc.2011.02.026; Wang GC, 2012, MAT SCI ENG C-MATER, V32, P1818, DOI 10.1016/j.msec.2012.04.068; Wang HP, 2008, CERAM INT, V34, P1405, DOI 10.1016/j.ceramint.2007.05.001; Wu CT, 2008, ACTA BIOMATER, V4, P343, DOI 10.1016/j.actbio.2007.08.010; Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f; Wu CT, 2011, ACTA BIOMATER, V7, P2644, DOI 10.1016/j.actbio.2011.03.009; Wu CT, 2010, ACTA BIOMATER, V6, P2237, DOI 10.1016/j.actbio.2009.12.022; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; Yen HC, 2012, J EUR CERAM SOC, V32, P3123, DOI 10.1016/j.jeurceramsoc.2012.04.014; Yun YH, 2002, CERAM INT, V28, P503, DOI 10.1016/S0272-8842(02)00002-0; Zhang JH, 2014, ACTA BIOMATER, V10, P2269, DOI 10.1016/j.actbio.2014.01.001	37	37	38	0	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143713	10.1371/journal.pone.0143713	http://dx.doi.org/10.1371/journal.pone.0143713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618362	Green Submitted, gold, Green Published			2022-12-26	WOS:000365889800061
J	Brant, JO; Lopez, MC; Baker, HV; Barbazuk, WB; Maden, M				Brant, Jason Orr; Lopez, Maria-Cecilia; Baker, Henry V.; Barbazuk, W. Brad; Maden, Malcolm			A Comparative Analysis of Gene Expression Profiles during Skin Regeneration in Mus and Acomys	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; GROWTH-FACTORS; WOUND REPAIR; FETAL; COLLAGEN; INFLAMMATION; CYCLOOXYGENASE-2; INTERLEUKIN-4; NEUTROPHILS; MATRIX	The African spiny mouse (Acomys spp.) can heal full thickness excisional skin wounds in a scar-free manner with regeneration of all dermal components including hair and associated structures. Comparing Acomys scar-free healing from Mus scarring identifies gene expression differences that discriminate these processes. We have performed an extensive comparison of gene expression profiles in response to 8mm full-thickness excisional wounds at days 3, 5, 7 and 14 post-wounding between Acomys and Mus to characterize differences in wound healing, and identify mechanisms involved in scar-free healing. We also identify similarities with scar-free healing observed in fetal wounds. While wounding in Mus elicits a strong inflammatory response, wounding in Acomys produces a moderated immune response and little to no increase in expression for most cytokines and chemokines assayed. We also identified differences in the ECM profiles of the Acomys wounds, which appear to have a collagen profile more similar to fetal wounds, with larger increases in expression of collagen types III and V. In contrast, Mus wounds have very high levels of collagen XII. This data suggests that an overall lack of induction of cytokines and chemokines, coupled with an ECM profile more similar to fetal wounds, may underlie scar-free wound healing in Acomys skin. These data identify candidate genes for further testing in order to elucidate the causal mechanisms of scar-free healing.	[Brant, Jason Orr; Barbazuk, W. Brad; Maden, Malcolm] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Brant, Jason Orr; Lopez, Maria-Cecilia; Baker, Henry V.; Barbazuk, W. Brad; Maden, Malcolm] Univ Florida, UF Genet Inst, Gainesville, FL USA; [Lopez, Maria-Cecilia; Baker, Henry V.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Brant, JO (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	jobrant@ufl.edu	Brant, Jason/AAA-5275-2022; Lopez, Maria/HHC-3659-2022; Brant, Jason Orr/GNH-5703-2022	Brant, Jason Orr/0000-0002-9800-9251; Barbazuk, William/0000-0002-0909-4563	WM Keck Foundation	WM Keck Foundation(W.M. Keck Foundation)	This work was funded by a grant from the WM Keck Foundation, grant: The Transformative Role of the Regenerating Spiny Mouse to MM and BB (http://www.wmkeck.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a grant from the WM Keck Foundation. Based in Los Angeles, the W. M. Keck Foundation was established in 1954 by the late W. M. Keck, founder of the Superior Oil Company. The Foundation's grant making is focused primarily on pioneering efforts in the areas of medical, science and engineering research. The Foundation also maintains an undergraduate education program that promotes distinctive learning and research experiences for students in the sciences and in the liberal arts, and a Southern California Grant Program that provides support for the Los Angeles community, with a special emphasis on children and youth from low-income families, special needs populations and safety-net services. For more information visit www.wmkeck.org	ADZICK NS, 1985, J PEDIATR SURG, V20, P315; Annes JP, 2002, FEBS LETT, V511, P65, DOI 10.1016/S0014-5793(01)03280-X; BEGLEY CG, 1986, BLOOD, V68, P162; Clark R. A. F., 1988, MOL CELLULAR BIOL WO; Cowin AJ, 1998, DEV DYNAM, V212, P385; Cowin AJ, 2001, EUR J DERMATOL, V11, P424; Cuttle L, 2005, WOUND REPAIR REGEN, V13, P198, DOI 10.1111/j.1067-1927.2005.130211.x; Dang CM, 2003, PLAST RECONSTR SURG, V111, P2273, DOI 10.1097/01.PRS.0000060102.57809.DA; Dang CM, 2003, PLAST RECONSTR SURG, V111, P1969, DOI 10.1097/01.PRS.0000054837.47432.E7; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; DIXON JB, 1960, J PATHOL BACTERIOL, V80, P73, DOI 10.1002/path.1700800109; ESTES JM, 1994, DIFFERENTIATION, V56, P173, DOI 10.1046/j.1432-0436.1994.5630173.x; FERTIN C, 1991, CELL MOL BIOL, V37, P823; FRAMPTON JE, 1994, DRUGS, V48, P731, DOI 10.2165/00003495-199448050-00007; Futagami A, 2002, LAB INVEST, V82, P1503, DOI 10.1097/01.LAB.0000035024.75914.39; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; GILLERY P, 1992, FEBS LETT, V302, P231, DOI 10.1016/0014-5793(92)80448-P; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; HALLOCK GG, 1988, ANN PLAS SURG, V21, P310, DOI 10.1097/00000637-198810000-00003; HAYNES JH, 1994, J PEDIATR SURG, V29, P1405, DOI 10.1016/0022-3468(94)90130-9; JENNINGS RW, 1991, J PEDIATR SURG, V26, P853, DOI 10.1016/0022-3468(91)90155-M; KURTJONES EA, 1985, P NATL ACAD SCI USA, V82, P1204, DOI 10.1073/pnas.82.4.1204; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Levesque M, 2010, J EXP ZOOL PART B, V314B, P684, DOI 10.1002/jez.b.21371; Liechty KW, 1998, J SURG RES, V77, P80, DOI 10.1006/jsre.1998.5345; Liechty KW, 2000, CYTOKINE, V12, P671, DOI 10.1006/cyto.1999.0598; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo DD, 2012, BIRTH DEFECTS RES C, V96, P237, DOI 10.1002/bdrc.21018; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; OBanion MK, 1996, J NEUROCHEM, V66, P2532; Olutoye OO, 1997, J PEDIATR SURG, V32, P827, DOI 10.1016/S0022-3468(97)90629-1; Olutoye OO, 1997, J PEDIATR SURG, V32, P1037, DOI 10.1016/S0022-3468(97)90394-8; Ozturk S, 2001, BRIT J PLAST SURG, V54, P47, DOI 10.1054/bjps.2000.3460; Peled ZM, 2002, PLAST RECONSTR SURG, V110, P801, DOI 10.1097/01.PRS.0000019915.20203.EC; Plasari G, 2009, MOL CELL BIOL, V29, P6006, DOI 10.1128/MCB.01921-08; Rolfe K J, 2012, ISRN Dermatol, V2012, P698034, DOI 10.5402/2012/698034; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; Salmon-Ehr V, 2000, LAB INVEST, V80, P1337, DOI 10.1038/labinvest.3780141; Satish L, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/790234; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; SMITH LT, 1986, AM J ANAT, V175, P507, DOI 10.1002/aja.1001750409; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; SULLIVAN KM, 1995, J PEDIATR SURG, V30, P198, DOI 10.1016/0022-3468(95)90560-X; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wilgus TA, 2004, AM J PATHOL, V165, P753, DOI 10.1016/S0002-9440(10)63338-X; Wilgus TA, 2003, WOUND REPAIR REGEN, V11, P25, DOI 10.1046/j.1524-475X.2003.11106.x; Wilgus TA, 2013, ADV WOUND CARE, V2, P379, DOI 10.1089/wound.2012.0383; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	59	51	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142931	10.1371/journal.pone.0142931	http://dx.doi.org/10.1371/journal.pone.0142931			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606282	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300037
J	Alves, Z; Melo, A; Figueiredo, AR; Coimbra, MA; Gomes, AC; Rocha, SM				Alves, Zelia; Melo, Andre; Figueiredo, Ana Raquel; Coimbra, Manuel A.; Gomes, Ana C.; Rocha, Silvia M.			Exploring the Saccharomyces cerevisiae Volatile Metabolome: Indigenous versus Commercial Strains	PLOS ONE			English	Article							MINIMUM REPORTING STANDARDS; MONOTERPENE ALCOHOLS; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; SENSORY PROFILES; YEAST; AROMA; BIOTRANSFORMATION; METABOANALYST; FERMENTATION	Winemaking is a highly industrialized process and a number of commercial Saccharomyces cerevisiae strains are used around the world, neglecting the diversity of native yeast strains that are responsible for the production of wines peculiar flavours. The aim of this study was to in-depth establish the S. cerevisiae volatile metabolome and to assess inter-strains variability. To fulfill this objective, two indigenous strains (BT2652 and BT2453 isolated from spontaneous fermentation of grapes collected in Bairrada Appellation, Portugal) and two commercial strains (CSc1 and CSc2) S. cerevisiae were analysed using a methodology based on advanced multidimensional gas chromatography (HS-SPME/GCxGC-ToFMS) tandem with multivariate analysis. A total of 257 volatile metabolites were identified, distributed over the chemical families of acetals, acids, alcohols, aldehydes, ketones, terpenic compounds, esters, ethers, furan-type compounds, hydrocarbons, pyrans, pyrazines and S-compounds. Some of these families are related with metabolic pathways of amino acid, carbohydrate and fatty acid metabolism as well as mono and sesquiterpenic biosynthesis. Principal Component Analysis (PCA) was used with a dataset comprising all variables (257 volatile components), and a distinction was observed between commercial and indigenous strains, which suggests inter-strains variability. In a second step, a subset containing esters and terpenic compounds (C-10 and C-15), metabolites of particular relevance to wine aroma, was also analysed using PCA. The terpenic and ester profiles express the strains variability and their potential contribution to the wine aromas, specially the BT2453, which produced the higher terpenic content. This research contributes to understand the metabolic diversity of indigenous wine microflora versus commercial strains and achieved knowledge that may be further exploited to produce wines with peculiar aroma properties.	[Alves, Zelia; Figueiredo, Ana Raquel; Coimbra, Manuel A.; Rocha, Silvia M.] Univ Aveiro, Dept Chem, P-3810193 Aveiro, Portugal; [Alves, Zelia; Figueiredo, Ana Raquel; Coimbra, Manuel A.; Rocha, Silvia M.] Univ Aveiro, QOPNA, P-3810193 Aveiro, Portugal; [Melo, Andre; Figueiredo, Ana Raquel; Gomes, Ana C.] Parque Tecnol Cantanhede, Biocant Biotechnol Innovat Ctr, Genom Unit, P-3060197 Cantanhede, Portugal; [Melo, Andre] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Melo, Andre] Univ Aveiro, CESAM, P-3810193 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro	Rocha, SM (corresponding author), Univ Aveiro, Dept Chem, P-3810193 Aveiro, Portugal.	smrocha@ua.pt	Coimbra, Manuel A./L-2527-2014; Gomes, Ana Catarina/A-2628-2015	Coimbra, Manuel A./0000-0001-8898-6342; Rocha, Silvia/0000-0002-0396-3019; Gomes, Ana Catarina/0000-0002-4989-6026	European Regional Development Fund (FEDER) through the Competitive Factors Thematic Operational Program (COMPETE); FCT, Portugal [62/94 QOPNA, FCT UID/QUI/00062/2013]; project HoliWine: Holistic approaches to oenology [FCOMP-01-0124-FEDER-027411]	European Regional Development Fund (FEDER) through the Competitive Factors Thematic Operational Program (COMPETE); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); project HoliWine: Holistic approaches to oenology	Funding is acknowledged from the European Regional Development Fund (FEDER) through the Competitive Factors Thematic Operational Program (COMPETE) and from the FCT, Portugal, for supporting the Organic Chemistry Research Unit (62/94 QOPNA, under projects FCT UID/QUI/00062/2013), and project HoliWine: Holistic approaches to oenology (FCOMP-01-0124-FEDER-027411).	Barbosa C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122709; Bell S, 2005, IMPLICATIONS NITROGE, P242; Bisson LF, 2010, ANNU REV FOOD SCI T, V1, P139, DOI 10.1146/annurev.food.080708.100734; Rojas IB, 2012, WORLD J MICROB BIOT, V28, P3311, DOI 10.1007/s11274-012-1142-y; Callejon RM, 2010, ANAL CHIM ACTA, V660, P68, DOI 10.1016/j.aca.2009.09.040; Carrau FM, 2005, FEMS MICROBIOL LETT, V243, P107, DOI 10.1016/j.femsle.2004.11.050; CHEONG MW, 2011, J ESSENT OIL RES, V23, P34; Coelho E, 2006, ANAL CHIM ACTA, V563, P204, DOI 10.1016/j.aca.2005.11.018; Cordente AG, 2012, APPL MICROBIOL BIOT, V96, P601, DOI 10.1007/s00253-012-4370-z; Etschmann MMW, 2008, APPL MICROBIOL BIOT, V80, P579, DOI 10.1007/s00253-008-1573-4; Fiehn O, 2007, METABOLOMICS, V3, P175, DOI 10.1007/s11306-007-0070-6; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Franco-Duarte R, 2011, ELECTROPHORESIS, V32, P1447, DOI 10.1002/elps.201000640; Gomes Pereira AS, 2012, THESIS; Goodacre R, 2007, METABOLOMICS, V3, P231, DOI 10.1007/s11306-007-0081-3; Horak T, 2009, J AGR FOOD CHEM, V57, P11081, DOI 10.1021/jf9028305; Hu LS, 2011, J MED PLANTS RES, V5, P3298; King A, 2000, YEAST, V16, P499, DOI 10.1002/(SICI)1097-0061(200004)16:6<499::AID-YEA548>3.3.CO;2-5; Lambrechts M. G., 2000, South African Journal of Enology and Viticulture, V21, P97; Liang HY, 2013, FOOD RES INT, V51, P855, DOI 10.1016/j.foodres.2013.01.056; Lourenco AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055439; Martini A, 2003, INT MICROBIOL, V6, P207, DOI 10.1007/s10123-003-0135-y; Moreno-Garcia J, 2014, INT J FOOD MICROBIOL, V172, P21, DOI 10.1016/j.ijfoodmicro.2013.11.030; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Procopio S, 2011, EUR FOOD RES TECHNOL, V233, P721, DOI 10.1007/s00217-011-1567-9; Rocha SM, 2007, J CHROMATOGR A, V1161, P292, DOI 10.1016/j.chroma.2007.05.093; Romano P, 1998, FOOD TECHNOL BIOTECH, V36, P69; Romano P, 1997, FOOD TECHNOL BIOTECH, V35, P255; Rossouw D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-530; Saberi S, 2012, FOOD RES INT, V48, P725, DOI 10.1016/j.foodres.2012.06.012; Schuller D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032507; Styger G, 2011, J IND MICROBIOL BIOT, V38, P1145, DOI 10.1007/s10295-011-1018-4; Sumby KM, 2010, FOOD CHEM, V121, P1, DOI 10.1016/j.foodchem.2009.12.004; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Swiegers JH, 2006, CURR GENET, V50, P161, DOI 10.1007/s00294-006-0084-z; Swiegers JH, 2005, AUST J GRAPE WINE R, V11, P139, DOI 10.1111/j.1755-0238.2005.tb00285.x; Takoi K, 2010, J AGR FOOD CHEM, V58, P5050, DOI 10.1021/jf1000524; Tang J, 2011, CURR GENOMICS, V12, P391, DOI 10.2174/138920211797248619; Tufariello M, 2014, LWT-FOOD SCI TECHNOL, V58, P35, DOI 10.1016/j.lwt.2014.03.016; Ugliano M, 2006, J AGR FOOD CHEM, V54, P6322, DOI 10.1021/jf0607718; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356	43	44	44	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143641	10.1371/journal.pone.0143641	http://dx.doi.org/10.1371/journal.pone.0143641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600152	gold, Green Published			2022-12-26	WOS:000365862600098
J	Fraser, DI; Liu, KT; Reid, BJ; Hawkins, E; Sevier, A; Pyle, M; Robinson, JW; Ouellette, PHR; Ballantyne, JS				Fraser, David I.; Liu, Kyle T.; Reid, Bryan J.; Hawkins, Emily; Sevier, Andrew; Pyle, Michelle; Robinson, Jacob W.; Ouellette, Pierre H. R.; Ballantyne, James S.			Widespread Natural Occurrence of Hydroxyurea in Animals	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; NITRIC-OXIDE; RIBONUCLEOTIDE REDUCTASE; UREA TRANSPORTER; MAMMALIAN-CELLS; DNA SYNTHESIS; INHIBITION; ACID; INTERMEDIATE; METABOLISM	Here we report the widespread natural occurrence of a known antibiotic and antineoplastic compound, hydroxyurea in animals from many taxonomic groups. Hydroxyurea occurs in all the organisms we have examined including invertebrates (molluscs and crustaceans), fishes from several major groups, amphibians and mammals. The species with highest concentrations was an elasmobranch (sharks, skates and rays), the little skate Leucoraja erinacea with levels up to 250 mu M, high enough to have antiviral, antimicrobial and antineoplastic effects based on in vitro studies. Embryos of L. erinacea showed increasing levels of hydroxyurea with development, indicating the capacity for hydroxyurea synthesis. Certain tissues of other organisms (e.g. skin of the frog (64 mu M), intestine of lobster (138 mu M) gills of the surf clam (100 mu M)) had levels high enough to have antiviral effects based on in vitro studies. Hydroxyurea is widely used clinically in the treatment of certain human cancers, sickle cell anemia, psoriasis, myeloproliferative diseases, and has been investigated as a potential treatment of HIV infection and its presence at high levels in tissues of elasmobranchs and other organisms suggests a novel mechanism for fighting disease that may explain the disease resistance of some groups. In light of the known production of nitric oxide from exogenously applied hydroxyurea, endogenous hydoxyurea may play a hitherto unknown role in nitric oxide dynamics.	[Fraser, David I.; Liu, Kyle T.; Reid, Bryan J.; Hawkins, Emily; Sevier, Andrew; Pyle, Michelle; Ouellette, Pierre H. R.; Ballantyne, James S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Robinson, Jacob W.] Durham Coll, Oshawa, ON, Canada	University of Guelph	Ballantyne, JS (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	jballant@uoguelph.ca	Ouellette, Pierre/GSO-0159-2022		Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by Natural Science and Engineering Research Council of Canada www.nserc-crsng.gc.ca.	Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Ballantyne JS, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1807; BERGLUND O, 1979, J BIOL CHEM, V254, P253; BOUCHER JL, 1994, BIOCHEM BIOPH RES CO, V203, P1614, DOI 10.1006/bbrc.1994.2371; Burkitt MJ, 2006, BLOOD, V107, P2219, DOI 10.1182/blood-2005-08-3429; Crow G.L., 2004, ELASMOBRANCH HUSBAND, V1st ed., P467; Dresler WFC, 1869, LIEBIGS ANN CHEM, V150, P1317; ELFORD HL, 1968, BIOCHEM BIOPH RES CO, V33, P129, DOI 10.1016/0006-291X(68)90266-0; FABRICIUS E, 1971, REV EUR ETUD CL BIOL, V16, P679; Fontecave M, 1998, FEBS LETT, V421, P277, DOI 10.1016/S0014-5793(97)01572-X; Frick NT, 2008, COMP BIOCHEM PHYS A, V151, P85, DOI 10.1016/j.cbpa.2008.06.003; GALE GR, 1964, CANCER RES, V24, P1012; Gaylor DW, 2000, TOXICOLOGY, V149, P17, DOI 10.1016/S0300-483X(00)00228-6; Topal JLG, 2006, J PHARMACOL EXP THER, V318, P1368, DOI 10.1124/jpet.106.103747; GRIMES D J, 1990, NOAA Technical Report NMFS, P63; Harshbarger J. C., 1977, Annals NY Acad Sci, V298, P280, DOI 10.1111/j.1749-6632.1977.tb19272.x; Harshbarger JC, 1981, PHYLETIC APPROACHES, P357; Hoff GR, 2009, J FISH BIOL, V74, P483, DOI 10.1111/j.1095-8649.2008.02138.x; Kettani T, 2009, J CHROMATOGR B, V877, P446, DOI 10.1016/j.jchromb.2008.12.048; King SB, 2004, FREE RADICAL BIO MED, V37, P737, DOI 10.1016/j.freeradbiomed.2004.02.073; King SB, 2003, CURR MED CHEM, V10, P437, DOI 10.2174/0929867033368213; LARSEN IK, 1982, EUR J BIOCHEM, V125, P75; LORI F, 1994, SCIENCE, V266, P801, DOI 10.1126/science.7973634; Mariotti F, 2013, AM J CLIN NUTR, V97, P972, DOI 10.3945/ajcn.112.048025; Martinez-Rojano H, 2008, ANTIMICROB AGENTS CH, V52, P3642, DOI 10.1128/AAC.00124-08; MOHLER WC, 1964, CANCER CHEMOTH REP, P1; Morgan RL, 2003, J EXP BIOL, V206, P3285, DOI 10.1242/jeb.00554; Mori M, 2007, J NUTR, V137, p1616S, DOI 10.1093/jn/137.6.1616S; Mylniczenko ND, 2007, J AQUAT ANIM HEALTH, V19, P159, DOI 10.1577/H06-039.1; Nozaki A, 2010, ARCH VIROL, V155, P601, DOI 10.1007/s00705-010-0624-1; Parker JN, 2004, HYDROXYUREA MED DICT; PFEIFFER SE, 1967, CANCER RES, V27, P124; RAHMATULLAH M, 1980, CLIN CHIM ACTA, V107, P3, DOI 10.1016/0009-8981(80)90407-6; Roa D, 1997, J CLIN LAB ANAL, V11, P208, DOI 10.1002/(SICI)1098-2825(1997)11:4<208::AID-JCLA6>3.0.CO;2-4; Robinson JW, 2011, AMINO ACIDS, V40, P689, DOI 10.1007/s00726-010-0703-3; ROSENKRANZ HS, 1966, VIROLOGY, V28, P510, DOI 10.1016/0042-6822(66)90235-2; ROSENKRANZ HS, 1973, J BACTERIOL, V115, P682, DOI 10.1128/JB.115.2.682-690.1973; Schlapfer E, 2003, AIDS, V17, P1613, DOI [10.1097/00002030-200307250-00005, 10.1097/01.aids.0000072664.21517.ad]; Scott DK, 2010, METHODS MOL BIOL, V603, P279, DOI 10.1007/978-1-60761-459-3_26; SINCLAIR WK, 1965, SCIENCE, V150, P1729, DOI 10.1126/science.150.3704.1729; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; SVENSSON ML, 1981, ARCH MICROBIOL, V129, P210, DOI 10.1007/BF00425252; VEALE D, 1988, CANCER CHEMOTH PHARM, V21, P53; Villani P, 1996, J CLIN PHARMACOL, V36, P117, DOI 10.1002/j.1552-4604.1996.tb04176.x; Walker AL, 2011, EXP HEMATOL, V39, P446, DOI 10.1016/j.exphem.2011.01.004; World Health Organization, 2013, WHO MOD LIST ESS MED; YARBRO JW, 1965, P NATL ACAD SCI USA, V53, P1033, DOI 10.1073/pnas.53.5.1033; YOUNG CW, 1964, SCIENCE, V146, P1172, DOI 10.1126/science.146.3648.1172; Zhao D, 2007, BBA-BIOMEMBRANES, V1768, P1815, DOI 10.1016/j.bbamem.2007.04.010	49	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142890	10.1371/journal.pone.0142890	http://dx.doi.org/10.1371/journal.pone.0142890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600157	gold, Green Published, Green Submitted			2022-12-26	WOS:000365862600021
J	Laguardia-Nascimento, M; Branco, KMGR; Gasparini, MR; Giannattasio-Ferraz, S; Leite, LR; Araujo, FMG; Salim, ACD; Nicoli, JR; de Oliveira, GC; Barbosa-Stancioli, EF				Laguardia-Nascimento, Mateus; Grillo Ribeiro Branco, Kelly Moreira; Gasparini, Marcela Ribeiro; Giannattasio-Ferraz, Silvia; Leite, Laura Rabelo; Gomes Araujo, Flavio Marcos; de Matos Salim, Anna Christina; Nicoli, Jacques Robert; de Oliveira, Guilherme Correa; Barbosa-Stancioli, Edel Figueiredo			Vaginal Microbiome Characterization of Nellore Cattle Using Metagenomic Analysis	PLOS ONE			English	Article							HUMAN GUT; DIVERSITY; BACTERIAL; IDENTIFICATION; GROWTH; TRACT; PREVALENCE; UROVAGINA; INFECTION; ARCHAEA	Understanding of microbial communities inhabiting cattle vaginal tract may lead to a better comprehension of bovine physiology and reproductive health being of great economic interest. Up to date, studies involving cattle microbiota are focused on the gastrointestinal tract, and little is known about the vaginal microbiota. This study aimed to investigate the vaginal microbiome in Nellore cattle, heifers and cows, pregnant and non-pregnant, using a culture independent approach. The main bacterial phyla found were Firmicutes (similar to 40-50%), Bacteroidetes (similar to 15-25%) and Proteobacteria (similar to 5-25%), in addition to similar to 10-20% of non-classified bacteria. 45-55% of the samples were represented by only ten OTUs: Aeribacillus, Bacteroides, Clostridium, Ruminococcus, Rikenella, Alistipes, Bacillus, Eubacterium, Prevotella and non-classified bacteria. Interestingly, microbiota from all 20 animals could be grouped according to the respiratory metabolism of the main OTUs found, creating three groups of vaginal microbiota in cattle. Archaeal samples were dominated by the Methano-brevibacter genus (Euryarchaeota, similar to 55-70%). Ascomycota was the main fungal phylum (similar to 80-95%) and Mycosphaerella the most abundant genus (similar to 70-85%). Hormonal influence was not clear, but a tendency for the reduction of bacterial and increase of archaeal populations in pregnant animals was observed. Eukaryotes did not vary significantly between pregnant and non-pregnant animals, but tended to be more abundant on cows than on heifers. The present work describes a great microbial variability in the vaginal community among the evaluated animals and groups (heifers and cows, pregnant and non-pregnant), which is significantly different from the findings previously reported using culture dependent methods, pointing out the need for further studies on this issue. The microbiome found also indicates that the vaginal colonization appears to be influenced by the gastrointestinal community.	[Laguardia-Nascimento, Mateus; Grillo Ribeiro Branco, Kelly Moreira; Gasparini, Marcela Ribeiro; Giannattasio-Ferraz, Silvia; Nicoli, Jacques Robert; Barbosa-Stancioli, Edel Figueiredo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Leite, Laura Rabelo; Gomes Araujo, Flavio Marcos; de Matos Salim, Anna Christina; de Oliveira, Guilherme Correa] Fiocruz MS, Rene Rachou Res Ctr, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Barbosa-Stancioli, EF (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.	edelfb@icb.ufmg.br	Nicoli, Jacques R/K-4807-2015; Barbosa-Stancioli, Edel F/J-7230-2012; Oliveira, Guilherme/E-2624-2014	Nicoli, Jacques R/0000-0003-2390-2608; Barbosa-Stancioli, Edel F/0000-0001-6584-4333; Oliveira, Guilherme/0000-0003-0054-3438	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473879/2013-1, 309312/2012-4]; Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) [RED-00014-14]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant 473879/2013-1) EFBS (http://www.cnpq.br/); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant 309312/2012-4) GCO (http://www.cnpq.br/); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG Grant RED-00014-14) GCO (http://www.fapemig.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amin J. D., 1996, Bulletin of Animal Health and Production in Africa, V44, P15; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Branco KMGR, 2010, BRAZ J MED BIOL RES, V43, P338, DOI [10.1590/S0100-879X2010007500013, 10.1590/S0100-879X2010000400003]; BRYANT MP, 1970, AM J CLIN NUTR, V23, P1440; Carberry CA, 2014, APPL ENVIRON MICROB, V80, P586, DOI 10.1128/AEM.03131-13; Dhillon B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1132; DOHMEN MJW, 1995, THERIOGENOLOGY, V43, P1379, DOI 10.1016/0093-691X(95)00123-P; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dumonceaux Tim J, 2009, J Clin Microbiol, V47, P4067, DOI 10.1128/JCM.00112-09; El-Said A. H. M., 2008, Mycobiology, V36, P1, DOI 10.4489/MYCO.2008.36.1.001; Faveri M, 2011, J PERIODONTAL RES, V46, P338, DOI 10.1111/j.1600-0765.2011.01347.x; Gaci N, 2014, WORLD J GASTROENTERO, V20, P16062, DOI 10.3748/wjg.v20.i43.16062; Gautam G, 2009, THERIOGENOLOGY, V71, P1451, DOI 10.1016/j.theriogenology.2008.12.027; HERTHELIUS M, 1989, INFECT IMMUN, V57, P2447, DOI 10.1128/IAI.57.8.2447-2451.1989; Hristov AN, 2012, J ANIM SCI, V90, P4449, DOI 10.2527/jas.2011-4624; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Khelaifia S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00073-14; Kim M, 2014, J ANIM SCI, V92, P683, DOI 10.2527/jas.2013-6841; Kwiatkowski NP, 2012, J MOL DIAGN, V14, P393, DOI 10.1016/j.jmoldx.2012.02.004; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Larsen A, 2013, FEMS MICROBIOL ECOL, V85, P483, DOI 10.1111/1574-6941.12136; LeBlanc SJ, 2011, THERIOGENOLOGY, V76, P1610, DOI 10.1016/j.theriogenology.2011.07.017; Lee J, 2013, ADVANCES IN MODELING AND DESIGN OF ADHESIVELY BONDED SYSTEMS, P1; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; McCann JC, 2014, BIOINFORM BIOL INSIG, V8, P109, DOI 10.4137/BBI.S15389; McDonald MC, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00102; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minana-Galbis D, 2010, INT J SYST EVOL MICR, V60, P1600, DOI 10.1099/ijs.0.003699-0; Moreno C, 2011, NAT PROD COMMUN, V6, P835; NELSEN TC, 1985, J ANIM SCI, V61, P470, DOI 10.2527/jas1985.612470x; Oikonomou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085904; Oliveira LJ, 2012, REPROD DOMEST ANIM, V47, P384, DOI 10.1111/j.1439-0531.2012.02102.x; Otero C, 1999, ANAEROBE, V5, P305, DOI 10.1006/anae.1999.0245; Otero C, 2000, LETT APPL MICROBIOL, V31, P251, DOI 10.1046/j.1365-2672.2000.00809.x; Patel V, 2014, APPL MICROBIOL BIOT, V98, P9749, DOI 10.1007/s00253-014-6153-1; Pereira CB, 2015, J ANTIBIOT, V68, P436, DOI 10.1038/ja.2015.11; Petri RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104167; REID G, 1985, INFECT IMMUN, V49, P320, DOI 10.1128/IAI.49.2.320-324.1985; Reti KL, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-8; Sevim E, 2011, J BACTERIOL, V193, P575, DOI 10.1128/JB.01193-10; SIJPESTEIJN AK, 1951, J GEN MICROBIOL, V5, P869, DOI 10.1099/00221287-5-5-869; Singh J, 2008, VET J, V175, P301, DOI 10.1016/j.tvjl.2007.02.003; Singh Jagtar, 2009, Biotechnology Journal, V4, P480, DOI 10.1002/biot.200800201; Snelling TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106491; STJEAN G, 1988, VET SURG, V17, P258, DOI 10.1111/j.1532-950X.1988.tb01011.x; Swartz Jeffrey D, 2014, Front Vet Sci, V1, P19, DOI 10.3389/fvets.2014.00019; Switt AIM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-26; USDA, 2014, LIV POULTR WORLD MAR; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; Wagner RD, 2011, ANTIMICROB AGENTS CH, V55, P4990, DOI 10.1128/AAC.00008-11; Williams EJ, 2005, THERIOGENOLOGY, V63, P102, DOI 10.1016/j.theriogenology.2004.03.017; Ziemer CJ, 2014, APPL ENVIRON MICROB, V80, P574, DOI 10.1128/AEM.03016-13	56	60	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143294	10.1371/journal.pone.0143294	http://dx.doi.org/10.1371/journal.pone.0143294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599789	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600045
J	Sun, JS; Yang, M; Sreevatsan, S; Davies, PR				Sun, Jisun; Yang, My; Sreevatsan, Srinand; Davies, Peter R.			Prevalence and Characterization of Staphylococcus aureus in Growing Pigs in the USA	PLOS ONE			English	Article							LIVESTOCK-ASSOCIATED MRSA; METHICILLIN-RESISTANT; UNITED-STATES; MOLECULAR CHARACTERIZATION; NASAL COLONIZATION; RISK-FACTOR; SLAUGHTER; CARRIAGE; STRAINS; FARMERS	A decade of research of methicillin-resistant S. aureus (MRSA) in pigs shows that the prevalence and predominant genotypes (i.e., ST398, ST9, ST5) of MRSA vary widely geographically, yet knowledge of the epidemiology of S. aureus generally in swine remains rudimentary. To characterize S. aureus, including MRSA, in the US swine industry, we sampled 38 swine herds in 11 states in major swine producing regions. The herds sampled included pigs sourced from 9 different breeding stock companies, and the sample was likely biased towards larger herds that use regular veterinary services. Twenty nasal swabs were collected from 36 groups of growing pigs by 36 swine veterinarians, 2 more herds were sampled opportunistically, and a historically MRSA-positive herd was included as a positive control. S. aureus was detected on 37 of the 38 herds, and in 77% of pigs sampled. Other than the positive control herd, no MRSA were detected in the study sample, yielding a 95% upper confidence limit of 9.3% for MRSA herd prevalence. All but two (ST1-t127; ST2007-t8314) of 1200 isolates belonged to three MLST lineages (ST9, ST398, and ST5) that have been prominent in studies of MRSA in pigs globally. A total of 35 spa types were detected, with the most prevalent being t337 (ST9), t034 (ST398), and t002 (ST5). A purposively diverse subset of 128 isolates was uniformly negative on PCR testing for major enterotoxin genes. The findings support previous studies suggesting a relatively low herd prevalence of MRSA in the US swine industry, but confirm that methicillin susceptible variants of the most common MRSA genotypes found in swine globally are endemic in the US. The absence of enterotoxin genes suggests that the source of toxigenic S. aureus capable of causing foodborne enterotoxicosis from pork products is most likely post-harvest contamination.	[Sun, Jisun; Yang, My; Sreevatsan, Srinand; Davies, Peter R.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Davies, PR (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	davie001@umn.edu	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403	National Pork Board [13-056]	National Pork Board	Funded by National Pork Board Grant #13-056 (http://www.pork.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerso Y, 2012, VET MICROBIOL, V157, P246, DOI 10.1016/j.vetmic.2011.12.023; Alt K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-69; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Bennett SD, 2013, CLIN INFECT DIS, V57, P425, DOI 10.1093/cid/cit244; Bisdorff B, 2012, EPIDEMIOL INFECT, V140, P1800, DOI 10.1017/S0950268811002378; Boost MV, 2012, VET REC, V171, P156, DOI 10.1136/vr.100779; Broens EM, 2011, PREV VET MED, V102, P41, DOI 10.1016/j.prevetmed.2011.06.005; Chroboczek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068462; Chuang YY, 2015, INT J ANTIMICROB AG, V45, P334, DOI 10.1016/j.ijantimicag.2014.12.007; Crombe F, 2012, MICROB DRUG RESIST, V18, P125, DOI 10.1089/mdr.2011.0138; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Davies PR, 2011, EMERG INFECT DIS, V17, P1152, DOI [10.3201/eid/1706.101394, 10.3201/eid1706.101394]; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Dressler AE, 2012, VET REC, V170, P495, DOI 10.1136/vr.100570; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Espinosa-Gongora C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101988; Fall C, 2012, FOODBORNE PATHOG DIS, V9, P962, DOI 10.1089/fpd.2012.1197; Frana TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053738; Gordoncillo MJ, 2012, ZOONOSES PUBLIC HLTH, V59, P212, DOI 10.1111/j.1863-2378.2011.01437.x; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Guinane CM, 2011, VIRULENCE, V2, P241, DOI 10.4161/viru.2.3.16193; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hau SJ, PLOS ONE ACCEPTED; He WQ, 2013, FOODBORNE PATHOG DIS, V10, P782, DOI 10.1089/fpd.2012.1452; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Lekkerkerk WSN, 2015, J CLIN MICROBIOL, V53, P1836, DOI 10.1128/JCM.02702-14; Linhares LL, 2015, J VET DIAGN INVEST, V27, P55, DOI 10.1177/1040638714559598; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Miko BA, 2013, J CLIN MICROBIOL, V51, P874, DOI 10.1128/JCM.00923-12; Molla B, 2012, J CLIN MICROBIOL, V50, P3687, DOI 10.1128/JCM.01971-12; Moodley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049344; Nadimpalli M, 2015, OCCUP ENVIRON MED, V72, P90, DOI 10.1136/oemed-2014-102095; Normanno G, 2015, FOOD MICROBIOL, V51, P51, DOI 10.1016/j.fm.2015.04.007; OEDING P, 1972, ACTA PATHOLOG MICROB, VB 80, P525; Osadebe LU, 2013, ZOONOSES PUBLIC HLTH, V60, P234, DOI 10.1111/j.1863-2378.2012.01527.x; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; Smith TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063704; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Sun J, 2015, PROCEEDINGS 11TH INT, P157; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; Verkade E, 2013, CLIN INFECT DIS, V57, pE11, DOI 10.1093/cid/cit228; Viana D, 2015, NAT GENET, V47, P361, DOI 10.1038/ng.3219; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wales A, 2013, ISRN Vet Sci, V2013, P943126, DOI 10.1155/2013/943126; Wardyn SE, 2015, CLIN INFECT DIS, V61, P59, DOI 10.1093/cid/civ234; Weese JS, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-41; Yan XM, 2014, INT J MED MICROBIOL, V304, P379, DOI 10.1016/j.ijmm.2013.12.003	53	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143670	10.1371/journal.pone.0143670	http://dx.doi.org/10.1371/journal.pone.0143670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599635	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600103
J	Wu, SM; Duncan, F; Anderson, NH; Kuppuswamy, A; Macloed, MR; Mead, GE				Wu, Simiao; Duncan, Fiona; Anderson, Niall H.; Kuppuswamy, Annapoorna; Macloed, Malcolm R.; Mead, Gillian E.			Exploratory Cohort Study of Associations between Serum C - Reactive Protein and Fatigue after Stroke	PLOS ONE			English	Article							ISCHEMIC-STROKE; INFLAMMATORY RESPONSE; POSTSTROKE FATIGUE; INFECTION	Background and Aim Post-stroke fatigue is a common and distressing problem but little is known about its biological mechanisms. This cohort study was to investigate associations between C-reactive protein (CRP) and fatigue after stroke. Methods Patients were assessed at one, six and 12 months after their stroke onset, with the Fatigue Assessment Scale, a case definition of post-stroke fatigue, Hospital Anxiety and Depression Scale, and daily step counts. Blood samples were collected at each assessment and the CRP level was determined by a standard CRP immunoassay. Cross-sectional associations between CRP and fatigue at each time point were determined by Pearson correlation coefficient and independent-samples t-test. Whether CRP levels at one month predict fatigue scores at six and 12 months was explored by multiple linear regression, with anxiety, depression, and daily step counts as covariates. Results Sixty-five patients (mean age 67 years, 65% men) were included: 61 at one month, 49 at six months, and 41 at 12 months. CRP levels and fatigue scores were not associated at one month (p = 0.88) or 12 months (p = 0.56), but weakly associated at six months (r = 0.27, p = 0.04); however, this association was no longer significant (p = 0.14) after controlling for the effects of covariates. The CRP level was not associated with the fulfilment of case definition of post-stroke fatigue at any time points (all p > 0.05). The CRP level at one month was not a significant predictor for fatigue levels at either six months (p = 0.93) or 12 months (p = 0.78). Conclusions There is insufficient evidence for the association between CRP and PSF in stroke patients. Future studies with larger sample sizes and controlling for potential confounders are needed to investigate whether this association exists.	[Wu, Simiao; Macloed, Malcolm R.; Mead, Gillian E.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Wu, Simiao] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Peoples R China; [Duncan, Fiona] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Anderson, Niall H.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Kuppuswamy, Annapoorna] UCL, Sobell Dept Motor Neurosci, London, England	University of Edinburgh; Sichuan University; Glasgow Caledonian University; University of Edinburgh; University of London; University College London	Mead, GE (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	gillian.e.mead@ed.ac.uk		Kuppuswamy, Annapoorna/0000-0002-4288-0814; WU, SIMIAO/0000-0002-4557-7386	Chief Scientist Office of Scottish Government [CZH/4/536]; University of Edinburgh; China Scholarships Council [2011624011]	Chief Scientist Office of Scottish Government; University of Edinburgh; China Scholarships Council	This study was supported by The Chief Scientist Office of Scottish Government (CZH/4/536, http://www.cso.scot.nhs.uk/) and The University of Edinburgh and China Scholarships Council joint scholarship (2011624011, http://www.ed.ac.uk/student-funding/postgraduate/international/region/asia/china-council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour VL, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/863031; Beamer NB, 1998, NEUROLOGY, V50, P1722, DOI 10.1212/WNL.50.6.1722; Becker K, 2015, J STROKE CEREBROVASC, V24, P618, DOI 10.1016/j.jstrokecerebrovasdis.2014.10.008; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Di Napoli M, 2005, STROKE, V36, P1316, DOI 10.1161/01.STR.0000165929.78756.ed; Di Napoli M, 2001, STROKE, V32, P917, DOI 10.1161/01.STR.32.4.917; Duncan F, 2015, STROKE, V46, P1052, DOI 10.1161/STROKEAHA.114.008079; Duncan F, 2014, J PSYCHOSOM RES, V77, P368, DOI 10.1016/j.jpsychores.2014.06.013; Emsley HCA, 2003, J NEUROIMMUNOL, V139, P93, DOI 10.1016/S0165-5728(03)00134-6; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; Harel O, 2009, J APPL STAT, V36, P1109, DOI 10.1080/02664760802553000; Klimas NG, 2012, BRAIN BEHAV IMMUN, V26, P1202, DOI 10.1016/j.bbi.2012.06.006; Lynch J, 2007, J PSYCHOSOM RES, V63, P539, DOI 10.1016/j.jpsychores.2007.08.004; McKechnie F, 2010, J ROY COLL PHYS EDIN, V40, P9, DOI 10.4997/JRCPE.2010.103; Michielsen HJ, 2004, EUR J PSYCHOL ASSESS, V20, P39, DOI 10.1027/1015-5759.20.1.39; Morris G, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0259-2; Ormstad H, 2011, J NEUROL, V258, P670, DOI 10.1007/s00415-011-5962-8; Reiner AP, 2008, ARTERIOSCL THROM VAS, V28, P1407, DOI 10.1161/ATVBAHA.108.167437; Wu SM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007030.pub3; Wu SM, 2015, STROKE, V46, P893, DOI 10.1161/STROKEAHA.114.006647; Wu SM, 2014, STROKE, V45, P1778, DOI 10.1161/STROKEAHA.113.004584; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	22	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143784	10.1371/journal.pone.0143784	http://dx.doi.org/10.1371/journal.pone.0143784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599129	gold, Green Submitted, Green Published			2022-12-26	WOS:000365862600122
J	Kryukova, OV; Tikhomirova, VE; Golukhova, EZ; Evdokimov, VV; Kalantarov, GF; Trakht, IN; Schwartz, DE; Dull, RO; Gusakov, AV; Uporov, IV; Kost, OA; Danilov, SM				Kryukova, Olga V.; Tikhomirova, Victoria E.; Golukhova, Elena Z.; Evdokimov, Valery V.; Kalantarov, Gavreel F.; Trakht, Ilya N.; Schwartz, David E.; Dull, Randal O.; Gusakov, Alexander V.; Uporov, Igor V.; Kost, Olga A.; Danilov, Sergei M.			Tissue Specificity of Human Angiotensin I-Converting Enzyme	PLOS ONE			English	Article							MALE GENITAL-TRACT; MONOCLONAL-ANTIBODIES; N-DOMAIN; POSTTRANSLATIONAL MODIFICATIONS; GLYCOSYLATION SITES; PLASMA-MEMBRANE; SEMINAL PLASMA; HUMAN-PROSTATE; HUMAN TESTIS; HUMAN BLOOD	Background Angiotensin-converting enzyme (ACE), which metabolizes many peptides and plays a key role in blood pressure regulation and vascular remodeling, as well as in reproductive functions, is expressed as a type-1 membrane glycoprotein on the surface of endothelial and epithelial cells. ACE also presents as a soluble form in biological fluids, among which seminal fluid being the richest in ACE content -50-fold more than that in blood. Methods/Principal Findings We performed conformational fingerprinting of lung and seminal fluid ACEs using a set of monoclonal antibodies (mAbs) to 17 epitopes of human ACE and determined the effects of potential ACE-binding partners on mAbs binding to these two different ACEs. Patterns of mAbs binding to ACEs from lung and from seminal fluid dramatically differed, which reflects difference in the local conformations of these ACEs, likely due to different patterns of ACE glycosylation in the lung endothelial cells and epithelial cells of epididymis/prostate (source of seminal fluid ACE), confirmed by mass-spectrometry of ACEs tryptic digests. Conclusions Dramatic differences in the local conformations of seminal fluid and lung ACEs, as well as the effects of ACE-binding partners on mAbs binding to these ACEs, suggest different regulation of ACE functions and shedding from epithelial cells in epididymis and prostate and endothelial cells of lung capillaries. The differences in local conformation of ACE could be the base for the generation of mAbs distingushing tissue-specific ACEs.	[Kryukova, Olga V.; Tikhomirova, Victoria E.; Gusakov, Alexander V.; Uporov, Igor V.; Kost, Olga A.] Moscow MV Lomonosov State Univ, Fac Chem, Moscow 117234, Russia; [Golukhova, Elena Z.] Bakulev Ctr Cardiovasc Surg, Moscow, Russia; [Evdokimov, Valery V.] Inst Urol, Moscow, Russia; [Kalantarov, Gavreel F.; Trakht, Ilya N.] Columbia Univ, Dept Med, New York, NY USA; [Schwartz, David E.; Dull, Randal O.; Danilov, Sergei M.] Univ Illinois, Dept Anesthesiol, Chicago, IL USA	Lomonosov Moscow State University; Russian Academy of Medical Sciences; Bakulev Scientific Center for Cardiovascular Surgery; Columbia University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kost, OA (corresponding author), Moscow MV Lomonosov State Univ, Fac Chem, Moscow 117234, Russia.	olga.a.kost@gmail.com; danilov@uic.edu	Gusakov, Alexander V/B-7783-2013; Golukhova, Elena/Q-1768-2015; Tikhomirova, Victoria/E-4966-2019	Gusakov, Alexander V/0000-0002-5234-4863; Golukhova, Elena/0000-0002-6252-0322; Tikhomirova, Victoria/0000-0003-4368-3430; Uporov, Igor/0000-0003-3190-2851; Bulaeva, Naida/0000-0002-5091-0518	Ministry of Science and Education of Russian Federation [14.Z50.31.0026]; Department of Anesthesiology, University of Illinois at Chicago	Ministry of Science and Education of Russian Federation(Ministry of Education and Science, Russian Federation); Department of Anesthesiology, University of Illinois at Chicago	This work was supported in parts by 1) Ministry of Science and Education of Russian Federation, grant 14.Z50.31.0026; 2) Department of Anesthesiology, University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Ministry of Science and Education of Russian Federation, grant 14.Z50.31.0026, and by the Department of Anesthesiology, University of Illinois at Chicago.	Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; Balyasnikova IV, 2005, HYBRIDOMA, V24, P14, DOI 10.1089/hyb.2005.24.14; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Beyazit F, 2015, ARCH GYNECOL OBSTET, V292, P415, DOI 10.1007/s00404-015-3661-x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brogren H, 2008, THROMB RES, V122, P271, DOI 10.1016/j.thromres.2008.04.008; CHING SF, 1983, ARTERIOSCLEROSIS, V3, P581, DOI 10.1161/01.ATV.3.6.581; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov SM, 2008, J CARDIOVASC PHARM, V52, P90, DOI 10.1097/FJC.0b013e31817fd3bc; Danilov SM, 2007, BIOCHEMISTRY-US, V46, P9019, DOI 10.1021/bi700489v; Danilov SM, 2010, J PROTEOME RES, V9, P5782, DOI 10.1021/pr100564r; Danilov SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010438; Danilov SM, 2005, CLIN CHEM, V51, P1040, DOI 10.1373/clinchem.2004.045633; Ehlers MR, 1989, BIOCHEMISTRY-US, V8, P5311; EHLERS MRW, 1992, BIOCHEM BIOPH RES CO, V183, P199, DOI 10.1016/0006-291X(92)91628-4; Elzanaty S, 2007, ANDROLOGIA, V39, P60, DOI 10.1111/j.1439-0272.2007.00764.x; ERDOS EG, 1985, LAB INVEST, V52, P437; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087844; Fagyas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087843; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; HOHLBRUGGER G, 1984, FERTIL STERIL, V41, P324; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; Jokubaitis VJ, 2008, BLOOD, V111, P4055, DOI 10.1182/blood-2007-05-091710; Kohlstedt K, 2002, CIRC RES, V91, P749, DOI 10.1161/01.RES.0000038114.17939.C8; Kost OA, 2000, J MOL RECOGNIT, V13, P360, DOI 10.1002/1099-1352(200011/12)13:6<360::AID-JMR508>3.3.CO;2-B; KRASSNIGG F, 1989, INT J ANDROL, V12, P22, DOI 10.1111/j.1365-2605.1989.tb01282.x; LANZILLO JJ, 1983, ARCH BIOCHEM BIOPHYS, V227, P434, DOI 10.1016/0003-9861(83)90473-3; Liddy KA, 2013, GENOME MED, V5, DOI 10.1186/gm424; LIEBERMAN J, 1983, LAB INVEST, V48, P711; Lui T, 2005, J PROTEOME RES, V4, P2070; Metzger R, 2011, MICROVASC RES, V81, P206, DOI 10.1016/j.mvr.2010.12.003; Naperova IA, 2008, J PROTEOME RES, V7, P3396, DOI 10.1021/pr800142w; Nassis L, 2001, J PATHOL, V195, P571, DOI 10.1002/path.999; Nikolaeva MA, 2006, AM J REPROD IMMUNOL, V55, P54, DOI 10.1111/j.1600-0897.2005.00326.x; Osawa S, 2006, CLIN CHIM ACTA, V366, P146, DOI 10.1016/j.cca.2005.09.031; Parkin ET, 2004, PROTEIN PEPTIDE LETT, V11, P423, DOI 10.2174/0929866043406544; Pauls K, 2003, ANDROLOGIA, V35, P32, DOI 10.1046/j.1439-0272.2003.00535.x; RIPKA JE, 1993, BIOCHEM BIOPH RES CO, V196, P503, DOI 10.1006/bbrc.1993.2278; Salvesen G., 2012, HDB PROTEOLYTIC ENZY, V3rd, P480; Skirgello OE, 2006, BIOCHEMISTRY-US, V45, P4831, DOI 10.1021/bi052591h; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; VIVET F, 1987, HISTOCHEMISTRY, V86, P499, DOI 10.1007/BF00500623; WEI L, 1991, J BIOL CHEM, V266, P5540; West MB, 2010, J BIOL CHEM, V285, P29511, DOI 10.1074/jbc.M110.145938; Woodman ZL, 2000, BIOCHEM J, V347, P711, DOI 10.1042/0264-6021:3470711; YOKOYAMA M, 1980, CLIN CHIM ACTA, V100, P253, DOI 10.1016/0009-8981(80)90274-0; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511	50	14	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143455	10.1371/journal.pone.0143455	http://dx.doi.org/10.1371/journal.pone.0143455			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600189	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900126
J	Romanolo, KF; Gorski, L; Wang, S; Lauzon, CR				Romanolo, K. F.; Gorski, L.; Wang, S.; Lauzon, C. R.			Rapid Identification and Classification of Listeria spp. and Serotype Assignment of Listeria monocytogenes Using Fourier Transform-Infrared Spectroscopy and Artificial Neural Network Analysis	PLOS ONE			English	Article							FT-IR SPECTROSCOPY; UNITED-STATES; DISCRIMINATION; PATHOGENS; CULTURES; ASSAY	The use of Fourier Transform-Infrared Spectroscopy (FT-IR) in conjunction with Artificial Neural Network software NeuroDeveloper (TM) was examined for the rapid identification and classification of Listeria species and serotyping of Listeria monocytogenes. A spectral library was created for 245 strains of Listeria spp. to give a biochemical fingerprint from which identification of unknown samples were made. This technology was able to accurately distinguish the Listeria species with 99.03% accuracy. Eleven serotypes of Listeria monocytogenes including 1/2a, 1/2b, and 4b were identified with 96.58% accuracy. In addition, motile and non-motile forms of Listeria were used to create a more robust model for identification. FT-IR coupled with NeuroDeveloper (TM) appear to be a more accurate and economic choice for rapid identification of pathogenic Listeria spp. than current methods.	[Romanolo, K. F.; Lauzon, C. R.] Calif State Univ East Bay, Dept Biol Sci, Hayward, CA 94542 USA; [Romanolo, K. F.; Gorski, L.] ARS, USDA, Western Reg Res Ctr, Albany, CA USA; [Wang, S.] Bruker Opt Inc, Fremont, CA USA	California State University System; California State University East Bay; United States Department of Agriculture (USDA); Bruker Corporation	Lauzon, CR (corresponding author), Calif State Univ East Bay, Dept Biol Sci, Hayward, CA 94542 USA.	Carol.Lauzon@csueastbay.edu		Gorski, Lisa/0000-0003-2387-1012	CSUPERB (CSU Program for Education and Research in Biotechnology) Joint Venture Program [FY 13/14]; Agricultural Research Service CRIS project [2030-42000-046-00D]; Bruker Optics, Inc	CSUPERB (CSU Program for Education and Research in Biotechnology) Joint Venture Program; Agricultural Research Service CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Bruker Optics, Inc	This work was funded by a grant from CSUPERB (CSU Program for Education and Research in Biotechnology) Joint Venture Program FY 13/14 (https://www.calstate.edu/csuperb/) and funds from Agricultural Research Service CRIS project 2030-42000-046-00D. Bruker Optics, Inc provided support in the form of salary for SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Al-Holy MA, 2006, FOOD MICROBIOL, V23, P162, DOI 10.1016/j.fm.2005.01.017; Al-Qadiri HM, 2008, J FOOD SCI, V73, pM54, DOI 10.1111/j.1750-3841.2007.00640.x; Burgula Y, 2007, REV MIDINFRARED FORU; CDC, 2013, FOOD BIT BACK PROT T; Chee J.-Y., 2010, CURRENT RES TECHNOLO; Davis R, 2011, INT J FOOD MICROBIOL, V150, P140, DOI 10.1016/j.ijfoodmicro.2011.07.024; Doumith M, 2005, J FOOD PROTECT, V68, P2648, DOI 10.4315/0362-028X-68.12.2648; Janbu AO, 2008, FEMS MICROBIOL LETT, V278, P164, DOI 10.1111/j.1574-6968.2007.00995.x; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Lefier D, 1997, FEMS MICROBIOL LETT, V147, P45, DOI 10.1016/S0378-1097(96)00500-9; Lin MS, 2004, J AGR FOOD CHEM, V52, P5769, DOI 10.1021/jf049354q; Maquelin K, 2003, J CLIN MICROBIOL, V41, P324, DOI 10.1128/JCM.41.1.324-329.2003; Palumbo JD, 2003, J CLIN MICROBIOL, V41, P564, DOI 10.1128/JCM.41.2.564-571.2003; Rebuffo CA, 2006, APPL ENVIRON MICROB, V72, P994, DOI 10.1128/AEM.72.2.994-1000.2006; Rebuffo-Scheer CA, 2007, APPL ENVIRON MICROB, V73, P1036, DOI 10.1128/AEM.02004-06; Rohilla A., 2010, HDB BACTERIOLOGY, P302; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; TAPPERO JW, 1995, JAMA-J AM MED ASSOC, V273, P1118, DOI 10.1001/jama.273.14.1118; Vaz M, 2013, J MICROBIOL METH, V93, P102, DOI 10.1016/j.mimet.2013.02.008; Wang S., 2014, COMMUNICATIONS	20	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143425	10.1371/journal.pone.0143425	http://dx.doi.org/10.1371/journal.pone.0143425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600423	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900117
J	Auvergne, R; Wu, C; Connell, A; Au, S; Cornwell, A; Osipovitch, M; Benraiss, A; Dangelmajer, S; Guerrero-Cazares, H; Quinones-Hinojosa, A; Goldman, SA				Auvergne, R.; Wu, C.; Connell, A.; Au, S.; Cornwell, A.; Osipovitch, M.; Benraiss, A.; Dangelmajer, S.; Guerrero-Cazares, H.; Quinones-Hinojosa, A.; Goldman, S. A.			PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo	ONCOGENE			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; SMALL-MOLECULE ANTAGONISTS; CANCER STEM-CELLS; HUMAN GLIOBLASTOMA; GENE-EXPRESSION; HUMAN BRAIN; THROMBIN; IDENTIFICATION; EGFR; ANGIOGENESIS	Glioblastoma (GBM) remains the most common and lethal intracranial tumor. In a comparison of gene expression by A2B5-defined tumor-initiating progenitor cells (TPCs) to glial progenitor cells derived from normal adult human brain, we found that the F2R gene encoding PAR1 was differentially overexpressed by A2B5-sorted TPCs isolated from gliomas at all stages of malignant development. In this study, we asked if PAR1 is causally associated with glioma progression. Lentiviral knockdown of PAR1 inhibited the expansion and self-renewal of human GBM-derived A2B5(+) TPCs in vitro, while pharmacological inhibition of PAR 1 similarly slowed both the growth and migration of A2B5(+) TPCs in culture. In addition, PAR1 silencing potently suppressed tumor expansion in vivo, and significantly prolonged the survival of mice following intracranial transplantation of human TPCs. These data strongly suggest the importance of PAR1 to the self-renewal and tumorigenicity of A2B5-defined glioma TPCs; as such, the abrogation of PAR1-dependent signaling pathways may prove a promising strategy for gliomas.	[Auvergne, R.; Wu, C.; Connell, A.; Au, S.; Cornwell, A.; Osipovitch, M.; Benraiss, A.; Goldman, S. A.] Neurol Univ Rochester, Med Ctr, Ctr Translat Neuromed, Dept Neurol, Rochester, NY USA; [Auvergne, R.; Wu, C.; Connell, A.; Au, S.; Cornwell, A.; Osipovitch, M.; Benraiss, A.; Goldman, S. A.] Neurol Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Dangelmajer, S.; Guerrero-Cazares, H.; Quinones-Hinojosa, A.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Goldman, S. A.] Univ Copenhagen, Ctr Basic & Translat Neurosci, Copenhagen, Denmark	University of Rochester; University of Rochester; Johns Hopkins University; University of Copenhagen	Auvergne, R; Goldman, SA (corresponding author), Neurol Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA.; Auvergne, R; Goldman, SA (corresponding author), Neurol Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.	romane_auvergne@urmc.rochester.edu; steven_goldman@urmc.rochester.edu	Auvergne, Romane M/N-2624-2016; Benraiss, Abdellatif/AAI-8584-2021	Auvergne, Romane M/0000-0002-9497-0184; Benraiss, Abdellatif/0000-0002-0325-6234; Guerrero-Cazares, Hugo/0000-0003-1307-719X; Goldman, Steven/0000-0002-5498-4303; Au, Sandra/0000-0002-7924-3982; Cornwell, Adam/0000-0002-0572-3107	Dr Miriam and Sheldon G Adelson Medical Research Foundation; New York State Stem Cell Research Program; NIH [R01NS070024]; Novo Nordisk Fonden [NNF13OC0004260] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104701, R01MH099578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075345] Funding Source: NIH RePORTER	Dr Miriam and Sheldon G Adelson Medical Research Foundation; New York State Stem Cell Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr Mahlon Johnson for the histopathological validation of tumor stage, Dr Kevin Walter for arranging tissue donation and Shengtao Qu and Eric Franklin for technical assistance. This work was supported by the Dr Miriam and Sheldon G Adelson Medical Research Foundation, and by the New York State Stem Cell Research Program. Tissue collection, processing and studies on human tissue derived from Johns Hopkins University were supported by NIH R01NS070024.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Auvergne RM, 2013, CELL REP, V3, P2127, DOI 10.1016/j.celrep.2013.04.035; Baumer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094993; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bar-Shavit R, 2011, IUBMB LIFE, V63, P397, DOI 10.1002/iub.452; Bergmann S, 2006, ONCOL REP, V15, P889; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Brat DJ, 2004, LAB INVEST, V84, P397, DOI 10.1038/labinvest.3700070; Carneiro-Lobo TC, 2014, ONCOL REP, V31, P679, DOI 10.3892/or.2013.2880; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Defeo K, 2010, CANCER BIOL THER, V10, P1001, DOI 10.4161/cbt.10.10.13236; Du XL, 2011, JPN J CLIN ONCOL, V41, P1086, DOI 10.1093/jjco/hyr108; Elste AP, 2010, J MOL HISTOL, V41, P89, DOI 10.1007/s10735-010-9274-6; Eroglu A, 2012, ANN SURG ONCOL, V19, P1365, DOI 10.1245/s10434-011-1969-8; Feve M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091519; Fujimoto D, 2008, ANTICANCER RES, V28, P847; Garcia-Lopez MT, 2010, CURR MED CHEM, V17, P109, DOI 10.2174/092986710790112639; Garnier D, 2010, THROMB RES, V125, pS44, DOI 10.1016/S0049-3848(10)70012-8; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghio P, 2006, CLIN LUNG CANCER, V7, P395, DOI 10.3816/CLC.2006.n.023; Gibson E, 2012, CURR OPIN ONCOL, V24, P672, DOI 10.1097/CCO.0b013e3283571a8e; Gieseler F, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-86; Guo H, 2013, J NEUROSCI, V33, P6181, DOI 10.1523/JNEUROSCI.4491-12.2013; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Kaufmann R, 1998, NEUROREPORT, V9, P709, DOI 10.1097/00001756-199803090-00027; Kaufmann R, 2012, ADV EXP MED BIOL, V740, P979, DOI 10.1007/978-94-007-2888-2_45; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kuhn SA, 2014, NEUROL RES, V36, P709, DOI 10.1179/1743132813Y.0000000303; Lee CJ, 2011, BRIT J CLIN PHARMACO, V72, P581, DOI 10.1111/j.1365-2125.2011.03916.x; Lin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094871; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Magnus N, 2013, J THROMB HAEMOST, V11, P1197, DOI 10.1111/jth.12242; Massi D, 2005, HUM PATHOL, V36, P676, DOI 10.1016/j.humpath.2005.04.008; Milsom C, 2009, ARTERIOSCL THROM VAS, V29, P2005, DOI 10.1161/ATVBAHA.108.177444; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Perry JR, 2012, NEURO-ONCOLOGY, V14, P73, DOI 10.1093/neuonc/nos197; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Queiroz KCS, 2014, INT J CANCER, V135, P2294, DOI 10.1002/ijc.28726; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Stangier J, 2008, CLIN PHARMACOKINET, V47, P285, DOI 10.2165/00003088-200847050-00001; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Talloen W, 2007, BIOINFORMATICS, V23, P2897, DOI 10.1093/bioinformatics/btm478; Tchoghandjian A, 2010, BRAIN PATHOL, V20, P211, DOI 10.1111/j.1750-3639.2009.00269.x; Tsopanoglou NE, 2007, SEMIN THROMB HEMOST, V33, P680, DOI 10.1055/s-2007-991535; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Villares GJ, 2011, ONCOTARGET, V2, P8; Zania P, 2006, J PHARMACOL EXP THER, V318, P246, DOI 10.1124/jpet.105.099069; Zhang Y, 2011, PATHOL RES PRACT, V207, P24, DOI 10.1016/j.prp.2010.10.003; Zhao PS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00067; Zigler M, 2011, CANCER RES, V71, P6561, DOI 10.1158/0008-5472.CAN-11-1432	60	33	34	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3817	3828		10.1038/onc.2015.452	http://dx.doi.org/10.1038/onc.2015.452			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26616854	Green Accepted			2022-12-26	WOS:000380753200007
J	Pilecki, B; Holm, AT; Schlosser, A; Moeller, JB; Wohl, AP; Zuk, AV; Heumuller, SE; Wallis, R; Moestrup, SK; Sengle, G; Holmskov, U; Sorensen, GL				Pilecki, Bartosz; Holm, Anne T.; Schlosser, Anders; Moeller, Jesper B.; Wohl, Alexander P.; Zuk, Alexandra V.; Heumueller, Stefanie E.; Wallis, Russell; Moestrup, Soren K.; Sengle, Gerhard; Holmskov, Uffe; Sorensen, Grith L.			Characterization of Microfibrillar-associated Protein 4 (MFAP4) as a Tropoelastin-and Fibrillin-binding Protein Involved in Elastic Fiber Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS-MODEL; CRYSTAL-STRUCTURE; CROSS-LINKING; LYSYL-OXIDASE; GLYCOPROTEIN MAGP-36; INNATE IMMUNITY; COACERVATION; EXPRESSION; FICOLIN; DOMAIN	MFAP4 (microfibrillar-associated protein 4) is an extracellular glycoprotein found in elastic fibers without a clearly defined role in elastic fiber assembly. In the present study, we characterized molecular interactions between MFAP4 and elastic fiber components. We established that MFAP4 primarily assembles into trimeric and hexameric structures of homodimers. Binding analysis revealed that MFAP4 specifically binds tropoelastin and fibrillin-1 and -2, as well as the elastin cross-linking amino acid desmosine, and that it co-localizes with fibrillin-1-positive fibers in vivo. Site-directed mutagenesis disclosed residues Phe(241) and Ser(203) in MFAP4 as being crucial for type I collagen, elastin, and tropoelastin binding. Furthermore, we found that MFAP4 actively promotes tropoelastin self-assembly. In conclusion, our data identify MFAP4 as a new ligand of microfibrils and tropoelastin involved in proper elastic fiber organization.	[Pilecki, Bartosz; Holm, Anne T.; Schlosser, Anders; Moeller, Jesper B.; Moestrup, Soren K.; Holmskov, Uffe; Sorensen, Grith L.] Univ Southern Denmark, Fac Hlth Sci, Inst Mol Med, Dept Canc & Inflammat Res, DK-5000 Odense C, Denmark; [Wohl, Alexander P.; Zuk, Alexandra V.; Heumueller, Stefanie E.; Sengle, Gerhard] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Heumueller, Stefanie E.; Sengle, Gerhard] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Wallis, Russell] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England; [Wallis, Russell] Univ Leicester, Dept Mol & Cell Biol, Leicester LE1 9HN, Leics, England; [Moestrup, Soren K.] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense C, Denmark	University of Southern Denmark; University of Cologne; University of Cologne; University of Leicester; University of Leicester; University of Southern Denmark; Odense University Hospital	Sorensen, GL (corresponding author), Inst Mol Med, JB Winslows Vej 25-3, DK-5000 Odense C, Denmark.	glsorensen@health.sdu.dk	Moestrup, Søren Kragh/AAD-1735-2019; Pilecki, Bartosz/O-5031-2015; Holmskov, Uffe/AAA-3056-2022; Moeller, Jesper B/E-6377-2015; Moestrup, Soren Kragh/A-1403-2014	Pilecki, Bartosz/0000-0001-8636-2245; Holmskov, Uffe/0000-0002-2391-9445; Moeller, Jesper B/0000-0001-8786-8037; Sorensen, Grith Lykke/0000-0002-5273-1097; Holm, Anne Trommelholt/0000-0001-6090-9820; Wallis, Russell/0000-0002-8705-5295; Moestrup, Soren Kragh/0000-0003-3862-2107	Danish Medical Research Council; Th. Maigaards Benthine Lunds Fond; Familien Hede Nielsens Fond; Fonden til Laegevidenskabens Fremme; Deutsche Forschungsgemeinschaft [SFB829]; Koln Fortune; Lundbeck Foundation [R108-2012-10802, R164-2013-15355, R67-2010-6409] Funding Source: researchfish; Novo Nordisk Fonden [NNF15SA0018400, NNF14OC0011537, NNF15OC0014052] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Th. Maigaards Benthine Lunds Fond; Familien Hede Nielsens Fond; Fonden til Laegevidenskabens Fremme; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Koln Fortune; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Medical Research Council, Th. Maigaards Benthine Lunds Fond af 1.6.1978, Familien Hede Nielsens Fond, Fonden til Laegevidenskabens Fremme, Deutsche Forschungsgemeinschaft SFB829/Project B12, and Koln Fortune (to G.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baldwin AK, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.9; BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345; Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512; Brandsma CA, 2015, THORAX, V70, P21, DOI 10.1136/thoraxjnl-2014-205091; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau NL, 2010, J BIOL CHEM, V285, P24943, DOI 10.1074/jbc.M110.130021; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d; Doolittle RF, 2012, PROTEIN SCI, V21, P1808, DOI 10.1002/pro.2177; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Holm AT, 2015, AM J PHYSIOL-LUNG C, V308, pL1114, DOI 10.1152/ajplung.00351.2014; Horiguchi M, 2009, P NATL ACAD SCI USA, V106, P19029, DOI 10.1073/pnas.0908268106; Johansson SL, 2014, RESP MED, V108, P1336, DOI 10.1016/j.rmed.2014.06.003; Kairies N, 2001, P NATL ACAD SCI USA, V98, P13519, DOI 10.1073/pnas.201523798; Kasamatsu S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00164; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KOBAYASHI R, 1989, J BIOL CHEM, V264, P17437; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lausen M, 1999, J BIOL CHEM, V274, P32234, DOI 10.1074/jbc.274.45.32234; Lemaire R, 2007, J BIOL CHEM, V282, P800, DOI 10.1074/jbc.M609692200; Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487; Lindberg CA, 2012, EUR RESPIR J, V39, P839, DOI 10.1183/09031936.00064611; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Ma SR, 2011, J CHROMATOGR B, V879, P1893, DOI 10.1016/j.jchromb.2011.05.011; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; NARAYANAN AS, 1978, BIOCHEM J, V173, P857, DOI 10.1042/bj1730857; PEITSCH MC, 1995, TRENDS BIOCHEM SCI, V20, P82, DOI 10.1016/S0968-0004(00)88963-X; Pilecki B, 2015, THORAX, V70, P862, DOI 10.1136/thoraxjnl-2014-206609; Pilop C, 2009, CIRCULATION, V120, P983, DOI 10.1161/CIRCULATIONAHA.108.843516; Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; Saekmose SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082383; Schlosser A, 2006, SCAND J IMMUNOL, V64, P104, DOI 10.1111/j.1365-3083.2006.01778.x; Schlosser A, 2009, J IMMUNOL, V183, P3800, DOI 10.4049/jimmunol.0901526; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Shrive AK, 2014, J BIOL CHEM, V289, P2880, DOI 10.1074/jbc.M113.520577; Tanio M, 2007, J BIOL CHEM, V282, P3889, DOI 10.1074/jbc.M608627200; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; Thomsen T, 2011, MOL IMMUNOL, V48, P369, DOI 10.1016/j.molimm.2010.09.019; Thomsen T, 2010, J BIOL CHEM, V285, P1229, DOI 10.1074/jbc.M109.061523; Toyoshima T, 2005, EXP CELL RES, V307, P224, DOI 10.1016/j.yexcr.2005.03.005; Toyoshima T, 1999, J HISTOCHEM CYTOCHEM, V47, P1049, DOI 10.1177/002215549904700809; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Wachi H, 2007, BIOCHEM J, V402, P63, DOI 10.1042/BJ20061145; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wallis R, 1997, BIOCHEM J, V325, P391, DOI 10.1042/bj3250391; Wu WJ, 1999, EUR J BIOCHEM, V266, P308, DOI 10.1046/j.1432-1327.1999.00891.x; Wulf-Johansson H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082243; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165	65	65	69	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1103	1114		10.1074/jbc.M115.681775	http://dx.doi.org/10.1074/jbc.M115.681775			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26601954	Green Published, hybrid			2022-12-26	WOS:000368068300007
J	Andersson, T; Ahlbom, A; Carlsson, S				Andersson, Tomas; Ahlbom, Anders; Carlsson, Sofia			Diabetes Prevalence in Sweden at Present and Projections for Year 2050	PLOS ONE			English	Article							MORTALITY; MELLITUS; TRENDS; REGISTER; BURDEN; COHORT; RATES	Background Data on the future diabetes burden in Scandinavia is limited. Our aim was to project the future burden of diabetes in Sweden by modelling data on incidence, prevalence, mortality, and demographic factors. Method To project the future burden of diabetes we used information on the prevalence of diabetes from the national drug prescription registry (adults >= 20 years), previously published data on relative mortality in people with diabetes, and population demographics and projections from Statistics Sweden. Alternative scenarios were created based on different assumptions regarding the future incidence of diabetes. Results Between 2007 and 2013 the prevalence of diabetes rose from 5.8 to 6.8% in Sweden but incidence remained constant at 4.4 per 1000 (2013). With constant incidence and continued improvement in relative survival, prevalence will increase to 10.4% by year 2050 and the number of afflicted individuals will increase to 940 000. Of this rise, 30% is accounted for by changes in the age structure of the population and 14% by improved relative survival in people with diabetes. A hypothesized 1% annual rise in incidence will result in a prevalence of 12.6% and 1 136 000 cases. Even with decreasing incidence at 1% per year, prevalence of diabetes will continue to increase. Conclusion We can expect diabetes prevalence to rise substantially in Sweden over the next 35 years as a result of demographic changes and improved survival among people with diabetes. A dramatic reduction in incidence is required to prevent this development.	[Andersson, Tomas; Ahlbom, Anders; Carlsson, Sofia] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Andersson, Tomas; Ahlbom, Anders] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden	Karolinska Institutet; Stockholm County Council	Carlsson, S (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	Sofia.carlsson@ki.se		carlsson, sofia/0000-0002-9497-2331				Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Andersson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104033; [Anonymous], 2005, GUID ATC CLASS DDD A; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Brinks R, 2012, EUR J EPIDEMIOL, V27, P791, DOI 10.1007/s10654-012-9726-2; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Eliasson M, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-32; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gudbjornsdottir S., 2013, NAT DIAB REG SWED; Holman N, 2011, DIABETIC MED, V28, P575, DOI 10.1111/j.1464-5491.2010.03216.x; Lilja M, 2008, OBESITY, V16, P1120, DOI [10.1038/oby.2008.230, 10.1038/oby.2008.8]; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Lindahl B, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5222; National board of health and Welfare, DRUG PRESCR REG; Nwaneri C, 2012, POSTGRAD MED J, V88, P679, DOI 10.1136/postgradmedj-2012-130877; Rawshani A, 2014, DIABETOLOGIA, V57, P1375, DOI 10.1007/s00125-014-3225-9; Ringborg A, 2008, DIABETIC MED, V25, P1178, DOI 10.1111/j.1464-5491.2008.02541.x; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; The future population of Sweden, 2014, BE18SM1401; Waldeyer R, 2013, DIABETIC MED, V30, P999, DOI 10.1111/dme.12177; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	22	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143084	10.1371/journal.pone.0143084	http://dx.doi.org/10.1371/journal.pone.0143084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619340	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800024
J	Carroll, JM; Davis, CA; Elmore, RD; Fuhlendorf, SD				Carroll, J. Matthew; Davis, Craig A.; Elmore, R. Dwayne; Fuhlendorf, Samuel D.			A Ground-Nesting Galliform's Response to Thermal Heterogeneity: Implications for Ground-Dwelling Birds	PLOS ONE			English	Article							CLIMATE-CHANGE; NORTHERN BOBWHITES; HABITAT SELECTION; SITE SELECTION; CONSERVATION IMPLICATIONS; OPERATIVE TEMPERATURE; PREDATION RISK; MICROCLIMATE; ENVIRONMENT; MICROHABITAT	The habitat selection choices that individuals make in response to thermal environments influence both survival and reproduction. Importantly, the way that organisms behaviorally respond to thermal environments depends on the availability and juxtaposition of sites affording tolerable or preferredmicroclimates. Although, ground nesting birds are especially susceptible to heat extremes across many reproductive stages (i.e., breeding, nesting, brood rearing), the mechanistic drivers of nest site selection for these species are not well established from a thermal perspective. Our goal was to assess nest site selection relative to the configuration of the thermal landscape by quantifying thermal environments available to a ground-nesting bird species inhabiting a climatically stressful environment. Using northern bobwhite (Colinus virginanus) as a model species, we measured black bulb temperature (T-bb) and vegetation parameters at 87 nests, 87 paired sites and 205 random landscape sites in Western Oklahoma during spring and summer 2013 and 2014. We found that thermal space within the study area exhibited differences in T-bb of up to 40 degrees C during peak diurnal heating, resulting in a diverse thermal landscape available to ground-nesting birds. Within this thermally heterogeneous landscape, nest sites moderated T-bb by more than 12 degrees C compared to random landscape sites. Furthermore, successful nests remained on average 6 degrees C cooler than unsuccessful nests on days experiencing ambient temperatures >= 39 degrees C. Models of future T-bb associated with 2080 climate change projections indicate that nesting bobwhites will face substantially greater T-bb throughout the landscape for longer durations, placing an even greater importance on thermal choices for nest sites in the future. These results highlight the capacity of landscape features to act as moderators of thermal extremes and demonstrate how thermal complexity at organism-specific scales can dictate habitat selection.	[Carroll, J. Matthew; Davis, Craig A.; Elmore, R. Dwayne; Fuhlendorf, Samuel D.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Carroll, JM (corresponding author), Oklahoma State Univ, Dept Nat Resource Ecol & Management, 008C Ag Hall, Stillwater, OK 74078 USA.	matt.carroll@okstate.edu	; Fuhlendorf, Samuel/A-2931-2011	Chiaradia, Andre/0000-0002-6178-4211; Fuhlendorf, Samuel/0000-0002-8726-9402	Oklahoma Department of Wildlife Conservation [F11AF00069]; Oklahoma Cooperative Fish and Wildlife Research Unit; Oklahoma Agricultural Experiment Station; National Science Foundation [IIA-1301789, 1413900]	Oklahoma Department of Wildlife Conservation; Oklahoma Cooperative Fish and Wildlife Research Unit; Oklahoma Agricultural Experiment Station; National Science Foundation(National Science Foundation (NSF))	Funding for this research was provided by the Oklahoma Department of Wildlife Conservation grant #F11AF00069, to CAD RDE and SDF. The Oklahoma Cooperative Fish and Wildlife Research Unit administered funding and provided logistical and administrative support. Further support was provided by the Oklahoma Agricultural Experiment Station. Some of this manuscript is based on work supported by the National Science Foundation under grant no. IIA-1301789 and grant no. 1413900 to SDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TP, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00057.1; Allred BW, 2013, GLOBAL CHANGE BIOL, V19, P1875, DOI 10.1111/gcb.12183; Angilletta MJ, 2009, ECOLOGY, V90, P2933, DOI 10.1890/08-2224.1; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Arndt D., 2003, THE CLIMATE OKLAHOMA; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Avgar T, 2013, J ANIM ECOL, V82, P96, DOI 10.1111/j.1365-2656.2012.02035.x; BENNETT AF, 1981, PHYSIOL ZOOL, V54, P146, DOI 10.1086/physzool.54.1.30155813; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calder W.A., 1974, AVIAN BIOL, V4, P259; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Cavallo C, 2015, FUNCT ECOL, V29, P768, DOI 10.1111/1365-2435.12389; Christensen N.L, 1997, ECOLOGICAL BASIS CON, P167, DOI [10.1007/978-1-4615-6003-6_17, DOI 10.1007/978-1-4615-6003-6_17]; Cowles Raymond Bridgman, 1944, BULL AMER MUS NAT HIST, V83, P261; Cunningham S. J., 2013, PLOS ONE, V8; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Davies ZG, 2006, J ANIM ECOL, V75, P247, DOI 10.1111/j.1365-2656.2006.01044.x; Dawson RD, 2005, OECOLOGIA, V144, P499, DOI 10.1007/s00442-005-0075-7; DeMaso SJ, 1997, J WILDLIFE MANAGE, V61, P846, DOI 10.2307/3802193; Duarte H, 2012, GLOBAL CHANGE BIOL, V18, P412, DOI 10.1111/j.1365-2486.2011.02518.x; Dubois Y, 2009, J ANIM ECOL, V78, P1023, DOI 10.1111/j.1365-2656.2009.01555.x; DuRant SE, 2013, BIOL REV, V88, P499, DOI 10.1111/brv.12015; Dzialowski EM, 2005, J THERM BIOL, V30, P317, DOI 10.1016/j.jtherbio.2005.01.005; Ford KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065008; Forman R.T.T., 1986, LANDSCAPE ECOL; Forrester ND, 1998, J WILDLIFE MANAGE, V62, P1506, DOI 10.2307/3802017; Girvetz EH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008320; Gloutney ML, 1997, AUK, V114, P381, DOI 10.2307/4089240; GOLDSTEIN DL, 1984, AUK, V101, P542, DOI 10.1093/auk/101.3.542; Guthery F.S., 2000, ON BOBWHITES; Guthery FS, 2005, WILDLIFE MONOGR, P1; GUTHERY FS, 1981, J RANGE MANAGE, V34, P157, DOI 10.2307/3898138; Guthery FS, 2001, J WILDLIFE MANAGE, V65, P111, DOI 10.2307/3803282; GUTHERY FS, 1988, J WILDLIFE MANAGE, V52, P144, DOI 10.2307/3801075; Hannah L, 2014, TRENDS ECOL EVOL, V29, P390, DOI 10.1016/j.tree.2014.04.006; Hansell MH, 2002, OX ORN SER, V13, P8; Hiller TL, 2005, J WILDLIFE MANAGE, V69, P140, DOI 10.2193/0022-541X(2005)069&lt;0140:MVPRIR&gt;2.0.CO;2; Hovick TJ, 2015, RANGELAND ECOL MANAG, V68, P186, DOI 10.1016/j.rama.2015.01.009; Hovick TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00340.1; Huang WS, 2011, FUNCT ECOL, V25, P1125, DOI 10.1111/j.1365-2435.2011.01855.x; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; JOHNSON DB, 1988, J WILDLIFE MANAGE, V52, P464, DOI 10.2307/3801592; KENDEIGH SC, 1969, WILSON BULL, V81, P441; Kopp SD, 1998, J WILDLIFE MANAGE, V62, P884, DOI 10.2307/3802539; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; La Sorte FA, 2010, J EXP BIOL, V213, P862, DOI 10.1242/jeb.038356; Larcher W, 1991, PHYSL PLANT ECOLOGY; Lawson CR, 2014, ECOGRAPHY, V37, P732, DOI 10.1111/ecog.00535; Limb R, 2009, ENVIRON MANAGE, V43, P100, DOI 10.1007/s00267-008-9147-x; Logan ML, 2013, GLOBAL CHANGE BIOL, V19, P3093, DOI 10.1111/gcb.12253; Mainwaring M. C., 2014, ECOLOGY EVOLUTION, V4, P851, DOI DOI 10.1002/ECE3.952; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; McKechnie AE, 2012, EMU, V112, pI, DOI 10.1071/MUv112n2_ED; Mesonet Oklahoma, ARN STAT TEMPS 1994; Mesonet Oklahoma, ARN STAT RAINF 1994; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; NUDDS T D, 1977, Wildlife Society Bulletin, V5, P113; Patten MA, 2005, J WILDLIFE MANAGE, V69, P1270, DOI 10.2193/0022-541X(2005)069[1270:EOMAMS]2.0.CO;2; Patten MA, 2012, BIOL CONSERV, V155, P85, DOI 10.1016/j.biocon.2012.06.004; Perfecto I, 1996, OECOLOGIA, V108, P577, DOI 10.1007/BF00333736; Peterman WE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062184; PETERSON RS, 1998, RMRSGTR16 US FOR SER; Pike DA, 2014, GLOBAL CHANGE BIOL, V20, P7, DOI 10.1111/gcb.12397; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; RICKLEFS RE, 1968, ECOLOGY, V49, P227, DOI 10.2307/1934451; Robertson BA, 2009, AUK, V126, P500, DOI 10.1525/auk.2009.08148; Rosenberg N.J., 1983, MICROCLIMATE BIOL EN; Saalfeld ST, 2012, J WILDLIFE MANAGE, V76, P1703, DOI 10.1002/jwmg.404; SALZMAN AG, 1982, ECOLOGY, V63, P742, DOI 10.2307/1936795; SAUER JR, 2011, N AM BREEDING BIRD S; Schofield G, 2009, J ANIM ECOL, V78, P14, DOI 10.1111/j.1365-2656.2008.01454.x; Seabrook L, 2014, DIVERS DISTRIB, V20, P95, DOI 10.1111/ddi.12152; Sears MW, 2011, INTEGR COMP BIOL, V51, P666, DOI 10.1093/icb/icr111; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; SMITH RL, 2000, ELEMENTS ECOLOGY; Telemeco RS, 2009, ECOLOGY, V90, P17, DOI 10.1890/08-1452.1; Tieleman BI, 2008, CONDOR, V110, P116, DOI 10.1525/cond.2008.110.1.116; van Beest FM, 2012, ANIM BEHAV, V84, P723, DOI 10.1016/j.anbehav.2012.06.032; van Moorter B, 2013, J ANIM ECOL, V82, P770, DOI 10.1111/1365-2656.12045; Varner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104648; Vermeire L. T., 2001, Rangelands, V23, P19; WALSBERG GE, 1981, CONDOR, V83, P86, DOI 10.2307/1367612; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Weber SB, 2012, P ROY SOC B-BIOL SCI, V279, P1077, DOI 10.1098/rspb.2011.1238; Wiebe KL, 1998, ANIM BEHAV, V56, P1137, DOI 10.1006/anbe.1998.0862; WIEDEMAN V. E., 1960, SOUTHWESTERN NAT, V5, P117, DOI 10.2307/3669506; Wiens J. A., 1997, ECOLOGICAL BASIS CON, P93; WITH KA, 1993, CONDOR, V95, P401, DOI 10.2307/1369363; Wong BBM, 2015, BEHAV ECOL, V26, P665, DOI 10.1093/beheco/aru183; Woods HA, 2014, J THERM BIOL, P1; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao F, 2014, J ANIM ECOL, V83, P769, DOI 10.1111/1365-2656.12196	95	14	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143676	10.1371/journal.pone.0143676	http://dx.doi.org/10.1371/journal.pone.0143676			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618845	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800056
J	Smeets, CCJ; Codd, V; Samani, NJ; Hokken-Koelega, ACS				Smeets, Carolina C. J.; Codd, Veryan; Samani, Nilesh J.; Hokken-Koelega, Anita C. S.			Leukocyte Telomere Length in Young Adults Born Preterm: Support for Accelerated Biological Ageing	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN SENSITIVITY; INTRAUTERINE GROWTH; OXIDATIVE STRESS; STEM-CELLS; BIRTH; ASSOCIATION; DISEASE; LIFE; MORTALITY	Background Subjects born preterm have an increased risk for age-associated diseases, such as cardiovascular disease in later life, but the underlying causes are largely unknown. Shorter leukocyte telomere length (LTL), a marker of biological age, is associated with increased risk of cardiovascular disease. Objectives To compare LTL between subjects born preterm and at term and to assess if LTL is associated with other putative cardiovascular risk factors at young adult age. Methods We measured mean LTL in 470 young adults. LTL was measured using a quantitative PCR assay and expressed as T/S ratio. We analyzed the influence of gestational age on LTL and compared LTL between subjects born preterm (n = 186) and at term (n = 284). Additionally, we analyzed the correlation between LTL and potential risk factors of cardiovascular disease. Results Gestational age was positively associated with LTL (r = 0.11, p = 0.02). Subjects born preterm had shorter LTL (mean (SD) T/S ratio = 3.12 (0.44)) than subjects born at term (mean (SD) T/S ratio = 3.25 (0.46)), p = 0.003). The difference remained significant after adjustment for gender and size at birth (p = 0.001). There was no association of LTL with any one of the putative risk factors analyzed. Conclusions Young adults born preterm have shorter LTL than young adults born at term. Although we found no correlation between LTL and risk for CVD at this young adult age, this biological ageing indicator may contribute to CVD and other adult onset diseases at a later age in those born preterm.	[Smeets, Carolina C. J.; Hokken-Koelega, Anita C. S.] Erasmus Univ, Med Ctr, Dept Pediat, Subdiv Endocrinol, Rotterdam, Netherlands; [Hokken-Koelega, Anita C. S.] Dutch Growth Res Fdn, Rotterdam, Netherlands; [Codd, Veryan; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Codd, Veryan; Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England	Erasmus University Rotterdam; Erasmus MC; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Smeets, CCJ (corresponding author), Erasmus Univ, Med Ctr, Dept Pediat, Subdiv Endocrinol, Rotterdam, Netherlands.	l.smeets@erasmusmc.nl		Codd, Veryan/0000-0002-9430-8254	British Heart Foundation; Medical Research Council [MR/M012816/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish; MRC [MR/M012816/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NJS holds a chair funded by the British Heart Foundation and is a NIHR Senior Investigator.	ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Anwar, 1997, Blood Press Monit, V2, P105; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Breukhoven PE, 2012, J CLIN ENDOCR METAB, V97, P1294, DOI 10.1210/jc.2011-2621; Brouilette S, 2003, EUR HEART J, V24, P121, DOI 10.1016/S0195-668X(03)94107-8; Brouilette SW, 2008, HEART, V94, pA58; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; CentraalBureauStatistiek, 2006, DUTCH STANDARD CLASS; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Entringer S, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.033; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Evensen KAI, 2009, EARLY HUM DEV, V85, P239, DOI 10.1016/j.earlhumdev.2008.10.008; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Friedrich U, 2001, PEDIATR RES, V49, P252, DOI 10.1203/00006450-200102000-00020; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hadchouel A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136123; Henckel E, 2011, PEDIATR RES, V70, P136, DOI 10.1038/pr.2011.361; Kajantie E, 2012, INT J EPIDEMIOL, V41, P1400, DOI 10.1093/ije/dys127; Kerkhof GF, 2012, J PEDIATR-US, V161, P390, DOI 10.1016/j.jpeds.2012.03.048; Kerkhof GF, 2009, J CLIN ENDOCR METAB, V94, P4243, DOI 10.1210/jc.2009-1036; Laganovic M, 2014, J HYPERTENS, V32, P1613, DOI 10.1097/HJH.0000000000000217; Lansdorp PM, 2008, BLOOD, V111, P1759, DOI 10.1182/blood-2007-09-084913; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Marseglia L, 2014, OXIDATIVE MEDICINE A; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Minamino T, 2002, CURR OPIN LIPIDOL, V13, P537, DOI 10.1097/00041433-200210000-00010; Mukherjee M, 2009, HEART, V95, P669, DOI 10.1136/hrt.2008.150250; Nilsson PM, 2008, J HYPERTENS, V26, P1049, DOI 10.1097/HJH.0b013e3282f82c3e; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; Samani NJ, 2008, HEART, V94, P537, DOI 10.1136/hrt.2007.136010; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Sipola-Leppanen M, 2014, PEDIATRICS, V134, pE1072, DOI 10.1542/peds.2013-4186; Tinnion R, 2014, ARCH DIS CHILD, V99, P362, DOI 10.1136/archdischild-2013-304615; Turner KJ, 2014, BIOMARK MED, V8, P485, DOI 10.2217/bmm.14.13; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Zeichner SL, 1999, BLOOD, V93, P2824	45	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143951	10.1371/journal.pone.0143951	http://dx.doi.org/10.1371/journal.pone.0143951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619005	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800093
J	Al-Rubaye, AAK; Couger, MB; Ojha, S; Pummill, JF; Koon, JA; Wideman, RF; Rhoads, DD				Al-Rubaye, Adnan A. K.; Couger, M. Brian; Ojha, Sohita; Pummill, Jeff F.; Koon, Joseph A., II; Wideman, Robert F., Jr.; Rhoads, Douglas D.			Genome Analysis of Staphylococcus agnetis, an Agent of Lameness in Broiler Chickens	PLOS ONE			English	Article							BACTERIAL CHONDRONECROSIS; FEMORAL-HEAD; LEG WEAKNESS; OSTEOMYELITIS; GENES; NECROSIS; DISEASE; MODEL	Lameness in broiler chickens is a significant animal welfare and financial issue. Lameness can be enhanced by rearing young broilers on wire flooring. We have identified Staphylococcus agnetis as significantly involved in bacterial chondronecrosis with osteomyelitis (BCO) in proximal tibia and femorae, leading to lameness in broiler chickens in the wire floor system. Administration of S. agnetis in water induces lameness. Previously reported in some cases of cattle mastitis, this is the first report of this poorly described pathogen in chickens. We used long and short read next generation sequencing to assemble single finished contigs for the genome and a large plasmid from the chicken pathogen. Comparison of the S. agnetis genome to those of other pathogenic Staphylococci shows that S. agnetis contains a distinct repertoire of virulence determinants. Additionally, the S. agnetis genome has several regions that differ substantially from the genomes of other pathogenic Staphylococci. Comparison of our finished genome to a recent draft genome for a cattle mastitis isolate suggests that future investigations focus on the evolutionary epidemiology of this emerging pathogen of domestic animals.	[Al-Rubaye, Adnan A. K.; Ojha, Sohita; Wideman, Robert F., Jr.; Rhoads, Douglas D.] Univ Arkansas, Interdisciplinary Grad Program Cell & Mol Biol, Fayetteville, AR 72701 USA; [Al-Rubaye, Adnan A. K.; Ojha, Sohita; Rhoads, Douglas D.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Couger, M. Brian] Oklahoma State Univ, Dept Microbiol, Stillwater, OK 74078 USA; [Pummill, Jeff F.] Univ Arkansas, Arkansas High Performance Comp Ctr, Fayetteville, AR 72701 USA; [Koon, Joseph A., II] Ouachita Baptist Univ, Dept Biol, Arkadelphia, AR USA; [Wideman, Robert F., Jr.] Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; Oklahoma State University System; Oklahoma State University - Stillwater; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Rhoads, DD (corresponding author), Univ Arkansas, Interdisciplinary Grad Program Cell & Mol Biol, Fayetteville, AR 72701 USA.	drhoads@uark.edu	Rhoads, Douglas/AAP-6270-2020	Koon, Joseph/0000-0002-5041-3474; Couger, Matthew/0000-0003-3692-1613; Pummill, Jeff/0000-0003-2998-0586	Arkansas Biosciences Institute; Translational Research Institute through the NIH National Center for Research Resources [UL1TR000039]; National Center for Advancing Translational Sciences; Center for Microbial Pathogenesis and Host Inflammatory Responses [P20-GM103450]; Arkansas INBRE program; National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [P20 GM103429]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103450, P20GM103429] Funding Source: NIH RePORTER	Arkansas Biosciences Institute; Translational Research Institute through the NIH National Center for Research Resources; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Center for Microbial Pathogenesis and Host Inflammatory Responses(Ohio State University); Arkansas INBRE program; National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the Arkansas Biosciences Institute, by the Translational Research Institute (UL1TR000039) through the NIH National Center for Research Resources and National Center for Advancing Translational Sciences, and by the core facilities supported by the Center for Microbial Pathogenesis and Host Inflammatory Responses (P20-GM103450). J. A. Koon was supported by the Arkansas INBRE program, supported by grant funding from the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) (P20 GM103429) (formerly P20RR016460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ANDREASEN JR, 1993, AVIAN DIS, V37, P284, DOI 10.2307/1591650; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Ben Zakour NL, 2011, J BACTERIOL, V193, P2363, DOI 10.1128/JB.00137-11; Butterworth A, 1999, WORLD POULTRY SCI J, V55, P327, DOI 10.1079/WPS19990024; Calcutt MJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00883-14; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Casanova C, 2011, J CLIN MICROBIOL, V49, P4377, DOI 10.1128/JCM.05645-11; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Dinev I, 2009, BRIT POULTRY SCI, V50, P284, DOI 10.1080/00071660902942783; Foster AP, 2012, VET DERMATOL, V23, P342, DOI 10.1111/j.1365-3164.2012.01093.x; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hogg JC, 1999, APPL ENVIRON MICROB, V65, P4227; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ingavale S, 2005, INFECT IMMUN, V73, P1423, DOI 10.1128/IAI.73.3.1423-1431.2005; Jiang TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124403; Joiner KS, 2005, VET PATHOL, V42, P275, DOI 10.1354/vp.42-3-275; Kense MJ, 2011, AVIAN PATHOL, V40, P603, DOI 10.1080/03079457.2011.619165; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; McNamee PT, 1998, VET REC, V143, P131, DOI 10.1136/vr.143.5.131; McNamee PT, 2000, AVIAN PATHOL, V29, P477, DOI 10.1080/030794500750047243; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; MUTALIB A, 1983, AVIAN DIS, V27, P141, DOI 10.2307/1590379; NAIRN ME, 1972, AUST VET J, V48, P645, DOI 10.1111/j.1751-0813.1972.tb09237.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Powers ME, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003871; Smeltzer MS, 2000, POULTRY SCI, V79, P1042, DOI 10.1093/ps/79.7.1042; Stalker MJ, 2010, J VET DIAGN INVEST, V22, P643, DOI 10.1177/104063871002200426; Taponen S, 2012, INT J SYST EVOL MICR, V62, P61, DOI 10.1099/ijs.0.028365-0; TATE CR, 1993, AVIAN DIS, V37, P905, DOI 10.2307/1592052; THORP BH, 1993, AVIAN PATHOL, V22, P325, DOI 10.1080/03079459308418924; Treangen TJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01110-14; Tse H, 2011, J BACTERIOL, V193, P1783, DOI 10.1128/JB.00023-11; Wideman RF, 2015, POULTRY SCI, V94, P25, DOI 10.3382/ps/peu025; Wideman RF, 2014, POULTRY SCI, V93, P1675, DOI 10.3382/ps.2014-03912; Wideman RF, 2013, POULTRY SCI, V92, P2311, DOI 10.3382/ps.2013-03150; Wideman RF, 2012, POULTRY SCI, V91, P2464, DOI 10.3382/ps.2012-02386; Wideman RF, 2012, POULTRY SCI, V91, P870, DOI 10.3382/ps.2011-01907; Wideman Robert F, 2012, Front Endocrinol (Lausanne), V3, P183, DOI 10.3389/fendo.2012.00183; Wideman RF, 2016, POULTRY SCI, V95, P325, DOI 10.3382/ps/pev320; Wolanski Marcin, 2014, Front Microbiol, V5, P735, DOI 10.3389/fmicb.2014.00735	46	30	31	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143336	10.1371/journal.pone.0143336	http://dx.doi.org/10.1371/journal.pone.0143336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606420	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300058
J	Delannoy, J; Mandai, O; Honore, J; Kobayashi, T; Sequeira, H				Delannoy, Julien; Mandai, Osamu; Honore, Jacques; Kobayashi, Toshinori; Sequeira, Henrique			Diurnal Emotional States Impact the Sleep Course	PLOS ONE			English	Article							SPONTANEOUS ELECTRODERMAL ACTIVITY; EYE-MOVEMENT SLEEP; SLOW-WAVE SLEEP; REM-SLEEP; PSYCHOPHYSIOLOGICAL REACTIVITY; STRESS; BRAIN; NIGHT; DURATION; FILMS	Background Diurnal emotional experiences seem to affect several characteristics of sleep architecture. However, this influence remains unclear, especially for positive emotions. In addition, electrodermal activity (EDA), a sympathetic robust indicator of emotional arousal, differs depending on the sleep stage. The present research has a double aim: to identify the specific effects of pre-sleep emotional states on the architecture of the subsequent sleep period; to relate such states to the sympathetic activation during the same sleep period. Methods Twelve healthy volunteers (20.1 +/- 1.0 yo.) participated in the experiment and each one slept 9 nights at the laboratory, divided into 3 sessions, one per week. Each session was organized over three nights. A reference night, allowing baseline pre-sleep and sleep recordings, preceded an experimental night before which participants watched a negative, neutral, or positive movie. The third and last night was devoted to analyzing the potential recovery or persistence of emotional effects induced before the experimental night. Standard polysomnography and EDA were recorded during all the nights. Results Firstly, we found that experimental pre-sleep emotional induction increased the Rapid Eye Movement (REM) sleep rate following both negative and positive movies. While this increase was spread over the whole night for positive induction, it was limited to the second half of the sleep period for negative induction. Secondly, the valence of the pre-sleep movie also impacted the sympathetic activation during Non-REM stage 3 sleep, which increased after negative induction and decreased after positive induction. Conclusion Pre-sleep controlled emotional states impacted the subsequent REM sleep rate and modulated the sympathetic activity during the sleep period. The outcomes of this study offer interesting perspectives related to the effect of diurnal emotional influences on sleep regulation and open new avenues for potential practices designed to alleviate sleep disturbances.	[Delannoy, Julien; Honore, Jacques; Sequeira, Henrique] Univ Lille, CNRS UMR 9193, SCALab, Lille, France; [Mandai, Osamu; Kobayashi, Toshinori] Ashikaga Inst Technol, Sleep Res Ctr, Ashikaga, Japan; [Sequeira, Henrique] Univ Lille, UFR Biol, Neurosci, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Delannoy, J (corresponding author), Univ Lille, CNRS UMR 9193, SCALab, Lille, France.	Julien.Delannoy@univ-lille2.fr; Henrique.Sequeira@univ-lille1.fr						Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; Akerstedt T, 2007, BIOL PSYCHOL, V76, P170, DOI 10.1016/j.biopsycho.2007.07.010; Antrobus JS, 2009, ENCY NEUROSCIENCE, V8, P1021; Auxemery Y, 2012, ENCEPHALE, V38, P373, DOI 10.1016/j.encep.2011.12.003; BAEKELAND F, 1968, PSYCHOPHYSIOLOGY, V4, P436; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; BAQUE EFI, 1983, BIOL PSYCHOL, V17, P137, DOI 10.1016/0301-0511(83)90014-5; BAQUE EFI, 1980, BIOL PSYCHOL, V10, P219, DOI 10.1016/0301-0511(80)90017-4; BAQUE EFI, 1983, SLEEP, V6, P77, DOI 10.1093/sleep/6.1.77; BES F, 1991, SLEEP, V14, P5, DOI 10.1093/sleep/14.1.5; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brand S, 2010, WORLD J BIOL PSYCHIA, V11, P744, DOI 10.3109/15622971003624205; Carskadon M.A., 2011, PRINC PRACT SLEEP ME, V4, P16, DOI [10.1016/b978-1-4160-6645-3.00002-5, DOI 10.1016/B978-1-4160-6645-3.00002-5]; CARTWRIGHT RD, 1991, PSYCHIAT RES, V39, P199, DOI 10.1016/0165-1781(91)90088-7; Cluydts R, 1980, Waking Sleeping, V4, P199; COHEN DB, 1975, J PERS SOC PSYCHOL, V32, P1090, DOI 10.1037/0022-3514.32.6.1090; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; DELERM B, 1981, BIOL PSYCHOL, V12, P299, DOI 10.1016/0301-0511(81)90003-X; Deliens G, 2014, EXP BRAIN RES, V232, P1403, DOI 10.1007/s00221-014-3832-1; DUNLEAVY DL, 1972, BRIT J PSYCHIAT, V120, P663, DOI 10.1192/bjp.120.559.663; Ermis U, 2010, J SLEEP RES, V19, P400, DOI 10.1111/j.1365-2869.2010.00831.x; Fleischman DS, 2010, PSYCHOL SCI, V21, P750, DOI 10.1177/0956797610368062; Fortunato VJ, 2006, PERS INDIV DIFFER, V41, P825, DOI 10.1016/j.paid.2006.03.024; Galambos NL, 2011, J RES ADOLESCENCE, V21, P342, DOI 10.1111/j.1532-7795.2010.00679.x; Germain A, 2003, PSYCHOSOM MED, V65, P857, DOI 10.1097/01.PSY.0000079376.87711.B0; Gilet AL, 2008, ENCEPHALE, V34, P233, DOI 10.1016/j.encep.2006.08.003; GOODENOUGH DR, 1975, PSYCHOPHYSIOLOGY, V12, P313, DOI 10.1111/j.1469-8986.1975.tb01298.x; Grano N, 2008, INT J BEHAV MED, V15, P73, DOI 10.1080/10705500801929510; Gruber R, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0500-x; HICKS RA, 1987, PERCEPT MOTOR SKILL, V64, P44, DOI 10.2466/pms.1987.64.1.44; Iber C., 2007, AASM MANUAL SCORING; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; JOHNSON LC, 1966, PSYCHOPHYSIOLOGY, V3, P8, DOI 10.1111/j.1469-8986.1966.tb02673.x; Kahn M, 2013, INT J PSYCHOPHYSIOLO; Kawahito J, 2012, HIROSHIMA PSYCHOL RE, V11, P225; Kecklund G, 2004, BIOL PSYCHOL, V66, P169, DOI 10.1016/j.biopsycho.2003.10.004; Kerkhof GA, 2010, PROG BRAIN RES, V185, P49, DOI 10.1016/B978-0-444-53702-7.00004-X; Kim Eui-Joong, 2007, Behav Sleep Med, V5, P256; Kimata H, 2007, INDIAN PEDIATR, V44, P281; Kobayashi T, 1998, PSYCHIAT CLIN NEUROS, V52, P130, DOI 10.1111/j.1440-1819.1998.tb00989.x; Kraft NO, 2002, AVIAT SPACE ENVIR MD, V73, P1089; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; KUSHNIRUK A, 1985, SLEEP, V8, P146, DOI 10.1093/sleep/8.2.146; LANG PJ, 1994, PSYCHOL REV, V101, P211, DOI 10.1037/0033-295X.101.2.211; LAUER C, 1987, PSYCHOPHYSIOLOGY, V24, P263, DOI 10.1111/j.1469-8986.1987.tb00293.x; LESTER BK, 1967, PSYCHOPHYSIOLOGY, V3, P238, DOI 10.1111/j.1469-8986.1967.tb02701.x; Lorenzo JL, 2002, PSYCHOPHYSIOLOGY, V39, P409, DOI 10.1017/S0048577202394010; Lundh LG, 2000, J PSYCHOSOM RES, V49, P299, DOI 10.1016/S0022-3999(00)00150-1; Mallick BN, 2012, PROG NEUROBIOL, V97, P259, DOI 10.1016/j.pneurobio.2012.04.001; Marinesco S, 1999, NEUROSCIENCE, V92, P921, DOI 10.1016/S0306-4522(99)00045-7; MCDONALD DG, 1976, PSYCHOPHYSIOLOGY, V13, P128, DOI 10.1111/j.1469-8986.1976.tb00087.x; Mezick EJ, 2009, PSYCHONEUROENDOCRINO, V34, P1346, DOI 10.1016/j.psyneuen.2009.04.005; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ong JC, 2011, J SLEEP RES, V20, P606, DOI 10.1111/j.1365-2869.2011.00907.x; Philbert J, 2011, BEHAV BRAIN RES, V221, P149, DOI 10.1016/j.bbr.2011.02.039; Pigeon WR, 2015, SLEEP MED CLIN, V10, P41, DOI 10.1016/j.jsmc.2014.11.010; Rosenthal R., 1966, EXPT EFFECTS BEHAV R; ROSS RJ, 1995, BRAIN RES, V701, P129, DOI 10.1016/0006-8993(95)00984-X; Ryff CD, 2004, PHILOS T R SOC B, V359, P1383, DOI 10.1098/rstb.2004.1521; Sanford LD, 2010, SLEEP, V33, P621, DOI 10.1093/sleep/33.5.621; Sano A, 2013, BOD SENS NETW BSN 20; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; Sequeira H, 2009, INT J PSYCHOPHYSIOL, V71, P50, DOI 10.1016/j.ijpsycho.2008.07.009; Settineri S, 2010, NEUROL SCI, V31, P459, DOI 10.1007/s10072-010-0255-z; Steptoe A, 2008, J PSYCHOSOM RES, V64, P409, DOI 10.1016/j.jpsychores.2007.11.008; Suchecki Deborah, 2012, Front Neurol, V3, P41, DOI 10.3389/fneur.2012.00041; SUER C, 1992, INT J NEUROSCI, V65, P91; Talamini LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062480; Troxel WM, 2009, BEHAV SLEEP MED, V7, P2, DOI 10.1080/15402000802577736; Tsypes A, 2013, J ANXIETY DISORD, V27, P197, DOI 10.1016/j.janxdis.2013.01.008; Vandekerckhove M, 2011, PSYCHOPHYSIOLOGY, V48, P1738, DOI 10.1111/j.1469-8986.2011.01281.x; Vein A M, 2002, Neurosci Behav Physiol, V32, P513, DOI 10.1023/A:1019859606601; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Weise S, 2013, BIOL PSYCHOL, V94, P61, DOI 10.1016/j.biopsycho.2013.04.009; Werner GG, 2015, PSYCHOPHYSIOLOGY, V52, P813, DOI 10.1111/psyp.12404; YAMAMOTO K, 1994, SCHIZOPHR RES, V13, P145, DOI 10.1016/0920-9964(94)90095-7	77	5	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142721	10.1371/journal.pone.0142721	http://dx.doi.org/10.1371/journal.pone.0142721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7ES	26606526	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300029
J	Jang, SH; Lee, S; Chung, HY				Jang, Su Hwa; Lee, Sohyun; Chung, Hee Yong			Characterization of Leukemia-Inducing Genes Using a Proto-Oncogene/Homeobox Gene Retroviral Human cDNA Library in a Mouse In Vivo Model	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; BONE-MARROW-CELLS; C-MYC; HOX GENES; EXPRESSION; MEIS1; MICE; MUTATIONS; TRANSFORMATION	The purpose of this research is to develop a method to screen a large number of potential driver mutations of acute myeloid leukemia (AML) using a retroviral cDNA library and murine bone marrow transduction-transplantation system. As a proof-of-concept, murine bone marrow (BM) cells were transduced with a retroviral cDNA library encoding well-characterized oncogenes and homeobox genes, and the virus-transduced cells were transplanted into lethally irradiated mice. The proto-oncogenes responsible for leukemia initiation were identified by PCR amplification of cDNA inserts from genomic DNA isolated from leukemic cells. In an initial screen of ten leukemic mice, the MYC proto-oncogene was detected in all the leukemic mice. Of ten leukemic mice, 3 (30%) had MYC as the only transgene, and seven mice (70%) had additional proto-oncogene inserts. We repeated the same experiment after removing MYC-related genes from the library to characterize additional leukemia-inducing gene combinations. Our second screen using the MYC-deleted protooncogene library confirmed MEIS1and the HOX family as cooperating oncogenes in leukemia pathogenesis. The model system we introduced in this study will be valuable in functionally screening novel combinations of genes for leukemogenic potential in vivo, and the system will help in the discovery of new targets for leukemia therapy.	[Jang, Su Hwa; Lee, Sohyun; Chung, Hee Yong] Hanyang Univ, Grad Sch Biomed Sci & Engn, Dept Biomed Sci, Seoul 133791, South Korea	Hanyang University	Chung, HY (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Dept Biomed Sci, Seoul 133791, South Korea.	hychung@hanyang.ac.kr		Chung, Hee Yong/0000-0001-7580-0537; Jang, Su Hwa/0000-0002-3022-6612	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1D1A1A01060923]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF, http://ernd.nrf.re.kr/index) funded by the Ministry of Science, ICT & Future Planning (Grant# 2015R1D1A1A01060923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Adam M, 2006, CANCER RES, V66, P3828, DOI 10.1158/0008-5472.CAN-05-2309; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Afonja O, 2000, LEUKEMIA RES, V24, P849, DOI 10.1016/S0145-2126(00)00059-X; Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Bach C, 2010, BLOOD, V115, P2910, DOI 10.1182/blood-2009-04-216606; Bansal D, 2006, P NATL ACAD SCI USA, V103, P16924, DOI 10.1073/pnas.0604579103; Barber BA, 2010, ANN ANAT, V192, P261, DOI 10.1016/j.aanat.2010.07.009; BREUER ML, 1989, EMBO J, V8, P743, DOI 10.1002/j.1460-2075.1989.tb03434.x; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Calvo KR, 2001, P NATL ACAD SCI USA, V98, P13120, DOI 10.1073/pnas.231115398; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Dickson GJ, 2009, EXP HEMATOL, V37, P322, DOI 10.1016/j.exphem.2008.10.015; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fischbach NA, 2005, BLOOD, V105, P1456, DOI 10.1182/blood-2004-04-1583; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grisolano JL, 2003, P NATL ACAD SCI USA, V100, P9506, DOI 10.1073/pnas.1531730100; Jang SH, 2012, MOL CELLS, V34, P201, DOI 10.1007/s10059-012-0142-y; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; LAND H, 1986, MOL CELL BIOL, V6, P1917, DOI 10.1128/MCB.6.6.1917; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; MAVILIO F, 1986, P NATL ACAD SCI USA, V83, P4394, DOI 10.1073/pnas.83.12.4394; Mullighan CG, 2007, LEUKEMIA, V21, P2000, DOI 10.1038/sj.leu.2404808; Pineault N, 2004, MOL CELL BIOL, V24, P1907, DOI 10.1128/MCB.24.5.1907-1917.2004; ROLINK A, 1993, EUR J IMMUNOL, V23, P1284, DOI 10.1002/eji.1830230614; Schmidt M, 2001, ANN NY ACAD SCI, V938, P146; Schnittger S, 2006, BLOOD, V107, P1791, DOI 10.1182/blood-2005-04-1466; SELTEN G, 1985, EMBO J, V4, P1793, DOI 10.1002/j.1460-2075.1985.tb03852.x; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143240	10.1371/journal.pone.0143240	http://dx.doi.org/10.1371/journal.pone.0143240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606454	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300048
J	Lehle, K; Philipp, A; Zeman, F; Lunz, D; Lubnow, M; Wendel, HP; Gobolos, L; Schmid, C; Muller, T				Lehle, Karla; Philipp, Alois; Zeman, Florian; Lunz, Dirk; Lubnow, Matthias; Wendel, Hans-Peter; Gobolos, Laszlo; Schmid, Christof; Mueller, Thomas			Technical-Induced Hemolysis in Patients with Respiratory Failure Supported with Veno-Venous ECMO - Prevalence and Risk Factors	PLOS ONE			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; NITRIC-OXIDE CONSUMPTION; FREE HEMOGLOBIN; CARDIAC-SURGERY; BLOOD; ADULTS; PREDICTION; MORTALITY; DAMAGE; PUMPS	The aim of the study was to explore the prevalence and risk factors for technical-induced hemolysis in adults supported with veno-venous extracorporeal membrane oxygenation (vvECMO) and to analyze the effect of hemolytic episodes on outcome. This was a retrospective, single-center study that included 318 adult patients (Regensburg ECMO Registry, 2009-2014) with acute respiratory failure treated with different modern miniaturized ECMO systems. Free plasma hemoglobin (fHb) was used as indicator for hemolysis. Throughout a cumulative support duration of 4,142 days on ECMO only 1.7% of the fHb levels were above a critical value of 500 mg/l. A grave rise in fHb indicated pumphead thrombosis (n = 8), while acute oxygenator thrombosis (n = 15) did not affect fHb. Replacement of the pumphead normalized fHb within two days. Neither pump or cannula type nor duration on the first system was associated with hemolysis. Multiple trauma, need for kidney replacement therapy, increased daily red blood cell transfusion requirements, and high blood flow (3.0-4.5 L/min) through small-sized cannulas significantly resulted in augmented blood cell trauma. Survivors were characterized by lower peak levels of fHb [90 (60, 142) mg/l] in comparison to non-survivors [148 (91, 256) mg/l, p <= 0.001]. In conclusion, marked hemolysis is not common in vvECMO with modern devices. Clinically obvious hemolysis often is caused by pumphead thrombosis. High flow velocity through small cannulas may also cause technical-induced hemolysis. In patients who developed lung failure due to trauma, fHb was elevated independantly of ECMO. In our cohort, the occurance of hemolysis was associated with increased mortality.	[Lehle, Karla; Philipp, Alois; Schmid, Christof] Univ Med Ctr Regensburg, Dept Cardiothorac Surg, Regensburg, Germany; [Lubnow, Matthias; Mueller, Thomas] Univ Med Ctr Regensburg, Dept Internal Med 2, Regensburg, Germany; [Lunz, Dirk] Univ Med Ctr Regensburg, Dept Anesthesiol, Regensburg, Germany; [Zeman, Florian] Univ Med Ctr Regensburg, Ctr Clin Studies, Regensburg, Germany; [Wendel, Hans-Peter] Univ Hosp Tuebingen, Dept Thorac Cardiac & Vasc Surg, Tubingen, Germany; [Gobolos, Laszlo] Southampton Univ Hosp Trust, Dept Cardiothorac Surg, Southampton, Hants, England	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust	Lehle, K (corresponding author), Univ Med Ctr Regensburg, Dept Cardiothorac Surg, Regensburg, Germany.	karla.lehle@ukr.de	Göbölös, Laszlo/I-3524-2019; Zeman, Florian/GNH-3239-2022					Abrams D, 2014, CLIN CHEST MED, V35, P765, DOI 10.1016/j.ccm.2014.08.013; Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11425; Bakir I, 2007, ARTIF ORGANS, V31, P316, DOI 10.1111/j.1525-1594.2007.00381.x; Bein T, 2012, J TRAUMA ACUTE CARE, V73, P1450, DOI 10.1097/TA.0b013e3182782480; Betrus Christopher, 2007, Ann Thorac Cardiovasc Surg, V13, P378; Brodie D, 2011, NEW ENGL J MED, V365, P1905, DOI 10.1056/NEJMct1103720; Cappellini Maria Domenica, 2007, Hematology Am Soc Hematol Educ Program, P74; Dornia C, 2015, ARTIF ORGANS, V39, P782, DOI 10.1111/aor.12460; Enger TB, 2014, CRIT CARE, V18, DOI 10.1186/cc13824; Erdmann J, 2014, NAT MED, V20, P979, DOI 10.1038/nm0914-979; Gbadegesin R, 2009, PEDIATR NEPHROL, V24, P589, DOI 10.1007/s00467-008-1047-z; Green T P, 1991, ASAIO Trans, V37, P572; Guttendorf J, 2014, AM J CRIT CARE, V23, P365, DOI 10.4037/ajcc2014115; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Kawahito S, 2002, ASAIO J, V48, P636, DOI 10.1097/00002480-200211000-00010; Klaus S, 2002, INT J ARTIF ORGANS, V25, P306, DOI 10.1177/039139880202500409; Lee SG, 2014, ANN THORAC CARDIOVAS, V20, P26, DOI 10.5761/atcs.oa.12.00203; Lehle K, 2014, ARTIF ORGANS, V38, P391, DOI 10.1111/aor.12180; LEVERETT LB, 1972, BIOPHYS J, V12, P257, DOI 10.1016/S0006-3495(72)86085-5; Lou S, 2014, CRIT CARE MED, V42, P1213, DOI 10.1097/CCM.0000000000000128; Lubnow M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112316; Lubnow M, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.12.008; Muller T, 2013, DTSCH ARZTEBL INT, V110, P159, DOI 10.3238/arztebl.2013.0159; Murphy DA, 2015, TRANSFUS MED REV, V29, P90, DOI 10.1016/j.tmrv.2014.12.001; Omar HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124034; Ozment CP, 2013, TRANSFUSION, V53, P732, DOI 10.1111/j.1537-2995.2012.03837.x; Palanzo DA, 2013, ARTIF ORGANS, V37, pE162, DOI 10.1111/aor.12158; Pan KC, 2015, PERFUSION; Ricci Z, 2014, INTERACT CARDIOV TH, V19, P183, DOI 10.1093/icvts/ivu129; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Sauer CM, 2015, ASAIO J, V61, P31, DOI 10.1097/MAT.0000000000000160; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; SHIMONO T, 1995, ARTIF ORGANS, V19, P571, DOI 10.1111/j.1525-1594.1995.tb02383.x; Skogby M, 1998, ARTIF ORGANS, V22, P1045; STEINHORN RH, 1989, J PEDIATR-US, V115, P625, DOI 10.1016/S0022-3476(89)80299-9; Toomasian JM, 2011, PERFUSION-UK, V26, P5, DOI 10.1177/0267659110396015; Vercaemst Leen, 2008, J Extra Corpor Technol, V40, P257; WIELOGORSKI JW, 1975, J BIOMECH, V8, P321, DOI 10.1016/0021-9290(75)90084-6; Williams DC, 2015, ASAIO J, V61, P190, DOI 10.1097/MAT.0000000000000173; Windsant ICV, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00340; Windsant ICV, 2012, CRIT CARE, V16, DOI 10.1186/cc11359; Zangrillo A, 2013, CRIT CARE RESUSC, V15, P172	42	58	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143527	10.1371/journal.pone.0143527	http://dx.doi.org/10.1371/journal.pone.0143527			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606144	Green Submitted, gold, Green Published			2022-12-26	WOS:000365865300076
J	Westhoff, JH; Tonshoff, B; Waldherr, S; Poschl, J; Teufel, U; Westhoff, TH; Fichtner, A				Westhoff, Jens H.; Toenshoff, Burkhard; Waldherr, Sina; Poeschl, Johannes; Teufel, Ulrike; Westhoff, Timm H.; Fichtner, Alexander			Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) center dot Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury	PLOS ONE			English	Article							CYCLE ARREST BIOMARKERS; GLOMERULAR-FILTRATION-RATE; ACUTE-RENAL-FAILURE; CONSENSUS CONFERENCE; RIFLE CRITERIA; CHILDREN; EPIDEMIOLOGY; VALIDATION; MORTALITY; DEFINITION	Background The G1 cell cycle inhibitors tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) have been identified as promising biomarkers for the prediction of adverse outcomes including renal replacement therapy (RRT) and mortality in critically ill adult patients who develop acute kidney injury (AKI). However, the prognostic value of urinary TIMP-2 and IGFBP7 in neonatal and pediatric AKI for adverse outcome has not been investigated yet. Methods The product of the urinary concentration of TIMP-2 and IGFBP7 ([TIMP-2]-[IGFBP7]) was assessed by a commercially available immunoassay (NephroCheck (TM)) in a prospective cohort study in 133 subjects aged 0-18 years including 46 patients with established AKI according to pRIFLE criteria, 27 patients without AKI (non-AKI group I) and 60 apparently healthy neonates and children (non-AKI group II). AKI etiologies were: dehydration/hypovolemia (n = 7), hemodynamic instability (n = 7), perinatal asphyxia (n = 9), septic shock (n = 7), typical hemolytic-uremic syndrome (HUS; n = 5), interstitial nephritis (n = 5), vasculitis (n = 4), nephrotoxic injury (n = 1) and renal vein thrombosis (n = 1). Results When AKI patients were classified into pRIFLE criteria, 6/46 (13%) patients fulfilled the criteria for the category "Risk", 13/46 (28%) for "Injury", 26/46 (57%) for "Failure" and 1/46 (2%) for "Loss". Patients in the "Failure" stage had a median 3.7-fold higher urinary [TIMP-2]center dot[IGFBP7] compared to non-AKI subjects (P<0.001). When analyzed for AKI etiology, highest [TIMP-2]center dot[IGFBP7] values were found in patients with septic shock (P<0.001 vs. non-AKI I+II). Receiver operating characteristic (ROC) curve analyses in the AKI group revealed good performance of [TIMP-2]center dot[IGFBP7] in predicting 30-day (area under the curve (AUC) 0.79; 95% CI, 0.61-0.97) and 3-month mortality (AUC 0.84; 95% CI, 0.67-0.99) and moderate performance in predicting RRT (AUC 0.67; 95% CI, 0.50-0.84). Conclusions This study shows that urinary [TIMP-2]center dot[IGFBP7] has a good diagnostic performance in predicting adverse outcomes in neonatal and pediatric AKI of heterogeneous etiology.	[Westhoff, Jens H.; Toenshoff, Burkhard; Teufel, Ulrike; Fichtner, Alexander] Univ Childrens Hosp, Dept Pediat 1, Heidelberg, Germany; [Waldherr, Sina; Poeschl, Johannes] Univ Childrens Hosp, Dept Neonatol, Heidelberg, Germany; [Westhoff, Timm H.] Ruhr Univ Bochum, Univ Klin Marien Hosp Herne, Med Klin 1, Bochum, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruhr University Bochum; St. Marien Hospital	Westhoff, JH (corresponding author), Univ Childrens Hosp, Dept Pediat 1, Heidelberg, Germany.	jens.westhoff@med.uni-heidelberg.de	Westhoff, Jens H./AAO-7185-2021	Westhoff, Timm H./0000-0001-5797-834X				Abitbol CL, 2014, J PEDIATR-US, V164, P1026, DOI 10.1016/j.jpeds.2014.01.044; Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Al-Ismaili Z, 2011, PEDIATR NEPHROL, V26, P29, DOI 10.1007/s00467-010-1576-0; Aregger F, 2014, KIDNEY INT, V85, P909, DOI 10.1038/ki.2013.363; Basu RK, 2012, PEDIATR NEPHROL, V27, P1067, DOI 10.1007/s00467-011-2024-5; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bihorac A, 2014, AM J RESP CRIT CARE, V189, P932, DOI 10.1164/rccm.201401-0077OC; Blackburn S T, 1994, J Perinat Neonatal Nurs, V8, P37; Endre ZH, 2013, CONTRIB NEPHROL, V182, P30, DOI 10.1159/000349964; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Flynn JT, 2002, PEDIATR NEPHROL, V17, P61, DOI 10.1007/s004670200011; Greenberg JH, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-184; Hoste EAJ, 2014, NEPHROL DIAL TRANSPL, V29, P2054, DOI 10.1093/ndt/gfu292; Hui-Stickle S, 2005, AM J KIDNEY DIS, V45, P96, DOI 10.1053/j.ajkd.2004.09.028; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Koraishy FM, 2014, SEMIN DIALYSIS, V27, P236, DOI 10.1111/sdi.12208; Koyner JL, 2015, J AM SOC NEPHROL, V26, P1747, DOI 10.1681/ASN.2014060556; Meersch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110865; Schneider J, 2010, CRIT CARE MED, V38, P933, DOI 10.1097/CCM.0b013e3181cd12e1; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Selewski DT, 2015, PEDIATRICS, V136, pE463, DOI 10.1542/peds.2014-3819; Slater MB, 2012, KIDNEY INT, V81, P791, DOI 10.1038/ki.2011.466; Srisawat N, 2010, BLOOD PURIFICAT, V29, P300, DOI 10.1159/000280099; Sutherland SM, 2013, CLIN J AM SOC NEPHRO, V8, P1661, DOI 10.2215/CJN.00270113; Treiber M, 2015, PEDIATR NEPHROL, V30, P1297, DOI 10.1007/s00467-014-3029-7; Wan Li, 2003, Curr Opin Crit Care, V9, P496, DOI 10.1097/00075198-200312000-00006; Wasilewska AM, 2008, PEDIATR NEPHROL, V23, P1795, DOI 10.1007/s00467-008-0881-3; Wasung ME, 2015, CLIN CHIM ACTA, V438, P350, DOI 10.1016/j.cca.2014.08.039; Westhoff JH, 2010, J AM SOC NEPHROL, V21, P327, DOI 10.1681/ASN.2009010072; Westhoff JH, 2008, HYPERTENSION, V52, P123, DOI 10.1161/HYPERTENSIONAHA.107.099432; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Yang HC, 2010, J AM SOC NEPHROL, V21, P1436, DOI 10.1681/ASN.2010020205; Yang QH, 2009, J INFECTION, V58, P459, DOI 10.1016/j.jinf.2009.04.003; Zappitelli M, 2008, CLIN J AM SOC NEPHRO, V3, P948, DOI 10.2215/CJN.05431207	35	57	60	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143628	10.1371/journal.pone.0143628	http://dx.doi.org/10.1371/journal.pone.0143628			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606754	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300091
J	Ahmad, A; Mbofung, GY; Acharya, J; Schmidt, CL; Robertson, AE				Ahmad, Azeem; Mbofung, Gladys Y.; Acharya, Jyotsna; Schmidt, Clarice L.; Robertson, Alison E.			Characterization and Comparison of Clavibacter michiganensis subsp nebraskensis Strains Recovered from Epiphytic and Symptomatic Infections of Maize in Iowa	PLOS ONE			English	Article							GOSSS BACTERIAL WILT; GENETIC DIVERSITY; ANION CHANNEL; LEAF-BLIGHT; 1ST REPORT; CORN	Clavibacter michiganensis subsp. nebraskensis (Cmn), the causal organism of Goss's wilt and leaf blight of maize, can be detected in the phyllosphere of its host prior to disease development. We compared the morphology and pathogenicity of 37 putative isolates of Cmn recovered from asymptomatic and symptomatic maize leaves. Thirty-three of the isolates produced mucoid orange colonies, irrespective of the source of isolation and all but four of these isolates were pathogenic on maize. The remaining 4 isolates recovered from asymptomatic leaves had large fluidal yellow colonies, and were non-pathogenic on maize. Isolates varied in their aggressiveness on a susceptible hybrid of maize but no significant differences in aggressiveness were detected between epiphytic isolates and those recovered from diseased maize tissues. The genomics of Cmn is poorly understood; therefore as a first step to determining what genes may play a role in virulence, we compared 33 putative virulence gene sequences from 6 pathogenic and a non-pathogenic isolate recovered from the phyllosphere. Sequence polymorphisms were detected in 5 genes, cellulase A, two endoglucanases, xylanase B and a pectate lyase but there was no relationship with pathogenicity. Further research is needed to determine what genes play a role in virulence of Cmn. Our data show however, that the virulence factors in Cmn likely differ from those reported for the closely related subspecies michiganensis and sepedonicus.	[Ahmad, Azeem; Mbofung, Gladys Y.; Acharya, Jyotsna; Schmidt, Clarice L.; Robertson, Alison E.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA	Iowa State University	Robertson, AE (corresponding author), Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA.	alisonr@iastate.edu		Robertson, Alison/0000-0003-4281-6350				Agarkova IV, 2011, CAN J MICROBIOL, V57, P366, DOI [10.1139/W11-016, 10.1139/w11-016]; Bentley SD, 2008, J BACTERIOL, V190, P2150, DOI 10.1128/JB.01598-07; BIDDLE JA, 1990, PLANT DIS, V74, P908, DOI 10.1094/PD-74-0908; Bradley C., 2010, BULLETIN; Brody JR, 2011, BIOINFORMATICS, V36, P214; Cho MS, 2012, J MICROBIOL, V50, P496, DOI 10.1007/s12275-012-1611-x; Claflin L.E., 1999, COMPENDIUM CORN DIS, V3rd edition, P4; Eichenlaub R, 2006, PLANT-ASSOCIATED BACTERIA, P385; Eichenlaub R, 2011, ANNU REV PHYTOPATHOL, V49, P445, DOI 10.1146/annurev-phyto-072910-095258; GROSS DC, 1979, J GEN MICROBIOL, V115, P479, DOI 10.1099/00221287-115-2-479; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hollier CA, 2014, PHYTOPATHOLOGY S2, V104, P5; Howard RJ, 2015, PLANT DIS, V99, P1034, DOI 10.1094/PDIS-11-14-1117-PDN; Jackson T. A., 2007, Plant Health Progress, P0919; Jackson TA, 2007, GOSSS BACTERIAL WILT; Korus KA, 2011, PLANT DIS, V95, P73, DOI 10.1094/PDIS-07-10-0541; Korus KA, 2011, THESIS; Louws FJ, 1998, PHYTOPATHOLOGY, V88, P862, DOI 10.1094/PHYTO.1998.88.8.862; Madden L.V., 2007, STUDY PLANT DIS EPID; Malvick D, 2010, PLANT DIS, V94, P1064, DOI 10.1094/PDIS-94-8-1064A; Marlay S., 2011, EXTERNAL PUBLICATION; MELETZUS D, 1991, J BACTERIOL, V173, P184, DOI 10.1128/jb.173.1.184-190.1991; Michalke A, 2001, EUR BIOPHYS J BIOPHY, V30, P421, DOI 10.1007/s002490100154; Michalke A, 2001, LANGMUIR, V17, P2251, DOI 10.1021/la0013493; Robertson A, 2008, INTEGRATED CROP MANA; Ruhl G, 2009, PLANT DIS, V93, P841, DOI 10.1094/PDIS-93-8-0841B; SCHURHOLZ T, 1991, J MEMBRANE BIOL, V123, P1, DOI 10.1007/BF01993957; SCHURHOLZ T, 1993, BIOPHYS J, V64, P58, DOI 10.1016/S0006-3495(93)81340-7; Schuster ML, 1975, UNL RES B; Shepherd L, 1999, THESIS; Stewart S, 2011, BIOTECHNOL LETT, V33, P2217, DOI 10.1007/s10529-011-0682-9; VIDAVER AK, 1974, INT J SYST BACTERIOL, V24, P482, DOI 10.1099/00207713-24-4-482; Waleron M, 2011, EUR J PLANT PATHOL, V131, P341, DOI 10.1007/s10658-011-9812-4; WYSONG DS, 1973, PLANT DIS REP, V/057, P291; Zaluga J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-392	35	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143553	10.1371/journal.pone.0143553	http://dx.doi.org/10.1371/journal.pone.0143553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599211	gold, Green Submitted, Green Published			2022-12-26	WOS:000365862600083
J	Kault, D; Kault, S				Kault, David; Kault, Sam			From P-Values to Objective Probabilities in Assessing Medical Treatments	PLOS ONE			English	Article								The assessment of the effectiveness of a treatment in a clinical trial, depends on calculating p-values. However, p-values are only indirect and partial indicators of a genuine effect. Particularly in situations where publication bias is very likely, assessment using a p-value of 0.05 may not be sufficiently cautious. In other situations it seems reasonable to believe that assessment based on p-values may be unduly conservative. Assessments could be improved by using prior information. This implies using a Bayesian approach to take account of prior probability. However, the use of prior information in the form of expert opinion can allow bias. A method is given here that applies to assessments already included or likely to be included in the Cochrane Collaboration, excluding those reviews concerning new drugs. This method uses prior information and a Bayesian approach, but the prior information comes not from expert opinion but simply from the distribution of effectiveness apparent in a random sample of summary statistics in the Cochrane Collaboration. The method takes certain types of summary statistics and their confidence intervals and with the help of a graph, translates this into probabilities that the treatments being trialled are effective.	[Kault, David] James Cook Univ, Coll Sci Technol & Engn, Discipline Math, Townsville, Qld 4811, Australia; [Kault, Sam] Griffith Univ, Ctr Appl Hlth Econ, Menzies Hlth Inst, Brisbane, Qld 4111, Australia	James Cook University; Griffith University; Menzies Health Institute Queensland	Kault, D (corresponding author), James Cook Univ, Coll Sci Technol & Engn, Discipline Math, Townsville, Qld 4811, Australia.	David.Kault@jcu.edu.au						Braithwaite RS, 2013, JAMA-J AM MED ASSOC, V310, P2149, DOI 10.1001/jama.2013.281996; Dowden J, 2015, AUST PRESCR, V38, P2, DOI 10.18773/austprescr.2015.001; Dubben HH, 2005, BRIT MED J, V331, P433, DOI 10.1136/bmj.38478.497164.F7; Fisher, 2004, SIGNIFICANCE, V1, P26; Flicker L, 2012, AUST PRESCR, V35, P74, DOI 10.18773/austprescr.2012.031; Freedman B, 1987, NEW ENGL J MED, V317, P141, DOI [10.1056/NEJM198707163170304, DOI 10.1056/NEJM198707163170304]; Goldacre B., 2012, BAD PHARM DRUG CO MI; HINE LK, 1989, ARCH INTERN MED, V149, P2694, DOI 10.1001/archinte.149.12.2694; IOANNIDIS J, 2005, PLOS MED; Kault DA, 2014, J MED STATS INFORM, V2; Leek JT, 2015, NATURE, V520, P612, DOI 10.1038/520612a; LILFORD RJ, 1990, NEW ENGL J MED, V322, P780; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Prasad V, 2013, MAYO CLIN PROC, V88, P790, DOI 10.1016/j.mayocp.2013.05.012; Press W, 1989, NUMERICAL RECIPES AR; R Core Team, 2021, R LANGUAGE ENV STAT; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Seife C, 2015, JAMA INTERNAL MEDICI; Song FJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-79; Westover MB, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-20	20	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142132	10.1371/journal.pone.0142132	http://dx.doi.org/10.1371/journal.pone.0142132			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600468	Green Published, Green Accepted, gold			2022-12-26	WOS:000365862600007
J	Ferreira, HS; Lucio, GMA; Assuncao, ML; Silva, BCV; Oliveira, JS; Florencio, TMMT; Geraldes, AAR; Horta, BL				Ferreira, Haroldo S.; Lucio, Glicia Maris A.; Assuncao, Monica L.; Silva, Barbara Coelho V.; Oliveira, Juliana S.; Florencio, Telma Maria M. T.; Geraldes, Amandio Aristides R.; Horta, Bernardo L.			High Blood Pressure among Students in Public and Private Schools in Maceio, Brazil	PLOS ONE			English	Article							RISK-FACTORS; CHILDREN; OBESITY; PREVALENCE; HYPERTENSION; ADOLESCENTS; STATE; SCHOOLCHILDREN; OVERWEIGHT; TRENDS	The prevalence of hypertension in childhood is increasing, and investigation of its distribution is important for planning timely interventions. This study assessed the prevalence of high blood pressure (HBP) and associated factors in students between 9 and 11 years of age enrolled in public and private schools in Maceio, Brazil. A cross-sectional study was performed in a probabilistic sample of students (10.3 +/- 0.5 years). The students were selected from a systematic sampling of 80 schools (40 public and 40 private). To maintain similar proportions of students existing in public and private schools in Maceio, 21 and 14 students were randomly selected from each public and private school, respectively. The prevalence ratio (PR) was estimated using Poisson regression. A total of 1,338 students were evaluated (800 from public schools and 538 from private schools). No differences were observed between school types in terms of student age and gender (p > 0.05). The prevalence of obesity (19.9% vs. 9.0%; PR = 2.2; 95% CI = 1.67-2.92) and hypertension (21.2% vs. 11.4%; PR = 1.86; 95% CI = 1.45-2.40) were higher in private schools. The association between high blood pressure and type of school (public or private) remained statistically significant even after adjustment for obesity (PR = 1.53; 95% CI = 1.19-1.97). In conclusion: (a) students from private schools have higher socioeconomic status, BMI, and HBP prevalence compared to those of public school; (b) among the evaluated students, the prevalence of obesity only partially explained the higher prevalence of high blood pressure among students from private schools. Other factors related to lifestyle of children from private schools may explain the higher prevalence of HBP. This results show the need to implement measures to promote healthy lifestyles in the school environment, since children with HBP are more likely to become hypertensive adults. Therefore, early detection and intervention in children with HBP is an important action for the prevention of hypertension in adulthood.	[Ferreira, Haroldo S.; Assuncao, Monica L.; Florencio, Telma Maria M. T.] Univ Fed Alagoas, Fac Nutr, Maceio, Alagoas, Brazil; [Lucio, Glicia Maris A.; Silva, Barbara Coelho V.] Univ Fed Alagoas, Fac Nutr, Postgrad Program Nutr, Maceio, Alagoas, Brazil; [Oliveira, Juliana S.] Univ Fed Pernambuco, Acad Ctr Vitoria, Vitoria De Santo Antao, PE, Brazil; [Geraldes, Amandio Aristides R.] Univ Fed Alagoas, Educ Ctr, Maceio, Alagoas, Brazil; [Horta, Bernardo L.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil	Universidade Federal de Alagoas; Universidade Federal de Alagoas; Universidade Federal de Pernambuco; Universidade Federal de Alagoas; Universidade Federal de Pelotas	Ferreira, HS (corresponding author), Univ Fed Alagoas, Fac Nutr, Maceio, Alagoas, Brazil.	haroldo.ufal@gmail.com	Ferrreira, Haroldo S/H-9513-2015; Florencio, Telma/AAE-3394-2019; Geraldes, Amandio AR/I-7977-2014; Horta, Bernardo/A-7604-2008; Ferrreira, Haroldo/ABG-4233-2020	Ferrreira, Haroldo S/0000-0002-1789-3138; Horta, Bernardo/0000-0001-9843-412X; Ferrreira, Haroldo/0000-0002-1789-3138; Geraldes, Amandio/0000-0002-4222-2264	FAPEAL (Foundation for Research Support of the State of Alagoas); CNPq (National Research Council) under the PRONEM programme - Support Emerging Research Groups [20110818-006-0018-0017]	FAPEAL (Foundation for Research Support of the State of Alagoas); CNPq (National Research Council) under the PRONEM programme - Support Emerging Research Groups	This work was supported by FAPEAL (Foundation for Research Support of the State of Alagoas) and CNPq (National Research Council) under the PRONEM programme - Support Emerging Research Groups (grant number 20110818-006-0018-0017).	Bammann K, 2013, PEDIATR OBES, V8, P1, DOI 10.1111/j.2047-6310.2012.00075.x; de Souza MGB, 2010, ARQ BRAS CARDIOL, V94, P714, DOI 10.1590/S0066-782X2010005000039; Beunza JJ, 2007, AM J HYPERTENS, V20, P1156, DOI 10.1016/j.amjhyper.2007.06.007; Borges LMP, 2007, REV SAUDE PUBL, V41, P530, DOI 10.1590/S0034-89102006005000040; Brasil Instituto Nacional de Estudos e Pesquisas Educacionais, 2013, CENS ED 2012; Chiolero A, 2007, J HUM HYPERTENS, V21, P120, DOI 10.1038/sj.jhh.1002125; Costanzi CB, 2009, J PEDIAT-BRAZIL, V85, P335, DOI [10.2223/JPED.1913, 10.1590/S0021-75572009000400011]; de Oliveira TC, 2010, REV SAUDE PUBL, V44, P996, DOI 10.1590/S0034-89102010000600003; de Queiroz VM, 2010, ARQ BRAS CARDIOL, V95, P629, DOI 10.1590/S0066-782X2010001500011; Rezende Dilermando Fazito de, 2003, Arq. Bras. Cardiol., V81, P381, DOI 10.1590/S0066-782X2003001200005; Christofaro DGD, 2009, ARQ BRAS CARDIOL, V92, P9, DOI 10.1590/S0066-782X2009000100003; Dong B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009050; Farajian P, 2008, BRIT J NUTR, V99, P918, DOI 10.1017/S000711450783741X; Fernandes RA, 2008, REV ASSOC MED BRAS, V54, P334, DOI 10.1590/S0104-42302008000400019; Fernandes RA, 2011, CIENC SAUDE COLETIVA, V16, P4051, DOI 10.1590/S1413-81232011001100010; Ferreira HD, 2013, CAD SAUDE PUBLICA, V29, P793, DOI [10.1590/S0102-311X2013000800016, 10.1590/S0102-311X2013000400016]; Frisancho AR, 1990, ANTHROPOMETRIC STAND; Furusawa EA, 2011, AM J HYPERTENS, V24, P893, DOI 10.1038/ajh.2011.72; Hendriksen MAH, 2014, AM J CLIN NUTR, V99, P446, DOI 10.3945/ajcn.113.062018; Huang RC, 2015, AM J HYPERTENS, V28, P1056, DOI 10.1093/ajh/hpu266; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Nogueira PCK, 2007, REV ASSOC MED BRAS, V53, P426, DOI 10.1590/S0104-42302007000500019; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Magalhães Marina Gabriella Pereira de Andrada, 2013, Rev. bras. epidemiol., V16, P849, DOI 10.1590/S1415-790X2013000400005; Miyazaki Y, 2015, SOC SCI MED, V128, P57, DOI 10.1016/j.socscimed.2014.12.032; Mocanu V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/537451; Monego Estelamaris T., 2006, Arq. Bras. Cardiol., V87, P37, DOI 10.1590/S0066-782X2006001400006; Moura Adriana A, 2004, J. Pediatr. (Rio J.), V80, P35, DOI 10.1590/S0021-75572004000100008; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Oliveira Ana Mayra A. de, 2004, Arq Bras Endocrinol Metab, V48, P849, DOI 10.1590/S0004-27302004000600011; Pinto SL, 2011, CAD SAUDE PUBLICA, V27, P1065, DOI 10.1590/S0102-311X2011000600004; Mazaro IAR, 2011, REV ASSOC MED BRAS, V57, P674, DOI 10.1590/S0104-42302011000600015; Gomes BDR, 2009, CAD SAUDE PUBLICA, V25, P375, DOI 10.1590/S0102-311X2009000200016; Rosaneli CF, 2014, ARQ BRAS CARDIOL, V103, P238, DOI 10.5935/abc.20140104; Seidell JC, 2015, NEDERLANDS TIJDSCHRI, V158, pA8503; Silva Giselia Alves Pontes da, 2005, Rev. Bras. Saude Mater. Infant., V5, P53, DOI 10.1590/S1519-38292005000100007; Takahashi H, 2015, BLOOD PRESS MONIT, V20, P286, DOI 10.1097/MBP.0000000000000127; Thibault H, 2013, PUBLIC HEALTH NUTR, V16, P193, DOI 10.1017/S136898001200359X; VI Diretrizes Brasileiras de Hipertensao, 2010, ARQUIVOS BRASILEIROS, V95, pI; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; WHO, 2009, ANTHROPLUS PERS COMP; World Health Organization (WHO), 2007, GROWTH REF 5 19 YEAR; Zhang YX, 2015, INT J CARDIOL, V179, P536, DOI 10.1016/j.ijcard.2014.10.163	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142982	10.1371/journal.pone.0142982	http://dx.doi.org/10.1371/journal.pone.0142982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599324	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900050
J	Homann, J; Suo, J; Schmidt, M; de Bruin, N; Scholich, K; Geisslinger, G; Ferreiros, N				Homann, Julia; Suo, Jing; Schmidt, Mike; de Bruin, Natasja; Scholich, Klaus; Geisslinger, Gerd; Ferreiros, Nerea			In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse	PLOS ONE			English	Article							ASPIRIN-TRIGGERED LIPOXINS; FORMYL PEPTIDE RECEPTORS; DOCOSAHEXAENOIC ACID; STABLE ANALOGS; 15-EPI-LIPOXIN A(4); SKIN INFLAMMATION; LEUKOTRIENE B-4; INDUCED COLITIS; RESOLUTION; ACTIVATION	The activation and infiltration of polymorphonuclear neutrophils (PMN) are critical key steps in inflammation. PMN-mediated inflammation is limited by anti-inflammatory and pro-resolving mechanisms, including specialized pro-resolving lipid mediators (SPM). We examined the effects of 15-epi-LXA(4) on inflammation and the biosynthesis of pro-inflammatory mediators, such as prostaglandins, leukotriene B-4 and various hydroxyeicosatetraenoic acids and SPM, in an oxazolone (OXA)-induced hypersensitivity model for dermal inflammation. 15-epi-LXA(4) (100 mu M, 5 mu L subcutaneously injected) significantly (P < 0.05) reduced inflammation in skin, 24 hours after the OXA challenge, as compared to skin treated with vehicle. No significant influence on the biosynthesis of prostaglandins or leukotriene B-4 was observed, whereas the level of 15S-hydroxy-eicosatetraenoic acid was significantly (P < 0.05) lower in the skin areas treated with 15-epi-LXA(4). In spite of the use of a fully validated analytical procedure, no SPM were detected in the biological samples. To investigate the reason for the lack of analytical signal, we tried to mimic the production of SPM (lipoxins, resolvins, maresin and protectin) by injecting them subcutaneously into the skin of mice and studying the in vivo availability and distribution of the compounds. All analytes showed very little lateral distribution in skin tissue and their levels were markedly decreased (> 95%) 2 hours after injection. However, docosahexaenoic acid derivatives were biologically more stable than SPM derived from arachidonic acid or eicosapentaenoic acid.	[Homann, Julia; Suo, Jing; Scholich, Klaus; Geisslinger, Gerd; Ferreiros, Nerea] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, D-60054 Frankfurt, Germany; [Schmidt, Mike; de Bruin, Natasja; Geisslinger, Gerd] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp TMP, Frankfurt, Germany	Goethe University Frankfurt; Fraunhofer Gesellschaft	Ferreiros, N (corresponding author), Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, D-60054 Frankfurt, Germany.	ferreirosbouzas@em.uni-frankfurt.de	de Bruin, Natasja/D-8063-2014	de Bruin, Natasja/0000-0002-2456-2783	Deutsche Forschungsgemeinschaft (DFG) [SFB 1039/Z01]; Land Hessen, (LOEWE-Zentrum Translationale Medizin und Pharmakologie)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Land Hessen, (LOEWE-Zentrum Translationale Medizin und Pharmakologie)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), SFB 1039/Z01 and Land Hessen, (LOEWE-Zentrum Translationale Medizin und Pharmakologie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Canetti C, 2001, BRIT J PHARMACOL, V134, P1619, DOI 10.1038/sj.bjp.0704403; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003; Christophe T, 2002, SCAND J IMMUNOL, V56, P470, DOI 10.1046/j.1365-3083.2002.01149.x; EKERDT R, 1992, ARCH DERMATOL RES, V284, pS18, DOI 10.1007/BF00638235; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Fiorucci S, 2004, P NATL ACAD SCI USA, V101, P15736, DOI 10.1073/pnas.0404722101; Forsman H, 2011, SCAND J IMMUNOL, V74, P227, DOI 10.1111/j.1365-3083.2011.02570.x; Forsman H, 2009, SCAND J IMMUNOL, V70, P396, DOI 10.1111/j.1365-3083.2009.02311.x; Freire MO, 2013, PERIODONTOL 2000, V63, P149, DOI 10.1111/prd.12034; Gewirtz AT, 2002, J IMMUNOL, V168, P5260, DOI 10.4049/jimmunol.168.10.5260; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gronert K, 2001, AM J PATHOL, V158, P3, DOI 10.1016/S0002-9440(10)63937-5; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Hanson J, 2013, BIOCHEM PHARMACOL, V85, P1795, DOI 10.1016/j.bcp.2013.04.019; Homann J, 2014, J CHROMATOGR A, V1360, P150, DOI 10.1016/j.chroma.2014.07.068; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kishida T, 2012, J TOXICOL SCI, V37, P1143, DOI 10.2131/jts.37.1143; Knorr RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115357; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Maddox JF, 1997, J BIOL CHEM, V272, P6972, DOI 10.1074/jbc.272.11.6972; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; MARKS F, 1981, CANCER RES, V41, P696; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; McMahon B, 2002, FASEB J, V16, P1817, DOI 10.1096/fj.02-0416fje; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; MUFSON RA, 1979, CANCER RES, V39, P4791; Nicolaou A, 2013, PROSTAG LEUKOTR ESS, V88, P131, DOI 10.1016/j.plefa.2012.03.009; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; PALMBLAD J, 1981, BLOOD, V58, P658; Petasis NA, 2005, PROSTAG LEUKOTR ESS, V73, P301, DOI 10.1016/j.plefa.2005.05.020; Schottelius AJ, 2002, J IMMUNOL, V169, P7063, DOI 10.4049/jimmunol.169.12.7063; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; SIMCHOWITZ L, 1994, AM J PHYSIOL-CELL PH, V267, pC1525, DOI 10.1152/ajpcell.1994.267.6.C1525; Sisignano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081228; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Takano T, 1997, J EXP MED, V185, P1693, DOI 10.1084/jem.185.9.1693; Takano T, 1998, J CLIN INVEST, V101, P819, DOI 10.1172/JCI1578; Tkalcevic VI, 2012, INFLAMMATION, V35, P192, DOI 10.1007/s10753-011-9305-9; Tungen JE, 2014, J NAT PROD, V77, P2241, DOI 10.1021/np500498j; US Department of Health and Human Services, 2001, GUID IND BIOAN METH; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202; Vaughn MW, 2002, J IMMUNOL, V169, P3363, DOI 10.4049/jimmunol.169.6.3363; Wang X, 2014, ALZHEIMERS DEMENTIA; Weiss GA, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-89; Yacoubian S, 2007, NAT CLIN PRACT RHEUM, V3, P570, DOI 10.1038/ncprheum0616; Zhang GJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/930124	60	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143141	10.1371/journal.pone.0143141	http://dx.doi.org/10.1371/journal.pone.0143141			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599340	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900070
J	Powell, JSV; Babbitt, KJ				Powell, Jessica S. Veysey; Babbitt, Kimberly J.			Despite Buffers, Experimental Forest Clearcuts Impact Amphibian Body Size and Biomass	PLOS ONE			English	Article							SALAMANDERS AMBYSTOMA-MACULATUM; POOL-BREEDING AMPHIBIANS; SPOTTED SALAMANDERS; WOOD FROG; LARVAL DENSITY; TERRESTRIAL SALAMANDERS; TIMBER MANAGEMENT; RANA-SYLVATICA; LARGE-SCALE; POSTBREEDING EMIGRATION	Forest buffers are a primary tool used to protect wetland-dependent wildlife. Though implemented widely, buffer efficacy is untested for most amphibian species. Consequently, it remains unclear whether buffers are sufficient for maintaining amphibian populations and if so, how wide buffers should be. We present evidence from a six-year, landscape-scale experiment testing the impacts of clearcutting, buffer width, and hydroperiod on body size and condition and biomass of breeding adults for two amphibian species at 11 vernal pools in the northeastern United States. We randomly assigned treatments (i.e., reference, 100m buffer, 30m buffer) across pools, clearcut to create buffers, and captured all spotted salamanders and wood frogs. Clearcuts strongly and negatively impacted size, condition, and biomass, but wider buffers mitigated effect magnitude and duration. Among recaptured individuals, for example, 30m-treatment salamanders were predicted to be about 9.5 mm shorter than, while 100m-treatment salamanders did not differ in length from, reference-treatment salamanders. Similarly, among recaptured frogs, mean length in the 30m treatment was predicted to decrease by about 1 mm/year, while in the 100m and reference treatments, length was time-invariant. Some, but not all, metrics recovered with time. For example, female new-captured and recaptured salamanders were predicted, respectively and on average, to weigh 4.5 and 7 g less in the 30m versus reference treatment right after the cut. While recaptured-female mass was predicted to recover by 9.5 years post-cut, new-captured-female mass did not recover. Hydroperiod was an important mediator: in the 100m treatment, cutting predominately affected pools that were stressed hydrologically. Overall, salamanders and female frogs were impacted more than male frogs. Our results highlight the importance of individualized metrics like body size, which can reveal sublethal effects and illuminate mechanisms by which habitat disturbance impacts wildlife populations. Individualized metrics thus provide critical insights that complement species occurrence and abundance-based population assessments.	[Powell, Jessica S. Veysey; Babbitt, Kimberly J.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Powell, JSV (corresponding author), Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA.	jss4@unh.edu		Veysey Powell, Jessica/0000-0002-6706-9075	National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service [2003-35101-12922, 2007-35101-18281]; Northeastern States Research Cooperative; Robert and Patricia Switzer Foundation; University of New Hampshire Graduate School; University of New Hampshire Cooperative Extension; New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture McIntire-Stennis Project [0226124, 2614]	National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Northeastern States Research Cooperative; Robert and Patricia Switzer Foundation; University of New Hampshire Graduate School; University of New Hampshire Cooperative Extension; New Hampshire Agricultural Experiment Station; USDA National Institute of Food and Agriculture McIntire-Stennis Project	The project was supported by grants to KJB from: the National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service (http://www.csrees.usda.gov/funding/rfas/nri_rfa.html), grant numbers: 2003-35101-12922 and 2007-35101-18281; and the Northeastern States Research Cooperative (http://nsrcforest.org/). The project was also supported by fellowships to JSVP from: the Robert and Patricia Switzer Foundation (http://www.switzernetwork.org/), the University of New Hampshire Graduate School (http://www.gradschool.unh.edu/), and the University of New Hampshire Cooperative Extension (http://extension.unh.edu/). Partial funding was provided by a grant to KJB from the New Hampshire Agricultural Experiment Station (http://www.colsa.unh.edu/aes). This is Scientific Contribution number: 2614. This work was supported by the USDA National Institute of Food and Agriculture McIntire-Stennis Project, accession number: 0226124. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BT, 2010, CLIMATIC CHANGE, V99, P403, DOI 10.1007/s10584-009-9674-3; [Anonymous], 1999, FOREST REGENERATION; Apodaca JJ, 2015, FORESTS, V6, P827, DOI 10.3390/f6030827; Ardia DR, 2005, FUNCT ECOL, V19, P414, DOI 10.1111/j.1365-2435.2005.00997.x; Aubry KB, 2000, J WILDLIFE MANAGE, V64, P1041, DOI 10.2307/3803215; Babbitt KJ, 2003, CAN J ZOOL, V81, P1539, DOI 10.1139/Z03-131; Baber MJ, 2004, OIKOS, V107, P16; Baldwin RF, 2006, CAN J ZOOL, V84, P1604, DOI 10.1139/Z06-146; Baldwin RF, 2006, J HERPETOL, V40, P442, DOI 10.1670/0022-1511(2006)40[442:CPFASW]2.0.CO;2; Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; Bauer DM, 2013, ECOL ECON, V95, P159, DOI 10.1016/j.ecolecon.2013.08.013; Bauer DM, 2010, ECOL APPL, V20, P798, DOI 10.1890/08-2209.1; Beck CW, 2000, FUNCT ECOL, V14, P32, DOI 10.1046/j.1365-2435.2000.00386.x; Beese W. J., 2005, General Technical Report - Pacific Northwest Research Station, USDA Forest Service, P55; Begon M., 1996, ECOLOGY; Bellis E. D., 1962, American Midland Naturalist, V68, P139, DOI 10.2307/2422640; BENNETT AF, 1989, AM J PHYSIOL, V256, pR1200, DOI 10.1152/ajpregu.1989.256.6.R1200; Benton TG, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P41; BERVEN KA, 1981, EVOLUTION, V35, P707, DOI 10.1111/j.1558-5646.1981.tb04931.x; BERVEN KA, 1988, COPEIA, P605, DOI 10.2307/1445378; BERVEN KA, 1990, EVOLUTION, V44, P2047, DOI 10.1111/j.1558-5646.1990.tb04310.x; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; BERVEN KA, 1983, AM ZOOL, V23, P85; Berven KA, 2009, COPEIA, P328, DOI 10.1643/CH-08-052; Blomquist SM, 2007, J HERPETOL, V41, P430, DOI 10.1670/0022-1511(2007)41[430:EARHLE]2.0.CO;2; Bonte D, 2009, J EVOLUTION BIOL, V22, P1242, DOI 10.1111/j.1420-9101.2009.01737.x; Brepson L, 2013, BEHAV ECOL, V24, P488, DOI 10.1093/beheco/ars189; Brodeur JC, 2011, ECOTOX ENVIRON SAFE, V74, P1370, DOI 10.1016/j.ecoenv.2011.04.024; Brodman R, 1996, COPEIA, P372, DOI 10.2307/1446853; Burghelea C, 2013, AMPHIBIA-REPTILIA, V34, P505, DOI 10.1163/15685381-00002908; Chandler CH, 2008, MOL ECOL, V17, P1564, DOI 10.1111/j.1365-294X.2007.03614.x; Chazal AC, 1998, ECOL APPL, V8, P1133, DOI 10.1890/1051-0761(1998)008[1133:ROMSTC]2.0.CO;2; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; Church DR, 2007, ECOLOGY, V88, P891, DOI 10.1890/06-0896; Cole EC, 1997, J WILDLIFE MANAGE, V61, P656, DOI 10.2307/3802173; Cooperman MD, 2004, CAN J ZOOL, V82, P1795, DOI 10.1139/Z04-150; CORN PS, 1989, FOREST ECOL MANAG, V29, P39, DOI 10.1016/0378-1127(89)90055-8; Coster SS, 2015, HERPETOL CONSERV BIO, V10, P64; Coster SS, 2015, MOL ECOL, V24, P742, DOI 10.1111/mec.13062; Crawford JA, 2007, CONSERV BIOL, V21, P152, DOI 10.1111/j.1523-1739.2006.00556.x; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; De Meester L, 2005, AQUAT CONSERV, V15, P715, DOI 10.1002/aqc.748; DeGraaf R.M., 2001, UPNE; Deichmann JL, 2008, J HERPETOL, V42, P238, DOI 10.1670/07-0731.1; Delgado-Acevedo J, 2008, CONSERV BIOL, V22, P773, DOI 10.1111/j.1523-1739.2008.00930.x; Demaynadier PG, 1998, CONSERV BIOL, V12, P340, DOI 10.1046/j.1523-1739.1998.96412.x; deMaynadier PG, 2008, SCI CONSERVATION VER, P392; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; DUCEY PK, 1988, COPEIA, P1008, DOI 10.2307/1445725; Dupuis L, 1999, FOREST ECOL MANAG, V124, P35, DOI 10.1016/S0378-1127(99)00051-1; DuShane GP, 1944, ECOLOGY, V25, P414, DOI 10.2307/1932016; Egan RS, 2004, WETLANDS, V24, P1, DOI 10.1672/0277-5212(2004)024[0001:WPAOBW]2.0.CO;2; Eggert C, 2003, CAN J ZOOL, V81, P46, DOI 10.1139/Z02-224; EMERSON SB, 1978, EVOLUTION, V32, P551, DOI 10.1111/j.1558-5646.1978.tb04598.x; ENGE KM, 1986, FOREST ECOL MANAG, V14, P177, DOI 10.1016/0378-1127(86)90116-7; Faccio SD, 2003, J HERPETOL, V37, P479, DOI 10.1670/155-02A; FAO, 2012, STAT WORLDS FOR 2012; Ferner John W., 2010, P123; Ficetola GF, 2009, CONSERV BIOL, V23, P114, DOI 10.1111/j.1523-1739.2008.01081.x; Freidenfelds NA, 2011, FOREST ECOL MANAG, V261, P2115, DOI 10.1016/j.foreco.2011.03.005; FRETWELL S D, 1972, P217; Friedland A. J., 2004, Journal of Sustainable Forestry, V18, P1, DOI 10.1300/J091v18n01_01; Garner TWJ, 2011, GLOBAL CHANGE BIOL, V17, P667, DOI 10.1111/j.1365-2486.2010.02272.x; GFGS, 2009, GOOD FOR GRAN STAT A; Gibbons JW, 2006, CONSERV BIOL, V20, P1457, DOI 10.1111/j.1523-1739.2006.00443.x; GILL DE, 1985, ECOLOGY, V66, P344, DOI 10.2307/1940384; GOATER CP, 1993, OIKOS, V66, P129, DOI 10.2307/3545205; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Guerry AD, 2002, CONSERV BIOL, V16, P745, DOI 10.1046/j.1523-1739.2002.00557.x; Hannon SJ, 2002, CAN J FOREST RES, V32, P1784, DOI 10.1139/X02-092; Harper CA, 1999, FOREST ECOL MANAG, V114, P245, DOI 10.1016/S0378-1127(98)00355-7; Harper EB, 2008, CONSERV BIOL, V22, P1205, DOI 10.1111/j.1523-1739.2008.01015.x; Harpole DN, 1999, FOREST ECOL MANAG, V114, P349, DOI 10.1016/S0378-1127(98)00365-X; Hart DD, 2010, FRESHWATER BIOL, V55, P258, DOI 10.1111/j.1365-2427.2009.02370.x; Hawkes VC, 2012, FOREST ECOL MANAG, V274, P67, DOI 10.1016/j.foreco.2012.02.015; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; HEATWOLE HAROLD, 1961, AMER MIDLAND NAT, V66, P301, DOI 10.2307/2423030; Holbrook CT, 2004, COPEIA, P932, DOI 10.1643/CE-04-037R1; Homan RN, 2003, ANIM CONSERV, V6, P11, DOI 10.1017/S13679430030032; Homyack JA, 2011, J WILDLIFE MANAGE, V75, P1267, DOI 10.1002/jwmg.175; Homyack JA, 2010, WILDLIFE RES, V37, P332, DOI 10.1071/WR08093; HOWARD RD, 1985, EVOLUTION, V39, P260, DOI 10.1111/j.1558-5646.1985.tb05665.x; Humfeld SC, 2013, BEHAV ECOL, V24, P859, DOI 10.1093/beheco/art024; Irland L.C, 1999, NE CHANGING FOREST; Janin A, 2011, BIOL CONSERV, V144, P1008, DOI 10.1016/j.biocon.2010.12.009; JOHNALDER HB, 1990, COPEIA, P856, DOI 10.2307/1446453; Johnston B, 2002, CAN J ZOOL, V80, P2170, DOI 10.1139/Z02-213; Johst K, 1997, OIKOS, V78, P612, DOI 10.2307/3545624; KAPLAN RH, 1979, AM NAT, V113, P671, DOI 10.1086/283425; Karraker NE, 2006, BIOL CONSERV, V131, P132, DOI 10.1016/j.biocon.2006.02.013; Klenner W, 2009, FOREST ECOL MANAG, V258, pS1, DOI 10.1016/j.foreco.2009.10.037; Knox CB, 1999, MAINE AMPHIBIANS REP, P111; Komoroski MJ, 1998, PHYSIOL ZOOL, V71, P633, DOI 10.1086/515989; Lee P, 2004, J ENVIRON MANAGE, V70, P165, DOI 10.1016/j.jenvman.2003.11.009; Lemckert FL, 2011, FOREST ECOL MANAG, V262, P1199, DOI 10.1016/j.foreco.2011.06.014; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; MacCracken JG, 2012, J HERPETOL, V46, P346, DOI 10.1670/10-292; Madison DM, 1998, COPEIA, P402; Madison DM, 1997, J HERPETOL, V31, P542, DOI 10.2307/1565607; MARSHALL WH, 1955, ECOLOGY, V36, P381, DOI 10.2307/1929572; Mazerolle MJ, 2001, J HERPETOL, V35, P13, DOI 10.2307/1566017; McMurry ST, 2009, J HERPETOL, V43, P421, DOI 10.1670/07-126R2.1; MEDIFW, 2005, MAIN COMPR WILDL CON; Morris KM, 2007, J WILDLIFE MANAGE, V71, P1034, DOI 10.2193/2005-469; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Neckel-Oliveira S, 2006, BIOL CONSERV, V128, P308, DOI 10.1016/j.biocon.2005.09.037; NEWMAN RA, 1994, COPEIA, P372; Olson DH, 2007, FOREST SCI, V53, P331; Patrick DA, 2008, ECOLOGY, V89, P2563, DOI 10.1890/07-0906.1; Patrick DA, 2006, FOREST ECOL MANAG, V234, P323, DOI 10.1016/j.foreco.2006.07.015; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Perkins DW, 2006, J WILDLIFE MANAGE, V70, P657, DOI 10.2193/0022-541X(2006)70[657:EORTMO]2.0.CO;2; Peterson CE, 2002, PNWGTR564 US DEP AGR; Peterson CE, 2009, FOREST ECOL MANAG, V258, P409, DOI 10.1016/j.foreco.2008.12.029; Petranka JW, 2004, ECOL APPL, V14, P1065, DOI 10.1890/02-5394; Petranka JW, 1998, HERPETOLOGICA, V54, P1; Petranka JW, 1999, OECOLOGIA, V120, P621, DOI 10.1007/s004420050898; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pollett KL, 2010, FOREST ECOL MANAG, V260, P1083, DOI 10.1016/j.foreco.2010.06.035; Ponsero A, 1998, ARCH HYDROBIOL, V142, P343; Popescu VD, 2011, ECOL APPL, V21, P1283, DOI 10.1890/10-0658.1; POUGH FH, 1980, AM NAT, V115, P92, DOI 10.1086/283547; Powell JSV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133642; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; READING CJ, 1995, OECOLOGIA, V102, P453, DOI 10.1007/BF00341357; Regester KJ, 2006, OECOLOGIA, V147, P303, DOI 10.1007/s00442-005-0266-2; Regester KJ, 2006, COPEIA, P640, DOI 10.1643/0045-8511(2006)6[640:DROSAM]2.0.CO;2; Regosin JV, 2004, COPEIA, P152, DOI 10.1643/CE-02-119R2; Regosin JV, 2003, CAN J ZOOL, V81, P596, DOI 10.1139/Z03-046; Reniers J, 2015, OECOLOGIA, V178, P931, DOI 10.1007/s00442-015-3258-x; Renken RB, 2004, CONSERV BIOL, V18, P174, DOI 10.1111/j.1523-1739.2004.00312.x; Rittenhouse TAG, 2009, ECOLOGY, V90, P1620, DOI 10.1890/08-0326.1; Rittenhouse TAG, 2008, COPEIA, P807, DOI 10.1643/CH-07-176; Rodenhouse NL, 2009, CAN J FOREST RES, V39, P249, DOI 10.1139/X08-160; Rothermel BB, 2006, CAN J ZOOL, V84, P797, DOI 10.1139/Z06-056; Rothermel BB, 2005, J HERPETOL, V39, P619, DOI 10.1670/251-04A.1; ROWE CL, 1995, OECOLOGIA, V102, P397, DOI 10.1007/BF00341351; Russell KR, 2002, J WILDLIFE MANAGE, V66, P603, DOI 10.2307/3803127; Schauble CS, 2004, BIOL J LINN SOC, V82, P39, DOI 10.1111/j.1095-8312.2004.00315.x; Schriever TA, 2014, AQUAT SCI, V76, P131, DOI 10.1007/s00027-013-0320-9; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Scott D.E., 1995, AMBYSTOMA OPACUM HER, V51, P462; Scott DE, 2007, OECOLOGIA, V153, P521, DOI 10.1007/s00442-007-0755-6; SCOTT DE, 1990, ECOLOGY, V71, P296, DOI 10.2307/1940269; SCOTT DE, 1994, ECOLOGY, V75, P1383, DOI 10.2307/1937462; SEMLITSCH RD, 1987, ECOLOGY, V68, P994, DOI 10.2307/1938370; SEMLITSCH RD, 1985, OECOLOGIA, V65, P305, DOI 10.1007/BF00378903; SEMLITSCH RD, 1987, COPEIA, P61, DOI 10.2307/1446038; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Seymour RS, 2006, ALLG FORST JAGDZTG, V177, P104; SHOOP CR, 1965, SCIENCE, V149, P558, DOI 10.1126/science.149.3683.558; SHOOP CR, 1974, ECOLOGY, V55, P440, DOI 10.2307/1935233; Sieg AE, 2010, THESIS; Skelly DK, 1999, ECOLOGY, V80, P2326, DOI 10.1890/0012-9658(1999)080[2326:LTDDOA]2.0.CO;2; Smith MA, 2005, ECOGRAPHY, V28, P110; Smyers SD, 2002, HERPETOLOGICA, V58, P422, DOI 10.1655/0018-0831(2002)058[0422:IAICOB]2.0.CO;2; Snodgrass JW, 2000, ECOL APPL, V10, P1219, DOI 10.1890/1051-0761(2000)010[1219:DOEOLA]2.0.CO;2; SPOTILA JR, 1972, ECOL MONOGR, V42, P95, DOI 10.2307/1942232; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Taylor BE, 2006, CONSERV BIOL, V20, P792, DOI 10.1111/j.1523-1739.2005.00321.x; Taylor BE, 1997, HERPETOLOGICA, V53, P132; Tilghman JM, 2012, BIOL CONSERV, V152, P1, DOI 10.1016/j.biocon.2012.03.030; Todd BD, 2006, BIOL CONSERV, V133, P178, DOI 10.1016/j.biocon.2006.06.003; Turtle SL, 2000, J HERPETOL, V34, P60, DOI 10.2307/1565239; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Vesely DG, 2002, FOREST SCI, V48, P291; Veysey JS, 2011, LANDSCAPE ECOL, V26, P661, DOI 10.1007/s10980-011-9590-6; Veysey JS, 2009, BIOL CONSERV, V142, P2227, DOI 10.1016/j.biocon.2009.04.024; WALLS SC, 1990, ECOLOGY, V71, P307, DOI 10.2307/1940270; Watson RT, 2004, BEHAV PROCESS, V65, P201, DOI 10.1016/j.beproc.2003.09.007; Welsh HH, 2008, BIOL CONSERV, V141, P1149, DOI 10.1016/j.biocon.2008.02.014; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; WHITFORD WG, 1973, AM ZOOL, V13, P505; WHITFORD WG, 1967, PHYSIOL ZOOL, V40, P127, DOI 10.1086/physzool.40.2.30152447; Willson John D., 2010, P229; Windmiller B. S., 1996, THESIS; WOODWARD BD, 1982, COPEIA, P157, DOI 10.2307/1444279; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x	179	4	4	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143505	10.1371/journal.pone.0143505	http://dx.doi.org/10.1371/journal.pone.0143505			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600386	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900134
J	Heinicke, U; Kupka, J; Fichter, I; Fulda, S				Heinicke, U.; Kupka, J.; Fichter, I.; Fulda, S.			Critical role of mitochondria-mediated apoptosis for JNJ-26481585-induced antitumor activity in rhabdomyosarcoma	ONCOGENE			English	Article							HISTONE DEACETYLASE INHIBITOR; QUISINOSTAT JNJ-26481585; CANCER; VORINOSTAT; LYMPHOMA; CHILDREN; CELLS; CHEMOTHERAPY; FREQUENCY; CASPASE-8	JNJ-26481585 is a second-generation histone deacetylase inhibitor with broad-range efficacy and improved pharmacodynamic properties. In the present study, we investigated the therapeutic potential of JNJ-26481585 and its molecular mechanisms of action in rhabdomyosarcoma (RMS). Here, we report that JNJ-26481585's anticancer activity critically depends on an intact mitochondrial pathway of apoptosis. JNJ-26481585 induces apoptosis and also inhibits long-term clonogenic survival of several RMS cell lines at nanomolar concentrations that cause histone acetylation. Importantly, JNJ-26481585 significantly suppresses tumor growth in vivo in two preclinical RMS models, that is, the chorioallantoic membrane model and a xenograft mouse model. Mechanistically, we identify activation of the mitochondrial pathway of apoptosis as a key event that is critically required for JNJ-26481585-mediated cell death. JNJ-26481585 upregulates expression levels of several BH3-only proteins including Bim, Puma and Noxa, which all contribute to JNJ-26481585-mediated apoptosis, as knockdown of Bim, Puma or Noxa significantly inhibits cell death. This shift toward proapoptotic Bcl-2 proteins promotes activation of Bax and Bak as a critical event, as genetic silencing of Bax or Bak protects against JNJ-26481585-induced apoptosis. Intriguingly, rescue experiments reveal that JNJ-26481585 triggers Bax/Bak activation independently of caspase activation and activates caspase-9 as the initiator caspase in the cascade, as Bcl-2 overexpression, but not the broad-range caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (zVAD.fmk) blocks JNJ-26481585-induced Bax/Bak activation and caspase-9 cleavage. In conclusion, JNJ-26481585 exerts potent antitumor activity against RMS in vitro and in vivo by engaging mitochondrial apoptosis before caspase activation and represents a promising therapeutic for further investigation in RMS.	[Heinicke, U.; Kupka, J.; Fulda, S.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3a, D-60528 Frankfurt, Hesse, Germany; [Fichter, I.] Expt Pharmacol & Oncol GmbH, Berlin, Germany; [Fulda, S.] German Canc Consortium DKTK, Heidelberg, Germany; [Fulda, S.] German Canc Res Ctr, Heidelberg, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3a, D-60528 Frankfurt, Hesse, Germany.	simone.fulda@kgu.de		Fulda, Simone/0000-0002-0459-6417	BMBF; Deutsche Kinderkrebsstiftung	BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Kinderkrebsstiftung	We thank C. Hugenberg for expert secretarial assistance. This work has been partially supported by grants from the BMBF and the Deutsche Kinderkrebsstiftung (to SF).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Arts J, 2009, CLIN CANCER RES, V15, P6841, DOI 10.1158/1078-0432.CCR-09-0547; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Carol H, 2014, PEDIATR BLOOD CANCER, V61, P245, DOI 10.1002/pbc.24724; Chen X, 2013, CANCER CELL, V24, P710, DOI 10.1016/j.ccr.2013.11.002; Dagher R, 1999, Oncologist, V4, P34; Dantonello TM, 2009, J CLIN ONCOL, V27, P1446, DOI 10.1200/JCO.2007.15.0466; Deleu S, 2009, LEUKEMIA, V23, P1894, DOI 10.1038/leu.2009.121; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; FELIX CA, 1992, CANCER RES, V52, P2243; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 1997, CANCER RES, V57, P3823; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Graab U, 2015, ONCOTARGET, V6, P8722, DOI 10.18632/oncotarget.2726; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Happo L, 2012, J CELL SCI, V125, P1081, DOI 10.1242/jcs.090514; Hayes-Jordan A, 2009, CURR OPIN PEDIATR, V21, P373, DOI 10.1097/MOP.0b013e32832b4171; Heinicke U, 2014, CANCER LETT, V351, P50, DOI 10.1016/j.canlet.2014.04.021; Inoue S, 2007, LEUKEMIA, V21, P1773, DOI 10.1038/sj.leu.2404760; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Matthews GM, 2012, ADV CANCER RES, V116, P165, DOI 10.1016/B978-0-12-394387-3.00005-7; MILLER RW, 1995, CANCER, V75, P395, DOI 10.1002/1097-0142(19950101)75:1+<395::AID-CNCR2820751321>3.0.CO;2-W; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Stuhmer T, 2010, BRIT J HAEMATOL, V149, P529, DOI 10.1111/j.1365-2141.2010.08126.x; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Taylor AC, 2000, MED PEDIATR ONCOL, V35, P96, DOI 10.1002/1096-911X(200008)35:2<96::AID-MPO2>3.0.CO;2-Z; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Venugopal B, 2013, CLIN CANCER RES, V19, P4262, DOI 10.1158/1078-0432.CCR-13-0312; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Wiegmans AP, 2011, CANCER RES, V71, P3603, DOI 10.1158/0008-5472.CAN-10-3289; Witt O, 2012, KLIN PADIATR, V224, P398, DOI 10.1055/s-0032-1323692; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Xargay-Torrent S, 2011, CLIN CANCER RES, V17, P3956, DOI 10.1158/1078-0432.CCR-10-3412	35	26	26	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 14	2016	35	28					3729	3741		10.1038/onc.2015.440	http://dx.doi.org/10.1038/onc.2015.440			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UQ	26616861				2022-12-26	WOS:000379622800011
J	Seebacher, NA; Lane, DJR; Jansson, PJ; Richardson, DR				Seebacher, Nicole A.; Lane, Darius J. R.; Jansson, Patric J.; Richardson, Des R.			Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug delivery; drug resistance; drug transport; endocytosis; glucose; lysosome; glucose-induced stress	CLATHRIN-MEDIATED ENDOCYTOSIS; MULTIDRUG-RESISTANCE; IRON CHELATORS; ANTITUMOR-ACTIVITY; REGULATED GENE-1; MEMBRANE PERMEABILIZATION; METASTASIS SUPPRESSOR; HIPPOCAMPAL-NEURONS; LANTHANUM COMPOUND; ENDOTHELIAL-CELLS	Pgp is functional on the plasma membrane and lysosomal membrane. Lysosomal-Pgp can pump substrates into the organelle, thereby trapping certain chemotherapeutics (e.g. doxorubicin; DOX). This mechanism serves as a safe house to protect cells against cytotoxic drugs. Interestingly, in contrast to DOX, lysosomal sequestration of the novel anti-tumor agent and P-glycoprotein (Pgp) substrate, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), induces lysosomal membrane permeabilization. This mechanism of lysosomal-Pgp utilization enhances cytotoxicity to multidrug-resistant cells. Consequently, Dp44mT has greater anti-tumor activity in drug-resistant relative to non-Pgp-expressing tumors. Interestingly, stressors in the tumor microenvironment trigger endocytosis for cell signaling to assist cell survival. Hence, this investigation examined how glucose variation-induced stress regulated early endosome and lysosome formation via endocytosis of the plasma membrane. Furthermore, the impact of glucose variation-induced stress on resistance to DOX was compared with Dp44mT and its structurally related analogue, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC). These studies showed that glucose variation-induced stress-stimulated formation of early endosomes and lysosomes. In fact, through the process of fluid-phase endocytosis, Pgp was redistributed from the plasma membrane to the lysosomal membrane via early endosome formation. This lysosomal-Pgp actively transported the Pgp substrate, DOX, into the lysosome where it became trapped as a result of protonation at pH 5. Due to increased lysosomal DOX trapping, Pgp-expressing cells became more resistant to DOX. In contrast, cytotoxicity of Dp44mT and DpC was potentiated due to more lysosomes containing functional Pgp under glucose-induced stress. These thiosemicarbazones increased lysosomal membrane permeabilization and cell death. This mechanism has critical implications for drug-targeting in multidrug-resistant tumors where a stressful micro-environment exists.	[Seebacher, Nicole A.; Lane, Darius J. R.; Jansson, Patric J.; Richardson, Des R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Blackburn Bldg D06, Sydney, NSW 2006, Australia	University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Blackburn Bldg D06, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Jansson, Patric/AAC-4221-2022	Jansson, Patric/0000-0002-9322-653X; Richardson, Des/0000-0003-0960-6415; Lane, Darius/0000-0001-8725-6903; Richardson, Des/0000-0002-5506-3274; Seebacher, Nicole/0000-0002-8616-8407	Tomorrow Fund Award from AMP Foundation; Sydney Medical School Foundation; Cancer Institute New South Wales Early Career Research Fellowship; Senior Principal Research Fellowship; National Health and Medical Research Council of Australia (NHMRC); National Breast Cancer Foundation [PS-16-030] Funding Source: researchfish	Tomorrow Fund Award from AMP Foundation; Sydney Medical School Foundation; Cancer Institute New South Wales Early Career Research Fellowship; Senior Principal Research Fellowship; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	Supported by a Tomorrow Fund Award from the AMP Foundation and the Sydney Medical School Foundation for Fellowship support.; Supported by a Cancer Institute New South Wales Early Career Research Fellowship. To whom correspondence may be addressed. Tel.: 61-2-9351-6150; Fax: 61-2-9351-3429; E-mail: patric.jansson@sydney.edu.au.; Supported by a Senior Principal Research Fellowship and Project Grant funding from the National Health and Medical Research Council of Australia (NHMRC). To whom correspondence may be addressed. Tel.: 61-2-9036-6548; Fax: 61-2-9351-3429; E-mail: d.richardson@med.usyd.edu.au.	Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; Annibaldi A, 2010, CURR OPIN CLIN NUTR, V13, P466, DOI 10.1097/MCO.0b013e32833a5577; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; CANONICO PG, 1969, J CELL BIOL, V43, P367, DOI 10.1083/jcb.43.2.367; Chaplain MAJ, 1996, MATH COMPUT MODEL, V23, P47, DOI 10.1016/0895-7177(96)00019-2; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; FISZERSZAFARZ B, 1977, CANCER RES, V37, P354; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; HAWKINS HK, 1972, AM J PATHOL, V68, P255; Heffeter P, 2007, BIOCHEM PHARMACOL, V73, P1873, DOI 10.1016/j.bcp.2007.03.002; Heffeter P, 2006, BIOCHEM PHARMACOL, V71, P426, DOI 10.1016/j.bcp.2005.11.009; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hua CT, 1998, CLIN CHEM, V44, P2094; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Hwang JJ, 2008, J NEUROSCI, V28, P3114, DOI 10.1523/JNEUROSCI.0199-08.2008; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; JAFFREZOU JP, 1992, CANCER RES, V52, P6440; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jansson PJ, 2015, J BIOL CHEM, V290, P9588, DOI 10.1074/jbc.M114.631283; Jansson PJ, 2010, J INORG BIOCHEM, V104, P1224, DOI 10.1016/j.jinorgbio.2010.07.012; Jansson PJ, 2010, J MED CHEM, V53, P5759, DOI 10.1021/jm100561b; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; KARTNER N, 1989, SCI AM, V260, P44, DOI 10.1038/scientificamerican0389-44; Kawabata M, 1997, Rinsho Byori, V45, P891; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kwon Y, 1996, J PHARM SCI, V85, P935, DOI 10.1021/js9600540; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Ludwig JA, 2006, CANCER RES, V66, P4808, DOI 10.1158/0008-5472.CAN-05-3322; Marambio P, 2010, BBA-MOL BASIS DIS, V1802, P509, DOI 10.1016/j.bbadis.2010.02.002; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; Milane L, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-3; MORALES C, 1986, BIOL REPROD, V34, P207, DOI 10.1095/biolreprod34.1.207; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Neuzil J, 1999, FEBS LETT, V445, P295, DOI 10.1016/S0014-5793(99)00141-6; Niwa K, 2006, FREE RADICAL RES, V40, P167, DOI 10.1080/10715760500474287; OLLINGER K, 1995, FREE RADICAL BIO MED, V19, P565, DOI 10.1016/0891-5849(95)00062-3; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Petriz J, 1997, LEUKEMIA, V11, P1124, DOI 10.1038/sj.leu.2400659; Ramirez-Peinado S, 2013, J BIOL CHEM, V288, P30387, DOI 10.1074/jbc.M113.490581; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; RICHARDSON D, 1992, J BIOL CHEM, V267, P13972; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Seebacher NA, 2015, BRIT J PHARMACOL, V172, P2557, DOI 10.1111/bph.13079; Sharom F. J., 2006, DRUG TRANSPORTERS, P223, DOI [10.1002/9780470140505, DOI 10.1002/9780470140505.CH10]; SHEN DW, 1986, J BIOL CHEM, V261, P7762; Shurety W, 1998, MOL BIOL CELL, V9, P957, DOI 10.1091/mbc.9.4.957; Smit JW, 1998, BRIT J PHARMACOL, V123, P361, DOI 10.1038/sj.bjp.0701606; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; SOROKIN LM, 1987, J CELL PHYSIOL, V131, P342, DOI 10.1002/jcp.1041310306; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; SUNDQVIST T, 1993, ACTA PHYSIOL SCAND, V149, P127, DOI 10.1111/j.1748-1716.1993.tb09604.x; THILO L, 1995, J CELL SCI, V108, P1791; TWENTYMAN PR, 1994, EUR J CANCER, V30A, P1360, DOI 10.1016/0959-8049(94)90187-2; Vega VL, 2010, CELL STRESS CHAPERON, V15, P517, DOI 10.1007/s12192-009-0165-2; Wang JB, 2014, ONCOTARGET, V5, P8478, DOI 10.18632/oncotarget.2328; Wartenberg M, 2003, FASEB J, V17, P503, DOI 10.1096/fj.02-0358fje; Wek RC, 2010, EMBO J, V29, P1946, DOI 10.1038/emboj.2010.110; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Xie J, 2013, ONCOL LETT, V6, P232, DOI 10.3892/ol.2013.1321; Yamagishi Tetsuo, 2013, J Biol Chem, V288, P31761, DOI 10.1074/jbc.M113.514091; Zhong DS, 2008, CANCER RES, V68, P7270, DOI 10.1158/0008-5472.CAN-08-1484	81	45	44	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3796	3820		10.1074/jbc.M115.682450	http://dx.doi.org/10.1074/jbc.M115.682450			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26601947	Green Published, hybrid			2022-12-26	WOS:000371338400011
J	Ando, R; Shima, H; Tamahara, T; Sato, Y; Watanabe-Matsui, M; Kato, H; Sax, N; Motohashi, H; Taguchi, K; Yamamoto, M; Nio, M; Maeda, T; Ochiai, K; Muto, A; Igarashi, K				Ando, Ryo; Shima, Hiroki; Tamahara, Toru; Sato, Yoshihiro; Watanabe-Matsui, Miki; Kato, Hiroki; Sax, Nicolas; Motohashi, Hozumi; Taguchi, Keiko; Yamamoto, Masayuki; Nio, Masaki; Maeda, Tatsuya; Ochiai, Kyoko; Muto, Akihiko; Igarashi, Kazuhiko			The Transcription Factor Bach2 Is Phosphorylated at Multiple Sites in Murine B Cells but a Single Site Prevents Its Nuclear Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; GENOME-WIDE ASSOCIATION; GENE REGULATORY NETWORK; ANTIBODY CLASS SWITCH; REPRESSOR BACH2; SUSCEPTIBILITY LOCI; HEME OXYGENASE-1; T-CELLS; FACTOR BLIMP-1; RISK LOCI	The transcription factor Bach2 regulates the immune system at multiple points, including class switch recombination (CSR) in activated B cells and the function of T cells in part by restricting their terminal differentiation. However, the regulation of Bach2 expression and its activity in the immune cells are still unclear. Here, we demonstrated that Bach2 mRNA expression decreased in Pten-deficient primary B cells. Bach2 was phosphorylated in primary B cells, which was increased upon the activation of the B cell receptor by an anti-immunoglobulin M (IgM) antibody or CD40 ligand. Using specific inhibitors of kinases, the phosphorylation of Bach2 in activated B cells was shown to depend on the phosphatidylinositol 3-kinase (PI3K)Akt-mammalian target of rapamycin (mTOR) pathway. The complex of mTOR and Raptor phosphorylated Bach2 in vitro. We identified multiple new phosphorylation sites of Bach2 by mass spectrometry analysis of epitope-tagged Bach2 expressed in the mature B cell line BAL17. Among the sites identified, serine 535 (Ser-535) was critical for the regulation of Bach2 because a single mutation of Ser-535 abolished cytoplasmic accumulation of Bach2, promoting its nuclear accumulation in pre-B cells, whereas Ser-509 played an auxiliary role. Bach2 repressor activity was enhanced by the Ser-535 mutation in B cells. These results suggest that the PI3K-Akt-mTOR pathway inhibits Bach2 by both repressing its expression and inducing its phosphorylation in B cells.	[Ando, Ryo; Shima, Hiroki; Tamahara, Toru; Sato, Yoshihiro; Watanabe-Matsui, Miki; Kato, Hiroki; Sax, Nicolas; Ochiai, Kyoko; Muto, Akihiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Ando, Ryo; Nio, Masaki] Tohoku Univ, Grad Sch Med, Dept Pediat Surg, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Taguchi, Keiko; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Motohashi, Hozumi] Tohoku Univ, Dept Gene Express Regulat, Inst Dev Aging & Canc, Seiryo Machi 4-1, Sendai, Miyagi 9808575, Japan; [Ochiai, Kyoko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Tamahara, Toru] Tohoku Univ, Grad Sch Dent, Dept Prevent Dent, Seiryo Machi 4-1, Sendai, Miyagi 9808575, Japan; [Shima, Hiroki; Tamahara, Toru; Sax, Nicolas; Ochiai, Kyoko; Muto, Akihiko; Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan; [Maeda, Tatsuya] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Membrane Proteins, 1-1-1 Yayoi, Tokyo 1130032, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); University of Tokyo	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.	igarashi@med.tohoku.ac.jp	Motohashi, Hozumi/AAZ-2628-2020; Maeda, Tatsuya/L-5540-2019; Yamamoto, Masayuki/A-4873-2010; Nio, Masaki/AAF-4406-2019	Yamamoto, Masayuki/0000-0002-9073-9436; Igarashi, Kazuhiko/0000-0002-2470-2475; Taguchi, Keiko/0000-0002-5798-0076; Sato, Yoshihiro/0000-0003-3722-6815	Japan Society for the Promotion of Science [15H02506, 25670156, 24390066, 23116003, 21249014, 17054028, 25291042]; Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science; Grants-in-Aid for Scientific Research [15H04692, 16J40189] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 15H02506, 25670156, 24390066, 23116003, 21249014, 17054028, and 25291042 from the Japan Society for the Promotion of Science and the Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science. The authors declare that they have no conflicts of interest with the contents of this article.	Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Baretic D, 2014, SEMIN CELL DEV BIOL, V36, P91, DOI 10.1016/j.semcdb.2014.09.024; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoshino H, 2000, J BIOL CHEM, V275, P15370, DOI 10.1074/jbc.275.20.15370; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Igarashi K, 2014, IMMUNOL REV, V261, P116, DOI 10.1111/imr.12201; Itoh-Nakadai A, 2014, NAT IMMUNOL, V15, P1171, DOI 10.1038/ni.3024; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Kim EH, 2014, J IMMUNOL, V192, P985, DOI 10.4049/jimmunol.1302378; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lawrence Ann-Marie, 2009, J Vis Exp, DOI 10.3791/1350; Li HYS, 2014, IMMUNOL REV, V261, P84, DOI 10.1111/imr.12198; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; McAllister K, 2013, ARTHRITIS RHEUM-US, V65, P3058, DOI 10.1002/art.38183; Medici M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004123; Mizuno T, 2005, J IMMUNOL, V174, P3369, DOI 10.4049/jimmunol.174.6.3369; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 2002, J BIOL CHEM, V277, P20724, DOI 10.1074/jbc.M112003200; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028; Nishi H, 2015, J MOL BIOL, V427, P511, DOI 10.1016/j.jmb.2014.11.001; Ochiai K, 2008, INT IMMUNOL, V20, P453, DOI 10.1093/intimm/dxn005; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Swaminathan S, 2013, NAT MED, V19, P1014, DOI 10.1038/nm.3247; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsukumo S, 2013, P NATL ACAD SCI USA, V110, P10735, DOI 10.1073/pnas.1306691110; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Watanabe-Matsui M, 2015, ARCH BIOCHEM BIOPHYS, V565, P25, DOI 10.1016/j.abb.2014.11.005; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; Yamasaki C, 2005, J BIOCHEM, V137, P287, DOI 10.1093/jb/mvi031; Yoshida C, 2007, BLOOD, V109, P1211, DOI 10.1182/blood-2005-12-040972; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	55	22	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1826	1840		10.1074/jbc.M115.661702	http://dx.doi.org/10.1074/jbc.M115.661702			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26620562	hybrid, Green Published			2022-12-26	WOS:000368620700023
J	Isasa, M; Suner, C; Diaz, M; Puig-Sarries, P; Zuin, A; Bichman, A; Gygi, SP; Rebollo, E; Crosas, B				Isasa, Marta; Suner, Clara; Diaz, Miguel; Puig-Sarries, Pilar; Zuin, Alice; Bichman, Anne; Gygi, Steven P.; Rebollo, Elena; Crosas, Bernat			Cold Temperature Induces the Reprogramming of Proteolytic Pathways in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIUBIQUITIN-CHAIN-BINDING; SACCHAROMYCES-CEREVISIAE; UBIQUITIN-LIGASE; MASS-SPECTROMETRY; PROTEIN-TURNOVER; 26S PROTEASOME; MEMBRANE-PROTEINS; DEGRADATION; ENDOCYTOSIS; PROTEOMICS	Despite much evidence of the involvement of the proteasome-ubiquitin signaling system in temperature stress response, the dynamics of the ubiquitylome during cold response has not yet been studied. Here, we have compared quantitative ubiquitylomes from a strain deficient in proteasome substrate recruitment and a reference strain during cold response. We have observed that a large group of proteins showing increased ubiquitylation in the proteasome mutant at low temperature is comprised by reverses suppressor of Ty-phenotype 5 (Rsp5)-regulated plasma membrane proteins. Analysis of internalization and degradation of plasma membrane proteins at low temperature showed that the proteasome becomes determinant for this process, whereas, at 30 degrees C, the proteasome is dispensable. Moreover, our observations indicate that proteasomes have increased capacity to interact with lysine 63-polyubiquitylated proteins during low temperature in vivo. These unanticipated observations indicate that, during cold response, there is a proteolytic cellular reprogramming in which the proteasome acquires a role in the endocytic-vacuolar pathway.	[Isasa, Marta; Suner, Clara; Diaz, Miguel; Puig-Sarries, Pilar; Zuin, Alice; Bichman, Anne; Rebollo, Elena; Crosas, Bernat] Consejo Super lnvest Cient, Inst Biol Mol Barcelona, Barcelona Sci Pk,Baldiri & Reixac 15-21, Barcelona 08028, Spain; [Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Harvard University; Harvard Medical School	Crosas, B (corresponding author), Consejo Super lnvest Cient, Inst Biol Mol Barcelona, Barcelona Sci Pk,Baldiri & Reixac 15-21, Barcelona 08028, Spain.	bernat.crosas@ibmb.csic.es		Suner Navarro, Clara/0000-0003-2581-8864; Rebollo, Elena/0000-0001-8899-0317	Spanish Government (Ministry of Economy and Competitiveness) [BFU2009-06985, BFU2012-35716]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009SGR-1482, FI-DGR 2013]; European Molecular Biology Organization [ASTF 363.00-2010]	Spanish Government (Ministry of Economy and Competitiveness); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by Spanish Government (Ministry of Economy and Competitiveness) Grants BFU2009-06985 and BFU2012-35716, Agencia de Gestio d'Ajuts Universitaris i de Recerca Grants 2009SGR-1482 and FI-DGR 2013, and European Molecular Biology Organization Fellowship ASTF 363.00-2010. The authors declare no conflict of interest.	Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Arendt CS, 1999, EMBO J, V18, P3575, DOI 10.1093/emboj/18.13.3575; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Brachmann CB, 1998, YEAST, V14, P115; Butler PL, 2010, J BIOL CHEM, V285, P6246, DOI 10.1074/jbc.M109.017350; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Lambertson D, 1999, GENETICS, V153, P69; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Paraskevopoulos K, 2014, MOL CELL, V56, P453, DOI 10.1016/j.molcel.2014.09.008; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Tai SL, 2007, MOL BIOL CELL, V18, P5100, DOI 10.1091/mbc.E07-02-0131; Thibault G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013193; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Walther D, 2010, OMICS, V14, P261, DOI 10.1089/omi.2010.0010; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	45	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1664	1675		10.1074/jbc.M115.698662	http://dx.doi.org/10.1074/jbc.M115.698662			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601941	hybrid, Green Published			2022-12-26	WOS:000368620700011
J	Carlsson, JA; Wold, AE; Sandberg, AS; Ostman, SM				Carlsson, Johan A.; Wold, Agnes E.; Sandberg, Ann-Sofie; Ostman, Sofia M.			The Polyunsaturated Fatty Acids Arachidonic Acid and Docosahexaenoic Acid Induce Mouse Dendritic Cells Maturation but Reduce T-Cell Responses In Vitro	PLOS ONE			English	Article							CD83 EXPRESSION; B-CELLS; IMMUNE-RESPONSES; MURINE CD83; ACTIVATION; N-3; RECEPTOR; LIGAND; CTLA-4; PD-1	Long-chain polyunsaturated fatty acids (PUFAs) might regulate T-cell activation and lineage commitment. Here, we measured the effects of omega-3 (n-3), n-6 and n-9 fatty acids on the interaction between dendritic cells (DCs) and naive T cells. Spleen DCs from BALB/c mice were cultured in vitro with ovalbumin (OVA) with 50 mu M fatty acids; alpha-linolenic acid, arachidonic acid (AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid or oleic acid and thereafter OVA-specific DO11.10 T cells were added to the cultures. Fatty acids were taken up by the DCs, as shown by gas chromatography analysis. After culture with arachidonic acid or DHA CD11c(+) CD11b(+) and CD11c(+) CD11b(neg) DCs expressed more CD40, CD80, CD83, CD86 and PDL-1, while IA(d) remained unchanged. However, fewer T cells co-cultured with these DCs proliferated (CellTrace Violet(low)) and expressed CD69 or CD25, while more were necrotic (7AAD(+)). We noted an increased proportion of T cells with a regulatory T cell (Treg) phenotype, i.e., when gating on CD4(+) FoxP3(+) CTLA-4(+), CD4(+) FoxP3(+) Helios(+) or CD4(+) FoxP3(+) PD-1(+), in co-cultures with arachidonic acid-or DHA-primed DCs relative to control cultures. The proportion of putative Tregs was inversely correlated to T-cell proliferation, indicating a suppressive function of these cells. With arachidonic acid DCs produced higher levels of prostaglandin E-2 while T cells produced lower amounts of IL-10 and IFN gamma. In conclusion arachidonic acid and DHA induced up-regulation of activation markers on DCs. However arachidonic acid-and DHA-primed DCs reduced T-cell proliferation and increased the proportion of T cells expressing FoxP3, indicating that these fatty acids can promote induction of regulatory T cells.	[Carlsson, Johan A.; Wold, Agnes E.; Ostman, Sofia M.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Sandberg, Ann-Sofie] Chalmers, Dept Biol & Biol Engn, Div Food, S-41296 Gothenburg, Sweden; [Sandberg, Ann-Sofie] Chalmers, Dept Biol & Biol Engn, Div Nutr Sci, S-41296 Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology; Chalmers University of Technology	Ostman, SM (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden.	sofia.ostman@microbio.gu.se	sandberg, ann-sofie/B-6857-2016	sandberg, ann-sofie/0000-0002-9681-3342	IngaBritt and Arne Lundbergs foundation; Wilhelm and Martina Lundgrens Foundation; Sahlgrenska Academy of the University of Gothenburg; Graduate School in Environment and Health	IngaBritt and Arne Lundbergs foundation; Wilhelm and Martina Lundgrens Foundation; Sahlgrenska Academy of the University of Gothenburg; Graduate School in Environment and Health	The work was supported by IngaBritt and Arne Lundbergs foundation (http://www.lundbergsstiftelsen.se/index.html), Wilhelm and Martina Lundgrens Foundation (www.wmlundgren.se/) (JC), the Sahlgrenska Academy of the University of Gothenburg (http://sahlgrenska.gu.se/) (JC) and the Graduate School in Environment and Health, a cooperation between University of Gothenburg, Chalmers University of Technology and the Vastra Gotaland Region, coordinated by the Centre for Environment and Sustainability (http://gmv.gu.se/miljohalsa) (AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts-Toegaert C, 2007, EUR J IMMUNOL, V37, P686, DOI 10.1002/eji.200636535; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Berchtold S, 1999, FEBS LETT, V461, P211, DOI 10.1016/S0014-5793(99)01465-9; Brix S, 2010, IMMUNOLOGY, V129, P338, DOI 10.1111/j.1365-2567.2009.03163.x; BROUARD C, 1993, ANN NUTR METAB, V37, P146, DOI 10.1159/000177763; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; CALDER PC, 1991, INT J BIOCHEM, V23, P579; CALDER PC, 1995, BIOCHEM SOC T, V23, P302, DOI 10.1042/bst0230302; Chen LW, 2011, P NATL ACAD SCI USA, V108, P18778, DOI 10.1073/pnas.1018994108; Cramer SO, 2000, INT IMMUNOL, V12, P1347, DOI 10.1093/intimm/12.9.1347; DEMARCO DM, 1994, J LEUKOCYTE BIOL, V56, P612, DOI 10.1002/jlb.56.5.612; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fujimoto Y, 2002, CELL, V108, P755, DOI 10.1016/S0092-8674(02)00673-6; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Gosset P, 2001, EUR J IMMUNOL, V31, P2857, DOI 10.1002/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hirano N, 2006, BLOOD, V107, P1528, DOI 10.1182/blood-2005-05-2073; Hock BD, 2004, LEUKEMIA RES, V28, P237, DOI 10.1016/S0145-2126(03)00255-8; Hughes DA, 1996, J NUTR, V126, P603, DOI 10.1093/jn/126.3.603; Ibrahim J, 2012, GASTROENTEROLOGY, V143, P1061, DOI 10.1053/j.gastro.2012.06.003; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Itakura H, 2011, J ATHEROSCLER THROMB, V18, P99, DOI 10.5551/jat.5876; Iwami D, 2009, AM J TRANSPLANT, V9, P1294, DOI 10.1111/j.1600-6143.2009.02641.x; Johansson S, 2010, CLIN EXP IMMUNOL, V160, P411, DOI 10.1111/j.1365-2249.2010.04107.x; Jolly CA, 1997, J NUTR, V127, P37, DOI 10.1093/jn/127.1.37; Klotz L, 2007, J IMMUNOL, V178, P2122, DOI 10.4049/jimmunol.178.4.2122; Knight SC, 2008, IMMUNITY, V28, P135, DOI 10.1016/j.immuni.2008.01.003; Kong WM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-12; Kretschmer B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000755; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kuwano Y, 2007, INT IMMUNOL, V19, P977, DOI 10.1093/intimm/dxm067; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lechmann M, 2001, J EXP MED, V194, P1813, DOI 10.1084/jem.194.12.1813; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; MARANGONI F, 1993, BIOCHIM BIOPHYS ACTA, V1210, P55, DOI 10.1016/0005-2760(93)90049-F; MURPHY MG, 1990, J NUTR BIOCHEM, V1, P68, DOI 10.1016/0955-2863(90)90052-M; Prazma CM, 2007, J IMMUNOL, V179, P4550, DOI 10.4049/jimmunol.179.7.4550; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Sala-Vila A, 2008, CLIN EXP ALLERGY, V38, P1432, DOI 10.1111/j.1365-2222.2008.03072.x; Sampath H, 2004, NUTR REV, V62, P333, DOI [10.1301/nr.2004.sept.333-339, 10.1111/j.1753-4887.2004.tb00058.x]; Sanderson P, 1997, J LEUKOCYTE BIOL, V62, P771, DOI 10.1002/jlb.62.6.771; SHAPIRO AC, 1993, PROSTAGLANDINS, V45, P229, DOI 10.1016/0090-6980(93)90049-D; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Teague H, 2013, IMMUNOLOGY, V139, P386, DOI 10.1111/imm.12088; Wang H, 2007, NUTRITION, V23, P474, DOI 10.1016/j.nut.2007.04.002; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Weatherill AR, 2005, J IMMUNOL, V174, P5390, DOI 10.4049/jimmunol.174.9.5390; Weise C, 2011, PEDIAT ALLERG IMM-UK, V22, P497, DOI 10.1111/j.1399-3038.2010.01133.x; Wu L, 2004, CELL MOL IMMUNOL, V1, P112; Zapata-Gonzalez F, 2008, J LEUKOCYTE BIOL, V84, P1172, DOI 10.1189/jlb.1007688; Zarnani AH, 2007, REPRODUCTION, V133, P275, DOI 10.1530/rep.1.01232; Zeyda M, 2005, J BIOL CHEM, V280, P14293, DOI 10.1074/jbc.M410000200; Zeyda M, 2003, J IMMUNOL, V170, P6033, DOI 10.4049/jimmunol.170.12.6033; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zurier RB, 1999, PROSTAG LEUKOTR ESS, V60, P371, DOI 10.1016/S0952-3278(99)80015-5	61	32	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143741	10.1371/journal.pone.0143741	http://dx.doi.org/10.1371/journal.pone.0143741			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619195	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800067
J	Chukkapalli, SS; Velsko, IM; Rivera-Kweh, MF; Zheng, DH; Lucas, AR; Kesavalu, L				Chukkapalli, Sasanka S.; Velsko, Irina M.; Rivera-Kweh, Mercedes F.; Zheng, Donghang; Lucas, Alexandra R.; Kesavalu, Lakshmyya			Polymicrobial Oral Infection with Four Periodontal Bacteria Orchestrates a Distinct Inflammatory Response and Atherosclerosis in ApoE(null) Mice	PLOS ONE			English	Article							TISSUE TRANSCRIPTIONAL PROFILES; PORPHYROMONAS-GINGIVALIS; TANNERELLA-FORSYTHIA; TREPONEMA-DENTICOLA; SOFT-TISSUE; CALVARIAL BONE; RAT MODEL; DISEASE; PATHOGENS; IDENTIFICATION	Periodontal disease (PD) develops from a synergy of complex subgingival oral microbiome, and is linked to systemic inflammatory atherosclerotic vascular disease (ASVD). To investigate how a polybacterial microbiome infection influences atherosclerotic plaque progression, we infected the oral cavity of ApoE(null) mice with a polybacterial consortium of 4 well-characterized periodontal pathogens, Porphyromonas gingivalis, Treponema denticola, Tannerealla forsythia and Fusobacterium nucleatum, that have been identified in human atherosclerotic plaque by DNA screening. We assessed periodontal disease characteristics, hematogenous dissemination of bacteria, peripheral T cell response, serum inflammatory cytokines, atherosclerosis risk factors, atherosclerotic plaque development, and alteration of aortic gene expression. Polybacterial infections have established gingival colonization in ApoE(null) hyperlipidemic mice and displayed invasive characteristics with hematogenous dissemination into cardiovascular tissues such as the heart and aorta. Polybacterial infection induced significantly higher levels of serum risk factors oxidized LDL (p < 0.05), nitric oxide (p < 0.01), altered lipid profiles (cholesterol, triglycerides, Chylomicrons, VLDL) (p < 0.05) as well as accelerated aortic plaque formation in ApoE(null) mice (p < 0.05). Periodontal microbiome infection is associated with significant decreases in Apoa1, Apob, Birc3, Fga, FgB genes that are associated with atherosclerosis. Periodontal infection for 12 weeks had modified levels of inflammatory molecules, with decreased Fas ligand, IL-13, SDF-1 and increased chemokine RANTES. In contrast, 24 weeks of infection induced new changes in other inflammatory molecules with reduced KC, MCSF, enhancing GM-CSF, IFN gamma, IL-1 beta, IL-13, IL-4, IL-13, lymphotactin, RANTES, and also an increase in select inflammatory molecules. This study demonstrates unique differences in the host immune response to a polybacterial periodontal infection with atherosclerotic lesion progression in a mouse model.	[Chukkapalli, Sasanka S.; Velsko, Irina M.; Rivera-Kweh, Mercedes F.; Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32611 USA; [Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Zheng, Donghang; Lucas, Alexandra R.] Univ Florida, Dept Med, Div Cardiovasc Med, Gainesville, FL USA; [Lucas, Alexandra R.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kesavalu, L (corresponding author), Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32611 USA.	Kesavalu@dental.ufl.edu		chukkapalli, sasanka/0000-0001-9063-6907	NIH National Institute for Dental and Craniofacial Research [R01DE020820]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020820] Funding Source: NIH RePORTER	NIH National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH National Institute for Dental and Craniofacial Research (R01DE020820; Dr. Kesavalu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruni AW, 2011, INFECT IMMUN, V79, P3872, DOI 10.1128/IAI.05631-11; Bakthavatchalu V, 2011, MOL ORAL MICROBIOL, V26, P303, DOI 10.1111/j.2041-1014.2011.00619.x; Bakthavatchalu V, 2010, MOL ORAL MICROBIOL, V25, P317, DOI 10.1111/j.2041-1014.2010.00583.x; Bakthavatchalu V, 2010, MOL ORAL MICROBIOL, V25, P260, DOI 10.1111/j.2041-1014.2010.00575.x; Boon E, 2014, FEMS MICROBIOL REV, V38, P90, DOI 10.1111/1574-6976.12035; Chukkapalli SS, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv009; Chukkapalli SS, 2014, INFECT IMMUN, V82, P1959, DOI 10.1128/IAI.01511-14; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Feuille F, 1996, INFECT IMMUN, V64, P2095, DOI 10.1128/IAI.64.6.2094-2100.1996; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; GRENIER D, 1986, INFECT IMMUN, V53, P616, DOI 10.1128/IAI.53.3.616-620.1986; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kim YJ, 2014, J MICROBIOL, V52, P702, DOI 10.1007/s12275-014-4324-5; Kuo LE, 2007, PEPTIDES, V28, P435, DOI 10.1016/j.peptides.2006.08.035; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lanter BB, 2014, MBIO, V5, DOI 10.1128/mBio.01206-14; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Meka A, 2010, MOL ORAL MICROBIOL, V25, P61, DOI 10.1111/j.2041-1014.2009.00555.x; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rafferty B, 2011, J INTERN MED, V270, P273, DOI 10.1111/j.1365-2796.2011.02373.x; Rivera MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057178; Sarkar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088361; Shin JE, 2013, IMMUNOL CELL BIOL, V91, P503, DOI 10.1038/icb.2013.35; Tan KH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003955; Velsko IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129795; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Verma RK, 2010, ORAL DIS, V16, P686, DOI 10.1111/j.1601-0825.2010.01678.x; Verma RK, 2010, INTERDISCIP PERSPECT, V2010, DOI DOI 10.1155/2010/605125; Xie H, 2012, J PERIODONTAL RES, V47, P578, DOI 10.1111/j.1600-0765.2012.01469.x; Yoneda M, 2005, J PERIODONTAL RES, V40, P105, DOI 10.1111/j.1600-0765.2005.00774.x	35	53	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143291	10.1371/journal.pone.0143291	http://dx.doi.org/10.1371/journal.pone.0143291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619277	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800032
J	Kroll, AJ; Garcia, TS; Jones, JE; Dugger, K; Murden, B; Johnson, J; Peerman, S; Brintz, B; Rochelle, M				Kroll, Andrew J.; Garcia, Tiffany S.; Jones, Jay E.; Dugger, Katie; Murden, Blake; Johnson, Josh; Peerman, Summer; Brintz, Ben; Rochelle, Michael			Evaluating Multi-Level Models to Test Occupancy State Responses of Plethodontid Salamanders	PLOS ONE			English	Article							DETECTION PROBABILITY PARAMETERS; STREAM-ASSOCIATED AMPHIBIANS; FORESTS; PERSISTENCE; EVOLUTION	Plethodontid salamanders are diverse and widely distributed taxa and play critical roles in ecosystem processes. Due to salamander use of structurally complex habitats, and because only a portion of a population is available for sampling, evaluation of sampling designs and estimators is critical to provide strong inference about Plethodontid ecology and responses to conservation and management activities. We conducted a simulation study to evaluate the effectiveness of multi-scale and hierarchical single-scale occupancy models in the context of a Before-After Control-Impact (BACI) experimental design with multiple levels of sampling. Also, we fit the hierarchical single-scale model to empirical data collected for Oregon slender and Ensatina salamanders across two years on 66 forest stands in the Cascade Range, Oregon, USA. All models were fit within a Bayesian framework. Estimator precision in both models improved with increasing numbers of primary and secondary sampling units, underscoring the potential gains accrued when adding secondary sampling units. Both models showed evidence of estimator bias at low detection probabilities and low sample sizes; this problem was particularly acute for the multi-scale model. Our results suggested that sufficient sample sizes at both the primary and secondary sampling levels could ameliorate this issue. Empirical data indicated Oregon slender salamander occupancy was associated strongly with the amount of coarse woody debris (posterior mean = 0.74; SD = 0.24); Ensatina occupancy was not associated with amount of coarse woody debris (posterior mean = -0.01; SD = 0.29). Our simulation results indicate that either model is suitable for use in an experimental study of Plethodontid salamanders provided that sample sizes are sufficiently large. However, hierarchical single-scale and multi-scale models describe different processes and estimate different parameters. As a result, we recommend careful consideration of study questions and objectives prior to sampling data and fitting models.	[Kroll, Andrew J.; Jones, Jay E.] Weyerhaeuser, Federal Way, WA 98003 USA; [Garcia, Tiffany S.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Dugger, Katie] Oregon State Univ, US Geol Survey, Dept Fisheries & Wildlife, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Murden, Blake] Port Blakely Tree Farms LP, Tumwater, WA USA; [Johnson, Josh; Peerman, Summer; Rochelle, Michael] Weyerhaeuser, Lebanon, WA USA; [Brintz, Ben] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; United States Department of the Interior; United States Geological Survey; Oregon State University	Kroll, AJ (corresponding author), Weyerhaeuser, Federal Way, WA 98003 USA.	aj.kroll@weyerhaeuser.com	Kroll, Andrew/ABB-3724-2020	Kroll, Andrew/0000-0001-7747-830X	Oregon State University Fish and Wildlife in Managed Forests Program; Oregon Forest Industries Council; Port Blakely Tree Farms; Weyerhaeuser	Oregon State University Fish and Wildlife in Managed Forests Program; Oregon Forest Industries Council; Port Blakely Tree Farms; Weyerhaeuser	Oregon State University Fish and Wildlife in Managed Forests Program, Oregon Forest Industries Council, Port Blakely Tree Farms, and Weyerhaeuser provided funding to collect empirical data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [AJK, TG, JJ, KD, BM, JJ, SP, MR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2010, SALAMANDERS US CANAD; Archaux F, 2012, METHODS ECOL EVOL, V3, P188, DOI 10.1111/j.2041-210X.2011.00142.x; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P1, DOI 10.2193/0022-541X(2004)068[0001:EDPPFP]2.0.CO;2; Best ML, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00302.1; Clayton DR, 2007, CONSERVATION ASSESSM; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; Gelman A., 2004, BAYESIAN DATA ANAL; Grant EHC, 2010, P NATL ACAD SCI USA, V107, P6936, DOI 10.1073/pnas.1000266107; Guillera-Arroita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099571; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Hayes MP, 2006, J HERPETOL, V40, P531, DOI 10.1670/0022-1511(2006)40[531:DOCTFA]2.0.CO;2; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; Homyack JA, 2014, FORESTS, V5, P2750, DOI 10.3390/f5112750; Homyack JA, 2010, J HERPETOL, V44, P447, DOI 10.1670/09-107.1; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Jones LLC, 2005, AMPHIBIANS PACIFIC N; Kroll AJ, 2008, FOREST ECOL MANAG, V255, P3726, DOI 10.1016/j.foreco.2008.03.005; Kroll AJ, 2010, J WILDLIFE MANAGE, V74, P1580, DOI 10.2193/2009-265; Kroll AJ, 2009, FRESHWATER BIOL, V54, P2364, DOI 10.1111/j.1365-2427.2009.02245.x; Kroll AJ, 2009, BIOL CONSERV, V142, P2802, DOI 10.1016/j.biocon.2009.05.033; Kroll AJ, 2009, FOREST ECOL MANAG, V257, P1188, DOI 10.1016/j.foreco.2008.12.008; Linden DW, 2015, ECOL EVOL, V5, P3378, DOI 10.1002/ece3.1618; Lindstrom Jan, 2010, BMC Ecology, V10, P4, DOI 10.1186/1472-6785-10-4; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maret TJ, 2006, BIOL CONSERV, V127, P129, DOI 10.1016/j.biocon.2005.08.003; McDonald TL, 2000, J AGRIC BIOL ENVIR S, V5, P262, DOI 10.2307/1400453; McIntyre AP, 2012, FOREST ECOL MANAG, V286, P129, DOI 10.1016/j.foreco.2012.08.039; Mordecai RS, 2011, J APPL ECOL, V48, P56, DOI 10.1111/j.1365-2664.2010.01921.x; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; O'Donnell KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117216; Otto CRV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093859; Otto CRV, 2013, ECOGRAPHY, V36, P1299, DOI 10.1111/j.1600-0587.2013.00137.x; Otto CRV, 2013, FOREST ECOL MANAG, V304, P275, DOI 10.1016/j.foreco.2013.04.023; Pavlacky DC, 2012, J WILDLIFE MANAGE, V76, P154, DOI 10.1002/jwmg.245; Pearson SF, 2015, PLOS ONE IN PRESS; Plummer M., 2003, PROC 3 INT WORK DIST, P1; R Development Core Team, 2010, R LANG ENV STAT COMP; REAGAN NL, 1991, AM NAT, V138, P1307, DOI 10.1086/285288; Semlitsch RD, 2008, ECOL APPL, V18, P283, DOI 10.1890/07-0853.1; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; TILLEY SG, 1980, COPEIA, P806, DOI 10.2307/1444460; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P19715, DOI 10.1073/pnas.0902956106	46	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0142903	10.1371/journal.pone.0142903	http://dx.doi.org/10.1371/journal.pone.0142903			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619010	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800021
J	Kanderian, S; Jiang, LX; Knight, I				Kanderian, Sami; Jiang, Lingxia; Knight, Ivor			Automated Classification and Cluster Visualization of Genotypes Derived from High Resolution Melt Curves	PLOS ONE			English	Article							DNA; DIFFERENTIATION; INSTRUMENTS; PCR	Introduction High Resolution Melting (HRM) following PCR has been used to identify DNA genotypes. Fluorescent dyes bounded to double strand DNA lose their fluorescence with increasing temperature, yielding different signatures for different genotypes. Recent software tools have been made available to aid in the distinction of different genotypes, but they are not fully automated, used only for research purposes, or require some level of interaction or confirmation from an analyst. Materials and Methods We describe a fully automated machine learning software algorithm that classifies unknown genotypes. Dynamic melt curves are transformed to multidimensional clusters of points whereby a training set is used to establish the distribution of genotype clusters. Subsequently, probabilistic and statistical methods were used to classify the genotypes of unknown DNA samples on 4 different assays (40 VKORC1, CYP2C9*2, CYP2C9*3 samples in triplicate, and 49 MTHFR c.665C>T samples in triplicate) run on the Roche LC480. Melt curves of each of the triplicates were genotyped separately. Results Automated genotyping called 100% of VKORC1, CYP2C9* 3 and MTHFR c.665C>T samples correctly. 97.5% of CYP2C9*2 melt curves were genotyped correctly with the remaining 2.5% given a no call due to the inability to decipher 3 melt curves in close proximity as either homozygous mutant or wild-type with greater than 99.5% posterior probability. Conclusions We demonstrate the ability to fully automate DNA genotyping from HRM curves systematically and accurately without requiring any user interpretation or interaction with the data. Visualization of genotype clusters and quantification of the expected misclassification rate is also available to provide feedback to assay scientists and engineers as changes are made to the assay or instrument.	[Kanderian, Sami; Jiang, Lingxia; Knight, Ivor] Canon US Life Sci, Rockville, MD 20850 USA	Canon Incorporated	Kanderian, S (corresponding author), Canon US Life Sci, Rockville, MD 20850 USA.	skanderian@canon.uslifesciences.com			Canon U.S. Life Sciences, Inc.	Canon U.S. Life Sciences, Inc.	All authors are employed by Canon U.S. Life Sciences, Inc., which provided support in the form of salaries for the authors, funded the studies described in the paper, and supported the authors' decision to publish the work. The funder did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript.	Athamanolap P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109094; Bastien R, 2008, HUM MUTAT, V29, P757, DOI 10.1002/humu.20726; Boles D, 2012, Ref Type: Patent, Patent No. [US8145433 B2, 8145433]; Boles D, 2012, Ref Type: Patent, Patent No. [US 12/ 258,098[, 1258098]; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Dwight ZL, 2012, IEEE ACM T COMPUT BI, V9, P1805, DOI 10.1109/TCBB.2012.112; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; Li M, 2014, CLIN CHEM, V60, P864, DOI 10.1373/clinchem.2013.220160; Palais R, 2009, METHOD ENZYMOL, V454, P323, DOI [10.1016/S0076-6879(08)03813-5, 10.1016/S0076-6879(08)03913-5]; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Seipp MT, 2007, J MOL DIAGN, V9, P284, DOI 10.2353/jmoldx.2007.060136; STEINIER J, 1972, ANAL CHEM, V44, P1906, DOI 10.1021/ac60319a045; Sundberg SO, 2014, CLIN CHEM, V60, P1306, DOI 10.1373/clinchem.2014.223768; Vandersteen JG, 2007, CLIN CHEM, V53, P1191, DOI 10.1373/clinchem.2007.085407; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wittwer CT, 2010, PCR REVOLUTION BASIC, P48; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; YEN WS, 1980, BIOPOLYMERS, V19, P681, DOI 10.1002/bip.1980.360190316	22	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143295	10.1371/journal.pone.0143295	http://dx.doi.org/10.1371/journal.pone.0143295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605797	gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300053
J	Muller, NG; Vellage, AK; Heinze, HJ; Zaehle, T				Mueller, Notger G.; Vellage, Anne-Katrin; Heinze, Hans-Jochen; Zaehle, Tino			Entrainment of Human Alpha Oscillations Selectively Enhances Visual Conjunction Search	PLOS ONE			English	Article							ALTERNATING-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; BRAIN-STIMULATION; TOP-DOWN; FEATURE-INTEGRATION; BAND OSCILLATIONS; OCCIPITAL CORTEX; MULTIPLE DAYS; ATTENTION; EEG	The functional role of the alpha-rhythm which dominates the human electroencephalogram (EEG) is unclear. It has been related to visual processing, attentional selection and object coherence, respectively. Here we tested the interaction of alpha oscillations of the human brain with visual search tasks that differed in their attentional demands (pre-attentive vs. attentive) and also in the necessity to establish object coherence (conjunction vs. single feature). Between pre- and post-assessment elderly subjects received 20 min/d of repetitive transcranial alternating current stimulation (tACS) over the occipital cortex adjusted to their individual alpha frequency over five consecutive days. Compared to sham the entrained alpha oscillations led to a selective, set size independent improvement in the conjunction search task performance but not in the easy or in the hard feature search task. These findings suggest that cortical alpha oscillations play a specific role in establishing object coherence through suppression of distracting objects.	[Mueller, Notger G.; Vellage, Anne-Katrin] German Ctr Neurodegenerat Dis DZNE, Neuroprotect Grp, Magdeburg, Germany; [Mueller, Notger G.; Heinze, Hans-Jochen; Zaehle, Tino] Univ Magdeburg, Neurol Clin, D-39106 Magdeburg, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Otto von Guericke University	Muller, NG (corresponding author), German Ctr Neurodegenerat Dis DZNE, Neuroprotect Grp, Magdeburg, Germany.	notger.mueller@dzne.de	Zaehle, Tino/A-5088-2019	Zaehle, Tino/0000-0003-3673-4869; Mueller, Notger/0000-0002-5483-6423	Deutsche Forschungsgemeinschaft (DFG) [Mu1364/4]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grant Mu1364/4 to NM.	Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bonnefond M, 2012, CURR BIOL, V22, P1969, DOI 10.1016/j.cub.2012.08.029; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Chang YC, 2012, INT J PSYCHOPHYSIOL, V86, P39, DOI 10.1016/j.ijpsycho.2012.09.001; de Graaf TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060035; Dent K, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00278; Donner T, 2000, EUR J NEUROSCI, V12, P3407, DOI 10.1046/j.1460-9568.2000.00223.x; Donner TH, 2002, NEUROIMAGE, V15, P16, DOI 10.1006/nimg.2001.0951; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Feige B, 2005, J NEUROPHYSIOL, V93, P2864, DOI 10.1152/jn.00721.2004; Fiori V, 2011, J COGNITIVE NEUROSCI, V23, P2309, DOI 10.1162/jocn.2010.21579; Floel A, 2011, STROKE, V42, P2065, DOI 10.1161/STROKEAHA.110.609032; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Jauch-Chara K, 2014, AM J CLIN NUTR; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Klauss J, 2014, INT J NEUROPSYCHOPH, P1; Klimesch W, 2003, EUR J NEUROSCI, V17, P1129, DOI 10.1046/j.1460-9568.2003.02517.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Kuo MF, 2014, NEUROIMAGE, V85, P948, DOI 10.1016/j.neuroimage.2013.05.117; Lindenberg R, 2010, NEUROLOGY, V75, P2176, DOI 10.1212/WNL.0b013e318202013a; Martin DM, 2013, INT J NEUROPSYCHOPH, V16, P1927, DOI 10.1017/S1461145713000539; Meinzer M, 2014, CORTEX, V50, P137, DOI 10.1016/j.cortex.2013.07.013; Merlet I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057330; Muggleton NG, 2008, NEUROPSYCHOLOGIA, V46, P2198, DOI 10.1016/j.neuropsychologia.2008.02.016; Muller NG, 2003, NEUROIMAGE, V20, P1578, DOI 10.1016/S1053-8119(03)00416-6; Neuling T, 2012, NEUROIMAGE, V63, P771, DOI 10.1016/j.neuroimage.2012.07.024; Neuling T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00161; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Phillips S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032502; Phillips S, 2009, INT J PSYCHOPHYSIOL, V73, P350, DOI 10.1016/j.ijpsycho.2009.05.011; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; SALINSKY MC, 1991, ELECTROEN CLIN NEURO, V79, P382, DOI 10.1016/0013-4694(91)90203-G; Schankin A, 2011, BIOL PSYCHOL, V87, P58, DOI 10.1016/j.biopsycho.2011.02.003; Simonetta-Moreau M, 2014, ANN PHYS REHABIL MED; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TREISMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P459, DOI 10.1037/0096-1523.16.3.459; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; VanRullen R, 2005, P NATL ACAD SCI USA, V102, P5291, DOI 10.1073/pnas.0409172102; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Worden MS, 2000, J NEUROSCI, V20; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	50	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143533	10.1371/journal.pone.0143533	http://dx.doi.org/10.1371/journal.pone.0143533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606255	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300077
J	Herington, JL; Swale, DR; Brown, N; Shelton, EL; Choi, H; Williams, CH; Hong, CC; Paria, BC; Denton, JS; Reese, J				Herington, Jennifer L.; Swale, Daniel R.; Brown, Naoko; Shelton, Elaine L.; Choi, Hyehun; Williams, Charles H.; Hong, Charles C.; Paria, Bibhash C.; Denton, Jerod S.; Reese, Jeff			High-Throughput Screening of Myometrial Calcium-Mobilization to Identify Modulators of Uterine Contractility	PLOS ONE			English	Article							SMOOTH-MUSCLE; OXYTOCIN ANTAGONISTS; PRETERM DELIVERY; IN-VITRO; MECHANISMS; INHIBITION; TOCOLYTICS; RECEPTORS; PREGNANCY; PATHWAYS	The uterine myometrium (UT-myo) is a therapeutic target for preterm labor, labor induction, and postpartum hemorrhage. Stimulation of intracellular Ca2+-release in UT-myo cells by oxytocin is a final pathway controlling myometrial contractions. The goal of this study was to develop a dual-addition assay for high-throughput screening of small molecular compounds, which could regulate Ca2+-mobilization in UT-myo cells, and hence, myometrial contractions. Primary murine UT-myo cells in 384-well plates were loaded with a Ca2+-sensitive fluorescent probe, and then screened for inducers of Ca2+-mobilization and inhibitors of oxytocin-induced Ca2+-mobilization. The assay exhibited robust screening statistics (Z' = 0.73), DMSO-tolerance, and was validated for high-throughput screening against 2,727 small molecules from the Spectrum, NIH Clinical I and II collections of well-annotated compounds. The screen revealed a hit-rate of 1.80% for agonist and 1.39% for antagonist compounds. Concentration-dependent responses of hit-compounds demonstrated an EC50 less than 10 mu M for 21 hit-antagonist compounds, compared to only 7 hit-agonist compounds. Subsequent studies focused on hit-antagonist compounds. Based on the percent inhibition and functional annotation analyses, we selected 4 confirmed hit-antagonist compounds (benzbromarone, dipyridamole, fenoterol hydrobromide and nisoldipine) for further analysis. Using an ex vivo isometric contractility assay, each compound significantly inhibited uterine contractility, at different potencies (IC50). Overall, these results demonstrate for the first time that high-throughput small-molecules screening of myometrial Ca2+-mobilization is an ideal primary approach for discovering modulators of uterine contractility.	[Herington, Jennifer L.; Brown, Naoko; Shelton, Elaine L.; Paria, Bibhash C.; Reese, Jeff] Vanderbilt Univ, Sch Med, Dept Pediat, Div Neonatol, Nashville, TN 37212 USA; [Swale, Daniel R.] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA; [Choi, Hyehun] Vanderbilt Univ, Sch Med, Dept Pediat, Div Crit Care Med, Nashville, TN 37212 USA; [Williams, Charles H.; Reese, Jeff] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Hong, Charles C.; Denton, Jerod S.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA	Vanderbilt University; Louisiana State University System; Louisiana State University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Herington, JL (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Div Neonatol, Nashville, TN 37212 USA.	jennifer.l.herington@vanderbilt.edu	; Williams, Charles/H-2351-2015	Reese, Jeff/0000-0001-8751-6146; Williams, Charles/0000-0002-0331-5652; Shelton, Elaine/0000-0003-0929-2882	Vanderbilt Office of Clinical and Translational Scientist Development; CTSA from the National Center for Advancing Translational Sciences [UL1TR000445, KL2TR000446]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD044741, HD081121]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044741, R01HD081121] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000446, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115305] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000771] Funding Source: NIH RePORTER	Vanderbilt Office of Clinical and Translational Scientist Development; CTSA from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This project was supported by research funds (J. L. H.) from the Vanderbilt Office of Clinical and Translational Scientist Development and CTSA award numbers UL1TR000445 and KL2TR000446 from the National Center for Advancing Translational Sciences. This work was also supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [Grants HD044741 (B. C. P.), HD081121 to (J. R.)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Baumbach J, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.011; Buhimschi CS, 2000, AM J OBSTET GYNECOL, V183, P68, DOI 10.1067/mob.2000.105348; Burghardt RC, 1999, BIOL REPROD, V60, P777, DOI 10.1095/biolreprod60.4.777; Cirillo R, 2003, J PHARMACOL EXP THER, V306, P253, DOI 10.1124/jpet.103.049395; Crankshaw DJ, 2013, REPROD SCI, V20, P882, DOI 10.1177/1933719112468949; de Heus R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b744; Devost D, 2007, AM J PHYSIOL-ENDOC M, V292, pE1, DOI 10.1152/ajpendo.00529.2005; Eglen R, 2011, ASSAY DRUG DEV TECHN, V9, P108, DOI 10.1089/adt.2010.0305; Fejgin MD, 1998, J SOC GYNECOL INVEST, V5, P251, DOI 10.1016/S1071-5576(98)00021-5; Fitzgibbon J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-2; Giles W, 2007, BEST PRACT RES CL OB, V21, P857, DOI 10.1016/j.bpobgyn.2007.03.011; Groom KM, 2000, BRIT J OBSTET GYNAEC, V107, P1182, DOI 10.1111/j.1471-0528.2000.tb11132.x; Haas DM, 2014, INT J WOMENS HEALTH, V6, P343, DOI 10.2147/IJWH.S44048; Kamel RM, 2010, ARCH GYNECOL OBSTET, V281, P975, DOI 10.1007/s00404-010-1365-9; Kasten F H, 1975, Adv Exp Med Biol, V53, P389; Kitazawa T, 1998, BRIT J PHARMACOL, V123, P173, DOI 10.1038/sj.bjp.0701583; LI FF, 1992, ACTA PHARM SINIC, V13, P59; LIPSHITZ J, 1977, BRIT J OBSTET GYNAEC, V84, P737, DOI 10.1111/j.1471-0528.1977.tb12482.x; McCloskey C, 2014, EMBO MOL MED, V6, P1161, DOI 10.15252/emmm.201403944; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Mitchell BF, 2013, FACTS VIEWS VIS OBGY, V5, P72; Munglue P, 2013, REPROD SCI, V20, P437, DOI 10.1177/1933719112459223; Nonnenmacher A, 2009, Z Geburtshilfe Neonatol, V213, P201, DOI 10.1055/s-0029-1225640; Norman JE, 1997, J REPROD FERTIL, V110, P249; Norwitz ER, 1999, NEW ENGL J MED, V341, P660, DOI 10.1056/NEJM199908263410906; Oger S, 2004, BIOL REPROD, V70, P458, DOI 10.1095/biolreprod.103.023051; Olson DM, 2008, EXPERT OPIN EMERG DR, V13, P695, DOI 10.1517/14728210802568764 ; PAK SC, 1994, BIOL REPROD, V51, P1140, DOI 10.1095/biolreprod51.6.1140; Petraglia F, 2010, ENDOCR REV, V31, P783, DOI 10.1210/er.2009-0019; Pierce SL, 2010, PHYSIOL GENOMICS, V42, P310, DOI 10.1152/physiolgenomics.00058.2010; Prudencio AB, 2013, DIANAS, V2; Robinson H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046278; Savitsky AG, 2013, J MATERN-FETAL NEO M, V26, P566, DOI 10.3109/14767058.2012.738261; Sawdy R, 1998, BRIT J PHARMACOL, V125, P1212, DOI 10.1038/sj.bjp.0702211; Shynlova O, 2009, EUR J OBSTET GYN R B, V144, pS2, DOI 10.1016/j.ejogrb.2009.02.044; Stymiest JL, 2005, J ORG CHEM, V70, P7799, DOI 10.1021/jo050539l; Tong WC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00399; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Tribe RM, 2000, BIOL REPROD, V63, P748, DOI 10.1095/biolreprod63.3.748; Voltolini C, 2013, REPROD SCI, V20, P1274, DOI 10.1177/1933719113477496; Vrachnis N, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/350546; WHO, 2012, WORLD HLTH ORG WHO G; Yasuda K, 2007, REPRODUCTION, V133, P797, DOI 10.1530/REP-06-0041; Young RC, 2001, J SOC GYNECOL INVEST, V8, P210, DOI 10.1016/S1071-5576(01)00109-5; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	46	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143243	10.1371/journal.pone.0143243	http://dx.doi.org/10.1371/journal.pone.0143243			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600013	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600041
J	Miller, RR; Hird, TJ; Tang, P; Zlosnik, JEA				Miller, Ruth R.; Hird, Trevor J.; Tang, Patrick; Zlosnik, James E. A.			Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA-COMPLEX; LUNG TRANSPLANTATION; PSEUDOMONAS-CEPACIA; EXOPOLYSACCHARIDE BIOSYNTHESIS; PHOSPHOTYROSINE PHOSPHATASE; EPIDEMIOLOGY; INFECTION; BACTERIA; TRANSMISSION; MULTIVORANS	Burkholderia cepacia complex bacteria are amongst the most feared of pathogens in cystic fibrosis (CF). The BCC comprises at least 20 distinct species that can cause chronic and unpredictable lung infections in CF. Historically the species B. cenocepacia has been the most prevalent in CF infections and has been associated in some centers with high rates of mortality. Modeling chronic infection by B. cenocepacia in the laboratory is challenging and no models exist which effectively recapitulate CF disease caused by BCC bacteria. Therefore our understanding of factors that contribute towards the morbidity and mortality caused by this organism is limited. In this study we used whole-genome sequencing to examine the evolution of 3 clonal clinical isolates of B. cenocepacia from a patient with cystic fibrosis. The first isolate was from the beginning of infection, and the second two almost 10 years later during the final year of the patients' life. These isolates also demonstrated phenotypic heterogeneity, with the first isolate displaying the mucoid phenotype (conferred by the overproduction of exopolysaccharide), while one of the later two was nonmucoid. In addition we also sequenced a nonmucoid derivative of the initial mucoid isolate, acquired in the laboratory by antibiotic pressure. Examination of sequence data revealed that the two late stage isolates shared 20 variant nucleotides in common compared to the early isolate. However, despite their isolation within 10 months of one another, there was also considerable variation between the late stage isolates, including 42 single nucleotide variants and three deletions. Additionally, no sequence differences were identified between the initial mucoid isolate and its laboratory acquired nonmucoid derivative, however transcript analysis indicated at least partial down regulation of genes involved in exopolysaccharide production. Our study examines the progression of B. cenocepacia throughout chronic infection, including establishment of sub-populations likely evolved from the original isolate, suggestive of parallel evolution. Additionally, the lack of sequence differences between two of the isolates with differing mucoid phenotypes suggests that other factors, such as gene regulation, come into play in establishing the mucoid phenotype.	[Miller, Ruth R.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Miller, Ruth R.; Tang, Patrick] Univ British Columbia, British Columbia Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada; [Hird, Trevor J.; Zlosnik, James E. A.] Univ British Columbia, Fac Med, Dept Pediat, Ctr Understanding & Preventing Infect Children, Vancouver, BC, Canada; [Tang, Patrick] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Zlosnik, JEA (corresponding author), Univ British Columbia, Fac Med, Dept Pediat, Ctr Understanding & Preventing Infect Children, Vancouver, BC, Canada.	jzlosnik@cfri.ubc.ca		Zlosnik, James/0000-0002-9708-9034; Tang, Patrick/0000-0003-1583-5484	Cystic Fibrosis Canada [20R32976]; BC CDC Foundation for Population and Public Health [20R67183]	Cystic Fibrosis Canada; BC CDC Foundation for Population and Public Health	This work was supported by Cystic Fibrosis Canada (www.cysticfibrosis.ca, Grant#: 20R32976), and by BC CDC Foundation for Population and Public Health (http://www.bccdc.ca/util/about/BCCDCFoundation/default.htm, Grant #20R67183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoli K, 2014, APPL ENVIRON MICROB, V80, P1340, DOI 10.1128/AEM.03330-13; Alexander BD, 2008, AM J TRANSPLANT, V8, P1025, DOI 10.1111/j.1600-6143.2008.02186.x; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Bartholdson SJ, 2008, MICROBIOL-SGM, V154, P2513, DOI 10.1099/mic.0.2008/019216-0; Bosi E, 2015, BIOINFORMATICS, V31, P2443, DOI 10.1093/bioinformatics/btv171; Boussaud V, 2008, THORAX, V63, P732, DOI 10.1136/thx.2007.089458; Chiarini Luigi, 2004, J Cyst Fibros, V3, P165, DOI 10.1016/j.jcf.2004.04.004; Conway BAD, 2004, J INFECT DIS, V190, P957, DOI 10.1086/423141; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; Coutinho CP, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00012; Cuzzi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094372; Darling AE, 2010, PLOS ONE, P5; De Smet B, 2015, INT J SYST EVOL MICR, V65, P2265, DOI 10.1099/ijs.0.000251; De Soyza A, 2010, J HEART LUNG TRANSPL, V29, P1395, DOI 10.1016/j.healun.2010.06.007; Dolfi S, 2015, CARBOHYD RES, V411, P42, DOI 10.1016/j.carres.2015.04.012; Drevinek P, 2005, J MED MICROBIOL, V54, P655, DOI 10.1099/jmm.0.46025-0; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Ferreira AS, 2007, APPL ENVIRON MICROB, V73, P524, DOI 10.1128/AEM.01450-06; Ferreira AS, 2015, INFECT IMMUN, V83, P812, DOI 10.1128/IAI.02713-14; Ferreira AS, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00016; Ferreira AS, 2010, APPL ENVIRON MICROB, V76, P441, DOI 10.1128/AEM.01828-09; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; GOVAN JRW, 1993, LANCET, V342, P15, DOI 10.1016/0140-6736(93)91881-L; Herasimenka Y, 2007, J CYST FIBROS, V6, P145, DOI 10.1016/j.jcf.2006.06.004; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Kalferstova L, 2015, J CLIN MICROBIOL, V53, P1515, DOI 10.1128/JCM.03605-14; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; LIPUMA JJ, 1990, LANCET, V336, P1094, DOI 10.1016/0140-6736(90)92571-X; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Marvig RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003741; Murray S, 2008, AM J RESP CRIT CARE, V178, P363, DOI 10.1164/rccm.200712-1834OC; Nzula S, 2002, J ANTIMICROB CHEMOTH, V50, P265, DOI 10.1093/jac/dkf137; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Peeters C, 2013, SYST APPL MICROBIOL, V36, P483, DOI 10.1016/j.syapm.2013.06.003; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Price EP, 2015, J CLIN MICROBIOL, V53, P282, DOI 10.1128/JCM.02560-14; Price EP, 2013, MBIO, V4, DOI 10.1128/mBio.00388-13; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Traverse CC, 2013, P NATL ACAD SCI USA, V110, pE250, DOI 10.1073/pnas.1207025110; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zlosnik JEA, 2008, J CLIN MICROBIOL, V46, P1470, DOI 10.1128/JCM.02273-07; Zlosnik JEA, 2015, ANN AM THORAC SOC, V12, P70, DOI 10.1513/AnnalsATS.201408-395OC; Zlosnik JEA, 2011, AM J RESP CRIT CARE, V183, P67, DOI 10.1164/rccm.201002-0203OC; Zlosnik JEA, 2010, J INFECT DIS, V202, P770, DOI 10.1086/655663	54	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143472	10.1371/journal.pone.0143472	http://dx.doi.org/10.1371/journal.pone.0143472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599356	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600069
J	Norambuena, F; Morais, S; Emery, JA; Turchini, GM				Norambuena, Fernando; Morais, Sofia; Emery, James A.; Turchini, Giovanni M.			Arachidonic Acid and Eicosapentaenoic Acid Metabolism in Juvenile Atlantic Salmon as Affected by Water Temperature	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; POLYUNSATURATED FATTY-ACIDS; SOLE SOLEA-SENEGALENSIS; BETA-OXIDATION CAPACITY; DIETARY FISH-OIL; RAINBOW-TROUT; SALAR L.; GENE-EXPRESSION; LIPID-METABOLISM; TELEOST FISH	Salmons raised in aquaculture farms around the world are increasingly subjected to suboptimal environmental conditions, such as high water temperatures during summer seasons. Aerobic scope increases and lipid metabolism changes are known plasticity responses of fish for a better acclimation to high water temperature. The present study aimed at investigating the effect of high water temperature on the regulation of fatty acid metabolism in juvenile Atlantic salmon fed different dietary ARA/EPA ratios (arachidonic acid, 20: 4n-6/eicosapentaenoic acid, 20: 5n-3), with particular focus on apparent in vivo enzyme activities and gene expression of lipid metabolism pathways. Three experimental diets were formulated to be identical, except for the ratio EPA/ARA, and fed to triplicate groups of Atlantic salmon (Salmo salar) kept either at 10 degrees C or 20 degrees C. Results showed that fatty acid metabolic utilisation, and likely also their dietary requirements for optimal performance, can be affected by changes in their relative levels and by environmental temperature in Atlantic salmon. Thus, the increase in temperature, independently from dietary treatment, had a significant effect on the beta-oxidation of a fatty acid including EPA, as observed by the apparent in vivo enzyme activity and mRNA expression of ppar alpha-transcription factor in lipid metabolism, including beta-oxidation genes-and cpt1-key enzyme responsible for the movement of LC-PUFA from the cytosol into the mitochondria for beta-oxidation-, were both increased at the higher water temperature. An interesting interaction was observed in the transcription and in vivo enzyme activity of Delta 5fad-time-limiting enzyme in the biosynthesis pathway of EPA and ARA. Such, at lower temperature, the highest mRNA expression and enzyme activity was recorded in fish with limited supply of dietary EPA, whereas at higher temperature these were recorded in fish with limited ARA supply. In consideration that fish at higher water temperature recorded a significantly increased feed intake, these results clearly suggested that at high, sub-optimal water temperature, fish metabolism attempted to increment its overall ARA status - the most bioactive LC-PUFA participating in the inflammatory response-by modulating the metabolic fate of dietary ARA (expressed as % of net intake), reducing its beta-oxidation and favouring synthesis and deposition. This correlates also with results from other recent studies showing that both immune- and stress-responses in fish are up regulated in fish held at high temperatures. This is a novel and fundamental information that warrants industry and scientific attention, in consideration of the imminent increase in water temperatures, continuous expansion of aquaculture operations, resources utilisation in aquafeed and much needed seasonal/adaptive nutritional strategies.	[Norambuena, Fernando; Emery, James A.; Turchini, Giovanni M.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic 3280, Australia; [Morais, Sofia] IRTA, San Carlos de la Rapita 43540, Spain	Deakin University; IRTA	Norambuena, F (corresponding author), BioMar Chile SA, Bernardino 1981,Piso 3,Parque Ind San Andres, Puerto Montt, Chile.	f.norambuena@deakin.edu.au	Morais, Sofia/D-8921-2011	Turchini, Giovanni/0000-0003-0694-4283	Australian Research Council [DP1093570]; European Commission [274184]	Australian Research Council(Australian Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported under the Australian Research Council's Discovery Projects funding scheme (Project DP1093570). The views expressed herein are those of the authors and are not necessarily those of the Australian Research Council. SM was supported by the European Commission Marie Curie Actions (FP7-PEOPLE-2010-RG, Project No. 274184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MJ, 2000, BRIT J NUTR, V84, P619; Martins DA, 2012, BRIT J NUTR, V108, P864, DOI 10.1017/S0007114511006143; AOAC, 2005, AN FEED OFF METH AN, P52; Arts MT, 2012, LIPIDS, V47, P1181, DOI 10.1007/s11745-012-3719-5; Beasley D, 1999, AM J PHYSIOL-HEART C, V276, pH1369, DOI 10.1152/ajpheart.1999.276.4.H1369; BELL JG, 2011, FISH OIL REPLACEMENT, P21; BELL MV, 1986, COMP BIOCHEM PHYS B, V83, P711, DOI 10.1016/0305-0491(86)90135-5; Bendiksen EA, 2003, FISH PHYSIOL BIOCHEM, V29, P133, DOI 10.1023/B:FISH.0000035937.68098.83; Benitez-Santana T, 2007, AQUACULTURE, V264, P408, DOI 10.1016/j.aquaculture.2006.10.024; Berge RK, 1999, BIOCHEM J, V343, P191, DOI 10.1042/0264-6021:3430191; Bordoni A, 2006, GENES NUTR, V1, P95, DOI 10.1007/BF02829951; Buzzi M, 1996, BBA-LIPID LIPID MET, V1299, P235, DOI 10.1016/0005-2760(95)00211-1; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Coccia E, 2014, LIPIDS, V49, P1033, DOI 10.1007/s11745-014-3939-y; Cochrane K, 2009, CLIMATE CHANGE IMPLI; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Egginton S, 1996, J FISH BIOL, V49, P753, DOI 10.1111/j.1095-8649.1996.tb00074.x; FARKAS T, 1976, LIPIDS, V11, P401, DOI 10.1007/BF02532847; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fountoulaki E, 2003, AQUACULTURE, V225, P309, DOI 10.1016/S0044-8486(03)00298-9; Froyland L, 2000, AQUACULT NUTR, V6, P85; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; HAGAR AF, 1985, J COMP PHYSIOL B, V156, P35, DOI 10.1007/BF00692924; HAZEL JR, 1984, AM J PHYSIOL, V246, pR460, DOI 10.1152/ajpregu.1984.246.4.R460; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZEL JR, 1979, AM J PHYSIOL, V236, pR91, DOI 10.1152/ajpregu.1979.236.1.R91; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Higgs D, 2000, ENCY AQUACULTURE, P476; Holen E, 2015, FISH SHELLFISH IMMUN, P1; Huguet CT, 2015, AQUACULTURE, V436, P160, DOI 10.1016/j.aquaculture.2014.11.011; Jobling M, 2003, AQUAC RES, V34, P1423, DOI 10.1111/j.1365-2109.2003.00970.x; Jorgensen Sven Martin, 2014, BMC Physiology, V14, P2, DOI 10.1186/1472-6793-14-2; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kieffer JD, 1998, J EXP BIOL, V201, P3123; Klaiman JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024464; Kowalska A, 2014, AQUACULT INT, V22, P185, DOI 10.1007/s10499-013-9684-z; Le WP, 2000, BBA-MOL CELL BIOL L, V1485, P121, DOI 10.1016/S1388-1981(00)00034-2; Leaver MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-299; Ma JJ, 2013, J WORLD AQUACULT SOC, V44, P311, DOI 10.1111/jwas.12032; Maskrey BH, 2011, ARTERIOSCL THROM VAS, V31, P1001, DOI 10.1161/ATVBAHA.110.213850; McKenzie DJ, 1998, FISH PHYSIOL BIOCHEM, V19, P111, DOI 10.1023/A:1007779619087; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Moya-Falcon C, 2006, COMP BIOCHEM PHYS B, V145, P68, DOI 10.1016/j.cbpb.2006.06.004; NEAS NP, 1985, J EXP ZOOL, V233, P51, DOI 10.1002/jez.1402330108; Neuman C, 2016, AQUAC RES, V47, P660, DOI 10.1111/are.12522; Ng WK, 2010, AQUACULTURE, V309, P165, DOI 10.1016/j.aquaculture.2010.08.035; Norambuena F, 2016, AQUACULTURE, V450, P48, DOI 10.1016/j.aquaculture.2015.06.044; Norambuena F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081705; Norambuena F, 2013, GEN COMP ENDOCR, V191, P92, DOI 10.1016/j.ygcen.2013.06.006; Norambuena F, 2013, AQUACULTURE, V372, P80, DOI 10.1016/j.aquaculture.2012.10.035; Norambuena F, 2012, GEN COMP ENDOCR, V177, P256, DOI 10.1016/j.ygcen.2012.04.009; Nordgarden U, 2003, AQUACULT NUTR, V9, P295, DOI 10.1046/j.1365-2095.2003.00260.x; Olsen RE, 1998, AQUAC RES, V29, P695, DOI 10.1046/j.1365-2109.1998.29100695.x; Orr S, 2013, BIOCHEMICAL PHYSIOLO; Rett BS, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-36; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Sargent JR, 1995, J APPL ICHTHYOL, V11, P183, DOI 10.1111/j.1439-0426.1995.tb00018.x; SCHUNKE M, 1983, BIOCHIM BIOPHYS ACTA, V734, P70, DOI 10.1016/0005-2736(83)90076-7; Sessler AM, 1998, J NUTR, V128, P923, DOI 10.1093/jn/128.6.923; SINCLAIR AJ, 1983, LIPIDS, V18, P877, DOI 10.1007/BF02534565; Stenslokken KO, 2002, J COMP PHYSIOL B, V172, P363, DOI 10.1007/s00360-002-0258-z; Stipanuk MH, 2013, BIOCHEMICAL PHYSIOLO; Stubhaug I, 2007, AQUACULT NUTR, V13, P145, DOI 10.1111/j.1365-2095.2007.00462.x; TEBBEY PW, 1992, BIOCHIM BIOPHYS ACTA, V1171, P27, DOI 10.1016/0167-4781(92)90136-N; Tian JJ, 2014, AQUACULTURE, V430, P57, DOI 10.1016/j.aquaculture.2014.03.020; Tocher DR, 2015, AQUACULTURE, V449, P94, DOI 10.1016/j.aquaculture.2015.01.010; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2004, COMP BIOCHEM PHYS B, V137, P49, DOI 10.1016/j.cbpc.2003.10.002; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Turchini GM, 2007, LIPIDS, V42, P1065, DOI 10.1007/s11745-007-3105-x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Van Anholt RD, 2004, J EXP BIOL, V207, P3419, DOI 10.1242/jeb.01166; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veilleux HD, 2015, NAT CLIM CHANGE, V5, P1074, DOI [10.1038/nclimate2724, 10.1038/NCLIMATE2724]; Wall R., 2010, FATTY ACIDS FROM FIS, P280; Wang Y, 2005, J LIPID RES, V46, P706, DOI 10.1194/jlr.M400335-JLR200; Wijendran V, 2013, PROSTAG LEUKOTR ESS, V89, P345, DOI 10.1016/j.plefa.2013.08.004; WILLUMSEN N, 1993, LIPIDS, V28, P683, DOI 10.1007/BF02535987; WODTKE E, 1978, BIOCHIM BIOPHYS ACTA, V529, P280, DOI 10.1016/0005-2760(78)90071-1	82	37	37	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143622	10.1371/journal.pone.0143622	http://dx.doi.org/10.1371/journal.pone.0143622			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599513	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600094
J	Duong, J; Booth, SC; McCartney, NK; Rabin, HR; Parkins, MD; Storey, DG				Duong, Jessica; Booth, Sean C.; McCartney, Nathan K.; Rabin, Harvey R.; Parkins, Michael D.; Storey, Douglas G.			Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis	PLOS ONE			English	Article							TRANSMISSIBLE STRAINS; CLINICAL-OUTCOMES; CHRONIC INFECTION; CLONAL STRAINS; RISK-FACTORS; SPREAD; IDENTIFICATION; EXACERBATION; POPULATION; VIRULENCE	Epidemic strains of Pseudomonas aeruginosa have been found worldwide among the cystic fibrosis (CF) patient population. Using pulse-field gel electrophoresis, the Prairie Epidemic Strain (PES) has recently been found in one-third of patients attending the Calgary Adult CF Clinic in Canada. Using multi-locus sequence typing, PES isolates from unrelated patients were found to consistently have ST192. Though most patients acquired PES prior to enrolling in the clinic, some patients were observed to experience strain replacement upon transitioning to the clinic whereby local non-epidemic P. aeruginosa isolates were displaced by PES. Here we genotypically and phenotypically compared PES to other P. aeruginosa epidemic strains (OES) found around the world as well as local non-epidemic CF P. aeruginosa isolates in order to characterize PES. Since some epidemic strains are associated with worse clinical outcomes, we assessed the pathogenic potential of PES to determine if these isolates are virulent, shared properties with OES, and if its phenotypic properties may offer a competitive advantage in displacing local non-epidemic isolates during strain replacement. As such, we conducted a comparative analysis using fourteen phenotypic traits, including virulence factor production, biofilm formation, planktonic growth, mucoidy, and antibiotic susceptibility to characterize PES, OES, and local non-epidemic isolates. We observed that PES and OES could be differentiated from local non-epidemic isolates based on biofilm growth with PES isolates being more mucoid. Pairwise comparisons indicated that PES produced significantly higher levels of proteases and formed better biofilms than OES but were more susceptible to antibiotic treatment. Amongst five patients experiencing strain replacement, we found that super-infecting PES produced lower levels of proteases and elastases but were more resistant to antibiotics compared to the displaced non-epidemic isolates. This comparative analysis is the first to be completed on a large scale between groups of epidemic and non-epidemic CF P. aeruginosa isolates.	[Duong, Jessica; Booth, Sean C.; McCartney, Nathan K.; Storey, Douglas G.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Parkins, Michael D.; Storey, Douglas G.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Rabin, Harvey R.; Parkins, Michael D.] Univ Calgary, Dept Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Storey, DG (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	storey@ucalgary.ca	Booth, Sean Cameron/H-6480-2019; Storey, Doug/AAH-3066-2022; Storey, Doug/AFM-0647-2022	Booth, Sean Cameron/0000-0003-2552-5324; Storey, Douglas/0000-0001-8927-0493	Natural Science and Engineering Research Council [RGPIN 203595-2013]; Cystic Fibrosis Canada	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada	This study was funded by a Natural Science and Engineering Research Council Discovery Grant (RGPIN 203595-2013) to DGS and a Cystic Fibrosis Canada grant to MDP.	Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Armstrong DS, 2002, AM J RESP CRIT CARE, V166, P983, DOI 10.1164/rccm.200204-269OC; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Beaudoin T, 2010, CAN J MICROBIOL, V56, P548, DOI [10.1139/W10-043, 10.1139/w10-043]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BODEY GP, 1983, REV INFECT DIS, V5, P279; Bradbury R, 2008, RESPIROLOGY, V13, P886, DOI 10.1111/j.1440-1843.2008.01383.x; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chambers D, 2005, EUR RESPIR J, V26, P651, DOI 10.1183/09031936.05.00126704; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Denning GM, 1998, AM J PHYSIOL-LUNG C, V274, pL893, DOI 10.1152/ajplung.1998.274.6.L893; Dettman JR, 2013, P NATL ACAD SCI USA, V110, P21065, DOI 10.1073/pnas.1307862110; European Bioplastics, 2015, BIOPL FURTH EFF WAST, P1; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; Foweraker JE, 2005, J ANTIMICROB CHEMOTH, V55, P921, DOI 10.1093/jac/dki146; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; Kidd TJ, 2013, EUR RESPIR J, V41, P1091, DOI 10.1183/09031936.00060512; Kidd TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044199; Kidd TJ, 2011, J CLIN MICROBIOL, V49, P263, DOI 10.1128/JCM.01421-10; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Konings AF, 2013, INFECT IMMUN, V81, P2697, DOI 10.1128/IAI.00418-13; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Lam JC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0856-5; Lelong E, 2011, CLIN MICROBIOL INFEC, V17, P1415, DOI 10.1111/j.1469-0691.2010.03431.x; LONON MK, 1988, J CLIN MICROBIOL, V26, P979, DOI 10.1128/JCM.26.5.979-984.1988; Luna RA, 2013, J CLIN MICROBIOL, V51, P1237, DOI 10.1128/JCM.02157-12; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Manos J, 2013, EUR J CLIN MICROBIOL, V32, P1583, DOI 10.1007/s10096-013-1916-7; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; McCallum SJ, 2001, LANCET, V358, P558, DOI 10.1016/S0140-6736(01)05715-4; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; O'Carroll MR, 2004, EUR RESPIR J, V24, P101, DOI 10.1183/09031936.04.00122903; Parkins MD, 2014, J CLIN MICROBIOL, V52, P1127, DOI 10.1128/JCM.03218-13; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; PEDERSEN SS, 1992, THORAX, V47, P6, DOI 10.1136/thx.47.1.6; PEDERSEN SS, 1986, J ANTIMICROB CHEMOTH, V17, P505, DOI 10.1093/jac/17.4.505; Poonja A, 2015, 29 ANN N AM CYST FIB; ROMLING U, 1994, J INFECT DIS, V170, P1616, DOI 10.1093/infdis/170.6.1616; RUST L, 1994, METHOD ENZYMOL, V235, P554; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; SOKOL PA, 1979, J CLIN MICROBIOL, V9, P538; Somayaji R, 2015, 38 ANN EUR CYST FIBR; Stapper AP, 2004, J MED MICROBIOL, V53, P679, DOI 10.1099/jmm.0.45539-0; Storey DG, 1998, INFECT IMMUN, V66, P2521, DOI 10.1128/IAI.66.6.2521-2528.1998; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; Waine DJ, 2009, J CLIN MICROBIOL, V47, P3444, DOI 10.1128/JCM.00459-09; Waters V, 2012, EUR RESPIR J, V40, P61, DOI 10.1183/09031936.00159111; WOODS DE, 1991, J INFECT DIS, V163, P143, DOI 10.1093/infdis/163.1.143; Workentine ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060225; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	60	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143466	10.1371/journal.pone.0143466	http://dx.doi.org/10.1371/journal.pone.0143466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599104	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900129
J	Giese, APJ; Guarnaschelli, JG; Ward, JA; Choo, DI; Riazuddin, S; Ahmed, ZM				Giese, Arnaud P. J.; Guarnaschelli, Jess G.; Ward, Jonette A.; Choo, Daniel I.; Riazuddin, Salma; Ahmed, Zubair M.			Radioprotective Effect of Aminothiol PrC-210 on Irradiated Inner Ear of Guinea Pig	PLOS ONE			English	Article							RADIATION-THERAPY; AMIFOSTINE; PROTECTS	Radiotherapy of individuals suffering with head & neck or brain tumors subserve the risk of sensorineural hearing loss. Here, we evaluated the protective effect of Aminothiol PrC-210 (3-(methyl-amino)-2-((methylamino) methyl) propane-1-thiol) on the irradiated inner ear of guinea pigs. An intra-peritoneal or intra-tympanic dose of PrC-210 was administered prior to receiving a dose of gamma radiation (3000 cGy) to each ear. Auditory Brainstem Responses (ABRs) were recorded one week and two weeks after the radiation and compared with the sham animal group. ABR thresholds of guinea pigs that received an intraperitoneal dose of PrC-210 were significantly better compared to the non-treated, control animals at one week post-radiation. Morphologic analysis of the inner ear revealed significant inflammation and degeneration of the spiral ganglion in the irradiated animals not treated with PrC-210. In contrast, when treated with PrC-210 the radiation effect and injury to the spiral ganglion was significantly alleviated. PrC-210 had no apparent cytotoxic effect in vivo and did not affect the morphology or count of cochlear hair cells. These findings suggest that aminothiol PrC-210 attenuated radiation-induced cochlea damage for at least one week and protected hearing.	[Giese, Arnaud P. J.; Riazuddin, Salma; Ahmed, Zubair M.] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Guarnaschelli, Jess G.] Univ Cincinnati, Dept Radiat Oncol, Cincinnati, OH 45221 USA; [Guarnaschelli, Jess G.] TriHlth Canc Inst, Dept Radiat Oncol, Cincinnati, OH USA; [Ward, Jonette A.; Choo, Daniel I.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Otolaryngol Head & Neck Surg, Cincinnati, OH 45229 USA	University System of Maryland; University of Maryland Baltimore; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Guarnaschelli, JG (corresponding author), Univ Cincinnati, Dept Radiat Oncol, Cincinnati, OH 45221 USA.	Jessica_Guarnaschelli@trihealth.com; zahmed@smail.umaryland.edu	Giese, Arnaud P.J./P-1683-2019	Giese, Arnaud/0000-0001-7228-9542	Department of Radiation, University of Cincinnati	Department of Radiation, University of Cincinnati	Supported by funds from Department of Radiation, University of Cincinnati. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. F. Smith, J. Breneman, W. Barrett, M. Lamba, and W. Kassing for their support and helpful discussion. We also thank M. Davis and J. Bailey for their technical assistance. Supported by the funds from Department of Radiation, University of Cincinnati.	Altas E, 2006, ANN CLIN LAB SCI, V36, P312; Altas E, 2006, BIOL PHARM BULL, V29, P1460, DOI 10.1248/bpb.29.1460; Fleury B, 2010, CANCER RADIOTHER, V14, P284, DOI 10.1016/j.canrad.2010.02.011; GAMBLE JE, 1968, ARCH OTOLARYNGOL, V88, P156; Huang E, 2002, INT J RADIAT ONCOL, V52, P599, DOI 10.1016/S0360-3016(01)02641-4; Ingham NJ, 1998, ACTA OTO-LARYNGOL, V118, P673; Johnke RM, 2014, FUTURE ONCOL, V10, P2345, DOI 10.2217/fon.14.175; Lessa Ricardo Miranda, 2009, Braz. j. otorhinolaryngol., V75, P694; Low WK, 2008, ACTA OTO-LARYNGOL, V128, P440, DOI 10.1080/00016480701762490; Mujica-Mota MA, 2014, HEARING RES, V312, P60, DOI 10.1016/j.heares.2014.03.003; Oshima CTF, 2015, ANTICANCER RES, V35, P2817; Page EE, 2015, J PLAST RECONSTR AES, V68, P98, DOI 10.1016/j.bjps.2014.08.054; Peebles DD, 2012, RADIAT RES, V178, P57, DOI 10.1667/RR2806.1; Pyun JH, 2011, NEUROSCIENCE, V199, P410, DOI 10.1016/j.neuroscience.2011.09.012; Soref CM, 2012, INT J RADIAT ONCOL, V82, pE701, DOI 10.1016/j.ijrobp.2011.11.038; Stieber VW, 2007, NEUROL CLIN, V25, P1005, DOI 10.1016/j.ncl.2007.07.005; WINTHER FO, 1969, ACTA OTO-LARYNGOL, V68, P98, DOI 10.3109/00016486909121548; Yildirim BA, 2015, RETINA-J RET VIT DIS, V35, P1458, DOI 10.1097/IAE.0000000000000493; Young YH, 1999, J LARYNGOL OTOL, V113, P815, DOI 10.1017/S0022215100145281	19	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143606	10.1371/journal.pone.0143606	http://dx.doi.org/10.1371/journal.pone.0143606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599238	gold, Green Submitted, Green Published			2022-12-26	WOS:000365853900148
J	Zhang, C; Liu, FF; Chang, H; Li, HG; Zhou, X; Lu, J; Qin, CK; Sun, YJ; Sun, HD; Lin, JB				Zhang, Chi; Liu, Fangfeng; Chang, Hong; Li, Hongguang; Zhou, Xu; Lu, Jun; Qin, Chengkun; Sun, Yongjie; Sun, Huidong; Lin, Jianbo			Less Aggressive Surgical Procedure for Treatment of Solid Pseudopapillary Tumor: Limited Experience from a Single Institute	PLOS ONE			English	Article							CLINICAL-FEATURES; PANCREAS; NEOPLASM; DIAGNOSIS; PROGNOSIS; DISTINCT; HEAD	Objectives To evaluate the clinical characteristics and radiological features of solid pseudopapillary tumor (SPT) and assess surgical therapy strategy. Methods A retrospective review was performed in 62 patients pathologically confirmed of SPT treated between 2003 and 2014. The clinical features, radiological examinations and surgical strategies were analyzed. Results 56 females and 6 males were included in this study, mean age was 26 years old (range: 8-66 years old) with mean size of the tumor was 7.2 cm (range: 3-15 cm), and most tumor were commonly located in the head of pancreas (n = 29). Among all the cases, 3 patients had liver metastasis and underwent resection of SPT and liver metastasis. Furthermore, we performed 29 cases of local tumor excision; other patients underwent pancreaticoduo-denectomy, middle pancreatectomy, middle pancreatectomy with splenectomy, distal pancreatectomy with spleen preservation, distal pancreatectomy with splenectomy and duodenum-preserving pancreatic head resection. No patient suffered from lymph node metastases. After median follow-up of 46 months (range: 2-135 months), no mortality or local recurrence or distant metastasis was found. Conclusions Solid pseudopapillary tumor is a latent malignant tumor with excellent prognosis. If feasible, less aggressive resection without regular lymphadenectomy is recommended for treatment of patients with SPT.	[Zhang, Chi; Liu, Fangfeng; Chang, Hong; Li, Hongguang; Zhou, Xu; Lu, Jun; Qin, Chengkun; Sun, Yongjie; Sun, Huidong; Lin, Jianbo] Shandong Univ, Dept Gen Surg, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Chang, H (corresponding author), Shandong Univ, Dept Gen Surg, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China.	changhong@sdu.edu.cn						Adams AL, 2008, ADV ANAT PATHOL, V15, P39, DOI 10.1097/PAP.0b013e31815e5237; Akiyama H, 2002, J GASTROINTEST CANC, V32, P47, DOI 10.1385/IJGC:32:1:47; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; BEGER HG, 1985, SURGERY, V97, P467; Butte JM, 2011, J GASTROINTEST SURG, V15, P350, DOI 10.1007/s11605-010-1337-1; Cai YQ, 2014, WORLD J GASTROENTERO, V20, P6939, DOI 10.3748/wjg.v20.i22.6939; Cai YQ, 2014, J GASTROINTEST SURG, V18, P935, DOI 10.1007/s11605-014-2476-6; Chang Hong, 2010, Int J Med Sci, V7, P309; Chetty R, 2008, HUM PATHOL, V39, P1407, DOI 10.1016/j.humpath.2008.05.015; Dan D, 2014, CASE REP MED, V2014, DOI 10.1155/2014/356379; de Castro SMM, 2007, WORLD J SURG, V31, P1129, DOI 10.1007/s00268-006-0214-2; El Nakeeb A, 2013, INT J SURG, V11, P447, DOI 10.1016/j.ijsu.2013.04.009; Geers C, 2006, AM J SURG PATHOL, V30, P1243, DOI 10.1097/01.pas.0000213311.28682.b2; Kawamoto S, 2011, CLIN IMAG, V35, P21, DOI 10.1016/j.clinimag.2009.11.007; Kim MJ, 2014, BRIT J SURG, V101, P1266, DOI 10.1002/bjs.9577; Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F; Li ZJ, 2011, SURG TODAY, V41, P91, DOI 10.1007/s00595-009-4225-0; Machado MCC, 2008, SURGERY, V143, P29, DOI 10.1016/j.surg.2007.07.030; Morikawa T, 2013, SURG TODAY, V43, P26, DOI 10.1007/s00595-012-0345-z; Papavramidis T, 2005, J AM COLL SURGEONS, V200, P965, DOI 10.1016/j.jamcollsurg.2005.02.011; Pettinato G, 2002, DIAGN CYTOPATHOL, V27, P325, DOI 10.1002/dc.10189; Raffel A, 2004, SURG ONCOL, V13, P1, DOI 10.1016/j.suronc.2003.09.003; Rebhandl W, 2001, J SURG ONCOL, V76, P289, DOI 10.1002/jso.1048; Romics L, 2010, LANGENBECK ARCH SURG, V395, P747, DOI 10.1007/s00423-010-0599-0; Sperti C, 2008, WORLD J GASTROENTERO, V14, P960, DOI 10.3748/wjg.14.960; Tanaka Y, 2001, CANCER RES, V61, P8401; Wang WB, 2014, EJSO-EUR J SURG ONC, V40, P1572, DOI 10.1016/j.ejso.2014.05.012; Yagci A, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-308; Yang F, 2008, J GASTROEN HEPATOL, V23, P1847, DOI 10.1111/j.1440-1746.2008.05526.x; Ye JH, 2012, J SURG ONCOL, V106, P728, DOI 10.1002/jso.23195; Yin QH, 2012, EUR J RADIOL, V81, P3010, DOI 10.1016/j.ejrad.2012.03.013; Yu PF, 2010, WORLD J GASTROENTERO, V16, P1209, DOI 10.3748/wjg.v16.i10.1209; Zhang Hao, 2006, Hepatobiliary Pancreat Dis Int, V5, P454	33	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143452	10.1371/journal.pone.0143452	http://dx.doi.org/10.1371/journal.pone.0143452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599966	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900124
J	Vidic, J; Richard, CA; Pechoux, C; Da Costa, B; Bertho, N; Mazerat, S; Delmas, B; Chevalier, C				Vidic, Jasmina; Richard, Charles-Adrien; Pechoux, Christine; Da Costa, Bruno; Bertho, Nicolas; Mazerat, Sandra; Delmas, Bernard; Chevalier, Christophe			Amyloid Assemblies of Influenza A Virus PB1-F2 Protein Damage Membrane and Induce Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; ELECTROCHEMICAL DETECTION; MITOCHONDRIAL-MEMBRANE; MISFOLDING DISEASES; LIPID-MEMBRANES; ALPHA-SYNUCLEIN; INFECTED-CELLS; MESSENGER-RNA; MECHANISM; BINDING	PB1-F2 is a small accessory protein encoded by an alternative open reading frame in PB1 segments of most influenza A virus. PB1-F2 is involved in virulence by inducing mitochondria-mediated immune cells apoptosis, increasing inflammation, and enhancing predisposition to secondary bacterial infections. Using biophysical approaches we characterized membrane disruptive activity of the full-length PB1-F2 (90 amino acids), its N-terminal domain (52 amino acids), expressed by currently circulating H1N1 viruses, and its C-terminal domain (38 amino acids). Both full-length and N-terminal domain of PB1-F2 are soluble at pH values <= 6, whereas the C-terminal fragment was found soluble only at pH <= 3. All three peptides are intrinsically disordered. At pH >= 7, the C-terminal part of PB1-F2 spontaneously switches to amyloid oligomers, whereas full-length and the N-terminal domain of PB1-F2 aggregate to amorphous structures. When incubated with anionic liposomes at pH 5, full-length and the C-terminal part of PB1-F2 assemble into amyloid structures and disrupt membrane at nanomolar concentrations. PB1-F2 and its C-terminal exhibit no significant antimicrobial activity. When added in the culture medium of mammalian cells, PB1-F2 amorphous aggregates show no cytotoxicity, whereas PB1-F2 pre-assembled into amyloid oligomers or fragmented nanoscaled fibrils was highly cytotoxic. Furthermore, the formation of PB1-F2 amyloid oligomers in infected cells was directly reflected by membrane disruption and cell death as observed in U937 and A549 cells. Altogether our results demonstrate that membrane-lytic activity of PB1-F2 is closely linked to supramolecular organization of the protein.	[Vidic, Jasmina; Richard, Charles-Adrien; Da Costa, Bruno; Bertho, Nicolas; Delmas, Bernard; Chevalier, Christophe] INRA, Unite Virol & Immunol Mol, UR892, F-78350 Jouy En Josas, France; [Pechoux, Christine] INRA, Genet Anim & Biol Integrat, UMR1313, F-78350 Jouy En Josas, France; [Mazerat, Sandra] Univ Paris 11, Inst Chim Mol & Mat Orsay, CNRS, UMR 8182, F-91400 Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Vidic, J (corresponding author), INRA, Unite Virol & Immunol Mol, UR892, F-78350 Jouy En Josas, France.	jasmina.vidic@jouy.inra.fr	Chevalier, Christophe/C-2575-2009; Vidic, Jasmina/AFP-6747-2022; Chevalier, Christophe/AAW-5560-2020; BERTHO, Nicolas/B-8167-2019; Chevalier, Christophe/AAK-4461-2020	Chevalier, Christophe/0000-0003-3231-9027; Vidic, Jasmina/0000-0002-8549-8199; BERTHO, Nicolas/0000-0002-6732-3483; RICHARD, Charles-Adrien/0000-0001-5306-2297				Alymova IV, 2014, J VIROL, V88, P503, DOI 10.1128/JVI.01373-13; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chakrabarti AK, 2013, VIROLOGY, V440, P97, DOI 10.1016/j.virol.2013.02.025; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Daude N, 2010, J NEUROCHEM, V113, P92, DOI 10.1111/j.1471-4159.2010.06575.x; Domanov YA, 2008, J MOL BIOL, V376, P42, DOI 10.1016/j.jmb.2007.11.077; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Goodchild SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104492; Henkel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011112; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kosik I, 2013, VIROLOGY, V447, P1, DOI 10.1016/j.virol.2013.08.022; Krumbholz A, 2011, MED MICROBIOL IMMUN, V200, P69, DOI 10.1007/s00430-010-0176-8; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Li QJ, 2013, BIOCHEM BIOPH RES CO, V438, P519, DOI 10.1016/j.bbrc.2013.07.104; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; Miodek A, 2014, ANAL CHEM, V86, P9098, DOI 10.1021/ac5018056; Miodek A, 2014, BIOSENS BIOELECTRON, V59, P6, DOI 10.1016/j.bios.2014.02.037; Muramoto Y, 2013, J VIROL, V87, P2455, DOI 10.1128/JVI.02656-12; Relini A, 2014, ADV COLLOID INTERFAC, V207, P81, DOI 10.1016/j.cis.2013.10.015; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Steunou S, 2010, BIOSENS BIOELECTRON, V26, P1399, DOI 10.1016/j.bios.2010.07.064; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; Terakawa MS, 2015, J BIOL CHEM, V290, P815, DOI 10.1074/jbc.M114.592527; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Vasin AV, 2014, VIRUS RES, V185, P53, DOI 10.1016/j.virusres.2014.03.015; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Vidic J., 2013, J ANAL BIOANAL TECH, V4, P169; Walsh P, 2014, J BIOL CHEM, V289, P10419, DOI 10.1074/jbc.M113.515866; Weeks-Gorospe JN, 2012, J VIROL, V86, P9035, DOI 10.1128/JVI.00369-12; Wise HM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002998; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wright P., 2007, ORTHOMYXOVIRUSES; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40	53	35	38	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					739	751		10.1074/jbc.M115.652917	http://dx.doi.org/10.1074/jbc.M115.652917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26601953	Green Published, hybrid			2022-12-26	WOS:000367830500022
J	Chavez, JR; Ibancovichi, JA; Sanchez-Aparicio, P; Acevedo-Arcique, CM; Moran-Munoz, R; Recillas-Morales, S				Chavez, Julio R.; Ibancovichi, Jose A.; Sanchez-Aparicio, Pedro; Acevedo-Arcique, Carlos M.; Moran-Munoz, Rafael; Recillas-Morales, Sergio			Effect of Acetaminophen Alone and in Combination with Morphine and Tramadol on the Minimum Alveolar Concentration of Isoflurane in Rats	PLOS ONE			English	Article							CYCLOOXYGENASE INHIBITORS; ANESTHETIC CONCENTRATION; PARACETAMOL; REDUCTION; MELOXICAM; FENTANYL; SURGERY; ANTINOCICEPTION; REMIFENTANIL; BUTORPHANOL	Background It has been observed that acetaminophen potentiates the analgesic effect of morphine and tramadol in postoperative pain management. Its capacity as an analgesic drug or in combinations thereof to reduce the minimum alveolar concentration (MAC) of inhalational anesthetics represents an objective measure of this effect during general anesthesia. In this study, the effect of acetaminophen with and without morphine or tramadol was evaluated on the isoflurane MAC. Methods Forty-eight male Wistar rats were anesthetized with isoflurane in oxygen. MACISO was determined from alveolar gas samples at the time of tail clamping without the drug, after administering acetaminophen (300 mg/kg), morphine (3 mg/kg), tramadol (10mg/kg), acetaminophen (300 mg/kg) + morphine (3 mg/kg), and acetaminophen (300 mg/kg) + tramadol (10 mg/kg). Results The control and acetaminophen groups did not present statistically significant differences (rho = 0.98). The values determined for MACISO after treatment with acetaminophen + morphine, acetaminophen + tramadol, morphine, and tramadol were 0.98% +/- 0.04%, 0.99% +/- 0.009%, 0.97% +/- 0.02%, and 0.99% +/- 0.01%, respectively. Conclusions The administration of acetaminophen did not reduce the MAC of isoflurane and did not potentiate the reduction in MACISO by morphine and tramadol in rats, and therefore does not present a sparing effect of morphine or tramadol in rats anesthetized with isoflurane.	[Chavez, Julio R.; Ibancovichi, Jose A.; Moran-Munoz, Rafael] Univ Autonoma Estado Mexico, Dept Anesthesiol, Fac Vet Med, Toluca, Estado De Mexic, Mexico; [Sanchez-Aparicio, Pedro; Recillas-Morales, Sergio] Univ Autonoma Estado Mexico, Dept Pharmacol, Fac Vet Med, Toluca, Estado De Mexic, Mexico; [Acevedo-Arcique, Carlos M.] Univ Autonoma Yucatan, Fac Vet Med, Dept Anesthesiol & Pharmacol, Merida, Yucatan, Mexico	Universidad Autonoma de Yucatan	Ibancovichi, JA (corresponding author), Univ Autonoma Estado Mexico, Dept Anesthesiol, Fac Vet Med, Toluca, Estado De Mexic, Mexico.	ibanvet@gmail.com	Recillas, Sergio/K-5484-2014; aparicio, pedro sanchez/AAS-4265-2021	Recillas, Sergio/0000-0001-5963-8269; aparicio, pedro sanchez/0000-0002-6511-6595; Chavez Monteagudo, Julio Raul/0000-0002-2078-1217; Ibancovichi, Jose Antonio/0000-0003-1760-687X	Autonomous University of the State of Mexico	Autonomous University of the State of Mexico	This study was funded from the Autonomous University of the State of Mexico in order to strengthen research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano G, 2011, EUR REV MED PHARMACO, V15, P205; Alloui A, 2002, EUR J PHARMACOL, V443, P71, DOI 10.1016/S0014-2999(02)01578-9; BEAVER WT, 1984, AM J MED, V77, P38, DOI 10.1016/S0002-9343(84)80101-1; Benito J, 2010, BRIT J ANAESTH, V105, P810, DOI 10.1093/bja/aeq241; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; Bjornsson GA, 2003, BRIT J CLIN PHARMACO, V55, P405, DOI 10.1046/j.1365-2125.2003.01779.x; Botting RM, 2006, J PHYSIOL PHARMACOL, V57, P113; Bujalska M, 2004, POL J PHARMACOL, V56, P605; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Cobby TF, 1999, BRIT J ANAESTH, V83, P253, DOI 10.1093/bja/83.2.253; Criado AB, 2003, VET ANAESTH ANALG, V30, P250, DOI 10.1046/j.1467-2995.2003.00123.x; de Segura IAG, 1998, ANESTHESIOLOGY, V89, P1489, DOI 10.1097/00000542-199812000-00027; de Wolff MH, 1999, BRIT J ANAESTH, V83, P780, DOI 10.1093/bja/83.5.780; DELBOS A, 1995, J PAIN SYMPTOM MANAG, V10, P279, DOI 10.1016/0885-3924(95)00004-I; Dhillon S, 2010, CLIN DRUG INVEST, V30, P711, DOI 10.2165/11205830-000000000-00000; Docquier MA, 2003, ANESTH ANALG, V97, P1033, DOI 10.1213/01.ANE.0000078587.51622.D0; Doherty TJ, 2004, VET ANAESTH ANALG, V31, P97, DOI 10.1111/j.1467-2987.2004.00156.x; EGER EI, 1965, ANESTHESIOLOGY, V26, P756, DOI 10.1097/00000542-196511000-00010; FLOWER RJ, 1972, NATURE, V240, P410, DOI 10.1038/240410a0; Graham Garry G., 2003, Inflammopharmacology, V11, P401, DOI 10.1163/156856003322699573; Gutierrez-Blanco E, 2013, VET ANAESTH ANALG, V40, P599, DOI 10.1111/vaa.12079; Hinz B, 2008, FASEB J, V22, P383, DOI 10.1096/fj.07-8506com; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Jahr Jonathan S, 2010, Anesthesiol Clin, V28, P619, DOI 10.1016/j.anclin.2010.08.006; Jozwiak-Bebenista M, 2014, ACTA POL PHARM, V71, P11; Kis B, 2005, J PHARMACOL EXP THER, V315, P1, DOI 10.1124/jpet.105.085431; Knych HKD, 2009, AM J VET RES, V70, P1193, DOI 10.2460/ajvr.70.10.1193; Lewis KS, 1997, AM J HEALTH-SYST PH, V54, P643, DOI 10.1093/ajhp/54.6.643; Nakamura K, 2001, NEUROSCIENCE, V103, P763, DOI 10.1016/S0306-4522(01)00027-6; Pini LA, 1997, J PHARMACOL EXP THER, V280, P934; QUASHA AL, 1980, ANESTHESIOLOGY, V53, P315, DOI 10.1097/00000542-198010000-00008; Remy C, 2005, BRIT J ANAESTH, V94, P505, DOI 10.1093/bja/aei085; Santos M, 2004, ANESTH ANALG, V98, P359, DOI 10.1213/01.ANE.0000097849.18820.C4; Schug SA, 2006, CLIN RHEUMATOL, V25, pS16, DOI 10.1007/s10067; Smith HS, 2009, PAIN PHYSICIAN, V12, P269; Steagall PVM, 2006, JAVMA-J AM VET MED A, V229, P522, DOI 10.2460/javma.229.4.522; Turner PV, 2006, AM J VET RES, V67, P770, DOI 10.2460/ajvr.67.5.770; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Vaughan CW, 1998, BRIT J PHARMACOL, V123, P1479, DOI 10.1038/sj.bjp.0701818; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; Yamashita K, 2008, J VET MED SCI, V70, P29, DOI 10.1292/jvms.70.29	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143710	10.1371/journal.pone.0143710	http://dx.doi.org/10.1371/journal.pone.0143710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605541	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300102
J	Kopriva, D; Kisheev, A; Meena, D; Pelle, S; Karnitsky, M; Lavoie, A; Buttigieg, J				Kopriva, David; Kisheev, Anastasye; Meena, Deiter; Pelle, Shaneen; Karnitsky, Max; Lavoie, Andrea; Buttigieg, Josef			The Nature of Iron Deposits Differs between Symptomatic and Asymptomatic Carotid Atherosclerotic Plaques	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; CORONARY-ARTERY-DISEASE; STENOSIS; CALCIFICATION; MACROPHAGES; PROGRESSION; OXIDATION; ENDARTERECTOMY; ATHEROMA; INSIGHTS	Iron within atherosclerotic plaque has been implicated as a catalyst of oxidative stress that causes progression of plaque, and plaque rupture. Iron is believed to accumulate within plaque by incorporation of erythrocytes following plaque rupture and hemorrhage. There is only indirect evidence to support this hypothesis. Plaque specimens were obtained from ten symptomatic and fifteen asymptomatic patients undergoing carotid endarterectomy at a single institution. Plaques were sectioned for study using synchrotron radiation induced X-ray fluorescence the study the distribution of zinc, calcium and iron. Histologic staining was carried out with Prussian Blue, and immunohistochemical staining was done to localize macrophages with CD68. Data were compared against patient clinical variables. Ten symptomatic (15 +/- 10 days between index symptoms and surgery) and fifteen asymptomatic carotid plaques were studied. Zinc and calcium co-localized in mineralized areas of symptomatic and asymptomatic plaque. Iron was identified away from zinc and calcium in both symptomatic and asymptomatic plaques. Within the symptomatic plaques, iron was found within the thrombus associated with plaque rupture and hemorrhage. It did not stain with Prussian Blue, but was found in association with CD68 positive macrophages. In symptomatic plaques, the abundance of iron showed an association with the source patient's LDL cholesterol (R-2 = 0.39, Significance F = 0.05). Iron in asymptomatic plaque was present as hemosiderin/ferritin that stained positive with Prussian Blue, and was observed in association with CD68 positive macrophages. Iron in acutely symptomatic plaques is found within thrombus, in the presence of macrophages. The abundance of iron in symptomatic plaques is associated with the source patient's LDL cholesterol. Within asymptomatic plaques, iron is found in association with macrophages, as hemosiderin/ferritin.	[Kopriva, David] Univ Saskatchewan, Coll Med, Regina QuAppelle Hlth Reg, Dept Surg Vasc Surg, Regina, SK, Canada; [Kisheev, Anastasye; Pelle, Shaneen; Karnitsky, Max; Buttigieg, Josef] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada; [Meena, Deiter] Univ Saskatchewan, Coll Med, Regina, SK, Canada; [Lavoie, Andrea] Univ Saskatchewan, Coll Med, Regina QuAppelle Hlth Reg, Dept Med Cardiol, Regina, SK, Canada	University of Saskatchewan; University of Regina; University of Saskatchewan; University of Saskatchewan	Buttigieg, J (corresponding author), Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada.	Josef.buttigieg@uregina.ca			Saskatchewan Health Research Foundation, Collaborative Innovation Development Grant; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]	Saskatchewan Health Research Foundation, Collaborative Innovation Development Grant; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Funded by Saskatchewan Health Research Foundation, Collaborative Innovation Development Grant.; Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02- 76SF00515.	[Anonymous], 1992, Mayo Clin Proc, V67, P513; Arbab-Zadeh A, 2012, J AM COLL CARDIOL, V59, P379, DOI 10.1016/j.jacc.2011.06.079; ARBUSTINI E, 1991, AM J CARDIOL, V68, pB36, DOI 10.1016/0002-9149(91)90383-V; Bories G, 2013, CIRC RES, V113, P1196, DOI 10.1161/CIRCRESAHA.113.301656; Burke AP, 2001, CIRCULATION, V103, P934; Carr S, 1996, J VASC SURG, V23, P755, DOI 10.1016/S0741-5214(96)70237-9; Davies MJ, 1996, THROMB RES, V82, P1, DOI 10.1016/0049-3848(96)00035-7; DAVIES MJ, 1989, EUR HEART J, V10, P203, DOI 10.1093/oxfordjournals.eurheartj.a059467; DIENER HC, 1991, STROKE, V22, P1229; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Ferguson GG, 1999, STROKE J CEREBRAL CI; Finn AV, 2012, J AM COLL CARDIOL, V59, P166, DOI 10.1016/j.jacc.2011.10.852; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Hasty AH, 2013, CIRC RES, V113, P1182, DOI 10.1161/CIRCRESAHA.113.302613; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; HUDSON J, 1974, ATHEROSCLEROSIS, V19, P543, DOI 10.1016/S0021-9150(74)80018-3; Hunt JL, 2002, STROKE, V33, P1214, DOI 10.1161/01.STR.0000013741.41309.67; Kolodgie FD, 2004, HEART, V90, P1385, DOI 10.1136/hrt.2004.041798; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Marso SP, 2012, JACC-CARDIOVASC IMAG, V5, pS42, DOI 10.1016/j.jcmg.2012.01.008; Miwa K, 2010, INTERNAL MED, V49, P817, DOI 10.2169/internalmedicine.49.3211; MOORE WS, 1968, AM J SURG, V116, P237, DOI 10.1016/0002-9610(68)90499-6; MOORE WS, 1970, ARCH SURG-CHICAGO, V101, P708; Nandalur KR, 2007, STROKE, V38, P935, DOI 10.1161/01.STR.0000257995.74834.92; Peeters W, 2009, ARTERIOSCL THROM VAS, V29, P128, DOI 10.1161/ATVBAHA.108.173658; Rajendran R, 2012, FREE RADICAL BIO MED, V53, P1675, DOI 10.1016/j.freeradbiomed.2012.07.014; Raman SV, 2008, JACC-CARDIOVASC IMAG, V1, P49, DOI 10.1016/j.jcmg.2007.09.002; Sakakura K, 2013, HEART LUNG CIRC, V22, P399, DOI 10.1016/j.hlc.2013.03.001; SEEGER JM, 1995, J SURG RES, V58, P330, DOI 10.1006/jsre.1995.1051; Sharkey-Toppen TP, 2014, J CARDIOVASC TRANSL, V7, P533, DOI 10.1007/s12265-014-9551-y; Stadler N, 2004, ARTERIOSCL THROM VAS, V24, P949, DOI 10.1161/01.ATV.0000124892.90999.cb; Stadler N, 2008, ARTERIOSCL THROM VAS, V28, P1024, DOI 10.1161/ATVBAHA.108.162735; Stanley N, 2006, FREE RADICAL BIO MED, V40, P1636, DOI 10.1016/j.freeradbiomed.2005.12.031; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Yuan XM, 1999, FREE RADICAL RES, V30, P221, DOI 10.1080/10715769900300241; Yuan XM, 1996, ATHEROSCLEROSIS, V124, P61, DOI 10.1016/0021-9150(96)05817-0	39	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143138	10.1371/journal.pone.0143138	http://dx.doi.org/10.1371/journal.pone.0143138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606178	gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300046
J	Rose, AS; Zachariae, U; Grubmuller, H; Hofmann, KP; Scheerer, P; Hildebrand, PW				Rose, Alexander S.; Zachariae, Ulrich; Grubmueller, Helmut; Hofmann, Klaus Peter; Scheerer, Patrick; Hildebrand, Peter W.			Role of Structural Dynamics at the Receptor G Protein Interface for Signal Transduction	PLOS ONE			English	Article							BETA(2) ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; COUPLED RECEPTOR; RHODOPSIN MUTANTS; ACTIVATION; COMPLEX; POTENTIALS; EFFICIENT; BILAYER; OPSIN	GPCRs catalyze GDP/GTP exchange in the a-subunit of heterotrimeric G proteins (G alpha beta gamma) through displacement of the G alpha C-terminal alpha 5 helix, which directly connects the interface of the active receptor (R*) to the nucleotide binding pocket of G. Hydrogen-deuterium exchange mass spectrometry and kinetic analysis of R* catalysed G protein activation have suggested that displacement of a5 starts from an intermediate GDP bound complex (R*center dot G(GDP)). To elucidate the structural basis of receptor-catalysed displacement of alpha 5, we modelled the structure of R*center dot G(GDP). A flexible docking protocol yielded an intermediate R*center dot G(GDP) complex, with a similar overall arrangement as in the X-ray structure of the nucleotide free complex (R*center dot G(empty)), however with the alpha 5 C-terminus (G alpha CT) forming different polar contacts with R*. Starting molecular dynamics simulations of G alpha CT bound to R* in the intermediate position, we observe a screw-like motion, which restores the specific interactions of alpha 5 with R* in R*center dot G(empty). The observed rotation of alpha 5 by 60 degrees is in line with experimental data. Reformation of hydrogen bonds, water expulsion and formation of hydrophobic interactions are driving forces of the alpha 5 displacement. We conclude that the identified interactions between R* and G protein define a structural framework in which the alpha 5 displacement promotes direct transmission of the signal from R* to the GDP binding pocket.	[Rose, Alexander S.; Hofmann, Klaus Peter; Scheerer, Patrick; Hildebrand, Peter W.] Univ Med Berlin, Inst Med Phys & Biophys CC2, D-10098 Berlin, Germany; [Rose, Alexander S.; Hildebrand, Peter W.] Univ Med Berlin, Team ProteiInformat, D-10098 Berlin, Germany; [Scheerer, Patrick] Charite, Team Prot Xray Crystallog & Signal Transduct, D-10098 Berlin, Germany; [Hofmann, Klaus Peter] Humboldt Univ, Ctr Biophys & Bioinformat, D-10115 Berlin, Germany; [Zachariae, Ulrich; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Zachariae, Ulrich] Univ Dundee, Sch Sci & Engn, Sch Life Sci & Phys, Computat Biol, Dundee DD1 5EH, Scotland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Max Planck Society; University of Dundee	Hildebrand, PW (corresponding author), Univ Med Berlin, Inst Med Phys & Biophys CC2, Charitepl 1, D-10098 Berlin, Germany.	peter.hildebrand@charite.de	Rose, Alexander/I-4371-2019	Rose, Alexander/0000-0002-0893-5551; Zachariae, Ulrich/0000-0003-3287-8494; Scheerer, Patrick/0000-0001-5028-2075	Deutsche Forschungsgemeinschaft [Sfb740, Sfb1078-B6]; Scottish Universities Physics Alliance; UK National Physical Laboratory; DFG [HI 1502/1-1, BI 893/8]; DFG Cluster of Excellence 'Unifying Concepts in Catalysis' [D3/E3-1]; ERC Advanced grant [ERC-2009/249910-TUDOR]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Scottish Universities Physics Alliance; UK National Physical Laboratory; DFG(German Research Foundation (DFG)); DFG Cluster of Excellence 'Unifying Concepts in Catalysis'(German Research Foundation (DFG)); ERC Advanced grant(European Research Council (ERC))	This work was supported by the Deutsche Forschungsgemeinschaft Sfb740 (to K.P.H., P.S. and P.W.H.), Sfb1078-B6 (to P.S.), DFG HI 1502/1-1 (to P.W.H.), BI 893/8 (to P.W.H.), DFG Cluster of Excellence 'Unifying Concepts in Catalysis' (Research Field D3/E3-1 to P.S.) and ERC Advanced grant (ERC-2009/249910-TUDOR to K.P.H.). The computer time necessary for this project was provided in part by the "Norddeutscher Verbund fuur Hoch und Houchstleistungsrechner" (HLRN). U.Z. acknowledges funding from the Scottish Universities Physics Alliance and the UK National Physical Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deutsche Forschungsgemeinschaft Sfb740 (to K.P.H., P.S. and P.W.H.), Sfb1078-B6 (to P.S.), DFG HI 1502/1-1 (to P.W.H.), BI 893/8 (to P.W.H.), DFG Cluster of Excellence 'Unifying Concepts in Catalysis' (Research Field D3/E3-1 to P.S.) and ERC Advanced grant (ERC-2009/249910-TUDOR to K.P.H.). The computer time necessary for this project was provided in part by the "Norddeutscher Verbund fuur Hoch und Houchstleistungsrechner" (HLRN). U.Z. acknowledges funding from the Scottish Universities Physics Alliance and the UK National Physical Laboratory.	Alexander NS, 2014, NAT STRUCT MOL BIOL, V21, P56, DOI 10.1038/nsmb.2705; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Elgeti M, 2013, J AM CHEM SOC, V135, P12305, DOI 10.1021/ja405133k; ERNST OP, 1995, J BIOL CHEM, V270, P10580, DOI 10.1074/jbc.270.18.10580; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hildebrand PW, 2009, NUCLEIC ACIDS RES, V37, pW571, DOI 10.1093/nar/gkp338; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kim TH, 2013, J AM CHEM SOC, V135, P9465, DOI 10.1021/ja404305k; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mnpotra JS, 2014, J BIOL CHEM, V289, P20259, DOI 10.1074/jbc.M113.539916; Natochin M, 2000, J BIOL CHEM, V275, P2669, DOI 10.1074/jbc.275.4.2669; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rose AS, 2014, J AM CHEM SOC, V136, P11244, DOI 10.1021/ja5055109; RUBENSTEIN RC, 1987, J BIOL CHEM, V262, P16655; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scheerer P, 2009, P NATL ACAD SCI USA, V106, P10660, DOI 10.1073/pnas.0900072106; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shim JY, 2013, J BIOL CHEM, V288, P32449, DOI 10.1074/jbc.M113.489153; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507	41	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143399	10.1371/journal.pone.0143399	http://dx.doi.org/10.1371/journal.pone.0143399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606751	gold, Green Published			2022-12-26	WOS:000365865300061
J	Bhatt, SP; Misra, A; Nigam, P; Guleria, R; Pasha, MAQ				Bhatt, Surya Prakash; Misra, Anoop; Nigam, Priyanka; Guleria, Randeep; Pasha, M. A. Qadar			Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; METABOLIC SYNDROME; SOUTH ASIANS; VISCERAL FAT; STEATOSIS; ADOLESCENTS; CHILDREN; POPULATION; PREVALENCE	Objective In this study, we have attempted comparison of detailed body composition phenotype of Asian Indians with non-alcoholic fatty liver disease (NAFLD) vs. those without, in a case controlled manner. We also aim to analyse prediction equations for NAFLD for non-diabetic Asian Indians, and compare performance of these with published prediction equations researched from other populations. Methods In this case-control study, 162 cases and 173 age-and sex-matched controls were recruited. Clinical, anthropometric, metabolic, and body composition profiles, and liver ultrasound were done. Fasting insulin levels, value of homeostasis model assessment of insulin resistance (HOMA-IR), and serum high sensitive C-reactive protein (hs-CRP) levels were evaluated. Multivariate logistic and linear regression analyses were used to arrive at prediction equations for fatty liver [Indian fatty liver index (IFLI)]. Results As compared to those without fatty liver, those with fatty liver exhibited the following; Excess dorsocervical fat ('Buffalo hump'), skin tags, xanthelasma, 'double chin', arcus; excess total, abdominal and subcutaneous adiposity, and high blood pressure, blood glucose, measures of insulin resistance (fasting insulin and HOMA-IR values), lipids and hs-CRP levels. Two prediction equations were developed; Clinical [Indian Fatty Liver Index-Clinical; IFLIC]: 1(double chin) + 15.5 (systolic blood pressure) + 13.8 (buffalo hump); and IFLI-Clinical and Biochemical (CB): serum triglycerides+ 12 (insulin)+ 1(systolic blood pressure) + 18 (buffalo hump). On ROC Curve analysis, IFLI performed better than all published prediction equations, except one. Conclusion Non-diabetic Asian Indians with NAFLD researched by us were overweight/obese, had excess abdominal and subcutaneous fat, multiple other phenotypic markers, had higher insulin resistance, glycemia, dyslipidemia and subclinical inflammation than those without. Prediction score developed by us for NAFLD; IFLI-C and IFLI-CB, should be useful for clinicians and researchers.	[Bhatt, Surya Prakash; Misra, Anoop; Nigam, Priyanka] Diabet Fdn India, New Delhi, India; [Bhatt, Surya Prakash; Misra, Anoop; Nigam, Priyanka] Natl Diabet Obes & Cholesterol Fdn N DOC, New Delhi, India; [Bhatt, Surya Prakash; Guleria, Randeep] All India Inst Med Sci, Dept Pulm Med & Sleep Disorders, New Delhi, India; [Misra, Anoop] Fortis C DOC Ctr Excellence Diabet Metab Dis & En, New Delhi, India; [Bhatt, Surya Prakash; Pasha, M. A. Qadar] CSIR, Inst Genom & Integrat Biol, Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Misra, A (corresponding author), Diabet Fdn India, New Delhi, India.	anoopmisra@gmail.com	Bhatt, Surya/K-5263-2019; Bhatt, Surya Prakash/X-5941-2018	Bhatt, Surya/0000-0001-9489-9747; Bhatt, Surya Prakash/0000-0001-9489-9747	Indian Council of Medical Research Government of India [5/9/70/2008-RHM]	Indian Council of Medical Research Government of India(Indian Council of Medical Research (ICMR))	This study was fully supported by a grant from the Indian Council of Medical Research (No. 5/9/70/2008-RHM) Government of India. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj S, 2009, INDIAN J MED RES, V129, P285; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bedogni G, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-98; Bhatt SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040977; CHANDALIA M, 2012, J CLIN ENDOCR METAB, V97, P4663, DOI [DOI 10.1210/jc.2012-2018, DOI 10.1210/JC.2012-2018]; Chowdhury B, 1996, METABOLISM, V45, P634, DOI 10.1016/S0026-0495(96)90036-0; Damaso AR, 2008, DIGEST LIVER DIS, V40, P132, DOI 10.1016/j.dld.2007.09.009; Dudeja V, 2001, BRIT J NUTR, V86, P105, DOI 10.1079/BJN2001382; Fallo F, 2009, NUTR METAB CARDIOVAS, V19, P646, DOI 10.1016/j.numecd.2008.12.007; Garg A, 2004, INT TXB DIABETES MEL; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Joseph L, 2011, DIABETES TECHNOL THE, V13, P899, DOI 10.1089/dia.2011.0014; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lambert M, 2004, INT J OBESITY, V28, P833, DOI 10.1038/sj.ijo.0802694; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI DOI 10.1093/AJE/KWS448; Lin YC, 2010, PEDIATR NEONATOL, V51, P149, DOI 10.1016/S1875-9572(10)60028-9; Liu SH, 2013, J GASTROENTEROL, V48, P1151, DOI 10.1007/s00535-012-0715-8; Madhavan Malini, 2005, Lipids Health Dis, V4, P20, DOI 10.1186/1476-511X-4-20; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Misra A, 2014, DIABETIC MED, V31, P1153, DOI 10.1111/dme.12540; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, PLOS ONE IN PRESS; Misra A., 2008, DIABETES RES CLIN PR, V79, P1; Misra A, 2013, NUTRIENTS, V5, P2708, DOI 10.3390/nu5072708; Misra A, 2009, METAB SYNDR RELAT D, V7, P497, DOI 10.1089/met.2009.0024; Mohan V, 2009, DIABETES RES CLIN PR, V84, P84, DOI 10.1016/j.diabres.2008.11.039; Nishi T, 2015, J DIABETES INVEST, V6, P309, DOI 10.1111/jdi.12290; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; PETERS J, 1992, ANN HUM BIOL, V19, P17, DOI 10.1080/03014469200001882; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; Santos RR, 2006, REV BRAS NUTR CLIN, V21, P229; TAM K-M, 1986, Taiwan yixuehui zazhi, V85, P45	35	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142260	10.1371/journal.pone.0142260	http://dx.doi.org/10.1371/journal.pone.0142260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599361	gold, Green Published, Green Submitted			2022-12-26	WOS:000365862600009
J	Masso, A; Sanchez, A; Gimenez-Llort, L; Lizcano, JM; Canete, M; Garcia, B; Torres-Lista, V; Puig, M; Bosch, A; Chillon, M				Masso, Anna; Sanchez, Angela; Gimenez-Llort, Lydia; Lizcano, Jose Miguel; Canete, Manuel; Garcia, Belen; Torres-Lista, Virginia; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel			Secreted and Transmembrane alpha Klotho Isoforms Have Different Spatio-Temporal Profiles in the Brain during Aging and Alzheimer's Disease Progression	PLOS ONE			English	Article							TRANSCRIPTS ENCODING MEMBRANE; ANTIAGING PROTEIN KLOTHO; ENHANCES COGNITION; RHESUS-MONKEY; GENE; MOUSE; MICE; EXPRESSION; CLEAVAGE; IDENTIFICATION	The Klotho protein is a beta-glucuronidase, and its overexpression is associated with life extension. Its mechanism of action is not fully understood, although it has been recently reported that alpha Klotho improves synaptic and cognitive functions, and it may also influence a variety of structures and functions during CNS maturation and aging. The alpha Klotho gene has two transcripts, one encoding a transmembrane isoform (m-KL), and the other a putative secreted isoform (s-KL). Unfortunately, little is known about the secreted alpha Klotho isoform, since available antibodies cannot discriminate s-KL from the KL1 domain cleaved from the transmembrane isoform. This study shows, for the first time, that the klotho transcript produced by alternative splicing generates a stable protein (70 kDa), and that in contrast to the transmembrane Klotho isoform, it is ten times more abundant in the brain than in the kidney suggesting that the two isoforms may have different functions. We also studied whether klotho expression in the CNS was influenced by aging, Alzheimer's disease (AD), or a healthy lifestyle, such as voluntary moderate continuous exercise. We observed a strong correlation between high expression levels of the two klotho transcripts and the healthy status of the animals. Expression of Klotho in brain areas decayed more rapidly in the 3xTg-AD model of AD than in healthy animals, whilst moderate continuous exercise in adulthood prevents the decline in expression of both klotho transcripts.	[Masso, Anna; Sanchez, Angela; Lizcano, Jose Miguel; Canete, Manuel; Garcia, Belen; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Masso, Anna; Sanchez, Angela; Canete, Manuel; Garcia, Belen; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy CBATEG, Bellaterra, Spain; [Gimenez-Llort, Lydia; Lizcano, Jose Miguel; Torres-Lista, Virginia] Univ Autonoma Barcelona, Inst Neurociencies, Bellaterra, Spain; [Gimenez-Llort, Lydia; Torres-Lista, Virginia] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Bellaterra, Spain; [Chillon, Miguel] ICREA, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; ICREA	Chillon, M (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain.	miguel.chillon@uab.es	Bosch, Assumpcio/C-7593-2015; Llort, Lydia Gimenez/AAS-7415-2020; lizcano, jose m/AAK-3577-2020; Giménez-Llort, Lydia/I-3347-2015; Lizcano, Jose M/E-6080-2010; Giménez-Llort, Lydia/AAI-5182-2021; Torres-Lista, Virginia/AAM-6753-2020; Masso, Anna/AAA-7656-2019	Bosch, Assumpcio/0000-0002-7205-2796; lizcano, jose m/0000-0002-3154-5383; Lizcano, Jose M/0000-0002-3154-5383; Giménez-Llort, Lydia/0000-0002-4091-489X; Torres-Lista, Virginia/0000-0002-0603-5111; 	Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR14-1354, SGR09-1300]; Universitat Autonoma de Barcelona; FPU-Ministerio de Educacion, Cultura y Deporte national fellowship; ICREA Funding Source: Custom	Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Universitat Autonoma de Barcelona; FPU-Ministerio de Educacion, Cultura y Deporte national fellowship; ICREA(ICREA)	This work was supported by the Agencia de Gestio d'Ajuts Universitaris i de Recerca SGR14-1354 and SGR09-1300. M.P. and A.S. have been recipients of the TSR program from the Universitat Autonoma de Barcelona, and of an FPU-Ministerio de Educacion, Cultura y Deporte national fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-155; Bartke A, 2006, TRENDS ENDOCRIN MET, V17, P33, DOI 10.1016/j.tem.2006.01.002; Bektas A, 2004, MAMM GENOME, V15, P759, DOI 10.1007/s00335-004-2375-3; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen CD, 2014, BIOCHEMISTRY-US, V53, P5579, DOI 10.1021/bi500409n; Chen CD, 2013, J NEUROSCI, V33, P1927, DOI 10.1523/JNEUROSCI.2080-12.2013; Clinton SM, 2013, BRAIN RES, V1527, P1, DOI 10.1016/j.brainres.2013.06.044; Di Bona D, 2014, REJUV RES, V17, P212, DOI 10.1089/rej.2013.1523; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Forster RE, 2011, BIOCHEM BIOPH RES CO, V414, P557, DOI 10.1016/j.bbrc.2011.09.117; Garcia-Mesa Y, 2016, J GERONTOL A-BIOL, V71, P40, DOI 10.1093/gerona/glv005; Garcia-Mesa Y, 2011, J ALZHEIMERS DIS, V24, P421, DOI 10.3233/JAD-2011-101635; German DC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.018; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; King GD, 2012, AGE, V34, P1405, DOI 10.1007/s11357-011-9315-4; Kosakai A, 2011, BRAIN RES, V1382, P109, DOI 10.1016/j.brainres.2011.01.056; Kuang X, 2014, NEUROBIOL AGING, V35, P169, DOI 10.1016/j.neurobiolaging.2013.07.019; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Matsubara T, 2014, AM J PHYSIOL-HEART C, V306, pH348, DOI 10.1152/ajpheart.00429.2013; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Nagai Taku, 2003, FASEB Journal, V17, P50; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Papaconstantinou J, 2009, MOL CELL ENDOCRINOL, V299, P89, DOI 10.1016/j.mce.2008.11.025; Park SJ, 2014, ENDOCRINOL METAB, V29, P336, DOI 10.3803/EnM.2014.29.3.336; Phelps M, 2013, BIOGERONTOLOGY, V14, P729, DOI 10.1007/s10522-013-9447-2; Semba RD, 2014, NEUROSCI LETT, V558, P37, DOI 10.1016/j.neulet.2013.10.058; Shiozaki M, 2008, NEUROSCIENCE, V152, P924, DOI 10.1016/j.neuroscience.2008.01.032; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Uchida A, 2001, J NEUROSCI RES, V64, P364, DOI 10.1002/jnr.1087; Wang YH, 2009, AGEING RES REV, V8, P43, DOI 10.1016/j.arr.2008.10.002	36	41	43	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143623	10.1371/journal.pone.0143623	http://dx.doi.org/10.1371/journal.pone.0143623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599613	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600095
J	Chung, T; Youn, H; Yeom, CJ; Kang, KW; Chung, JK				Chung, Taemoon; Youn, Hyewon; Yeom, Chan Joo; Kang, Keon Wook; Chung, June-Key			Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; N-LINKED GLYCOSYLATION; THYROID NA+/I-SYMPORTER; REPORTER GENE; CYCLIC-AMP; EXPRESSION; BREAST; TUNICAMYCIN; CELLS; GLYCOPROTEIN	Purpose Human sodium/iodide symporter (hNIS) protein is a membrane glycoprotein that transports iodide ions into thyroid cells. The function of this membrane protein is closely regulated by post-translational glycosylation. In this study, we measured glycosylation-mediated changes in subcellular location of hNIS and its function of iodine uptake. Methods HeLa cells were stably transfected with hNIS/tdTomato fusion gene in order to monitor the expression of hNIS. Cellular localization of hNIS was visualized by confocal microscopy of the red fluorescence of tdTomato. The expression of hNIS was evaluated by RT-PCR and immunoblot analysis. Functional activity of hNIS was estimated by radioiodine uptake. Cyclic AMP (cAMP) and tunicamycin were used to stimulate and inhibit glycosylation, respectively. In vivo images were obtained using a Maestro fluorescence imaging system. Results cAMP-mediated Glycosylation of NIS resulted in increased expression of hNIS, stimulating membrane translocation, and enhanced radioiodine uptake. In contrast, inhibition of glycosylation by treatment with tunicamycin dramatically reduced membrane translocation of intracellular hNIS, resulting in reduced radioiodine uptake. In addition, our hNIS/tdTomato fusion reporter successfully visualized cAMP-induced hNIS expression in xenografted tumors from mouse model. Conclusions These findings clearly reveal that the membrane localization of hNIS and its function of iodine uptake are glycosylation-dependent, as our results highlight enhancement of NIS expression and glycosylation with subsequent membrane localization after cAMP treatment. Therefore, enhancing functional NIS by the increasing level of glycosylation may be suggested as a promising therapeutic strategy for cancer patients who show refractory response to conventional radioiodine treatment.	[Chung, Taemoon; Youn, Hyewon; Yeom, Chan Joo; Kang, Keon Wook; Chung, June-Key] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Chung, Taemoon; Kang, Keon Wook; Chung, June-Key] Seoul Natl Univ, Coll Med, Biomed Sci, Seoul, South Korea; [Chung, Taemoon; Youn, Hyewon; Kang, Keon Wook; Chung, June-Key] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Youn, Hyewon; Chung, June-Key] Seoul Natl Univ, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea; [Youn, Hyewon] Seoul Natl Univ Hosp, Canc Imaging Ctr, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Youn, H (corresponding author), Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea.	hwyoun@snu.ac.kr; jkchung@snu.ac.kr	Kang, Keon Wook/J-1385-2012	Kang, Keon Wook/0000-0003-2622-9017; Youn, Hyewon/0000-0003-1006-2689	National Research Foundation (NRF) - Ministry of Science and ICT & Future Planning (MSIP) [2011-0030001, 2012M2A2A7014020]; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C0311020014, HI13C0826, HI14C1072]; KRIBB Research Initiative Program; SNUH Research funds [03-2011-0420111150, 03-2012-0320120360]	National Research Foundation (NRF) - Ministry of Science and ICT & Future Planning (MSIP); Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; KRIBB Research Initiative Program; SNUH Research funds	This work was supported by grants from the National Research Foundation (NRF) funded by the Ministry of Science and ICT & Future Planning (MSIP) (2011-0030001, 2012M2A2A7014020), and the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C0311020014, HI13C0826, HI14C1072), the KRIBB Research Initiative Program, and SNUH Research funds (03-2011-0420111150, 03-2012-0320120360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2000, GENE THER, V7, P694, DOI 10.1038/sj.gt.3301145; Bengel FM, 2005, EUR J NUCL MED MOL I, V32, pS404, DOI 10.1007/s00259-005-1898-5; Beyer S, 2011, ENDOCRINOLOGY, V152, P782, DOI 10.1210/en.2010-0782; Boelaert K, 2003, LANCET, V361, P796, DOI 10.1016/S0140-6736(03)12720-1; Cho JY, 2000, GENE THER, V7, P740, DOI 10.1038/sj.gt.3301170; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Dricu A, 1997, CANCER RES, V57, P543; Dwyer RM, 2011, STEM CELLS, V29, P1149, DOI 10.1002/stem.665; Gao XF, 2014, ASIAN J ANDROL, V16, P120, DOI 10.4103/1008-682X.122354; Guo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102011; Huet G, 2003, BIOCHIMIE, V85, P323, DOI 10.1016/S0300-9084(03)00056-7; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Johnson AS, 2004, MICROBIOL-SGM, V150, P2815, DOI 10.1099/mic.0.27223-0; Kang JH, 2005, J NUCL MED, V46, P479; Kang JH, 2008, J NUCL MED, V49, p164S, DOI 10.2967/jnumed.107.045955; Knostman KAB, 2004, J CLIN ENDOCR METAB, V89, P5196, DOI 10.1210/jc.2004-0907; Knostman KAB, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-137; Kogai T, 2006, ENDOCR-RELAT CANCER, V13, P797, DOI 10.1677/erc.1.01143; KONRAD M, 1994, J BIOL CHEM, V269, P8659; Konrad M, 1996, BIOCHEM J, V316, P575, DOI 10.1042/bj3160575; LARSSON O, 1993, J CELL SCI, V106, P299; LEAVITT R, 1977, J VIROL, V21, P375, DOI 10.1128/JVI.21.1.375-385.1977; Levy O, 1997, P NATL ACAD SCI USA, V94, P5568, DOI 10.1073/pnas.94.11.5568; Levy O, 1998, J BIOL CHEM, V273, P22657, DOI 10.1074/jbc.273.35.22657; Luster M, 2008, EUR J NUCL MED MOL I, V35, P1941, DOI 10.1007/s00259-008-0883-1; Min JJ, 2001, EUR J NUCL MED, V28, P639, DOI 10.1007/s002590100509; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; Riedel C, 2001, J BIOL CHEM, V276, P21458, DOI 10.1074/jbc.M100561200; Seo JH, 2010, J NUCL MED, V51, P1637, DOI 10.2967/jnumed.110.077891; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shin JH, 2004, EUR J NUCL MED MOL I, V31, P425, DOI 10.1007/s00259-003-1394-8; Spitzweg Christine, 2002, Hormones (Athens), V1, P22; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Yeom CJ, 2015, MOL IMAGING, V14, DOI 10.2310/7290.2014.00056; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583	39	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142984	10.1371/journal.pone.0142984	http://dx.doi.org/10.1371/journal.pone.0142984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599396	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900051
J	Guyot, E; Solovyova, Y; Tomkiewicz, C; Leblanc, A; Pierre, S; El Balkhi, S; Le Frere-Belda, MA; Lecuru, F; Poupon, J; Barouki, R; Aggerbeck, M; Coumoul, X				Guyot, Erwan; Solovyova, Yevgeniya; Tomkiewicz, Celine; Leblanc, Alix; Pierre, Stpehane; El Balkhi, Souleiman; Le Frere-Belda, Marie-Aude; Lecuru, Fabrice; Poupon, Joel; Barouki, Robert; Aggerbeck, Martine; Coumoul, Xavier			Determination of Heavy Metal Concentrations in Normal and Pathological Human Endometrial Biopsies and In Vitro Regulation of Gene Expression by Metals in the Ishikawa and Hec-1b Endometrial Cell Line	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; NAD(P)H-QUINONE OXIDOREDUCTASE-1; MERCURIC-CHLORIDE; OXIDATIVE STRESS; CANCER-CELLS; COPPER; LEAD; ESTROGEN; MODULATION; TOXICITY	It is well known that several metals, such as lead, mercury, cadmium, and vanadium, can mimic the effects of estrogens (metallo-estrogens). Nevertheless, there are only a few studies that have assessed the effects of toxic metals on the female genital tract and, in particular, endometrial tissue. In this context, we measured the concentrations of several trace elements in human endometrial tissue samples from individuals with hyperplasia or adenocarcinoma and in normal tissues. Hyperplasic endometrial tissue has a 4-fold higher concentration of mercury than normal tissue. Mercury can affect both the AhR and ROS signaling pathways. Thus, we investigated the possible toxic effects of mercury by in vitro studies. We found that mercury increases oxidative stress (increased HO1 and NQO1 mRNA levels) and alters the cytoskeleton in the human endometrial Ishikawa cell line and to a lesser extent, in the "less-differentiated" human endometrial Hec-1b cells. The results might help to explain a potential link between this metal and the occurrence of endometrial hyperplasia.	[Guyot, Erwan; Solovyova, Yevgeniya; Tomkiewicz, Celine; Leblanc, Alix; Pierre, Stpehane; Le Frere-Belda, Marie-Aude; Lecuru, Fabrice; Barouki, Robert; Aggerbeck, Martine; Coumoul, Xavier] INSERM, UMR S Toxicol Pharmacol & Signalisat Cellulaire 1, F-75006 Paris, France; [El Balkhi, Souleiman; Poupon, Joel] Hop Lariboisiere, AP HP, Lab Toxicol Biol, F-75475 Paris, France; [Le Frere-Belda, Marie-Aude; Lecuru, Fabrice] Hop Europeen Georges Pompidou, AP HP, Serv Chirurg Gynecol & Cancerol, F-75015 Paris, France; [Guyot, Erwan; Solovyova, Yevgeniya; Tomkiewicz, Celine; Leblanc, Alix; Pierre, Stpehane; Le Frere-Belda, Marie-Aude; Lecuru, Fabrice; Barouki, Robert; Aggerbeck, Martine; Coumoul, Xavier] Univ Paris 05, Sorbonne Paris Cite, Ctr Univ St Peres, F-75006 Paris, France; [Barouki, Robert] Hop Necker Enfants Malad, AP HP, F-75743 Paris, France; [Solovyova, Yevgeniya] Ukrainian Acad Med Sci, Inst Urgent & Recovery Surg, UA-83045 Donetsk, Ukraine	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; National Academy of Medical Sciences of Ukraine	Coumoul, X (corresponding author), INSERM, UMR S Toxicol Pharmacol & Signalisat Cellulaire 1, 45 Rue St Peres, F-75006 Paris, France.	xavier.coumoul@parisdescartes.fr	/A-2002-2017; COUMOUL, Xavier/AAR-3649-2020; Balkhi, Souleiman El/ABB-7385-2020; Guyot, Erwan/ABF-7608-2020	/0000-0002-9743-5603; COUMOUL, Xavier/0000-0003-2928-9648; Guyot, Erwan/0000-0003-3468-030X	ARC (Association pour la Recherche sur le Cancer) [SFI20101201842]; CNRS (Centre National de la recherche scientifique); INCa (Institut National du Cancer); INSERM (Institut National de la Sante et de la Recherche Medicale); Ministere de l'enseignement superieur et de la recherche; Region Ile de France; Universite Paris Descartes; PRES; Assistance Publique (AP/HP); Institute of Urgent and Recovery Surgery	ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); CNRS (Centre National de la recherche scientifique)(Centre National de la Recherche Scientifique (CNRS)); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'enseignement superieur et de la recherche; Region Ile de France(Region Ile-de-France); Universite Paris Descartes; PRES; Assistance Publique (AP/HP); Institute of Urgent and Recovery Surgery	This work was supported by ARC (Association pour la Recherche sur le Cancer, SFI20101201842); the CNRS (Centre National de la recherche scientifique, Martine Aggerbeck); INCa (Institut National du Cancer); INSERM (Institut National de la Sante et de la Recherche Medicale, Celine Tomkiewicz); the Ministere de l'enseignement superieur et de la recherche (Doctoral fellowship, Alix Leblanc); the Region Ile de France (Doctoral fellowship, Dr Stephane Pierre); the Universite Paris Descartes and PRES (Pr Xavier Coumoul); the Assistance Publique (AP/HP; Dr Erwan Guyot); the Institute of Urgent and Recovery Surgery (Dr Y. Solovyova). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara IEA, 2010, TOXICOL LETT, V199, P225, DOI 10.1016/j.toxlet.2010.09.003; Andersen HH, 2014, CELL MOL LIFE SCI, V71, P1607, DOI 10.1007/s00018-013-1509-8; Anwar-Mohamed A, 2009, EXPERT OPIN DRUG MET, V5, P501, DOI [10.1517/17425250902918302 , 10.1517/17425250902918302]; Bamberger AM, 1998, HUM REPROD UPDATE, V4, P526, DOI 10.1093/humupd/4.5.526; Bonacker D, 2004, ARCH TOXICOL, V78, P575, DOI 10.1007/s00204-004-0578-8; Bui LC, 2009, ONCOGENE, V28, P3642, DOI 10.1038/onc.2009.224; Choe SY, 2003, SCI TOTAL ENVIRON, V312, P15, DOI 10.1016/S0048-9697(03)00190-6; Darbre PD, 2006, J APPL TOXICOL, V26, P191, DOI 10.1002/jat.1135; Davis BJ, 2001, TOXICOL SCI, V59, P291, DOI 10.1093/toxsci/59.2.291; ELLIGET KA, 1991, CELL BIOL TOXICOL, V7, P263; Fujimoto J, 1996, TUMOR BIOL, V17, P48, DOI 10.1159/000217966; Gado AM, 2013, DRUG DES DEV THER, V7, P1245, DOI 10.2147/DDDT.S50928; HAGENFELDT K, 1977, ACTA ENDOCRINOL-COP, V85, P406, DOI 10.1530/acta.0.0850406; Heo J, 2008, CELL BIOCHEM BIOPHYS, V51, P21, DOI 10.1007/s12013-008-9010-y; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Korashy HM, 2008, J BIOCHEM MOL TOXIC, V22, P274, DOI 10.1002/jbt.20238; Korashy HM, 2008, TOXICOL IN VITRO, V22, P154, DOI 10.1016/j.tiv.2007.08.003; Korashy HM, 2006, CHEM-BIOL INTERACT, V162, P237, DOI 10.1016/j.cbi.2006.07.002; Korashy HM, 2006, DRUG METAB DISPOS, V34, P152, DOI 10.1124/dmd.105.005397; Korashy HM, 2004, TOXICOLOGY, V201, P153, DOI 10.1016/j.tox.2004.04.011; LESSEY BA, 1995, AM J PATHOL, V146, P717; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Liu Kang-sheng, 2013, Chinese Medical Sciences Journal, V28, P178; Martin MB, 2003, ENDOCRINOLOGY, V144, P2425, DOI 10.1210/en.2002-221054; Martinez-Campa C, 2006, J PINEAL RES, V40, P291, DOI 10.1111/j.1600-079X.2006.00315.x; Perez G, 2005, J ENVIRON MONITOR, V7, P29, DOI 10.1039/b411316k; Purchase Rupert, 2013, Science Progress, V96, P213, DOI 10.3184/003685013X13712193905878; Soyer C, 2007, ENVIRON MONIT ASSESS, V130, P141, DOI 10.1007/s10661-006-9384-5; Stefansson IM, 2004, J CLIN ONCOL, V22, P1242, DOI 10.1200/JCO.2004.09.034; Stoiber T, 2004, TOXICOL LETT, V151, P99, DOI 10.1016/j.toxlet.2003.11.017; Tan SW, 2009, CRIT REV TOXICOL, V39, P228, DOI 10.1080/10408440802233259; Thier R, 2003, TOXICOL LETT, V140, P75, DOI 10.1016/S0378-4274(02)00502-7; Tiwari AK, 2011, CURR PHARM BIOTECHNO, V12, P570; Ung CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-212; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wang B, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/898034; Wang MH, 2013, AQUAT TOXICOL, V130, P123, DOI 10.1016/j.aquatox.2013.01.012; Yang S, 2011, TRENDS ENDOCRIN MET, V22, P145, DOI 10.1016/j.tem.2011.01.005; Zhang XJ, 2008, BIOMETALS, V21, P143, DOI 10.1007/s10534-007-9102-y	39	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142590	10.1371/journal.pone.0142590	http://dx.doi.org/10.1371/journal.pone.0142590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600472	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900029
J	Ito, F; Ku, AW; Bucsek, MJ; Muhitch, JB; Vardam-Kaur, T; Kim, M; Fisher, DT; Camoriano, M; Khoury, T; Skitzki, JJ; Gollnick, SO; Evans, SS				Ito, Fumito; Ku, Amy W.; Bucsek, Mark J.; Muhitch, Jason B.; Vardam-Kaur, Trupti; Kim, Minhyung; Fisher, Daniel T.; Camoriano, Marta; Khoury, Thaer; Skitzki, Joseph J.; Gollnick, Sandra O.; Evans, Sharon S.			Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer	PLOS ONE			English	Article							RADIO-FREQUENCY ABLATION; RENAL-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; SPONTANEOUS REGRESSION; BREAST-CARCINOMA; THERMAL ABLATION; DENDRITIC CELLS; TUMOR-GROWTH; IMPACT; MOUSE	Purpose While surgical resection is a cornerstone of cancer treatment, local and distant recurrences continue to adversely affect outcome in a significant proportion of patients. Evidence that an alternative debulking strategy involving radiofrequency ablation (RFA) induces antitumor immunity prompted the current investigation of the efficacy of performing RFA prior to surgical resection (pre-resectional RFA) in a preclinical mouse model. Experimental Design Therapeutic efficacy and systemic immune responses were assessed following pre-resectional RFA treatment of murine CT26 colon adenocarcinoma. Results Treatment with pre-resectional RFA significantly delayed tumor growth and improved overall survival compared to sham surgery, RFA, or resection alone. Mice in the pre-resectional RFA group that achieved a complete response demonstrated durable antitumor immunity upon tumor re-challenge. Failure to achieve a therapeutic benefit in immunodeficient mice confirmed that tumor control by pre-resectional RFA depends on an intact adaptive immune response rather than changes in physical parameters that make ablated tumors more amenable to a complete surgical excision. RFA causes a marked increase in intratumoral CD8(+) T lymphocyte infiltration, thus substantially enhancing the ratio of CD8(+) effector T cells: FoxP3(+) regulatory T cells. Importantly, pre-resectional RFA significantly increases the number of antigen-specific CD8(+) T cells within the tumor microenvironment and tumor-draining lymph node but had no impact on infiltration by myeloid-derived suppressor cells, M1 macrophages or M2 macrophages at tumor sites or in peripheral lymphoid organs (i.e., spleen). Finally, pre-resectional RFA of primary tumors delayed growth of distant tumors through a mechanism that depends on systemic CD8(+) T cell-mediated antitumor immunity. Conclusion Improved survival and antitumor systemic immunity elicited by pre-resectional RFA support the translational potential of this neoadjuvant treatment for cancer patients with high-risk of local and systemic recurrence.	[Ito, Fumito; Ku, Amy W.; Bucsek, Mark J.; Muhitch, Jason B.; Vardam-Kaur, Trupti; Kim, Minhyung; Fisher, Daniel T.; Camoriano, Marta; Evans, Sharon S.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Ito, Fumito; Kim, Minhyung; Skitzki, Joseph J.] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA; [Ito, Fumito] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Muhitch, Jason B.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Vardam-Kaur, Trupti] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Edwin L Steele Lab,Dept Radiat Oncol, Boston, MA USA; [Khoury, Thaer] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Gollnick, Sandra O.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; University of Michigan System; University of Michigan; Roswell Park Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Evans, SS (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	sharon.evans@roswellpark.org		Ito, Fumito/0000-0002-6866-671X; Muhitch, Jason/0000-0002-7703-1425	National Institutes of Health [CA79765, AI082039, CA098156, CA109480, P30CA016056]; Jennifer Linscott Tietgen Family Foundation; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA098156, P01CA055791, R01CA079765, R01CA109480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI082039, R01AI082039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jennifer Linscott Tietgen Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (CA79765 and AI082039 to S.S. Evans; CA098156 and CA109480 to S.O. Gollnick; and P30CA016056 to Roswell Park Cancer Institute); and the Jennifer Linscott Tietgen Family Foundation (J.J. Skitzki and S.S. Evans). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ali MY, 2005, J HEPATOL, V43, P817, DOI 10.1016/j.jhep.2005.04.016; Arihara F, 2013, CANCER IMMUNOL IMMUN, V62, P1421, DOI 10.1007/s00262-013-1447-1; Behm B, 2016, GUT, V65, P134, DOI 10.1136/gutjnl-2014-308286; BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Brackett CM, 2013, J IMMUNOL, V191, P4348, DOI 10.4049/jimmunol.1103621; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Burak WE, 2003, CANCER, V98, P1369, DOI 10.1002/cncr.11642; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; de Bethlenfalva-Hora CE, 2014, CLIN SCI, V126, P243, DOI 10.1042/CS20130089; de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b; den Brok MHMGM, 2006, BRIT J CANCER, V95, P896, DOI 10.1038/sj.bjc.6603341; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; den Brok MHMGM, 2004, CANCER RES, V64, P4024, DOI 10.1158/0008-5472.CAN-03-3949; Dromi SA, 2009, RADIOLOGY, V251, P58, DOI 10.1148/radiol.2511072175; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Evrard S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114404; Fisher DT, 2011, J CLIN INVEST, V121, P3846, DOI 10.1172/JCI44952; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gameiro SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070417; Harrison L, 2004, ONCOLOGIST, V9, P31, DOI 10.1634/theoncologist.9-90005-31; Hyder O, 2013, SURGERY, V153, P811, DOI 10.1016/j.surg.2012.12.005; Iida N, 2010, CANCER RES, V70, P6556, DOI 10.1158/0008-5472.CAN-10-0096; Ito F, 2009, ANN SURG, V250, P210, DOI 10.1097/SLA.0b013e3181afe0ab; Izzo F, 2001, CANCER, V92, P2036, DOI 10.1002/1097-0142(20011015)92:8<2036::AID-CNCR1542>3.0.CO;2-W; Jeffrey SS, 1999, ARCH SURG-CHICAGO, V134, P1064, DOI 10.1001/archsurg.134.10.1064; Johnson EE, 2009, CLIN CANCER RES, V15, P4875, DOI 10.1158/1078-0432.CCR-09-0110; Katz SC, 2013, ANN SURG ONCOL, V20, P946, DOI 10.1245/s10434-012-2668-9; Kim H, 2008, KOREAN J RADIOL, V9, P470, DOI 10.3348/kjr.2008.9.5.470; Kroeze SGC, 2012, J UROLOGY, V188, P607, DOI 10.1016/j.juro.2012.03.116; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Liu Q, 2009, MOL THER, V17, P2049, DOI 10.1038/mt.2009.221; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Michel S, 2008, BRIT J CANCER, V99, P1867, DOI 10.1038/sj.bjc.6604756; MOLE RH, 1953, BRIT J RADIOL, V26, P234, DOI 10.1259/0007-1285-26-305-234; Picardo A, 1998, SURGERY, V124, P57, DOI 10.1067/msy.1998.88371; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Rai R, 2005, J SURG RES, V129, P147, DOI 10.1016/j.jss.2005.03.020; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sanchez-Ortiz RF, 2003, J UROLOGY, V170, P178, DOI 10.1097/01.ju.0000070823.38336.7b; Schneider T, 2015, CLIN EXP IMMUNOL, V180, P467, DOI 10.1111/cei.12596; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; SOANES WA, 1970, J UROLOGY, V104, P154, DOI 10.1016/S0022-5347(17)61690-2; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vicari AP, 2000, J IMMUNOL, V165, P1992, DOI 10.4049/jimmunol.165.4.1992; Whiteside TL, 2012, SEMIN CANCER BIOL, V22, P327, DOI 10.1016/j.semcancer.2012.03.004; Wissniowski TT, 2003, CANCER RES, V63, P6496; Wong SL, 2010, J CLIN ONCOL, V28, P493, DOI 10.1200/JCO.2009.23.4450; Yang WL, 2004, ANN SURG ONCOL, V11, P399, DOI 10.1245/ASO.2004.08.013; Zerbini A, 2006, CANCER RES, V66, P1139, DOI 10.1158/0008-5472.CAN-05-2244; Zerbini A, 2008, J IMMUNOTHER, V31, P271, DOI 10.1097/CJI.0b013e318160ff1c; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	63	27	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143370	10.1371/journal.pone.0143370	http://dx.doi.org/10.1371/journal.pone.0143370			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599402	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900101
J	Mufenda, J; Gebhardt, S; van Rooyen, R; Theron, G				Mufenda, Josef; Gebhardt, Stefan; van Rooyen, Rita; Theron, Gerhard			Introducing a Mobile-Connected Umbilical Doppler Device (UmbiFlow (TM)) into a Primary Care Maternity Setting: Does This Reduce Unnecessary Referrals to Specialised Care? Results of a Pilot Study in Kraaifontein, South Africa	PLOS ONE			English	Article							RISK PREGNANCIES; CENTILE CHART; GROWTH; ARTERY; MANAGEMENT; WEIGHT; VELOCIMETRY; DIAGNOSIS; LIGHT	Objectives UmbiFlow (TM) is a mobile-connected Doppler device that utilises a continuous waveform to measure resistance in the umbilical artery. The main aim of this pilot study was to determine whether the use of UmbiFlow (TM) for umbilical artery Doppler in patients with a suspected decreased symphysis fundal (SF) growth could safely lead to a decreased number of patients requiring referral to a more specialised level of care. A secondary aim of the study was to evaluate the effectiveness of UmbiFlow (TM) Doppler as a screening tool for concealed placental insufficiency in late bookers by using a single screening cut-off value that will be abnormal for any gestation > 28 weeks. Methods The cohort comprised two groups of patients: The first group included all follow-up patients with suspected intra-uterine growth restriction (a decreased symphysis-fundus measurement based on serial assessment) who underwent on-site UmbiFlow (TM) Doppler testing performed by the midwife directly after the clinical examination. The second group included late bookers, where gestation was uncertain; but estimated > 28 weeks based on clinical grounds. This group was comprised of unselected patients who report to antenatal care late for the first time and received an UmbiFlow (TM) Doppler test for concealed placental insufficiency. Results UmbiFlow (TM) Doppler could reduce the number of false referrals to hospital by 55%. A single UmbiFlow (TM) Doppler test in late bookers appeared to identify a group of women at moderate risk of lower birth weight babies.	[Mufenda, Josef; Gebhardt, Stefan; Theron, Gerhard] Univ Stellenbosch, Dept Obstet & Gynaecol, Cape Town, South Africa; [Mufenda, Josef; Gebhardt, Stefan; Theron, Gerhard] Tygerberg Hosp, Cape Town, South Africa; [van Rooyen, Rita] MHealth Inc, San Diego, CA 92130 USA	Stellenbosch University; Tygerberg Hospital	Gebhardt, S (corresponding author), Univ Stellenbosch, Dept Obstet & Gynaecol, Cape Town, South Africa.	gsgeb@sun.ac.za		Gebhardt, Gabriel/0000-0001-8999-8193	Medical Research Council of South Africa; Council for Scientific and Industrial Research of South Africa; CSIR's	Medical Research Council of South Africa(South African Medical Research Council); Council for Scientific and Industrial Research of South Africa; CSIR's	The equipment used in this study as well as the salary for the research nurse was sponsored and funded entirely by the Medical Research Council of South Africa as well as the Council for Scientific and Industrial Research of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Council for Scientific & Industrial Research (CSIR), in collaboration with the Medical Research Council (MRC), developed the UmbiFlow (TM) system for use at primary health care clinics, aimed at ante-natal care. In order to test the system's impact in a primary health care setting, CSIR contracted Rita van Rooyen, of mHealth Inc., to help facilitate the running of a clinical study. This required consultation with the other authors of the study. CSIR's financial contribution was to the salary of Rita van Rooyen as well as to provide the UmbiFlow (TM) systems to the study. The CSIR did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of Rita van Rooyen as an author is articulated in the "author contributions" section.	Alfirevic Z, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001450.pub3; Ananth CV, 2014, SEMIN PERINATOL, V38, P131, DOI 10.1053/j.semperi.2014.03.001; [Anonymous], 2012, OBST GYN ULTR POL PR; Bolz N, 2013, J PERINAT MED, V41, P165, DOI 10.1515/jpm-2012-0042; BRINK AL, 1987, S AFR MED J, V72, P250; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Filmar G, 2013, ARCH GYNECOL OBSTET, V288, P279, DOI 10.1007/s00404-013-2764-5; Goffinet F, 1997, BRIT J OBSTET GYNAEC, V104, P425, DOI 10.1111/j.1471-0528.1997.tb11493.x; Higgins M, 2014, AM J OBSTET GYNECOL, V210, pS209, DOI 10.1016/j.ajog.2013.10.446; Lausman A, 2012, J OBSTET GYNAECOL CA, V34, P17, DOI 10.1016/S1701-2163(16)35129-5; MacDonald TM, 2015, AUST NZ J OBSTET GYN, V55, P3, DOI 10.1111/ajo.12264; Mason D, 2014, TYGERBERG HOSP PERIN; McClure EM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-73; Odendaal HJ, 2008, SAJOG-S AFR J OBSTET, V14, P33; Parra-Saavedra M, 2013, PLACENTA, V34, P1136, DOI 10.1016/j.placenta.2013.09.018; PATTINSON RC, 1989, S AFR MED J, V76, P623; Savchev S, 2014, FETAL DIAGN THER, V36, P129, DOI 10.1159/000360419; Theron GB, 2008, SAMJ S AFR MED J, V98, P270; Theron GB, 1995, S AFR MED J, V85, P1289; Theron GB, 2005, SAMJ S AFR MED J, V95, P62; Theron GB, 2002, INT J GYNECOL OBSTET, V79, P263, DOI 10.1016/S0020-7292(02)00300-4; THERON GB, 1992, INT J GYNECOL OBSTET, V39, P93, DOI 10.1016/0020-7292(92)90903-V; Thompson ML, 1997, EUR J OBSTET GYN R B, V72, P3, DOI 10.1016/S0301-2115(96)02643-7; Vedmedovska N, 2011, ARCH GYNECOL OBSTET, V284, P1087, DOI 10.1007/s00404-010-1781-x; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142743	10.1371/journal.pone.0142743	http://dx.doi.org/10.1371/journal.pone.0142743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600311	gold, Green Published			2022-12-26	WOS:000365853900038
J	Zhu, J; Wang, BB; Miao, QH; Tan, YG; Li, CF; Chen, ZY; Guo, HM; Liu, GQ				Zhu, Jie; Wang, Binbin; Miao, Qiuhong; Tan, Yonggui; Li, Chuanfeng; Chen, Zongyan; Guo, Huimin; Liu, Guangqing			Viral Genome-Linked Protein (VPg) Is Essential for Translation Initiation of Rabbit Hemorrhagic Disease Virus (RHDV)	PLOS ONE			English	Article							SUBGENOMIC RNAS; CALICIVIRUS; VISUALIZATION; EIF4E; CELLS; 4E	Rabbit hemorrhagic disease virus (RHDV), the causative agent of rabbit hemorrhagic disease, is an important member of the caliciviridae family. Currently, no suitable tissue culture system is available for proliferating RHDV, limiting the study of the pathogenesis of RHDV. In addition, the mechanisms underlying RHDV translation and replication are largely unknown compared with other caliciviridae viruses. The RHDV replicon recently constructed in our laboratory provides an appropriate model to study the pathogenesis of RHDV without in vitro RHDV propagation and culture. Using this RHDV replicon, we demonstrated that the viral genome-linked protein (VPg) is essential for RHDV translation in RK-13 cells for the first time. In addition, we showed that VPg interacts with eukaryotic initiation factor 4E (eIF4E) in vivo and in vitro and that eIF4E silencing inhibits RHDV translation, suggesting the interaction between VPg and eIF4E is involved in RHDV translation. Our results support the hypothesis that VPg serves as a novel cap substitute during the initiation of RHDV translation.	[Zhu, Jie; Wang, Binbin; Miao, Qiuhong; Tan, Yonggui; Li, Chuanfeng; Chen, Zongyan; Guo, Huimin; Liu, Guangqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Liu, GQ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China.	liugq@shvri.ac.cn	chen, zongyan/ABG-9170-2021; Zhu, Jie/X-6219-2019; Miao, Qiuhong/AAJ-1747-2020	Zhu, Jie/0000-0001-7941-4166; Miao, Qiuhong/0000-0003-3670-6227	Chinese Natural Sciences Foundation [31270194]; Innovation Project of Science and Technology Commission Foundation of Shanghai [13391901602]; National Advanced Technology Research and Development Program of China (863 Program) [2011AA10A200]	Chinese Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Innovation Project of Science and Technology Commission Foundation of Shanghai; National Advanced Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Chinese Natural Sciences Foundation (31270194), http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list; the Innovation Project of Science and Technology Commission Foundation of Shanghai (No. 13391901602), http://www.cn-hightech.org/zjzz.asp; the National Advanced Technology Research and Development Program of China (863 Program) (No. 2011AA10A200), http://finance.most.gov.cn/. All funders had important roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchemin C, 2007, J VIROL, V81, P775, DOI 10.1128/JVI.01277-06; Cancellotti F.M., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P409; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; FINKEL T, 1993, J BIOL CHEM, V268, P5; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Goodfellow IG, 2008, INT J BIOCHEM CELL B, V40, P2675, DOI 10.1016/j.biocel.2007.10.023; Gregg D A, 1991, Rev Sci Tech, V10, P435; Grzela R, 2006, BIOCHIMIE, V88, P887, DOI 10.1016/j.biochi.2006.02.012; Kerppola Tom K, 2013, Cold Spring Harb Protoc, V2013, P727, DOI 10.1101/pdb.prot076497; Kerppola Tom K, 2013, Cold Spring Harb Protoc, V2013, P714, DOI 10.1101/pdb.top076489; Kodama Y, 2012, METHOD CELL BIOL, V113, P107, DOI 10.1016/B978-0-12-407239-8.00006-9; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Lee C. S., 1987, Korean Journal of Veterinary Research, V27, P277; Liu GQ, 2006, CHINESE SCI BULL, V51, P1698, DOI 10.1007/s11434-006-2044-x; Liu S. J., 1984, Animal Husbandry and Veterinary Medicine (Xumu yu Shouyi), V16, P253; Luo Y, 1997, BIOTECHNIQUES, V22, P350, DOI 10.2144/97222pf02; MEYERS G, 1991, VIROLOGY, V184, P664, DOI 10.1016/0042-6822(91)90436-F; MEYERS G, 1991, VIROLOGY, V184, P677, DOI 10.1016/0042-6822(91)90437-G; Miller WA, 2000, VIROLOGY, V273, P1, DOI 10.1006/viro.2000.0421; Miyoshi H, 2006, BIOCHIMIE, V88, P329, DOI 10.1016/j.biochi.2005.09.002; Morisse J.-P., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P269; MOUSSA A, 1992, VET MICROBIOL, V33, P375, DOI 10.1016/0378-1135(92)90065-2; Nowotny N, 1997, ARCH VIROL, V142, P657, DOI 10.1007/s007050050109; PARRA F, 1990, J VIROL, V64, P4013, DOI 10.1128/JVI.64.8.4013-4015.1990; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Wang BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060316; Wang BinBin, 2013, Journal of Northwest A & F University - Natural Science Edition, V41, P45; [杨宗伟 YANG Zongwei], 2011, [甘肃农业大学学报, Journal of Gansu Agricultural University], V46, P8	30	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143467	10.1371/journal.pone.0143467	http://dx.doi.org/10.1371/journal.pone.0143467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599265	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900130
J	Ambadapadi, S; Munuswamy-Ramanujam, G; Zheng, DH; Sullivan, C; Dai, E; Morshed, S; McFadden, B; Feldman, E; Pinard, M; McKenna, R; Tibbetts, S; Lucas, A				Ambadapadi, Sriram; Munuswamy-Ramanujam, Ganesh; Zheng, Donghang; Sullivan, Colin; Dai, Erbin; Morshed, Sufi; McFadden, Baron; Feldman, Emily; Pinard, Melissa; McKenna, Robert; Tibbetts, Scott; Lucas, Alexandra			Reactive Center Loop (RCL) Peptides Derived from Serpins Display Independent Coagulation and Immune Modulating Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; MYXOMA VIRAL SERPIN; HEPARIN-COFACTOR-II; SERINE PROTEINASE; P-SELECTIN; ACTIVATION; INHIBITOR; SURVIVAL; INJECTION; ANALOGS	Serpins regulate coagulation and inflammation, binding serine proteases in suicide-inhibitory complexes. Target proteases cleave the serpin reactive center loop scissile P1-P1' bond, resulting in serpin-protease suicide-inhibitory complexes. This inhibition requires a near full-length serpin sequence. Myxomavirus Serp-1 inhibits thrombolytic and thrombotic proteases, whereas mammalian neuroserpin (NSP) inhibits only thrombolytic proteases. Both serpins markedly reduce arterial inflammation and plaque in rodent models after single dose infusion. In contrast, Serp-1 but not NSP improves survival in a lethal murine gammaherpesvirus68 (MHV68) infection in interferon gamma-receptor-deficient mice (IFN gamma R-/-). Serp-1 has also been successfully tested in a Phase 2a clinical trial. We postulated that proteolytic cleavage of the reactive center loop produces active peptide derivatives with expanded function. Eight peptides encompassing predicted protease cleavage sites for Serp-1 and NSP were synthesized and tested for inhibitory function in vitro and in vivo. In engrafted aorta, selected peptides containing Arg or Arg-Asn, not Arg-Met, with a 0 or +1 charge, significantly reduced plaque. Conversely, S-6 a hydrophobic peptide of NSP, lacking Arg or Arg-Asn with -4 charge, induced early thrombosis and mortality. S-1 and S-6 also significantly reduced CD11b(+) monocyte counts in mouse splenocytes. S-1 peptide had increased efficacy in plasminogen activator inhibitor-1 serpin-deficient transplants. Plaque reduction correlated with mononuclear cell activation. In a separate study, Serp-1 peptide S-7 improved survival in the MHV68 vasculitis model, whereas an inverse S-7 peptide was inactive. Reactive center peptides derived from Serp-1 and NSP with suitable charge and hydrophobicity have the potential to extend immunomodulatory functions of serpins.	[Ambadapadi, Sriram; Munuswamy-Ramanujam, Ganesh; Zheng, Donghang; Sullivan, Colin; Dai, Erbin; Morshed, Sufi; Lucas, Alexandra] Univ Florida, Dept Med, Div Cardiovasc Med, Gainesville, FL 32608 USA; [McFadden, Baron; Feldman, Emily; Pinard, Melissa; McKenna, Robert; Tibbetts, Scott; Lucas, Alexandra] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32608 USA; [Munuswamy-Ramanujam, Ganesh] SRM Univ, Interdisciplinary Inst Indian Syst Med, Kattankulathur 603203, Tamil Nadu, India	State University System of Florida; University of Florida; State University System of Florida; University of Florida; SRM Institute of Science & Technology Chennai	Lucas, A (corresponding author), Univ Florida, Dept Med, Div Cardiol & Rheumatol, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	Alexandra.lucas@medicine.ufl.edu	Munuswamy-Ramanujam, Ganesh/ABE-7225-2021	Munuswamy-Ramanujam, Ganesh/0000-0001-8021-601X; Ambadapadi, Sriram/0000-0001-6542-4259	National Institutes of Health [1RC1HL100202-01, 1 R01 AI100987-01A1]; American Heart Association [0855421 E]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health Grants 1RC1HL100202-01 and 1 R01 AI100987-01A1 and American Heart Association Grant 0855421 E. Dr. Lucas consults for and holds minor shares in a small biotechnology company, Viron Therapeutics, Inc. (London, Canada). Viron did not provide research funding for these studies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; Anbanandam A, 2008, J MOL BIOL, V384, P219, DOI 10.1016/j.jmb.2008.09.021; Barata TS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002095; Bedard ELR, 2006, TRANSPLANTATION, V81, P908, DOI 10.1097/01.tp.0000203141.02725.8a; Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; Bocksch L, 2007, ATHEROSCLEROSIS, V194, P116, DOI 10.1016/j.atherosclerosis.2006.10.014; Chen H, 2013, ANTIMICROB AGENTS CH, V57, P4114, DOI 10.1128/AAC.02594-12; Chen H, 2011, METHOD ENZYMOL, V499, P301, DOI 10.1016/B978-0-12-386471-0.00015-8; Christov A, 2001, LASER SURG MED, V28, P414; Congote LF, 2006, BIOCHEM BIOPH RES CO, V343, P617, DOI 10.1016/j.bbrc.2006.02.190; Dai E, 1997, ARTERIOSCL THROM VAS, V17, P2359, DOI 10.1161/01.ATV.17.11.2359; Dai E, 2003, J BIOL CHEM, V278, P18563, DOI 10.1074/jbc.M209683200; Dai EB, 2006, J BIOL CHEM, V281, P8041, DOI 10.1074/jbc.M509454200; Doss M, 2012, J IMMUNOL, V188, P2759, DOI 10.4049/jimmunol.1101335; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Jia QY, 2012, BIOORG MED CHEM LETT, V22, P2393, DOI 10.1016/j.bmcl.2012.02.037; Jiang J, 2007, TRANSPLANTATION, V84, P1158, DOI 10.1097/01.tp.0000286099.50532.b0; Kalle M, 2013, J IMMUNOL, V190, P6303, DOI 10.4049/jimmunol.1203030; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lee E, 2011, J PEPT SCI, V17, P675, DOI 10.1002/psc.1387; Lucas A, 1996, CIRCULATION, V94, P2890, DOI 10.1161/01.CIR.94.11.2890; Lucas A, 2009, ADV EXP MED BIOL, V666, P132; Ma J, 2012, J NEUROIMMUNE PHARM, V7, P750, DOI 10.1007/s11481-012-9367-y; Nagaoka I, 2002, CLIN DIAGN LAB IMMUN, V9, P972, DOI 10.1128/CDLI.9.5.972-982.2002; Phillips JW, 2003, CIRCULATION, V107, P2244, DOI 10.1161/01.CIR.0000065604.56839.18; Raguine L, 2013, CHEM BIOL DRUG DES, V81, P167, DOI 10.1111/cbdd.12080; Sadler K, 2002, BIOCHEMISTRY-US, V41, P14150, DOI 10.1021/bi026661l; Shmueli RB, 2013, BIOMATERIALS, V34, P7544, DOI 10.1016/j.biomaterials.2013.06.044; Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Singh KK, 2013, J THORAC CARDIOV SUR, V146, P949, DOI 10.1016/j.jtcvs.2012.12.064; Sutherland JS, 2007, THROMB HAEMOSTASIS, V98, P1014, DOI 10.1160/TH07-03-0197; Tardif JC, 2010, CIRC-CARDIOVASC INTE, V3, P543, DOI 10.1161/CIRCINTERVENTIONS.110.953885; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; Viswanathan K, 2006, THROMB HAEMOSTASIS, V95, P499, DOI 10.1160/TH05-07-0492; Viswanathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044694; Viswanathan K, 2009, J LEUKOCYTE BIOL, V85, P418, DOI 10.1189/jlb.0808506; Wang L, 2004, BRAIN RES, V1015, P175, DOI 10.1016/j.brainres.2004.04.053; Zalai CV, 2001, J AM COLL CARDIOL, V38, P1340, DOI 10.1016/S0735-1097(01)01570-4; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	41	34	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2874	2887		10.1074/jbc.M115.704841	http://dx.doi.org/10.1074/jbc.M115.704841			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26620556	Green Published, hybrid			2022-12-26	WOS:000369626900026
J	Purushothaman, A; Bandari, SK; Liu, J; Mobley, JA; Brown, EE; Sanderson, RD				Purushothaman, Anurag; Bandari, Shyam Kumar; Liu, Jian; Mobley, James A.; Brown, Elizabeth E.; Sanderson, Ralph D.			Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING DOMAIN; MULTIPLE-MYELOMA; EXTRACELLULAR VESICLES; PROMOTES; ADHESION; SULFATE; EXPRESSION; SYNDECAN-1; SECRETION; PHENOTYPE	Exosomes regulate cell behavior by binding to and delivering their cargo to target cells; however, the mechanisms mediating exosome-cell interactions are poorly understood. Heparan sulfates on target cell surfaces can act as receptors for exosome uptake, but the ligand for heparan sulfate on exosomes has not been identified. Using exosomes isolated from myeloma cell lines and from myeloma patients, we identify exosomal fibronectin as a key heparan sulfate-binding ligand and mediator of exosome-cell interactions. We discovered that heparan sulfate plays a dual role in exosome-cell interaction; heparan sulfate on exosomes captures fibronectin, and on target cells it acts as a receptor for fibronectin. Removal of heparan sulfate from the exosome surface releases fibronectin and dramatically inhibits exosome-target cell interaction. Antibody specific for the Hep-II heparin-binding domain of fibronectin blocks exosome interaction with tumor cells or with marrow stromal cells. Regarding exosome function, fibronectin-mediated binding of exosomes to myeloma cells activated p38 and pERK signaling and expression of downstream target genes DKK1 and MMP-9, two molecules that promote myeloma progression. Antibody against fibronectin inhibited the ability of myeloma-derived exosomes to stimulate endothelial cell invasion. Heparin or heparin mimetics including Roneparstat, a modified heparin in phase I trials in myeloma patients, significantly inhibited exosome-cell interactions. These studies provide the first evidence that fibronectin binding to heparan sulfate mediates exosome-cell interactions, revealing a fundamental mechanism important for exosome-mediated cross-talk within tumor microenvironments. Moreover, these results imply that therapeutic disruption of fibronectin-heparan sulfate interactions will negatively impact myeloma tumor growth and progression.	[Purushothaman, Anurag; Bandari, Shyam Kumar; Brown, Elizabeth E.; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Purushothaman, Anurag; Brown, Elizabeth E.; Sanderson, Ralph D.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill	Purushothaman, A (corresponding author), Univ Alabama Birmingham, Dept Pathol, WTI 602A,1720 Second Ave S, Birmingham, AL 35294 USA.; Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, WTI 602B,1720 Second Ave S, Birmingham, AL 35294 USA.	anuragp@uab.edu; sanderson@uab.edu			National Institutes of Health [CA138340, CA186646]; National Institute of Health [P30 AR048311, CA013148, AR048311]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA138340, R01CA186646] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM102137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA138340 (to R. D. S.) and CA186646 (to E. E. B.). This work was also supported in part by National Institute of Health Grants P30 AR048311 (to the University of Alabama at Birmingham Comprehensive Flow Cytometry Core Facility), CA013148 (to the University of Alabama at Birmingham Mass Spectrometry/Proteomics Shared Facility), and CA013148 and AR048311 (to the University of Alabama at Birmingham High Resolution Imaging Shared Facility). R. D. S. is a member of the Scientific Advisory Board of Sigma-Tau Research Switzerland.	Atai NA, 2013, J NEURO-ONCOL, V115, P343, DOI 10.1007/s11060-013-1235-y; Atay S, 2011, AM J REPROD IMMUNOL, V66, P259, DOI 10.1111/j.1600-0897.2011.00995.x; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Balaj L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10266; Bayer-Garner IB, 2001, MODERN PATHOL, V14, P1052, DOI 10.1038/modpathol.3880435; Borset M, 2000, BLOOD, V96, P2528; Carpentier M, 2014, GLYCOCONJUGATE J, V31, P161, DOI 10.1007/s10719-013-9512-8; Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; DALTON BA, 1995, J CELL SCI, V108, P2083; Deng ZB, 2012, AM J PATHOL, V180, P390, DOI 10.1016/j.ajpath.2011.09.023; Di Noto G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00517; Hubbard B, 2014, MATRIX BIOL, V34, P124, DOI 10.1016/j.matbio.2013.10.006; Kelly T, 2003, CANCER RES, V63, P8749; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Liu J, 2014, NAT PROD REP, V31, P1676, DOI 10.1039/c4np00076e; Marimpietri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075054; Meares GP, 2014, MOL CELL BIOL, V34, P3911, DOI 10.1128/MCB.00980-14; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mu W, 2013, NEOPLASIA, V15, P875, DOI 10.1593/neo.13786; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2014, J BIOL CHEM, V289, P5499, DOI 10.1074/jbc.M113.532143; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Raimondi L, 2015, ONCOTARGET, V6, P13772, DOI 10.18632/oncotarget.3830; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; Roucourt B, 2015, CELL RES, V25, P412, DOI 10.1038/cr.2015.29; Sung BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8164; Szalat R, 2015, CURR OPIN GENET DEV, V30, P56, DOI 10.1016/j.gde.2015.03.008; Thompson CA, 2013, J BIOL CHEM, V288, P10093, DOI 10.1074/jbc.C112.444562; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; Umezu T, 2014, BLOOD, V124, P3748, DOI 10.1182/blood-2014-05-576116; UNDERWOOD PA, 1992, J CELL SCI, V102, P833; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027	41	174	180	6	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1652	1663		10.1074/jbc.M115.686295	http://dx.doi.org/10.1074/jbc.M115.686295			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601950	hybrid, Green Published			2022-12-26	WOS:000368620700010
J	Liang, QZ; Shang, LG; Wang, YM; Hua, JP				Liang, Qingzhi; Shang, Lianguang; Wang, Yumei; Hua, Jinping			Partial Dominance, Overdominance and Epistasis as the Genetic Basis of Heterosis in Upland Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							RECOMBINANT INBRED LINES; INBREEDING DEPRESSION; GENOME STRUCTURE; FIBER TRAITS; QTL ANALYSIS; LINKAGE MAP; YIELD COMPONENTS; RICE; HYBRID; PERFORMANCE	Determination of genetic basis of heterosis may promote hybrid production in Upland cotton (Gossypium hirsutum L.). This study was designed to explore the genetic mechanism of heterosis for yield and yield components in F-2: 3 and F-2: 4 populations derived from a hybrid 'Xinza No. 1'. Replicated yield field trials of the progenies were conducted in 2008 and 2009. Phenotypic data analyses indicated overdominance in F-1 for yield and yield components. Additive and dominance effects at single-locus level and digenic epistatic interactions at two-locus level were analyzed by 421 marker loci spanning 3814 cM of the genome. A total of 38 and 49 QTLs controlling yield and yield components were identified in F-2: 3 and F-2: 4 populations, respectively. Analyses of these QTLs indicated that the effects of partial dominance and overdominance contributed to heterosis in Upland cotton simultaneously. Most of the QTLs showed partial dominance whereas 13 QTLs showing overdominance in F-2: 3 population, and 19 QTLs showed overdominance in F-2: 4. Among them, 21 QTLs were common in both F2: 3 and F2: 4 populations. A large number of two-locus interactions for yield and yield components were detected in both generations. AA (additive x additive) epistasis accounted for majority portion of epistatic effects. Thirty three complementary two-locus homozygotes (11/22 and 22/11) were the best genotypes for AA interactions in terms of bolls per plant. Genotypes of double homozygotes, 11/22, 22/11 and 22/22, performed best for AD/DA interactions, while genotype of 11/12 performed best for DD interactions. These results indicated that (1) partial dominance and overdominance effects at single-locus level and (2) epistasis at two-locus level elucidated the genetic basis of heterosis in Upland cotton.	[Liang, Qingzhi; Shang, Lianguang; Hua, Jinping] China Agr Univ, Minist Educ, Dept Plant Genet & Breeding, Key Lab Crop Heterosis & Utilizat, Beijing 100193, Peoples R China; [Wang, Yumei] Hubei Acad Agr Sci, Res Inst Cash Crops, Wuhan 430064, Hubei, Peoples R China	China Agricultural University; Hubei Academy of Agricultural Sciences	Hua, JP (corresponding author), China Agr Univ, Minist Educ, Dept Plant Genet & Breeding, Key Lab Crop Heterosis & Utilizat, Beijing 100193, Peoples R China.	jinping_hua@cau.edu.cn	Hua, Jinping/L-3221-2019		National Natural Science Foundation of China [31171591]; National High Technology Research and Development Program [2011AA10A102]; New Century Excellent Talents of Ministry of Education [NCET-06-0106]; Key Project of Ministry of Education [10712]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); New Century Excellent Talents of Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Key Project of Ministry of Education	This research was supported in part by a grant from the National Natural Science Foundation of China (www.nsfc.gov.cn) (31171591), grants from the National High Technology Research and Development Program (2011AA10A102), the New Century Excellent Talents of the Ministry of Education (NCET-06-0106), and the Key Project of Ministry of Education (10712) to J HUA.	Basunanda P, 2010, THEOR APPL GENET, V120, P271, DOI 10.1007/s00122-009-1133-z; BERNARDO R, 1992, THEOR APPL GENET, V83, P628, DOI 10.1007/BF00226908; Blenda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045739; Bowman DT, 1996, CROP SCI, V36, P577, DOI 10.2135/cropsci1996.0011183X003600030008x; Bruce A. B., 1910, Science New York N S, V32, DOI 10.1126/science.32.827.627-a; Burton JW, 2006, CROP SCI, V46, P2643, DOI 10.2135/cropsci2006.03.0156; Carr DE, 2003, PHILOS T R SOC B, V358, P1071, DOI 10.1098/rstb.2003.1295; CROW JF, 1948, GENETICS, V33, P477; Davenport CB, 1908, SCIENCE, V28, P454, DOI 10.1126/science.28.718.454-b; FASOULAS AC, 1962, GENETICS, V47, P899; Galanopoulou-Sendouca S, 1999, EUR J AGRON, V11, P53, DOI 10.1016/S1161-0301(99)00018-0; Guo TT, 2014, THEOR APPL GENET, V127, P2149, DOI 10.1007/s00122-014-2368-x; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; He DH, 2007, EUPHYTICA, V153, P181, DOI 10.1007/s10681-006-9254-9; He DH, 2005, EUPHYTICA, V144, P141, DOI 10.1007/s10681-005-5297-6; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hochholdinger F, 2007, TRENDS PLANT SCI, V12, P427, DOI 10.1016/j.tplants.2007.08.005; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Hua JP, 2002, GENETICS, V162, P1885; HULL FH, 1945, J AM SOC AGRON, V37, P134; Jones DF, 1917, GENETICS, V2, P466; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Lacape JM, 2003, GENOME, V46, P612, DOI [10.1139/G03-050, 10.1139/g03-050]; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li ChengQi, 2008, Cotton Science, V20, P163; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li JX, 2000, THEOR APPL GENET, V101, P248, DOI 10.1007/s001220051476; Li ZK, 1997, GENETICS, V145, P1139; Li ZK, 2001, GENETICS, V158, P1737; Liang QZ, 2013, CHINESE SCI BULL, V58, P3233, DOI 10.1007/s11434-013-5807-1; Liang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-539; Lin ZX, 2009, EUPHYTICA, V166, P35, DOI 10.1007/s10681-008-9822-2; Liu RZ, 2012, MOL BREEDING, V29, P297, DOI 10.1007/s11032-011-9547-0; Lu H, 2003, THEOR APPL GENET, V107, P494, DOI 10.1007/s00122-003-1271-7; Luo LJ, 2001, GENETICS, V158, P1755; McCarty JC, 2008, EUPHYTICA, V161, P337, DOI 10.1007/s10681-007-9562-8; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; MEREDITH WR, 1972, CROP SCI, V12, P304, DOI 10.2135/cropsci1972.0011183X001200030015x; Meyer RC, 2010, THEOR APPL GENET, V120, P227, DOI 10.1007/s00122-009-1074-6; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Powers L, 1944, AM NAT, V78, P275, DOI 10.1086/281199; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; REINISCH AJ, 1994, GENETICS, V138, P829; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Rousselle Y, 2011, HEREDITY, V106, P289, DOI 10.1038/hdy.2010.72; Shang LG, 2015, PLANT BREEDING; Shang LG, 2016, EUPHYTICA, V207, P645, DOI 10.1007/s10681-015-1564-3; Shang LG, 2015, EUPHYTICA, V205, P877, DOI 10.1007/s10681-015-1434-z; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Shen XL, 2006, CROP SCI, V46, P61, DOI 10.2135/cropsci2005.0056; StatSoft Inc, 1997, STATISTICA WIND; STUBER CW, 1992, GENETICS, V132, P823; Sun J., 1994, ACTA GOSSYPII SIN, V3, P135; Tan ZY, 2015, EUPHYTICA, V203, P615, DOI 10.1007/s10681-014-1288-9; Tang SY, 2015, EUPHYTICA, V201, P195, DOI [10.1007/s10681-014-1189-y, 10.1007/s10681-]; Ulloa M., 2000, Journal of Cotton Science, V4, P161; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang Baohua, 2007, Journal of Genetics and Genomics, V34, P35, DOI 10.1016/S1673-8527(07)60005-8; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang S., 2005, WINDOWS QTL CARTOGRA; WILLIAMS W, 1959, NATURE, V184, P527, DOI 10.1038/184527a0; Wright S., 1984, EVOLUTION GENETICS P; Wu JX, 2009, EUPHYTICA, V165, P231, DOI 10.1007/s10681-008-9748-8; Wu YT, 2004, PLANT BREEDING, V123, P285, DOI 10.1111/j.1439-0523.2004.00990.x; Xiao J, 2009, J COTTON SCI, V13, P75; XIAO JH, 1995, GENETICS, V140, P745; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Zeng LH, 2011, CROP SCI, V51, P2362, DOI 10.2135/cropsci2010.09.0536; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1; Zhou G, 2012, P NATL ACAD SCI USA, V109, P15847, DOI 10.1073/pnas.1214141109; Zhou SR, 2010, GENET RES, V92, P127, DOI 10.1017/S0016672310000133	82	26	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143548	10.1371/journal.pone.0143548	http://dx.doi.org/10.1371/journal.pone.0143548			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618635	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800045
J	Salheen, SM; Panchapakesan, U; Pollock, CA; Woodman, OL				Salheen, Salheen M.; Panchapakesan, Usha; Pollock, Carol A.; Woodman, Owen L.			The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Preserves Endothelial Function in Mesenteric Arteries from Type 1 Diabetic Rats without Decreasing Plasma Glucose	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; DEPENDENT RELAXATION; NITRIC-OXIDE; GROWTH-FACTOR; DYSFUNCTION; IMPAIRMENT; MECHANISMS; MELLITUS; IMPROVEMENT; EXENDIN-4	The aim of the study was to investigate the effect of the DPP-4 inhibitor linagliptin on the mechanism( s) of endothelium-dependent relaxation inmesenteric arteries from STZ-induced diabetic rats. Both normal and diabetic animals received linagliptin (2 mg/kg) daily by oral gavage for a period of 4 weeks. To measure superoxide generation in mesenteric arteries, lucigenin-enhanced chemiluminescence was used. ACh-induced relaxation of mesenteric arteries was assessed using organ bath techniques and Western blotting was used to investigate protein expression. Pharmacological tools (1 mu M TRAM-34, 1 mu M apamin, 100 nMIbtx, 100 mu M LNNA, 10 mu M ODQ) were used to distinguish between NO and EDH-mediated relaxation. Linagliptin did not affect plasma glucose, but did decrease vascular superoxide levels. Diabetes reduced responses to ACh but did not affect endothelium-independent responses to SNP. Linagliptin improved endothelial function indicated by a significant increase in responses to ACh. Diabetes impaired the contribution of both nitric oxide (NO) and endothelium-dependent hyperpolarization (EDH) to endothelium-dependent relaxation and linagliptin treatment significantly enhanced the contribution of both relaxing factors. Western blotting demonstrated that diabetes also increased expression of Nox2 and decreased expression and dimerization of endothelial NO synthase, effects that were reversed by linagliptin. These findings demonstrate treatment of type 1 diabetic rats with linagliptin significantly reduced vascular superoxide levels and preserved both NO and EDH-mediated relaxation indicating that linagliptin can improve endothelial function in diabetes independently of any glucose lowering activity.	[Salheen, Salheen M.; Woodman, Owen L.] RMIT Univ, Sch Med Sci, Bundoora, Vic, Australia; [Panchapakesan, Usha; Pollock, Carol A.] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia	Royal Melbourne Institute of Technology (RMIT); Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Woodman, OL (corresponding author), RMIT Univ, Sch Med Sci, Bundoora, Vic, Australia.	owen.woodman@rmit.edu.au	Woodman, Owen L/H-7297-2019	Woodman, Owen L/0000-0003-3759-1396				Aroor AR, 2013, ENDOCRINOLOGY, V154, P2501, DOI 10.1210/en.2013-1096; Basu A, 2007, AM J PHYSIOL-ENDOC M, V293, pE1289, DOI 10.1152/ajpendo.00373.2007; Burnham MP, 2006, BRIT J PHARMACOL, V148, P434, DOI 10.1038/sj.bjp.0706748; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Drucker DJ, 2007, DIABETES CARE, V30, P1335, DOI 10.2337/dc07-0228; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Fatehi-Hassanabad Z, 2010, EUR J PHARMACOL, V636, P8, DOI 10.1016/j.ejphar.2010.03.048; Feletou M, 1999, J MOL CELL CARDIOL, V31, P15, DOI 10.1006/jmcc.1998.0840; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Fukao M, 1997, BRIT J PHARMACOL, V121, P1383, DOI 10.1038/sj.bjp.0701258; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Green BD, 2008, ARCH BIOCHEM BIOPHYS, V478, P136, DOI 10.1016/j.abb.2008.08.001; Ishibashi Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-125; Jones RB, 2014, EUR J PHARMACOL, V729, P59, DOI 10.1016/j.ejphar.2014.02.004; Kitayama J, 2006, STROKE, V37, P2129, DOI 10.1161/01.STR.0000231654.79017.df; Koibuchi N, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0157-0; Kroller-Schon S, 2012, CARDIOVASC RES, V96, P140, DOI 10.1093/cvr/cvs246; Leo CH, 2011, BRIT J PHARMACOL, V162, P365, DOI 10.1111/j.1476-5381.2010.01023.x; Leo CH, 2010, AM J PHYSIOL-HEART C, V299, pH502, DOI 10.1152/ajpheart.01197.2009; Ma X, 2008, LIFE SCI, V83, P110, DOI 10.1016/j.lfs.2008.05.010; Makino A, 2000, BRIT J PHARMACOL, V130, P549, DOI 10.1038/sj.bjp.0703354; Matsumoto T, 2003, AM J PHYSIOL-HEART C, V285, pH283, DOI 10.1152/ajpheart.00954.2002; Matsumoto T, 2005, AM J PHYSIOL-HEART C, V289, pH1933, DOI 10.1152/ajpheart.00303.2005; Matsumoto T, 2006, VASC PHARMACOL, V44, P450, DOI 10.1016/j.vph.2006.02.007; MCPHERSON GA, 1992, CLIN EXP PHARMACOL P, V19, P815, DOI 10.1111/j.1440-1681.1992.tb00420.x; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nikolaidis LA, 2004, CIRCULATION, V110, P955, DOI 10.1161/01.CIR.0000139339.85840.DD; Nistala R, 2014, OBESITY, V22, P2172, DOI 10.1002/oby.20833; Pieper GM, 1999, DIABETOLOGIA, V42, P204, DOI 10.1007/s001250051140; Rosenstock Julio, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P98, DOI 10.1097/MED.0b013e3280a02f65; Salheen SM, 2015, PHARMACOL RES, V94, P26, DOI 10.1016/j.phrs.2015.02.003; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; Weston AH, 2008, BRIT J PHARMACOL, V154, P652, DOI 10.1038/bjp.2008.108; Yamagishi S, 2014, INT J CARDIOL, V176, P550, DOI 10.1016/j.ijcard.2014.07.023; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Zhao TC, 2006, J PHARMACOL EXP THER, V317, P1106, DOI 10.1124/jpet.106.100982	40	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143941	10.1371/journal.pone.0143941	http://dx.doi.org/10.1371/journal.pone.0143941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618855	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800092
J	Xie, E; Kotha, A; Biaco, T; Sedani, N; Zou, J; Stashenko, P; Duncan, MJ; Campos-Neto, A; Cayabyab, MJ				Xie, Emily; Kotha, Abhiroop; Biaco, Tracy; Sedani, Nikita; Zou, Jonathan; Stashenko, Phillip; Duncan, Margaret J.; Campos-Neto, Antonio; Cayabyab, Mark J.			Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance	PLOS ONE			English	Article							IN-VIVO; GASTROINTESTINAL-TRACT; TRANSGENIC MICE; SIV INFECTION; CAVITY; REPLICATION; PULLULANASE; INDUCTION; DEPLETION; DELETION	The pioneer human oral commensal bacterium Streptococcus mitis has unique biologic features that make it an attractive mucosal vaccine or therapeutic delivery vector. S. mitis is safe as a natural persistent colonizer of the mouth, throat and nasopharynx and the oral commensal bacterium is capable of inducing mucosal antibody responses. A recombinant S. mitis (rS. mitis) that stably expresses HIV envelope protein was generated and tested in the germ-free mouse model to evaluate the potential usefulness of this vector as a mucosal vaccine against HIV. Oral vaccination led to the efficient and persistent bacterial colonization of the mouth and the induction of both salivary and systemic antibody responses. Interestingly, persistently colonized animals developed antigen-specific systemic T cell tolerance. Based on these findings we propose the use of rS. mitis vaccine vector for the induction of mucosal antibodies that will prevent the penetration of the mucosa by pathogens such as HIV. Moreover, the first demonstration of rS. mitis having the ability to elicit T cell tolerance suggest the potential use of rS. mitis as an immunotherapeutic vector to treat inflammatory, allergic and autoimmune diseases.	[Xie, Emily; Kotha, Abhiroop; Biaco, Tracy; Sedani, Nikita; Zou, Jonathan; Stashenko, Phillip; Campos-Neto, Antonio; Cayabyab, Mark J.] Forsyth Inst, Global Infect Dis Res Ctr, Cambridge, MA 02115 USA; [Xie, Emily; Kotha, Abhiroop; Biaco, Tracy; Sedani, Nikita; Zou, Jonathan; Stashenko, Phillip; Campos-Neto, Antonio; Cayabyab, Mark J.] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA; [Duncan, Margaret J.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Stashenko, Phillip; Campos-Neto, Antonio; Cayabyab, Mark J.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard University; Forsyth Institute; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Cayabyab, MJ (corresponding author), Forsyth Inst, Global Infect Dis Res Ctr, 245 First St, Cambridge, MA 02115 USA.	mcayabyab@forsyth.org			National Institute of Dental and Craniofacial Research [RO3 DE022525]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE022525] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant (RO3 DE022525) from the National Institute of Dental and Craniofacial Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ben Mkaddem S, 2014, CURR TOP MICROBIOL, V382, P221, DOI 10.1007/978-3-319-07911-0_10; Bensing BA, 2007, J BACTERIOL, V189, P3846, DOI 10.1128/JB.00027-07; Benson JM, 2000, J CLIN INVEST, V106, P1031, DOI 10.1172/JCI10738; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cayabyab MJ, 2013, VACCINE, V31, P4834, DOI 10.1016/j.vaccine.2013.07.077; Cayabyab MJ, 2006, J VIROL, V80, P1645, DOI 10.1128/JVI.80.4.1645-1652.2006; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; Daifalla N, 2015, MICROBES INFECT, V17, P237, DOI 10.1016/j.micinf.2014.11.002; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Engen SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104306; FISHMANLOBELL J, 1994, EUR J IMMUNOL, V24, P2720, DOI 10.1002/eji.1830241122; Fitzsimmons S, 1996, CLIN DIAGN LAB IMMUN, V3, P517, DOI 10.1128/CDLI.3.5.517-522.1996; GIBBONS RJ, 1964, J BACTERIOL, V88, P1316, DOI 10.1128/JB.88.5.1316-1323.1964; Haynes BF, 2014, J ALLERGY CLIN IMMUN, V134, P3, DOI 10.1016/j.jaci.2014.04.025; Hurst SD, 1997, P NATL ACAD SCI USA, V94, P3920, DOI 10.1073/pnas.94.8.3920; Hytonen J, 2003, INFECT IMMUN, V71, P784, DOI 10.1128/IAI.71.2.784-793.2003; KILIAN M, 1981, INFECT IMMUN, V31, P868, DOI 10.1128/IAI.31.3.868-873.1981; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Marth T, 1996, J IMMUNOL, V157, P2348; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mukherjee S, 2005, J IMMUNOL, V175, P5298, DOI 10.4049/jimmunol.175.8.5298; Nutsch KM, 2012, CURR OPIN IMMUNOL, V24, P385, DOI 10.1016/j.coi.2012.04.009; Pape KA, 1998, J IMMUNOL, V160, P4719; PLAUT AG, 1974, J IMMUNOL, V113, P289; Santi I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003787; SMITH DJ, 1993, ORAL MICROBIOL IMMUN, V8, P1, DOI 10.1111/j.1399-302X.1993.tb00535.x; SMITH DJ, 1992, CRIT REV ORAL BIOL M, V3, P109, DOI 10.1177/10454411920030010201; SMITH DJ, 1990, ORAL MICROBIOL IMMUN, V5, P57, DOI 10.1111/j.1399-302X.1990.tb00228.x; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; TOBIAN JA, 1982, J BACTERIOL, V152, P215; Tomaras GD, 2014, VACCINES, V2, P15, DOI 10.3390/vaccines2010015; VanHouten N, 1996, J IMMUNOL, V157, P1337; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wirth KA, 2008, ARCH ORAL BIOL, V53, P141, DOI 10.1016/j.archoralbio.2007.08.003	38	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143422	10.1371/journal.pone.0143422	http://dx.doi.org/10.1371/journal.pone.0143422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618634	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800036
J	Corrales, M; Cusco, P; Usmanova, DR; Chen, HC; Bogatyreva, NS; Filion, GJ; Ivankov, DN				Corrales, Marc; Cusco, Pol; Usmanova, Dinara R.; Chen, Heng-Chang; Bogatyreva, Natalya S.; Filion, Guillaume J.; Ivankov, Dmitry N.			Machine Learning: How Much Does It Tell about Protein Folding Rates?	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; SINGLE-DOMAIN PROTEINS; RATE PREDICTION; SECONDARY STRUCTURE; GLOBULAR-PROTEINS; 2-STATE PROTEINS; TRANSITION-STATE; CONTACT ORDER; CHAIN-LENGTH; KINETICS	The prediction of protein folding rates is a necessary step towards understanding the principles of protein folding. Due to the increasing amount of experimental data, numerous protein folding models and predictors of protein folding rates have been developed in the last decade. The problem has also attracted the attention of scientists from computational fields, which led to the publication of several machine learning-based models to predict the rate of protein folding. Some of them claim to predict the logarithm of protein folding rate with an accuracy greater than 90%. However, there are reasons to believe that such claims are exaggerated due to large fluctuations and overfitting of the estimates. When we confronted three selected published models with new data, we found a much lower predictive power than reported in the original publications. Overly optimistic predictive powers appear from violations of the basic principles of machine-learning. We highlight common misconceptions in the studies claiming excessive predictive power and propose to use learning curves as a safeguard against those mistakes. As an example, we show that the current amount of experimental data is insufficient to build a linear predictor of logarithms of folding rates based on protein amino acid composition.	[Corrales, Marc; Cusco, Pol; Chen, Heng-Chang; Filion, Guillaume J.] Ctr Genom Regulat CRG, Genome Architecture Gene Regulat Stem Cells & Can, Barcelona, Spain; [Corrales, Marc; Cusco, Pol; Usmanova, Dinara R.; Chen, Heng-Chang; Bogatyreva, Natalya S.; Filion, Guillaume J.; Ivankov, Dmitry N.] Univ Pompeu Fabra UPF, Barcelona, Spain; [Corrales, Marc; Cusco, Pol; Chen, Heng-Chang; Filion, Guillaume J.] Ctr Genom Regulat CRG, Spain Genome Architecture Gene Regulat Stem Cells, Barcelona, Spain; [Usmanova, Dinara R.; Bogatyreva, Natalya S.; Ivankov, Dmitry N.] Ctr Genom Regulat CRG, Bioinformat & Genom Programme, Barcelona, Spain; [Usmanova, Dinara R.] Moscow Inst Phys & Technol, Moscow, Russia; [Bogatyreva, Natalya S.; Ivankov, Dmitry N.] Russian Acad Sci, Inst Prot Res, Lab Prot Phys, Pushchino 142292, Moscow Region, Russia	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Moscow Institute of Physics & Technology; Russian Academy of Sciences	Ivankov, DN (corresponding author), Univ Pompeu Fabra UPF, Barcelona, Spain.	ivankov13@gmail.com	Ivankov, Dmitry/AAD-8104-2019; Filion, Guillaume/G-9619-2015; Usmanova, Dinara Ravilevna/I-9370-2014; Bogatyreva, Natalya S/B-9598-2017; Cusco, Pol/J-8638-2015	Ivankov, Dmitry/0000-0002-8224-4118; Filion, Guillaume/0000-0002-3473-1632; Bogatyreva, Natalya/0000-0002-1719-1136; Cusco, Pol/0000-0002-6523-2916	Russian Science Foundation [14-24-00157]; ERC [335980_EinME]; Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa' [SEV-2012-0208]; Spanish Ministry of Economy and Competitiveness; Spanish Ministry of Economy and Competitiveness (including State Training Subprogram: predoctoral fellowships for the training of PhD students (FPI); CRG	Russian Science Foundation(Russian Science Foundation (RSF)); ERC(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa'(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy and Competitiveness (including State Training Subprogram: predoctoral fellowships for the training of PhD students (FPI); CRG	NSB was supported by the Russian Science Foundation Grant 14-24-00157. DRU and DNI were supported by ERC grant 335980_EinME. The authors acknowledge support of the Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa 2013-2017', SEV-2012-0208. HCC and PC were supported by the Spanish Ministry of Economy and Competitiveness (including State Training Subprogram: predoctoral fellowships for the training of PhD students (FPI) 2013). MC and GF were supported by the CRG. The publication cost was covered by CRG.	Bogatyreva NS, 2009, NUCLEIC ACIDS RES, V37, pD342, DOI 10.1093/nar/gkn696; Capriotti E, 2007, BIOINFORMATICS, V23, P385, DOI 10.1093/bioinformatics/btl610; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Finkel'shtein A. V., 1997, Molekulyarnaya Biologiya (Moscow), V31, P469; Finkelstein AV, 1997, FOLD DES, V2, P115, DOI 10.1016/S1359-0278(97)00016-3; Galzitskaya OV, 2003, PROTEINS, V51, P162, DOI 10.1002/prot.10343; Garbuzynskiy SO, 2013, P NATL ACAD SCI USA, V110, P147, DOI 10.1073/pnas.1210180110; GOLDBERG ME, 1990, FEBS LETT, V263, P51, DOI 10.1016/0014-5793(90)80703-L; Gong HP, 2003, J MOL BIOL, V327, P1149, DOI 10.1016/S0022-2836(03)00211-0; Grantcharova V, 2001, CURR OPIN STRUC BIOL, V11, P70, DOI 10.1016/S0959-440X(00)00176-7; Gromiha MM, 2006, NUCLEIC ACIDS RES, V34, pW70, DOI 10.1093/nar/gkl043; Gromiha MM, 2009, J CHEM INF MODEL, V49, P1130, DOI 10.1021/ci800440x; Gromiha MM, 2005, J CHEM INF MODEL, V45, P494, DOI 10.1021/ci049757q; Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Huang JT, 2006, PROTEINS, V63, P551, DOI 10.1002/prot.20911; Huang LT, 2008, J COMPUT CHEM, V29, P1675, DOI 10.1002/jcc.20925; Ivankov DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006476; Ivankov DN, 2004, P NATL ACAD SCI USA, V101, P8942, DOI 10.1073/pnas.0402659101; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jiang YF, 2009, J COMPUT CHEM, V30, P772, DOI 10.1002/jcc.21096; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Levinthal C., 1969, MOSSBAUER SPECTROSC, V67, P22; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Ma BG, 2006, PROTEINS, V65, P362, DOI 10.1002/prot.21140; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141; SALI A, 1994, J MOL BIOL, V235, P1614, DOI 10.1006/jmbi.1994.1110; Shao H, 2003, PROTEIN PEPTIDE LETT, V10, P277, DOI 10.2174/0929866033478906; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; THIRUMALAI D, 1995, J PHYS I, V5, P1457, DOI 10.1051/jp1:1995209; Zhang LX, 2005, BIOPHYS CHEM, V113, P9, DOI 10.1016/j.bpc.2004.07.036; Zhang LX, 2003, POLYMER, V44, P1751, DOI 10.1016/S0032-3861(03)00021-1	38	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143166	10.1371/journal.pone.0143166	http://dx.doi.org/10.1371/journal.pone.0143166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606303	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300047
J	Davidson, AF; Glasscock, C; McClanahan, DR; Benson, JD; Higgins, AZ				Davidson, Allyson Fry; Glasscock, Cameron; McClanahan, Danielle R.; Benson, James D.; Higgins, Adam Z.			Toxicity Minimized Cryoprotectant Addition and Removal Procedures for Adherent Endothelial Cells	PLOS ONE			English	Article							INTRACELLULAR ICE FORMATION; EMBRYONIC STEM-CELLS; SURFACE-BASED CRYOPRESERVATION; ARTICULAR-CARTILAGE; PERMEABLE CRYOPROTECTANTS; VITRIFICATION; TRANSPORT; GLYCEROL; MODEL; CHIP	Ice-free cryopreservation, known as vitrification, is an appealing approach for banking of adherent cells and tissues because it prevents dissociation and morphological damage that may result from ice crystal formation. However, current vitrification methods are often limited by the cytotoxicity of the concentrated cryoprotective agent (CPA) solutions that are required to suppress ice formation. Recently, we described a mathematical strategy for identifying minimally toxic CPA equilibration procedures based on the minimization of a toxicity cost function. Here we provide direct experimental support for the feasibility of these methods when applied to adherent endothelial cells. We first developed a concentration- and temperature-dependent toxicity cost function by exposing the cells to a range of glycerol concentrations at 21 degrees C and 37 degrees C, and fitting the resulting viability data to a first order cell death model. This cost function was then numerically minimized in our state constrained optimization routine to determine addition and removal procedures for 17 molal (mol/kg water) glycerol solutions. Using these predicted optimal procedures, we obtained 81% recovery after exposure to vitrification solutions, as well as successful vitrification with the relatively slow cooling and warming rates of 50 degrees C/min and 130 C/min. In comparison, conventional multistep CPA equilibration procedures resulted in much lower cell yields of about 10%. Our results demonstrate the potential for rational design of minimally toxic vitrification procedures and pave the way for extension of our optimization approach to other adherent cell types as well as more complex systems such as tissues and organs.	[Davidson, Allyson Fry; Glasscock, Cameron; McClanahan, Danielle R.; Higgins, Adam Z.] Oregon State Univ, Sch Chem Biol & Environm Engn, Corvallis, OR 97331 USA; [Benson, James D.] No Illinois Univ, Dept Math Sci, De Kalb, IL 60115 USA	Oregon State University; Northern Illinois University	Higgins, AZ (corresponding author), Oregon State Univ, Sch Chem Biol & Environm Engn, Corvallis, OR 97331 USA.	adam.higgins@oregonstate.edu			National Science Foundation [1150861]; Oregon State University Libraries & Press Open Access Fund	National Science Foundation(National Science Foundation (NSF)); Oregon State University Libraries & Press Open Access Fund	This work was supported by a National Science Foundation grant (#1150861) to AZH (www.nsf.gov). Publication of this article in an open access journal was funded by the Oregon State University Libraries & Press Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazari A, 2012, BIOPHYS J, V102, P1284, DOI 10.1016/j.bpj.2011.12.058; Acker JP, 1999, CRYOBIOLOGY, V38, P363, DOI 10.1006/cryo.1999.2179; Almansoori KA, 2012, CRYOBIOLOGY, V64, P185, DOI 10.1016/j.cryobiol.2012.01.006; Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001; Beier AFJ, 2011, CRYOBIOLOGY, V63, P175, DOI 10.1016/j.cryobiol.2011.06.003; Benson JD, 2014, MATH BIOSCI, V254, P64, DOI 10.1016/j.mbs.2014.06.003; Benson JD, 2012, B MATH BIOL, V74, P1516, DOI 10.1007/s11538-012-9724-2; Benson JD, 2012, CRYOBIOLOGY, V64, P144, DOI 10.1016/j.cryobiol.2012.01.001; Benson JD, 2010, J MATH BIOL, DOI [10.1007/s00285-010-0374-4, DOI 10.1007/S00285-010-0374]; Davidson AF, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-13; Elmoazzen Heidi Y., 2007, Cell and Tissue Banking, V8, P125, DOI 10.1007/s10561-006-9023-y; Fahmy MD, 2014, CRYOBIOLOGY, V68, P50, DOI 10.1016/j.cryobiol.2013.11.006; Fahy GM, 2004, CRYOBIOLOGY, V48, P157, DOI 10.1016/j.cryobiol.2004.02.002; Fahy GM, 2004, CRYOBIOLOGY, V48, P22, DOI 10.1016/j.cryobiol.2003.11.004; Fry AK, 2012, CELL MOL BIOENG, V5, P287, DOI 10.1007/s12195-012-0235-x; GAO DY, 1995, HUM REPROD, V10, P1109, DOI 10.1093/oxfordjournals.humrep.a136103; Green D.W., 2019, PERRYS CHEM ENGINEER, V9; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Higgins AZ, 2013, BIOPHYS J, V105, P2006, DOI 10.1016/j.bpj.2013.09.028; Hornung J, 1996, CRYOBIOLOGY, V33, P260, DOI 10.1006/cryo.1996.0026; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Ji L, 2004, BIOTECHNOL BIOENG, V88, P299, DOI 10.1002/bit.20243; Jomha NM, 2012, BIOMATERIALS, V33, P6061, DOI 10.1016/j.biomaterials.2012.05.007; Karlsson JOM, 2014, CRYOBIOLOGY, V68, P18, DOI 10.1016/j.cryobiol.2013.11.002; Karlsson JOM, 2009, MOL REPROD DEV, V76, P321, DOI 10.1002/mrd.20956; Kashuba CM, 2014, CRYOBIOLOGY, V68, P166, DOI 10.1016/j.cryobiol.2013.12.007; Katkov II, 1998, CRYOBIOLOGY, V37, P325, DOI 10.1006/cryo.1998.2128; Kuleshova L, 1999, HUM REPROD, V14, P3077, DOI 10.1093/humrep/14.12.3077; Lawson A, 2012, CRYOBIOLOGY, V64, P1, DOI 10.1016/j.cryobiol.2011.11.006; Lawson A, 2011, CRYOBIOLOGY, V62, P115, DOI 10.1016/j.cryobiol.2011.01.012; LEVIN RL, 1981, CRYOBIOLOGY, V18, P32, DOI 10.1016/0011-2240(81)90004-3; LEVIN RL, 1982, J BIOMECH ENG-T ASME, V104, P81, DOI 10.1115/1.3138341; Lusianti RE, 2013, BIOTECHNOL PROGR, V29, P609, DOI 10.1002/btpr.1710; Ma W, 2006, NEUROSCI LETT, V403, P84, DOI 10.1016/j.neulet.2006.04.064; Malpique R, 2012, BIOTECHNOL PROGR, V28, P1079, DOI 10.1002/btpr.1572; Malpique R, 2009, TISSUE ENG PART C-ME, V15, P373, DOI 10.1089/ten.tec.2008.0410; May KML, 2004, ANAL CHEM, V76, P4156, DOI 10.1021/ac049810+; Meryman HT, 2007, TRANSFUSION, V47, P935, DOI 10.1111/j.1537-2995.2007.01212.x; Miyamoto Y, 2009, CELL TRANSPLANT, V18, P619, DOI 10.1177/096368970901805-618; Mukherjee IN, 2007, CRYOBIOLOGY, V55, P10, DOI 10.1016/j.cryobiol.2007.04.002; Pasch J, 1999, CRYOBIOLOGY, V39, P158, DOI 10.1006/cryo.1999.2197; Song YC, 2000, NAT BIOTECHNOL, V18, P296, DOI 10.1038/73737; Stott SL, 2009, CRYOBIOLOGY, V58, P84, DOI 10.1016/j.cryobiol.2008.11.003; Wang X, 2007, CRYOBIOLOGY, V55, P60, DOI 10.1016/j.cryobiol.2007.05.006; Wusteman MC, 2002, CRYOBIOLOGY, V44, P24, DOI 10.1016/S0011-2240(02)00002-0; Zou LL, 2015, CRYOBIOLOGY, V71, P210, DOI 10.1016/j.cryobiol.2015.07.001	47	36	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142828	10.1371/journal.pone.0142828	http://dx.doi.org/10.1371/journal.pone.0142828			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605546	Green Submitted, gold, Green Published			2022-12-26	WOS:000365865300032
J	Eichenberger, EM; Thaden, JT; Sharma-Kuinkel, B; Park, LP; Rude, TH; Ruffin, F; Hos, NJ; Seifert, H; Rieg, S; Kern, WV; Lower, SK; Fowler, VG; Kaasch, AJ				Eichenberger, Emily M.; Thaden, Joshua T.; Sharma-Kuinkel, Batu; Park, Lawrence P.; Rude, Thomas H.; Ruffin, Felicia; Hos, Nina J.; Seifert, Harald; Rieg, Siegbert; Kern, Winfried V.; Lower, Steven K.; Fowler, Vance G., Jr.; Kaasch, Achim J.			Polymorphisms in Fibronectin Binding Proteins A and B among Staphylococcus aureus Bloodstream Isolates Are Not Associated with Arthroplasty Infection	PLOS ONE			English	Article							BIOFILM FORMATION; FIBRINOGEN; ADHERENCE; GENES; GENOTYPE; FNBA	Background Nonsynonymous single nucleotide polymorphisms (SNPs) in fibronectin binding protein A (fnbA) of Staphylococcus aureus are associated with cardiac device infections. However, the role of fnbA SNPs in S. aureus arthroplasty infection is unknown. Methods Bloodstream S. aureus isolates from a derivation cohort of patients at a single U.S. medical center with S. aureus bacteremia (SAB) and prosthetic hip or knee arthroplasties that were infected (PJI, n = 27) or uninfected (PJU, n = 43) underwent sequencing of fnbA and fnbB. A validation cohort of S. aureus bloodstream PJI (n = 12) and PJU (n = 58) isolates from Germany also underwent fnbA and fnbB sequencing. Results Overall, none of the individual fnbA or fnbB SNPs were significantly associated with the PJI or PJU clinical groups within the derivation cohort. Similarly, none of the individual fnbA or fnbB SNPs were associated with PJI or PJU when the analysis was restricted to patients with either early SAB (i.e., bacteremia occurring <1 year after placement or manipulation of prostheses) or late SAB (i.e., bacteremia >1 year after placement or manipulation of prostheses). Conclusions In contrast to cardiac device infections, there is no association between nonsynonymous SNPs in fnbA or fnbB of bloodstream S. aureus isolates and arthroplasty infection. These results suggest that initial steps leading to S. aureus infection of cardiovascular and orthopedic prostheses may arise by distinct processes.	[Eichenberger, Emily M.; Thaden, Joshua T.; Sharma-Kuinkel, Batu; Park, Lawrence P.; Rude, Thomas H.; Ruffin, Felicia; Fowler, Vance G., Jr.] Duke Univ, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA; [Park, Lawrence P.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA; [Hos, Nina J.; Seifert, Harald; Kaasch, Achim J.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany; [Seifert, Harald] Univ Cologne, German Ctr Infect Res DZIF, D-50923 Cologne, Germany; [Rieg, Siegbert; Kern, Winfried V.] Univ Med Ctr Freiburg, Div Infect Dis, Dept Med 2, D-79106 Freiburg, Germany; [Lower, Steven K.] Ohio State Univ, Div Nat & Math Sci, Columbus, OH 43210 USA	Duke University; Duke University; University of Cologne; German Center for Infection Research; University of Cologne; University of Freiburg; University System of Ohio; Ohio State University	Fowler, VG (corresponding author), Duke Univ, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.	vance.fowler@duke.edu	Kaasch, Achim J/F-8414-2012; Lower, Steven/A-2440-2008; Rieg, Siegbert/ABB-7954-2020; Fowler, Vance/AAW-2017-2021; Eichenberger, Emily/AHC-5402-2022	Lower, Steven/0000-0001-9796-0830; Rieg, Siegbert/0000-0001-7493-7080; Eichenberger, Emily/0000-0002-2469-0638; Kaasch, Achim/0000-0002-6659-6738	National Institutes of Health [K24-AI093969, R01-AI068804, R01-HL119648]; German Research Foundation [KA 3104/1-1]; Paul-Ehrlich Gesellschaft fur Chemotherapie; Federal Ministry of Education and Research [BMBF 01KI1017]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI093969, R01AI068804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Paul-Ehrlich Gesellschaft fur Chemotherapie; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (www.nih.gov): K24-AI093969 (V.G.F.), R01-AI068804 (V.G.F.), and R01-HL119648 (S.K.L.). The INSTINCT study was supported by the German Research Foundation (www.dgf.de; KA 3104/1-1 to A.J.K.), the Paul-Ehrlich Gesellschaft fur Chemotherapie (www.p-e-g.org; to H.S. and W.V.K.), and the Federal Ministry of Education and Research (www.bmbf.de; BMBF 01KI1017 to A.J.K.). The funders above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciola CR, 2005, FEMS MICROBIOL LETT, V246, P81, DOI 10.1016/j.femsle.2005.03.035; Barberan J, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2006.03.036; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Buck AW, 2010, LANGMUIR, V26, P10764, DOI 10.1021/la100549u; Campoccia D, 2009, BIOMATERIALS, V30, P6621, DOI 10.1016/j.biomaterials.2009.08.032; Casillas-Ituarte NN, 2012, J BIOL CHEM, V287, P6693, DOI 10.1074/jbc.M111.285692; Geoghegan JA, 2013, J BACTERIOL, V195, P2675, DOI 10.1128/JB.02128-12; Haqqani HM, 2009, PACE, V32, P1336, DOI 10.1111/j.1540-8159.2009.02492.x; HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693; Hos NJ, 2015, J INFECTION, V70, P153, DOI 10.1016/j.jinf.2014.09.005; HOSHAL VL, 1971, ARCH SURG-CHICAGO, V102, P353; Kaasch AJ, 2014, J INFECTION, V68, P242, DOI 10.1016/j.jinf.2013.10.015; Kaasch AJ, 2011, CLIN INFECT DIS, V53, P1, DOI 10.1093/cid/cir320; Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002; Lower SK, 2011, P NATL ACAD SCI USA, V108, P18372, DOI 10.1073/pnas.1109071108; McCourt J, 2014, FEMS MICROBIOL LETT, V353, P157, DOI 10.1111/1574-6968.12424; Mehall JR, 2002, CRIT CARE MED, V30, P908, DOI 10.1097/00003246-200204000-00033; Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389; O'Neill E, 2009, J MED MICROBIOL, V58, P399, DOI 10.1099/jmm.0.005504-0; Padera RF, 2006, CARDIOVASC PATHOL, V15, P264, DOI 10.1016/j.carpath.2006.04.008; Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657; Peersman G, 2001, CLIN ORTHOP RELAT R, P15, DOI 10.1097/00003086-200111000-00003; Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; Vancraeynest D, 2004, VET MICROBIOL, V103, P241, DOI 10.1016/j.vetmic.2004.09.002; VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302; Xiong YQ, 2015, INFECT IMMUN, V83, P4772, DOI 10.1128/IAI.01074-15	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0141436	10.1371/journal.pone.0141436	http://dx.doi.org/10.1371/journal.pone.0141436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606522	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300009
J	Kim, BJ; Kim, YH; Kim, N; Kwon, SU; Kim, SJ; Kim, JS; Kang, DW				Kim, Bum Joon; Kim, Yong-Hwan; Kim, Namkug; Kwon, Sun U.; Kim, Sang Joon; Kim, Jong S.; Kang, Dong-Wha			Lesion Location-Based Prediction of Visual Field Improvement after Cerebral Infarction	PLOS ONE			English	Article							ISCHEMIC-STROKE; VISION RESTORATION; HOMONYMOUS HEMIANOPIA; RECOVERY; BRAIN; MRI; HEMIPLEGIA; PROGNOSIS; DEFECTS; THERAPY	Background Although the prognosis of ischemic stroke is highly dependent on the lesion location, it has rarely been quantitatively utilized. We investigated the usefulness of regional extent of ischemic lesion (rEIL) predicting the improvement of visual field defect (VFD) in patients with posterior cerebral artery infarction. Methods The rEILs were measured in each individual cortex after transforming the lesions to a standard atlas. Significant improvement of VFD was tentatively defined as 20% improvement at 3 months after stroke. The performances of clinical and imaging variables predicting significant improvement were measured by support vector machine. The maximum performance of variables predicting the significant improvement was compared between subgroups of variables (clinical, baseline severity and lesion volume) and the effect of adding rEIL to those subgroups of variables was evaluated. Results A total of 35 patients were enrolled in this study. Left PCA infarct, MR-time from onset, rEILs in the lingual, calcarine, and cuneus cortices were good prognostic indicators of hemi-VFD (performance for predicting the significant improvement: 72.8 +/- 11.8%, 66.1 +/- 11.2%, respectively). A combination of the rEILs of each cortical subregions demonstrated a better predictive performance for hemi-VFD (83.8 +/- 9.5%) compared to a combination of clinical variables (72.8 +/- 11.8; p<0.001), baseline severity (63.0 +/- 11.9%; p<0.001), or lesion volume (62.6 +/- 12.7%; p<0.001). Adding a rEIL to other variables improved the prognostic prediction for hemi-VFD (74.4 +/- 11.6% to 91.3 +/- 7.7%; p<0.001). Conclusions An estimation of rEIL provides useful information regarding the ischemic lesion location. rEIL accurately predicts the significant improvement of VFD and enhances the prediction power when combined with other variables.	[Kim, Bum Joon; Kwon, Sun U.; Kim, Jong S.; Kang, Dong-Wha] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea; [Kim, Yong-Hwan; Kang, Dong-Wha] Asan Med Ctr, Asan Inst Life Sci, Vis Image & Learning Lab, Seoul, South Korea; [Kim, Namkug; Kim, Sang Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Namkug] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kang, DW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea.	dwkang@amc.seoul.kr	Kim, Bum Joon/S-2156-2017; Kim, Yong-Hwan/AAF-4280-2019; Kim, Namkug/E-3843-2012; Kim, Bum Joon/AAS-2541-2020	Kim, Bum Joon/0000-0002-3278-3252; Kim, Namkug/0000-0002-3438-2217; Kim, Yong-Hwan/0000-0002-9275-199X	National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2014R1A2A1A11051280]; Ministry for Healthcare & Welfare, Republic of Korea [HI12C1847, HI14C1983]; Korea Health Technology RD Project	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Ministry for Healthcare & Welfare, Republic of Korea; Korea Health Technology RD Project	This study was supported by grants from the National Research Foundation of Korea (NRF) funded by the Korean government (MEST) (NRF-2014R1A2A1A11051280), and the Korea Health Technology R&D Project and Ministry for Healthcare & Welfare, Republic of Korea (HI12C1847 and HI14C1983).	ADAMS GF, 1961, BRIT MED J, V1, P309, DOI 10.1136/bmj.1.5222.309; Bang OY, 2009, J CLIN NEUROL, V5, P107, DOI 10.3988/jcn.2009.5.3.107; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Celebisoy M, 2011, J NEUROL NEUROSUR PS, V82, P695, DOI 10.1136/jnnp.2010.214387; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DENES G, 1982, BRAIN, V105, P543, DOI 10.1093/brain/105.3.543; Guenther T, 2009, IEEE T BIO-MED ENG, V56, P572, DOI 10.1109/TBME.2008.2009995; Hankey GJ, 2007, NEUROLOGY, V68, P1583, DOI 10.1212/01.wnl.0000260967.77422.97; Holloway RG, 2005, JAMA-J AM MED ASSOC, V294, P725; Hope TMH, 2013, NEUROIMAGE-CLIN, V2, P424, DOI 10.1016/j.nicl.2013.03.005; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim BJ, 2014, J STROKE, V16, P131, DOI 10.5853/jos.2014.16.3.131; Lim JS, 2015, J STROKE, V17, P256, DOI 10.5853/jos.2015.17.3.256; Macciocchi SN, 1998, ARCH PHYS MED REHAB, V79, P1255, DOI 10.1016/S0003-9993(98)90271-4; MARINKOVIC SV, 1987, STROKE, V18, P728, DOI 10.1161/01.STR.18.4.728; Payabvash S, 2012, NEUROLOGY, V78, P1853, DOI 10.1212/WNL.0b013e318258f799; Payabvash S, 2010, AM J NEURORADIOL, V31, P1661, DOI 10.3174/ajnr.A2125; Poggel DA, 2004, NEUROLOGY, V63, P2069, DOI 10.1212/01.WNL.0000145773.26378.E5; Sabel BA, 2013, RESTOR NEUROL NEUROS, V31, P787, DOI 10.3233/RNN-139019; Sabel BA, 2011, PROG BRAIN RES, V192, P199, DOI 10.1016/B978-0-444-53355-5.00013-0; Shelton FDAP, 2001, STROKE, V32, P107, DOI 10.1161/01.STR.32.1.107; Stinear C, 2010, LANCET NEUROL, V9, P1228, DOI 10.1016/S1474-4422(10)70247-7; TIEL K, 1991, NEURO-OPHTHALMOLOGY, V11, P33, DOI 10.3109/01658109109009640; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ween JE, 1996, NEUROLOGY, V47, P388, DOI 10.1212/WNL.47.2.388; Wong AMF, 1999, ARCH OPHTHALMOL-CHIC, V117, P208; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143882	10.1371/journal.pone.0143882	http://dx.doi.org/10.1371/journal.pone.0143882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606516	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300119
J	Palus, K; Calka, J				Palus, Katarzyna; Calka, Jaroslaw			The Influence of Prolonged Acetylsalicylic Acid Supplementation-Induced Gastritis on the Neurochemistry of the Sympathetic Neurons Supplying Prepyloric Region of the Porcine Stomach	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; VASOACTIVE-INTESTINAL-PEPTIDE; LI NERVE STRUCTURES; SUPERIOR MESENTERIC GANGLION; AXOTOMY-INDUCED CHANGES; NITRIC-OXIDE; GASTROINTESTINAL-TRACT; DESCENDING COLON; NEUROPEPTIDE-Y; RAT STOMACH	This experiment was designed to establish the localization and neurochemical phenotyping of sympathetic neurons supplying prepyloric area of the porcine stomach in a physiological state and during acetylsalicylic acid (ASA) induced gastritis. In order to localize the sympathetic perikarya the stomachs of both control and acetylsalicylic acid treated (ASA group) animals were injected with neuronal retrograde tracer Fast Blue (FB). Seven days post FB injection, animals were divided into a control and ASA supplementation group. The ASA group was given 100 mg/kg of b.w. ASA orally for 21 days. On the 28th day all pigs were euthanized with gradual overdose of anesthetic. Then fourteen-micrometer-thick cryostat sections were processed for routine double-labeling immunofluorescence, using primary antisera directed towards tyrosine hydroxylase (TH), dopamine beta-hydroxylase (D beta H), neuropeptide Y (NPY), galanin (GAL), neuronal nitric oxide synthase (nNOS), leu 5-enkephalin (LENK), cocaine-and amphetamine-regulated transcript peptide (CART), calcitonin gene-related peptide (CGRP), substance P (SP) and vasoactive intestinal peptide (VIP). The data obtained in this study indicate that postganglionic sympathetic nerve fibers supplying prepyloric area of the porcine stomach originate from the coeliac-cranial mesenteric ganglion complex (CCMG). In control animals, the FB-labelled neurons expressed TH (94.85 +/- 1.01%), DaH (97.10 +/- 0.97%), NPY (46.88 +/- 2.53%) and GAL (8.40 +/- 0.53%). In ASA group, TH- and D beta H-positive nerve cells were reduced (85.78 +/- 2.65% and 88.82 +/- 1.63% respectively). Moreover, ASA-induced gastritis resulted in increased expression of NPY (76.59 +/- 3.02%) and GAL (26.45 +/- 2.75%) as well as the novo-synthesis of nNOS (6.13 +/- 1.11%) and LENK (4.77 +/- 0.42%) in traced CCMG neurons. Additionally, a network of CART-, CGRP-, SP-, VIP-, LENK-, nNOS-immunoreactive (IR) nerve fibers encircling the FB-positive perikarya were observed in both intact and ASA-treated animals. The results of this study indicate involvement of these neuropeptides in the development or presumably counteraction of gastric inflammation.	[Palus, Katarzyna; Calka, Jaroslaw] Univ Warmia & Mazury, Fac Vet Med, Dept Clin Physiol, Olsztyn, Poland	University of Warmia & Mazury	Palus, K (corresponding author), Univ Warmia & Mazury, Fac Vet Med, Dept Clin Physiol, Olsztyn, Poland.	katarzyna.palus@uwm.edu.pl		Palus, Katarzyna/0000-0002-7593-9552	Polish State Committee for Scientific Research [1890/B/P01/2010/39]; University of Warmia and Mazury in Olsztyn [15.610.003-300]; Ministry of Science and Higher Education [05-1/KNOW2/2015]	Polish State Committee for Scientific Research(Polish State Committee for Scientific Research); University of Warmia and Mazury in Olsztyn; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Publication supported by the Polish State Committee for Scientific Research number 1890/B/P01/2010/39, the University of Warmia and Mazury in Olsztyn (statutory research) grant No 15.610.003-300 and KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food", decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015.	ABRAHAMSSON H, 1984, SCAND J GASTROENTERO, V19, P83; AHREN B, 1990, CELL TISSUE RES, V261, P49, DOI 10.1007/BF00329437; Akimoto M, 2000, J CARDIOVASC PHARM, V36, pS282, DOI 10.1097/00005344-200036051-00083; Anderson RL, 2001, J COMP NEUROL, V429, P419, DOI 10.1002/1096-9861(20010115)429:3<419::AID-CNE5>3.0.CO;2-D; Arciszewski MB, 2008, ANN ANAT, V190, P360, DOI 10.1016/j.aanat.2008.04.004; Arciszewski MB, 2005, REGUL PEPTIDES, V125, P185, DOI 10.1016/j.regpep.2004.08.036; Barrachina MD, 2001, CURR PHARM DESIGN, V7, P31, DOI 10.2174/1381612013398491; BracciLaudiero L, 1996, NEUROREPORT, V7, P485, DOI 10.1097/00001756-199601310-00026; Bulc M, 2014, ACTA HISTOCHEM, V116, P1029, DOI 10.1016/j.acthis.2014.04.009; Burlinski PJ, 2013, J MOL NEUROSCI, V49, P62, DOI 10.1007/s12031-012-9889-z; Calka J, 2006, FOLIA HISTOCHEM CYTO, V44, P3; Cervi AL, 2014, AUTON NEUROSCI-BASIC, V182, P83, DOI 10.1016/j.autneu.2013.12.003; Dallos A, 2006, J PERIPHER NERV SYST, V11, P156, DOI 10.1111/j.1085-9489.2006.00081.x; Dijkstra Gerard, 2004, Curr Opin Investig Drugs, V5, P529; Dinh QT, 2004, CLIN EXP ALLERGY, V34, P1934, DOI 10.1111/j.1365-2222.2004.02114.x; Ekblad E, 2004, NEUROGASTROENT MOTIL, V16, P123, DOI 10.1111/j.1743-3150.2004.00487.x; Ekblad E, 2000, MICROSC RES TECHNIQ, V48, P241, DOI 10.1002/(SICI)1097-0029(20000301)48:5<241::AID-JEMT2>3.0.CO;2-2; Ekblad E, 2003, NEUROGASTROENT MOTIL, V15, P545, DOI 10.1046/j.1365-2982.2003.00437.x; Ernfors P, 2001, CELL MOL LIFE SCI, V58, P1036, DOI 10.1007/PL00000918; Feher E, 2001, NEUROIMMUNOMODULAT, V9, P247, DOI 10.1159/000054287; Furness JB, 2000, AUTON NEUROSCI-BASIC, V83, P81, DOI 10.1016/S0165-1838(00)00159-4; Fuster V, 2011, CIRCULATION, V123, P768, DOI 10.1161/CIRCULATIONAHA.110.963843; Ganko M, 2014, J MOL NEUROSCI, V52, P90, DOI 10.1007/s12031-013-0102-9; Gonkowski S, 2012, J MOL NEUROSCI, V48, P777, DOI 10.1007/s12031-012-9838-x; Gonkowski S, 2012, B VET I PULAWY, V56, P199; Gonkowski S, 2010, ACTA VET HUNG, V58, P91, DOI 10.1556/AVet.58.2010.1.10; Gonkowski S, 2009, ACTA VET HUNG, V57, P509, DOI 10.1556/AVet.57.2009.4.5; GREEN T, 1987, NEUROSCI LETT, V76, P151, DOI 10.1016/0304-3940(87)90707-5; Gunnarsdottir A, 2007, EUR J PEDIATR SURG, V17, P184, DOI 10.1055/s-2007-965164; Hayakawa T, 2007, AUTON NEUROSCI-BASIC, V134, P8, DOI 10.1016/j.autneu.2007.01.011; Itina L V, 1995, Fiziol Zh Im I M Sechenova, V81, P164; Kaleczyc J, 2007, ANAT HISTOL EMBRYOL, V36, P186, DOI 10.1111/j.1439-0264.2006.00744.x; Kaleczyc J., 2004, Polish Journal of Veterinary Sciences, V7, P199; Kisfalvi I, 2000, J PHYSIOL-PARIS, V94, P37, DOI 10.1016/S0928-4257(99)00105-9; KREULEN DL, 1983, AM J PHYSIOL, V245, pG369, DOI 10.1152/ajpgi.1983.245.3.G369; Kubes P, 1995, MEDIAT INFLAMM, V4, P397, DOI 10.1155/S0962935195000640; LAKOMY M, 1993, FOLIA HISTOCHEM CYTO, V31, P181; Lanas A, 2011, EXPERT OPIN DRUG SAF, V10, P45, DOI 10.1517/14740338.2010.507629; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; LINDH B, 1986, J NEUROSCI, V6, P2371; Lundgren O, 2000, GUT, V47, P33; Lundgren O, 2000, GUT S4, V47, piv36; Majewski M, 2000, FOLIA MORPHOL WARSZA, V58, P65; Martin MJ, 2001, CURR PHARM DESIGN, V7, P881, DOI 10.2174/1381612013397645; Masliukov P M, 2005, Morfologiia, V128, P41; Matkowskyj K, 2009, GUT, V58, P1201, DOI 10.1136/gut.2008.163832; Miampamba M, 1999, NEUROGASTROENT MOTIL, V11, P193; Miolan JP, 1996, J AUTONOM NERV SYST, V58, P125, DOI 10.1016/0165-1838(95)00128-X; Mohney RP, 1998, J NEUROSCI, V18, P5285, DOI 10.1523/JNEUROSCI.18-14-05285.1998; Mousa SA, 2010, BRAIN BEHAV IMMUN, V24, P1310, DOI 10.1016/j.bbi.2010.06.008; Nishio H, 2006, LIFE SCI, V79, P1523, DOI 10.1016/j.lfs.2006.04.013; Okumura T, 2000, ENDOCRINOLOGY, V141, P2854, DOI 10.1210/en.141.8.2854; Palus K, 2013, FOLIA MORPHOL, V72, P328, DOI 10.5603/FM.2013.0055; Pidsudko Z, 2011, NEUROGASTROENT MOTIL, V23, pE213, DOI 10.1111/j.1365-2982.2011.01694.x; Porcher C, 2000, J HISTOCHEM CYTOCHEM, V48, P333, DOI 10.1177/002215540004800303; Porter AJ, 1998, INT J COLORECTAL DIS, V13, P208, DOI 10.1007/s003840050163; Quinson N, 2000, EUR J NEUROSCI, V12, P1521, DOI 10.1046/j.1460-9568.2000.00056.x; Quinson N, 2001, ARCH HISTOL CYTOL, V64, P281, DOI 10.1679/aohc.64.281; Ribeiro AACM, 2002, ANAT HISTOL EMBRYOL, V31, P344, DOI 10.1046/j.1439-0264.2002.00415.x; Rich M, 2000, SEMIN ARTHRITIS RHEU, V30, P167, DOI 10.1053/sarh.2000.16643; Rytel L, 2015, ANAT HISTOL EMBRYOL, V44, P86, DOI 10.1111/ahe.12111; SHEIKH SP, 1991, AM J PHYSIOL, V261, pG701, DOI 10.1152/ajpgi.1991.261.5.G701; Shiotani A, 2009, J GASTROENTEROL, V44, P717, DOI 10.1007/s00535-009-0068-0; Simpson J, 2009, NEUROGASTROENT MOTIL, V21, P847, DOI 10.1111/j.1365-2982.2009.01308.x; Sipos G, 2006, DIGEST DIS SCI, V51, P1810, DOI 10.1007/s10620-006-9085-5; Skobowiat C, 2011, EXP MOL PATHOL, V90, P13, DOI 10.1016/j.yexmp.2010.11.004; Skobowiat C, 2010, J VET MED SCI, V72, P1269, DOI 10.1292/jvms.10-0081; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Talero E, 2007, REGUL PEPTIDES, V141, P96, DOI 10.1016/j.regpep.2006.12.029; TRUDRUNG P, 1994, ARCH HISTOL CYTOL, V57, P139, DOI 10.1679/aohc.57.139; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Verma N, 2011, PROTEOMICS, V11, P776, DOI 10.1002/pmic.201000320; Vona-Davis LC, 2007, CURR TOP MED CHEM, V7, P1710, DOI 10.2174/156802607782340966; Wallace JL, 2013, WORLD J GASTROENTERO, V19, P1861, DOI 10.3748/wjg.v19.i12.1861; WHITTLE BJR, 1980, NATURE, V284, P271, DOI 10.1038/284271a0; Wojtkiewicz J, 2012, J MOL NEUROSCI, V48, P757, DOI 10.1007/s12031-011-9691-3; Yamada M, 2006, NEUROSCI RES, V54, P261, DOI 10.1016/j.neures.2005.12.007; Yeomans ND, 2011, J GASTROEN HEPATOL, V26, P426, DOI 10.1111/j.1440-1746.2010.06569.x	79	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143661	10.1371/journal.pone.0143661	http://dx.doi.org/10.1371/journal.pone.0143661			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606050	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300095
J	Tanaka, K; Zelenitsky, DK; Therrien, F				Tanaka, Kohei; Zelenitsky, Darla K.; Therrien, Francois			Eggshell Porosity Provides Insight on Evolution of Nesting in Dinosaurs	PLOS ONE			English	Article							WATER-VAPOR CONDUCTANCE; 2 MEDICINE FORMATION; TROODON-FORMOSUS; GAS CONDUCTANCE; EGG CLUTCH; AVIAN EGG; OOSP NOV; THEROPOD; REVEALS; MOA	Knowledge about the types of nests built by dinosaurs can provide insight into the evolution of nesting and reproductive behaviors among archosaurs. However, the low preservation potential of their nesting materials and nesting structures means that most information can only be gleaned indirectly through comparison with extant archosaurs. Two general nest types are recognized among living archosaurs: 1) covered nests, in which eggs are incubated while fully covered by nesting material (as in crocodylians and megapodes), and 2) open nests, in which eggs are exposed in the nest and brooded (as in most birds). Previously, dinosaur nest types had been inferred by estimating the water vapor conductance (i.e., diffusive capacity) of their eggs, based on the premise that high conductance corresponds to covered nests and low conductance to open nests. However, a lack of statistical rigor and inconsistencies in this method render its application problematic and its validity questionable. As an alternative we propose a statistically rigorous approach to infer nest type based on large datasets of eggshell porosity and egg mass compiled for over 120 extant archosaur species and 29 archosaur extinct taxa/ootaxa. The presence of a strong correlation between eggshell porosity and nest type among extant archosaurs indicates that eggshell porosity can be used as a proxy for nest type, and thus discriminant analyses can help predict nest type in extinct taxa. Our results suggest that: 1) covered nests are likely the primitive condition for dinosaurs (and probably archosaurs), and 2) open nests first evolved among non-avian theropods more derived than Lourinhanosaurus and were likely widespread in non-avian maniraptorans, well before the appearance of birds. Although taphonomic evidence suggests that basal open nesters (i. e., oviraptorosaurs and troodontids) were potentially the first dinosaurs to brood their clutches, they still partially buried their eggs in sediment. Open nests with fully exposed eggs only became widespread among Euornithes. A potential co-evolution of open nests and brooding behavior among maniraptorans may have freed theropods from the ground-based restrictions inherent to covered nests and allowed the exploitation of alternate nesting locations. These changes in nesting styles and behaviors thus may have played a role in the evolutionary success of maniraptorans (including birds).	[Tanaka, Kohei; Zelenitsky, Darla K.] Univ Calgary, Dept Geosci, Calgary, AB, Canada; [Therrien, Francois] Royal Tyrrell Museum Palaeontol, Drumheller, AB, Canada	University of Calgary	Tanaka, K (corresponding author), Univ Calgary, Dept Geosci, Calgary, AB, Canada.	ktanaka@ucalgary.ca		Therrien, Francois/0000-0002-2652-908X	Yoshida Scholarship Foundation; Japan Student Services Organization (JASSO); Natural Sciences and Engineering Research Council of Canada (NSERC)	Yoshida Scholarship Foundation(Yoshida Scholarship Foundation); Japan Student Services Organization (JASSO)(Japan Student Services Organization); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The Yoshida Scholarship Foundation (http://www.ysf.or.jp/englishpage/index.html) and the Japan Student Services Organization (JASSO) (http://www.jasso.go.jp/index_e.html) provided funding to KT. The Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (http://www.nserc-crsng.gc.ca/index_eng.asp) provided funding to DKZ.	Angielczyk KD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1642; Antunes MT, 1998, MEM ACAD CIEN LISB, V37, P83; AR A, 1985, RESP PHYSIOL, V61, P1, DOI 10.1016/0034-5687(85)90024-6; AR A, 1974, CONDOR, V76, P153, DOI 10.2307/1366725; Archey G., 1941, Bull Aukland Inst Mus, Vno. 1, P1; Archey G., 1931, Records of the Auckland Institute and Museum, V1, P113; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; BOARD RG, 1975, J MICROSC-OXFORD, V103, P281, DOI 10.1111/j.1365-2818.1975.tb03906.x; BOARD RG, 1977, J ZOOL, V182, P251, DOI 10.1111/j.1469-7998.1977.tb04158.x; Brazaitis P, 2011, HIST BIOL, V23, P73, DOI 10.1080/08912963.2011.560723; BRICKHILL J, 1987, EMU, V87, P42, DOI 10.1071/MU9870042; BROLEY CHARLES L., 1947, WILSON BULL, V59, P3; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Carey C, 2002, OX ORN SER, V13, P238; CAREY C, 1980, BIOSCIENCE, V30, P819, DOI 10.2307/1308374; Carpenter K., 1999, EGGS NESTS BABY DINO; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Cheng YN, 2008, ACTA GEOL SIN-ENGL, V82, P1089; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Chiappe LM, 2004, PALAIOS, V19, P89, DOI 10.1669/0883-1351(2004)019<0089:NSFSSC>2.0.CO;2; Chiappe LM, 2001, 1 INT S DIN EGGS BAB, P23; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Clark James M., 1999, American Museum Novitates, V3265, P1; Clayburn JK, 2004, PALAIOS, V19, P170, DOI 10.1669/0883-1351(2004)019<0170:TEOPAT>2.0.CO;2; Close RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036664; COOMBS WP, 1989, GEOL S AM S, V238, P21; Cunha P, 2004, 23 IAS M SED, P93; Davies SJJF., 2002, RATITES TINAMOUS TIN; DAVIS TA, 1984, PHYSIOL ZOOL, V57, P384, DOI 10.1086/physzool.57.4.30163340; DAVIS TA, 1985, AUK, V102, P640, DOI 10.1093/auk/102.3.640; Deeming DC, 2006, PALAEONTOLOGY, V49, P171, DOI 10.1111/j.1475-4983.2005.00536.x; Deeming DC, 2002, OX ORN SER, V13, P1; Deeming DC, 2002, OX ORN SER, V13, P63; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; Dunn EH, 1995, BIRDS N AM, V147; Fanti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031330; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Garcia G, 2001, PALAEOGEOGR PALAEOCL, V169, P153, DOI 10.1016/S0031-0182(01)00215-2; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gartner GEA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P43, DOI 10.1086/648509; Gill B. J., 2006, Records of the Auckland Museum, V43, P55; Gill BJ, 2000, J ROY SOC NEW ZEAL, V30, P131; Grant G.S., 1982, ORNITHOL MONOGR, V30, P1, DOI [10.2307/40166669, DOI 10.2307/40166669]; Grellet-Tinner G, 2012, PALAIOS, V27, P35, DOI 10.2110/palo.2011.p11-061r; Grigorescu Dan, 1994, P75; Grigorescu D, 2010, PALAEOGEOGR PALAEOCL, V293, P360, DOI 10.1016/j.palaeo.2010.03.031; Hall MI, 2012, P ROY SOC B-BIOL SCI, V279, P4962, DOI 10.1098/rspb.2012.2258; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; Howell TR, 1979, BREEDING BIOL EGYPTI; HOYT DF, 1979, AUK, V96, P73; Huynen L, 2010, P NATL ACAD SCI USA, V107, P16201, DOI 10.1073/pnas.0914096107; Jackson FD, 2008, PALEOBIOLOGY, V34, P229, DOI 10.1666/0094-8373(2008)034[0229:COWVCI]2.0.CO;2; Jackson FD, 2015, PALAIOS, V30, P362, DOI 10.2110/palo.2014.052; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Kathju Kandarp, 2007, Forktail, V23, P165; Kear J., 2005, DUCKS GEESE SWANS; Kurochkin EN, 2013, PALEONTOL J+, V47, P1252, DOI 10.1134/S0031030113110087; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Lopez-Martinez N, 2000, PALAEOGEOGR PALAEOCL, V160, P153, DOI 10.1016/S0031-0182(00)00063-8; Lopez-Martinez N, 2012, PALAEONTOLOGY, V55, P325, DOI 10.1111/j.1475-4983.2011.01114.x; MACLEAN G L, 1974, Ostrich, V45, P167, DOI 10.1080/00306525.1974.9634053; Maddison W., 2018, MESQUITE MODULAR SYS; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; Marzola M, 2015, HIST BIOL, V27, P115, DOI 10.1080/08912963.2013.871009; MAZZOTTI FJ, 1989, B MAR SCI, V44, P220; McIntyre J.W., 1997, BIRDS N AM; Midford PE, 2010, PDAP PACKAGE MESQUIE; Mikhailov Konstantin, 1994, P88; Mitchell KJ, 2014, SCIENCE, V344, P898, DOI 10.1126/science.1251981; Motani R, 2011, EVOLUTION, V65, P2245, DOI 10.1111/j.1558-5646.2011.01271.x; Mou Yun, 1992, Vertebrata Palasiatica, V30, P120; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Norell Mark A., 2001, American Museum Novitates, V3315, P1, DOI 10.1206/0003-0082(2001)315<0001:AEODTF>2.0.CO;2; Novas FE, 2015, NATURE, V522, P331, DOI 10.1038/nature14307; Oaks JR, 2011, EVOLUTION, V65, P3285, DOI 10.1111/j.1558-5646.2011.01373.x; Oliveira CEM, 2011, PALAEONTOLOGY, V54, P309, DOI 10.1111/j.1475-4983.2010.01028.x; PAGANELLI CV, 1974, CONDOR, V76, P319, DOI 10.2307/1366345; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Rigby JK, 1993, GEOL SOC AM ABSTR, V25, pA296; SABATH K, 1991, Acta Palaeontologica Polonica, V36, P151; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Selles A.G., 2015, HIST BIOL; SEYMOUR RS, 1979, PALEOBIOLOGY, V5, P1; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; Tanaka K, 2014, CAN J ZOOL, V92, P1049, DOI 10.1139/cjz-2014-0078; Tanaka K, 2014, HIST BIOL, V26, P122, DOI 10.1080/08912963.2013.772169; TYLER C, 1979, J ZOOL, V187, P283; Tyler C., 1959, Proceedings of the Zoological Society of London, V133, P201; Varricchio DJ, 2015, ACTA PALAEONTOL POL, V60, P11, DOI 10.4202/app.00085.2014; Varricchio DJ, 2013, PALEOBIOLOGY, V39, P278, DOI 10.1666/11042; Varricchio DJ, 1999, J VERTEBR PALEONTOL, V19, P91, DOI 10.1080/02724634.1999.10011125; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Varricchio DJ, 2002, J VERTEBR PALEONTOL, V22, P564, DOI 10.1671/0272-4634(2002)022[0564:EAEFTC]2.0.CO;2; Vila B, 2010, LETHAIA, V43, P197, DOI 10.1111/j.1502-3931.2009.00183.x; Villamarin-Jurado F, 2007, J HERPETOL, V41, P164, DOI 10.1670/0022-1511(2007)41[164:NOTBCM]2.0.CO;2; Wang M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7987; Weishampel DB, 2008, J VERTEBR PALEONTOL, V28, P1110, DOI 10.1671/0272-4634-28.4.1110; White DW, 1997, CONDOR, V99, P873, DOI 10.2307/1370137; Wiemann J, 2015, PEERJ PREPRINTS, V3, pe1323, DOI DOI 10.7287/PEERJ.PREPRINTS.1080V1; WILLIAMS DLG, 1984, PALAEOGEOGR PALAEOCL, V45, P23, DOI 10.1016/0031-0182(84)90107-X; Wilson JA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000322; Zelenitsky DK, 2008, PALAEONTOLOGY, V51, P807, DOI 10.1111/j.1475-4983.2008.00770.x; Zelenitsky DK, 2008, PALAEONTOLOGY, V51, P1253, DOI 10.1111/j.1475-4983.2008.00815.x; Zelenitsky DK, 1996, CAN J EARTH SCI, V33, P1655, DOI 10.1139/e96-126; Zelenitsky DK, 1996, CAN J EARTH SCI, V33, P1127, DOI 10.1139/e96-085; Zhao Zi-kui, 1975, Vertebrata Palasiatica, V13, P105; Zhao ZK, 2013, CHINESE SCI BULL, V58, P4663, DOI 10.1007/s11434-013-6059-9	115	36	38	2	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142829	10.1371/journal.pone.0142829	http://dx.doi.org/10.1371/journal.pone.0142829			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605799	Green Submitted, gold, Green Published			2022-12-26	WOS:000365865300033
J	Zhou, P; Liu, JM; Li, XL; Takahashi, Y; Qi, FX				Zhou, Peng; Liu, Jinman; Li, Xiaoli; Takahashi, Yukihiro; Qi, Fengxia			The Sialic Acid Binding Protein, Hsa, in Streptococcus gordonii DL1 also Mediates Intergeneric Coaggregation with Veillonella Species	PLOS ONE			English	Article							SURFACE GLYCOPROTEINS GSPB; CELL-WALL; ACTINOMYCES-NAESLUNDII; BACTERIAL INTERACTIONS; HUMAN-PLATELETS; ADHESIN; IDENTIFICATION; COLONIZATION; RECEPTORS; BIOFILM	Dental biofilm development involves initial colonization of the tooth's surface by pioneer colonizers, followed by cell-cell coaggregation between the pioneer and later colonizers. Streptococcus gordonii is one of the pioneer colonizers. In addition to its role in oral biofilm development, S. gordonii also is a pathogen in infective endocarditis in susceptible humans. A surface adhesin, Hsa, has been shown to play a critical role in colonization of S. gordonii on the heart tissue; however, its role in oral biofilm development has not been reported. In this study we demonstrate that Hsa is essential for coaggregation between S. gordonii and Veillonella sp., which are bridging species connecting the pioneer colonizers to the late colonizers. Interestingly, the same domains shown to be required for Hsa binding to sialic acid on the human cell surface are also required for coaggregation with Veillonella sp. However, sialic acid appeared not to be required for this intergeneric coaggregation. This result suggests that although the same domains of Hsa are involved in binding to eukaryotic as well as Veillonella cells, the binding mechanism is different. The gene expression pattern of hsa was also studied and shown not to be induced by coaggregation with Veillonella sp.	[Zhou, Peng; Liu, Jinman; Li, Xiaoli; Qi, Fengxia] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Qi, Fengxia] Univ Oklahoma, Hlth Sci Ctr, Coll Dent, Dept Oral Biol, Oklahoma City, OK 73104 USA; [Takahashi, Yukihiro] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Microbiol, Chiyoda Ku, Tokyo 1028159, Japan	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Nippon Dental University	Qi, FX (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA.	Felicia-qi@ouhsc.edu	Takahashi, Yukihiro/ABA-4333-2020; zhou, peng/S-9353-2019; Li, Xiaoli/GYQ-7384-2022	Zhou, Peng/0000-0002-0221-5967; Zhou, Peng/0000-0001-8619-1124	National Institutes of Health [2R15DE019940, 5R21DE024235]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE024235, R15DE019940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by 2R15DE019940, 5R21DE024235, National Institutes of Health, http://www.nih.gov.	Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; HANDLEY PS, 1988, J GEN MICROBIOL, V134, P3165; HERZBERG MC, 1983, INFECT IMMUN, V39, P1457, DOI 10.1128/IAI.39.3.1457-1469.1983; Huang RJ, 2011, VIRULENCE, V2, P435, DOI 10.4161/viru.2.5.16140; HUGHES CV, 1992, INFECT IMMUN, V60, P1178, DOI 10.1128/IAI.60.3.1178-1186.1992; HUGHES CV, 1988, APPL ENVIRON MICROB, V54, P1957, DOI 10.1128/AEM.54.8.1957-1963.1988; Jakubovics NS, 2005, INFECT IMMUN, V73, P6629, DOI 10.1128/IAI.73.10.6629-6638.2005; Jung CJ, 2012, J INFECT DIS, V205, P1066, DOI 10.1093/infdis/jis021; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kolenbrander PE, 2011, INT J ORAL SCI, V3, P49, DOI 10.4248/IJOS11025; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; KOLENBRANDER PE, 1988, ANNU REV MICROBIOL, V42, P627, DOI 10.1146/annurev.mi.42.100188.003211; Liu JM, 2012, APPL ENVIRON MICROB, V78, P3488, DOI 10.1128/AEM.00196-12; McNab R, 1999, J BACTERIOL, V181, P3087, DOI 10.1128/JB.181.10.3087-3095.1999; Nobbs AH, 2007, MICROBIOL-SGM, V153, P4088, DOI 10.1099/mic.0.2007/007252-0; NYVAD B, 1987, SCAND J DENT RES, V95, P369; PAKULA R, 1963, J GEN MICROBIOL, V31, P125, DOI 10.1099/00221287-31-1-125; Ruhl S, 2000, INFECT IMMUN, V68, P6346, DOI 10.1128/IAI.68.11.6346-6354.2000; Takahashi Y, 2006, INFECT IMMUN, V74, P740, DOI 10.1128/IAI.74.1.740-743.2006; Takahashi Y, 2004, INFECT IMMUN, V72, P3876, DOI 10.1128/IAI.72.7.3876-3882.2004; Takahashi Y, 2002, INFECT IMMUN, V70, P1209, DOI 10.1128/IAI.70.3.1209-1218.2002; Takahashi Y, 1997, INFECT IMMUN, V65, P5042, DOI 10.1128/IAI.65.12.5042-5051.1997; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Tanzer JM, 2003, MICROBIOL-SGM, V149, P2653, DOI 10.1099/mic.0.26022-0; Urano-Tashiro Y, 2012, ODONTOLOGY, V100, P144, DOI 10.1007/s10266-011-0044-z; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; WEERKAMP AH, 1981, INFECT IMMUN, V32, P723, DOI 10.1128/IAI.32.2.723-730.1981; Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x; Zhou P, 2015, MOL ORAL MICROBIOL, V30, P269, DOI 10.1111/omi.12091	33	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143898	10.1371/journal.pone.0143898	http://dx.doi.org/10.1371/journal.pone.0143898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606595	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300120
J	Amelkina, O; Zschockelt, L; Painer, J; Serra, R; Villaespesa, F; Braun, BC; Jewgenow, K				Amelkina, Olga; Zschockelt, Lina; Painer, Johanna; Serra, Rodrigo; Villaespesa, Francisco; Braun, Beate C.; Jewgenow, Katarina			Apoptosis-Related Factors in the Luteal Phase of the Domestic Cat and Their Involvement in the Persistence of Corpora Lutea in Lynx	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RAT CORPUS-LUTEUM; CYCLE-DEPENDENT CHANGES; FAS/FAS LIGAND SYSTEM; IBERIAN LYNX; FAS LIGAND; ESTROUS-CYCLE; ENZYME-ACTIVITY; CELL APOPTOSIS; AND-9 PROTEINS	The corpus luteum (CL) is a transient gland formed in the ovary after ovulation and is the major source of progesterone. In the Iberian and Eurasian lynx, CL physiologically persist after parturition and retain their capacity to produce progesterone, thus suppressing the ovarian activity. This unique reproductive characteristic has a big impact on the success of assisted reproduction techniques in the endangered Iberian lynx. The mechanisms behind CL persistence are not yet understood and require extensive studies on potential luteotropic and luteolytic factors in felids. Because the apoptosis system has been shown to be involved in structural regression of CL in many species, we aimed to investigate the capacity of perCL to undergo apoptosis. In addition, we performed initial studies on the apoptosis system in the luteal phase of the domestic cat. No previous research on this system has been made in this species. Our factors of interest included agents of the intrinsic apoptosis pathway, i.e., pro-survival B-cell CLL/lymphoma 2 (BCL2) and pro-apoptotic BCL2-associated X protein (BAX), the executioner caspase-3 (CASP3), as well as of the extrinsic pathway, i.e., pro-apoptotic receptor FAS, and tumor necrosis factor (TNF) and its receptors (pro-apoptotic TNFRSF1A and pro-survival TNFRSF1B). We analyzed the relative mRNA levels of these factors, as well as protein localization of CASP3 and TNF during stages of pregnancy and the non-pregnant luteal phase in CL of domestic cats. The same factors were investigated in freshly ovulated CL (frCL) and perCL of Iberian and Eurasian lynx, which were histologically analyzed. All factors were present in the CL tissue of both domestic cat and lynx throughout all analyzed stages. The presence of pro-apoptotic factors BAX, CASP3, FAS and TNFRSF1A in perCL of the Eurasian and Iberian lynx might indicate the potential sensitivity of perCL to apoptotic signals. The expression of pro-survival factors BCL2 and TNFRSF1B was significantly higher in perCL compared to frCL of studied Iberian lynx, suggesting the potential involvement of these factors in the structural integrity of perCL. In both Iberian lynx and pregnant and non-pregnant domestic cats, the expression of TNFRSF1A was significantly higher in forming CL compared to other stages, suggesting the conserved involvement of this factor in the tissue reorganization during formation of the feline CL. The mRNA levels of CASP3 and TNFRSF1B were highest during regression stages of domestic cat CL. The current study provides initial results on the possible involvement of the apoptosis system in the structure and function of the feline CL and in its physiological persistence.	[Amelkina, Olga; Zschockelt, Lina; Painer, Johanna; Braun, Beate C.; Jewgenow, Katarina] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol, Berlin, Germany; [Serra, Rodrigo] Ctr Nacl Reprod Lince Iberico, Iberian Iynx Capt Breeding Program, Silves, Portugal; [Villaespesa, Francisco] Ctr Cria Lince Iberico El Acebuche, Iberian Iynx Capt Breeding Program, Huelva, Spain	Leibniz Institut fur Zoo und Wildtierforschung	Amelkina, O (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol, Berlin, Germany.	olga.amelkina@gmail.com	Schölkopf, Bernhard/A-7570-2013; Rätsch, Gunnar/B-8182-2009; Braun, Beate C/J-8641-2016; Rätsch, Gunnar/O-5914-2017; Scholz, Matthias/B-3508-2018	Schölkopf, Bernhard/0000-0002-8177-0925; Rätsch, Gunnar/0000-0001-5486-8532; Scholz, Matthias/0000-0003-1414-5924; Painer - Gigler, Johanna/0000-0003-3929-511X; Jewgenow, Katarina/0000-0002-6173-840X	German Research Foundation (DFG) [Je 163/11-1]; German Academic Exchange Service (DAAD) [A/10/86242]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The work was supported by the German Research Foundation (DFG; Je 163/11-1; URL http://www.dfg.de/en/) and German Academic Exchange Service (DAAD; A/10/86242; https://www.daad.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo M, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-50; Amelkina O, 2015, THERIOGENOLOGY, V83, P711, DOI 10.1016/j.theriogenology.2014.11.008; Baird DD, 2003, BIOL REPROD, V68, P448, DOI 10.1095/biolreprod.102.008425; Braun BC, 2012, J STEROID BIOCHEM, V132, P295, DOI 10.1016/j.jsbmb.2012.07.005; Braun BC, 2012, REPRODUCTION, V143, P399, DOI 10.1530/REP-11-0316; Carambula SF, 2002, ENDOCRINOLOGY, V143, P1495, DOI 10.1210/en.143.4.1495; Carnaby K, 2012, REPRODUCTION, V144, P477, DOI 10.1530/REP-12-0166; Casas-Marce M, 2013, MOL ECOL, V22, P5503, DOI 10.1111/mec.12498; Castracane VD, 1998, HUM REPROD UPDATE, V4, P383, DOI 10.1093/humupd/4.4.383; CROWE DM, 1975, J MAMMAL, V56, P177, DOI 10.2307/1379615; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Davis JS, 2002, FRONT BIOSCI-LANDMRK, V7, pD1949, DOI 10.2741/davis1; DUKE KL, 1949, ANAT RECORD, V103, P111, DOI 10.1002/ar.1091030108; Duncan A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-90; Duncan WC, 2000, REV REPROD, V5, P12, DOI 10.1530/revreprod/5.1.12; Fanson KV, 2010, GEN COMP ENDOCR, V169, P217, DOI 10.1016/j.ygcen.2010.09.003; Ferreira-Dias G, 2007, REPROD DOMEST ANIM, V42, P380, DOI 10.1111/j.1439-0531.2006.00795.x; Galvao AM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/420186; Galvao AM, 2010, BIOL REPROD, V83, P901, DOI 10.1095/biolreprod.110.084699; Gillies LA, 2014, J CELL BIOCHEM, V115, P632, DOI 10.1002/jcb.24709; Goritz F, 2009, REPROD DOMEST ANIM, V44, P87, DOI 10.1111/j.1439-0531.2009.01380.x; Goyeneche AA, 2003, BIOL REPROD, V68, P2322, DOI 10.1095/biolreprod.102.013540; Goyeneche AA, 2003, BIOL REPROD, V68, P151, DOI 10.1095/biolreprod.102.007898; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hojo T, 2010, J REPROD DEVELOP, V56, P515, DOI 10.1262/jrd.10-056T; IUCN, IUCN RED LIST THREAT; Jewgenow K, 2014, REPROD BIOL, V14, P83, DOI 10.1016/j.repbio.2014.03.002; Jewgenow K, 2009, J ANDROL, V30, P460, DOI 10.2164/jandrol.108.006726; JUENGEL JL, 1993, ENDOCRINOLOGY, V132, P249, DOI 10.1210/en.132.1.249; Knospe C, 2002, ANAT HISTOL EMBRYOL, V31, P37, DOI 10.1046/j.1439-0264.2002.00360.x; Komatsu K, 2003, MOL REPROD DEV, V65, P345, DOI 10.1002/mrd.10312; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; Korzekwa A, 2008, REPROD BIOL, V8, P245, DOI 10.1016/S1642-431X(12)60015-1; Kowalewski MP, 2014, REPROD BIOL, V14, P89, DOI 10.1016/j.repbio.2013.11.004; Kuranaga E, 1999, BIOCHEM BIOPH RES CO, V260, P167, DOI 10.1006/bbrc.1999.0858; Kuranaga E, 2000, FEBS LETT, V472, P137, DOI 10.1016/S0014-5793(00)01426-5; KVAM T, 1991, Z SAUGETIERKD, V56, P146; Liszewska E, 2005, PROSTAG OTH LIPID M, V78, P67, DOI 10.1016/j.prostaglandins.2005.03.003; Magata F, 2012, J REPROD DEVELOP, V58, P445, DOI 10.1262/jrd.2011-049; McCormack JT, 1998, BIOL REPROD, V58, P255, DOI 10.1095/biolreprod58.1.255; McCracken JA, 1999, PHYSIOL REV, V79, P263, DOI 10.1152/physrev.1999.79.2.263; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Okuda Kiyoshi, 2003, Reprod Biol Endocrinol, V1, P95, DOI 10.1186/1477-7827-1-95; Painer J, 2014, THERIOGENOLOGY, V82, P557, DOI 10.1016/j.theriogenology.2014.05.004; Painer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090469; Palomares F, 2005, BIOL CONSERV, V122, P53, DOI 10.1016/j.biocon.2004.06.020; Palomares F, 2012, CONSERV BIOL, V26, P689, DOI 10.1111/j.1523-1739.2012.01870.x; Pate JL, 2012, REPROD DOMEST ANIM, V47, P297, DOI 10.1111/j.1439-0531.2012.02089.x; Peluffo MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1215, DOI 10.1152/ajpendo.00261.2007; Peluffo MC, 2006, REPRODUCTION, V132, P465, DOI 10.1530/rep.1.00910; Peluffo MC, 2009, MOL REPROD DEV, V76, P367, DOI 10.1002/mrd.20970; Peluffo MC, 2005, J CLIN ENDOCR METAB, V90, P2327, DOI 10.1210/jc.2004-2214; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Poole KG, 2003, CAN FIELD NAT, V117, P360, DOI 10.22621/cfn.v117i3.738; RODGER FE, 1995, HUM REPROD, V10, P1566, DOI 10.1093/HUMREP/10.6.1566; Schnorr B., 2006, EMBRYOLOGIE HAUSTIER; Siemieniuch MJ, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-89; SimuEn, 2012, 10 YEARS CONSERVING; Skarzynski DJ, 2013, REPROD DOMEST ANIM, V48, P25, DOI 10.1111/rda.12203; Slot KA, 2006, J ENDOCRINOL, V188, P179, DOI 10.1677/joe.1.06165; Stewart RA, 2010, GEN COMP ENDOCR, V166, P409, DOI 10.1016/j.ygcen.2009.12.016; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Sugino N, 2000, J CLIN ENDOCR METAB, V85, P4379, DOI 10.1210/jc.85.11.4379; Sugino N, 2007, J REPROD DEVELOP, V53, P977, DOI 10.1262/jrd.19047; Suzuki C, 2014, VET RES COMMUN, V38, P1, DOI 10.1007/s11259-013-9575-9; Taniguchi H, 2002, BIOL REPROD, V66, P754, DOI 10.1095/biolreprod66.3.754; Telleria CM, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-53; Terranova PF, 1997, DOMEST ANIM ENDOCRIN, V14, P1, DOI 10.1016/S0739-7240(96)00094-X; TSUTSUI T, 1993, J REPROD FERTIL, P29; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERHAGE HG, 1976, BIOL REPROD, V14, P579, DOI 10.1095/biolreprod14.5.579; Volkmann N, 2014, CELL DEATH DIFFER, V21, P206, DOI 10.1038/cdd.2013.153; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; WILDT DE, 1981, BIOL REPROD, V25, P15, DOI 10.1095/biolreprod25.1.15; Woshner VM, 2001, PROCEEDINGS OF THE FIFTY-FIFTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P427; Zambelli D, 2006, THERIOGENOLOGY, V66, P135, DOI 10.1016/j.theriogenology.2006.04.004; Zorrilla LM, 2013, REPROD DOMEST ANIM, V48, P755, DOI 10.1111/rda.12156; Zschockelt L, 2015, J STEROID BIOCHEM, V154, P75, DOI 10.1016/j.jsbmb.2015.07.001; Zschockelt L, 2014, J STEROID BIOCHEM, V144, P373, DOI 10.1016/j.jsbmb.2014.08.010	82	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143414	10.1371/journal.pone.0143414	http://dx.doi.org/10.1371/journal.pone.0143414			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599641	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600062
J	Fan, QQ; Song, AP; Xin, JJ; Chen, SM; Jiang, JF; Wang, YJ; Li, XR; Chen, FD				Fan, Qingqing; Song, Aiping; Xin, Jingjing; Chen, Sumei; Jiang, Jiafu; Wang, Yinjie; Li, Xiran; Chen, Fadi			CmWRKY15 Facilitates Alternaria tenuissima Infection of Chrysanthemum	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; STRESS TOLERANCE; FACTOR GENES; ARABIDOPSIS; RESISTANCE; EXPRESSION; DEFENSE; ABA; BIOSYNTHESIS; PATHOGENS	Abscisic acid (ABA) has an important role in the responses of plants to pathogens due to its ability to induce stomatal closure and interact with salicylic acid (SA) and jasmonic acid (JA). WRKY transcription factors serve as antagonistic or synergistic regulators in the response of plants to a variety of pathogens. Here, we demonstrated that CmWRKY15, a group IIa WRKY family member, was not transcriptionally activated in yeast cells. Subcellular localization experiments in which onion epidermal cells were transiently transfected with CmWRKY15 indicated that CmWRKY15 localized to the nucleus in vivo. The expression of CmWRKY15 could be markedly induced by the presence of Alternaria tenuissima inoculum in chrysanthemum. Furthermore, the disease severity index (DSI) data of CmWRKY15-overexpressing plants indicated that CmWRKY15 overexpression enhanced the susceptibility of chrysanthemum to A. tenuissima infection compared to controls. To illustrate the mechanisms by which CmWRKY15 regulates the response to A. tenuissima inoculation, the expression levels of ABA-responsive and ABA signaling genes, such as ABF4, ABI4, ABI5, MYB2, RAB18, DREB1A, DREB2A, PYL2, PP2C, RCAR1, SnRK2.2, SnRK2.3, NCED3A, NCED3B, GTG1, AKT1, AKT2, KAT1, KAT2, and KC1were compared between transgenic plants and controls. In summary, our data suggest that CmWRKY15 might facilitate A. tenuissima infection by antagonistically regulating the expression of ABA-responsive genes and genes involved in ABA signaling, either directly or indirectly.	[Fan, Qingqing; Song, Aiping; Xin, Jingjing; Chen, Sumei; Jiang, Jiafu; Wang, Yinjie; Li, Xiran; Chen, Fadi] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Fan, Qingqing; Chen, Fadi] Jiangsu Prov Engn Lab Modern Facil Agr Technol &, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chen, FD (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	chenfd@njau.edu.cn			National Natural Science Foundation of China [31471913, 31301809]; National Science Fund for Distinguished Young Scholars [31425022]; Fundamental Research Funds for the Central Universities [KYTZ201401]; Special Fund for Agroscientific Research in the Public Interest [201403039]; Six Talent Peaks Project in Jiangsu Province [2013-NY-022]; China Postdoctoral Science Foundation [2014M561673, 2015T80564]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Agroscientific Research in the Public Interest; Six Talent Peaks Project in Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was funded by the National Natural Science Foundation of China (31471913, 31301809), the National Science Fund for Distinguished Young Scholars (31425022), the Fundamental Research Funds for the Central Universities (KYTZ201401), Special Fund for Agroscientific Research in the Public Interest (201403039), the Six Talent Peaks Project in Jiangsu Province (2013-NY-022), and the China Postdoctoral Science Foundation (2014M561673, 2015T80564).	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Campbell R, 2010, PLANT PHYSIOL, V154, P656, DOI 10.1104/pp.110.158733; Cormack RS, 2002, BBA-GENE STRUCT EXPR, V1576, P92, DOI 10.1016/S0167-4781(02)00298-1; De Coninck B, 2015, TRENDS PLANT SCI, V20, P91, DOI 10.1016/j.tplants.2014.09.007; De Vleesschauwer D, 2010, PLANT PHYSIOL, V152, P2036, DOI 10.1104/pp.109.152702; Deng YM, 2012, SCI HORTIC-AMSTERDAM, V134, P185, DOI 10.1016/j.scienta.2011.11.012; Espasandin FD, 2014, PLANT PHYSIOL BIOCH, V76, P29, DOI 10.1016/j.plaphy.2013.12.018; Fan LM, 2008, P NATL ACAD SCI USA, V105, P8476, DOI 10.1073/pnas.0800980105; Fan XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126148; Gao HS, 2012, PLANTA, V235, P979, DOI 10.1007/s00425-011-1558-x; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Li PL, 2015, PLANT CELL REP, V34, P1365, DOI 10.1007/s00299-015-1793-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammarella ND, 2015, PHYTOCHEMISTRY, V112, P110, DOI 10.1016/j.phytochem.2014.07.010; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Schluttenhofer C, 2014, BMC GENOMICS, V15; Schon M, 2013, MOL PLANT MICROBE IN, V26, P758, DOI 10.1094/MPMI-11-12-0265-R; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Song AP, 2014, INT J MOL SCI, V15, P14442, DOI 10.3390/ijms150814442; Song AP, 2014, PLANT PHYSIOL BIOCH, V80, P114, DOI 10.1016/j.plaphy.2014.03.030; Song AP, 2014, INT J MOL SCI, V15, P5063, DOI 10.3390/ijms15035063; Song AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057229; Song WW, 2011, PLANT PHYSIOL BIOCH, V49, P693, DOI 10.1016/j.plaphy.2011.03.018; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Ulferts S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0409-x; Wang QS, 2011, GENETICA, V139, P973, DOI 10.1007/s10709-011-9599-4; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097265; Xu G, 2011, RUSS J PLANT PHYSL+, V58, P491, DOI 10.1134/S1021443711030216; Yang B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-68; Yang X, 2015, INT J MOL SCI, V16, P7608, DOI 10.3390/ijms16047608; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhu ZG, 2012, PLANT CELL REP, V31, P2109, DOI 10.1007/s00299-012-1321-1	42	10	15	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143349	10.1371/journal.pone.0143349	http://dx.doi.org/10.1371/journal.pone.0143349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600125	Green Submitted, gold, Green Published			2022-12-26	WOS:000365862600053
J	Mena-Ulecia, K; Tiznado, W; Caballero, J				Mena-Ulecia, Karel; Tiznado, William; Caballero, Julio			Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA	PLOS ONE			English	Article							QUANTITATIVE STRUCTURE; CRYSTALLOGRAPHIC ANALYSIS; STRUCTURAL REQUIREMENTS; DRUG-RESISTANCE; FREE-ENERGY; FACTOR-XA; BINDING; POTENT; OXYGUANIDINES; SPECIFICITY	Non-peptidic thrombin inhibitors (TIs; 177 compounds) with diverse groups at motifs P-1 (such as oxyguanidine, amidinohydrazone, amidine, amidinopiperidine), P-2 (such as cyano-fluorophenylacetamide, 2-(2-chloro-6-fluorophenyl)acetamide), and P-3 (such as phenylethyl, arylsulfonate groups) were studied using molecular modeling to analyze their interactions with S-1, S-2, and S-3 subsites of the thrombin binding site. Firstly, a protocol combining docking and three dimensional quantitative structure-activity relationship was performed. We described the orientations and preferred active conformations of the studied inhibitors, and derived a predictive CoMSIA model including steric, donor hydrogen bond, and acceptor hydrogen bond fields. Secondly, the dynamic behaviors of some selected TIs (compounds 26, 133, 147, 149, 162, and 177 in this manuscript) that contain different molecular features and different activities were analyzed by creating the solvated models and using molecular dynamics (MD) simulations. We used the conformational structures derived from MD to accomplish binding free energetic calculations using MM-GBSA. With this analysis, we theorized about the effect of van der Waals contacts, electrostatic interactions and solvation in the potency of TIs. In general, the contents reported in this article help to understand the physical and chemical characteristics of thrombin-inhibitor complexes.	[Mena-Ulecia, Karel; Tiznado, William] Univ Andres Bello, Fac Ciencias Exactas, Dept Quim, Santiago, Chile; [Mena-Ulecia, Karel; Caballero, Julio] Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, Talca, Chile	Universidad Andres Bello; Universidad de Talca	Caballero, J (corresponding author), Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, 2 Norte 685,Casilla 721, Talca, Chile.	jcaballero@utalca.cl	Caballero, Julio/G-3654-2014; Tiznado, william/G-7479-2014	Caballero, Julio/0000-0003-0182-1444; Tiznado, william/0000-0002-6061-8879	Fondecyt, Chile [1130141]	Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the grant no. 1130141 (J.C.) from Fondecyt, Chile. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Adasme-Carreno F, 2014, PHYS CHEM CHEM PHYS, V16, P14047, DOI 10.1039/c4cp01378f; [Anonymous], 1699, SYBYL VERS 7 3; [Anonymous], 2007, MAESTR VERS 9 0; [Anonymous], 2011, LIGPR VERS 2 5; Bhunia SS, 2011, J CHEM INF MODEL, V51, P1966, DOI 10.1021/ci200185q; Bohm M, 1999, J MED CHEM, V42, P458, DOI 10.1021/jm981062r; BUSH BL, 1993, J COMPUT AID MOL DES, V7, P587, DOI 10.1007/BF00124364; Caballero J, 2008, BIOORGAN MED CHEM, V16, P6103, DOI 10.1016/j.bmc.2008.04.048; Caballero J, 2011, CHEM BIOL DRUG DES, V78, P631, DOI 10.1111/j.1747-0285.2011.01186.x; Caballero J, 2011, J COMPUT AID MOL DES, V25, P349, DOI 10.1007/s10822-011-9425-1; Caballero J, 2009, MOL DIVERS, V13, P493, DOI 10.1007/s11030-009-9140-1; Coppens M, 2012, CIRC RES, V111, P920, DOI 10.1161/CIRCRESAHA.112.264903; de Candia M, 2013, J MED CHEM, V56, P8696, DOI 10.1021/jm401169a; Deswal S, 2006, EUR J MED CHEM, V41, P1339, DOI 10.1016/j.ejmech.2006.07.001; Doweyko AM, 2004, J COMPUT AID MOL DES, V18, P587, DOI 10.1007/s10822-004-4068-0; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fuentes E, 2014, THROMB HAEMOSTASIS, V111, P491, DOI 10.1160/TH13-05-0386; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hou TJ, 2007, J MED CHEM, V50, P1177, DOI 10.1021/jm0609162; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kontogiorgis CA, 2003, CURR MED CHEM, V10, P525, DOI 10.2174/0929867033457935; Kreutter KD, 2008, BIOORG MED CHEM LETT, V18, P2865, DOI 10.1016/j.bmcl.2008.03.087; Lee L, 2007, BIOORG MED CHEM LETT, V17, P6266, DOI 10.1016/j.bmcl.2007.09.013; Li ML, 2015, EUR J MED CHEM, V96, P122, DOI 10.1016/j.ejmech.2015.04.012; Lu TB, 2000, BIOORG MED CHEM LETT, V10, P83, DOI 10.1016/S0960-894X(99)00616-2; Lu TB, 2004, BIOORG MED CHEM LETT, V14, P3727, DOI 10.1016/j.bmcl.2004.05.002; Lu TB, 1998, BIOORG MED CHEM LETT, V8, P1595, DOI 10.1016/S0960-894X(98)00290-X; Lu TB, 2000, BIOORG MED CHEM LETT, V10, P79, DOI 10.1016/S0960-894X(99)00617-4; Lu TB, 2010, J MED CHEM, V53, P1843, DOI 10.1021/jm901802n; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Melnikova I, 2009, NAT REV DRUG DISCOV, V8, P353, DOI 10.1038/nrd2851; Mena-Ulecia K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109639; Muley L, 2010, J MED CHEM, V53, P2126, DOI 10.1021/jm9016416; Munoz C, 2012, J MOL GRAPH MODEL, V32, P39, DOI 10.1016/j.jmgm.2011.10.005; Nilsson M, 2009, J MED CHEM, V52, P2708, DOI 10.1021/jm8011849; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Ramirez-Galicia G, 2012, J ENZYM INHIB MED CH, V27, P174, DOI 10.3109/14756366.2011.582467; Silva VD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024735; Soll RM, 2000, BIOORG MED CHEM LETT, V10, P1, DOI 10.1016/S0960-894X(99)00632-0; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Tanaka KA, 2009, ANESTH ANALG, V108, P1433, DOI 10.1213/ane.0b013e31819bcc9c; Tomczuk B, 2003, BIOORG MED CHEM LETT, V13, P1495, DOI 10.1016/S0960-894X(03)00125-2; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Verma RP, 2005, BIOORGAN MED CHEM, V13, P4597, DOI 10.1016/j.bmc.2005.05.002; Wang W, 2001, P NATL ACAD SCI USA, V98, P14937, DOI 10.1073/pnas.251265598	48	64	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142774	10.1371/journal.pone.0142774	http://dx.doi.org/10.1371/journal.pone.0142774			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599107	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600018
J	Nibouche, S; Mississipi, S; Fartek, B; Delatte, H; Reynaud, B; Costet, L				Nibouche, Samuel; Mississipi, Stelly; Fartek, Benjamin; Delatte, Helene; Reynaud, Bernard; Costet, Laurent			Host Plant Specialization in the Sugarcane Aphid Melanaphis sacchari	PLOS ONE			English	Article							YELLOW-LEAF-VIRUS; ECOLOGICAL SPECIALIZATION; SCHIZAPHIS-GRAMINUM; HEMIPTERA; RESISTANCE; POPULATIONS; DIVERGENCE; EXPERIENCE; CLONALITY; HOMOPTERA	Most aphids are highly specialized on one or two related plant species and generalist species often include sympatric populations adapted to different host plants. Our aim was to test the hypothesis of the existence of host specialized lineages of the aphid Melanaphis sacchari in Reunion Island. To this end, we investigated the genetic diversity of the aphid and its association with host plants by analyzing the effect of wild sorghum Sorghum bicolor subsp. verticilliflorum or sugarcane as host plants on the genetic structuring of populations and by performing laboratory host transfer experiments to detect trade-offs in host use. Genotyping of 31 samples with 10 microsatellite loci enabled identification of 13 multilocus genotypes (MLG). Three of these, Ms11, Ms16 and Ms15, were the most frequent ones. The genetic structure of the populations was linked to the host plants. Ms11 and Ms16 were significantly more frequently observed on sugarcane, while Ms15 was almost exclusively collected in colonies on wild sorghum. Laboratory transfer experiments demonstrated the existence of fitness trade-offs. An Ms11 isofemale lineage performed better on sugarcane than on sorghum, whereas an Ms15 lineage developed very poorly on sugarcane, and two Ms16 lineages showed no significant difference in performances between both hosts. Both field and laboratory results support the existence of host plant specialization in M. sacchari in Reunion Island, despite low genetic differentiation. This study illustrates the ability of asexual aphid lineages to rapidly undergo adaptive changes including shifting from one host plant to another.	[Nibouche, Samuel; Mississipi, Stelly; Fartek, Benjamin; Delatte, Helene; Reynaud, Bernard; Costet, Laurent] Cirad, UMR PVBMT, F-97410 Saint Pierre, Reunion, France; [Fartek, Benjamin] Univ la Reunion, UMR PVBMT, F-97410 Saint Pierre, Reunion, France	CIRAD; University of La Reunion	Nibouche, S (corresponding author), Cirad, UMR PVBMT, F-97410 Saint Pierre, Reunion, France.	samuel.nibouche@cirad.fr	Costet, Laurent/C-2281-2011; Nibouche, Samuel/C-1964-2008; Costet, Laurent/AAQ-1579-2020	Nibouche, Samuel/0000-0003-2675-1382; Costet, Laurent/0000-0003-3199-2885	European Union; Conseil Regional de la Reunion; Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD); European Union; Conseil Regional de la Reunion; Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD)	European Union(European Commission); Conseil Regional de la Reunion; Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD); European Union(European Commission); Conseil Regional de la Reunion; Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD)	This work was funded by the European Union: European regional development fund (ERDF), by the Conseil Regional de la Reunion and by the Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Ahmad Y, 2007, PLANT DIS, V91, P253, DOI 10.1094/PDIS-91-3-0253; Andris M, 2010, MOL ECOL RESOUR, V10, P1106, DOI 10.1111/j.1755-0998.2010.02916.x; [Anonymous], 2012, GEN VERS 5 6 6; Anstead JA, 2002, B ENTOMOL RES, V92, P17, DOI 10.1079/BER2001141; Armstrong JS, 2015, J ECON ENTOMOL, V108, P576, DOI 10.1093/jee/tou065; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Blackman RL, 1990, WORLD PERSPECTIVES B, P197; Brewer M, 2013, 25 TEX PLANT PROT C; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; DEBARRO PJ, 1995, MOL ECOL, V4, P375, DOI 10.1111/j.1365-294X.1995.tb00230.x; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Fartek B, 2012, ENTOMOL EXP APPL, V144, P270, DOI 10.1111/j.1570-7458.2012.01286.x; Fartek B, 2014, PLANT BREEDING, V133, P771, DOI 10.1111/pbr.12204; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Lopes-da-Silva M., 2014, Current Agricultural Science and Technology, V20, P21; Loxdale HD, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P535, DOI 10.1007/978-90-481-2770-2_25; Margaritopoulos JT, 2006, B ENTOMOL RES, V96, P153, DOI 10.1079/BER2005410; Margaritopoulos JT, 2003, B ENTOMOL RES, V93, P131, DOI 10.1079/BER2002222; Mead F. W., 1978, COOP PLANT PEST REP, V3, P475; MONTLLOR CB, 1983, ENTOMOL EXP APPL, V34, P99, DOI 10.1007/BF00300907; Nibouche S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106067; Peccoud J, 2010, CR BIOL, V333, P474, DOI 10.1016/j.crvi.2010.03.004; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Ramirez CC, 2000, J INSECT BEHAV, V13, P699, DOI 10.1023/A:1007844027368; Remaudiere G., 1997, CATALOGUE WORLDS APH; Rott P., 2008, Sugar Cane International, V26, P18; SAS Institute, 2008, SAS ONLINEDOC 9 2; Singh BU, 2004, CROP PROT, V23, P739, DOI 10.1016/j.cropro.2004.01.004; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stroup W. W., 2013, GEN LINEAR MIXED MOD; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; VIA S, 1990, ANNU REV ENTOMOL, V35, P421, DOI 10.1146/annurev.en.35.010190.002225; VIA S, 1991, ECOLOGY, V72, P1420, DOI 10.2307/1941114; WEBER G, 1985, Z ANGEW ENTOMOL, V100, P100; White WH, 2001, FLA ENTOMOL, V84, P435, DOI 10.2307/3496505; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	43	17	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143704	10.1371/journal.pone.0143704	http://dx.doi.org/10.1371/journal.pone.0143704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600253	gold, Green Submitted, Green Published			2022-12-26	WOS:000365862600106
J	Reisinger, N; Schaumberger, S; Nagl, V; Hessenberger, S; Schatzmayr, G				Reisinger, Nicole; Schaumberger, Simone; Nagl, Veronika; Hessenberger, Sabine; Schatzmayr, Gerd			Concentration Dependent Influence of Lipopolysaccharides on Separation of Hoof Explants and Supernatant Lactic Acid Concentration in an Ex Vivo/In Vitro Laminitis Model	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EQUINE LAMINITIS; ENDOTOXIN CONCENTRATION; PLASMA-CONCENTRATIONS; GLUCOSE-TRANSPORT; ENDOTHELIAL-CELLS; INSULIN DYNAMICS; HORSES; ACTIVATION; INTERLEUKIN-6	Laminitis is one of the most common diseases in horses. It is not only painful for the animal, but also has a significant financial impact on the equine industry. This multifactorial disease affects the connective tissue of the hoof. However, the pathogenesis of laminitis is still not fully understood. Endotoxins, also known as lipopolysaccharides (LPS), and bacterial exotoxins seem to play an important role during the development of laminitis. The aim of our study was to investigate the effect of increasing LPS concentrations (0, 2.5, 5, 10, and 100 mu g/mL) on cell viability of isolated epidermal and dermal hoof cells as well as on the tissue integrity of hoof explants. Furthermore, glucose, acetic acid, lactic acid, and propionic acid concentrations in explant supernatants were measured to evaluate the energy metabolism in the hoof tissue. LPS did not exhibit cytotoxic effects on epidermal or dermal cells. Force required to separate LPS treated hoof explants decreased in a concentration dependent manner. Specifically, explants incubated with 10 and 100 mu g/mL needed significantly less force to separate compared to control explants. Lactic acid concentrations were significantly decreased in explants incubated with 5, 10, or 100 mu g/mL LPS, while glucose, acetic acid and propionic acid concentrations were unaffected by LPS treatment. Our study indicates that LPS has no cytotoxic effect on epidermal and dermal cells isolated from hoof tissue, but impairs integrity of hoof explants. In addition, LPS led to an alteration of the lactic acid production in the lamellar tissue. Since our data highlight that LPS can affect the integrity of the equine hoof tissue in vitro, endotoxins should be further explored for their contribution to facilitate the development of laminitis.	[Reisinger, Nicole; Schaumberger, Simone; Nagl, Veronika; Hessenberger, Sabine; Schatzmayr, Gerd] BIOMIN Res Ctr, Tulln, Austria		Reisinger, N (corresponding author), BIOMIN Res Ctr, Tulln, Austria.	nicole.reisinger@biomin.net		Nagl, Veronika/0000-0002-8534-4149; Reisinger, Nicole/0000-0002-9207-452X	Austrian Research Promotion Agency [839107]; Biomin Research Center	Austrian Research Promotion Agency; Biomin Research Center	This work was supported by Austrian Research Promotion Agency (https://www.ffg.at/) (839107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biomin Research Center provided support in the form of salaries for authors NR, SS, VN, SH, and GS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen D., 1998, ACUTE LAMINITIS; Asplin KE, 2011, EQUINE VET J, V43, P196, DOI 10.1111/j.2042-3306.2010.00127.x; Bailey SR, 2009, VET IMMUNOL IMMUNOP, V129, P167, DOI 10.1016/j.vetimm.2008.11.009; Barton MH, 1999, J VET INTERN MED, V13, P457, DOI 10.1892/0891-6640(1999)013&lt;0457:TNFAIA&gt;2.3.CO;2; Brooks AC, 2009, VET IMMUNOL IMMUNOP, V129, P174, DOI 10.1016/j.vetimm.2008.11.008; de Laat MA, 2015, EQUINE VET J, V47, P494, DOI 10.1111/evj.12320; de Laat MA, 2012, VET IMMUNOL IMMUNOP, V145, P395, DOI 10.1016/j.vetimm.2011.12.016; DUNCAN SG, 1985, AM J VET RES, V46, P1287; Fessler J F, 1989, Equine Vet J Suppl, P24, DOI 10.1111/j.2042-3306.1989.tb05650.x; French KR, 2004, EQUINE VET J, V36, P261, DOI 10.2746/0425164044877170; GARNER HE, 1977, J ANIM SCI, V45, P1037; HUNT RJ, 1990, AM J VET RES, V51, P1703; Katz LM, 2012, EQUINE VET J, V44, P752, DOI 10.1111/j.2042-3306.2012.00664.x; Kim ID, 2009, TOXICOL IN VITRO, V23, P1014, DOI 10.1016/j.tiv.2009.06.019; Kyaw-Tanner M, 2004, EQUINE VET J, V36, P221, DOI 10.2746/0425164044877242; Kyaw-Tanner MT, 2008, EQUINE VET J, V40, P482, DOI 10.2746/042516408X270353; Lankveld DPK, 2005, VET RES, V36, P257, DOI 10.1051/vetres:2004061; Loftus JP, 2007, AM J VET RES, V68, P1205, DOI 10.2460/ajvr.68.11.1205; Mani V, 2013, J ANIM SCI, V91, P2141, DOI 10.2527/jas.2012-6053; Medina-Torres CE, 2016, EQUINE VET J, V48, P246, DOI 10.1111/evj.12417; Medina-Torres CE, 2016, EQUINE VET J, V48, P114, DOI 10.1111/evj.12377; Medina-Torres CE, 2014, VET J, V201, P275, DOI 10.1016/j.tvjl.2014.05.030; Medina-Torres Carlos E, 2011, Vet J, V190, pe54, DOI 10.1016/j.tvjl.2011.02.026; Menzies-Gow NJ, 2004, EQUINE VET J, V36, P273, DOI 10.2746/0425164044877260; Mungall BA, 2002, J COMP PATHOL, V126, P9, DOI 10.1053/jcpa.2001.0515; Mungall BA, 2001, VET MICROBIOL, V79, P209, DOI 10.1016/S0378-1135(00)00359-X; Pass M A, 1998, Equine Vet J Suppl, P133; Patan-Zugaj B, 2012, AM J VET RES, V73, P1462, DOI 10.2460/ajvr.73.9.1462; Peek SF, 2004, VET CLIN PATH, V33, P29, DOI 10.1111/j.1939-165X.2004.tb00346.x; Pollitt CC, 1996, EQUINE VET J, V28, P38, DOI 10.1111/j.2042-3306.1996.tb01588.x; Reisinger N, 2014, TOXINS, V6, P2962, DOI 10.3390/toxins6102962; Sharma R, 2016, J TISSUE ENG REGEN M, V10, P627, DOI 10.1002/term.1788; SPROUSE RF, 1987, EQUINE VET J, V19, P25, DOI 10.1111/j.2042-3306.1987.tb02571.x; Tadros EM, 2012, VET IMMUNOL IMMUNOP, V150, P90, DOI 10.1016/j.vetimm.2012.09.002; Toth F, 2009, EQUINE VET J, V41, P852, DOI 10.2746/042516409X479027; Toth F, 2008, AM J VET RES, V69, P82, DOI 10.2460/ajvr.69.1.82; US Department of Agriculture, 2000, LAMENESS LAMINITIS U; Vidovic A, 1999, PFERDEHEILKUNDE, V15, P325, DOI 10.21836/PEM19990405; Visser MB, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-16; Wattle O., 2004, Clinical Techniques in Equine Practice, V3, P22, DOI 10.1053/j.ctep.2004.07.002; Wunn D, 1999, AM J VET RES, V60, P128; Yang H, 2002, PHYTOTHER RES, V16, P43, DOI 10.1002/ptr.912; Yue G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-608	43	7	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143754	10.1371/journal.pone.0143754	http://dx.doi.org/10.1371/journal.pone.0143754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599864	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600117
J	Ye, WM; Zeng, YS; Kerns, J				Ye, Weimin; Zeng, Yongsan; Kerns, James			Molecular Characterisation and Diagnosis of Root-Knot Nematodes (Meloidogyne spp.) from Turfgrasses in North Carolina, USA	PLOS ONE			English	Article							MARYLANDI INFECTING BERMUDAGRASS; 1ST REPORT; PHYLOGENETIC-RELATIONSHIPS; INTERGENIC REGION; IDENTIFICATION; JAVANICA; PCR; DIVERSITY; INCOGNITA; BRAZIL	Root-knot nematodes (Meloidogyne spp.) are the most common and destructive plant-parasitic nematode group worldwide and adversely influence both crop quality and yield. In this study, a total of 51 root-knot nematode populations from turfgrasses were tested, of which 44 were from North Carolina, 6 from South Carolina and 1 from Virginia. Molecular characterisation was performed on these samples by DNA sequencing on the ribosomal DNA 18S, ITS and 28S D2/D3. Species-specific primers were developed to identify turfgrass root-knot nematode through simplex or duplex PCR. Four species were identified, including M. marylandi Jepson & Golden in Jepson, 1987, M. graminis (Sledge & Golden, 1964) Whitehead, 1968, M. incognita (Kofoid & White, 1919) Chitwood, 1949 and M. naasi Franklin, 1965 through a combined analysis of DNA sequencing and PCR by species-specific primers. M. marylandi has been reported from North Carolina and South Carolina for the first time. Molecular diagnosis using PCR by species-specific primers provides a rapid and cheap species identification approach for turfgrass root-knot nematodes.	[Ye, Weimin] North Carolina Dept Agr & Consumer Serv, Nematode Assay Sect, Div Agron, Raleigh, NC 27607 USA; [Zeng, Yongsan; Kerns, James] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Zeng, Yongsan] Zhongkai Univ Agr & Engn, Dept Plant Protect, Guangzhou, Guangdong, Peoples R China	University of North Carolina; North Carolina State University; Zhongkai University of Agriculture & Engineering	Ye, WM (corresponding author), North Carolina Dept Agr & Consumer Serv, Nematode Assay Sect, Div Agron, Raleigh, NC 27607 USA.	weimin.ye@ncagr.gov	Kerns, James/AAC-3208-2020	Kerns, James/0000-0002-1980-0126	Carolinas Golf Course Superintendents Association Rounds 4 Research	Carolinas Golf Course Superintendents Association Rounds 4 Research	This work was supported by the Carolinas Golf Course Superintendents Association Rounds 4 Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MAM, 2007, PLANT PATHOL, V56, P190, DOI 10.1111/j.1365-3059.2006.01455.x; Adam MAM, 2005, NEMATOLOGY, V7, P599, DOI 10.1163/156854105774384840; Adams BJ, 2010, ROOT-KNOT NEMATODES, P119; [Anonymous], 1992, THESIS; Araki Masaaki, 1992, Japanese Journal of Nematology, V22, P49; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Berry SD, 2008, MOL CELL PROBE, V22, P168, DOI 10.1016/j.mcp.2008.01.003; Blok VC, 1997, J NEMATOL, V29, P16; Blok VC, 2010, ROOT-KNOT NEMATODES, P98; BYRD DW, 1976, J NEMATOL, V8, P206; Carneiro RMDG, 2014, NEMATOLOGY, V16, P289, DOI 10.1163/15685411-00002765; Cherry T, 1997, J NEMATOL, V29, P23; Crow W. T., 2005, Outlooks on Pest Management, V16, P10, DOI 10.1564/16feb04; De Ley IT, 2002, J NEMATOL, V34, P319; Eisenback J. D., 1985, An advanced treatise on Meloidogyne. Volume 1: Biology and control., P95; Emmons R., 1995, TURFGRASS SCI MANAGE; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FRANKLIN MARY T., 1965, NEMATOLOGICA, V11, P79; GOLDEN AM, 1989, J NEMATOL, V21, P453; Holterman MHM, 2012, J PHYTOPATHOL, V160, P59, DOI 10.1111/j.1439-0434.2011.01859.x; Hu MX, 2011, PHYTOPATHOLOGY, V101, P1270, DOI 10.1094/PHYTO-04-11-0095; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphreys-Pereira DA, 2014, NEMATOLOGY, V16, P643, DOI 10.1163/15685411-00002794; Hunt DJ, 2010, ROOT-KNOT NEMATODES, P55; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Jepson S.B., 1987, P263; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lyman GT, 2007, APPL TURFGRASS SCI, DOI 1094/ATS-2007-1107-01-RS; McClure MA, 2012, PLANT DIS, V96, P635, DOI 10.1094/PDIS-09-11-0808; Mullin PG, 2005, NEMATOLOGY, V7, P59, DOI 10.1163/1568541054192199; MULVEY RH, 1975, CAN J ZOOL, V53, P1528, DOI 10.1139/z75-188; Nischwitz C, 2013, PLANT DIS, V97, P1424, DOI 10.1094/PDIS-03-13-0263-RE; Oka Y, 2003, NEMATOLOGY, V5, P727, DOI 10.1163/156854103322746904; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Powers TO, 2005, J NEMATOL, V37, P226; Randig O, 2002, GENOME, V45, P862, DOI [10.1139/g02-054, 10.1139/G02-054]; Salazar L, 2013, PLANT DIS, V97, P1005, DOI 10.1094/PDIS-11-12-1079-PDN; Sekora NS, 2012, PLANT DIS, V96, P1583, DOI 10.1094/PDIS-06-12-0544-PDN; SLEDGE EB, 1964, P HELM SOC WASH, V31, P83; Starr JL, 2007, NEMATROPICA, V37, P43; Tigano MS, 2005, NEMATOLOGY, V7, P851, DOI 10.1163/156854105776186325; Vandenbossche B, 2011, NEMATOLOGY, V13, P245, DOI 10.1163/138855410X517084; Vrain T.C., 1992, J NEMATOL, V29, P250; Walker N, 2014, PLANT DIS, V98, P1286, DOI 10.1094/PDIS-04-14-0399-PDN; Ye W, 2012, CAROLINAS GREEN  MAR, P26; Zeng Y, 2015, PLANT DIS IN PRESS; Zeng YS, 2012, ZOOTAXA, P1; Zijlstra C, 2000, NEMATOLOGY, V2, P847, DOI 10.1163/156854100750112798	49	43	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143556	10.1371/journal.pone.0143556	http://dx.doi.org/10.1371/journal.pone.0143556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599462	gold, Green Published, Green Submitted			2022-12-26	WOS:000365862600084
J	Ahn, SJ; Park, KH; Ryoo, NK; Hong, JH; Jung, C; Yoon, CH; Han, MK; Woo, SJ				Ahn, Seong Joon; Park, Kyu Hyung; Ryoo, Na-Kyung; Hong, Jeong-Ho; Jung, Cheolkyu; Yoon, Chang-Hwan; Han, Moon-Ku; Woo, Se Joon			No-Reflow Phenomenon in Central Retinal Artery Occlusion: Incidence, Risk Factors, and Clinical Implications	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; LOCAL INTRAARTERIAL FIBRINOLYSIS; CONSERVATIVE TREATMENT; THROMBOLYSIS; REPERFUSION; APPEARANCE; PREDICTOR; PROGNOSIS; TIME	Purpose To investigate the incidence and risk factors of the no-reflow phenomenon in central retinal artery occlusion (CRAO) patients and to determine its effects on visual and anatomic outcomes. Methods In 102 eyes with CRAO in which arterial recanalization was obtained within 1 week from baseline, fluorescein angiography images obtained at baseline and 1 week were retrospectively reviewed. The no-reflow phenomenon in the retina was defined as macular capillary nonperfusion following arterial recanalization on fluorescein angiographs. We investigated the incidence and risk factors for the no-reflow phenomenon and compared the anatomical and visual outcomes between eyes with and without the phenomenon. Results Among the 102 CRAO eyes with arterial recanalization, 39 exhibited the no-reflow phenomenon, resulting in an incidence of 38.2%. The incidence among the eyes with treatment-induced and spontaneous recanalization was 43.4% and 15.8%, respectively, and it increased with the CRAO stage. CRAO stage and increased central macular thickness were risk factors for the phenomenon, with an odds ratio of 4.47 [95% confidence interval (CI), 1.19-16.8; P = 0.027] and 1.69 (95% CI, 1.12-2.55; P = 0.012) per 100-mu m increase, respectively. The visual outcome was significantly poorer and retinal atrophy and photoreceptor disruption was greater in eyes with the no-reflow phenomenon than in those without. Conclusions The no-reflow phenomenon may occur after arterial recanalization in approximately one-third of CRAO patients and can affect anatomical and visual outcomes. This phenomenon may provide an additional explanation regarding the permanent retinal damage and vision loss in eyes with CRAO.	[Ahn, Seong Joon; Park, Kyu Hyung; Ryoo, Na-Kyung; Woo, Se Joon] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea; [Hong, Jeong-Ho] Keimyung Univ, Dongsan Med Ctr, Dept Neurol, Taegu, South Korea; [Hong, Jeong-Ho; Han, Moon-Ku] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Songnam, South Korea; [Jung, Cheolkyu] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Songnam, South Korea; [Yoon, Chang-Hwan] Seoul Natl Univ, Bundang Hosp, Dept Cardiol, Songnam, South Korea	Seoul National University (SNU); Keimyung University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Woo, SJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Songnam, South Korea.	sejoon1@hanmail.net	Hong, Jeong-Ho/T-8099-2018; Hong, Jeong-Ho/AAE-1002-2022	Hong, Jeong-Ho/0000-0002-8235-9855; Hong, Jeong-Ho/0000-0002-8235-9855; HAN, MOON-KU/0000-0003-0166-387X; Yoon, Chang-Hwan/0000-0001-6305-4442	Seoul National University Bundang Hospital Research Fund [14-2014-022]	Seoul National University Bundang Hospital Research Fund	This work was supported by a grant from the Seoul National University Bundang Hospital Research Fund (Grant No. 14-2014-022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2015, AM J OPHTHALMOL, V159, P667, DOI 10.1016/j.ajo.2015.01.001; Ahn SJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/209735; Ahn SJ, 2013, INVEST OPHTH VIS SCI, V54, P2115, DOI 10.1167/iovs.12-11542; AMES A, 1968, AM J PATHOL, V52, P437; Biousse V, 2007, J NEURO-OPHTHALMOL, V27, P215, DOI 10.1097/WNO.0b013e31814b1f66; Bolognese L, 2004, CIRCULATION, V109, P1121, DOI 10.1161/01.CIR.0000118496.44135.A7; Brosh D, 2007, AM J CARDIOL, V99, P442, DOI 10.1016/j.amjcard.2006.08.054; DAVID NJ, 1961, ARCH NEUROL-CHICAGO, V5, P165, DOI 10.1001/archneur.1961.00450140047004; Fiess A, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-28; Galiuto L, 2008, J AM COLL CARDIOL, V51, P552, DOI 10.1016/j.jacc.2007.09.051; Hayreh SS, 2011, PROG RETIN EYE RES, V30, P359, DOI 10.1016/j.preteyeres.2011.05.001; Hayreh SS, 2005, AM J OPHTHALMOL, V140, P376, DOI 10.1016/j.ajo.2005.03.038; Hayreh SS, 2004, EXP EYE RES, V78, P723, DOI 10.1016/S0014-4835(03)00214-8; Henriques JPS, 2003, CIRCULATION, V107, P2115, DOI 10.1161/01.CIR.0000065221.06430.ED; ITO H, 1992, CIRCULATION, V85, P1699, DOI 10.1161/01.CIR.85.5.1699; Ito H, 1998, AM J CARDIOL, V81, p8G, DOI 10.1016/S0002-9149(98)00046-0; Ito H, 2001, J Cardiol, V37 Suppl 1, P39; Ito H, 1996, CIRCULATION, V93, P223, DOI 10.1161/01.CIR.93.2.223; Ito H, 2006, NAT CLIN PRACT CARD, V3, P499, DOI 10.1038/ncpcardio0632; ITO U, 1980, STROKE, V11, P517, DOI 10.1161/01.STR.11.5.517; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P137, DOI 10.1007/s00417-008-0926-0; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; OJI EO, 1978, T OPHTHAL SOC UK, V98, P156; Schmidt DP, 2002, AM J NEURORADIOL, V23, P1301; Schumacher M, 2010, OPHTHALMOLOGY, V117, P1367, DOI 10.1016/j.ophtha.2010.03.061; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142852	10.1371/journal.pone.0142852	http://dx.doi.org/10.1371/journal.pone.0142852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599539	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900042
J	Sanger, C; Schenk, A; Schwen, LO; Wang, L; Gremse, F; Zafarnia, S; Kiessling, F; Xie, CC; Wei, WW; Richter, B; Dirsch, O; Dahmen, U				Saenger, Constanze; Schenk, Andrea; Schwen, Lars Ole; Wang, Lei; Gremse, Felix; Zafarnia, Sara; Kiessling, Fabian; Xie, Chichi; Wei, Weiwei; Richter, Beate; Dirsch, Olaf; Dahmen, Uta			Intrahepatic Vascular Anatomy in Rats and Mice-Variations and Surgical Implications	PLOS ONE			English	Article							LIVER; SIZE	Introduction The intra-hepatic vascular anatomy in rodents, its variations and corresponding supplying and draining territories in respect to the lobar structure of the liver have not been described. We performed a detailed anatomical imaging study in rats and mice to allow for further refinement of experimental surgical approaches. Methods LEWIS-Rats and C57Bl/6N-Mice were subjected to ex-vivo imaging using mu CT. The image data were used for semi-automated segmentation to extract the hepatic vascular tree as prerequisite for 3D visualization. The underlying vascular anatomy was reconstructed, analysed and used for determining hepatic vascular territories. Results The four major liver lobes have their own lobar portal supply and hepatic drainage territories. In contrast, the paracaval liver is supplied by various small branches from right and caudate portal veins and drains directly into the vena cava. Variations in hepatic vascular anatomy were observed in terms of branching pattern and distance of branches to each other. The portal vein anatomy is more variable than the hepatic vein anatomy. Surgically relevant variations were primarily observed in portal venous supply. Conclusions For the first time the key variations of intrahepatic vascular anatomy in mice and rats and their surgical implications were described. We showed that lobar borders of the liver do not always match vascular territorial borders. These findings are of importance for the design of new surgical procedures and for understanding eventual complications following hepatic surgery.	[Saenger, Constanze; Xie, Chichi; Wei, Weiwei; Richter, Beate; Dahmen, Uta] Univ Klinikum Jena, Klin Allgemein Viszeral & Gefasschirurg, Expt Transplantat Chirurg, Jena, Germany; [Schenk, Andrea; Schwen, Lars Ole; Wang, Lei] Fraunhofer Inst Med Image Comp MEVIS, Bremen, Germany; [Gremse, Felix; Zafarnia, Sara; Kiessling, Fabian] Univ Klinikum RHTW Aachen, Dept Expt Mol Imaging ExMI, Aachen, Germany; [Dirsch, Olaf] Klinikum Chemnitz gGmbH, Inst Pathol, Chemnitz, Germany	Friedrich Schiller University of Jena; Fraunhofer Gesellschaft; Chemnitz Clinic	Sanger, C (corresponding author), Univ Klinikum Jena, Klin Allgemein Viszeral & Gefasschirurg, Expt Transplantat Chirurg, Jena, Germany.	Constanze.Saenger@uni-jena.de	Richter, Beate/GZL-7799-2022; Kiessling, Fabian/Y-2417-2019; Schenk, Andrea/AAF-1323-2021; Schwen, Lars Ole/AAI-8048-2020	Richter, Beate/0000-0001-7241-3566; Kiessling, Fabian/0000-0002-7341-0399; Schenk, Andrea/0000-0003-1806-8380; Schwen, Lars Ole/0000-0003-0195-9603	German Federal Ministry for Education and Research (BMBF) as part of the "Virtual Liver Network" [0315765, 0317569, 0315743]	German Federal Ministry for Education and Research (BMBF) as part of the "Virtual Liver Network"	This research is supported by the German Federal Ministry for Education and Research (BMBF) as part of the "Virtual Liver Network"(0315765, 0317569 and 0315743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Couinaud C, 1981, CONTROLLED HEPATECTO, P9; Kamei H, 2007, LIVER TRANSPLANT, V13, P1295, DOI 10.1002/lt.21231; Kogure K, 1999, J Hepatobiliary Pancreat Surg, V6, P171, DOI 10.1007/s005340050101; Kubota T., 1997, J HEPATOBILIARY PANC, V4, P398, DOI [10.1007/BF02488972, DOI 10.1007/BF02488972]; Madrahimov N, 2006, ANN SURG, V244, P89, DOI 10.1097/01.sla.0000218093.12408.0f; Martins PNA, 2008, LIVER INT, V28, P3, DOI 10.1111/j.1478-3231.2007.01628.x; Martins PNA, 2007, LIVER INT, V27, P384, DOI 10.1111/j.1478-3231.2006.01414.x; Torres OJM, 2012, ABCD-ARQ BRAS CIR DI, V25, P290, DOI 10.1590/S0102-67202012000400015; Schnitzbauer AA, 2012, ANN SURG, V255, P405, DOI 10.1097/SLA.0b013e31824856f5; Selle D, 2000, SPRINGERS SPECIAL BO, P1039; Tanaka K, 2003, LIVING DONOR LIVER T; Wang L, 2014, SPIE MED IMAGING COM, V9035	12	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0141798	10.1371/journal.pone.0141798	http://dx.doi.org/10.1371/journal.pone.0141798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618494	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800008
J	Schicker, RS; Hiruy, N; Melak, B; Gelaye, W; Bezabih, B; Stephenson, R; Patterson, AE; Tadesse, Z; Emerson, PM; Richards, FO; Noland, GS				Schicker, Rebekah Stewart; Hiruy, Neway; Melak, Berhanu; Gelaye, Woyneshet; Bezabih, Belay; Stephenson, Rob; Patterson, Amy E.; Tadesse, Zerihun; Emerson, Paul M.; Richards, Frank O., Jr.; Noland, Gregory S.			A Venue-Based Survey of Malaria, Anemia and Mobility Patterns among Migrant Farm Workers in Amhara Region, Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; HEMOGLOBIN LEVELS; TRANSMISSION; ELIMINATION; IMPACT; POPULATION; PREVALENCE; SEX; MEN; PREVENTION	Background Mobile populations present unique challenges to malaria control and elimination efforts. Each year, a large number of individuals travel to northwest Amhara Region, Ethiopia to seek seasonal employment on large-scale farms. Agricultural areas typically report the heaviest malaria burden within Amhara thereby placing migrants at high risk of infection. Yet little is known about these seasonal migrants and their malaria-related risk factors. Methods and Findings In July 2013, a venue-based survey of 605 migrant laborers 18 years or older was conducted in two districts of North Gondar zone, Amhara. The study population was predominantly male (97.7%) and young (mean age 22.8 years). Plasmodium prevalence by rapid diagnostic test (RDT) was 12.0%; One quarter (28.3%) of individuals were anemic (hemoglobin <13 g/dl). Nearly all participants (95.6%) originated from within Amhara Region, with half (51.6%) coming from within North Gondar zone. Around half (51.2%) slept in temporary shelters, while 20.5% regularly slept outside. Only 11.9% of participants had access to a long lasting insecticidal net (LLIN). Reported net use the previous night was 8.8% overall but 74.6% among those with LLIN access. Nearly one-third (30.1%) reported having fever within the past two weeks, of whom 31.3% sought care. Cost and distance were the main reported barriers to seeking care. LLIN access (odds ratio 1OR] = 0.30, P = 0.04) and malaria knowledge (OR = 0.50, P = 0.02) were significantly associated with reduced Plasmodium infection among migrants, with a similar but non-significant trend observed for reported net use the previous night (OR = 0.16, P = 0.14). Conclusions High prevalence of malaria and anemia were observed among a young population that originated from relatively proximate areas. Low access to care and low IRS and LLIN coverage likely place migrant workers at significant risk of malaria in this area and their return home may facilitate parasite transport to other areas. Strategies specifically tailored to migrant farm workers are needed to support malaria control and elimination activities in Ethiopia.	[Schicker, Rebekah Stewart] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Schicker, Rebekah Stewart] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Hiruy, Neway; Melak, Berhanu; Tadesse, Zerihun] Carter Ctr, Addis Ababa, Ethiopia; [Gelaye, Woyneshet] Amhara Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia; [Bezabih, Belay] Amhara Natl Reg State Hlth Bur, Bahir Dar, Ethiopia; [Stephenson, Rob] Univ Michigan, Sch Nursing, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA; [Stephenson, Rob] Univ Michigan, Ctr Sexual & Hlth Dispar, Ann Arbor, MI 48109 USA; [Patterson, Amy E.; Emerson, Paul M.; Richards, Frank O., Jr.; Noland, Gregory S.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA; [Patterson, Amy E.] Agnes Scott Coll, Dept Publ Hlth, Decatur, GA 30030 USA; [Emerson, Paul M.] Task Force Global Hlth, Int Trachoma Initiat, Atlanta, GA USA	Emory University; Rollins School Public Health; Emory University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Emory University	Noland, GS (corresponding author), Emory Univ, Carter Ctr, Atlanta, GA 30322 USA.	gregory.noland@cartercenter.org		Noland, Gregory/0000-0003-1332-4832; Emerson, Paul/0000-0002-6478-8816	Institute for Developing Nations at Emory University; Global Field Experience fund of the Rollins School for Public Health at Emory University (RSS)	Institute for Developing Nations at Emory University; Global Field Experience fund of the Rollins School for Public Health at Emory University (RSS)	This research was supported in part by graduate student funding grants from the Institute for Developing Nations at Emory University and by the Global Field Experience fund of the Rollins School for Public Health at Emory University (RSS). The content is solely the responsibility of the authors and does not necessarily represent the Institute for Developing Nations or the Rollins School for Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095341; Alemu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079966; Amhara National Regional State Health Bureau, 2013, AMH NAT REG STAT HLT; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; COLLINS WE, 1971, AM J TROP MED HYG, V20, P199, DOI 10.4269/ajtmh.1971.20.199; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Daniels R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060780; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Eziefula AC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-360; Federal Democratic Republic of Ethiopia, 2011, NAT STRAT PLAN MAL P; Federal Democratic Republic of Ethiopia, 2008, ETH NAT MAL IND SURV; Federal Democratic Republic of Ethiopia, 2011, ETH NAT MAL IND SURV; Ferede Getachew, 2013, Malar Res Treat, V2013, P704730, DOI 10.1155/2013/704730; Golassa L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-352; Graves PM, 2009, T ROY SOC TROP MED H, V103, P1211, DOI 10.1016/j.trstmh.2008.11.016; Gustafson P, 2013, AM J EPIDEMIOL, V177, P1157, DOI 10.1093/aje/kws358; Hwang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063433; Jaleta KT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-350; Khamsiriwatchara A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-120; Kibret S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-360; King JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074570; Leon L, 2015, BIOSTATISTICS, V16, P565, DOI 10.1093/biostatistics/kxu061; MacKellar D, 1996, PUBLIC HEALTH REP, V111, P138; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Mamo H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-51; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Mittal PK, 2011, J VECTOR DIS, V48, P138; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Noland GS, 2008, INFECT IMMUN, V76, P5721, DOI 10.1128/IAI.00591-08; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Parsons JT, 2008, J DRUG ISSUES, V38, P1061, DOI 10.1177/002204260803800407; PETERS WH, 1984, ETHIOPIAN MED J, V22, P17; Pindolia DK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-169; Pulford J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-342; Reithinger R, 2013, T ROY SOC TROP MED H, V107, P769, DOI 10.1093/trstmh/trt096; Robinson WT, 2006, J URBAN HEALTH, V83, pI29, DOI 10.1007/s11524-006-9100-3; Roll Back Malaria, 2014, RAD ACT EL MAL END Z; Sanchez MA, 2012, JAIDS-J ACQ IMM DEF, V61, P610, DOI 10.1097/QAI.0b013e318273b651; Santana-Morales MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-435; Semaan Salaam, 2002, AIDS Reviews, V4, P213; Smith C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-377; Stephenson R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062592; Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514; Tadesse FG, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0821-1; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Wakgari Deressa, 2006, Ethiopian Journal of Health Development, V20, P137; Wangroongsarb P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-117; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wimberly MC, 2012, TROP MED INT HEALTH, V17, P1192, DOI 10.1111/j.1365-3156.2012.03058.x; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2015, GUID TREATM MAL, Vthird; Yukich JO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-33; ZEIN ZA, 1987, ETHIOPIAN MED J, V25, P105	56	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143829	10.1371/journal.pone.0143829	http://dx.doi.org/10.1371/journal.pone.0143829			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619114	gold, Green Published, Green Submitted			2022-12-26	WOS:000365889800076
J	Torres-Perez, JL; Guild, LS; Armstrong, RA; Corredor, J; Zuluaga-Montero, A; Polanco, R				Torres-Perez, Juan L.; Guild, Liane S.; Armstrong, Roy A.; Corredor, Jorge; Zuluaga-Montero, Anabella; Polanco, Ramon			Relative Pigment Composition and Remote Sensing Reflectance of Caribbean Shallow-Water Corals	PLOS ONE			English	Article							REEF CORALS; PHOTOSYNTHETIC PIGMENTS; SPECTRAL REFLECTANCE; LIGHT-ABSORPTION; ZOOXANTHELLAE; CHLOROPHYLLS; DIVERSITY; ALGAE; HOST; FLUCTUATIONS	Reef corals typically contain a number of pigments, mostly due to their symbiotic relationship with photosynthetic dinoflagellates. These pigments usually vary in presence and concentration and influence the spectral characteristics of corals. We studied the variations in pigment composition among seven Caribbean shallow-water Scleractinian corals by means of High Performance Liquid Chromatography (HPLC) analysis to further resolve the discrimination of corals. We found a total of 27 different pigments among the coral species, including some alteration products of the main pigments. Additionally, pigments typically found in endolithic algae were also identified. A Principal Components Analysis and a Hierarchical Cluster Analysis showed the separation of coral species based on pigment composition. All the corals were collected under the same physical environmental conditions. This suggests that pigment in the coral's symbionts might be more genetically-determined than influenced by prevailing physical conditions of the reef. We further investigated the use of remote sensing reflectance (Rrs) as a tool for estimating the total pigment concentration of reef corals. Depending on the coral species, the Rrs and the total symbiont pigment concentration per coral tissue area correlation showed 79.5-98.5% confidence levels demonstrating its use as a non-invasive robust technique to estimate pigment concentration in studies of coral reef biodiversity and health.	[Torres-Perez, Juan L.] NASA, Ames Res Ctr, Bay Area Environm Res Inst, Moffett Field, CA 94035 USA; [Guild, Liane S.] NASA, Ames Res Ctr, Div Earth Sci, Moffett Field, CA 94035 USA; [Armstrong, Roy A.] Univ Puerto Rico, Dept Marine Sci, Bioopt Oceanog Lab, Mayaguez, PR 00680 USA; [Corredor, Jorge] Univ Puerto Rico, Dept Marine Sci, Chem Oceanog Lab, Mayaguez, PR 00680 USA; [Zuluaga-Montero, Anabella] Univ Puerto Rico, Soc Ambiente Marino, San Juan, PR 00931 USA; [Polanco, Ramon] Univ Turabo, Escuela Ciencias Nat & Tecnol, Gurabo, PR 00778 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Puerto Rico	Torres-Perez, JL (corresponding author), NASA, Ames Res Ctr, Bay Area Environm Res Inst, MS 245-4,Bldg 245,Rm 120, Moffett Field, CA 94035 USA.	juan.l.torresperez@nasa.gov			NASA Postdoctoral Program [NNH06CC03B]	NASA Postdoctoral Program(National Aeronautics & Space Administration (NASA))	JLTP was funded under the NASA Postdoctoral Program (NNH06CC03B) during part of this study.	Ambarsari I, 1997, MAR ECOL PROG SER, V159, P303, DOI 10.3354/meps159303; Apprill AM, 2007, CORAL REEFS, V26, P387, DOI 10.1007/s00338-007-0209-y; Baums IB, 2010, CORAL REEFS, V29, P835, DOI 10.1007/s00338-010-0645-y; Bidigare R.R., 2005, ALGAL CULTURING TECH, P327; BIDIGARE RR, 1991, GEOPH MONOG SERIES, V63, P119; Brown BE, 1999, CORAL REEFS, V18, P99; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Chalker B.E., 1982, Proceedings of the International Coral Reef Symposium, P45; Dove SG, 1995, BIOL BULL, V189, P288, DOI 10.2307/1542146; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Egeland ES., 2011, PHYTOPLANKTON PIGMEN, P665; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; FUNG T, 1987, PHOTOGRAMM ENG REM S, V53, P1649; Gil-Turnes S., 1982, Proceedings of the International Coral Reef Symposium, P51; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Hedley JD, 2004, CORAL REEFS, V23, P60, DOI 10.1007/s00338-003-0354-x; Hedley JD, 2002, ADV MAR BIOL, P279; Helmuth BST, 1997, MAR BIOL, V130, P1, DOI 10.1007/s002270050219; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hochberg EJ, 2006, CORAL REEFS, V25, P99, DOI 10.1007/s00338-005-0071-8; Hochberg EJ, 2004, CORAL REEFS, V23, P84, DOI 10.1007/s00338-003-0350-1; Hochberg EJ, 2003, REMOTE SENS ENVIRON, V85, P174, DOI 10.1016/S0034-4257(02)00202-X; Hochberg EJ, 2003, REMOTE SENS ENVIRON, V85, P159, DOI 10.1016/S0034-4257(02)00201-8; Holden H, 1999, INT J REMOTE SENS, V20, P2545, DOI 10.1080/014311699211921; Jeffrey S.W., 2011, PHYTOPLANKTON PIGMEN, P3, DOI [10.1017/cbo9780511732263, DOI 10.1017/CBO9780511732263.004]; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN; JEFFREY SW, 1968, BIOL BULL, V135, P149, DOI 10.2307/1539622; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jones RJ, 1997, MAR ECOL PROG SER, V149, P163, DOI 10.3354/meps149163; Kawaguti S., 1944, Palao Tropical Biological Station Studies Tokyo, V2, P617; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Lesser MP, 2000, LIMNOL OCEANOGR, V45, P76, DOI 10.4319/lo.2000.45.1.0076; MARSH JA, 1970, ECOLOGY, V51, P254; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P390, DOI 10.4319/lo.2003.48.1_part_2.0390; Mazel CH, 1997, P SOC PHOTO-OPT INS, V2963, P240, DOI 10.1117/12.266450; McDougall KE, 2006, MAR ECOL PROG SER, V325, P137, DOI 10.3354/meps325137; Myers MR, 1999, CORAL REEFS, V18, P179, DOI 10.1007/s003380050177; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; Ott R., 2008, INTRO STAT METHODS D; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; RINKEVICH B, 1983, J EXP MAR BIOL ECOL, V73, P175, DOI 10.1016/0022-0981(83)90082-5; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Ruffin C, 2008, GISCI REMOTE SENS, V45, P1, DOI 10.2747/1548-1603.45.1.1; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Silverstein RN, 2012, P ROY SOC B-BIOL SCI, V279, P2609, DOI 10.1098/rspb.2012.0055; SMITH CM, 1994, MAR BIOL, V118, P511, DOI 10.1007/BF00350308; Stambler N, 2005, CORAL REEFS, V24, P1, DOI 10.1007/s00338-004-0452-4; Torres JL, 2007, PHOTOCHEM PHOTOBIOL, V83, P839, DOI 10.1562/2006-09-01-RA-1025; Torres-Perez JL, 2012, REMOTE SENS-BASEL, V4, P3813, DOI 10.3390/rs4123813; Tsai F, 1998, REMOTE SENS ENVIRON, V66, P41, DOI 10.1016/S0034-4257(98)00032-7; Ugalde JA, 2004, SCIENCE, V305, P1433, DOI 10.1126/science.1099597; Venn AA, 2006, PLANT CELL ENVIRON, V29, P2133, DOI 10.1111/j.1365-3040.2006.001587.x; Warner ME, 2006, J EXP MAR BIOL ECOL, V339, P86, DOI 10.1016/j.jembe.2006.07.011; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; WRIGHT SW, 1984, J CHROMATOGR, V294, P281, DOI 10.1016/S0021-9673(01)96134-5; WRIGHT SW, 1987, MAR ECOL PROG SER, V38, P259, DOI 10.3354/meps038259	61	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143709	10.1371/journal.pone.0143709	http://dx.doi.org/10.1371/journal.pone.0143709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619210	gold, Green Submitted, Green Published			2022-12-26	WOS:000365889800059
J	Adeniran, I; MacIver, DH; Garratt, CJ; Ye, JQ; Hancox, JC; Zhang, HG				Adeniran, Ismail; MacIver, David H.; Garratt, Clifford J.; Ye, Jianqiao; Hancox, Jules C.; Zhang, Henggui			Effects of Persistent Atrial Fibrillation-Induced Electrical Remodeling on Atrial Electro-Mechanics - Insights from a 3D Model of the Human Atria	PLOS ONE			English	Article							ACTION-POTENTIAL HETEROGENEITY; SHORT QT SYNDROME; ELECTROMECHANICAL MODEL; IONIC MECHANISMS; CONTRACTILE DYSFUNCTION; NUMERICAL-METHOD; MOLECULAR-BASIS; GAP-JUNCTIONS; CA2+ CURRENTS; CANINE RIGHT	Aims Atrial stunning, a loss of atrial mechanical contraction, can occur following a successful cardioversion. It is hypothesized that persistent atrial fibrillation-induced electrical remodeling (AFER) on atrial electrophysiology may be responsible for such impaired atrial mechanics. This simulation study aimed to investigate the effects of AFER on atrial electro-mechanics. Methods and Results A 3D electromechanical model of the human atria was developed to investigate the effects of AFER on atrial electro-mechanics. Simulations were carried out in 3 conditions for 4 states: (i) the control condition, representing the normal tissue (state 1) and the tissue 2-3 months after cardioversion (state 2) when the atrial tissue recovers its electrophysiological properties after completion of reverse electrophysiological remodelling; (ii) AFER-SR condition for AF-remodeled tissue with normal sinus rhythm (SR) (state 3); and (iii) AFER-AF condition for AF-remodeled tissue with re-entrant excitation waves (state 4). Our results indicate that at the cellular level, AFER (states 3 & 4) abbreviated action potentials and reduced the Ca2+ content in the sarcoplasmic reticulum, resulting in a reduced amplitude of the intracellular Ca2+ transient leading to decreased cell active force and cell shortening as compared to the control condition (states 1 & 2). Consequently at the whole organ level, atrial contraction in AFER-SR condition (state 3) was dramatically reduced. In the AFER-AF condition (state 4) atrial contraction was almost abolished. Conclusions This study provides novel insights into understanding atrial electro-mechanics illustrating that AFER impairs atrial contraction due to reduced intracellular Ca2+ transients.	[Adeniran, Ismail; MacIver, David H.; Hancox, Jules C.; Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Biol Phys Grp, Manchester, Lancs, England; [MacIver, David H.] Taunton & Somerset Hosp, Somerset, England; [Garratt, Clifford J.] Manchester Royal Infirm, Manchester Heart Ctr, Manchester M13 9WL, Lancs, England; [Ye, Jianqiao] Univ Lancaster, Dept Engn, Lancaster, England; [Hancox, Jules C.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Ye, Jianqiao] Univ Bristol, Cardiovasc Res Labs, Bristol, Avon, England	University of Manchester; University of Manchester; Lancaster University; University of Bristol; University of Bristol	Zhang, HG (corresponding author), Univ Manchester, Sch Phys & Astron, Biol Phys Grp, Manchester, Lancs, England.	henggui.zhang@manchester.ac.uk	Zhang, Henggui/D-6712-2011; Zhang, Henggui/AAM-1043-2020; Hancox, Jules C./Z-1550-2019; Ye, Jianqiao/D-1521-2013	Ye, Jianqiao/0000-0002-1039-1944; Adeniran, Ismail/0000-0002-9775-3249	Engineering and Physical Science Research Council UK [EP/J00958X/1, EP/I029826/1, EP/J009482/1]; EPSRC [EP/J009482/1, EP/I029826/1, EP/J00958X/1] Funding Source: UKRI; British Heart Foundation [FS/14/5/30533] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J009482/1, EP/J00958X/1, EP/I029826/1] Funding Source: researchfish	Engineering and Physical Science Research Council UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the project grant from Engineering and Physical Science Research Council UK (EP/J00958X/1; EP/I029826/1 and EP/J009482/1).	Adeniran I., 2013, J BIOMED SCI ENG, V6, P47, DOI DOI 10.4236/JBISE.2013.612A007; Adeniran I, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00078; Adeniran I, 2014, COMPUT CARDIOL CONF, V41, P1037; Adeniran I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00166; Adeniran I, 2012, CARDIOVASC RES, V94, P66, DOI 10.1093/cvr/cvs082; Adeniran I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002313; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Alnaes MS, 2014, ACM T MATH SOFTWARE, V40, DOI 10.1145/2566630; Ambrosi D, 2012, J ELASTICITY, V107, P199, DOI 10.1007/s10659-011-9351-4; Ambrosi D, 2011, SIAM J APPL MATH, V71, P605, DOI 10.1137/100788379; Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Ausma J, 1997, CIRCULATION, V96, P3157, DOI 10.1161/01.CIR.96.9.3157; Balay S, 1997, MODERN SOFTWARE TOOLS FOR SCIENTIFIC COMPUTING, P163; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BOINEAU JP, 1985, CIRCULATION, V72, P249, DOI 10.1161/01.CIR.72.2.249; Bonet J, 2008, NONLINEAR CONTINUUM MECHANICS FOR FINITE ELEMENT ANALYSIS, 2ND EDITION, P1, DOI 10.1017/CBO9780511755446; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; BOUTJDIR M, 1986, PACE, V9, P1095, DOI 10.1111/j.1540-8159.1986.tb06676.x; Braess D, 2007, FINITE ELEMENTS THEO, V3rd; Brenner S. C., 2010, MATH THEORY FINITE E; Burashnikov A, 2004, AM J PHYSIOL-HEART C, V286, pH2393, DOI 10.1152/ajpheart.01242.2003; Burnett D., 1987, FINITE ELEM ANAL DES; Butters TD, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0067; Chamberland E, 2010, COMPUT STRUCT, V88, P664, DOI 10.1016/j.compstruc.2010.02.007; Cherubini C, 2008, PROG BIOPHYS MOL BIO, V97, P562, DOI 10.1016/j.pbiomolbio.2008.02.001; Climent V, 2006, INT J CARDIOL, V110, P427, DOI 10.1016/j.ijcard.2005.11.041; Cohen S. D., 1996, Computers in Physics, V10, P138; Colli-Franzone P, 2005, MATH BIOSCI, V197, P35, DOI 10.1016/j.mbs.2005.04.003; Collin A, 2013, LECT NOTES COMPUT SC, V7945, P352, DOI 10.1007/978-3-642-38899-6_42; Colman MA, 2014, DEV FAMILY REGIONAL, P87; Colman MA, 2013, J PHYSIOL-LONDON, V591, P4249, DOI 10.1113/jphysiol.2013.254987; Constantin P, 1988, NAVIER STOKES EQUATI; Costa KD, 2001, PHILOS T R SOC A, V359, P1233, DOI 10.1098/rsta.2001.0828; Coudiere Y, 2015, J MATH BIOL, V71, P1607, DOI 10.1007/s00285-015-0861-8; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Dobrev D, 2003, BASIC RES CARDIOL, V98, P137, DOI 10.1007/s00395-003-0409-8; Dobrev D, 2001, CIRCULATION, V104, P2551, DOI 10.1161/hc4601.099466; Ehrlich JR, 2003, J PHYSIOL-LONDON, V551, P801, DOI 10.1113/jphysiol.2003.046417; Falk RH, 1998, AM J CARDIOL, V82, p10N, DOI 10.1016/S0002-9149(98)00735-8; Falk RH, 2001, NEW ENGL J MED, V344, P1067, DOI 10.1056/NEJM200104053441407; Feng JL, 1998, CIRC RES, V83, P541, DOI 10.1161/01.RES.83.5.541; Fink M, 2011, PROG BIOPHYS MOL BIO, V104, P2, DOI 10.1016/j.pbiomolbio.2010.03.002; Fritz T., 2013, Biomedical Engineering-Biomedizinische Technik, V58, DOI 10.1515/bmt-2013-4321; Gong DM, 2008, CELL PHYSIOL BIOCHEM, V21, P385, DOI 10.1159/000129631; de la Fuente MG, 2013, CARDIOVASC RES, V97, P379, DOI 10.1093/cvr/cvs313; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; GUCCIONE JM, 1991, J BIOMECH ENG-T ASME, V113, P42, DOI 10.1115/1.2894084; Guermond, 2010, THEORY PRACTICE FINI; Gurev V, 2015, BIOMECH MODEL MECHAN, V14, P829, DOI 10.1007/s10237-014-0639-8; Haga JB, 2012, INT J NUMER ANAL MET, V36, P1507, DOI 10.1002/nag.1062; Harrild DM, 2000, CIRC RES, V87, pE25; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Holzapfel G., 2000, NONLINEAR SOLID MECH; Hu YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060287; Hughes T.J. R., 2000, FINITE ELEMENT METHO; HUNTER PJ, 1997, COMPUTATIONAL BIOL H, P345; Keener J, 2008, MATH PHYSL; Khan IA, 2003, INT J CARDIOL, V92, P113, DOI 10.1016/S0167-5273(03)00107-4; Khan IA, 2003, AM HEART J, V145, P787, DOI 10.1016/S0002-8703(03)00086-3; Krishnamurthy A, 2013, J COMPUT PHYS, V244, P4, DOI 10.1016/j.jcp.2012.09.015; Krueger MW, 2013, MED BIOL ENG COMPUT, V51, P1105, DOI 10.1007/s11517-013-1090-1; Krueger MW, 2013, IEEE T MED IMAGING, V32, P73, DOI 10.1109/TMI.2012.2201948; Krueger MW, 2011, LECT NOTES COMPUT SC, V6666, P223, DOI 10.1007/978-3-642-21028-0_28; Krueger MW, 2012, PERSONALIZED MULTISC; Lafortune Aris R, 2012, COUPLED ELECTROMECHA; Land S, 2012, IEEE T BIO-MED ENG, V59, P1219, DOI 10.1109/TBME.2011.2112359; Leistad E, 1996, CIRCULATION, V93, P1747, DOI 10.1161/01.CIR.93.9.1747; Li DS, 2001, CIRC RES, V88, P1168, DOI 10.1161/hh1101.091266; Lip GYH, 2007, HEART, V93, P542, DOI 10.1136/hrt.2006.110791; Logg A., 2012, AUTOMATED SOLUTION D; Marsden J.E, 1994, MATH FDN ELASTICITY; Narolska NA, 2005, J MUSCLE RES CELL M, V26, P39, DOI 10.1007/s10974-005-9005-x; Nash MP, 2004, PROG BIOPHYS MOL BIO, V85, P501, DOI 10.1016/j.pbiomolbio.2004.01.016; Niederer SA, 2009, EXP PHYSIOL, V94, P486, DOI 10.1113/expphysiol.2008.044610; Niederer SA, 2008, PROG BIOPHYS MOL BIO, V96, P90, DOI 10.1016/j.pbiomolbio.2007.08.001; Nobile F, 2012, INT J NUMER METH BIO, V28, P52, DOI 10.1002/cnm.1468; Pandit S.V., 2014, CARDIAC ELECTROPHYSI, P309, DOI [10.1016/b978-1-4557-2856-5.00031-5, DOI 10.1016/B978-1-4557-2856-5.00031-5]; Pathmanathan P, 2010, Q J MECH APPL MATH, V63, P375, DOI 10.1093/qjmam/hbq014; Pathmanathan P, 2009, ANN BIOMED ENG, V37, P860, DOI 10.1007/s10439-009-9663-8; Polontchouk L, 2001, J AM COLL CARDIOL, V38, P883, DOI 10.1016/S0735-1097(01)01443-7; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; QI AZ, 1994, AM J PHYSIOL, V266, pH643, DOI 10.1152/ajpheart.1994.266.2.H643; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; Rigo F, 2000, CARDIAC ARRHYTHMIAS, P99, DOI DOI 10.1007/978-88-470-2139-6_; Rossi S, 2014, EUR J MECH A-SOLID, V48, P129, DOI 10.1016/j.euromechsol.2013.10.009; RUSH S, 1978, IEEE T BIO-MED ENG, V25, P389, DOI 10.1109/TBME.1978.326270; Sainte-Marie J, 2006, COMPUT STRUCT, V84, P1743, DOI 10.1016/j.compstruc.2006.05.003; Schotten U, 2002, CARDIOVASC RES, V53, P192, DOI 10.1016/S0008-6363(01)00453-9; Schotten U, 2001, CIRCULATION, V103, P691; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Sugiura S, 2013, BME, V51, DOI 10.11239/jsmbe.51.M-61; Sundnes J, 2005, MATH BIOSCI, V194, P233, DOI 10.1016/j.mbs.2005.01.001; Talbot H, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0091; van der Velden HMW, 2002, CARDIOVASC RES, V54, P270, DOI 10.1016/S0008-6363(01)00557-0; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; Van Wagoner DR, 2000, J MOL CELL CARDIOL, V32, P1101, DOI 10.1006/jmcc.2000.1147; Vazquez M, 2011, INT J NUMER METH BIO, V27, P1911, DOI 10.1002/cnm.1443; Voigt N, 2014, CIRCULATION, V129, P145, DOI 10.1161/CIRCULATIONAHA.113.006641; Voigt N, 2009, CIRCULATION, V120, pS667; Wang J, 1996, AM J PHYSIOL-HEART C, V271, pH148, DOI 10.1152/ajpheart.1996.271.1.H148; Wettwer E, 2004, CIRCULATION, V110, P2299, DOI 10.1161/01.CIR.0000145155.60288.71; Whiteley JP, 2007, B MATH BIOL, V69, P2199, DOI 10.1007/s11538-007-9213-1; Workman AJ, 2001, CARDIOVASC RES, V52, P226, DOI 10.1016/S0008-6363(01)00380-7; Zhang HG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00241	105	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142397	10.1371/journal.pone.0142397	http://dx.doi.org/10.1371/journal.pone.0142397			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606047	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300015
J	Li, RK; Palmer, SL; Zeng, MS; Qiang, JW; Chen, F; Rao, SX; Chen, LL; Dai, YM				Li, Ruo-kun; Palmer, Suzanne L.; Zeng, Meng-su; Qiang, Jin-wei; Chen, Frank; Rao, Sheng-xiang; Chen, Ling-li; Dai, Yong-ming			Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver	PLOS ONE			English	Article							MACROREGENERATIVE NODULES; IMPROVING DETECTION; SIDEROTIC NODULES; FOCI; HEMOCHROMATOSIS; QUANTIFICATION; DIAGNOSIS; OVERLOAD	Objective To investigate the value of susceptibility-weighted imaging (SWI) for characterization of hepatocellular carcinoma (HCC) and dysplastic nodule (DN). Materials and Methods Sixty-eight cirrhotic patients with 89 hepatocellular nodules underwent SWI. The radiological features of hepatocellular nodules on SWI were classified into three types: type A (isoor hypointensity, and background liver siderosis), type B (hyperintensity, and background liver siderosis), or type C (hyperintensity, and no background liver siderosis). Intranodular and background liver iron content was quantified and correlated with SWI pattern. Prussian blue staining was performed to quantify intranodular and background liver iron content. Results Type A pattern (n = 12) contained 11 (91.7%) DNs and 1 (8.3%) HCC, Type B pattern (n = 66) comprised 1 (1.5%) DN and 65 (98.5%) HCCs (including 12 DN-HCCs and 53 overt HCCs), and type C pattern (n = 11) was exclusively seen in HCCs. The iron scores of DNHCCs and overt HCCs were significantly lower than those of background livers [(0.091 +/- 0.30) VS (2.18 +/- 0.87), P = 0.000; (0.11 +/- 0.41) VS (2.16 +/- 0.97), P = 0.000; respectively]. There was no significant difference between iron scores of DNs and those of background livers [(1.92 +/- 0.29) VS (2.17 +/- 039), P = 0.191]. For lesion-based and patient-based analysis of HCCs (DN-HCCs and overt HCCs), type B pattern showed a sensitivity, specificity, accuracy, positive predicative value (PPV), and negative predicative value (NPV) of 84.4% and 84.4%, 91.7% and 75%, 85.4% and 83.8%, 98.5% and 98.2%, 47.8% and 23.1%, respectively. Conclusion SWI can provide valuable information for characterization of HCC and DN based on endogenous iron reduction during hepatocarcinogenesis.	[Li, Ruo-kun; Zeng, Meng-su; Rao, Sheng-xiang] Fudan Univ, Zhongshan Hosp, Dept Diagnost Radiol, Shanghai 200433, Peoples R China; [Li, Ruo-kun; Qiang, Jin-wei] Fudan Univ, Jinshan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Palmer, Suzanne L.; Chen, Frank] Univ So Calif, Dept Radiol, Keck Med Ctr, Los Angeles, CA USA; [Chen, Ling-li] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Dai, Yong-ming] Siemens Ltd, China Healthcare Sect MR Business, Shanghai, Peoples R China	Fudan University; Fudan University; University of Southern California; Fudan University; Siemens AG	Zeng, MS (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Diagnost Radiol, Shanghai 200433, Peoples R China.	zengmengsu@gmail.com; dr.jinweiqiang@163.com	Rao, Sheng-Xiang/AGL-7232-2022; Rao, Sheng-Xiang/I-8612-2019	Rao, Sheng-Xiang/0000-0001-7722-8327; Rao, Sheng-Xiang/0000-0001-7722-8327; Palmer, Suzanne/0000-0002-3492-7459	Natural Science Foundation of Shanghai [12ZR1441700]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	The Project was supported by the Natural Science Foundation of Shanghai, Grant number 12ZR1441700 (http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder and commercial affiliation (Siemens Ltd) provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alustiza JM, 2004, RADIOLOGY, V230, P479, DOI 10.1148/radiol.2302020820; Beal EW, 2014, J SURG ONCOL, V110, P967, DOI 10.1002/jso.23765; Bota S, 2012, LIVER CANCER, V1, P190, DOI 10.1159/000343833; Chen W, 2014, PLOS ONE, V30; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036454; Chou CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107869; Chou CT, 2013, WORLD J GASTROENTERO, V19, P7433, DOI 10.3748/wjg.v19.i42.7433; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; DEUGNIER YM, 1993, HEPATOLOGY, V18, P1363, DOI 10.1002/hep.1840180613; Deugnier Y, 2011, SEMIN LIVER DIS, V31, P260, DOI 10.1055/s-0031-1286057; Di Tommaso L, 2013, BEST PRACT RES CL GA, V27, P269, DOI 10.1016/j.bpg.2013.03.015; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Gong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087120; Guyader D, 1999, AM J GASTROENTEROL, V94, P1083; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Hanna RF, 2008, RADIOGRAPHICS, V28, P747, DOI 10.1148/rg.283055108; Hardie AD, 2011, J COMPUT ASSIST TOMO, V35, P711, DOI 10.1097/RCT.0b013e31823421ac; Hardie AD, 2011, EUR J RADIOL, V80, pE249, DOI 10.1016/j.ejrad.2010.10.027; Hardie AD, 2010, MAGN RESON IMAGING, V28, P281, DOI 10.1016/j.mri.2009.12.010; Hernando D, 2014, J MAGN RESON IMAGING, V40, P1003, DOI 10.1002/jmri.24584; Hirohashi S, 2000, PATHOLOGY GENETICS T, P157; Hodel J, 2012, J NEURORADIOLOGY, V39, P71, DOI 10.1016/j.neurad.2011.11.006; Kanwar P, 2013, EXPERT REV GASTROENT, V7, P517, DOI 10.1586/17474124.2013.816114; Kew MC, 2014, LIVER CANCER, V3, P31, DOI 10.1159/000343856; Kobayashi M, 2006, CANCER-AM CANCER SOC, V106, P636, DOI 10.1002/cncr.21607; Lee YJ, 2015, RADIOLOGY, V275, P97, DOI 10.1148/radiol.14140690; Li RK, 2012, J MAGN RESON IMAGING, V36, P900, DOI 10.1002/jmri.23734; Ludwig J, 1997, GASTROENTEROLOGY, V112, P882, DOI 10.1053/gast.1997.v112.pm9041250; Fernandez-Real JM, 2014, LANCET DIABETES ENDO, V2, P513, DOI 10.1016/S2213-8587(13)70174-8; Sciarra A, 2015, J HEPATOL; TERADA T, 1990, CANCER, V65, P1994, DOI 10.1002/1097-0142(19900501)65:9<1994::AID-CNCR2820650919>3.0.CO;2-B; TERADA T, 1989, ARCH PATHOL LAB MED, V113, P916; TERADA T, 1989, HEPATOLOGY, V10, P851, DOI 10.1002/hep.1840100517; Willatt JM, 2008, RADIOLOGY, V247, P311, DOI 10.1148/radiol.2472061331; Yuan ZG, 2014, ACAD RADIOL, V21, P971, DOI 10.1016/j.acra.2014.03.008; Zhang JB, 2004, NMR BIOMED, V17, P459, DOI 10.1002/nbm.926	36	9	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142882	10.1371/journal.pone.0142882	http://dx.doi.org/10.1371/journal.pone.0142882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605946	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300034
J	Montes-Cobos, E; Li, X; Fischer, HJ; Sasse, A; Kugler, S; Didie, M; Toischer, K; Fassnacht, M; Dressel, R; Reichardt, HM				Montes-Cobos, Elena; Li, Xiao; Fischer, Henrike J.; Sasse, Andre; Kuegler, Sebastian; Didie, Michael; Toischer, Karl; Fassnacht, Martin; Dressel, Ralf; Reichardt, Holger M.			Inducible Knock-Down of the Mineralocorticoid Receptor in Mice Disturbs Regulation of the Renin-Angiotensin-Aldosterone System and Attenuates Heart Failure Induced by Pressure Overload	PLOS ONE			English	Article							TRANSGENIC RATS; POLARIZATION; BALANCE; CELLS	Mineralocorticoid receptor (MR) inactivation in mice results in early postnatal lethality. Therefore we generated mice in which MR expression can be silenced during adulthood by administration of doxycycline (Dox). Using a lentiviral approach, we obtained two lines of transgenic mice harboring a construct that allows for regulatable MR inactivation by RNAi and concomitant expression of eGFP. MR mRNA levels in heart and kidney of inducible MR knock-down mice were unaltered in the absence of Dox, confirming the tightness of the system. In contrast, two weeks after Dox administration MR expression was significantly diminished in a variety of tissues. In the kidney, this resulted in lower mRNA levels of selected target genes, which was accompanied by strongly increased serum aldosterone and plasma renin levels as well as by elevated sodium excretion. In the healthy heart, gene expression and the amount of collagen were unchanged despite MR levels being significantly reduced. After transverse aortic constriction, however, cardiac hypertrophy and progressive heart failure were attenuated by MR silencing, fibrosis was unaffected and mRNA levels of a subset of genes reduced. Taken together, we believe that this mouse model is a useful tool to investigate the role of the MR in pathophysiological processes.	[Montes-Cobos, Elena; Li, Xiao; Fischer, Henrike J.; Sasse, Andre; Dressel, Ralf; Reichardt, Holger M.] Univ Med Ctr Gottingen, Inst Cellular & Mol Immunol, D-37073 Gottingen, Germany; [Kuegler, Sebastian] Univ Med Ctr Gottingen, Ctr Mol Physiol Brain, Dept Neurol, D-37073 Gottingen, Germany; [Didie, Michael] Univ Med Ctr Gottingen, Inst Pharmacol, D-37073 Gottingen, Germany; [Didie, Michael; Toischer, Karl] Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, D-37073 Gottingen, Germany; [Fassnacht, Martin] Univ Wurzburg, Dept Internal Med 1, Endocrine & Diabet Unit, D-97080 Wurzburg, Germany; [Didie, Michael; Toischer, Karl; Dressel, Ralf] German Ctr Cardiovasc Res DZHK, Partner Site Gottingen, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen; University of Wurzburg; German Centre for Cardiovascular Research	Reichardt, HM (corresponding author), Univ Med Ctr Gottingen, Inst Cellular & Mol Immunol, D-37073 Gottingen, Germany.	hreichardt@med.uni-goettingen.de	Dressel, Ralf/R-7065-2016; Fassnacht, Martin/N-9614-2019; Reichardt, Holger/AAF-3048-2020	Dressel, Ralf/0000-0002-1651-1214; Fassnacht, Martin/0000-0001-6170-6398; Reichardt, Holger/0000-0003-4647-057X	Deutsche Forschungsgemeinschaft [RE1631/7-1, SFB1002/TP-C05, SFB1002/TP-S]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported through grants of the Deutsche Forschungsgemeinschaft (www.dfg.de): RE1631/7-1 to H.M.R., SFB1002/TP-C05 to R.D. and SFB1002/TP-S to M.D. and K.T.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424; Bonvalet JP, 1998, KIDNEY INT, pS49; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Franco V, 2006, CLIN EXP PHARMACOL P, V33, P773, DOI 10.1111/j.1440-1681.2006.04434.x; Funder JW, 2013, INTEGR BLOOD PRESS C, V6, P129, DOI 10.2147/IBPC.S13783; Funder JW, 2005, HEART FAIL REV, V10, P15, DOI 10.1007/s10741-005-2344-2; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110950; Lim HY, 2008, MOL ENDOCRINOL, V22, P1304, DOI 10.1210/me.2007-0417; Lim HY, 2007, IMMUNOLOGY, V122, P47, DOI 10.1111/j.1365-2567.2007.02611.x; Lother A, 2011, HYPERTENSION, V57, P746, DOI 10.1161/HYPERTENSIONAHA.110.163287; McCurley A, 2012, NAT MED, V18, P1429, DOI 10.1038/nm.2891; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Reichardt HM, 2016, METHODS MOL BIOL, V1304, P25, DOI 10.1007/7651_2014_107; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; Ronzaud C, 2011, AM J PHYSIOL-RENAL, V300, pF756, DOI 10.1152/ajprenal.00728.2009; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Tanaka J, 1997, GLIA, V20, P23, DOI 10.1002/(SICI)1098-1136(199705)20:1<23::AID-GLIA3>3.3.CO;2-U; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Toischer K, 2010, CIRCULATION, V122, P993, DOI 10.1161/CIRCULATIONAHA.110.943431; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; van den Brandt J, 2004, GENESIS, V39, P94, DOI 10.1002/gene.20037	26	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143954	10.1371/journal.pone.0143954	http://dx.doi.org/10.1371/journal.pone.0143954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605921	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300124
J	Delgado, E; Cuevas, MT; Dominguez, F; Vega, Y; Cabello, M; Fernandez-Garcia, A; Perez-Losada, M; Castro, MA; Montero, V; Sanchez, M; Marino, A; Alvarez, H; Ordonez, P; Ocampo, A; Miralles, C; Perez-Castro, S; Lopez-Alvarez, MJ; Rodriguez, R; Trigo, M; Diz-Aren, J; Hinojosa, C; Bachiller, P; Hernaez-Crespo, S; Cisterna, R; Garduno, E; Perez-Alvarez, L; Thomson, MM				Delgado, Elena; Teresa Cuevas, Maria; Dominguez, Francisco; Vega, Yolanda; Cabello, Marina; Fernandez-Garcia, Aurora; Perez-Losada, Marcos; Angeles Castro, Maria; Montero, Vanessa; Sanchez, Monica; Marino, Ana; Alvarez, Hortensia; Ordonez, Patricia; Ocampo, Antonio; Miralles, Celia; Perez-Castro, Sonia; Jose Lopez-Alvarez, Maria; Rodriguez, Raul; Trigo, Matilde; Diz-Aren, Julio; Hinojosa, Carmen; Bachiller, Pablo; Hernaez-Crespo, Silvia; Cisterna, Ramon; Garduno, Eugenio; Perez-Alvarez, Lucia; Thomson, Michael M.			Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANCE; ANTIRETROVIRAL THERAPY; TRANSMISSION CLUSTER; POPULATION-DYNAMICS; GENETIC DIVERSITY; INFECTION; TYPE-1; IDENTIFICATION	We recently reported the rapid expansion of an HIV-1 subtype F cluster among men who have sex with men (MSM) in the region of Galicia, Northwest Spain. Here we update this outbreak, analyze near full-length genomes, determine phylogenetic relationships, and estimate its origin. For this study, we used sequences of HIV-1 protease-reverse transcriptase and env V3 region, and for 17 samples, near full-length genome sequences were obtained. Phylogenetic analyses were performed via maximum likelihood. Locations and times of most recent common ancestors were estimated using Bayesian inference. Among samples analyzed by us, 100 HIV-1 F1 subsubtype infections of monophyletic origin were diagnosed in Spain, including 88 in Galicia and 12 in four other regions. Most viruses (n = 90) grouped in a subcluster (Galician subcluster), while 7 from Valladolid (Central Spain) grouped in another subcluster. At least 94 individuals were sexually-infected males and at least 71 were MSM. Seventeen near full-length genomes were uniformly of F1 subsubtype. Through similarity searches and phylogenetic analyses, we identified 18 viruses from four other Western European countries [Switzerland (n = 8), Belgium (n = 5), France (n = 3), and United Kingdom (n = 2)] and one from Brazil, from samples collected in 2005-2011, which branched within the subtype F cluster, outside of both Spanish subclusters, most of them corresponding to recently infected individuals. The most probable geographic origin and age of the Galician subcluster was Ferrol, Northwest Galicia, around 2007, while the Western European cluster probably emerged in Switzerland around 2002. In conclusion, a recently expanded HIV-1 subtype F cluster, the largest non-subtype B cluster reported in Western Europe, continues to spread among MSM in Spain; this cluster is part of a larger cluster with a wide geographic circulation in diverse Western European countries.	[Delgado, Elena; Teresa Cuevas, Maria; Dominguez, Francisco; Vega, Yolanda; Cabello, Marina; Fernandez-Garcia, Aurora; Montero, Vanessa; Sanchez, Monica; Perez-Alvarez, Lucia; Thomson, Michael M.] Inst Salud Carlos III, Ctr Nacl Microbiol, HIV Biol & Variabil Unit, Madrid, Spain; [Perez-Losada, Marcos] Ctr Invest Biodiversidade & Recursos Genet CIBIO, Vairao, Portugal; [Angeles Castro, Maria] Complejo Hosp Univ A Coruna, Dept Internal Med, La Coruna, Spain; [Marino, Ana; Alvarez, Hortensia] Complejo Hosp Univ Arquitecto Marcide, Dept Internal Med, Infect Dis Unit, Ferrol, A Coruna, Spain; [Ordonez, Patricia] Complejo Hosp Univ Arquitecto Marcide, Dept Microbiol, Ferrol, A Coruna, Spain; [Ocampo, Antonio; Miralles, Celia] Complejo Hosp Univ Vigo, Dept Internal Med, Vigo, Pontevedra, Spain; [Perez-Castro, Sonia] Complejo Hosp Univ Vigo, Dept Microbiol, Vigo, Pontevedra, Spain; [Jose Lopez-Alvarez, Maria] Hosp Univ Lucus Augusti, Infect Disesases Unit, Lugo, Spain; [Rodriguez, Raul] Complejo Hosp Univ Ourense, Dept Internal Med, Orense, Spain; [Trigo, Matilde] Complejo Hosp Prov Pontevedra, Dept Microbiol, Pontevedra, Spain; [Diz-Aren, Julio] Complejo Hosp Prov Pontevedra, Dept Internal Med, Pontevedra, Spain; [Hinojosa, Carmen] Hosp Clin Univ Valladolid, Dept Internal Med, Valladolid, Spain; [Bachiller, Pablo] Hosp Univ Rio Hortega, Dept Internal Med, Valladolid, Spain; [Hernaez-Crespo, Silvia; Cisterna, Ramon] Hosp Univ Basurto, Dept Clin Microbiol & Infect Control, Bilbao, Vizcaya, Spain; [Garduno, Eugenio] Hosp Infanta Cristina, Dept Microbiol, Badajoz, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidade do Porto; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Complejo Hospitalario Universitario de Ferrol; Complejo Hospitalario Universitario de Ferrol; Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Vigo; Hospital Universitario Lucus Augusti-Lugo; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; Complexo Hospitalario Universitario de Pontevedra; Complexo Hospitalario Universitario de Pontevedra; Hospital del Rio Hortega; Basurto Hospital	Thomson, MM (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, HIV Biol & Variabil Unit, Madrid, Spain.	mthomson@isciii.es	Perez-Losada, Marcos/I-4407-2013; Dominguez, Francisco/AAA-7260-2020; Thomson, Michael M/P-8949-2017; gonzalez-nico, maria teresa cuevas/E-2001-2014; Delgado, Elena/E-2785-2019	Perez-Losada, Marcos/0000-0002-2585-4657; Dominguez, Francisco/0000-0002-7620-8081; Thomson, Michael M/0000-0002-0622-7527; gonzalez-nico, maria teresa cuevas/0000-0002-4195-1975; Dominguez, Francisco/0000-0002-8573-5668; Matilde, Trigo Dapota/0000-0001-7006-2854; Delgado, Elena/0000-0002-0754-8533; PEREZ CASTRO, SONIA/0000-0003-1734-1904; OCAMPO HERMIDA, ANTONIO/0000-0002-3176-9758	Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain [EC11-272]; European Network of Excellence EUROPRISE (Rational Design of HIV Vaccines and Microbicides) [LSHP-CT-2006-037611]; European Research Infrastructures for Poverty Related Diseases (EURIPRED) [312661]; Instituto de Salud Carlos III, Subdireccion General de Evaluacion, and Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I [RD12/0017/0026]; Conselleria de Sanidade, Government of Galicia, Spain [MVI 1291/08]; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain [MVI-1255-08]; District of Columbia Developmental Center for AIDS Research [P30AI087714]; George Washington University; CIBER in Epidemiology and Public Health, Instituto de Salud Carlos III, Madrid, Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714] Funding Source: NIH RePORTER	Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain; European Network of Excellence EUROPRISE (Rational Design of HIV Vaccines and Microbicides); European Research Infrastructures for Poverty Related Diseases (EURIPRED); Instituto de Salud Carlos III, Subdireccion General de Evaluacion, and Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I; Conselleria de Sanidade, Government of Galicia, Spain; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain; District of Columbia Developmental Center for AIDS Research; George Washington University; CIBER in Epidemiology and Public Health, Instituto de Salud Carlos III, Madrid, Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received support from the Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain, grant EC11-272; European Network of Excellence EUROPRISE (Rational Design of HIV Vaccines and Microbicides), grant LSHP-CT-2006-037611; European Research Infrastructures for Poverty Related Diseases (EURIPRED). Seventh Framework Programme: FP7-Capacities-infrastructures-2012-1, grant agreement 312661; Instituto de Salud Carlos III, Subdireccion General de Evaluacion, and Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I, through project RD12/0017/0026; Conselleria de Sanidade, Government of Galicia, Spain (MVI 1291/08); and the Osakidetza-Servicio Vasco de Salud, Basque Country, Spain (MVI-1255-08). Marcos Perez-Losada was supported by a DC D-CFAR Research Award from the District of Columbia Developmental Center for AIDS Research (P30AI087714) and by an University Facilitating Fund award from George Washington University. Aurora Fernandez-Garcia is supported by CIBER in Epidemiology and Public Health, Instituto de Salud Carlos III, Madrid, Spain.	Ambrosioni J, 2012, AIDS, V26, P2079, DOI 10.1097/QAD.0b013e32835805b6; Antoniadou ZA, 2014, AIDS RES HUM RETROV, V30, P225, DOI [10.1089/AID.2013.0166, 10.1089/aid.2013.0166]; Audelin AM, 2013, JAIDS-J ACQ IMM DEF, V62, P102, DOI 10.1097/QAI.0b013e318276becc; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Castro E, 2010, AIDS RES HUM RETROV, V26, P1233, DOI 10.1089/aid.2010.0083; Chalmet K, 2012, J INFECT DIS, V205, P174, DOI 10.1093/infdis/jir714; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Ciccozzi M, 2007, AIDS, V21, P1213, DOI 10.1097/QAD.0b013e32813aee1a; Cuevas M, 2009, EURO SURVEIL, V14; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Delgado E, 2002, J ACQ IMMUN DEF SYND, V29, P536, DOI 10.1097/00126334-200204150-00016; Delgado E, 2012, J ANTIMICROB CHEMOTH, V67, P25, DOI 10.1093/jac/dkr438; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Han XX, 2013, JAIDS-J ACQ IMM DEF, V64, P16, DOI 10.1097/QAI.0b013e3182932210; Hraber P, 2014, J VIROL, V88, P12623, DOI 10.1128/JVI.01705-14; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kuiken C, 2000, AM J EPIDEMIOL, V152, P814, DOI 10.1093/aje/152.9.814; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Monno L, 2012, J CLIN VIROL, V55, P370, DOI 10.1016/j.jcv.2012.08.014; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Paraskevis D, 2015, INFECT GENET EVOL, V30, P96, DOI 10.1016/j.meegid.2014.12.012; Perez L, 2006, AIDS RES HUM RETROV, V22, P724, DOI 10.1089/aid.2006.22.724; Pernas B, 2014, AIDS, V28, P1837, DOI 10.1097/QAD.0000000000000326; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shcherbakova NS, 2014, AIDS RES HUM RETROV, V30, P912, DOI [10.1089/aid.2014.0075, 10.1089/AID.2014.0075]; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Skar H, 2011, J VIROL, V85, P510, DOI 10.1128/JVI.01413-10; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; Thomson MM, 2012, JAIDS-J ACQ IMM DEF, V59, pE49, DOI 10.1097/QAI.0b013e3182400fc4; Thomson MM, 2011, VIROLOGY, V415, P30, DOI 10.1016/j.virol.2011.03.021; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; Cardoso LPV, 2009, J CLIN VIROL, V46, P134, DOI 10.1016/j.jcv.2009.07.009; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Ye JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054238; Yebra G, 2014, ARCH VIROL, V159, P1079, DOI 10.1007/s00705-013-1933-y; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	50	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143325	10.1371/journal.pone.0143325	http://dx.doi.org/10.1371/journal.pone.0143325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599410	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600051
J	van Werkhoven, CH; Huijts, SM; Postma, DF; Oosterheert, JJ; Bonten, MJM				van Werkhoven, Cornelis H.; Huijts, Susanne M.; Postma, Douwe F.; Oosterheert, Jan Jelrik; Bonten, Marc J. M.			Predictors of Bacteraemia in Patients with Suspected Community-Acquired Pneumonia	PLOS ONE			English	Article							BLOOD CULTURES; MANAGEMENT; GUIDELINES; ACCURACY	Introduction The diagnostic yield of blood cultures is limited in patients with community-acquired pneumonia (CAP). Yet, positive blood culture results provide important information for antibiotic treatment and for monitoring epidemiologic trends. We investigated the potential of clinical predictors to improve the cost-benefit ratio of obtaining blood cultures. Methods Data from two prospective cohort studies of adults with suspected CAP, admitted to non-ICU wards, were combined. Two models were created, one using readily available parameters and one additionally including laboratory parameters. Results 3,786 patients were included (2,626 (69%) with X-ray confirmed CAP). Blood cultures were obtained from 2,977 (79%) patients (and from 2,107 (80%) with X-ray confirmed CAP). 266 (8.9%) of the patients with a blood culture had bacteraemia. Clinical predictors of bacteraemia were absence of pre-admission antibiotic treatment, pleuritic pain, gastro-intestinal symptoms, tachycardia, tachypnea, hypotension and absence of hypoxia. After including laboratory results in the model, younger age, C-reactive protein, leukocytosis or leukopenia, low thrombocyte count, low sodium level, elevated urea and elevated arterial pH were added, while gastro-intestinal symptoms and hypotension were no longer significant. The area under the receiver operating characteristics curve was 0.66 (95% confidence interval 0.63-0.70) for the first model and 0.76 (95% confidence interval 0.73-0.79) for the second model. Conclusion In conclusion, in patients hospitalized with CAP, bacteraemia was moderately predictable using clinical parameters only. We recommend against the use of a risk prediction model for the decision to obtain blood cultures.	[van Werkhoven, Cornelis H.; Huijts, Susanne M.; Postma, Douwe F.; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Huijts, Susanne M.] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Postma, Douwe F.; Oosterheert, Jan Jelrik] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Postma, Douwe F.] Diakonessenhuis Utrecht, Dept Internal Med, Utrecht, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Diakonessenhuis; Utrecht University; Utrecht University Medical Center	van Werkhoven, CH (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	c.h.vanwerkhoven@umcutrecht.nl	Postma, Douwe F./AAB-9922-2022; van Werkhoven, Henri/F-7915-2013	Postma, Douwe F./0000-0002-0675-8459; van Werkhoven, Henri/0000-0002-0626-4635; Oosterheert, Jan Jelrik/0000-0001-6146-3808	Netherlands Organization for Health Research and Development (ZONmw) [171202002]; Wyeth by Pfizer Inc [6115A1-3012]	Netherlands Organization for Health Research and Development (ZONmw)(Netherlands Organization for Health Research and Development); Wyeth by Pfizer Inc	CAP-START was supported by a financial grant from The Netherlands Organization for Health Research and Development (ZONmw, Health care efficiency research, project id: 171202002). CAP-pilot was supported by a financial grant from Wyeth, which was acquired by Pfizer Inc in October 2009. (study number 6115A1-3012). No funding has been received for the current manuscript.	Campbell SG, 2003, CHEST, V123, P1142, DOI 10.1378/chest.123.4.1142; Capelastegui A, 2010, J INFECTION, V61, P364, DOI 10.1016/j.jinf.2010.07.015; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; Colice GL, 2004, CHEST, V125, P2140, DOI 10.1378/chest.125.6.2140; Corbo J, 2004, EMERG MED J, V21, P446, DOI 10.1136/emj.2003.005306; Falguera M, 2009, CLIN INFECT DIS, V49, P409, DOI 10.1086/600291; Huijts SM, 2013, EUR RESPIR J, V42, P1283, DOI 10.1183/09031936.00137412; LeBude B, 2014, JAMA INTERN MED, V174, P1546, DOI 10.1001/jamainternmed.2014.3687; Lee CC, 2012, DIAGN MICR INFEC DIS, V73, P168, DOI 10.1016/j.diagmicrobio.2012.02.009; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARRIE TJ, 1989, REV INFECT DIS, V11, P586; Metersky ML, 2004, AM J RESP CRIT CARE, V169, P342, DOI 10.1164/rccm.200309-1248OC; Muller B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-10; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Paolucci M, 2010, INT J ANTIMICROB AG, V36, pS6, DOI 10.1016/j.ijantimicag.2010.11.010; Previsdomini M, 2012, CROAT MED J, V53, P30, DOI 10.3325/cmj.2012.53.30; R Core Team, 2021, R LANGUAGE ENV STAT; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Skerrett SJ, 1999, CLIN CHEST MED, V20, P531, DOI 10.1016/S0272-5231(05)70234-3; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Werkhoven CH, 2014, NETH J MED, V72, P170; Wiersinga WJ, 2012, NETH J MED, V70, P90	24	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143817	10.1371/journal.pone.0143817	http://dx.doi.org/10.1371/journal.pone.0143817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599636	gold, Green Published			2022-12-26	WOS:000365862600124
J	Galdino, TVD; Picanco, MC; Ferreira, DO; Silva, GAR; de Souza, TC; Silva, GA				da Silva Galdino, Tarcisio Visintin; Picanco, Marcelo Coutinho; Ferreira, Dalton Oliveira; Resende Silva, Geverson Aelton; de Souza, Thadeu Carlos; Silva, Gerson Adriano			Is the Performance of a Specialist Herbivore Affected by Female Choices and the Adaptability of the Offspring?	PLOS ONE			English	Article							AMERICAN TOMATO PINWORM; TUTA-ABSOLUTA MEYRICK; OVIPOSITION PREFERENCE; HELICOVERPA-ARMIGERA; EVOLUTIONARY ECOLOGY; PHYTOPHAGOUS INSECTS; NATURAL ENEMIES; PLANT DEFENSE; HOST-PLANT; SOIL TYPE	The performance of herbivorous insects is related to the locations of defenses and nutrients found in the different plant organs on which they feed. In this context, the females of herbivorous insect species select certain parts of the plant where their offspring can develop well. In addition, their offspring can adapt to plant defenses. A system where these ecological relationships can be studied occurs in the specialist herbivore, Tuta absoluta, on tomato plants. In our experiments we evaluated: (i) the performance of the herbivore T. absoluta in relation to the tomato plant parts on which their offspring had fed, (ii) the spatial distribution of the insect stages on the plant canopy and (iii) the larval resistance to starvation and their walking speed at different instar stages. We found that the T. absoluta females preferred to lay their eggs in the tomato plant parts where their offspring had greater chances of success. We verified that the T. absoluta females laid their eggs on both sides of the leaves to better exploit resources. We also observed that the older larvae (3rd and 4th instars) moved to the most nutritious parts of the plant, thus increasing their performance. The T. absoluta females and offspring (larvae) were capable of identifying plant sites where their chances of better performance were higher. Additionally, their offspring (larvae) spread across the plant to better exploit the available plant nutrients. These behavioral strategies of T. absoluta facilitate improvement in their performance after acquiring better resources, which help reduce their mortality by preventing the stimulation of plant defense compounds and the action of natural enemies.	[da Silva Galdino, Tarcisio Visintin] Univ Fed Vicosa, Dept Plant Sci, Vicosa, MG, Brazil; [Picanco, Marcelo Coutinho; Ferreira, Dalton Oliveira; Resende Silva, Geverson Aelton; de Souza, Thadeu Carlos; Silva, Gerson Adriano] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Galdino, TVD (corresponding author), Univ Fed Vicosa, Dept Plant Sci, Vicosa, MG, Brazil.	tarcsilva@gmail.com	Galdino, Tarcisio V S/J-2437-2015; De Oliveira Ferreira, Dalton/GVC-5262-2022; Picanço, Marcelo Coutinho/P-6172-2019; Silva, Gerson Adriano/AAK-4887-2020; Picanço, Marcelo/AAQ-2477-2020	Galdino, Tarcisio V S/0000-0001-7317-0789; De Oliveira Ferreira, Dalton/0000-0002-8777-5719; Silva, Gerson Adriano/0000-0002-1445-9758; Picanço, Marcelo/0000-0002-1294-6210	Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES Foundation (Brazilian Ministry of Education)); National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq); Research Support Foundation of Minas Gerais State Foundation for Research Aid (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG)	Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES Foundation (Brazilian Ministry of Education)); National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Support Foundation of Minas Gerais State Foundation for Research Aid (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG)	Fellowships and financial resources were granted to the authors by the Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES Foundation (Brazilian Ministry of Education)), the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq), and the Research Support Foundation of Minas Gerais State Foundation for Research Aid (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais-FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; ALVARADORODRIGUEZ B, 1982, J ECON ENTOMOL, V75, P895, DOI 10.1093/jee/75.5.895; Antonio AD, 2011, PESQUI AGROPECU BRAS, V46, P74, DOI 10.1590/S0100-204X2011000100010; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bjorkman C, 1997, OIKOS, V79, P45, DOI 10.2307/3546088; COELHO MDF, 1987, PESQUI AGROPECU BRAS, V22, P129; Cornelissen T, 2006, ECOL ENTOMOL, V31, P32, DOI 10.1111/j.0307-6946.2006.00752.x; Cunningham JP, 2012, J EVOLUTION BIOL, V25, P244, DOI 10.1111/j.1420-9101.2011.02435.x; Galdino TVD, 2011, CIENC AGROTEC, V35, P869, DOI 10.1590/S1413-70542011000500002; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Ellis JD, 2004, ENVIRON ENTOMOL, V33, P794, DOI 10.1603/0046-225X-33.4.794; Faraji F, 2002, ECOL ENTOMOL, V27, P660, DOI 10.1046/j.1365-2311.2002.00456.x; Friedman M, 2004, J CHROMATOGR A, V1054, P143, DOI 10.1016/j.chroma.2004.04.049; Gary C, 1998, J EXP BOT, V49, P49, DOI 10.1093/jexbot/49.318.49; Gontijo PC, 2013, ANN APPL BIOL, V162, P50, DOI 10.1111/aab.12000; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Hou BH, 2006, APPL ENTOMOL ZOOL, V41, P515, DOI 10.1303/aez.2006.515; Hoy CW, 1998, ANNU REV ENTOMOL, V43, P571, DOI 10.1146/annurev.ento.43.1.571; Hulthen AD, 2006, AUST J ENTOMOL, V45, P16, DOI 10.1111/j.1440-6055.2006.00518.x; Irvin NA, 2004, FLA ENTOMOL, V87, P504, DOI 10.1653/0015-4040(2004)087[0504:OPOHCF]2.0.CO;2; Johnson MTJ, 2011, FUNCT ECOL, V25, P305, DOI 10.1111/j.1365-2435.2011.01838.x; Johnson SN, 2006, ECOL ENTOMOL, V31, P395, DOI 10.1111/j.1365-2311.2006.00776.x; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Kloth KJ, 2012, TRENDS PLANT SCI, V17, P311, DOI 10.1016/j.tplants.2012.01.002; Knolhoff LM, 2014, ANNU REV ENTOMOL, V59, P263, DOI 10.1146/annurev-ento-011613-161945; Kozukue N, 2004, J AGR FOOD CHEM, V52, P2079, DOI 10.1021/jf0306845; Leite G. L. D., 1998, Manejo Integrado de Plagas, V49, P26; Leite GLD, 2001, SCI HORTIC-AMSTERDAM, V89, P103, DOI 10.1016/S0304-4238(00)00224-7; Li YX, 2015, INSECT SCI, V22, P273, DOI 10.1111/1744-7917.12104; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu TX, 2002, J ECON ENTOMOL, V95, P360, DOI 10.1603/0022-0493-95.2.360; Maluf WR, 2010, EUPHYTICA, V176, P113, DOI 10.1007/s10681-010-0234-8; Miranda Moacyr Mascarenhas Motta, 2005, Cienc. Rural, V35, P204, DOI 10.1590/S0103-84782005000100033; Miranda MMM, 1998, BIOCONTROL SCI TECHN, V8, P597, DOI 10.1080/09583159830117; Pereira EJG, 2007, BIOCONTROL SCI TECHN, V17, P441, DOI 10.1080/09583150701309337; Picanco MC, 2007, AGR FOREST ENTOMOL, V9, P327, DOI 10.1111/j.1461-9563.2007.00346.x; Rajapakse CNK, 2006, PHYSIOL ENTOMOL, V31, P270, DOI 10.1111/j.1365-3032.2006.00517.x; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; Robert CAM, 2012, ECOL LETT, V15, P55, DOI 10.1111/j.1461-0248.2011.01708.x; Scriber JM, 2002, ENTOMOL EXP APPL, V104, P217, DOI 10.1023/A:1021292604205; SCRIBER JM, 1979, ECOLOGY, V60, P829, DOI 10.2307/1936618; Silva DJH., 2007, TOMATE TECNOLOGIA PR, P7; Silva GA, 2011, PEST MANAG SCI, V67, P913, DOI 10.1002/ps.2131; Slansky F. Jr, 1985, P87; Southwood TRE, 2000, ECOLOGICAL METHODS M; Stadler E, 2009, PHYTOCHEM REV, V8, P207, DOI 10.1007/s11101-008-9108-2; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Wang D, 2009, PEST MANAG SCI, V65, P223, DOI 10.1002/ps.1672; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220; [No title captured]	52	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143389	10.1371/journal.pone.0143389	http://dx.doi.org/10.1371/journal.pone.0143389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600074	gold, Green Submitted, Green Published			2022-12-26	WOS:000365853900104
J	Koh, MJ; Kim, W; Kang, JI; Namkoong, K; Kim, SJ				Koh, Min Jung; Kim, Wonji; Kang, Jee In; Namkoong, Kee; Kim, Se Joo			Lack of Association between Oxytocin Receptor (OXTR) Gene Polymorphisms and Alexithymia: Evidence from Patients with Obsessive-Compulsive Disorder	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; BEHAVIOR; VASOPRESSIN; POPULATION; EMOTION; EMPATHY; SCALE; VULNERABILITY; ADOLESCENTS; DEPRESSION	Oxytocin receptor gene single nucleotide polymorphisms have been associated with structural and functional alterations in brain regions, which involve social-emotional processing. Therefore, oxytocin receptor gene polymorphisms may contribute to individual differences in alexithymia, which is considered to be a dysfunction of emotional processing. The aim of this study was to evaluate the association between oxytocin receptor gene single nucleotide polymorphisms or haplotypes and alexithymia in patients with obsessive-compulsive disorder. We recruited 355 patients with obsessive-compulsive disorder (234 men, 121 women). Alexithymia was measured by using the Toronto Alexithymia Scale. We performed single-marker and haplotype association analyses with eight single nucleotide polymorphisms (rs237885, rs237887, rs2268490, rs4686301, rs2254298, rs13316193, rs53576, and rs2268498) in the oxytocin receptor gene. There were no significant associations between any of the eight single nucleotide polymorphism of the oxytocin receptor gene and alexithymia. In addition, a six-locus haplotype block (rs237885-rs237887-rs2268490-rs4686301-rs2254298-rs13316193) was not significantly associated with alexithymia. These findings suggest that genetic variations in the oxytocin receptor gene may not explain a significant part of alexithymia in patients with obsessive-compulsive disorder.	[Koh, Min Jung] Bundang Jesaeng Hosp, Dept Psychiat, Seongnam Gyeonggi, South Korea; [Koh, Min Jung] Yonsei Univ, Grad Sch, Dept Psychiat, Seoul 120749, South Korea; [Kim, Wonji] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Kang, Jee In; Namkoong, Kee; Kim, Se Joo] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kang, Jee In; Namkoong, Kee; Kim, Se Joo] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea	Yonsei University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea.	kimsejoo@yuhs.ac		NAMKOONG, KEE/0000-0003-1400-8057; kang, jee in/0000-0002-2818-7183; KIM, SE JOO/0000-0002-5438-8210	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0022363]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by a grant (to S. J. Kim) from the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0022363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bakermans-Kranenburg MJ, 2014, PSYCHIAT GENET, V24, P45, DOI 10.1097/YPG.0b013e3283643684; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Berthoz S, 2005, EUR PSYCHIAT, V20, P291, DOI 10.1016/j.eurpsy.2004.06.013; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; Brune M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-38; Cochran DM, 2013, HARVARD REV PSYCHIAT, V21, P219, DOI 10.1097/HRP.0b013e3182a75b7d; Constantinou E, 2014, BIOL PSYCHOL, V103, P212, DOI 10.1016/j.biopsycho.2014.09.011; De Berardis D, 2005, EUR ARCH PSY CLIN N, V255, P350, DOI 10.1007/s00406-005-0573-y; Domes G, 2007, BIOL PSYCHIAT, V62, P1187, DOI 10.1016/j.biopsych.2007.03.025; FeldmanHall O, 2013, CORTEX, V49, P899, DOI 10.1016/j.cortex.2012.10.015; First M.B., 2014, STRUCTURED CLIN INTE; Goodman W, 1991, VERHALTENSTHERAPIE, V1, P226; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Haviland MG, 2004, J PERS ASSESS, V82, P306, DOI 10.1207/s15327752jpa8203_06; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Jorgensen MM, 2007, PSYCHOTHER PSYCHOSOM, V76, P369, DOI 10.1159/000107565; Kang JI, 2012, J AFFECT DISORDERS, V141, P286, DOI 10.1016/j.jad.2012.04.001; Kano M, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-1; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Kogan A, 2011, P NATL ACAD SCI USA, V108, P19189, DOI 10.1073/pnas.1112658108; Krueger F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00004; Kumsta R, 2013, CURR OPIN NEUROBIOL, V23, P11, DOI 10.1016/j.conb.2012.09.004; Lane A, 2013, INT J PSYCHOL, V48, P676, DOI 10.1080/00207594.2012.677540; Laursen HR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00423; Lee JK, 2003, J HUM GENET, V48, P213, DOI 10.1007/s10038-003-0011-9; LEE YH, 1996, J KOREAN NEUROPSYCHI, V35, P888; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; Liu XX, 2010, J HUM GENET, V55, P137, DOI 10.1038/jhg.2009.140; LoParo D, 2015, MOL PSYCHIATR, V20, P640, DOI 10.1038/mp.2014.77; Luminet O, 2011, BIOL PSYCHOL, V87, P401, DOI 10.1016/j.biopsycho.2011.05.005; McQuaid RJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00128; Melchers M, 2013, BEHAV NEUROSCI, V127, P780, DOI 10.1037/a0033748; Montag C, 2011, BIOL PSYCHIAT, V69, P601, DOI 10.1016/j.biopsych.2010.10.026; Montag C, 2013, WORLD J BIOL PSYCHIA, V14, P500, DOI 10.3109/15622975.2012.677547; Montag C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051882; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Nyffeler Johanna, 2014, J Mol Psychiatry, V2, P1, DOI 10.1186/2049-9256-2-1; Park J, 2010, PROG NEURO-PSYCHOPH, V34, P697, DOI 10.1016/j.pnpbp.2010.03.029; Picardi A, 2011, J PSYCHOSOM RES, V71, P256, DOI 10.1016/j.jpsychores.2011.02.016; Poulin MJ, 2012, PSYCHOL SCI, V23, P446, DOI 10.1177/0956797611428471; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Roh D, 2011, J NERV MENT DIS, V199, P690, DOI 10.1097/NMD.0b013e318229d209; Rushton JP, 2004, P ROY SOC B-BIOL SCI, V271, P2583, DOI 10.1098/rspb.2004.2941; RUSHTON JP, 1984, ACTA GENET MED GEMEL, V33, P265, DOI 10.1017/S0001566000007315; Samur D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00861; Sayar K, 2001, ISRAEL J PSYCHIAT, V38, P81; Seo SS, 2009, PSYCHIAT INVEST, V6, P173, DOI 10.4306/pi.2009.6.3.173; Tansey KE, 2010, NEUROSCI LETT, V474, P163, DOI 10.1016/j.neulet.2010.03.035; Taylor GJ, 2000, CAN J PSYCHIAT, V45, P134, DOI 10.1177/070674370004500203; Taylor GJ, 1997, DISORDERS AFFECT REG, Vxxii; Tost H, 2011, BIOL PSYCHIAT, V70, pE37, DOI 10.1016/j.biopsych.2011.06.034; Uzefovsky F, 2015, HORM BEHAV, V67, P60, DOI 10.1016/j.yhbeh.2014.11.007; van der Velde J, 2013, NEUROSCI BIOBEHAV R, V37, P1774, DOI 10.1016/j.neubiorev.2013.07.008; Wermter AK, 2010, AM J MED GENET B, V153B, P629, DOI 10.1002/ajmg.b.31032; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013	61	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143168	10.1371/journal.pone.0143168	http://dx.doi.org/10.1371/journal.pone.0143168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599592	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900071
J	Lu, L; Guo, J; Li, SF; Li, A; Zhang, LY; Liu, ZH; Luo, XG				Lu, Lin; Guo, Jiang; Li, Sufen; Li, Ang; Zhang, Liyang; Liu, Zhenhua; Luo, Xugang			Influence of Phytase Transgenic Corn on the Intestinal Microflora and the Fate of Transgenic DNA and Protein in Digesta and Tissues of Broilers	PLOS ONE			English	Article							ENDOGENOUS PLANT DNA; LAYING HENS; GASTROINTESTINAL-TRACT; POLYACRYLAMIDE-GELS; FEED; GENE; SUPPLEMENTATION; AVAILABILITY; DEGRADATION; PERFORMANCE	An experiment was conducted to investigate the effect of phytase transgenic corn (PTC) on intestinal microflora, and the fate of transgenic DNA and protein in the digesta and tissues of broilers. A total of 160 1-day-old Arbor Acres commercial male broilers were randomly assigned to 20 cages (8 chicks per cage) with 10 cages (replicates) for each treatment. Birds were fed with a diet containing either PTC (54.0% during 1-21 days and 61.0% during 22-42 days) or non-transgenic isogenic control corn (CC) for a duration of 42 days. There were no significant differences (P>0.05) between birds fed with the PTC diets and those fed with the CC diets in the quantities of aerobic bacteria, anaerobic bacteria, colibacillus and lactobacilli, or microbial diversities in the contents of ileum and cecum. Transgenic phyA2 DNA was not detected, but phyA2 protein was detected in the digesta of duodenum and jejunum of broilers fed with the PTC diets. Both transgenic phyA2 DNA and protein fragments were not found in the digesta of the ileum and rectum, heart, liver, kidney, and breast or thigh muscles of broilers fed with the PTC diets. It was concluded that PTC had no adverse effect on the quantity and diversity of gut microorganisms; Transgenic phyA2 DNA or protein was rapidly degraded in the intestinal tract and was not transferred to the tissues of broilers.	[Lu, Lin; Guo, Jiang; Zhang, Liyang; Luo, Xugang] Chinese Acad Agr Sci, Inst Anim Sci, Mineral Nutr Res Div, Beijing 100193, Peoples R China; [Guo, Jiang; Li, Ang] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Peoples R China; [Li, Sufen] Hebei Normal Univ Sci & Technol, Dept Anim Sci, Qinhuangdao, Peoples R China; [Liu, Zhenhua] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Nutr, Amherst, MA 01003 USA	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Fujian Agriculture & Forestry University; Hebei Normal University of Science & Technology; University of Massachusetts System; University of Massachusetts Amherst	Luo, XG (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Mineral Nutr Res Div, Beijing 100193, Peoples R China.	wlysz@263.net			Genetically Modified Organisms Breeding Major Projects (Beijing, P. R. China) [2009ZX08011-005B]; Agricultural Science and Technology Innovation Program (Beijing, P. R. China) [ASTIP-IAS08]; China Agriculture Research System (Beijing, P. R. China) [CARS-42]	Genetically Modified Organisms Breeding Major Projects (Beijing, P. R. China); Agricultural Science and Technology Innovation Program (Beijing, P. R. China); China Agriculture Research System (Beijing, P. R. China)	This work was supported by the Genetically Modified Organisms Breeding Major Projects (project No. 2009ZX08011-005B; Beijing, P. R. China), the Agricultural Science and Technology Innovation Program (ASTIP-IAS08; Beijing, P. R. China), and China Agriculture Research System (project No. CARS-42; Beijing, P. R. China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson PH, 1999, SCIENCE, V283, P2015, DOI 10.1126/science.283.5410.2015; Ash J, 2003, J APPL POULTRY RES, V12, P242, DOI 10.1093/japr/12.2.242; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bassam BJ, 2007, NAT PROTOC, V2, P2649, DOI 10.1038/nprot.2007.330; Bertoni G, 2005, VET RES COMMUN, V29, P13, DOI 10.1007/s11259-005-0004-6; Chambers PA, 2002, J ANTIMICROB CHEMOTH, V49, P161, DOI 10.1093/jac/49.1.161; Chen RM, 2008, TRANSGENIC RES, V17, P633, DOI 10.1007/s11248-007-9138-3; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; Chrastinova L, 2002, P SOC NUTR PHYSL, V11, P195; Denbow DM, 1998, POULTRY SCI, V77, P878, DOI 10.1093/ps/77.6.878; Du H, 2006, AGR SCI; Engelen AJ, 2001, J AOAC INT, V84, P629; Gao CQ, 2013, POULTRY SCI, V92, P2923, DOI 10.3382/ps.2013-03226; Gao CQ, 2012, POULTRY SCI, V91, P1142, DOI 10.3382/ps.2011-01915; Gaskins HR, 1997, GASTROINTESTINAL MIC, V2; Guertler P, 2010, LIVEST SCI, V131, P250, DOI 10.1016/j.livsci.2010.04.010; Jennings JC, 2003, J ANIM SCI, V81, P1447; Jennings JC, 2003, POULTRY SCI, V82, P371, DOI 10.1093/ps/82.3.371; Leske KL, 1999, POULTRY SCI, V78, P1151, DOI 10.1093/ps/78.8.1151; Li SF, 2013, J ANIM SCI, V91, P298, DOI 10.2527/jas.2012-5211; Liu J., 2012, AM J MOL BIOL, V2, P217; Lu L, 2013, ANIM PROD SCI, V53, P142, DOI 10.1071/AN12123; Lu L, 2010, BIOL TRACE ELEM RES, V138, P181, DOI 10.1007/s12011-010-8623-3; Ma QG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061138; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; National Research Council, 1994, NUTR REQ POULTR; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Netherwood T, 2004, NAT BIOTECHNOL, V22, P204, DOI 10.1038/nbt934; Nyannor EKD, 2009, POULTRY SCI, V88, P1413, DOI 10.3382/ps.2009-00003; Onyango EM, 2005, POULTRY SCI, V84, P248, DOI 10.1093/ps/84.2.248; PEELER HT, 1972, J ANIM SCI, V35, P695; REDDY NR, 1982, ADV FOOD RES, V28, P1; Reid CA, 1999, ANIM SCI, V68, P503, DOI 10.1017/S1357729800050529; Sanden M, 2004, AQUACULTURE, V237, P391, DOI 10.1016/j.aquaculture.2004.04.004; SAVORY CJ, 1992, BRIT J NUTR, V67, P91, DOI 10.1079/BJN19920011; Schubbert R, 1997, P NATL ACAD SCI USA, V94, P961, DOI 10.1073/pnas.94.3.961; Scott M. L., 1982, NUTR CHICKEN, V3rd; Tony MA, 2003, ARCH ANIM NUTR, V57, P235, DOI 10.1080/00039420310001594397; Walsh MC, 2013, BRIT J NUTR, V109, P873, DOI 10.1017/S0007114512002607; Xu ZR, 2003, POULTRY SCI, V82, P1030, DOI 10.1093/ps/82.6.1030; Zhang ZB, 2000, J ANIM SCI, V78, P2868; [赵康宁 Zhao Kangning], 2012, [南京农业大学学报, Journal of Nanjing Agricultural University], V35, P118	43	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143408	10.1371/journal.pone.0143408	http://dx.doi.org/10.1371/journal.pone.0143408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599444	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900112
J	Preussel, K; Milde-Busch, A; Schmich, P; Wetzstein, M; Stark, K; Werber, D				Preussel, Karina; Milde-Busch, Astrid; Schmich, Patrick; Wetzstein, Matthias; Stark, Klaus; Werber, Dirk			Risk Factors for Sporadic Non-Pregnancy Associated Listeriosis in Germany-Immunocompromised Patients and Frequently Consumed Ready-To-Eat Products	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; MONOCYTOGENES INFECTION; SOCIOECONOMIC-STATUS; PASTEURIZED MILK; UNITED-STATES; FOOD; CHEESE; OUTBREAK; SUSCEPTIBILITY; CONTAMINATION	Non-pregnancy associated (N-PA) listeriosis, caused by Listeria monocytogenes, is a rare but severe disease, and is predominantly food-borne. Most cases appear sporadic and their infection vehicle remains unknown. Incidence has increased since 2008 in Germany. We aimed to identify underlying conditions and foods associated with sporadic N-PA listeriosis in Germany. We performed a nationwide case-control study from March 2012-December 2013. Cases were sporadic N-PA listeriosis patients notified to public health. Control subjects were age (40-65 years, 66-75 years, >= 76 years) frequency-matched persons from a nationwide random telephone sample. A structured questionnaire collected information on underlying diseases, therapies and > 60 food items. We conducted multivariable logistic regression analysis, adjusting for host factors identified by causal diagram theory, and calculated population attributable fractions. We enrolled 109 cases and 1982 controls. Cases' median age was 69 years, 55% were male, 44% received immunosuppressive therapy within 3 months prior to illness onset; a further 28% had at least one immunocompromising disease. In multivariable analysis, immunosuppressive therapy (OR 8.8, 95%CI 4.9-15.6), immunocompromising disease (OR 2.7; 95% CI 1.4-5.2), gastric acid suppression (OR 3.0; 95%CI 1.4-6.3), the consumption of cold cooked sausages (OR 2.6; 95% CI 1.6-4.4), the preferred consumption of packaged cheese (OR 2.1; 95%CI 1.3-3.5) and pre-sliced cheese (OR 2.2; 95%CI 1.3-3.7) were significantly associated with N-PA listeriosis. These foods accounted for 59% of all cases. Typical high risk foods, e.g. cold seafood, certain types of cheeses, tended to be negatively associated with disease. In conclusion, immunosuppressive therapy and frequently consumed ready-to-eat foods are the main risk factors for sporadic N-PA listeriosis in Germany. To reduce their risk, immunocompromised persons should consume the identified foods well before the `use-by' date. The microbiological criteria for Listeria monocytogenes in ready-to-eat foods may insufficiently protect persons who are markedly immunocompromised.	[Preussel, Karina; Milde-Busch, Astrid; Stark, Klaus; Werber, Dirk] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Schmich, Patrick; Wetzstein, Matthias] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Preussel, K (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	preusselk@rki.de	Werber, Dirk/L-2264-2019	Werber, Dirk/0000-0002-8076-788X				Ahrens D, 2012, INT J CLIN PRACT, V66, P767, DOI 10.1111/j.1742-1241.2012.02973.x; [Anonymous], 2013, MILCH MARKETING, P16; Bavarian Consumer Organisation, 2013, MARK CHECK UP SELF L; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; BOHNSACK JF, 1986, ANNU REV MED, V37, P49, DOI 10.1146/annurev.me.37.020186.000405; Cartwright EJ, 2013, EMERG INFECT DIS, V19, P1, DOI [10.3201/eid1901.120393, 10.3201/eid1908.121511]; Dalton CB, 2011, EPIDEMIOL INFECT, V139, P437, DOI 10.1017/S0950268810000944; DEMARIE S, 1993, EUR J CLIN MICROBIOL, V12, P36; FDA/FSIS (U.S. Food and Drug Administration/Food Safety and Inspection Service), 2003, QUANT ASS REL RISK P; Friesema IH, 2015, EURO SURVEILL, V20; Fuchs J, 2012, BUNDESGESUNDHEITSBLA, V55, P576, DOI 10.1007/s00103-012-1464-9; Gan YH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003794; Gillespie IA, 2010, FOODBORNE PATHOG DIS, V7, P1373, DOI 10.1089/fpd.2010.0568; GLASS KA, 1989, APPL ENVIRON MICROB, V55, P1565, DOI 10.1128/AEM.55.6.1565-1569.1989; Gomez CR, 2005, CURR OPIN IMMUNOL, V17, P457, DOI 10.1016/j.coi.2005.07.013; Gould LH, 2014, FOODBORNE PATHOG DIS, V11, P545, DOI 10.1089/fpd.2013.1650; Goulet V, 1996, SCAND J INFECT DIS, V28, P367, DOI 10.3109/00365549609037921; Goulet V, 2012, CLIN INFECT DIS, V54, P652, DOI 10.1093/cid/cir902; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hader S., 1998, TELEFONSTICHPROBEN D, P69, DOI [DOI 10.1007/978-3-322-83334-1_6, 10.1007/978-3-322-83334-1_6]; Hartung M, 2012, ZOONOTIC PATHOGENS G; HO JL, 1986, ARCH INTERN MED, V146, P520, DOI 10.1001/archinte.146.3.520; Hoffmann F, 2015, Z GASTROENTEROL, V53, P95, DOI 10.1055/s-0034-1384973; Hulshof KFAM, 2003, EUR J CLIN NUTR, V57, P128, DOI 10.1038/sj.ejcn.1601503; JENSEN A, 1994, SCAND J INFECT DIS, V26, P171, DOI 10.3109/00365549409011781; Johansson T, 1999, INT J FOOD MICROBIOL, V47, P111, DOI 10.1016/S0168-1605(99)00019-7; Jungjohann SM, 2005, BRIT J NUTR, V93, P361, DOI 10.1079/BJN20041333; Koch J, 2010, FOODBORNE PATHOG DIS, V7, P1581, DOI 10.1089/fpd.2010.0631; Koscielska-Kasprzak K, 2014, ARCH IMMUNOL THER EX, V62, P47, DOI 10.1007/s00005-013-0254-x; Kousta M, 2010, FOOD CONTROL, V21, P805, DOI 10.1016/j.foodcont.2009.11.015; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P814, DOI 10.1007/s00103-013-1695-4; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P131, DOI 10.1007/s00103-012-1583-3; Little CL, 2008, FOOD MICROBIOL, V25, P304, DOI 10.1016/j.fm.2007.10.007; Max Rubner Institute, 2008, NAT FOOD CONS SURV 2; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miettinen MK, 1999, J CLIN MICROBIOL, V37, P2358, DOI 10.1128/JCM.37.7.2358-2360.1999; Mook P, 2013, EPIDEMIOL INFECT, V141, P36, DOI 10.1017/S095026881200026X; Mook P, 2011, EMERG INFECT DIS, V17, P38, DOI 10.3201/eid1701.101174; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Nocon M, 2006, ALIMENT PHARM THER, V23, P1601, DOI 10.1111/j.1365-2036.2006.02924.x; Norton DM, 2001, APPL ENVIRON MICROB, V67, P646, DOI 10.1128/AEM.67.2.646-653.2001; Pal A, 2009, J FOOD PROTECT, V72, P1878, DOI 10.4315/0362-028X-72.9.1878; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pouillot R, 2012, CLIN INFECT DIS, V54, pS405, DOI 10.1093/cid/cis269; Roche SM, 2003, INFECT IMMUN, V71, P3429, DOI 10.1128/IAI.71.6.3429-3436.2003; SCHLECH WF, 1993, INT J FOOD MICROBIOL, V18, P15, DOI 10.1016/0168-1605(93)90003-Y; Sheen S, 2008, FOODBORNE PATHOG DIS, V5, P135, DOI 10.1089/fpd.2007.0049; Sheth K, 2001, Curr Opin Crit Care, V7, P99, DOI 10.1097/00075198-200104000-00008; Silk BJ, 2013, MMWR-MORBID MORTAL W, V62, P448, DOI 10.1016/j.annemergmed.2013.08.006; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Van Boxel OS, 2009, ALIMENT PHARM THER, V29, P571, DOI 10.1111/j.1365-2036.2008.03900.x; Varma JK, 2007, CLIN INFECT DIS, V44, P521, DOI 10.1086/509920; Voigt LF, 2003, AM J EPIDEMIOL, V157, P66, DOI 10.1093/aje/kwf185; WALKER SJ, 1990, J APPL BACTERIOL, V68, P157, DOI 10.1111/j.1365-2672.1990.tb02561.x; Wallace FM, 2003, J FOOD PROTECT, V66, P584, DOI 10.4315/0362-028X-66.4.584; WENGER JD, 1990, J FOOD PROTECT, V53, P1015, DOI 10.4315/0362-028X-53.12.1015; Werber D, 2013, EPIDEMIOL INFECT, V141, P961, DOI 10.1017/S0950268812001550; Whitley E, 2000, J APPL MICROBIOL, V88, P52, DOI 10.1046/j.1365-2672.2000.00859.x; Yde M, 2012, EURO SURVEILL, V17; Yeretssian G, 2009, P NATL ACAD SCI USA, V106, P9016, DOI 10.1073/pnas.0813362106	61	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142986	10.1371/journal.pone.0142986	http://dx.doi.org/10.1371/journal.pone.0142986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599484	Green Published, gold			2022-12-26	WOS:000365853900052
J	Peskin, AV; Pace, PE; Behring, JB; Paton, LN; Soethoudt, M; Bachschmid, MM; Winterbourn, CC				Peskin, Alexander V.; Pace, Paul E.; Behring, Jessica B.; Paton, Louise N.; Soethoudt, Marjolein; Bachschmid, Markus M.; Winterbourn, Christine C.			Glutathionylation of the Active Site Cysteines of Peroxiredoxin 2 and Recycling by Glutaredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; MAMMALIAN PEROXIREDOXIN; THIOREDOXIN REDUCTASE; 2-CYS PEROXIREDOXIN; OXIDATIVE STRESS; MECHANISMS; DISULFIDE; HYPEROXIDATION; SIGNAL; GENE	Peroxiredoxin 2 (Prx2) is a thiol protein that functions as an antioxidant, regulator of cellular peroxide concentrations, and sensor of redox signals. Its redox cycle is widely accepted to involve oxidation by a peroxide and reduction by thioredoxin/thioredoxin reductase. Interactions of Prx2 with other thiols are not well characterized. Here we show that the active site Cys residues of Prx2 form stable mixed disulfides with glutathione (GSH). Glutathionylation was reversed by glutaredoxin 1 (Grx1), and GSH plus Grx1 was able to support the peroxidase activity of Prx2. Prx2 became glutathionylated when its disulfide was incubated with GSH and when the reduced protein was treated with H2O2 and GSH. The latter reaction occurred via the sulfenic acid, which reacted sufficiently rapidly (k = 500 M-1 s(-1)) for physiological concentrations of GSH to inhibit Prx disulfide formation and protect against hyperoxidation to the sulfinic acid. Glutathionylated Prx2 was detected in erythrocytes from Grx1 knock-out mice after peroxide challenge. We conclude that Prx2 glutathionylation is a favorable reaction that can occur in cells under oxidative stress and may have a role in redox signaling. GSH/Grx1 provide an alternative mechanism to thioredoxin and thioredoxin reductase for Prx2 recycling.	[Peskin, Alexander V.; Pace, Paul E.; Paton, Louise N.; Soethoudt, Marjolein; Winterbourn, Christine C.] Univ Otago, Ctr Free Radical Res, Christchurch 8140, New Zealand; [Behring, Jessica B.; Bachschmid, Markus M.] Boston Univ Sch Med, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect,Dept Med, Boston, MA 02118 USA; [Behring, Jessica B.; Bachschmid, Markus M.] Boston Univ Sch Med, Sch Med, Whitaker Cardiovasc Inst, Cardiovasc Prote Ctr,Dept Med, Boston, MA 02118 USA	University of Otago; Boston University; Boston University	Winterbourn, CC (corresponding author), Univ Otago, Dept Pathol, POB 4345, Christchurch 8140, New Zealand.	christine.winterbourn@otago.ac.nz	Pace, Paul E/A-3104-2012; Peskin, alexander/R-6457-2019	Pace, Paul E/0000-0003-1855-5760; Paton, Louise N/0000-0002-7055-5170; peskin, alexander/0000-0001-9890-6043; Bachschmid, Markus Michael/0000-0002-0748-5528	Health Research Council of New Zealand; NHLBI, National Institutes of Health, Department of Health and Human Services [HHSN268201000031C]; National Institutes of Health [PO1 HL068758, R01 DK103750, R37 HL104017]; American Heart Association Grant [16GRNT27660006]; National Institutes of Health Training Grant [T32 HL007501]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758, R37HL104017, T32HL007501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103750] Funding Source: NIH RePORTER	Health Research Council of New Zealand(Health Research Council of New Zealand); NHLBI, National Institutes of Health, Department of Health and Human Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant(American Heart Association); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Health Research Council of New Zealand; the NHLBI, National Institutes of Health, Department of Health and Human Services, under Contract HHSN268201000031C; National Institutes of Health Grants PO1 HL068758, R01 DK103750, and R37 HL104017; American Heart Association Grant 16GRNT27660006; and National Institutes of Health Training Grant T32 HL007501 (to J.B.). The authors have no conflicts of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Checconi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127086; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Du YT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392225; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Harwood DT, 2009, J CHROMATOGR B, V877, P3393, DOI 10.1016/j.jchromb.2009.04.018; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Karplus PA, 2015, FREE RADICAL BIO MED, V80, P183, DOI 10.1016/j.freeradbiomed.2014.10.009; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Nagy P., 2010, ADV MOL TOXICOLOGY, P183, DOI DOI 10.1016/S0012-821X(03)00488-6; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Pace PE, 2013, BIOCHEM J, V453, P475, DOI 10.1042/BJ20130030; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; Park JW, 2009, J BIOL CHEM, V284, P23364, DOI 10.1074/jbc.M109.021394; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Randall LM, 2013, METHOD ENZYMOL, V527, P41, DOI 10.1016/B978-0-12-405882-8.00003-9; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Seo JH, 2009, J BIOL CHEM, V284, P13455, DOI 10.1074/jbc.M900641200; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2015, NAT CHEM BIOL, V11, P5, DOI 10.1038/nchembio.1722; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Zhang HH, 2014, ANTIOXID REDOX SIGN, V21, P669, DOI 10.1089/ars.2013.5499	40	75	76	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3053	3062		10.1074/jbc.M115.692798	http://dx.doi.org/10.1074/jbc.M115.692798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26601956	hybrid, Green Published			2022-12-26	WOS:000369626900041
J	Cardoso, BA; Belo, H; Barata, JT; Almeida, AM				Cardoso, Bruno A.; Belo, Helio; Barata, Joao T.; Almeida, Antonio M.			The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HISTONE-DEACETYLASE INHIBITOR; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; PROGENITOR CELLS; STEM-CELL; PRIMARY MYELOFIBROSIS; PHASE-II; MUTATION	The classical BCR-ABL-negative Myeloproliferative Neoplasms (MPN) are a group of heterogeneous haematological diseases characterized by constitutive JAK-STAT pathway activation. Targeted therapy with Ruxolitinib, a JAK1/2-specific inhibitor, achieves symptomatic improvement but does not eliminate the neoplastic clone. Similar effects are seen with histone deacetylase inhibitors (HDACi), albeit with poorer tolerance. Here, we show that bone marrow (BM) stromal cells (HS-5) protected MPN-derived cell lines (SET-2; HEL and UKE-1) and MPN patient-derived BM cells from the cytotoxic effects of Ruxolitinib and the HDACi Vorinostat. This protective effect was mediated, at least in part, by the secretion of soluble factors from the BM stroma. In addition, it correlated with the activation of signalling pathways important for cellular homeostasis, such as JAK-STAT, PI3K, JNK, MEK-ERK and NF-kappa B. Importantly, the pharmacological inhibition of JNK and PI3K pathways completely abrogated the BM protective effect on MPN cell lines and MPN patient samples. Our findings shed light on mechanisms of tumour survival and may indicate novel therapeutic approaches for the treatment of MPN.	[Cardoso, Bruno A.; Belo, Helio; Almeida, Antonio M.] EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Unidade Invest Patobiol Mol, Lisbon, Portugal; [Cardoso, Bruno A.; Belo, Helio; Almeida, Antonio M.] Univ Nova Lisboa, Fac Ciencias Med, Sch Med, Ctr Estudos Doencas Cron,CEDOC,NOVA, P-1200 Lisbon, Portugal; [Barata, Joao T.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa	Almeida, AM (corresponding author), EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Unidade Invest Patobiol Mol, Lisbon, Portugal.	amalmeida@ipolisboa.min-saude.pt	Barata, João T./D-9181-2015	Barata, João T./0000-0002-4826-8976; Cardoso, Bruno/0000-0002-6521-7257; Almeida, Antonio/0000-0003-4361-0928	"Instituto Portugues de Oncologia de Lisboa-Francisco Gentil" (IPOL-FG); "Associacao Portuguesa Contra a Leucemia" (APCL); "Liga Portuguesa Contra o Cancro" (LPCC); Fundacao para a Ciencia e Tecnologia [FCT-SFRH/BPD/79209/2011]; LPCC	"Instituto Portugues de Oncologia de Lisboa-Francisco Gentil" (IPOL-FG); "Associacao Portuguesa Contra a Leucemia" (APCL); "Liga Portuguesa Contra o Cancro" (LPCC); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); LPCC	This study was funded by research grants from "Instituto Portugues de Oncologia de Lisboa-Francisco Gentil" (IPOL-FG), "Associacao Portuguesa Contra a Leucemia" (APCL) and "Liga Portuguesa Contra o Cancro" (LPCC). BAC is a recipient of a Post-Doc fellowship from "Fundacao para a Ciencia e Tecnologia" (FCT-SFRH/BPD/79209/2011) and HB from LPCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Akada H, 2012, BLOOD, V119, P3779, DOI 10.1182/blood-2011-02-336743; Andersen CL, 2013, BRIT J HAEMATOL, V162, P498, DOI 10.1111/bjh.12416; Barata JT, 2005, LEUKEMIA LYMPHOMA, V46, P483, DOI 10.1080/10428190400027852; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Cardoso BA, 2011, LEUKEMIA, V25, P1578, DOI 10.1038/leu.2011.140; Chen P., 2014, MOL CARCINOG; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; DeAngelo DJ, 2013, BRIT J HAEMATOL, V162, P326, DOI 10.1111/bjh.12384; FIALKOW PJ, 1981, BLOOD, V58, P916; Fiedler W, 2000, CANCER-AM CANCER SOC, V88, P344, DOI 10.1002/(SICI)1097-0142(20000115)88:2<344::AID-CNCR14>3.0.CO;2-6; Fiskus W, 2013, MOL CANCER THER, V12, P577, DOI 10.1158/1535-7163.MCT-12-0862; HARIGAYA K, 1985, P NATL ACAD SCI USA, V82, P3477, DOI 10.1073/pnas.82.10.3477; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Hoermann G, 2012, FASEB J, V26, P894, DOI 10.1096/fj.11-193078; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lataillade JJ, 2008, BLOOD, V112, P3026, DOI 10.1182/blood-2008-06-158386; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lin CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118473; Manshouri T, 2011, CANCER RES, V71, P3831, DOI 10.1158/0008-5472.CAN-10-4002; Mascarenhas J, 2012, CLIN CANCER RES, V18, P3008, DOI 10.1158/1078-0432.CCR-11-3145; Mascarenhas JO, 2014, BLOOD REV, V28, P189, DOI 10.1016/j.blre.2014.06.002; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Miller AL, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-3; Moura-Alves P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019829; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Pandey R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0388-z; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Rambaldi A, 2010, BRIT J HAEMATOL, V150, P446, DOI 10.1111/j.1365-2141.2010.08266.x; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Shi JG, 2011, J CLIN PHARMACOL, V51, P1644, DOI 10.1177/0091270010389469; Shulak L, 2014, J VIROL, V88, P2927, DOI 10.1128/JVI.03406-13; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053766; Smith JNP, 2013, STEM CELLS, V31, P1044, DOI 10.1002/stem.1370; Tesfai Y, 2012, LEUKEMIA RES, V36, P299, DOI 10.1016/j.leukres.2011.08.001; Uozumi K, 2000, LEUKEMIA, V14, P142, DOI 10.1038/sj.leu.2401608; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Vannucchi AM, 2009, CA-CANCER J CLIN, V59, P171, DOI 10.3322/caac.20009; Verstovsek S, 2014, CANCER-AM CANCER SOC, V120, P513, DOI 10.1002/cncr.28441; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Wandzioch E, 2004, BLOOD, V104, P51, DOI 10.1182/blood-2003-07-2554; Weisberg E, 2012, LEUKEMIA, V26, P2233, DOI 10.1038/leu.2012.96; Weisberg E, 2008, MOL CANCER THER, V7, P1121, DOI 10.1158/1535-7163.MCT-07-2331; Weisberg E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056473; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; You H, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.26845; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zhang B, 2013, BLOOD, V121, P1824, DOI 10.1182/blood-2012-02-412890; Zhang YH, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-282	57	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143897	10.1371/journal.pone.0143897	http://dx.doi.org/10.1371/journal.pone.0143897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26623653	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600072
J	Dixon, SD; Huynh, MM; Tamilselvam, B; Spiegelman, LM; Son, SB; Eshraghi, A; Blanke, SR; Bradley, KA				Dixon, Shandee D.; Huynh, Melanie M.; Tamilselvam, Batcha; Spiegelman, Lindsey M.; Son, Sophia B.; Eshraghi, Aria; Blanke, Steven R.; Bradley, Kenneth A.			Distinct Roles for CdtA and CdtC during Intoxication by Cytolethal Distending Toxins	PLOS ONE			English	Article							CELL-CYCLE ARREST; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; HAEMOPHILUS-DUCREYI; CAMPYLOBACTER-JEJUNI; HELICOBACTER-HEPATICUS; HELA-CELLS; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; BACTERIAL TOXIN; DNA-DAMAGE; HOST-CELLS	Cytolethal distending toxins (CDTs) are heterotrimeric protein exotoxins produced by a diverse array of Gram-negative pathogens. The enzymatic subunit, CdtB, possesses DNase and phosphatidylinositol 3-4-5 trisphosphate phosphatase activities that induce host cell cycle arrest, cellular distension and apoptosis. To exert cyclomodulatory and cytotoxic effects CDTs must be taken up from the host cell surface and transported intracellularly in a manner that ultimately results in localization of CdtB to the nucleus. However, the molecular details and mechanism by which CDTs bind to host cells and exploit existing uptake and transport pathways to gain access to the nucleus are poorly understood. Here, we report that CdtA and CdtC subunits of CDTs derived from Haemophilus ducreyi (Hd-CDT) and enteropathogenic E. coli (Ec-CDT) are independently sufficient to support intoxication by their respective CdtB subunits. CdtA supported CdtB-mediated killing of T-cells and epithelial cells that was nearly as efficient as that observed with holotoxin. In contrast, the efficiency by which CdtC supported intoxication was dependent on the source of the toxin as well as the target cell type. Further, CdtC was found to alter the subcellular trafficking of Ec-CDT as determined by sensitivity to EGA, an inhibitor of endosomal trafficking, colocalization with markers of early and late endosomes, and the kinetics of DNA damage response. Finally, host cellular cholesterol was found to influence sensitivity to intoxication mediated by Ec-CdtA, revealing a role for cholesterol or cholesterol-rich membrane domains in intoxication mediated by this subunit. In summary, data presented here support a model in which CdtA and CdtC each bind distinct receptors on host cell surfaces that direct alternate intracellular uptake and/or trafficking pathways.	[Dixon, Shandee D.; Huynh, Melanie M.; Spiegelman, Lindsey M.; Eshraghi, Aria; Bradley, Kenneth A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Tamilselvam, Batcha; Son, Sophia B.; Blanke, Steven R.] Univ Illinois, Dept Microbiol, Inst Genom Biol, Urbana, IL 61801 USA; [Bradley, Kenneth A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Los Angeles	Bradley, KA (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	kbradley@microbio.ucla.edu	Tamilselvam, Batcha/A-8212-2010	Tamilselvam, Batcha/0000-0001-9241-3846	U.S. National Institutes of Health [GM098756]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098756] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institutes of Health through grant number GM098756. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akifusa S, 2005, MICROBIOL-SGM, V151, P1395, DOI 10.1099/mic.0.27671-0; Akifusa S, 2001, INFECT IMMUN, V69, P5925, DOI 10.1128/IAI.69.9.5925-5930.2001; BAG PK, 1993, FEMS MICROBIOL LETT, V114, P285, DOI 10.1111/j.1574-6968.1993.tb06587.x; Boesze-Battaglia K, 2006, CELL MICROBIOL, V8, P823, DOI 10.1111/j.1462-5822.2005.00669.x; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cao L, 2005, MOL MICROBIOL, V58, P1303, DOI 10.1111/j.1365-2958.2005.04905.x; Cao L, 2008, INFECT IMMUN, V76, P2812, DOI 10.1128/IAI.00126-08; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cortes-Bratti X, 2000, INFECT IMMUN, V68, P6903, DOI 10.1128/IAI.68.12.6903-6911.2000; Damek-Poprawa M, 2012, INFECT IMMUN, V80, P2761, DOI 10.1128/IAI.00385-12; De Rycke J, 2000, EUR J CELL BIOL, V79, P192, DOI 10.1078/S0171-9335(04)70022-9; Deng KP, 2003, INFECT IMMUN, V71, P6633, DOI 10.1128/IAI.71.11.6633-6640.2003; Deng KP, 2001, BIOCHEM BIOPH RES CO, V285, P609, DOI 10.1006/bbrc.2001.5223; DiRienzo JM, 2014, CELLS-BASEL, V3, P476, DOI 10.3390/cells3020476; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Eshraghi A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004295; Eshraghi A, 2010, J BIOL CHEM, V285, P18199, DOI 10.1074/jbc.M110.112912; Fox JG, 2004, INFECT IMMUN, V72, P1116, DOI 10.1128/IAI.72.2.1116-1125.2004; Frisk A, 2001, MICROB PATHOGENESIS, V30, P313, DOI 10.1006/mpat.2000.0436; Gargi A, 2013, THE JOURNAL OF BIOLO; Gargi A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00124; Ge ZM, 2008, CELL MICROBIOL, V10, P1599, DOI 10.1111/j.1462-5822.2008.01173.x; Ge ZM, 2005, INFECT IMMUN, V73, P3559, DOI 10.1128/IAI.73.6.3559-3567.2005; Gelfanova V, 1999, INFECT IMMUN, V67, P6394; Gillespie EJ, 2013, P NATL ACAD SCI USA, V110, pE4904, DOI 10.1073/pnas.1302334110; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Guidi R, 2013, CELL MICROBIOL, V15, P98, DOI 10.1111/cmi.12034; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; Lai CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066202; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2002, TRENDS MICROBIOL, V10, P147, DOI 10.1016/S0966-842X(02)02316-8; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lee RB, 2003, INFECT IMMUN, V71, P4883, DOI 10.1128/IAI.71.9.4883-4890.2003; Lewis DA, 2001, INFECT IMMUN, V69, P5626, DOI 10.1128/IAI.69.9.5626-5634.2001; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065729; Lin CD, 2011, INFECT IMMUN, V79, P3563, DOI 10.1128/IAI.05175-11; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; McSweeney LA, 2005, INFECT IMMUN, V73, P2051, DOI 10.1128/IAI.73.4.2051-2060.2005; Mise K, 2005, INFECT IMMUN, V73, P4846, DOI 10.1128/IAI.73.8.4846-4852.2005; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nesic D, 2005, PLOS PATHOG, V1, P214, DOI 10.1371/journal.ppat.0010028; Peres SY, 1997, MOL MICROBIOL, V24, P1095, DOI 10.1046/j.1365-2958.1997.4181785.x; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; Pratt JS, 2006, INFECT IMMUN, V74, P4496, DOI 10.1128/IAI.00503-06; Purdy D, 2000, J MED MICROBIOL, V49, P473, DOI 10.1099/0022-1317-49-5-473; Saiki K, 2001, MICROBIOL IMMUNOL, V45, P497, DOI 10.1111/j.1348-0421.2001.tb02650.x; Sert V, 1999, ONCOGENE, V18, P6296, DOI 10.1038/sj.onc.1203007; Shenker BJ, 2005, J IMMUNOL, V174, P2228, DOI 10.4049/jimmunol.174.4.2228; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Spano S, 2008, CELL HOST MICROBE, V3, P30, DOI 10.1016/j.chom.2007.11.001; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Yamada T, 2006, PROTEIN SCI, V15, P362, DOI 10.1110/ps.051790506; Young VB, 2004, INFECT IMMUN, V72, P2521, DOI 10.1128/IAI.72.5.2521-2527.2004	63	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143977	10.1371/journal.pone.0143977	http://dx.doi.org/10.1371/journal.pone.0143977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618479	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800098
J	Dhayat, SA; Mardin, WA; Seggewiss, J; Strose, AJ; Matuszcak, C; Hummel, R; Senninger, N; Mees, ST; Haier, J				Dhayat, Sameer A.; Mardin, Wolf Arif; Seggewiss, Jochen; Stroese, Anda Jana; Matuszcak, Christiane; Hummel, Richard; Senninger, Norbert; Mees, Soeren Torge; Haier, Joerg			MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							TUMOR PROGRESSION; UP-REGULATION; CELL-GROWTH; EXPRESSION PROFILES; GENE-EXPRESSION; DOWN-REGULATION; CANCER CELLS; RESISTANCE; APOPTOSIS; GAIN	Background No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic ductal adenocarcinoma (PDAC). MicroRNAs (miR) are epigenetic gene regulators with tumor-suppressive or oncogenic roles in various carcinomas. This study assesses chemoresistant PDAC for its specific miR expression pattern. Methods Gemcitabine-resistant variants of two mutant p53 human PDAC cell lines were established. Survival rates were analyzed by cytotoxicity and apoptosis assays. Expression of 1733 human miRs was investigated by microarray and validated by qRT-PCR. After in-silico analysis of specific target genes and proteins of dysregulated miRs, expression of MRP-1, Bcl-2, mutant p53, and CDK1 was quantified by Western blot. Results Both established PDAC clones showed a significant resistance to gemcitabine (p<0.02) with low apoptosis rate (p<0.001) vs. parental cells. MiR-screening revealed significantly upregulated (miR-21, miR-99a, miR-100, miR-125b, miR-138, miR-210) and downregulated miRs (miR-31*, miR-330, miR-378) in chemoresistant PDAC (p<0.05). Bioinformatic analysis suggested involvement of these miRs in pathways controlling cell death and cycle. MRP-1 (p<0.02) and Bcl-2 (p<0.003) were significantly overexpressed in both resistant cell clones and mutant p53 (p = 0.023) in one clone. Conclusion Consistent miR expression profiles, in part regulated by mutant TP53 gene, were identified in gemcitabine-resistant PDAC with significant MRP-1 and Bcl-2 overexpression. These results provide a basis for further elucidation of chemoresistance mechanisms and therapeutic approaches to overcome chemoresistance in PDAC.	[Dhayat, Sameer A.; Mardin, Wolf Arif; Matuszcak, Christiane; Hummel, Richard; Senninger, Norbert; Mees, Soeren Torge] Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany; [Seggewiss, Jochen] Univ Munster, Fac Med, Interdisciplinary Ctr Clin Res, Integrated Funct Genom, D-48149 Munster, Germany; [Stroese, Anda Jana; Haier, Joerg] Univ Hosp Muenster, Comprehens Canc Ctr Muenster, Munster, Germany	University of Munster; University of Munster; University of Munster	Dhayat, SA (corresponding author), Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany.	sameer.dhayat@ukmuenster.de			Forderverein Peter Geiger e.V.; Beilstein, Germany; Open Access Publication Fund of University of Muenster	Forderverein Peter Geiger e.V.; Beilstein, Germany; Open Access Publication Fund of University of Muenster	The authors acknowledge support by Forderverein Peter Geiger e.V., Beilstein, Germany and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Frauke Spiecker, and Ludgera Weber-Koberg for their support and expert technical assistance. We acknowledge support by Forderverein Peter Geiger e.V., Beilstein, Germany and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106343; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bouvet M, 1998, ANN SURG ONCOL, V5, P681, DOI 10.1007/BF02303477; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; CAMPLING BG, 1991, BRIT J CANCER, V63, P75, DOI 10.1038/bjc.1991.16; CARMICHAEL J, 1988, BRIT J CANCER, V57, P540, DOI 10.1038/bjc.1988.125; Cui EH, 2013, ACTA PHARMACOL SIN, V34, P309, DOI 10.1038/aps.2012.125; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Delpu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055513; Dhayat S, 2011, INT J CANCER, V129, P1031, DOI 10.1002/ijc.26078; Dong J, 2011, ARCH MED RES, V42, P8, DOI 10.1016/j.arcmed.2011.01.006; Emmrich S, 2014, GENE DEV, V28, P858, DOI 10.1101/gad.233791.113; Fiorini C, 2015, BBA-MOL CELL RES, V1853, P89, DOI 10.1016/j.bbamcr.2014.10.003; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Greenhalf W, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt347; Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Iwagami Y, 2013, BRIT J CANCER, V109, P502, DOI 10.1038/bjc.2013.320; Kim J, 2014, CANCER RES, V74, P1541, DOI 10.1158/0008-5472.CAN-13-1449; Koay EJ, 2014, J CLIN INVEST, V124, P1525, DOI 10.1172/JCI73455; Kopper F, 2014, CELL CYCLE, V13, P884, DOI 10.4161/cc.28292; Kozinn Spencer I, 2013, Genes Cancer, V4, P61, DOI 10.1177/1947601913484495; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Li B, 2014, CLIN CANCER RES, V20, P2651, DOI 10.1158/1078-0432.CCR-13-2735; Li XL, 2014, FEBS LETT, V588, P2610, DOI 10.1016/j.febslet.2014.03.054; Lynam-Lennon N, 2012, J MOL MED, V90, P1449, DOI 10.1007/s00109-012-0924-x; Ma JC, 2010, J SURG RES, V160, P90, DOI 10.1016/j.jss.2008.08.016; Marechal R, 2012, GASTROENTEROLOGY, V143, P664, DOI 10.1053/j.gastro.2012.06.006; Masciarelli S, 2014, ONCOGENE, V33, P1601, DOI 10.1038/onc.2013.106; Matsubara J, 2010, MOL CELL PROTEOMICS, V9, P695, DOI 10.1074/mcp.M900234-MCP200; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Reichert M, 2007, CANCER RES, V67, P4149, DOI 10.1158/0008-5472.CAN-06-4484; Scian MJ, 2004, CANCER RES, V64, P7447, DOI 10.1158/0008-5472.CAN-04-1568; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Sheikh R, 2010, EXPERT REV ANTICANC, V10, P1647, DOI [10.1586/era.10.148, 10.1586/ERA.10.148]; Shen YH, 2015, TUMOR BIOL, V36, P4525, DOI 10.1007/s13277-015-3097-8; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song T, 2010, ASIAN PAC J CANCER P, V11, P905; Tahiri A, 2014, CARCINOGENESIS, V35, P76, DOI 10.1093/carcin/bgt333; Tian XD, 2013, DIGEST DIS SCI, V58, P2705, DOI 10.1007/s10620-013-2673-2; Trehoux S, 2015, BBA-MOL CELL RES, V1853, P2392, DOI 10.1016/j.bbamcr.2015.05.033; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Ujifuku K, 2010, CANCER LETT, V296, P241, DOI 10.1016/j.canlet.2010.04.013; Veltkamp SA, 2008, ONCOLOGIST, V13, P261, DOI 10.1634/theoncologist.2007-0215; Wada M, 1998, ANTICANCER RES, V18, P2559; Wang H, 2012, PLOS ONE, V7, P34210, DOI DOI 10.1371/J0URNAL.P0NE.0034210; Wang J, 2014, ONCOGENE, V33, P1181, DOI 10.1038/onc.2013.42; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wang QJ, 1998, CANCER RES, V58, P5762; Wang S, 2013, CLIN TRANSL ONCOL, V15, P849, DOI 10.1007/s12094-013-1014-4; Wang S, 2014, J NEUROL SCI, V338, P71, DOI 10.1016/j.jns.2013.12.019; Watson MB, 2007, ANTI-CANCER DRUG, V18, P749, DOI 10.1097/CAD.0b013e3280a02f43; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Wu N, 2013, BRIT J CANCER, V109, P2853, DOI 10.1038/bjc.2013.672; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhang GJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-109; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	62	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143755	10.1371/journal.pone.0143755	http://dx.doi.org/10.1371/journal.pone.0143755			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606261	gold, Green Published			2022-12-26	WOS:000365865300107
J	Lakhani, VV; Hinde, E; Gratton, E; Elston, TC				Lakhani, Vinal V.; Hinde, Elizabeth; Gratton, Enrico; Elston, Timothy C.			Spatio-Temporal Regulation of Rac1 Mobility by Actin Islands	PLOS ONE			English	Article							DIFFUSION; DYNAMICS; RHO	Rho GTPases play important roles in many aspects of cell migration, including polarity establishment and organizing actin cytoskeleton. In particular, the Rho GTPase Rac1 has been associated with the generation of protrusions at leading edge of migrating cells. Previously we showed the mobility of Rac1 molecules is not uniform throughout a migrating cell (Hinde E et. al. PNAS 2013). Specifically, the closer a Rac1 molecule is to the leading edge, the slower the molecule diffuses. Because actin-bound Rac1 diffuses slower than unbound Rac1, we hypothesized that regions of high actin concentration, called "actin islands", act as diffusive traps and are responsible for the non-uniform diffusion observed in vivo. Here, in silico model simulations demonstrate that equally spaced actin islands can regulate the time scale for Rac1 diffusion in a manner consistent with data from live-cell imaging experiments. Additionally, we find this mechanism is robust; different patterns of Rac1 mobility can be achieved by changing the actin islands' positions or their affinity for Rac1.	[Lakhani, Vinal V.; Elston, Timothy C.] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC USA; [Lakhani, Vinal V.; Elston, Timothy C.] Univ N Carolina, Mol & Cellular Biophys Program, Chapel Hill, NC USA; [Lakhani, Vinal V.; Elston, Timothy C.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Hinde, Elizabeth] Univ New S Wales, Australian Ctr NanoMed, Sydney, NSW, Australia; [Gratton, Enrico] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of New South Wales Sydney; University of California System; University of California Irvine	Gratton, E (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	egratton22@gmail.com; timothy_elston@med.unc.edu		Hinde, Elizabeth/0000-0001-8317-1152	National Institutes of Health (NIH) [GM079271, GM114136, P50 GM076516, P41 GM103540, T32 GM067553]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516, T32GM067553, P41GM103540, R01GM114136, R01GM079271] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (NIH) funded the following authors with the following grants: TE and VL were supported by GM079271 and GM114136, EG and EH were supported through P50 GM076516 and P41 GM103540, and VL was supported by T32 GM067553 (URL for the NIH: http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Digman MA, 2009, BIOPHYS J, V97, P665, DOI 10.1016/j.bpj.2009.04.048; Erban R, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046001; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Hinde E, 2013, P NATL ACAD SCI USA, V110, P135, DOI 10.1073/pnas.1211882110; Hinde Elizabeth, 2011, Biophys Rev, V3, P119, DOI 10.1007/s12551-011-0051-x; Hinde E, 2010, P NATL ACAD SCI USA, V107, P16560, DOI 10.1073/pnas.1006731107; Katsuki T, 2011, DEV NEUROBIOL, V71, P458, DOI 10.1002/dneu.20859; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005	11	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143753	10.1371/journal.pone.0143753	http://dx.doi.org/10.1371/journal.pone.0143753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606145	Green Published, gold			2022-12-26	WOS:000365865300106
J	Pe, R; Chim, B; Thai, S; Lynen, L; van Griensven, J				Pe, Reaksmey; Chim, Bopha; Thai, Sopheak; Lynen, Lutgarde; van Griensven, Johan			Advanced HIV Disease at Enrolment in HIV Care: Trends and Associated Factors over a Ten Year Period in Cambodia	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; RISK-FACTORS; INITIATION; MORTALITY; TUBERCULOSIS; DIAGNOSIS	Background Early HIV diagnosis and enrolment in care is needed to achieve early antiretroviral treatment (ART) initiation. Studies on HIV disease stage at enrolment in care from Asian countries are limited. We evaluated trends in and factors associated with late HIV disease presentation over a ten-year period in the largest ART center in Cambodia. Methods We conducted a retrospective analysis of program data including all ARV-naive adults (>18 years old) enrolling into HIV care from March 2003-December 2013 in a non-governmental hospital in Phnom Penh, Cambodia. We calculated the proportion presenting with advanced stage HIV disease (WHO clinical stage IV or CD4 cell count <100 cells/mu L) and the probability of ART initiation by six months after enrolment. Factors associated with late presentation were determined using multivariate logistic regression. Results From 2003-2013, a total of 5642 HIV-infected patients enrolled in HIV care. The proportion of late presenters decreased from 67% in 2003 to 44% in 2009 and 41% in 2013; a temporary increase to 52% occurred in 2011 coinciding with logistical/budgetary constraints at the national program level. Median CD4 counts increased from 32 cells/mu L (IQR 11-127) in 2003 to 239 cells/mu L (IQR 63-291) in 2013. Older age and male sex were associated with late presentation across the ten-year period. The probability of ART initiation by six months after enrolment increased from 22.6% in 2003-2006 to 79.9% in 2011-2013. Conclusion Although a gradual improvement was observed over time, a large proportion of patients still enroll late, particularly older or male patients. Interventions to achieve early HIV testing and efficient linkage to care are warranted.	[Pe, Reaksmey; Chim, Bopha; Thai, Sopheak; van Griensven, Johan] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Lynen, Lutgarde; van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	van Griensven, J (corresponding author), Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia.	jvangriensven@itg.be	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine, Antwerp; Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine, Antwerp; Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide	The HIV program was supported by the Belgian Directorate General of Development Cooperation through the framework agreement with the Institute of Tropical Medicine, Antwerp, the Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, 2013 UNAIDS REP GLOB; Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; Bendavid Eran, 2012, AIDS, V26 Suppl 1, pS85; Boettiger DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106525; Chim B, 2013, AIDS CLIN RES, V4; Choun K, 2013, T ROY SOC TROP MED H, V107, P235, DOI 10.1093/trstmh/trt001; Choun K, 2013, B WORLD HEALTH ORGAN, V91, P195, DOI 10.2471/BLT.12.111153; Coetzer M, 2013, AIDS RES HUM RETROV, V29, P985, DOI [10.1089/aid.2013.0025, 10.1089/AID.2013.0025]; Cornell M, 2013, AIDS, V27, P849, DOI 10.1097/QAD.0b013e32835e399b; Fitzgerald M, 2010, AIDS CARE, V22, P355, DOI 10.1080/09540120903111536; Govindasamy D, 2014, T ROY SOC TROP MED H, V108, P1, DOI 10.1093/trstmh/trt105; Hall HI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077763; Hanna DB, 2007, AIDS CARE, V19, P264, DOI 10.1080/09540120600834729; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kiertiburanakul S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18804; Krentz HB, 2010, AIDS, V24, P2750, DOI 10.1097/QAD.0b013e32833f9e1d; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lahuerta M, 2013, J HEALTH CARE POOR U, V24, P359, DOI 10.1353/hpu.2013.0014; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Mojumdar K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-416; NCHADS, 2011, EST HIV PREV GEN POP; Nouhin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073744; Phan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030647; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Saphonn V, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-7; Srasuebkul P, 2009, CLIN INFECT DIS, V48, P940, DOI 10.1086/597354; Thanawuth N, 2008, AIDS CARE, V20, P43, DOI 10.1080/09540120701439303; van Griensven J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088552; van Griensven J, 2011, T ROY SOC TROP MED H, V105, P694, DOI 10.1016/j.trstmh.2011.08.007; White J, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/504792; WHO, 2010, ANT THER HIV INF ADU; WHO, 2014, ANT MED LOW AND MIDD; WHO, 2006, ANT THER HIV INF ADU; WHO, 2013, GLOB UPD HIV TREATM; Xing JN, 2014, CLIN INFECT DIS, V59, DOI 10.1093/cid/ciu214	39	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143320	10.1371/journal.pone.0143320	http://dx.doi.org/10.1371/journal.pone.0143320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7ES	26606057	Green Published, gold			2022-12-26	WOS:000365865300055
J	Wang, SY; Cu, Y; Wang, C; Xie, W; Ma, L; Zhu, JF; Zhang, Y; Dang, R; Wang, DC; Wu, YH; Wu, QH				Wang, Shengyuan; Cu, Yu; Wang, Chao; Xie, Wei; Ma, Lan; Zhu, Jinfeng; Zhang, Yan; Dang, Rui; Wang, Decai; Wu, Yonghui; Wu, Qunhong			Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							OXIDATIVE STRESS; COGNITIVE FUNCTION; ACETYLCHOLINESTERASE; MECHANISMS; OMEGA-3-FATTY-ACIDS; INHIBITORS; MICROGLIA; PROTEIN; BURDEN	Objective This study investigated the effects of intervention with a combination of nutrients in the amyloid precursor protein-presenilin (APP-PSN) C57BL/6J double transgenic mouse model of Alzheimer's disease (AD). Methods A total of 72 2-month-old APP-PSN mice were randomly assigned to three groups. The model group (MG) was fed regular, unsupplemented chow, while the low-and high-dose treatment groups (LG and HG, respectively) were given a combination of nutrients that included phosphatidylserine, blueberry extracts, docosahexaenoic acid, and eicosapentaenoic acid as part of their diet. An additional 24 wild-type littermates that were fed unsupplemented chow served as the negative control group (NG). After 3 and 7 months of treatment, the cognitive performance was assessed with the Morris water maze and the shuttle box escape/avoidance task, and the biochemical parameters and oxidative stress were evaluated in both the blood and brain. Results An improvement in antioxidant capacity was observed in the treatment groups relative to the MG at 3 months, while superior behavioral test results were observed in the mice of the HG and NG groups. In the MG, pycnosis was detected in neuronal nuclei, and a loss of neurons was observed in the cerebral cortex and the hippocampus. At 7 months, the beta-amyloid(1- 42) peptide accumulation was significantly elevated in the MG but was markedly lower in the mice fed the nutrient combination. The antioxidant capacity and behavioral test scores were also higher in these mice. Conclusions Early intervention with a combination of nutrients should be considered as a strategy for preventing cognitive decline and other symptoms associated with AD.	[Cu, Yu; Wu, Qunhong] Harbin Med Univ, Dept Social Med, Coll Publ Hlth, Harbin, Peoples R China; [Wang, Chao] YanZhou Peoples Hosp, Dept Nutr, Yangzhou, Peoples R China; [Xie, Wei; Ma, Lan; Zhu, Jinfeng; Zhang, Yan; Dang, Rui; Wang, Decai] Harbin Med Univ, Dept Nutr & Food Hyg, Coll Publ Hlth, Harbin, Peoples R China; [Wang, Shengyuan; Wu, Yonghui] Harbin Med Univ, Dept Occupat Hlth, Coll Publ Hlth, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Wu, YH (corresponding author), Harbin Med Univ, Dept Occupat Hlth, Coll Publ Hlth, Harbin, Peoples R China.	wuyonghui777@163.com; wuqunhonghyd@163.com	张, 西京/HIK-3273-2022		National Natural Science Foundation of China [81273193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by a grant from the National Natural Science Foundation of China (no. 81273193).; The study was supported by a grant from the National Natural Science Foundation of China (no. 81273193). No conflicts of interest are declared.	Aliev G, 2008, MINI-REV MED CHEM, V8, P1395, DOI 10.2174/138955708786369582; Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Armstrong R A, 2011, Int J Alzheimers Dis, V2011, P630865, DOI 10.4061/2011/630865; Banerjee R, 2012, RES REV J NEUROSCIEN, V2, P12; Bhalla V, 2012, CHEM COMMUN, V48, P4722, DOI 10.1039/c2cc17802h; Bignante EA, 2013, NEUROBIOL AGING, V34, P2525, DOI 10.1016/j.neurobiolaging.2013.04.021; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Butterfield DA, 2013, ANTIOXID REDOX SIGN, V19, P823, DOI 10.1089/ars.2012.5027; Chew EY, 2015, JAMA-J AM MED ASSOC, V314, P791, DOI 10.1001/jama.2015.9677; Clarke R, 2000, Indian Heart J, V52, pS59; Colantuoni E, 2010, ALZHEIMERS DEMENT, V6, P425, DOI 10.1016/j.jalz.2010.01.014; Darreh-Shori T, 2010, CURR ALZHEIMER RES, V7, P67, DOI 10.2174/156720510790274455; Dong ZF, 2013, NEUROPHARMACOLOGY, V64, P65, DOI 10.1016/j.neuropharm.2012.06.027; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Golde TE, 2010, EXP NEUROL, V223, P252, DOI 10.1016/j.expneurol.2009.07.035; Hjorth E, 2013, J ALZHEIMERS DIS, V35, P697, DOI 10.3233/JAD-130131; Hofrichter J, 2013, CURR ALZHEIMER RES, V10, P1057, DOI 10.2174/15672050113106660171; Hu JJ, 2011, NEUROSCIENCE MED, V2, P355; Jager R, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-5; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Ji HF, 2011, MOLECULES, V16, P6732, DOI 10.3390/molecules16086732; Johnson EJ, 2012, AM J CLIN NUTR, V96, p1161S, DOI 10.3945/ajcn.112.034611; Kaladhar DSVGK, 2012, J COMPUTATIONAL METH, V2, P122; Kamphuis PJGH, 2010, J ALZHEIMERS DIS, V20, P765, DOI 10.3233/JAD-2010-091558; Lane RM, 2004, CLIN NEUROPHARMACOL, V27, P141, DOI 10.1097/00002826-200405000-00011; LITTLE A, 1985, J NEUROL NEUROSUR PS, V48, P736, DOI 10.1136/jnnp.48.8.736; Mangialasche F, 2009, AGEING RES REV, V8, P285, DOI 10.1016/j.arr.2009.04.002; Mastroeni D, 2011, NEUROBIOL AGING, V32, P1161, DOI 10.1016/j.neurobiolaging.2010.08.017; McKeith I, 2005, LANCET NEUROL, V4, P735, DOI 10.1016/S1474-4422(05)70219-2; Mitew S, 2013, NEUROBIOL AGING, V34, P2341, DOI 10.1016/j.neurobiolaging.2013.04.010; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Munoz-Torrero D, 2008, CURR MED CHEM, V15, P2433, DOI 10.2174/092986708785909067; Naik RS, 2009, J PHARM PHARM SCI, V12, P79, DOI 10.18433/J3MK59; Nolan JM, 2015, J ALZHEIMERS DIS, V44, P1157, DOI 10.3233/JAD-142265; Parker AG, 2011, J INT SOC SPORT NUTR, V8, DOI 10.1186/1550-2783-8-16; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Qiu Hong, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P101; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Scheltens P, 2010, ALZHEIMERS DEMENT, V6, P1, DOI 10.1016/j.jalz.2009.10.003; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Subash Selvaraju, 2015, J Ayurveda Integr Med, V6, P111, DOI 10.4103/0975-9476.159073; Subash S, 2015, NUTR NEUROSCI, V18, P281, DOI 10.1179/1476830514Y.0000000134; Tassoni D, 2008, ASIA PAC J CLIN NUTR, V17, P220; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT, V6, P456, DOI 10.1016/j.jalz.2010.01.013	49	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143135	10.1371/journal.pone.0143135	http://dx.doi.org/10.1371/journal.pone.0143135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606074	Green Submitted, gold, Green Published			2022-12-26	WOS:000365865300045
J	Guillon, A; Chevaleyre, C; Barc, C; Berri, M; Adriaensen, H; Lecompte, F; Villemagne, T; Pezant, J; Delaunay, R; Moenne-Loccoz, J; Berthon, P; Bahr, A; Wolf, E; Klymiuk, N; Attucci, S; Ramphal, R; Sarradin, P; Buzoni-Gatel, D; Si-Tahar, M; Caballero, I				Guillon, Antoine; Chevaleyre, Claire; Barc, Celine; Berri, Mustapha; Adriaensen, Hans; Lecompte, Francois; Villemagne, Thierry; Pezant, Jeremy; Delaunay, Remi; Moenne-Loccoz, Joseph; Berthon, Patricia; Baehr, Andrea; Wolf, Eckhard; Klymiuk, Nikolai; Attucci, Sylvie; Ramphal, Reuben; Sarradin, Pierre; Buzoni-Gatel, Dominique; Si-Tahar, Mustapha; Caballero, Ignacio			Computed Tomography (CT) Scanning Facilitates Early Identification of Neonatal Cystic Fibrosis Piglets	PLOS ONE			English	Article							MECONIUM ILEUS; INTESTINAL-OBSTRUCTION; LUNG-DISEASE; MODEL; PATHOPHYSIOLOGY; EXPRESSION; NUMBERS; TISSUE	Background Cystic Fibrosis (CF) is the most prevalent autosomal recessive disease in the Caucasian population. A cystic fibrosis transmembrane conductance regulator knockout (CFTR-/-) pig that displays most of the features of the human CF disease has been recently developed. However, CFTR-/- pigs presents a 100% prevalence of meconium ileus that leads to death in the first hours after birth, requiring a rapid diagnosis and surgical intervention to relieve intestinal obstruction. Identification of CFTR-/- piglets is usually performed by PCR genotyping, a procedure that lasts between 4 to 6 h. Here, we aimed to develop a procedure for rapid identification of CFTR-/- piglets that will allow placing them under intensive care soon after birth and immediately proceeding with the surgical correction. Methods and Principal Findings Male and female CFTR+/- pigs were crossed and the progeny was examined by computed tomography (CT) scan to detect the presence of meconium ileus and facilitate a rapid postnatal surgical intervention. Genotype was confirmed by PCR. CT scan presented a 94.4% sensitivity to diagnose CFTR-/- piglets. Diagnosis by CT scan reduced the birth-to-surgery time from a minimum of 10 h down to a minimum of 2.5 h and increased the survival of CFTR-/- piglets to a maximum of 13 days post-surgery as opposed to just 66 h after later surgery. Conclusion CT scan imaging of meconium ileus is an accurate method for rapid identification of CFTR-/- piglets. Early CT detection of meconium ileus may help to extend the lifespan of CFTR-/- piglets and, thus, improve experimental research on CF, still an incurable disease.	[Guillon, Antoine; Attucci, Sylvie; Ramphal, Reuben; Si-Tahar, Mustapha] INSERM, UMR 1100, EA6305, Ctr Etud Pathol Resp, Tours, France; [Guillon, Antoine] CHU Tours, Serv Reanimat Polyvalente, Tours, France; [Chevaleyre, Claire; Berri, Mustapha; Berthon, Patricia; Buzoni-Gatel, Dominique; Caballero, Ignacio] INRA, UMR1282, ISP, F-37380 Nouzilly, France; [Barc, Celine; Pezant, Jeremy; Delaunay, Remi; Sarradin, Pierre] INRA, UMR1277, PFIE, F-37380 Nouzilly, France; [Adriaensen, Hans; Lecompte, Francois] INRA, CIRE, F-37380 Nouzilly, France; [Villemagne, Thierry] CHU Clocheville, Tours, France; [Moenne-Loccoz, Joseph] CHU Tours, Serv Anesthesie Reanimat, Tours, France; [Baehr, Andrea; Wolf, Eckhard; Klymiuk, Nikolai] Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany; [Baehr, Andrea; Wolf, Eckhard; Klymiuk, Nikolai] Ludwig Maximilians Univ Munchen, Ctr Innovat Med Models, Munich, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; INRAE; INRAE; INRAE; CHU Tours; CHU Tours; University of Munich; University of Munich	Caballero, I (corresponding author), INRA, UMR1282, ISP, F-37380 Nouzilly, France.	icaballerop@tours.inra.fr	Si-Tahar, Mustapha/W-8034-2019; Klymiuk, Nikolai/AAB-8345-2022; SI-TAHAR, Mustapha/L-4149-2014; Adriaensen, Hans/N-6699-2018; Wolf, Eckhard/AAT-7500-2021	Si-Tahar, Mustapha/0000-0002-5792-7742; Klymiuk, Nikolai/0000-0003-3532-1659; SI-TAHAR, Mustapha/0000-0002-5792-7742; Wolf, Eckhard/0000-0002-0430-9510; guillon, antoine/0000-0002-4884-8620; Barc, Celine/0000-0002-5912-4652; Caballero, Ignacio/0000-0002-0628-4134	Foundation Vaincre la Mucoviscidose [RF20130500925]; Region Centre, France [32000604]	Foundation Vaincre la Mucoviscidose; Region Centre, France(Region Centre-Val de Loire)	This research was supported by the Foundation Vaincre la Mucoviscidose (http://www.vaincrelamuco.org/), grant RF20130500925, and Region Centre, France (http://www.regioncentre-valdeloire.fr/), grant 32000604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrons GA, 1996, RADIOGRAPHICS, V16, P871, DOI 10.1148/radiographics.16.4.8835977; Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Bodas M, 2010, DISCOV MED, V9, P346; Brea D, 2012, BIOCHEM J, V447, P363, DOI 10.1042/BJ20120818; Burjonrappa SC, 2010, J PERINATOL, V30, P27, DOI 10.1038/jp.2009.102; Carlyle BE, 2012, J PEDIATR SURG, V47, P772, DOI 10.1016/j.jpedsurg.2012.02.019; Casaccia G, 2003, PEDIATR SURG INT, V19, P75, DOI 10.1007/s00383-002-0781-8; Constantine S, 2004, Australas Radiol, V48, P450, DOI 10.1111/j.1440-1673.2004.01345.x; CORDES D O, 1971, New Zealand Veterinary Journal, V19, P108, DOI 10.1080/00480169.1971.33943; Drumm ML, 2012, ANNU REV PATHOL-MECH, V7, P267, DOI 10.1146/annurev-pathol-011811-120900; GORDON JI, 1985, J BIOL CHEM, V260, P1995; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Klymiuk N, 2012, J MOL MED, V90, P597, DOI 10.1007/s00109-011-0839-y; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Nassenstein K, 2005, GUT, V54, P1662, DOI 10.1136/gut.2005.075994; Neal MR, 1997, J ULTRAS MED, V16, P263; Okamoto K, 2005, JPEN-PARENTER ENTER, V29, P56, DOI 10.1177/014860710502900156; Okamoto K, 2013, ANN SURG, V258, P1059, DOI 10.1097/SLA.0b013e31827a0e05; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Scotet V, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.08.033; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Stoltz DA, 2013, J CLIN INVEST, V123, P2685, DOI 10.1172/JCI68867; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; van der Doef Hubert P J, 2011, Curr Gastroenterol Rep, V13, P265, DOI 10.1007/s11894-011-0185-9; Veyrac C, 2012, PEDIATR RADIOL, V42, P107, DOI 10.1007/s00247-011-2173-5; Ware LB, 2008, AM J PHYSIOL-LUNG C, V294, pL149, DOI 10.1152/ajplung.00472.2007; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Wine JJ, 1999, J CLIN INVEST, V103, P309, DOI 10.1172/JCI6222; ZHOU L, 1994, SCIENCE, V266, P1705, DOI 10.1126/science.7527588	32	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143459	10.1371/journal.pone.0143459	http://dx.doi.org/10.1371/journal.pone.0143459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600426	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900128
J	Syam, AF; Miftahussurur, M; Makmun, D; Nusi, IA; Zain, LH; Zulkhairi; Akil, F; Uswan, WB; Simanjuntak, D; Uchida, T; Adi, P; Utari, AP; Rezkitha, YAA; Subsomwong, P; Nasronudin; Suzuki, R; Yamaoka, Y				Syam, Ari Fahrial; Miftahussurur, Muhammad; Makmun, Dadang; Nusi, Iswan Abbas; Zain, Lukman Hakim; Zulkhairi; Akil, Fardah; Uswan, Willi Brodus; Simanjuntak, David; Uchida, Tomohisa; Adi, Pangestu; Utari, Amanda Pitarini; Rezkitha, Yudith Annisa Ayu; Subsomwong, Phawinee; Nasronudin; Suzuki, Rumiko; Yamaoka, Yoshio			Risk Factors and Prevalence of Helicobacter pylori in Five Largest Islands of Indonesia: A Preliminary Study	PLOS ONE			English	Article							INFECTION; IDENTIFICATION; GASTROSCOPY; MANAGEMENT; GENOTYPES; DISEASES; REGION	The prevalence of Helicobacter pylori infection in Indonesia is still controversial and mainly investigated in the largest ethnic group, Javanese. We examined the prevalence of H. pylori infection using four different tests including culture, histology confirmed by immunohistochemistry and rapid urease test. We also analyzed risk factors associated with H. pylori infection in five largest islands in Indonesia. From January 2014-February 2015 we consecutively recruited a total of 267 patients with dyspeptic symptoms in Java, Papua, Sulawesi, Borneo and Sumatera Island. Overall, the prevalence of H. pylori infection was 22.1%(59/267). Papuan, Batak and Buginese ethnics had higher risk for H. pylori infection than Javanese, Dayak and Chinese ethnics (OR = 30.57, 6.31, 4.95; OR = 28.39, 5.81, 4.61 and OR = 23.23, 4.76, 3.77, respectively, P < 0.05). The sensitivity and specificity for RUT and culture were 90.2%, 92.9% and 80.5%, 98.2%, respectively. The patients aged 50-59 years group had significantly higher H. pylori infection than 30-39 years group (OR 2.98, P = 0.05). Protestant had significantly higher H. pylori infection rate than that among Catholic (OR 4.42, P = 0.008). It was also significantly lower among peoples who used tap water as source of drinking water than from Wells/river (OR 9.67, P = 0.03). However only ethnics as become independent risk factors for H. pylori infection. Although we confirmed low prevalence of H. pylori in Javanese; predominant ethnic in Indonesia, several ethnic groups had higher risk of H. pylori infection. The age, religion and water source may implicate as a risk factor for H. pylori infection in Indonesia.	[Syam, Ari Fahrial; Makmun, Dadang] Univ Indonesia, Div Gastroenterol, Dept Internal Med, Fac Med, Jakarta, Indonesia; [Miftahussurur, Muhammad; Subsomwong, Phawinee; Suzuki, Rumiko; Yamaoka, Yoshio] Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan; [Miftahussurur, Muhammad; Nusi, Iswan Abbas] Airlangga Univ, Fac Med, Gastroenterohepatol Div, Dept Internal Med, Surabaya, Indonesia; [Miftahussurur, Muhammad; Adi, Pangestu; Rezkitha, Yudith Annisa Ayu; Nasronudin] Airlangga Univ, Inst Trop Dis, Surabaya, Indonesia; [Zain, Lukman Hakim; Zulkhairi] Univ Sumatera Utara, Fac Med, Dept Internal Med, Div Gastroenterohepatol, Medan, Indonesia; [Akil, Fardah] Hasanuddin Univ, Fac Med, Dept Internal Med, Ctr Gastroenterohepatol, Makassar, Indonesia; [Uswan, Willi Brodus] Santo Antonius Hosp, Dept Internal Med, Pontianak, Indonesia; [Simanjuntak, David] Yowari Hosp, Dept Internal Med, Jayapura, Indonesia; [Uchida, Tomohisa] Oita Univ, Dept Mol Pathol, Fac Med, Yufu, Japan; [Yamaoka, Yoshio] Baylor Coll Med, Dept Gastroenterol & Hepatol, Houston, TX 77030 USA; [Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Houston, TX USA	University of Indonesia; Oita University; Airlangga University; Airlangga University; University of North Sumatra; Universitas Hasanuddin; Oita University; Baylor College of Medicine; Baylor College of Medicine	Yamaoka, Y (corresponding author), Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan.	yyamaoka@oita-u.ac.jp	Syam, Ari Fahrial/ABI-4994-2020; Miftahussurur, Muhammad/AAB-6151-2021	Miftahussurur, Muhammad/0000-0003-1415-6033; Syam, Ari Fahrial/0000-0003-0041-3553; Akil, Fardah/0000-0002-4222-6011; effendi, wiwin is/0000-0003-3716-2452; Subsomwong, Phawinee/0000-0002-9961-9350; Rezkitha, Yudith Annisa Ayu/0000-0001-7600-9114; nasronudin, nasronudin/0000-0001-7882-9992; Yamaoka, Yoshio/0000-0002-1222-5819	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24406015, 24659200, 25293104, 26640114, 15H02657, 221S0002, 26440198]; Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK062813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This report is based on work supported in part by grants from the National Institutes of Health (DK62813) (YY), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (24406015, 24659200, 25293104, 26640114, 15H02657 and 221S0002) (YY), (26440198) (RS). This work was also supported by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits and the Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST).	Abdullah M, 2009, WORLD J GASTROENTERO, V15, P4928, DOI 10.3748/wjg.15.4928; Al-Hawajri AA, 2004, DIGEST DIS SCI, V49, P1091, DOI 10.1023/B:DDAS.0000037793.28069.44; Arinton I Gede, 2011, Acta Med Indones, V43, P88; Aulia Diana, 2009, Acta Med Indones, V41, P107; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; CHOW TKF, 1995, J GASTROEN HEPATOL, V10, P562, DOI 10.1111/j.1440-1746.1995.tb01347.x; Destura Raul V, 2004, Ann Clin Microbiol Antimicrob, V3, P25, DOI 10.1186/1476-0711-3-25; Dube C., 2009, Reviews on Environmental Health, V24, P1; Elitsur Y, 2009, J CLIN GASTROENTEROL, V43, P147, DOI 10.1097/MCG.0b013e318157e4e7; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Lee YY, 2013, HELICOBACTER, V18, P338, DOI 10.1111/hel.12058; Lee YY, 2012, HELICOBACTER, V17, P54, DOI 10.1111/j.1523-5378.2011.00917.x; Maran S, 2013, WORLD J GASTROENTERO, V19, P3615, DOI 10.3748/wjg.v19.i23.3615; Mhaskar RS, 2013, J GLOB INFECT DIS, V5, P60, DOI 10.4103/0974-777X.112288; Miftahussurur M, 2015, EPIDEMIOL INFECT, V143, P986, DOI 10.1017/S095026881400154X; Miftahussurur M, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0042-0; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Nguyen LT, 2010, EUR J CLIN MICROBIOL, V29, P651, DOI 10.1007/s10096-010-0909-z; Nguyen TL, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-114; Parsonnet J, 1999, JAMA-J AM MED ASSOC, V282, P2240, DOI 10.1001/jama.282.23.2240; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Perger R, 2013, ZOOKEYS, P77, DOI 10.3897/zookeys.293.5133; Rahim AA, 2010, AM J TROP MED HYG, V83, P1119, DOI 10.4269/ajtmh.2010.10-0226; RICHENS J, 1989, PAPUA NEW GUINEA MED, V32, P23; Sahara S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-223; Saragih J Boas, 2007, Acta Med Indones, V39, P79; Shiota S, 2014, J MED MICROBIOL, V63, P1189, DOI 10.1099/jmm.0.075275-0; Shiota S, 2010, EXPERT REV GASTROENT, V4, P149, DOI [10.1586/egh.10.7, 10.1586/EGH.10.7]; Sugimoto M, 2011, J GASTROEN HEPATOL, V26, P1677, DOI 10.1111/j.1440-1746.2011.06817.x; Sugimoto M, 2009, J GASTROEN HEPATOL, V24, P1725, DOI 10.1111/j.1440-1746.2009.06047.x; Syam AF, 2006, WORLD J GASTROENTERO, V12, P6216, DOI 10.3748/wjg.v12.i38.6216; Syam AF, 2005, WORLD J GASTROENTERO, V11, P386, DOI 10.3748/wjg.v11.i3.386; Tokudome S, 2005, CANCER SCI, V96, P873, DOI 10.1111/j.1349-7006.2005.00122.x; Tokudome S, 2005, CANCER LETT, V219, P57, DOI 10.1016/j.canlet.2004.09.043; Tumonggor MK, 2013, J HUM GENET, V58, P165, DOI 10.1038/jhg.2012.154; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Utsumi T, 2009, J CLIN MICROBIOL, V47, P1842, DOI 10.1128/JCM.02328-08; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; Zhao Y, 2012, ASIAN PAC J CANCER P, V13, P1247, DOI 10.7314/APJCP.2012.13.4.1247	40	50	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0140186	10.1371/journal.pone.0140186	http://dx.doi.org/10.1371/journal.pone.0140186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599790	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000365853900007
J	Bharti, R; Dey, G; Ojha, PK; Rajput, S; Jaganathan, SK; Sen, R; Mandal, M				Bharti, R.; Dey, G.; Ojha, P. K.; Rajput, S.; Jaganathan, S. K.; Sen, R.; Mandal, M.			Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer	ONCOGENE			English	Article							MULTIPLE-MYELOMA; PROSTATE-CANCER; CELL-SURVIVAL; INTERLEUKIN-6; PATHWAY; STAT3; IL-6; GP130; PHOSPHORYLATION; GROWTH	Interleukin-6 (IL-6) signaling network has been implicated in oncogenic transformations making it attractive target for the discovery of novel cancer therapeutics. In this study, potent antiproliferative and apoptotic effect of diacerein were observed against breast cancer. In vitro apoptosis was induced by this drug in breast cancer cells as verified by increased sub-G(1) population, LIVE/DEAD assay, cell cytotoxicity and presence of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells, as well as downregulation of antiapoptotic proteins Bcl-2 and Bcl-xL and upregulation of apoptotic protein Bax. In addition, apoptosis induction was found to be caspase dependent. Further molecular investigations indicated that diacerein instigated apoptosis was associated with inhibition of IL-6/IL-6R autocrine signaling axis. Suppression of STAT3, MAPK and Akt pathways were also observed as a consequence of diacerein-mediated upstream inhibition of IL-6/IL-6R. Fluorescence study and western blot analysis revealed cytosolic accumulation of STAT3 in diacerein-treated cells. The docking study showed diacerein/IL-6R interaction that was further validated by competitive binding assay and isothermal titration calorimetry. Most interestingly, it was found that diacerein considerably suppressed tumor growth in MDA-MB-231 xenograft model. The in vivo antitumor effect was correlated with decreased proliferation (Ki-67), increased apoptosis (TUNEL) and inhibition of IL-6/IL-6R-mediated STAT3, MAPK and Akt pathway in tumor remnants. Taken together, diacerein offered a novel blueprint for cancer therapy by hampering IL-6/IL-6R/STAT3/MAPK/Akt network.	[Bharti, R.; Dey, G.; Rajput, S.; Mandal, M.] Indian Inst Technol Kharagpur, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India; [Ojha, P. K.] Jadavpur Univ, Dept Pharmaceut Technol, Div Med & Pharmaceut Chem, Drug Theoret & Cheminformat Lab, Kolkata, India; [Jaganathan, S. K.] Univ Teknol, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Skudai, Johor, Malaysia; [Sen, R.] Indian Inst Technol Kharagpur, Dept Biotechnol, Kharagpur, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Jadavpur University; Universiti Teknologi Malaysia; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Mandal, M (corresponding author), Indian Inst Technol Kharagpur, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.	mahitosh@smst.iitkgp.ernet.in	Mandal, Mahitosh/Q-7421-2016; Sen, Ramkrishna/C-8772-2014; Jaganathan, Saravana Kumar/N-2385-2017; jain, shashi/AAF-4706-2020; JAIN, SHASHI/N-8877-2017; Mandal, Mahitosh/GMW-6195-2022	Mandal, Mahitosh/0000-0003-3861-3323; Sen, Ramkrishna/0000-0002-6207-3307; Jaganathan, Saravana Kumar/0000-0002-2785-137X; jain, shashi/0000-0001-9428-0135; JAIN, SHASHI/0000-0001-9428-0135; Mandal, Mahitosh/0000-0003-3861-3323; Dey, Goutam/0000-0002-8210-3219; OJHA, PROBIR KUMAR/0000-0003-4796-3915; Bharti, Rashmi/0000-0002-7612-7695	MHRD; CSIR; MoES, India [MoES/16/48/09/RDEAS]	MHRD; CSIR(Council of Scientific & Industrial Research (CSIR) - India); MoES, India	We thank MHRD, CSIR and MoES, India (Grant No: MoES/16/48/09/RDEAS; Date: 15-07-2010).	Andersen JL, 2014, ACTA CRYSTALLOGR D, V70, P451, DOI 10.1107/S1399004713030149; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Ataie-Kachoie P, 2013, CYTOKINE GROWTH F R, V24, P163, DOI 10.1016/j.cytogfr.2012.09.001; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Brinkmann K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.61; Calisto KL, 2012, CRIT CARE, V16, DOI 10.1186/cc11478; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Chakravarti N, 2006, INT J CANCER, V119, P1268, DOI 10.1002/ijc.21967; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Conze D, 2001, CANCER RES, V61, P8851; Culig Z, 2011, BBA-MOL CELL RES, V1813, P308, DOI 10.1016/j.bbamcr.2010.12.010; Das Subhasis, 2012, J Exp Ther Oncol, V10, P139; Dey G, 2015, SCI REP-UK, V5, DOI 10.1038/srep10316; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Gadotti VM, 2012, PHARMACOL BIOCHEM BE, V102, P549, DOI 10.1016/j.pbb.2012.06.018; Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030; Gibson RM, 2000, J BIOL CHEM, V275, P22574, DOI 10.1074/jbc.M907658199; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hideshima T, 2001, BLOOD, V98, p639a; Johnson Christopher, 2012, Transl Gastrointest Cancer, V1, P58; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kamran MZ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/421821; Liu Y, 2011, CANCER PREV RES, V4, P1296, DOI 10.1158/1940-6207.CAPR-10-0317; Liu Y, 2010, J BIOL CHEM, V285, P27429, DOI 10.1074/jbc.M110.142752; Liu YX, 2009, MOL PHARMACOL, V76, P91, DOI 10.1124/mol.109.056085; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Mahata D, 2014, INT J BIOL MACROMOL, V69, P5, DOI 10.1016/j.ijbiomac.2014.05.017; Mandal M, 1998, ONCOGENE, V17, P999, DOI 10.1038/sj.onc.1202020; Michaud-Levesque J, 2012, EXP CELL RES, V318, P925, DOI 10.1016/j.yexcr.2012.02.017; Palumbo A, 2008, BLOOD, V111, P3968, DOI 10.1182/blood-2007-10-117457; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Pooja S, 2012, CYTOKINE, V60, P122, DOI 10.1016/j.cyto.2012.06.241; Puthier D, 1999, BRIT J HAEMATOL, V107, P392, DOI 10.1046/j.1365-2141.1999.01705.x; Rajput S, 2013, LIFE SCI, V93, P783, DOI 10.1016/j.lfs.2013.09.009; Rajput S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061342; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Rose-John S, 2002, TRENDS BIOTECHNOL, V20, P417, DOI 10.1016/S0167-7799(02)02056-5; Sachdev JC, 2012, CLIN BREAST CANCER, V12, P19, DOI 10.1016/j.clbc.2011.07.001; Sarkar S, 2011, J CELL PHYSIOL, V226, P375, DOI 10.1002/jcp.22343; Sethi G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-66; Shariat SF, 2011, J UROLOGY, V186, P2107, DOI 10.1016/j.juro.2011.06.048; Silver JS, 2010, J LEUKOCYTE BIOL, V88, P1145, DOI 10.1189/jlb.0410217; Su JL, 2005, CANCER RES, V65, P4827, DOI 10.1158/0008-5472.CAN-05-0188; Varghese JN, 2002, P NATL ACAD SCI USA, V99, P15959, DOI 10.1073/pnas.232432399; Venkatesan P, 2011, BIOMATERIALS, V32, P3794, DOI 10.1016/j.biomaterials.2011.01.027; Venkatesan SK, 2010, J COMPUT CHEM, V31, P2463, DOI 10.1002/jcc.21538; Voorhees PM, 2007, CLIN CANCER RES, V13, P6469, DOI 10.1158/1078-0432.CCR-07-1293; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Yosifov DY, 2012, LEUKEMIA RES, V36, P764, DOI 10.1016/j.leukres.2012.02.016	52	46	47	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 28	2016	35	30					3965	3975		10.1038/onc.2015.466	http://dx.doi.org/10.1038/onc.2015.466			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8DJ	26616855				2022-12-26	WOS:000381013100008
J	O'Hayre, M; Inoue, A; Kufareva, I; Wang, Z; Mikelis, CM; Drummond, RA; Avino, S; Finkel, K; Kalim, KW; DiPasquale, G; Guo, F; Aoki, J; Zheng, Y; Lionakis, MS; Molinolo, AA; Gutkind, JS				O'Hayre, M.; Inoue, A.; Kufareva, I.; Wang, Z.; Mikelis, C. M.; Drummond, R. A.; Avino, S.; Finkel, K.; Kalim, K. W.; DiPasquale, G.; Guo, F.; Aoki, J.; Zheng, Y.; Lionakis, M. S.; Molinolo, A. A.; Gutkind, J. S.			Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the G alpha(13)/RhoA axis in B cells	ONCOGENE			English	Article							PROTEIN-COUPLED RECEPTORS; HETEROTRIMERIC G-PROTEINS; SOMATIC MUTATIONS; UVEAL MELANOMA; ALPHA-SUBUNIT; P115 RHOGEF; G12 FAMILY; MIGRATION; GTPASE; ACTIVATION	G proteins and their cognate G protein-coupled receptors (GPCRs) function as critical signal transduction molecules that regulate cell survival, proliferation, motility and differentiation. The aberrant expression and/or function of these molecules have been linked to the growth, progression and metastasis of various cancers. As such, the analysis of mutations in the genes encoding GPCRs, G proteins and their downstream targets provides important clues regarding how these signaling cascades contribute to malignancy. Recent genome-wide sequencing efforts have unveiled the presence of frequent mutations in GNA13, the gene encoding the G protein G alpha(13), in Burkitt's lymphoma and diffuse large B-cell lymphoma (DLBCL). We found that mutations in the downstream target of G alpha(13), RhoA, are also present in Burkitt's lymphoma and DLBCL. By multiple complementary approaches, we now show that that these cancer-specific GNA13 and RHOA mutations are inhibitory in nature, and that the expression of wild-type G alpha(13) in B-cell lymphoma cells with mutant GNA13 has limited impact in vitro but results in a remarkable growth inhibition in vivo. Thus, although G alpha(13) and RhoA activity has previously been linked to cellular transformation and metastatic potential of epithelial cancers, our findings support a tumor suppressive role for G alpha(13) and RhoA in Burkitt's lymphoma and DLBCL.	[O'Hayre, M.; Wang, Z.; Avino, S.; Finkel, K.; Molinolo, A. A.; Gutkind, J. S.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Inoue, A.; Aoki, J.] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Inoue, A.] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Kufareva, I.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Mikelis, C. M.] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA; [Drummond, R. A.; Lionakis, M. S.] NIAID, Fungal Pathogenesis Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Avino, S.] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Cs, Italy; [Kalim, K. W.; Guo, F.; Zheng, Y.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [DiPasquale, G.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Aoki, J.] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, AMED, Chiyoda Ku, Tokyo, Japan; [Gutkind, J. S.] UC San Diego Moores Canc Ctr, Dept Pharmacol, 3855 Hlth Sci Dr,0803, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tohoku University; Japan Science & Technology Agency (JST); University of California System; University of California San Diego; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Calabria; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gutkind, JS (corresponding author), UC San Diego Moores Canc Ctr, Dept Pharmacol, 3855 Hlth Sci Dr,0803, La Jolla, CA 92093 USA.	sgutkind@ucsd.edu	Lionakis, Michail/J-8840-2017; Gutkind, J. Silvio/J-1201-2016; Drummond, Rebecca/I-3155-2019; Mikelis, Constantinos/AGF-9423-2022	Lionakis, Michail/0000-0003-4994-9500; Gutkind, J. Silvio/0000-0002-5150-4482; Drummond, Rebecca/0000-0001-5424-7074; Aoki, Junken/0000-0001-9435-1896; Kufareva, Irina/0000-0001-9083-7039	National Institute of Dental and Craniofacial Research intramural program at NIH; PRESTO from JST; AMED-CREST from AMED; Division of Intramural Research, NIAID, NIH; NIH [R01 GM071872, R01 AI118985]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118985, ZIAAI001175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071872] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research intramural program at NIH; PRESTO from JST(Japan Science & Technology Agency (JST)); AMED-CREST from AMED; Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institute of Dental and Craniofacial Research intramural program at NIH. We thank Maria S Degese for her help with immunohistochemistry. AI was funded by PRESTO from JST. JA was funded by AMED-CREST from AMED. We thank Miho Morikawa for technical assistance with the TGF alpha shedding assay. RAD and MSL are supported by the Division of Intramural Research, NIAID, NIH. IK is supported by NIH grants R01 GM071872 and R01 AI118985.	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Cattoretti G, 2009, CANCER RES, V69, P8686, DOI 10.1158/0008-5472.CAN-09-1110; Cools J, 2014, NAT GENET, V46, P320, DOI 10.1038/ng.2937; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Garcia-Marcos M, 2015, J BIOL CHEM, V290, P6697, DOI 10.1074/jbc.R114.613414; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Gutkind JS, 1998, CONT ENDOCRINOL, V6, P101; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Jaffe ES, 2011, HEMATOL-AM SOC HEMAT, P506, DOI 10.1182/asheducation-2011.1.506; Juneja J, 2009, BRIT J PHARMACOL, V158, P32, DOI 10.1111/j.1476-5381.2009.00180.x; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Manso R, 2014, BLOOD, V123, P2893, DOI 10.1182/blood-2014-02-555946; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Menon MP, 2012, CANCER J, V18, P411, DOI 10.1097/PPO.0b013e31826aee97; Mikelis CM, 2013, J BIOL CHEM, V288, P12232, DOI 10.1074/jbc.M112.428599; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rasheed SAK, 2013, J BIOL CHEM, V288, P7986, DOI 10.1074/jbc.M112.437749; Rohde M, 2014, GENE CHROMOSOME CANC, V53, P911, DOI 10.1002/gcc.22202; Roschewski M, 2014, NAT REV CLIN ONCOL, V11, P12, DOI 10.1038/nrclinonc.2013.197; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wang ZY, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju215; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916	47	48	49	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3771	3780		10.1038/onc.2015.442	http://dx.doi.org/10.1038/onc.2015.442			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26616858	Green Accepted			2022-12-26	WOS:000380753200003
J	Assayag-Asherie, N; Sever, D; Bogdani, M; Johnson, P; Weiss, T; Ginzberg, A; Perles, S; Weiss, L; Sebban, LE; Turley, EA; Okon, E; Raz, I; Naor, D				Assayag-Asherie, Nathalie; Sever, Dror; Bogdani, Marika; Johnson, Pamela; Weiss, Talya; Ginzberg, Ariel; Perles, Sharon; Weiss, Lola; Sebban, Lora Eshkar; Turley, Eva A.; Okon, Elimelech; Raz, Itamar; Naor, David			Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PANCREATIC BETA-CELLS; TOLL-LIKE RECEPTORS; MONOCLONAL-ANTIBODY; HYALURONIC-ACID; CANCER-CELLS; MICE; EXPRESSION; DEATH; MECHANISMS	CD44 is a multi-functional receptor with multiple of isoforms engaged in modulation of cell trafficking and transmission of apoptotic signals. We have previously shown that injection of anti-CD44 antibody into NOD mice induced resistance to type 1 diabetes (T1D). In this communication we describe our efforts to understand the mechanism underlying this effect. We found that CD44-deficient NOD mice develop stronger resistance to T1D than wild-type littermates. This effect is not explained by the involvement of CD44 in cell migration, because CD44-deficient inflammatory cells surprisingly had greater invasive potential than the corresponding wild type cells, probably owing to molecular redundancy. We have previously reported and we show here again that CD44 expression and hyaluronic acid (HA, the principal ligand for CD44) accumulation are detected in pancreatic islets of diabetic NOD mice, but not of non-diabetic DBA/1 mice. Expression of CD44 on insulin-secreting beta cells renders them susceptible to the autoimmune attack, and is associated with a diminution in beta-cells function (e.g., less insulin production and/or insulin secretion) and possibly also with an enhanced apoptosis rate. The diabetes-supportive effect of CD44 expression on beta cells was assessed by the TUNEL assay and further strengthened by functional assays exhibiting increased nitric oxide release, reduced insulin secretion after glucose stimulation and decreased insulin content in beta cells. All these parameters could not be detected in CD44-deficient islets. We further suggest that HA-binding to CD44-expressing a cells is implicated in beta-cell demise. Altogether, these data agree with the concept that CD44 is a receptor capable of modulating cell fate. This finding is important for other pathologies (e.g., cancer, neurodegenerative diseases) in which CD44 and HA appear to be implicated.	[Assayag-Asherie, Nathalie; Weiss, Talya; Ginzberg, Ariel; Perles, Sharon; Sebban, Lora Eshkar; Naor, David] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Lautenberg Ctr Immunol & Canc Res, IL-91120 Jerusalem, Israel; [Sever, Dror] Hadassah Univ Hosp, Dept Endocrinol, IL-91120 Jerusalem, Israel; [Bogdani, Marika; Johnson, Pamela] Benaroya Res Inst, Matrix Biol Program, Seattle, WA USA; [Weiss, Lola] Hebrew Univ Jerusalem, Hadassah Univ Hosp Ein Kerem, Dept Bone Marrow Transplantat & Canc Immunotherap, IL-91120 Jerusalem, Israel; [Turley, Eva A.] Univ Western Ontario, London Reg Canc Ctr, London, ON, Canada; [Okon, Elimelech] LEM Labs Sci Pk, Rehovot, Israel; [Raz, Itamar] Hadassah Univ Hosp, Diabet Unit, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Benaroya Research Institute; Hebrew University of Jerusalem; Western University (University of Western Ontario); Hebrew University of Jerusalem	Naor, D (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Lautenberg Ctr Immunol & Canc Res, IL-91120 Jerusalem, Israel.	davidn@ekmd.huji.ac.il			Johnson & Johnson Focused Giving program; Johnson & Johnson Corporate Office of Science and Technology (COSAT); LEM Laboratories Company	Johnson & Johnson Focused Giving program(Johnson & JohnsonJohnson & Johnson USA); Johnson & Johnson Corporate Office of Science and Technology (COSAT)(Johnson & JohnsonJohnson & Johnson USA); LEM Laboratories Company	The authors are grateful for support by Johnson & Johnson Focused Giving program and Johnson & Johnson Corporate Office of Science and Technology (COSAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Elimelech Okon is employed by LEM Laboratories Company. LEM Laboratories Company provided support in the form of salary for author EO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Benitez A, 2011, CANCER RES, V71, P4085, DOI 10.1158/0008-5472.CAN-10-4610; Boerner BP, 2011, ANN NY ACAD SCI, V1243, P103, DOI 10.1111/j.1749-6632.2011.06340.x; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Dasu MR, 2012, CLIN SCI, V122, P203, DOI 10.1042/CS20110357; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Du YR, 2013, INT J GYNECOL CANCER, V23, P1367, DOI 10.1097/IGC.0b013e3182a1d023; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 1996, DIABETOLOGIA, V39, P875; Golan I, 2007, J AUTOIMMUN, V28, P99, DOI 10.1016/j.jaut.2007.02.007; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Green L.C., 1982, BIOCHEMISTRY-US, V126, P131, DOI DOI 10.1016/0003-2697(82)90118-X; Hui HX, 2004, J CELL PHYSIOL, V200, P177, DOI 10.1002/jcp.20021; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kacheva S, 2011, CYTOKINE, V55, P195, DOI 10.1016/j.cyto.2011.04.002; Kang HH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058417, 10.1371/journal.pone.0084097]; Kodama K, 2012, P NATL ACAD SCI USA, V109, P7049, DOI 10.1073/pnas.1114513109; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Marino E, 2011, TRENDS IMMUNOL, V32, P287, DOI 10.1016/j.it.2011.03.006; Moore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031062; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Nedvetzki S, 2003, J CLIN INVEST, V111, P1211, DOI 10.1172/JCI200317100; Notkins AL, 2002, J BIOL CHEM, V277, P43545, DOI 10.1074/jbc.R200012200; PILARSKI LM, 1994, LEUKEMIA LYMPHOMA, V14, P363, DOI 10.3109/10428199409049691; Rockey DC, 1998, HEPATOLOGY, V27, P86, DOI 10.1002/hep.510270115; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Savinov AY, 2006, FASEB J, V20, P1793, DOI 10.1096/fj.06-6207com; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Sheehan KM, 2004, LIFE SCI, V75, P3087, DOI 10.1016/j.lfs.2004.02.038; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Tamada M, 2012, CANCER RES, V72, P1438, DOI 10.1158/0008-5472.CAN-11-3024; Tripathy D, 2010, CURR DIABETES REP, V10, P184, DOI 10.1007/s11892-010-0115-5; Vagima Y, 2009, J CLIN INVEST, V119, P492, DOI 10.1172/JCI36541; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Wang Q, 2002, AM J PATHOL, V161, P2219, DOI 10.1016/S0002-9440(10)64498-7; Weiss L, 2000, P NATL ACAD SCI USA, V97, P285, DOI 10.1073/pnas.97.1.285; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; YANG XD, 1994, P NATL ACAD SCI USA, V91, P12604, DOI 10.1073/pnas.91.26.12604	45	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143589	10.1371/journal.pone.0143589	http://dx.doi.org/10.1371/journal.pone.0143589			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624007	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600037
J	Luhung, I; Wu, Y; Ng, CK; Miller, D; Cao, B; Chang, VWC				Luhung, Irvan; Wu, Yan; Ng, Chun Kiat; Miller, Dana; Cao, Bin; Chang, Victor Wei-Chung			Protocol Improvements for Low Concentration DNA-Based Bioaerosol Sampling and Analysis	PLOS ONE			English	Article							AIRBORNE BACTERIA; TEMPORAL VARIABILITY; MICROORGANISMS; QUANTIFICATION; FUNGI; IDENTIFICATION; PARTICLES; TRANSPORT; SAMPLERS; SCIENCE	Introduction As bioaerosol research attracts increasing attention, there is a need for additional efforts that focus on method development to deal with different environmental samples. Bioaerosol environmental samples typically have very low biomass concentrations in the air, which often leaves researchers with limited options in choosing the downstream analysis steps, especially when culture-independent methods are intended. Objectives This study investigates the impacts of three important factors that can influence the performance of culture-independent DNA-based analysis in dealing with bioaerosol environmental samples engaged in this study. The factors are: 1) enhanced high temperature sonication during DNA extraction; 2) effect of sampling duration on DNA recoverability; and 3) an alternative method for concentrating composite samples. In this study, DNA extracted from samples was analysed using the Qubit fluorometer (for direct total DNA measurement) and quantitative polymerase chain reaction (qPCR). Results and Findings The findings suggest that additional lysis from high temperature sonication is crucial: DNA yields from both high and low biomass samples increased up to 600% when the protocol included 30-min sonication at 65 degrees C. Long air sampling duration on a filter media was shown to have a negative impact on DNA recoverability with up to 98% of DNA lost over a 20-h sampling period. Pooling DNA from separate samples during extraction was proven to be feasible with margins of error below 30%.	[Luhung, Irvan; Wu, Yan; Chang, Victor Wei-Chung] Berkeley Educ Alliance Res Singapore, SinBerBEST Program, Singapore, Singapore; [Luhung, Irvan; Wu, Yan; Cao, Bin; Chang, Victor Wei-Chung] Nanyang Technol Univ, Sch Civil & Environm Engn, Singapore 639798, Singapore; [Ng, Chun Kiat; Miller, Dana; Cao, Bin] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore; [Ng, Chun Kiat] Nanyang Technol Univ, Interdisciplinary Grad Sch, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chang, VWC (corresponding author), Berkeley Educ Alliance Res Singapore, SinBerBEST Program, Singapore, Singapore.	wcchang@ntu.edu.sg	Cao, Bin/AAA-3829-2021; CHANG, Victor Wei-Chung/A-3796-2011; Cao, Bin/H-2639-2012	CHANG, Victor Wei-Chung/0000-0003-4683-1267; Cao, Bin/0000-0002-9462-496X; Ng, Chun Kiat/0000-0002-1723-9988	Republic of Singapore's National Research Foundation; Singapore's National Research Foundation [NRF-CRP8-2011-03]; Ministry of Education - Singapore [MOE2013-T3-1-013]	Republic of Singapore's National Research Foundation(National Research Foundation, Singapore); Singapore's National Research Foundation(National Research Foundation, Singapore); Ministry of Education - Singapore(Ministry of Education, Singapore)	This research was funded by the Republic of Singapore's National Research Foundation through a grant to the Berkeley Education Alliance for Research in Singapore (BEARS) for the Singapore Berkeley Building Efficiency and Sustainability in the Tropics (SinBerBEST) Program. BEARS has been established by the University of California, Berkeley as a center for intellectual excellence in research and education in Singapore (http://sinberbest.berkeley.edu/). This research was also funded by Singapore's National Research Foundation, Award Number NRF-CRP8-2011-03; and Ministry of Education - Singapore, Award Number MOE2013-T3-1-013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HR, 2006, ATMOS ENVIRON, V40, P7924, DOI 10.1016/j.atmosenv.2006.07.020; Ariatti A., 1993, AEROBIOLOGIA, V9, P5; Betelli L, 2013, J MICROBIOL METH, V92, P25, DOI 10.1016/j.mimet.2012.10.009; Boreson J, 2004, ATMOS ENVIRON, V38, P6029, DOI 10.1016/j.atmosenv.2004.06.040; Burrows SM, 2009, ATMOS CHEM PHYS, V9, P9263, DOI 10.5194/acp-9-9263-2009; Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472; Carnelley T, 1888, P ROY SOC LONDON, V44, P455; Crook Brian, 2010, Fungal Biology Reviews, V24, P106, DOI 10.1016/j.fbr.2010.05.001; Cyprowski M, 2011, AEROBIOLOGIA, V27, P345, DOI 10.1007/s10453-011-9201-7; Duchaine C, 2001, APPL ENVIRON MICROB, V67, P2775, DOI 10.1128/AEM.67.6.2775-2780.2001; Dutkiewicz J., 1997, Annals of Agricultural and Environmental Medicine, V4, P11; Dybwad M, 2014, APPL ENVIRON MICROB, V80, P257, DOI 10.1128/AEM.02849-13; Eduard W, 1998, AM IND HYG ASSOC J, V59, P113, DOI 10.1080/15428119891010370; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gravesen S, 1999, ENVIRON HEALTH PERSP, V107, P505, DOI 10.1289/ehp.99107s3505; Green JL, 2014, INDOOR AIR, V24, P113, DOI 10.1111/ina.12090; GREGORY PH, 1971, PROC R SOC SER B-BIO, V177, P469, DOI 10.1098/rspb.1971.0043; HENNINGSON EW, 1994, J AEROSOL SCI, V25, P1459, DOI 10.1016/0021-8502(94)90219-4; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Hospodsky D, 2010, APPL ENVIRON MICROB, V76, P7004, DOI 10.1128/AEM.01240-10; JENSEN PA, 1992, AM IND HYG ASSOC J, V53, P660, DOI 10.1202/0002-8894(1992)053<0660:EOEBSC>2.0.CO;2; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; Lin XJ, 1999, ATMOS ENVIRON, V33, P4291, DOI 10.1016/S1352-2310(99)00169-7; Liu CM, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-56, 10.1186/1471-2180-12-255]; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Nazaroff WW, 2016, INDOOR AIR, V26, P61, DOI 10.1111/ina.12174; Nonnenmann MW, 2010, J OCCUP ENVIRON HYG, V7, P693, DOI 10.1080/15459624.2010.526893; Noris F, 2011, ATMOS ENVIRON, V45, P338, DOI 10.1016/j.atmosenv.2010.10.017; Peccia J, 2006, ATMOS ENVIRON, V40, P3941, DOI 10.1016/j.atmosenv.2006.02.029; Pilli S, 2011, ULTRASON SONOCHEM, V18, P1, DOI 10.1016/j.ultsonch.2010.02.014; Pribylka A, 2013, LAB CHIP, V13, P1695, DOI 10.1039/c3lc41305e; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Radosevich JL, 2002, LETT APPL MICROBIOL, V34, P162, DOI 10.1046/j.1472-765x.2002.01048.x; Rajasekar A, 2011, BUILD ENVIRON, V46, P2081, DOI 10.1016/j.buildenv.2011.04.021; Rintala H, 2012, ADV APPL MICROBIOL, V78, P75, DOI 10.1016/B978-0-12-394805-2.00004-X; Robe P, 2003, EUR J SOIL BIOL, V39, P183, DOI 10.1016/S1164-5563(03)00033-5; Schafer MP, 1999, AEROSOL SCI TECH, V30, P161, DOI 10.1080/027868299304750; Simon X, 2011, J AEROSOL SCI, V42, P517, DOI 10.1016/j.jaerosci.2011.05.002; Smith DJ, 2012, MICROB ECOL, V64, P973, DOI 10.1007/s00248-012-0088-9; THORNE PS, 1992, APPL ENVIRON MICROB, V58, P2543, DOI 10.1128/AEM.58.8.2543-2551.1992; Thos C, 1887, PHILOS T R SOC B, V178, P61, DOI DOI 10.1098/RSTB.1887.0004; Toivola M, 2002, J ENVIRON MONITOR, V4, P166, DOI 10.1039/b108682k; Tyler KD, 1997, J CLIN MICROBIOL, V35, P339, DOI 10.1128/JCM.35.2.339-346.1997; Vacher S, 2010, BUILD ENVIRON, V45, P916, DOI 10.1016/j.buildenv.2009.09.011; Wang CC, 2008, ENVIRON FORENSICS, V9, P6, DOI 10.1080/15275920701729175; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Wu Y, 2010, J AEROSOL SCI, V41, P869, DOI 10.1016/j.jaerosci.2010.05.006; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056896; Xu ZQ, 2011, AEROSOL SCI TECH, V45, P1337, DOI 10.1080/02786826.2011.593591; Yamamoto N, 2011, INDOOR AIR; Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731; Zhang YD, 2014, MOL BIOSYST, V10, P1035, DOI 10.1039/c3mb70520j	54	37	38	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0141158	10.1371/journal.pone.0141158	http://dx.doi.org/10.1371/journal.pone.0141158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619279	Green Published, gold			2022-12-26	WOS:000365889800005
J	Falandysz, J; Zhang, J; Wang, YZ; Saba, M; Krasinska, G; Wiejak, A; Li, T				Falandysz, Jerzy; Zhang, Ji; Wang, Yuan-Zhong; Saba, Martyna; Krasinska, Grazyna; Wiejak, Anna; Li, Tao			Evaluation of Mercury Contamination in Fungi Boletus Species from Latosols, Lateritic Red Earths, and Red and Yellow Earths in the Circum-Pacific Mercuriferous Belt of Southwestern China	PLOS ONE			English	Article							MUSHROOM MACROLEPIOTA-PROCERA; UNDERLYING SOIL SUBSTRATE; BIOCONCENTRATION FACTORS; EDIBLE MUSHROOMS; XEROCOMUS-BADIUS; FRUITING BODIES; WILD MUSHROOMS; MINERAL CONSTITUENTS; EDULIS MUSHROOM; HEAVY-METALS	For the first time, highly elevated levels of mercury (Hg) have been documented for several species of the edible Fungi genus Boletus growing in latosols, lateritic red earths, and red and yellow earths from the Yunnan province of China. Analysis of Hg concentrations in the genus suggests that geogenic Hg is the dominant source of Hg in the fungi, whereas anthropogenic sources accumulate largely in the organic layer of the forest soil horizon. Among the 21 species studied from 32 locations across Yunnan and 2 places in Sichuan Province, the Hg was found at elevated level in all samples from Yunnan but not in the samples from Sichuan, which is located outside the mercuriferous belt. Particularly abundant in Hg were the caps of fruiting bodies of Boletus aereus (up to 13mg kg(-1) dry matter), Boletus bicolor (up to 5.5 mg kg(-1) dry matter), Boletus edulis (up to 22mg kg(-1) dry matter), Boletus luridus (up to 11mg kg(-1) dry matter), Boletus magnificus (up to 13mg kg(-1) dry matter), Boletus obscureumbrinus (up to 9.4 mg kg(-1) dry matter), Boletus purpureus (up to 16 mg kg(-1) dry matter), Boletus sinicus (up to 6.8mg kg(-1) dry matter), Boletus speciosus (up to 4.9mg kg(-1) dry matter), Boletus tomentipes (up to 13mg kg(-1) dry matter), and Boletus umbriniporus (up to 4.9 mg kg(-1) dry matter). Soil samples of the 0-10 cm topsoil layer from the widely distributed locations had mercury levels ranging between 0.034 to 3.4 mg kg(-1) dry matter. In Yunnan, both the soil parent rock and fruiting bodies of Boletus spp. were enriched in Hg, whereas the same species from Sichuan, located outside the mercuriferous belt, had low Hg concentrations, suggesting that the Hg in the Yunnan samples is mainly from geogenic sources rather than anthropogenic sources. However, the contribution of anthropogenically-derived Hg sequestered within soils of Yunnan has not been quantified, so more future research is required. Our results suggest that high rates of consumption of Boletus spp. from Yunnan can deliver relatively high doses of Hg to consumers, but that rates can differ widely because of large variability in mercury concentrations between species and locations.	[Falandysz, Jerzy; Saba, Martyna; Krasinska, Grazyna; Wiejak, Anna] Univ Gdansk, Lab Environm Chem & Ecotoxicol, PL-80952 Gdansk, Poland; [Zhang, Ji; Wang, Yuan-Zhong] Yunnan Acad Agr Sci, Inst Med Plants, Kunming, Yunnan, Peoples R China; [Zhang, Ji; Wang, Yuan-Zhong] Yunnan Tech Ctr Qual Chinese Mat Med, Kunming, Peoples R China; [Li, Tao] Yuxi Normal Univ, Yuxi, Yunnan, Peoples R China	Fahrenheit Universities; University of Gdansk; Yunnan Academy of Agricultural Sciences; Yuxi Normal University	Falandysz, J (corresponding author), Univ Gdansk, Lab Environm Chem & Ecotoxicol, PL-80952 Gdansk, Poland.	jerzy.falandysz@ug.edu.pl; zjyaas@hotmail.com	Zhang, Ji/B-2830-2013; Lv, Yuanjie/AER-0767-2022; Falandysz, Jerzy/AAR-9241-2020	Zhang, Ji/0000-0002-7737-0785; Falandysz, Jerzy/0000-0003-2547-2496; Saba, Martyna/0000-0001-6210-898X	National Science Centre of Poland [UMO-2011/03/N/NZ9/04136]; National Natural Science Foundation of China [31460538, 31260496]; Science Foundation of the Yunnan Province Department of Education [2013Z074]	National Science Centre of Poland(National Science Centre, Poland); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the Yunnan Province Department of Education	This project in part was supported by the National Science Centre of Poland (UMO-2011/03/N/NZ9/04136), the National Natural Science Foundation of China (Nos. 31460538, 31260496), and the Science Foundation of the Yunnan Province Department of Education (2013Z074).	Arvay J, 2014, J ENVIRON SCI HEAL B, V49, P815, DOI 10.1080/03601234.2014.938550; BARGAGLI R, 1984, CHEMOSPHERE, V13, P1059, DOI 10.1016/0045-6535(84)90065-1; Bernas E, 2010, ACTA SCI POLON-TECHN, V9, P295; BYRNE AR, 1988, J ENVIRON RADIOACTIV, V6, P177, DOI 10.1016/0265-931X(88)90060-4; Chudzynski K, 2009, B ENVIRON CONTAM TOX, V83, P275, DOI 10.1007/s00128-009-9723-7; Cocchi L, 2006, FOOD CHEM, V98, P277, DOI 10.1016/j.foodchem.2005.05.068; Costa-Silva F, 2011, FOOD CHEM, V126, P91, DOI 10.1016/j.foodchem.2010.10.082; Drewnowska M, 2015, ECOTOX ENVIRON SAFE, V113, P9, DOI 10.1016/j.ecoenv.2014.11.028; Eckschlager K., 1974, BLEDY ANALIZIE CHEM; Falandysz J, 2008, J ENVIRON SCI HEAL A, V43, P1692, DOI 10.1080/10934520802330206; Falandysz J, 2007, FOOD CHEM, V105, P635, DOI 10.1016/j.foodchem.2007.04.024; FALANDYSZ J, 1991, FOOD ADDIT CONTAM, V8, P71, DOI 10.1080/02652039109373957; Falandysz J, 2012, FOOD ADDIT CONTAM A, V29, P951, DOI 10.1080/19440049.2012.662702; Falandysz J, 2003, WATER AIR SOIL POLL, V148, P127, DOI 10.1023/A:1025422017868; Falandysz J, 2003, J AGR FOOD CHEM, V51, P2832, DOI 10.1021/jf026016l; Falandysz J, 2003, FOOD ADDIT CONTAM, V20, P247, DOI 10.1080/0265203021000057485; Falandysz J, 2002, ENVIRON INT, V28, P421, DOI 10.1016/S0160-4120(02)00067-3; Falandysz J, 2002, J ENVIRON SCI HEAL A, V37, P343, DOI 10.1081/ESE-120002833; Falandysz J, 2002, J ENVIRON MONITOR, V4, P473, DOI 10.1039/b202946d; Falandysz J, 1985, Rocz Panstw Zakl Hig, V36, P119; Falandysz J, 2001, FOOD ADDIT CONTAM, V18, P503, DOI 10.1080/02652030010027624; Falandysz J, 2001, B ENVIRON CONTAM TOX, V67, P763; Falandysz J, 1996, Rocz Panstw Zakl Hig, V47, P377; FALANDYSZ J, 1990, FOOD CHEM, V38, P171, DOI 10.1016/0308-8146(90)90191-6; Falandysz J, 1996, ROCZN PANSTW ZAKL HI, V47, P206; Falandysz J, 2008, J ENVIRON SCI HEAL C, V26, P256, DOI 10.1080/10590500802350086; Falandysz J, 2008, ENVIRON GEOCHEM HLTH, V30, P121, DOI 10.1007/s10653-008-9133-5; Falandysz J, 2007, J ENVIRON SCI HEAL A, V42, P2089, DOI 10.1080/10934520701627058; Falandysz J, 2007, J ENVIRON SCI HEAL B, V42, P735, DOI 10.1080/03601230701466005; Falandysz J, 2015, SCI TOTAL ENVIRON, V537, P470, DOI 10.1016/j.scitotenv.2015.07.159; Falandysz J, 2015, ECOTOX ENVIRON SAFE, V115, P49, DOI 10.1016/j.ecoenv.2015.02.004; Falandysz J, 2014, ECOTOX ENVIRON SAFE, V110, P68, DOI 10.1016/j.ecoenv.2014.08.018; Falandysz J, 2014, J ENVIRON SCI HEAL B, V49, P690, DOI 10.1080/03601234.2014.922853; Falandysz J, 2014, ECOTOX ENVIRON SAFE, V104, P18, DOI 10.1016/j.ecoenv.2014.02.012; Falandysz J, 2013, APPL MICROBIOL BIOT, V97, P477, DOI 10.1007/s00253-012-4552-8; Falandysz J, 2013, FOOD CHEM, V138, P242, DOI 10.1016/j.foodchem.2012.10.046; Falandysz J, 2012, FOOD CHEM, V133, P842, DOI 10.1016/j.foodchem.2012.01.102; Falandysz J, 2011, J ENVIRON SCI HEAL B, V46, P231, DOI 10.1080/03601234.2011.540528; FISCHER RG, 1995, ENVIRON SCI TECHNOL, V29, P993, DOI 10.1021/es00004a020; Frankowska A, 2010, FOOD ADDIT CONTAM B, V3, P1, DOI 10.1080/19440040903505232; Giannaccini G, 2012, ENVIRON MONIT ASSESS, V184, P7579, DOI 10.1007/s10661-012-2520-5; Gucia M, 2012, J ENVIRON SCI HEAL B, V47, P81, DOI 10.1080/03601234.2012.611433; Gucia M, 2012, ENVIRON SCI POLLUT R, V19, P416, DOI 10.1007/s11356-011-0574-5; Gustin MS, 1999, J GEOPHYS RES-ATMOS, V104, P21831, DOI 10.1029/1999JD900351; He ZL, 2004, RED SOILS OF CHINA: THEIR NATURE, MANAGEMENT AND UTILIZATION, P29; Huang CF, 2007, TOXICOL APPL PHARM, V224, P192, DOI 10.1016/j.taap.2007.07.003; Index Fungorum, 2015, INDEX FUNGORUM; Isaac S., 1995, MYCOLOGIST, V9, P90; Jarzynska G, 2011, J ENVIRON SCI HEAL A, V46, P569, DOI 10.1080/10934529.2011.562816; JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2010, 72 M ROM FEBR 16 25; Kabata-Pendias Alina, 2010, P1; Kalac P., 1997, POTRAV VEDY, V15, P405; Kojta AK, 2012, J GEOCHEM EXPLOR, V121, P76, DOI 10.1016/j.gexplo.2012.08.004; Li T, 2008, SPECTROSC SPECT ANAL, V28, P943; Ma Pei, 2012, Environmental Science & Technology (China), V35, P5; Martena MJ, 2010, FOOD ADDIT CONTAM A, V27, P190, DOI 10.1080/02652030903207235; Melgar MJ, 2009, SCI TOTAL ENVIRON, V407, P5328, DOI 10.1016/j.scitotenv.2009.07.001; Mietelski JW, 2010, J ENVIRON RADIOACTIV, V101, P706, DOI 10.1016/j.jenvrad.2010.04.010; Mleczek M, 2013, J ENVIRON SCI HEAL B, V48, P308, DOI 10.1080/03601234.2013.743799; Mleczek M, 2013, J ENVIRON SCI HEAL B, V48, P69, DOI 10.1080/03601234.2012.716733; Nasr M, 2011, APPL GEOCHEM, V26, P1905, DOI 10.1016/j.apgeochem.2011.06.014; Nnorom IC, 2013, J FOOD COMPOS ANAL, V29, P73, DOI 10.1016/j.jfca.2012.10.001; Ostos C, 2015, J FOOD COMPOS ANAL, V37, P136, DOI 10.1016/j.jfca.2014.04.014; Qiu GL, 2012, APPL GEOCHEM, V27, P2280, DOI 10.1016/j.apgeochem.2012.08.003; Ralston NVC, 2010, TOXICOLOGY, V278, P112, DOI 10.1016/j.tox.2010.06.004; Ralston NVC, 2014, SELENIUM ENV HUMAN H, P203; Rieder SR, 2011, ENVIRON POLLUT, V159, P2861, DOI 10.1016/j.envpol.2011.04.040; Rodrigues SM, 2014, SCI TOTAL ENVIRON, V496, P649, DOI 10.1016/j.scitotenv.2014.06.115; SCHEMENAUER RS, 1995, ATMOS ENVIRON, V29, P2235, DOI 10.1016/1352-2310(95)00153-P; SCHUSTER E, 1991, WATER AIR SOIL POLL, V56, P667, DOI 10.1007/BF00342308; SEEGER R, 1981, SCI TOTAL ENVIRON, V19, P253, DOI 10.1016/0048-9697(81)90021-8; Shi JB, 2013, ENVIRON SCI POLLUT R, V20, P1756, DOI 10.1007/s11356-012-1115-6; Stijve T, 1974, TRAV CHIM ALIMENT HY, V65, P209; Svoboda L, 2000, SCI TOTAL ENVIRON, V246, P61, DOI 10.1016/S0048-9697(99)00411-8; Svoboda L, 2002, FOOD CHEM, V79, P41, DOI 10.1016/S0308-8146(02)00175-9; Tan HP, 2005, J AGR SCI, V18, P747; Wen X., 2007, GEOCHIMICA, V36, P633, DOI DOI 10.19700/J.0379-1726.2007.06.010; Wiejak A, 2015, SPECTROSC S IN PRESS, V35; Wiejak A, 2014, J ENVIRON SCI HEAL B, V49, P811, DOI 10.1080/03601234.2014.938549; Zhang D, 2010, AFR J AGR RES, V5, P3050; [张丹 ZHANG Dan], 2008, [安全与环境学报, Journal of Safety and Environment], V8, P112; [张丹 ZHANG Dan], 2006, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V12, P348; [张丹 Zhang Dan], 2004, [山地学报, Journal of Mountain Science], V22, P767; Zhang H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03322; Zhang H, 2010, ENVIRON HEALTH PERSP, V118, P1183, DOI 10.1289/ehp.1001915	85	55	56	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143608	10.1371/journal.pone.0143608	http://dx.doi.org/10.1371/journal.pone.0143608			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606425	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300088
J	Kopp, M; Rychlik, M				Kopp, Markus; Rychlik, Michael			Quantitation of 5-Methyltetrahydrofolic Acid in Dried Blood Spots and Dried Plasma Spots by Stable Isotope Dilution Assays	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; FOLIC-ACID; LC-MS/MS; FOLATE; SERUM; VITAMERS	Because of minimal data available on folate analysis in dried matrix spots (DMSs), we combined the advantages of stable isotope dilution assays followed by LC-MS/MS analysis with DMS sampling to develop a reliable method for the quantitation of plasma 5-methyltetrahydrofolic acid in dried blood spots (DBSs) and dried plasma spots (DPSs) as well as for the quantitation of whole blood 5-methyltetrahydrofolic acid in DBSs. We focused on two diagnostically conclusive parameters exhibited by the plasma and whole blood 5-methyltetrahydrofolic acid levels that reflect both temporary and long-term folate status. The method is performed using the [H-2(4)]-labeled isotopologue of the vitamin as the internal standard, and three steps are required for the extraction procedure. Elution of the punched out matrix spots was performed using stabilization buffer including Triton X-100 in a standardized ultrasonication treatment followed by enzymatic digestion (whole blood only) and solidphase extraction with SAX cartridges. This method is sensitive enough to quantify 27 nmol/L whole blood 5-methyltetrahydrofolic acid in DBSs and 6.3 and 4.4 nmol/L plasma 5-methyltetrahydrofolic acid in DBSs and DPSs, respectively. The unprecedented accurate quantification of plasma 5-methyltetrahydrofolic acid in DBSs was achieved by thermal treatment prior to ultrasonication, inhibiting plasma conjugase activity. Mass screenings are more feasible and easier to facilitate for this method in terms of sample collection and storage compared with conventional clinical sampling for the assessment of folate status.	[Kopp, Markus; Rychlik, Michael] Tech Univ Munich, Chair Analyt Food Chem, Freising Weihenstephan, Germany; [Kopp, Markus] Tech Univ Munich, Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich	Rychlik, M (corresponding author), Tech Univ Munich, Chair Analyt Food Chem, Freising Weihenstephan, Germany.	michael.rychlik@tum.de	Rychlik, Michael/G-6064-2015	Rychlik, Michael/0000-0002-5826-6288; Kopp, Markus/0000-0003-2166-3164	TUM, DFG; TUM Open Access Publishing Fund; TUM Graduate School; Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany	TUM, DFG; TUM Open Access Publishing Fund; TUM Graduate School; Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany	Funded by TUM, DFG (http://www.ub.tum.de/en/publication-fund), TUM Open Access Publishing Fund, and TUM Graduate School (https://www.gs.tum.de/en/about-tum-gs/) (Support for MK).; The assistance of Sami Kaviani-Nejad and Ines Otte from the German Research Centre for Food Chemistry (Freising, Germany) for operating the LC-MS/MS equipment, and the participation of all volunteers involved in the pilot studies is greatly acknowledged. Moreover, the authors gratefully acknowledge the support by the Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany.	Caudill M, 2004, J FOOD SCI, V69, pS55, DOI 10.1111/j.1365-2621.2004.tb17887.x; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; da Silva AL, 2006, GENET MOL BIOL, V29, P439, DOI 10.1590/S1415-47572006000300005; Deep A., 2012, INT J PHARM SCI REV, V15, P90; Demirev PA, 2013, ANAL CHEM, V85, P779, DOI 10.1021/ac303205m; European Food Safety Authority, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3835, 10.2903/j.efsa.2014.3595, 10.2903/j.efsa.2014.3761]; Fazili Z, 2004, CLIN CHEM, V50, P2378, DOI 10.1373/clinchem.2004.036541; Fazili Z, 2008, CLIN CHEM, V54, P197, DOI 10.1373/clinchem.2007.096545; Fogh-Andersen N, 1998, CLIN CHEM, V44, P655; Freisleben A, 2002, J AGR FOOD CHEM, V50, P4760, DOI 10.1021/jf025571k; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Izmirli M, 2013, MOL BIOL REP, V40, P625, DOI 10.1007/s11033-012-2101-2; Krawinkel MB, 2014, EUR J CLIN NUTR, V68, P719, DOI 10.1038/ejcn.2014.45; Leichtle AB, 2010, J TRANSPLANT, V2010, DOI 10.1155/2010/201918; Monch S, 2010, ANAL BIOCHEM, V398, P150, DOI 10.1016/j.ab.2009.11.007; O'Broin S, 2002, CLIN CHEM, V48, P1128; O'Broin SD, 1999, AM J CLIN NUTR, V70, P359; OBroin SD, 1997, AM J CLIN NUTR, V66, P1398, DOI 10.1093/ajcn/66.6.1398; Ohrvik VE, 2010, AM J CLIN NUTR, V92, P532, DOI 10.3945/ajcn.2009.29031; Pfeiffer CM, 2004, CLIN CHEM, V50, P423, DOI 10.1373/clinchem.2003.026955; REED LS, 1980, J AGR FOOD CHEM, V28, P801, DOI 10.1021/jf60230a044; Ringling C, 2013, EUR FOOD RES TECHNOL, V236, P17, DOI 10.1007/s00217-012-1849-x; Robinson K, 2000, HEART, V83, P127, DOI 10.1136/heart.83.2.127; Rychlik M, 2003, J CHROMATOGR B, V792, P167, DOI 10.1016/S1570-0232(03)00254-X; Rychlik M, 2012, B VITAMINS FOLATE, P396; Selhub J, 2002, J Nutr Health Aging, V6, P39; Snowdon DA, 2000, AM J CLIN NUTR, V71, P993; Thomas AH, 2000, J PHOTOCH PHOTOBIO A, V135, P147, DOI 10.1016/S1010-6030(00)00304-X; Verlinde PHCJ, 2010, J AGR FOOD CHEM, V58, P6190, DOI 10.1021/jf9041134; Vogelgesang J, 1998, ACCREDIT QUAL ASSUR, V3, P242, DOI 10.1007/s007690050234	30	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143639	10.1371/journal.pone.0143639	http://dx.doi.org/10.1371/journal.pone.0143639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605791	gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300093
J	Levin, L; Bar-Yaacov, D; Bouskila, A; Chorev, M; Carmel, L; Mishmar, D				Levin, Liron; Bar-Yaacov, Dan; Bouskila, Amos; Chorev, Michal; Carmel, Liran; Mishmar, Dan			LEMONS - A Tool for the Identification of Splice Junctions in Transcriptomes of Organisms Lacking Reference Genomes	PLOS ONE			English	Article							RNA-SEQ DATA; INTRON POSITIONS; CONSERVATION; EVOLUTION; SYSTEM; MATE	RNA-seq is becoming a preferred tool for genomics studies of model and non-model organisms. However, DNA-based analysis of organisms lacking sequenced genomes cannot rely on RNA-seq data alone to isolate most genes of interest, as DNA codes both exons and introns. With this in mind, we designed a novel tool, LEMONS, that exploits the evolutionary conservation of both exon/intron boundary positions and splice junction recognition signals to produce high throughput splice-junction predictions in the absence of a reference genome. When tested on multiple annotated vertebrate mRNA data, LEMONS accurately identified 87% (average) of the splice-junctions. LEMONS was then applied to our updated Mediterranean chameleon transcriptome, which lacks a reference genome, and predicted a total of 90,820 exon-exon junctions. We experimentally verified these splice-junction predictions by amplifying and sequencing twenty randomly selected genes from chameleon DNA templates. Exons and introns were detected in 19 of 20 of the positions predicted by LEMONS. To the best of our knowledge, LEMONS is currently the only experimentally verified tool that can accurately predict splice-junctions in organisms that lack a reference genome.	[Levin, Liron; Bar-Yaacov, Dan; Bouskila, Amos; Mishmar, Dan] Ben Gurion Univ Negev, Dept Life Sci, IL-8410501 Beer Sheva, Israel; [Chorev, Michal; Carmel, Liran] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; [Chorev, Michal] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel	Ben Gurion University; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Mishmar, D (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-8410501 Beer Sheva, Israel.	dmishmar@bgu.ac.il	Mishmar, Dan/AAJ-6109-2020; Bouskila, Amos/B-4847-2010	Mishmar, Dan/0000-0003-3488-8792; Bouskila, Amos/0000-0002-6995-5070; Chorev, Michal/0000-0003-3533-2913; Bar Yaacov, Dan/0000-0002-0599-5153	Israeli Science Foundation (ISF) [610-12]; Binational Science Foundation (BSF); Kreitman School of Advanced Graduate Studies	Israeli Science Foundation (ISF)(Israel Science Foundation); Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Kreitman School of Advanced Graduate Studies	This work was supported by the Israeli Science Foundation (ISF) (grant number 610-12) and Binational Science Foundation (BSF) grant awarded to DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Kreitman School of Advanced Graduate Studies for a Negev Scholarship of Excellence granted to DBY and LL.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ameur A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r34; Au KF, 2010, NUCLEIC ACIDS RES, V38, P4570, DOI 10.1093/nar/gkq211; Bar-Yaacov D, 2013, GENOME BIOL EVOL, V5, P1792, DOI 10.1093/gbe/evt131; Barreto FS, 2011, MOL ECOL, V20, P560, DOI 10.1111/j.1365-294X.2010.04963.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Chorev M, 2013, NUCLEIC ACIDS RES, V41, P5604, DOI 10.1093/nar/gkt244; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Cloonan N, 2009, BIOINFORMATICS, V25, P2615, DOI 10.1093/bioinformatics/btp459; Fedorov A, 2002, P NATL ACAD SCI USA, V99, P16128, DOI 10.1073/pnas.242624899; Gelfman S, 2012, GENOME RES, V22, P35, DOI 10.1101/gr.119834.110; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hasan S, 2013, BIOINFORMATION, V9, P210, DOI 10.6026/97320630009210; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Romiguier J, 2014, NATURE, V515, P261, DOI 10.1038/nature13685; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trier CN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004075; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wood DLA, 2011, BIOINFORMATICS, V27, P580, DOI 10.1093/bioinformatics/btq698; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143329	10.1371/journal.pone.0143329	http://dx.doi.org/10.1371/journal.pone.0143329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606265	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300057
J	Poiroux, E; Cavaro-Menard, C; Leruez, S; Lemee, JM; Richard, I; Dinomais, M				Poiroux, Elodie; Cavaro-Menard, Christine; Leruez, Stephanie; Lemee, Jean Michel; Richard, Isabelle; Dinomais, Mickael			What Do Eye Gaze Metrics Tell Us about Motor Imagery?	PLOS ONE			English	Article							MENTAL PRACTICE; MOVEMENTS; STROKE; CHRONOMETRY; SCANPATHS; CORTEX; PERFORMANCE; ACTIVATION; SIMULATION; EXECUTION	Many of the brain structures involved in performing real movements also have increased activity during imagined movements or during motor observation, and this could be the neural substrate underlying the effects of motor imagery in motor learning or motor rehabilitation. In the absence of any objective physiological method of measurement, it is currently impossible to be sure that the patient is indeed performing the task as instructed. Eye gaze recording during a motor imagery task could be a possible way to "spy" on the activity an individual is really engaged in. The aim of the present study was to compare the pattern of eye movement metrics during motor observation, visual and kinesthetic motor imagery (VI, KI), target fixation, and mental calculation. Twenty-two healthy subjects (16 females and 6 males), were required to perform tests in five conditions using imagery in the Box and Block Test tasks following the procedure described by Liepert et al. Eye movements were analysed by a non-invasive oculometric measure (SMI RED250 system). Two parameters describing gaze pattern were calculated: the index of ocular mobility (saccade duration over saccade + fixation duration) and the number of midline crossings (i.e. the number of times the subjects gaze crossed the midline of the screen when performing the different tasks). Both parameters were significantly different between visual imagery and kinesthesic imagery, visual imagery and mental calculation, and visual imagery and target fixation. For the first time we were able to show that eye movement patterns are different during VI and KI tasks. Our results suggest gaze metric parameters could be used as an objective unobtrusive approach to assess engagement in a motor imagery task. Further studies should define how oculomotor parameters could be used as an indicator of the rehabilitation task a patient is engaged in.	[Poiroux, Elodie; Cavaro-Menard, Christine; Leruez, Stephanie; Dinomais, Mickael] Univ Angers, LUNAM, LARIS, EA 7315, F-49000 Angers, France; [Poiroux, Elodie; Richard, Isabelle; Dinomais, Mickael] Univ Angers, LUNAM, Dept Med Phys & Readaptat, CHU Angers, F-49933 Angers 9, France; [Leruez, Stephanie] Univ Angers, LUNAM, Dept Ophtalmol, CHU Angers, F-49933 Angers 9, France; [Lemee, Jean Michel] Univ Angers, LUNAM, Dept Neurochirurg, CHU Angers, F-49933 Angers 9, France; [Lemee, Jean Michel] Univ Angers, LUNAM, INSERM Micro & Nanomed Biomimet U1066, CHU Angers, F-49933 Angers 9, France; [Richard, Isabelle] Univ Angers, LUNAM, Lab Epidemiol Ergon & Sante Travail, EA 4626, F-49000 Angers, France	Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers	Poiroux, E (corresponding author), Univ Angers, LUNAM, LARIS, EA 7315, F-49000 Angers, France.	elodie.poiroux@laposte.net	Lemee, Jean-Michel/L-6884-2015	Lemee, Jean-Michel/0000-0002-0720-9101				Brandt SA, 1997, J COGN NEUROSCI, V9; Braun SM, 2006, ARCH PHYS MED REHAB, V87, P842, DOI 10.1016/j.apmr.2006.02.034; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Causer J, 2013, FRONT HUM NEUROSCI, V7; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; de'Sperati C, 2003, J COGNITIVE NEUROSCI, V15, P1244, DOI 10.1162/089892903322598184; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Dickstein R, 2007, PHYS THER, V87, P942, DOI 10.2522/ptj.20060331; Dodakian L, 2014, J REHABIL MED, V46, P843, DOI 10.2340/16501977-1844; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Flanagan JR, 2003, NATURE, P424; Foulsham T, 2012, J EYE MOVEMENT RES, V5; Funahashi S, 2014, FRONT INTEGR NEUROSC, P8; Gregg M, 2010, EVID-BASED COMPL ALT, V7, P249, DOI 10.1093/ecam/nem170; Greiner J, 2014, ARCH GERONTOL GERIAT, V58, P226, DOI 10.1016/j.archger.2013.09.003; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Gueugneau N, 2008, BRAIN RES, V1187, P95, DOI 10.1016/j.brainres.2007.10.042; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guillot A, 2005, J MOT BEHAV, V37; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; HEBB DO, 1968, PSYCHOL REV, V75, P466, DOI 10.1037/h0026771; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Heremans E, 2011, NEUROSCIENCE, V195, P37, DOI 10.1016/j.neuroscience.2011.07.030; Heremans E, 2008, BEHAV BRAIN RES, V187, P351, DOI 10.1016/j.bbr.2007.09.028; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Hetu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024728; Ietswaart M, 2011, BRAIN, V134, P1373, DOI 10.1093/brain/awr077; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Josephson S, 2002, BEHAV RES METH INS C, V34, P539, DOI 10.3758/BF03195483; Kosilo M, 2013, FRONT PSYCHOL, P4; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; Lebon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037850; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Liepert J, 2012, NEUROREHAB NEURAL RE, V26, P470, DOI 10.1177/1545968311425924; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Loison B., 2013, Annals of Physical and Rehabilitation Medicine, V56, P157, DOI 10.1016/j.rehab.2013.01.001; Macuga KL, 2011, NEUROIMAGE, P2798, DOI DOI 10.1016/J.NEUROIMAGE.2011.09.083; Malouin F, 2013, FRONT HUM NEUROSCI, V7; Malouin F, 2008, NEUROREHAB NEURAL RE, V22, P330, DOI 10.1177/1545968307313499; Malouin F, 2008, ARCH PHYS MED REHAB, V89, P311, DOI 10.1016/j.apmr.2007.11.006; McCormick SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067761; McCormick SA, 2012, BRAIN COGNITION, V80, P83, DOI 10.1016/j.bandc.2012.04.010; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Mutha PK, 2011, J NEUROSCI, V31, P6972, DOI 10.1523/JNEUROSCI.6432-10.2011; NOTON D, 1971, VISION RES, V11, P929, DOI 10.1016/0042-6989(71)90213-6; NOTON D, 1971, SCIENCE, V171, P308, DOI 10.1126/science.171.3968.308; Oostra KM, 2014, J REHABIL MED; Page SJ, 2001, PHYS THER, V81, P1455, DOI 10.1093/ptj/81.8.1455; Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, J EXP PSYCHOL GEN, V116, P172, DOI 10.1037/0096-3445.116.2.172; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Porro CA, 1996, J NEUROSCI, V16, P7688; Privitera CM, 2000, IEEE T PATTERN ANAL, V22, P970, DOI 10.1109/34.877520; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Siegenthaler E, 2014, EUR J NEUROSCI, V39, P287, DOI 10.1111/ejn.12395; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Spivey MJ, 2001, PSYCHOL RES-PSYCH FO, V65, P235, DOI 10.1007/s004260100059; Ter Horst AC, 2012, PLOS ONE, V7; Torres EB, 2010, J NEUROPHYSIOL, V104, P2375, DOI 10.1152/jn.00089.2010; Totten E., 1935, COMP PSYCHOL MONOGR, V11, P46; Turella L, 2009, NEUROIMAGE, V46, P844, DOI 10.1016/j.neuroimage.2009.03.002; Vernet M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00088	66	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143831	10.1371/journal.pone.0143831	http://dx.doi.org/10.1371/journal.pone.0143831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7ES	26605915	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300114
J	Kong, XM; Zhang, XL; Xing, XY; Zhang, B; Hong, J; Yang, WY				Kong, Xiaomu; Zhang, Xuelian; Xing, Xiaoyan; Zhang, Bo; Hong, Jing; Yang, Wenying			The Association of Type 2 Diabetes Loci Identified in Genome-Wide Association Studies with Metabolic Syndrome and Its Components in a Chinese Population with Type 2 Diabetes	PLOS ONE			English	Article							BETA-CELL FUNCTION; ORAL GLUCOSE-TOLERANCE; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; COMMON VARIANTS; GLYCEMIC TRAITS; LIPID-LEVELS; PPAR-GAMMA	Metabolic syndrome (MetS) is prevalent in type 2 diabetes (T2D) patients. The comorbidity of MetS and T2D increases the risk of cardiovascular complications. The aim of the present study was to determine the T2D-related genetic variants that contribute to MetS-related components in T2D patients of Chinese ancestry. We successfully genotyped 25 genome wide association study validated T2D-related single nucleotide polymorphisms (SNPs) among 5,169 T2D individuals and 4,560 normal glycemic controls recruited from the Chinese National Diabetes and Metabolic Disorders Study (DMS). We defined MetS in this population using the harmonized criteria (2009) combined with the Chinese criteria for abdominal obesity. The associations between SNPs and MetS-related components, as well as the associations between SNPs and risk for T2D with or without MetS, were subjected to logistic regression analysis adjusted for age and sex. Results showed that the T2D risk alleles of rs243021 located near BCL11A, rs10830963 in MTNR1B, and rs2237895 in KCNQ1 were related to a lower risk for abdominal obesity in T2D patients (rs243021: 0.92 (0.84, 1.00), P = 4.42 x 10(-2); rs10830963: 0.92 (0.85, 1.00), P = 4.07 x 10(-2); rs2237895: 0.89 (0.82, 0.98), P = 1.29 x 10(-2)). The T2D risk alleles of rs972283 near KLF14 contributed to a higher risk of elevated blood pressure (1.10 (1.00, 1.22), P = 4.48 x 10(-2)), while the T2D risk allele of rs7903146 in TCF7L2 was related to a lower risk for elevated blood pressure (0.74 (0.61, 0.90), P = 2.56 x 10(-3)). The T2D risk alleles of rs972283 near KLF14 and rs11634397 near ZFAND6 were associated with a higher risk for elevated triglycerides (rs972283: 1.11 (1.02, 1.24), P = 1.46 x 10(-2); rs11634397: 1.14 (1.00, 1.29), P = 4.66 x 10(-2)), while the T2D risk alleles of rs780094 in GCKR and rs7903146 in TCF7L2 were related to a lower risk of elevated triglycerides (rs780094: 0.86 (0.80, 0.93), P = 1.35x 10-4; rs7903146: 0.82 (0.69, 0.98), P = 3.18 x 10(-2)). The genotype risk score of the 25 T2D-related SNPs was related to a lower risk for abdominal obesity (Ptrend = 1.29 x 10(-2)) and lower waist circumference (P = 2.20 x 10(-3)). Genetic variants of WFS1, CDKAL1, CDKN2BAS, TCF7L2, HHEX, KCNQ1, TSPAN8/LGR5, FTO, and TCF2 were associated with the risk for T2D with MetS, as well as the risk for development of T2D with at least one of the MetS components (P < 0.05). addition, genetic variants of BCL11A, GCKR, ADAMTS9, CDKAL1, KLF14, CDKN2BAS, TCF7L2, CDC123/CAMK1D, HHEX, MTNR1B, and KCNQ1 contributed to the risk for T2D without MetS (P < 0.05). In conclusion, these findings highlight the contribution of T2D-related genetic loci to MetS in a Chinese Han population. The study also provides insight into the pleotropic effects of genome-wide association loci of diabetes onmetabolic regulation.	[Kong, Xiaomu; Zhang, Xuelian; Xing, Xiaoyan; Zhang, Bo; Hong, Jing; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China	China-Japan Friendship Hospital	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China.	ywying_1010@163.com	Zhang, Bo/ABE-8008-2020	Kong, Xiaomu/0000-0002-5920-4759; Yang, Wenying/0000-0002-7997-9404	Chinese Medical Association Foundation; Sanofi (China) Investment Company Limited; National 973 Program [2011CB504001]; China Postdoctoral Science Foundation [2012M520200]; Fogarty International Center of the National Institutes of Health [D43TW009107]	Chinese Medical Association Foundation; Sanofi (China) Investment Company Limited; National 973 Program(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Chinese National Diabetes and Metabolic Disorders Study was supported by grants from the Chinese Medical Association Foundation (http://en.cma.org.cn), Sanofi (China) Investment Company Limited (http://www.sanofi.cn/l/cn/zh/index.jsp) and the National 973 Program (2011CB504001) (http://www.973.gov.cn). XK was supported by Award Number 2012M520200 from China Postdoctoral Science Foundation Grant (http://res.chinapostdoctor.org.cn) and the Award Number D43TW009107 from Fogarty International Center of the National Institutes of Health (http://www.fic.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar SA, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-5; Ali O, 2013, WORLD J DIABETES, V4, P114, DOI 10.4239/wjd.v4.i4.114; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bao YQ, 2008, ATHEROSCLEROSIS, V201, P378, DOI 10.1016/j.atherosclerosis.2008.03.001; Bellia A, 2009, NUTR METAB CARDIOVAS, V19, P455, DOI 10.1016/j.numecd.2008.11.002; Bonnet F, 2013, DIABETOLOGIA, V56, P2414, DOI 10.1007/s00125-013-3021-y; Brunetti A, 2014, WORLD J DIABETES, V5, P128, DOI 10.4239/wjd.v5.i2.128; Chen X, 2012, J THROMB HAEMOST, V10, P1508, DOI 10.1111/j.1538-7836.2012.04815.x; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Cruz M, 2010, DIABETES-METAB RES, V26, P261, DOI 10.1002/dmrr.1082; de Assuncao TM, 2014, J BIOL CHEM, V289, P15798, DOI 10.1074/jbc.M113.544346; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Hossain S, 2014, DIABETES METAB SYNDR; Hotta K, 2011, J HUM GENET, V56, P647, DOI 10.1038/jhg.2011.74; Irwin DM, 2014, MOL PHYLOGENET EVOL, V70, P195, DOI 10.1016/j.ympev.2013.09.016; Jeong Seok Won, 2014, Genomics & Informatics, V12, P187, DOI 10.5808/GI.2014.12.4.187; Jonsson A, 2013, DIABETES, V62, P2978, DOI 10.2337/db12-1627; Karns R, 2011, EUR J HUM GENET, V19, P341, DOI 10.1038/ejhg.2010.178; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kong XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071399; Ling Y, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-66; Liu Y, 2009, DIABETOLOGIA, V52, P1315, DOI 10.1007/s00125-009-1375-y; Liu Y, 2011, J LIPID RES, V52, P354, DOI 10.1194/jlr.P007476; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Monda Keri L., 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P86; Mulder H, 2009, DIABETOLOGIA, V52, P1240, DOI 10.1007/s00125-009-1359-y; Peter I, 2012, OBESITY, V20, P1675, DOI 10.1038/oby.2012.11; Phillips CM, 2012, J NUTR BIOCHEM, V23, P239, DOI 10.1016/j.jnutbio.2010.11.020; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Pokharel DR, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0104-3; Povel CM, 2011, OBES REV, V12, P952, DOI 10.1111/j.1467-789X.2011.00907.x; Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Rodriguez A, 2011, DIABET METAB SYND OB, V4, P1, DOI 10.2147/DMSOTT.S13457; Saadi H, 2008, DIABETES RES CLIN PR, V80, P392, DOI 10.1016/j.diabres.2008.01.008; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Sanghera DK, 2009, J HUM GENET, V54, P162, DOI 10.1038/jhg.2009.7; Sarzani R, 2008, J HUM HYPERTENS, V22, P373, DOI 10.1038/jhh.2008.8; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schleinitz D, 2010, HORM METAB RES, V42, P14, DOI 10.1055/s-0029-1233480; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shi H, 2012, ARCH MED RES, V43, P233, DOI 10.1016/j.arcmed.2012.03.006; Simonis-Bik AM, 2010, DIABETES, V59, P293, DOI 10.2337/db09-1048; Sjogren M, 2008, DIABETOLOGIA, V51, P2242, DOI 10.1007/s00125-008-1151-4; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sookoian S, 2011, CURR HYPERTENS REP, V13, P149, DOI 10.1007/s11906-010-0164-9; Stancakova A, 2014, REV ENDOCR METAB DIS, V15, P243, DOI 10.1007/s11154-014-9293-9; Stancakova A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Sun X, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/926713; Tan MC, 2014, SE ASIAN J TROP MED, V45, P226; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wang JJ, 2014, HUM IMMUNOL, V75, P342, DOI 10.1016/j.humimm.2014.01.008; Wang T, 2010, CHINESE MED J-PEKING, V123, P1852, DOI 10.3760/cma.j.issn.0366-6999.2010.14.005; Wang Yu-ping, 2013, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V30, P467, DOI 10.3760/cma.j.issn.1003-9406.2013.04.019; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yamagata K, 2011, BIOCHEM BIOPH RES CO, V407, P620, DOI 10.1016/j.bbrc.2011.03.083; Yang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100548; Yang LL, 2009, ARCH MED RES, V40, P89, DOI 10.1016/j.arcmed.2008.11.005; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yu W, 2012, DIABETOLOGIA, V55, P2655, DOI 10.1007/s00125-012-2636-8; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091790	75	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143607	10.1371/journal.pone.0143607	http://dx.doi.org/10.1371/journal.pone.0143607			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599349	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600093
J	Leclercq, A; Veillat, V; Loriot, S; Spuul, P; Madonna, F; Roques, X; Genot, E				Leclercq, Anne; Veillat, Veronique; Loriot, Sandrine; Spuul, Pirjo; Madonna, Francesco; Roques, Xavier; Genot, Elisabeth			A Methodology for Concomitant Isolation of Intimal and Adventitial Endothelial Cells from the Human Thoracic Aorta	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; PHENOTYPIC HETEROGENEITY; VASA VASORUM; IN-VITRO; ANEURYSMS; EXPRESSION; CULTURE	Background Aortic diseases are diverse and involve a multiplicity of biological systems in the vascular wall. Aortic dissection, which is usually preceded by aortic aneurysm, is a leading cause of morbidity and mortality in modern societies. Although the endothelium is now known to play an important role in vascular diseases, its contribution to aneurysmal aortic lesions remains largely unknown. The aim of this study was to define a reliable methodology for the isolation of aortic intimal and adventitial endothelial cells in order to throw light on issues relevant to endothelial cell biology in aneurysmal diseases. Methodology/Principal Findings We set up protocols to isolate endothelial cells from both the intima and the adventitia of human aneurysmal aortic vessel segments. Throughout the procedure, analysis of cell morphology and endothelial markers allowed us to select an endothelial fraction which after two rounds of expansion yielded a population of >90% pure endothelial cells. These cells have the features and functionalities of freshly isolated cells and can be used for biochemical studies. The technique was successfully used for aortic vessel segments of 20 patients and 3 healthy donors. Conclusions/Significance This simple and highly reproducible method allows the simultaneous preparation of reasonably pure primary cultures of intimal and adventitial human endothelial cells, thus providing a reliable source for investigating their biology and involvement in both thoracic aneurysms and other aortic diseases.	[Leclercq, Anne; Veillat, Veronique; Loriot, Sandrine; Spuul, Pirjo; Genot, Elisabeth] Univ Bordeaux, Bordeaux, France; [Leclercq, Anne; Veillat, Veronique; Spuul, Pirjo; Genot, Elisabeth] INSERM, U1045, Bordeaux, France; [Leclercq, Anne] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Loriot, Sandrine] SFR TransBioMed, Bordeaux, France; [Madonna, Francesco; Roques, Xavier] Hop Haut LEveque, Serv Chirurg Cardiaque & Vasc, Pessac, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Leclercq, A (corresponding author), Univ Bordeaux, Bordeaux, France.	anne_leclercq@yahoo.com; elisabeth.genot@inserm.fr	leclercq, anne/AAA-1233-2020; Spuul, Pirjo/A-7211-2015; Genot, Elisabeth/G-8031-2014	Spuul, Pirjo/0000-0001-9410-721X; 	Fondation Lefoulon-Delalande; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche [ANR-2010-BLAN-1237-01]	Fondation Lefoulon-Delalande; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by Fondation Lefoulon-Delalande (to AL), Fondation pour la Recherche Medicale (to AL), and Agence Nationale de la Recherche, ANR-2010-BLAN-1237-01 (to EG).	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; ANTONOV AS, 1986, ATHEROSCLEROSIS, V59, P1, DOI 10.1016/0021-9150(86)90027-4; ARCINIEGAS E, 1992, J CELL SCI, V103, P521; Azuma K, 2009, BIOCHEM BIOPH RES CO, V380, P620, DOI 10.1016/j.bbrc.2009.01.135; Bachetti T, 2000, PHARMACOL RES, V42, P9, DOI 10.1006/phrs.1999.0655; Bijman MNA, 2006, MOL CANCER THER, V5, P2348, DOI 10.1158/1535-7163.MCT-06-0242; Borges LF, 2005, CELL TISSUE RES, V320, P551, DOI 10.1007/s00441-005-1108-6; Borges LF, 2010, HISTOPATHOLOGY, V57, P917, DOI 10.1111/j.1365-2559.2010.03719.x; Borges LF, 2009, HUM PATHOL, V40, P306, DOI 10.1016/j.humpath.2008.08.002; Deissler H, 2006, INT J MOL MED, V18, P577; Fan LM, 2014, CIRCULATION, V129, P2661, DOI 10.1161/CIRCULATIONAHA.113.005062; Forte A, 2013, HISTOL HISTOPATHOL, V28, P795, DOI 10.14670/HH-28.795; Frid Maria G, 2004, Paediatr Respir Rev, V5 Suppl A, pS253, DOI 10.1016/S1526-0542(04)90048-6; Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Gingras M, 2009, J AM SOC HYPERTENS, V3, P166, DOI 10.1016/j.jash.2009.03.002; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; HEWETT PW, 1993, IN VITRO CELL DEV-AN, V29A, P325; Hillebrand M, 2014, CLIN CARDIOL, V37, P672, DOI 10.1002/clc.22320; Holifield B, 1996, J CLIN INVEST, V97, P814, DOI 10.1172/JCI118481; IMCKE E, 1991, ARCH DERMATOL RES, V283, P149, DOI 10.1007/BF00372054; Jimenez N, 2013, CYTOTECHNOLOGY, V65, P1, DOI 10.1007/s10616-012-9459-9; Jondeau G, 2011, HEART, V97, P1206, DOI 10.1136/hrt.2010.212100; Kessler K, 2014, CARDIOVASC RES, V104, P147, DOI 10.1093/cvr/cvu196; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153; Majesky MW, 2011, CIRC RES, V108, P528, DOI 10.1161/CIRCRESAHA.111.240861; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Muller AM, 2002, EXP MOL PATHOL, V73, P171, DOI 10.1006/exmp.2002.2446; Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424; Mulligan-Kehoe MJ, 2014, CIRCULATION, V129, P2557, DOI 10.1161/CIRCULATIONAHA.113.007189; Osada H, 2013, EUR J CARDIO-THORAC, V43, pE82, DOI 10.1093/ejcts/ezs640; Paschoalin T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-44; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Pyeritz RE, 2014, CURR OPIN CARDIOL, V29, P97, DOI 10.1097/HCO.0000000000000023; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; REPIN VS, 1984, ATHEROSCLEROSIS, V50, P35, DOI 10.1016/0021-9150(84)90006-6; Ritman EL, 2007, CARDIOVASC RES, V75, P649, DOI 10.1016/j.cardiores.2007.06.020; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; Saratzis A, 2014, HEART, V100, P916, DOI 10.1136/heartjnl-2013-305130; SCHOR AM, 1983, J CELL SCI, V62, P267; SCOTT PAE, 1993, J CELL SCI, V105, P269; Shen YH, 2012, ANN THORAC SURG, V93, P1524, DOI 10.1016/j.athoracsur.2012.01.063; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; Stenmark KR, 2013, ANNU REV PHYSIOL, V75, P23, DOI 10.1146/annurev-physiol-030212-183802; Suzuki T, 2011, J AM COLL CARDIOL, V58, P775, DOI 10.1016/j.jacc.2010.01.079; TOKUNAGA O, 1989, AM J PATHOL, V135, P967; Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Wessa P, 2012, SPEARMAN RANK CORREL; WOLINSKY H, 1967, CIRC RES, V20, P99, DOI 10.1161/01.RES.20.1.99; WOLINSKY H, 1969, CIRC RES, V25, P677, DOI 10.1161/01.RES.25.6.677	56	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143144	10.1371/journal.pone.0143144	http://dx.doi.org/10.1371/journal.pone.0143144			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599408	Green Published, gold			2022-12-26	WOS:000365862600032
J	Robbins, HA; Fennell, CE; Gillison, M; Xiao, WH; Guo, YS; Wentz, A; Kirk, GD; Mehta, SH; D'Souza, G				Robbins, Hilary A.; Fennell, Christina E.; Gillison, Maura; Xiao, Weihong; Guo, Yingshi; Wentz, Alicia; Kirk, Gregory D.; Mehta, Shruti H.; D'Souza, Gypsyamber			Prevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject Drugs	PLOS ONE			English	Article							HPV INFECTION; SEXUAL-BEHAVIORS; MEN; EPIDEMIOLOGY; CLEARANCE; WOMEN; HEAD	Background Human papillomavirus (HPV) causes most oropharyngeal cancers in the United States. Oral HPV prevalence is associated with immunosuppression, and drug use can be immunosuppressive, but the epidemiology of oral HPV among people who use drugs is not well described. Methods We enrolled men and women with a current or prior history of injection drug use in this cross-sectional sub-study within the AIDS Linked to the Intravenous Experience (ALIVE) cohort. We tested oral rinse samples for 37 types of HPV DNA and collected self-reported risk factor information. We compared oral HPV prevalence across categories using chisquared statistics and multivariable logistic regression. Results Among 199 subjects, 32% were HIV-positive (median CD4 count 384 cells/mu L), 90% were Black, 56% had less than a high school education, 17% had recently used injection drugs, and the median age was 54 years. Most had performed oral sex (82%) but had fewer than 5 lifetime partners (58%). The prevalence of any oral HPV was 29%, and of any oncogenic oral HPV was 13%. Oral HPV prevalence was high among both heterosexual men (30%) and women (20%). After adjustment, odds of oral HPV were increased among HIV-positive individuals with a low CD4 count (<350 cells/mu l, aOR = 2.7, 95% CI = 1.2-6.4, vs. HIV-negative individuals), but not among HIV-positive individuals with a higher CD4 cell count. Odds were also elevated for those who had recently performed oral sex on a woman (aOR = 2.2, 95% CI = 1.01-4.6) and, even after this adjustment, among bisexual/lesbian females (aOR = 5.6, 95% CI = 1.4-23, vs. heterosexual females). Oral HPV prevalence was not associated with vaginal sex, performing oral sex on a man, or recent drug use. Conclusions Recent drug use was not associated with oral HPV prevalence in our study. However, despite modest numbers of sexual partners, the prevalence of oral HPV among this largely Black population with lower socioeconomic status was high.	[Robbins, Hilary A.; Wentz, Alicia; Kirk, Gregory D.; Mehta, Shruti H.; D'Souza, Gypsyamber] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Fennell, Christina E.] Spelman Coll, Atlanta, GA 30314 USA; [Gillison, Maura; Xiao, Weihong; Guo, Yingshi] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Spelman College; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	D'Souza, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	gdsouza2@jhu.edu		Robbins, Hilary/0000-0001-6041-6866	National Institute of Dental and Craniofacial Research [R01DE021395]; National Institute on Drug Abuse [NIDA] [R01DA12568, U01DA036297]; Johns Hopkins Center for AIDS Research [P30AI094189]; Cancer Epidemiology, Prevention, and Control training grant (National Cancer Institute) [T32CA009314]; NATIONAL CANCER INSTITUTE [T32CA009314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, K24AI118591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012568, U01DA036297] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Drug Abuse [NIDA](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Johns Hopkins Center for AIDS Research; Cancer Epidemiology, Prevention, and Control training grant (National Cancer Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by R01DE021395 (National Institute of Dental and Craniofacial Research), R01DA12568 (National Institute on Drug Abuse [NIDA]), U01DA036297 (NIDA), and P30AI094189 (Johns Hopkins Center for AIDS Research). H.A. Robbins was supported by the Cancer Epidemiology, Prevention, and Control training grant (National Cancer Institute T32CA009314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenor M, 2015, ANN INTERN MED, V163, P99, DOI 10.7326/M14-2108; Antonsson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091761; Beachler DC, 2015, AM J EPIDEMIOL, V181, P40, DOI 10.1093/aje/kwu247; Beachler DC, 2013, CURR OPIN ONCOL, V25, P503, DOI 10.1097/CCO.0b013e32836242b4; Beachler DC, 2013, J INFECT DIS, V208, P330, DOI 10.1093/infdis/jit170; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Broutian TR, 2011, J CLIN VIROL, V50, P270, DOI 10.1016/j.jcv.2010.12.005; Chaturvedi AK, 2015, CANCER RES, V75, P2468, DOI 10.1158/0008-5472.CAN-14-2843; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chung CH, 2014, ORAL ONCOL, V50, P364, DOI 10.1016/j.oraloncology.2013.09.003; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; D'Souza Gypsyamber, 2014, Cancers (Basel), V6, P1691, DOI 10.3390/cancers6031691; D'Souza G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086023; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0; Kreimer AR, 2011, CANCER EPIDEM BIOMAR, V20, P172, DOI 10.1158/1055-9965.EPI-10-0682; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Mooij SH, 2013, AIDS, V27, P2117, DOI 10.1097/QAD.0b013e328362395c; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ortiz AP, 2014, P R HEALTH SCI J, V33, P190; Phelan DF, 2009, SEX TRANSM DIS, V36, P149, DOI 10.1097/OLQ.0b013e31818d3df3; Pickard RKL, 2012, SEX TRANSM DIS, V39, P559, DOI 10.1097/OLQ.0b013e31824f1c65; Read TRH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049324; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Wu Xiaocheng, 2012, Morbidity and Mortality Weekly Report, V61, P258	31	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143698	10.1371/journal.pone.0143698	http://dx.doi.org/10.1371/journal.pone.0143698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600158	gold, Green Submitted, Green Published			2022-12-26	WOS:000365862600105
J	Rothe, M; Kleeberg, A; Gruneberg, B; Friese, K; Perez-Mayo, M; Hupfer, M				Rothe, Matthias; Kleeberg, Andreas; Grueneberg, Bjoern; Friese, Kurt; Perez-Mayo, Manuel; Hupfer, Michael			Sedimentary Sulphur: Iron Ratio Indicates Vivianite Occurrence: A Study from Two Contrasting Freshwater Systems	PLOS ONE			English	Article							PHOSPHORUS RETENTION; HYDROGEN-SULFIDE; LAKE-SEDIMENTS; EUTROPHICATION; REDUCTION; MOBILIZATION; MINERALS; RELEASE; MATTER; FORMS	An increasing number of studies constrain the importance of iron for the long-term retention of phosphorus (P) under anoxic conditions, i.e. the formation of reduced iron phosphate minerals such as vivianite (Fe-3(PO4)(2)center dot 8H(2)O). Much remains unknown about vivianite formation, the factors controlling its occurrence, and its relevance for P burial during early sediment diagenesis. To study the occurrence of vivianite and to assess its relevance for P binding, surface sediments of two hydrologically contrasting waters were analysed by heavy-liquid separation and subsequent powder X-ray diffraction. In Lake Arendsee, vivianite was present in deeper sediment horizons and not in the uppermost layers with a sharp transition between vivianite and non-vivianite bearing layers. In contrast, in lowland river Lower Havel vivianite was present in the upper sediment layers and not in deeper horizons with a gradual transition between non-vivianite and vivianite bearing layers. In both waters, vivianite occurrence was accompanied by the presence of pyrite (FeS2). Vivianite formation was favoured by an elevated iron availability through a lower degree of sulphidisation and was present at a molar ratio of total sulphur to reactive iron smaller than 1.1, only. A longer lasting burden of sediments by organic matter, i.e. due to eutrophication, favours the release of sulphides, and the formation of insoluble iron sulphides leading to a lack of available iron and to less or no vivianite formation. This weakening in sedimentary P retention, representing a negative feedback mechanism (P release) in terms of water quality, could be partly compensated by harmless Fe amendments.	[Rothe, Matthias; Kleeberg, Andreas; Hupfer, Michael] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Chem Analyt & Biogeochem, Berlin, Germany; [Rothe, Matthias] Humboldt Univ, Dept Geog, D-10099 Berlin, Germany; [Grueneberg, Bjoern] Brandenburg Univ Technol Cottbus Senftenberg, Dept Freshwater Conservat, Bad Saarow Pieskow, Germany; [Friese, Kurt] Helmholtz Ctr Environm Res, UFZ Dept Lake Res, Magdeburg, Germany; [Perez-Mayo, Manuel] Univ Bremen, Inst Environm Phys, D-28359 Bremen, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin; Brandenburg University of Technology Cottbus; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bremen	Rothe, M (corresponding author), State Lab Berlin Brandenburg, Kleinmachnow, Germany.	rothe@igb-berlin.de	Friese, Kurt/E-1395-2012	Friese, Kurt/0000-0002-7769-0818; Perez Mayo, Manuel/0000-0002-6003-649X	Deutsche Forschungsgemeinschaft of the German Federal Ministry of Education and Research [HU 740/5-1, 033L041A]	Deutsche Forschungsgemeinschaft of the German Federal Ministry of Education and Research	The study was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) within the project "RedoxPhos" (Grant Number: HU 740/5-1) (MH AK) and the framework programme Research for Sustainable Development (Grant Number: 033L041A) of the German Federal Ministry of Education and Research (http://www.bmbf.de/) within the research project NITROLIMIT (BG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN JM, 1976, WATER RES, V10, P329, DOI 10.1016/0043-1354(76)90175-5; BERNER RA, 1981, J SEDIMENT PETROL, V51, P359, DOI 10.1306/212F7C7F-2B24-11D7-8648000102C1865D; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; Cosmidis J, 2014, GEOCHIM COSMOCHIM AC, V126, P78, DOI 10.1016/j.gca.2013.10.037; DEVITRE RR, 1988, GEOCHIM COSMOCHIM AC, V52, P1601, DOI 10.1016/0016-7037(88)90229-3; Dijkstra N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101139; DUNNETTE DA, 1985, WATER RES, V19, P875, DOI 10.1016/0043-1354(85)90146-0; Einsele W, 1936, ARCH HYDROBIOL, V29, P664; Findlay DL, 1998, J PALEOLIMNOL, V19, P41, DOI 10.1023/A:1007906611087; Gachter R, 2003, LIMNOL OCEANOGR, V48, P929; Gruneberg B, 2015, BIOGEOCHEMISTRY, V123, P185, DOI 10.1007/s10533-014-0062-3; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; HORDIJK CA, 1989, WATER RES, V23, P853, DOI 10.1016/0043-1354(89)90009-2; Howarth RW, 1992, SULPHUR CYCLING ON T; Hsu TW, 2014, J ASIAN EARTH SCI, V89, P88, DOI 10.1016/j.jseaes.2014.03.027; Hupfer M, 2000, WATER RES, V34, P859, DOI 10.1016/S0043-1354(99)00229-8; Hupfer M, 1995, AQUAT SCI, V57, P305, DOI 10.1007/BF00878395; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; Hyacinthe C, 2004, MAR CHEM, V91, P227, DOI 10.1016/j.marchem.2004.04.006; Jilbert T, 2013, GEOCHIM COSMOCHIM AC, V107, P155, DOI 10.1016/j.gca.2013.01.005; Kleeberg A, 2013, WATER RES, V47, P1491, DOI 10.1016/j.watres.2012.12.014; Kleeberg A, 2012, J SOIL SEDIMENT, V12, P1593, DOI 10.1007/s11368-012-0590-1; Lalonde K, 2012, NATURE, V483, P198, DOI 10.1038/nature10855; Lehtoranta J, 2009, AMBIO, V38, P303, DOI 10.1579/09-A-656.1; LIKENS GE, 1989, HYDROBIOLOGIA, V176, P331, DOI 10.1007/BF00026568; Losher A, 1989, THESIS; Marz C, 2008, MAR GEOL, V255, P118, DOI 10.1016/j.margeo.2008.05.013; Meinikmann K, 2015, J HYDROL, V524, P214, DOI 10.1016/j.jhydrol.2015.02.031; MORSE JW, 1987, EARTH-SCI REV, V24, P1, DOI 10.1016/0012-8252(87)90046-8; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; MURRAY TE, 1995, CAN J FISH AQUAT SCI, V52, P1190, DOI 10.1139/f95-115; NEMBRINI GP, 1983, GEOCHIM COSMOCHIM AC, V47, P1459, DOI 10.1016/0016-7037(83)90304-6; NRIAGU JO, 1972, GEOCHIM COSMOCHIM AC, V36, P459, DOI 10.1016/0016-7037(72)90035-X; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; PSENNER R, 1984, Archiv fuer Hydrobiologie Supplement, V70, P111; Robbins J.A., 1978, BIOGEOCHEMISTRY LEAD, V1A, P285; Roden EE, 1997, ARCH HYDROBIOL, V139, P347; Rothe M, 2014, BIOGEOSCIENCES, V11, P5169, DOI 10.5194/bg-11-5169-2014; Ruban V, 1999, J ENVIRON MONITOR, V1, P51, DOI 10.1039/a807778i; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; Slomp CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062386; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; SMOLDERS A, 1993, AQUAT BOT, V46, P247, DOI 10.1016/0304-3770(93)90005-H; Sondergaard M, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 1, P184; Stumm W, 1981, AQUATIC CHEMISTRY AN; WILLIAMS JDH, 1980, SOIL SCI SOC AM J, V44, P462, DOI 10.2136/sssaj1980.03615995004400030004x; Withers PJA, 2014, SUSTAINABILITY-BASEL, V6, P5853, DOI 10.3390/su6095853; Zak D, 2006, BIOGEOCHEMISTRY, V80, P109, DOI 10.1007/s10533-006-0003-x	49	35	38	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143737	10.1371/journal.pone.0143737	http://dx.doi.org/10.1371/journal.pone.0143737			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599406	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600113
J	Zhang, YX; Gao, TS; Hu, SY; Lin, B; Yan, DC; Xu, ZY; Zhang, ZJ; Mao, YL; Mao, HM; Wang, LT; Wang, GS; Xiong, YZ; Zuo, B				Zhang, Yunxia; Gao, Tengsen; Hu, Shanyao; Lin, Bin; Yan, Dechao; Xu, Zaiyan; Zhang, Zijun; Mao, Yuanliang; Mao, Huimin; Wang, Litong; Wang, Guoshui; Xiong, Yuanzhu; Zuo, Bo			The Functional SNPs in the 5 ' Regulatory Region of the Porcine PPARD Gene Have Significant Association with Fat Deposition Traits	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-DELTA; COLORECTAL-CANCER; BACKFAT THICKNESS; CANDIDATE GENES; SUS-SCROFA; FATNESS; EXPRESSION; GROWTH; LOCI; DIFFERENTIATION	Peroxisome proliferator-activated receptor delta (PPARD) is a key regulator of lipid metabolism, insulin sensitivity, cell proliferation and differentiation. In this study, we identified two Single Nucleotide Polymorphisms (SNPs, g.1015 A>G and g.1018 T>C) constituting four haplotypes (GT, GC, AC and AT) in the 5' regulatory region of porcine PPARD gene. Functional analysis of the four haplotypes showed that the transcriptional activity of the PPARD promoter fragment carrying haplotype AC was significantly lower than that of the other haplotypes in 3T3-L1, C2C12 and PK-15 cells, and haplotype AC had the lowest binding capacities to the nuclear extracts. Transcription factor 7-like 2 (TCF7L2) enhanced the transcription activities of promoter fragments of PPARD gene carrying haplotypes GT, GC and AT in C2C12 and 3T3-L1 cells, and increased the protein expression of PPARD gene in C2C12 myoblasts. TCF7L2 differentially bound to the four haplotypes, and the binding capacity of TCF7L2 to haplotype AC was the lowest. There were significant associations between -655A/G and fat deposition traits in three pig populations including the Large White x Meishan F-2 pigs, France and American Large White pigs. Pigs with genotype GG had significantly higher expression of PPARD at both mRNA and protein level than those with genotype AG. These results strongly suggested that the SNPs in 5' regulatory region of PPARD genes had significant impact on pig fat deposition traits.	[Zhang, Yunxia; Gao, Tengsen; Hu, Shanyao; Lin, Bin; Yan, Dechao; Xu, Zaiyan; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Minist Agr, Key Lab Swine Genet & Breeding, Wuhan, Peoples R China; [Zhang, Yunxia; Gao, Tengsen; Hu, Shanyao; Lin, Bin; Yan, Dechao; Xu, Zaiyan; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Minist Educ, Key Lab Agr Anim Genet & Breeding, Wuhan, Peoples R China; [Zhang, Zijun; Mao, Yuanliang; Mao, Huimin; Wang, Litong; Wang, Guoshui] Tianpeng Grp, Jiangshan, Zhejiang, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Zuo, B (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Vet Med, Minist Agr, Key Lab Swine Genet & Breeding, Wuhan, Peoples R China.	zuobo@mail.hzau.edu.cn			Key National High Technology Development Project of China [2011AA100301]; National Key Technology Support Program of China [2014BAD20B01]; Agricultural Innovation Fund of Hubei Province [2007-620]; Fundamental Research Funds for the Central Universities [2014PY038]; Key Project of Science and Technology of Zhejiang Province [2014C02010]	Key National High Technology Development Project of China; National Key Technology Support Program of China(National Key Technology R&D Program); Agricultural Innovation Fund of Hubei Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Project of Science and Technology of Zhejiang Province	The study was financially supported by the Key National High Technology Development Project of China (Grant No. 2011AA100301), the National Key Technology Support Program of China (Grant No. 2014BAD20B01), the Agricultural Innovation Fund of Hubei Province (Grant No. 2007-620), the Fundamental Research Funds for the Central Universities (Grant No. 2014PY038) and the Key Project of Science and Technology of Zhejiang Province (Grant No. 2014C02010). The last funder is Tianpeng Group. The funder provided support in the form of salaries for authors [ZZ, YM, HM, LW, GW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai H, 2012, ANIM GENET, V43, P383, DOI 10.1111/j.1365-2052.2011.02282.x; Ali FY, 2006, AM J RESP CELL MOL, V34, P242, DOI 10.1165/rcmb.2005-0289OC; Andrulionyte L, 2006, DIABETES, V55, P2148, DOI 10.2337/db05-1629; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Archbold HC, 2012, ACTA PHYSIOL, V204, P74, DOI 10.1111/j.1748-1716.2011.02293.x; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bastie C, 2000, J BIOL CHEM, V275, P38768, DOI 10.1074/jbc.M006450200; Bidanel JP, 2001, GENET SEL EVOL, V33, P289, DOI 10.1051/gse:2001120; Burch LR, 2010, J CLIN ENDOCR METAB, V95, P1830, DOI 10.1210/jc.2009-1201; Burch LR, 2009, J CLIN ENDOCR METAB, V94, P2587, DOI 10.1210/jc.2009-0392; Chen LH, 2014, PPAR RES, V2014, DOI 10.1155/2014/653017; de Koning DJ, 1999, GENETICS, V152, P1679; Demeure O, 2005, J ANIM SCI, V83, P1979; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Duan YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075925; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Gondret F, 2012, J ANIM BREED GENET, V129, P316, DOI 10.1111/j.1439-0388.2011.00965.x; Grarup N, 2007, DIABETOLOGIA, V50, P1201, DOI 10.1007/s00125-007-0668-2; Grimaldi PA, 2001, PROG LIPID RES, V40, P269, DOI 10.1016/S0163-7827(01)00005-4; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Higashiyama H, 2007, HISTOCHEM CELL BIOL, V127, P485, DOI 10.1007/s00418-007-0279-5; Huang H, 2011, GENET MOL RES, V10, P3090, DOI 10.4238/2011.December.14.2; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Kim DJ, 2006, CELL DEATH DIFFER, V13, P53, DOI 10.1038/sj.cdd.4401713; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Leibowitz MD, 2000, FEBS LETT, V473, P333, DOI 10.1016/S0014-5793(00)01554-4; Liu GJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/903947; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meidtner K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-76; Neher MD, 2012, PPAR RES, V2012, DOI 10.1155/2012/728461; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Pesant M, 2006, CARDIOVASC RES, V69, P440, DOI 10.1016/j.cardiores.2005.10.019; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Qiao RM, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0089-5; Rattink AP, 2000, MAMM GENOME, V11, P656, DOI 10.1007/s003350010117; Ren J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002043; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Su Yu-Hong, 2002, Acta Genetica Sinica, V29, P681; Tanaka M, 2006, ANIM GENET, V37, P10, DOI 10.1111/j.1365-2052.2005.01362.x; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Thamer C, 2008, J CLIN ENDOCR METAB, V93, P1497, DOI 10.1210/jc.2007-1209; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Xiong YZ, 1999, PRINCIPLE METHOD SWI; Xu ZY, 2010, MOL BIOL REP, V37, P3609, DOI 10.1007/s11033-010-0010-9; Zhang HJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P25, DOI 10.1016/j.abb.2007.01.028; Zuo B, 2004, ASIAN AUSTRAL J ANIM, V17, P1350, DOI 10.5713/ajas.2004.1350; [左波 Zuo Bo], 2003, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V34, P139	51	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143734	10.1371/journal.pone.0143734	http://dx.doi.org/10.1371/journal.pone.0143734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599230	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600111
J	Bourceret, A; Leyval, C; de Fouquet, C; Cebron, A				Bourceret, Amelia; Leyval, Corinne; de Fouquet, Chantal; Cebron, Aurelie			Mapping the Centimeter-Scale Spatial Variability of PAHs and Microbial Populations in the Rhizosphere of Two Plants	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; BACTERIAL COMMUNITY STRUCTURE; CREOSOTE-CONTAMINATED SOIL; POLLUTED SOIL; PHENANTHRENE DEGRADATION; DEGRADING BACTERIA; FUNGAL COMMUNITIES; BIODEGRADATION; PHYTOREMEDIATION; HETEROGENEITY	Rhizoremediation uses root development and exudation to favor microbial activity. Thus it can enhance polycyclic aromatic hydrocarbon (PAH) biodegradation in contaminated soils. Spatial heterogeneity of rhizosphere processes, mainly linked to the root development stage and to the plant species, could explain the contrasted rhizoremediation efficiency levels reported in the literature. Aim of the present study was to test if spatial variability in the whole plant rhizosphere, explored at the centimetre-scale, would influence the abundance of microorganisms (bacteria and fungi), and the abundance and activity of PAH-degrading bacteria, leading to spatial variability in PAH concentrations. Two contrasted rhizospheres were compared after 37 days of alfalfa or ryegrass growth in independent rhizotron devices. Almost all spiked PAHs were degraded, and the density of the PAH-degrading bacterial populations increased in both rhizospheres during the incubation period. Mapping of multi-parametric data through geostatistical estimation (kriging) revealed that although root biomass was spatially structured, PAH distribution was not. However a greater variability of the PAH content was observed in the rhizosphere of alfalfa. Yet, in the ryegrass-planted rhizotron, the Gram-positive PAH-degraders followed a reverse depth gradient to root biomass, but were positively correlated to the soil pH and carbohydrate concentrations. The two rhizospheres structured the microbial community differently: a fungus-to-bacterium depth gradient similar to the root biomass gradient only formed in the alfalfa rhizotron.	[Bourceret, Amelia; Leyval, Corinne; Cebron, Aurelie] Fac Sci & Technol, CNRS, LIEC, UMR7360, F-54506 Vandoeuvre Les Nancy, France; [Bourceret, Amelia; Leyval, Corinne; Cebron, Aurelie] Univ Lorraine, Fac Sci & Technol, LIEC, UMR7360, F-54506 Vandoeuvre Les Nancy, France; [de Fouquet, Chantal] Ecole Natl Super Mines, Ctr Geosci Geostat, MINES ParisTech, F-77305 Fontainebleau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech	Cebron, A (corresponding author), Fac Sci & Technol, CNRS, LIEC, UMR7360, Bd Aiguillettes,BP70239, F-54506 Vandoeuvre Les Nancy, France.	aurelie.cebron@univ-lorraine.fr			Agence Nationale de la Recherche [ANR-13-JSV7-0007_01]; French national Research Agency through the laboratory of Excellence ARBRE [ANR-11-LABX-0002-01]	Agence Nationale de la Recherche(French National Research Agency (ANR)); French national Research Agency through the laboratory of Excellence ARBRE(French National Research Agency (ANR))	This study was funded by the Agence Nationale de la Recherche (ANR-13-JSV7-0007_01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Agence Nationale de la Recherche (ANR-13-JSV7-0007_01). The authors thank the GISFI (www.gisfi.fr) for soil providing, David Billet, Florence Coste and Genevieve Magnin and interns Maximilien Jeanvoine and Paul Dessaint for technical assistance. Carbohydrate analyses were performed by Jacqueline Marchand belonging to the PTEF facility that is supported by the French national Research Agency through the laboratory of Excellence ARBRE (ANR-11-LABX-0002-01). The authors also thank Annie Buchwalter for editing English language.	Allard AS, 2000, INT BIODETER BIODEGR, V46, P43, DOI 10.1016/S0964-8305(00)00050-0; Amellal N, 2001, BIODEGRADATION, V12, P49, DOI 10.1023/A:1011909107858; Anderson TA, 1993, ENVIRON SCI TECHNOL, V27, P2631; APRILL W, 1990, CHEMOSPHERE, V20, P253, DOI 10.1016/0045-6535(90)90100-8; Baudoin E, 2002, APPL SOIL ECOL, V19, P135, DOI 10.1016/S0929-1393(01)00185-8; Becker JM, 2006, MICROB ECOL, V51, P220, DOI 10.1007/s00248-005-0002-9; Bengtsson G, 2009, RISK ANAL, V29, P48, DOI 10.1111/j.1539-6924.2008.01128.x; Bengtsson G, 2013, MICROB ECOL, V65, P91, DOI 10.1007/s00248-012-0112-0; Bengtsson G, 2010, ENVIRON POLLUT, V158, P2865, DOI 10.1016/j.envpol.2010.06.010; Binet P, 2001, ORG GEOCHEM, V32, P217, DOI 10.1016/S0146-6380(00)00168-6; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Cebron A, 2008, J MICROBIOL METH, V73, P148, DOI 10.1016/j.mimet.2008.01.009; Cebron A, 2013, ENVIRON POLLUT, V177, P98, DOI 10.1016/j.envpol.2013.01.043; Cebron A, 2011, ENVIRON MICROBIOL, V13, P722, DOI 10.1111/j.1462-2920.2010.02376.x; Cebron A, 2009, APPL ENVIRON MICROB, V75, P6322, DOI 10.1128/AEM.02862-08; Chaudhry Q, 2005, ENVIRON SCI POLLUT R, V12, P34, DOI 10.1065/espr2004.08.213; Chiapusio G, 2007, PLANT SOIL, V294, P103, DOI 10.1007/s11104-007-9234-4; Chiles J.-P., 2012, GEOSTATISTICS MODELI; Choudhary VR, 2000, LANGMUIR, V16, P7031, DOI 10.1021/la991714u; Corgie SC, 2004, APPL ENVIRON MICROB, V70, P3552, DOI 10.1128/AEM.70.6.3552-3557.2004; Corgie SC, 2003, PLANT SOIL, V257, P143, DOI 10.1023/A:1026278424871; Cornelissen G, 2005, ENVIRON SCI TECHNOL, V39, P6881, DOI 10.1021/es050191b; D'Orazio V, 2013, CLEAN-SOIL AIR WATER, V41, P377, DOI 10.1002/clen.201100653; de Fouquet C, 2011, EUR J SOIL SCI, V62, P454, DOI 10.1111/j.1365-2389.2011.01374.x; De Fouquet C, 2010, P CONS SALZB; De Fouquet C, 2011, AM SOC MECH ENG, P1307; Demougeot-Renard H, 2004, ENVIRON SCI TECHNOL, V38, P5120, DOI 10.1021/es0351084; Demougeot-Renard H, 2004, J ENVIRON QUAL, V33, P1694, DOI 10.2134/jeq2004.1694; Faucheux C, 2008, CHARACTERISATION HYD, P961; Felske A, 1998, APPL ENVIRON MICROB, V64, P4581; Gerhardt KE, 2009, PLANT SCI, V176, P20, DOI 10.1016/j.plantsci.2008.09.014; Hafner S, 2014, PLANT SOIL, V380, P101, DOI 10.1007/s11104-014-2059-z; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Hertenberger G, 2002, J PLANT NUTR SOIL SC, V165, P557, DOI 10.1002/1522-2624(200210)165:5<557::AID-JPLN1111557>3.0.CO;2-G; Hinsinger P, 2003, PLANT SOIL, V248, P43, DOI 10.1023/A:1022371130939; Hinsinger P, 2005, NEW PHYTOL, V168, P293, DOI 10.1111/j.1469-8137.2005.01512.x; Hybholt TK, 2011, ENVIRON POLLUT, V159, P1085, DOI 10.1016/j.envpol.2011.02.028; Johnsen AR, 2014, FEMS MICROBIOL ECOL, V88, P84, DOI 10.1111/1574-6941.12272; Joner EJ, 2002, SOIL BIOL BIOCHEM, V34, P859, DOI 10.1016/S0038-0717(02)00018-4; Joner EJ, 2003, ENVIRON SCI TECHNOL, V37, P2371, DOI 10.1021/es020196y; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; Khan S, 2009, J SOIL SEDIMENT, V9, P482, DOI 10.1007/s11368-009-0061-5; Kuiper I, 2004, MOL PLANT MICROBE IN, V17, P6, DOI 10.1094/MPMI.2004.17.1.6; Kumar R, 2006, CURR SCI INDIA, V91, P885; Ling WT, 2013, J SOIL SEDIMENT, V13, P677, DOI 10.1007/s11368-013-0655-9; Liste HH, 2006, CHEMOSPHERE, V62, P1411, DOI 10.1016/j.chemosphere.2005.05.018; Liste HH, 2000, CHEMOSPHERE, V40, P7, DOI 10.1016/S0045-6535(99)00216-7; Louvel B, 2011, INT BIODETER BIODEGR, V65, P947, DOI 10.1016/j.ibiod.2011.07.003; Lueders T, 2004, ENVIRON MICROBIOL, V6, P60, DOI 10.1046/j.1462-2920.2003.00535.x; Ma B, 2012, ENVIRON POLLUT, V162, P413, DOI 10.1016/j.envpol.2011.10.034; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Mukherjee S, 2014, ISME J, V8, P2131, DOI 10.1038/ismej.2014.151; Oliveira V, 2014, MOL ECOL, V23, P1392, DOI 10.1111/mec.12559; Ouvrard S, 2011, INT J PHYTOREMEDIAT, V13, P245, DOI 10.1080/15226514.2011.568546; Phillips LA, 2008, SOIL BIOL BIOCHEM, V40, P3054, DOI 10.1016/j.soilbio.2008.09.006; Reid BJ, 2000, ENVIRON SCI TECHNOL, V34, P3174, DOI 10.1021/es990946c; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Shann JR, 1994, INFLUENCE PLANT SPEC; Siciliano SD, 2003, APPL ENVIRON MICROB, V69, P483, DOI 10.1128/AEM.69.1.483-489.2003; Soleimani M, 2010, CHEMOSPHERE, V81, P1084, DOI 10.1016/j.chemosphere.2010.09.034; Storey S, 2014, J APPL MICROBIOL, V117, P74, DOI 10.1111/jam.12518; Styrishave B, 2012, WATER AIR SOIL POLL, V223, P969, DOI 10.1007/s11270-011-0916-4; Sun BQ, 2013, J SOIL SEDIMENT, V13, P1161, DOI 10.1007/s11368-013-0712-4; Tejeda-Agredano MC, 2013, SOIL BIOL BIOCHEM, V57, P830, DOI 10.1016/j.soilbio.2012.08.008; Thion C, 2012, FEMS MICROBIOL ECOL, V82, P169, DOI 10.1111/j.1574-6941.2012.01414.x; Torneman N, 2008, ENVIRON TOXICOL CHEM, V27, P1039, DOI 10.1897/07-440.1; Tunega D, 2009, J COLLOID INTERF SCI, V330, P244, DOI 10.1016/j.jcis.2008.10.056; VANCURA V., 1965, "Plant Microbes Relationships" Proc. Symp. Prague., V1963, P21, DOI 10.1007/BF01377686; Villanneau EJ, 2013, ENVIRON CHEM LETT, V11, P99, DOI 10.1007/s10311-013-0401-y; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Yang CH, 2000, APPL ENVIRON MICROB, V66, P345, DOI 10.1128/AEM.66.1.345-351.2000	72	18	18	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142851	10.1371/journal.pone.0142851	http://dx.doi.org/10.1371/journal.pone.0142851			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599438	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900041
J	Islam, T; Manna, M; Reddy, MK				Islam, Tahmina; Manna, Mrinalini; Reddy, Malireddy K.			Glutathione Peroxidase of Pennisetum glaucum (PgGPx) Is a Functional Cd2+ Dependent Peroxiredoxin that Enhances Tolerance against Salinity and Drought Stress	PLOS ONE			English	Article							THIOREDOXIN PEROXIDASE; SUPEROXIDE-DISMUTASE; MOLECULAR CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; 2-CYS PEROXIREDOXIN; LIPID-PEROXIDATION; HELIANTHUS-ANNUUS; ESCHERICHIA-COLI; REDOX-TRANSDUCER	Reactive oxygen species (ROS) arise in the plant system due to inevitable influence of various environmental stimuli. Glutathione peroxidases are one of the important ROS scavengers inside the cell. A glutathione peroxidase (PgGPx) gene was previously found from Pennisetum glauccum abiotic stressed cDNA library. Enzyme kinetics data revealed that PgGPx possessed preference towards thioredoxin rather than glutathione as electron donor and thus belongs to the functional peroxiredoxin group. Moreover, its activity was found to be dependent on divalent cations, especially Cd2+ and homology model showed the presence of Cd2+ binding site in the protein. Site directed mutagenesis study of PgGPx protein revealed the vital role of two conserved Cysteine residues for its enzymatic activity and structural folding. Expression analysis suggested that PgGPx transcript is highly up-regulated in response to salinity and drought stresses. When expressed ectopically, PgGPx showed enhanced tolerance against multiple abiotic stresses in prokaryotic E. coli and model plant, rice. Transgenic rice plants showed lesser accumulation of MDA and H2O2; and higher accumulation of proline as compared to wild type (WT) plants in response to both salinity and drought stresses that clearly indicates suppression of lipid peroxidation and ROS generation in transgenic lines. Moreover, transgenic plants maintained better photosynthesis efficiency and higher level of antioxidant enzyme activity as compared to WT plants under stress conditions. These results clearly indicate the imperative role of PgGPx in cellular redox homeostasis under stress conditions, leading to the maintenance of membrane integrity and increased tolerance towards oxidative stress.	[Islam, Tahmina; Manna, Mrinalini; Reddy, Malireddy K.] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi 110067, India; [Islam, Tahmina] Univ Dhaka, Dept Bot, Dhaka 1000, Bangladesh	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Dhaka	Islam, T (corresponding author), Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	subarna.islam@gmail.com	Islam, Tahmina/AAU-9539-2021	Islam, Tahmina/0000-0002-0542-0050	International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India; Department of Biotechnology, Government of India; CSIR; ICGEB	International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); ICGEB(Department of Biotechnology (DBT) India)	Funded by International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India and Department of Biotechnology, Government of India. MM acknowledges CSIR for providing Pre-doctoral and SRF fellowship.; MKR acknowledges International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India. TI acknowledges ICGEB and MM acknowledges CSIR for providing Pre-doctoral and SRF fellowship, respectively.	Agrawal GK, 2002, GENE, V283, P227, DOI 10.1016/S0378-1119(01)00854-X; Brigelius-Flohe R, 2003, BIOFACTORS, V17, P93, DOI 10.1002/biof.5520170110; Chen SR, 2004, PLANT PHYSIOL, V135, P1630, DOI 10.1104/pp.103.038091; CRIQUI MC, 1992, PLANT MOL BIOL, V18, P623, DOI 10.1007/BF00040684; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Depege N, 1998, EUR J BIOCHEM, V253, P445, DOI 10.1046/j.1432-1327.1998.2530445.x; Finkemeier I, 2005, J BIOL CHEM, V280, P12168, DOI 10.1074/jbc.M413189200; Gaber A, 2012, PLANT CELL PHYSIOL, V53, P1596, DOI 10.1093/pcp/pcs100; Ghiani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099239; Ghosh A, 2014, PLANT J, V80, P93, DOI 10.1111/tpj.12621; Hazebrouck S, 2000, J BIOL CHEM, V275, P28715, DOI 10.1074/jbc.M004985200; Herbette S, 2002, EUR J BIOCHEM, V269, P2414, DOI 10.1046/j.1432-1033.2002.02905.x; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; HOLLAND D, 1993, PLANT MOL BIOL, V21, P923, DOI 10.1007/BF00027124; Islam T, 2015, PLANT MOL BIOL REP, P1; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; JOHNSON RR, 1995, PLANT MOL BIOL, V28, P113, DOI 10.1007/BF00042043; Jung BG, 2002, J BIOL CHEM, V277, P12572, DOI 10.1074/jbc.M110791200; Kadota Y, 2005, BIOCHEM BIOPH RES CO, V336, P1259, DOI 10.1016/j.bbrc.2005.09.004; Karan R, 2009, FUNCT INTEGR GENOMIC, V9, P411, DOI 10.1007/s10142-009-0119-x; Koh CS, 2007, J MOL BIOL, V370, P512, DOI 10.1016/j.jmb.2007.04.031; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Li WJ, 2000, BBA-GENE STRUCT EXPR, V1493, P225, DOI 10.1016/S0167-4781(00)00152-4; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230; Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x; Milla MAR, 2002, PLANT PHYSIOL, V130, P1706, DOI 10.1104/pp.009969; Mishra RN, 2007, PLANT MOL BIOL, V64, P713, DOI 10.1007/s11103-007-9193-4; Mullineaux PM, 1998, PLANT J, V13, P375, DOI 10.1046/j.1365-313X.1998.00052.x; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Pareek, 2015, BIO-PROTOCOL, V5, pE1440, DOI [10.21769/BioProtoc.1440, DOI 10.21769/BIOPROTOC.1440]; Passaia G, 2013, PLANT SCI, V208, P93, DOI 10.1016/j.plantsci.2013.03.017; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pulido P, 2010, J EXP BOT, V61, P4043, DOI 10.1093/jxb/erq218; Ramos J, 2009, NEW PHYTOL, V181, P103, DOI 10.1111/j.1469-8137.2008.02629.x; Roeckel-Drevet P, 1998, PHYSIOL PLANTARUM, V103, P385, DOI 10.1034/j.1399-3054.1998.1030312.x; Rouhier N, 2005, FREE RADICAL BIO MED, V38, P1413, DOI 10.1016/j.freeradbiomed.2004.07.037; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Roxas VP, 1997, NAT BIOTECHNOL, V15, P988, DOI 10.1038/nbt1097-988; Sairam RK, 2005, BIOL PLANTARUM, V49, P85, DOI 10.1007/s10535-005-5091-2; Sreenivasulu N, 2004, J PLANT PHYSIOL, V161, P467, DOI 10.1078/0176-1617-01112; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tanaka T, 2005, J BIOL CHEM, V280, P42078, DOI 10.1074/jbc.M508622200; Turan S, 2013, PROTOPLASMA, V250, P209, DOI 10.1007/s00709-012-0395-5; Wang LJ, 2006, PLANT SCI, V170, P685, DOI 10.1016/j.plantsci.2005.09.005; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Yoshida S, 1971, INT RICE RES I; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Zhai CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073989; Zhang HX, 2008, PLANTA, V227, P465, DOI 10.1007/s00425-007-0632-x	53	35	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143344	10.1371/journal.pone.0143344	http://dx.doi.org/10.1371/journal.pone.0143344			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600014	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900097
J	Ladoni, M; Kravchenko, AN; Robertson, GP				Ladoni, Moslem; Kravchenko, Alexandra N.; Robertson, G. Phillip			Topography Mediates the Influence of Cover Crops on Soil Nitrate Levels in Row Crop Agricultural Systems	PLOS ONE			English	Article							AVAILABLE NITROGEN; CORN YIELD; CEREAL RYE; MANAGEMENT; LANDSCAPE; VARIABILITY; MIXTURES; RESIDUES; RECOVERY; BENEFITS	Supplying adequate amounts of soil N for plant growth during the growing season and across large agricultural fields is a challenge for conservational agricultural systems with cover crops. Knowledge about cover crop effects on N comes mostly from small, flat research plots and performance of cover crops across topographically diverse agricultural land is poorly understood. Our objective was to assess effects of both leguminous (red clover) and non-leguminous (winter rye) cover crops on potentially mineralizable N (PMN) and NO3- -N levels across a topographically diverse landscape. We studied conventional, low-input, and organic managements in corn-soybean-wheat rotation. The rotations of low-input and organic managements included rye and red clover cover crops. The managements were implemented in twenty large undulating fields in Southwest Michigan starting from 2006. The data collection and analysis were conducted during three growing seasons of 2011, 2012 and 2013. Observational micro-plots with and without cover crops were laid within each field on three contrasting topographical positions of depression, slope and summit. Soil samples were collected 4-5 times during each growing season and analyzed for NO3- -N and PMN. The results showed that all three managements were similar in their temporal and spatial distributions of NO3- -N. Red clover cover crop increased NO3- -N by 35% on depression, 20% on slope and 32% on summit positions. Rye cover crop had a significant 15% negative effect on NO3- -N in topographical depressions but not in slope and summit positions. The magnitude of the cover crop effects on soil mineral nitrogen across topographically diverse fields was associated with the amount of cover crop growth and residue production. The results emphasize the potential environmental and economic benefits that can be generated by implementing site-specific topography-driven cover crop management in row-crop agricultural systems.	[Ladoni, Moslem] Climate Corp, San Francisco, CA USA; [Kravchenko, Alexandra N.; Robertson, G. Phillip] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Robertson, G. Phillip] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA	Michigan State University; Michigan State University	Kravchenko, AN (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.	kravche1@msu.edu	Robertson, G Philip/H-3885-2011; Farmaha, Bhupinder/ABH-1387-2020	Robertson, G Philip/0000-0001-9771-9895; 	United States Department of Agriculture [2011-68002-30190]; United States Department of Agriculture Ecosystem service program [2010-65615-20614]; US National Science Foundation LTER Program [DEB 1027253]; LTER; Division Of Environmental Biology [1027253] Funding Source: National Science Foundation	United States Department of Agriculture(United States Department of Agriculture (USDA)); United States Department of Agriculture Ecosystem service program; US National Science Foundation LTER Program; LTER; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for this research was provided in part by the United States Department of Agriculture, Award No. 2011-68002-30190 "Cropping Systems Coordinated Agricultural Project (CAP): Climate Change, Mitigation and Adaptation in Corn-based Cropping Systems" (AK), the United States Department of Agriculture Ecosystem service program, Award No. 2010-65615-20614 (AK), and by the US National Science Foundation LTER Program (DEB 1027253) (GPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank LTER support personnel for managing the experimental fields and helping with sampling and data collection.	Addiscott TM, 2005, NITRATE, AGRICULTURE AND THE ENVIRONMENT, P1, DOI 10.1079/9780851999135.0001; Andraski TW, 2005, AGRON J, V97, P1239, DOI 10.2134/agronj2005.0052; Asagi N, 2009, PLANT SOIL, V322, P251, DOI 10.1007/s11104-009-9913-4; Bair KE, 2008, HORTSCIENCE, V43, P875, DOI 10.21273/HORTSCI.43.3.875; Chan C, 2007, CAN J SOIL SCI, V87, P495, DOI 10.4141/CJSS07022; Collins HP, 2007, AGRON J, V99, P27, DOI 10.2134/agronj2005.0357; Corre MD, 2002, SOIL BIOL BIOCHEM, V34, P445, DOI 10.1016/S0038-0717(01)00198-5; Cueto-Wong JA, 2001, J SUSTAIN AGR, V17, P27, DOI 10.1300/J064v17n04_04; Dabney SM, 2001, COMMUN SOIL SCI PLAN, V32, P1221, DOI 10.1081/CSS-100104110; Dharmakeerthi RS, 2005, SOIL SCI SOC AM J, V69, P453, DOI 10.2136/sssaj2005.0453; Fageria NK, 2007, J PLANT NUTR, V30, P691, DOI 10.1080/01904160701289529; Garten CT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001918; Groffman P.M., 1999, STANDARD SOIL METHOD, P272; Havlin JL, 1996, SOIL FERTILITY FERTI; Haynes RJ, 1997, BIOL FERT SOILS, V25, P130, DOI 10.1007/s003740050292; Jiang P, 2004, AGRON J, V96, P252, DOI 10.2134/agronj2004.0252; Kay BD, 2006, SOIL SCI SOC AM J, V70, P1210, DOI 10.2136/sssaj2005.0039; Kramberger B, 2009, EUR J AGRON, V31, P103, DOI 10.1016/j.eja.2009.05.006; Kravchenko AN, 2005, AGRON J, V97, P514, DOI 10.2134/agronj2005.0514; Kuo S, 2002, AGRON J, V94, P501; Ladoni M, 2015, SOIL SCI SO IN PRESS; Lawson A, 2013, RENEW AGR FOOD SYST, V28, P59, DOI 10.1017/S1742170512000014; Mirsky SB, 2009, AGRON J, V101, P1589, DOI 10.2134/agronj2009.0130; Mulvaney RL, 1996, SSSA BOOK SER 3, V5; Munoz JD, 2014, AGR ECOSYST ENVIRON, V189, P229, DOI [10.1016/j.agee., 10.1016/j.agee.2014.03.045]; Munoz JD, 2012, GEOMORPHOLOGY, V179, P197, DOI 10.1016/j.geomorph.2012.08.011; Robertson G.P., 2015, ECOLOGY AGR LANDSCAP, P1; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Ruffo ML, 2004, AGRON J, V96, P800, DOI 10.2134/agronj2004.0800; Sainju UM, 2001, AGRON J, V93, P878, DOI 10.2134/agronj2001.934878x; Sainju UM, 2008, AGRON J, V100, P619, DOI 10.2134/agronj2007.0236; Schomberg HH, 2004, BIOL FERT SOILS, V40, P398, DOI 10.1007/s00374-004-0795-6; Soon YK, 2005, CAN J SOIL SCI, V85, P579, DOI 10.4141/S04-072; Starovoytov A, 2010, AGRON J, V102, P895, DOI 10.2134/agronj2009.0402; Tonitto C, 2006, AGR ECOSYST ENVIRON, V112, P58, DOI 10.1016/j.agee.2005.07.003; Wortman SE, 2012, AGRON J, V104, P1425, DOI 10.2134/agronj2012.0185; Zotarelli L, 2009, AGRON J, V101, P252, DOI 10.2134/agronj2008.0033x	37	21	21	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143358	10.1371/journal.pone.0143358	http://dx.doi.org/10.1371/journal.pone.0143358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600462	Green Published, gold			2022-12-26	WOS:000365853900098
J	Liu, LX; Li, H; Guo, ZZ; Ma, XF; Cao, N; Zheng, YQ; Geng, SN; Duan, YJ; Han, G; Du, GJ				Liu, Linxin; Li, Hong; Guo, Zhenzhen; Ma, Xiaofang; Cao, Ning; Zheng, Yaqiu; Geng, Shengnan; Duan, Yongjian; Han, Guang; Du, Gangjun			The Combination of Three Natural Compounds Effectively Prevented Lung Carcinogenesis by Optimal Wound Healing	PLOS ONE			English	Article							PANAX-NOTOGINSENG; STEM-CELLS; CANCER CELLS; IN-VITRO; TUMORIGENESIS; ACTIVATION; THERAPY; INFLAMMATION; DEBRIDEMENT; MECHANISM	The tumor stroma has been described as "normal wound healing gone awry". We explored whether the restoration of a wound healing-like microenvironment may facilitate tumor healing. Firstly, we screened three natural compounds (shikonin, notoginsenoside R1 and aconitine) from wound healing agents and evaluated the efficacies of wound healing microenvironment for limiting single agent-elicited carcinogenesis and two-stage carcinogenesis. The results showed that three compounds used alone could promote wound healing but had unfavorable efficacy to exert wound healing, and that the combination of three compounds made up treatment disadvantage of a single compound in wound healing and led to optimal wound healing. Although individual treatment with these agents may prevent cancer, they were not effective for the treatment of established tumors. However, combination treatment with these three compounds almost completely prevented urethane-induced lung carcinogenesis and reduced tumor burden. Different from previous studies, we found that urethane-induced lung carcinogenesis was associated with lung injury independent of pulmonary inflammation. LPS-induced pulmonary inflammation did not increase lung carcinogenesis, whereas decreased pulmonary inflammation by macrophage depletion promoted lung carcinogenesis. In addition, urethane damaged wound healing in skin excision wound model, reversed lung carcinogenic efficacy by the combination of three compounds was consistent with skin wound healing. Further, the combination of these three agents reduced the number of lung cancer stem cells (CSCs) by inducing cell differentiation, restoration of gap junction intercellular communication (GJIC) and blockade of the epithelial-to-mesenchymal transition (EMT). Our results suggest that restoration of a wound healing microenvironment represents an effective strategy for cancer prevention.	[Liu, Linxin; Li, Hong; Guo, Zhenzhen; Ma, Xiaofang; Cao, Ning; Zheng, Yaqiu; Geng, Shengnan; Han, Guang; Du, Gangjun] Henan Univ, Coll Pharm, Inst Pharm, Kaifeng 475004, Henan Provice, Peoples R China; [Duan, Yongjian] Henan Univ, Dept Oncol, Hosp Affiliated 1, Kaifeng 475001, Henan Provice, Peoples R China	Henan University; Henan University	Han, G (corresponding author), Henan Univ, Coll Pharm, Inst Pharm, Kaifeng 475004, Henan Provice, Peoples R China.	Hang@henu.edu.cn; 724200@henu.edu.cn			National Natural Science Foundation of China [81173094, 81373974, 81472745]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81173094, 81373974, 81472745).; The authors thank Prof. Ming Bai and Prof. Ming-San Miao for generous assistance. We thank AJE (American Journal Experts) for editing the manuscript. This work was supported by National Natural Science Foundation of China (No. 81173094, 81373974, 81472745).	Andujar I, 2013, EUR J PHARM SCI, V49, P637, DOI 10.1016/j.ejps.2013.05.018; Andujar I, 2013, PLANTA MED, V79, P1685, DOI 10.1055/s-0033-1350934; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Du GJ, 2013, EUR J PHARMACOL, V715, P395, DOI 10.1016/j.ejphar.2013.04.031; Du Juan, 2013, Molecules, V18, P757, DOI 10.3390/molecules18010757; Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209; Fu M, 2007, BIOCHEM BIOPH RES CO, V354, P929, DOI 10.1016/j.bbrc.2007.01.082; Grimwade D, 2010, CANCER TREAT RES, V145, P219, DOI 10.1007/978-0-387-69259-3_13; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Ho PL, 2012, NAT REV UROL, V9, P583, DOI 10.1038/nrurol.2012.142; Hong SJ, 2009, PHYTOTHER RES, V23, P677, DOI 10.1002/ptr.2705; Huang L, 2014, BIOINFORMATICS, V30, P228, DOI 10.1093/bioinformatics/btu278; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ke Q, 2013, HUM MOL GENET, V22, P2221, DOI 10.1093/hmg/ddt074; Kisley LR, 2002, CARCINOGENESIS, V23, P1653, DOI 10.1093/carcin/23.10.1653; Madhok BM, 2013, INT WOUND J, V10, P247, DOI 10.1111/iwj.12045; Maeda TM, 2014, CLIN EXP DERMATOL, V39, P911, DOI 10.1111/ced.12454; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Papageorgiou VP, 2008, CURR MED CHEM, V15, P3248, DOI 10.2174/092986708786848532; Paranjape AN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-785; Piccoli C, 2012, FREE RADICAL BIO MED, V52, P916, DOI 10.1016/j.freeradbiomed.2011.12.018; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song IY, 2015, SEMIN CANCER BIOL, V32, P32, DOI 10.1016/j.semcancer.2014.03.006; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Sun DQ, 2007, CARCINOGENESIS, V28, P1859, DOI 10.1093/carcin/bgm079; Tang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102967; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Wang B, 2011, GENOME MED, V3, DOI 10.1186/gm225; Wang CZ, 2009, PHYTOTHER RES, V23, P6, DOI 10.1002/ptr.2383; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052706; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yoshikawa M, 1997, CHEM PHARM BULL, V45, P1039, DOI 10.1248/cpb.45.1039; Yunhe F., 2012, J PHARM, V689, P255, DOI DOI 10.1016/J.EJPHAR.2012.05.038; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zyuz'kov GN, 2012, B EXP BIOL MED+, V153, P847, DOI 10.1007/s10517-012-1841-2	35	27	27	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143438	10.1371/journal.pone.0143438	http://dx.doi.org/10.1371/journal.pone.0143438			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599445	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900122
J	Phillips, C; Zeringue, AL; McDonald, JR; Eisen, SA; Ranganathan, P				Phillips, Christopher; Zeringue, Angelique L.; McDonald, Jay R.; Eisen, Seth A.; Ranganathan, Prabha			Tumor Necrosis Factor Inhibition and Head and Neck Cancer Recurrence and Death in Rheumatoid Arthritis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; VETERANS; THERAPY; SCORES; RISK	The objective of this retrospective cohort study was to determine the effect of tumor necrosis factor inhibitor (TNFi) therapy on the risk of head and neck cancer (HNC) recurrence or HNC-attributable death in patients with rheumatoid arthritis (RA). RA patients with HNC were assembled from the US national Veterans' Affairs (VA) administrative databases, and diagnoses confirmed and data collected by electronic medical record review. The cohort was divided into those treated with non-biologic disease-modifying anti-rheumatic drugs (nbDMARDs) versus TNF inhibitors (TNFi) after a diagnosis of HNC. Likelihood of a composite endpoint of recurrence or HNC-attributable death was determined by Cox proportional hazards regression. Of 180 patients with RA and HNC, 31 were treated with TNFi and 149 with nbDMARDs after the diagnosis of HNC. Recurrence or HNC-attributable death occurred in 5/31 (16.1%) patients in the TNFi group and 44/149 (29.5%) patients in the nbDMARD group (p = 0.17); it occurred in 2/16 (13%) patients who received TNFi in the year prior to HNC diagnosis but not after. Overall stage at diagnosis (p = 0.03) and stage 4 HNC (HR 2.49 [CI 1.06-5.89]; p = 0.04) were risk factors for recurrence or HNC-attributable death; treatment with radiation or surgery was associated with a lower risk (HR 0.35 [CI 0.17-0.74]; p = 0.01 and HR 0.39 [CI 0.20-0.76]; p = 0.01 respectively). Treatment with TNFi was not a risk factor for recurrence or HNC-attributable death (HR 0.75; CI 0.31-1.85; p = 0.54). We conclude that treatment with TNFi may be safe in patients with RA and HNC, especially as the time interval between HNC treatment and non-recurrence increases. In this study, TNF inhibition was not associated with an increase in recurrence or HNC-attributable death.	[Phillips, Christopher; Zeringue, Angelique L.; McDonald, Jay R.; Eisen, Seth A.; Ranganathan, Prabha] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Zeringue, Angelique L.; McDonald, Jay R.; Eisen, Seth A.] St Louis Vet Affairs Med Ctr, St Louis, MO USA	Washington University (WUSTL)	Ranganathan, P (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.	prangana@dom.wustl.edu		Eisen, Seth/0000-0001-7746-6624; Zeringue, Angelique/0000-0003-3654-4109	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service project [IAF 06-026]	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service project	Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service project number IAF 06-026.	Amari W, 2011, RHEUMATOLOGY, V50, P1431, DOI 10.1093/rheumatology/ker113; Askling J, 2011, PHARMACOEPIDEM DR S, V20, P119, DOI 10.1002/pds.2046; Engel SH, 2008, LARYNGOSCOPE, V118, P450, DOI 10.1097/MLG.0b013e31815abf4c; Fakhry C, 2006, J CLIN ONCOL, V24, P2606, DOI 10.1200/JCO.2006.06.1291; Hashibe M, 2012, HEAD NECK; Jan JC, 2011, J ORAL MAXIL SURG, V69, P396, DOI 10.1016/j.joms.2010.05.017; Kim L, 2010, ONCOLOGY-NY, V24, P915; Mariette X, 2011, ANN RHEUM DIS, V70, P1895, DOI 10.1136/ard.2010.149419; Park HJ, 2012, DISCOV MED, V13, P229; Rahman N, 2010, JCR-J CLIN RHEUMATOL, V16, P197, DOI 10.1097/RHU.0b013e3181df8932; Rousseau A, 2009, REV STOMATOL CHIR, V110, P306, DOI 10.1016/j.stomax.2009.07.002; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Singh JA, 2004, ARTHRIT RHEUM-ARTHR, V51, P952, DOI 10.1002/art.20827; Urba S, 2012, ORAL ONCOL, V48, P723, DOI 10.1016/j.oraloncology.2012.02.016; Zitelli KB, 2013, CUTIS, V92, P35	15	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143286	10.1371/journal.pone.0143286	http://dx.doi.org/10.1371/journal.pone.0143286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599370	Green Submitted, gold, Green Published			2022-12-26	WOS:000365853900085
J	Wang, G; Yu, Y; Sun, C; Liu, T; Liang, T; Zhan, L; Lin, X; Feng, XH				Wang, G.; Yu, Y.; Sun, C.; Liu, T.; Liang, T.; Zhan, L.; Lin, X.; Feng, X-H			STAT3 selectively interacts with Smad3 to antagonize TGF-beta signalling	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; CANCER; CELLS; TRANSCRIPTION; ROLES; PHOSPHORYLATION; SUPPRESSION; INHIBITION; EXPRESSION; GENERATION	Smad and STAT proteins are critical signal transducers and transcription factors in controlling cell growth and tumorigenesis. Here we report that the STAT3 signaling pathway attenuates transforming growth factor-beta (TGF-beta)-induced responses through a direct Smad3-STAT3 interplay. Activated STAT3 blunts TGF-beta-mediated signaling. Depletion of STAT3 promotes TGF-beta-mediated transcriptional and physiological responses, including cell cycle arrest, apoptosis and epithelial-to-mesenchymal transition. STAT3 directly interacts with Smad3 in vivo and in vitro, resulting in attenuation of the Smad3-Smad4 complex formation and suppression of DNA-binding ability of Smad3. The N-terminal region of DNA-binding domain of STAT3 is responsible for the STAT3-Smad3 interaction and also indispensable for STAT3-mediated inhibition of TGF-beta signaling. Thus, our finding illustrates a direct crosstalk between the STAT3 and Smad3 signaling pathways that may contribute to tumor development and inflammation.	[Wang, G.; Yu, Y.; Liu, T.; Feng, X-H] Zhejiang Univ, Inst Life Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, G.; Yu, Y.; Liu, T.; Feng, X-H] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou, Zhejiang, Peoples R China; [Wang, G.; Lin, X.; Feng, X-H] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Sun, C.; Feng, X-H] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Liang, T.] Zhejiang Univ, Dept Hepatobiliary & Pancreat Surg, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Liang, T.] Zhejiang Univ, Affiliated Hosp 2, Key Lab Canc Prevent & Intervent, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Zhan, L.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Feng, X-H] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sun, C.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Zhejiang University; Zhejiang University; Baylor College of Medicine; Baylor College of Medicine; Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Feng, XH (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou, Zhejiang, Peoples R China.; Feng, XH (corresponding author), Baylor Coll Med, Dept Surg, One Baylor Plaza,Rm R712, Houston, TX 77030 USA.	xhfeng@zju.edu.cn			MOST [2012CB966600]; NSFC [31571447, 31090360]; NIH [R01GM63773, R01 AR053591, R01CA108454, R01DK073932]; Project 985; Fundamental Research Funds for Central Universities; Project 111; NATIONAL CANCER INSTITUTE [R21CA112939, R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	MOST; NSFC(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project 985; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Project 111(Ministry of Education, China - 111 Project); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank David Luskutoff for p800 (PAI-1)-luc, Peter ten Dijke for CAGA-luc, Bert Vogelstein for WWP1 (p21)-luc and SBE-luc and Xiao-Fan Wang for p15-luc. We are grateful to colleagues in our laboratories for helpful discussion and technical assistance. This research was partly supported by grants from MOST (2012CB966600) and NSFC (31571447; 31090360), NIH (R01GM63773, R01 AR053591, R01CA108454 and R01DK073932), Project 111, Project 985 and the Fundamental Research Funds for the Central Universities.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Campbell JDM, 2001, J IMMUNOL, V167, P553, DOI 10.4049/jimmunol.167.1.553; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2007, THE TGF BETA FAMILY, P1; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Dunfield LD, 2003, ONCOGENE, V22, P4745, DOI 10.1038/sj.onc.1206617; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Ghosh AK, 2001, J BIOL CHEM, V276, P11041, DOI 10.1074/jbc.M004709200; Gunaje Jagadambika J., 2000, Molecular Cell Biology Research Communications, V4, P151, DOI 10.1006/mcbr.2001.0272; Han SU, 2004, ONCOGENE, V23, P1333, DOI 10.1038/sj.onc.1207259; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirai H, 2001, CANCER CHEMOTH PHARM, V48, pS35, DOI 10.1007/s002800100303; Huang D, 2014, CONNECT TISSUE RES, V55, P391, DOI 10.3109/03008207.2014.959118; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Kim SG, 2005, MOL BIOL CELL, V16, P4672, DOI 10.1091/mbc.E05-01-0054; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lin X, 2003, MOL CELL BIOL, V23, P9081, DOI 10.1128/MCB.23.24.9081-9093.2003; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Luwor RB, 2013, ONCOGENE, V32, P2433, DOI 10.1038/onc.2012.260; Martinez GJ, 2010, J BIOL CHEM, V285, P29039, DOI 10.1074/jbc.C110.155820; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Schmierer B, 2003, J BIOL CHEM, V278, P21197, DOI 10.1074/jbc.M212425200; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Walia B, 2003, FASEB J, V17, P2130, DOI 10.1096/fj.02-1211fje; Wang DG, 2008, CANCER RES, V68, P783, DOI 10.1158/0008-5472.CAN-07-0008; Wierenga ATJ, 2002, LEUKEMIA, V16, P675, DOI 10.1038/sj.leu.2402425; Wolfraim LA, 2004, NEW ENGL J MED, V351, P552, DOI 10.1056/NEJMoa031197; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yamamoto T, 2001, FEBS LETT, V492, P247, DOI 10.1016/S0014-5793(01)02258-X; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zauberman A, 2001, J BIOL CHEM, V276, P24719, DOI 10.1074/jbc.M005813200; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zheng R, 2008, CELL BIOCHEM FUNCT, V26, P548, DOI 10.1002/cbf.1464	50	53	55	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	33					4388	4398		10.1038/onc.2015.446	http://dx.doi.org/10.1038/onc.2015.446			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3ZU	26616859	Green Accepted, Green Submitted			2022-12-26	WOS:000382152100010
J	Goto, A; Charman, M; Ridgway, ND				Goto, Asako; Charman, Mark; Ridgway, Neale D.			Oxysterol-binding Protein Activation at Endoplasmic Reticulum-Golgi Contact Sites Reorganizes Phosphatidylinositol 4-Phosphate Pools	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; HAMSTER OVARY CELLS; SPHINGOMYELIN SYNTHESIS; CERAMIDE TRANSPORT; CHOLESTEROL; PHOSPHORYLATION; REVEALS; STEROL; 25-HYDROXYCHOLESTEROL; PHOSPHOINOSITIDES	Oxysterol-binding protein (OSBP) exchanges cholesterol and phosphatidylinositol 4-phosphate (PI-4P) at contact sites between the endoplasmic reticulum (ER) and the trans-Golgi/ trans-Golgi network. 25-Hydroxycholesterol (25OH) competitively inhibits this exchange reaction in vitro and causes the constitutive localization of OSBP at the ER/Golgi interface and PI-4P-dependent recruitment of ceramide transfer protein (CERT) for sphingomyelin synthesis. Weused PI-4P probes and mass analysis to determine how OSBP controls the availability of PI-4P for this metabolic pathway. Treatment of fibroblasts or Chinese hamster ovary (CHO) cells with 25OH caused a 50-70% reduction in Golgi-associated immunoreactive PI-4P that correlated with Golgi localization of OSBP. In contrast, 25OH caused an OSBP-dependent enrichment in Golgi PI-4P that was detected with a pleckstrin homology domain probe. The cellular mass of phosphatidylinositol monophosphates and Golgi PI-4P measured with an unbiased PI-4P probe (P4M) was unaffected by 25OH and OSBP silencing, indicating that OSBP shifts the distribution of PI-4P upon localization to ER-Golgi contact sites. The PI-4P and sterol binding activities of OSBP were both required for 25OH activation of sphingomyelin synthesis, suggesting that 25OH must be exchanged for PI-4P to be concentrated at contact sites. We propose a model wherein 25OH activation of OSBP promotes the binding and retention of PI-4P at ER-Golgi contact sites. This pool of PI-4P specifically recruits pleckstrin homology domain-containing proteins involved in lipid transfer and metabolism, such as CERT.	Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4R2, Canada; Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University	Ridgway, ND (corresponding author), Dalhousie Univ, Rm C306 CRC,5849 Univ Av, Halifax, NS B3H 4R2, Canada.	nridgway@dal.ca		Goto, Asako/0000-0002-0002-2619; Ridgway, Neale/0000-0002-0441-6228	Canadian Institutes of Health Research [MOP-15284]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-15284 from the Canadian Institutes of Health Research. The authors declare that they have no conflict of interest with the content of this article.	Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; Banerji S, 2010, MOL BIOL CELL, V21, P4141, DOI 10.1091/mbc.E10-05-0424; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Charman M, 2014, J BIOL CHEM, V289, P15705, DOI 10.1074/jbc.M114.571216; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Gehrig K, 2011, BBA-MOL CELL BIOL L, V1811, P377, DOI 10.1016/j.bbalip.2011.04.001; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Goto A, 2012, MOL BIOL CELL, V23, P3624, DOI 10.1091/mbc.E12-04-0283; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; KANDUTSCH AA, 1984, J BIOL CHEM, V259, P2388; Lagace TA, 1997, BIOCHEM J, V326, P205, DOI 10.1042/bj3260205; Lagace TA, 2013, BBA-MOL CELL RES, V1833, P2499, DOI 10.1016/j.bbamcr.2013.05.018; Liu XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108368; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mesmin B, 2013, CELL MOL LIFE SCI, V70, P3405, DOI 10.1007/s00018-012-1247-3; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perry RJ, 2005, BBA-MOL CELL BIOL L, V1734, P220, DOI 10.1016/j.bbalip.2005.04.001; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Ridgway ND, 1998, J BIOL CHEM, V273, P31621, DOI 10.1074/jbc.273.47.31621; Sarkes D, 2010, BIOCHEM J, V428, P375, DOI 10.1042/BJ20100129; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Storey MK, 1998, BIOCHEM J, V336, P247, DOI 10.1042/bj3360247; Strating JRPM, 2015, CELL REP, V10, P600, DOI 10.1016/j.celrep.2014.12.054; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; von Filseck JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7671; Wakelam MJO, 2014, BBA-MOL CELL BIOL L, V1841, P1102, DOI 10.1016/j.bbalip.2014.04.005	40	29	29	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1336	1347		10.1074/jbc.M115.682997	http://dx.doi.org/10.1074/jbc.M115.682997			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26601944	hybrid, Green Published			2022-12-26	WOS:000368068300027
J	Weil, IA; Seicean, S; Neuhauser, D; Schiltz, NK; Seicean, A				Weil, Isabel A.; Seicean, Sinziana; Neuhauser, Duncan; Schiltz, Nicholas K.; Seicean, Andreea			Use and Utility of Hemostatic Screening in Adults Undergoing Elective, Non-Cardiac Surgery	PLOS ONE			English	Article							PREOPERATIVE ANEMIA; TESTS; TRANSFUSION; OUTCOMES	Introduction One view of value in medicine is outcome relative to cost of care provided. With respect to operative care, increased attention has been placed on evaluation and optimization of patients prior to undergoing an elective surgery. We examined more than 2 million patients having elective, non-cardiac surgery to assess the incidence and utility of pre-operative hemostatic screening, compared with a composite of history variables that may indicate a propensity for bleeding, to assess several important outcomes of surgery. Materials & Methods We queried the NSQIP database to identify 2,020,533 patients and compared hemostatic tests (PT, aPTT, platelet count) and history covariables indicative of potential for abnormal hemostasis. We compared outcomes across predictor values; used Person's chi-square tests to compare differences, and logistic regression to model outcomes. Results Approximately 36% of patients had all three tests pre-operatively while 16% had none of them; 11.2% had a history predictive of potential abnormal bleeding. Outcomes of interest across the cohort included death in 0.7%, unplanned return to the operating room or readmission within 30 days in 3.8% and 6.2% of patients; 5.3% received a transfusion during or after surgery. Sub-analyses in each of the nine surgical specialties' most common procedures yielded similar results. Conclusion The limited predictive value of each hemostatic screening test, as well as excess costs associated with them, across a broad spectrum of elective surgeries, suggests that limiting pre-operative testing to a more select group of patients may be reasonable, equally efficacious, efficient, and cost-effective.	[Weil, Isabel A.; Neuhauser, Duncan; Schiltz, Nicholas K.; Seicean, Andreea] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Seicean, Sinziana] Cleveland Clin, Inst Heart & Vasc, Cleveland, OH 44106 USA; [Seicean, Sinziana] Univ Hosp, Dept Pulm Crit Care & Sleep Med, Cleveland, OH USA	Case Western Reserve University; Cleveland Clinic Foundation; University Hospitals of Cleveland	Seicean, A (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	aas33@case.edu		Schiltz, Nicholas/0000-0003-0122-6477	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000439] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Alan N, 2014, J NEUROSURG, V120, P764, DOI 10.3171/2013.10.JNS131028; *AM COLL SURG NAT, ACS NSQIP DAT COLL O; Amer Soc Anesthesiolgists, 2012, ANESTHESIOLOGY, V116, P522, DOI 10.1097/ALN.0b013e31823c1067; American Society of Anesthesiologists, 5 THINGS PHYS PAT SH; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bennett-Guerrero E, 2010, J CARDIOTHOR VASC AN, V24, P814, DOI 10.1053/j.jvca.2010.06.003; Carless PA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub2; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Czoski-Murray C, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16500; Elixhauser A, 2010, ARCH SURG-CHICAGO, V145, P1201, DOI 10.1001/archsurg.2010.269; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Glance LG, 2014, JAMA SURG, V149, P439, DOI 10.1001/jamasurg.2014.4; Griffin JH, 2010, WILLIAMS HEMATOLOGY, P1845; HCUP Cost-to-Charge Ratio Files (CCR), 2012, HLTH COST UT PROJ HC; Hebert PC, 2014, NEW ENGL J MED, V371, P1459, DOI 10.1056/NEJMe1408976; Horvath A Rita, 2013, Clin Biochem Rev, V34, P47; HOURY S, 1995, AM J SURG, V170, P19, DOI 10.1016/S0002-9610(99)80245-1; Huffman KM, 2014, ANN SURG; KANG J, 1994, INT J PEDIATR OTORHI, V28, P157, DOI 10.1016/0165-5876(94)90007-8; KAPLAN EB, 1985, JAMA-J AM MED ASSOC, V253, P3576, DOI 10.1001/jama.253.24.3576; Khuri SF, 2005, SURGERY, V138, P837, DOI 10.1016/j.surg.2005.08.016; Khuri SF, 2007, J AM COLL SURGEONS, V204, P1089, DOI 10.1016/j.jamcollsurg.2007.03.028; Ng KFJ, 2002, WORLD J SURG, V26, P515, DOI 10.1007/s00268-001-0260-8; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011; ROHRER MJ, 1988, ANN SURG, V208, P554, DOI 10.1097/00000658-198811000-00002; Ryan DH, 2010, WILLIAMS HEMATOLOGY, P11; Seicean A, 2013, SPINE, V38, P1331, DOI 10.1097/BRS.0b013e3182912c6b; Seicean A, 2012, J NEUROSURG, V116, P1097, DOI 10.3171/2012.1.JNS111760; Shiloach M, 2010, J AM COLL SURGEONS, V210, P6, DOI 10.1016/j.jamcollsurg.2009.09.031; Smyth S. S., 2010, WILLIAMS HEMATOLOGY, P1735	30	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0139139	10.1371/journal.pone.0139139	http://dx.doi.org/10.1371/journal.pone.0139139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26623648	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600001
J	DeLoss, DJ; Andersen, GJ				DeLoss, Denton J.; Andersen, George J.			Aging, Spatial Disparity, and the Sound-Induced Flash Illusion	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; ENHANCEMENT	The present study examined age-related differences in multisensory integration and the effect of spatial disparity on the sound-induced flash illusion-an illusion used in previous research to assess age-related differences in multisensory integration. Prior to participation in the study, both younger and older participants demonstrated their ability to detect 1-2 visual flashes and 1-2 auditory beep presented unimodally. After passing the pre-test, participants were then presented 1-2 flashes paired with 0-2 beeps that originated from one of five speakers positioned equidistantly 100cm from the participant. One speaker was positioned directly below the screen, two speakers were positioned 50cm to the left and right from the center of the screen, and two more speakers positioned to the left and right 100cm from the center of the screen. Participants were told to report the number of flashes presented and to ignore the beeps. Both age groups showed a significant effect of the beeps on the perceived number of flashes. However, neither younger nor older individuals showed any significant effect of spatial disparity on the sound-induced flash illusion. The presence of a congruent number of beeps increased accuracy for both older and younger individuals. Reaction time data was also analyzed. As expected, older individuals showed significantly longer reaction times when compared to younger individuals. In addition, both older and younger individuals showed a significant increase in reaction time for fusion trials, where two flashes and one beep are perceived as a single flash, as compared to congruent single flash trials. This increase in reaction time was not found for fission trials, where one flash and two beeps were perceived as two flashes. This suggests that processing may differ for the two forms for fission as compared to fusion illusions.	[DeLoss, Denton J.; Andersen, George J.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Andersen, GJ (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.	Andersen@ucr.edu			National Institute on Aging [AG031941]; NATIONAL INSTITUTE ON AGING [R01AG031941] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was suppported by the National Institute on Aging, AG031941, https://www.nia.nih.gov/.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Appollonio I, 1996, AGE AGEING, V25, P89, DOI 10.1093/ageing/25.2.89; Bizley JK, 2008, BRAIN RES, V1242, P24, DOI 10.1016/j.brainres.2008.02.087; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; DeLoss D, 2015, J VIS, V15, P849, DOI [10.1167/15.12.849, DOI 10.1167/15.12.849]; DeLoss DJ, 2013, PSYCHOL AGING, V28, P802, DOI 10.1037/a0033289; Diederich A, 2008, NEUROPSYCHOLOGIA, V46, P2556, DOI 10.1016/j.neuropsychologia.2008.03.026; Falchier A, 2002, J NEUROSCI, V22, P5749; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Innes-Brown H, 2011, DEVELOPMENTAL SCI, V14, P1089, DOI 10.1111/j.1467-7687.2011.01059.x; Innes-Brown H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006450; JONES E G, 1970, Brain Behavior and Evolution, V93, P793, DOI 10.1093/brain/93.4.793; Keidser G, 2015, INT J AUDIOL, V54, P653, DOI 10.3109/14992027.2015.1046503; Kleiner M, 2007, PERCEPTION, V36, P14; Laurienti PJ, 2006, NEUROBIOL AGING, V27, P1155, DOI 10.1016/j.neurobiolaging.2005.05.024; McGovern DP, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00250; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Meredith MA, 1986, SPATIAL FACTORS DETE, V5, P350; Peiffer AM, 2007, NEUROREPORT, V18, P1077, DOI 10.1097/WNR.0b013e3281e72ae7; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Roudaia E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00267; Setti A, 2011, EXP BRAIN RES, V209, P375, DOI 10.1007/s00221-011-2560-z; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Stein BE., 1993, MERGING SENSES; Stephen JM, 2010, NEUROSCI LETT, V484, P76, DOI 10.1016/j.neulet.2010.08.023; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Van Wanrooij MM, 2009, EXP BRAIN RES, V198, P425, DOI 10.1007/s00221-009-1815-4; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd	31	12	13	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143773	10.1371/journal.pone.0143773	http://dx.doi.org/10.1371/journal.pone.0143773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7NW	26619352	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800069
J	Gaviria, J; Engelbrecht, BMJ				Gaviria, Julian; Engelbrecht, Bettina M. J.			Effects of Drought, Pest Pressure and Light Availability on Seedling Establishment and Growth: Their Role for Distribution of Tree Species across a Tropical Rainfall Gradient	PLOS ONE			English	Article							DISTRIBUTION PATTERNS; INSECT HERBIVORES; LIFE-HISTORY; FOREST; PERFORMANCE; CLIMATE; DIVERSITY; DENSITY; TRAITS; SOIL	Tree species distributions associated with rainfall are among the most prominent patterns in tropical forests. Understanding the mechanisms shaping these patterns is important to project impacts of global climate change on tree distributions and diversity in the tropics. Beside direct effects of water availability, additional factors co-varying with rainfall have been hypothesized to play an important role, including pest pressure and light availability. While low water availability is expected to exclude drought-intolerant wet forest species from drier forests (physiological tolerance hypothesis), high pest pressure or low light availability are hypothesized to exclude dry forest species from wetter forests (pest pressure gradient and light availability hypothesis, respectively). To test these hypotheses at the seed-to-seedling transition, the potentially most critical stage for species discrimination, we conducted a reciprocal transplant experiment combined with a pest exclosure treatment at a wet and a dry forest site in Panama with seeds of 26 species with contrasting origin. Establishment success after one year did not reflect species distribution patterns. However, in the wet forest, wet origin species had a home advantage over dry forest species through higher growth rates. At the same time, drought limited survival of wet origin species in the dry forest, supporting the physiological tolerance hypothesis. Together these processes sort species over longer time frames, and exclude species outside their respective home range. Although we found pronounced effects of pests and some effects of light availability on the seedlings, they did not corroborate the pest pressure nor light availability hypotheses at the seed-to-seedling transition. Our results underline that changes in water availability due to climate change will have direct consequences on tree regeneration and distributions along tropical rainfall gradients, while indirect effects of light and pests are less important.	[Gaviria, Julian; Engelbrecht, Bettina M. J.] Univ Bayreuth, Dept Plant Ecol, Bayreuth Ctr Ecol & Environm Res BayCEER, Bayreuth, Germany; [Engelbrecht, Bettina M. J.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	University of Bayreuth; Smithsonian Institution; Smithsonian Tropical Research Institute	Gaviria, J (corresponding author), Univ Bayreuth, Dept Plant Ecol, Bayreuth Ctr Ecol & Environm Res BayCEER, Bayreuth, Germany.	julian.gaviria@uni-bayreuth.de			Freistaat Bayern; University of Bayreuth	Freistaat Bayern; University of Bayreuth	Funding was provided by the Freistaat Bayern, represented by the University of Bayreuth [http://www.uni-bayreuth.de/de/index.html]. This publication was funded by the University of Bayreuth in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amissah L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121004; Amissah L, 2014, J TROP ECOL, V30, P435, DOI 10.1017/S026646741400025X; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Baltzer JL, 2008, FUNCT ECOL, V22, P221, DOI 10.1111/j.1365-2435.2007.01374.x; Baltzer JL, 2007, J BIOGEOGR, V34, P1916, DOI 10.1111/j.1365-2699.2007.01739.x; Baltzer JL, 2012, ECOL EVOL, V2, P2682, DOI 10.1002/ece3.383; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Bongers F, 1999, J VEG SCI, V10, P371, DOI 10.2307/3237066; Bongers Frans, 2005, FOREST CLIMBING PLAN; Brenes-Arguedas T, 2011, OECOLOGIA, V166, P443, DOI 10.1007/s00442-010-1832-9; Brenes-Arguedas T, 2008, OIKOS, V117, P1453, DOI 10.1111/j.0030-1299.2008.16903.x; Brenes-Arguedas T, 2009, ECOLOGY, V90, P1751, DOI 10.1890/08-1271.1; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Comita L. S., 2013, FORESTS GLOBAL CHANG, P261; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 2013, P NATL ACAD SCI USA, V110, P5064, DOI 10.1073/pnas.1218042110; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Daws MI, 2005, PLANT ECOL, V179, P93, DOI 10.1007/s11258-004-5801-4; Eichhorn MP, 2010, ECOLOGY, V91, P1092, DOI 10.1890/09-0300.1; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; ESP, DATA SETS PROVIDED B; Fayolle A, 2014, J BIOGEOGR, V41, P2320, DOI 10.1111/jbi.12382; Fernandez RJ, 2000, OECOLOGIA, V123, P90, DOI 10.1007/s004420050993; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Gripenberg S, 2014, OIKOS, V123, P185, DOI 10.1111/j.1600-0706.2013.00835.x; Harms KE, 2004, BIOTROPICA, V36, P40; Harper J.L., 1977, POPULATION BIOLOGY O; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huston MA, 1994, BIOLOGICAL DIVERSITY; Lenth R. V., 2014, R PACKAGE VERSION 2; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Markesteijn L, 2009, J ECOL, V97, P311, DOI 10.1111/j.1365-2745.2008.01466.x; Markesteijn L, 2011, NEW PHYTOL, V191, P480, DOI 10.1111/j.1469-8137.2011.03708.x; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; O'Brien MJ, 2015, NEW PHYTOL, V205, P1083, DOI 10.1111/nph.13134; Polley HW, 2002, TREE PHYSIOL, V22, P383, DOI 10.1093/treephys/22.6.383; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; R Core Team, 2013, R A LANGUAGE AND ENV; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SMITH T, 1989, VEGETATIO, V83, P49, DOI 10.1007/BF00031680; Spear ER, 2015, J ECOL, V103, P165, DOI 10.1111/1365-2745.12339; Sterck F, 2014, ECOLOGY, V95, P2514, DOI 10.1890/13-2377.1; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Toledo M, 2012, J ECOL, V100, P253, DOI 10.1111/j.1365-2745.2011.01890.x; Toledo M, 2011, J ECOL, V99, P254, DOI 10.1111/j.1365-2745.2010.01741.x; Tremblay A., 2013, R PACKAGE VERSION 2; WELDEN CW, 1991, ECOLOGY, V72, P35, DOI 10.2307/1938900; Wikberg J, 2004, TREES-STRUCT FUNCT, V18, P70, DOI 10.1007/s00468-003-0282-y; Wright S Joseph, 2010, Ecology, V91, P3664, DOI 10.1890/09-2335.1	54	21	22	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143955	10.1371/journal.pone.0143955	http://dx.doi.org/10.1371/journal.pone.0143955			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619138	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800094
J	Jeon, JY; Wang, HJ; Ock, SY; Xu, W; Lee, JD; Lee, JH; Kim, HJ; Kim, DJ; Lee, KW; Han, SJ				Jeon, Ja Young; Wang, Hee-Jung; Ock, So Young; Xu, Weiguang; Lee, Jung-Dong; Lee, Jei Hee; Kim, Hae Jin; Kim, Dae Jung; Lee, Kwan Woo; Han, Seung Jin			Newly Developed Sarcopenia as a Prognostic Factor for Survival in Patients who Underwent Liver Transplantation	PLOS ONE			English	Article							SKELETAL-MUSCLE; BODY-COMPOSITION; CIRRHOSIS; CONSENSUS; OUTCOMES; QUALITY; IMPACT; RISK; MASS	Introduction The relationship between a perioperative change in sarcopenic status and clinical outcome of liver transplantation (LT) is unknown. We investigated whether post-LT sarcopenia and changes in sarcopenic status were associated with the survival of patients. Method This retrospective study was based on a cohort of 145 patients from a single transplant center who during a mean of 1 year after LT underwent computed tomography imaging evaluation. The cross-sectional area of the psoas muscle of LT patients was compared with that of age-and sex-matched healthy individuals. The Cox proportional hazards regression model was used to determine whether post-LT sarcopenia and changes in sarcopenic status affect post-LT survival. Results The mean age at LT of the 116 male and 29 female patients was 50.2 +/- 7.9 years; the mean follow-up duration was 51.6 +/- 32.9 months. All pre-LT patients with sarcopenia still had sarcopenia 1 year after LT; 14 (15%) patients had newly developed sarcopenia. The mean survival duration was 91.8 +/- 4.2 months for non-sarcopenic patients and 80.0 +/- 5.2 months for sarcopenic patients (log-rank test, p = 0.069). In subgroup analysis, newly developed sarcopenia was an independent negative predictor for post-LT survival (hazard ratio: 10.53, 95% confidence interval: 1.37-80.93, p = 0.024). Conclusion Sarcopenia in LT recipients did not improve in any of the previously sarcopenic patients and newly developed within 1 year in others. Newly developed sarcopenia was associated with increased mortality. Newly developed sarcopenia can be used to stratify patients with regard to the risk of post-LT mortality.	[Jeon, Ja Young; Ock, So Young; Kim, Hae Jin; Kim, Dae Jung; Lee, Kwan Woo; Han, Seung Jin] Ajou Univ, Sch Med, Dept Endocrinol & Metab, Suwon 441749, South Korea; [Wang, Hee-Jung; Xu, Weiguang] Ajou Univ, Sch Med, Dept Surg, Suwon 441749, South Korea; [Lee, Jung-Dong] Ajou Univ, Sch Med, Off Biostat, Suwon 441749, South Korea; [Lee, Jei Hee] Ajou Univ, Sch Med, Dept Diagnost Radiol, Suwon 441749, South Korea	Ajou University; Ajou University; Ajou University; Ajou University	Han, SJ (corresponding author), Ajou Univ, Sch Med, Dept Endocrinol & Metab, Suwon 441749, South Korea.	hsj@ajou.ac.kr	Kim, Dae Jung/AAJ-7518-2021	Kim, Dae Jung/0000-0003-1025-2044; Jeon, Ja Young/0000-0002-3877-0479				Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Choi KM, 2013, ENDOCRINOL METAB, V28, P86, DOI 10.3803/EnM.2013.28.2.86; Cooper C, 2013, CALCIFIED TISSUE INT, V93, P201, DOI 10.1007/s00223-013-9757-z; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dasarathy S, 2013, DIGEST DIS SCI, V58, P3103, DOI 10.1007/s10620-013-2791-x; Dasarathy S, 2012, J CACHEXIA SARCOPENI, V3, P225, DOI 10.1007/s13539-012-0069-3; Duffy JP, 2010, ANN SURG, V252, P652, DOI 10.1097/SLA.0b013e3181f5f23a; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Giusto M, 2014, WORLD J GASTROENTERO, V20, P10682, DOI 10.3748/wjg.v20.i31.10682; Hamaguchi Y, 2014, LIVER TRANSPLANT, V20, P1413, DOI 10.1002/lt.23970; HASSE JM, 1995, JPEN-PARENTER ENTER, V19, P437, DOI 10.1177/0148607195019006437; Hussaini SH, 1998, LIVER, V18, P173; Hussaini SH, 1998, APPL RADIAT ISOTOPES, V49, P663, DOI 10.1016/S0969-8043(97)00088-2; Kaido T, 2013, AM J TRANSPLANT, V13, P1549, DOI 10.1111/ajt.12221; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Keogh JB, 1999, NUTRITION, V15, P661, DOI 10.1016/S0899-9007(99)00121-5; Kim BW, 2012, TRANSPL INT, V25, P1072, DOI 10.1111/j.1432-2277.2012.01538.x; Kim BW, 2011, LIVER TRANSPLANT, V17, P1046, DOI 10.1002/lt.22338; Kim HK, 2013, INFECT CHEMOTHER, V45, P315, DOI 10.3947/ic.2013.45.3.315; Krell RW, 2013, LIVER TRANSPLANT, V19, P1396, DOI 10.1002/lt.23752; Lee CS, 2014, CLIN TRANSPLANT, V28, P1092, DOI 10.1111/ctr.12422; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; Masuda T, 2014, LIVER TRANSPLANT, V20, P401, DOI 10.1002/lt.23811; Montano-Loza AJ, 2014, LIVER TRANSPLANT, V20, P640, DOI 10.1002/lt.23863; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; MULLER MJ, 1994, CLIN NUTR, V13, P145, DOI 10.1016/0261-5614(94)90093-0; Periyalwar P, 2012, CLIN LIVER DIS, V16, P95, DOI 10.1016/j.cld.2011.12.009; Plank LD, 2001, ANN SURG, V234, P245, DOI 10.1097/00000658-200108000-00015; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Tsien C, 2014, J GASTROEN HEPATOL, V29, P1250, DOI 10.1111/jgh.12524; Valero V, 2015, J GASTROINTEST SURG, V19, P272, DOI 10.1007/s11605-014-2680-4; Song ATW, 2014, WORLD J GASTROENTERO, V20, P5363, DOI 10.3748/wjg.v20.i18.5363; Zarrinpar A, 2013, NAT REV GASTRO HEPAT, V10, P434, DOI 10.1038/nrgastro.2013.88	35	23	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143966	10.1371/journal.pone.0143966	http://dx.doi.org/10.1371/journal.pone.0143966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619224	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800095
J	Hsieh, YH; Chiu, WC; Lin, CF; Chan, HL; Liang, HY; Lee, Y; McIntyre, RS; Chen, VCH				Hsieh, Yi-Hsuan; Chiu, Wei-Che; Lin, Chiao-Fan; Chan, Hsiang-Lin; Liang, Hsin-Yi; Lee, Yena; McIntyre, Roger S.; Chen, Vincent Chin-Hung			Antidepressants and Gastric Cancer: A Nationwide Population-Based Nested Case-Control Study	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RISK; MIRTAZAPINE; MEDICATIONS; FLUOXETINE; PAROXETINE; LESIONS; ULCER; RATS	Background To our knowledge, no epidemiological study has reported on whether an association between antidepressant exposure and gastric cancer exists. Herein, we aim to investigate the possible association between antidepressant exposure and gastric cancer incidence. Methods Using a nested case-control design, we identified 26289 cases with gastric cancer and 127984 controls from Taiwan's National Health Insurance Research Database (NHIRD). The data were analyzed using a conditional logistic regression model adjusting for possible confounding variables. Results We found antidepressant use did not increase the risk of gastric cancer. The lack of an association between antidepressant prescription and elevated gastric cancer incidence was apparent for across selective serotonin-reuptake inhibitors (SSRIs), tricyclic agents (TCAs), serotonin-norepinephrine reuptake inhibitors (SNRIs), reversible inhibitors of monoamine oxidase A (RIMA), trazodone, mirtazapine and bupropion. There were slightly decreased gastric cancer risks of SSRIs use (>= 28 DDD group, adjusted OR = 0.87; 95% CI = 0.78-0.96). Sensitive analysis showed SSRIs, TCAs, and SNRIs did not increase gastric cancer risks significantly even in the group with peptic ulcer history. Conclusions An association between antidepressant exposure and gastric cancer was not apparent in this analysis.	[Hsieh, Yi-Hsuan; Lin, Chiao-Fan; Chan, Hsiang-Lin; Liang, Hsin-Yi] Linkou Chang Gung Mem Hosp, Dept Child & Adolescent Psychiat, Taoyuan, Taiwan; [Chiu, Wei-Che] Cathay Gen Hosp, Dept Psychiat, Taipei 10630, Taiwan; [Chiu, Wei-Che; Lee, Yena] Fu Jen Catholic Univ, Sch Med, Taipei 24205, Taiwan; [McIntyre, Roger S.] Univ Toronto, Dept Psychiat, Mood Disorders Psychopharmacol Unit, Univ Hlth Network, Toronto, ON, Canada; [Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan	Chang Gung Memorial Hospital; Cathay General Hospital; Fu Jen Catholic University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Chang Gung Memorial Hospital	Chen, VCH (corresponding author), Chiayi Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan.	hjcch@yahoo.com.tw	Students, MDPU/ABE-8402-2020; Lee, Yena/L-5505-2019; McIntyre, Roger/AAU-1000-2020; Lee, Yena/D-9016-2019	Lee, Yena/0000-0003-0629-9456; McIntyre, Roger/0000-0003-4733-2523; Lee, Yena/0000-0003-0629-9456				Abdel-Sater KA, 2012, EUR J PHARMACOL, V688, P42, DOI 10.1016/j.ejphar.2012.04.019; Andrade C, 2010, J CLIN PSYCHIAT, V71, P1565, DOI 10.4088/JCP.09r05786blu; Anglin R, 2014, AM J GASTROENTEROL, V109, P810, DOI 10.1038/ajg.2014.82; Bilici M, 2012, ASIAN PAC J CANCER P, V13, P4897, DOI 10.7314/APJCP.2012.13.10.4897; Dalton SO, 2000, EPIDEMIOLOGY, V11, P171, DOI 10.1097/00001648-200003000-00015; Dalton SO, 2003, ARCH INTERN MED, V163, P59, DOI 10.1001/archinte.163.1.59; Dursun H, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-36; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Haukka J, 2010, INT J CANCER, V126, P285, DOI 10.1002/ijc.24537; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji CX, 2012, EUR J PHARMACOL, V691, P46, DOI 10.1016/j.ejphar.2012.06.041; ROTHMAN KJ, 1981, AM J EPIDEMIOL, V114, P253, DOI 10.1093/oxfordjournals.aje.a113189; Suleyman H, 2009, CHEM-BIOL INTERACT, V180, P318, DOI 10.1016/j.cbi.2009.03.002; Takahashi T, 2012, PROG NEURO-PSYCHOPH, V36, P39, DOI 10.1016/j.pnpbp.2011.08.017; Takeuchi K, 2011, J PHARMACOL EXP THER, V338, P850, DOI 10.1124/jpet.111.183293; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Vaughan TL, 1998, CANCER EPIDEM BIOMAR, V7, P749; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Wang YP, 2014, AM J PSYCHIAT, V171, P54, DOI 10.1176/appi.ajp.2013.12111467; WHO, ATC CLASS IND DDDS 2; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695	21	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143668	10.1371/journal.pone.0143668	http://dx.doi.org/10.1371/journal.pone.0143668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606417	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300098
J	Lambie, EJ; Bruce, RD; Zielich, J; Yuen, SN				Lambie, Eric J.; Bruce, Robert D., III; Zielich, Jeffrey; Yuen, Sonia N.			Novel Alleles of gon-2, a C-elegans Ortholog of Mammalian TRPM6 and TRPM7, Obtained by Genetic Reversion Screens	PLOS ONE			English	Article							CATION CHANNEL; ION-CHANNEL; SECONDARY HYPOCALCEMIA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MOLECULAR DETERMINANTS; CAENORHABDITIS-ELEGANS; MAGNESIUM HOMEOSTASIS; KINASE-ACTIVITY; COILED-COIL; PROTEIN	TRP (Transient Receptor Potential) cation channels of the TRPM subfamily have been found to be critically important for the regulation of Mg2+ homeostasis in both protostomes (e.g., the nematode, C. elegans, and the insect, D. melanogaster) and deuterostomes (e.g., humans). Although significant progress has been made toward understanding how the activities of these channels are regulated, there are still major gaps in our understanding of the potential regulatory roles of extensive, evolutionarily conserved, regions of these proteins. The C. elegans genes, gon-2, gtl-1 and gtl-2, encode paralogous TRP cation channel proteins that are similar in sequence and function to human TRPM6 and TRPM7. We isolated fourteen revertants of the missense mutant, gon-2(q338), and these mutations affect nine different residues within GON-2. Since eight of the nine affected residues are situated within regions that have high similarity to human TRPM1,3,6 and 7, these mutations identify sections of these channels that are potentially critical for channel regulation. We also isolated a single mutant allele of gon-2 during a screen for revertants of the Mg2+-hypersensitive phenotype of gtl-2(-) mutants. This allele of gon-2 converts a serine to phenylalanine within the highly conserved TRP domain, and is antimorphic against both gon-2(+) and gtl-1 (+). Interestingly, others have reported that mutation of the corresponding residue in TRPM7 to glutamate results in deregulated channel activity.	[Lambie, Eric J.; Zielich, Jeffrey] Univ Munich, Dept Cell & Dev Biol, Munich, Germany; [Bruce, Robert D., III] Madigan Army Med Ctr, Dept Internal Med, Washington, DC USA; [Yuen, Sonia N.] Boston Childrens Hosp, Dept Otolaryngol, Boston, MA USA	University of Munich; Harvard University; Boston Children's Hospital	Lambie, EJ (corresponding author), Univ Munich, Dept Cell & Dev Biol, Munich, Germany.	lambie@bio.lmu.de			National Institutes of Health [R01GM49785]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	EJL was the recipient of National Institutes of Health grant R01GM49785. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RT, 2008, J AM SOC NEPHROL, V19, P1451, DOI 10.1681/ASN.2008010098; Bousova K, 2015, BIOPHYS CHEM, V205, P24, DOI 10.1016/j.bpc.2015.06.004; Brandao K, 2014, CELL MOL LIFE SCI, V71, P4853, DOI 10.1007/s00018-014-1647-7; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Chubanov V, 2014, HANDB EXP PHARMACOL, V222, P503, DOI 10.1007/978-3-642-54215-2_20; Church DL, 2003, GENETICS, V165, P563; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Estevez AY, 2005, J PHYSIOL-LONDON, V567, P239, DOI 10.1113/jphysiol.2005.091900; Estevez AY, 2003, J GEN PHYSIOL, V122, P207, DOI 10.1085/jgp.200308804; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann T, 2014, PFLUG ARCH EUR J PHY, V466, P2177, DOI 10.1007/s00424-014-1488-0; Hofmann T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010519; Jalkanen R, 2006, EUR J HUM GENET, V14, P55, DOI 10.1038/sj.ejhg.5201515; Kemp BJ, 2009, GENETICS, V181, P581, DOI 10.1534/genetics.108.094870; Knowles H, 2013, IMMUNOL RES, V55, P241, DOI 10.1007/s12026-012-8373-8; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Lainez S, 2014, EUR J HUM GENET, V22, P497, DOI 10.1038/ejhg.2013.178; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054131; Luo JL, 2012, J INVEST DERMATOL, V132, P2158, DOI 10.1038/jid.2012.144; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Mei ZZ, 2009, J MEMBRANE BIOL, V230, P93, DOI 10.1007/s00232-009-9190-4; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Obukhov AG, 2005, J NEUROSCI, V25, P1234, DOI 10.1523/JNEUROSCI.4451-04.2005; Paravicini TM, 2012, INT J BIOCHEM CELL B, V44, P1381, DOI 10.1016/j.biocel.2012.05.010; Paulsen CE, 2015, NATURE, V525, P552, DOI 10.1038/nature14871; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Poblete H, 2015, J BIOL CHEM, V290, P2086, DOI 10.1074/jbc.M114.613620; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Raychowdhury MK, 2004, HUM MOL GENET, V13, P617, DOI 10.1093/hmg/ddh067; Reynolds DM, 1999, J AM SOC NEPHROL, V10, P2342; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Schlingmann KP, 2005, J AM SOC NEPHROL, V16, P3061, DOI 10.1681/ASN.2004110989; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599; Stawicki TM, 2011, CURR BIOL, V21, P883, DOI 10.1016/j.cub.2011.03.070; Su ZW, 2007, P NATL ACAD SCI USA, V104, P19607, DOI 10.1073/pnas.0708584104; Sun AY, 1997, GENETICS, V147, P1077; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Teramoto T, 2010, PLOS ONE, V5, pA228, DOI 10.1371/journal.pone.0009589; Toth B, 2014, P NATL ACAD SCI USA, V111, P16949, DOI 10.1073/pnas.1412449111; Ufret-Vincenty CA, 2015, J GEN PHYSIOL, V145, P431, DOI 10.1085/jgp.201511354; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; VOLLAND C, 1994, FOLIA MICROBIOL, V39, P554, DOI 10.1007/BF02814106; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; West RJ, 2001, GENE, V266, P103, DOI 10.1016/S0378-1119(01)00373-0; Xie J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00146; Xing J, 2008, J GEN PHYSIOL, V131, P245, DOI 10.1085/jgp.200709914; Xing J, 2010, AM J PHYSIOL-CELL PH, V298, pC274, DOI 10.1152/ajpcell.00394.2009; Yamaguchi S, 2014, J BIOL CHEM, V289, P35265, DOI 10.1074/jbc.M114.606087; Zhang Z, 2014, J BIOL CHEM, V289, P5217, DOI 10.1074/jbc.M113.512285	63	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143445	10.1371/journal.pone.0143445	http://dx.doi.org/10.1371/journal.pone.0143445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606136	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300066
J	Sanders, MR; Clulow, S; Bower, DS; Clulow, J; Mahony, MJ				Sanders, Madeleine R.; Clulow, Simon; Bower, Deborah S.; Clulow, John; Mahony, Michael J.			Predator Presence and Vegetation Density Affect Capture Rates and Detectability of Litoria aurea Tadpoles: Wide-Ranging Implications for a Common Survey Technique	PLOS ONE			English	Article							ANTIPREDATOR RESPONSES; BEHAVIORAL-RESPONSES; EASTERN AUSTRALIA; LARVAL ANURANS; PREY; BIAS; HABITATS; RISK; FISH; CONSEQUENCES	Trapping is a common sampling technique used to estimate fundamental population metrics of animal species such as abundance, survival and distribution. However, capture success for any trapping method can be heavily influenced by individuals' behavioural plasticity, which in turn affects the accuracy of any population estimates derived from the data. Funnel trapping is one of the most common methods for sampling aquatic vertebrates, although, apart from fish studies, almost nothing is known about the effects of behavioural plasticity on trapping success. We used a full factorial experiment to investigate the effects that two common environmental parameters (predator presence and vegetation density) have on the trapping success of tadpoles. We estimated that the odds of tadpoles being captured in traps was 4.3 times higher when predators were absent compared to present and 2.1 times higher when vegetation density was high compared to low, using odds ratios based on fitted model means. The odds of tadpoles being detected in traps were also 2.9 times higher in predator-free environments. These results indicate that common environmental factors can trigger behavioural plasticity in tadpoles that biases trapping success. We issue a warning to researchers and surveyors that trapping biases may be commonplace when conducting surveys such as these, and urge caution in interpreting data without consideration of important environmental factors present in the study system. Left unconsidered, trapping biases in capture success have the potential to lead to incorrect interpretations of data sets, and misdirection of limited resources for managing species.	[Sanders, Madeleine R.; Clulow, Simon; Bower, Deborah S.; Clulow, John; Mahony, Michael J.] Univ Newcastle, Sch Environm & Life Sci, Newcastle, NSW 2300, Australia	University of Newcastle	Sanders, MR (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Newcastle, NSW 2300, Australia.	msan3740@gmail.com	Bower, Deborah/P-2605-2017	Bower, Deborah/0000-0003-0188-3290; Clulow, John/0000-0001-8991-1449; Clulow, Simon/0000-0002-5700-6345	ARC Linkage grant (Industry partners: Australian Research Council, Sydney Olympic Park Authority, Strathfield council, South Australian Museum, NSW Roads and Traffic Authority, NSW Department of Environment and Climate Change) [LP0989459]	ARC Linkage grant (Industry partners: Australian Research Council, Sydney Olympic Park Authority, Strathfield council, South Australian Museum, NSW Roads and Traffic Authority, NSW Department of Environment and Climate Change)(Australian Research Council)	This study was funded by ARC Linkage grant LP0989459 (Industry partners: Australian Research Council, Sydney Olympic Park Authority, Strathfield council, South Australian Museum, NSW Roads and Traffic Authority, NSW Department of Environment and Climate Change). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg R, 2002, ECOLOGY, V83, P2542, DOI 10.2307/3071813; AZEVEDORAMOS C, 1992, J HERPETOL, V26, P335, DOI 10.2307/1564891; Babbitt KJ, 1996, COPEIA, P485; Biro PA, 2013, OECOLOGIA, V171, P339, DOI 10.1007/s00442-012-2426-5; Brown C, 1997, BEHAV ECOL SOCIOBIOL, V41, P61, DOI 10.1007/s002650050364; Buech Richard R., 2002, Herpetological Review, V33, P182; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Dorn NJ, 2005, J N AM BENTHOL SOC, V24, P346, DOI 10.1899/04-037.1; Dupuch A, 2011, J FISH BIOL, V79, P533, DOI 10.1111/j.1095-8649.2011.03029.x; Fronzuto J, 2000, J HERPETOL, V34, P146, DOI 10.2307/1565252; Gosner K. L., 1960, Herpetologica, V16, P183; Hamer AJ, 2002, OECOLOGIA, V132, P445, DOI 10.1007/s00442-002-0968-7; Heyer W.R., 1975, Biotopica, V7, P100; Hyde EJ, 2001, J WILDLIFE MANAGE, V65, P624, DOI 10.2307/3803013; Jung RE, 2002, J HERPETOL, V36, P465, DOI 10.1670/0022-1511(2002)036[0465:AEOPIA]2.0.CO;2; Krebs C. J., 2009, ECOLOGY; LAWLER SP, 1989, ANIM BEHAV, V38, P1039, DOI 10.1016/S0003-3472(89)80142-3; Layman CA, 2001, WETLANDS, V21, P145, DOI 10.1672/0277-5212(2001)021[0145:SBOMTI]2.0.CO;2; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; Mahony MJ, 2013, HERPETOL CONSERV BIO, V8, P519; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; Morgan L. A., 1996, Australian Zoologist, V30, P143; NEW TR, 2000, CONSERVATION BIOL IN; Obaza A, 2011, J FISH BIOL, V78, P495, DOI 10.1111/j.1095-8649.2010.02867.x; PERSSON L, 1995, ECOLOGY, V76, P70, DOI 10.2307/1940632; PETRANKA JW, 1987, ANIM BEHAV, V35, P420, DOI 10.1016/S0003-3472(87)80266-X; Relyea RA, 2001, ECOLOGY, V82, P541, DOI 10.1890/0012-9658(2001)082[0541:TRBPRA]2.0.CO;2; Richter Klaus O., 1995, Herpetological Review, V26, P90; Rozas LP, 1997, ESTUARIES, V20, P199, DOI 10.2307/1352731; Sargent WB, 1987, P 14 ANN C WETL REST, P194; SAVINO JF, 1989, ANIM BEHAV, V37, P311, DOI 10.1016/0003-3472(89)90120-6; Shaffer HB, 1994, MEASURING MONITORING, P130; SKELLY DK, 1995, ECOLOGY, V76, P150, DOI 10.2307/1940638; Snow NP, 2013, WILDLIFE SOC B, V1, P1; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Webb Cameron, 1997, Australian Zoologist, V30, P316; Werner EE, 1996, ECOLOGY, V77, P157, DOI 10.2307/2265664	37	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143733	10.1371/journal.pone.0143733	http://dx.doi.org/10.1371/journal.pone.0143733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605923	gold, Green Accepted, Green Published			2022-12-26	WOS:000365865300104
J	Burger, D; Dolivo, G; Wedekind, C				Burger, Dominik; Dolivo, Guillaume; Wedekind, Claus			Ejaculate Characteristics Depend on Social Environment in the Horse (Equus caballus)	PLOS ONE			English	Article							SPERM COMPETITION; SEXUAL SELECTION; HAREM SIZE; TESTOSTERONE LEVELS; RISK; STALLIONS; SPERMATOGENESIS; METAANALYSES; FREEZABILITY; INVESTMENT	Sperm competition theory predicts semen characteristics to be affected by the social environment. We used the polygamous horse (Equus caballus) to experimentally study within-subject plasticity in response to different social environments. Stallions were sequentially exposed, over a period of 8 weeks each, to other stallions and then singly to mares, or vice versa (in adjacent boxes separated by grills). Ejaculates were collected to determine semen characteristics. Highest sperm numbers were found in stallions that were first exposed to other stallions and then to mares, while lowest sperm numbers were observed in stallions that had been exposed to mares but not yet to other stallions. One of three sperm velocity measures (curvilinear velocity) was consistently elevated in stallions that were first exposed to stallions and then to mares. Sperm number after exposure to mares and curvilinear sperm velocity after exposure to stallions were both positively correlated to average blood testosterone levels during the corresponding period of exposure. We conclude that ejaculate characteristics are plastic traits affected by the social environment in horses.	[Burger, Dominik; Dolivo, Guillaume] Agroscope, Swiss Inst Equine Med, Avenches, Switzerland; [Burger, Dominik; Dolivo, Guillaume] Univ Bern, Avenches, Switzerland; [Wedekind, Claus] Univ Lausanne, Biophore, Dept Ecol & Evolut, Lausanne, Switzerland	Swiss Federal Research Station Agroscope; University of Bern; University of Lausanne	Wedekind, C (corresponding author), Univ Lausanne, Biophore, Dept Ecol & Evolut, Lausanne, Switzerland.	claus.wedekind@unil.ch	Wedekind, Claus/S-3353-2016	Wedekind, Claus/0000-0001-6143-4716	Swiss Institute of Equine Medicine Research	Swiss Institute of Equine Medicine Research	This work was supported by the Swiss Institute of Equine Medicine Research to DB (http://ismequine.ch/wp/?lang=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R. P., 2011, Equine reproduction, Volume 1, P881; Arundell KL, 2014, ANIM BEHAV, V87, P231, DOI 10.1016/j.anbehav.2013.11.005; Aurich C, 1999, REPROD DOMEST ANIM, V34, P405, DOI 10.1111/j.1439-0531.1999.tb01393.x; Ball MA, 1998, J THEOR BIOL, V194, P251, DOI 10.1006/jtbi.1998.0756; Bauer C, 2006, VETERINARMEDIZINISCH, P89; BERNDTSON WE, 1977, J ANIM SCI, V44, P818, DOI 10.2527/jas1977.445818x; Birkhead TR, 1998, SPERM COMPETITION SE; Bribiescas RG, 2001, YEARB PHYS ANTHROPOL, V44, P148, DOI 10.1002/ajpa.10025; Burger D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0407; delBarco-Trillo J, 2004, NATURE, V431, P446, DOI 10.1038/nature02845; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Firman RC, 2013, EVOLUTION, V67, P3061, DOI 10.1111/evo.12164; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Gasparini C, 2009, BIOL LETTERS, V5, P792, DOI 10.1098/rsbl.2009.0413; GEBAUER MR, 1974, J ANIM SCI, V39, P737, DOI 10.2527/jas1974.394737x; Gleason ED, 2009, FRONT NEUROENDOCRIN, V30, P460, DOI 10.1016/j.yfrne.2009.04.009; Gomendio M, 2011, P ROY SOC B-BIOL SCI, V278, P3135, DOI 10.1098/rspb.2011.0275; Montoto LG, 2011, REPRODUCTION, V142, P819, DOI 10.1530/REP-11-0232; Hirschenhauser K, 2006, ANIM BEHAV, V71, P265, DOI 10.1016/j.anbehav.2005.04.014; Janett F, 2006, THERIOGENOLOGY, V65, P1737, DOI 10.1016/j.theriogenology.2005.09.017; Janett F, 2003, ANIM REPROD SCI, V77, P213, DOI 10.1016/S0378-4320(03)00039-3; Janett F, 2009, ANIM REPROD SCI, V115, P88, DOI 10.1016/j.anireprosci.2008.11.011; Johnson L, 1997, THERIOGENOLOGY, V48, P1199, DOI 10.1016/S0093-691X(97)00353-1; Kaseda Y, 1996, APPL ANIM BEHAV SCI, V47, P163, DOI 10.1016/0168-1591(95)00675-3; Kelly CD, 2011, BIOL REV, V86, P863, DOI 10.1111/j.1469-185X.2011.00175.x; Khalil AM, 1998, J VET MED SCI, V60, P643, DOI 10.1292/jvms.60.643; Khalil AM, 2009, J VET MED SCI, V71, P1075, DOI 10.1292/jvms.71.1075; Kimura K, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-264; Koyama S, 2000, PHYSIOL BEHAV, V71, P415, DOI 10.1016/S0031-9384(00)00361-9; Lacava RV, 2011, HORM BEHAV, V59, P51, DOI 10.1016/j.yhbeh.2010.10.003; Lemaitre JF, 2012, J EVOLUTION BIOL, V25, P1216, DOI 10.1111/j.1420-9101.2012.02511.x; Lemaitre JF, 2011, P ROY SOC B-BIOL SCI, V278, P1171, DOI 10.1098/rspb.2010.1828; Linklater WL, 2000, BIOL REV, V75, P1, DOI 10.1017/S0006323199005411; Lupold S, 2013, EVOLUTION, V67, P3052, DOI 10.1111/evo.12132; MACRIDES F, 1975, SCIENCE, V189, P1104, DOI 10.1126/science.1162363; McDonnell S. M., 2011, Equine reproduction, Volume 1, P1385; McDonnell S. M., 1995, BIOLOGICAL REPROD, V1, P577; McDonnell SM, 2000, ANIM REPROD SCI, V60, P211, DOI 10.1016/S0378-4320(00)00136-6; Moatt JP, 2014, PHYSIOL BEHAV, V131, P111, DOI 10.1016/j.physbeh.2014.04.027; MOORE MC, 1991, HORM BEHAV, V25, P154, DOI 10.1016/0018-506X(91)90048-M; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Petrulis A, 2013, HORM BEHAV, V63, P723, DOI 10.1016/j.yhbeh.2013.03.011; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Ramm SA, 2009, P ROY SOC B-BIOL SCI, V276, P745, DOI 10.1098/rspb.2008.1296; Rudolfsen G, 2006, P ROY SOC B-BIOL SCI, V273, P325, DOI 10.1098/rspb.2005.3305; Smith CC, 2011, BIOL LETTERS, V7, P733, DOI 10.1098/rsbl.2011.0286; Stich K, 2002, THERIOGENOLOGY, V58, P397; Thompson JA, 2004, THERIOGENOLOGY, V62, P1607, DOI 10.1016/j.theriogenology.2004.03.015; Tourmente M, 2013, EVOLUTION, V67, P1838, DOI 10.1111/evo.12079; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	52	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143185	10.1371/journal.pone.0143185	http://dx.doi.org/10.1371/journal.pone.0143185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599821	Green Published, gold			2022-12-26	WOS:000365862600034
J	Ju, ZH; Wang, CF; Wang, XG; Yang, CH; Sun, Y; Jiang, Q; Wang, F; Li, MJ; Zhong, JF; Huang, JM				Ju, Zhihua; Wang, Changfa; Wang, Xiuge; Yang, Chunhong; Sun, Yan; Jiang, Qiang; Wang, Fei; Li, Mengjiao; Zhong, Jifeng; Huang, Jinming			Role of an SNP in Alternative Splicing of Bovine NCF4 and Mastitis Susceptibility	PLOS ONE			English	Article							NADPH OXIDASE COMPONENTS; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; MAMMARY-GLAND; DAIRY-CATTLE; PX DOMAIN; DISEASE; CELLS; GENE; NEUTROPHIL	Neutrophil cytosolic factor 4 (NCF4) is component of the nicotinamide dinucleotide phosphate oxidase complex, a key factor in biochemical pathways and innate immune responses. In this study, splice variants and functional single-nucleotide polymorphism (SNP) of NCF4 were identified to determine the variability and association of the gene with susceptibility to bovine mastitis characterized by inflammation. A novel splice variant, designated as NCF4-TV and characterized by the retention of a 48 bp sequence in intron 9, was detected in the mammary gland tissues of infected cows. The expression of the NCF4-reference main transcript in the mastitic mammary tissues was higher than that in normal tissues. A novel SNP, g. 18174 A>G, was also found in the retained 48 bp region of intron 9. To determine whether NCF4-TV could be due to the g. 18174 A>G mutation, we constructed two mini-gene expression vectors with the wild-type or mutant NCF4 g. 18174 A>G fragment. The vectors were then transiently transfected into 293T cells, and alternative splicing of NCF4 was analyzed by reverse transcription-PCR and sequencing. Mini-gene splicing assay demonstrated that the aberrantly spliced NCF4-TV with 48 bp retained fragment in intron 9 could be due to g. 18174 A>G, which was associated with milk somatic count score and increased risk of mastitis infection in cows. NCF4 expression was also regulated by alternative splicing. This study proposes that NCF4 splice variants generated by functional SNP are important risk factors for mastitis susceptibility in dairy cows.	[Ju, Zhihua; Wang, Changfa; Wang, Xiuge; Yang, Chunhong; Sun, Yan; Jiang, Qiang; Wang, Fei; Li, Mengjiao; Zhong, Jifeng; Huang, Jinming] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan 250131, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences	Ju, ZH (corresponding author), Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan 250131, Shandong, Peoples R China.	juzhihua283@163.com; huangjinm@sina.com		wang, changfa/0000-0002-5186-1703	National Natural Science Foundation of China [31371255, 31271328, 31401050]; Major Project of National Transgenics in China [2014ZX08007-001]; National Cow Industrial Technology System Program [CARS-37]; Cow Innovation Team of the Shandong Province Modern Agricultural Industry Technology System [SDAIT-12-011-02]; Natural Science Foundation of Shandong Province [ZR2013CQ035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of National Transgenics in China; National Cow Industrial Technology System Program; Cow Innovation Team of the Shandong Province Modern Agricultural Industry Technology System; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by grants from the National Natural Science Foundation of China (31371255, 31271328, and 31401050), the Major Project of National Transgenics in China (2014ZX08007-001), the National Cow Industrial Technology System Program (CARS-37), the Cow Innovation Team of the Shandong Province Modern Agricultural Industry Technology System (SDAIT-12-011-02), and the Natural Science Foundation of Shandong Province (ZR2013CQ035).	Anderson KE, 2008, BLOOD, V112, P5202, DOI 10.1182/blood-2008-04-149450; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Buckley Rebecca H, 2004, Paediatr Respir Rev, V5 Suppl A, pS225, DOI 10.1016/S1526-0542(04)90043-7; Caminsky Natasha, 2014, F1000Res, V3, P282, DOI 10.12688/f1000research.5654.1; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Gao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084355; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Gustafson HL, 2014, AM J HEMATOL, V89, P639, DOI 10.1002/ajh.23709; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Hua J, 2001, INFLAMM RES, V50, P156, DOI 10.1007/s000110050740; Huang JM, 2011, GENET MOL RES, V10, P3199, DOI 10.4238/2011.December.21.1; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Ju ZH, 2012, MOL BIOL REP, V39, P4155, DOI 10.1007/s11033-011-1198-z; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim YM, 2014, CELL SIGNAL, V26, P784, DOI 10.1016/j.cellsig.2013.12.005; Lim KH, 2011, P NATL ACAD SCI USA, V108, P11093, DOI 10.1073/pnas.1101135108; Ma J. S., 2014, J APPL MATH, V2014, P1, DOI DOI 10.1155/2014/304202; Mantegazza AR, 2008, BLOOD, V112, P4712, DOI 10.1182/blood-2008-01-134791; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Olsson LM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2299; Palhais B, 2015, NUCLEIC ACIDS RES, V43, P4627, DOI 10.1093/nar/gkv275; Tejedor JR, 2015, RNA, V21, P1187, DOI 10.1261/rna.049890.115; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rupp R, 1999, J DAIRY SCI, V82, P2198, DOI 10.3168/jds.S0022-0302(99)75465-2; Ryan BM, 2014, INT J CANCER, V134, P1399, DOI 10.1002/ijc.28457; Sordillo LM, 1997, J DAIRY SCI, V80, P1851, DOI 10.3168/jds.S0022-0302(97)76121-6; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Tarazona-Santos E, 2013, MOL BIOL EVOL, V30, P2157, DOI 10.1093/molbev/mst119; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-630; Wang XG, 2012, IMMUNOGENETICS, V64, P807, DOI 10.1007/s00251-012-0639-8; Wientjes FB, 2001, BIOCHEM BIOPH RES CO, V289, P382, DOI 10.1006/bbrc.2001.5982; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Zhan Y, 2004, J CELL BIOCHEM, V92, P795, DOI 10.1002/jcb.20084; Zhang ZJ, 2015, MICROBIOL RES, V174, P24, DOI 10.1016/j.micres.2015.03.005	40	15	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143705	10.1371/journal.pone.0143705	http://dx.doi.org/10.1371/journal.pone.0143705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600390	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600107
J	Perkin, MR; Bader, T; Rudnicka, AR; Strachan, DP; Owen, CG				Perkin, Michael R.; Bader, Tara; Rudnicka, Alicja R.; Strachan, David P.; Owen, Christopher G.			Inter-Relationship between Rhinitis and Conjunctivitis in Allergic Rhinoconjunctivitis and Associated Risk Factors in Rural UK Children	PLOS ONE			English	Article							ATOPIC SENSITIZATION; LIFE-STYLE; ASTHMA; PREVALENCE	Objective Allergic conjunctivitis (AC) is a common condition, especially in childhood. The extent to which it occurs concurrently with or independently from allergic rhinitis (AR) has not been well described. Aim To examine the inter-relationship between rhinitis and conjunctivitis and the epidemiological risk factors for these conditions in a rural UK population. Methods Cross-sectional study of rural school children (aged 5-11 years). Parental questionnaires were used to diagnose allergic outcomes (including conjunctivitis, rhinitis and rhinoconjunctivitis), and to collect data on atopic history, demographic and environmental exposures. Odds ratios of allergic outcome by exposure were examined adjusted for age, sex, breast-feeding, family history of allergy, number of older and younger siblings. Results Prevalence of conjunctivitis was 17.5%, rhinitis 15.1% and rhinoconjunctivitis 13.0%. Seasonality of symptoms varied by condition: 64.7% of those with conjunctivitis had seasonal symptoms (April-Sept only), 46.7% of those with rhinitis and 92.2% of those with rhinoconjunctivitis. Living on a farm consistently reduced the risk of conjunctivitis (odds ratio 0.47, 95% CI 0.29-0.79, p = 0.004), rhinitis (OR 0.57, 95% CI 0.33-1.01, p = 0.05) and rhinoconjunctivitis (OR 0.57, 95% CI 0.32-1.03, p = 0.06). Exposure to farm animals (particularly in early life), current consumption of unpasteurised milk and playing in a barn or stable significantly reduced the risk of all three conditions. Conclusion More children had parent-reported conjunctivitis than rhinitis. The majority of children with either condition also reported symptoms with the other condition. Farmers' children have less eye and/or nasal symptoms. A number of farming variables linked with the farm microbial environment are likely to be mediating the protective effect.	[Perkin, Michael R.; Bader, Tara; Rudnicka, Alicja R.; Strachan, David P.; Owen, Christopher G.] Univ London, Populat Hlth Res Inst, London SW17 ORE, England	University of London	Perkin, MR (corresponding author), Univ London, Populat Hlth Res Inst, Cranmer Terrace, London SW17 ORE, England.	m.perkin@sgul.ac.uk	Perkin, Michael/AID-7491-2022	Rudnicka, Alicja R/0000-0003-0369-8574; Perkin, Michael/0000-0001-9272-2585; Owen, Christopher/0000-0003-1135-5977	Wellcome Research Training Fellowship in Clinical Epidemiology [056906/Z/99/Z]	Wellcome Research Training Fellowship in Clinical Epidemiology	The work was supported by a Wellcome Research Training Fellowship in Clinical Epidemiology (056906/Z/99/Z), held by MRP. The funder had no involvement in the study.	Alfven T, 2006, ALLERGY, V61, P414, DOI 10.1111/j.1398-9995.2005.00939.x; [Anonymous], 2011, SHROPSHIRE STAR  FEB; Elholm G, 2013, J ALLERGY CLIN IMMUN, V132, P1239, DOI 10.1016/j.jaci.2013.07.003; Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Ma Y, 2009, PEDIATR PULM, V44, P793, DOI 10.1002/ppul.21061; Manners T, 1997, BRIT MED J, V315, P816; Ono SJ, 2005, J ALLERGY CLIN IMMUN, V115, P118, DOI 10.1016/j.jaci.2004.10.042; Perkin MR, 2006, J ALLERGY CLIN IMMUN, V117, P1374, DOI 10.1016/j.jaci.2006.03.008; Pfefferle PI, 2010, J ALLERGY CLIN IMMUN, V125, P108, DOI 10.1016/j.jaci.2009.09.019; Pitt AD, 2004, OPHTHAL EPIDEMIOL, V11, P17, DOI 10.1076/opep.11.1.17.26437; Remes ST, 2002, ACTA PAEDIATR, V91, P1163, DOI 10.1111/j.1651-2227.2002.tb00122.x; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Shropshire Council, 2011, AGR FOR FISH AGR LAN; Singh K, 2010, J ALLERGY CLIN IMMUN, V126, P778, DOI 10.1016/j.jaci.2010.06.050; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Strachan DP, 1997, PEDIAT ALLERG IMM-UK, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Walker S, 2007, J ALLERGY CLIN IMMUN, V120, P381, DOI 10.1016/j.jaci.2007.03.034	20	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143651	10.1371/journal.pone.0143651	http://dx.doi.org/10.1371/journal.pone.0143651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600465	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600100
J	Ahmad-Sohdi, NAS; Seman-Kamarulzaman, AF; Mohamed-Hussein, ZA; Hassan, M				Ahmad-Sohdi, Nor-Ain-Shahajar; Seman-Kamarulzaman, Ahmad-Faris; Mohamed-Hussein, Zeti-Azura; Hassan, Maizom			Purification and Characterization of a Novel NAD(P)(+)-Farnesol Dehydrogenase from Polygonum minus Leaves	PLOS ONE			English	Article							INSECT JUVENILE-HORMONE; CINNAMYL ALCOHOL-DEHYDROGENASE; CELL-SUSPENSION CULTURES; GERANIOL DEHYDROGENASE; FARNESOL DEHYDROGENASE; MOLECULAR-CLONING; CORPORA ALLATA; ESSENTIAL OIL; KEY ENZYME; BIOSYNTHESIS	Juvenile hormones have attracted attention as safe and selective targets for the design and development of environmentally friendly and biorational insecticides. In the juvenile hormone III biosynthetic pathway, the enzyme farnesol dehydrogenase catalyzes the oxidation of farnesol to farnesal. In this study, farnesol dehydrogenase was extracted from Polygonum minus leaves and purified 204-fold to apparent homogeneity by ion-exchange chromatography using DEAE-Toyopearl, SP-Toyopearl, and Super-Q Toyopearl, followed by three successive purifications by gel filtration chromatography on a TSK-gel GS3000SW. The enzyme is a heterodimer comprised of subunits with molecular masses of 65 kDa and 70 kDa. The optimum temperature and pH were 35 degrees C and pH 9.5, respectively. Activity was inhibited by sulfhydryl reagents, metal-chelating agents and heavy metal ions. The enzyme utilized both NAD(+) and NADP(+) as coenzymes with Km values of 0.74 mM and 40 mM, respectively. Trans, trans-farnesol was the preferred substrate for the P. minus farnesol dehydrogenase. Geometrical isomers of trans, trans-farnesol, cis, trans-farnesol and cis, cis-farnesol were also oxidized by the enzyme with lower activity. The K-m values for trans, trans-farnesol, cis, trans-farnesol and cis, cis-farnesol appeared to be 0.17 mM, 0.33 mM and 0.42 mM, respectively. The amino acid sequences of 4 tryptic peptides of the enzyme were analyzed by MALDI-TOF/TOF-MS spectrometry, and showed no significant similarity to those of previously reported farnesol dehydrogenases. These results suggest that the purified enzyme is a novel NAD(P)(+)-dependent farnesol dehydrogenase. The purification and characterization established in the current study will serve as a basis to provide new information for recombinant production of the enzyme. Therefore, recombinant farnesol dehydrogenase may provide a useful molecular tool in manipulating juvenile hormone biosynthesis to generate transgenic plants for pest control.	[Ahmad-Sohdi, Nor-Ain-Shahajar; Seman-Kamarulzaman, Ahmad-Faris; Mohamed-Hussein, Zeti-Azura; Hassan, Maizom] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi 43600, Selangor, Malaysia; [Mohamed-Hussein, Zeti-Azura] Univ Kebangsaan Malaysia, Sch Biosci & Biotechnol, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Hassan, M (corresponding author), Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi 43600, Selangor, Malaysia.	maizom@ukm.edu.my	Mohamed-Hussein, Zeti-Azura/R-9631-2018; SEMAN-KAMARULZAMAN, AHMAD-FARIS/E-5544-2018	Mohamed-Hussein, Zeti-Azura/0000-0002-5386-7260; SEMAN-KAMARULZAMAN, AHMAD-FARIS/0000-0002-3021-2077	Ministry of Science, Technology Innovation [02-01-02-SF0852]; International Foundation for Science [RB-IFS-001-2012]	Ministry of Science, Technology Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); International Foundation for Science(International Foundation for Science)	This work was funded by the Ministry of Science, Technology & Innovation (Grant number: 02-01-02-SF0852, URL: http://www.mosti.gov.my/), and International Foundation for Science (Grant number: RB-IFS-001-2012, URL: http://www.ifs.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanassiou CG, 2011, J PEST SCI, V84, P61, DOI 10.1007/s10340-010-0326-1; Baharum SN, 2010, MOLECULES, V15, P7006, DOI 10.3390/molecules15107006; BAKER FC, 1983, J LIPID RES, V24, P1586; BALLAL NR, 1968, INDIAN J BIOCHEM, V5, P1; Bede JC, 1999, PHYTOCHEMISTRY, V52, P1269, DOI 10.1016/S0031-9422(99)00438-0; Bede JC, 2001, PLANT PHYSIOL, V127, P584, DOI 10.1104/pp.010264; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Bhandari J, 2010, PLANT PHYSIOL, V154, P1116, DOI 10.1104/pp.110.157784; Castillo-Gracia M, 1999, EUR J BIOCHEM, V262, P365, DOI 10.1046/j.1432-1327.1999.00385.x; CHAYET L, 1973, PHYTOCHEMISTRY, V12, P95, DOI 10.1016/S0031-9422(00)84629-4; CROTEAU R, 1978, ARCH BIOCHEM BIOPHYS, V188, P182, DOI 10.1016/0003-9861(78)90371-5; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; Curtis AJ, 1999, BIOCHEM BIOPH RES CO, V259, P220, DOI 10.1006/bbrc.1999.0738; de Kraker JW, 2003, TETRAHEDRON, V59, P409, DOI 10.1016/S0040-4020(02)01479-5; Flores-Sanchez IJ, 2002, PLANT CELL PHYSIOL, V43, P1502, DOI 10.1093/pcp/pcf181; Gaffe J, 2000, PLANT PHYSIOL, V123, P1351, DOI 10.1104/pp.123.4.1351; Ha SB, 2003, BIOL PLANTARUM, V47, P477, DOI 10.1023/B:BIOP.0000023901.49409.7b; HALLAHAN DL, 1995, ARCH BIOCHEM BIOPHYS, V318, P105, DOI 10.1006/abbi.1995.1210; HALPIN C, 1992, PLANT PHYSIOL, V98, P12, DOI 10.1104/pp.98.1.12; Hassan M, 2012, BIOSCI BIOTECH BIOCH, V76, P1463, DOI 10.1271/bbb.120137; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Hirata T, 2000, PHYTOCHEMISTRY, V55, P297, DOI 10.1016/S0031-9422(00)00326-5; Hoffmann KH, 1998, PHYTOPARASITICA, V26, P323, DOI 10.1007/BF02981447; IGAUE I, 1982, PLANT CELL PHYSIOL, V23, P213; Iijima Y, 2006, ARCH BIOCHEM BIOPHYS, V448, P141, DOI 10.1016/j.abb.2005.07.026; IKEDA H, 1991, J BIOCHEM-TOKYO, V109, P341; INOUE H, 1984, AGR BIOL CHEM TOKYO, V48, P733, DOI 10.1080/00021369.1984.10866210; Kamita SG, 2010, J PESTIC SCI, V35, P265, DOI 10.1584/jpestics.R10-09; KJONAAS RB, 1985, ARCH BIOCHEM BIOPHYS, V238, P49, DOI 10.1016/0003-9861(85)90139-0; Koutsompogeras P, 2006, J AGR FOOD CHEM, V54, P235, DOI 10.1021/jf0516033; Kuwano E, 2008, J PESTIC SCI, V33, P14, DOI 10.1584/jpestics.R07-08; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Lopez O, 2005, GREEN CHEM, V7, P431, DOI 10.1039/b500733j; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luddeke F, 2012, APPL ENVIRON MICROB, V78, P2128, DOI 10.1128/AEM.07226-11; MACKINTOSH RW, 1988, BIOCHEM J, V255, P653; Malone VF, 1999, APPL ENVIRON MICROB, V65, P2622; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Mayoral JG, 2009, P NATL ACAD SCI USA, V106, P21091, DOI 10.1073/pnas.0909938106; Mayoral JG, 2009, INSECT BIOCHEM MOLEC, V39, P31, DOI 10.1016/j.ibmb.2008.09.010; Minakuchi C, 2006, J PESTIC SCI, V31, P77, DOI 10.1584/jpestics.31.77; Miyazawa M, 2007, FLAVOUR FRAG J, V22, P188, DOI 10.1002/ffj.1779; Nah J, 2001, PLANT CELL PHYSIOL, V42, P864, DOI 10.1093/pcp/pce102; Noge K, 2008, FEBS J, V275, P2807, DOI 10.1111/j.1742-4658.2008.06421.x; Nyati P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071967; OMALLEY DM, 1992, PLANT PHYSIOL, V98, P1364, DOI 10.1104/pp.98.4.1364; Pedigo LP., 2009, ENTOMOLOGY PEST MANA; POTTY VH, 1970, PHYTOCHEMISTRY, V9, P1003, DOI 10.1016/S0031-9422(00)85218-8; Qader SW, 2011, MOLECULES, V16, P3433, DOI 10.3390/molecules16043433; SANGWAN RS, 1993, J PLANT PHYSIOL, V142, P129, DOI 10.1016/S0176-1617(11)80952-1; Sarah S. A., 2013, International Food Research Journal, V20, P897; Sarker LS, 2012, ARCH BIOCHEM BIOPHYS, V528, P163, DOI 10.1016/j.abb.2012.09.013; Sekiwa-Iijima Y, 2001, J AGR FOOD CHEM, V49, P5902, DOI 10.1021/jf0102970; Sen SE, 2007, INSECT BIOCHEM MOLEC, V37, P1198, DOI 10.1016/j.ibmb.2007.07.011; Sharma Hari C., 2000, EJB Electronic Journal of Biotechnology, V3, P1, DOI 10.2225/vol3-issue2-fulltext-3; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Slama K., 1979, HERBIVORES THEIR INT, P683; Sperry AE, 2001, INSECT BIOCHEM MOLEC, V31, P171, DOI 10.1016/S0965-1748(00)00115-6; Suhaila M, 1999, PESTIC SCI, V47, P259; Suhailah Wasman Qader, 2012, Scientific Research and Essays, V7, P90; Takeda M, 2011, BIOSCI BIOTECH BIOCH, V75, P2384, DOI 10.1271/bbb.110607; TONG WF, 1988, BOT BULL ACAD SINICA, V29, P245; TOONG YC, 1988, NATURE, V333, P170, DOI 10.1038/333170a0; Wasman SQ, 2010, J MED PLANTS RES, V4, P2658; Wiart C., 2006, MED PLANTS ASIA PACI; Yang Y, 2006, ARCH BIOCHEM BIOPHYS, V448, P123, DOI 10.1016/j.abb.2005.08.006; Yu XD, 2014, THEOR APPL GENET, V127, P2065, DOI 10.1007/s00122-014-2371-2; Zhao YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125415	69	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143310	10.1371/journal.pone.0143310	http://dx.doi.org/10.1371/journal.pone.0143310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600471	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900091
J	Bain, PA; Papanicolaou, A; Kumar, A				Bain, Peter A.; Papanicolaou, Alexie; Kumar, Anupama			Identification of Putative Nuclear Receptors and Steroidogenic Enzymes in Murray-Darling Rainbowfish (Melanotaenia fluviatilis) Using RNA-Seq and De Novo Transcriptome Assembly	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; MINNOW PIMEPHALES-PROMELAS; PERSONAL CARE PRODUCTS; WASTE-WATER TREATMENT; KILLIFISH FUNDULUS-HETEROCLITUS; ENDOCRINE-DISRUPTING CHEMICALS; ESFENVALERATE PULSE-EXPOSURE; REPORTER GENE ASSAY; GENOME DUPLICATION; ENVIRONMENTAL CONTAMINATION	Murray-Darling rainbowfish (Melanotaenia fluviatilis [Castelnau, 1878]; Atheriniformes: Melanotaeniidae) is a small-bodied teleost currently under development in Australasia as a test species for aquatic toxicological studies. To date, efforts towards the development of molecular biomarkers of contaminant exposure have been hindered by the lack of available sequence data. To address this, we sequenced messenger RNA from brain, liver and gonads of mature male and female fish and generated a high-quality draft transcriptome using a de novo assembly approach. 149,742 clusters of putative transcripts were obtained, encompassing 43,841 non-redundant protein-coding regions. Deduced amino acid sequences were annotated by functional inference based on similarity with sequences from manually curated protein sequence databases. The draft assembly contained protein-coding regions homologous to 95.7% of the complete cohort of predicted proteins from the taxonomically related species, Oryzias latipes (Japanese medaka). The mean length of rainbowfish protein-coding sequences relative to their medaka homologues was 92.1%, indicating that despite the limited number of tissues sampled a large proportion of the total expected number of protein-coding genes was captured in the study. Because of our interest in the effects of environmental contaminants on endocrine pathways, we manually curated subsets of coding regions for putative nuclear receptors and steroidogenic enzymes in the rainbowfish transcriptome, revealing 61 candidate nuclear receptors encompassing all known subfamilies, and 41 putative steroidogenic enzymes representing all major steroidogenic enzymes occurring in teleosts. The transcriptome presented here will be a valuable resource for researchers interested in biomarker development, protein structure and function, and contaminant-response genomics in Murray-Darling rainbowfish.	[Bain, Peter A.; Kumar, Anupama] CSIRO, Div Land & Water, Urrbrae, SA, Australia; [Papanicolaou, Alexie] CSIRO, Div Land & Water, Black Mt, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Bain, PA (corresponding author), CSIRO, Div Land & Water, Urrbrae, SA, Australia.	peter.bain@csiro.au	Bain, Peter/A-9067-2013; Papanicolaou, Alexie/A-1618-2011; Kumar, Anu/E-9643-2011	Bain, Peter/0000-0002-0159-8417; Papanicolaou, Alexie/0000-0002-3635-6848; Kumar, Anu/0000-0002-3175-9867	Commonwealth Scientific and Industrial Research Organisation Division of Land and Water Capability Development Theme [R-00325-14-012]; BRAEMBL/NCISF in St Lucia, QLD, Australia	Commonwealth Scientific and Industrial Research Organisation Division of Land and Water Capability Development Theme; BRAEMBL/NCISF in St Lucia, QLD, Australia	The study was supported by the Commonwealth Scientific and Industrial Research Organisation Division of Land and Water Capability Development Theme, project R-00325-14-012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Hai Doan and Debra Gonzago for the maintenance of laboratory fish stocks and the provision of suitable specimens, and to Adrienne Gregg for assistance with RNA extractions. We gratefully acknowledge the support of the BRAEMBL/NCISF in St Lucia, QLD, Australia and the use of the High Performance Computing cluster "Barrine" to complete this research. Hosting of the web interface for JAMp annotations is gratefully provided through the National eResearch Collaboration Tools and Resources (NeCTAR) scheme, part of the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Andreasen EA, 2002, MOL PHARMACOL, V62, P234, DOI 10.1124/mol.62.2.234; Ankley GT, 2007, ENVIRON TOXICOL CHEM, V26, P1214, DOI 10.1897/06-428R.1; Ankley GT, 2002, TOXICOL SCI, V67, P121, DOI 10.1093/toxsci/67.1.121; [Anonymous], 2014, R LANG ENV STAT COMP; Arukwe A, 1997, ENVIRON HEALTH PERSP, V105, P418, DOI 10.2307/3433339; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Australian Bureau of Statistics [ABS], 2014, GROSS VAL IRR AGR PR; Bain PA, 2015, AQUAT TOXICOL, V163, P97, DOI 10.1016/j.aquatox.2015.03.021; Bain PA, 2015, GEN COMP ENDOCR, V212, P84, DOI 10.1016/j.ygcen.2015.01.024; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; BARRY MJ, 1995, ENVIRON TOXIC WATER, V10, P267, DOI 10.1002/tox.2530100406; BARRY MJ, 1995, AQUAT TOXICOL, V32, P115, DOI 10.1016/0166-445X(94)00084-4; BARRY MJ, 1995, ARCH ENVIRON CON TOX, V28, P459, DOI 10.1007/BF00211628; Bhatia H, 2014, ENVIRON TOXICOL CHEM, V33, P1098, DOI 10.1002/etc.2524; Bhatia H, 2014, AQUAT TOXICOL, V149, P103, DOI 10.1016/j.aquatox.2014.01.025; Bhatia H, 2013, ENVIRON TOXICOL CHEM, V32, P2335, DOI 10.1002/etc.2304; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BUCHELI TD, 1995, CRIT REV ENV SCI TEC, V25, P201, DOI 10.1080/10643389509388479; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Callard GV, 2001, J STEROID BIOCHEM, V79, P305, DOI 10.1016/S0960-0760(01)00147-9; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosnefroy A, 2012, TOXICOL SCI, V125, P439, DOI 10.1093/toxsci/kfr297; Cotter KA, 2015, AQUAT TOXICOL, V159, P184, DOI 10.1016/j.aquatox.2014.12.012; Cotter KA, 2013, GEN COMP ENDOCR, V194, P217, DOI 10.1016/j.ygcen.2013.09.014; Denslow ND, 1999, ECOTOXICOLOGY, V8, P385, DOI 10.1023/A:1008986522208; Diotel N, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00137; Douard V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-336; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Ellestad LE, 2014, ENVIRON SCI TECHNOL, V48, P8179, DOI 10.1021/es501428u; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Filby AL, 2005, BIOL REPROD, V73, P648, DOI 10.1095/biolreprod.105.039701; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Gelinas D, 1998, MOL CELL ENDOCRINOL, V138, P81, DOI 10.1016/S0303-7207(98)00015-X; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greytak SR, 2007, GEN COMP ENDOCR, V150, P174, DOI 10.1016/j.ygcen.2006.07.017; Guyomard Rene, 2012, BMC Genet, V13, P15, DOI 10.1186/1471-2156-13-15; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Haggstrom Stannered, 2014, WIKIVERSITY J MED; Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8; Halm S, 2002, AQUAT TOXICOL, V60, P285, DOI 10.1016/S0166-445X(02)00011-5; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hansson MC, 2003, GENE, V303, P197, DOI 10.1016/S0378-1119(02)01178-2; Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; HOLDWAY DA, 1994, AQUAT TOXICOL, V28, P169, DOI 10.1016/0166-445X(94)90032-9; Holdway DA, 2008, ENVIRON TOXICOL, V23, P253, DOI 10.1002/tox.20329; Hook SE, 2014, ENVIRON SCI TECHNOL, V48, P3504, DOI 10.1021/es405322s; Hook SE, 2014, AQUAT TOXICOL, V146, P247, DOI 10.1016/j.aquatox.2013.11.001; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Jobling S, 2002, BIOL REPROD, V66, P272, DOI 10.1095/biolreprod66.2.272; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karchner SI, 2005, BIOCHEM J, V392, P153, DOI 10.1042/BJ20050713; Karchner SI, 1999, J BIOL CHEM, V274, P33814, DOI 10.1074/jbc.274.47.33814; Kasprzyk-Hordern B, 2009, WATER RES, V43, P363, DOI 10.1016/j.watres.2008.10.047; Katsu Y, 2007, ENVIRON SCI TECHNOL, V41, P3368, DOI 10.1021/es062797l; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kookana RS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0586; Kumar A, 1998, ENVIRON TOXICOL CHEM, V17, P1799, DOI [10.1002/etc.5620170920, 10.1897/1551-5028(1998)017&lt;1799:PTTTER&gt;2.3.CO;2]; Kumar A, 2012, EP12292 CSIRO; LaLone CA, 2012, ENVIRON TOXICOL CHEM, V31, P611, DOI 10.1002/etc.1729; Lange A, 2012, AQUAT TOXICOL, V109, P250, DOI 10.1016/j.aquatox.2011.09.004; Leaver MJ, 2005, ENDOCRINOLOGY, V146, P3150, DOI 10.1210/en.2004-1638; Legler J, 2002, ENVIRON SCI TECHNOL, V36, P4410, DOI 10.1021/es010323a; LEITZ T, 1987, GEN COMP ENDOCR, V66, P145, DOI 10.1016/0016-6480(87)90359-5; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077292; Liu GL, 2005, ENVIRON TOXICOL CHEM, V24, P2260, DOI 10.1897/04-405R.1; Liu JL, 2013, ENVIRON INT, V59, P208, DOI 10.1016/j.envint.2013.06.012; Liu NY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-597; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Margiotta-Casaluci L, 2013, GEN COMP ENDOCR, V191, P202, DOI 10.1016/j.ygcen.2013.06.017; Martin J, 2012, J HAZARD MATER, V239, P40, DOI 10.1016/j.jhazmat.2012.04.068; Martyniuk CJ, 2013, GEN COMP ENDOCR, V194, P264, DOI 10.1016/j.ygcen.2013.09.019; Metcalfe CD, 2001, ENVIRON TOXICOL CHEM, V20, P297, DOI [10.1897/1551-5028(2001)020&lt;0297:EPOCDI&gt;2.0.CO;2, 10.1002/etc.5620200210]; Miyagawa S, 2014, ENVIRON SCI TECHNOL, V48, P5254, DOI 10.1021/es5002659; Nelson DR, 2003, ARCH BIOCHEM BIOPHYS, V409, P18, DOI 10.1016/S0003-9861(02)00553-2; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Noaksson E, 2003, GEN COMP ENDOCR, V134, P273, DOI 10.1016/S0016-6480(03)00267-3; Ogino Y, 2009, ENDOCRINOLOGY, V150, P5415, DOI 10.1210/en.2009-0523; Overturf MD, 2014, AQUAT TOXICOL, V148, P152, DOI 10.1016/j.aquatox.2014.01.012; Pakdel F, 2000, ENDOCRINOLOGY, V141, P571, DOI 10.1210/en.141.2.571; Pal A, 2010, SCI TOTAL ENVIRON, V408, P6062, DOI 10.1016/j.scitotenv.2010.09.026; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Patino R, 2000, GEN COMP ENDOCR, V120, P314, DOI 10.1006/gcen.2000.7566; Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001; Petit FG, 1999, EUR J BIOCHEM, V259, P385, DOI 10.1046/j.1432-1327.1999.00072.x; PIFERRER F, 1994, J EXP ZOOL, V270, P255, DOI 10.1002/jez.1402700304; Pinto PIS, 2012, GENE, V503, P18, DOI 10.1016/j.gene.2012.04.081; Pollino CA, 2002, ENVIRON TOXICOL, V17, P138, DOI 10.1002/tox.10043; Pollino CA, 2002, ECOTOX ENVIRON SAFE, V52, P180, DOI 10.1006/eesa.2002.2190; Pollino CA, 2007, ENVIRON TOXICOL CHEM, V26, P2171, DOI 10.1897/06-603R.1; Pollino CA, 2009, ECOTOX ENVIRON SAFE, V72, P1265, DOI 10.1016/j.ecoenv.2009.01.012; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; REID HP, 1995, WATER RES, V29, P2010, DOI 10.1016/0043-1354(95)00007-8; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Sabo-Attwood T, 2004, MOL CELL ENDOCRINOL, V218, P107, DOI 10.1016/j.mce.2003.12.007; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; Sanderson JT, 2002, TOXICOL APPL PHARM, V182, P44, DOI 10.1006/taap.2002.9420; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Seo JS, 2006, BIOCHEM BIOPH RES CO, V346, P213, DOI 10.1016/j.bbrc.2006.05.123; Shanthanagouda AH, 2013, COMP BIOCHEM PHYS C, V157, P162, DOI 10.1016/j.cbpc.2012.11.004; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Svensson J, 2014, AQUAT TOXICOL, V147, P84, DOI 10.1016/j.aquatox.2013.12.013; Svensson J, 2013, ENVIRON SCI TECHNOL, V47, P2043, DOI 10.1021/es304305k; Tan NS, 1996, MOL CELL ENDOCRINOL, V120, P177, DOI 10.1016/0303-7207(96)03836-1; Udy DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134738; Urushitani H, 2003, MOL CELL ENDOCRINOL, V203, P41, DOI 10.1016/S0303-7207(03)00118-7; Vajda AM, 2015, ENVIRON TOXICOL CHEM, V34, P1078, DOI 10.1002/etc.2895; Villeneuve DL, 2007, TOXICOL SCI, V98, P395, DOI 10.1093/toxsci/kfm124; Watson JD, 2014, TOXICOL APPL PHARM, V274, P445, DOI 10.1016/j.taap.2013.12.004; Whitehead SA, 2006, BEST PRACT RES CL EN, V20, P45, DOI 10.1016/j.beem.2005.09.003; Williams ND, 2000, ENVIRON TOXICOL, V15, P165, DOI 10.1002/1522-7278(2000)15:3<165::AID-TOX3>3.0.CO;2-Q; Woods M, 2011, ENVIRON TOXICOL CHEM, V30, P2620, DOI 10.1002/etc.660; Xia ZF, 1999, GEN COMP ENDOCR, V113, P360, DOI 10.1006/gcen.1999.7196; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Yamaguchi A, 2005, AQUAT TOXICOL, V72, P239, DOI 10.1016/j.aquatox.2004.12.011; Yu Y, 2013, SCI TOTAL ENVIRON, V442, P310, DOI 10.1016/j.scitotenv.2012.10.001; Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	134	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142636	10.1371/journal.pone.0142636	http://dx.doi.org/10.1371/journal.pone.0142636			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599404	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900032
J	Bertille, N; Pons, G; Khoshnood, B; Fournier-Charriere, E; Chalumeau, M				Bertille, Nathalie; Pons, Gerard; Khoshnood, Babak; Fournier-Charriere, Elisabeth; Chalumeau, Martin			Symptomatic Management of Fever in Children: A National Survey of Healthcare Professionals' Practices in France	PLOS ONE			English	Article							PEDIATRIC EMERGENCY-DEPARTMENT; CLINICAL-PRACTICE GUIDELINES; CROSS-SECTIONAL SURVEY; WEB-BASED SURVEY; GENERAL-PRACTITIONERS; PRESCHOOL-CHILDREN; CHILDHOOD FEVER; SELF-CARE; DRUG-USE; PHYSICIANS	Despite the production and dissemination of recommendations related to managing fever in children, this symptom saturates the practices of primary healthcare professionals (HPs). Data on parent practices related to fever are available, but data on HPs' practices are limited. We studied HPs' practices, determinants of practices and concordance with recommendations in France. We conducted a national cross-sectional observational study between 2007 and 2008 among French general practitioners, primary care pediatricians and pharmacists. HPs were asked to include 5 consecutive patients aged 1 month to 12 years with acute fever. HPs completed a questionnaire about their practices for the current fever episode. We used a multilevel logistic regression model to assess the joint effects of patient-and HP-level variables associated with this behavior. In all, 1,534 HPs (participation rate 13%) included 6,596 children (mean age 3.7 +/- 2.7 years). Physicians measured the temperature of 40% of children. Primary HPs recommended drug treatment for 84% of children (including monotherapy for 92%) and physical treatment for 62% (including all recommended physical treatments for 7%). HPs gave written advice or a pamphlet for 13% of children. Significant practice variations were associated with characteristics of the child (age, fever level and diagnosis) and HP (profession and experience). In France, despite the production and dissemination of national recommendations for managing fever in children, primary HPs' observed practices differed greatly from current recommendations, which suggests potential targets for continuing medical education.	[Bertille, Nathalie; Khoshnood, Babak; Chalumeau, Martin] Paris Descartes Univ, Obstet Perinatal & Pediat Epidemiol Res Team Epop, Sorbonne Paris Cite CRESS, Inserm,U1153,Ctr Epidemiol & Stat, Paris, France; [Bertille, Nathalie] Univ Paris 06, Sorbonne Univ, Paris, France; [Bertille, Nathalie; Chalumeau, Martin] Hop Necker Enfants Malad, AP HP, Dept Gen Pediat, Paris, France; [Pons, Gerard] Paris Descartes Univ, Grp Hosp Cochin Broca Hotel Dieu, AP HP, Clin Pharmacol, Paris, France; [Pons, Gerard] INSERM, Pediat Epilepsies & Brain Plast U663, Paris, France; [Fournier-Charriere, Elisabeth] Hop Bicetre, AP HP, Pain Ctr, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Bertille, N (corresponding author), Paris Descartes Univ, Obstet Perinatal & Pediat Epidemiol Res Team Epop, Sorbonne Paris Cite CRESS, Inserm,U1153,Ctr Epidemiol & Stat, Paris, France.	nathalie.bertille@inserm.fr	Chalumeau, Martin/F-4293-2017; Khoshnood, Babak/N-9096-2017	Chalumeau, Martin/0000-0001-8175-3706; Khoshnood, Babak/0000-0002-4031-4915; Bertille, Nathalie/0000-0001-7159-2646	Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie and Ecole Doctorale (Sorbonne Universites, UPMC Univ Paris) [393]; Sanofi Aventis	Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie and Ecole Doctorale (Sorbonne Universites, UPMC Univ Paris); Sanofi Aventis(Sanofi-Aventis)	NB is supported by educational grants from Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie and Ecole Doctorale 393 (Sorbonne Universites, UPMC Univ Paris 06). EFC and GP received honoraria from Sanofi Aventis. MC belongs to the Assistance Publique-Hopitaux de Paris, which has received research grants from Sanofi Aventis. This does not alter our adherence to PLOS ONE policies on sharingdata and materials. We have no patents, products in development or marketed products to declare.	Agence nationale de securite du medicament et des produits de sante, 2005, MIS POINT PRIS CHARG; Al-Eissa YA, 2001, SAUDI MED J, V22, P124; Bardage C, 2013, HEALTH POLICY, V110, P76, DOI 10.1016/j.healthpol.2012.12.006; Bertille N, 2015, ACTA PAEDIA IN PRESS; Bertille N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083469; Bettinelli A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-51; Betz MG, 2006, EUR J EMERG MED, V13, P129, DOI 10.1097/01.mej.0000194401.15335.c7; Blacklock C, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656810; Bocquet A, 2005, ARCH PEDIATRIE, V12, P1688, DOI 10.1016/j.arcped.2005.06.014; Boivin JM, 2007, ARCH PEDIATRIE, V14, P322, DOI 10.1016/j.arcped.2006.12.018; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cavazos JM, 2008, ALIMENT PHARM THER, V28, P789, DOI 10.1111/j.1365-2036.2008.03791.x; Chiappini E, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-210; Chiappini E, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-97; Crocetti M, 2001, PEDIATRICS, V107, P1241, DOI 10.1542/peds.107.6.1241; Deligne J, 2007, PHARMACOEPIDEM DR S, V16, P812, DOI 10.1002/pds.1422; Demir F, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-40; El Khoury AC, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-95; ESKERUD JR, 1993, PHARM WORLD SCI, V15, P156, DOI 10.1007/BF01880558; ESKERUD JR, 1993, PHARM WORLD SCI, V15, P161, DOI 10.1007/BF01880559; Grimaldi-Bensouda L, 2010, EUR J CLIN PHARMACOL, V66, P831, DOI 10.1007/s00228-010-0832-3; Impicciatore P, 1998, PREV MED, V27, P268, DOI 10.1006/pmed.1998.0262; Karwowska Anna, 2002, CJEM, V4, P394; Langer T, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-41; Lava SAG, 2013, BRIT J CLIN PHARMACO, V75, P236, DOI 10.1111/j.1365-2125.2012.04311.x; Lava SAG, 2012, CLIN THER, V34, P250, DOI 10.1016/j.clinthera.2011.12.002; Martinot A, 2008, ARCH PEDIATRIE, V15, P656, DOI 10.1016/S0929-693X(08)71865-7; Matziou V, 2008, INT J NURS STUD, V45, P829, DOI 10.1016/j.ijnurstu.2006.04.021; MAY A, 1992, PEDIATRICS, V90, P851; McCullough H N, 1998, Paediatr Child Health, V3, P246; McIntyre J, 2011, ARCH DIS CHILD, V96, P1173, DOI 10.1136/archdischild-2011-301094; Mikaeloff Y, 2008, BRIT J CLIN PHARMACO, V65, P203, DOI 10.1111/j.1365-2125.2007.02997.x; Nash DR, 2002, ARCH PEDIAT ADOL MED, V156, P1114, DOI 10.1001/archpedi.156.11.1114; *NAT I HLTH CLIN E, 2007, FEV ILLN CHILDR ASS; Poirier MP, 2010, CLIN PEDIATR, V49, P530, DOI 10.1177/0009922809355312; Poirier MP, 2000, PEDIATR EMERG CARE, V16, P9, DOI 10.1097/00006565-200002000-00003; Pruvost I, 2012, ARCH PEDIATRIE, V19, P248, DOI 10.1016/j.arcped.2011.12.013; Roque F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1276; Sokal E, FIEVRE CHEZ ENFANT P; Sullivan JE, 2011, PEDIATRICS, V127, P580, DOI 10.1542/peds.2010-3852; Taveras EM, 2004, PEDIATR EMERG CARE, V20, P579, DOI 10.1097/01.pec.0000139739.46591.dd; Thompson M, 2008, BRIT J GEN PRACT, V58, P236, DOI 10.3399/bjgp08X279689; Ulinski T, 2004, EUR J PEDIATR, V163, P148, DOI 10.1007/s00431-003-1392-7; Vigier Rv, 2003, PAEDIATRICA, V14, P28; Walsh AM, 2005, J ADV NURS, V49, P453, DOI 10.1111/j.1365-2648.2004.03318.x	45	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143230	10.1371/journal.pone.0143230	http://dx.doi.org/10.1371/journal.pone.0143230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599740	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900079
J	Erdoes, G; Lippuner, C; Kocsis, I; Schiff, M; Stucki, M; Carrel, T; Windecker, S; Eberle, B; Stueber, F; Book, M				Erdoes, Gabor; Lippuner, Christoph; Kocsis, Istvan; Schiff, Marcel; Stucki, Monika; Carrel, Thierry; Windecker, Stephan; Eberle, Balthasar; Stueber, Frank; Book, Malte			Technical Approach Determines Inflammatory Response after Surgical and Transcatheter Aortic Valve Replacement	PLOS ONE			English	Article							CARDIOPULMONARY BYPASS; ON-PUMP; HIGH-RISK; SURGERY; IMPLANTATION; STENOSIS; CALCIFICATION; INTERLEUKIN-6; MYOCARDIUM; SYSTEM	Objective To investigate the periprocedural inflammatory response in patients with isolated aortic valve stenosis undergoing surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) with different technical approaches. Material and Methods Patients were prospectively allocated to one of the following treatments: SAVR using conventional extracorporeal circulation (CECC, n = 47) or minimized extracorporeal circulation (MECC, n = 15), or TAVI using either transapical (TA, n = 15) or transfemoral (TF, n = 24) access. Exclusion criteria included infection, pre-procedural immunosuppressive or antibiotic drug therapy and emergency indications. We investigated interleukin (IL)-6, IL-8, IL-10, human leukocyte antigen (HLA-DR), white blood cell count, high-sensitivity C-reactive protein (hs-CRP) and soluble L-selectin (sCD62L) levels before the procedure and at 4, 24, and 48 h after aortic valve replacement. Data are presented for group interaction (p-values for inter-group comparison) as determined by the Greenhouse-Geisser correction. Results SAVR on CECC was associated with the highest levels of IL-8 and hs-CRP (p<0.017, and 0.007, respectively). SAVR on MECC showed the highest descent in levels of HLA-DR and sCD62L (both p<0.001) in the perioperative period. TA-TAVI showed increased intraprocedural concentration and the highest peak of IL-6 (p = 0.017). Significantly smaller changes in the inflammatory markers were observed in TF-TAVI. Conclusion Surgical and interventional approaches to aortic valve replacement result in inflammatory modulation which differs according to the invasiveness of the procedure. As expected, extracorporeal circulation is associated with the most marked pro-inflammatory activation, whereas TF-TAVI emerges as the approach with the most attenuated inflammatory response. Factors such as the pre-treatment patient condition and the extent of myocardial injury also significantly affect inflammatory biomarker patterns. Accordingly, TA-TAVI is to be classified not as an interventional but a true surgical procedure, with inflammatory biomarker profiles comparable to those found after SAVR. Our study could not establish an obvious link between the extent of the periprocedural inflammatory response and clinical outcome parameters.	[Erdoes, Gabor; Lippuner, Christoph; Schiff, Marcel; Stucki, Monika; Eberle, Balthasar; Stueber, Frank; Book, Malte] Univ Bern, Inselspital, Univ Hosp Bern, Dept Anesthesiol & Pain Med, CH-3010 Bern, Switzerland; [Lippuner, Christoph; Schiff, Marcel; Stueber, Frank; Book, Malte] Univ Bern, Inselspital, Univ Hosp Bern, Dept Clin Res,Anesthesiol Grp, CH-3010 Bern, Switzerland; [Kocsis, Istvan] Semmelweis Univ, Dept Obstet & Gynecol 2, Budapest, Hungary; [Carrel, Thierry] Univ Bern, Inselspital, Univ Hosp Bern, Dept Cardiovasc Surg,Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland; [Windecker, Stephan] Univ Bern, Inselspital, Univ Hosp Bern, Dept Cardiol,Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Semmelweis University; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Erdoes, G (corresponding author), Univ Bern, Inselspital, Univ Hosp Bern, Dept Anesthesiol & Pain Med, CH-3010 Bern, Switzerland.	gabor.erdoes@insel.ch	Carrel, Thierry/AAI-5910-2021	Lippuner, Christoph/0000-0003-2872-9381				Abdelbaky A, 2015, ATHEROSCLEROSIS, V238, P165, DOI 10.1016/j.atherosclerosis.2014.11.026; Amonn K, 2013, EUR J CARDIO-THORAC, V43, P34, DOI 10.1093/ejcts/ezs173; Bical OM, 2006, EUR J CARDIO-THORAC, V29, P699, DOI 10.1016/j.ejcts.2006.01.053; Biglioli P, 2003, EUR J CARDIO-THORAC, V24, P260, DOI 10.1016/S1010-7940(03)00295-1; Blume ED, 1997, CIRCULATION, V96, P352; Bone RC, 1992, ACCP SCCM CONS C COM; Buellesfeld L, 2010, EUR HEART J, V31, P984, DOI 10.1093/eurheartj/ehp570; CRUICKSHANK AM, 1990, CLIN SCI, V79, P161, DOI 10.1042/cs0790161; Dahl JS, 2013, AM J CARDIOL, V112, P1433, DOI 10.1016/j.amjcard.2013.06.015; Dweck MR, 2013, EUR HEART J, V34, P1567, DOI 10.1093/eurheartj/eht034; Dybdahl B, 2004, EUR J CARDIO-THORAC, V25, P985, DOI 10.1016/j.ejcts.2004.03.002; Eppinger MJ, 1996, J THORAC CARDIOV SUR, V112, P1301, DOI 10.1016/S0022-5223(96)70144-7; Erdoes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053045; FAIST E, 1986, ARCH SURG-CHICAGO, V121, P1000; Fitzgerald DC, 2015, INNOVATIONS; Gessler P, 2003, J THORAC CARDIOV SUR, V126, P718, DOI 10.1016/S0022-5223(03)00685-8; Goetzenich A, 2011, THORAC CARDIOV SURG, V59, P465, DOI 10.1055/s-0031-1280370; Husser O, 2013, JACC-CARDIOVASC INTE, V6, P487, DOI 10.1016/j.jcin.2013.02.006; Issitt RW, 2008, ANN THORAC SURG, V86, P627, DOI 10.1016/j.athoracsur.2008.03.015; Jongman RM, 2014, SHOCK, V42, P121, DOI 10.1097/SHK.0000000000000190; Kiaii Bob, 2012, Innovations (Phila), V7, P23, DOI 10.1097/IMI.0b013e3182552ade; Kobayashi Y, 2010, ASAIO J, V56, P309, DOI 10.1097/MAT.0b013e3181e03d6c; Krumsdorf U, 2012, J INVASIVE CARDIOL, V24, P282; KUKIELKA GL, 1995, CIRCULATION, V92, P1866, DOI 10.1161/01.CIR.92.7.1866; Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X; Lindman BR, 2015, HEART, V101, P537, DOI 10.1136/heartjnl-2014-307057; Lindman BR, 2014, J AM COLL CARDIOL, V63, P1090, DOI 10.1016/j.jacc.2013.10.057; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Mahoney CB, 2000, PERFUSION-UK, V15, P467, DOI 10.1177/026765910001500510; Onorati F, 2010, EUR J CARDIO-THORAC, V37, P897, DOI 10.1016/j.ejcts.2009.11.010; Remadi JP, 2004, J THORAC CARDIOV SUR, V128, P436, DOI 10.1016/j.jtcvs.2004.01.041; Schewel D, 2015, CATHETER CARDIO INTE, V85, P502, DOI 10.1002/ccd.25295; Sinning JM, 2012, EUR HEART J, V33, P1459, DOI 10.1093/eurheartj/ehs002; SPERTINI O, 1992, J IMMUNOL METHODS, V156, P115, DOI 10.1016/0022-1759(92)90017-N; Stahli BE, 2012, J INVASIVE CARDIOL, V24, P407; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Walther T, 2011, SEMIN THORAC CARDIOV, V23, P55, DOI 10.1053/j.semtcvs.2011.05.006; Wan IYP, 2004, J THORAC CARDIOV SUR, V127, P1624, DOI 10.1016/j.jtcvs.2003.10.043; Wan S, 1996, J THORAC CARDIOV SUR, V112, P806, DOI 10.1016/S0022-5223(96)70068-5; Yutzey KE, 2014, CALCIFIC AORTIC VALV, P2387	40	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143089	10.1371/journal.pone.0143089	http://dx.doi.org/10.1371/journal.pone.0143089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599610	Green Published, gold			2022-12-26	WOS:000365853900063
J	Hudson, LN; Blagoderov, V; Heaton, A; Holtzhausen, P; Livermore, L; Price, BW; van der Walt, S; Smith, VS				Hudson, Lawrence N.; Blagoderov, Vladimir; Heaton, Alice; Holtzhausen, Pieter; Livermore, Laurence; Price, Benjamin W.; van der Walt, Stefan; Smith, Vincent S.			Inselect: Automating the Digitization of Natural History Collections	PLOS ONE			English	Article							MUSEUM COLLECTIONS	The world's natural history collections constitute an enormous evidence base for scientific research on the natural world. To facilitate these studies and improve access to collections, many organisations are embarking on major programmes of digitization. This requires automated approaches to mass-digitization that support rapid imaging of specimens and associated data capture, in order to process the tens of millions of specimens common to most natural history collections. In this paper we present Inselect-a modular, easy-to-use, cross-platform suite of open-source software tools that supports the semi-automated processing of specimen images generated by natural history digitization programmes. The software is made up of a Windows, Mac OS X, and Linux desktop application, together with command-line tools that are designed for unattended operation on batches of images. Blending image visualisation algorithms that automatically recognise specimens together with workflows to support post-processing tasks such as barcode reading, label transcription and metadata capture, Inselect fills a critical gap to increase the rate of specimen digitization.	[Hudson, Lawrence N.; Blagoderov, Vladimir; Heaton, Alice; Livermore, Laurence; Price, Benjamin W.; Smith, Vincent S.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Holtzhausen, Pieter; van der Walt, Stefan] Univ Stellenbosch, Div Appl Math, ZA-7600 Stellenbosch, South Africa; [van der Walt, Stefan] Univ Calif Berkeley, Berkeley Inst Data Sci, Berkeley, CA 94720 USA	Natural History Museum London; Stellenbosch University; University of California System; University of California Berkeley	Hudson, LN (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	l.hudson@nhm.ac.uk	Smith, Vincent/AAK-7335-2020; Livermore, Laurence/H-8062-2019; Price, Benjamin/Y-5971-2019; Hudson, Lawrence/H-2918-2013	Smith, Vincent/0000-0001-5297-7452; Livermore, Laurence/0000-0002-7341-1842; Price, Benjamin/0000-0001-5497-4087; Hudson, Lawrence/0000-0003-4072-7469	SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 Integrating Activities Programme [312253]; Natural Environment Research Council [NE/H02185X/1] Funding Source: researchfish; NERC [NE/H02185X/1] Funding Source: UKRI	SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 Integrating Activities Programme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research received support from the SYNTHESYS Project, http://www.synthesys.info/, which is financed by European Community Research Infrastructure Action under the FP7 Integrating Activities Programme (Grant agreement number 312253).	Arino AH, 2010, BIODIVERS INFORM, V7, P81, DOI [10.17161/bi.v7i2.3991, DOI 10.17161/BI.V7I2.3991]; Beaman RS, 2012, ZOOKEYS, P7, DOI 10.3897/zookeys.209.3313; Beck J, 2007, J APPL ECOL, V44, P672, DOI 10.1111/j.1365-2664.2007.01291.x; Blagoderov V, 2012, ZOOKEYS, P133, DOI 10.3897/zookeys.209.3178; Brooks SJ, 2014, INT J BIOMETEOROL, V58, P1749, DOI 10.1007/s00484-013-0780-6; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Dietrich C, 2012, ZOOKEYS, P165, DOI 10.3897/zookeys.209.3571; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Holovachov O, 2014, J CONSERV MUS STUD, V12, DOI 10.5334/jcms.1021218; Lister AM, 2011, TRENDS ECOL EVOL, V26, P153, DOI 10.1016/j.tree.2010.12.009; Mantle BL, 2012, ZOOKEYS, P147, DOI 10.3897/zookeys.209.3169; Nelson G, 2012, ZOOKEYS, P19, DOI 10.3897/zookeys.209.3135; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Rocha LA, 2014, SCIENCE, V344, P814, DOI 10.1126/science.344.6186.814; Schmidt S, 2012, ZOOKEYS, P183, DOI 10.3897/zookeys.209.3115; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715	17	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143402	10.1371/journal.pone.0143402	http://dx.doi.org/10.1371/journal.pone.0143402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599208	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900109
J	Kanatsou, S; Fearey, BC; Kuil, LE; Lucassen, PJ; Harris, AP; Seckl, JR; Krugers, H; Joels, M				Kanatsou, Sofia; Fearey, Brenna C.; Kuil, Laura E.; Lucassen, Paul J.; Harris, Anjanette P.; Seckl, Jonathan R.; Krugers, Harm; Joels, Marian			Overexpression of Mineralocorticoid Receptors Partially Prevents Chronic Stress-Induced Reductions in Hippocampal Memory and Structural Plasticity	PLOS ONE			English	Article							CHRONIC PSYCHOSOCIAL STRESS; LONG-TERM POTENTIATION; DENTATE GYRUS; ADULT NEUROGENESIS; RECOGNITION MEMORY; LIFE STRESS; GLUCOCORTICOID-RECEPTORS; HORMONE CORTICOSTERONE; PYRAMIDAL NEURONS; CHRONIC RESTRAINT	Exposure to chronic stress is a risk factor for cognitive decline and psychopathology in genetically predisposed individuals. Preliminary evidence in humans suggests that mineralocorticoid receptors (MRs) may confer resilience to these stress-related changes. We specifically tested this idea using a well-controlled mouse model for chronic stress in combination with transgenic MR overexpression in the forebrain. Exposure to unpredictable stressors for 21 days in adulthood reduced learning and memory formation in a low arousing hippocampus-dependent contextual learning task, but enhanced stressful contextual fear learning. We found support for a moderating effect of MR background on chronic stress only for contextual memory formation under low arousing conditions. In an attempt to understand potentially contributing factors, we studied structural plasticity. Chronic stress altered dendritic morphology in the hippocampal CA3 area and reduced the total number of double-cortin- positive immature neurons in the infrapyramidal blade of the dentate gyrus. The latter reduction was absent in MR overexpressing mice. We therefore provide partial support for the idea that overexpression of MRs may confer resilience to the effects of chronic stress on hippocampus-dependent function and structural plasticity.	[Kanatsou, Sofia; Fearey, Brenna C.; Joels, Marian] Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Kuil, Laura E.; Lucassen, Paul J.; Krugers, Harm] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Harris, Anjanette P.; Seckl, Jonathan R.] Univ Edinburgh, Endocrinol Unit, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	Utrecht University; Utrecht University Medical Center; University of Amsterdam; University of Edinburgh	Kanatsou, S (corresponding author), Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	s.kanatsou@gmail.com	Lucassen, Paul/ABA-3113-2020; Joëls, Marian/P-6415-2016; harris, Anjanette/D-8008-2011	Lucassen, Paul/0000-0001-9708-9133; Fearey, Brenna/0000-0002-2649-7727; Joels, Marian/0000-0002-4826-6209	ALW grant from the Netherlands Organization for Scientific Research NWO [821-02-007]	ALW grant from the Netherlands Organization for Scientific Research NWO	SFK was supported by ALW grant # 821-02-007 from the Netherlands Organization for Scientific Research NWO. The funding source had no involvement in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Alfarez DN, 2003, EUR J NEUROSCI, V17, P1928, DOI 10.1046/j.1460-9568.2003.02622.x; Bagot RC, 2009, NEUROBIOL LEARN MEM, V92, P292, DOI 10.1016/j.nlm.2009.03.004; Baker KB, 2002, LEARN MEMORY, V9, P58, DOI 10.1101/lm.46102; Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Bogdan R, 2012, AM J PSYCHIAT, V169, P515, DOI 10.1176/appi.ajp.2011.11060855; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Cornelisse S, 2011, NEUROPSYCHOPHARMACOL, V36, P2720, DOI 10.1038/npp.2011.162; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; DeRijk RH, 2008, EUR J PHARMACOL, V585, P492, DOI 10.1016/j.ejphar.2008.03.012; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gass P, 2000, EMBO REP, V1, P447, DOI 10.1093/embo-reports/kvd088; Gould E, 1997, J NEUROSCI, V17, P2492; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; Hu P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046224; Joels M, 2008, TRENDS NEUROSCI, V31, P1, DOI 10.1016/j.tins.2007.10.005; Joels M, 2012, PHARMACOL REV, V64, P901, DOI 10.1124/pr.112.005892; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Klok MD, 2011, J PSYCHIATR RES, V45, P871, DOI 10.1016/j.jpsychires.2010.12.002; Krugers HJ, 1997, HIPPOCAMPUS, V7, P427, DOI 10.1002/(SICI)1098-1063(1997)7:4<427::AID-HIPO8>3.3.CO;2-L; Kuningas M, 2007, NEUROPSYCHOPHARMACOL, V32, P1295, DOI 10.1038/sj.npp.1301260; Lai M, 2007, EUR J NEUROSCI, V25, P1832, DOI 10.1111/j.1460-9568.2007.05427.x; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Marlatt MW, 2010, BRAIN RES, V1341, P93, DOI 10.1016/j.brainres.2010.03.086; McEwen BS, 2004, EUR NEUROPSYCHOPHARM, V14, pS497, DOI 10.1016/j.euroneuro.2004.09.008; McKittrick CR, 2000, SYNAPSE, V36, P85, DOI 10.1002/(SICI)1098-2396(200005)36:2<85::AID-SYN1>3.0.CO;2-Y; Mitra R, 2009, BIOL PSYCHIAT, V66, P686, DOI 10.1016/j.biopsych.2009.04.016; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Naninck EFG, 2015, HIPPOCAMPUS, V25, P309, DOI 10.1002/hipo.22374; OITZL MS, 1994, EUR J NEUROSCI, V6, P1072, DOI 10.1111/j.1460-9568.1994.tb00604.x; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Oomen CA, 2014, WIRES COGN SCI, V5, P573, DOI 10.1002/wcs.1304; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Otte C, 2007, NEUROPSYCHOPHARMACOL, V32, P232, DOI 10.1038/sj.npp.1301217; Otte C, 2015, NEUROPSYCHOPHARMACOL, V40, P386, DOI 10.1038/npp.2014.181; Pugh CR, 1997, BEHAV NEUROSCI, V111, P503, DOI 10.1037/0735-7044.111.3.503; Reagan LP, 2004, P NATL ACAD SCI USA, V101, P2179, DOI 10.1073/pnas.0307294101; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Sandi C, 2006, NEUROBIOL AGING, V27, P128, DOI 10.1016/j.neurobiolaging.2005.01.006; Schwabe L, 2013, BIOL PSYCHIAT, V74, P801, DOI 10.1016/j.biopsych.2013.06.001; Schwabe L, 2010, J COGNITIVE NEUROSCI, V22, P1362, DOI 10.1162/jocn.2009.21278; Smith DM, 2006, J NEUROSCI, V26, P3154, DOI 10.1523/JNEUROSCI.3234-05.2006; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Vogel S, 2015, BIOL PSYCHIAT, VS0006-3223, P00124; Vogel S, 2015, NEUROPSYCHOPHARMACOL, V40, P947, DOI 10.1038/npp.2014.271; Wang XD, 2013, NAT NEUROSCI, V16, P706, DOI 10.1038/nn.3395; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Wright RL, 2005, STRESS, V8, P151, DOI 10.1080/10253890500156663; Zhou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026220; Zhou M, 2010, NEUROBIOL LEARN MEM, V94, P530, DOI 10.1016/j.nlm.2010.09.005; Zhou M, 2009, EUR J NEUROSCI, V30, P1559, DOI 10.1111/j.1460-9568.2009.06951.x	70	22	23	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142012	10.1371/journal.pone.0142012	http://dx.doi.org/10.1371/journal.pone.0142012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600250	Green Published, gold			2022-12-26	WOS:000365853900019
J	Kim, HJ; Cho, JC				Kim, Hye-Jin; Cho, Jae-Chang			Genotypic Diversity and Population Structure of Vibrio vulnificus Strains Isolated in Taiwan and Korea as Determined by Multilocus Sequence Typing	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; REAL-TIME PCR; WOUND-INFECTION; ENVIRONMENTAL STRAINS; STATISTICAL TESTS; GENETIC-VARIATION; COASTAL WATERS; POLYMORPHISM; OYSTERS; VIRULENCE	The genetic diversity and population structure of Vibrio vulnificus isolates from Korea and Taiwan were investigated using PCR-based assays targeting putative virulence-related genes and multilocus sequence typing (MLST). BOX-PCR genomic fingerprinting identified 52 unique genotypes in 84 environmental and clinical V. vulnificus isolates. The majority (>50%) of strains had pathogenic genotypes for all loci tested; moreover, many environmental strains had pathogenic genotypes. Although significant (p < 0.05) inter-relationships among the genotypes were observed, the association between genotype and strain source (environmental or clinical) was not significant, indicating that genotypic characteristics alone are not sufficient to predict the isolation source or the virulence of a given V. vulnificus strain and vice versa. MLST revealed 23-35 allelic types per locus analyzed, resulting in a total of 44 unique sequence types (STs). Two major monophyletic groups (lineages A and B) corresponding to the two known lineages of V. vulnificus were observed; lineage A had six STs that were exclusively environmental, whereas lineage B had STs from both environmental and clinical sources. Pathogenic and nonpathogenic genotypes predominated in MLST lineages B and A, respectively. In addition, V. vulnificus was shown to be in linkage disequilibrium (p < 0.05), although two different recombination tests (PHI and Sawyer's tests) detected significant evidence of recombination. Tajima's D test also indicated that V. vulnificus might be comprised of recently sub-divided lineages. These results suggested that the two lineages revealed by MLST correspond to two distinct ecotypes of V. vulnificus.	[Kim, Hye-Jin; Cho, Jae-Chang] Hankuk Univ Foreign Studies, Inst Environm Sci, Yongin, South Korea; [Kim, Hye-Jin; Cho, Jae-Chang] Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin, South Korea; [Cho, Jae-Chang] Solana Informat, San Diego, CA USA	Hankuk University Foreign Studies; Hankuk University Foreign Studies	Cho, JC (corresponding author), Hankuk Univ Foreign Studies, Inst Environm Sci, Yongin, South Korea.	chojc@hufs.ac.kr			Gyunggi Regional Research Center [GRRCHUFS-2013-B02]; Hankuk University of Foreign Studies [HUFS-2014]; National Research Foundation of Korea [NRF-2012R1A1A2004270]; Korea Environmental Industry and Technology Institute (GAIA) [20130005501]; GRRC [GRRCHUFS-2013-B02]; HUFS [HUFS-2014]; NRF [NRF-2012R1A1A2004270]; KEITI (GAIA) [20130005501]	Gyunggi Regional Research Center; Hankuk University of Foreign Studies; National Research Foundation of Korea(National Research Foundation of Korea); Korea Environmental Industry and Technology Institute (GAIA); GRRC; HUFS; NRF; KEITI (GAIA)	This work was supported by a research grant from the Gyunggi Regional Research Center (program no. GRRCHUFS-2013-B02) and Hankuk University of Foreign Studies (program no. HUFS-2014). H-J Kim was supported in part by the National Research Foundation of Korea (grant no. NRF-2012R1A1A2004270) and Korea Environmental Industry and Technology Institute (GAIA project no. 20130005501).; We thank K-H Lee, JD Oliver, and H-C Wong for providing Vibrio vulnificus strains. This work was supported by a research grant from the GRRC (program no. GRRCHUFS-2013-B02) and HUFS (program no. HUFS-2014). H-J Kim was supported in part by the NRF (grant no. NRF-2012R1A1A2004270) and KEITI (GAIA project no. 20130005501).	ATWOOD KC, 1951, P NATL ACAD SCI USA, V37, P146, DOI 10.1073/pnas.37.3.146; Baizabal-Ramirez Oscar, 2011, Rev Med Inst Mex Seguro Soc, V49, P433; Baker-Austin C, 2012, FOOD MICROBIOL, V30, P17, DOI 10.1016/j.fm.2011.09.002; Franca JCB, 2013, AN BRAS DERMATOL, V88, P424, DOI 10.1590/abd1806-4841.20131780; Bier N, 2013, APPL ENVIRON MICROB, V79, P3570, DOI 10.1128/AEM.00477-13; Biosca EG, 1997, APPL ENVIRON MICROB, V63, P1460, DOI 10.1128/AEM.63.4.1460-1466.1997; BIOSCA EG, 1991, J FISH DIS, V14, P103, DOI 10.1111/j.1365-2761.1991.tb00581.x; Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Bisharat N, 1999, LANCET, V354, P1421, DOI 10.1016/S0140-6736(99)02471-X; Bisharat N, 2007, INFECT GENET EVOL, V7, P685, DOI 10.1016/j.meegid.2007.07.007; Bogard RW, 2007, APPL ENVIRON MICROB, V73, P7501, DOI 10.1128/AEM.01551-07; BOYD EF, 1994, P NATL ACAD SCI USA, V91, P1280, DOI 10.1073/pnas.91.4.1280; Broza YY, 2007, J CLIN MICROBIOL, V45, P2951, DOI 10.1128/JCM.00236-07; Broza YY, 2012, INT J FOOD MICROBIOL, V153, P436, DOI 10.1016/j.ijfoodmicro.2011.12.011; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cazorla C, 2011, EMERG INFECT DIS, V17, P136, DOI 10.3201/eid1701.100603; CDC, 2007, SUMM HUM VIBR IS REP; CHAO A, 1984, SCAND J STAT, V11, P265; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Chatzidaki-Livanis M, 2006, APPL ENVIRON MICROB, V72, P6136, DOI 10.1128/AEM.00341-06; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Chu Chaeshin, 2011, Osong Public Health Res Perspect, V2, P51, DOI 10.1016/j.phrp.2011.05.002; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohen ALV, 2007, APPL ENVIRON MICROB, V73, P5553, DOI 10.1128/AEM.00635-07; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; den Bakker HC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-277; Do T, 2009, MICROBIOL-SGM, V155, P2593, DOI 10.1099/mic.0.027284-0; Drake SL, 2010, FOODBORNE PATHOG DIS, V7, P97, DOI 10.1089/fpd.2009.0362; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Gonzalez-Escalona N, 2007, APPL ENVIRON MICROB, V73, P7494, DOI 10.1128/AEM.00738-07; Gordon KV, 2008, APPL ENVIRON MICROB, V74, P1704, DOI 10.1128/AEM.01100-07; GRAY LD, 1987, J INFECT DIS, V155, P236, DOI 10.1093/infdis/155.2.236; GRAY LD, 1985, INFECT IMMUN, V48, P62, DOI 10.1128/IAI.48.1.62-72.1985; Gutacker M, 2003, APPL ENVIRON MICROB, V69, P3203, DOI 10.1128/AEM.69.6.3203-3212.2003; Han F, 2010, LETT APPL MICROBIOL, V51, P234, DOI 10.1111/j.1472-765X.2010.02887.x; Han FF, 2009, FOODBORNE PATHOG DIS, V6, P1251, DOI 10.1089/fpd.2009.0343; HANE BG, 1993, ELECTROPHORESIS, V14, P967, DOI 10.1002/elps.11501401154; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; HOLLIS DG, 1976, J CLIN MICROBIOL, V3, P425; Horseman MA, 2011, INT J INFECT DIS, V15, pE157, DOI 10.1016/j.ijid.2010.11.003; Hsueh PR, 2004, EMERG INFECT DIS, V10, P1363, DOI 10.3201/eid1008.040047; HUDSON RR, 1994, J EVOLUTION BIOL, V7, P535, DOI 10.1046/j.1420-9101.1994.7050535.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Inoue Y, 2008, J DERMATOL, V35, P129, DOI 10.1111/j.1346-8138.2008.00432.x; Jeong Hye Sook, 2011, Osong Public Health Res Perspect, V2, P8, DOI 10.1016/j.phrp.2011.04.008; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jones JL, 2013, INT J FOOD MICROBIOL, V167, P322, DOI 10.1016/j.ijfoodmicro.2013.09.017; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; JUKES T H, 1969, P21; Kaysner CA, 2001, VIBRIO, P405; KCDC, 2010, KCDCS ANN REP 2007; Keymer DP, 2011, APPL ENVIRON MICROB, V77, P537, DOI 10.1128/AEM.02062-10; Kim HJ, 2012, FOOD CONTROL, V23, P491, DOI 10.1016/j.foodcont.2011.08.019; Kim KY, 1999, J MICROBIOL BIOTECHN, V9, P78; Kim MS, 2001, AQUACULTURE, V193, P199, DOI 10.1016/S0044-8486(00)00495-6; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Kim YR, 2003, BIOCHEM BIOPH RES CO, V304, P405, DOI 10.1016/S0006-291X(03)00613-2; Kotetishvili M, 2003, J CLIN MICROBIOL, V41, P2191, DOI 10.1128/JCM.41.5.2191-2196.2003; Lee JH, 2007, J MICROBIOL, V45, P146; Lee JH, 2004, INFECT IMMUN, V72, P4905, DOI 10.1128/IAI.72.8.4905-4910.2004; Lee JH, 2001, J MICROBIOL BIOTECHN, V11, P302; Lee SH, 2013, JPN J INFECT DIS, V66, P331, DOI 10.7883/yoken.66.331; Robles AL, 2013, J WATER HEALTH, V11, P700, DOI 10.2166/wh.2013.160; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x; Martin DP, 2011, MOL ECOL RESOUR, V11, P943, DOI 10.1111/j.1755-0998.2011.03026.x; Matui T, 2004, ARCH DERMATOL, V140, P888, DOI 10.1001/archderm.140.7.888; MCPHERSON VL, 1991, MICROBIOS, V67, P141; Miller MC, 2007, APPL ENVIRON MICROB, V73, P3695, DOI 10.1128/AEM.02735-06; Motes ML, 1998, APPL ENVIRON MICROB, V64, P1459; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nightingale KK, 2005, J BACTERIOL, V187, P5537, DOI 10.1128/JB.187.16.5537-5551.2005; Nilsson WB, 2003, J CLIN MICROBIOL, V41, P442, DOI 10.1128/JCM.41.1.442-446.2003; Oishi Hirotaka, 2006, Kansenshogaku Zasshi, V80, P680; OLIVER JD, 1982, APPL ENVIRON MICROB, V44, P1404, DOI 10.1128/AEM.44.6.1404-1414.1982; Oliver JD, 2005, EPIDEMIOL INFECT, V133, P383, DOI 10.1017/S0950268805003894; Oliver JD, 1989, VIBRIO VULNIFICUS; Osaka K, 2004, EPIDEMIOL INFECT, V132, P993, DOI 10.1017/S0950268804002407; Panicker G, 2004, CAN J MICROBIOL, V50, P911, DOI 10.1139/W04-085; Paranjpye RN, 2005, INFECT IMMUN, V73, P1411, DOI 10.1128/IAI.73.3.1411-1422.2005; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Park KH, 2007, EXP MOL MED, V39, P673, DOI 10.1038/emm.2007.73; PENMAN AD, 1995, SOUTHERN MED J, V88, P531, DOI 10.1097/00007611-199505000-00004; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Rademaker J. L. W., 1998, MOL MICROBIAL ECOLOG, P1; Rademaker JLW, 2000, INT J SYST EVOL MICR, V50, P665, DOI 10.1099/00207713-50-2-665; Reynaud Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083357; Roig FJ, 2010, APPL ENVIRON MICROB, V76, P1328, DOI 10.1128/AEM.01042-09; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Ruppert J, 2004, EUR J CLIN MICROBIOL, V23, P912, DOI 10.1007/s10096-004-1241-2; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Shao CP, 2000, INFECT IMMUN, V68, P3569, DOI 10.1128/IAI.68.6.3569-3573.2000; Shapiro RL, 1998, J INFECT DIS, V178, P752, DOI 10.1086/515367; SIMONSEN KL, 1995, GENETICS, V141, P413; SIMPSON LM, 1987, INFECT IMMUN, V55, P269, DOI 10.1128/IAI.55.1.269-272.1987; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiaville PC, 2011, INFECT IMMUN, V79, P1194, DOI 10.1128/IAI.01031-10; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TISON DL, 1982, APPL ENVIRON MICROB, V44, P640, DOI 10.1128/AEM.44.3.640-646.1982; Torres L, 2002, EUR J CLIN MICROBIOL, V21, P537, DOI 10.1007/s10096-002-0767-4; Tsao CH, 2013, J INFECT DEV COUNTR, V7, P533, DOI 10.3855/jidc.3008; Vickery MCL, 2007, J MICROBIOL METH, V68, P376, DOI 10.1016/j.mimet.2006.02.018; Vinuesa P, 1998, APPL ENVIRON MICROB, V64, P2096; Warner E, 2008, APPL ENVIRON MICROB, V74, P80, DOI 10.1128/AEM.01434-07; Wong HC, 2004, APPL ENVIRON MICROB, V70, P5153, DOI 10.1128/AEM.70.9.5153-5158.2004; Wood RR, 2012, J APPL MICROBIOL, V113, P172, DOI 10.1111/j.1365-2672.2012.05306.x; World Health Organization and Food and Agriculture Organization of the United Nations, 2005, RISK ASS VIBR VULN R; WRIGHT AC, 1990, INFECT IMMUN, V58, P1769, DOI 10.1128/IAI.58.6.1769-1773.1990; WRIGHT AC, 1981, INFECT IMMUN, V34, P503, DOI 10.1128/IAI.34.2.503-507.1981; Yokochi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055219; YOSHIDA SI, 1985, INFECT IMMUN, V47, P446, DOI 10.1128/IAI.47.2.446-451.1985; Zaidenstein R, 2008, EMERG INFECT DIS, V14, P1875, DOI 10.3201/eid1412.080499	123	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142657	10.1371/journal.pone.0142657	http://dx.doi.org/10.1371/journal.pone.0142657			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599487	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900033
J	Zhang, X; Zhang, YL; Liu, XF; Fang, AJ; Li, PL; Li, ZW; Liu, T; Yang, YM; Du, LT; Wang, CX				Zhang, Xin; Zhang, Yanli; Liu, Xinfeng; Fang, Aiju; Li, Peilong; Li, Zewu; Liu, Tong; Yang, Yongmei; Du, Lutao; Wang, Chuanxin			MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin	PLOS ONE			English	Article							DOWN-REGULATION; RESISTANCE; MULTICENTER; SENSITIVITY; EXPRESSION; SIGNATURES; CARCINOMA; CELLS; HEAD	Resistance to cisplatin-based chemotherapy is a major cause of treatment failure in advanced bladder cancer (BC) patients. There is increasing evidence that microRNAs are involved in the development and progression of BC. However, little is known about the function of microRNAs in predicting the effect of adjuvant chemotherapy on BC survival and regulating response to cisplatin. To address this issue, we employed RT-qPCR to evaluate the clinical significance of miR-203 expression in 108 tissues of BC patients receiving cisplatin-based adjuvant chemotherapy, and performed in vitro studies to explore chemotherapeutic sensitivity to cisplatin in miR-203 overexpressing BC cells. We found miR-203 levels were significantly lower in BC progression group than non-progression group (P<0.001). ROC curve analysis illustrated miR-203 could significantly distinguish progressed patients from those without progression (P<0.001), yielding an area under the ROC curve of 0.839 (95% CI, 0.756-0.903). Moreover, low miR-203 expression correlated with shortened progression free survival (PFS) and overall survival (OS) of BC patients, and was an independent prognostic factor. Overexpression of miR-203 in 5637 and T24 BC cells could decrease cell viability, enhance cisplatin cytotoxicity, and promote apoptosis. Western blotting and luciferase reporter assay showed Bcl-w and Survivin were direct downstream targets of miR-203. There was also a significant inverse association between miR-203 and Bcl-w or Survivin expression in BC tissues (r=-0.781, -0.740, both P<0.001). In conclusion, decreased miR-203 predicts progression and poor prognosis for BC patients treated with cisplatin-based chemotherapy while miR-203 overexpression can enhance cisplatin sensitization by promoting apoptosis via directly targeting Bcl-w and Survivin.	[Zhang, Xin; Li, Peilong; Li, Zewu; Liu, Tong; Yang, Yongmei; Du, Lutao; Wang, Chuanxin] Shandong Univ, Dept Clin Lab, Qilu Hosp, Jinan 250100, Peoples R China; [Zhang, Yanli; Liu, Xinfeng] Traff Hosp Shandong Prov, Dept Clin Lab, Jinan, Peoples R China; [Fang, Aiju] Traff Hosp Shandong Prov, Dept Pathol, Jinan, Peoples R China	Shandong University	Wang, CX (corresponding author), Shandong Univ, Dept Clin Lab, Qilu Hosp, Jinan 250100, Peoples R China.	cxwang@sdu.edu.cn		Li, Peilong/0000-0002-7441-6514	National Natural Science Foundation of China [81271916, 81301506]; Natural Science Foundation of Shandong Province [ZR2013HQ063]; Doctoral Program of Higher Education of China [20130131120067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (http://www.nsfc. gov.cn/) to CW (No. 81271916); National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to XZ (No. 81301506); Natural Science Foundation of Shandong Province (http://www.sdnsf.gov.cn/portal/) to XZ (ZR2013HQ063); and Doctoral Program of Higher Education of China (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm) to XZ (No. 20130131120067).	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Chen XN, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0070-3; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Drayton RM, 2014, CLIN CANCER RES, V20, P1990, DOI 10.1158/1078-0432.CCR-13-2805; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; He JG, 2013, J SURG ONCOL, V108, P121, DOI 10.1002/jso.23315; Jamali Z, 2015, ORAL ONCOL, V51, P321, DOI 10.1016/j.oraloncology.2015.01.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Kumar B, 2012, MOL CANCER THER, V11, P1988, DOI 10.1158/1535-7163.MCT-12-0167; Li H, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-8; Li JA, 2011, CANCER LETT, V304, P52, DOI 10.1016/j.canlet.2011.02.003; Li NW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128886; Li ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116170; Nordentoft I, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-40; Phatak P, 2015, ONCOGENE; Roberts JT, 2006, ANN ONCOL, V17, pV118, DOI 10.1093/annonc/mdj965; Saini S, 2011, CANCER PREV RES, V4, P1698, DOI 10.1158/1940-6207.CAPR-11-0267; Shariat SF, 2009, CLIN CANCER RES, V15, P7012, DOI 10.1158/1078-0432.CCR-08-2554; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Sternberg CN, 2013, EUR UROL, V63, P58, DOI 10.1016/j.eururo.2012.08.010; Tian HW, 2012, J BIOMED NANOTECHNOL, V8, P633, DOI 10.1166/jbn.2012.1419; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vinall RL, 2012, INT J CANCER, V130, P2526, DOI 10.1002/ijc.26256; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; Herr HW, 2007, J UROLOGY, V177, P437, DOI 10.1016/j.juro.2006.09.027; Wang F, 2013, FEBS LETT, V587, P488, DOI 10.1016/j.febslet.2013.01.016; Wang XD, 2001, GENE DEV, V15, P2922; Wu XF, 2013, CANCER PREV RES, V6, P196, DOI 10.1158/1940-6207.CAPR-12-0276; Yin JH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-71; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhou YF, 2014, MOL ONCOL, V8, P83, DOI 10.1016/j.molonc.2013.09.004	36	8	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143441	10.1371/journal.pone.0143441	http://dx.doi.org/10.1371/journal.pone.0143441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599571	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900123
J	Castro, V; Bertrand, L; Luethen, M; Dabrowski, S; Lombardi, J; Morgan, L; Sharova, N; Stevenson, M; Blasig, IE; Toborek, M				Castro, Victor; Bertrand, Luc; Luethen, Mareen; Dabrowski, Sebastian; Lombardi, Jorge; Morgan, Laura; Sharova, Natalia; Stevenson, Mario; Blasig, Ingolf E.; Toborek, Michal			Occludin controls HIV transcription in brain pericytes via regulation of SIRT-1 activation	FASEB JOURNAL			English	Article						blood-brain barrier; human macrophage; metabolic regulation; NADH oxidase; tight junction protein	NF-KAPPA-B; HUMAN-IMMUNODEFICIENCY-VIRUS; TIGHT JUNCTION PROTEINS; UP-REGULATION; BARRIER; CELLS; IDENTIFICATION; KINASE; MACROPHAGES; METABOLISM	HIV invades the brain early after infection; however, its interactions with the cells of the blood-brain barrier (BBB) remain poorly understood. Our goal was to evaluate the role of occludin, one of the tight junction proteins that regulate BBB functions in HIV infection of BBB pericytes. We provide evidence that occludin levels largely control the metabolic responses of human pericytes to HIV. Occludin in BBB pericytes decreased by 10% during the first 48 h after HIV infection, correlating with increased nuclear translocation of the gene repressor C-terminal-binding protein (CtBP)-1 and NF kappa B-p65 activation. These changes were associated with decreased expression and activation of the class III histone deacetylase sirtuin (SIRT)-1. Occludin levels recovered 96 h after infection, restoring SIRT-1 and reducing HIV transcription to 20% of its highest values. We characterized occludin biochemically as a novel NADH oxidase that controls the expression and activation of SIRT-1. The inverse correlation between occludin and HIV transcription was then replicated in human primary macrophages and differentiated monocytic U937 cells, in which occludin silencing resulted in 75 and 250% increased viral transcription, respectively. Our work shows that occludin has previously unsuspected metabolic properties and is a target of HIV infection, opening the possibility of designing novel pharmacological approaches to control HIV transcription.	[Castro, Victor; Bertrand, Luc; Lombardi, Jorge; Morgan, Laura; Toborek, Michal] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 1011 NW 15th St, Miami, FL 33136 USA; [Sharova, Natalia; Stevenson, Mario] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA; [Luethen, Mareen] Free Univ Berlin, Dept Biol, Berlin, Germany; [Dabrowski, Sebastian; Blasig, Ingolf E.] Leibniz Inst Mol Pharmacol, Robert Rosslestr 10, D-13125 Berlin, Germany	University of Miami; University of Miami; Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Castro, V; Toborek, M (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 1011 NW 15th St, Miami, FL 33136 USA.; Blasig, IE (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rosslestr 10, D-13125 Berlin, Germany.	vcastrovillela@med.miami.edu; iblasig@fmp-berlin.de; mtoborek@med.miami.edu		Luthen, Mareen/0000-0001-5557-6419	U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute Grant [HL126559]; Institute of Drug Abuse [DA039576, DA027569]; Institute of Mental Health [MH098891, MH63022, MH072567]; Miami Center for AIDS Research - NIH Grant [P30AI073961]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072567, R01MH063022, R01MH098891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA039576, R01DA027569, R01DA044579] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute Grant; Institute of Drug Abuse; Institute of Mental Health; Miami Center for AIDS Research - NIH Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Mr. N. Ramsingh (University of Miami Miller School of Medicine) for his assistance with MARVEL D3 modeling. This work was supported by the U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute Grant HL126559; Institute of Drug Abuse Grants DA039576 and DA027569; and Institute of Mental Health Grants MH098891, MH63022, and MH072567 and by the Miami Center for AIDS Research funded by NIH Grant P30AI073961. The authors declare no conflicts of interest.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bagasra O, 1996, AIDS, V10, P573, DOI 10.1097/00002030-199606000-00002; Bal MS, 2012, J CELL BIOCHEM, V113, P934, DOI 10.1002/jcb.23422; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Blasig IE, 2011, ANTIOXID REDOX SIGN, V15, P1195, DOI 10.1089/ars.2010.3542; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Chan JK, 2012, IMMUNOL REV, V246, P286, DOI 10.1111/j.1600-065X.2012.01094.x; Chaudhuri AD, 2013, FASEB J, V27, P3720, DOI 10.1096/fj.13-232678; Deng Y, 2010, ONCOGENE, V29, P6603, DOI 10.1038/onc.2010.406; Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Furler RL, 2010, IMMUNOL RES, V48, P99, DOI 10.1007/s12026-010-8170-1; Gu Y, 2001, VIROLOGY, V286, P62, DOI 10.1006/viro.2001.0998; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Huang W, 2009, FASEB J, V23, P1596, DOI 10.1096/fj.08-121624; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Luo XY, 2015, J NEUROVIROL, V21, P66, DOI 10.1007/s13365-014-0304-0; McCaffrey G, 2009, J NEUROCHEM, V110, P58, DOI 10.1111/j.1471-4159.2009.06113.x; Nakagawa S, 2012, J CELL MOL MED, V16, P2950, DOI 10.1111/j.1582-4934.2012.01622.x; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nisimoto Y, 2010, BIOCHEMISTRY-US, V49, P2433, DOI 10.1021/bi9022285; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200; Salmen S, 2010, CELL IMMUNOL, V263, P166, DOI 10.1016/j.cellimm.2010.03.012; Scuto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.159; Sharova N, 2005, EMBO J, V24, P2481, DOI 10.1038/sj.emboj.7600707; Shimizu F, 2008, J CELL PHYSIOL, V217, P388, DOI 10.1002/jcp.21508; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; Walter JK, 2009, CELL MOL LIFE SCI, V66, P3655, DOI 10.1007/s00018-009-0150-z; West MJ, 2001, J VIROL, V75, P8524, DOI 10.1128/JVI.75.18.8524-8537.2001; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang HS, 2009, LIFE SCI, V85, P484, DOI 10.1016/j.lfs.2009.07.014	37	32	33	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1234	1246		10.1096/fj.15-277673	http://dx.doi.org/10.1096/fj.15-277673			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26601824	Green Published			2022-12-26	WOS:000370387800020
J	Crenshaw, E; Leung, BP; Kwok, CK; Sharoni, M; Olson, K; Sebastian, NP; Ansaloni, S; Schweitzer-Stenner, R; Akins, MR; Bevilacqua, PC; Saunders, AJ				Crenshaw, Ezekiel; Leung, Brian P.; Kwok, Chun Kit; Sharoni, Michal; Olson, Kalee; Sebastian, Neeraj P.; Ansaloni, Sara; Schweitzer-Stenner, Reinhard; Akins, Michael R.; Bevilacqua, Philip C.; Saunders, Aleister J.			Amyloid Precursor Protein Translation Is Regulated by a 3 ' UTR Guanine Quadruplex	PLOS ONE			English	Article							RNA G-QUADRUPLEXES; STABLE G-QUADRUPLEX; MESSENGER-RNA; ALZHEIMERS-DISEASE; BINDING-PROTEINS; REPRESSES TRANSLATION; SECONDARY STRUCTURE; EUKARYOTIC CELLS; BETA-PEPTIDE; HUMAN GENOME	A central event in Alzheimer's disease is the accumulation of amyloid beta (A beta) peptides generated by the proteolytic cleavage of the amyloid precursor protein (APP). APP overexpression leads to increased A beta generation and Alzheimer's disease in humans and altered neuronal migration and increased long term depression in mice. Conversely, reduction of APP expression results in decreased A beta levels in mice as well as impaired learning and memory and decreased numbers of dendritic spines. Together these findings indicate that therapeutic interventions that aim to restore APP and A beta levels must do so within an ideal range. To better understand the effects of modulating APP levels, we explored the mechanisms regulating APP expression focusing on post-transcriptional regulation. Such regulation can be mediated by RNA regulatory elements such as guanine quadruplexes (G-quadruplexes), non-canonical structured RNA motifs that affect RNA stability and translation. Via a bioinformatics approach, we identified a candidate G-quadruplex within the APP mRNA in its 3' UTR (untranslated region) at residues 3008-3027 (NM_201414.2). This sequence exhibited characteristics of a parallel G-quadruplex structure as revealed by circular dichroism spectrophotometry. Further, as with other G-quadruplexes, the formation of this structure was dependent on the presence of potassium ions. This G-quadruplex has no apparent role in regulating transcription or mRNA stability as wild type and mutant constructs exhibited equivalent mRNA levels as determined by real time PCR. Instead, we demonstrate that this G-quadruplex negatively regulates APP protein expression using dual luciferase reporter and Western blot analysis. Taken together, our studies reveal post-transcriptional regulation by a 3' UTR G-quadruplex as a novel mechanism regulating APP expression.	[Crenshaw, Ezekiel; Leung, Brian P.; Sharoni, Michal; Sebastian, Neeraj P.; Ansaloni, Sara; Akins, Michael R.; Saunders, Aleister J.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Leung, Brian P.; Schweitzer-Stenner, Reinhard] Drexel Univ, Dept Chem, Philadelphia, PA 19104 USA; [Kwok, Chun Kit; Olson, Kalee; Bevilacqua, Philip C.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Kwok, Chun Kit; Bevilacqua, Philip C.] Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA; [Kwok, Chun Kit] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Saunders, Aleister J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA; [Akins, Michael R.; Saunders, Aleister J.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Cambridge; Drexel University; Drexel University	Saunders, AJ (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	Aleister.Saunders@drexel.edu	Schweitzer-Stenner, Reinhard/AAV-1058-2021; Akins, Michael/P-7309-2019	Akins, Michael/0000-0003-2420-2582; Bevilacqua, Philip/0000-0001-8074-3434; Crenshaw, Ezekiel/0000-0002-6490-6173; Saunders, Aleister/0000-0002-7298-7823; KWOK, Chun Kit/0000-0001-9175-8543	National Institutes of Health [R01NS057295, R36AG048247, R00MH90237]; Human Frontier Science Program grant [RGP0002/2009-C]; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH090237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R36AG048247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program grant(Human Frontier Science Program); Cure Alzheimer's Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by the grants from the National Institutes of Health [R01NS057295 (AJS), R36AG048247 (EC), and R00MH90237 (MRA)] and by Human Frontier Science Program grant RGP0002/2009-C (PCB). Finally, the Cure Alzheimer's Fund provided support as well (AJS).	Arora A, 2008, RNA, V14, P1290, DOI 10.1261/rna.1001708; Arora A, 2011, RNA BIOL, V8, P802, DOI 10.4161/rna.8.5.16038; Beaudoin JD, 2013, METHODS, V64, P79, DOI 10.1016/j.ymeth.2013.02.017; Beaudoin JD, 2013, NUCLEIC ACIDS RES, V41, P5898, DOI 10.1093/nar/gkt265; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; CULVENOR JG, 1995, EXP CELL RES, V220, P474, DOI 10.1006/excr.1995.1339; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; DING Y, 2013, NATURE, DOI DOI 10.1038/NATURE12756; Diwa A, 2000, GENE DEV, V14, P1249; Donev R, 2007, MOL PSYCHIATR, V12, P681, DOI 10.1038/sj.mp.4001971; Endoh T, 2013, METHODS, V64, P73, DOI 10.1016/j.ymeth.2013.05.026; Endoh T, 2013, NUCLEIC ACIDS RES, V41, P6222, DOI 10.1093/nar/gkt286; Fisette JF, 2012, J NEUROCHEM, V121, P763, DOI 10.1111/j.1471-4159.2012.07680.x; Granholm AC, 2012, ALZHEIMERS DIS DOWN, DOI [10.4172/2161-0460.1000e108, DOI 10.4172/2161-0460.1000E108]; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Joachimi A, 2009, BIOORGAN MED CHEM, V17, P6811, DOI 10.1016/j.bmc.2009.08.043; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kwok CK, 2015, BIOCHEM J, V467, P91, DOI 10.1042/BJ20141063; Kwok CK, 2013, BIOCHEMISTRY-US, V52, P3019, DOI 10.1021/bi400139e; Kwok CK, 2013, ANGEW CHEM INT EDIT, V52, P683, DOI 10.1002/anie.201206475; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lammich S, 2011, J BIOL CHEM, V286, P45063, DOI 10.1074/jbc.M111.296921; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Malgowska M, 2014, NUCLEIC ACIDS RES, V42, P10196, DOI 10.1093/nar/gku710; Menendez C, 2012, NUCLEIC ACIDS RES, V40, pW96, DOI 10.1093/nar/gks422; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Morris MJ, 2009, BIOCHEMISTRY-US, V48, P5313, DOI 10.1021/bi900498z; Mullen MA, 2012, J AM CHEM SOC, V134, P812, DOI 10.1021/ja2096255; Mullen MA, 2010, NUCLEIC ACIDS RES, V38, P8149, DOI 10.1093/nar/gkq804; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Ruttkay-Nedecky B, 2013, MOLECULES, V18, P14760, DOI 10.3390/molecules181214760; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shahid R, 2010, BIOCHEMISTRY-US, V49, P8300, DOI 10.1021/bi100957h; Sosnick T R, 2001, Curr Protoc Nucleic Acid Chem, VChapter 11, DOI 10.1002/0471142700.nc1105s04; Stefanovic S, 2015, MOL BIOSYST, V11, P3222, DOI 10.1039/c5mb00423c; Stefanovic S, 2015, RNA, V21, P48, DOI 10.1261/rna.046722.114; Subaran SS, 2010, NATURE STRUCTURAL MO, V17, P732, DOI [10.1038/nsmb.1815, DOI 10.1038/NSMB.1815]; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Tanzi RE, 2005, NAT NEUROSCI, V8, P977, DOI 10.1038/nn0805-977; von Hacht A, 2014, NUCLEIC ACIDS RES, V42, P6630, DOI 10.1093/nar/gku290; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Westmark CJ, 2012, AGEING RES REV, V11, P450, DOI 10.1016/j.arr.2012.03.005; Weyer SW, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-36; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Woo HH, 2013, MOL CELL PROTEOMICS, V12, P1661, DOI 10.1074/mcp.M112.025288; Yang YCT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1273-2; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zettl H, 2010, TRENDS PHARMACOL SCI, V31, P402, DOI 10.1016/j.tips.2010.05.007; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	72	30	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143160	10.1371/journal.pone.0143160	http://dx.doi.org/10.1371/journal.pone.0143160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618502	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800026
J	Dedic, T; Jirsa, M; Keil, R; Rygl, M; Snajdauf, J; Kotalova, R				Dedic, Tomas; Jirsa, Milan; Keil, Radan; Rygl, Michal; Snajdauf, Jiri; Kotalova, Radana			Alagille Syndrome Mimicking Biliary Atresia in Early Infancy	PLOS ONE			English	Article							JAG1 MUTATIONS; HUMAN JAGGED1; BILE-DUCTS; GENE; CHILDHOOD; FEATURES; PAUCITY; LIGAND	Alagille syndrome may mimic biliary atresia in early infancy. Since mutations in JAG1 typical for Alagille syndrome type 1 have also been found in biliary atresia, we aimed to identify JAG1 mutations in newborns with proven biliary atresia (n = 72). Five biliary atresia patients with cholestasis, one additional characteristic feature of Alagille syndrome and ambiguous liver histology were single heterozygotes for nonsense or frameshift mutations in JAG1. No mutations were found in the remaining 67 patients. All "biliary atresia" carriers of JAG1 null mutations developed typical Alagille syndrome at the age of three years. Our data do not support association of biliary atresia with JAG1 mutations, at least in Czech patients. Rapid testing for JAG1 mutations could prevent misdiagnosis of Alagille syndrome in early infancy and improve their outcome.	[Dedic, Tomas; Kotalova, Radana] Charles Univ Prague, Dept Paediat, Fac Med 2, Prague, Czech Republic; [Dedic, Tomas; Keil, Radan; Rygl, Michal; Snajdauf, Jiri; Kotalova, Radana] Motol Univ Hosp, Prague, Czech Republic; [Jirsa, Milan] Inst Clin & Expt Med, Lab Expt Hepatol, Prague, Czech Republic; [Keil, Radan] Charles Univ Prague, Dept Internal Med, Fac Med 2, Prague, Czech Republic; [Rygl, Michal; Snajdauf, Jiri] Charles Univ Prague, Dept Paediat Surg, Fac Med 2, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Charles University Prague	Kotalova, R (corresponding author), Charles Univ Prague, Dept Paediat, Fac Med 2, Prague, Czech Republic.	radana.kotalova@gmail.com	Keil, Radan/AAQ-6496-2021; Jirsa, Milan/C-9340-2017	Jirsa, Milan/0000-0001-7300-6735	Univerzita Karlova v Praze [GAUK 630512]; Ministerstvo Zdravotnictvi Ceske Republiky [00023001]; Hlavni mesto Praha; EU by the Operational Program Prague Competitiveness, project "CEVKOON" [CZ.2.16/3.1.00/22126]	Univerzita Karlova v Praze; Ministerstvo Zdravotnictvi Ceske Republiky; Hlavni mesto Praha; EU by the Operational Program Prague Competitiveness, project "CEVKOON"	This work was supported by Univerzita Karlova v Praze (CZ), www.cuni.cz, grant GAUK 630512 (to TD); Ministerstvo Zdravotnictvi Ceske Republiky (CZ), www.mzcr.cz, project for development of research organization 00023001 (IKEM) (to MJ); and Hlavni mesto Praha (CZ), http://www.prahafondy.eu/cz/oppk.html, support from the EU by the Operational Program Prague Competitiveness, project "CEVKOON" (#CZ.2.16/3.1.00/22126) (to MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Chardot C, 2013, J HEPATOL, V58, P1209, DOI 10.1016/j.jhep.2013.01.040; Cui S, 2013, GASTROENTEROLOGY, V144, P1107, DOI 10.1053/j.gastro.2013.01.022; DAHMS BB, 1982, HEPATOLOGY, V2, P350; Davenport M, 2012, SEMIN PEDIATR SURG, V21, P175, DOI 10.1053/j.sempedsurg.2012.05.010; Davit-Spraul A, 2008, J PEDIATR GASTR NUTR, V46, P111, DOI 10.1097/01.mpg.0000304465.60788.f4; DEPRETTERE A, 1987, J PEDIATR GASTR NUTR, V6, P865, DOI 10.1097/00005176-198711000-00008; Emerick KM, 1999, HEPATOLOGY, V29, P822, DOI 10.1002/hep.510290331; Fabris L, 2007, AM J PATHOL, V171, P641, DOI 10.2353/ajpath.2007.070073; Guegan K, 2012, CLIN GENET, V82, P33, DOI 10.1111/j.1399-0004.2011.01749.x; HASHIDA Y, 1988, Pediatric Pathology, V8, P1; HOFFENBERG EJ, 1995, J PEDIATR-US, V127, P220, DOI 10.1016/S0022-3476(95)70298-9; Kamath BM, 2003, J MED GENET, V40, P891, DOI 10.1136/jmg.40.12.891; Kaye AJ, 2010, J PEDIATR GASTR NUTR, V51, P319, DOI 10.1097/MPG.0b013e3181df5fd8; Kohsaka T, 2002, HEPATOLOGY, V36, P904, DOI 10.1053/jhep.2002.35820; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Schon P, 2002, HUM GENET, V110, P157, DOI 10.1007/s00439-001-0655-5; Yuan ZR, 2001, CLIN GENET, V59, P330, DOI 10.1034/j.1399-0004.2001.590506.x	20	14	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143939	10.1371/journal.pone.0143939	http://dx.doi.org/10.1371/journal.pone.0143939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618708	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800091
J	Mowles, SL; Jepson, NM				Mowles, Sophie L.; Jepson, Natalie M.			Physiological Costs of Repetitive Courtship Displays in Cockroaches Handicap Locomotor Performance	PLOS ONE			English	Article							FIELD CRICKETS; ANOLIS-CRISTATELLUS; FEMALE PREFERENCE; SEXUAL SELECTION; IMMUNE FUNCTION; SHELL FIGHTS; LIFE-HISTORY; MATE CHOICE; SIGNAL; ENERGETICS	Courtship displays are typically thought to have evolved via female choice, whereby females select mates based on the characteristics of a display that is expected to honestly reflect some aspect of the male's quality. Honesty is typically enforced by mechanistic costs and constraints that limit the level at which a display can be performed. It is becoming increasingly apparent that these costs may be energetic costs involved in the production of dynamic, often repetitive displays. A female attending to such a display may thus be assessing the physical fitness of a male as an index of his quality. Such assessment would provide information on his current physical quality as well as his ability to carry out other demanding activities, qualities with which a choosy female should want to provision her offspring. In the current study we use courtship interactions in the Cuban burrowing cockroach, Byrsotria fumigata to directly test whether courtship is associated with a signaler's performance capacity. Males that had produced courtship displays achieved significantly lower speeds and distances in locomotor trials than non-courting control males. We also found that females mated more readily with males that produced a more vigorous display. Thus, males of this species have developed a strategy where they produce a demanding courtship display, while females choose males based on their ability to produce this display. Courtship displays in many taxa often involve dynamic repetitive actions and as such, signals of stamina in courtship may be more widespread than previously thought.	[Mowles, Sophie L.] Anglia Ruskin Univ, Dept Life Sci, Cambridge, England; [Mowles, Sophie L.; Jepson, Natalie M.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England	Anglia Ruskin University; University of Nottingham	Mowles, SL (corresponding author), Anglia Ruskin Univ, Dept Life Sci, Cambridge, England.	sophie.mowles@anglia.ac.uk			University of Nottingham Anne McLaren Fellowship	University of Nottingham Anne McLaren Fellowship	SLM was funded by a University of Nottingham Anne McLaren Fellowship (http://nottingham.ac.uk/research/fellowships/anne-mclarenfellowships/index.aspx).	Alatalo RV, 1998, P ROY SOC B-BIOL SCI, V265, P2297, DOI 10.1098/rspb.1998.0574; ANDERSSON M, 1982, BIOL J LINN SOC, V17, P375, DOI 10.1111/j.1095-8312.1982.tb02028.x; BARTH R. H., 1964, BEHAVIOUR, V23, P1, DOI 10.1163/156853964X00067; Basolo AL, 2003, P ROY SOC B-BIOL SCI, V270, P1631, DOI 10.1098/rspb.2003.2388; Bennett A.F., 1990, Oxford Surveys in Evolutionary Biology, V7, P251; Bernal XE, 2006, BEHAV ECOL, V17, P709, DOI 10.1093/beheco/arl003; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Brandt Y, 2003, P ROY SOC B-BIOL SCI, V270, P1061, DOI 10.1098/rspb.2003.2343; Briffa M, 2007, FUNCT ECOL, V21, P627, DOI 10.1111/j.1365-2435.2006.01188.x; Briffa M, 2005, ANIM BEHAV, V70, P119, DOI 10.1016/j.anbehav.2004.10.013; Briffa M, 2004, P ROY SOC B-BIOL SCI, V271, P373, DOI 10.1098/rspb.2003.2633; Briffa M, 2001, ANIM BEHAV, V62, P505, DOI 10.1006/anbe.2001.1764; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Fisher RA, 1930, GENETICAL THEORY NAT; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Hack MA, 1998, J INSECT BEHAV, V11, P853, DOI 10.1023/A:1020864111073; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Harrison JF, 2000, ANNU REV PHYSIOL, V62, P179, DOI 10.1146/annurev.physiol.62.1.179; HERREID CF, 1981, J EXP BIOL, V94, P189; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Huyghe K, 2005, FUNCT ECOL, V19, P800, DOI 10.1111/j.1365-2435.2005.01038.x; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Lailvaux SP, 2014, Q REV BIOL, V89, P285, DOI 10.1086/678567; Lailvaux SP, 2010, ECOLOGY, V91, P1530, DOI 10.1890/09-0963.1; Lailvaux SP, 2005, FUNCT ECOL, V19, P632, DOI 10.1111/j.1365-2435.2005.01024.x; Leal M, 1999, ANIM BEHAV, V58, P521, DOI 10.1006/anbe.1999.1181; Matsumasa M, 2005, ANIM BEHAV, V69, P569, DOI 10.1016/j.anbehav.2004.06.017; Mitra C, 2011, ECOL ENTOMOL, V36, P152, DOI 10.1111/j.1365-2311.2010.01254.x; Mowles SL, 2014, ANIM BEHAV, V89, P39, DOI 10.1016/j.anbehav.2013.12.014; Mowles SL, 2012, BEHAV ECOL, V23, P1324, DOI 10.1093/beheco/ars124; Mowles SL, 2012, ANIM BEHAV, V84, P295, DOI 10.1016/j.anbehav.2012.05.015; Mowles SL, 2010, ANIM BEHAV, V80, P277, DOI 10.1016/j.anbehav.2010.05.004; Murai M, 2006, BEHAV ECOL SOCIOBIOL, V60, P736, DOI 10.1007/s00265-006-0217-x; O'Steen S, 2010, FUNCT ECOL, V24, P1045, DOI 10.1111/j.1365-2435.2010.01725.x; Parri S, 1997, ANIM BEHAV, V53, P305, DOI 10.1006/anbe.1996.0371; Payne RJH, 1996, J THEOR BIOL, V183, P185, DOI 10.1006/jtbi.1996.0212; Payne RJH, 1998, ANIM BEHAV, V56, P651, DOI 10.1006/anbe.1998.0835; Payne RJH, 1997, ANIM BEHAV, V54, P109, DOI 10.1006/anbe.1996.0391; Perry G, 2004, ANIM BEHAV, V67, P37, DOI 10.1016/j.anbehav.2003.02.003; Rantala MJ, 2003, BIOL J LINN SOC, V79, P503, DOI 10.1046/j.1095-8312.2003.00202.x; Rosenthal GG, 1996, ANIM BEHAV, V51, P811, DOI 10.1006/anbe.1996.0085; SAKALUK SK, 1995, P ROY SOC B-BIOL SCI, V261, P65, DOI 10.1098/rspb.1995.0118; Seymour RM, 2009, J THEOR BIOL, V256, P1, DOI 10.1016/j.jtbi.2008.09.026; Shamble PS, 2009, BEHAV ECOL, V20, P1242, DOI 10.1093/beheco/arp116; Sinervo B, 2000, HORM BEHAV, V38, P222, DOI 10.1006/hbeh.2000.1622; Sreng L, 2006, EUR J ENTOMOL, V103, P817, DOI 10.14411/eje.2006.112; Tregenza T, 2006, ANIM BEHAV, V72, P809, DOI 10.1016/j.anbehav.2006.01.019; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; van der Sluijs I, 2011, EVOL ECOL, V25, P623, DOI 10.1007/s10682-010-9450-x; Vishnudas V, 2006, MOL B INT U, P188; Weinstein RB, 2000, EXPTL BIOL REV, P33; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539	53	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143664	10.1371/journal.pone.0143664	http://dx.doi.org/10.1371/journal.pone.0143664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606147	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000365865300096
J	Bonnevie, ED; Galesso, D; Secchieri, C; Cohen, I; Bonassar, LJ				Bonnevie, Edward D.; Galesso, Devis; Secchieri, Cynthia; Cohen, Itai; Bonassar, Lawrence J.			Elastoviscous Transitions of Articular Cartilage Reveal a Mechanism of Synergy between Lubricin and Hyaluronic Acid	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURIZATION; BOUNDARY-LUBRICATING ABILITY; SYNOVIAL-FLUID; RECOMBINANT LUBRICIN; PROTEOGLYCAN 4; CONTACT AREA; LOW-FRICTION; OSTEOARTHRITIS; PREVENTION; SURFACES	When lubricated by synovial fluid, articular cartilage provides some of the lowest friction coefficients found in nature. While it is known that macromolecular constituents of synovial fluid provide it with its lubricating ability, it is not fully understood how two of the main molecules, lubricin and hyaluronic acid, lubricate and interact with one another. Here, we develop a novel framework for cartilage lubrication based on the elastoviscous transition to show that lubricin and hyaluronic acid lubricate by distinct mechanisms. Such analysis revealed nonspecific interactions between these molecules in which lubricin acts to concentrate hyaluronic acid near the tissue surface and promotes a transition to a low friction regime consistent with the theory of viscous boundary lubrication. Understanding the mechanics of synovial fluid not only provides insight into the progression of diseases such as arthritis, but also may be applicable to the development of new biomimetic lubricants.	[Bonnevie, Edward D.; Bonassar, Lawrence J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Galesso, Devis; Secchieri, Cynthia] Fidia Farmaceut SpA, Dept Res & Dev, Padua, Italy; [Cohen, Itai] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Bonassar, Lawrence J.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA	Cornell University; Cornell University; Cornell University	Bonassar, LJ (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	lb244@cornell.edu	Bonassar, Lawrence J/C-2103-2016	Bonassar, Lawrence J/0000-0003-1094-6433; Galesso, Devis/0000-0002-1193-8067; Cohen, Itai/0000-0001-9218-043X	National Science Foundation; Fidia Farmaceutici SpA; National Science Foundation [DMR-1056662]; NSF MRSEC program [DMR-1120296]; National Institutes of Health [1S10RR025502-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025502] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Fidia Farmaceutici SpA; National Science Foundation(National Science Foundation (NSF)); NSF MRSEC program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by the National Science Foundation Graduate Research Fellowship Program (EDB) and Fidia Farmaceutici SpA and partially supported by the National Science Foundation under award No. DMR-1056662 (IC). Facilities and instruments used in this study were also supported by the NSF MRSEC program (DMR-1120296), and the National Institutes of Health (1S10RR025502-01). Coauthors Galesso and Secchieri are employees of Fidia Farmaceutici SpA and were involved in experimental design, material preparation, and manuscript preparation.	Abubacker S, 2016, ANN BIOMED ENG, V44, P1128, DOI 10.1007/s10439-015-1390-8; Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040; BALAZS EA, 1993, J RHEUMATOL, V20, P3; BALAZS EA, 1967, ARTHRITIS RHEUM, V10, P357, DOI 10.1002/art.1780100407; Banquy X, 2014, ADV FUNCT MATER, V24, P3152, DOI 10.1002/adfm.201302959; Bonnevie ED, 2012, J BIOMECH, V45, P1036, DOI 10.1016/j.jbiomech.2011.12.019; Bonnevie ED, 2011, TRIBOL LETT, V41, P83, DOI 10.1007/s11249-010-9687-0; Bonnevie ED, 2014, J BIOMECH, V47, P2183, DOI 10.1016/j.jbiomech.2013.10.028; Burris DL, 2009, TRIBOL LETT, V35, P17, DOI 10.1007/s11249-009-9438-2; Caligaris M, 2008, OSTEOARTHR CARTILAGE, V16, P1220, DOI 10.1016/j.joca.2008.02.020; Cui Z, 2015, BONE, V74, P37, DOI 10.1016/j.bone.2014.12.065; Das S, 2013, BIOMACROMOLECULES, V14, P1669, DOI 10.1021/bm400327a; Dunn AC, 2014, TRIBOL LETT, V54, P59, DOI 10.1007/s11249-014-0308-1; Elsaid KA, 2005, ARTHRITIS RHEUM-US, V52, P1746, DOI 10.1002/art.21038; Finelli I, 2011, BIORHEOLOGY, V48, P263, DOI 10.3233/BIR-2011-0596; Finelli I, 2009, MACROMOL BIOSCI, V9, P646, DOI 10.1002/mabi.200900009; Flannery CR, 2009, ARTHRITIS RHEUM-US, V60, P840, DOI 10.1002/art.24304; GIBBS DA, 1968, BIOPOLYMERS, V6, P777, DOI 10.1002/bip.1968.360060603; Gleghorn JP, 2008, J BIOMECH, V41, P1910, DOI 10.1016/j.jbiomech.2008.03.043; Gleghorn JP, 2009, J ORTHOP RES, V27, P771, DOI 10.1002/jor.20798; Greene GW, 2011, P NATL ACAD SCI USA, V108, P5255, DOI 10.1073/pnas.1101002108; Hersey MD, 1914, J WASH ACAD SCI, V4, P542; Hyun K, 2002, J NON-NEWTON FLUID, V107, P51, DOI 10.1016/S0377-0257(02)00141-6; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; Jay GD, 1998, J BIOMED MATER RES, V40, P414, DOI 10.1002/(SICI)1097-4636(19980605)40:3<414::AID-JBM11>3.0.CO;2-J; Jay GD, 2009, CHARACTERIZATION BOV; Jay GD, 2009, CHEM SERFACE ACTIVIT; Jay GD, 2007, ARTHRITIS RHEUM-US, V56, P3662, DOI 10.1002/art.22974; Jay GD, 2010, ARTHRITIS RHEUM-US, V62, P2382, DOI 10.1002/art.27550; Jones ARC, 2007, J ORTHOP RES, V25, P283, DOI 10.1002/jor.20325; Krishnan R, 2004, J ORTHOP RES, V22, P565, DOI 10.1016/j.orthres.2003.07.002; Kwiecinski JJ, 2011, OSTEOARTHR CARTILAGE, V19, P1356, DOI 10.1016/j.joca.2011.07.019; LAI WM, 1978, J BIOMECH ENG-T ASME, V100, P169, DOI 10.1115/1.3426208; LINN F C, 1968, Journal of Biomechanics, V1, P193, DOI 10.1016/0021-9290(68)90004-3; Majd SE, 2014, LANGMUIR, V30, P14566, DOI 10.1021/la504345c; McCutchen C. W., 1962, WEAR, V5, P1, DOI [10.1016/0043-1648(62)90176-X, DOI 10.1016/0043-1648(62)90176-X]; Park JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112684; RAGAN C, 1949, J CLIN INVEST, V28, P56, DOI 10.1172/JCI102053; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; SWANN DA, 1974, ANN RHEUM DIS, V33, P318, DOI 10.1136/ard.33.4.318; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; Teeple E, 2011, AM J SPORT MED, V39, P164, DOI 10.1177/0363546510378088; Unsworth A, 1991, Proc Inst Mech Eng H, V205, P163, DOI 10.1243/PIME_PROC_1991_205_287_02; Waller KA, 2013, P NATL ACAD SCI USA, V110, P5852, DOI 10.1073/pnas.1219289110; Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005; Worden K, 2007, MECH SYST SIGNAL PR, V21, P514, DOI 10.1016/j.ymssp.2005.09.004; Yakubov GE, 2009, LANGMUIR, V25, P2313, DOI 10.1021/la8018666	47	80	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143415	10.1371/journal.pone.0143415	http://dx.doi.org/10.1371/journal.pone.0143415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599797	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600063
J	Johansson, A; Alfredsson, J; Eriksson, N; Wallentin, L; Siegbahn, A				Johansson, Asa; Alfredsson, Jenny; Eriksson, Niclas; Wallentin, Lars; Siegbahn, Agneta			Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							ARTERY-DISEASE; LINKAGE PHASE; INFLAMMATION; DETERMINANT; INFARCTION; OUTCOMES; TRAITS; TESTS; SERUM	Introduction Acute coronary syndrome (ACS) is a major cause of mortality worldwide. We have previously shown that increased interleukin-10 (IL-10) levels are associated with poor outcome in ACS patients. Method We performed a genome-wide association study in 2864 ACS patients and 408 healthy controls, to identify genetic variants associated with IL-10 levels. Then haplotype analyses of the identified loci were done and comparisons to levels of IL-10 and other known ACS related biomarkers. Results Genetic variants at the ABO blood group locus associated with IL-10 levels (top SNP: rs676457, P = 4.4 x 10(-10)) were identified in the ACS patients. Haplotype analysis, using SNPs tagging the four main ABO antigens (A1, A2, B and O), showed that O and A2 homozygous individuals, or O/A2 heterozygotes have much higher levels of IL-10 compared to individuals with other antigen combinations. In the ACS patients, associations between ABO antigens and von Willebrand factor (VWF, P = 9.2 x 10(-13)), and soluble tissue factor (sTF, P = 8.6 x 10(-4)) were also found. In the healthy control cohort, the associations with VWF and sTF were similar to those in ACS patients (P = 1.2 x 10(-15) and P = 1.0 x 10(-5) respectively), but the healthy cohort showed no association with IL-10 levels (P>0.05). In the ACS patients, the O antigen was also associated with an increased risk of cardiovascular death, all causes of death, and recurrent myocardial infarction (odds ratio [OR] = 1.24-1.29, P = 0.029-0.00067). Conclusion Our results suggest that the ABO antigens play important roles, not only for the immunological response in ACS patients, but also for the outcome of the disease.	[Johansson, Asa] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Eriksson, Niclas; Wallentin, Lars; Siegbahn, Agneta] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Alfredsson, Jenny; Siegbahn, Agneta] Uppsala Univ, Clin Chem, Dept Med Sci, Uppsala, Sweden; [Alfredsson, Jenny; Siegbahn, Agneta] Uppsala Univ, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	Johansson, A (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	asa.johansson@igp.uu.se	Johansson, Åsa/AAG-6799-2021; Johansson, Åsa/G-5270-2011	Johansson, Åsa/0000-0002-2915-4498; Johansson, Åsa/0000-0002-2915-4498	Swedish Research Council; Swedish Heart and Lung foundation; Goran Gustafssons Foundation; Swedish Society for Medical Research (SSMF); Kjell och Marta Beijers Foundation; Marcus Borgstrom Foundation; Ake Wiberg Foundation; Vleugels Foundation; Uppsala University; Swedish Research Council (VR-RFI) [80576801, 70374401]; Science for Life Laboratory-Sweden (SciLifeLab)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); Goran Gustafssons Foundation; Swedish Society for Medical Research (SSMF); Kjell och Marta Beijers Foundation; Marcus Borgstrom Foundation; Ake Wiberg Foundation; Vleugels Foundation; Uppsala University; Swedish Research Council (VR-RFI)(Swedish Research Council); Science for Life Laboratory-Sweden (SciLifeLab)	This study was supported by grants from the Swedish Research Council and the Swedish Heart and Lung foundation (AS). AJ is funded by the Swedish research council, the Goran Gustafssons Foundation, the Swedish Society for Medical Research (SSMF), the Kjell och Marta Beijers Foundation, the Marcus Borgstrom Foundation, the Ake Wiberg Foundation and the Vleugels Foundation.; Genotyping was performed by the SNP & SEQ Technology Platform in Uppsala, which is supported by Uppsala University, Science for Life Laboratory-Sweden (SciLifeLab) and the Swedish Research Council (VR-RFI, Contracts 80576801 and 70374401).	Alkout AM, 2000, J INFECT DIS, V181, P1364, DOI 10.1086/315375; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Dean L., 2005, BLOOD CELLS IT CONTA; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; GILL JC, 1987, BLOOD, V69, P1691; Goh L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-415; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161/01.CIR.0000065232.57371.25; Hosoi E, 2008, J MED INVESTIG, V55, P174, DOI 10.2152/jmi.55.174; James SK, 2005, AM HEART J, V149, P619, DOI 10.1016/j.ahj.2004.08.026; Januszkiewicz L, 2013, POL ARCH MED WEWN, V123, P460; Johnston N, 2006, AM J CARDIOL, V97, P640, DOI 10.1016/j.amjcard.2005.09.123; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; Malarstig A, 2008, HEART, V94, P724, DOI 10.1136/hrt.2007.119271; Malarstig A, 2007, THROMB RES, V119, P467, DOI 10.1016/j.thromres.2006.05.001; Malarstig A, 2006, ARTERIOSCL THROM VAS, V26, P1667, DOI 10.1161/01.ATV.0000222908.78873.36; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; O'Donnell J, 2002, ARTERIOSCL THROM VAS, V22, P335, DOI 10.1161/hq0202.103997; O'Donnell J, 2001, TRANSFUSION MED, V11, P343, DOI 10.1046/j.1365-3148.2001.00315.x; Oldgren J, 2005, J INTERN MED, V258, P420, DOI 10.1111/j.1365-2796.2005.01562.x; Pare G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000118; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sarode R, 2000, BRIT J HAEMATOL, V109, P857, DOI 10.1046/j.1365-2141.2000.02113.x; SCHACHTER H, 1971, BIOCHEM BIOPH RES CO, V45, P1011, DOI 10.1016/0006-291X(71)90438-4; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Storry J R, 2009, Immunohematology, V25, P48; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 1999, LANCET, V354, P701; Wolpin BM, 2010, THROMB HAEMOSTASIS, V104, P962, DOI 10.1160/TH10-05-0312	35	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142518	10.1371/journal.pone.0142518	http://dx.doi.org/10.1371/journal.pone.0142518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600159	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600012
J	Jung, M; Mody, M; Saito, DN; Tomoda, A; Okazawa, H; Wada, Y; Kosaka, H				Jung, Minyoung; Mody, Maria; Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka			Sex Differences in the Default Mode Network with Regard to Autism Spectrum Traits: A Resting State fMRI Study	PLOS ONE			English	Article							LOW-FREQUENCY OSCILLATIONS; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; QUOTIENT AQ; GENDER-DIFFERENCES; AMPLITUDE; SCHIZOPHRENIA; ACTIVATION; MOTION; CORTEX	Autism spectrum traits exist on a continuum and are more common in males than in females, but the basis for this sex difference is unclear. To this end, the present study draws on the extreme male brain theory, investigating the relationship between sex difference and the default mode network (DMN), both known to be associated with autism spectrum traits. Resting-state functional magnetic resonance imaging (MRI) was carried out in 42 females (mean age +/- standard deviation, 22.4 +/- 4.2 years) and 43 males (mean age +/- standard deviation, 23.8 +/- 3.9 years) with typical development. Using a combination of different analyses (viz., independent component analysis (ICA), fractional amplitude of low-frequency fluctuation (fALFF), regional homogeneity (ReHo), and seed-based analyses), we examined sex differences in the DMN and the relationship to autism spectrum traits as measured by autism-spectrum quotient (AQ) scores. We found significant differences between female and male subjects in DMN brain regions, with seed-based analysis revealing a significant negative correlation between default-mode resting state functional connectivity of the anterior medial prefrontal cortex seed (aMPFC) and AQ scores in males. However, there were no relationships between DMN sex differences and autism spectrum traits in females. Our findings may provide important insight into the skewed balance of functional connectivity in males compared to females that could serve as a potential biomarker of the degree of autism spectrum traits in line with the extreme male brain theory.	[Jung, Minyoung; Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Univ Fukui, Res Ctr Child Mental Dev, Eiheiji, Fukui, Japan; [Jung, Minyoung; Mody, Maria] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Osaka Univ, United Grad Sch Child Dev, Dept Child Dev, Dev Emot Intelligence,Div Dev Higher Brain Funct, Eiheiji, Fukui, Japan; [Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Kanazawa Univ, Eiheiji, Fukui, Japan; [Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Hamamatsu Univ Sch Med, Eiheiji, Fukui, Japan; [Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Chiba Univ, Eiheiji, Fukui, Japan; [Saito, Daisuke N.; Tomoda, Akemi; Okazawa, Hidehiko; Wada, Yuji; Kosaka, Hirotaka] Univ Fukui, Eiheiji, Fukui, Japan; [Saito, Daisuke N.; Okazawa, Hidehiko] Univ Fukui, Biomed Imaging Res Ctr, Eiheiji, Fukui, Japan; [Wada, Yuji; Kosaka, Hirotaka] Univ Fukui, Fac Med Sci, Dept Neuropsychiat, Eiheiji, Fukui, Japan	University of Fukui; Harvard University; Massachusetts General Hospital; Osaka University; University of Fukui; University of Fukui; University of Fukui	Kosaka, H (corresponding author), Univ Fukui, Res Ctr Child Mental Dev, Eiheiji, Fukui, Japan.	hirotaka@u-fukui.ac.jp	Okazawa, Hidehiko/B-2795-2016; Okazawa, Hidehiko/I-2488-2019; Kosaka, Hirotaka/AFG-5500-2022; Mody, Maria/Q-6662-2017	Okazawa, Hidehiko/0000-0001-7046-3383; Okazawa, Hidehiko/0000-0001-7046-3383; Kosaka, Hirotaka/0000-0003-2210-5025; Jung, Minyoung/0000-0001-9188-0549	Japan Society for the Promotion of Science [26118505]; Grants-in-Aid for Scientific Research [26118505, 15K12720] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded in part by Research Fellowships for Young Scientists and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (26118505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003622; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0102251; Baron-cohen S, 2004, THE EMPATHY QUOTIENT; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Constantino JN, 2003, J AM ACAD CHILD PSY, V42, P458, DOI 10.1097/01.CHI.0000046811.95464.21; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Di Martino A, 2013, BIOL PSYCHIAT, V74, P623, DOI 10.1016/j.biopsych.2013.02.011; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Falquez R, 2014, FRONT BEHAV NEUROSCI, V8, P1, DOI 10.3389/fnbeh.2014.00165; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frith U., 1991, AUTISM ASPERGER SYND; Fujisawa TX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136427; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hadjikhani N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.113; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Hong JY, 2013, J NEUROSCI, V33, P11994, DOI 10.1523/JNEUROSCI.5733-12.2013; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Inuggi A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00156; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Jung M, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-35; Kirkovski M, 2013, J AUTISM DEV DISORD, V43, P2584, DOI 10.1007/s10803-013-1811-1; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; Lai CH, 2012, J AFFECT DISORDERS, V142, P180, DOI 10.1016/j.jad.2012.04.021; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; Lai MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001544; Lee MR, 2014, NEUROPSYCHOLOGIA, V53, P257, DOI 10.1016/j.neuropsychologia.2013.11.022; Libero LE, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-50; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rudie JD, 2012, NEURON, V75, P904, DOI 10.1016/j.neuron.2012.07.010; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shukla DK, 2010, NEUROSCI LETT, V476, P46, DOI 10.1016/j.neulet.2010.03.080; Skuse DH, 2000, PEDIATR RES, V47, P9, DOI 10.1203/00006450-200001000-00006; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Wijngaarden-Cremers PJM, 2014, J AUTISM DEV DISORD, V44, P627, DOI 10.1007/s10803-013-1913-9; von dem Hagen EAH, 2013, SOC COGN AFFECT NEUR, V8, P694, DOI 10.1093/scan/nss053; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Wang LQ, 2011, NEUROSCI LETT, V488, P275, DOI 10.1016/j.neulet.2010.11.046; Weissman-Fogel I, 2010, HUM BRAIN MAPP, V31, P1713, DOI 10.1002/hbm.20968; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	71	22	24	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143126	10.1371/journal.pone.0143126	http://dx.doi.org/10.1371/journal.pone.0143126			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600385	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600030
J	Tang, YF; Zhang, C; Cao, SX; Wang, X; Qi, HY				Tang, Yufan; Zhang, Chong; Cao, Songxiao; Wang, Xiao; Qi, Hongyan			The Effect of CmLOXs on the Production of Volatile Organic Compounds in Four Aroma Types of Melon (Cucumis melo)	PLOS ONE			English	Article							LIPOXYGENASE GENE-EXPRESSION; SOLID-PHASE MICROEXTRACTION; VAR. MAKUWA MAKINO; MALUS X DOMESTICA; ETHYLENE BIOSYNTHESIS; RIPENING KIWIFRUIT; FLAVOR COMPOUNDS; BRANCHED-CHAIN; FUJI APPLES; FRUIT	Lipoxygenases (LOXs) play important role in the synthesis of volatile organic compounds (VOCs), which influence the aroma of fruit. In this study, we elucidate that there is a positive relationship between LOXs activity and VOC production in melon (Cucumis melo), and CmLOX genes are involved in fruit aroma generation in melon. To this end, we tested four aroma types of melon that feature a thin pericarp: two aromatic cultivars of the oriental melons (C. melo var. makuwa Makino), 'Yu Meiren' (YMR) and 'Cui Bao' (CB); a non-aromatic oriental pickling melon (C. melo var. conomon), 'Shao Gua' (SHAO); and a non-aromatic snake melon (C. melo L. var. flexuosus Naud), 'Cai Gua' (CAI). A principal component analysis (PCA) revealed that the aromas of SHAO and CAI are similar in nature because their ester contents are lower than those of YMR and CB. Ethyl acetate, benzyl acetate, (E, Z)-2, 6-nonadienal and menthol are four principal volatile compounds that affect the aromatic characteristics of these four types of melons. The LOX activity and total ester content in YMR were the highest among the examined melon varieties. The expression patterns of 18 CmLOX genes were found to vary based on the aromatic nature of the melon. Four of them were highly expressed in YMR. Moreover, we treated the fruit disks of YMR with LOX substrates (linoleic acid and linolenic acid) and LOX inhibitors (n-propyl gallate and nordihydroguariaretic acid). Substrate application promoted LOX activity and induced accumulation of hexanal, (2E)-nonenal and straight-chain esters, such as ethyl acetate. In contrast, LOX inhibitors decreased the levels of these compounds. The effect of CmLOXs in the biosynthesis of esters in melons are discussed.	[Tang, Yufan; Zhang, Chong; Cao, Songxiao; Wang, Xiao; Qi, Hongyan] Shenyang Agr Univ, Coll Hort, Key Lab Protected Hort, Minist Educ & Liaoning Prov, Shenyang 110161, Liaoning Provin, Peoples R China	Shenyang Agricultural University	Qi, HY (corresponding author), Shenyang Agr Univ, Coll Hort, Shenyang 110161, Liaoning Provin, Peoples R China.	hyqiaaa@126.com			National Natural Science Foundation of China [31272154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (31272154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmann S, 2010, PLANT CELL ENVIRON, V33, P2028, DOI 10.1111/j.1365-3040.2010.02203.x; Altisent R, 2009, J AGR FOOD CHEM, V57, P4305, DOI 10.1021/jf803930j; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Araguez I, 2013, BIOTECHNOL J, V8, P1144, DOI 10.1002/biot.201300113; Aubert C, 2004, J AGR FOOD CHEM, V52, P4522, DOI 10.1021/jf049777s; Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; Baysal T, 2007, ENZYME MICROB TECH, V40, P491, DOI 10.1016/j.enzmictec.2006.11.025; Beaulieu JC, 2001, J AGR FOOD CHEM, V49, P1345, DOI 10.1021/jf0005768; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burger Y, 2006, ISR J PLANT SCI, V54, P233, DOI 10.1560/IJPS_54_3_233; Gonzalez-Mas MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022016; Chen GP, 2004, PLANT PHYSIOL, V136, P2641, DOI 10.1104/pp.104.041608; Cheong KW, 2010, FOOD RES INT, V43, P1267, DOI 10.1016/j.foodres.2010.03.001; Defilippi BG, 2005, J AGR FOOD CHEM, V53, P3133, DOI 10.1021/jf047892x; Dixon J, 2000, NEW ZEAL J CROP HORT, V28, P155, DOI 10.1080/01140671.2000.9514136; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; Dunemann F, 2012, MOL BREEDING, V29, P609, DOI 10.1007/s11032-011-9577-7; Echeverria G, 2004, POSTHARVEST BIOL TEC, V31, P217, DOI 10.1016/j.postharvbio.2003.09.003; El Hadi MAM, 2013, MOLECULES, V18, P8200, DOI 10.3390/molecules18078200; El-Sharkawy I, 2005, PLANT MOL BIOL, V59, P345, DOI 10.1007/s11103-005-8884-y; Ezura H, 2008, PLANT SCI, V175, P121, DOI 10.1016/j.plantsci.2008.02.004; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Golding JB, 1999, J AGR FOOD CHEM, V47, P1646, DOI 10.1021/jf980906c; Gonda I, 2010, J EXP BOT, V61, P1111, DOI 10.1093/jxb/erp390; Jin YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101730; Jordan MJ, 2001, J AGR FOOD CHEM, V49, P5929, DOI 10.1021/jf010954o; Khanom MM, 2008, POSTHARVEST BIOL TEC, V50, P18, DOI 10.1016/j.postharvbio.2008.02.015; Kourkoutas D, 2006, FOOD CHEM, V97, P95, DOI 10.1016/j.foodchem.2005.03.026; Kunsong C, 2003, J FRUIT SCI, V6, P002; Lalel HJD, 2003, POSTHARVEST BIOL TEC, V27, P323, DOI 10.1016/S0925-5214(02)00117-5; Lara I, 2006, POSTHARVEST BIOL TEC, V39, P19, DOI 10.1016/j.postharvbio.2005.09.001; Lara I, 2003, POSTHARVEST BIOL TEC, V29, P29, DOI 10.1016/S0925-5214(02)00230-2; Li M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-444; Li Y, 2011, J HORTIC SCI BIOTECH, V86, P517, DOI 10.1080/14620316.2011.11512798; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Liu WW, 2012, POSTHARVEST BIOL TEC, V67, P75, DOI 10.1016/j.postharvbio.2011.12.015; Ma YK, 2007, FOOD SCI TECHNOL INT, V13, P259, DOI 10.1177/1082013207081776; Mandal S, 2014, FOOD CHEM, V146, P394, DOI 10.1016/j.foodchem.2013.08.100; Manriquez D, 2006, PLANT MOL BIOL, V61, P675, DOI 10.1007/s11103-006-0040-9; Maul F, 2000, J FOOD SCI, V65, P1228, DOI 10.1111/j.1365-2621.2000.tb10270.x; Obando-Ulloa JM, 2008, POSTHARVEST BIOL TEC, V49, P27, DOI 10.1016/j.postharvbio.2007.11.004; Obando-Ulloa JM, 2010, FOOD CHEM, V118, P815, DOI 10.1016/j.foodchem.2009.05.068; Oliveira I, 2011, FOOD CHEM, V128, P667, DOI 10.1016/j.foodchem.2011.03.084; Ortiz A, 2010, FOOD CHEM, V123, P698, DOI 10.1016/j.foodchem.2010.05.037; Perry PL, 2009, FLAVOUR FRAG J, V24, P341, DOI 10.1002/ffj.1947; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Portnoy V, 2008, PLANT MOL BIOL, V66, P647, DOI 10.1007/s11103-008-9296-6; Rowan DD, 2009, J AGR FOOD CHEM, V57, P7953, DOI 10.1021/jf901678v; Sanchez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038992; Sanz C, 1996, AROMA BIOCH FRUITS V, P125; Senesi E, 2002, J SCI FOOD AGR, V82, P655, DOI 10.1002/jsfa.1087; Shalit M, 2001, J AGR FOOD CHEM, V49, P794, DOI 10.1021/jf001075p; Shalit M, 2000, ACTA HORTIC, P455, DOI 10.17660/ActaHortic.2000.510.72; Song J, 2003, POSTHARVEST BIOL TEC, V30, P113, DOI 10.1016/S0925-5214(03)00098-X; Ties P, 2012, J FOOD SCI, V77, pC830, DOI 10.1111/j.1750-3841.2012.02775.x; Tijet N, 2001, ARCH BIOCHEM BIOPHYS, V386, P281, DOI 10.1006/abbi.2000.2218; Tijskens LMM, 2009, POSTHARVEST BIOL TEC, V51, P320, DOI 10.1016/j.postharvbio.2008.06.001; Umate P, 2011, PLANT SIGNAL BEHAV, V6, P335, DOI 10.4161/psb.6.3.13546; Urruty L, 2002, J AGR FOOD CHEM, V50, P3129, DOI 10.1021/jf0116799; Visai C, 1997, SCI HORTIC-AMSTERDAM, V70, P15, DOI 10.1016/S0304-4238(97)00032-0; Vogt J, 2013, TREE GENET GENOMES, V9, P1493, DOI 10.1007/s11295-013-0653-5; Wyllie SG, 2000, J AGR FOOD CHEM, V48, P3493, DOI 10.1021/jf0001841; Zhang B, 2006, J EXP BOT, V57, P3825, DOI 10.1093/jxb/erl151; Zhang B, 2010, J AGR FOOD CHEM, V58, P6157, DOI 10.1021/jf100172e; Zhang B, 2009, J AM SOC HORTIC SCI, V134, P472, DOI 10.21273/JASHS.134.4.472; Zhang B, 2009, J AGR FOOD CHEM, V57, P2875, DOI 10.1021/jf9000378; Zhang C, 2014, SCI HORTIC-AMSTERDAM, V170, P94, DOI 10.1016/j.scienta.2014.03.005; Zhu SH, 2006, POSTHARVEST BIOL TEC, V42, P41, DOI 10.1016/j.postharvbio.2006.05.004	69	23	26	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143567	10.1371/journal.pone.0143567	http://dx.doi.org/10.1371/journal.pone.0143567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599669	Green Submitted, gold, Green Published			2022-12-26	WOS:000365862600086
J	Tedeschi, LO				Tedeschi, Luis O.			Integrating Genomics with Nutrition Models to Improve the Prediction of Cattle Performance and Carcass Composition under Feedlot Conditions	PLOS ONE			English	Article							4 SIMULATION-MODELS; BEEF-CATTLE; BODY-COMPOSITION; DYNAMIC-MODEL; COMPUTER-MODEL; LEPTIN GENE; GROWTH; ASSOCIATION; QUALITY; EFFICIENCY	Cattle body composition is difficult to model because several factors affect the composition of the average daily gain (ADG) of growing animals. The objective of this study was to identify commercial single nucleotide polymorphism (SNP) panels that could improve the predictability of days on feed (DOF) to reach a target United States Department of Agriculture (USDA) grade given animal, diet, and environmental information under feedyard conditions. The data for this study was comprised of crossbred heifers (n = 681) and steers (n = 836) from commercial feedyards. Eleven molecular breeding value (MBV) scores derived from SNP panels of candidate gene polymorphisms and two-leptin gene SNP (UASMS2 and E2FB) were evaluated. The empty body fat (EBF) and the shrunk body weight (SBW) at 28% EBF (AFSBW) were computed by the Cattle Value Discovery System (CVDS) model using hip height (EBFHH and AFSBW(HH)) or carcass traits (EBFCT and AFSBW(CT)) of the animals. The DOFHH was calculated when AFSBW(HH) and ADG(HH) were used and DOFCT was calculated when AFSBW(CT) and ADG(CT) were used. The CVDS estimates dry matter required (DMR) by individuals fed in groups when observed ADG and AFSBW are provided. The AFSBW(CT) was assumed more accurate than the AFSBW(HH) because it was computed using carcass traits. The difference between AFSBW(CT) and AFSBW(HH), DOFCT and DOFHH, and DMR and dry matter intake (DMI) were regressed on the MBV scores and leptin gene SNP to explain the variation. Our results indicate quite a large range of correlations among MBV scores and model input and output variables, but MBV ribeye area was the most strongly correlated with the differences in DOF, AFSBW, and DMI by explaining 8, 13.2 and 6.5%, respectively, of the variation. This suggests that specific MBV scores might explain additional variation of input and output variables used by nutritional models in predicting individual animal performance.	[Tedeschi, Luis O.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Tedeschi, LO (corresponding author), Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.	luis.tedeschi@tamu.edu			Texas A&M AgriLife Research [Hatch 09123]	Texas A&M AgriLife Research	This work was supported by Texas A&M AgriLife Research Hatch 09123.	Anele UY, 2014, J ANIM SCI, V92, P2660, DOI 10.2527/jas.2014-7557; [Anonymous], 2014, R LANG ENV STAT COMP; ARNOLD RN, 1991, AGR SYST, V35, P401, DOI 10.1016/0308-521X(91)90117-S; ARNOLD RN, 1991, AGR SYST, V36, P17, DOI 10.1016/0308-521X(91)90106-K; Baker MJ, 2006, J ANIM SCI, V84, P2666, DOI 10.2527/jas.2006-006; Beef Improvement Federation, 2010, GUIDELINES UNIFORM B, V9, P1; Bibby J., 1977, PREDICTION IMPROVED; Bourg B, 2007, P 2 INT S EN PROT ME; Bourg BM., 2007, THESIS; Buchanan FC, 2002, GENET SEL EVOL, V34, P105, DOI [10.1051/gse:2001006, 10.1186/1297-9686-34-1-105]; Cruz GD, 2011, J ANIM SCI, V89, P1640, DOI 10.2527/jas.2010-3416; Davidson A.C., 1997, BOOTSTRAP METHODS TH; DeVuyst EA, 2011, J ANIM SCI, V89, P1260, DOI 10.2527/jas.2009-2372; DIMARCO ON, 1989, AGR SYST, V29, P247, DOI 10.1016/0308-521X(89)90055-3; Efron B, 1998, INTRO BOOTSTRAP; Federation of Animal Science Societies, 2010, GUID CAR US AGR AN R; FOX DG, 1984, J ANIM SCI, V58, P725, DOI 10.2527/jas1984.583725x; FOX DG, 1988, J ANIM SCI, V66, P1475; Fox DG, 2004, ANIM FEED SCI TECH, V112, P29, DOI 10.1016/j.anifeedsci.2003.10.006; Garrett WN, 1978, J ANIM SCI S1, V47, P417; Greenwood PL, 2013, J ANIM SCI, V91, P5912, DOI 10.2527/jas.2013-6960; Guiroy PJ, 2001, J ANIM SCI, V79, P1983; Hoch T, 2004, AGR SYST, V81, P1, DOI 10.1016/j.agsy.2003.08.005; Kachman SD, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-30; KEELE JW, 1992, J ANIM SCI, V70, P841, DOI 10.2527/1992.703841x; Khatib H, 2009, J DAIRY SCI, V92, P6186, DOI 10.3168/jds.2009-2439; Kilpatrick DJ, 1999, AGR SYST, V61, P95, DOI 10.1016/S0308-521X(99)00040-2; Kirschten DP, 2006, P JOINT ANN M AM SOC; Kirschten DP, 2007, P JOINT ANN M AM SOC; Kononoff PJ, 2005, J ANIM SCI, V83, P927; Lancaster PA, 2009, J ANIM SCI, V87, P3887, DOI 10.2527/jas.2009-2041; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lusk JL, 2007, J ANIM SCI, V85, pCP6, DOI 10.2527/jas.2006-665; MacNeil MD, 2010, J ANIM SCI, V88, P517, DOI 10.2527/jas.2009-2022; Moore MC, 2012, J ANIM SCI, V90, P5143, DOI 10.2527/jas.2012-5550; National Research Council, 2000, NUTR REQ BEEF CATTL; Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234; Nkrumah JD, 2009, P JOINT ANN M AM SOC; OLTJEN JW, 1986, J ANIM SCI, V62, P86, DOI 10.2527/jas1986.62186x; Rincon G, 2009, ANIM GENET, V40, P878, DOI 10.1111/j.1365-2052.2009.01934.x; Schenkel FS, 2005, J ANIM SCI, V83, P2009; Sharma A, 2015, ASIAN AUSTRAL J ANIM, V28, P1371, DOI 10.5713/ajas.14.0715; Tedeschi LO, 2010, MODELLING NUTRIENT DIGESTION AND UTILISATION IN FARM ANIMALS, P91; Tedeschi LO, 2006, AGR SYST, V89, P225, DOI 10.1016/j.agsy.2005.11.004; Tedeschi LO, 2006, J ANIM SCI, V84, P767, DOI 10.2527/2006.843767x; Tedeschi LO, 2004, AGR SYST, V79, P171, DOI 10.1016/S0308-521X(03)00070-2; Tedeschi LO, 2010, P 3 INT S EN PROT ME; Tedford JL, 2014, J ANIM SCI, V92, P3685, DOI 10.2527/jas.2014-7739; Vasconcelos JT, 2007, J ANIM SCI, V85, P2772, DOI 10.2527/jas.2007-0261; Vasconcelos J. T., 2007, Professional Animal Scientist, V23, P340; Wang YP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002459; Williams CB, 2010, J ANIM SCI, V88, P2523, DOI 10.2527/jas.2009-2655; Williams CB, 2006, J ANIM SCI, V84, P1310, DOI 10.2527/2006.8461310x; WILLIAMS CB, 1995, J ANIM SCI, V73, P2903; Woronuk GN, 2012, ANIM GENET, V43, P608, DOI 10.1111/j.1365-2052.2012.02320.x	55	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143483	10.1371/journal.pone.0143483	http://dx.doi.org/10.1371/journal.pone.0143483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599759	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600070
J	Yue, YP; Huang, W; Liang, JJ; Guo, J; Ji, J; Yao, YL; Zheng, MZ; Cai, ZJ; Lu, LR; Wang, JL				Yue, Yinpu; Huang, Wei; Liang, Jingjing; Guo, Jing; Ji, Jian; Yao, Yunliang; Zheng, Mingzhu; Cai, Zhijian; Lu, Linrong; Wang, Jianli			IL4I1 Is a Novel Regulator of M2 Macrophage Polarization That Can Inhibit T Cell Activation via L-Tryptophan and Arginine Depletion and IL-10 Production	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; MONONUCLEAR PHAGOCYTES; ALTERNATIVE ACTIVATION; IL-4-INDUCED GENE-1; DENDRITIC CELLS; IN-VIVO; PROLIFERATION; STAT6; INFECTIONS; CATABOLISM	Interleukin 4-induced gene-1 (IL4I1) was initially described as an early IL-4-inducible gene in B cells. IL4I1 protein can inhibit T cell proliferation by releasing its enzymatic catabolite, H2O2, and this effect is associated with transient down-regulation of T cell CD3 receptor-zeta (TCR zeta) expression. Herein, we show that IL4I1 contributes to the regulation of macrophage programming. We found that expression of IL4I1 increased during bone marrow-derived macrophage (BMDM) differentiation, expression of IL4I1 is much higher in primary macrophages than monocytes, and IL4I1 expression in BMDMs could be induced by Th1 and Th2 cytokines in two different patterns. Gene expression analysis revealed that overexpression of IL4I1 drove the expression of M2 markers (Fizz1, Arg1, YM-1, MR) and inhibited the expression of M1-associated cytokines. Conversely, knockdown of IL4I1 by siRNA resulted in opposite effects, and also attenuated STAT-3 and STAT-6 phosphorylation. Furthermore, IL4I1 produced by macrophages catalyzed L-tryptophan degradation, while levo-1-methyl-tryptophan (L-1-MT), but not dextro-1-methyl-tryptophan, partially rescued IL4I1-dependent inhibition of T cell activation. Other inhibitors, such as diphenylene iodonium (DPI), an anti-IL-10Ra blocking antibody, and a nitric oxide synthase inhibitor, NG-monomethyl-L-arginine, also had this effect. Overall, our findings indicate that IL4I1 promotes an enhanced M2 functional phenotype, which is most likely associated with the phosphorylation of STAT-6 and STAT-3. Moreover, DPI, L-1-MT, NG-monomethyl-L-arginine, and anti-IL-10Ra blocking antibody were all found to be effective IL4I1 inhibitors in vitro.	[Yue, Yinpu; Huang, Wei; Liang, Jingjing; Guo, Jing; Yao, Yunliang; Zheng, Mingzhu; Cai, Zhijian; Lu, Linrong; Wang, Jianli] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Linrong] Zhejiang Univ, Sch Med, Program Mol & Cellular Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Ji, Jian] Zhejiang Univ, Minist Educ, Key Lab Anim Mol Nutr, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Yao, Yunliang] Huzhou Teachers Coll, Sch Med, Dept Microbiol & Immunol, Huzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Huzhou University	Lu, LR (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China.	lu_linrong@zju.edu.cn; jlwang@zju.edu.cn	Zheng, Mingzhu/AAF-6010-2019; Liang, Jingjing/AAO-6865-2020; Zheng, Mingzhu/AAC-7818-2022	Liang, Jingjing/0000-0002-6766-4747; Zheng, Mingzhu/0000-0002-9399-9225; Lu, Linrong/0000-0002-0171-4115	Public Welfare Technology Application Research Project of Zhejiang Province [2013C33155]	Public Welfare Technology Application Research Project of Zhejiang Province	This work was supported by grants from the Public Welfare Technology Application Research Project of Zhejiang Province (2013C33155).	Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Carbonnelle-Puscian A, 2009, LEUKEMIA, V23, P952, DOI 10.1038/leu.2008.380; Chu CC, 1997, P NATL ACAD SCI USA, V94, P2507, DOI 10.1073/pnas.94.6.2507; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lasoudris F, 2011, EUR J IMMUNOL, V41, P1629, DOI 10.1002/eji.201041119; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marquet J, 2010, EUR J IMMUNOL, V40, P2557, DOI 10.1002/eji.201040428; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mason JM, 2004, J IMMUNOL, V173, P4561, DOI 10.4049/jimmunol.173.7.4561; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNN DH, 1993, CANCER RES, V53, P2603; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Munn DH, 1996, J IMMUNOL, V156, P523; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; Puiffe ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054589; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stutz AM, 2003, J IMMUNOL, V170, P1789, DOI 10.4049/jimmunol.170.4.1789; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9	35	50	57	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142979	10.1371/journal.pone.0142979	http://dx.doi.org/10.1371/journal.pone.0142979			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599209	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600023
J	Dammers, C; Gremer, L; Reiss, K; Klein, AN; Neudecker, P; Hartmann, R; Sun, N; Demuth, HU; Schwarten, M; Willbold, D				Dammers, Christina; Gremer, Lothar; Reiss, Kerstin; Klein, Antonia N.; Neudecker, Philipp; Hartmann, Rudolf; Sun, Na; Demuth, Hans-Ulrich; Schwarten, Melanie; Willbold, Dieter			Structural Analysis and Aggregation Propensity of Pyroglutamate A beta(3-40) in Aqueous Trifluoroethanol	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDES; ALZHEIMERS-DISEASE BRAIN; A-BETA; NMR-SPECTROSCOPY; CHEMICAL-SHIFTS; MOUSE MODEL; IN-VITRO; PROTEIN; IDENTIFICATION; A-BETA-40	A hallmark of Alzheimer's disease (AD) is the accumulation of extracellular amyloid-beta (A beta) plaques in the brains of patients. N-terminally truncated pyroglutamate-modified A beta (pEA beta) has been described as a major compound of A beta species in senile plaques. pEA beta is more resistant to degradation, shows higher toxicity and has increased aggregation propensity and beta-sheet stabilization compared to non-modified A beta. Here we characterized recombinant pEA beta(3-40) in aqueous trifluoroethanol (TFE) solution regarding its aggregation propensity and structural changes in comparison to its non-pyroglutamate-modified variant A beta (1-40). Secondary structure analysis by circular dichroism spectroscopy suggests that pEA beta(3-40) shows an increased tendency to form beta-sheet-rich structures in 20% TFE containing solutions where A beta(1-40) forms alpha-helices. Aggregation kinetics of pEA beta(3-40) in the presence of 20% TFE monitored by thioflavin-T (ThT) assay showed a typical sigmoidal aggregation in contrast to A beta(1-40), which lacks ThT positive structures under the same conditions. Transmission electron microscopy confirms that pEA beta(3-40) aggregated to large fibrils and high molecular weight aggregates in spite of the presence of the helix stabilizing co-solvent TFE. High resolution NMR spectroscopy of recombinantly produced and uniformly isotope labeled [U-N-15 ]-pEA beta(3-40) in TFE containing solutions indicates that the pyroglutamate formation affects significantly the N-terminal region, which in turn leads to decreased monomer stability and increased aggregation propensity.	[Dammers, Christina; Gremer, Lothar; Reiss, Kerstin; Klein, Antonia N.; Neudecker, Philipp; Hartmann, Rudolf; Sun, Na; Schwarten, Melanie; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany; [Gremer, Lothar; Neudecker, Philipp; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Demuth, Hans-Ulrich] Fraunhofer Inst Cell Therapy & Immunol, Dept Drug Design & Target Validat, D-06120 Halle, Saale, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Fraunhofer Gesellschaft	Willbold, D (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany.	d.willbold@fz-juelich.de	Schwarten, Melanie/G-6407-2013; Sun, Na/ABC-7810-2020; Neudecker, Philipp/G-5265-2013; Neudecker, Philipp/AAP-9005-2020; Hartmann, Rudolf/H-9345-2017; Gremer, Lothar/H-9128-2013; Willbold, Dieter/A-6280-2013	Schwarten, Melanie/0000-0001-8920-9668; Sun, Na/0000-0003-0155-1763; Neudecker, Philipp/0000-0002-0557-966X; Neudecker, Philipp/0000-0002-0557-966X; Hartmann, Rudolf/0000-0001-7807-6273; Gremer, Lothar/0000-0001-7065-5027; Willbold, Dieter/0000-0002-0065-7366; Dammers, Christina/0000-0001-5650-090X	International NRW Research School BioStruct - Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich Heine University of Dusseldorf; Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf; Portfolio Technology and Medicine; Portfolio Drug Research; Helmholtz-Validierungsfonds of the "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft"	International NRW Research School BioStruct - Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich Heine University of Dusseldorf; Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf; Portfolio Technology and Medicine; Portfolio Drug Research; Helmholtz-Validierungsfonds of the "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft"	We gratefully acknowledge support of CD from the International NRW Research School BioStruct, granted by the Ministry of Innovation, Science and Research of the State North Rhine-Westphalia, the Heinrich Heine University of Dusseldorf, and the Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf. DW was supported by grants from the "Portfolio Technology and Medicine", the "Portfolio Drug Research" and the Helmholtz-Validierungsfonds of the "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Matthias Stoldt, Justin Lecher and Maren Thomaier are highly acknowledged for fruitful discussions. We gratefully acknowledge support of CD from the International NRW Research School BioStruct, granted by the Ministry of Innovation, Science and Research of the State North Rhine-Westphalia, the Heinrich Heine University of Dusseldorf, and the Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf. The authors acknowledge access to the Julich-Dusseldorf Biomolecular NMR Cent. DW was supported by grants from the "Portfolio Technology and Medicine", the "Portfolio Drug Research" and the Helmholtz-Validierungsfonds of the "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft".	Amani S, 2014, BIOCHEM ENG J, V91, P120, DOI 10.1016/j.bej.2014.08.004; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Ballard C, 2011, CAN J PSYCHIAT, V56, P589, DOI 10.1177/070674371105601004; Bayer TA, 2014, ACTA NEUROPATHOL, V127, P787, DOI 10.1007/s00401-014-1287-x; Chen YR, 2006, J BIOCHEM, V139, P733, DOI 10.1093/jb/mvj083; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Cummins PM, 1998, BBA-PROTEIN STRUCT M, V1429, P1, DOI 10.1016/S0167-4838(98)00248-9; Cynis H, 2008, J MOL BIOL, V379, P966, DOI 10.1016/j.jmb.2008.03.078; Dammers C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139710; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Gil-Caballero S, 2014, J BIOMOL NMR, V60, P1, DOI 10.1007/s10858-014-9847-x; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Gunn AP, 2010, INT J BIOCHEM CELL B, V42, P1915, DOI 10.1016/j.biocel.2010.08.015; Gupta P, 2014, BIOCHEM BIOPH RES CO, V449, P126, DOI 10.1016/j.bbrc.2014.04.160; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Jawhar S, 2011, J BIOL CHEM, V286, P38825, DOI 10.1074/jbc.R111.288308; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Khan MV, 2014, INT J BIOL MACROMOL, V70, P606, DOI 10.1016/j.ijbiomac.2014.07.027; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kumar S, 2009, BIOCHEMISTRY-US, V48, P6441, DOI 10.1021/bi900682w; Marinelli P, 2013, INT J MOL SCI, V14, P17830, DOI 10.3390/ijms140917830; Meissner JN, 2015, J ALZHEIMERS DIS, V45, P471, DOI 10.3233/JAD-142868; Mischo A, 2012, CHEMBIOCHEM, V13, P1421, DOI 10.1002/cbic.201200178; MORI H, 1992, J BIOL CHEM, V267, P17082; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Perez-Garmendia R, 2013, CURR NEUROPHARMACOL, V11, P491, DOI 10.2174/1570159X11311050004; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2012, J NEUROCHEM, V121, P774, DOI 10.1111/j.1471-4159.2012.07707.x; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Sergeant N, 2003, J NEUROCHEM, V85, P1581, DOI 10.1046/j.1471-4159.2003.01818.x; Shao HY, 1999, J MOL BIOL, V285, P755, DOI 10.1006/jmbi.1998.2348; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Sun N, 2012, J PEPT SCI, V18, P691, DOI 10.1002/psc.2456; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wirths O, 2010, J BIOL CHEM, V285, P41517, DOI 10.1074/jbc.M110.178707; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	53	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143647	10.1371/journal.pone.0143647	http://dx.doi.org/10.1371/journal.pone.0143647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600248	Green Published, gold			2022-12-26	WOS:000365853900151
J	Peci, A; Winter, AL; Warshawsky, B; Booth, TF; Eshaghi, A; Li, AM; Perusini, S; Olsha, R; Marchand-Austin, A; Kristjanson, E; Gubbay, JB				Peci, Adriana; Winter, Anne-Luise; Warshawsky, Bryna; Booth, Tim F.; Eshaghi, AliReza; Li, Aimin; Perusini, Stephen; Olsha, Romy; Marchand-Austin, Alex; Kristjanson, Erik; Gubbay, Jonathan B.			Epidemiology of Enterovirus D68 in Ontario	PLOS ONE			English	Article							PCR	In August 2014, children's hospitals in Kansas City, Missouri and Chicago, Illinois notified the Centers for Disease Control and Prevention (CDC) about increased numbers of pediatric patients hospitalized with severe respiratory illness (SRI). In response to CDC reports, Public Health Ontario Laboratories (PHOL) launched an investigation of patients being tested for enterovirus D-68 (EV-D68) in Ontario, Canada. The purpose of this investigation was to enhance our understanding of EV-D68 epidemiology and clinical features. Data for this study included specimens submitted for EV-D68 testing at PHOL from September 1, 2014 to October 31, 2014. Comparisons were made between patients who tested positive for the virus (cases) and those testing negative (controls). EV-D68 was identified in 153/907 (16.8%) of patients tested. In the logistic regression model adjusting for age, sex, setting and time to specimen collection, individuals younger than 20 years of age were more likely to be diagnosed with EV-D68 compared to those 20 and over, with peak positivity at ages 5-9 years. Cases were not more likely to be hospitalized than controls. Cases were more likely to be identified in September than October (OR 8.07; 95% CI 5.15 to 12.64). Routine viral culture and multiplex PCR were inadequate methods to identify EV-D68 due to poor sensitivity and inability to differentiate EV-D68 from other enterovirus serotypes or rhinovirus. Testing for EV-D68 in Ontario from July to December, 2014 detected the presence of EV-D68 virus among young children during September-October, 2014, with most cases detected in September. There was no difference in hospitalization status between cases and controls. In order to better understand the epidemiology of this virus, surveillance for EV-D68 should include testing of symptomatic individuals from all treatment settings and patient age groups, with collection and analysis of comprehensive clinical and epidemiological data.	[Peci, Adriana; Eshaghi, AliReza; Li, Aimin; Perusini, Stephen; Olsha, Romy; Marchand-Austin, Alex; Kristjanson, Erik; Gubbay, Jonathan B.] Publ Hlth Ontario Lab, Toronto, ON, Canada; [Winter, Anne-Luise; Warshawsky, Bryna] Publ Hlth Ontario, Toronto, ON, Canada; [Booth, Tim F.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	Public Health Agency of Canada	Peci, A (corresponding author), Publ Hlth Ontario Lab, 661 Univ Ave, Toronto, ON, Canada.	adriana.peci@oahpp.ca	Gubbay, Jonathan/Q-8580-2019	Gubbay, Jonathan/0000-0003-0026-3786; Eshaghi, Alireza/0000-0001-5150-483X; Marchand-Austin, Alex/0000-0001-5932-2037	GlaxoSmith Kline Inc; Hoffman-La Roche Ltd; Pfizer Inc	GlaxoSmith Kline Inc(GlaxoSmithKline); Hoffman-La Roche Ltd; Pfizer Inc(Pfizer)	The authors of this manuscript have the following competing interests: Dr. Gubbay has received research grants from GlaxoSmith Kline Inc, and Hoffman-La Roche Ltd to study antiviral resistance in influenza, and from Pfizer Inc, to conduct microbiological surveillance of Streptococcus pneumonia. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Other co-authors have no conflict of interest to declare.	CDC, 2014, ENT D68 US; CDC, 2014, ENT D68 EV D68 2014; CDC, 2014, SUMM FIND INV AC FLA; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Jaramillo-Gutierrez G, 2013, J VIROL METHODS, V190, P53, DOI 10.1016/j.jviromet.2013.02.010; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, V55, P1; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Lang M, 2014, EUROSURVEILLANCE; Lauinger IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036005; Leshem E, 2015, MMWR-MORBID MORTAL W, V63, P1243; MEIJER A, 2014, EUROSURVEILLANCE, V19, P2011; MMWR, 2008, CLUST AC RESP ILLN A; National Collaborating Centre for Infectious Diseases (NCCID), DIS DEBR EV D68; Nelson R, 2014, LANCET RESP MED, V2, P791, DOI 10.1016/S2213-2600(14)70190-0; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2010, J CLIN VIROL, V49, P73, DOI 10.1016/j.jcv.2010.06.022; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Opanda SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102866; Rahamat-Langendoen J, 2011, J CLIN VIROL, V52, P103, DOI 10.1016/j.jcv.2011.06.019; Robinson JL, 2014, CAN J INFECT DIS MED, V25, P296, DOI 10.1155/2014/201846; Sherwood MDGS, 2014, BC MED J, V56, P495; Todd AK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-103; Waghmare A, 2015, BLOOD, V125, P1724, DOI 10.1182/blood-2014-12-616516	23	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142841	10.1371/journal.pone.0142841	http://dx.doi.org/10.1371/journal.pone.0142841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599365	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900040
J	Stephens, D; Diesing, M				Stephens, David; Diesing, Markus			Towards Quantitative Spatial Models of Seabed Sediment Composition	PLOS ONE			English	Article							EUROPEAN CONTINENTAL-SHELF; SORTED BEDFORMS; SAND TRANSPORT; RANDOM FORESTS; GRAIN-SIZE; CLASSIFICATION; REGRESSION; INTERPOLATION; BACKSCATTER; COMMUNITIES	There is a need for fit-for-purpose maps for accurately depicting the types of seabed substrate and habitat and the properties of the seabed for the benefits of research, resource management, conservation and spatial planning. The aim of this study is to determine whether it is possible to predict substrate composition across a large area of seabed using legacy grain-size data and environmental predictors. The study area includes the North Sea up to approximately 58.44 degrees N and the United Kingdom's parts of the English Channel and the Celtic Seas. The analysis combines outputs from hydrodynamic models as well as optical remote sensing data from satellite platforms and bathymetric variables, which are mainly derived from acoustic remote sensing. We build a statistical regression model to make quantitative predictions of sediment composition (fractions of mud, sand and gravel) using the random forest algorithm. The compositional data is analysed on the additive log-ratio scale. An independent test set indicates that approximately 66% and 71% of the variability of the two log-ratio variables are explained by the predictive models. A EUNIS substrate model, derived from the predicted sediment composition, achieved an overall accuracy of 83% and a kappa coefficient of 0.60. We demonstrate that it is feasible to spatially predict the seabed sediment composition across a large area of continental shelf in a repeatable and validated way. We also highlight the potential for further improvements to the method.	[Stephens, David; Diesing, Markus] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England	Centre for Environment Fisheries & Aquaculture Science	Stephens, D (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England.	davesteps@gmail.com	Diesing, Markus/D-6868-2011	Diesing, Markus/0000-0003-4331-7553	project DEVOTES (Development of innovative tools for understanding marine biodiversity and assessing good Environmental Status) - EU FP7 [308392]	project DEVOTES (Development of innovative tools for understanding marine biodiversity and assessing good Environmental Status) - EU FP7	This work was made possible through funding from the project DEVOTES (Development of innovative tools for understanding marine biodiversity and assessing good Environmental Status) funded by the EU FP7 (grant agreement no. 308392), www.devotes-project.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO; Aldridge JN, 2015, CONT SHELF RES, V108, P121, DOI 10.1016/j.csr.2015.03.004; Alpaydin E., 2010, INTRO MACHINE LEARNI; [Anonymous], 2002, INTRO STAT R; Anthony D, 2002, MAR GEOL, V182, P247, DOI 10.1016/S0025-3227(01)00245-6; Astrium OceanWise, 2011, CREAT HIGH RES DIG E; Bekkby T, 2009, MAR GEOD, V32, P379, DOI 10.1080/01490410903297816; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Boero F, 2015, J SEA RES, V101, P12, DOI 10.1016/j.seares.2014.07.008; Bradwell T, 2008, EARTH-SCI REV, V88, P207, DOI 10.1016/j.earscirev.2008.01.008; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; British Geological Survey, 2014, BGS LEG PART SIZ AN; Buhl-Mortensen P, 2009, ICES J MAR SCI, V66, P2026, DOI 10.1093/icesjms/fsp200; Calvert J, 2015, ICES J MAR SCI, V72, P1498, DOI 10.1093/icesjms/fsu223; Campbell N, 2009, ICES J MAR SCI, V66, P2052, DOI 10.1093/icesjms/fsp176; Capuzzo E, 2015, GLOB CHANG BIOL; Chan JCW, 2008, REMOTE SENS ENVIRON, V112, P2999, DOI 10.1016/j.rse.2008.02.011; Chapman DS, 2010, J BIOGEOGR, V37, P37, DOI 10.1111/j.1365-2699.2009.02186.x; Clark CD, 2012, QUATERNARY SCI REV, V44, P112, DOI 10.1016/j.quascirev.2010.07.019; Coggan R, 2012, ESTUAR COAST SHELF S, V111, P118, DOI 10.1016/j.ecss.2012.06.017; Coggan RA, 2012, ELSEV INSIGHT, P471, DOI 10.1016/B978-0-12-385140-6.00033-5; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Connor D.W., 2006, UKSEAMAP MAPPING SEA, V3rd ed.; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dartnell P, 2004, PHOTOGRAMM ENG REM S, V70, P1081, DOI 10.14358/PERS.70.9.1081; Diesing M, 2006, CONT SHELF RES, V26, P902, DOI 10.1016/j.csr.2006.02.009; Diesing M, 2015, J SEA RES, V100, P62, DOI 10.1016/j.seares.2014.10.013; Diesing M, 2014, CONT SHELF RES, V84, P107, DOI 10.1016/j.csr.2014.05.004; Diesing M, 2009, ESTUAR COAST SHELF S, V83, P647, DOI 10.1016/j.ecss.2009.05.018; Dunn DC, 2009, MAR ECOL PROG SER, V377, P1, DOI 10.3354/meps07839; FOLK RL, 1954, J GEOL, V62, P344, DOI 10.1086/626171; Goff JA, 2005, CONT SHELF RES, V25, P461, DOI 10.1016/j.csr.2004.09.019; Goff JA, 2004, MAR GEOL, V209, P147, DOI 10.1016/j.margeo.2004.05.030; Gohin F, 2005, REMOTE SENS ENVIRON, P95; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hasan RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097339; Hasan RC, 2012, REMOTE SENS-BASEL, V4, P3427, DOI 10.3390/rs4113427; Hasan RC, 2012, ESTUAR COAST SHELF S, V97, P1, DOI 10.1016/j.ecss.2011.10.004; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hengl T., 2009, PRACTICAL GUIDE GEOS, DOI DOI 10.1016/0277-9390(86)90082-8; Holt JT, 2001, J GEOPHYS RES-OCEANS, V106, P14015, DOI 10.1029/2000JC000304; Huang Z, 2008, POW EN SOC GEN M CON, P1; Ierodiaconou D, 2011, CONT SHELF RES, V31, pS28, DOI 10.1016/j.csr.2010.01.012; Isaaks E.H, 1989, INTRO APPL GEOSTATIS; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Jenkins J, 2014, SEABED SUBSTRATES DA; Johnson H D, 1996, SEDIMENTARY ENV PROC, P232; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Kursa M. B., 2010, J STAT SOFTW, V36; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; LEVINS R, 1966, AM SCI, V54, P421; Li J, 2014, ENVIRON MODELL SOFTW, V53, P173, DOI 10.1016/j.envsoft.2013.12.008; Li J, 2011, CONT SHELF RES, V31, P1365, DOI 10.1016/j.csr.2011.05.015; Long D, 2006, BGS DETAILED EXPLANA; Lucieer V, 2013, ESTUAR COAST SHELF S, V117, P94, DOI 10.1016/j.ecss.2012.11.001; Lundblad E., 2006, GEOD, V29, P89, DOI [10.1080/01490410600738021, DOI 10.1080/01490410600738021]; Marsh I, 2009, APPL ACOUST, V70, P1269, DOI 10.1016/j.apacoust.2008.07.012; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Ojeda GY, 2004, ESTUAR COAST SHELF S, V59, P399, DOI 10.1016/j.ecss.2003.09.012; Oliveira S, 2012, FOREST ECOL MANAG, V275, P117, DOI 10.1016/j.foreco.2012.03.003; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Perkins TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112951; PINGREE RD, 1979, J MAR BIOL ASSOC UK, V59, P497, DOI 10.1017/S0025315400042806; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R Core Team, 2021, R LANGUAGE ENV STAT; Rattray A, 2009, ESTUAR COAST SHELF S, V84, P237, DOI 10.1016/j.ecss.2009.06.023; Rooper CN, 2007, CONT SHELF RES, V27, P947, DOI 10.1016/j.csr.2006.12.006; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Schwarzer K, 2003, MAR GEOL, V194, P79, DOI 10.1016/S0025-3227(02)00700-4; Simons DG, 2009, APPL ACOUST, V70, P1258, DOI 10.1016/j.apacoust.2008.07.013; Stephens D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093950; Sternberg RW, 1999, J SEA RES, V41, P55, DOI 10.1016/S1385-1101(98)00037-9; STIVE MJF, 1995, MAR GEOL, V126, P235, DOI 10.1016/0025-3227(95)00080-I; Strong JA, 2012, J MAPS, V8, P129, DOI 10.1080/17445647.2012.680746; Valerius J., 2014, TRANSNATIONAL DATABA; van der Molen J, 2002, CONT SHELF RES, V22, P2739, DOI 10.1016/S0278-4343(02)00124-3; van Heteren S., 2015, COLLABORATIVE KNOWLE, P154, DOI [DOI 10.4018/978-1-4666-6567-5.CH008, 10.4018/978-1-4666-6567-5.ch008]; Van Landeghem KJJ, 2009, BOREAS, V38, P119, DOI 10.1111/j.1502-3885.2008.00041.x; Visser H, 2006, ENVIRON MODELL SOFTW, V21, P346, DOI 10.1016/j.envsoft.2004.11.013; WARWICK RM, 1980, MAR ECOL PROG SER, V3, P97, DOI 10.3354/meps003097; Weltje GJ, 2006, GEOL SOC SPEC PUBL, V264, P79, DOI 10.1144/GSL.SP.2006.264.01.07; Wilson AM, 2008, ESTUAR COAST SHELF S, V80, P193, DOI 10.1016/j.ecss.2008.06.011; Woodroffe C.D, 2003, COASTS FORM PROCESS; Zhi H, 2014, MAR GEOL, V357, P37, DOI 10.1016/j.margeo.2014.07.012	85	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142502	10.1371/journal.pone.0142502	http://dx.doi.org/10.1371/journal.pone.0142502			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600040	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900026
J	Vanlandewijck, M; Lebouvier, T; Mae, MA; Nahar, K; Hornemann, S; Kenkel, D; Cunha, SI; Lennartsson, J; Boss, A; Heldin, CH; Keller, A; Betsholtz, C				Vanlandewijck, Michael; Lebouvier, Thibaud; Mae, Maarja Andaloussi; Nahar, Khayrun; Hornemann, Simone; Kenkel, David; Cunha, Sara I.; Lennartsson, Johan; Boss, Andreas; Heldin, Carl-Henrik; Keller, Annika; Betsholtz, Christer			Functional Characterization of Germline Mutations in PDGFB and PDGFRB in Primary Familial Brain Calcification	PLOS ONE			English	Article							BASAL GANGLIA CALCIFICATION; GROWTH-FACTOR; RECEPTOR; BETA; PERICYTES; MECHANISM; CELLS; ACTIVATION; DEFICIENT; INDUCTION	Primary Familial Brain Calcification (PFBC), a neurodegenerative disease characterized by progressive pericapillary calcifications, has recently been linked to heterozygous mutations in PDGFB and PDGFRB genes. Here, we functionally analyzed several of these mutations in vitro. All six analyzed PDGFB mutations led to complete loss of PDGF-B function either through abolished protein synthesis or through defective binding and/or stimulation of PDGF-R beta. The three analyzed PDGFRB mutations had more diverse consequences. Whereas PDGF-R beta autophosphorylation was almost totally abolished in the PDGFRB L658P mutation, the two sporadic PDGFRB mutations R987W and E1071V caused reductions in protein levels and specific changes in the intensity and kinetics of PLC. activation, respectively. Since at least some of the PDGFB mutations were predicted to act through haploinsufficiency, we explored the consequences of reduced Pdgfb or Pdgfrb transcript and protein levels in mice. Heterozygous Pdgfb or Pdgfrb knockouts, as well as double Pdgfb(+/-); Pdgfrb(+/-) mice did not develop brain calcification, nor did Pdgfrb(redeye/redeye) mice, which show a 90% reduction of PDGFR beta protein levels. In contrast, Pdgfb(ret/ret) mice, which have altered tissue distribution of PDGF-B protein due to loss of a proteoglycan binding motif, developed brain calcifications. We also determined pericyte coverage in calcification-prone and non-calcification-prone brain regions in Pdgfb(ret/ret) mice. Surprisingly and contrary to our hypothesis, we found that the calcification-prone brain regions in Pdgfb(ret/ret) mice model had a higher pericyte coverage and a more intact blood-brain barrier (BBB) compared to non-calcification-prone brain regions. While our findings provide clear evidence that loss-of-function mutations in PDGFB or PDGFRB cause PFBC, they also demonstrate species differences in the threshold levels of PDGF-B/PDGF-R beta signaling that protect against small-vessel calcification in the brain. They further implicate region-specific susceptibility factor(s) in PFBC pathogenesis that are distinct from pericyte and BBB deficiency.	[Vanlandewijck, Michael; Lebouvier, Thibaud; Mae, Maarja Andaloussi; Nahar, Khayrun; Cunha, Sara I.; Betsholtz, Christer] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Hornemann, Simone] Univ Zurich, Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Kenkel, David; Boss, Andreas] Univ Zurich, Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland; [Cunha, Sara I.; Lennartsson, Johan; Heldin, Carl-Henrik] Uppsala Univ, Sci Life Lab, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Keller, Annika] Univ Zurich, Univ Zurich Hosp, Div Neurosurg, CH-8091 Zurich, Switzerland; [Vanlandewijck, Michael] Karolinska Inst, Novum, ICMC, SE-14157 Stockholm, Sweden	Uppsala University; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Ludwig Institute for Cancer Research; Uppsala University; University of Zurich; University Zurich Hospital; Karolinska Institutet	Betsholtz, C (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Dag Hammarskjolds Vag 20, S-75185 Uppsala, Sweden.	Christer.Betsholtz@igp.uu.se	Lebouvier, Thibaud/G-7053-2018; Boss, Andreas/A-7484-2014; Andaloussi Mäe, Maarja/AAA-9215-2022	Lebouvier, Thibaud/0000-0002-4386-6045; Keller, Annika/0000-0003-1466-3633; Vanlandewijck, Michael/0000-0002-0709-7808	European Research Council [294556 BBBARRIER]; Swedish Research Council; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; Leducq Foundation; Uppsala University; Swiss National Science Foundation; Synapsis Foundation	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Leducq Foundation(Leducq Foundation); Uppsala University; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Synapsis Foundation	Work in Christer Betholtz's group was funded by: the European Research Council (Advanced grant no 294556 BBBARRIER) (http://erc.europa.eu); the Swedish Research Council (http://www.vr.se); the Swedish Cancer Foundation (https://www.cancerfonden.se); the Knut and Alice Wallenberg Foundation (https://www.wallenberg.com); a transatlantic network grant (Sphingonet) from the Leducq Foundation (https://www.fondationleducq.org/network/sphingosine-1-phosphate-in-neurovascular-biology-and-disease-sphingonet/); and Uppsala University (http://www.uu.se/en). Work in Annika Keller's group was funded by the Swiss National Science Foundation (http://www.snf.ch/en) and The Synapsis Foundation (http://www.alzheimer-synapsis.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Cecilia Olsson, Helene Leksell, Pia Peterson, and Jana Chmielniakova for technical assistance. This work was funded by the European Research Council (Advanced grant no 294556 BBBARRIER), the Swedish Research Council, the Swedish Cancer Foundation, the Knut and Alice Wallenberg Foundation, a transatlantic network grant (Sphingonet) from the Leducq Foundation, and Uppsala University to CB, and the Swiss National Science Foundation and The Synapsis Foundation to AK.	ANDERSSON M, 1992, J BIOL CHEM, V267, P11260; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arts FA, 2015, J CELL MOL MED, V19, P239, DOI 10.1111/jcmm.12443; Cheung YH, 2013, AM J HUM GENET, V92, P996, DOI 10.1016/j.ajhg.2013.04.026; Delacour A, 1850, ANN MED PSYCHOL; Goswami R, 2012, CLIN ENDOCRINOL, V77, P200, DOI 10.1111/j.1365-2265.2012.04353.x; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12; Jadeja S, 2013, INVEST OPHTH VIS SCI, V54, P3569, DOI 10.1167/iovs.12-11125; Kakita A, 2004, ATHEROSCLEROSIS, V174, P17, DOI 10.1016/j.atherosclerosis.2003.12.039; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; KOBAYASHI S, 1987, ACTA NEUROPATHOL, V73, P62, DOI 10.1007/BF00695503; Lee JW, 2013, CLIN GENET, V84, P340, DOI 10.1111/cge.12238; Legati A, 2015, NAT GENET, V47, P579, DOI 10.1038/ng.3289; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu YW, 2013, CIRC RES, V112, pE99, DOI 10.1161/CIRCRESAHA.111.300543; Manyam BV, 2005, PARKINSONISM RELAT D, V11, P73, DOI 10.1016/j.parkreldis.2004.12.001; Martignetti JA, 2013, AM J HUM GENET, V92, P1001, DOI 10.1016/j.ajhg.2013.04.024; McArthur GA, 2005, J CLIN ONCOL, V23, P866, DOI 10.1200/JCO.2005.07.088; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7; Nicolas G, 2014, EUR J HUM GENET, V22, P1236, DOI 10.1038/ejhg.2014.9; Nicolas G, 2014, J MOL NEUROSCI, V53, P171, DOI 10.1007/s12031-014-0265-z; Nicolas G, 2013, BRAIN, V136, P3395, DOI 10.1093/brain/awt255; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; OSTMAN A, 1992, J CELL BIOL, V118, P509, DOI 10.1083/jcb.118.3.509; Ruusala A, 1998, J CELL SCI, V111, P111; Saleem S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-156; Sanchez-Contreras M, 2014, HUM MUTAT, V35, P964, DOI 10.1002/humu.22582; Schindelin J., 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, DOI 10.1038/NMETH.2019]; Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Tsai WH, 1985, COMPUTER VISION; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; WESTERMARK B, 1990, P NATL ACAD SCI USA, V87, P128, DOI 10.1073/pnas.87.1.128; Wider C, 2009, J NEUROL, V256, P839, DOI 10.1007/s00415-009-5025-6	48	61	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143407	10.1371/journal.pone.0143407	http://dx.doi.org/10.1371/journal.pone.0143407			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599395	Green Submitted, gold, Green Published			2022-12-26	WOS:000365853900111
J	Yamashiro, K; Sato, D; Onishi, H; Sugawara, K; Nakazawa, S; Shimojo, H; Akatsuka, K; Nakata, H; Maruyama, A				Yamashiro, Koya; Sato, Daisuke; Onishi, Hideaki; Sugawara, Kazuhiro; Nakazawa, Sho; Shimojo, Hirofumi; Akatsuka, Kosuke; Nakata, Hiroki; Maruyama, Atsuo			Skill-Specific Changes in Somatosensory Nogo Potentials in Baseball Players	PLOS ONE			English	Article							EVOKED POTENTIALS; ERP COMPONENTS; GO; PERFORMANCE; EXERCISE; SPEED; TASKS; P300	Athletic training is known to induce neuroplastic alterations in specific somatosensory circuits, which are reflected by changes in somatosensory evoked potentials and event-related potentials. The aim of this study was to clarify whether specific athletic training also affects somatosensory Nogo potentials related to the inhibition of movements. The Nogo potentials were recorded at nine cortical electrode positions (Fz, Cz, Pz, F3, F4, C3, C4, P3 and P4) in 12 baseball players (baseball group) and in 12 athletes in sports, such as track and field events and swimming, that do not require response inhibition, such as batting for training or performance (sports group). The Nogo potentials and Go/Nogo reaction times (Go/Nogo RTs) were measured under a somatosensory Go/Nogo paradigm in which subjects were instructed to rapidly push a button in response to stimulus presentation. The Nogo potentials were obtained by subtracting the Go trial from the Nogo trial. The peak Nogo-N2 was significantly shorter in the baseball group than that in the sports group. In addition, the amplitude of Nogo-N2 in the frontal area was significantly larger in the baseball group than that in the sports group. There was a significant positive correlation between the latency of Nogo-N2 and Go/Nogo RT. Moreover, there were significant correlations between the Go/Nogo RT and both the amplitude of Nogo-N2 and Nogo-P3 (i.e., amplitude of the Nogo-potentials increases with shorter RT). Specific athletic training regimens may induce neuroplastic alterations in sensorimotor inhibitory processes.	[Yamashiro, Koya; Sato, Daisuke; Onishi, Hideaki; Sugawara, Kazuhiro; Shimojo, Hirofumi; Maruyama, Atsuo] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan; [Yamashiro, Koya; Sato, Daisuke; Nakazawa, Sho; Shimojo, Hirofumi; Maruyama, Atsuo] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Japan; [Onishi, Hideaki; Sugawara, Kazuhiro] Niigata Univ Hlth & Welf, Dept Phys Theraphy, Niigata, Japan; [Akatsuka, Kosuke] Kurume Natl Coll Technol, Dept Liberal Arts, Fukuoka, Japan; [Nakata, Hiroki] Nara Womens Univ, Dept HealthSci, Fac Human Life & Environm, Nara 630, Japan	Niigata University; Niigata University; Niigata University; Nara Womens University	Yamashiro, K (corresponding author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan.	yamashiro@nuhw.ac.jp	Shimojo, Hirofumi/AAP-2794-2021		Japan Society for the Promotion of Science (JSPS); Niigata University of Health and Welfare	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Niigata University of Health and Welfare	This study was supported by a Grant-in-aid for young scientists (B) from the Japan Society for the Promotion of Science (JSPS) and a Grant-in-aid for Advanced Research from Niigata University of Health and Welfare.	Band GPH, 2003, PSYCHOL RES-PSYCH FO, V67, P266, DOI 10.1007/s00426-002-0127-0; Bulut S, 2003, INT J NEUROSCI, V113, P315, DOI 10.1080/00207450390162119; DESMEDT JE, 1977, J PHYSIOL-LONDON, V271, P761, DOI 10.1113/jphysiol.1977.sp012025; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Eimer M, 2003, EXP BRAIN RES, V151, P24, DOI 10.1007/s00221-003-1437-1; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Filipovic SR, 2000, EXP BRAIN RES, V132, P411, DOI 10.1007/s002210000349; Hashimoto I, 2004, CLIN NEUROPHYSIOL, V115, P435, DOI 10.1016/S1388-2457(03)00340-7; Iwadate M, 2005, EXP BRAIN RES, V160, P528, DOI 10.1007/s00221-004-2125-5; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; Kida N, 2005, COGNITIVE BRAIN RES, V22, P257, DOI 10.1016/j.cogbrainres.2004.09.003; Kida T, 2004, COGNITIVE BRAIN RES, V19, P33, DOI 10.1016/j.cogbrainres.2003.10.016; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Lavric A, 2004, EUR J NEUROSCI, V20, P2483, DOI 10.1111/j.1460-9568.2004.03683.x; Murakami T, 2008, CLIN NEUROPHYSIOL, V119, P2862, DOI 10.1016/j.clinph.2008.09.002; Nakamoto H, 2008, BRAIN RES, V1189, P179, DOI 10.1016/j.brainres.2007.10.096; Nakata H, 2005, EXP BRAIN RES, V162, P293, DOI 10.1007/s00221-004-2195-4; Nakata H, 2004, CLIN NEUROPHYSIOL, V115, P361, DOI 10.1016/j.clinph.2003.09.013; Nakata H, 2014, J PHYSIOL SCI, V64, P233, DOI 10.1007/s12576-014-0320-0; Nakata H, 2012, EUR J APPL PHYSIOL, V112, P207, DOI 10.1007/s00421-011-1973-5; Nakata H, 2009, NEUROREPORT, V20, P1149, DOI 10.1097/WNR.0b013e32832f81d6; Smith JL, 2006, INT J PSYCHOPHYSIOL, V61, P121, DOI 10.1016/j.ijpsycho.2005.07.013; Thomas NG, 1996, MED SCI SPORT EXER, V28, P473, DOI 10.1097/00005768-199604000-00012; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Vallesi A, 2009, NEUROPSYCHOLOGIA, V47, P577, DOI 10.1016/j.neuropsychologia.2008.10.018; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Yamanaka K, 2002, EXP BRAIN RES, V142, P301, DOI 10.1007/s00221-001-0943-2; Yamashiro K, 2013, EXP BRAIN RES, V225, P197, DOI 10.1007/s00221-012-3361-8	29	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142581	10.1371/journal.pone.0142581	http://dx.doi.org/10.1371/journal.pone.0142581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600391	Green Published, gold			2022-12-26	WOS:000365853900028
J	Jia, WH; Liao, XL; Pan, YS; Wang, YL; Cui, T; Zhou, LC; Wang, YJ				Jia, Weihua; Liao, Xiaoling; Pan, Yuesong; Wang, Yilong; Cui, Tao; Zhou, Lichun; Wang, Yongjun		TIMS-CHINA Investigators	Thrombolytic-Related Asymptomatic Hemorrhagic Transformation Does Not Deteriorate Clinical Outcome: Data from TIMS in China	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INTRAVENOUS ALTEPLASE; PREDICTORS	Objective It has been unclear whether thrombolytic-related asymptomatic hemorrhagic transformation (AHT) affects the clinical outcome. To answer this question, we examined whether thrombolytic-related AHT affect short-term and long-term clinical outcome. Methods All data were collected from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China) registry. The patients were diagnosed as having AHT group and non-hemorrhagic transformation (HT) group based on clinical and imaging data. The patients with symptomatic hemorrhagic transformation were excluded from this study. Thrombolytic-related AHT was defined according to European-Australasian Acute Stroke Study (ECASS) II criteria. 90-day functional outcome, 7-day National Institutes of Health Stroke Scale (NIHSS) score, 7-day and 90-day mortalities were compared between two groups. Logistic regression analysis was used to evaluate the effects of AHT on a short-term and long-term clinical outcome. Results 904 of all 1440 patients in TIMS-China registry were enrolled. 89 (9.6%) patients presented with AHT after thrombolysis within 24-36h. These patients with AHT were more likely to be elder age, cardioembolic subtype, and to have higher National Institutes of Health Stroke Scale score before thrombolysis than patients without AHT. No significant difference was found on the odds of 7-day (95% CI:0.692 (0.218-2.195), (P = 0.532) or 90-day mortalities (95% CI: 0.548 (0.237-1.268), P = 0.160) and modified Rankin Score(0-1) at 90-day (95% CI: 0.798 (0.460-1.386), P = 0.423) or modified Rankin Score(0-2) at 90-day (95% CI: 0.732 (0.429-1.253), P = 0.116) or modified Rankin Score(5-6) at 90-day (95% CI: 0.375 (0.169-1.830), P = 0.116) between two groups. Conclusions Thrombolytic-related AHT does not deteriorate short-term and long-term clinical outcome.	[Jia, Weihua; Liao, Xiaoling; Pan, Yuesong; Wang, Yilong; Cui, Tao; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Ctr Stroke, Beijing, Peoples R China; [Jia, Weihua; Liao, Xiaoling; Pan, Yuesong; Wang, Yilong; Cui, Tao; Wang, Yongjun] Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Jia, Weihua; Liao, Xiaoling; Pan, Yuesong; Wang, Yilong; Wang, Yongjun] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Jia, Weihua; Liao, Xiaoling; Pan, Yuesong; Wang, Yilong; Wang, Yongjun] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Jia, Weihua; Zhou, Lichun] Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhou, LC (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China.	13701279076@163.com; yongjunwang1962@gmail.com	Pan, Yuesong/AAI-6303-2020	Pan, Yuesong/0000-0003-3082-6789; Wang, Shaoshi/0000-0003-2547-0247; Xu, An-Ding/0000-0003-3154-0985	National Science and Technology, Major Project of China [2011BAI08B02, 2006BA101A11]	National Science and Technology, Major Project of China	This study was funded by the National Science and Technology, Major Project of China (2011BAI08B02 and 2006BA101A11).	D'Amelio M, 2014, J STROKE CEREBROVASC, V23, P649, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.005; Dzialowski I, 2007, STROKE, V38, P75, DOI 10.1161/01.STR.0000251644.76546.62; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Jickling GC, 2014, J CEREBR BLOOD F MET, V34, P185, DOI 10.1038/jcbfm.2013.203; Kablau M, 2011, CEREBROVASC DIS, V32, P334, DOI 10.1159/000331702; Kerenyi L, 2006, EUR J NEUROL, V13, P1251, DOI 10.1111/j.1468-1331.2006.01489.x; Kernan WN, 2014, GUIDELINES PREVENTIO, V45, P1; Lei CY, 2014, J STROKE CEREBROVASC, V23, P2767, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.024; Liao XL, 2013, CNS NEUROSCI THER, V19, P43, DOI 10.1111/cns.12031; Liao XL, 2014, STROKE, V45, P2354, DOI 10.1161/STROKEAHA.114.005989; Libman R, 2004, J STROKE VASC DIS, V14, P50; Libman RB, 2012, NEUROLOGY, V78, P1703, DOI 10.1212/WNL.0b013e3182598e5b; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Nakagawara J, 2010, STROKE, V41, P1984, DOI 10.1161/STROKEAHA.110.589606; Paciaroni M, 2008, STROKE, V39, P2249, DOI 10.1161/STROKEAHA.107.510321; Park JH, 2012, NEUROLOGY, V78, P421, DOI 10.1212/WNL.0b013e318245d22c; Sussman ES, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00069; Tan S, 2014, J NEUROL, V261, P905, DOI 10.1007/s00415-014-7297-8; Trouillas P, 2006, STROKE, V37, P556, DOI 10.1161/01.STR.0000196942.84707.71; Tu HT, 2013, INT J STROKE; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Zhang J, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.08	22	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0142381	10.1371/journal.pone.0142381	http://dx.doi.org/10.1371/journal.pone.0142381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619008	gold, Green Published, Green Submitted			2022-12-26	WOS:000365889800012
J	Wiencierz, AM; Kernbach, M; Ecklebe, J; Monnerat, G; Tomiuk, S; Raulf, A; Christalla, P; Malan, D; Hesse, M; Bosio, A; Fleischmann, BK; Eckardt, D				Wiencierz, Anne Maria; Kernbach, Manuel; Ecklebe, Josephine; Monnerat, Gustavo; Tomiuk, Stefan; Raulf, Alexandra; Christalla, Peter; Malan, Daniela; Hesse, Michael; Bosio, Andreas; Fleischmann, Bernd K.; Eckardt, Dominik			Differential Expression Levels of Integrin alpha 6 Enable the Selective Identification and Isolation of Atrial and Ventricular Cardiomyocytes	PLOS ONE			English	Article							GENE-EXPRESSION; CELL-CYCLE; COUP-TFII; MOUSE; HEART; PURIFICATION; ENRICHMENT; CHANNEL; GROWTH	Rationale Central questions such as cardiomyocyte subtype emergence during cardiogenesis or the availability of cardiomyocyte subtypes for cell replacement therapy require selective identification and purification of atrial and ventricular cardiomyocytes. However, current methodologies do not allow for a transgene-free selective isolation of atrial or ventricular cardiomyocytes due to the lack of subtype specific cell surface markers. Methods and Results In order to develop cell surface marker-based isolation procedures for cardiomyocyte subtypes, we performed an antibody-based screening on embryonic mouse hearts. Our data indicate that atrial and ventricular cardiomyocytes are characterized by differential expression of integrin alpha 6 (ITGA6) throughout development and in the adult heart. We discovered that the expression level of this surface marker correlates with the intracellular subtype-specific expression of MLC-2a and MLC-2v on the single cell level and thereby enables the discrimination of cardiomyocyte subtypes by flow cytometry. Based on the differential expression of ITGA6 in atria and ventricles during cardiogenesis, we developed purification protocols for atrial and ventricular cardiomyocytes from mouse hearts. Atrial and ventricular identities of sorted cells were confirmed by expression profiling and patch clamp analysis. Conclusion Here, we introduce a non-genetic, antibody-based approach to specifically isolate highly pure and viable atrial and ventricular cardiomyocytes from mouse hearts of various developmental stages. This will facilitate in-depth characterization of the individual cellular subsets and support translational research applications.	[Wiencierz, Anne Maria; Kernbach, Manuel; Ecklebe, Josephine; Tomiuk, Stefan; Christalla, Peter; Bosio, Andreas; Eckardt, Dominik] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Monnerat, Gustavo; Raulf, Alexandra; Malan, Daniela; Hesse, Michael; Fleischmann, Bernd K.] Univ Bonn, Inst Physiol 1, Life & Brain Ctr, D-53115 Bonn, Germany	Miltenyi Biotec; University of Bonn	Eckardt, D (corresponding author), Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.	dominike@miltenyibiotec.de	Monnerat, Gustavo/J-6907-2019; Hesse, Michael/AAV-9285-2021; monnerat, gustavo/E-3398-2015	Hesse, Michael/0000-0002-7518-0224; monnerat, gustavo/0000-0002-1010-6314; Bosio, Andreas/0000-0001-9776-2535	"Science Without Borders" program of CNPq-Brazil; Miltenyl Biotec GmbH	"Science Without Borders" program of CNPq-Brazil; Miltenyl Biotec GmbH	G.M. was supported by a scholarship from "Science Without Borders" program of CNPq-Brazil; he performed all the experimental work during his stay at the Institute of Physiology I, Life & Brain Center, University of Bonn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Miltenyl Biotec GmbH provided support in the form of salaries for authors [A.M.W., M.K., J.E., S.T., P.C., A.B., D.E.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors is articulated in the 'author contributions' section.	Ban KW, 2013, CIRCULATION, V128, P1897, DOI 10.1161/CIRCULATIONAHA.113.004228; Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Barral S, 2013, STEM CELL RES, V10, P133, DOI 10.1016/j.scr.2012.10.005; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chen XP, 2012, MOL ENDOCRINOL, V26, P1268, DOI 10.1210/me.2011-1305; de Sousa Lopes SMC, 2006, DEV DYNAM, V235, P1994, DOI 10.1002/dvdy.20830; Fleischmann BK, 2004, J CLIN INVEST, V114, P994, DOI 10.1172/JCI200415925; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Hierck BP, 1996, DEV DYNAM, V206, P100, DOI 10.1002/(SICI)1097-0177(199605)206:1<100::AID-AJA9>3.0.CO;2-M; Hirata H, 2006, CELLS TISSUES ORGANS, V184, P172, DOI 10.1159/000099624; Israeli-Rosenberg S, 2014, CIRC RES, V114, P572, DOI 10.1161/CIRCRESAHA.114.301275; Ji GJ, 1999, FASEB J, V13, P313, DOI 10.1096/fasebj.13.2.313; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Malan D, 2009, STEM CELLS, V27, P88, DOI 10.1634/stemcells.2008-0335; McGrath MF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-254; Niederquell M, 2013, EUR J IMMUNOL, V43, P2993, DOI 10.1002/eji.201343498; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; Ponten A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082403; Rust W, 2009, REGEN MED, V4, P225, DOI 10.2217/17460751.4.2.225; Scavone A, 2013, CIRC RES, V113, P389, DOI 10.1161/CIRCRESAHA.113.301283; Tabibiazar R, 2003, CIRC RES, V93, P1193, DOI 10.1161/01.RES.0000103171.42654.DD; Tarnawski L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135880; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wu SP, 2013, DEV CELL, V25, P417, DOI 10.1016/j.devcel.2013.04.017; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91	29	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143538	10.1371/journal.pone.0143538	http://dx.doi.org/10.1371/journal.pone.0143538			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618511	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800044
J	Burri, A; Ogata, S; Livshits, G; Williams, F				Burri, Andrea; Ogata, Soshiro; Livshits, Gregory; Williams, Frances			The Association between Chronic Widespread Musculoskeletal Pain, Depression and Fatigue Is Genetically Mediated	PLOS ONE			English	Article							LONDON FIBROMYALGIA EPIDEMIOLOGY; RISK-FACTORS; DEHYDROEPIANDROSTERONE REPLACEMENT; WOMEN; POPULATION; TWIN; DHEA; PREVALENCE; STEROIDS; INSULIN	Background Chronic widespread muscoloskeletal pain (CWP) is prevalent in the general population and associated with high health care costs, so understanding the risk factors for chronic pain is important for both those affected and for society. In the present study we investigated the underlying etiological structure of CWP to understand better the association between the major clinical features of fatigue, depression and dihydroepiandrosterone sulphate (DHEAS) using a multivariate twin design. Methodology/Principle Findings Data were available in 463 UK female twin pairs including CWP status and information on depression, chronic fatigue and serum DHEAS levels. High to moderate heritabilities for all phenotypes were obtained (42.58% to 74.24%). The highest phenotypic correlation was observed between fatigue and CWP (r = 0.45), and the highest genetic correlation between CWP and fatigue (r(g) = 0.78). Structural equation modeling revealed the AE Cholesky model to provide the best model of the observed data. In this model, two additive genetic factors could be detected loading heavily on CWP-A2 explaining 40% of the variance and A3 20%. The factor loading heaviest on DHEAS showed only a small loading on the other phenotypes and none on fatigue at all. Furthermore, one distinct non-shared environmental factor loading specifically on CWP-but not on any of the other phenotypes-could be detected suggesting that the association between CWP and the other phenotypes is due only to genetic factors. Conclusions/Significance Our results suggest that CWP and its associated features share a genetic predisposition but that they are relatively distinct in their environmental determinants.	[Burri, Andrea; Livshits, Gregory; Williams, Frances] Kings Coll London, Dept Twin Res & Genet Epidemiol, St Thomas Hosp, London WC2R 2LS, England; [Burri, Andrea] Univ Zurich, Dept Psychol, CH-8050 Zurich, Switzerland; [Ogata, Soshiro] Osaka Univ, Dept Hlth Promot Sci, Grad Sch Med, Suita, Osaka 565087, Japan; [Livshits, Gregory] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Zurich; Osaka University; Tel Aviv University; Sackler Faculty of Medicine	Burri, A (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, St Thomas Hosp, London WC2R 2LS, England.	a.burri@psychologie.uzh.ch	Livshits, Gregory/AAG-7051-2019	Livshits, Gregory/0000-0003-3766-7493; Williams, Frances/0000-0002-2998-2744; Burri, Andrea/0000-0002-4705-3551	Wellcome Trust; European Community; National Institute for Health Research (NIHR); Swiss National Science Foundation; Swisslife Jubilaumsstiftung; Pain Research Foundation; Arthritis Research UK; Versus Arthritis [20682] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swisslife Jubilaumsstiftung; Pain Research Foundation; Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	This work was supported by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. Additionally, AB reports an Ambizione personal career fellowship by the Swiss National Science Foundation. AB also acknowledges a research grant support from the Swisslife Jubilaumsstiftung. FW has grant support from the Pain Research Foundation and Arthritis Research UK.	Aaron LA, BEST PRACT RES CLIN, V17, P563; Abeles AM, 2007, ANN INTERN MED, V146, P726, DOI 10.7326/0003-4819-146-10-200705150-00006; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Bhui K, 1997, BRIT J HOSP MED, V58, P145; Bradley LA, 2000, CURR RHEUMATOL REP, V2, P31; Bradley Laurence A, 2005, Curr Pain Headache Rep, V9, P79, DOI 10.1007/s11916-005-0042-3; Burri A, 2015, PAIN; Burri A, 2015, TWIN RES HUM GENET, V18, P188, DOI 10.1017/thg.2015.7; Burri A, 2014, J SEX MED, V11, P2772, DOI 10.1111/jsm.12651; Casale R, 2011, BEST PRACT RES CL RH, V25, P241, DOI 10.1016/j.berh.2011.01.016; Cleare AJ, 2004, PSYCHONEUROENDOCRINO, V29, P724, DOI 10.1016/S0306-4530(03)00104-5; Croft P, 2002, J MUSCULOSKELET PAIN, V10, P191, DOI 10.1300/J094v10n01_15; Freitas RPD, 2012, J BACK MUSCULOSKELET, V25, P245, DOI 10.3233/BMR-2012-0331; Dessein PH, 1999, PAIN, V83, P313, DOI 10.1016/S0304-3959(99)00113-X; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Erosheva EA, 2002, AM STAT, V56, P273, DOI 10.1198/000313002579; Finckh A, 2005, J RHEUMATOL, V32, P1336; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gupta A, 2004, ARTHRITIS RES THER, V6, P98, DOI 10.1186/ar1176; Guymer EK, 2002, RHEUM DIS CLIN N AM, V28, P367, DOI 10.1016/S0889-857X(01)00007-2; Hartkamp A, 2008, ANN RHEUM DIS, V67, P91, DOI 10.1136/ard.2007.071563; Hotopf M, 1997, J PSYCHOSOM RES, V43, P1, DOI 10.1016/S0022-3999(97)00115-3; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650; Hur YM, 2008, TWIN RES HUM GENET, V11, P306, DOI 10.1375/twin.11.3.306; Kato K, 2009, PSYCHOL MED, V39, P497, DOI 10.1017/S0033291708003784; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Kato K, 2006, ARTHRITIS RHEUM-US, V54, P1682, DOI 10.1002/art.21798; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Livshits G, 2015, PAIN; Lovas K, 2003, J CLIN ENDOCR METAB, V88, P1112, DOI 10.1210/jc.2002-020769; Markkula R, 2009, EUR J PAIN, V13, P744, DOI 10.1016/j.ejpain.2008.09.007; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; MORALES AJ, 1994, J CLIN ENDOCR METAB, V78, P1360, DOI 10.1210/jc.78.6.1360; Nestler JE, 2002, J CLIN ENDOCR METAB, V87, P682, DOI 10.1210/jc.87.2.682; Ogata S, 2014, J EPIDEMIOL, V24, P31, DOI 10.2188/jea.JE20130070; Pamuk ON, 2009, CLIN RHEUMATOL, V28, P561, DOI 10.1007/s10067-009-1087-1; Papageorgiou AC, 2002, ANN RHEUM DIS, V61, P1071, DOI 10.1136/ard.61.12.1071; Peters MJ, 2013, ANN RHEUM DIS, V72, P427, DOI 10.1136/annrheumdis-2012-201742; Plomin R., 2013, BEHAV GENET; Posthuma D, 2010, HANDBOOK OF BEHAVIOR GENETICS, P47, DOI 10.1007/978-0-387-76727-7_4; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Rohrbeck J, 2007, BRIT J GEN PRACT, V57, P109; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Spencer NFL, 1996, EXP GERONTOL, V31, P393, DOI 10.1016/0531-5565(95)02033-0; Staud Roland, 2009, Curr Rheumatol Rep, V11, P433; Straub RH, 2002, J ENDOCRINOL, V175, P467, DOI 10.1677/joe.0.1750467; van Rensburg SJ, 2001, BRAIN RES BULL, V55, P319, DOI 10.1016/S0361-9230(01)00478-6; Virkki LM, 2010, ARTHRIT CARE RES, V62, P118, DOI 10.1002/acr.20022; Walker JG, 2007, CLIN RHEUMATOL, V26, P671, DOI 10.1007/s10067-006-0450-8; White KP, 1999, J RHEUMATOL, V26, P880; White KP, 1999, J RHEUMATOL, V26, P885; Williams FMK, 2010, RHEUMATOLOGY, V49, P1753, DOI 10.1093/rheumatology/keq170; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 1996, J RHEUMATOL, V23, P1407; Yildiz BO, 2006, FERTIL STERIL, V86, P1688, DOI 10.1016/j.fertnstert.2006.05.045	58	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0140289	10.1371/journal.pone.0140289	http://dx.doi.org/10.1371/journal.pone.0140289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599910	Green Accepted, Green Published, gold			2022-12-26	WOS:000365862600002
J	Cheng, H; Liu, L; Yu, WM; Zhang, H; Luo, DZ; Zheng, GY				Cheng, Hui; Liu, Li; Yu, Weimin; Zhang, Hong; Luo, Dianzhong; Zheng, Guoyan			Comparison of 2.5D and 3D Quantification of Femoral Head Coverage in Normal Control Subjects and Patients with Hip Dysplasia	PLOS ONE			English	Article							FEMOROACETABULAR IMPINGEMENT; PERIACETABULAR OSTEOTOMY; RADIOGRAPHIC ANALYSIS; ACETABULAR COVERAGE; PELVIC RADIOGRAPHS; RADIATION-EXPOSURE; CANCER-RISKS; CT; RELIABILITY; VERSION	Hip dysplasia is characterized by insufficient femoral head coverage (FHC). Quantification of FHC is of importance as the underlying goal of the surgery to treat hip dysplasia is to restore a normal acetabular morphology and thereby to improve FHC. Unlike a pure 2D X-ray radiograph-based measurement method or a pure 3D CT-based measurement method, previously we presented a 2.5D method to quantify FHC from a single anteriorposterior (AP) pelvic radiograph. In this study, we first quantified and compared 3D FHC between a normal control group and a patient group using a CT-based measurement method. Taking the CT-based 3D measurements of FHC as the gold standard, we further quantified the bias, precision and correlation between the 2.5D measurements and the 3D measurements on both the control group and the patient group. Based on digitally reconstructed radiographs (DRRs), we investigated the influence of the pelvic tilt on the 2.5D measurements of FHC. The intraclass correlation coefficients (ICCs) for absolute agreement was used to quantify interobserver reliability and intraobserver reproducibility of the 2.5D measurement technique. The Pearson correlation coefficient, r, was used to determine the strength of the linear association between the 2.5D and the 3D measurements. Student's t-test was used to determine whether the differences between different measurements were statistically significant. Our experimental results demonstrated that both the interobserver reliability and the intraobserver reproducibility of the 2.5D measurement technique were very good (ICCs > 0.8). Regression analysis indicated that the correlation was very strong between the 2.5D and the 3D measurements (r = 0.89, p < 0.001). Student's t-test showed that there were no statistically significant differences between the 2.5D and the 3D measurements of FHC on the patient group (p > 0.05). The results of this study provided convincing evidence demonstrating the validity of the 2.5D measurements of FHC from a single AP pelvic radiograph and proved that it could serve as a surrogate for 3D CT-based measurements. Thus it may be possible to use this method to avoid a CT scan for the purpose of estimating 3D FHC in diagnosis and post-operative treatment evaluation of patients with hip dysplasia.	[Cheng, Hui; Zhang, Hong; Luo, Dianzhong] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Orthopaed Surg, Div Joint Surg, Beijing, Peoples R China; [Cheng, Hui; Liu, Li; Yu, Weimin; Zheng, Guoyan] Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland	Chinese People's Liberation Army General Hospital; University of Bern	Zheng, GY (corresponding author), Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland.	guoyan.zheng@ieee.org	, Guoyan/M-3617-2018; Zheng, Guoyan/C-8079-2014	, Guoyan/0000-0003-4173-0379; Cheng, Hui/0000-0003-2137-2041	Sino-Swiss Science and Technology Cooperation Program [EG 11-032014]	Sino-Swiss Science and Technology Cooperation Program	This work was partially supported by Sino-Swiss Science and Technology Cooperation Program, EG 11-032014 (GZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2012, SKELETAL RADIOL, V41, P1411, DOI 10.1007/s00256-012-1368-7; Clohisy JC, 2008, J BONE JOINT SURG AM, V90A, P47, DOI 10.2106/JBJS.H.00756; Collier MB, 2003, J BONE JOINT SURG AM, V85A, P2410, DOI 10.2106/00004623-200312000-00020; Cooperman D, 2013, J PEDIATR ORTHOPED, V33, pS2, DOI 10.1097/BPO.0b013e3182770a8d; COOPERMAN DR, 1983, CLIN ORTHOP RELAT R, P79; Dandachli W, 2008, J BONE JOINT SURG BR, V90B, P1428, DOI 10.1302/0301-620X.90B11.20073; Engesaeter IO, 2012, SKELETAL RADIOL, V41, P775, DOI 10.1007/s00256-011-1283-3; Flohr TG, 2005, RADIOLOGY, V235, P756, DOI 10.1148/radiol.2353040037; GANZ R, 1988, CLIN ORTHOP RELAT R, P26; HARRIS WH, 1986, CLIN ORTHOP RELAT R, P20; KLAUE K, 1988, CLIN ORTHOP RELAT R, P15; Kleinerman RA, 2006, PEDIATR RADIOL, V36, P121, DOI 10.1007/s00247-006-0191-5; KONISHI N, 1993, J BONE JOINT SURG AM, V75A, P1318, DOI 10.2106/00004623-199309000-00007; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lembeck B, 2005, ACTA ORTHOP, V76, P517, DOI 10.1080/17453670510041501; Liu L., 2014, COMPUTER ASSISTED PL, P643; Liu L, 2015, MED ENG PHY IN PRESS; Morvan J, 2013, J RHEUMATOL, V40, P1583, DOI 10.3899/jrheum.121544; MURPHY SB, 1995, J BONE JOINT SURG AM, V77A, P985, DOI 10.2106/00004623-199507000-00002; Nepple JJ, 2014, AM J SPORT MED, V42, P2393, DOI 10.1177/0363546514542797; Nho JH, 2012, J BONE JOINT SURG BR, V94B, P32, DOI 10.1302/0301-620X.94B1.27621; Pedersen DR, 2004, J PEDIATR ORTHOPED, V24, P156, DOI 10.1097/01241398-200403000-00004; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; STEEL HH, 1977, CLIN ORTHOP RELAT R, P116; Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P782, DOI 10.1007/s11999-008-0141-7; Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P1633, DOI 10.1007/s11999-008-0242-3; Tannast M, 2005, CLIN ORTHOP RELAT R, P182, DOI 10.1097/01.blo.0000167669.26068.c5; Tannast M, 2008, J ORTHOP RES, V26, P1199, DOI 10.1002/jor.20653; Wiberg G., 1939, ACTA CHIR SCAND, V83, P53; Zheng G, 2007, COMPUT METH PROG BIO, V87, P36, DOI 10.1016/j.cmpb.2007.02.010	31	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143498	10.1371/journal.pone.0143498	http://dx.doi.org/10.1371/journal.pone.0143498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599869	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600071
J	Faruque, MRI; Hossain, MI; Misran, N; Singh, M; Islam, MT				Faruque, M. R. I.; Hossain, M. I.; Misran, N.; Singh, M.; Islam, M. T.			Metamaterial-Embedded Low SAR PIFA for Cellular Phone	PLOS ONE			English	Article							ANTENNA	A metamaterial-embedded planar inverted-F antenna (PIFA) is proposed in this study for cellular phone applications. A dual-band PIFA is designed to operate both GSM 900 MHz and DCS 1800 MHz. The ground plane of a conventional PIFA is modified using a planar one-dimensional metamaterial array. The investigation is performed using the Finite Integration Technique (FIT) of CST Microwave Studio. The performance of the developed antenna was measured in an anechoic chamber. The specific absorption rate (SAR) values are calculated considering two different holding positions: cheek and tilt. The SAR values are measured using COMOSAR measurement system. Good agreement is observed between the simulated and measured data. The results indicate that the proposed metamaterial-embedded antenna produces significantly lower SAR in the human head compared to the conventional PIFA. Moreover, the modified antenna substrate leads to slight improvement of the antenna performances.	[Faruque, M. R. I.; Hossain, M. I.] Univ Kebangsaan Malaysia, Space Sci Ctr ANGKASA, Bangi 43600, Selangor, Malaysia; [Misran, N.; Singh, M.; Islam, M. T.] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Faruque, MRI (corresponding author), Univ Kebangsaan Malaysia, Space Sci Ctr ANGKASA, Bangi 43600, Selangor, Malaysia.	rashedgen@yahoo.com	Islam, Mohammad Tariqul/E-6380-2012; Faruque, Mohammad Rashed Iqbal/Q-5957-2019; Misran, Norbahiah/U-1666-2019; Hossain, Ikbal/AAS-7099-2021; Islam, Mohammad Tariqul/M-7377-2016	Islam, Mohammad Tariqul/0000-0002-4929-3209; Faruque, Mohammad Rashed Iqbal/0000-0003-4086-7672; Misran, Norbahiah/0000-0002-6142-8591; Hossain, Ikbal/0000-0002-3985-5255; Islam, Mohammad Tariqul/0000-0002-4929-3209	Research Universiti Grant, Dana Lonjakan Penerbitan [DLP-2014-003]	Research Universiti Grant, Dana Lonjakan Penerbitan	This work was supported by the Research Universiti Grant, Dana Lonjakan Penerbitan, grant No. DLP-2014-003.	[Anonymous], 1996, 96326 FCC; Barroso JJ, 2010, J ELECTROMAGNET WAVE, V24, P1563, DOI 10.1163/156939310792149759; Bonev I. B., 2011, Proceedings of the 2011 International Conference on Electromagnetics in Advanced Applications & IEEE-APS Topical Conference on Antennas & Propagation in Wireless Communications (ICEAA 2011), P769, DOI 10.1109/ICEAA.2011.6046443; Ebrahimi-Ganjeh MA, 2007, PROG ELECTROMAGN RES, V77, P225, DOI 10.2528/PIER07081804; Faruque MRI, 2013, MEAS SCI REV, V13, P70, DOI 10.2478/msr-2013-0011; Faruque MRI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109947; Goldsmith JR, 1996, SCI TOTAL ENVIRON, V180, P3, DOI 10.1016/0048-9697(95)04914-2; Hossain MI, 2015, PROG BIOPHYS MOL BIO, V119, P103, DOI 10.1016/j.pbiomolbio.2015.03.008; Hossain MI, 2015, APPL COMPUT ELECTROM, V30, P792; Hossain M. I., 2014, Advanced Materials Research, V974, P288, DOI 10.4028/www.scientific.net/AMR.974.288; Hossain MI, 2015, MATERIALS, V8, P57, DOI 10.3390/ma8010057; Islam MT, 2012, PROG ELECTROMAGN RES, V128, P121, DOI 10.2528/PIER12030105; Kahng S, 2014, J ELECTR ENG TECHNOL, V9, P622, DOI 10.5370/JEET.2014.9.2.622; Kusuma AH, 2011, PROG ELECTROMAGN RES, V112, P23, DOI 10.2528/PIER10101802; Kwak SI, 2007, 2007 EUROPEAN MICROWAVE CONFERENCE, VOLS 1-4, P937; McKinlay AF, 2004, HEALTH PHYS, V87, P171; Moulder JE, 2005, INT J RADIAT BIOL, V81, P189, DOI 10.1080/09553000500091097; NICOLSON AM, 1970, IEEE T INSTRUM MEAS, VIM19, P377, DOI 10.1109/TIM.1970.4313932; Panagamuwa Chinthana J., 2007, 2007 Loughborough Antennas and Propagation Conference, P261, DOI 10.1109/LAPC.2007.367479; Seker S, 2003, IEEE INT S EL COMP E; WHO, 2014, CELL PHON US CAN INC	21	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142663	10.1371/journal.pone.0142663	http://dx.doi.org/10.1371/journal.pone.0142663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599584	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900034
J	Li, ZW; Sun, F; Zhang, YH; Chen, H; He, NN; Chen, H; Song, PH; Wang, Y; Yan, S; Zheng, SS				Li, Zhiwei; Sun, Fei; Zhang, Yaohui; Chen, Hao; He, Ningning; Chen, Hui; Song, Penghong; Wang, Yan; Yan, Sheng; Zheng, Shusen			Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects	PLOS ONE			English	Article							ONSET DIABETES-MELLITUS; KIDNEY-TRANSPLANT RECIPIENTS; SOLID-ORGAN TRANSPLANTATION; IMMUNOSUPPRESSIVE DRUGS; LIVER-TRANSPLANTATION; COTRANSPORTER SGLT1; RISK-FACTORS; TRANSPORT; HYPERINSULINEMIA; INTESTINE	Background The use of the immunosuppressive drug tacrolimus (TAC) is related to new onset diabetes after transplantation. Herein, we examined the effect of intraperitoneal administered TAC on intestinal glucose absorption in mice. Methods Animals received low, medium, or high dose TAC (0.5, 1, or 5 mg/kg/d, respectively), or 0.9% saline solution (control) for 14 days. Oral glucose tolerance test (OGTT), insulin concentration test, and serum TAC concentration measurements was performed after 14 days of TAC exposure. Plasma insulin was assessed and electrogenic glucose absorption were measured by the sodium-dependent increase of the short-circuit current. Expression levels of the glucose transporters sodium glucose co-transporter (SGLT) 1, glucose transporter (GLUT) 2, and GLUT5 were also determined. Results Oral glucose absorption assessed by OGTT was significantly enhanced in the low, medium, and high groups. Serum insulin was elevated in the medium and high group compared with the control. Moreover, glucose-induced Isc was significantly higher in TAC administrated groups, which indicates that SGLT1 activity increased. Transcription levels and protein abundance of SGLT1 in the experimental groups also increased compared with the control. Conclusions TAC induced insulin resistance and strengthened intestinal glucose absorption by increasing the activity and expression of the glucose transporter, SGLT1.	[Li, Zhiwei; Sun, Fei; Zhang, Yaohui; Chen, Hao; He, Ningning; Chen, Hui; Song, Penghong; Wang, Yan; Yan, Sheng; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Shusen] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn		Sun, Fei/0000-0002-2499-6864	Public Welfare Technology Application Research Plan of Zhejiang [2015C33117]; National ST Major Project [2012ZX10002017]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81121002]	Public Welfare Technology Application Research Plan of Zhejiang; National ST Major Project; Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Public Welfare Technology Application Research Plan of Zhejiang (no. 2015C33117), National S&T Major Project (no. 2012ZX10002017) and Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No. 81121002).	Abe T, 2014, TRANSPL P, V46, P865, DOI 10.1016/j.transproceed.2013.12.027; Balakrishnan A, 2008, SURGERY, V143, P813, DOI 10.1016/j.surg.2008.03.018; Chen QJ, 2015, RENAL FAILURE, V37, P601, DOI 10.3109/0886022X.2015.1007833; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; Dong M, 2012, DIABETIC MED, V29, pE1, DOI 10.1111/j.1464-5491.2012.03617.x; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Heisel O, 2004, AM J TRANSPLANT, V4, P583, DOI 10.1046/j.1600-6143.2003.00372.x; Hjelmesaeth J, 2006, KIDNEY INT, V69, P588, DOI 10.1038/sj.ki.5000116; Hjelmesth J, 2005, CURR DIABETES REV, V1, P1, DOI 10.2174/1573399052952604; Kesiraju S, 2014, TRANSPL IMMUNOL, V30, P52, DOI 10.1016/j.trim.2013.10.006; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Kisielinski K, 2002, CLIN EXP MED, V2, P131, DOI 10.1007/s102380200018; Lankarani KB, 2014, EXP CLIN TRANSPLANT, V12, P46, DOI 10.6002/ect.2013.0047; Larsen JL, 2006, TRANSPLANTATION, V82, P466, DOI 10.1097/01.tp.0000229384.22217.15; Malinowski M, 2011, TRANSPL INT, V24, P184, DOI 10.1111/j.1432-2277.2010.01167.x; Malinowski M, 2009, ANN TRANSPL, V14, P38; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Pereira MJ, 2014, J CLIN ENDOCR METAB, V99, pE1885, DOI 10.1210/jc.2014-1266; Pham PTT, 2007, ENDOCRIN METAB CLIN, V36, P873, DOI 10.1016/j.ecl.2007.07.007; Rexhepaj R, 2011, PFLUG ARCH EUR J PHY, V462, P489, DOI 10.1007/s00424-011-0987-5; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Shirazi-Beechey SP, 2011, P NUTR SOC, V70, P185, DOI 10.1017/S0029665111000103; Stockmann M, 2002, TRANSPLANT P, V34, P1449, DOI 10.1016/S0041-1345(02)02924-X; Storset E, 2015, TRANSPLANTATION, V99, P2158, DOI 10.1097/TP.0000000000000708; Sui WG, 2008, TRANSPL IMMUNOL, V20, P95, DOI 10.1016/j.trim.2008.07.003; Valderhaug TG, 2011, DIABETOLOGIA, V54, P1341, DOI 10.1007/s00125-011-2105-9; Valderhaug TG, 2012, TRANSPLANTATION, V94, P714, DOI 10.1097/TP.0b013e31825f4434; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x; Xavier GD, 2012, DIABETOLOGIA, V55, P2667, DOI 10.1007/s00125-012-2600-7; Yan S, 2013, OBES SURG, V23, P1361, DOI 10.1007/s11695-013-0954-7; Yanchar NL, 1996, TRANSPLANTATION, V61, P630, DOI 10.1097/00007890-199602270-00019; Yu SF, 2006, TRANSPLANTATION, V81, P46, DOI 10.1097/01.tp.0000188118.34633.bf	34	24	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143405	10.1371/journal.pone.0143405	http://dx.doi.org/10.1371/journal.pone.0143405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599323	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900110
J	Lixandru, BE; Cotar, AI; Straut, M; Usein, CR; Cristea, D; Ciontea, S; Tatu-Chitoiu, D; Codita, I; Rafila, A; Nica, M; Buzea, M; Baicus, A; Ghita, MC; Nistor, I; Tuchilus, C; Indreas, M; Antohe, F; Glasner, C; Grundmann, H; Jasir, A; Damian, M				Lixandru, Brandusa Elena; Cotar, Ani Ioana; Straut, Monica; Usein, Codruta Romanita; Cristea, Dana; Ciontea, Simona; Tatu-Chitoiu, Dorina; Codita, Irina; Rafila, Alexandru; Nica, Maria; Buzea, Mariana; Baicus, Anda; Ghita, Mihaela Camelia; Nistor, Irina; Tuchilus, Cristina; Indreas, Marina; Antohe, Felicia; Glasner, Corinna; Grundmann, Hajo; Jasir, Aftab; Damian, Maria			Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey	PLOS ONE			English	Article							BETA-LACTAMASE; PSEUDOMONAS-AERUGINOSA; ENTEROBACTERIACEAE; PLASMID; SPREAD; RESISTANCE; EMERGENCE; OUTBREAK; STRAINS; TURKEY	This study presents the first characterization of carbapenem-non-susceptible Klebsiella pneumoniae isolates by means of a structured six-month survey performed in Romania as part of an Europe-wide investigation. Klebsiella pneumoniae clinical isolates from different anatomical sites were tested for antibiotic susceptibility by phenotypic methods and confirmed by PCR for the presence of four carbapenemase genes. Genome macrorestriction fingerprinting with XbaI was used to analyze the relatedness of carbapenemase-producing Klebsiella pneumoniae isolates collected from eight hospitals. Among 75 non-susceptible isolates, 65 were carbapenemase producers. The most frequently identified genotype was OXA-48 (n = 51 isolates), eight isolates were positive for bla(NDM-1) gene, four had the bla(KPC-2) gene, whereas two were positive for bla(VIM-1). The analysis of PFGE profiles of OXA-48 and NDM-1 producing K. pneumoniae suggests inter-hospitals and regional transmission of epidemic clones. This study presents the first description of K. pneumoniae strains harbouring blaKPC-2 and blaVIM-1 genes in Romania. The results of this study highlight the urgent need for the strengthening of hospital infection control measures in Romania in order to curb the further spread of the antibiotic resistance.	[Lixandru, Brandusa Elena; Cotar, Ani Ioana; Straut, Monica; Usein, Codruta Romanita; Cristea, Dana; Ciontea, Simona; Tatu-Chitoiu, Dorina; Codita, Irina; Damian, Maria] Cantacuzino Natl Inst Res Dev Microbiol & Immunol, Bucharest, Romania; [Cotar, Ani Ioana; Jasir, Aftab] European Ctr Dis Prevent & Control ECDC, European Programme Publ Hlth Microbiol Training E, Stockholm, Sweden; [Rafila, Alexandru] Matei Bals Natl Inst Infect Dis, Bucharest, Romania; [Nica, Maria] Victor Babes Hosp Infect & Trop Dis, Bucharest, Romania; [Buzea, Mariana] Elias Emergency Univ Hosp, Bucharest, Romania; [Baicus, Anda] Emergency Univ Hosp Bucharest, Bucharest, Romania; [Ghita, Mihaela Camelia] Fundeni Clin Inst, Bucharest, Romania; [Nistor, Irina] Grigore Alexandrescu Emergency Children Hosp, Bucharest, Romania; [Tuchilus, Cristina] St Spiridon Emergency Clin Hosp, Iasi, Romania; [Indreas, Marina] Bacau Cty Emergency Hosp, Bacau, Romania; [Antohe, Felicia] Nicolae Simionescu Inst Cellular Biol & Pathol, Bucharest, Romania; [Glasner, Corinna; Grundmann, Hajo] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 GZ Groningen, Netherlands	Cantacuzino Institute Bucharest; European Centre for Disease Prevention & Control; National Institute for Infectious Diseases "Matei Bals"; Victor Babes National Institute of Pathology; Institutul Clinic Fundeni; Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology; University of Groningen	Cotar, AI (corresponding author), Cantacuzino Natl Inst Res Dev Microbiol & Immunol, Splaiul Independentei 103, Bucharest, Romania.	aniioana@gmail.com	ANTOHE, Felicia/B-9860-2011; Codita, Irina/K-1057-2016; Cotar, Ani Ioana/AAV-3624-2021	Codita, Irina/0000-0002-0892-3120; ANTOHE, Felicia/0000-0002-3325-2867; Codita, Irina/0000-0002-2834-365X; Cotar, Ani Ioana/0000-0003-3770-8515	Romanian Ministry of Education and Research [PN 0922]	Romanian Ministry of Education and Research(Ministry of Education and Research - Romania)	The results presented in this work were supported by the Romanian Ministry of Education and Research, PN 0922 grant "Modernization the diagnosis of infectious diseases and improvement their surveillance through applications based on identifying the molecular mechanisms of resistance to antibiotics and antivirals and of genetic structures involved in the dissemination of resistance phenotype", coordinated by Monica Straut.	[Anonymous], 2002, OFFICIAL J EUROPEAN; Berger S, 2013, ANTIMICROB AGENTS CH, V57, P4064, DOI 10.1128/AAC.02550-12; Bogaerts P, 2011, ANTIMICROB AGENTS CH, V55, P3036, DOI 10.1128/AAC.00049-11; Bratu S, 2005, J ANTIMICROB CHEMOTH, V56, P128, DOI 10.1093/jac/dki175; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128/AAC.01672-07; Carrer A, 2010, ANTIMICROB AGENTS CH, V54, P1369, DOI 10.1128/AAC.01312-09; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P2420, DOI 10.1128/AAC.01452-10; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; EUCAST, 2013, EUCAST GUIDELINES DE; Gheorghe I, 2014, J MED MICROBIOL, V63, P1303, DOI 10.1099/jmm.0.074039-0; Glasner C, 2013, Euro Surveill, V18, DOI 10.2807/1560-7917.ES2013.18.28.20525; Grundmann H, 2010, EUROSURVEILLANCE, V15, P22; Hansen DS, 2004, J CLIN MICROBIOL, V42, P3665, DOI 10.1128/jcm.42.8.3665-3669.2004; Mavroidi A, 2000, J ANTIMICROB CHEMOTH, V46, P1041, DOI 10.1093/jac/46.6.1041; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Peirano G, 2011, DIAGN MICR INFEC DIS, V71, P106, DOI 10.1016/j.diagmicrobio.2011.06.013; Pitart C, 2011, ANTIMICROB AGENTS CH, V55, P4398, DOI 10.1128/AAC.00329-11; Pitout JDD, 2005, J CLIN MICROBIOL, V43, P3129, DOI 10.1128/JCM.43.7.3129-3135.2005; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; PulseNet, 2013, STANDARD OPERATING P; Shin SY, 2012, J MED MICROBIOL, V61, P239, DOI 10.1099/jmm.0.037036-0; Struelens MJ, 2010, EUROSURVEILLANCE, V15, P9; Szekely E, 2013, INT J MED MICROBIOL, V303, P697, DOI 10.1016/j.ijmm.2013.10.001; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Voulgari E, 2013, J ANTIMICROB CHEMOTH, V68, P84, DOI 10.1093/jac/dks356; Wang XD, 2009, J MED MICROBIOL, V58, P1196, DOI 10.1099/jmm.0.008094-0	31	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143214	10.1371/journal.pone.0143214	http://dx.doi.org/10.1371/journal.pone.0143214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599338	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900077
J	Lv, XG; Shi, YF; Xu, X; Wei, YL; Wang, HM; Zhang, XB; Wu, JL				Lv, Xiang-guang; Shi, Yong-feng; Xu, Xia; Wei, Yan-lin; Wang, Hui-mei; Zhang, Xiao-bo; Wu, Jian-li			Oryza sativa Chloroplast Signal Recognition Particle 43 (OscpSRP43) Is Required for Chloroplast Development and Photosynthesis	PLOS ONE			English	Article							HARVESTING COMPLEX-II; YELLOW COLORING 1; CHLOROPHYLL BIOSYNTHESIS; GENETIC-ANALYSIS; ANKYRIN REPEAT; MUTANT REVEALS; LEAF MUTANT; PROTEIN; REDUCTASE; DOMAIN	A rice chlorophyll-deficient mutant w67 was isolated from an ethyl methane sulfonate (EMS)-induced IR64 (Oryza sativa L. ssp. indica) mutant bank. The mutant exhibited a distinct yellow-green leaf phenotype in the whole plant growth duration with significantly reduced levels of chlorophyll and carotenoid, impaired chloroplast development and lowered capacity of photosynthesis compared with the wild-type IR64. Expression of a number of genes associated with chlorophyll metabolism, chloroplast biogenesis and photosynthesis was significantly altered in the mutant. Genetic analysis indicated that the yellow-green phenotype was controlled by a single recessive nuclear gene located on the short arm of chromosome 3. Using map-based strategy, the mutation was isolated and predicted to encode a chloroplast signal recognition particle 43 KD protein (cpSRP43) with 388 amino acid residuals. A single base substitution from A to T at position 160 resulted in a premature stop codon. OscpSRP43 was constitutively expressed in various organs with the highest level in the leaf. Functional complementation could rescue the mutant phenotype and subcellular localization showed that the cpSRP43:GFP fusion protein was targeted to the chloroplast. The data suggested that Oryza sativa cpSRP43 (OscpSRP43) was required for the normal development of chloroplasts and photosynthesis in rice.	[Lv, Xiang-guang; Shi, Yong-feng; Xu, Xia; Wei, Yan-lin; Wang, Hui-mei; Zhang, Xiao-bo; Wu, Jian-li] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Wu, JL (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	beishangd@163.com		xiang guang, lu/0000-0001-9588-1717; wang, hui mei/0000-0002-8353-8978	National High Technology Research and Development Program of China [2014AA10A603, 2012AA101102]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (Nos. 2014AA10A603 and 2012AA101102).	Agne B, 2010, PLANT PHYSIOL, V153, P1016, DOI 10.1104/pp.110.158048; Agne B, 2009, J BIOL CHEM, V284, P8661, DOI 10.1074/jbc.M804235200; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asakura Y, 2004, PLANT CELL, V16, P201, DOI 10.1105/tpc.014787; Asakura Y, 2008, PLANT J, V56, P1007, DOI 10.1111/j.1365-313X.2008.03659.x; Barry CS, 2012, PLANT PHYSIOL, V159, P1086, DOI 10.1104/pp.112.197483; Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; Belcher S, 2015, BBA-BIOENERGETICS, V1847, P1004, DOI 10.1016/j.bbabio.2015.02.014; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Christ B, 2014, J PLANT GROWTH REGUL, V33, P4, DOI 10.1007/s00344-013-9392-y; Dong H, 2013, PLANT PHYSIOL, V162, P1867, DOI 10.1104/pp.113.217604; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Holdermann I, 2012, NAT STRUCT MOL BIOL, V19, P260, DOI 10.1038/nsmb.2196; Huang QN, 2016, J INTEGR PLANT BIOL, V58, P12, DOI 10.1111/jipb.12372; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Jia T, 2015, PLANT J, V81, P586, DOI 10.1111/tpj.12753; Jiang Q, 2014, PLANT SCI, V215, P172, DOI 10.1016/j.plantsci.2013.11.003; Kim S, 2013, PLANT CELL, V25, P4984, DOI 10.1105/tpc.113.119172; Kirst H, 2012, PLANT PHYSIOL, V160, P2251, DOI 10.1104/pp.112.206672; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kumar AM, 2000, PLANT PHYSIOL, V122, P49, DOI 10.1104/pp.122.1.49; Kumar KK, 2005, PLANT MOL BIOL REP, V23, P67, DOI 10.1007/BF02772648; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Lee KH, 2003, J BIOL CHEM, V278, P36794, DOI 10.1074/jbc.M304457200; Lee S, 2005, PLANT MOL BIOL, V57, P805, DOI 10.1007/s11103-005-2066-9; Lin YP, 2014, PLANT J, V80, P14, DOI 10.1111/tpj.12611; Lu Y. J., 1992, Chinese Journal of Rice Science, V6, P47; McCormac AC, 2001, PLANT J, V25, P549, DOI 10.1046/j.1365-313x.2001.00986.x; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; PARHAM R, 1995, ANAL BIOCHEM, V231, P164, DOI 10.1006/abio.1995.1516; Piskozub M, 2015, J BIOENERG BIOMEMBR, V47, P265, DOI 10.1007/s10863-014-9598-0; Sakuraba Y, 2013, BIOCHEM BIOPH RES CO, V430, P32, DOI 10.1016/j.bbrc.2012.11.050; Sato Y, 2009, PLANT J, V57, P120, DOI 10.1111/j.1365-313X.2008.03670.x; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Shi DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080107; Shi YF, 2009, SCI CHINA SER C, V52, P885, DOI 10.1007/s11427-009-0109-1; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Thomas H, 2014, J EXP BOT, V65, P3889, DOI 10.1093/jxb/eru037; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Vothknecht UC, 2012, J EXP BOT, V63, P1699, DOI 10.1093/jxb/err357; Wang PR, 2010, PLANT PHYSIOL, V153, P994, DOI 10.1104/pp.110.158477; Wang Q, 2004, PLANT PHYSIOL, V136, P3594, DOI 10.1104/pp.104.049841; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Zhang LG, 2012, PLANT CELL, V24, P3695, DOI 10.1105/tpc.112.103606; Zhou KN, 2013, PLANTA, V237, P279, DOI 10.1007/s00425-012-1756-1	51	23	29	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143249	10.1371/journal.pone.0143249	http://dx.doi.org/10.1371/journal.pone.0143249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600124	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900081
J	Thrane, S; Janitzek, CM; Agerbaek, MO; Ditlev, SB; Resende, M; Nielsen, MA; Theander, TG; Salanti, A; Sander, AF				Thrane, Susan; Janitzek, Christoph M.; Agerbaek, Mette O.; Ditlev, Sisse B.; Resende, Mafalda; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali; Sander, Adam F.			A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; PLASMODIUM-FALCIPARUM PARASITES; STREPTAVIDIN MONOMER; PROTEIN; ANTIBODIES; INDUCTION; ADHESION; DELIVERY; BINDING	Placental malaria caused by Plasmodium falciparum is a major cause of mortality and severe morbidity. Clinical testing of a soluble protein-based vaccine containing the parasite ligand, VAR2CSA, has been initiated. VAR2CSA binds to the human receptor chondroitin sulphate A (CSA) and is responsible for sequestration of Plasmodium falciparum infected erythrocytes in the placenta. It is imperative that a vaccine against malaria in pregnancy, if administered to women before they become pregnant, can induce a strong and long lasting immune response. While most soluble protein-based vaccines have failed during clinical testing, virus-like particle (VLP) based vaccines (e.g., the licensed human papillomavirus vaccines) have demonstrated high efficacy, suggesting that the spatial assembly of the vaccine antigen is a critical parameter for inducing an optimal long-lasting protective immune response. We have developed a VLP vaccine display platform by identifying regions of the HPV16 L1 coat protein where a biotin acceptor site (AviTag (TM)) can be inserted without compromising VLP-assembly. Subsequent biotinylation of Avi-L1 VLPs allow us to anchor monovalent streptavidin (mSA)-fused proteins to the biotin, thereby obtaining a dense and repetitive VLP-display of the vaccine antigen. The mSA-VAR2CSA antigen was delivered on the Avi-L1 VLP platform and tested in C57BL/6 mice in comparison to two soluble protein-based vaccines consisting of naked VAR2CSA and mSA-VAR2CSA. The mSA-VAR2CSA Avi-L1 VLP and soluble mSA-VAR2CSA vaccines induced higher antibody titers than the soluble naked VAR2CSA vaccine after three immunizations. The VAR2CSA Avi-L1 VLP vaccine induced statistically significantly higher endpoint titres compared to the soluble mSA-VAR2CSA vaccine, after 1st and 2nd immunization; however, this difference was not statistically significant after 3rd immunization. Importantly, the VLP-VAR2CSA induced antibodies were functional in inhibiting the binding of parasites to CSA. This study demonstrates that the described Avi-L1 VLP-platform may serve as a versatile system for facilitating optimal VLP-display of large and complex vaccine antigens.	[Thrane, Susan; Janitzek, Christoph M.; Agerbaek, Mette O.; Ditlev, Sisse B.; Resende, Mafalda; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali; Sander, Adam F.] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Thrane, Susan; Janitzek, Christoph M.; Agerbaek, Mette O.; Ditlev, Sisse B.; Resende, Mafalda; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali; Sander, Adam F.] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Sander, AF (corresponding author), Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.	adamsander@gmail.com	Theander, Thor/F-6714-2015	Theander, Thor/0000-0002-3509-7514; Thrane, Susan/0000-0001-6596-3527; Agerbaek, Mette Orskov/0000-0001-5865-2034; Nielsen, Morten Agertoug/0000-0003-2668-4992; Bertelsen, Adam Frederik Sander/0000-0002-8782-7830; Salanti, Ali/0000-0003-2207-5575; Ditlev, Sisse Bolm/0000-0003-4417-9711; Janitzek, Christoph Mikkel/0000-0001-6529-9355	Bill and Melinda Gates Foundation [APP178218]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The project was funded through a grant from Bill and Melinda Gates Foundation Grant ID APP178218 [http://www.gatesfoundation.org]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Bill and Melinda Gates foundation for financial support.	Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2007, CURRENT PROTOCOLS CE, V26, P1, DOI DOI 10.1002/0471143030.CB2601S37; Cardone G, 2014, MATURATION HUMAN PAP; Chackerian B, 2002, J IMMUNOL, V169, P6120, DOI 10.4049/jimmunol.169.11.6120; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; De Vincenzo R, 2014, INT J WOMENS HEALTH, V6, P999, DOI 10.2147/IJWH.S50365; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Hartman TK, 2010, ANN TROP PAEDIATR, V30, P271, DOI 10.1179/146532810X12858955921032; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Koho T, 2015, EUR J PHARM BIOPHARM, V96, P22, DOI 10.1016/j.ejpb.2015.07.002; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; Lechner F, 2002, INTERVIROLOGY, V45, P212, DOI 10.1159/000067912; Lim KH, 2013, BIOTECHNOL BIOENG, V110, P57, DOI 10.1002/bit.24605; Lim KH, 2011, BIOCHEMISTRY-US, V50, P8682, DOI 10.1021/bi2010366; Moyle PM, 2013, CHEMMEDCHEM, V8, P360, DOI 10.1002/cmdc.201200487; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nielsen MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135406; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Peacey M, 2007, BIOTECHNOL BIOENG, V98, P968, DOI 10.1002/bit.21518; Safaeian M, 2013, CANCER PREV RES, V6, P1242, DOI 10.1158/1940-6207.CAPR-13-0203; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Schiller J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004254; Schmiegelow C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053794; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Tuikuendam N, 2015, DEV VACCINES PREVENT, P1; World Health Organization, 2013, NATURE	36	42	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143071	10.1371/journal.pone.0143071	http://dx.doi.org/10.1371/journal.pone.0143071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599509	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900062
J	Zembe, YZ; Townsend, L; Thorson, A; Silberschmidt, M; Ekstrom, AM				Zembe, Yanga Z.; Townsend, Loraine; Thorson, Anna; Silberschmidt, Margrethe; Ekstrom, Anna Mia			Intimate Partner Violence, Relationship Power Inequity and the Role of Sexual and Social Risk Factors in the Production of Violence among Young Women Who Have Multiple Sexual Partners in a Peri-Urban Setting in South Africa	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; ADOLESCENT GIRLS; HIV; PREVENTION; ATTITUDES; MEN	Introduction This paper aims to assess the extent and correlates of intimate partner violence (IPV), explore relationship power inequity and the role of sexual and social risk factors in the production of violence among young women aged 16-24 reporting more than one partner in the past three months in a peri-urban setting in the Western Cape, South Africa. Recent estimates suggest that every six hours a woman is killed by an intimate partner in South Africa, making IPV a leading public health problem in the country. While there is mounting evidence that levels of IPV are high in peri-urban settings in South Africa, not much is known about how it manifests among women who engage in concomitantly high HIV risk behaviours such as multiple sexual partnering, transactional sex and age mixing. We know even less about how such women negotiate power and control if exposed to violence in such sexual networks. Methods Two hundred and fifty nine women with multiple sexual partners, residing in a predominantly Black peri-urban community in the Western Cape, South Africa, were recruited into a bio-behavioural survey using Respondent Driven Sampling (RDS). After the survey, focus group discussions and individual interviews were conducted among young women and men to understand the underlying factors informing their risk behaviours and experiences of violence. Findings 86% of the young women experienced IPV in the past 12 months. Sexual IPV was significantly correlated with sex with a man who was 5 years or older than the index female partner (OR 1.7, 95% CI 1.0-3.2) and transactional sex with most recent casual partner (OR 2.1, 95% CI 1.1-3.8). Predictably, women experienced high levels of relationship power inequity. However, they also identified areas in their controlling relationships where they shared decision making power. Discussion Levels of IPV among young women with multiple sexual partners were much higher than what is reported among women in the general population and shown to be associated with sexual risk taking. Interventions targeting IPV need to address sexual risk taking as it heightens vulnerability to violence.	[Zembe, Yanga Z.; Townsend, Loraine] Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Zembe, Yanga Z.; Thorson, Anna; Ekstrom, Anna Mia] Karolinska Inst, Dept Publ Hlth Sci Global Hlth, Stockholm, Sweden; [Zembe, Yanga Z.; Thorson, Anna; Ekstrom, Anna Mia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Silberschmidt, Margrethe] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Copenhagen	Zembe, YZ (corresponding author), Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa.	yanga.zembe@mrc.ac.za	Fazli, Ghazal/AAE-8320-2022	Thorson, Anna/0000-0002-8703-6561	International Development Research Centre (IDRC); Health Economics HIV/AIDS Research Division (HEARD) at the University of Kwazulu Natal; Centers for Disease Control and Prevention (CDC); Fogarty AIDS International Training and Research Program (AITRP); IDRC/HEARD	International Development Research Centre (IDRC); Health Economics HIV/AIDS Research Division (HEARD) at the University of Kwazulu Natal; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty AIDS International Training and Research Program (AITRP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); IDRC/HEARD	The International Development Research Centre (IDRC) and the Health Economics HIV/AIDS Research Division (HEARD) at the University of Kwazulu Natal funded the development and implementation of the qualitative study. The Centers for Disease Control and Prevention (CDC) funded the data collection activities of the quantitative component and the Fogarty AIDS International Training and Research Program (AITRP) funded the manuscript preparation activities. The IDRC/HEARD funders contributed insights to the interpretation of the findings of the qualitative component of this manuscript, through two symposiums that were held wherein the lead author shared the preliminary findings of the study with the funders and other donor recipients who were participants at the symposiums. The IDRC/HEARD funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The CDC and the ARTRP had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrahams Naeemah, 2006, Violence Vict, V21, P247; Abrahams N, 2009, VIOLENCE VICTIMS, V24, P546, DOI 10.1891/0886-6708.24.4.546; Burn SM, 2009, SEX ROLES, V60, P779, DOI 10.1007/s11199-008-9581-5; Chopra M, 2009, JAIDS-J ACQ IMM DEF, V51, P72, DOI 10.1097/QAI.0b013e31819907de; Dunkle K, 2006, AIDS, V20, P2017; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Graham K, 2014, DRUG ALCOHOL REV, V33, P393, DOI 10.1111/dar.12153; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hindin MJ, 2003, B WORLD HEALTH ORGAN, V81, P501; Hunter M, 2005, CULT HEALTH SEX, V7, P209, DOI 10.1080/13691050412331293458; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kabeer Naila., 2005, GENDER DEV, V13, P13, DOI [10.1080/13552070512331332273, DOI 10.1080/13552070512331332273]; Kalichman SC, 2010, ALCOHOL RES HLTH, V33; Kim J, 2002, SOC SCI MED, V54, P1243, DOI 10.1016/S0277-9536(01)00093-4; Leclerc-Madlala S, 2008, INTERGENERATIONAL AG; Luke N, 2002, CROSS GENERATIONAL S; Luke N, 2005, INT FAMILY PLANNING, V31, P1; Machisa M, 2011, WAR HOME FINDINGS GE; Norman R, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-32; Petersen I, 2005, CHILD ABUSE NEGLECT, V29, P1233, DOI 10.1016/j.chiabu.2005.02.012; Pettifor AE, 2004, EMERGING INFECT DIS, V10; Pitpitan EV, 2012, SOC SCI MED, V75, P1417, DOI 10.1016/j.socscimed.2012.06.020; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Santelli JS, 2001, FAM PLANN PERSPECT, V33, P200, DOI 10.2307/2673782; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Shields N, 2008, CHILD ABUSE NEGLECT, V32, P589, DOI 10.1016/j.chiabu.2007.07.010; SHISANA O, 2005, S AFRICAN NATL HIV P; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; Singh K, 2010, AIDS BEHAV, V14, P200, DOI 10.1007/s10461-009-9572-8; South African Police Services, 2012, CRIM MBEKW WC APR MA; South African Police Services, 2006, SAF AND SEC; Statistics South Africa, 2012, 030141105 STAT S AFR; Townsend L, 2011, AIDS BEHAV, V15, P132, DOI 10.1007/s10461-010-9680-5; Walker L, 2005, CULT HEALTH SEX, V7, P225, DOI 10.1080/13691050410001713215; Weir SS, 2008, TROP MED INT HEALTH, V13, P801, DOI 10.1111/j.1365-3156.2008.02057.x; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; WHO, 2005, MULT STUD WOM HLTH D; Wilson HW, 2012, PSYCHOL VIOLENCE, V2, P194, DOI 10.1037/a0027265; Wood K, 1997, Gend Dev, V5, P41; Zembe YZ, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-28; Zembe YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051998	44	40	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0139430	10.1371/journal.pone.0139430	http://dx.doi.org/10.1371/journal.pone.0139430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599394	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900003
J	Zhao, HF; Feng, L; Jiang, WD; Liu, Y; Jiang, J; Wu, P; Zhao, J; Kuang, SY; Tang, L; Tang, WN; Zhang, YA; Zhou, XQ				Zhao, Hua-Fu; Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Jiang, Jun; Wu, Pei; Zhao, Juan; Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng; Zhang, Yong-An; Zhou, Xiao-Qiu			Flesh Shear Force, Cooking Loss, Muscle Antioxidant Status and Relative Expression of Signaling Molecules (Nrf2, Keap1, TOR, and CK2) and Their Target Genes in Young Grass Carp (Ctenopharyngodon idella) Muscle Fed with Graded Levels of Choline	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; WATER-HOLDING CAPACITY; COD GADUS-MORHUA; ATLANTIC SALMON; GROWTH-PERFORMANCE; ENZYME-ACTIVITIES; DIETARY CHOLINE; JUVENILE JIAN; VAR. JIAN; VITAMIN-E	Six groups of grass carp (average weight 266.9 +/- 0.6 g) were fed diets containing 197, 385, 770, 1082, 1436 and 1795 mg choline/kg, for 8 weeks. Fish growth, and muscle nutrient (protein, fat and amino acid) content of young grass carp were significantly improved by appropriate dietary choline. Furthermore, muscle hydroxyproline concentration, lactate content and shear force were improved by optimum dietary choline supplementation. However, the muscle pH value, cooking loss and cathepsins activities showed an opposite trend. Additionally, optimum dietary choline supplementation attenuated muscle oxidative damage in grass carp. The muscle antioxidant enzyme (catalase and glutathione reductase did not change) activities and glutathione content were enhanced by optimum dietary choline supplementation. Muscle cooking loss was negatively correlated with antioxidant enzyme activities and glutathione content. At the gene level, these antioxidant enzymes, as well as the targets of rapamycin, casein kinase 2 and NF-E2-related factor 2 transcripts in fish muscle were always up-regulated by suitable choline. However, suitable choline significantly decreased Kelch-like ECH-associated protein 1 a (Keap1a) and Kelch-like ECH-associated protein 1 b (Keap1b) mRNA levels in muscle. In conclusion, suitable dietary choline enhanced fish flesh quality, and the decreased cooking loss was due to the elevated antioxidant status that may be regulated by Nrf2 signaling.	[Zhao, Hua-Fu; Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Jiang, Jun; Wu, Pei; Zhao, Juan; Zhou, Xiao-Qiu] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Jiang, Jun; Wu, Pei; Zhou, Xiao-Qiu] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu 611130, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Jiang, Jun; Wu, Pei; Zhou, Xiao-Qiu] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, China Minist Educ, Chengdu 611130, Peoples R China; [Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu 610066, Peoples R China; [Zhang, Yong-An] Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhou, XQ (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China.	xqzhouqq@tom.com	Jun, Jiang/CAE-8962-2022; jiang, jun/GWC-9329-2022; liu, yang/HHY-8583-2022	Zhang, Yong-An/0000-0002-9956-3879	National Basic Research Program of China (973 Program) [2014CB138600]; National Department Public Benefit Research Foundation (Agriculture) of China [201003020]; Science and Technology Support Programme of Sichuan Province of China [2014NZ0003]; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2012NC0007, 2013NC0045]; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2015CC0011]; Natural Science Foundation for Young Scientists of Sichuan Province [2014JQ0007]; Sichuan Province Research Foundation for Basic Research [2013JY0082]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Department Public Benefit Research Foundation (Agriculture) of China; Science and Technology Support Programme of Sichuan Province of China; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Natural Science Foundation for Young Scientists of Sichuan Province; Sichuan Province Research Foundation for Basic Research	This research was financially supported by the National Basic Research Program of China (973 Program) (2014CB138600), National Department Public Benefit Research Foundation (Agriculture) of China (201003020), Science and Technology Support Programme of Sichuan Province of China (2014NZ0003), Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2012NC0007, 2013NC0045), the Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2015CC0011), Natural Science Foundation for Young Scientists of Sichuan Province (2014JQ0007) and Sichuan Province Research Foundation for Basic Research (2013JY0082). The authors would like to thank the personnel of these teams for their kind assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2013, FOOD CHEM, V140, P238, DOI 10.1016/j.foodchem.2013.02.042; Alirezaei M., 2012, COMP CLIN PATHOL, V23, P161, DOI [10.1007/s00580-012-1589-0, DOI 10.1007/S00580-012-1589-0]; Armenteros M, 2009, MEAT SCI, V83, P104, DOI 10.1016/j.meatsci.2009.04.007; ASGHAR A, 1991, J SCI FOOD AGR, V57, P31, DOI 10.1002/jsfa.2740570104; Atli G, 2010, ECOTOX ENVIRON SAFE, V73, P1884, DOI 10.1016/j.ecoenv.2010.09.005; Belal IEH, 2005, BIORESOURCE TECHNOL, V96, P395, DOI 10.1016/j.biortech.2003.11.030; Bjorlykke GA, 2011, FOOD CHEM, V127, P1706, DOI 10.1016/j.foodchem.2011.02.045; Blaszczyk I, 2010, BIOL TRACE ELEM RES, V133, P60, DOI 10.1007/s12011-009-8412-z; Brinker A, 2011, AQUACULTURE, V310, P350, DOI 10.1016/j.aquaculture.2010.09.041; Cai DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105504; Chen SR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053662, 10.1371/journal.pone.0056380]; Craig SR, 1997, AQUACULTURE, V151, P259, DOI 10.1016/S0044-8486(96)01479-2; Deng YP, 2014, AQUACULTURE, V434, P66, DOI 10.1016/j.aquaculture.2014.07.026; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063388; Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818; Feng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069974; Flores-Mateo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105881; Fuentes A, 2010, FOOD CHEM, V119, P1514, DOI 10.1016/j.foodchem.2009.09.036; Gan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115129; GARDINER JE, 1974, J PHYSIOL-LONDON, V239, P459, DOI 10.1113/jphysiol.1974.sp010578; Geurden I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083162; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Godiksen H, 2009, FOOD CHEM, V113, P889, DOI 10.1016/j.foodchem.2008.08.012; Grattagliano I, 2000, J NUTR, V130, P2131, DOI 10.1093/jn/130.9.2131; He HJ, 2014, FOOD CHEM, V156, P394, DOI 10.1016/j.foodchem.2014.01.118; Hernandez MD, 2009, FOOD CHEM, V114, P237, DOI 10.1016/j.foodchem.2008.09.045; Hultmann L, 2007, FOOD CHEM, V104, P1687, DOI 10.1016/j.foodchem.2007.03.030; Hultmann L, 2012, FOOD CHEM, V134, P1399, DOI 10.1016/j.foodchem.2012.03.038; Ilcol YO, 2003, EUR J BIOCHEM, V270, P991, DOI 10.1046/j.1432-1033.2003.03472.x; Jiang J, 2009, AQUACULT NUTR, V15, P409, DOI 10.1111/j.1365-2095.2008.00605.x; Jiang WD, 2014, AQUAT TOXICOL, V155, P301, DOI 10.1016/j.aquatox.2014.07.003; Jiang WD, 2010, FOOD CHEM, V120, P692, DOI 10.1016/j.foodchem.2009.10.062; Jiang WD, 2009, AQUAC RES, V40, P955, DOI 10.1111/j.1365-2109.2009.02191.x; Johnston IA, 1999, AQUACULTURE, V177, P99, DOI 10.1016/S0044-8486(99)00072-1; Johnston IA, 2006, AQUACULTURE, V256, P323, DOI 10.1016/j.aquaculture.2006.02.048; Kamireddy N, 2011, J FOOD SCI, V76, pS233, DOI 10.1111/j.1750-3841.2011.02121.x; Khan MA, 2004, AQUAC RES, V35, P1277, DOI 10.1111/j.1365-2109.2004.01150.x; Khan N, 2011, PAK J ZOOL, V43, P1177; Larsson T, 2014, AQUACULTURE, V426, P288, DOI 10.1016/j.aquaculture.2014.01.034; Larsson T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039219; Li SH, 2008, FOOD CHEM, V111, P879, DOI 10.1016/j.foodchem.2008.04.072; Li XY, 2014, FISH PHYSIOL BIOCHEM, V40, P673, DOI 10.1007/s10695-013-9875-6; Liu DS, 2013, FOOD CHEM, V140, P105, DOI 10.1016/j.foodchem.2013.02.034; Lomiwes D, 2014, MEAT SCI, V96, P646, DOI 10.1016/j.meatsci.2013.08.022; Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]; Mai KS, 2009, AQUACULTURE, V289, P124, DOI 10.1016/j.aquaculture.2009.01.016; Martinez I, 2011, FOOD CHEM, V126, P140, DOI 10.1016/j.foodchem.2010.10.090; Matthews JO, 2001, J ANIM SCI, V79, P967; Mehta AK, 2009, EUR J CLIN INVEST, V39, P934, DOI 10.1111/j.1365-2362.2009.02190.x; Menezes C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114233; Mercado N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088168; Morkore T, 2003, J FOOD SCI, V68, P1492, DOI 10.1111/j.1365-2621.2003.tb09672.x; Nieto N, 2007, J HEPATOL, V46, P330, DOI 10.1016/j.jhep.2006.09.010; Ogino C, 1970, Bull. Jap. Soc. scient. Fish., V36, P1140; Okouchi M, 2006, CURR NEUROVASC RES, V3, P249, DOI 10.2174/156720206778792876; Olsen BB, 2012, INT J ONCOL, V41, P1967, DOI 10.3892/ijo.2012.1635; Olsson GB, 2003, LEBENSM-WISS TECHNOL, V36, P125, DOI 10.1016/S0023-6438(02)00205-0; Ossani G, 2007, FRONT BIOSCI-LANDMRK, V12, P1174, DOI 10.2741/2135; Pacelli C, 2010, J NUTR, V140, P1072, DOI 10.3945/jn.109.116673; Pearce KL, 2011, MEAT SCI, V89, P111, DOI 10.1016/j.meatsci.2011.04.007; Periago Ma.J., 2005, Aquaculture, V249, P175, DOI 10.1016/j.aquaculture.2005.02.047; POSTON HA, 1991, PROG FISH CULT, V53, P220, DOI 10.1577/1548-8640(1991)053&lt;0220:CROSUR&gt;2.3.CO;2; Qiao H, 2009, J VASC RES, V46, P15, DOI 10.1159/000135661; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Repetto MG, 2010, EXP MOL PATHOL, V88, P143, DOI 10.1016/j.yexmp.2009.11.002; Rhee JS, 2013, AQUAT TOXICOL, V132, P182, DOI 10.1016/j.aquatox.2013.02.013; Richard L, 2011, BRIT J NUTR, V106, P825, DOI 10.1017/S0007114511001115; RUMSEY GL, 1991, AQUACULTURE, V95, P107, DOI 10.1016/0044-8486(91)90077-K; Salmeron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075349; Seiliez I, 2011, GEN COMP ENDOCR, V172, P363, DOI 10.1016/j.ygcen.2011.03.026; Shay KP, 2012, BBA-MOL CELL RES, V1823, P1102, DOI 10.1016/j.bbamcr.2012.04.002; Sinha AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095319; Skipnes D, 2007, J FOOD ENG, V80, P1078, DOI 10.1016/j.jfoodeng.2006.08.015; Sriket C., 2014, International Food Research Journal, V21, P433; Tang QQ, 2013, BIOL TRACE ELEM RES, V155, P370, DOI 10.1007/s12011-013-9785-6; Utrera M, 2014, MEAT SCI, V96, P812, DOI 10.1016/j.meatsci.2013.09.006; Venugopal PB, 1985, METHODS VITAMIN ASSA, P555; Venugopal V, 1996, FOOD REV INT, V12, P175, DOI 10.1080/87559129609541074; Wang B, 2015, FOOD CHEM, V167, P91, DOI 10.1016/j.foodchem.2014.06.091; Wang DaoZun, 1995, Journal of Fisheries of China, V19, P133; Wang ZG, 2009, POULTRY SCI, V88, P1096, DOI 10.3382/ps.2008-00207; Wu P, 2014, FISH SHELLFISH IMMUN, V38, P374, DOI 10.1016/j.fsi.2014.03.032; Wu P, 2011, AQUACULTURE, V317, P107, DOI 10.1016/j.aquaculture.2011.03.042; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Wu YP, 2015, AQUAC RES, V46, P2360, DOI 10.1111/are.12392; ZEISEL SH, 1981, ANNU REV NUTR, V1, P95, DOI 10.1146/annurev.nu.01.070181.000523; Zhang JF, 2004, CHEMOSPHERE, V55, P167, DOI 10.1016/j.chemosphere.2003.10.048; Zhang JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058115, 10.1371/journal.pone.0076378]; Zhou QC, 2013, AQUACULTURE, V392, P142, DOI 10.1016/j.aquaculture.2013.01.026	89	21	22	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142915	10.1371/journal.pone.0142915	http://dx.doi.org/10.1371/journal.pone.0142915			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600252	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900046
J	Crespo, R; Villar-Alvarez, E; Taboada, P; Rocha, FA; Damas, AM; Martins, PM				Crespo, Rosa; Villar-Alvarez, Eva; Taboada, Pablo; Rocha, Fernando A.; Damas, Ana M.; Martins, Pedro M.			What Can the Kinetics of Amyloid Fibril Formation Tell about Off-pathway Aggregation?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN AGGREGATION; TRANSTHYRETIN AGGREGATION; SERUM-ALBUMIN; OLIGOMERS; NUCLEATION; SUPERSATURATION; PROTOFIBRILS; ULTRASONICATION; MECHANISM; MODEL	Some of the most prevalent neurodegenerative diseases are characterized by the accumulation of amyloid fibrils in organs and tissues. Although the pathogenic role of these fibrils has not been completely established, increasing evidence suggests off-pathway aggregation as a source of toxic/detoxicating deposits that still remains to be targeted. The present work is a step toward the development of off-pathway modulators using the same amyloid-specific dyes as those conventionally employed to screen amyloid inhibitors. We identified a series of kinetic signatures revealing the quantitative importance of off-pathway aggregation relative to amyloid fibrillization; these include nonlinear semilog plots of amyloid progress curves, highly variable end point signals, and half-life coordinates weakly influenced by concentration. Molecules that attenuate/intensify the magnitude of these signals are considered promising off-pathway inhibitors/promoters. An illustrative example shows that amyloid deposits of lysozyme are only the tip of an iceberg hiding a crowd of insoluble aggregates. Thoroughly validated using advanced microscopy techniques and complementary measurements of dynamic light scattering, CD, and soluble protein depletion, the new analytical tools are compatible with the high-throughput methods currently employed in drug discovery.	[Crespo, Rosa; Rocha, Fernando A.; Martins, Pedro M.] Univ Porto, Fac Engn, Dept Engn Quim, Lab Engn Proc Ambiente Biotecnol & Energia, Rua Dr Roberto Frias, P-4200465 Oporto, Portugal; [Villar-Alvarez, Eva; Taboada, Pablo] Univ Santiago de Compostela, Fac Fis, Dept Fis Mat Condensada, Santiago De Compostela 15782, Spain; [Damas, Ana M.; Martins, Pedro M.] Univ Porto, Inst Ciencias Biomed Abel Salazar, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal	Universidade do Porto; Universidade de Santiago de Compostela; Universidade do Porto	Martins, PM (corresponding author), Univ Porto, Inst Ciencias Biomed Abel Salazar, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.	pmmartins@icbas.up.pt	Martins, Pedro M/J-3765-2013; Martins, Pedro/GWC-7702-2022; Taboada, Pablo/C-3000-2015; Rocha, Fernando A/D-4324-2014; Taboada, Pablo/GXA-1489-2022	Taboada, Pablo/0000-0002-2903-7857; Rocha, Fernando A/0000-0002-2778-8374; Crespo Rodriguez, Rosa/0000-0003-4980-2074; Villar-Alvarez, Eva/0000-0003-4023-1375; Martins, Pedro Miguel/0000-0002-6908-1828	FEDER funds through Programa Operational Competitividade e Internacionalizacao COMPETE [UID/EQU/00511/2013-LEPABE, EQU/00511]; Fundacao para a Ciencia e a Tecnologia (FCT); Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [SFRH/BD/74174/2010]; Spanish Ministerio de Economia y Competitividad FPU [AP2012-2921]; Ministerio de Economia y Competitividad (MINECO) [MAT 2013-40971-R]; Xunta de Galicia [EM2013-046]; European Union	FEDER funds through Programa Operational Competitividade e Internacionalizacao COMPETE; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Spanish Ministerio de Economia y Competitividad FPU; Ministerio de Economia y Competitividad (MINECO); Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Union(European Commission)	This work was supported by Project UID/EQU/00511/2013-LEPABE (Laboratory for Process Engineering, Environment, Biotechnology, and Energy EQU/00511) by FEDER funds through Programa Operational Competitividade e Internacionalizacao COMPETE2020 and by Fundacao para a Ciencia e a Tecnologia (FCT). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, Grant SFRH/BD/74174/2010.; Recipient of Spanish Ministerio de Economia y Competitividad FPU Fellowship AP2012-2921.; Supported by Ministerio de Economia y Competitividad (MINECO) and Xunta de Galicia Research Projects MAT 2013-40971-R and EM2013-046, respectively.; Recipient of mobility grants from the European Union Iacobus and Erasmus+ Programmes.	Adachi M, 2015, J BIOL CHEM, V290, P18134, DOI 10.1074/jbc.M115.648139; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Brender J. R., 2015, SOFT MATTER, VB119, P2886; Breydo L, 2014, BBA-PROTEINS PROTEOM, V1844, P346, DOI 10.1016/j.bbapap.2013.11.004; Chatani E, 2012, J BIOL CHEM, V287, P22827, DOI 10.1074/jbc.M111.333310; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Crespo R, 2012, J BIOL CHEM, V287, P30585, DOI 10.1074/jbc.M112.375345; Eden K, 2015, BIOPHYS J, V108, P632, DOI 10.1016/j.bpj.2014.11.3465; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Faria TQ, 2015, PHYS CHEM CHEM PHYS, V17, P7255, DOI 10.1039/c4cp04549a; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; Gillam JE, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/37/373101; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hall D, 2015, FEBS LETT, V589, P672, DOI 10.1016/j.febslet.2015.01.032; Hill SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018171; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Hopping G, 2014, ELIFE, V3, DOI 10.7554/eLife.01681; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Ikenoue T, 2014, P NATL ACAD SCI USA, V111, P6654, DOI 10.1073/pnas.1322602111; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Martins PM, 2013, PRION, V7, P136, DOI 10.4161/pri.23111; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Morris RJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2909; Mulaj M, 2014, J AM CHEM SOC, V136, P8947, DOI 10.1021/ja502529m; Muta H, 2014, J BIOL CHEM, V289, P18228, DOI 10.1074/jbc.M114.566950; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Ruggeri FS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8831; Streets AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054541; Szavits-Nossan J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.098101; Umemoto A, 2014, J BIOL CHEM, V289, P27290, DOI 10.1074/jbc.M114.569814; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Wang Y, 2012, NAT MATER, V11, P724, DOI [10.1038/NMAT3362, 10.1038/nmat3362]; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Yagi H, 2014, BBA-PROTEINS PROTEOM, V1844, P1881, DOI 10.1016/j.bbapap.2014.06.014; Yang S, 2012, J MOL BIOL, V421, P364, DOI 10.1016/j.jmb.2012.02.026; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109	49	32	32	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					2018	2032		10.1074/jbc.M115.699348	http://dx.doi.org/10.1074/jbc.M115.699348			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601940	Green Published, hybrid			2022-12-26	WOS:000368620700037
J	Leary, E; Young, LJ; DuClos, C; Jordan, MM				Leary, Emily; Young, Linda J.; DuClos, Chris; Jordan, Melissa M.			Identifying Heat Waves in Florida: Considerations of Missing Weather Data	PLOS ONE			English	Article							APPROXIMATE BAYESIAN-INFERENCE; CLIMATE-CHANGE; MORTALITY; TEMPERATURE; CITIES; IMPACT; ASSOCIATION; DISEASES; MODELS; RISK	Background Using current climate models, regional-scale changes for Florida over the next 100 years are predicted to include warming over terrestrial areas and very likely increases in the number of high temperature extremes. No uniform definition of a heat wave exists. Most past research on heat waves has focused on evaluating the aftermath of known heat waves, with minimal consideration of missing exposure information. Objectives To identify and discuss methods of handling and imputing missing weather data and how those methods can affect identified periods of extreme heat in Florida. Methods In addition to ignoring missing data, temporal, spatial, and spatio-temporal models are described and utilized to impute missing historical weather data from 1973 to 2012 from 43 Florida weather monitors. Calculated thresholds are used to define periods of extreme heat across Florida. Results Modeling of missing data and imputing missing values can affect the identified periods of extreme heat, through the missing data itself or through the computed thresholds. The differences observed are related to the amount of missingness during June, July, and August, the warmest months of the warm season (April through September). Conclusions Missing data considerations are important when defining periods of extreme heat. Spatiotemporal methods are recommended for data imputation. A heat wave definition that incorporates information from all monitors is advised.	[Leary, Emily] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Young, Linda J.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [DuClos, Chris; Jordan, Melissa M.] Florida Dept Hlth, Publ Hlth Res Unit, Tallahassee, FL 32399 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Florida Department of Health	Leary, E (corresponding author), 182D Galena Hall,DC018-00,One Hosp Dr, Columbia, MO 65212 USA.	LearyE@health.missouri.edu		Young, Linda/0000-0002-3541-4313; Leary, Emily/0000-0003-0836-7440	Centers for Disease Control and Prevention [U38-EH000941]; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U38EH000941] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by Centers for Disease Control and Prevention, grant number U38-EH000941 awarded to the Florida Environmental Public Health Tracking Network Implementation. Funding was available for this project through CD and MMJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.	Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2013, AM J RESP CRIT CARE, V187, P1098, DOI 10.1164/rccm.201211-1969OC; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Barnett AG, 2012, ENVIRON RES, V112, P218, DOI 10.1016/j.envres.2011.12.010; Barnett AG, 2010, ENVIRON RES, V110, P604, DOI 10.1016/j.envres.2010.05.006; Barreca AI, 2012, J ENVIRON ECON MANAG, V63, P19, DOI 10.1016/j.jeem.2011.07.004; Basu R, 2008, EPIDEMIOLOGY, V19, P138, DOI 10.1097/EDE.0b013e31815c1da7; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V4, P33, DOI 10.1016/j.sste.2012.12.001; Bobb JF, 2011, BIOMETRICS, V67, P1605, DOI 10.1111/j.1541-0420.2011.01583.x; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Davis RE, 2004, CLIM RES, V26, P61, DOI 10.3354/cr026061; Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152; Fletcher BA, 2012, AM J EPIDEMIOL, V175, P907, DOI 10.1093/aje/kwr417; Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Haslett J, 2006, J R STAT SOC A STAT, V169, P395, DOI 10.1111/j.1467-985X.2006.00429.x; Huth R, 2000, CLIMATIC CHANGE, V46, P29, DOI 10.1023/A:1005633925903; Kent ST, 2014, ENVIRON HEALTH PERSP, V122, P151, DOI 10.1289/ehp.1307262; Lippmann SJ, 2013, ENVIRON RES, V124, P35, DOI 10.1016/j.envres.2013.03.009; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; National Oceanic and Atmospheric Administration National Weather Service, 2014, NOAAS WATCH WARN ADV; National Weather Service. Weather Prediction Center, HEAT IND EQ; Nitschke M, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-42; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Pantavou K, 2011, BUILD ENVIRON, V46, P339, DOI 10.1016/j.buildenv.2010.07.026; Peng RD, 2011, ENVIRON HEALTH PERSP, V119, P701, DOI 10.1289/ehp.1002430; Rocklov J, 2009, EUR RESPIR J, V33, P245, DOI 10.1183/09031936.00037808; Rocklov J, 2011, OCCUP ENVIRON MED, V68, P531, DOI 10.1136/oem.2010.058818; Rue H, 2007, J STAT PLAN INFER, V137, P3177, DOI 10.1016/j.jspi.2006.07.016; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sung TI, 2013, SCI TOTAL ENVIRON, V442, P275, DOI 10.1016/j.scitotenv.2012.09.068; Tong SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012155; Winsberg M, ANAL BEGINNING END L	34	2	2	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143471	10.1371/journal.pone.0143471	http://dx.doi.org/10.1371/journal.pone.0143471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619198	gold, Green Published, Green Submitted			2022-12-26	WOS:000365889800040
J	Vickers, TW; Clifford, DL; Garcelon, DK; King, JL; Duncan, CL; Gaffney, PM; Boyce, WM				Vickers, T. Winston; Clifford, Deana L.; Garcelon, David K.; King, Julie L.; Duncan, Calvin L.; Gaffney, Patricia M.; Boyce, Walter M.			Pathology and Epidemiology of Ceruminous Gland Tumors among Endangered Santa Catalina Island Foxes (Urocyon littoralis catalinae) in the Channel Islands, USA	PLOS ONE			English	Article							WILDLIFE; DECLINE; CANCER; PAPILLOMAVIRUS; MITES; DOGS	In this study, we examined the prevalence, pathology, and epidemiology of tumors in free-ranging island foxes occurring on three islands in the California Channel Islands, USA. We found a remarkably high prevalence of ceruminous gland tumors in endangered foxes (Uro-cyon littoralis catalinae) occurring on Santa Catalina Island (SCA)-48.9% of the dead foxes examined from 2001-2008 had tumors in their ears, and tumors were found in 52.2% of randomly-selected mature (>= 4 years) foxes captured in 2007-2008, representing one of the highest prevalences of tumors ever documented in a wildlife population. In contrast, no tumors were detected in foxes from San Nicolas Island or San Clemente Island, although ear mites (Otodectes cynotis), a predisposing factor for ceruminous gland tumors in dogs and cats, were highly prevalent on all three islands. On SCA, otitis externa secondary to ear mite infection was highly correlated with ceruminous gland hyperplasia (CGH), and tumors were significantly associated with the severity of CGH, ceruminous gland dysplasia, and age group (older foxes). We propose a conceptual model for the formation of ceruminous gland tumors in foxes on SCA that is based on persistent, ubiquitous infection with ear mites, and an innate, over exuberant inflammatory and hyperplastic response of SCA foxes to these mites. Foxes on SCA are now opportunistically treated with acaricides in an attempt to reduce mite infections and the morbidity and mortality associated with this highly prevalent tumor.	[Vickers, T. Winston; Garcelon, David K.] Inst Wildlife Studies, Arcata, CA 95518 USA; [Vickers, T. Winston; Clifford, Deana L.; Boyce, Walter M.] Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, Davis, CA 95616 USA; [Clifford, Deana L.] Calif Dept Fish & Wildlife, Wildlife Invest Lab, Rancho Cordova, CA USA; [King, Julie L.; Duncan, Calvin L.] Catalina Isl Conservancy, Avalon, CA USA; [Gaffney, Patricia M.; Boyce, Walter M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Gaffney, Patricia M.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Gaffney, Patricia M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Diego; University of California System; University of California San Diego	Vickers, TW (corresponding author), Inst Wildlife Studies, Arcata, CA 95518 USA.	twvickers@ucdavis.edu; wmboyce@ucdavis.edu		King, Julie/0000-0001-7900-8109	Morris Animal Foundation [D06ZO-100]; Institute for Wildlife Studies; Catalina Island Conservancy; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD017863] Funding Source: NIH RePORTER	Morris Animal Foundation; Institute for Wildlife Studies; Catalina Island Conservancy; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Morris Animal Foundation (TWV; Grant number D06ZO-100; http://www.morrisanimalfoundation.org/), Institute for Wildlife Studies (TWV, DKG; http://www.iws.org/), and Catalina Island Conservancy (JLK, CLD; http://www.catalinaconservancy.org/). The Institute for Wildlife Studies (TWV, DKG) and the Catalina Island Conservancy (JLK, CLD) helped with study design, as well as sample collection, analysis, decision to publish, and preparation of the manuscript. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; Angus JC, 2002, J AM VET MED ASSOC, V221, P1000, DOI 10.2460/javma.2002.221.1000; Beeton N, 2011, J APPL ECOL, V48, P1315, DOI 10.1111/j.1365-2664.2011.02060.x; BOYCE W, 1990, J PARASITOL, V76, P823, DOI 10.2307/3282800; Browning HM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0240; Buckles EL, 2006, J COMP PATHOL, V135, P183, DOI 10.1016/j.jcpa.2006.06.007; Collins PW, 1991, TAXONOMIC BIOGEOGRAP, P351; Coonan TJ, 2005, SOUTHWEST NAT, V50, P32, DOI 10.1894/0038-4909(2005)050<0032:DOAIFS>2.0.CO;2; Coonan TJ, 2010, DECLINE AND RECOVERY; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; DEGUISE S, 1994, VET PATHOL, V31, P444, DOI 10.1177/030098589403100406; Fancourt BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119303; Garcelon DK, 2013, ISLAND FOX MONITORIN; Goldschmidt MH, 2002, TUMORS IN DOMESTIC A; Goldschmidt MH, 1992, SKIN TUMORS OF THE D; GOODHEART CR, 1970, J AMER MED ASSOC, V211, P91, DOI 10.1001/jama.211.1.91; Gregory NC, 2013, SAN CLEMENTE ISLAND; Hamede R, 2012, CONSERV BIOL, V26, P124, DOI 10.1111/j.1523-1739.2011.01747.x; Hinton DE, 1995, MARINE POLLUTION BUL, V51, P635; Hollings T, 2014, CONSERV BIOL, V28, P63, DOI 10.1111/cobi.12152; HOSMER DW, 2000, WILEY PS TX, P1; King JL, 2014, MONOGRAPHS W N AM NA, P7382; Knowlton JL, 2007, SOUTHWEST NAT, V52, P528, DOI 10.1894/0038-4909(2007)52[528:EONMAT]2.0.CO;2; Long JS, 2001, REGRESSION MODELS FO; Martineau D, 2002, ENVIRON HEALTH PERSP, V110, P285, DOI 10.1289/ehp.02110285; McAloose D, 2009, NAT REV CANCER, V9, P517, DOI 10.1038/nrc2665; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; Moisan PG, 1996, J AM ANIM HOSP ASSOC, V32, P448, DOI 10.5326/15473317-32-5-448; Moore Claybourne M., 1995, Mammalian Species, V489, P1; Moriarty ME, 2015, PLOSONE SUBMITTED; Philbrick R. N., 1967, P S BIOL CAL ISL SAN, P245; Pimentel RA, 1979, MORPHOMETRICS THE MU; Ramey RR, 2000, J MED ENTOMOL, V37, P791, DOI 10.1603/0022-2585-37.6.791; Rector A, 2005, J GEN VIROL, V86, P2029, DOI 10.1099/vir.0.80874-0; Sula MJM, 2012, VET CLIN N AM-SMALL, V42, P1161, DOI 10.1016/j.cvsm.2012.08.004; Timm SF, 2009, J WILDLIFE DIS, V45, P333, DOI 10.7589/0090-3558-45.2.333; U.S. Fish and Wildlife Service, 2004, FED REGISTER, V69, P10335; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Vittecoq M, 2013, TRENDS ECOL EVOL, V28, P628, DOI 10.1016/j.tree.2013.07.005; WAYNE RK, 1991, EVOLUTION, V45, P1849, DOI 10.1111/j.1558-5646.1991.tb02692.x; Wood J. E., 1958, Journal of Mammalogy, V39, P74, DOI 10.2307/1376612	41	19	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143211	10.1371/journal.pone.0143211	http://dx.doi.org/10.1371/journal.pone.0143211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618759	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800028
J	Wu, N; Wei, J; Wang, YH; Yan, JY; Qin, Y; Tong, DD; Pang, B; Sun, DL; Sun, HM; Yu, Y; Sun, WJ; Meng, XN; Zhang, CY; Bai, J; Chen, F; Geng, JS; Lee, KY; Fu, SB; Jin, Y				Wu, Nan; Wei, Jia; Wang, Yuhui; Yan, Jinyan; Qin, Ying; Tong, Dandan; Pang, Bo; Sun, Donglin; Sun, Haiming; Yu, Yang; Sun, Wenjing; Meng, Xiangning; Zhang, Chunyu; Bai, Jing; Chen, Feng; Geng, Jingshu; Lee, Ki-Young; Fu, Songbin; Jin, Yan			Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition	PLOS ONE			English	Article							DOUBLE-MINUTE CHROMOSOMES; HOMOGENEOUSLY STAINING REGIONS; GENE-EXPRESSION; BREAST-CANCER; CELL INVASION; TUMOR-CELLS; PROTEIN; APOPTOSIS; TUMORIGENICITY; MICRONUCLEI	Double minute chromosomes (DMs) have important implications for cancer progression because oncogenes frequently amplified on them. We previously detected a functionally undefined gene amplified on DMs, Ribosomal L22-like1 (RPL22L1). The relationship between RPL22L1 and cancer progression is unknown. Here, RPL22L1 was characterized for its role in ovarian cancer (OC) metastasis and its underlying mechanism was examined. DNA copy number and mRNA expression of RPL22L1 in OC cells was analyzed using data obtained from The Cancer Genome Atlas and the Gene Expression Omnibus database. An immunohistochemical analysis of clinical OC specimens was performed and the relationships between expression level and clinicopathological factors were evaluated. Additionally, in vivo and in vitro assays were performed to understand the role of RPL22L1 in OC. RPL22L1 expression was higher in OC specimens than in normal tissues, and its expression level was highly positively correlated with invasion and lymph node metastasis (P < 0.05). RPL22L1 over-expression significantly enhanced intraperitoneal xenograft tumor development in nude mice and promoted invasion and migration in vitro. Additionally, RPL22L1 knockdown remarkably inhibited UACC-1598 cells invasion and migration. Further, RPL22L1 over-expression up-regulated the mesenchymal markers vimentin, fibronectin, and alpha-SMA, reduced expression of the epithelial markers E-cadherin, alpha-catenin, and beta-catenin. RPL22L1 inhibition reduced expression of vimentin and N-cadherin. These results suggest that RPL22L1 induces epithelial-to-mesenchymal transition (EMT). Our data showed that the DMs amplified gene RPL22L1 is critical in maintaining the aggressive phenotype of OC and in triggering cell metastasis by inducing EMT. It could be employed as a novel prognostic marker and/or effective therapeutic target for OC.	[Wu, Nan; Wei, Jia; Wang, Yuhui; Yan, Jinyan; Qin, Ying; Pang, Bo; Sun, Donglin; Sun, Haiming; Yu, Yang; Sun, Wenjing; Meng, Xiangning; Zhang, Chunyu; Bai, Jing; Chen, Feng; Fu, Songbin; Jin, Yan] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China; [Tong, Dandan] Harbin Med Univ, Dept Pathol, Harbin, Peoples R China; [Geng, Jingshu] Harbin Med Univ, Affiliated Clin Hosp 3, Dept Pathol, Harbin, Peoples R China; [Lee, Ki-Young] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 1N4, Canada	Harbin Medical University; Harbin Medical University; Harbin Medical University; University of Calgary	Fu, SB (corresponding author), Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China.	fusb@ems.hrbmu.edu.cn; jinyan@ems.hrbmu.edu.cn	王, 宇慧/GXZ-7548-2022; Zhang, Chun-yu/HDP-5776-2022		Programme for Changjiang Scholars and Innovative Research Team in University [IRT1230]; National Natural Science Foundation of China [81371617]; Outstanding Youth foundation of Heilongjiang Province of China [JC201215]	Programme for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth foundation of Heilongjiang Province of China	This study was supported by the Programme for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT1230 to YJ), the National Natural Science Foundation of China (Grant No. 81371617 to YJ), the Outstanding Youth foundation of Heilongjiang Province of China (Grant No. JC201215 to YJ).	Ambros IM, 1997, EUR J CANCER, V33, P2043, DOI 10.1016/S0959-8049(97)00204-9; BENNER SE, 1991, ANTI-CANCER DRUG, V2, P11, DOI 10.1097/00001813-199102000-00002; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Bronsert P, 2014, J PATHOL, V234, P410, DOI 10.1002/path.4416; Canute GW, 1998, NEUROSURGERY, V42, P609, DOI 10.1097/00006123-199803000-00031; Chavez-Rios R, 2003, MOL BIOCHEM PARASIT, V127, P151, DOI 10.1016/S0166-6851(02)00332-8; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; Deng XY, 2006, BIOCHEM BIOPH RES CO, V346, P1228, DOI 10.1016/j.bbrc.2006.06.041; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gos Monika, 2009, Postepy Biochem, V55, P121; Guan XY, 2004, CANCER RES, V64, P4197, DOI 10.1158/0008-5472.CAN-03-3747; GUAN XY, 1993, HUM MOL GENET, V2, P1117, DOI 10.1093/hmg/2.8.1117; Guan XY, 2001, CANCER RES, V61, P3806; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Ji W, 2014, INT J CANCER, V134, P1279, DOI 10.1002/ijc.28467; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Khanna N, 2000, BIOCHEM BIOPH RES CO, V277, P476, DOI 10.1006/bbrc.2000.3688; King ER, 2011, AM J SURG PATHOL, V35, P904, DOI 10.1097/PAS.0b013e318212ae22; Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831; Luo M, 2015, CURR PHARM DESIGN, V21, P1301, DOI 10.2174/1381612821666141211120604; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Naora H, 1998, J CELL BIOL, V141, P741, DOI 10.1083/jcb.141.3.741; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Neumann F, 1997, EXP CELL RES, V230, P252, DOI 10.1006/excr.1996.3417; O'Leary MN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003708; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2011, MUTAGENESIS, V26, P119, DOI 10.1093/mutage/geq053; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stany MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021121; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165, DOI 10.1073/pnas.89.17.8165; Yu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071988; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018; Zhu J, 2013, INT J CANCER, V133, P797, DOI 10.1002/ijc.28084; Zimmermann RA, 2003, CELL, V115, P130, DOI 10.1016/S0092-8674(03)00804-3	41	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143659	10.1371/journal.pone.0143659	http://dx.doi.org/10.1371/journal.pone.0143659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618703	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800055
J	Munyaka, PM; Eissa, N; Bernstein, CN; Khafipour, E; Ghia, JE				Munyaka, Peris Mumbi; Eissa, N.; Bernstein, Charles Noah; Khafipour, Ehsan; Ghia, Jean-Eric			Antepartum Antibiotic Treatment Increases Offspring Susceptibility to Experimental Colitis: A Role of the Gut Microbiota	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; DELIVERY MODE; LIFE; DISEASE; RISK; CONSEQUENCES; EXPOSURE; INFANTS; HEALTH; ASTHMA	Background and aims Postnatal maturation of the immune system is largely driven by exposure to microbes, and thus the nature of intestinal colonization may be associated with development of childhood diseases that may persist into adulthood. We investigated whether antepartum antibiotic (ATB) therapy can increase offspring susceptibility to experimental colitis through alteration of the gut microbiota. Methods Pregnant C57Bl/6 mice were treated with cefazolin at 160 mg/kg body weight or with saline starting six days before due date. At 7 weeks, fecal samples were collected from male offspring after which they received 4% dextran sulfate sodium (DSS) in drinking water for 5 days. Disease activity index, histology, colonic IL-6, IL-1 beta and serum C-reactive protein (CRP) were determined. The V3-V4 region of colonic and fecal bacterial 16S rRNA was sequenced. Alpha-, beta-diversity and differences at the phylum and genus levels were determined, while functional pathways of classified bacteria were predicted. Results ATB influenced fecal bacterial composition and hence bacterial functional pathways before induction of colitis. After induction of colitis, ATB increased onset of clinical disease, histologic score, and colonic IL-6. In addition, ATB decreased fecal microbial richness, changed fecal and colon microbial composition, which was accompanied by a modification of microbial functional pathways. Also, several taxa were associated with ATB at lower taxonomical levels. Conclusions The results support the hypothesis that antepartum antibiotics modulate offspring intestinal bacterial colonization and increase susceptibility to develop colonic inflammation in a murine model of colitis, and may guide future interventions to restore physiologic intestinal colonization in offspring born by antibiotic-exposed mothers.	[Munyaka, Peris Mumbi; Eissa, N.; Ghia, Jean-Eric] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Munyaka, Peris Mumbi; Khafipour, Ehsan] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Bernstein, Charles Noah; Ghia, Jean-Eric] Univ Manitoba, Dept Internal Med, Gastroenterol Sect, Winnipeg, MB, Canada; [Bernstein, Charles Noah; Ghia, Jean-Eric] Univ Manitoba, Inflammatory Bowel Dis Clin & Res Ctr, Winnipeg, MB, Canada; [Khafipour, Ehsan] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Khafipour, E (corresponding author), Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada.	Ehsan.Khafipour@umanitoba.ca; jean-eric.ghia@umanitoba.ca	Khafipour, Ehsan/W-9803-2019; Eissa, Nour/E-1464-2013; Khafipour, Ehsan/E-4140-2016	Khafipour, Ehsan/0000-0003-4673-7633; Eissa, Nour/0000-0002-3484-6720; Khafipour, Ehsan/0000-0003-4673-7633; Ghia, Jean-Eric/0000-0002-3018-9719	Research Manitoba; Canada Foundation for Innovation; Children's Hospital Research Institute of Manitoba	Research Manitoba; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Children's Hospital Research Institute of Manitoba	This study was supported by operating grants from Research Manitoba, the Canada Foundation for Innovation and by the Children's Hospital Research Institute of Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2005, PERMANOVA FORTRAN CO; [Anonymous], 2010, Obstet Gynecol, V116, P791, DOI 10.1097/AOG.0b013e3181f68086; [Anonymous], 1993, GUIDE CARE USE EXPT, V2nd ed; [Anonymous], 2010, REV PRESCRIRE, V30, P761; Arboleya S, 2015, J PEDIATR-US, V166, P538, DOI 10.1016/j.jpeds.2014.09.041; Azad MB, 2016, BJOG-INT J OBSTET GY, V123, P983, DOI 10.1111/1471-0528.13601; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Collignon A, 2010, GASTROEN CLIN BIOL, V34, pS71, DOI 10.1016/S0399-8320(10)70024-5; COOPER HS, 1993, LAB INVEST, V69, P238; de Silva-Sanigorski AM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-97; Derakhshani H, 2016, J BASIC MICROB, V56, P321, DOI 10.1002/jobm.201500420; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Droste JHJ, 2000, CLIN EXP ALLERGY, V30, P1547; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Aidy S, 2013, GUT MICROBES, V4, P118, DOI 10.4161/gmic.23362; Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184; Perez-Cobas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080201; Faa G, 2013, J MATERN-FETAL NEO M, V26, P35, DOI 10.3109/14767058.2013.829700; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Flenady V, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000246.pub2; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Gorkiewicz G, 2009, INT J ANTIMICROB AG, V33, pS37, DOI 10.1016/S0924-8579(09)70015-9; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Khan WI, 2002, INFECT IMMUN, V70, P5931, DOI 10.1128/IAI.70.11.5931-5937.2002; Konya T., 2014, ALLERGY ASTHMA CL IM, V10, pA31, DOI [10.1186/1710-1492-10-S1-A31, DOI 10.1186/1710-1492-10-S1-A31]; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051897; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Metsala J, 2013, EPIDEMIOLOGY, V24, P303, DOI 10.1097/EDE.0b013e31827f520f; Mohamed AO., 2015, INT J AGR ENV RES, V1, P1; Moon C, 2015, NATURE, V521, P90, DOI 10.1038/nature14139; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Murk W, 2011, PEDIATRICS, V127, P1125, DOI 10.1542/peds.2010-2092; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Persaud RR, 2015, J MATERN-FETAL NEO M, V28, P1190, DOI 10.3109/14767058.2014.947578; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Roberts SE, 2011, WORLD J GASTROENTERO, V17, P743, DOI 10.3748/wjg.v17.i6.743; Russell ARB, 2006, BJOG-INT J OBSTET GY, V113, P758, DOI 10.1111/j.1471-0528.2006.00952.x; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Shaw SY, 2010, AM J GASTROENTEROL, V105, P2687, DOI 10.1038/ajg.2010.398; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Tanaka S, 2009, FEMS IMMUNOL MED MIC, V56, P80, DOI 10.1111/j.1574-695X.2009.00553.x; Torrazza RM, 2011, J PERINATOL, V31, pS29, DOI 10.1038/jp.2010.172; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Villarreal Armando A, 2012, WMJ, V111, P17; Westerbeek EAM, 2006, CLIN NUTR, V25, P361, DOI 10.1016/j.clnu.2006.03.002	66	95	100	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142536	10.1371/journal.pone.0142536	http://dx.doi.org/10.1371/journal.pone.0142536			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605545	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300022
J	Przeslawski, R; Alvarez, B; Kool, J; Bridge, T; Caley, MJ; Nichol, S				Przeslawski, Rachel; Alvarez, Belinda; Kool, Johnathan; Bridge, Tom; Caley, M. Julian; Nichol, Scott			Implications of Sponge Biodiversity Patterns for the Management of a Marine Reserve in Northern Australia	PLOS ONE			English	Article							SPECIES RICHNESS; A-D; SPERMONDE ARCHIPELAGO; DISTRIBUTION MODELS; DIVERSITY; CONNECTIVITY; ALKALOIDS; MARGIN; SHELF; REEF	Marine reserves are becoming progressively more important as anthropogenic impacts continue to increase, but we have little baseline information for most marine environments. In this study, we focus on the Oceanic Shoals Commonwealth Marine Reserve (CMR) in northern Australia, particularly the carbonate banks and terraces of the Sahul Shelf and Van Diemen Rise which have been designated a Key Ecological Feature (KEF). We use a species-level inventory compiled from three marine surveys to the CMR to address several questions relevant to marine management: 1) Are carbonate banks and other raised geomorphic features associated with biodiversity hotspots? 2) Can environmental (depth, substrate hardness, slope) or biogeographic (east vs west) variables help explain local and regional differences in community structure? 3) Do sponge communities differ among individual raised geomorphic features? Approximately 750 sponge specimens were collected in the Oceanic Shoals CMR and assigned to 348 species, of which only 18% included taxonomically described species. Between eastern and western areas of the CMR, there was no difference between sponge species richness or assemblages on raised geomorphic features. Among individual raised geomorphic features, sponge assemblages were significantly different, but species richness was not. Species richness showed no linear relationships with measured environmental factors, but sponge assemblages were weakly associated with several environmental variables including mean depth and mean backscatter (east and west) and mean slope (east only). These patterns of sponge diversity are applied to support the future management and monitoring of this region, particularly noting the importance of spatial scale in biodiversity assessments and associated management strategies.	[Przeslawski, Rachel; Kool, Johnathan; Nichol, Scott] Geosci Australia, Natl Earth & Marine Observat Grp, Canberra, ACT, Australia; [Alvarez, Belinda] Museum & Art Gallery No Terr, Darwin, NT, Australia; [Bridge, Tom] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bridge, Tom; Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Geoscience Australia; Northern Territory Government; James Cook University; Australian Institute of Marine Science	Przeslawski, R (corresponding author), Geosci Australia, Natl Earth & Marine Observat Grp, GPO Box 378, Canberra, ACT, Australia.	rachel.przeslawski@ga.gov.au	Caley, Julian/A-4042-2008; Bridge, Tom/J-2693-2014	Caley, Julian/0000-0001-5739-749X; Bridge, Tom/0000-0003-3951-284X; Przeslawski, Rachel/0000-0003-0269-3755; Kool, Johnathan/0000-0002-9902-3522	Marine Biodiversity Hub [SOL5650, SS2012t07]; Australian Government's National Environmental Research Program (NERP); US National Cancer Institute [N02-CM-27003]	Marine Biodiversity Hub; Australian Government's National Environmental Research Program (NERP)(Australian Government); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Part of the survey work (SOL5650, SS2012t07) was undertaken as part of the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The taxonomic identification of sponges was partially supported by the 'Collection and Taxonomy of Shallow Water Marine Organisms' program for the US National Cancer Institute (Contract N02-CM-27003) subcontracted to MAGNT through Coral Reef Research Foundation. We are grateful to the scientific and ship crews of the R.V. Solander during surveys SOL4934, SOL5117, and SOL5650 and the R.V. Southern Surveyor during survey SS2012t07. Garrick Foy, Alyson Malpartida and Neil Ludvigsen kindly volunteered their time to work on specimens; and Gavin Dally and Suzanne Horner curated and catalogues the specimens at the MAGNT. We thank Lisa Goudie for her taxonomic identifications of sponges from SS2012t07. Sea time for the collection of samples during the transit voyage SS2012t0t on board of RV Southern Surveyor was provided by the Marine National Facility, CSIRO. Nic Bax and Jin Li provided helpful comments on manuscript drafts. This work was undertaken as part of the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). RP, JK, and SN publish with the permission of the Chief Executive Officer, Geoscience Australia.	Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson TJ, 2011, SEABED ENV EASTER J; [Anonymous], 2002, SYSTEMA PORIFERA GUI; Ballantine B, 2014, BIOL CONSERV, V176, P297, DOI 10.1016/j.biocon.2014.01.014; BANSE K, 1986, B MAR SCI, V39, P162; Bax N, 1999, OCEANOL ACTA, V22, P705, DOI 10.1016/S0399-1784(00)88961-6; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2015, CONSERV BIOL, V29, P42, DOI 10.1111/cobi.12447; Bridge TCL, 2011, CORAL REEFS, V30, P143, DOI 10.1007/s00338-010-0677-3; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; Briggs JC, 2013, J BIOGEOGR, V40, P1023, DOI 10.1111/jbi.12082; Brown CJ, 2009, APPL ACOUST, V70, P1242, DOI 10.1016/j.apacoust.2008.08.004; Brusca R.C., 1990, INVERTEBRATES SINAUE; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Caley MJ, 2014, TRENDS ECOL EVOL, V29, P187, DOI 10.1016/j.tree.2014.02.002; Cleary DFR, 2005, ESTUAR COAST SHELF S, V65, P557, DOI 10.1016/j.ecss.2005.06.025; Coleman MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020168; Commonwealth of Australia, 2012, MAR BIOR PLAN N MAR; Commonwealth of Australia, 2008, N MAR BIOR PLAN DESC; Davis RA, 2013, J ORG CHEM, V78, P9608, DOI 10.1021/jo400988y; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; de Voogd NJ, 2008, MAR ECOL-EVOL PERSP, V29, P205, DOI 10.1111/j.1439-0485.2008.00238.x; de Voogd NJ, 2009, MAR ECOL PROG SER, V396, P169, DOI 10.3354/meps08349; de Voogd NJ, 2006, MAR ECOL PROG SER, V309, P131, DOI 10.3354/meps309131; Duckworth AR, 2007, AQUACULTURE, V271, P188, DOI 10.1016/j.aquaculture.2007.06.037; Edgar GJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P730, DOI 10.1111/j.1466-8238.2010.00642.x; Fisher R, 2015, CURR BIOL, V25, P500, DOI 10.1016/j.cub.2014.12.022; Fisher R, 2011, CONSERV LETT, V4, P64, DOI 10.1111/j.1755-263X.2010.00146.x; Fromont J, 2012, HYDROBIOLOGIA, V687, P127, DOI 10.1007/s10750-011-0845-7; Grantham HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011430; Guisado DD, 2012, AQUAT BIOL, V14, P185, DOI 10.3354/ab00391; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harris PT, 2007, SUBMERGED CORAL REEF; Heap AD, 2008, AUST J EARTH SCI, V55, P555, DOI 10.1080/08120090801888669; Heap AD, 2010, SOL4934 GEOSC AUSTR; Heap AD, 2014, CONT SHELF RES, V83, P108, DOI 10.1016/j.csr.2014.02.008; Hewitt JE, 1998, J EXP MAR BIOL ECOL, V227, P251, DOI 10.1016/S0022-0981(97)00274-8; Heyward A, 1997, BIG BANK SHOALS TIMO; Hooper JNA, 2002, BIODIVERS CONSERV, V11, P851, DOI 10.1023/A:1015370312077; Hooper JNA, 2004, COLLATION VALIDATION; Hooper John N. A., 1996, Memoirs of the Queensland Museum, V40, P1; Huang Z, 2014, MAR FRESHWATER RES, V65, P409, DOI 10.1071/MF13104; Jacobi MN, 2012, ECOGRAPHY, V35, P1004, DOI 10.1111/j.1600-0587.2012.07281.x; Katavic PL, 2013, TETRAHEDRON, V69, P8074, DOI 10.1016/j.tet.2013.06.079; Khokhar S, 2013, J NAT PROD, V76, P2100, DOI 10.1021/np400617h; Klein CJ, 2013, CONSERV LETT, V6, P324, DOI 10.1111/conl.12005; Kool JT, 2015, ENVIRON MODELL SOFTW, V65, P67, DOI 10.1016/j.envsoft.2014.11.022; Kool JT, 2011, GLOBAL ECOL BIOGEOGR, V20, P695, DOI 10.1111/j.1466-8238.2010.00637.x; Levin N, 2014, MAR ECOL PROG SER, V508, P261, DOI 10.3354/meps10857; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; McEnnulty F.R., 2011, Records of the Western Australian Museum Supplement, V80, P1; Mehbub MF, 2014, MAR DRUGS, V12, P4539, DOI 10.3390/md12084539; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Mercier A, 2013, GLOBAL ECOL BIOGEOGR, V22, P517, DOI 10.1111/geb.12018; Nichol S., 2013, GA0339SOL5650; Olds AD, 2014, CONSERV BIOL, V28, P982, DOI 10.1111/cobi.12242; Peterson AT, 2000, BIOL CONSERV, V93, P85, DOI 10.1016/S0006-3207(99)00074-9; Plisson F, 2014, ORG BIOMOL CHEM, V12, P1579, DOI 10.1039/c4ob00091a; Poore GCB, 2015, MAR BIODIVERS, V45, P271, DOI 10.1007/s12526-014-0255-y; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Przeslawski R., 2011, SEABED HABITATS HAZA; Przeslawski R, 2014, HYDROBIOLOGIA, V730, P1, DOI 10.1007/s10750-013-1799-8; Pulsford I., 2011, CONNECTIVITY CONSERV; Reid WV, 1998, TRENDS ECOL EVOL, V13, P275, DOI 10.1016/S0169-5347(98)01363-9; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Ribeiro SM, 2003, ESTUAR COAST SHELF S, V57, P951, DOI 10.1016/S0272-7714(02)00425-0; Roberts DE, 1996, MAR FRESHWATER RES, V47, P897, DOI 10.1071/MF9960897; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rutzler K., 1978, Monographs on Oceanographic Methodology, P299; Samaai T, 2006, ZOOTAXA, P1; Schlacher TA, 2007, MAR ECOL PROG SER, V340, P73, DOI 10.3354/meps340073; Schonberg CHL, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P165, DOI 10.1007/978-3-540-77598-0_9; Schonberg CHL, 2012, HYDROBIOLOGIA, V687, P143, DOI 10.1007/s10750-011-0863-5; Shanks AL, 2009, BIOL BULL-US, V216, P373; Smale DA, 2010, ESTUAR COAST SHELF S, V86, P83, DOI 10.1016/j.ecss.2009.10.016; Sorokin S, 2007, T ROY SOC SOUTH AUST, V131, P192, DOI 10.1080/03721426.2007.10887083; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stowe SD, 2011, MAR DRUGS, V9, P2010, DOI 10.3390/md9102010; Sutcliffe PR, 2014, ECOGRAPHY, V37, P162, DOI 10.1111/j.1600-0587.2013.00102.x; Sutcliffe PR, 2012, ECOL APPL, V22, P1762, DOI 10.1890/11-0990.1; Teh LCL, 2012, MAR POLICY, V36, P1290, DOI 10.1016/j.marpol.2012.04.010; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Tulloch VJ, 2013, BIOL CONSERV, V162, P41, DOI 10.1016/j.biocon.2013.03.003; Utkina NK, 2012, CHEM NAT COMPD+, V48, P715, DOI 10.1007/s10600-012-0364-4; Van Soest R. W, 2014, WORLD PORIFERA DATAB; Whalan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117675; WILKINSON CR, 1989, CORAL REEFS, V8, P127, DOI 10.1007/BF00338268; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Xavier JR, 2012, HYDROBIOLOGIA, V687, P107, DOI 10.1007/s10750-011-0880-4; Yang JK, 2011, AQUAT MICROB ECOL, V62, P231, DOI 10.3354/ame01473	96	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0141813	10.1371/journal.pone.0141813	http://dx.doi.org/10.1371/journal.pone.0141813			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606745	Green Published, Green Accepted, gold			2022-12-26	WOS:000365865300011
J	Tong, XL; Lee, SMK; Lee, MML; Burnham, D				Tong, Xiuli; Lee, Stephen Man Kit; Lee, Meg Mei Ling; Burnham, Denis			A Tale of Two Features: Perception of Cantonese Lexical Tone and English Lexical Stress in Cantonese-English Bilinguals	PLOS ONE			English	Article							CATEGORICAL PERCEPTION; CROSS-LANGUAGE; ACQUISITION; SPEECH; DISCRIMINATION; EXPERIENCE	This study investigated the similarities and differences in perception of Cantonese tones and English stress patterns by Cantonese-English bilingual children, adults, and English monolingual adults. All three groups were asked to discriminate pairs of syllables that minimally differed in either Cantonese tone or in English stress. Bilingual children's performance on tone perception was comparable to their performance on stress perception. By contrast, bilingual adults' performance on tone perception was lower than their performance on stress perception, and there was a similar pattern in English monolingual adults. Bilingual adults tended to perform better than English monolingual adults on both the tone and stress perception tests. A significant correlation between tone perception and stress perception performance was found in bilingual children but not in bilingual adults. All three groups showed lower accuracy in the high rising-low rising contrast than any of the other 14 Cantonese tone contrasts. The acoustic analyses revealed that average FO, FO onset, and FO major slope were the critical acoustic correlates of Cantonese tones, whereas multiple acoustic correlates were salient in English stress, including average FO, spectral balance, duration and intensity. We argue that participants' difficulty in perceiving high rising-low rising contrasts originated from the contrasts' similarities in FO onset and average FO; indeed the difference between their major slopes was the only cue with which to distinguish them. Acoustic-perceptual correlation analyses showed that although the average FO and FO onset were associated with tone perception performance in all three groups, FO major slope was only associated with tone perception in the bilingual adult group. These results support a dynamic interactive account of suprasegmental speech perception by emphasizing the positive prosodic transfer between Cantonese tone and English stress, and the role that level of bilingual language experience and age play in shaping suprasegmental speech perception.	[Tong, Xiuli; Lee, Stephen Man Kit; Lee, Meg Mei Ling] Univ Hong Kong, Div Speech & Hearing Sci, Hong Kong, Hong Kong, Peoples R China; [Burnham, Denis] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia	University of Hong Kong; Western Sydney University	Tong, XL (corresponding author), Univ Hong Kong, Div Speech & Hearing Sci, Hong Kong, Hong Kong, Peoples R China.	xltong@hku.hk	Burnham, Denis/L-3742-2019; Tong, Xiuli/F-4454-2011	Burnham, Denis/0000-0002-1980-3458; Tong, Xiuli/0000-0003-3319-4609; Lee, Stephen Man Kit/0000-0003-0167-1810	National Academy of Education; Early Career Scheme (ECS) of the Hong Kong Government Research Council [27402514]; Seed Grant Programme for Basic Research [201210159050]	National Academy of Education; Early Career Scheme (ECS) of the Hong Kong Government Research Council; Seed Grant Programme for Basic Research	This research was supported, in part, by the Spencer Postdoctoral Fellowship/2011 National Academy of Education (http://www.naeducation.org/NAED_080379.html), the Early Career Scheme (ECS) of the Hong Kong Government Research Council (27402514), and the Seed Grant Programme for Basic Research (201210159050) awarded to Dr. Xiuli Tong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank former research assistant Rachel Ka Ying Tsui for her help with the acoustic and perceptual data analyses. We also thank William Tsun Man Choi for his help with some of the acoustic analyses. This research was supported, in part, by the Spencer Postdoctoral Fellowship/2011 National Academy of Education, the Early Career Scheme (ECS) of the Hong Kong Government Research Council (27402514), and the Seed Grant Programme for Basic Research (201210159050) awarded to Dr. Xiuli Tong.	ARCHIBALD J, 1992, CAN J LING/REV CAN L, V37, P301, DOI 10.1017/S0008413100019903; ARCHIBALD J, 1993, IRAL-INT REV APPL LI, V31, P129; Archibald J, 1992, NEW SOUNDS 92, P1; Arciuli J, 2010, J MEM LANG, V63, P180, DOI 10.1016/j.jml.2010.03.005; Battistella E.L., 1990, MARKEDNESS EVALUATIV; Bauer RS., 1997, GRUYTER, DOI [10.1515/9783110823707, DOI 10.1515/9783110823707]; Best C. T., 1995, SPEECH PERCEPTION LI, P171; Best CT, 2001, J ACOUST SOC AM, V109, P775, DOI 10.1121/1.1332378; Bialystok E, 1999, SEC LANG ACQ RES, P161; Bialystok E, 2009, J EXP PSYCHOL HUMAN, V35, P565, DOI 10.1037/a0012735; Bijeljac-Babic R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030843; Boersma P., 2013, PRAAT DOING PHONETIC; Bolinger Dwight., 1965, FORMS ENGLISH ACCENT; Burnham D, 2011, J EXP CHILD PSYCHOL, V108, P693, DOI 10.1016/j.jecp.2010.07.008; Chan MKK, 2008, PERCEPTION PRODUCTIO; Chao Y. R., 1930, MAITRE PHONETIQUE, V45, P24; Ciocca V., 2003, J MULTILINGUAL COMMU, V1, P141, DOI [10.1080/1476967031000090971, DOI 10.1080/1476967031000090971]; Cowan N, 1997, PSYCHON B REV, V4, P393, DOI 10.3758/BF03210799; COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341; Cutler A, 1997, PERCEPT PSYCHOPHYS, V59, P165, DOI 10.3758/BF03211886; Dupoux E, 1997, J MEM LANG, V36, P406, DOI 10.1006/jmla.1996.2500; EADY SJ, 1982, LANG SPEECH, V25, P29, DOI 10.1177/002383098202500103; Flege J.E, 1995, SPEECH PERCEPTION LI, V92, P233, DOI DOI 10.1075/LLLT.17.08STR; Flege J. E., 1989, STUDIES 2 LANGUAGE A, V11, P35, DOI DOI 10.1017/S0272263100007828; FLEGE JE, 1992, PHONOLOGICAL DEV MOD, P565; Francis AL, 2002, J EXP PSYCHOL HUMAN, V28, P349, DOI 10.1037//0096-1523.28.2.349; Francis AL, 2008, J PHONETICS, V36, P268, DOI 10.1016/j.wocn.2007.06.005; FRY DB, 1955, J ACOUST SOC AM, V27, P765, DOI 10.1121/1.1908022; FRY DB, 1958, LANG SPEECH, V1, P126, DOI 10.1177/002383095800100207; Gandour J, 1998, NEUROREPORT, V9, P2115, DOI 10.1097/00001756-199806220-00038; GANDOUR J, 1983, J PHONETICS, V11, P149, DOI 10.1016/S0095-4470(19)30813-7; GANDOUR J, 1981, J CHINESE LINGUIST, V9, P20; Gerrits E, 2004, PERCEPT PSYCHOPHYS, V66, P363, DOI 10.3758/BF03194885; Giegerich H., 1992, ENGLISH PHONOLOGY IN; GREENBERG JH, 1965, LINGUISTICS, P5; GROSJEAN Francois, 1995, ONE SPEAKER 2 LANGUA, P259, DOI DOI 10.1017/CBO9780511620867.012; Hong Kong Census and Statistics Department, 2006, 2006 POP BY CENS; Khouw E, 2007, J PHONETICS, V35, P104, DOI 10.1016/j.wocn.2005.10.003; KUHL PK, 1991, PERCEPT PSYCHOPHYS, V50, P93, DOI 10.3758/BF03212211; Lee KYS, 2002, LANG SPEECH, V45, P387; Lotto A.J., 2004, SOUND SENSE 50 YEARS; Mirman D, 2006, PSYCHON B REV, V13, P958, DOI 10.3758/BF03213909; Mok P, 2010, P SPEECH PROSODY, V2012, P462; Ng ML, 2004, ASIA PACIFIC J SPEEC, V9, P189; Peperkamp S, 2010, J PHONETICS, V38, P422, DOI 10.1016/j.wocn.2010.04.001; Pierrehumbert JB, 2003, PROBABILISTIC LINGUISTICS, P177; Pike K., 1945, INTONATION AM ENGLIS, DOI DOI 10.HTTPS://D0I.0RG/10.1111/J.1360-6441; Quam C, 2014, J EXP CHILD PSYCHOL, V123, P73, DOI 10.1016/j.jecp.2014.01.010; Skoruppa K, 2009, DEVELOPMENTAL SCI, V12, P914, DOI 10.1111/j.1467-7687.2009.00835.x; Sluijter AMC, 1996, J ACOUST SOC AM, V100, P2471, DOI 10.1121/1.417955; So CK, 2010, LANG SPEECH, V53, P273, DOI 10.1177/0023830909357156; So LKH, 1995, J CHILD LANG, V22, P473, DOI 10.1017/S0305000900009922; To CKS, 2013, J SPEECH LANG HEAR R, V56, P103, DOI 10.1044/1092-4388(2012/11-0080); Tong XL, 2014, J SPEECH LANG HEAR R, V57, P1589, DOI 10.1044/2014_JSLHR-S-13-0145; van Hessen AJ, 1999, PHONETICA, V56, P56, DOI 10.1159/000028441; Vennemann T., 1988, PREFERENCE LAWS SYLL; Wang Y, 2004, APPL PSYCHOLINGUIST, V25, P449, DOI 10.1017/S0142716404001213; Werner L. A, 1998, DEV AUDITORY SYSTEM, P12; Xu YS, 2006, J ACOUST SOC AM, V120, P1063, DOI 10.1121/1.2213572; Yu VY, 2010, J PSYCHOLINGUIST RES, V39, P323, DOI 10.1007/s10936-009-9142-2; Zhang CC, 2012, J ACOUST SOC AM, V132, P1088, DOI 10.1121/1.4731470; Zhang YH, 2008, J ACOUST SOC AM, V123, P4498, DOI 10.1121/1.2902165; [No title captured]	63	25	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142896	10.1371/journal.pone.0142896	http://dx.doi.org/10.1371/journal.pone.0142896			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CX7ES	26606073	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300035
J	Zhang, YN; Zuo, QS; Liu, ZY; Li, D; Tang, BB; Xiao, TR; Lian, C; Wang, YJ; Jin, K; Wang, YL; Zhang, WH; Li, BC				Zhang, Yani; Zuo, Qisheng; Liu, Zhiyong; Li, Dong; Tang, Beibei; Xiao, Tian-Rong; Lian, Chao; Wang, Yingjie; Jin, Kai; Wang, Yilin; Zhang, Wenhui; Li, Bichun			The Induction Effect of Am80 and TSA on ESC Differentiation via Regulation of Stra8 in Chicken	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; IN-VITRO DEVELOPMENT; HISTONE ACETYLATION; TRICHOSTATIN-A; ACID; MEIOSIS; CLONING; GENE; EXPRESSION; RETINOIDS	Stra8 encodes stimulated by retinoic acid gene 8, a protein that is important for initiation of meiosis in mammals and birds. This study was aimed at identifying the active control area of chicken STRA8 gene core promoter, to screen optimum inducers of the STRA8 gene, thus to enhance the differentiation of embryonic stem cells (ESCs) into spermatogonial stem cells. Fragments of chicken STRA8 gene promoter were cloned into fluorescent reporter plasmids and transfected into DF-1 cells. Then Dual-Luciferase (R) Reporter Assay System was used to identify the activity of the STRA8 gene under different inducers. Our studies showed that the promoter fragment -1055 bp to +54 bp of Suqin chicken Stra8 revealed the strongest activity. The dual-luciferase (R) reporter showed that Tamibarotene (Am80) and TrichostatinA (TSA) could significantly enhance STRA8 transcription. The in vitro inductive culture of chicken ESCs demonstrated that spermatogonial stem cells (SSC)-like cells appeared and Integrin beta 1 protein was expressed on day 10, indicating that Am80 and TSA can promote ESCs differentiation into SSCs via regulation of Stra8.	[Zhang, Yani; Zuo, Qisheng; Liu, Zhiyong; Li, Dong; Tang, Beibei; Xiao, Tian-Rong; Lian, Chao; Wang, Yingjie; Jin, Kai; Wang, Yilin; Zhang, Wenhui; Li, Bichun] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Yani; Zuo, Qisheng; Liu, Zhiyong; Li, Dong; Tang, Beibei; Xiao, Tian-Rong; Lian, Chao; Wang, Yingjie; Jin, Kai; Wang, Yilin; Li, Bichun] Key Lab Anim Breeding Reprod & Mol Design Jiangsu, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University	Li, BC (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China.	yubcli@yzu.edu.cn	JIN, KAI/AAY-8565-2020	JIN, KAI/0000-0003-2489-2173	National Natural Science Foundation of China [31301959, 1272429, 31472087]; Research Fund for the Doctoral Program of Higher Education [20123250120009]; China Postdoctoral Science Foundation funded project [2012M511326, 2014T70550]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (31301959, 1272429, 31472087); Research Fund for the Doctoral Program of Higher Education (20123250120009), China Postdoctoral Science Foundation funded project (2012M511326, 2014T70550); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are not any conflicts for the above grant numbers.	Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Beebe LFS, 2009, CLONING STEM CELLS, V11, P477, DOI 10.1089/clo.2009.0029; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Childs AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020249; Costa-Borges N, 2010, CELL REPROGRAM, V12, P437, DOI 10.1089/cell.2009.0108; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Desimio MG, 2015, CELL CYCLE, V14, P1036, DOI 10.1080/15384101.2015.1007721; Endo T, 2015, P NATL ACAD SCI USA, V112, pE2347, DOI 10.1073/pnas.1505683112; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Gely-Pernot A, 2012, ENDOCRINOLOGY, V153, P438, DOI 10.1210/en.2011-1102; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; HASHIMOTO Y, 1990, BIOCHEM BIOPH RES CO, V166, P1300, DOI 10.1016/0006-291X(90)91007-F; Hogarth CA, 2011, TRENDS ENDOCRIN MET, V22, P136, DOI 10.1016/j.tem.2011.01.001; Iager AE, 2008, CLONING STEM CELLS, V10, P371, DOI 10.1089/clo.2007.0002; Jorgensen Anne, 2014, Biomol Concepts, V5, P331, DOI 10.1515/bmc-2014-0014; Kagechika H, 2002, CURR MED CHEM, V9, P591, DOI 10.2174/0929867024606975; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kumar S, 2011, CELL, V147, P1422, DOI 10.1016/j.cell.2011.11.034; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Miwako I, 2007, DRUG TODAY, V43, P563, DOI 10.1358/dot.2007.43.8.1072615; Nakagomi M, 2013, PHARMACOL BIOCHEM BE, V104, P1, DOI 10.1016/j.pbb.2013.01.008; Saba R, 2014, DEV BIOL, V389, P173, DOI 10.1016/j.ydbio.2014.02.013; Shao GB, 2009, THERIOGENOLOGY, V71, P1245, DOI 10.1016/j.theriogenology.2009.01.004; Shi LH, 2008, DEV DYNAM, V237, P640, DOI 10.1002/dvdy.21450; Shikun M, 2015, MED RECAPITULATE, V14, P2500; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-85; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Wakayama T, 2007, J REPROD DEVELOP, V53, P13, DOI 10.1262/jrd.18120; Xinhua Z, 2009, MOL MECH AM80 REDUCE; Zhang YH, 2007, CLONING STEM CELLS, V9, P357, DOI 10.1089/clo.2006.0090; Zhao JG, 2010, CELL REPROGRAM, V12, P75, DOI 10.1089/cell.2009.0038; Zhentao Z, 2014, J ANIMAL HUSBANDRY V, V45, P38; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	41	2	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0140262	10.1371/journal.pone.0140262	http://dx.doi.org/10.1371/journal.pone.0140262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606052	gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300005
J	Grassi, E; Zapparoli, E; Molineris, I; Provero, P				Grassi, Elena; Zapparoli, Ettore; Molineris, Ivan; Provero, Paolo			Total Binding Affinity Profiles of Regulatory Regions Predict Transcription Factor Binding and Gene Expression in Human Cells	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; EMBRYONIC STEM-CELLS; CHIP-SEQ; GENOME; DATABASE; OCCUPANCY; MOUSE; MODEL	Transcription factors regulate gene expression by binding regulatory DNA. Understanding the rules governing such binding is an essential step in describing the network of regulatory interactions, and its pathological alterations. We show that describing regulatory regions in terms of their profile of total binding affinities for transcription factors leads to increased predictive power compared to methods based on the identification of discrete binding sites. This applies both to the prediction of transcription factor binding as revealed by ChIP-seq experiments and to the prediction of gene expression through RNA-seq. Further significant improvements in predictive power are obtained when regulatory regions are defined based on chromatin states inferred from histone modification data.	[Grassi, Elena; Zapparoli, Ettore; Molineris, Ivan; Provero, Paolo] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Provero, Paolo] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy	University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Provero, P (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.	paolo.provero@unito.it	Grassi, Elena/AAB-3099-2020; Provero, Paolo/AAC-1930-2019; Zapparoli, Ettore/AAN-1951-2020	Grassi, Elena/0000-0003-1066-927X; Zapparoli, Ettore/0000-0003-4170-7902; Molineris, Ivan/0000-0003-2102-0804	Italian Ministry of University and Research	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant to PP by the Italian Ministry of University and Research (http://www.istruzione.it/) under the PRIN 2010-2011 call, and by funding to the Graduate School of Biomedical Sciences and Oncology of the University of Turin by the same Italian Ministry of University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113; Budden DM, 2014, BRIEFINGS BIOINFORMA; Carey V, 2014, ROC UTILITIES ROC UA; Cheng C, 2012, NUCLEIC ACIDS RES, V40, P553, DOI 10.1093/nar/gkr752; Claeys M, 2012, BIOINFORMATICS, V28, P1931, DOI 10.1093/bioinformatics/bts293; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Grassi E, 2015, MATRIXRIDER OBTAIN T; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Liu X, 2002, J MOL BIOL, V323, P1, DOI 10.1016/S0022-2836(02)00894-X; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Molineris I, 2011, MOL BIOL EVOL, V28, P2173, DOI 10.1093/molbev/msr027; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Shannon P, 2015, MOTIFDB ANNOTATED CO; Tan G, 2015, TFBSTOOLS SOFTWARE P; Tan G, 2014, JASPAR2014 DATA PACK; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Tibshirani R, 2015, BOOTSTRAP FUNCTIONS; Ward LD, 2008, BIOINFORMATICS, V24, pI165, DOI 10.1093/bioinformatics/btn154; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xie Z, 2010, BIOINFORMATICS, V26, P287, DOI 10.1093/bioinformatics/btp631	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143627	10.1371/journal.pone.0143627	http://dx.doi.org/10.1371/journal.pone.0143627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599758	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600096
J	Meadows, DN; Bahous, RH; Best, AF; Rozen, R				Meadows, Danielle N.; Bahous, Renata H.; Best, Ana F.; Rozen, Rima			High Dietary Folate in Mice Alters Immune Response and Reduces Survival after Malarial Infection	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY; TUMOR-NECROSIS-FACTOR; NEURAL-TUBE DEFECTS; FOLIC-ACID; CEREBRAL MALARIA; METABOLISM; EXPRESSION; GENE; SUPPLEMENTATION; FORTIFICATION	Malaria is a significant global health issue, with nearly 200 million cases in 2013 alone. Parasites obtain folate from the host or synthesize it de novo. Folate consumption has increased in many populations, prompting concerns regarding potential deleterious consequences of higher intake. The impact of high dietary folate on the host's immune function and response to malaria has not been examined. Our goal was to determine whether high dietary folate would affect response to malarial infection in a murine model of cerebral malaria. Mice were fed control diets (CD, recommended folate level for rodents) or folic acid-supplemented diets (FASD, 10x recommended level) for 5 weeks before infection with Plasmodium berghei ANKA. Survival, parasitemia, numbers of immune cells and other infection parameters were assessed. FASD mice had reduced survival (p<0.01, Cox proportional hazards) and higher parasitemia (p<0.01, joint model of parasitemia and survival) compared with CD mice. FASD mice had lower numbers of splenocytes, total T cells, and lower numbers of specific T and NK cell sub-populations, compared with CD mice (p<0.05, linear mixed effects). Increased brain TNF alpha immunoreactive protein (p<0.01, t-test) and increased liver Abca1 mRNA (p<0.01, t-test), a modulator of TNF alpha, were observed in FASD mice; these variables correlated positively (r(s) = 0.63, p = 0.01). Bcl-xl/Bak mRNA was increased in liver of FASD mice (p<0.01, t-test), suggesting reduced apoptotic potential. We conclude that high dietary folate increases parasite replication, disturbs the immune response and reduces resistance to malaria in mice. These findings have relevance for malaria-endemic regions, when considering anti-folate anti-malarials, food fortification or vitamin supplementation programs.	[Meadows, Danielle N.; Bahous, Renata H.; Rozen, Rima] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada; [Best, Ana F.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Rozen, Rima] McGill Univ, Dept Pediat, Ctr Hlth, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; McGill University	Rozen, R (corresponding author), McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada.	rima.rozen@mcgill.ca	Rozen, Rima/AAE-9294-2020	Best, Ana/0000-0002-4467-1725	Canadian Institutes of Health Research [MOP 43232]; Fonds de recherche du Quebec-Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by a Canadian Institutes of Health Research grant to RR (MOP 43232). The McGill University Health Centre Research Institute is supported by a Centres grant from the Fonds de recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GUID DAIL IR FOL AC; Boulet SL, 2008, BIRTH DEFECTS RES A, V82, P527, DOI 10.1002/bdra.20468; Britto Jéssica Carrilho, 2014, Rev. Bras. Hematol. Hemoter., V36, P275, DOI 10.1016/j.bjhh.2014.03.018; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Carter JY, 2005, AM J TROP MED HYG, V73, P166, DOI 10.4269/ajtmh.2005.73.166; Castilla C, 2006, ENDOCRINOLOGY, V147, P4960, DOI 10.1210/en.2006-0502; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P513; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Christensen KE, 2015, AM J CLIN NUTR, V101, P646, DOI 10.3945/ajcn.114.086603; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Dzinjalamala FK, 2005, AM J TROP MED HYG, V72, P267, DOI 10.4269/ajtmh.2005.72.267; EUROCAT, 2015, FOL AC MAND FORT; Garcia-Crespo D, 2009, J NUTR, V139, P488, DOI 10.3945/jn.108.095661; GRAU GE, 1989, IMMUNOL REV, V112, P49, DOI 10.1111/j.1600-065X.1989.tb00552.x; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; Hansen DS, 2007, CURR OPIN IMMUNOL, V19, P416, DOI 10.1016/j.coi.2007.07.011; Haque A, 2011, INFECT IMMUN, V79, P1882, DOI 10.1128/IAI.01210-10; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; Hood AT, 1996, BLOOD, V87, P1600, DOI 10.1182/blood.V87.4.1600.bloodjournal8741600; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Kalmbach RD, 2008, AM J CLIN NUTR, V88, P763, DOI 10.1093/ajcn/88.3.763; Kicska GA, 2003, J INFECT DIS, V188, P1776, DOI 10.1086/379373; Knock E, 2006, CANCER RES, V66, P10349, DOI 10.1158/0008-5472.CAN-06-2477; Knock E, 2011, J NUTR BIOCHEM, V22, P1022, DOI 10.1016/j.jnutbio.2010.07.015; Krawinkel MB, 2014, EUR J CLIN NUTR, V68, P719, DOI 10.1038/ejcn.2014.45; Lawrance AK, 2009, GUT, V58, P805, DOI 10.1136/gut.2007.143107; Leclerc D, 2013, MOL NUTR FOOD RES, V57, P686, DOI 10.1002/mnfr.201200212; LEVANDER OA, 1995, J PARASITOL, V81, P99, DOI 10.2307/3284013; Li DQ, 2005, AM J CLIN NUTR, V82, P188, DOI 10.1093/ajcn/82.1.188; McDowell Margaret A, 2008, NCHS Data Brief, P1; MCGILCHRIST CA, 1991, BIOMETRICS, V47, P461, DOI 10.2307/2532138; Meadows DN, 2014, HUM MUTAT, V35, P594, DOI 10.1002/humu.22533; Mikael LG, 2013, BIRTH DEFECTS RES A, V97, P47, DOI 10.1002/bdra.23092; Mikael LG, 2006, CIRC RES, V98, P564, DOI 10.1161/01.RES.0000204825.66410.0b; Morris MS, 2010, AM J CLIN NUTR, V91, P1733, DOI 10.3945/ajcn.2009.28671; Muller IB, 2013, MOL BIOCHEM PARASIT, V188, P63, DOI 10.1016/j.molbiopara.2013.02.008; Mulenga M, 2006, AM J TROP MED HYG, V74, P986, DOI 10.4269/ajtmh.2006.74.986; Nzila A, 2005, TRENDS PARASITOL, V21, P334, DOI 10.1016/j.pt.2005.05.008; Nzila A, 2005, TRENDS PARASITOL, V21, P292, DOI 10.1016/j.pt.2005.04.002; Nzila A, 2014, J ANTIMICROB CHEMOTH, V69, P323, DOI 10.1093/jac/dkt394; Oakes D, 1998, LIFETIME DATA ANAL, V4, P209, DOI 10.1023/A:1009689630516; Pandya AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026780; Pfeiffer CM, 2012, J NUTR, V142, P886, DOI 10.3945/jn.111.156919; Pickell L, 2009, BIRTH DEFECTS RES A, V85, P531, DOI 10.1002/bdra.20575; Pinheiro J, 2015, NLME LINEAR NONLINEA; Protiva P, 2011, CANCER PREV RES, V4, P530, DOI 10.1158/1940-6207.CAPR-10-0143; R Core Team, 2013, R LANG ENV STAT COMP; Reeves PG, 1997, J NUTR, V127, pS838; Rizopoulos D, 2010, J STAT SOFTW, V35, P1; ROTH EF, 1988, J LAB CLIN MED, V111, P35; Rudin W, 1997, AM J PATHOL, V150, P257; Sepehr E, 2003, J NUTR, V133, P1347; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Spence PJ, 2012, CURR OPIN IMMUNOL, V24, P444, DOI 10.1016/j.coi.2012.05.003; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Therneau T.M., 2000, MODELING SURVIVAL DA; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Troen AM, 2006, J NUTR, V136, P189, DOI 10.1093/jn/136.1.189; Valera-Gran D, 2014, JAMA PEDIATR, V168, DOI 10.1001/jamapediatrics.2014.2611; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wilson RD, 2007, J OBSTET GYNAECOL CA, V29, P1003, DOI 10.1016/S1701-2163(16)32685-8; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; YING Z, 1994, J MULTIVARIATE ANAL, V50, P17, DOI 10.1006/jmva.1994.1031	68	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143738	10.1371/journal.pone.0143738	http://dx.doi.org/10.1371/journal.pone.0143738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599510	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600114
J	Schabrun, SM; Burns, E; Hodges, PW				Schabrun, Siobhan M.; Burns, Emma; Hodges, Paul W.			New Insight into the Time-Course of Motor and Sensory System Changes in Pain	PLOS ONE			English	Article							TONIC MUSCLE PAIN; ELECTRICAL-STIMULATION; PERIPHERAL INPUT; CORTEX; EXCITABILITY; INHIBITION; POTENTIALS; PARAMETERS; LORAZEPAM; HUMANS	Background Pain-related interactions between primary motor (M1) and primary sensory (S1) cortex are poorly understood. In particular, the time-course over which S1 processing and corticomotor output are altered in association with muscle pain is unclear. We aimed to examine the temporal profile of altered processing in S1 and altered corticomotor output with finer temporal resolution than has been used previously. Methods In 10 healthy individuals we recorded somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) in separate sessions at multiple time-points before, during and immediately after pain induced by hypertonic saline infusion in a hand muscle, and at 15 and 25 minutes follow-up. Results Participants reported an average pain intensity that was less in the session where SEPs were recorded (SEPs: 4.0 +/- 1.6; MEPs: 4.9 +/- 2.3). In addition, the time taken for pain to return to zero once infusion of hypertonic saline ceased was less for participants in the SEP session (SEPs: 4.7 +/- 3.8 mins; MEPs 9.4 +/- 7.4 mins). Both SEPs and MEPs began to reduce almost immediately after pain reached 5/10 following hypertonic saline injection and were significantly reduced from baseline by the second (SEPs) and third (MEPs) recording blocks during pain. Both parameters remained suppressed immediately after pain had resolved and at 15 and 25 minutes after the resolution of pain. Conclusions These data suggest S1 processing and corticomotor output may be co-modulated in association with muscle pain. Interestingly, this is in contrast to previous observations. This discrepancy may best be explained by an effect of the SEP test stimulus on the corticomotor pathway. This novel finding is critical to consider in experimental design and may be potentially useful to consider as an intervention for the management of pain.	[Schabrun, Siobhan M.; Burns, Emma] Univ Western Sydney, Brain Rehabil & Neuroplast Unit, Sch Sci & Hlth, Penrith, NSW 2751, Australia; [Hodges, Paul W.] Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Brisbane, Qld 4062, Australia	Western Sydney University; University of Queensland	Schabrun, SM (corresponding author), Univ Western Sydney, Brain Rehabil & Neuroplast Unit, Sch Sci & Hlth, Campbelltown Campus,Locked Bag 1797, Penrith, NSW 2751, Australia.	s.schabrun@westernsydney.edu.au	Hodges, Paul W/B-6578-2008	Hodges, Paul W/0000-0002-1206-9107; Schabrun, Siobhan/0000-0002-9083-3107	National Health and Medical Research Council of Australia [ID631612, ID1002190]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	SMS is supported by a Clinical Research Fellowship (ID631612) and PWH by a Senior Principal Research Fellowship (ID1002190), both from the National Health and Medical Research Council of Australia.	Andrews RK, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-51; ASANUMA H, 1984, J NEUROPHYSIOL, V52, P212, DOI 10.1152/jn.1984.52.2.212; ASANUMA H, 1980, EXP BRAIN RES, V38, P349; Chipchase LS, 2011, CLIN NEUROPHYSIOL, V122, P456, DOI 10.1016/j.clinph.2010.07.025; Chipchase L, 2012, CLIN NEUROPHYSIOL, V123, P1698, DOI 10.1016/j.clinph.2012.05.003; Chipchase LS, 2011, ARCH PHYS MED REHAB, V92, P1423, DOI 10.1016/j.apmr.2011.01.011; Coppieters MW, 2006, ARCH PHYS MED REHAB, V87, P1412, DOI 10.1016/j.apmr.2006.06.012; DARIANSMITH C, 1990, J COMP NEUROL, V299, P47, DOI 10.1002/cne.902990104; Di Lazzaro V, 2000, CLIN NEUROPHYSIOL, V111, P794, DOI 10.1016/S1388-2457(99)00314-4; Eichstaedt KE, 2013, NEUROREHABILITATION, V32, P693, DOI 10.3233/NRE-130893; Kaelin-Lang A, 2002, J PHYSIOL-LONDON, V540, P623, DOI 10.1113/jphysiol.2001.012801; KANEKO T, 1994, J COMP NEUROL, V345, P161, DOI 10.1002/cne.903450202; KANEKO T, 1994, J COMP NEUROL, V345, P172, DOI 10.1002/cne.903450203; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; Martin PG, 2008, J PHYSIOL-LONDON, V586, P1277, DOI 10.1113/jphysiol.2007.140426; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Rossi S, 2003, CLIN NEUROPHYSIOL, V114, P1351, DOI 10.1016/S1388-2457(03)00073-7; Rushton DN, 2003, MED ENG PHYS, V25, P75, DOI 10.1016/S1350-4533(02)00040-1; SAKAMOTO T, 1987, BRAIN RES, V413, P360, DOI 10.1016/0006-8993(87)91029-8; Schabrun SM, 2013, NEUROSCIENCE, V235, P159, DOI 10.1016/j.neuroscience.2012.12.072; Schabrun SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051298; Schabrun SM, 2012, J PAIN, V13, P187, DOI 10.1016/j.jpain.2011.10.013; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; Vance CGT, 2014, PAIN MANAG, V4, P197, DOI [10.2217/pmt.14.13, 10.2217/PMT.14.13]; Ziemann U, 1998, NEUROLOGY, V51, P1320, DOI 10.1212/WNL.51.5.1320; Ziemann U, 1996, EXP BRAIN RES, V109, P127	26	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142857	10.1371/journal.pone.0142857	http://dx.doi.org/10.1371/journal.pone.0142857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599632	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600020
J	Dai, HP; Ehrentraut, S; Nagel, S; Eberth, S; Pommerenke, C; Dirks, WG; Geffers, R; Kalavalapalli, S; Kaufmann, M; Meyer, C; Faehnrich, S; Chen, SN; Drexler, HG; MacLeod, RAF				Dai, Haiping; Ehrentraut, Stefan; Nagel, Stefan; Eberth, Sonja; Pommerenke, Claudia; Dirks, Wilhelm G.; Geffers, Robert; Kalavalapalli, Srilaxmi; Kaufmann, Maren; Meyer, Corrina; Faehnrich, Silke; Chen, Suning; Drexler, Hans G.; MacLeod, Roderick A. F.			Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; REED-STERNBERG CELLS; GRAY ZONE LYMPHOMA; HODGKINS-LYMPHOMA; IN-VITRO; MUTATIONS; FREQUENT; SOCS-1; REL	Primary mediastinal B-Cell lymphoma (PMBL) is a recently defined entity comprising similar to 2-10% non-Hodgkin lymphomas (NHL). Unlike most NHL subtypes, PMBL lacks recurrent gene rearrangements to serve as biomarkers or betray target genes. While druggable, late chemotherapeutic complications warrant the search for new targets and models. Well characterized tumor cell lines provide unlimited material to serve as preclinical resources for verifiable analyses directed at the discovery of new biomarkers and pathological targets using high throughput microarray technologies. The same cells may then be used to seek intelligent therapies directed at clinically validated targets. Four cell lines have emerged as potential PMBL models: FARAGE, KARPAS-1106P, MEDB-1 and U-2940. Transcriptionally, PMBL cell lines cluster near c(lassical)-HL and B-NHL examples showing they are related but separate entities. Here we document genomic alterations therein, by cytogenetics and high density oligonucleotide/SNP microarrays and parse their impact by integrated global expression profiling. PMBL cell lines were distinguished by moderate chromosome rearrangement levels undercutting cHL, while lacking oncogene translocations seen in B-NHL. In total 61 deletions were shared by two or more cell lines, together with 12 amplifications (>= 4x) and 72 homozygous regions. Integrated genomic and transcriptional profiling showed deletions to be the most important class of chromosome rearrangement. Lesions were mapped to several loci associated with PMBL, e.g. 2p15 (REL/COMMD1), 9p24 (JAK2, CD274), 16p13 (SOCS1, LITAF, CIITA); plus new or tenuously associated loci: 2p16 (MSH6), 6q23 (TNFAIP3), 9p22 (CDKN2A/B), 20p12 (PTPN1). Discrete homozygous regions sometimes substituted focal deletions accompanied by gene silencing implying a role for epigenetic or mutational inactivation. Genomic amplifications increasing gene expression or gene-activating rearrangements were respectively rare or absent. Our findings highlight biallelic deletions as a major class of chromosomal lesion in PMBL cell lines, while endorsing the latter as preclinical models for hunting and testing new biomarkers and actionable targets.	[Dai, Haiping; Ehrentraut, Stefan; Nagel, Stefan; Eberth, Sonja; Pommerenke, Claudia; Dirks, Wilhelm G.; Kaufmann, Maren; Meyer, Corrina; Faehnrich, Silke; Drexler, Hans G.; MacLeod, Roderick A. F.] Leibniz Inst DSMZ, German Collect Microorganisms & Cell Cultures, Braunschweig, Germany; [Dai, Haiping; Chen, Suning] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou, Jiangsu, Peoples R China; [Geffers, Robert] Helmholtz Ctr Infect Res, Dept Genome Anal, HZI, Braunschweig, Germany; [Kalavalapalli, Srilaxmi] Univ Florida, Gainesville, FL USA	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Soochow University - China; Helmholtz Association; Helmholtz-Center for Infection Research; State University System of Florida; University of Florida	MacLeod, RAF (corresponding author), Leibniz Inst DSMZ, German Collect Microorganisms & Cell Cultures, Braunschweig, Germany.	rml@dsmz.de		Dirks, Wilhelm/0000-0001-9781-0998				Bartuzi P, 2013, BBA-MOL BASIS DIS, V1832, P2315, DOI 10.1016/j.bbadis.2013.09.014; BENBASSAT H, 1992, LEUKEMIA LYMPHOMA, V6, P513, DOI 10.3109/10428199209053591; Bertolo C, 2013, BRIT J HAEMATOL, V162, P621, DOI 10.1111/bjh.12440; Boleti E, 2007, HEMATOL ONCOL, V25, P157, DOI 10.1002/hon.818; Carbone A, 2014, ANN HEMATOL, V93, P1263, DOI 10.1007/s00277-014-2116-y; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; de Miranda NFCC, 2013, J EXP MED, V210, P1729, DOI 10.1084/jem.20122842; Dirks Wilhelm G, 2013, Methods Mol Biol, V946, P27, DOI 10.1007/978-1-62703-128-8_3; Drexler HG, 2015, LEUKEMIA RES, V39, P18, DOI 10.1016/j.leukres.2014.11.002; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Dunleavy K, 2015, BLOOD, V125, P33, DOI 10.1182/blood-2014-05-575092; Eberle FC, 2011, HAEMATOL-HEMATOL J, V96, P558, DOI 10.3324/haematol.2010.033167; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Guiter C, 2004, BLOOD, V104, P543, DOI 10.1182/blood-2003-10-3545; Gunawardana J, 2014, NAT GENET, V46, P329, DOI 10.1038/ng.2900; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Hao YS, 2014, CLIN CANCER RES, V20, P2674, DOI 10.1158/1078-0432.CCR-13-3007; Joos S, 1996, BLOOD, V87, P1571, DOI 10.1182/blood.V87.4.1571.bloodjournal8741571; Kimm LR, 2007, GENE CHROMOSOME CANC, V46, P1090, DOI 10.1002/gcc.20495; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; MacLeod RAF, 2008, CURR MED CHEM, V15, P339, DOI 10.2174/092986708783497319; MacLeod RAF, 2007, NAT PROTOC, V2, P372, DOI 10.1038/nprot.2007.29; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Melzner I, 2006, INT J CANCER, V118, P1941, DOI 10.1002/ijc.21485; Melzner I, 2005, BLOOD, V105, P2535, DOI 10.1182/blood-2004-09-3701; Mestre C, 2005, LEUKEMIA, V19, P1082, DOI 10.1038/sj.leu.2403741; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mitelman F., 1995, INT SYSTEM HUMAN CYT; Moller P, 2001, INT J CANCER, V92, P348, DOI 10.1002/ijc.1211; Moreno BH, 2015, BRIT J CANCER, V112, P1421, DOI 10.1038/bjc.2015.124; NACHEVA E, 1994, BLOOD, V84, P3422, DOI 10.1182/blood.V84.10.3422.bloodjournal84103422; Ritz O, 2013, ONCOTARGET, V4, P1093, DOI 10.18632/oncotarget.1149; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Sambade C, 2006, INT J CANCER, V118, P555, DOI 10.1002/ijc.21417; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Taskinen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091031; Tiacci E, 2012, BLOOD, V120, P4609, DOI 10.1182/blood-2012-05-428896; Twa DDW, 2014, BLOOD, V123, P2062, DOI 10.1182/blood-2013-10-535443; Weniger MA, 2006, ONCOGENE, V25, P2679, DOI 10.1038/sj.onc.1209151; Weniger MA, 2007, GENE CHROMOSOME CANC, V46, P406, DOI 10.1002/gcc.20420; Wessendorf S, 2007, LEUKEMIA, V21, P2463, DOI 10.1038/sj.leu.2404919; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Zhou J, 2011, ONCOGENE, V30, P1892, DOI 10.1038/onc.2010.575	52	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0139663	10.1371/journal.pone.0139663	http://dx.doi.org/10.1371/journal.pone.0139663			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599546	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900005
J	Ding, XX; Wang, QM; Chang, PJ; Li, J; Savini, G; Huang, JH; Huang, SH; Zhao, YY; Liao, N; Lin, L; Yu, XY; Zhao, YE				Ding, Xixia; Wang, Qinmei; Chang, Pingjun; Li, Jin; Savini, Giacomo; Huang, Jinhai; Huang, Shenghai; Zhao, Yinying; Liao, Na; Lin, Lei; Yu, Xiaoyu; Zhao, Yun-e			The Repeatability Assessment of Three-Dimensional Capsule-Intraocular Lens Complex Measurements by Means of High-Speed Swept-Source Optical Coherence Tomography	PLOS ONE			English	Article							IN-VIVO; ANTERIOR SEGMENT; CATARACT-SURGERY; DECENTRATION; SILICONE; TILT; AGREEMENT; ADHESION; BIOMETRY; PURKINJE	Purpose To rebuild the three-dimensional (3-D) model of the anterior segment by high-speed swept-source optical coherence tomography (SSOCT) and evaluate the repeatability of measurement for the parameters of capsule-intraocular lens (C-IOL) complex. Methods Twenty-two pseudophakic eyes from 22 patients were enrolled. Three continuous SSOCT measurements were performed in all eyes and the tomograms obtained were used for 3-D reconstruction. The output data were used to evaluate the measurement repeatability. The parameters included postoperative aqueous depth (PAD), the area and diameter of the anterior capsule opening (Area and D), IOL tilt (IOL-T), horizontal, vertical, and space decentration of the IOL, anterior capsule opening, and IOL-anterior capsule opening. Results PAD, IOL-T, Area, D, and all decentration measurements showed high repeatability. Repeated measure analysis showed there was no statistically significant difference among the three continuous measurements (all P>.05). Pearson correlation analysis showed high correlation between each pair of them (all r>0.90, P<0.001). ICCs were all more than 0.9 for all parameters. The 95% LoAs of all parameters were narrow for comparison of three measurements, which showed high repeatability for three measurements. Conclusion SSOCT is available to be a new method for the 3-D measurement of C-IOL complex after cataract surgery. This method presented high repeatability in measuring the parameters of the C-IOL complex.	[Ding, Xixia; Wang, Qinmei; Chang, Pingjun; Li, Jin; Huang, Jinhai; Huang, Shenghai; Zhao, Yinying; Liao, Na; Lin, Lei; Yu, Xiaoyu; Zhao, Yun-e] Wenzhou Med Univ, Sch Optometry, Wenzhou, Zhejiang, Peoples R China; [Ding, Xixia; Wang, Qinmei; Chang, Pingjun; Li, Jin; Huang, Jinhai; Huang, Shenghai; Zhao, Yinying; Liao, Na; Lin, Lei; Yu, Xiaoyu; Zhao, Yun-e] Wenzhou Med Univ, Ophthalmol & Eye Hosp, Wenzhou, Zhejiang, Peoples R China; [Ding, Xixia; Wang, Qinmei; Chang, Pingjun; Li, Jin; Huang, Jinhai; Huang, Shenghai; Zhao, Yinying; Liao, Na; Lin, Lei; Yu, Xiaoyu; Zhao, Yun-e] Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Savini, Giacomo] GB Bietti Fdn IRCCS, Rome, Italy	Wenzhou Medical University; Wenzhou Medical University; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia	Zhao, YE (corresponding author), Wenzhou Med Univ, Sch Optometry, Wenzhou, Zhejiang, Peoples R China.	zye@mail.eye.ac.cn	Huang, Jinhai/ABH-4519-2020; Savini, Giacomo/J-9196-2018	Savini, Giacomo/0000-0003-0075-3582	Foundation of National Nature Science Foundation of China [80213050]; Zhejiang Provincial Natural Science Foundation of China [LY13H120005]; Italian Ministry of Health; Fondazione Roma	Foundation of National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission)	This study was supported by research grants from Foundation of National Nature Science Foundation of China (Grant No. 80213050 to Yun-e Zhao); and Zhejiang Provincial Natural Science Foundation of China (LY13H120005 to JL). The contribution of the G.B. Fondazione Bietti IRCCS in this paper was supported by the Italian Ministry of Health and by Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ale JB, 2011, NEPAL J OPHTHALMOL, V3, P68, DOI 10.3126/nepjoph.v3i1.4281; Apple DJ, 2000, SURV OPHTHALMOL, V45, pS5; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen Q, 2014, EYE CONTACT LENS, V40, P37, DOI 10.1097/ICL.0000000000000005; de Castro A, 2007, J CATARACT REFR SURG, V33, P418, DOI 10.1016/j.jcrs.2006.10.054; Grulkowski I, 2009, OPT EXPRESS, V17, P4842, DOI 10.1364/OE.17.004842; Hayashi H, 2002, OPHTHALMOLOGY, V109, P1427, DOI 10.1016/S0161-6420(02)01112-0; Hayashi K, 1997, OPHTHALMOLOGY, V104, P793, DOI 10.1016/S0161-6420(97)30231-0; Hoffer KJ, 2011, OPHTHALMOLOGY, V118, P1484, DOI 10.1016/j.ophtha.2011.03.009; Kumar DA, 2011, AM J OPHTHALMOL, V151, P406, DOI 10.1016/j.ajo.2010.09.013; Marcantonio JM, 2000, INVEST OPHTH VIS SCI, V41, P1130; Marcos S, 2014, OPHTHALMOLOGY, V121, P45, DOI 10.1016/j.ophtha.2013.06.025; Nagata T, 1998, J CATARACT REFR SURG, V24, P367, DOI 10.1016/S0886-3350(98)80325-8; Nishi O, 1998, OPHTHALMIC SURG LAS, V29, P587; Nishi O, 2002, J CATARACT REFR SURG, V28, P431, DOI 10.1016/S0886-3350(01)01094-X; Nishi Y, 2010, J CATARACT REFR SURG, V36, P1529, DOI 10.1016/j.jcrs.2010.03.043; Nixon DR, 2006, AM J OPHTHALMOL, V142, P557, DOI 10.1016/j.ajo.2006.05.049; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P472, DOI 10.1111/j.1600-0420.2007.00879.x; Ortiz S, 2013, BIOMED OPT EXPRESS, V4, P387, DOI 10.1364/BOE.4.000387; Ortiz S, 2010, OPT EXPRESS, V18, P2782, DOI 10.1364/OE.18.002782; Oshika T, 1998, BRIT J OPHTHALMOL, V82, P549, DOI 10.1136/bjo.82.5.549; Sacu S, 2005, J CATARACT REFR SURG, V31, P330, DOI 10.1016/j.jcrs.2004.04.057; Savini G, 2013, J REFRACT SURG, V29, P121, DOI 10.3928/1081597X-20130117-07; Tao AZ, 2013, INVEST OPHTH VIS SCI, V54, P6991, DOI 10.1167/iovs.13-12849; Wang XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059109; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; Zemaitiene Reda, 2004, Medicina (Kaunas), V40, P721; Zhao MT, 2010, OPT EXPRESS, V18, P8923, DOI 10.1364/OE.18.008923; Zhao YY, 2013, AM J OPHTHALMOL, V155, P484, DOI 10.1016/j.ajo.2012.08.019	29	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142556	10.1371/journal.pone.0142556	http://dx.doi.org/10.1371/journal.pone.0142556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600254	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900027
J	Kanda, E; Muneyuki, T; Suwa, K; Nakajima, K				Kanda, Eiichiro; Muneyuki, Toshitaka; Suwa, Kaname; Nakajima, Kei			Effects of Weight Loss Speed on Kidney Function Differ Depending on Body Mass Index in Nondiabetic Healthy People: A Prospective Cohort	PLOS ONE			English	Article							OBESITY-RELATED GLOMERULOPATHY; METABOLIC SYNDROME; RISK; DISEASE; CKD; ASSOCIATION; PROGRESSION; OVERWEIGHT; DECLINE; GENDER	Background Obesity is associated with diabetes mellitus and cardiovascular diseases. However, it has been reported that weight loss is associated with incident chronic kidney disease (CKD) in healthy males. The purpose of this prospective cohort study is to investigate the effects of weight loss on kidney function in healthy people in terms of body mass index (BMI) and gender. Methods A total of 8447 nondiabetic healthy people were enrolled in the Saitama Cardiometabolic Disease and Organ Impairment Study, Japan. Relationships between estimated glomerular filtration rate (eGFR) change, BMI, and BMI change were evaluated using 3D-scatter plots with spline and generalized additive models (GAMs) adjusted for baseline characteristics. Results The subjects were stratified into four groups according to BMI. The mean +/- standard deviations for males and females were, respectively, 40.11 +/- 9.49, and 40.3 +/- 9.71 years for age and 76.39 +/- 17.72 and 71.49 +/- 18.4 ml/min/1.73m(2) for eGFR. GAMs showed that a decreasing BMI change (<-1 kg/m(2)/year) was associated with a decreasing eGFR change in males with high normal BMIs (22 kg/m(2)<= BMI<25 kg/m(2)). A decreasing BMI change (<-2 kg/m(2)/year) was associated with an increasing eGFR change in overweight males (25 kg/m(2)<= BMI). Among underweight females (BMI<18.5 kg/m(2)), decreasing BMI was observed with decreasing eGFR. Conclusions These findings suggest that the benefit and risk of weight loss in relation to kidney function differs depending on BMI and weight loss speed, especially in males.	[Kanda, Eiichiro] Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan; [Kanda, Eiichiro] Tokyo Med & Dent Univ, Ctr Life Sci & Bioeth, Bunkyo Ku, Tokyo, Japan; [Muneyuki, Toshitaka] Funabashi City Rehabil Hosp, Dept Rehabil, Funabashi, Chiba, Japan; [Suwa, Kaname] Saitama Hlth Promot Corp, Hiki, Saitama, Japan; [Nakajima, Kei] Kuki Gen Hosp, Dept Metab, Kuki, Saitama, Japan	Tokyo Medical & Dental University (TMDU)	Kanda, E (corresponding author), Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan.	tokyo.kyosai.kanda@gmail.com	Nakajima, Kei/AAF-2801-2019	Nakajima, Kei/0000-0002-1788-3896				Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25; Bernieh B, 2010, SAUDI J KIDNEY DIS T, V21, P898; Chen HM, 2008, AM J KIDNEY DIS, V52, P58, DOI 10.1053/j.ajkd.2008.02.303; Cheng HT, 2012, J CLIN ENDOCR METAB, V97, P1268, DOI 10.1210/jc.2011-2658; Dittmann K, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-87; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Grubbs V, 2014, AM J KIDNEY DIS, V63, P590, DOI 10.1053/j.ajkd.2013.10.055; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Liu YF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/745410; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Morales E, 2003, AM J KIDNEY DIS, V41, P319, DOI 10.1053/ajkd.2003.50039; Muneyuki T, 2013, OPEN J ENDOCR METAB, V3, P144, DOI DOI 10.4236/0JEMD.2013.32022]; Muneyuki T, 2013, KIDNEY INT, V84, P1254, DOI 10.1038/ki.2013.222; Nagel G, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-177; Navarro-Diaz M, 2006, J AM SOC NEPHROL, V17, pS213, DOI 10.1681/ASN.2006080917; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Neugarten J, 2013, ADV CHRONIC KIDNEY D, V20, P390, DOI 10.1053/j.ackd.2013.05.004; Noori N, 2011, AM J KIDNEY DIS, V57, P130, DOI 10.1053/j.ajkd.2010.10.003; Panwar B, 2015, KIDNEY INT, V87, P1216, DOI 10.1038/ki.2014.384; Rogacev KS, 2011, NEW ENGL J MED, V365, P1745, DOI 10.1056/NEJMc1110239; Ryu S, 2008, J AM SOC NEPHROL, V19, P1798, DOI 10.1681/ASN.2007121286; Neto AS, 2009, J NEPHROL, V22, P637; Shen WW, 2010, CLIN J AM SOC NEPHRO, V5, P1401, DOI 10.2215/CJN.01370210; Straznicky NE, 2011, J HYPERTENS, V29, P553, DOI 10.1097/HJH.0b013e3283418875; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tokashiki K, 2009, CLIN EXP NEPHROL, V13, P55, DOI 10.1007/s10157-008-0085-y; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Tsuboi N, 2013, CLIN EXP NEPHROL, V17, P379, DOI 10.1007/s10157-012-0719-y; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488	34	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143434	10.1371/journal.pone.0143434	http://dx.doi.org/10.1371/journal.pone.0143434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599331	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900120
J	Ventura, S; Aryee, DNT; Felicetti, F; De Feo, A; Mancarella, C; Manara, MC; Picci, P; Colombo, MP; Kovar, H; Care, A; Scotlandi, K				Ventura, S.; Aryee, D. N. T.; Felicetti, F.; De Feo, A.; Mancarella, C.; Manara, M. C.; Picci, P.; Colombo, M. P.; Kovar, H.; Care, A.; Scotlandi, K.			CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-kappa B signaling	ONCOGENE			English	Article							MESENCHYMAL STEM-CELLS; PANCREATIC-CANCER CELLS; OSTEOGENIC DIFFERENTIATION; GENOMIC LANDSCAPE; DOWN-REGULATION; FAMILY TUMORS; GROWTH-FACTOR; IN-VITRO; EXPRESSION; PATHWAY	Sarcomas are mesenchymal tumors characterized by blocked differentiation process. In Ewing sarcoma (EWS) both CD99 and EWS-FLI1 concur to oncogenesis and inhibition of differentiation. Here, we demonstrate that uncoupling CD99 from EWS-FLI1 by silencing the former, nuclear factor-kappa B (NF-kappa B) signaling is inhibited and the neural differentiation program is re-established. NF-kappa B inhibition passes through miR-34a-mediated repression of Notch pathway. CD99 counteracts EWS-FLI1 in controlling NF-kappa B signaling through the miR-34a, which is increased and secreted into exosomes released by CD99-silenced EWS cells. Delivery of exosomes from CD99-silenced cells was sufficient to induce neural differentiation in recipient EWS cells through miR-34a inhibition of Notch-NF-kappa B signaling. Notably, even the partial delivery of CD99 small interfering RNA may have a broad effect on the entire tumor cell population owing to the spread operated by their miR-34a-enriched exosomes, a feature opening to a new therapeutic option.	[Ventura, S.; Mancarella, C.; Manara, M. C.; Picci, P.; Scotlandi, K.] Ist Ortoped Rizzoli, Expt Oncol Lab, CRS Dev Biomol Therapies, Via Barbiano 1-10, I-40136 Bologna, Italy; [Aryee, D. N. T.; Kovar, H.] St Anna Kinderkrebsforsch, Childrens Canc Res Inst, Vienna, Austria; [Aryee, D. N. T.; Kovar, H.] Med Univ, Dept Pediat, Vienna, Austria; [Felicetti, F.; De Feo, A.; Care, A.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, Rome, Italy; [Colombo, M. P.] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Mol Immunol Unit, Milan, Italy	IRCCS Istituto Ortopedico Rizzoli; Saint Anna Children's Hospital; Istituto Superiore di Sanita (ISS); Fondazione IRCCS Istituto Nazionale Tumori Milan	Scotlandi, K (corresponding author), Ist Ortoped Rizzoli, Expt Oncol Lab, CRS Dev Biomol Therapies, Via Barbiano 1-10, I-40136 Bologna, Italy.	katia.scotlandi@ior.it	Scotlandi, Katia/J-9009-2016; Mancarella, Caterina/C-7463-2019; Manara, Maria Cristina/K-3366-2018; Colombo, Mario P./V-7166-2017; De Feo, Alessandra/ABI-1458-2020; Felicetti, Federica/N-7077-2017; De Feo, Alessandra/C-7030-2019; Care, Alessandra/H-5090-2016	Scotlandi, Katia/0000-0001-6114-9499; Mancarella, Caterina/0000-0002-5778-4251; Manara, Maria Cristina/0000-0001-5686-720X; Colombo, Mario P./0000-0003-0042-7955; De Feo, Alessandra/0000-0002-9805-1361; Felicetti, Federica/0000-0003-4628-0696; De Feo, Alessandra/0000-0002-9805-1361; Kovar, Heinrich/0000-0001-6873-9109; Care, Alessandra/0000-0003-4106-3342	Italian Association for Cancer Research (AIRC project) [IG2013_14049, IG2012_13247]; Ministry of Education, Research and Universities (FIRB project) [RBAP11884 M_005]; Ministry of Health (PROVABES project) [PER-2011-2353839]; Austrian Science Fund [P24708-B21]; Austrian Science Fund (PROVABES project) [I-1225-B19]; fellowship 'Guglielmina Lucatello e Gino Mazzega' - Fondazione Italiana per la Ricerca sul Cancro (FIRC project) [13811]; Austrian Science Fund (FWF) [P 24708] Funding Source: researchfish	Italian Association for Cancer Research (AIRC project)(Fondazione AIRC per la ricerca sul cancro); Ministry of Education, Research and Universities (FIRB project); Ministry of Health (PROVABES project); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (PROVABES project)(Austrian Science Fund (FWF)); fellowship 'Guglielmina Lucatello e Gino Mazzega' - Fondazione Italiana per la Ricerca sul Cancro (FIRC project); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are indebted to Cristina Ghinelli for editing the manuscript. We wish to thank Dr Gianfranco Mattia for the assessment of immunofluorescence analysis on the exosome fusion. We are also grateful to Prof. Alain Israel and Dr Johannes Schmid for sharing NF-kappa B reporter and plasmids. This work was supported by grants from the Italian Association for Cancer Research (AIRC project: IG2013_14049 to KS; IG2012_13247 to AC), Ministry of Education, Research and Universities (FIRB project: RBAP11884 M_005 to KS), Ministry of Health (PROVABES project: PER-2011-2353839 to PP and KS), Austrian Science Fund (project: P24708-B21 and PROVABES project: I-1225-B19 to HK). Selena Ventura is in receipt of the fellowship 'Guglielmina Lucatello e Gino Mazzega' granted by Fondazione Italiana per la Ricerca sul Cancro (FIRC project code: 13811).	Ahmed AA, 2012, HUM PATHOL, V43, P1077, DOI 10.1016/j.humpath.2011.09.001; Alberti I, 2002, FASEB J, V16, P1946, DOI 10.1096/fj.02-0049fje; Armengol G, 1997, BRIT J CANCER, V75, P1403, DOI 10.1038/bjc.1997.242; Baliko F, 2007, AM J PATHOL, V170, P1686, DOI 10.2353/ajpath.2007.060971; Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145; Bennani-Baiti IM, 2011, J PATHOL, V225, P353, DOI 10.1002/path.2966; Bernard G, 1997, J IMMUNOL, V158, P2543; Braicu C, 2015, CELL DEATH DIFFER, V22, P34, DOI 10.1038/cdd.2014.130; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Carrillo J, 2007, CLIN CANCER RES, V13, P2429, DOI 10.1158/1078-0432.CCR-06-1762; Charytonowicz E, 2012, J CLIN INVEST, V122, P886, DOI 10.1172/JCI60015; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; De Molfetta GA, 2010, DIFFERENTIATION, V80, P195, DOI 10.1016/j.diff.2010.07.004; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Di Martino MT, 2012, CLIN CANCER RES, V18, P6260, DOI 10.1158/1078-0432.CCR-12-1708; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Franzetti GA, 2013, ONCOGENE, V32, P3915, DOI 10.1038/onc.2012.403; Garofalo C, 2012, MOL ENDOCRINOL, V26, P1603, DOI 10.1210/me.2012-1142; GELIN C, 1989, EMBO J, V8, P3253, DOI 10.1002/j.1460-2075.1989.tb08485.x; Ginsberg JP, 2010, JNCI-J NATL CANCER I, V102, P1272, DOI 10.1093/jnci/djq278; Gonzalez I, 2007, J MOL MED, V85, P1015, DOI 10.1007/s00109-007-0202-5; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Huang HY, 2005, J CLIN ONCOL, V23, P548, DOI 10.1200/JCO.2005.02.081; Javelaud D, 2002, INT J CANCER, V98, P193, DOI 10.1002/ijc.10192; Javelaud D, 2000, ONCOGENE, V19, P61, DOI 10.1038/sj.onc.1203246; Kok MGM, 2015, FASEB J, V29, P3853, DOI 10.1096/fj.15-271312; Lagirand-Cantaloube J, 2010, BIOCHEM BIOPH RES CO, V399, P705, DOI 10.1016/j.bbrc.2010.08.004; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Guerrero JA, 2001, LAB INVEST, V81, P803, DOI 10.1038/labinvest.3780290; Magnan H, 2015, PEDIATR BLOOD CANCER, V62, P594, DOI 10.1002/pbc.25373; Maksimenko A, 2005, EXPERT OPIN THER TAR, V9, P825, DOI 10.1517/14728222.9.4.825; Marino MT, 2014, ANN ONCOL, V25, P2080, DOI 10.1093/annonc/mdu249; McDermott AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083718; Miyagawa Y, 2008, MOL CELL BIOL, V28, P2125, DOI 10.1128/MCB.00740-07; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; Nogueira L, 2011, ONCOGENE, V30, P3537, DOI 10.1038/onc.2011.74; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; OUCHIDA M, 1995, ONCOGENE, V11, P1049; Ozeki A, 2012, NEUROREPORT, V23, P290, DOI 10.1097/WNR.0b013e3283509a79; Pang RTK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-25; Pata Supansa, 2011, BMC Res Notes, V4, P293, DOI 10.1186/1756-0500-4-293; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Rocchi A, 2010, J CLIN INVEST, V120, P668, DOI 10.1172/JCI36667; Rorie CJ, 2004, CANCER RES, V64, P1266, DOI 10.1158/0008-5472.CAN-03-3274; Sabolek M, 2006, NEUROREPORT, V17, P1719, DOI 10.1097/01.wnr.0000236862.08834.50; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Sonnemann J, 2007, J CANCER RES CLIN, V133, P847, DOI 10.1007/s00432-007-0227-8; Sonnemann J, 2011, EUR J CANCER, V47, P1432, DOI 10.1016/j.ejca.2011.01.015; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Teitell MA, 1999, LAB INVEST, V79, P1535; Amaral AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085814; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Toretsky JA, 1997, J BIOL CHEM, V272, P30822, DOI 10.1074/jbc.272.49.30822; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wang ZW, 2006, INT J CANCER, V118, P1930, DOI 10.1002/ijc.21589; Widera D, 2006, INT J DEV NEUROSCI, V24, P91, DOI 10.1016/j.ijdevneu.2005.11.017; Womer RB, 2012, J CLIN ONCOL, V30, P4148, DOI 10.1200/JCO.2011.41.5703; Yang CB, 2010, STEM CELLS, V28, P1970, DOI 10.1002/stem.528	72	34	38	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 28	2016	35	30					3944	3954		10.1038/onc.2015.463	http://dx.doi.org/10.1038/onc.2015.463			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8DJ	26616853	Green Accepted			2022-12-26	WOS:000381013100006
J	Wang, B; Merillat, SA; Vincent, M; Huber, AK; Basrur, V; Mangelberger, D; Zeng, L; Elenitoba-Johnson, K; Miller, RA; Irani, DN; Dlugosz, AA; Schnell, S; Scaglione, KM; Paulson, HL				Wang, Bo; Merillat, Sean A.; Vincent, Michael; Huber, Amanda K.; Basrur, Venkatesha; Mangelberger, Doris; Zeng, Li; Elenitoba-Johnson, Kojo; Miller, Richard A.; Irani, David N.; Dlugosz, Andrzej A.; Schnell, Santiago; Scaglione, Kenneth Matthew; Paulson, Henry L.			Loss of the Ubiquitin-conjugating Enzyme UBE2W Results in Susceptibility to Early Postnatal Lethality and Defects in Skin, Immune, and Male Reproductive Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL RESIDUE; EMBRYONIC-DEVELOPMENT; PROTEASOME SYSTEM; TUMOR-SUPPRESSOR; DEGRADATION; PROTEIN; PATHWAY; MICE; PREDICTION; STRESS	UBE2W ubiquitinates N termini of proteins rather than internal lysine residues, showing a preference for substrates with intrinsically disordered N termini. The in vivo functions of this intriguing E2, however, remain unknown. We generated Ube2w germ line KO mice that proved to be susceptible to early postnatal lethality without obvious developmental abnormalities. Although the basis of early death is uncertain, several organ systems manifest changes in Ube2w KO mice. Newborn Ube2w KO mice often show altered epidermal maturation with reduced expression of differentiation markers. Mirroring higher UBE2W expression levels in testis and thymus, Ube2w KO mice showed a disproportionate decrease in weight of these two organs (similar to 50%), suggesting a functional role for UBE2W in the immune and male reproductive systems. Indeed, Ube2w KO mice displayed sustained neutrophilia accompanied by increased G-CSF signaling and testicular vacuolation associated with decreased fertility. Proteomic analysis of a vulnerable organ, presymptomatic testis, showed a preferential accumulation of disordered proteins in the absence of UBE2W, consistent with the view that UBE2W preferentially targets disordered polypeptides. These mice further allowed us to establish that UBE2W is ubiquitously expressed as a single isoform localized to the cytoplasm and that the absence of UBE2W does not alter cell viability in response to various stressors. Our results establish that UBE2W is an important, albeit not essential, protein for early postnatal survival and normal functioning of multiple organ systems.	[Wang, Bo; Merillat, Sean A.; Huber, Amanda K.; Zeng, Li; Irani, David N.; Paulson, Henry L.] Univ Michigan, Dept Neurol, 109 Zina Pitcher Pl,Rm 4001, Ann Arbor, MI 48109 USA; [Vincent, Michael; Schnell, Santiago] Univ Michigan, Dept Mol & Integrat Physiol & Computat Med & Bioi, Ann Arbor, MI 48109 USA; [Mangelberger, Doris; Dlugosz, Andrzej A.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Wang, Bo] Univ Michigan, Grad Program Neurosci, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Univ Michigan, Pathol & Geriatr Ctr, Ann Arbor, MI 48109 USA; [Scaglione, Kenneth Matthew] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Scaglione, Kenneth Matthew] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Medical College of Wisconsin; Medical College of Wisconsin	Paulson, HL (corresponding author), Univ Michigan, Dept Neurol, 109 Zina Pitcher Pl,Rm 4001, Ann Arbor, MI 48109 USA.	henryp@med.umich.edu	Schnell, Santiago/B-8682-2008; Vincent, Michael/H-4939-2015	Schnell, Santiago/0000-0002-9477-3914; Huber, Amanda/0000-0003-0375-8709; Vincent, Michael/0000-0001-9669-4921; Scaglione, Kenneth/0000-0002-3858-9418; Elenitoba-Johnson, Kojo/0000-0002-1082-1545	National Institutes of Health [R01 AG034228, U19 AG023122, R01 AR045973, K99 NS073936]; University of Michigan Protein Folding Disease Initiative; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS073936, K99NS073936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019899, R01AG034228, U19AG023122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Protein Folding Disease Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was support by National Institutes of Health Grants R01 AG034228 (to H. L. P.), U19 AG023122 (to R. A. M.), R01 AR045973 (to A. A. D.), and K99 NS073936 (to K. M. S.) and the University of Michigan Protein Folding Disease Initiative. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Bedard N, 2005, MOL CELL BIOL, V25, P6346, DOI 10.1128/MCB.25.15.6346-6354.2005; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Bueter W, 2009, PEDIATR RES, V66, P487, DOI 10.1203/PDR.0b013e3181baa083; Byrne C, 2003, J ANAT, V202, P113, DOI 10.1046/j.1469-7580.2003.00142.x; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Fricker M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.38; Gitto E, 2002, BIOL NEONATE, V81, P146, DOI 10.1159/000051527; Harbers K, 1996, P NATL ACAD SCI USA, V93, P12412, DOI 10.1073/pnas.93.22.12412; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Ikeda M, 2002, VIROLOGY, V300, P153, DOI 10.1006/viro.2002.1562; Iwai K, 2012, TRENDS CELL BIOL, V22, P355, DOI 10.1016/j.tcb.2012.04.001; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lenhoff S, 1999, EUR CYTOKINE NETW, V10, P525; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Marseglia L, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/358375; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Roest HP, 2004, MOL CELL BIOL, V24, P5485, DOI 10.1128/MCB.24.12.5485-5495.2004; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Starita LM, 2013, P NATL ACAD SCI USA, V110, pE1263, DOI 10.1073/pnas.1303309110; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Vittal V, 2015, NAT CHEM BIOL, V11, P83, DOI [10.1038/NCHEMBIO.1700, 10.1038/nchembio.1700]; Vittal V, 2013, CELL BIOCHEM BIOPHYS, V67, P103, DOI 10.1007/s12013-013-9633-5; Vosper JMD, 2009, J BIOL CHEM, V284, P15458, DOI 10.1074/jbc.M809366200; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang YY, 2011, MOL CELLS, V31, P113, DOI 10.1007/s10059-011-0015-9; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	46	17	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3030	3042		10.1074/jbc.M115.676601	http://dx.doi.org/10.1074/jbc.M115.676601			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26601958	Green Published, hybrid			2022-12-26	WOS:000369626900039
J	Tomaszewski, P				Tomaszewski, Piotr			Constraints on Negative Prefixation in Polish Sign Language	PLOS ONE			English	Article								The aim of this article is to describe a negative prefix, NEG-, in Polish Sign Language (PJM) which appears to be indigenous to the language. This is of interest given the relative rarity of prefixes in sign languages. Prefixed PJM signs were analyzed on the basis of both a corpus of texts signed by 15 deaf PJM users who are either native or near-native signers, and material including a specified range of prefixed signs as demonstrated by native signers in dictionary form (i.e. signs produced in isolation, not as part of phrases or sentences). In order to define the morphological rules behind prefixation on both the phonological and morphological levels, native PJM users were consulted for their expertise. The research results can enrich models for describing processes of grammaticalization in the context of the visual-gestural modality that forms the basis for sign language structure.	[Tomaszewski, Piotr] Univ Warsaw, Fac Psychol, Warsaw, Poland	University of Warsaw	Tomaszewski, P (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	piotr.tomaszewski@psych.uw.edu.pl		Tomaszewski, Piotr/0000-0002-4083-067X	Principal Research Fund of the Faculty of Psychology, University of Warsaw [BST 171223/2014, BST 174419/2015]	Principal Research Fund of the Faculty of Psychology, University of Warsaw	The author's work was supported by the Principal Research Fund of the Faculty of Psychology, University of Warsaw (BST 171223/2014, BST 174419/2015). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PORADNIK JEZYKOWY, V3, P44; Antzakas K, 2006, THESIS; Aronoff M, 2005, LANGUAGE, V81, P301, DOI 10.1353/lan.2005.0043; Aronoff M, 2003, PERSPECTIVES ON CLASSIFIER CONSTRUCTIONS IN SIGN LANGUAGES, P53; Aronoff M, 2000, U MARYLAND WORKING P, V10, P1; Aronoff M, 2008, INTERACT STUD, V9, P133, DOI 10.1075/is.9.1.10aro; Aronoff M, 2005, YEARB MORPHOL, P19, DOI 10.1007/1-4020-2900-4_2; Battison R, 1974, SIGN LANGUAGE STUDIE, V5, P1, DOI DOI 10.1353/SLS.1974.0005; Battison R., 1978, LEXICAL BORROWING AM; Bauer Laurie, 2001, MORPHOLOGICAL PRODUC, DOI 10.1017/CBO9780511486210; Brennan M., 1992, DICT BRIT SIGN LANGU, P1, DOI DOI 10.1017/CBO9781139167048.002; Brennan Mary., 1990, WORD FORMATION BRIT; Brentari Diane, 1998, PROSODIC MODEL SIGN; Bybee JoanL., 1994, EVOLUTION GRAMMAR TE; Coulter G., 1990, LINGUISTICS, V1, P109; Heine B, 2002, WORLD LEXICON GRAMMA; Hendriks B., 2008, JORDANIAN SIGN LANGU; Hollak J., 1879, SLOWNIK MIMICZNY GLU; Johnston T., 2007, AUSTR SIGN LANGUAGE; Kennedy G, 2002, CONCISE DICT NZ SIGN; Klima E., 1979, SIGNS LANGUAGE; Lesson L, 2012, IRISH SIGN LANGUAGE; Liddell Scott, 1989, SIGN LANG STUD, V64, P195, DOI DOI 10.1353/SLS.1989.0027; LIDDELL SK, 1984, LANGUAGE, V60, P372, DOI 10.2307/413645; Mathur G., 2014, OXFORD HDB LANGUAGE, P379, DOI [10.1093/oxfordhb/9780199735471.013.005, DOI 10.1093/OXFORDHB/9780199735471.013.005]; Meir I., 2004, SIGN LANG LING, V7, P97, DOI [DOI 10.1075/SLL.7.2.03MEI, 10.1075/sll.7.2.03mei]; Meir I., 2012, SIGN LANGUAGE INT HD, P77, DOI DOI 10.1515/9783110261325.77; Meir I, 2010, AMST STUD THEORY HIS, V311, P301; Meir Irit, 2008, LANGUAGE SPACE STORY; PADDEN CA, 1990, SIGN LANGUAGE RESEARCH, P118; Padden CA, 1988, OUTSTANDING DISSER 4; Pfau Roland., 2006, LINGUISTICS POTSDAM, V24, P3; Sandler W, 2006, SIGN LANGUAGE AND LINGUISTIC UNIVERSALS, P1, DOI 10.2277/ 0521483956; Sandler W, 1996, LINGUA, V98, P197, DOI 10.1016/0024-3841(95)00038-0; Sandler W, 2005, CONT LINGUISTICS INT, P343; Sandler W., 1989, PHONOLOGICAL REPRESE; Sandler W, 1990, LINGUISTICS, V1, P7; Sandler W, 2011, NAT LANG LINGUIST TH, V29, P503, DOI 10.1007/s11049-011-9128-2; Sandler W, 2010, T PHILOL SOC, V108, P298, DOI 10.1111/j.1467-968X.2010.01242.x; Sandler Wendy., 1999, STUDIES PHONOLOGICAL, P223, DOI DOI 10.1075/CILT.174.09SAN; Sandler Wendy, 2010, BLACKWELL COMPANION, P577; Sutton-Spence R., 2001, HANDS ARE HEAD MOUTH, P1; Sutton-Spence Rachel, 1999, LINGUISTICS BRIT SIG; Tomaszewski P., 2005, PORADNIK JEZYKOWY, V2, P59; Tomaszewski P., 2010, STUDIES PSYCHOL LANG, P289; Tomaszewski P., 2010, FONOLOGIA WIZUALNA P; Valli Clayton., 2006, GALLAUDET DICT AM SI; Wilbur R.B., 1979, AM SIGN LANGUAGE SIG; Wilbur RB, 1999, LANG SPEECH, V42, P229, DOI 10.1177/00238309990420020501; Wojda P., 2010, SIGN LANGUAGES, P131, DOI [10.1017/cbo9780511712203.008, DOI 10.1017/CBO9780511712203.008]; WOODWARD J, 1977, LANG SOC, V6, P379, DOI 10.1017/S0047404500005078; Woodward James, 1974, SIGN LANGUAGE STUDIE, V5, P20, DOI DOI 10.1353/SLS.1974.0006; Yang J.H., 2002, SIGN LANG LINGUIST, V5, P167, DOI [https://doi.org/10.1075/sll.5.2.05yan, DOI 10.1075/SLL.5.2.05YAN, 10.1075/sll.5.2.05yan]; Zeshan U., 2004, LINGUIST TYPOL, V8, P1, DOI [10.1515/lity.2004.003, DOI 10.1515/LITY.2004.003]; Zeshan U., 2006, INTERROGATIVE NEGATI, P28, DOI 10.26530/OAPEN_453832; Zeshan Ulrike, 2000, SIGN LANGUAGE INDO P; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; ZWICKY AM, 1983, LANGUAGE, V59, P502, DOI 10.2307/413900	58	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143574	10.1371/journal.pone.0143574	http://dx.doi.org/10.1371/journal.pone.0143574			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CX7NW	26619066	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800048
J	Varga, BE; Gao, W; Laurik, KL; Tatrai, E; Simo, M; Somfai, GM; DeBuc, DC				Varga, Boglarka Eniko; Gao, Wei; Laurik, Kornelia Lenke; Tatrai, Erika; Simo, Magdolna; Somfai, Gabor Mark; DeBuc, Delia Cabrera			Investigating Tissue Optical Properties and Texture Descriptors of the Retina in Patients with Multiple Sclerosis	PLOS ONE			English	Article							NERVE-FIBER LAYER; COHERENCE TOMOGRAPHY SEGMENTATION; MICROCYSTIC MACULAR EDEMA; SIGNAL STRENGTH; ATTENUATION COEFFICIENT; FRACTAL DIMENSION; THICKNESS; PATHOLOGY; BRAIN; INFLAMMATION	Purpose To assess the differences in texture descriptors and optical properties of retinal tissue layers in patients with multiple sclerosis (MS) and to evaluate their usefulness in the detection of neurodegenerative changes using optical coherence tomography (OCT) image segmentation. Patients and Methods 38 patients with MS were examined using Stratus OCT. The raw macular OCT data were exported and processed using OCTRIMA software. The enrolled eyes were divided into two groups, based on the presence of optic neuritis (ON) in the history (MSON+ group, n = 36 and MSON-group, n = 31). Data of 29 eyes of 24 healthy subjects (H) were used as controls. A total of seven intraretinal layers were segmented and thickness as well as optical parameters such as contrast, fractal dimension, layer index and total reflectance were measured. Mixed-model ANOVA analysis was used for statistical comparisons. Results Significant thinning of the retinal nerve fiber layer (RNFL), ganglion cell/inner plexiform layer complex (GCL+IPL) and ganglion cell complex (GCC, RNFL+GCL+IPL) was observed between study groups in all comparisons. Significant difference was found in contrast in the RNFL, GCL+IPL, GCC, inner nuclear layer (INL) and outer plexiform layer when comparing MSON+ to the other groups. Higher fractal dimension values were observed in GCL+IPL and INL layers when comparing H vs. MSON+ groups. A significant difference was found in layer index in the RNFL, GCL+IPL and GCC layers in all comparisons. A significant difference was observed in total reflectance in the RNFL, GCL+IPL and GCC layers between the three examination groups. Conclusion Texture and optical properties of the retinal tissue undergo pronounced changes in MS even without optic neuritis. Our results may help to further improve the diagnostic efficacy of OCT in MS and neurodegeneration.	[Varga, Boglarka Eniko; Laurik, Kornelia Lenke; Tatrai, Erika; Somfai, Gabor Mark] Semmelweis Univ, Fac Med, Dept Ophthalmol, H-1085 Budapest, Hungary; [Gao, Wei; Somfai, Gabor Mark; DeBuc, Delia Cabrera] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Simo, Magdolna] Semmelweis Univ, Fac Med, Dept Neurol, H-1085 Budapest, Hungary	Semmelweis University; Bascom Palmer Eye Institute; University of Miami; Semmelweis University	DeBuc, DC (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	dcabrera2@med.miami.edu		Somfai, Gabor Mark/0000-0001-6329-442X; Cabrera DeBuc, Delia/0000-0002-4726-894X	Juvenile Diabetes Research Foundation Grant; National Institute of Health Grant [NIH R01EY020607]; National Institute of Health Center Grant [P30-EY014801]; Research to Prevent Blindness Inc.; Hungarian Academy of Sciences; Zsigmond Diabetes Fund; Hungarian Scholarship Fund; Eotvos Scholarship; Helen Keller Foundation; NATIONAL EYE INSTITUTE [P30EY014801, R01EY020607] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation Grant(Juvenile Diabetes Research Foundation); National Institute of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health Center Grant; Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Zsigmond Diabetes Fund; Hungarian Scholarship Fund; Eotvos Scholarship; Helen Keller Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a Juvenile Diabetes Research Foundation Grant (http://jdrf.org/grant-center/(DCD)); National Institute of Health Grant No. NIH R01EY020607 (http://grants.nih.gov/grants/funding/r01.htm (DCD)); National Institute of Health Center Grant No. P30-EY014801 (http://www.nimh.nih.gov/funding/grant-writing-and-applicationprocess/p30-centers-program-research-core-grants.shtml (DCD)); Research to Prevent Blindness Inc. (http://www.rpbusa.org/rpb/grants/grants/(unrestricted grant to the University of Miami, DCD)); Hungarian Academy of Sciences, Zsigmond Diabetes Fund (http://mta.hu/english/ (GMS)); Hungarian Scholarship Fund, Eotvos Scholarship (http://www.scholarship.hu/ (GMS)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by Helen Keller Foundation for Research and Education (http://www.helenkellerfoundation.org/ (GMS)). Also, the authors declare that this funder also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg M, 2014, OPHTHALMOLOGY, V121, P142, DOI 10.1016/j.ophtha.2013.08.045; Afshar AR, 2013, JAMA OPHTHALMOL, V131, P103, DOI 10.1001/jamaophthalmol.2013.570; Balcer LJ, 2015, BRAIN, V138, P11, DOI 10.1093/brain/awu335; Bizheva K, 2006, P NATL ACAD SCI USA, V103, P5066, DOI 10.1073/pnas.0506997103; Braaf B, 2012, OPT EXPRESS, V20, P20516, DOI 10.1364/OE.20.020516; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Cabrera Fernandez D, 2008, INVEST OPHTH VIS SCI, V49, P2751; Cheung CYL, 2008, OPHTHALMOLOGY, V115, P1347, DOI 10.1016/j.ophtha.2007.11.027; DeBuc C., 2011, IMAGE SEG, V1, P15, DOI DOI 10.5772/628; DeBuc D, 2013, J CLIN EXPT OPHTHALM; Debuc DC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470116; Debuc DC, 2010, MED SCI MONITOR, V16, pMT15; DeBuc DC, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3268773; Fernandez DC, 2005, OPT EXPRESS, V13, P10200, DOI 10.1364/OPEX.13.010200; Gao W, 2011, INVEST OPHTH VIS SCI, V52, P3689; Gao W, 2011, J BIOMED SCI ENG, V4, P657, DOI [DOI 10.4236/JBISE.2011.410082, 10.4236/jbise.2011.410082]; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Gills J P Jr, 1966, Trans Am Ophthalmol Soc, V64, P66; Gneiting T, 2004, SIAM REV, V46, P269, DOI 10.1137/S0036144501394387; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Gossage KW, 2003, J BIOMED OPT, V8, P570, DOI 10.1117/1.1577575; Grazioli E, 2008, J NEUROL SCI, V268, P12, DOI 10.1016/j.jns.2007.10.020; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Hammer M, 2000, OPT COMMUN, V186, P149, DOI 10.1016/S0030-4018(00)01054-3; Hasegawa M, 1996, WEAR, V192, P40, DOI 10.1016/0043-1648(95)06768-X; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang XR, 2012, INVEST OPHTH VIS SCI, V53, P5869, DOI 10.1167/iovs.12-10001; Huang Y. - C., 1999, THESIS; International Commission on Illumination, 1987, INT LIGHT VOC, V17.4; Jiang H, 2012, 38TH ANNUAL NORTH AM; Jiang H, 2014, NEUROLOGY S, V82, pP2264; Jiang H, 2015, NEUROLOGY S, V84; Kaufhold F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071145; KERRISON JB, 1994, RETINA-J RET VIT DIS, V14, P445, DOI 10.1097/00006982-199414050-00010; Minagar A, 2006, NEUROL RES, V28, P230, DOI 10.1179/016164106X98080; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Puliafito Carmen A, 2010, Ophthalmic Surg Lasers Imaging, V41 Suppl, pS5, DOI 10.3928/15428877-20101031-20; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Sadda SR, 2007, INVEST OPHTH VIS SCI, V48, P839, DOI 10.1167/iovs.06-0554; Saidha S, 2013, JAMA NEUROL, V70, P34, DOI 10.1001/jamaneurol.2013.573; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Saidha S, 2011, MULT SCLER J, V17, P1449, DOI 10.1177/1352458511418630; Samarawickrama C, 2010, INVEST OPHTH VIS SCI, V51, P4471, DOI 10.1167/iovs.09-3892; SARKAR N, 1992, PATTERN RECOGN, V25, P1035, DOI 10.1016/0031-3203(92)90066-R; Seigo MA, 2012, J NEUROL, V259, P2119, DOI 10.1007/s00415-012-6466-x; Somfai GM, 2013, INVEST OPHTH VIS SCI, V54; Somfai GM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-295; Sotirchos ES, 2013, CURR EYE RES, V38, P224, DOI 10.3109/02713683.2012.722243; Stein DM, 2006, BRIT J OPHTHALMOL, V90, P186, DOI 10.1136/bjo.2004.059824; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Svet VD, 2013, HOL INT APPR PRIM VI; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Tatrai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030922; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; van der Schoot J, 2012, INVEST OPHTH VIS SCI, V53, P2424, DOI 10.1167/iovs.11-8436; Vermeer KA, 2012, INVEST OPHTH VIS SCI, V53, P6102, DOI 10.1167/iovs.12-9933; Wang JH, 2004, INVEST OPHTH VIS SCI, V45, P1812, DOI 10.1167/iovs.03-1088; Wang XG, 2014, BRIT J OPHTHALMOL, V98, P1368, DOI 10.1136/bjophthalmol-2013-304547; Werner JS, 2011, EYE, V25, P279, DOI 10.1038/eye.2010.218; White BR, 2003, OPT EXPRESS, V11, P3490, DOI 10.1364/OE.11.003490; Wu ZQ, 2009, J GLAUCOMA, V18, P213, DOI 10.1097/IJG.0b013e31817eee20; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	62	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143711	10.1371/journal.pone.0143711	http://dx.doi.org/10.1371/journal.pone.0143711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619298	gold, Green Published			2022-12-26	WOS:000365889800060
J	Benz, R; Jones, MD; Younas, F; Maier, E; Modi, N; Mentele, R; Lottspeich, F; Kleinekathofer, U; Smit, J				Benz, Roland; Jones, Michael D.; Younas, Farhan; Maier, Elke; Modi, Niraj; Mentele, Reinhard; Lottspeich, Friedrich; Kleinekathoefer, Ulrich; Smit, John			OmpW of Caulobacter crescentus Functions as an Outer Membrane Channel for Cations	PLOS ONE			English	Article							MATRIX PROTEIN PORIN; AMINO-ACID-SEQUENCE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; IONIC SELECTIVITY; MOLECULAR-BASIS; CELL-WALL; TRANSPORT; MALTODEXTRINS; PERMEABILITY	Caulobacter crescentus is an oligotrophic bacterium that lives in dilute organic environments such as soil and freshwater. This bacterium represents an interesting model for cellular differentiation and regulation because daughter cells after division have different forms: one is motile while the other is non-motile and can adhere to surfaces. Interestingly, the known genome of C. crescentus does not contain genes predicted to code for outer membrane porins of the OmpF/C general diffusion type present in enteric bacteria or those coding for specific porins selective for classes of substrates. Instead, genes coding for 67 TonB-dependent outer membrane receptors have been identified, suggesting that active transport of specific nutrients may be the norm. Here, we report that high channel-forming activity was observed with crude outer membrane extracts of C. crescentus in lipid bilayer experiments, indicating that the outer membrane of C. crescentus contained an ion-permeable channel with a single-channel conductance of about 120 pS in 1M KCl. The channel-forming protein with an apparent molecular mass of about 20 kDa was purified to homogeneity. Partial protein sequencing of the protein indicated it was a member of the OmpW family of outer membrane proteins from Gram-negative bacteria. This channel was not observed in reconstitution experiments with crude outer membrane extracts of an OmpW deficient C. crescentus mutant. Biophysical analysis of the C. crescentus OmpW suggested that it has features that are special for general diffusion porins of Gram-negative outer membranes because it was not a wide aqueous channel. Furthermore, OmpW of C. crescentus seems to be different to known OmpW porins and has a preference for ions, in particular cations. A putative model for OmpW of C. crescentus was built on the basis of the known 3D-structures of OmpW of Escherichia coli and OprG of Pseudomonas aeruginosa using homology modeling. A comparison of the two known structures with the model of OmpW of C. crescentus suggested that it has a more hydrophilic interior and possibly a larger diameter.	[Benz, Roland; Younas, Farhan] Jacobs Univ Bremen, Dept Life Sci & Chem, D-28759 Bremen, Germany; [Benz, Roland; Maier, Elke] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97078 Wurzburg, Germany; [Jones, Michael D.; Smit, John] Univ British Columbia, Dept Microbiol & Immunol, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; [Modi, Niraj; Kleinekathoefer, Ulrich] Jacobs Univ Bremen, Dept Phys & Earth Sci, D-28759 Bremen, Germany; [Mentele, Reinhard; Lottspeich, Friedrich] Max Planck Inst Biochem, Dept Prot Analyt, D-82152 Martinsried, Germany	Jacobs University; German Research Foundation (DFG); University of Wurzburg; University of British Columbia; Jacobs University; Max Planck Society	Benz, R (corresponding author), Jacobs Univ Bremen, Dept Life Sci & Chem, Campus Ring 1, D-28759 Bremen, Germany.	r.benz@jacobs-university.de	Kleinekathöfer, Ulrich/I-2329-2013; Younas, Farhan/AAE-3686-2020	Kleinekathöfer, Ulrich/0000-0002-6114-7431; Younas, Farhan/0000-0001-6422-3842; Modi, Niraj/0000-0001-5864-7331	Innovative Medicines Joint Undertaking [115525]; European Union's seventh framework programme (FP7); EFPIA companies; Natural Sciences and Engineering Research Council of Canada (NSERC)	Innovative Medicines Joint Undertaking; European Union's seventh framework programme (FP7); EFPIA companies; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The research leading to these results was conducted as part of the Translocation Consortium and has received support from the Innovative Medicines Joint Undertaking under Grant Agreement no 115525, resources which are composed of financial contribution from the European Union's seventh framework programme (FP7/2007-2013) and EFPIA companies in kind contribution (to RB). This work was also supported by a grant to JS from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht R, 2006, ACTA CRYSTALLOGR F, V62, P415, DOI 10.1107/S1744309106010190; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beketskaia MS, 2014, J BACTERIOL, V196, P1908, DOI 10.1128/JB.01483-14; BENZ R, 1987, J GEN PHYSIOL, V89, P275, DOI 10.1085/jgp.89.2.275; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BENZ R, 1988, EUR J BIOCHEM, V176, P699, DOI 10.1111/j.1432-1033.1988.tb14333.x; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; Benz R., 1994, BACTERIAL CELL WALL, P397; Beveridge T J, 1981, Int Rev Cytol, V72, P229, DOI 10.1016/S0074-7696(08)61198-5; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Castellan GW, 1983, PHYS CHEM, P769; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; ECKERSKORN C, 1989, CHROMATOGRAPHIA, V28, P92, DOI 10.1007/BF02290390; Eisenbeis S, 2008, J BACTERIOL, V190, P5230, DOI 10.1128/JB.00194-08; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; FERENCI T, 1980, J BACTERIOL, V142, P521, DOI 10.1128/JB.142.2.521-526.1980; Ford MJ, 2007, J BACTERIOL, V189, P2226, DOI 10.1128/JB.01690-06; GILCHRIST A, 1991, J BACTERIOL, V173, P921, DOI 10.1128/jb.173.2.921-925.1991; HANCOCK REW, 1982, J BACTERIOL, V150, P730, DOI 10.1128/JB.150.2.730-738.1982; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau JHY, 2010, CAN J MICROBIOL, V56, P501, DOI [10.1139/W10-036, 10.1139/w10-036]; Lohmiller S, 2008, MICROBIOL-SGM, V154, P1748, DOI 10.1099/mic.0.2008/017350-0; Maniatis T., 1982, MOL CLONING; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; McPhee JB, 2009, FEMS MICROBIOL LETT, V296, P241, DOI 10.1111/j.1574-6968.2009.01651.x; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nomellini JF, 1997, J BACTERIOL, V179, P6349, DOI 10.1128/jb.179.20.6349-6354.1997; PAU PCF, 1990, J PHYS CHEM-US, V94, P2671, DOI 10.1021/j100369a080; PAULING L, 1961, NATURE CHEM BOND; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Riess FG, 1998, MOL MICROBIOL, V29, P139, DOI 10.1046/j.1365-2958.1998.00914.x; Schwartz M, 1987, ESCHERICHIA COLI SAL, P1482; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smirnov LS, 1997, PHYSICA B, V234, P66, DOI 10.1016/S0921-4526(96)00881-2; SMIT J, 1981, J BIOL CHEM, V256, P3092; Sugawara E, 1996, J BACTERIOL, V178, P6067, DOI 10.1128/jb.178.20.6067-6069.1996; Toporowski MC, 2004, J BACTERIOL, V186, P8000, DOI 10.1128/JB.186.23.8000-8009.2004; Touw DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015016; TRIAS J, 1994, MOL MICROBIOL, V14, P283, DOI 10.1111/j.1365-2958.1994.tb01289.x; TRIAS JQ, 1993, J BIOL CHEM, V268, P6234; WALKER SG, 1994, J BACTERIOL, V176, P6312, DOI 10.1128/jb.176.20.6312-6323.1994; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Zhang JH, 1997, GENOME RES, V7, P649, DOI 10.1101/gr.7.6.649	51	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143557	10.1371/journal.pone.0143557	http://dx.doi.org/10.1371/journal.pone.0143557			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606672	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300080
J	Khalid, T; Aggio, R; White, P; Costello, B; Persad, R; Al-Kateb, H; Jones, P; Probert, CS; Ratcliffe, N				Khalid, Tanzeela; Aggio, Raphael; White, Paul; Costello, Ben De Lacy; Persad, Raj; Al-Kateb, Huda; Jones, Peter; Probert, Chris S.; Ratcliffe, Norman			Urinary Volatile Organic Compounds for the Detection of Prostate Cancer	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; DIGITAL RECTAL EXAMINATION; OLFACTORY DETECTION; TOTAL PSA; MASS-SPECTROMETRY; EARLY-DIAGNOSIS; MARKER; ANTIGEN; NG/ML; SARCOSINE	The aim of this work was to investigate volatile organic compounds (VOCs) emanating from urine samples to determine whether they can be used to classify samples into those from prostate cancer and non-cancer groups. Participants were men referred for a trans-rectal ultrasound-guided prostate biopsy because of an elevated prostate specific antigen (PSA) level or abnormal findings on digital rectal examination. Urine samples were collected from patients with prostate cancer (n = 59) and cancer-free controls (n = 43), on the day of their biopsy, prior to their procedure. VOCs from the headspace of basified urine samples were extracted using solid-phase micro-extraction and analysed by gas chromatography/mass spectrometry. Classifiers were developed using Random Forest (RF) and Linear Discriminant Analysis (LDA) classification techniques. PSA alone had an accuracy of 62-64% in these samples. A model based on 4 VOCs, 2,6-dimethyl-7-octen-2-ol, pentanal, 3-octanone, and 2-octanone, was marginally more accurate 63-65%. When combined, PSA level and these four VOCs had mean accuracies of 74% and 65%, using RF and LDA, respectively. With repeated double cross-validation, the mean accuracies fell to 71% and 65%, using RF and LDA, respectively. Results from VOC profiling of urine headspace are encouraging and suggest that there are other metabolomic avenues worth exploring which could help improve the stratification of men at risk of prostate cancer. This study also adds to our knowledge on the profile of compounds found in basified urine, from controls and cancer patients, which is useful information for future studies comparing the urine from patients with other disease states.	[Khalid, Tanzeela] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Aggio, Raphael; Probert, Chris S.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [White, Paul; Costello, Ben De Lacy; Al-Kateb, Huda; Jones, Peter; Ratcliffe, Norman] Univ W England, Inst Biosensor Technol, Bristol BS16 1QY, Avon, England; [Persad, Raj] North Bristol NHS Trust, Bristol Urol Inst, Bristol, Avon, England	Imperial College London; University of Liverpool; University of West England; North Bristol NHS Trust	Probert, CS (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	Chris.Probert@liverpool.ac.uk	de Lacy Costello, Ben/ABG-2043-2021; De Lacy Costello, Ben/I-8259-2019; Khalid, Tanzeela/AAX-3520-2020	de Lacy Costello, Ben/0000-0003-2999-6801; Khalid, Tanzeela/0000-0003-3503-7762; Probert, Christopher/0000-0003-4550-0239; ALKATEB, HUDA/0000-0002-8194-8906	Rotary club; Ralph Shackman Trust, Woodfines Llp, Lockton House, Clarendon Road, Cambridge [CB28FH]	Rotary club; Ralph Shackman Trust, Woodfines Llp, Lockton House, Clarendon Road, Cambridge	This work was funded by the Rotary club, https://www.rotary.org/en. Additional funding was provided by the Ralph Shackman Trust, Woodfines Llp, Lockton House, Clarendon Road, Cambridge, CB28FH. No official URL is available though registration details of the charity can be found at: http://opencharities.org/charities/287406. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggio R, 2011, BIOINFORMATICS, V27, P2316, DOI 10.1093/bioinformatics/btr379; Anderssen E, 2006, CHEMOMETR INTELL LAB, V84, P69, DOI 10.1016/j.chemolab.2006.04.021; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Asimakopoulos AD, 2014, PROSTATE CANCER P D, V17, P206, DOI 10.1038/pcan.2014.11; Bensalah K, 2007, EUR UROL, V52, P1601, DOI 10.1016/j.eururo.2007.09.036; Boots AW, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/027108; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; Catalona WJ, 2000, UROLOGY, V56, P255, DOI 10.1016/S0090-4295(00)00637-3; Catalona WJ, 1997, JAMA-J AM MED ASSOC, V277, P1452, DOI 10.1001/jama.277.18.1452; CATALONA WJ, 1994, J UROLOGY, V151, P1283, DOI 10.1016/S0022-5347(17)35233-3; Chun FKH, 2007, WORLD J UROL, V25, P131, DOI 10.1007/s00345-007-0146-y; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Delen D, 2009, EXPERT SYST, V26, P100, DOI 10.1111/j.1468-0394.2008.00480.x; Elliker KR, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-22; Filipiak W, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-17; Filzmoser P, 2009, J CHEMOMETR, V23, P160, DOI 10.1002/cem.1225; Garattini S, 2010, NEW ENGL J MED, V363, P794, DOI 10.1056/NEJMc1005498; Groskopf J, 2006, CLIN CHEM, V52, P1089, DOI 10.1373/clinchem.2005.063289; Herwig R, 2008, EUR J CLIN INVEST, V38, P430, DOI 10.1111/j.1365-2362.2008.01953.x; Hessels D, 2007, CLIN CANCER RES, V13, P5103, DOI 10.1158/1078-0432.CCR-07-0700; Horvath G, 2008, INTEGR CANCER THER, V7, P76, DOI 10.1177/1534735408319058; Jentzmik F, 2010, EUR UROL, V58, P12, DOI 10.1016/j.eururo.2010.01.035; Killick E, 2013, SCI REP-UK, P3; Klecka W. R., 1980, DISCRIMINANT ANAL; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Kwiatkowski MK, 1998, UROLOGY, V52, P360, DOI 10.1016/S0090-4295(98)00245-3; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; Lazzeri M, 2013, EUR UROL, V63, P986, DOI 10.1016/j.eururo.2013.01.011; Leman ES, 2007, UROLOGY, V69, P714, DOI 10.1016/j.urology.2007.01.097; Lughezzani G, 2014, EUR UROL, V66, P906, DOI 10.1016/j.eururo.2013.12.005; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; Mills GA, 2001, J CHROMATOGR B, V753, P259, DOI 10.1016/S0378-4347(00)00554-5; Morgan R, 2011, CLIN CANCER RES, V17, P1090, DOI 10.1158/1078-0432.CCR-10-2410; Naughton CK, 2000, J UROLOGY, V164, P388, DOI 10.1016/S0022-5347(05)67367-3; NCI (NCIN), CANC MORT MAL ICD10; NCI NCIN, 2013, CANC INC MAL ICD10 C; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Pickel D, 2004, APPL ANIM BEHAV SCI, V89, P107, DOI 10.1016/j.applanim.2004.04.008; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Roine A, 2014, J UROLOGY, V192, P230, DOI 10.1016/j.juro.2014.01.113; Roobol MJ, 2010, EUR UROL, V58, P475, DOI 10.1016/j.eururo.2010.06.039; Rosenberg LH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-468; Schostak M, 2009, J UROLOGY, V181, P343, DOI 10.1016/j.juro.2008.08.119; Schroder FH, 2010, NEW ENGL J MED, V363, P4; Silva CL, 2011, BRIT J CANCER, V105, P1894, DOI 10.1038/bjc.2011.437; Silva CL, 2012, TALANTA, V89, P360, DOI 10.1016/j.talanta.2011.12.041; Smith S, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037022; Smith S, 2010, IEEE SENS J, V10, P92, DOI 10.1109/JSEN.2009.2035771; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Struys EA, 2010, ANN CLIN BIOCHEM, V47, P282, DOI 10.1258/acb.2010.009270; Taverna G, 2014, THE JOURNAL OF UROLO, pe546; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tomlins SA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001970; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Wu H, 2011, ANAL BIOANAL CHEM, V401, P635, DOI 10.1007/s00216-011-5098-9; Zhang Shucha, 2014, Methods Mol Biol, V1198, P265, DOI 10.1007/978-1-4939-1258-2_17	59	91	91	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143283	10.1371/journal.pone.0143283	http://dx.doi.org/10.1371/journal.pone.0143283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599280	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600044
J	Shamaa, OR; Mitra, S; Gavrilin, MA; Wewers, MD				Shamaa, Obada R.; Mitra, Srabani; Gavrilin, Mikhail A.; Wewers, Mark D.			Monocyte Caspase-1 Is Released in a Stable, Active High Molecular Weight Complex Distinct from the Unstable Cell Lysate-Activated Caspase-1	PLOS ONE			English	Article							INTERLEUKIN-1-BETA-CONVERTING ENZYME; IL-1-BETA-CONVERTING ENZYME; NLRP3 INFLAMMASOME; CYSTEINE PROTEASE; ASC; IL-1-BETA; DEATH; ICE; K+; PURIFICATION	Mononuclear phagocytes utilize caspase-1 activation as a means to respond to danger signals. Although caspase-1 was discovered using highly concentrated cell extracts that spontaneously activate caspase-1, it is now clear that in live cell models caspase-1 activation occurs in the process of its cellular release and is not an intracellular event. Therefore, we compared the characteristics of caspase-1 activation in the cell lysate model to that of caspase-1 that is released in response to exogenous inflammasome activation. Whereas both models generated active caspase-1, the cell-lysate induced caspase-1 required highly concentrated cell lysates and had a short half-life (similar to 15 min) whereas, the activation induced released caspase-1 required 2-3 log fold fewer cells and was stable for greater than 12 h. Both forms were able to cleave proIL-1beta but unexpectedly, the released activity was unable to be immunodepleted by caspase-1 antibodies. Size exclusion chromatography identified two antigenic forms of p20 caspase-1 in the activation induced released caspase-1: one at the predicted size of tetrameric, p20/p10 caspase-1 and the other at >200 kDa. However, only the high molecular weight form had stable functional activity. These results suggest that released caspase-1 exists in a unique complex that is functionally stable and protected from immunodepletion whereas cell-extract generated active caspase-1 is rapidly inhibited in the cytosolic milieu.	[Shamaa, Obada R.; Mitra, Srabani; Gavrilin, Mikhail A.; Wewers, Mark D.] Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Wexner Med Ctr,Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Wewers, MD (corresponding author), Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Wexner Med Ctr,Davis Heart & Lung Res Inst, 473 W 12th Ave,201 DHLRI, Columbus, OH 43210 USA.	wewers.2@osu.edu	Wewers, Mark/AAB-6202-2021	Gavrilin, Mikhail/0000-0003-2003-768X	National Institute of Heart Lung and Blood [HL076278, HL102724]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL102724, R01HL076278] Funding Source: NIH RePORTER	National Institute of Heart Lung and Blood(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Heart Lung and Blood, grants HL076278 and HL102724 supported this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdelaziz DH, 2011, J BIOL CHEM, V286, P3203, DOI 10.1074/jbc.M110.197681; AYALA JM, 1994, J IMMUNOL, V153, P2592; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; BLACK RA, 1988, J BIOL CHEM, V263, P9437; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Ghonime MG, 2012, BIOCHEM BIOPH RES CO, V425, P384, DOI 10.1016/j.bbrc.2012.07.102; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Labbe K, 2011, PROG INFLAMM RES SER, P17, DOI 10.1007/978-3-0348-0148-5_2; Laliberte RE, 1999, J BIOL CHEM, V274, P36944, DOI 10.1074/jbc.274.52.36944; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; MILLER DK, 1993, J BIOL CHEM, V268, P18062; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; RAMAGE P, 1995, J BIOL CHEM, V270, P9378, DOI 10.1074/jbc.270.16.9378; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Rayamajhi Manira, 2013, Methods Mol Biol, V1040, P85, DOI 10.1007/978-1-62703-523-1_7; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; SINGER II, 1995, J EXP MED, V182, P1447, DOI 10.1084/jem.182.5.1447; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Swaan PW, 2001, PHARMACEUT RES, V18, P1083, DOI 10.1023/A:1010958406364; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; WEWERS MD, 1988, J CLIN INVEST, V82, P1260, DOI 10.1172/JCI113724; Wewers MD, 1997, J IMMUNOL, V159, P5964; Wewers MD, 2004, P NATL ACAD SCI USA, V101, P10241, DOI 10.1073/pnas.0403971101; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zakharova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009900	45	38	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142203	10.1371/journal.pone.0142203	http://dx.doi.org/10.1371/journal.pone.0142203			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599267	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600008
J	Zhong, J; Shi, QQ; Zhu, MM; Shen, J; Wang, HH; Ma, D; Miao, CH				Zhong, Jing; Shi, Qi-Qing; Zhu, Min-Min; Shen, Jian; Wang, Hui-Hui; Ma, Duan; Miao, Chang-Hong			MFHAS1 Is Associated with Sepsis and Stimulates TLR2/NF-kappa B Signaling Pathway Following Negative Regulation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; INFLAMMATORY RESPONSE SYNDROME; ACUTE KIDNEY INJURY; MITOCHONDRIAL DYSFUNCTION; MASL1; RECOGNITION; BIOMARKERS; CELLS; SIRS; TLR	Malignant fibrous histiocytoma amplified sequence 1 (MFHAS1) has a potential immunoregulatory role dependent on Toll-like receptors (TLRs). TLR2, associated with deleterious systemic inflammation, cardiac dysfunction, and acute kidney injury, acts synergistically in sepsis. The role of MFHAS1 in targeting TLR2 involved in sepsis has not been examined thus far. This study aimed to examine the relationship of MFHAS1 and sepsis, and the effect of MFHAS1 on the TLR2 signaling pathway. Blood samples were collected from eight sepsis patients after surgery and eight patients undergoing selective surgery to determine blood MFHAS1 levels. HEK 293 cells, RAW 264.7 macrophages and THP-1 monocytes were used to confirm the effect of MFHAS1 on TLR2 signaling pathway. Our study showed that blood MFHAS1 was significantly elevated in septic patients, and MFHAS1 was more increased in mononuclear cells from septic patients. Pam3CSK4 (TLR2 ligand) was found to induce MFHAS1 production in RAW 264.7 murine macrophages and THP-1 human monocytes in a time-dependent manner. MFHAS1 has dual effects on TLR2 signaling pathway and inflammation, i.e., inhibitory effect at 6 hours, and then stimulatory effect after 24 hours through the activation of TLR2/NF-kappa B signaling pathway, and MFHAS1 induced the phosphorylation of JNK and p38 after TLR2 stimulation.	[Zhong, Jing; Zhu, Min-Min; Shen, Jian; Wang, Hui-Hui; Miao, Chang-Hong] Fudan Univ, Shanghai Canc Ctr, Dept Anesthesiol, Shanghai 200433, Peoples R China; [Zhong, Jing; Zhu, Min-Min; Shen, Jian; Wang, Hui-Hui; Miao, Chang-Hong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Shi, Qi-Qing] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Ma, Duan] Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Dept Biochem & Mol Biol,Key Lab Mol Med,Minist Ed, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Ma, D (corresponding author), Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Dept Biochem & Mol Biol,Key Lab Mol Med,Minist Ed, Shanghai 200433, Peoples R China.	duanma@fudan.edu.cn; miaochh@aliyun.com	Zhong, Jing/AAD-2291-2020; Ma, Duan/I-8330-2014; wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022	Zhong, Jing/0000-0002-8764-0187; 	Ministry of Education of the People's Republic of China [20110071110044]; Shanghai Municipal Commission of Health and Family Planning [20144Y0173]	Ministry of Education of the People's Republic of China(Ministry of Education, China); Shanghai Municipal Commission of Health and Family Planning	This study was funded by grants from Ministry of Education of the People's Republic of China No. 20110071110044; URL: http://www.moe.gov.cn/ to CHM and the Shanghai Municipal Commission of Health and Family Planning No. 20144Y0173; URL: http://www.wsjsw.gov.cn/wsj/ to JZ.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Balk RA, 2014, VIRULENCE, V5, P20, DOI 10.4161/viru.27135; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Bosmann M, 2013, TRENDS IMMUNOL, V34, P129, DOI 10.1016/j.it.2012.09.004; Brightbill HD, 2000, IMMUNOLOGY, V101, P1, DOI 10.1046/j.1365-2567.2000.00093.x; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dihanich S, 2014, FEBS J, V281, P261, DOI 10.1111/febs.12593; Dihanich S, 2012, BIOCHEM SOC T, V40, P1090, DOI 10.1042/BST20120127; Dumache R, 2015, ANAL CELL PATHOL, V2015, P1, DOI 10.1155/2015/186716; Dupuy AM, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-22; Ferrer R, 2009, AM J RESP CRIT CARE, V180, P861, DOI 10.1164/rccm.200812-1912OC; Fijen, 2000, Eur J Intern Med, V11, P89, DOI 10.1016/S0953-6205(00)00068-6; Foley NM, 2015, MILITARY MED RES, V2, pCP10, DOI 10.1186/s40779-014-0029-7; Gomez HG, 2014, CRIT CARE MED, V42, P771, DOI 10.1097/CCM.0000000000000100; Gong Y, 2014, ANESTHESIOLOGY, V121, P1236, DOI 10.1097/ALN.0000000000000470; Hoang M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115428; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Kojic Dubravka, 2015, World J Exp Med, V5, P50, DOI 10.5493/wjem.v5.i2.50; Kumkhaek C, 2013, BLOOD, V121, P3216, DOI 10.1182/blood-2011-10-385252; Li Y, 2015, IRAN J KIDNEY DIS, V9, P202; Ma J, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/984825; Marik PE, 2012, J TRAUMA ACUTE CARE, V73, P801, DOI 10.1097/TA.0b013e318265cf87; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Peng Y, 2015, RENAL FAILURE, V37, P694, DOI 10.3109/0886022X.2015.1011499; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rosenthal M, 2015, MINERVA ANESTESIOLOG; Sakabe T, 1999, CANCER RES, V59, P511; Schorr CA, 2014, TRENDS MOL MED, V20, P192, DOI 10.1016/j.molmed.2014.02.001; Sellge G, 2015, SEMIN IMMUNOL, V27, P75, DOI 10.1016/j.smim.2015.03.009; Sharawy N, 2015, J SURG RES, V194, P520, DOI 10.1016/j.jss.2014.12.014; Shibata T, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.585901; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Weng WH, 2004, CANCER GENET CYTOGEN, V150, P27, DOI 10.1016/j.cancergencyto.2003.08.009; Yao YM, 2015, METHODS MOL BIOL, V1237, P5, DOI 10.1007/978-1-4939-1776-1_2; Zheng GL, 2015, J RES MED SCI, V20, P185; Zhong J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001423	41	20	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143662	10.1371/journal.pone.0143662	http://dx.doi.org/10.1371/journal.pone.0143662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599367	gold, Green Submitted, Green Published			2022-12-26	WOS:000365862600102
J	Aguera, Z; Romero, X; Arcelus, J; Sanchez, I; Riesco, N; Jimenez-Murcia, S; Gonzalez-Gomez, J; Granero, R; Custal, N; de Bernabe, MMG; Tarrega, S; Banos, RM; Botella, C; de la Torre, R; Fernandez-Garcia, JC; Fernandez-Real, JM; Fruhbeck, G; Gomez-Ambrosi, J; Tinahones, FJ; Crujeiras, AB; Casanueva, FF; Menchon, JM; Fernandez-Aranda, F				Agueera, Zaida; Romero, Xandra; Arcelus, Jon; Sanchez, Isabel; Riesco, Nadine; Jimenez-Murcia, Susana; Gonzalez-Gomez, Jana; Granero, Roser; Custal, Nuria; de Bernabe, Monica Montserrat-Gil; Tarrega, Salome; Banos, Rosa M.; Botella, Cristina; de la Torre, Rafael; Fernandez-Garcia, Jose C.; Fernandez-Real, Jose M.; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Tinahones, Francisco J.; Crujeiras, Ana B.; Casanueva, Felipe F.; Menchon, Jose M.; Fernandez-Aranda, Fernando			Changes in Body Composition in Anorexia Nervosa: Predictors of Recovery and Treatment Outcome	PLOS ONE			English	Article							FAT DISTRIBUTION; WEIGHT-GAIN; BIOELECTRICAL-IMPEDANCE; ENERGY-EXPENDITURE; ADOLESCENTS; WOMEN; WATER; BIA	The restoration of body composition (BC) parameters is considered to be one of the most important goals in the treatment of patients with anorexia nervosa (AN). However, little is known about differences between AN diagnostic subtypes [restricting (AN-R) and binge/purging (AN-BP)] and weekly changes in BC during refeeding treatment. Therefore, the main objectives of our study were twofold: 1) to assess the changes in BC throughout nutritional treatment in an AN sample and 2) to analyze predictors of BC changes during treatment, as well as predictors of treatment outcome. The whole sample comprised 261 participants [118 adult females with AN (70 AN-R vs. 48 AN-BP), and 143 healthy controls]. BC was measured weekly during 15 weeks of day-hospital treatment using bioelectrical impedance analysis (BIA). Assessment measures also included the Eating Disorders Inventory-2, as well as a number of other clinical indices. Overall, the results showed that AN-R and AN-BP patients statistically differed in all BC measures at admission. However, no significant timexgroup interaction was found for almost all BC parameters. Significant timexgroup interactions were only found for basal metabolic rate (p =.041) and body mass index (BMI) (p =.035). Multiple regression models showed that the best predictors of pre-post changes in BC parameters (namely fat-free mass, muscular mass, total body water and BMI) were the baseline values of BC parameters. Stepwise predictive logistic regressions showed that only BMI and age were significantly associated with outcome, but not with the percentage of body fat. In conclusion, these data suggest that although AN patients tended to restore all BC parameters during nutritional treatment, only AN-BP patients obtained the same fat mass values as healthy controls. Put succinctly, the best predictors of changes in BC were baseline BC values, which did not, however, seem to influence treatment outcome.	[Agueera, Zaida; Romero, Xandra; Sanchez, Isabel; Riesco, Nadine; Jimenez-Murcia, Susana; Custal, Nuria; de Bernabe, Monica Montserrat-Gil; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Hosp Bellvitge, IDIBELL, Dept Psychiat, Barcelona, Spain; [Agueera, Zaida; Jimenez-Murcia, Susana; Granero, Roser; Banos, Rosa M.; Botella, Cristina; de la Torre, Rafael; Fernandez-Garcia, Jose C.; Fernandez-Real, Jose M.; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Tinahones, Francisco J.; Crujeiras, Ana B.; Casanueva, Felipe F.; Fernandez-Aranda, Fernando] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Arcelus, Jon] Univ Loughborough, Ctr Res Eating Disorders, Loughborough, Leics, England; [Jimenez-Murcia, Susana; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Gonzalez-Gomez, Jana] Marques de Valdecilla Publ Fdn Res Inst FMV IFIMA, Santander, Spain; [Granero, Roser; Tarrega, Salome] Univ Autonoma Barcelona, Dept Psychobiol & Methodol, E-08193 Barcelona, Spain; [de Bernabe, Monica Montserrat-Gil] Univ Hosp Bellvitge, Dietet & Nutr Unit, Barcelona, Spain; [Banos, Rosa M.] Univ Valencia, Dept Personal Evaluat & Psychol Treatment, Valencia, Spain; [Botella, Cristina] Univ Jaume 1, Dept Basic Psychol Clin & Psychobiol, Castellon de La Plana, Spain; [de la Torre, Rafael] IMIM Hosp Mar Med Res Inst, Neurosci Res Program, Human Pharmacol & Clin Neurosci Res Grp, Barcelona, Spain; [Fernandez-Garcia, Jose C.; Tinahones, Francisco J.] Hosp Clin Univ Virgen Victoria, Dept Diabet Endocrinol & Nutr, Malaga, Spain; [Fernandez-Real, Jose M.] Hosp Dr Josep Trueta, IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Fruehbeck, Gema; Gomez-Ambrosi, Javier] Univ Navarra, Univ Navarra Clin, Dept Endocrinol & Nutr, E-31080 Pamplona, Spain; [Crujeiras, Ana B.; Casanueva, Felipe F.] Complejo Hosp Univ Santiago, Div Endocrine, Santiago De Compostela, Spain; [Menchon, Jose M.] CIBER Salud Mental CIBERSAM, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Loughborough University; University of Barcelona; Hospital Universitario Marques de Valdecilla (HUMV); Autonomous University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Valencia; Universitat Jaume I; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital Virgen de la Victoria; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Navarra; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Fernandez-Aranda, F (corresponding author), Univ Hosp Bellvitge, IDIBELL, Dept Psychiat, Barcelona, Spain.	ffernandez@bellvitgehospital.cat	Gómez-Ambrosi, Javier/D-2984-2017; Larrea, Salomé Tárrega/AAE-2684-2020; Fernandez-Aranda, Fernando/L-9762-2014; García, José Carlos Fernández/X-3910-2019; Botella, Cristina/F-9230-2010; Tárrega, Salomé/D-8876-2011; Granero, Roser/S-3529-2019; Díaz, Isabel M Sánchez/G-7277-2017; Riesco, Nadine/L-1114-2014; Fernández-Real, Jose Manuel/AGH-3599-2022; Tinahones, Francisco José/AAB-2882-2020; García, José Carlos Fernández/B-3723-2013; Fernandez-Garcia, Jose Carlos/B-5312-2013; JIMENEZ-MURCIA, SUSANA/L-9786-2014; AGÜERA, ZAIDA/K-9771-2014; de la Torre, Rafael/D-3561-2018; Crujeiras, Ana/ABA-8866-2021; BAÑOS, ROSA MARIA/C-6077-2011; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Granero, Roser/F-9492-2016; Menchon, Jose/A-5242-2009	Gómez-Ambrosi, Javier/0000-0001-5601-1604; Larrea, Salomé Tárrega/0000-0002-5820-6795; Fernandez-Aranda, Fernando/0000-0002-2968-9898; García, José Carlos Fernández/0000-0003-2308-2865; Botella, Cristina/0000-0001-8783-6959; Tárrega, Salomé/0000-0002-5820-6795; Díaz, Isabel M Sánchez/0000-0001-5874-8204; Riesco, Nadine/0000-0002-6336-4907; Fernández-Real, Jose Manuel/0000-0002-7442-9323; García, José Carlos Fernández/0000-0003-2308-2865; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; AGÜERA, ZAIDA/0000-0003-4453-4939; de la Torre, Rafael/0000-0002-6765-1866; Crujeiras, Ana/0000-0003-4392-0301; BAÑOS, ROSA MARIA/0000-0003-0626-7665; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Granero, Roser/0000-0001-6308-3198; Arcelus, Jon/0000-0002-3805-0180; Tinahones, Francisco J/0000-0001-6871-4403; Romero, Xandra/0000-0003-4276-9793; Menchon, Jose/0000-0002-6231-6524	Instituto de Salud Carlos III [ISCIII] [FIS PI11/00210, FIS PI14/00290]; Fondos Europeos de Desarrollo Regional (FEDER) funds; Servicio Andaluz de Salud (SAS) [B-0033-2014]; Instituto de Salud Carlos III [Ministerio de de Economia y Competitividad] [PSI2011-28349]	Instituto de Salud Carlos III [ISCIII](Instituto de Salud Carlos IIIEuropean Commission); Fondos Europeos de Desarrollo Regional (FEDER) funds; Servicio Andaluz de Salud (SAS); Instituto de Salud Carlos III [Ministerio de de Economia y Competitividad]	The study was supported by Instituto de Salud Carlos III [ISCIII; FIS PI11/00210, FIS PI14/00290 and Ministerio de de Economia y Competitividad (PSI2011-28349)] and co-funded by Fondos Europeos de Desarrollo Regional (FEDER) funds - a way to build Europe. Jose C. Fernandez-Garcia is the recipient of a research contract from Servicio Andaluz de Salud (SAS) (B-0033-2014). CIBERobn and CIBERSAM are both initiatives of ISCIII.	American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT, V5th; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Bossu C, 2007, AM J PHYSIOL-ENDOC M, V292, pE132, DOI 10.1152/ajpendo.00241.2006; BREWERTON TD, 1995, INT J EAT DISORDER, V17, P413, DOI 10.1002/1098-108X(199505)17:4<413::AID-EAT2260170414>3.0.CO;2-0; Browning LM, 2011, OBESITY FACTS, V4, P9, DOI 10.1159/000324546; Bruni V, 2011, J PEDIATR ADOL GYNEC, V24, P347, DOI 10.1016/j.jpag.2011.06.004; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dalle Grave R, 2008, COMPR PSYCHIAT, V49, P346, DOI 10.1016/j.comppsych.2007.12.007; De Alvaro MTG, 2007, EUR J ENDOCRINOL, V157, P473, DOI 10.1530/EJE-07-0459; DEMPSEY DT, 1984, AM J CLIN NUTR, V40, P260, DOI 10.1093/ajcn/40.2.260; El Ghoch M, 2014, NUTRIENTS, V6, P3895, DOI 10.3390/nu6093895; El Ghoch M, 2014, AM J CLIN NUTR, V99, P771, DOI 10.3945/ajcn.113.078816; Garner D.M., 1998, INVENTARIO TRASTORNO; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Iketani T, 1999, INT J EAT DISORDER, V26, P275, DOI 10.1002/(SICI)1098-108X(199911)26:3&lt;275::AID-EAT4&gt;3.0.CO;2-I; KAYE WH, 1986, AM J CLIN NUTR, V44, P435, DOI 10.1093/ajcn/44.4.435; KRAHN DD, 1993, J AM DIET ASSOC, V93, P434, DOI 10.1016/0002-8223(93)92291-5; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Kyle UG, 2001, NUTRITION, V17, P534, DOI 10.1016/S0899-9007(01)00555-X; Lowe B, 2001, PSYCHOL MED, V31, P881, DOI 10.1017/S003329170100407X; Martinoli R, 2003, ACTA DIABETOL, V40, pS203, DOI 10.1007/s00592-003-0066-2; Marzola E, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-290; Mayer L, 2005, AM J CLIN NUTR, V81, P1286; Mika C, 2004, J NUTR, V134, P3026, DOI 10.1093/jn/134.11.3026; Misra M, 2003, AM J CLIN NUTR, V77, P1361, DOI 10.1093/ajcn/77.6.1361; Orphanidou CI, 1997, AM J CLIN NUTR, V65, P1034, DOI 10.1093/ajcn/65.4.1034; Polito A, 1998, EUR J CLIN NUTR, V52, P655, DOI 10.1038/sj.ejcn.1600618; Probst M, 2001, AM J CLIN NUTR, V73, P190; Probst M, 1996, BRIT J NUTR, V76, P639, DOI 10.1079/BJN19960072; Saladino CF, 2014, J EAT DISORD, V2, DOI 10.1186/s40337-014-0034-y; SALISBURY JJ, 1995, INT J EAT DISORDER, V17, P337, DOI 10.1002/1098-108X(199505)17:4&lt;337::AID-EAT2260170405&gt;3.0.CO;2-Q; Scalfi L, 2002, EUR J CLIN NUTR, V56, P15, DOI 10.1038/sj.ejcn.1601290; Terra X, 2013, INT J EAT DISORDER, V46, P855, DOI 10.1002/eat.22166; Yamashita S, 2010, INT J EAT DISORDER, V43, P365, DOI 10.1002/eat.20700	35	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143012	10.1371/journal.pone.0143012	http://dx.doi.org/10.1371/journal.pone.0143012			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600309	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900057
J	Weinberger, J; Jimenez-Heredia, R; Schaller, S; Suessner, S; Sunzenauer, J; Reindl-Schwaighofer, R; Weiss, R; Winkler, S; Gabriel, C; Danzer, M; Oberbauer, R				Weinberger, Johannes; Jimenez-Heredia, Raul; Schaller, Susanne; Suessner, Susanne; Sunzenauer, Judith; Reindl-Schwaighofer, Roman; Weiss, Richard; Winkler, Stephan; Gabriel, Christian; Danzer, Martin; Oberbauer, Rainer			Immune Repertoire Profiling Reveals that Clonally Expanded B and T Cells Infiltrating Diseased Human Kidneys Can Also Be Tracked in Blood	PLOS ONE			English	Article							ANTIGEN RECEPTOR; GENERATION; IMMUNOGLOBULIN; DIVERSITY; ORGAN	Recent advances in high-throughput sequencing allow for the competitive analysis of the human B and T cell immune repertoire. In this study we compared Immunoglobulin and T cell receptor repertoires of lymphocytes found in kidney and blood samples of 10 patients with various renal diseases based on next-generation sequencing data. We used Biomed-2 primer panels and ImmunExplorer software to sequence, analyze and compare complementarity determining regions and V-(D)-J elements. While generally an individual's renal receptor repertoire is different from the repertoire present in blood, 94% (30/32) of the lymphocytes with clonal expansion in kidney can also be traced in blood however, not all of these clonotypes are equally abundant. Summarizing the data of all analyzed patients, 68% of highly expanded T cell clonotypes and 30% of the highly expanded B cell clonotypes that have infiltrated the kidney can be found amongst the five most abundant clonotypes in blood. In addition, complementarity determining region 3 sequences of the immunoglobulin heavy chains are on average more diverse than T cell receptor beta chains. Immune repertoire analysis of tissue infiltrating B and T cells adds new approaches to the assessment of adaptive immune response in kidney diseases. Our data suggest that expanded clonotypes in the tissues might be traceable in blood samples in the course of treatment or the natural history of the disease.	[Weinberger, Johannes; Jimenez-Heredia, Raul; Suessner, Susanne; Gabriel, Christian; Danzer, Martin] Ludwig Boltzmann Inst Expt & Clin Traumatol, Linz, Austria; [Weinberger, Johannes; Jimenez-Heredia, Raul; Suessner, Susanne; Gabriel, Christian; Danzer, Martin] Red Cross Transfus Serv Upper Austria, Dept Immunogenet, Linz, Austria; [Schaller, Susanne; Winkler, Stephan] Univ Appl Sci Upper Austria, Bioinformat Res Grp, Hagenberg, Austria; [Sunzenauer, Judith; Reindl-Schwaighofer, Roman; Oberbauer, Rainer] KH Elisabethinen, Dept Internal Med 3, Linz, Austria; [Sunzenauer, Judith; Reindl-Schwaighofer, Roman; Oberbauer, Rainer] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria; [Weiss, Richard] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Ludwig Boltzmann Institute; Ordensklinikum Linz Elisabethinen; Medical University of Vienna; Salzburg University	Danzer, M (corresponding author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Linz, Austria.	martin.danzer@o.roteskreuz.at; rainer.oberbauer@meduniwien.ac.at	Weiss, Richard/N-7279-2013; Gabriel, Christian/A-1689-2014	Weiss, Richard/0000-0003-3185-7253; Gabriel, Christian/0000-0003-2043-9320; Jimenez Heredia, Raul/0000-0002-1406-0608	Austrian Science Funds [P25726]; European Regional Development Funds [DAABAA_00720]	Austrian Science Funds(Austrian Science Fund (FWF)); European Regional Development Funds(European Commission)	This work was supported by Austrian Science Funds P25726 (https://www.fwf.ac.at/en/) and European Regional Development Funds DAABAA_00720 (http://ec.europa.eu/regional_policy/en/funding/erdf/).	Abul K, 2014, CELLULAR MOL IMMUNOL; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Anders HJ, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-138; Batal I, 2015, J AM SOC NEPHROLOGY; Bisset LR, 2004, EUR J HAEMATOL, V72, P203, DOI 10.1046/j.0902-4441.2003.00199.x; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Brady BL, 2010, J IMMUNOL, V185, P3801, DOI 10.4049/jimmunol.1001158; Brown K, 2007, AM J PATHOL, V171, P1915, DOI 10.2353/ajpath.2007.070396; Cheng JL, 2011, P NATL ACAD SCI USA, V108, P5560, DOI 10.1073/pnas.1101148108; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Dziubianau M, 2013, AM J TRANSPLANT, V13, P2842, DOI 10.1111/ajt.12431; Emerson RO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111943; Fernandez-Ruiz M, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.3; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gonzalez D, 2007, BLOOD, V110, P3112, DOI 10.1182/blood-2007-02-069625; Hershberg U, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0239; Holcomb CL, 2014, TISSUE ANTIGENS, V83, P32, DOI 10.1111/tan.12269; Klarenbeek PL, 2012, ANN RHEUM DIS, V71, P1088, DOI 10.1136/annrheumdis-2011-200612; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Lewis M, 2008, IMMUNOL CELL BIOL, V86, P226, DOI 10.1038/sj.icb.7100132; Li DR, 2014, IMMUNOL LETT, V162, P170, DOI 10.1016/j.imlet.2014.08.012; Morris H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010760; NeudoerfI C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00046; Niklas N, 2014, CELL IMMUNOL, V288, P31, DOI 10.1016/j.cellimm.2014.02.001; Ochsenreither S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-35; Parameswaran P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/j.chom.2013.05.008; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Salou M, 2015, ANN CLIN TRANSL NEUR, V2, P609, DOI 10.1002/acn3.199; Schaller S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0687-9; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Silva HM, 2012, MOL MED, V18, P733, DOI 10.2119/molmed.2011.00281; SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6; Six A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00413; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Sun CY, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/954292; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020	41	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143125	10.1371/journal.pone.0143125	http://dx.doi.org/10.1371/journal.pone.0143125			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600245	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900066
J	Mueller, SC; Sommer, B; Backes, C; Haas, J; Meder, B; Meese, E; Keller, A				Mueller, Sabine C.; Sommer, Bjoern; Backes, Christina; Haas, Jan; Meder, Benjamin; Meese, Eckart; Keller, Andreas			From Single Variants to Protein Cascades MULTISCALE MODELING OF SINGLE NUCLEOTIDE VARIANT SETS IN GENETIC DISORDERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOINFORMATICS CHALLENGES; SEQUENCE; KNOWLEDGEBASE; INFORMATION; EXPRESSION; RESOURCE; DATABASE; SURFACE; SERVER; ATLAS	Understanding the role of genetics in disease has become a central part of medical research. Non-synonymous single nucleotide variants (nsSNVs) in coding regions of human genes frequently lead to pathological phenotypes. Beyond single variations, the individual combination of nsSNVs may add to pathogenic processes. We developed a multiscale pipeline to systematically analyze the existence of quantitative effects of multiple nsSNVs and gene combinations in single individuals on pathogenicity. Based on this pipeline, we detected in a data set of 842 nsSNVs discovered in 76 genes related to cardiomyopathies, associated nsSNV combinations in seven genes present in at least 70% of all 639 patient samples, but not in a control cohort of healthy humans. Structural analyses of these revealed primarily an influence on the protein stability. For amino acid substitutions located at the protein surface, we generally observed a proximity to putative binding pockets. To computationally analyze cumulative effects and their impact, pathogenicity methods are currently being developed. Our approach supports this process, as shown on the example of a cardiac phenotype but can be likewise applied to other diseases such as cancer.	[Mueller, Sabine C.; Backes, Christina; Keller, Andreas] Univ Saarland, Chair Clin Bioinformat, Campus Bldg E2-1, D-66123 Saarbrucken, Germany; [Mueller, Sabine C.; Meese, Eckart] Univ Saarland, Dept Human Genet, D-66421 Homburg, Germany; [Sommer, Bjoern] Univ Bielefeld, Fac Technol, Biomed Informat Dept, D-33501 Bielefeld, Germany; [Sommer, Bjoern] Monash Univ, Fac Informat Technol, Clayton Sch Informat Technol, Melbourne, Vic 3800, Australia; [Haas, Jan; Meder, Benjamin] Heidelberg Univ, Dept Internal Med 3, D-69120 Heidelberg, Germany; [Haas, Jan; Meder, Benjamin] DZHK German Ctr Cardiovasc Res, D-69120 Heidelberg, Germany	Saarland University; Saarland University; University of Bielefeld; Monash University; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research	Mueller, SC (corresponding author), Univ Saarland, Chair Clin Bioinformat, Campus Bldg E2-1, D-66123 Saarbrucken, Germany.	sabine.mueller@uniklinikum-saarland.de	Keller, Andreas/ABB-6412-2021; Meese, Eckart Ulrich/ABD-1983-2021	Keller, Andreas/0000-0002-5361-0895; Mueller, Sabine/0000-0001-5184-1254; Sommer, Bjorn/0000-0003-1514-9898	Best Ageing Grant from the European Union [306031]	Best Ageing Grant from the European Union	This work was supported by the Best Ageing Grant 306031 from the European Union. The authors declare that they have no competing interests.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey JNC, 2014, GENES-BASEL, V5, P518, DOI 10.3390/genes5030518; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; Capriotti E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S4-S3; Chang A, 2015, NUCLEIC ACIDS RES, V43, pD439, DOI 10.1093/nar/gku1068; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; de la Cruz X, 2001, J COMPUT AID MOL DES, V15, P521, DOI 10.1023/A:1011133332333; Fernald GH, 2011, BIOINFORMATICS, V27, P1741, DOI 10.1093/bioinformatics/btr295; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Ferrer-Costa C, 2007, J MOL BIOL, V365, P249, DOI 10.1016/j.jmb.2006.09.053; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Giacomini KM, 2007, CLIN PHARMACOL THER, V81, P328, DOI 10.1038/sj.clpt.6100087; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Hahsler M., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I15; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Jochen Hipp U. G., 2000, SIGKDD EXPLOR NEWSL, V2, P58; Kormeier B., 2014, DATA WAREHOUSES BIOI, P111; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marian AJ, 2013, CARDIOVASC PATHOL, V22, P309, DOI 10.1016/j.carpath.2013.05.002; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Mueller SC, 2015, BRIEF BIOINFORM, V16, P769, DOI 10.1093/bib/bbu054; Mueller SC, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0190-y; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nguyen H, 2015, J BIOL CHEM, V290, P13641, DOI 10.1074/jbc.M114.626861; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sommer B, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720013400052; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Westphal V, 2002, HUM MOL GENET, V11, P599, DOI 10.1093/hmg/11.5.599; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yang WP, 1998, J BIOL CHEM, V273, P19419, DOI 10.1074/jbc.273.31.19419; Yip YL, 2004, HUM MUTAT, V23, P464, DOI 10.1002/humu.20021; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	48	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1582	1590		10.1074/jbc.M115.695247	http://dx.doi.org/10.1074/jbc.M115.695247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601959	Green Published, hybrid			2022-12-26	WOS:000368620700003
J	Sin, Y; Tanaka, K; Saijo, M				Sin, Yooksil; Tanaka, Kiyoji; Saijo, Masafumi			The C-terminal Region and SUMOylation of Cockayne Syndrome Group B Protein Play Critical Roles in Transcription-coupled Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; UV-SENSITIVE SYNDROME; DNA-REPAIR; COMPLEMENTATION GROUPS; NUCLEAR-MATRIX; CSB PROTEIN; DAMAGE; TFIIH; TRANSLOCATION; DEGRADATION	Cockayne syndrome (CS) is a recessive disorder that results in deficiencies in transcription-coupled nucleotide excision repair (TC-NER), a subpathway of nucleotide excision repair, and cells from CS patients exhibit hypersensitivity to UV light. CS group B protein (CSB), which is the gene product of one of the genes responsible for CS, belongs to the SWI2/SNF2 DNA-dependent ATPase family and has an ATPase domain and an ubiquitinbinding domain (UBD) in the central region and the C-terminal region, respectively. The C-terminal region containing the UBD is essential for the functions of CSB. In this study, we generated several CSB deletion mutants and analyzed the functions of the C-terminal region of CSB in TC-NER. Not only the UBD but also the C-terminal 30-amino acid residues were required for UV light resistance and TC-NER. This region was needed for the interaction of CSB with RNA polymerase II, the translocation of CS group A protein to the nuclear matrix, and the association of CSB with chromatin after UV irradiation. CSB was modified by small ubiquitin-like modifier 2/3 in a UV light-dependent manner. This modification was abolished in a CSB mutant lacking the C-terminal 30 amino acid residues. However, the substitution of lysine residues in this region with arginine did not affect SUMOylation or TC-NER. By contrast, substitution of a lysine residue in the N-terminal region with arginine decreased SUMOylation and resulted in cells with defects in TC-NER. These results indicate that both the most C-terminal region and SUMOylation are important for the functions of CSB in TC-NER.	[Sin, Yooksil; Tanaka, Kiyoji; Saijo, Masafumi] Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan	Osaka University	Tanaka, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan.	ktanaka@fbs.osaka-u.ac.jp; saijom@fbs.osaka-u.ac.jp			Ministry of Education, Cultures, Sports, Science, and Technology (MEXT) [22131009, 15H02820]	Ministry of Education, Cultures, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas 22131009 (to K.T.) and Grant-in-Aid for Scientific Research (B) 15H02820 (to M.S.) from the Ministry of Education, Cultures, Sports, Science, and Technology (MEXT). The authors declare that they have no conflicts of interest with the contents of this article.	Akita M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10984; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Citterio E, 1998, J BIOL CHEM, V273, P11844, DOI 10.1074/jbc.273.19.11844; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Fei J, 2012, J BIOL CHEM, V287, P35118, DOI 10.1074/jbc.M112.398131; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gool AJ, 1997, EMBO J, V16, P5955; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Horibata K, 2011, GENES CELLS, V16, P101, DOI 10.1111/j.1365-2443.2010.01467.x; Imam SZ, 2007, NUCLEIC ACIDS RES, V35, P4941, DOI 10.1093/nar/gkm386; Kamiuchi S, 2002, P NATL ACAD SCI USA, V99, P201, DOI 10.1073/pnas.012473199; Kwei JSM, 2004, BIOCHEM BIOPH RES CO, V320, P1133, DOI 10.1016/j.bbrc.2004.06.066; Lake RJ, 2013, MECH AGEING DEV, V134, P202, DOI 10.1016/j.mad.2013.02.004; Lake RJ, 2010, MOL CELL, V37, P235, DOI 10.1016/j.molcel.2009.10.027; Laugel V, 2010, HUM MUTAT, V31, P113, DOI 10.1002/humu.21154; LEHMANN AR, 1982, MUTAT RES, V106, P347, DOI 10.1016/0027-5107(82)90115-4; LEHMANN AR, 1985, LANCET, V1, P486; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MAYNE LV, 1982, CANCER RES, V42, P1473; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Saijo M, 2007, MOL CELL BIOL, V27, P2538, DOI 10.1128/MCB.01288-06; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; TANAKA K, 1981, SOMAT CELL GENET, V7, P445, DOI 10.1007/BF01542989; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Velez-Cruz R, 2013, MECH AGEING DEV, V134, P234, DOI 10.1016/j.mad.2013.03.004; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang LF, 2014, P NATL ACAD SCI USA, V111, P18566, DOI 10.1073/pnas.1420227112; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Wei LZ, 2011, CANCER SCI, V102, P1840, DOI 10.1111/j.1349-7006.2011.02037.x; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	42	26	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1387	1397		10.1074/jbc.M115.683235	http://dx.doi.org/10.1074/jbc.M115.683235			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26620705	hybrid, Green Published			2022-12-26	WOS:000368068300030
J	Rodriguez, JM; Moreno, LT; Alejo, A; Lacasta, A; Rodriguez, F; Salas, ML				Rodriguez, Javier M.; Tais Moreno, Leticia; Alejo, Ali; Lacasta, Anna; Rodriguez, Fernando; Salas, Maria L.			Genome Sequence of African Swine Fever Virus BA71, the Virulent Parental Strain of the Nonpathogenic and Tissue-Culture Adapted BA71V	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; RNA-POLYMERASE; MULTIGENE FAMILY-360; GENETIC MANIPULATION; SIGNAL-TRANSDUCTION; DOMESTIC SWINE; VIRAL GENOME; PROTEIN; ISOLATE; DNA	The strain BA71V has played a key role in African swine fever virus (ASFV) research. It was the first genome sequenced, and remains the only genome completely determined. A large part of the studies on the function of ASFV genes, viral transcription, replication, DNA repair and morphogenesis, has been performed using this model. This avirulent strain was obtained by adaptation to grow in Vero cells of the highly virulent BA71 strain. We report here the analysis of the genome sequence of BA71 in comparison with that of BA71V. They possess the smallest genomes for a virulent or an attenuated ASFV, and are essentially identical except for a relatively small number of changes. We discuss the possible contribution of these changes to virulence. Analysis of the BA71 sequence allowed us to identify new similarities among ASFV proteins, and with database proteins including two ASFV proteins that could function as a two-component signaling network.	[Alejo, Ali; Salas, Maria L.] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Rodriguez, Javier M.] Inst Nacl Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Tais Moreno, Leticia] Parque Cient Madrid, Madrid, Spain; [Lacasta, Anna; Rodriguez, Fernando] IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); IRTA	Rodriguez, JM (corresponding author), Inst Nacl Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	j.rodriguez@isciii.es; mlsalas@cbm.csic.es	Rodriguez, Fernando/GLN-3947-2022; Alejo, Ali/AAF-1477-2020; Rodriguez Martinez, Javier Maria/A-5478-2017; Lacasta, Anna/P-2278-2017	Rodriguez, Fernando/0000-0001-7361-8408; Alejo, Ali/0000-0002-1613-6063; Rodriguez Martinez, Javier Maria/0000-0003-0146-9903; Lacasta, Anna/0000-0001-8381-9844	Spanish Ministerio de Economia y Competitividad [AGL2013-43998-C2-1/2-R]; Fundacion Ramon Areces	Spanish Ministerio de Economia y Competitividad(Spanish Government); Fundacion Ramon Areces	This study was supported by grants from the Spanish Ministerio de Economia y Competitividad (AGL2013-43998-C2-1/2-R) and by an institutional grant from Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams CC, 2013, VIROLOGY, V443, P99, DOI 10.1016/j.virol.2013.04.028; Afonso CL, 1998, J GEN VIROL, V79, P2543, DOI 10.1099/0022-1317-79-10-2543; ALMAZAN F, 1992, J VIROL, V66, P6655; Bishop RP, 2015, VIRUS GENES, V50, P303, DOI 10.1007/s11262-014-1156-7; BLASCO R, 1989, VIROLOGY, V168, P330, DOI 10.1016/0042-6822(89)90273-0; BLASCO R, 1989, VIROLOGY, V173, P251, DOI 10.1016/0042-6822(89)90241-9; Boinas F, 2001, 9 C INT MED VET LING, P267; Boinas FS, 2004, J GEN VIROL, V85, P2177, DOI 10.1099/vir.0.80058-0; Borca MV, 1998, J VIROL, V72, P2881, DOI 10.1128/JVI.72.4.2881-2889.1998; Burrage TG, 2004, J VIROL, V78, P2445, DOI 10.1128/JVI.78.5.2445-2453.2004; Bustos MJ, 2002, ARCH VIROL, V147, P1453, DOI 10.1007/s00705-002-0814-6; CARRASCOSA AL, 1982, J VIROL METHODS, V3, P303, DOI 10.1016/0166-0934(82)90034-9; Chapman DAG, 2008, J GEN VIROL, V89, P397, DOI 10.1099/vir.0.83343-0; Chapman DAG, 2011, EMERG INFECT DIS, V17, P599, DOI 10.3201/eid1704.101283; Cobbold C, 2001, J VIROL, V75, P7221, DOI 10.1128/JVI.75.16.7221-7229.2001; Darling AE, 2011, BIOINFORMATICS, V27, P2756, DOI 10.1093/bioinformatics/btr451; de Villiers EP, 2010, VIROLOGY, V400, P128, DOI 10.1016/j.virol.2010.01.019; DELAVEGA I, 1994, VIROLOGY, V201, P152, DOI 10.1006/viro.1994.1277; DELAVEGA I, 1990, VIROLOGY, V179, P234, DOI 10.1016/0042-6822(90)90293-Z; Dixon L.K., 2005, VIRUS TAXONOMY, P135, DOI DOI 10.1186/1743-422X-2-64; DIXON LK, 1994, J GEN VIROL, V75, P1655, DOI 10.1099/0022-1317-75-7-1655; EDWARDS JF, 1984, AM J VET RES, V45, P2414; ENJUANES L, 1976, J GEN VIROL, V32, P471, DOI 10.1099/0022-1317-32-3-471; Epifano C, 2006, J VIROL, V80, P12260, DOI 10.1128/JVI.01323-06; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Galindo-Cardiel I, 2013, VIRUS RES, V173, P180, DOI 10.1016/j.virusres.2012.12.018; Gallardo C, 2009, VIRUS GENES, V38, P85, DOI 10.1007/s11262-008-0293-2; GARCIA R, 1995, J BIOTECHNOL, V40, P121, DOI 10.1016/0168-1656(95)00037-Q; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HARESNAPE JM, 1989, EPIDEMIOL INFECT, V102, P507, DOI 10.1017/S0950268800030223; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; Hurtado C, 2010, J VIROL METHODS, V164, P131, DOI 10.1016/j.jviromet.2009.11.030; Ingmer H, 1998, MOL MICROBIOL, V29, P49, DOI 10.1046/j.1365-2958.1998.00895.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; King K, 2011, VACCINE, V29, P4593, DOI 10.1016/j.vaccine.2011.04.052; Krug PW, 2015, J VIROL, V89, P2324, DOI 10.1128/JVI.03250-14; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Lange U, 2004, MOL MICROBIOL, V52, P1133, DOI 10.1111/j.1365-2958.2004.04039.x; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Leitao A, 2001, J GEN VIROL, V82, P513, DOI 10.1099/0022-1317-82-3-513; Lewis T, 2000, J VIROL, V74, P1275, DOI 10.1128/JVI.74.3.1275-1285.2000; LEY V, 1984, VIROLOGY, V133, P249, DOI 10.1016/0042-6822(84)90392-1; Loh J, 2009, J VIROL, V83, P13019, DOI 10.1128/JVI.00638-09; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Moore DM, 1998, J VIROL, V72, P10310, DOI 10.1128/JVI.72.12.10310-10315.1998; Neilan JG, 2002, J VIROL, V76, P3095, DOI 10.1128/JVI.76.7.3095-3104.2002; Nix RJ, 2006, ARCH VIROL, V151, P2475, DOI 10.1007/s00705-006-0794-z; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Donnell V, 2015, J VIROL, V89, P6048, DOI 10.1128/JVI.00554-15; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Olson S A, 1994, Methods Mol Biol, V25, P195; PAN IC, 1992, J VET MED SCI, V54, P43, DOI 10.1292/jvms.54.43; Portugal R, 2015, J GEN VIROL, V96, P408, DOI 10.1099/vir.0.070508-0; PRADOS FJ, 1993, J VIROL, V67, P2475, DOI 10.1128/JVI.67.5.2475-2485.1993; Redrejo-Rodriguez M, 2013, J VIROL, V87, P9780, DOI 10.1128/JVI.01173-13; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Reteno DG, 2015, J VIROL, V89, P6585, DOI 10.1128/JVI.00115-15; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RODRIGUEZ JM, 1992, VIROLOGY, V186, P40, DOI 10.1016/0042-6822(92)90059-X; RODRIGUEZ JM, 1992, VIROLOGY, V188, P67, DOI 10.1016/0042-6822(92)90735-8; Salas M.L., 1999, ENCY VIROLOGY, P30; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schaller GE, 2011, CURR BIOL, V21, pR320, DOI 10.1016/j.cub.2011.02.045; Stewart RC, 2010, CURR OPIN MICROBIOL, V13, P133, DOI 10.1016/j.mib.2009.12.013; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Van Mullem V, 2002, J BIOL CHEM, V277, P10220, DOI 10.1074/jbc.M107207200; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Vigario J D, 1989, PESTE SUINA AFRICANA, P123; Wan XF, 2013, VIRUS GENES, V46, P441, DOI 10.1007/s11262-013-0878-2; Werner F, 2008, TRENDS MICROBIOL, V16, P247, DOI 10.1016/j.tim.2008.03.008; Werner F, 2007, MOL MICROBIOL, V65, P1395, DOI 10.1111/j.1365-2958.2007.05876.x; YANEZ RJ, 1995, VIROLOGY, V208, P249, DOI 10.1006/viro.1995.1149; Zsak L, 2005, J CLIN MICROBIOL, V43, P112, DOI 10.1128/JCM.43.1.112-119.2005; ZSAK L, 1993, VIROLOGY, V196, P596, DOI 10.1006/viro.1993.1515; Zsak L, 2001, J VIROL, V75, P3066, DOI 10.1128/JVI.75.7.3066-3076.2001; Zsak L, 1998, J VIROL, V72, P1028, DOI 10.1128/JVI.72.2.1028-1035.1998; Zsak L, 1996, J VIROL, V70, P8865, DOI 10.1128/JVI.70.12.8865-8871.1996	81	43	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0142889	10.1371/journal.pone.0142889	http://dx.doi.org/10.1371/journal.pone.0142889			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618713	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800019
J	Gong, J; Fields, MA; Moreira, EF; Bowrey, HE; Gooz, M; Ablonczy, Z; Del Priore, LV				Gong, Jie; Fields, Mark A.; Moreira, Ernesto F.; Bowrey, Hannah E.; Gooz, Monika; Ablonczy, Zsolt; Del Priore, Lucian V.			Differentiation of Human Protein-Induced Pluripotent Stem Cells toward a Retinal Pigment Epithelial Cell Fate	PLOS ONE			English	Article							OUTER SEGMENT MEMBRANES; MACULAR DEGENERATION; ROD; PHAGOCYTOSIS; GENERATION; HTRA1; ISOMEROHYDROLASE; STABILITY; INTEGRIN; BINDING	Compared with many induced pluripotent stem cell (iPSC) lines generated using retrovirus and other non-integrating methods, the utilization of human protein-induced iPSC (piPSC) lines may provide a safer alternative for the generation of retinal pigment epithelial (RPE) cells for transplantation in retinal degenerative diseases. Here we assess the ability of piPSCs to differentiate into RPE cells, and to perform native RPE cell behavior. piPSCs were seeded in 6-well low-attachment plates to allow embryoid body formation, and then analyzed for pluripotent stem cell markers NANOG, SSEA4 and TRA-1-60 by immunofluorescence. Following colony formation, piPSCs were assessed for confirmation of RPE cell differentiation by staining for zonula occludens (ZO-1), bestrophin, microphthalmia-associated transcription factor (MITF) and retinal pigment epithelium specific protein-65 (RPE65). To evaluate piPSC-RPE cell phagocytic ability, adult bovine photoreceptor rod outer segments (ROS) were fed to piPSC-RPE cells, which were analyzed by fluorescent microscopy and flow cytometry. Undifferentiated piPSCs expressed all pluripotent markers assessed and formed embryoid body aggregates after 7 days. Differentiated piPSC-RPE cells expressed ZO-1, bestrophin, MITF and RPE65, typical RPE cell markers. Flow cytometry revealed robust ingestion of fluorescently-labeled ROS by piPSC-RPE cells, which was over four-times greater than that of undifferentiated piPSCs and comparable to that of an immortalized RPE cell line. Phagocytosis activity by piPSC-RPE cells was significantly reduced after the addition of anti-integrin alpha V beta 5. In conclusion, piPSCs can be differentiated toward an RPE cell fate, expressing RPE cell markers and resembling native RPE cells in behavior. These results demonstrate that piPSCs can be differentiated into RPE-like cells using a method that has an increased safety profile, a critical consideration for the development of better treatments for retinal degenerative diseases such as age-related macular degeneration (AMD).	[Gong, Jie; Fields, Mark A.; Moreira, Ernesto F.; Bowrey, Hannah E.; Ablonczy, Zsolt; Del Priore, Lucian V.] Med Univ S Carolina, Storm Eye Inst, Dept Ophthalmol, Charleston, SC 29425 USA; [Fields, Mark A.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Gooz, Monika] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Del Priore, LV (corresponding author), Med Univ S Carolina, Storm Eye Inst, Dept Ophthalmol, Charleston, SC 29425 USA.	delprior@musc.edu		Bowrey, Hannah/0000-0002-3774-4201	Research to Prevent Blindness (RPB); Department of Ophthalmology, Medical University of South Carolina; Foundation Fighting Blindness (FFB) [C-RM-0710-0542-MUSC-03]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER	Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Department of Ophthalmology, Medical University of South Carolina; Foundation Fighting Blindness (FFB); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Research to Prevent Blindness (RPB), Department of Ophthalmology, Medical University of South Carolina (to LDP), and Foundation Fighting Blindness (FFB) C-RM-0710-0542-MUSC-03 (to LDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algvere PV, 1999, EUR J OPHTHALMOL, V9, P217, DOI 10.1177/112067219900900310; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Diniz B, 2013, INVEST OPHTH VIS SCI, V54, P5087, DOI 10.1167/iovs.12-11239; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; FONG SL, 1982, METHOD ENZYMOL, V81, P133; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Haruta M, 2004, INVEST OPHTH VIS SCI, V45, P1020, DOI 10.1167/iovs.03-1034; Heller JP, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.4.4; Hogan MJ, 1971, HISTOLOGY HUMAN EYE; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Kortvely E, 2010, INVEST OPHTH VIS SCI, V51, P79, DOI 10.1167/iovs.09-3850; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Lin H, 1998, INVEST OPHTH VIS SCI, V39, P1703; Lund RJ, 2012, NAT REV GENET, V13, P732, DOI 10.1038/nrg3271; Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705; Maruotti J, 2013, STEM CELL TRANSL MED, V2, P341, DOI 10.5966/sctm.2012-0106; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Singh R, 2013, INVEST OPHTH VIS SCI, V54, P6767, DOI 10.1167/iovs.13-11943; Singh R, 2013, HUM MOL GENET, V22, P593, DOI 10.1093/hmg/dds469; Sorkio A, 2015, TISSUE ENG PT A, V21, P2301, DOI [10.1089/ten.tea.2014.0640, 10.1089/ten.TEA.2014.0640]; Steinberg RH, 1979, RETINAL PIGMENT EPIT, P32; Sugino IK, 2011, INVEST OPHTH VIS SCI, V52, P4979, DOI 10.1167/iovs.10-5386; Sun K, 2007, MOL VIS, V13, P2310; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tezel TH, 1999, INVEST OPHTH VIS SCI, V40, P467; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Treharne AJ, 2012, J BIOMED MATER RES A, V100A, P2358, DOI 10.1002/jbm.a.34178; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1977, J ULTRA MOL STRUCT R, V61, P172, DOI 10.1016/S0022-5320(77)80084-1; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	48	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143272	10.1371/journal.pone.0143272	http://dx.doi.org/10.1371/journal.pone.0143272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606685	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300050
J	Jehle, S; Bornemann, A; Deprez, A; Speijer, RP				Jehle, Sofie; Bornemann, Andre; Deprez, Arne; Speijer, Robert P.			The Impact of the Latest Danian Event on Planktic Foraminiferal Faunas at ODP Site 1210 (Shatsky Rise, Pacific Ocean)	PLOS ONE			English	Article							EOCENE THERMAL MAXIMUM; SEA-SURFACE TEMPERATURES; STABLE-ISOTOPE; SELANDIAN TRANSITION; LATE PALEOCENE; DISSOLUTION SUSCEPTIBILITY; DANIAN/SELANDIAN BOUNDARY; ASTRONOMICAL CALIBRATION; CALCAREOUS NANNOPLANKTON; SOUTH ATLANTIC	The marine ecosystem has been severely disturbed by several transient paleoenvironmental events (<200 kyr duration) during the early Paleogene, of which the Paleocene-Eocene Thermal Maximum (PETM, similar to 56 Ma) was the most prominent. Over the last decade a number of similar events of Paleocene and Eocene age have been discovered. However, relatively little attention has been paid to pre-PETM events, such as the "Latest Danian Event" ("LDE", similar to 62.18 Ma), specifically from an open ocean perspective. Here we present new foraminiferal isotope (delta C-13, delta O-18) and faunal data from Ocean Drilling Program (ODP) Site 1210 at Shatsky Rise (Pacific Ocean) in order to reconstruct the prevailing paleoceano-graphic conditions. The studied five-meter-thick succession covers similar to 900 kyr and includes the 200-kyr-lasting LDE. All groups surface dwelling, subsurface dwelling and benthic foraminifera show a negative delta C-13 excursion of >0.6 parts per thousand, similar in magnitude to the one previously reported from neighboring Site 1209 for benthic foraminifera. delta O-18-inferred warming by 1.6 to 2.8 degrees C (0.4-0.7% delta O-18 measured on benthic and planktic foraminiferal tests) of the entire water column accompanies the negative delta C-13 excursion. A well stratified upper ocean directly before and during the LDE is proposed based on the stable isotope gradients between surface and subsurface dwellers. The gradient is less well developed, but still enhanced after the event. Isotope data are supplemented by comprehensive planktic foraminiferal faunal analyses revealing a dominance of Morozovella species together with Parasubbotina species. Subsurface-dwelling Parasubbotina shows high abundances during the LDE tracing changes in the strength of the isotope gradients and, thus, may indicate optimal living conditions within a well stratified surface ocean for this taxon. In addition, distinct faunal changes are reported like the disappearance of Praemurica species right at the base of the LDE and the continuous replacement of M. praeangulata with M. angulata across the LDE.	[Jehle, Sofie; Bornemann, Andre] Univ Leipzig, Inst Geophys & Geol, D-04103 Leipzig, Germany; [Bornemann, Andre] Bundesanstalt Geowissensch & Rohstoffe, D-30655 Hannover, Germany; [Deprez, Arne; Speijer, Robert P.] Katholieke Univ Leuven, Dept Earth & Environm Sci, B-3001 Leuven, Belgium	Leipzig University; KU Leuven	Jehle, S (corresponding author), Univ Leipzig, Inst Geophys & Geol, Talstr 35, D-04103 Leipzig, Germany.	sofie.jehle@uni-leipzig.de	Speijer, Robert/H-5073-2016; Bornemann, André/N-7239-2019; Bornemann, André/A-4145-2009	Speijer, Robert/0000-0002-5873-7203; Bornemann, André/0000-0003-4341-2366; Bornemann, André/0000-0003-4341-2366	NSF; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [BO2505/8-1, EH 89/20]; Research Fund KU Leuven [OT/08/018]; Universitat Leipzig; Joint Oceanographic Institutions (JOI)	NSF(National Science Foundation (NSF)); German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Research Fund KU Leuven(KU Leuven); Universitat Leipzig; Joint Oceanographic Institutions (JOI)	Samples were supplied by the International Ocean Discovery Program. This research used samples and data provided by the ODP. The ODP was sponsored by NSF and participating countries under the management of Joint Oceanographic Institutions (JOI). Financial support was provided by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) to AB (BO2505/8-1, EH 89/20). RPS and AD were supported by the Research Fund KU Leuven (OT/08/018). The authors acknowledge support from the Universitat Leipzig within the program of Open Access Publishing.; We greatly appreciate help with taxonomic determinations by Maria Rose Petrizzo (University of Milan, Italy). Lisa Petter (University of Leipzig) is thanked for the help with micropaleontological sample preparation. We further thank Stefan Kruger (University of Leipzig) very much for the stable isotope measurements. The manuscript benefited from constructive reviews of Eduardo Koutsoukos and an anonymous reviewer. We acknowledge support from the Universitat Leipzig within the program of Open Access Publishing.	Arenillas I, 2008, TERRA NOVA, V20, P38, DOI 10.1111/j.1365-3121.2007.00784.x; Aubry MP, 2012, AUSTRIAN J EARTH SCI, V105, P29; BERGER WH, 1970, MAR GEOL, V8, P111, DOI 10.1016/0025-3227(70)90001-0; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Berggren WA, 2005, J FORAMIN RES, V35, P279, DOI 10.2113/35.4.279; Berggren WA, 1997, MICROPALEONTOLOGY, V43, P1, DOI 10.2307/1485988; Bernaola G, 2007, GEOL SOC AM BULL, V119, P785, DOI 10.1130/B26132.1; Bornemann A, 2009, J GEOL SOC LONDON, V166, P1135, DOI 10.1144/0016-76492008-104; Bralower T.J., 2002, P OCEAN DRILLING PRO, V198, P1, DOI [DOI 10.2973/0DP.PR0CK.198.101.2002, 10.2973/odp.proc.ir.198.2002, DOI 10.2973/0DP.PR0C.IR.198.2002]; Bralower TJ, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000662; CASTRADORI D, 1993, PALEOCEANOGRAPHY, V8, P459, DOI 10.1029/93PA00756; Clyde WC, 2008, EARTH PLANET SC LETT, V269, P553, DOI 10.1016/j.epsl.2008.03.009; Clyde WC, 2010, J GEOL, V118, P131, DOI 10.1086/649893; Corfield R.M., 1988, Journal of Micropalaeontology, V7, P59; Crouch EM, 2001, GEOLOGY, V29, P315, DOI 10.1130/0091-7613(2001)029<0315:GDEAWT>2.0.CO;2; CULLEN JJ, 1982, CAN J FISH AQUAT SCI, V39, P791, DOI 10.1139/f82-108; DHONDT S, 1993, PALEOCEANOGRAPHY, V8, P527, DOI 10.1029/93PA00952; DHONDT S, 1994, PALEOBIOLOGY, V20, P391, DOI 10.1017/S0094837300012847; Dinares-Turell J, 2010, PALAEOGEOGR PALAEOCL, V297, P511, DOI 10.1016/j.palaeo.2010.09.004; Dinares-Turell J, 2014, EARTH PLANET SC LETT, V405, P119, DOI 10.1016/j.epsl.2014.08.027; Dinares-Turell J, 2012, TERRA NOVA, V24, P477, DOI 10.1111/j.1365-3121.2012.01086.x; Dittert N, 2000, DEEP-SEA RES PT I, V47, P603, DOI 10.1016/S0967-0637(99)00069-2; Dittert N., 1999, USE PROXIES PALEOCEA, P255, DOI DOI 10.1007/978-3-642-58646-0_10; Dutton A, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001098; Emeis KC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2000PA000617; EREZ J, 1983, GEOCHIM COSMOCHIM AC, V47, P1025, DOI 10.1016/0016-7037(83)90232-6; Fuqua LM, 2008, PALAIOS, V23, P185, DOI 10.2110/palo.2007.p07-004r; Guasti E, 2006, MAR MICROPALEONTOL, V59, P210, DOI 10.1016/j.marmicro.2006.02.008; Hancock HJ, 2006, P OCEAN DRILLING PRO; Hilgen FJ, 2015, NEWSL STRATIGR, V48, P91, DOI 10.1127/nos/2014/0054; Huisman J, 2006, NATURE, V439, P322, DOI 10.1038/nature04245; Jiang SJ, 2010, NAT GEOSCI, V3, P280, DOI 10.1038/NGEO775; Kelly DC, 1999, J FORAMIN RES, V29, P58; Kelly DC, 1996, PALEOBIOLOGY, V22, P266, DOI 10.1017/S0094837300016213; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KILLINGLEY JS, 1983, NATURE, V301, P594, DOI 10.1038/301594a0; Kucera M, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P409; Larson RL, P ODP SCI RESULTS, P615, DOI DOI 10.2973/ODP.PROC.SR.129.144.1992; Lourens LJ, 2005, NATURE, V435, P1083, DOI 10.1038/nature03814; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; McCarren H, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002116; McInerney FA, 2011, ANNU REV EARTH PL SC, V39, P489, DOI 10.1146/annurev-earth-040610-133431; Monechi S, 2013, MAR MICROPALEONTOL, V98, P28, DOI 10.1016/j.marmicro.2012.11.002; Nguyen TMP, 2011, MAR MICROPALEONTOL, V81, P1, DOI 10.1016/j.marmicro.2011.07.001; Norris RD, 1996, PALEOBIOLOGY, V22, P461, DOI 10.1017/S0094837300016468; Olsson R. K., 1999, ATLAS PALEOCENE PLAN; Ortiz JD, 1996, GEOCHIM COSMOCHIM AC, V60, P4509, DOI 10.1016/S0016-7037(96)00256-6; Pearson PN, 2015, J MICROPALAEONTOL, V34, P59, DOI 10.1144/jmpaleo2013-032; PEARSON PN, 1993, J FORAMIN RES, V23, P123, DOI 10.2113/gsjfr.23.2.123; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Petrizzo MR, 2008, J FORAMIN RES, V38, P357, DOI 10.2113/gsjfr.38.4.357; Petrizzo MR, 2007, MAR MICROPALEONTOL, V63, P187, DOI 10.1016/j.marmicro.2006.11.007; Petrizzo MR, 2005, P OC DRILL PROGR SCI, P198, DOI [10.2973/odp.proc.sr.198.102.005, DOI 10.2973/ODP.PROC.SR.198.110.2005]; Petrizzo MR, P OC DRILL PROGR SCI, P198; Quillevere F, 2002, PALAEOGEOGR PALAEOCL, V184, P371, DOI 10.1016/S0031-0182(02)00275-4; Quillevere F, 2008, EARTH PLANET SC LETT, V265, P600, DOI 10.1016/j.epsl.2007.10.040; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; Rohl U, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001784; Rohling EJ, 1989, PALEOCEANOGRAPHY, V4, P531, DOI 10.1029/PA004i005p00531; Rohling EJ, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001237; Sager WW, 2005, GEOLOGICAL SOC AM SP, V388, P721, DOI [DOI 10.1130/2005.2388(41), DOI 10.1130/0-8137-2388-4.721]; Schmitz B, 2011, EPISODES, V34, P220, DOI 10.18814/epiiugs/2011/v34i4/002; Schneider LJ, 2013, PALEOBIOLOGY, V39, P628, DOI 10.1666/12050; SCHRAG DP, 1995, GEOCHIM COSMOCHIM AC, V59, P2265, DOI 10.1016/0016-7037(95)00105-9; Schulte P, 2013, PALAEOGEOGR PALAEOCL, V371, P9, DOI 10.1016/j.palaeo.2012.11.027; Sexton PF, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001291; Sexton PF, 2011, NATURE, V471, P349, DOI 10.1038/nature09826; SHACKLETON NJ, 1985, J FORAMIN RES, V15, P321, DOI 10.2113/gsjfr.15.4.321; Sinton C. W., 1998, P OCEAN DRILLING PRO, V152, P387, DOI DOI 10.2973/0DP.PR0C.SR.152.234.1998; Sluijs A, 2007, NATURE, V450, P1218, DOI 10.1038/nature06400; Soldan DM, 2011, J FORAMIN RES, V41, P260, DOI 10.2113/gsjfr.41.3.260; Speijer RP, 2012, AUSTRIAN J EARTH SCI, V105, P6; Speijer RP, GEOLOGICAL SOC AM SP, P275; Sprong J, 2009, GEOL ACTA, V7, P63, DOI 10.1344/105.000000271; Stap L, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003097; Steurbaut E, 2008, MAR MICROPALEONTOL, V67, P1, DOI 10.1016/j.marmicro.2007.08.004; Thomas E., GEOLOGICAL SOC AM SP, P319; Vandenberghe N, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P855, DOI 10.1016/B978-0-444-59425-9.00028-7; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Weaver W., 1949, MATH THEORY COMMUNIC, V19, P1; Westerhold T, 2005, P OC DRILL PROGR SCI, P198; Westerhold T, 2008, PALAEOGEOGR PALAEOCL, V257, P377, DOI 10.1016/j.palaeo.2007.09.016; Westerhold T, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002092; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	85	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0141644	10.1371/journal.pone.0141644	http://dx.doi.org/10.1371/journal.pone.0141644			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606656	Green Published, gold			2022-12-26	WOS:000365865300010
J	Knight, JM; Mak, G; Shaw, J; Porter, P; McDermott, C; Roberts, L; You, R; Yuan, XY; Millien, VO; Qian, YP; Song, LZ; Frazier, V; Kim, C; Kim, JJ; Bond, RA; Milner, JD; Zhang, Y; Mandal, PK; Luong, A; Kheradmand, F; McMurray, JS; Corry, DB				Knight, John M.; Mak, Garbo; Shaw, Joanne; Porter, Paul; McDermott, Catherine; Roberts, Luz; You, Ran; Yuan, Xiaoyi; Millien, Valentine O.; Qian, Yuping; Song, Li-Zhen; Frazier, Vincent; Kim, Choel; Kim, Jeong Joo; Bond, Richard A.; Milner, Joshua D.; Zhang, Yuan; Mandal, Pijus K.; Luong, Amber; Kheradmand, Farrah; McMurray, John S.; Corry, David B.			Long-Acting Beta Agonists Enhance Allergic Airway Disease	PLOS ONE			English	Article							BETA(2)-ADRENERGIC RECEPTOR; MURINE MODEL; TRANSCRIPTION FACTOR; EXPERIMENTAL ASTHMA; SIGNALING PATHWAYS; LUNG-DISEASE; MILD ASTHMA; SH2 DOMAIN; MICE; INFLAMMATION	Asthma is one of the most common of medical illnesses and is treated in part by drugs that activate the beta-2-adrenoceptor (beta 2-AR) to dilate obstructed airways. Such drugs include long acting beta agonists (LABAs) that are paradoxically linked to excess asthma-related mortality. Here we show that LABAs such as salmeterol and structurally related beta 2-AR drugs such as formoterol and carvedilol, but not short-acting agonists (SABAs) such as albuterol, promote exaggerated asthma-like allergic airway disease and enhanced airway constriction in mice. We demonstrate that salmeterol aberrantly promotes activation of the allergic disease-related transcription factor signal transducer and activator of transcription 6 (STAT6) in multiple mouse and human cells. A novel inhibitor of STAT6, PM-242H, inhibited initiation of allergic disease induced by airway fungal challenge, reversed established allergic airway disease in mice, and blocked salmeterol-dependent enhanced allergic airway disease. Thus, structurally related beta 2-AR ligands aberrantly activate STAT6 and promote allergic airway disease. This untoward pharmacological property likely explains adverse outcomes observed with LABAs, which may be overcome by agents that antagonize STAT6.	[Knight, John M.; You, Ran; Yuan, Xiaoyi] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Knight, John M.; You, Ran; Yuan, Xiaoyi] Baylor Coll Med, Dept Immunol & Med, Houston, TX 77030 USA; [Mak, Garbo; Porter, Paul; McDermott, Catherine; Roberts, Luz; Qian, Yuping; Song, Li-Zhen; Frazier, Vincent] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Shaw, Joanne] Univ Texas Med Sch Houston, Dept Otorhinolaryngolgy Head & Neck Surg, Houston, TX USA; [Millien, Valentine O.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Millien, Valentine O.] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Kim, Choel] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Kim, Choel] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kim, Jeong Joo] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Bond, Richard A.] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA; [Milner, Joshua D.; Zhang, Yuan] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Mandal, Pijus K.; McMurray, John S.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Luong, Amber] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Luong, Amber] Univ Texas Med Sch Houston, Ctr Immunol & Autoimmune Dis, Brown Fdn Inst Mol Med Prevent Human Dis, Houston, TX USA; [Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA; [Kheradmand, Farrah; Corry, David B.] Michael DeBakey VA Ctr Translat Res Inflammatory, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	McMurray, JS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	jmcmurra@mdanderson.org; dcorry@bcm.edu	Zhang, Yuan/C-7777-2018	Zhang, Yuan/0000-0001-9932-917X	American Asthma Foundation [11-0360]; Clayton Foundation for Research [Corr2012]; Cancer Center Support Grant [P30 CA16672-38]; Intramural Research Program of the United States National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH, NIAID); NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001099] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002221] Funding Source: NIH RePORTER	American Asthma Foundation; Clayton Foundation for Research; Cancer Center Support Grant; Intramural Research Program of the United States National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH, NIAID); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the American Asthma Foundation, grant 11-0360 http://www.americanasthmafoundation.org; Clayton Foundation for Research, Corr2012, http://www.claytonbiotech.com; Cancer Center Support Grant P30 CA16672-38; and the Intramural Research Program of the United States National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH, NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported in part by the American Asthma Foundation (Award 11-0360) and the Intramural Research Program of the United States National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH, NIAID). We acknowledge the Cancer Center Support Grant (P30 CA16672-38) and the Translational Chemistry Core Facility for providing mass spectrometry services during the synthesis of PM-242H (both at MDACC). We thank Julia K. Walker, Ph.D., for providing beta arrestin 2-deficient mice.	Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barnes PJ, 2011, J BIOL CHEM, V286, P32899, DOI 10.1074/jbc.R110.206466; Beasley R, 1997, CIBA F SYMP, V206, P140; Beasley R, 1999, J ALLERGY CLIN IMMUN, V104, pS18, DOI 10.1016/S0091-6749(99)70270-8; Bel EH, 2013, NEW ENGL J MED, V369, P549, DOI 10.1056/NEJMcp1214826; Bezemer GFG, 2012, PHARMACOL REV, V64, P337, DOI 10.1124/pr.111.004622; Booth H, 1996, THORAX, V51, P1100, DOI 10.1136/thx.51.11.1100; Callaerts-Vegh Z, 2004, P NATL ACAD SCI USA, V101, P4948, DOI 10.1073/pnas.0400452101; Cates CJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010314.pub2; Cates CJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006923.pub3; Cates CJ, 2009, COCHRANE DB SYST REV, P3; Cates CJ, 2008, COCHRANE DATABASE SY, V3; Cazzola M, 2013, AM J RESP CRIT CARE, V187, P690, DOI 10.1164/rccm.201209-1739PP; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corry DB, 2006, IMMUNOL RES, V35, P279, DOI 10.1385/IR:35:3:279; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Corry DB, 1998, MOL MED, V4, P344, DOI 10.1007/BF03401741; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gavett SH, 1997, AM J PHYSIOL-LUNG C, V272, pL253, DOI 10.1152/ajplung.1997.272.2.L253; Goswami S, 2009, NAT IMMUNOL, V10, P496, DOI 10.1038/ni.1719; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hanania NA, 2008, PULM PHARMACOL THER, V21, P134, DOI 10.1016/j.pupt.2007.07.002; Hegener O, 2004, BIOCHEMISTRY-US, V43, P6190, DOI 10.1021/bi035928t; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Lee SY, 2003, J IND ENG CHEM, V9, P9; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lundblad LKA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-27; Mandal PK, 2011, J MED CHEM, V54, P3549, DOI 10.1021/jm2000882; Mandal PK, 2009, ORG LETT, V11, P3394, DOI 10.1021/ol9012662; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Mionnet C, 2010, NAT MED, V16, P1305, DOI 10.1038/nm.2253; Nakayama T, 2010, J IMMUNOL, V185, P6472, DOI 10.4049/jimmunol.0904126; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; Nino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032078; Patel PA, 2009, J MOL CELL CARDIOL, V46, P300, DOI 10.1016/j.yjmcc.2008.11.015; Polikepahad S, 2010, J VIS EXP, V38; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Riesenfeld EP, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-22; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rong YJ, 1999, BIOCHEMISTRY-US, V38, P11278, DOI 10.1021/bi9910676; Ryan JJ, 1996, IMMUNITY, V4, P123, DOI 10.1016/S1074-7613(00)80677-9; Shaw JL, 2013, AM J RESP CRIT CARE, V188, P432, DOI 10.1164/rccm.201212-2227OC; Shenoy SK, 2006, J BIOL CHEM, P281; Short PM, 2013, AM J RESP CRIT CARE, V187, P1308, DOI 10.1164/rccm.201212-2206OC; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; Walker JKL, 2011, BRIT J PHARMACOL, V163, P18, DOI 10.1111/j.1476-5381.2010.01178.x; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Walters EH, 2007, COCHRANE DB SYST REV, V1, P1; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	62	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142212	10.1371/journal.pone.0142212	http://dx.doi.org/10.1371/journal.pone.0142212			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605551	gold, Green Submitted, Green Published			2022-12-26	WOS:000365865300012
J	Tsai, EM; Wang, YC; Lee, TTY; Tsai, CF; Chen, HS; Lai, FJ; Yokoyama, KK; Hsieh, TH; Wu, RM; Lee, JN				Tsai, Eing-Mei; Wang, Yu-Chih; Lee, Tony Tung-Yin; Tsai, Cheng-Fang; Chen, Hung-Sheng; Lai, Feng-Jie; Yokoyama, Kazunari K.; Hsieh, Tsung-Hsun; Wu, Ruey-Meei; Lee, Jau-nan			Dynamic Trk and G Protein Signalings Regulate Dopaminergic Neurodifferentiation in Human Trophoblast Stem Cells	PLOS ONE			English	Article							RETINOIC ACID; SWITCH CONTROLS; NUCLEAR-FACTOR; HUMAN ES; NEURONS; DIFFERENTIATION; TRANSCRIPTION; RECEPTOR; GROWTH; PROLIFERATION	Understanding the mechanisms in the generation of neural stem cells from pluripotent stem cells is a fundamental step towards successful management of neurodegenerative diseases in translational medicine. Albeit all-trans retinoic acid (RA) has been associated with axon outgrowth and nerve regeneration, the maintenance of differentiated neurons, the association with degenerative disease like Parkinson's disease, and its regulatory molecular mechanism from pluripotent stem cells to neural stem cells remain fragmented. We have previously reported that RA is capable of differentiation of human trophoblast stem cells to dopamine (DA) committed progenitor cells. Intracranial implantation of such neural progenitor cells into the 6-OHDA-lesioned substantia nigra pars compacta successfully regenerates dopaminergic neurons and integrity of the nigrostriatal pathway, ameliorating the behavioral deficits in the Parkinson's disease rat model. Here, we demonstrated a dynamic molecular network in systematic analysis by addressing spatiotemporal molecular expression, intracellular protein-protein interaction and inhibition, imaging study, and genetic expression to explore the regulatory mechanisms of RA induction in the differentiation of human trophoblast stem cells to DA committed progenitor cells. We focused on the tyrosine receptor kinase (Trk), G proteins, canonical Wnt2B/beta-catenin, genomic and non-genomic RA signaling transductions with Tyrosine hydroxylase (TH) gene expression as the differentiation endpoint. We found that at the early stage, integration of TrkA and G protein signalings aims for axonogenesis and morphogenesis, involving the novel RXR alpha/G alpha(Q)/11 and RAR beta/G beta signaling pathways. While at the later stage, five distinct signaling pathways together with epigenetic histone modifications emerged to regulate expression of TH, a precursor of dopamine. RA induction generated DA committed progenitor cells in one day. Our results provided substantial mechanistic evidence that human trophoblast stem cell-derived neural stem cells can potentially be used for neurobiological study, drug discovery, and as an alternative source of cell-based therapy in neurodegenerative diseases like Parkinson's disease.	[Tsai, Eing-Mei; Wang, Yu-Chih; Chen, Hung-Sheng; Lee, Jau-nan] Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung 807, Taiwan; [Tsai, Eing-Mei; Wang, Yu-Chih; Chen, Hung-Sheng; Lee, Jau-nan] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan; [Lee, Tony Tung-Yin] Accelerated Biosci Corp, Manhattan Beach, CA 90266 USA; [Tsai, Cheng-Fang; Chen, Hung-Sheng; Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung 807, Taiwan; [Lai, Feng-Jie] Chi Mei Med Ctr, Dept Dermatol, Tainan 710, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Dept Phys Therapy, Taoyuan 33302, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan 33302, Taiwan; [Wu, Ruey-Meei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10048, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Chi Mei Hospital; Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Lee, JN (corresponding author), Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung 807, Taiwan.	jaunanlee@outlook.com	Hsieh, Tung-Hsun/AAZ-5010-2020; Wang, Yu-Chih/S-4805-2019	Hsieh, Tung-Hsun/0000-0002-1794-7941; Wu, Ruey-Meei/0000-0002-4947-5467	Taiwan Ministry of Science and Technology [101-2811-B-037-024]; Kaohsiung Medical University [101-1R27]; Accelerated Biosciences Corp. [AB-0001]	Taiwan Ministry of Science and Technology; Kaohsiung Medical University; Accelerated Biosciences Corp.	The work was supported by Taiwan Ministry of Science and Technology (www.most.gov.tw), 101-2811-B-037-024, EMT, and Kaohsiung Medical University (www.kmu.edu.tw), 101-1R27, EMT. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by Accelerated Biosciences Corp. (www.acceleratedbio.com), AB-0001, JNL. Accelerated Biosciences Corp. provided support in the form of a salary for author TTYL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Arenas E, 2014, J MOL CELL BIOL, V6, P42, DOI 10.1093/jmcb/mju001; Aronov S, 2002, J CELL SCI, V115, P3817, DOI 10.1242/jcs.00058; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Blochl A, 1996, J BIOL CHEM, V271, P21100; Carter CJ, 2010, DEV BIOL, V343, P124, DOI 10.1016/j.ydbio.2010.03.023; Cooper O, 2010, MOL CELL NEUROSCI, V45, P258, DOI 10.1016/j.mcn.2010.06.017; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Daadi MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041120; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Hirsch C, 2007, EXP CELL RES, V313, P572, DOI 10.1016/j.yexcr.2006.11.002; Hong S, 2014, STEM CELLS DEV, V23, P477, DOI 10.1089/scd.2013.0406; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang T, 2011, J BIOL CHEM, V286, P37399, DOI 10.1074/jbc.M111.251165; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; KOBAYASHI M, 1994, FEBS LETT, V356, P60, DOI 10.1016/0014-5793(94)01238-5; Lee HS, 2010, STEM CELLS, V28, P501, DOI 10.1002/stem.294; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Lee TTY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052491; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lewallen KA, 2011, J NEUROSCI, V31, P3032, DOI 10.1523/JNEUROSCI.4345-10.2011; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Martin DM, 2004, DEV BIOL, V267, P93, DOI 10.1016/j.ydbio.2003.10.035; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; Messmer K, 2007, INT J DEV NEUROSCI, V25, P29, DOI 10.1016/j.ijdevneu.2006.11.003; Moraes LA, 2007, BLOOD, V109, P3741, DOI 10.1182/blood-2006-05-022566; Murai K, 2010, STEM CELLS, V28, P1581, DOI 10.1002/stem.474; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Piskunov A, 2012, ONCOGENE, V31, P3333, DOI 10.1038/onc.2011.499; Polleux F, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001925; Ratnaparkhi A, 2002, J NEUROSCI, V22, P4499, DOI 10.1523/JNEUROSCI.22-11-04499.2002; Ren Y, 2003, J NEUROSCI, V23, P3316; Reyes S, 2012, J COMP NEUROL, V520, P2591, DOI 10.1002/cne.23051; Romano G, 2007, J CELL PHYSIOL, V211, P431, DOI 10.1002/jcp.20949; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sandstrom RS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05371; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Shigeoka T, 2013, J CELL BIOL, V202, P991, DOI 10.1083/jcb.201305139; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sousa KM, 2010, J BIOL CHEM, V285, P7246, DOI 10.1074/jbc.M109.079822; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sullivan AM, 2011, CYTOKINE GROWTH F R, V22, P157, DOI 10.1016/j.cytogfr.2011.05.001; Sutherland DJ, 2014, TRENDS NEUROSCI, V37, P424, DOI 10.1016/j.tins.2014.05.008; Vancura KL, 1998, SEMIN NEUROSCI, V9, P209, DOI 10.1006/smns.1997.0118; Vasudevan A, 2012, DEVELOPMENT, V139, P3136, DOI 10.1242/dev.078394; Waite MR, 2013, MOL CELL NEUROSCI, V52, P128, DOI 10.1016/j.mcn.2012.11.007; Wakatsuki S, 2011, NAT CELL BIOL, V13, P1415, DOI 10.1038/ncb2373; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Zhang YG, 2012, STEM CELLS, V30, P510, DOI 10.1002/stem.1006; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	70	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143852	10.1371/journal.pone.0143852	http://dx.doi.org/10.1371/journal.pone.0143852			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606046	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300115
J	Zhang, LQ; Mabwi, HA; Palange, NJ; Jia, RR; Ma, J; Bah, FB; Sah, RK; Li, D; Wang, DJ; Bah, FBM; Togo, J; Jin, HH; Ban, LY; Feng, XC; Zheng, YW				Zhang, Luqing; Mabwi, Humphrey A.; Palange, Norberto J.; Jia, Ruirui; Ma, Jun; Bah, Fatoumata Binta; Sah, Rajiv Kumar; Li, Dan; Wang, Daji; Bah, Fatoumata Binta Maci; Togo, Jacques; Jin, Honghong; Ban, Luying; Feng, Xuechao; Zheng, Yaowu			Expression Patterns and Potential Biological Roles of Dip2a	PLOS ONE			English	Article							FOLLISTATIN-LIKE 1; DROSOPHILA; FSTL1; MICE; RECEPTOR; HOMOLOG; PROTEIN; GENE	Disconnected (disco)-interacting protein 2 homolog A is a member of the DIP2 protein family encoded by Dip2a gene. Dip2a expression pattern has never been systematically studied. Functions of Dip2a in embryonic development and adult are not known. To investigate Dip2a gene expression and function in embryo and adult, a Dip2a-LacZ mouse model was generated by insertion of beta-Gal cDNA after Dip2a promoter using CRISPR/Cas9 technology. Dip2a-LacZ mouse was designed to be a lacZ reporter mouse as well as a Dip2a knockout mouse. Heterozygous mice were used to study endogenous Dip2a expression and homozygotes to study DIP2A-associated structure and function. LacZ staining indicated that Dip2a is broadly expressed in neuronal, reproductive and vascular tissues, as well as in heart, kidney, liver and lung. Results demonstrate that Dip2a is expressed in ectoderm- derived tissues in developing embryos. Adult tissues showed rich staining in neurons, mesenchymal, endothelial, smooth muscle cells and cardiomyocytes by cell types. The expression pattern highly overlaps with FSTL1 and supports previous report that DIP2A to be potential receptor of FSTL1 and its protective roles of cardiomyocytes. Broad and intense embryonic and adult expression of Dip2a has implied their multiple structural and physiological roles.	[Zhang, Luqing; Mabwi, Humphrey A.; Palange, Norberto J.; Jia, Ruirui; Ma, Jun; Bah, Fatoumata Binta; Sah, Rajiv Kumar; Li, Dan; Wang, Daji; Bah, Fatoumata Binta Maci; Togo, Jacques; Jin, Honghong; Ban, Luying; Zheng, Yaowu] NE Normal Univ, Sch Life Sci, Transgen Res Ctr, Changchun, Peoples R China; [Zhang, Luqing; Feng, Xuechao; Zheng, Yaowu] NE Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Feng, XC (corresponding author), NE Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China.	fengxc997@nenu.edu.cn; zhengyw442@nenu.edu.cn	Zhang, Luqing/A-1200-2019	Zhang, Luqing/0000-0001-7252-643X; feng, xuechao/0000-0003-2444-3757; Mabwi, Humphrey/0000-0002-5224-4870	National Natural Science Foundation of China [31301189, 81270953]; Research Funds for Central Universities [12QNJJ015, 10JCXK001]; Research Fund for Doctoral Program of Higher Education of China [20130043120010]; Science-Technology Foundation for Young Scientist of Jilin Province [20130522003JH]; Program of International ST cooperation [2015 DFA31580]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Funds for Central Universities; Research Fund for Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Science-Technology Foundation for Young Scientist of Jilin Province; Program of International ST cooperation	This work is supported in whole or in part by National Natural Science Foundation of China (31301189 and 81270953), Research Funds for Central Universities (12QNJJ015 and 10JCXK001), Research Fund for Doctoral Program of Higher Education of China (20130043120010), Science-Technology Foundation for Young Scientist of Jilin Province (20130522003JH) and Program of International S&T cooperation (2015 DFA31580). The funders had no role in study design, data collection and analysis or decision to publish.	Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Chen SY, 2009, CURR OPIN NEUROBIOL, V19, P471, DOI 10.1016/j.conb.2009.09.005; Cooper Margaret A, 2013, Methods Mol Biol, V1018, P189, DOI 10.1007/978-1-62703-444-9_18; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; Liu ZH, 2014, J NEUROSCI, V34, P2785, DOI 10.1523/JNEUROSCI.3547-13.2014; Malumbres M, 1997, BIOTECHNIQUES, V22, P1114, DOI 10.2144/97226st03; Milardi D, 2012, J ANDROL, V33, P1291, DOI 10.2164/jandrol.112.016600; Mukhopadhyay M, 2002, GENE, V293, P59, DOI 10.1016/S0378-1119(02)00694-7; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ouchi N, 2010, J BIOL CHEM, V285, P7127, DOI 10.1074/jbc.M109.069468; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; Suzuki D, 2014, GENE EXPR PATTERNS, V15, P21, DOI 10.1016/j.gep.2014.03.002; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Wei K, 2015, NATURE, V525, P479, DOI 10.1038/nature15372; Winnepenninckx B, 2007, AM J HUM GENET, V80, P221, DOI 10.1086/510800; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396	18	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143284	10.1371/journal.pone.0143284	http://dx.doi.org/10.1371/journal.pone.0143284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605542	gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300052
J	de Andrade, JNBM; Tang, JN; Hensley, MT; Vandergriff, A; Cores, J; Henry, E; Allen, TA; Caranasos, TG; Wang, ZG; Zhang, TX; Zhang, JY; Cheng, K				de Andrade, James N. B. M.; Tang, Junnan; Hensley, Michael Taylor; Vandergriff, Adam; Cores, Jhon; Henry, Eric; Allen, Tyler A.; Caranasos, Thomas George; Wang, Zegen; Zhang, Tianxia; Zhang, Jinying; Cheng, Ke			Rapid and Efficient Production of Coronary Artery Ligation and Myocardial Infarction in Mice Using Surgical Clips	PLOS ONE			English	Article							ATHEROSCLEROSIS; INDUCTION; MODEL	Aims The coronary artery ligation model in rodents mimics human myocardial infarction (MI). Normally mechanical ventilation and prolonged anesthesia period are needed. Recently, a method has been developed to create MI by popping-out the heart (without ventilation) followed by immediate suture ligation. Mortality is high due to the time-consuming suture ligation process while the heart is exposed. We sought to improve this method and reduce mortality by rapid coronary ligation using a surgical clip instead of a suture. Methods and Results Mice were randomized into 3 groups: clip MI (CMI), suture MI (SMI), or sham (SHAM). In all groups, heart was manually exposed without intubation through a small incision on the chest wall. Unlike the conventional SMI method, mice in the CMI group received a metal clip on left anterior descending artery (LAD), quickly dispensed by an AutoSuture Surgiclip T. The CMI method took only 1/3 of ligation time of the standard SMI method and improved post-MI survival rate. TTC staining and Masson's trichrome staining revealed a similar degree of infarct size in the SMI and CMI groups. Echocardiograph confirmed that both SMI and CMI groups had a similar reduction of ejection fraction and fraction shortening over the time. Histological analysis showed that the numbers of CD68(+) macrophages and apoptotic cells (TUNEL-positive) are indistinguishable between the two groups. Conclusion This new method, taking only less than 3 minutes to complete, represents an efficient myocardial infarction model in rodents.	[de Andrade, James N. B. M.; Tang, Junnan; Hensley, Michael Taylor; Vandergriff, Adam; Cores, Jhon; Henry, Eric; Allen, Tyler A.; Zhang, Tianxia; Cheng, Ke] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA; [de Andrade, James N. B. M.; Tang, Junnan; Hensley, Michael Taylor; Vandergriff, Adam; Cores, Jhon; Henry, Eric; Allen, Tyler A.; Zhang, Tianxia; Cheng, Ke] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC USA; [Vandergriff, Adam; Cores, Jhon; Henry, Eric; Cheng, Ke] Univ North Carolina Chapel Hill & North Carolina, Joint Dept Biomed Engn, Raleigh, NC USA; [Tang, Junnan; Zhang, Jinying] Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China; [Caranasos, Thomas George] Univ N Carolina, Div Cardiothorac Surg, Chapel Hill, NC USA; [Wang, Zegen; Cheng, Ke] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou, Peoples R China	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Zhengzhou University; University of North Carolina; University of North Carolina Chapel Hill; Soochow University - China	Zhang, JY (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China.	jyzhang@zzu.edu.cn; ke_cheng@ncsu.edu	Caranasos, Thomas/AAK-4580-2021; Cheng, Ke/HCH-8846-2022	Caranasos, Thomas/0000-0002-4347-0219; Vandergriff, Adam/0000-0001-7614-4834; Allen, Tyler/0000-0002-8729-6339	American Heart Association [12BGIA12040477]; National Institute of Health; NC State University Chancellor's Faculty Excellence Program; National Natural Science Foundation of China [H020381370216, 81570274]; Science and Technology Innovation Team Support Project of Henan Province [14IRTSTHN018]; Innovation Team of Science and Technology Project of Henan Province; China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123920] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NC State University Chancellor's Faculty Excellence Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Team Support Project of Henan Province; Innovation Team of Science and Technology Project of Henan Province; China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from American Heart Association 12BGIA12040477, National Institute of Health, NC State University Chancellor's Faculty Excellence Program, and National Natural Science Foundation of China H020381370216, Science and Technology Innovation Team Support Project of Henan Province 14IRTSTHN018, Innovation Team of Science and Technology Project of Henan Province and National Natural Science Foundation of China 81570274. Junnan Tang is supported by China Scholarship Council.	Ahmad F, 2014, J AM COLL CARDIOL, V64, P696, DOI 10.1016/j.jacc.2014.04.068; Ahn D, 2004, AM J PHYSIOL-HEART C, V286, pH1201, DOI 10.1152/ajpheart.00862.2003; Borst O, 2011, CELL PHYSIOL BIOCHEM, V28, P1, DOI 10.1159/000331708; Cheng K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001260; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Curaj A, 2015, JOVE-J VIS EXP, DOI 10.3791/52197; Degabriele NM, 2004, EXP PHYSIOL, V89, P497, DOI 10.1113/expphysiol.2004.027276; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Li JF, 2015, CIRC RES, V116, P70, DOI 10.1161/CIRCRESAHA.116.304472; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Muthuramu I, 2014, JOVE-J VIS EXP, DOI 10.3791/52206; Patten RD, 1998, AM J PHYSIOL, V274, P1812; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Vandergriff AC, 2014, BIOMATERIALS, V35, P8528, DOI 10.1016/j.biomaterials.2014.06.031; Virag JAI, 2011, JOVE-J VIS EXP, DOI 10.3791/2581; Wu YW, 2011, JOVE-J VIS EXP, DOI 10.3791/2464; Xu ZB, 2014, JOVE-J VIS EXP, DOI 10.3791/51329	19	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143221	10.1371/journal.pone.0143221	http://dx.doi.org/10.1371/journal.pone.0143221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599500	gold, Green Published, Green Submitted			2022-12-26	WOS:000365862600039
J	Kjellberg, MA; Lonnfors, M; Slotte, JP; Mattjus, P				Kjellberg, Matti A.; Lonnfors, Max; Slotte, J. Peter; Mattjus, Peter			Metabolic Conversion of Ceramides in HeLa Cells - A Cholesteryl Phosphocholine Delivery Approach	PLOS ONE			English	Article							AKT KINASE; SPHINGOMYELIN; APOPTOSIS; MEMBRANE; CHANNELS; ACID; SYNTHASE; DIHYDROCERAMIDE; SPHINGOSINE; DEGRADATION	Ceramides can be delivered to cultured cells without solvents in the form of complexes with cholesteryl phosphocholine. We have analysed the delivery of three different radiolabeled D-erythro-ceramides (C6-Cer, C10-Cer and C16-Cer) to HeLa cells, and followed their metabolism as well as the cell viability. We found that all three ceramides were successfully taken up by HeLa cells when complexed to CholPC in an equimolar ratio, and show that the ceramides show different rates of cellular uptake and metabolic fate. The C6-Cer had the highest incorporation rate, followed by C10-Cer and C16-Cer, respectively. The subsequent effect on cell viability strongly correlated with the rate of incorporation, where C6-Cer had the strongest apoptotic effects. Low-dose (1 mu M) treatment with C6-Cer favoured conversion of the precursor to sphingomyelin, whereas higher concentrations (25-100 mu M) yielded increased conversion to C6-glucosylceramide. Similar results were obtained for C10-Cer. In the lower-dose C16-Cer experiments, most of the precursor was degraded, whereas at high-dose concentrations the precursor remained un-metabolized. Using this method, we demonstrate that ceramides with different chain lengths clearly exhibit varying rates of cellular uptake. The cellular fate of the externally delivered ceramides are clearly connected to their rate of incorporation and their subsequent effects on cell viability may be in part determined by their chain length.	[Kjellberg, Matti A.; Lonnfors, Max; Slotte, J. Peter; Mattjus, Peter] Abo Akad Univ, Fac Sci & Engn, Biochem, Turku, Finland	Abo Akademi University	Mattjus, P (corresponding author), Abo Akad Univ, Fac Sci & Engn, Biochem, Turku, Finland.	pmattjus@abo.fi	Mattjus, Peter/ABE-3596-2021; Mattjus, Peter/AAQ-7531-2021	Mattjus, Peter/0000-0001-8991-5933; 	Academy of Finland; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation	This work was funded by Academy of Finland, the Sigrid Juselius Foundation and Magnus Ehrnrooth Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2002, TRENDS IMMUNOL, V23, P1, DOI 10.1016/S1471-4906(01)02091-9; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Bleicher RJ, 2002, BBA-MOL CELL BIOL L, V1585, P172, DOI 10.1016/S1388-1981(02)00338-4; Chapman JV, 2010, BIOCHEM PHARMACOL, V80, P308, DOI 10.1016/j.bcp.2010.04.001; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Ledesma MD, 2011, J NEUROCHEM, V116, P779, DOI 10.1111/j.1471-4159.2010.07034.x; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Ferreira NS, 2014, JIMD REP, V12, P71, DOI 10.1007/8904_2013_246; Gotoh M, 2006, CHEM BIODIVERS, V3, P198, DOI 10.1002/cbdv.200690023; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; Grilley MM, 1998, J BIOL CHEM, V273, P11062, DOI 10.1074/jbc.273.18.11062; Grullich C, 2000, J BIOL CHEM, V275, P8650, DOI 10.1074/jbc.275.12.8650; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hetz CA, 2002, J CELL SCI, V115, P4671, DOI 10.1242/jcs.00153; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Koivusalo M, 2004, BIOPHYS J, V86, P923, DOI 10.1016/S0006-3495(04)74168-5; Koivusalo M, 2007, MOL BIOL CELL, V18, P5113, DOI 10.1091/mbc.E07-04-0330; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Kolesnick RN, 2002, TRENDS BIOCHEM SCI, V24, P224; Leppimaki P, 1998, BIOCHEM J, V335, P285, DOI 10.1042/bj3350285; Lin CF, 2006, CURR MED CHEM, V13, P1609, DOI 10.2174/092986706777441986; Lonnfors M, 2013, LANGMUIR, V29, P2319, DOI 10.1021/la3051324; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao ZH, 2010, J BIOL CHEM, V285, P29078, DOI 10.1074/jbc.M110.105296; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Michel C, 1997, FEBS LETT, V416, P153, DOI 10.1016/S0014-5793(97)01187-3; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2008, J LIPID RES, V49, P2356, DOI 10.1194/jlr.M800158-JLR200; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Nybond S, 2005, BBA-BIOMEMBRANES, V1718, P61, DOI 10.1016/j.bbamem.2005.10.009; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Ohvo H, 1997, BBA-LIPID LIPID MET, V1349, P131, DOI 10.1016/S0005-2760(97)00126-4; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Omae F, 2004, BIOCHEM J, V379, P687, DOI 10.1042/BJ20031425; Perera MN, 2012, BBA-BIOMEMBRANES, V1818, P1291, DOI 10.1016/j.bbamem.2012.02.010; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; PORN MI, 1995, BIOCHEM J, V308, P269; PORN MI, 1990, BIOCHEM J, V271, P121, DOI 10.1042/bj2710121; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Shabbits JA, 2003, BBA-BIOMEMBRANES, V1612, P98, DOI 10.1016/S0005-2736(03)00108-1; SINGH I, 1983, J LIPID RES, V24, P662; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Smyth M J, 1997, Adv Pharmacol, V41, P133, DOI 10.1016/S1054-3589(08)61057-1; Smyth MJ, 1996, BIOCHEM J, V316, P25, DOI 10.1042/bj3160025; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Sukumaran P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061290; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Sun W, 2010, J BIOL CHEM, V285, P8995, DOI 10.1074/jbc.M109.069203; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Zhang Y, 2011, J LIPID RES, V52, P771, DOI 10.1194/jlr.M012880; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	66	10	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143385	10.1371/journal.pone.0143385	http://dx.doi.org/10.1371/journal.pone.0143385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599810	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600059
J	Arvidsson, S; Pilebro, B; Westermark, P; Lindqvist, P; Suhr, OB				Arvidsson, Sandra; Pilebro, Bjorn; Westermark, Per; Lindqvist, Per; Suhr, Ole B.			Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; MYOCARDIAL INVOLVEMENT; STANDARDS COMMITTEE; RECOMMENDATIONS; POLYNEUROPATHY; DIAGNOSIS; AGE; ECHOCARDIOGRAPHY; QUANTIFICATION; HYPERTROPHY	Purpose Transthyretin V30M (ATTR V30M) amyloidosis is a phenotypically diverse disease with symptoms ranging from predominant neuropathy to exclusive cardiac manifestations. The aims of this study were to determine the dispersion of the two types of fibrils found in Swedish ATTR V30M patients - Type A consisting of a mixture of truncated and full length ATTR fibrils and type B fibrils consisting of full length fibrils, and to estimate the severity of cardiac dysfunction in relation to fibril composition and sex. Material and Methods Echocardiographic data were analysed in 107 Swedish ATTR V30M patients with their fibril composition determined as either type A or type B. Measurements of left ventricular (LV) dimensions and evaluation of systolic and diastolic function including speckle tracking derived strain were performed. Patients were grouped according to fibril type and sex. Multivariate linear regression was utilised to determine factors of significant impact on LV thickness. Results There was no significant difference in proportions of the two types of fibrils between men and women. In patients with type A fibrils, women had significantly lower median septal (p = 0.007) and posterior wall thicknesses (p = 0.010), lower median LV mass indexed to height (p = 0.008), and higher septal strain (p = 0.037), as compared to males. These differences were not apparent in patients with type B fibrils. Multiple linear regression analysis revealed that fibril type, sex and age all had significant impact on LV septal thickness. Conclusion This study demonstrates a clear difference between sexes in the severity of amyloid heart disease in ATTR V30M amyloidosis patients. Even though type A fibrils were associated with more advanced amyloid heart disease compared to type B, women with type A fibrils generally developed less cardiac infiltration than men. The differences may explain the better outcome for liver transplanted late-onset female patients compared to males.	[Arvidsson, Sandra; Lindqvist, Per] Umea Univ, Dept Clin Physiol, Ctr Heart, Umea, Sweden; [Pilebro, Bjorn] Umea Univ, Dept Cardiol, Ctr Heart, Umea, Sweden; [Arvidsson, Sandra; Pilebro, Bjorn; Suhr, Ole B.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Westermark, Per] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Lindqvist, Per] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University; Umea University; Uppsala University; Umea University	Arvidsson, S (corresponding author), Umea Univ, Dept Clin Physiol, Ctr Heart, Umea, Sweden.	sandra.gustavsson@umu.se	LIndqvist, Per/AAK-1377-2021; Pilebro, Björn/AFS-1030-2022; Pilebro, Björn/AHE-8710-2022	Suhr, Ole/0000-0002-1175-2369	Swedish Heart-Lung Foundation; Umea University [VLL 365301]; Vasterbotten County Council/ALF [VLL 365301]; Heart Foundation of Northern Sweden; spearhead grant from Umea County	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Umea University; Vasterbotten County Council/ALF; Heart Foundation of Northern Sweden; spearhead grant from Umea County	This study was supported by grants from the Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se/) [PL, OBS], from a regional agreement between Umea University and Vasterbotten County Council/ALF [VLL 365301 for funding of SA], the Heart Foundation of Northern Sweden (http://www.hjartfonden.com/) [SA], and a spearhead grant from Umea County [OBS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 1976, Acta Med Scand Suppl, V590, P1; Ando Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-31; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Connors LH, 2009, AM HEART J, V158, P607, DOI 10.1016/j.ahj.2009.08.006; Deschepper CF, 2007, HYPERTENSION, V49, P401, DOI 10.1161/01.HYP.0000256279.49882.d8; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Foppa Murilo, 2005, Cardiovasc Ultrasound, V3, P17, DOI 10.1186/1476-7120-3-17; Gustafsson S, 2012, TRANSPLANTATION, V93, P1017, DOI 10.1097/TP.0b013e31824b3749; HOLMGREN G, 1994, J MED GENET, V31, P351, DOI 10.1136/jmg.31.5.351; Hornsten R, 2010, AMYLOID, V17, P63, DOI 10.3109/13506129.2010.483114; Ihse E, 2008, J PATHOL, V216, P253, DOI 10.1002/path.2411; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Ihse E, 2011, J MOL MED, V89, P171, DOI 10.1007/s00109-010-0695-1; Ikeda S, 2002, NEUROLOGY, V58, P1001, DOI 10.1212/WNL.58.7.1001; Koike H, 2012, AMYLOID, V19, P55, DOI 10.3109/13506129.2012.674580; Koike H, 2009, J NEUROL SCI, V287, P178, DOI 10.1016/j.jns.2009.07.028; Kyle RA, 1996, AM J MED, V101, P395, DOI 10.1016/S0002-9343(96)00229-X; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Ng B, 2005, ARCH INTERN MED, V165, P1425, DOI 10.1001/archinte.165.12.1425; Okamoto S, 2011, AMYLOID, V18, P200, DOI 10.3109/13506129.2011.615872; Okamoto S, 2009, LIVER TRANSPLANT, V15, P1229, DOI 10.1002/lt.21817; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rapezzi C, 2005, ARCH INTERN MED, V165, P2429, DOI 10.1001/archinte.165.20.2429; Rapezzi C, 2008, AMYLOID, V15, P40, DOI 10.1080/13506120701815373; Rapezzi C, 2013, EUR HEART J, V34, P520, DOI 10.1093/eurheartj/ehs123; Rapezzi C, 2011, JACC-CARDIOVASC IMAG, V4, P659, DOI 10.1016/j.jcmg.2011.03.016; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Suhr OB, 2006, AMYLOID, V13, P154, DOI 10.1080/13506120600876849; Svedenhag J, 2014, CLIN PHYSL FUNCT IMA; Tasaki M, 2013, INT J CARDIOL, V170, P69, DOI 10.1016/j.ijcard.2013.10.033; Taylor AL, 2015, CURR HEART FAIL REP; Westermark P, 2006, ACTA HISTOCHEM, V108, P209, DOI 10.1016/j.acthis.2006.03.011	34	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143456	10.1371/journal.pone.0143456	http://dx.doi.org/10.1371/journal.pone.0143456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600306	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900127
J	Hotegni, VNF; Lommen, WJM; Agbossou, EK; Struik, PC				Hotegni, V. Nicodeme Fassinou; Lommen, Willemien J. M.; Agbossou, Euloge K.; Struik, Paul C.			Trade-Offs of Flowering and Maturity Synchronisation for Pineapple Quality	PLOS ONE			English	Article							FRUIT-QUALITY; HETEROGENEITY; TEMPERATURE; GROWTH; YIELD	In the pineapple sector of Benin, poor fruit quality prevents pineapple producers to enter the European market. We investigated effects of common cultural practices, flowering and maturity synchronisation, (1) to quantify the trade-offs of flowering and maturity synchronisation for pineapple quality and the proportion of fruits exportable to European markets, and (2) to determine the effect of harvesting practice on quality attributes. Four on-farm experiments were conducted during three years using cultivars Sugarloaf and Smooth Cayenne. A split-split plot design was used in each experiment, with flowering induction practice as main factor (artificial or natural flowering induction), maturity induction practice as split factor (artificial or natural maturity induction) and harvesting practice as the split-split factor (farmers' harvest practice or individual fruit harvesting at optimum maturity). Artificial flowering induction gave fruits with lower infructescence weight, higher ratio crown: infructescence length, and a lower proportion of fruits exportable to European markets than natural flowering induction. The costs of the improvements by natural flowering induction were huge: the longer durations from planting to flowering induction and harvesting, the higher number of harvestings of the fruits increasing the labour cost and the lower proportion of plants producing fruits compared with crops from artificially flowering-induced plants. Artificial maturity induction decreased the total soluble solids concentration in the fruits compared with natural maturity induction thus decreasing the proportion of fruits exportable to European markets, at a benefit of only a slightly shorter time from flowering induction to harvesting. Harvesting individual fruits at optimum maturity gave fruits with higher total soluble solids in naturally maturity induced fruits compared with the farmers' harvest practice. Given the huge costs of natural flowering induction, options to use artificial flowering induction effectively for obtaining high fruit quality are discussed.	[Hotegni, V. Nicodeme Fassinou; Lommen, Willemien J. M.; Struik, Paul C.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands; [Hotegni, V. Nicodeme Fassinou; Agbossou, Euloge K.] Univ Abomey Calavi, Fac Sci Agron, Cotonou, Benin	Wageningen University & Research; University of Abomey Calavi	Lommen, WJM (corresponding author), Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands.	Willemien.Lommen@wur.nl		FASSINOU HOTEGNI, V. Nicodeme/0000-0001-5826-3688; Lommen, Willemien J.M./0000-0003-3254-6879	North-South Interdisciplinary Research and Education Fund (INREF) of Wageningen University and Research Centre; Netherlands Organisation for International Cooperation in Higher Education (NUFFIC) [NFP-PhD/CF7551/2011]	North-South Interdisciplinary Research and Education Fund (INREF) of Wageningen University and Research Centre; Netherlands Organisation for International Cooperation in Higher Education (NUFFIC)	The authors are thankful to the North-South Interdisciplinary Research and Education Fund (INREF) of Wageningen University and Research Centre and the Netherlands Organisation for International Cooperation in Higher Education (NUFFIC) for their financial support through the Co-Innovation for Quality in African Foods Chains (CoQA) Programme and the Netherlands Fellowship Programme (NFP-PhD/CF7551/2011), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hatab A, 2013, INT FOOD AGRIBUS MAN, V16, P77; Achigan-Dako EG, 2014, BIOTECHNOL AGRON SOC, V18, P49; Adams SR, 2001, ANN BOT-LONDON, V88, P869, DOI 10.1006/anbo.2001.1524; Adikaram N., 2012, Crop post-harvest: science and technology. Volume 3: perishables, P143; Aggelopoulou KD, 2010, PRECIS AGRIC, V11, P538, DOI 10.1007/s11119-009-9146-9; [Anonymous], 1936, J R STAT SOC B, DOI DOI 10.2307/2983678; [Anonymous], 2013, GENSTAT WINDOWS; Bartholomew D.P., 1994, HDB ENV PHYSL FRUIT, P243; Bartholomew Duane P., 2003, P167, DOI 10.1079/9780851995038.0167; Chen CC, 2000, J AM SOC HORTIC SCI, V125, P558, DOI 10.21273/JASHS.125.5.558; Chuenboonngarm N., 2007, Kasetsart Journal, Natural Sciences, V41, P205; Codex Alimentarius, 2005, 1821993 COD AL; CROCHON M, 1981, FRUITS, V36, P409; Devadas VS, 2005, ACTA HORTIC, P185, DOI 10.17660/ActaHortic.2005.666.17; FAO, 2012, STAT DAT; FERNANDEZ GCJ, 1992, HORTSCIENCE, V27, P297, DOI 10.21273/HORTSCI.27.4.297; FRIEND DJC, 1979, BOT GAZ, V140, P280, DOI 10.1086/337086; Gbaguidi A. A., 2015, International Journal of Biological and Chemical Sciences, V9, P1050, DOI 10.4314/ijbcs.v9i2.40; Gonzalez R, 2008, DATA ANAL EXPT DESIG; Hepton Anthony, 2003, P109, DOI 10.1079/9780851995038.0109; Hotegni VNF, 2012, ACTA HORTIC, V928, P47; Hotegni VNF, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00798; Hotegni VNF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00670; Hotegni VNF, 2014, INT FOOD AGRIBUS MAN, V17, P139; Kerns K. R., 1936, NEW PHYTOL, V35, P305, DOI [10.1111/j.1469-8137.1936.tb06884.x, DOI 10.1111/J.1469-8137.1936.TB06884.X]; Malezieux Eric, 2003, P143, DOI 10.1079/9780851995038.0143; MOSS GI, 1976, AUST J AGR RES, V27, P399, DOI 10.1071/AR9760399; Muasyal RM, 2006, NJAS-WAGEN J LIFE SC, V54, P5, DOI 10.1016/S1573-5214(06)80001-1; Neven D, 2009, WORLD DEV, V37, P1802, DOI 10.1016/j.worlddev.2008.08.026; Norman J., 1978, ACTA HORTIC, V84, P191; ONAHA A, 1983, J JPN SOC HORTIC SCI, V52, P280, DOI 10.2503/jjshs.52.280; Paull RE, 1996, SCI HORTIC-AMSTERDAM, V66, P59, DOI 10.1016/0304-4238(96)00905-3; Cunha Getúlio Augusto Pinto da, 2005, Bragantia, V64, P499, DOI 10.1590/S0006-87052005000400001; Py C, 1987, PINEAPPLE CULTIVATIO; Reardon T., 1999, INT FOOD AGRIBUS MAN, V2, P421, DOI DOI 10.1016/S1096-7508(01)00035-0; REID MS, 1991, PLANT HORMONE ETHYLE, P215; Royer A., 2012, African Journal of Agricultural Research, V7, P5344; Saltveit ME, 1999, POSTHARVEST BIOL TEC, V15, P279, DOI 10.1016/S0925-5214(98)00091-X; SHEWFELT RL, 1990, J FOOD QUALITY, V13, P37, DOI 10.1111/j.1745-4557.1990.tb00004.x; SIDERIS C. P., 1938, GROWTH, V2, P181; SINGLETO.VL, 1965, J FOOD SCI, V30, P19, DOI 10.1111/j.1365-2621.1965.tb00255.x; Trienekens J, 2008, INT J PROD ECON, V113, P107, DOI 10.1016/j.ijpe.2007.02.050; Vorley B, 2004, OECD AGR PROP GROWTH; Wassman R, 1991, PINEAPPLE FIELD DAY, P37; Wijesinghe W. A. J. P., 2002, Tropical Agricultural Research and Extension, V5, P53; Zuniga-Arias G, 2009, TRENDS FOOD SCI TECH, V20, P168, DOI 10.1016/j.tifs.2009.01.059; [No title captured]	47	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143290	10.1371/journal.pone.0143290	http://dx.doi.org/10.1371/journal.pone.0143290			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599545	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900087
J	Leidinger, P; Backes, C; Rheinheimer, S; Keller, A; Meese, E				Leidinger, Petra; Backes, Christina; Rheinheimer, Stefanie; Keller, Andreas; Meese, Eckart			Towards Clinical Applications of Blood-Borne miRNA Signatures: The Influence of the Anticoagulant EDTA on miRNA Abundance	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; QUALITY RNA; TNF-ALPHA; STABILIZATION; COLLECTION; SAMPLES	Background Circulating microRNAs (miRNAs) from blood are increasingly recognized as biomarker candidates for human diseases. Clinical routine settings frequently include blood sampling in tubes with EDTA as anticoagulant without considering the influence of phlebotomy on the overall miRNA expression pattern. We collected blood samples from six healthy individuals each in an EDTA blood collection tube. Subsequently, the blood was transferred into PAXgene (TM) tubes at three different time points, i.e. directly (0 min), 10 min, and 2 h after phlebotomy. As control blood was also directly collected in PAXgene (TM) blood RNA tubes that contain a reagent to directly lyse blood cells and stabilize their content. For all six blood donors at the four conditions (24 samples) we analyzed the abundance of 1,205 miRNAs by human Agilent miRNA V16 microarrays. Results While we found generally a homogenous pattern of the miRNA abundance in all 24 samples, the duration of the EDTA treatment appears to influence the miRNA abundance of specific miRNAs. The most significant changes are observed after longer EDTA exposition. Overall, the impact of the different blood sample conditions on the miRNA pattern was substantially lower than intra-individual variations. While samples belonging to one of the six individuals mostly cluster together, there was no comparable clustering for any of the four tested blood sampling conditions. The most affected miRNA was miR-769-3p that was not detected in any of the six PAXgene blood samples, but in all EDTA 2h samples. Accordingly, hsa-miR-769-3p was also the only miRNA that showed a significantly different abundance between the 4 blood sample conditions by an ANOVA analysis (Benjamini-Hochberg adjusted p-value of 0.003). Validation by qRT-PCR confirmed this finding. Conclusion The pattern of blood-borne miRNA abundance is rather homogenous between the four tested blood sample conditions of six blood donors. There was a clustering between the miRNA profiles that belong to a specific blood donor, but not between any of the four tested blood sampling conditions. The results show a limited overall impact of the blood sampling conditions on the miRNA pattern. Notwithstanding, the abundance of single miRNAs can be significantly altered by different blood sampling conditions.	[Leidinger, Petra; Rheinheimer, Stefanie; Meese, Eckart] Univ Saarland, Sch Med, Dept Human Genet, D-66421 Homburg, Germany; [Backes, Christina; Keller, Andreas] Univ Saarland, Dept Clin Bioinformat, D-66123 Saarbrucken, Germany	Saarland University; Saarland University	Meese, E (corresponding author), Univ Saarland, Sch Med, Dept Human Genet, Bldg 60, D-66421 Homburg, Germany.	hgemee@uks.eu	Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895	HOMFOR (Homburger Forschungsforderung)	HOMFOR (Homburger Forschungsforderung)	This study was funded by HOMFOR 2013 (Homburger Forschungsforderung).	Asare AL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-474; Beekman Johanna M., 2009, Journal of Pharmacological and Toxicological Methods, V59, P44, DOI 10.1016/j.vascn.2008.10.003; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Duttagupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031241; FREEMAN R, 1990, LANCET, V336, P312, DOI 10.1016/0140-6736(90)91848-5; Girardi C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/296747; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kim JH, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-76; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Nagler M, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-19; Pahl A, 2002, CLIN CHEM, V48, P2251; Ple H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050746; Pogue AI, 2010, NEUROSCI LETT, V476, P18, DOI 10.1016/j.neulet.2010.03.054; Rainen L, 2002, CLIN CHEM, V48, P1883; REDL H, 1992, CLIN CHIM ACTA, V205, P149, DOI 10.1016/S0009-8981(05)80010-5; RICHES P, 1992, J IMMUNOL METHODS, V153, P125, DOI 10.1016/0022-1759(92)90314-J; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Tanner MA, 2002, CLIN LAB HAEMATOL, V24, P337, DOI 10.1046/j.1365-2257.2002.00474.x; Viprey VF, 2012, ANAL BIOCHEM, V421, P566, DOI 10.1016/j.ab.2011.10.022; Yoshizawa M, 2011, INT J MOL SCI, V12, P9265, DOI 10.3390/ijms12129265	23	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143321	10.1371/journal.pone.0143321	http://dx.doi.org/10.1371/journal.pone.0143321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599228	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900093
J	Mahmud, SM; Bozat-Emre, S; Hammond, G; Elliott, L; Van Caeseele, P				Mahmud, Salaheddin M.; Bozat-Emre, Songul; Hammond, Gregory; Elliott, Lawrence; Van Caeseele, Paul			Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?	PLOS ONE			English	Article							ADMINISTRATIVE DATA; A H1N1; CHILDREN; MANITOBA; HOSPITALIZATION; METAANALYSIS; DATABASE	Background The extent to which A(H1N1) pdm09 influenza vaccines prevented hospital admissions with pneumonia and influenza (P&I) during the 2009 pandemic remains poorly understood. We evaluated the effectiveness of the A(H1N1) pdm09 and seasonal influenza vaccines (TIV) used during the 2009 mass vaccination campaign in Manitoba (Canada) in preventing P&I hospitalization. Methods A population-based record-linkage nested case-control study. Cases (N = 1,812) were persons hospitalized with influenza (ICD-10: J09-J11) or pneumonia (ICD-10: J12-J18) during the study period. Age-, gender-and area of residence-matched controls (N = 7,915) were randomly sampled from Manitoba's Population Registry. Information on receipt of A(H1N1) pdm09 vaccine and TIV was obtained from the Manitoba Immunization Monitoring System, a province-wide vaccine registry. Results Overall, the adjuvanted A(H1N1) pdm09 vaccine was 27% (95% CI 13-39%) effective against P& I hospitalization >= 14 days following administration. Effectiveness seemed lower among older (>= 65 years) adults (10%; -16-30%), particularly when compared to under-5 children (58%; 30-75%). The number-needed-to-vaccinate to prevent 1 P& I admission was lowest among < 4 year-olds (928) and >= 65 years (1,721). VE against hospitalization with laboratory-confirmed A(H1N1) pdm09 was 70% (39-85%) overall and (91%; 62-98%) >= 14 days following vaccination. Discussion Our data suggest that the adjuvanted A(H1N1)pdm09 vaccine was effective in preventing about 55-60% of P&I hospitalizations among children and younger adults who were at much higher risk of infection. Unfortunately, the vaccine was less effective among 65 or older adults. Despite that the vaccine still had a significant population-based impact especially among the very young (<5) and the older (>= 65 years).	[Mahmud, Salaheddin M.; Bozat-Emre, Songul; Elliott, Lawrence] Univ Manitoba, Community Hlth Sci, Winnipeg, MB, Canada; [Hammond, Gregory; Elliott, Lawrence; Van Caeseele, Paul] Univ Manitoba, Med Microbiol, Winnipeg, MB, Canada; [Hammond, Gregory] Univ Manitoba, Med, Winnipeg, MB, Canada; [Mahmud, Salaheddin M.; Elliott, Lawrence] Winnipeg Reg Hlth Author, Winnipeg, MB, Canada; [Van Caeseele, Paul] Cadham Prov Lab, Winnipeg, MB, Canada; [Mahmud, Salaheddin M.; Bozat-Emre, Songul; Elliott, Lawrence; Van Caeseele, Paul] Manitoba Hlth, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Mahmud, SM (corresponding author), Univ Manitoba, Community Hlth Sci, Winnipeg, MB, Canada.	Salah.mahmud@gmail.com			investigator-initiated grant from GSK Biologicals to the International Centre of Infectious Disease, Winnipeg, Canada	investigator-initiated grant from GSK Biologicals to the International Centre of Infectious Disease, Winnipeg, Canada	This work was funded by an investigator-initiated grant from GSK Biologicals to the International Centre of Infectious Disease, Winnipeg, Canada. Funders had no role in designing or conducting the study or in the decision to submit the results for publication. GSK: http://www.gsk.ca/english/index.html. International Centre of Infectious Disease: http://www.icid.com/.	[Anonymous], VACCINES; Baxter R, 2010, J INFECT DIS, V201, P186, DOI 10.1086/649568; Canadian Institute for Health Information, 2009, ICD 10 CA INT STAT C; Canadian Institute for Health Information, 2006, CAN CLASS HLTH INT; Dublin S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2137; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Emborg HD, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7901; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Gilca R, 2011, PEDIATRICS, V128, pE1084, DOI 10.1542/peds.2010-3492; Gilmour H, 2010, H1N1 VACCINATION HLT, V21; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Hadler JL, 2012, J INFECT DIS, V206, P49, DOI 10.1093/infdis/jis306; Hardy JR, 2004, PHARMACOEPIDEM DR S, V13, P749, DOI 10.1002/pds.935; Hills, 1993, STAT MODELS EPIDEMIO; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Kozyrskyj AL, 1998, ANN PHARMACOTHER, V32, P1152, DOI 10.1345/aph.18117; LeBlanc JJ, 2009, J CLIN MICROBIOL, V47, P3805, DOI 10.1128/JCM.01344-09; Lix L, 2006, DEFINING VALIDATING; Mahmud S, 2011, VACCINE, V29, P7975, DOI 10.1016/j.vaccine.2011.08.068; Mahmud SM, 2012, EMERG INFECT DIS, V18, P801, DOI 10.3201/eid1805.111596; Mahmud SM, 2010, CAN MED ASSOC J, V182, P1522, DOI 10.1503/cmaj.100488; Manitoba H, 2010, H1N1 FLU MANITOBA MA; Manzoli L, 2012, HUM VACC IMMUNOTHER, V8, P851, DOI 10.4161/hv.19917; Manzoli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024384; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Roberts JD, 1996, J CLIN EPIDEMIOL, V49, P51, DOI 10.1016/0895-4356(95)00522-6; ROBERTS JD, 1994, AM J PUBLIC HEALTH, V84, P1666, DOI 10.2105/AJPH.84.10.1666; Robinson JR, 1997, MED CARE, V35, P932, DOI 10.1097/00005650-199709000-00006; ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002; Simpson CR, 2010, HEALTH TECHNOL ASSES, V14, P323, DOI 10.3310/hta14340-05; Singh H, 2009, AM J GASTROENTEROL, V104, P3015, DOI 10.1038/ajg.2009.574; Steens A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-196; Thompson LH, 2012, CAN J INFECT DIS MED, V23, P65, DOI 10.1155/2012/484693; Viboud C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000259; Wong K, 2012, ARCH INTERN MED, V172, P484, DOI 10.1001/archinternmed.2011.2038; Yin JK, 2011, INFLUENZA OTHER RESP, V5, P299, DOI 10.1111/j.1750-2659.2011.00229.x	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142754	10.1371/journal.pone.0142754	http://dx.doi.org/10.1371/journal.pone.0142754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600435	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900039
J	Naczk, AM; Kolanowska, M				Naczk, Aleksandra M.; Kolanowska, Marta			Glacial Refugia and Future Habitat Coverage of Selected Dactylorhiza Representatives (Orchidaceae)	PLOS ONE			English	Article							INCARNATA/MACULATA COMPLEX ORCHIDACEAE; PLASTID DNA VARIATION; SPECIES DISTRIBUTION; POLYPLOID EVOLUTION; CLIMATE-CHANGE; GENETIC DIFFERENTIATION; POTENTIAL DISTRIBUTIONS; DECEPTIVE POLLINATION; TERRESTRIAL ORCHID; QUATERNARY REFUGIA	The intensively discussed taxonomic complexity of the Dactylorhiza genus is probably correlated with its migration history during glaciations and interglacial periods. Previous studies on past processes affecting the current distribution of Dactylorhiza species as well as the history of the polyploid complex formation were based only on molecular data. In the present study the ecological niche modeling (ENM) technique was applied in order to describe the distribution of potential refugia for the selected Dactylorhiza representatives during the Last Glacial Maximum. Additionally, future changes in their potential habitat coverage were measured with regard to three various climatic change scenarios. The maximum entropy method was used to create models of suitable niche distribution. A database of Dactylorhiza localities was prepared on the grounds of information collected from literature and data gathered during field works. Our research indicated that the habitats of majority of the studied taxa will decrease by 2080, except for D. incarnata var. incarnata, for which suitable habitats will increase almost two-fold in the global scale. Moreover, the potential habitats of some taxa are located outside their currently known geographical ranges, e.g. the Aleutian Islands, the western slopes of the Rocky Mountains, Newfoundland, southern Greenland and Iceland. ENM analysis did not confirm that the Balkans, central Europe or central Russia served as the most important refugia for individual representatives of the Dactylorhiza incarnata/maculata complex. Our study rather indicated that the Black Sea coast, southern Apennines and Corsica were the main areas characterized by habitats suitable for most of the taxa.	[Naczk, Aleksandra M.] Univ Gdansk, Dept Mol Evolut, PL-80308 Gdansk, Poland; [Kolanowska, Marta] Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80308 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Kolanowska, M (corresponding author), Univ Gdansk, Dept Plant Taxon & Nat Conservat, Wita Stwosza 59, PL-80308 Gdansk, Poland.	martakolanowska@wp.pl	Kolanowska, Marta/AAR-3107-2020	Kolanowska, Marta/0000-0001-5347-5403; Naczk, Aleksandra M./0000-0001-7731-4487	Polish Ministry of Science and Higher Education [NN 303 5491]; Foundation For Polish Science (Fundacja na rzecz Nauki Polskiej, FNP); European Social Fund	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation For Polish Science (Fundacja na rzecz Nauki Polskiej, FNP); European Social Fund(European Social Fund (ESF))	The present study was financially supported by the Polish Ministry of Science and Higher Education (grant no. NN 303 5491) and The Foundation For Polish Science (Fundacja na rzecz Nauki Polskiej, FNP). The publication is financed from European Social Fund as a part of the project "Educators for the elite-integrated training program for PhD students, post-docs and professors as academic teachers at University of Gdansk" within the framework of Human Capital Operational Programme, Action IV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to express our gratitude to Professors Dariusz L. Szlachetko and Marek S. Zietara for their valuable comments on the manuscript. This paper was prepared thanks to the support of The Foundation For Polish Science (Fundacja na rzecz Nauki Polskiej, FNP) and The Polish Ministry of Science and Higher Education (grant no. NN 303 5491). We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank National Center for Atmospheric Research for producing and making available their model output. For CMIP the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Adamowski Wojciech, 1995, Wiadomosci Botaniczne, V39, P105; Averyanov L., 1990, ORCHID BIOL REV PERS, VV, P159; Barredo J. I., 2015, Bulletin OEPP, V45, P273, DOI 10.1111/epp.12208; BATEMAN R M, 1989, Watsonia, V17, P319; Bateman RM, 2003, BOT J LINN SOC, V142, P1, DOI 10.1046/j.1095-8339.2003.00157.x; Baumann H., 2006, ORCHIDEEN EUROPAS AN; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Bernardos S, 2006, ACTA BOT GALLICA, V153, P273, DOI 10.1080/12538078.2006.10515546; Boex J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02118; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; BUSBY JR, 1986, AUST J ECOL, V11, P1, DOI 10.1111/j.1442-9993.1986.tb00912.x; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Clague JJ, 2002, QUATERNARY SCI REV, V21, P71, DOI 10.1016/S0277-3791(01)00070-1; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Coops NC, 2011, ECOL MODEL, V222, P2119, DOI 10.1016/j.ecolmodel.2011.03.033; Cozzolino S, 2005, P ROY SOC B-BIOL SCI, V272, P1271, DOI 10.1098/rspb.2005.3069; Cribb P.J., 2003, ORCHID CONSERVATION, P1; Delforge P, 2005, GUIDE ORCHIDEES EURO; Delforge P, 1995, ORCHIDS BRITAIN EURO; Devos N, 2006, MOL PHYLOGENET EVOL, V38, P767, DOI 10.1016/j.ympev.2005.11.013; Devos N, 2005, MOL PHYLOGENET EVOL, V36, P568, DOI 10.1016/j.ympev.2005.04.014; Devos N, 2003, PLANT SYST EVOL, V243, P85, DOI 10.1007/s00606-003-0068-0; DUFRENE M, 1991, PLANT SYST EVOL, V175, P55, DOI 10.1007/BF00942145; Elenga H, 2000, J BIOGEOGR, V27, P621, DOI 10.1046/j.1365-2699.2000.00430.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ferro VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107792; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Freeman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082404; Glennon KL, 2012, EVOL ECOL, V26, P909, DOI 10.1007/s10682-011-9539-x; Godsoe W, 2013, AM J BOT, V100, P496, DOI 10.3732/ajb.1200275; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Gormley KSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068263; Grant V., 1981, PLANT SPECIATION; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; HADLEY G, 1970, NEW PHYTOL, V69, P1015, DOI 10.1111/j.1469-8137.1970.tb02481.x; Hedren M., 1996, Watsonia, V21, P113; Hedren M, 2003, MOL ECOL, V12, P2669, DOI 10.1046/j.1365-294X.2003.01930.x; Hedren M, 1996, NORD J BOT, V16, P253, DOI 10.1111/j.1756-1051.1996.tb00225.x; Hedren M, 2001, AM J BOT, V88, P1868, DOI 10.2307/3558363; Hedren M, 2001, PLANT SYST EVOL, V229, P23, DOI 10.1007/s006060170016; Hedren M, 1996, PLANT SYST EVOL, V201, P31, DOI 10.1007/BF00989050; HEDREN M, 2002, J EUROPAISCHER ORCHI, V34, P707; Hedren M, 2008, MOL ECOL, V17, P5075, DOI 10.1111/j.1365-294X.2008.03965.x; Hedren M, 2007, AM J BOT, V94, P1205, DOI 10.3732/ajb.94.7.1205; Hedren M, 2012, NORD J BOT, V30, P257, DOI 10.1111/j.1756-1051.2012.01321.x; Hedren M, 2011, BIOL J LINN SOC, V104, P107, DOI 10.1111/j.1095-8312.2011.01708.x; Hedren Mikael, 2001, Lindleyana, V16, P17; Hedren M, 2009, ANN BOT-LONDON, V104, P527, DOI 10.1093/aob/mcp102; Hedren M, 2009, NORD J BOT, V27, P69, DOI 10.1111/j.1756-1051.2009.00274.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; HESLOP HARRISON J., 1951, SVENSK BOT TIDSKR, V45, P608; HESLOP-HARRISON J., 1954, BER GEOBOT FORSCHUNGSINST RUBEL ZURICH, V1953, P53; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hopkins DM, 1982, PALEOECOLOGY BERINGI; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1; JAGIELLO M, 1986, FRAGM FLORIST GEOBOT, V31, P385; Janeckova P, 2006, BIOL CONSERV, V129, P40, DOI 10.1016/j.biocon.2005.09.045; Khanum R, 2013, ACTA OECOL, V49, P23, DOI 10.1016/j.actao.2013.02.007; Kim SJ, 2003, CLIM DYNAM, V20, P635, DOI 10.1007/s00382-002-0292-2; Kolanowska M, 2015, ACTA SOC BOT POL, V84, P97, DOI 10.5586/asbp.2014.030; Kolanowska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077352; LAMMI A, 1995, OECOLOGIA, V101, P500, DOI 10.1007/BF00329430; Lammi A, 2003, ANN BOT FENN, V40, P331; Laport RG, 2013, J TORREY BOT SOC, V140, P349, DOI 10.3159/TORREY-D-13-00009.1; Lewis W. H., 1980, Polyploidy. Biological relevance. Part I. Polyploidy and plant evolution., P103; Malm JU, 2002, BIOL J LINN SOC, V77, P23, DOI 10.1046/j.1095-8312.1999.00079.x; McCullagh P, 1989, GEN LINEAR MODELS; McIntyre PJ, 2012, AM J BOT, V99, P655, DOI 10.3732/ajb.1100466; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Minasiewicz J, 2004, ACTA BOT CASSUB, V4, P139; Naczk AM, 2015, BOT J LINN SOC, V178, P121, DOI 10.1111/boj.12267; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P417, DOI 10.1177/194008290800100408; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Nordal I, 1998, BOT J LINN SOC, V128, P105, DOI 10.1111/j.1095-8339.1998.tb02110.x; Nordstrom S, 2008, PLANT SYST EVOL, V276, P73, DOI 10.1007/s00606-008-0084-1; Nordstrom S, 2009, NORD J BOT, V27, P548, DOI 10.1111/j.1756-1051.2009.00548.x; Nordstrom S, 2009, BIOL J LINN SOC, V97, P52, DOI 10.1111/j.1095-8312.2008.01183.x; Palme AE, 2003, MOL ECOL, V12, P201, DOI 10.1046/j.1365-294X.2003.01724.x; Pedersen HA, 1998, NORD J BOT, V18, P289, DOI 10.1111/j.1756-1051.1998.tb01881.x; Pedersen HA, 1998, NORD J BOT, V18, P15, DOI 10.1111/j.1756-1051.1998.tb01091.x; Pedersen HAE, 2002, NORD J BOT, V22, P641, DOI 10.1111/j.1756-1051.2002.tb01921.x; Pedersen HAE, 2001, NORD J BOT, V21, P177, DOI 10.1111/j.1756-1051.2001.tb01355.x; Pedersen HAE, 2009, BOT J LINN SOC, V159, P396, DOI 10.1111/j.1095-8339.2009.00954.x; Pellegrino G, 2009, BIOLOGIA, V64, P893, DOI 10.2478/s11756-009-0175-7; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pillon Y, 2006, BIOL CONSERV, V129, P4, DOI 10.1016/j.biocon.2005.06.036; Pillon Y, 2007, TAXON, V56, P1185, DOI 10.2307/25065911; Pridgeon A., 2001, GENERA ORCHIDACEAR 1, V2; Pridgeon Alec M., 1997, Lindleyana, V12, P89; Reinhard HR, 1985, MITT BL ARBEITSKR HE, V17, P321; Rendell S, 2002, MOL ECOL, V11, P69, DOI 10.1046/j.0962-1083.2001.01413.x; Schiemann K, 2000, PLANT SYST EVOL, V225, P119, DOI 10.1007/BF00985462; Schmitt T, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-22; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Shipunov AB, 2004, AM J BOT, V91, P1419, DOI 10.3732/ajb.91.9.1419; Songer Melissa, 2012, International Journal of Ecology, P1; Stahlberg D, 2008, PLANT SYST EVOL, V273, P107, DOI 10.1007/s00606-008-0035-x; Stahlberg D, 2010, BIOL J LINN SOC, V101, P503, DOI 10.1111/j.1095-8312.2010.01505.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Szalchetko DL, 1996, STORCZYKI POLSKI; Taberlet P, 2002, SCIENCE, V297, P2009, DOI 10.1126/science.297.5589.2009; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Toth JP, 2013, J INSECT CONSERV, V17, P245, DOI 10.1007/s10841-012-9503-2; TREMBLAY RL, 1992, CAN J BOT, V70, P642, DOI 10.1139/b92-083; TYTECA D, 2004, BER ARBEITSKR HEIM O, V21, P4; Tzedakis PC, 2002, SCIENCE, V297, P2044, DOI 10.1126/science.1073083; Varela S, 2011, PALAEOGEOGR PALAEOCL, V310, P451, DOI 10.1016/j.palaeo.2011.07.021; Velasquez-Tibata J, 2013, REG ENVIRON CHANGE, V13, P235, DOI 10.1007/s10113-012-0329-y; Voth W., 1978, LINZER BIOL BEITR, V10, P179; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Wang WG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111587; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Weisrock DW, 2000, MOL PHYLOGENET EVOL, V14, P152, DOI 10.1006/mpev.1999.0689; Weiss S, 2007, PHYLOGEOGRAPHY SO EU; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wotavova K, 2004, BIOL CONSERV, V118, P271, DOI 10.1016/j.biocon.2003.09.005	133	8	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143478	10.1371/journal.pone.0143478	http://dx.doi.org/10.1371/journal.pone.0143478			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599630	Green Published, gold			2022-12-26	WOS:000365853900133
J	Shi, YK; Li, JL; Zhang, SC; Wang, MZ; Yang, SJ; Li, N; Wu, G; Liu, W; Liao, GQ; Cai, KC; Chen, L; Zheng, MZ; Yu, P; Wang, XW; Liu, YP; Guo, QS; Nie, LG; Liu, JW; Han, XH				Shi, Yuankai; Li, Junling; Zhang, Shucai; Wang, Mengzhao; Yang, Shujun; Li, Ning; Wu, Gang; Liu, Wei; Liao, Guoqing; Cai, Kaican; Chen, Liang'an; Zheng, Meizhen; Yu, Ping; Wang, Xiuwen; Liu, Yunpeng; Guo, Qisen; Nie, Ligong; Liu, Jiwei; Han, Xiaohong			Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DRIVER MUTATIONS; SMOKERS VARIES; GENE-MUTATIONS; KINASE DOMAIN; NEVER-SMOKERS; OPEN-LABEL; GEFITINIB; SENSITIVITY; FREQUENCY	Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation frequency on lung adenocarcinoma is still limited to retrospective studies. The PIONEER study (NCT01185314) is a prospective molecular epidemiology study in Asian patients with newly diagnosed advanced lung adenocarcinoma, aiming to prospectively analyze EGFR mutation status in IIIB/IV treatment-naive lung adenocarcinomas in Asia. We report the mainland China subset results. Eligible patients (similar to 20 yrs old, IIIB/IV adenocarcinoma and treatment-naive) were registered in 17 hospitals in mainland China. EGFR was tested for mutations by amplification refractory mutation system using biopsy samples. Demographic and clinical characteristics were collected for subgroup analyses. A total of 747 patients were registered. Successful EGFR mutation analysis was performed in 741, with an overall mutation rate of 50.2%. The EGFR active mutation rate is 48.0% (with 1.3% of combined active and resistance mutations). Tobacco use (>30 pack-year vs. 0-10 pack-year, OR 0.27, 95% CI: 0.17-0.42) and regional lymph nodes involvement (N3 vs. N0, OR 0.47, 95% CI: 0.29-0.76) were independent predictors of EGFR mutation in multivariate analysis. However, even in regular smokers, the EGFR mutation frequency was 35.3%. The EGFR mutation frequency was similar between diverse biopsy sites and techniques. The overall EGFR mutation frequency of the mainland China subset was 50.2%, independently associated with the intensity of tobacco use and regional lymph nodes involvement. The relatively high frequency of EGFR mutations in the mainland China subset suggest that any effort to obtain tissue sample for EGFR mutation testing should be encouraged.	[Shi, Yuankai; Li, Junling; Han, Xiaohong] Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100021, Peoples R China; [Shi, Yuankai; Li, Junling; Han, Xiaohong] Peking Union Med Coll, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing 100021, Peoples R China; [Zhang, Shucai] Capital Med Univ, Beijing Chest Hosp, Dept Med Oncol, Beijing 1011429, Peoples R China; [Wang, Mengzhao] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Respirat Med, Beijing 100005, Peoples R China; [Wang, Mengzhao] Peking Union Med Coll, Beijing 100005, Peoples R China; [Yang, Shujun] Henan Canc Hosp, Dept Med Oncol, Zhengzhou 450008, Henan Province, Peoples R China; [Li, Ning] Guangzhou Chest Hosp, Dept Med Oncol, Guangzhou 510095, Guangdong, Peoples R China; [Wu, Gang] Huazhong Univ Sci & Technol, Ctr Canc, Union Hosp, Tongji Med Coll, Wuhan 430030, Hubei Province, Peoples R China; [Liu, Wei] Hebei Med Univ, Dept Med Oncol, Hosp 4, Shijiazhuang 050035, Hebei Province, Peoples R China; [Liao, Guoqing] Chinese Peoples Liberat Army, Hosp 309, Dept Med Oncol, Beijing 100091, Peoples R China; [Cai, Kaican] Southern Med Univ, Nanfang Hosp, Dept Med Oncol, Guangzhou 510515, Guangdong, Peoples R China; [Chen, Liang'an] Chinese Peoples Liberat Army Gen Hosp, Dept Respirat Med, Beijing 100853, Peoples R China; [Zheng, Meizhen] Liaoning Canc Hosp, Dept Med Oncol, Shenyang 110042, Liaoning Provin, Peoples R China; [Yu, Ping] Sichuan Canc Hosp, Dept Med Oncol, Chengdu 610041, Sichuan Provinc, Peoples R China; [Wang, Xiuwen] Shandong Univ, Qilu Hosp, Dept Med Oncol, Jinan 250012, Shandong, Peoples R China; [Liu, Yunpeng] China Med Univ, Dept Med Oncol, Hosp 1, Shenyang 110001, Liaoning Provin, Peoples R China; [Guo, Qisen] Shandong Canc Hosp, Dept Med Oncol, Jinan 250117, Shandong, Peoples R China; [Nie, Ligong] Peking Univ, Dept Respirat Med, Hosp 1, Beijing 100034, Peoples R China; [Liu, Jiwei] Dalian Med Univ, Dept Med Oncol, Affiliated Hosp 1, Dalian 116011, Liaoning Provin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhengzhou University; Huazhong University of Science & Technology; Hebei Medical University; Southern Medical University - China; Chinese People's Liberation Army General Hospital; Shandong University; China Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Peking University; Dalian Medical University	Shi, YK (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China.	syuankai@cicams.ac.cn	han, xiao/HDN-9782-2022	Chen, Liang-an/0000-0002-1829-3134	AstraZeneca; Chinese National Major Project for New Drug Innovation [2008ZX09312, 2012ZX09303012-001]; Research Special Fund for Public Welfare Industry of Health [200902002-1]	AstraZeneca(AstraZeneca); Chinese National Major Project for New Drug Innovation; Research Special Fund for Public Welfare Industry of Health	This study was funded by AstraZeneca and partly supported by Chinese National Major Project for New Drug Innovation (2008ZX09312, 2012ZX09303012-001) and Research Special Fund for Public Welfare Industry of Health (200902002-1).	Arcila ME, 2013, MOL CANCER THER, V12, P220, DOI 10.1158/1535-7163.MCT-12-0620; Chou TY, 2005, CLIN CANCER RES, V11, P3750, DOI 10.1158/1078-0432.CCR-04-1981; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li H, 2013, LUNG CANCER, V79, P8, DOI 10.1016/j.lungcan.2012.09.018; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Na Im Il, 2011, ISRN Oncol, V2011, P756265, DOI 10.5402/2011/756265; Oxnard GR, 2013, J THORAC ONCOL, V8, P179, DOI 10.1097/JTO.0b013e3182779d18; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sasaki H, 2007, LUNG CANCER, V58, P324, DOI 10.1016/j.lungcan.2007.06.024; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Sun YH, 2010, ACTA PHARMACOL SIN, V31, P647, DOI 10.1038/aps.2010.43; Wu SG, 2008, EUR RESPIR J, V32, P924, DOI 10.1183/09031936.00167407; Yasuda H, 2012, LANCET ONCOL, V13, pE23, DOI 10.1016/S1470-2045(11)70129-2; Zhang Y, 2012, CLIN CANCER RES, V18, P1947, DOI 10.1158/1078-0432.CCR-11-2511; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	24	105	135	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143515	10.1371/journal.pone.0143515	http://dx.doi.org/10.1371/journal.pone.0143515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599344	gold, Green Submitted, Green Published			2022-12-26	WOS:000365853900135
J	Summers, CF; Gulliford, CM; Carlson, CH; Lillis, JA; Carlson, MO; Cadle-Davidson, L; Gent, DH; Smart, CD				Summers, Carly F.; Gulliford, Colwyn M.; Carlson, Craig H.; Lillis, Jacquelyn A.; Carlson, Maryn O.; Cadle-Davidson, Lance; Gent, David H.; Smart, Christine D.			Identification of Genetic Variation between Obligate Plant Pathogens Pseudoperonospora cubensis and P-humuli Using RNA Sequencing and Genotyping-By-Sequencing	PLOS ONE			English	Article							DOWNY MILDEW; CAUSAL AGENT; MATING-TYPE; OOMYCETE; SEQ; SNPS; PERONOSPORALES; DISCOVERY; INFESTANS	RNA sequencing (RNA-seq) and genotyping-by-sequencing (GBS) were used for single nucleotide polymorphism (SNP) identification from two economically important obligate plant pathogens, Pseudoperonospora cubensis and P. humuli. Twenty isolates of P. cubensis and 19 isolates of P. humuli were genotyped using RNA-seq and GBS. Principle components analysis (PCA) of each data set showed genetic separation between the two species. Additionally, results supported previous findings that P. cubensis isolates from squash are genetically distinct from cucumber and cantaloupe isolates. A PCA-based procedure was used to identify SNPs correlated with the separation of the two species, with 994 and 4,231 PCA-correlated SNPs found within the RNA-seq and GBS data, respectively. The corresponding unigenes (n = 800) containing these potential species-specific SNPs were then annotated and 135 putative pathogenicity genes, including 3 effectors, were identified. The characterization of genes containing SNPs differentiating these two closely related downy mildew species may contribute to the development of improved detection and diagnosis strategies and improve our understanding of host specificity pathways.	[Summers, Carly F.; Carlson, Maryn O.; Smart, Christine D.] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA; [Gulliford, Colwyn M.] Cornell Univ, Cornell Lab Accelerator Based Sci & Educ, Ithaca, NY USA; [Carlson, Craig H.] Cornell Univ, Hort Sect, Sch Integrat Plant Sci, Geneva, NY USA; [Lillis, Jacquelyn A.; Cadle-Davidson, Lance] USDA ARS, Grape Genet Res Unit, Geneva, NY USA; [Gent, David H.] Oregon State Univ, USDA ARS, Forage Seed & Cereal Res Unit, Corvallis, OR 97331 USA; [Gent, David H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Cornell University; Cornell University; Cornell University; United States Department of Agriculture (USDA); Oregon State University; United States Department of Agriculture (USDA); Oregon State University	Smart, CD (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA.	cds14@cornell.edu	Carlson, Craig H/O-9716-2017	Smart, Christine/0000-0003-4162-9502; Carlson, Craig/0000-0003-2050-5455; Myers, Jacquelyn/0000-0002-5005-028X	United States Department of Agriculture Organic Research and Extension Initiative (NIFA) [2012-51300-20006]; National Institutes of Health [1S10OD010693-01]; NSF Graduate Research Fellowship [DGE-1144153]; ARS [ARS-0425016] Funding Source: Federal RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010693] Funding Source: NIH RePORTER	United States Department of Agriculture Organic Research and Extension Initiative (NIFA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was provided through the United States Department of Agriculture Organic Research and Extension Initiative (http://nifa.usda.gov/funding-opportunity/organic-agriculture-research-and-extension-initiative; NIFA contract no. 2012-51300-20006) and National Institutes of Health (http://www.nih.gov/; grant 1S10OD010693-01). Funding for C.F. Summers was also provided through an NSF Graduate Research Fellowship (www.nsfgrfp.org; DGE-1144153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergey CM, 2012, VCF TAB TO FASTA; Burkhardt A, 2015, MOL PLANT MICROBE IN, V28, P298, DOI 10.1094/MPMI-09-14-0300-FI; Chee HY, 2006, PLANT DIS, V90, P1283, DOI 10.1094/PD-90-1283; Choi YJ, 2005, MYCOL RES, V109, P841, DOI 10.1017/S0953756205002534; Cohen Y, 2013, PLANT DIS, V97, P292, DOI 10.1094/PDIS-10-12-0911-PDN; Cohen Y, 2003, PHYTOPARASITICA, V31, P458, DOI 10.1007/BF02979739; Cohen Y, 2015, PHYTOPATHOLOGY, V105, P998, DOI 10.1094/PHYTO-11-14-0334-FI; Cohen Y, 2012, EUR J PLANT PATHOL, V132, P577, DOI 10.1007/s10658-011-9902-3; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; De Wit P, 2015, MOL ECOL, V24, P2310, DOI 10.1111/mec.13165; Ellis J, 2006, PLANT CELL, V18, P523, DOI 10.1105/tpc.105.040584; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Flier WG, 2002, MYCOL RES, V106, P848, DOI 10.1017/S0953756202006123; Gent DH, 2008, PLANT DIS, V92, P463, DOI 10.1094/PDIS-92-3-0463; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Goodwin SB, 1999, MYCOLOGIA, V91, P796, DOI 10.2307/3761533; Hall GS, 1996, PLANT PATHOL, V45, P1009, DOI 10.1046/j.1365-3059.1996.d01-191.x; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Johnson JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127013; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Laloe D, 2012, GENETIC INTERPRETATI, P1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lebeda A, 2002, ACTA HORTIC, P137, DOI 10.17660/ActaHortic.2002.588.20; Lebeda A., 2011, European Journal of Plant Pathology, V129, P157, DOI 10.1007/s10658-010-9658-1; Li XR, 2012, GENOME RES, V22, P2436, DOI 10.1101/gr.140277.112; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng SW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S7; Mitchell MN, 2011, PHYTOPATHOLOGY, V101, P805, DOI 10.1094/PHYTO-10-10-0270; Northeast hop alliance, 2012, NYSP HOPS ED; Palti J, 1981, DOWNY MILDEWS, P45; Panabieres F, 2005, FUNGAL GENET BIOL, V42, P611, DOI 10.1016/j.fgb.2005.03.002; Paritosh K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-396; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quesada-Ocampo LM, 2012, PLANT DIS, V96, P1459, DOI 10.1094/PDIS-11-11-0943-RE; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; R Core Team, 2016, R FDN STAT COMP; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Riethmuller A, 2002, MYCOLOGIA, V94, P834, DOI 10.2307/3761698; Runge F, 2012, PLANT DIS, V96, P55, DOI 10.1094/PDIS-01-11-0035; Runge F, 2011, EUR J PLANT PATHOL, V129, P147, DOI 10.1007/s10658-010-9650-9; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savory EA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035796, 10.1371/journal.pone.0034701]; SKOTLAND CB, 1983, PLANT DIS, V67, P1183, DOI 10.1094/PD-67-1183; Studholme DJ, 2011, ANNU REV PHYTOPATHOL, V49, P87, DOI 10.1146/annurev-phyto-072910-095408; Summers CF, 2015, CAN J PLANT PATHOL, V37, P315, DOI 10.1080/07060661.2015.1053989; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thines M, 2014, EUR J PLANT PATHOL, V138, P431, DOI 10.1007/s10658-013-0366-5; Thomas A, 2014, PHYTOPATHOLOGY, V104, P118; THOMAS CE, 1987, PHYTOPATHOLOGY, V77, P1621, DOI 10.1094/Phyto-77-1621; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto-Alalibo TA, 2007, MOL PLANT MICROBE IN, V20, P781, DOI 10.1094/MPMI-20-7-0781; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; Vidal RO, 2012, GENET MOL BIOL, V35, P331, DOI 10.1590/S1415-47572012000200014; Voglmayr H, 1998, FUNGAL GENET BIOL, V25, P181, DOI 10.1006/fgbi.1998.1097; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199	65	21	21	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143665	10.1371/journal.pone.0143665	http://dx.doi.org/10.1371/journal.pone.0143665			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599440	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900154
J	Henrich, E; Ma, Y; Engels, I; Munch, D; Otten, C; Schneider, T; Henrichfreise, B; Sahl, HG; Dotsch, V; Bernhard, F				Henrich, Erik; Ma, Yi; Engels, Ina; Muench, Daniela; Otten, Christian; Schneider, Tanja; Henrichfreise, Beate; Sahl, Hans-Georg; Doetsch, Volker; Bernhard, Frank			Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL BIOSYNTHESIS; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; FREE EXPRESSION; D-GLUTAMATE; PEPTIDOGLYCAN; LIGASE; IDENTIFICATION; TRANSFERASE; CHLAMYDIA	Screening of new compounds directed against key protein targets must continually keep pace with emerging antibiotic resistances. Although periplasmic enzymes of bacterial cell wall biosynthesis have been among the first drug targets, compounds directed against the membrane-integrated catalysts are hardly available. A promising future target is the integral membrane protein MraY catalyzing the first membrane associated step within the cytoplasmic pathway of bacterial peptidoglycan biosynthesis. However, the expression of most MraY homologues in cellular expression systems is challenging and limits biochemical analysis. We report the efficient production of MraY homologues from various human pathogens by synthetic cell-free expression approaches and their subsequent characterization. MraY homologues originating from Bordetella pertussis, Helicobacter pylori, Chlamydia pneumoniae, Borrelia burgdorferi, and Escherichia coli as well as Bacillus subtilis were co-translationally solubilized using either detergent micelles or preformed nanodiscs assembled with defined membranes. All MraY enzymes originating from Gram-negative bacteria were sensitive to detergents and required nanodiscs containing negatively charged lipids for obtaining a stable and functionally folded conformation. In contrast, the Gram-positive B. subtilis MraY not only tolerates detergent but is also less specific for its lipid environment. The MraY.nanodisc complexes were able to reconstitute a complete in vitro lipid I and lipid II forming pipeline in combination with the cell-free expressed soluble enzymes MurA-F and with the membrane-associated protein MurG. As a proof of principle for future screening platforms, we demonstrate the inhibition of the in vitro lipid II biosynthesis with the specific inhibitors fosfomycin, feglymycin, and tunicamycin.	[Henrich, Erik; Ma, Yi; Doetsch, Volker; Bernhard, Frank] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Ma, Yi] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Engels, Ina; Muench, Daniela; Otten, Christian; Schneider, Tanja; Henrichfreise, Beate; Sahl, Hans-Georg] Univ Bonn, Inst Pharmaceut Microbiol, Bonn, Germany; [Ma, Yi; Schneider, Tanja; Sahl, Hans-Georg] German Ctr Infect Res DZIF, Partner Site Cologne Bonn, D-53115 Bonn, Germany; [Otten, Christian] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Goethe University Frankfurt; South China University of Technology; University of Bonn; German Center for Infection Research; Newcastle University - UK	Ma, Y (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China.; Bernhard, F (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	bimayikobe@scut.edu.cn; fbern@bpc.uni-frankfurt.de	Schneider, Tanja/L-8049-2013	Schneider, Tanja/0000-0001-7269-4716; Bernhard, Frank/0000-0002-4860-1783; Rausch, Daniela/0000-0003-3211-5745; Dotsch, Volker/0000-0001-5720-212X	Collaborative Research Center (SFB) of the German Research Foundation (Deutsche Forschungsgemeinschaft) [807]; German Ministry of Education and Science (BMBF); Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI); National Natural Science Foundation of China [21306055]; Natural Science Foundation of Guangdong Province, China [2014A030313261]	Collaborative Research Center (SFB) of the German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported in part by the Collaborative Research Center (SFB) Grant 807 of the German Research Foundation (Deutsche Forschungsgemeinschaft), the German Ministry of Education and Science (BMBF), and Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the National Natural Science Foundation of China Grant 21306055 and Natural Science Foundation of Guangdong Province, China Grant 2014A030313261. To whom correspondence may be addressed: School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China. E-mail: bimayikobe@scut.edu.cn.	Bechara C, 2015, NAT CHEM, V7, P255, DOI [10.1038/NCHEM.2172, 10.1038/nchem.2172]; Benson TE, 1996, STRUCTURE, V4, P47, DOI 10.1016/S0969-2126(96)00008-1; Bertrand JA, 1997, EMBO J, V16, P3416, DOI 10.1093/emboj/16.12.3416; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Dini C, 2000, BIOORG MED CHEM LETT, V10, P1839, DOI 10.1016/S0960-894X(00)00349-8; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; ELBEIN AD, 1979, ANNU REV PLANT PHYS, V30, P239, DOI 10.1146/annurev.pp.30.060179.001323; Gordon E, 2001, J BIOL CHEM, V276, P10999, DOI 10.1074/jbc.M009835200; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Hein C, 2014, ENG LIFE SCI, V14, P365, DOI 10.1002/elsc.201300050; Henrichfreise B, 2009, MOL MICROBIOL, V73, P913, DOI 10.1111/j.1365-2958.2009.06815.x; Huang LY, 2014, ANGEW CHEM INT EDIT, V53, P8060, DOI 10.1002/anie.201402313; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; INUKAI M, 1993, ANTIMICROB AGENTS CH, V37, P980, DOI 10.1128/AAC.37.5.980; Junge F, 2010, J STRUCT BIOL, V172, P94, DOI 10.1016/j.jsb.2010.05.004; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Keller T, 2011, J BIOL CHEM, V286, P37874, DOI 10.1074/jbc.M111.289330; Koga T, 2004, J ANTIMICROB CHEMOTH, V54, P755, DOI 10.1093/jac/dkh417; Koshy C, 2013, EMBO J, V32, P3096, DOI 10.1038/emboj.2013.226; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Ma Y, 2011, J BIOL CHEM, V286, P38844, DOI 10.1074/jbc.M111.301085; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; Matthies D, 2011, J MOL BIOL, V413, P593, DOI 10.1016/j.jmb.2011.08.055; Mihalyi A, 2014, BIOORGAN MED CHEM, V22, P4566, DOI 10.1016/j.bmc.2014.07.035; Mol CD, 2003, J BACTERIOL, V185, P4152, DOI 10.1128/JB.185.14.4152-4162.2003; Muller A, 2012, J BIOL CHEM, V287, P20270, DOI 10.1074/jbc.M112.369561; Packiam M, 2015, P NATL ACAD SCI USA, V112, P11660, DOI 10.1073/pnas.1514026112; Rausch S, 2011, CHEMBIOCHEM, V12, P1171, DOI 10.1002/cbic.201100120; Roos C, 2012, BBA-BIOMEMBRANES, V1818, P3098, DOI 10.1016/j.bbamem.2012.08.007; Rubinchik E, 2011, ANTIMICROB AGENTS CH, V55, P2743, DOI 10.1128/AAC.00170-11; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schneider B, 2010, METHODS MOL BIOL, V601, P165, DOI 10.1007/978-1-60761-344-2_11; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Sheng JY, 2014, APPL MICROBIOL BIOT, V98, P1785, DOI 10.1007/s00253-013-5467-8; Skarzynski T, 1996, STRUCTURE, V4, P1465, DOI 10.1016/S0969-2126(96)00153-0; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Yan YW, 2000, J MOL BIOL, V304, P435, DOI 10.1006/jmbi.2000.4215	45	43	43	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2535	2546		10.1074/jbc.M115.664292	http://dx.doi.org/10.1074/jbc.M115.664292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26620564	Green Published, hybrid			2022-12-26	WOS:000369610400040
J	Fiscella, K; Winters, P; Farah, S; Sanders, M; Mohile, SG				Fiscella, Kevin; Winters, Paul; Farah, Subrina; Sanders, Mechelle; Mohile, Supriya G.			Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics?	PLOS ONE			English	Article							RACIAL-DIFFERENCES; PREVENTION; NUMBER; HEALTH	Background Black patients have higher lung cancer risk despite lower pack years of smoking. We assessed lung cancer risk by race, ethnicity, and sex among a nationally representative population eligible for lung cancer screening based on Medicare criteria. Methods We used data from the National Health and Nutrition Examination Survey, 2007-2012 to assess lung cancer risk by sex, race and ethnicity among persons satisfying Medicare age and pack-year smoking eligibility criteria for lung cancer screening. We assessed Medicare eligibility based on age (55-77 years) and pack-years (>= 30). We assessed 6-year lung cancer risk using a risk prediction model from Prostate, Lung, Colorectal and Ovarian Cancer Screening trial that was modified in 2012 (PLCOm2012). We compared the proportions of eligible persons by sex, race and ethnicity using Medicare criteria with a risk cut-point that was adjusted to achieve comparable total number of persons eligible for screening. Results Among the 29.7 million persons aged 55-77 years who ever smoked, we found that 7.3 million (24.5%) were eligible for lung cancer screening under Medicare criteria. Among those eligible, Blacks had statistically significant higher (4.4%) and Hispanics lower lung cancer risk (1.2%) than non-Hispanic Whites (3.2%). At a cut-point of 2.12% risk for lung screening eligibility, the percentage of Blacks and Hispanics showed statistically significant changes. Blacks eligible rose by 48% and Hispanics eligible declined by 63%. Black men and Hispanic women were affected the most. There was little change in eligibility among Whites. Conclusion Medicare eligibility criteria for lung cancer screening do not align with estimated risk for lung cancer among Blacks and Hispanics. Data are urgently needed to determine whether use of risk-based eligibility screening improves lung cancer outcomes among minority patients.	[Fiscella, Kevin; Winters, Paul; Farah, Subrina; Sanders, Mechelle] Univ Rochester, Med Ctr, Dept Family Med, Rochester, NY 14642 USA; [Fiscella, Kevin] Univ Rochester, Med Ctr, Dept Publ Hlth Sci, Rochester, NY 14642 USA; [Mohile, Supriya G.] Univ Rochester, Med Ctr, Dept Med, Div Oncol, Rochester, NY 14642 USA; [Mohile, Supriya G.] Wilmot Canc Ctr, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Fiscella, K (corresponding author), Univ Rochester, Med Ctr, Dept Family Med, Rochester, NY 14642 USA.	kevin_fiscella@urmc.rochester.edu	Fiscella, Kevin Anthony/AFO-3350-2022; Mohile, Supriya/AHD-3603-2022	Fiscella, Kevin Anthony/0000-0003-3613-8012; 				Aberle DR, 2013, J CLIN ONCOL, V31, P1002, DOI 10.1200/JCO.2012.43.3110; Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; Benowitz NL, 2011, NICOTINE TOB RES, V13, P772, DOI 10.1093/ntr/ntr072; Berg JZ, 2010, J PHARMACOL EXP THER, V332, P202, DOI 10.1124/jpet.109.159855; Bindman A, 2015, JAMA-J AM MED ASSOC, V313, P17, DOI 10.1001/jama.2014.16429; Cote ML, 2005, JAMA-J AM MED ASSOC, V293, P3036, DOI 10.1001/jama.293.24.3036; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Fairley T. L., 2010, Morbidity and Mortality Weekly Report, V59, P1433; Federman DG, 2014, AM J MED; Field JK, 2013, LANCET, V382, P732, DOI 10.1016/S0140-6736(13)61614-1; Fiscella K, 2011, J HEALTH CARE POOR U, V22, P83, DOI 10.1353/hpu.2011.0023; Forrest LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001376; Fox JB, 2015, AM J PUBLIC HEALTH, V105, pE7, DOI 10.2105/AJPH.2014.302289; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Howe HL, 2006, CANCER-AM CANCER SOC, V107, P1711, DOI 10.1002/cncr.22193; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Johnson C.L., 2013, NATL HLTH NUTR EXAMI, P1999; Koh HK, 2010, NEW ENGL J MED, V363, P1296, DOI 10.1056/NEJMp1008560; Kohler BA, 2015, JNCI-J NATL CANCER I, P107; Latham K, 2012, J GERONTOLOGY B; Li K, 2015, CANCER PREVENTION RE; Ma JM, 2013, CANCER-AM CANCER SOC, V119, P1381, DOI 10.1002/cncr.27813; Montani F, 2015, JNCI-J NATL CANCER I, V107; Moyer VA, 2014, ANN INTERN MED, V160, P55, DOI 10.7326/M13-2568; National Center for Health Statistics, 2013, NAT HLTH NUTR EX SUR; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Persell SD, 2013, J GEN INTERN MED, V28, P554, DOI 10.1007/s11606-012-2268-1; Shillinglaw B, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-20; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; St Helen G, 2013, ADDICTION, V108, P607, DOI 10.1111/j.1360-0443.2012.04077.x; Tammemagi MC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001764; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Walsh KM, 2013, CANCER EPIDEM BIOMAR, V22, P251, DOI 10.1158/1055-9965.EPI-12-1007-T; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Williams CD, 2013, J CLIN ONCOL, V31, P475, DOI 10.1200/JCO.2012.44.1170; Zaslavsky AM, 2012, HEALTH SERV RES, V47, P1300, DOI 10.1111/j.1475-6773.2012.01411.x	37	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143789	10.1371/journal.pone.0143789	http://dx.doi.org/10.1371/journal.pone.0143789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7NW	26618478	gold, Green Submitted, Green Published			2022-12-26	WOS:000365889800071
J	Heckler, EJ; Kholodovych, V; Jain, M; Liu, T; Li, H; Beuve, A				Heckler, Erin J.; Kholodovych, Vladyslav; Jain, Mohit; Liu, Tong; Li, Hong; Beuve, Annie			Mapping Soluble Guanylyl Cyclase and Protein Disulfide Isomerase Regions of Interaction	PLOS ONE			English	Article							NITRIC-OXIDE; CATALYTIC DOMAINS; HEME DOMAIN; ACTIVATION; RECEPTOR; DOCKING	Soluble guanylyl cyclase (sGC) is a heterodimeric nitric oxide (NO) receptor that produces cyclic GMP. This signaling mechanism is a key component in the cardiovascular system. NO binds to heme in the beta subunit and stimulates the catalytic conversion of GTP to cGMP several hundred fold. Several endogenous factors have been identified that modulate sGC function in vitro and in vivo. In previous work, we determined that protein disulfide isomerase (PDI) interacts with sGC in a redox-dependent manner in vitro and that PDI inhibited NO-stimulated activity in cells. To our knowledge, this was the first report of a physical interaction between sGC and a thiol-redox protein. To characterize this interaction between sGC and PDI, we first identified peptide linkages between sGC and PDI, using a lysine cross-linking reagent and recently developed mass spectrometry analysis. Together with Flag-immunoprecipitation using sGC domain deletions, wild-type (WT) and mutated PDI, regions of sGC involved in this interaction were identified. The observed data were further explored with computational modeling to gain insight into the interaction mechanism between sGC and oxidized PDI. Our results indicate that PDI interacts preferentially with the catalytic domain of sGC, thus providing a mechanism for PDI inhibition of sGC. A model in which PDI interacts with either the a or the beta catalytic domain is proposed.	[Heckler, Erin J.; Beuve, Annie] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol & Physiol & Neurosci, Newark, NJ 07102 USA; [Kholodovych, Vladyslav] Rutgers State Univ, OIRT, High Performance & Res Comp, New Brunswick, NJ 08903 USA; [Kholodovych, Vladyslav] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Jain, Mohit; Liu, Tong; Li, Hong] Rutgers State Univ, New Jersey Med Sch, Prote Core, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Beuve, A (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol & Physiol & Neurosci, Newark, NJ 07102 USA.	beuveav@njms.rutgers.edu	Li, Hong/K-8436-2013	Heckler, Erin/0000-0002-9156-1318; Li, Hong/0000-0001-5731-5335	National Institutes of Health [GM067640, NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112415, R01GM067640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, grant GM067640 to AB, and grant NS046593 to HL for the support of Rutgers Neuroproteomics Core facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androwiki ACD, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00024; [Anonymous], 2015, MOLECULAR OPERATING; Baskaran P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026976; Baskaran P, 2011, BIOCHEMISTRY-US, V50, P4291, DOI 10.1021/bi2004087; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bernardoni P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.113; Busker M, 2014, J BIOL CHEM, V289, P476, DOI 10.1074/jbc.M113.504472; Cai CM, 2012, MOL ENDOCRINOL, V26, P292, DOI 10.1210/me.2010-0394; Campbell MG, 2014, P NATL ACAD SCI USA, V111, P2960, DOI 10.1073/pnas.1400711111; Case J. T. B. D. A., 2015, AMBER 2015; Fritz BG, 2013, BIOCHEMISTRY-US, V52, P1568, DOI 10.1021/bi301570m; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Haase T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011617; Heckler EJ, 2013, BIOCHEM J, V452, P161, DOI 10.1042/BJ20130298; Kallakunta VM, 2013, REDOX BIOL, V1, P373, DOI 10.1016/j.redox.2013.07.002; Kraehling JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025772; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Rancy PC, 2008, BIOCHEMISTRY-US, V47, P12047, DOI 10.1021/bi801604x; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Seeger F, 2014, BIOCHEMISTRY-US, V53, P2153, DOI 10.1021/bi500129k; Sobierajska K, 2014, J BIOL CHEM, V289, P5758, DOI 10.1074/jbc.M113.479477; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Underbakke ES, 2014, STRUCTURE, V22, P602, DOI 10.1016/j.str.2014.01.008; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Xu H, 2008, J PROTEOME RES, V7, P138, DOI 10.1021/pr070363z	28	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143523	10.1371/journal.pone.0143523	http://dx.doi.org/10.1371/journal.pone.0143523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618351	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800043
J	Taylor, ZN; Rice, DW; Palmer, JD				Taylor, Z. Nathan; Rice, Danny W.; Palmer, Jeffrey D.			The Complete Moss Mitochondrial Genome in the Angiosperm Amborella Is a Chimera Derived from Two Moss Whole-Genome Transfers	PLOS ONE			English	Article							EARLY LAND PLANTS; HORIZONTAL TRANSFER; GENE CONVERSION; DNA; PHYLOGENY; RECOMBINATION; ORIGIN; LOCUS; DIVERSIFICATION; REARRANGEMENTS	Sequencing of the 4-Mb mitochondrial genome of the angiosperm Amborella trichopoda has shown that it contains unprecedented amounts of foreign mitochondrial DNA, including four blocks of sequences that together correspond almost perfectly to one entire moss mitochondrial genome. This implies whole-genome transfer from a single moss donor but conflicts with phylogenetic results from an earlier, PCR-based study that suggested three different moss donors to Amborella. To resolve this conflict, we conducted an expanded set of phylogenetic analyses with respect to both moss lineages and mitochondrial loci. The moss DNA in Amborella was consistently placed in either of two positions, depending on the locus analyzed, as sister to the Ptychomniales or within the Hookeriales. This agrees with two of the three previously suggested donors, whereas the third is no longer supported. These results, combined with synteny analyses and other considerations, lead us to favor a model involving two successive moss-to-Amborella whole-genome transfers, followed by recombination that produced a single intact and chimeric moss mitochondrial genome integrated in the Amborella mitochondrial genome. Eight subsequent recombination events account for the state of fragmentation, rearrangement, duplication, and deletion of this chimeric moss mitochondrial genome as it currently exists in Amborella. Five of these events are associated with short-to-intermediate sized repeats. Two of the five probably occurred by reciprocal homologous recombination, whereas the other three probably occurred in a non-reciprocal manner via microhomology-mediated break-induced replication (MMBIR). These findings reinforce and extend recent evidence for an important role of MMBIR in plant mitochondrial DNA evolution.	[Taylor, Z. Nathan; Rice, Danny W.; Palmer, Jeffrey D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Palmer, JD (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jpalmer@indiana.edu	Palmer, Jeffrey/P-6747-2014	Palmer, Jeffrey/0000-0002-4626-2220; Rice, Danny/0000-0002-1123-4617	National Institutes of Health [RO1-GM-76012]; National Science Foundation [BSR-0910400, 1062432]; Lilly Endowment	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Lilly Endowment	This work was supported by the National Institutes of Health (RO1-GM-76012 to JDP), the National Science Foundation (BSR-0910400 to ZNT and JDP and 1062432 to Indiana University, which supported the computer cluster on which many of the analyses in this paper were performed), and the Lilly Endowment-funded METACyt Initiative of Indiana University.	Barkman TJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-248; Beckert S, 2001, MOL PHYLOGENET EVOL, V18, P117, DOI 10.1006/mpev.2000.0868; Bell NE, 2007, BRYOLOGIST, V110, P533, DOI 10.1639/0007-2745(2007)110[533:TAPITE]2.0.CO;2; Bendich AJ, 1996, J MOL BIOL, V255, P564, DOI 10.1006/jmbi.1996.0048; Bergthorsson U, 2004, P NATL ACAD SCI USA, V101, P17747, DOI 10.1073/pnas.0408336102; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Buck WR, 2004, SYST BIODIVERS, V2, P121; Cappadocia L, 2010, PLANT CELL, V22, P1849, DOI 10.1105/tpc.109.071399; Chang Y, 2011, AM J BOT, V98, P839, DOI 10.3732/ajb.0900384; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Drew BT, 2014, SYST BIOL, V63, P368, DOI 10.1093/sysbio/syt108; Geffert JL, 2013, J BRYOL, V35, P1, DOI 10.1179/1743282012Y.0000000038; Goremykin VV, 2013, SYST BIOL, V62, P50, DOI 10.1093/sysbio/sys070; Hao WL, 2010, P NATL ACAD SCI USA, V107, P21576, DOI 10.1073/pnas.1016295107; Hao WL, 2009, P NATL ACAD SCI USA, V106, P16728, DOI 10.1073/pnas.0908766106; HARTMANN C, 1994, CURR GENET, V25, P456, DOI 10.1007/BF00351786; Hepburn NJ, 2012, MOL BIOL EVOL, V29, P3111, DOI 10.1093/molbev/mss130; Janicka S, 2012, PLANT J, V72, P423, DOI 10.1111/j.1365-313X.2012.05097.x; KANAZAWA A, 1994, GENETICS, V138, P865; Kato S, 1998, CURR GENET, V34, P303, DOI 10.1007/s002940050400; Kuhn K, 2012, ADV BOT RES, V63, P215, DOI 10.1016/B978-0-12-394279-1.00009-0; Liu Y, 2014, SYST BIOL, V63, P862, DOI 10.1093/sysbio/syu049; Liu Y, 2014, MOL BIOL EVOL, V31, P2586, DOI 10.1093/molbev/msu199; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025836; LONSDALE DM, 1984, NUCLEIC ACIDS RES, V12, P9249, DOI 10.1093/nar/12.24.9249; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; MOEYKENS CA, 1995, PLANT MOL BIOL, V29, P245, DOI 10.1007/BF00043649; Mower JP, 2012, ADV BOT RES, V63, P41, DOI 10.1016/B978-0-12-394279-1.00003-X; Mower JP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-150; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Renner S.S., 2012, ADV PHOTOSYNTHESIS R, V35, P223; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Satoh M, 2006, THEOR APPL GENET, V113, P477, DOI 10.1007/s00122-006-0312-4; Scotti N, 2004, CURR GENET, V45, P378, DOI 10.1007/s00294-004-0496-6; Shaw AJ, 2011, AM J BOT, V98, P352, DOI 10.3732/ajb.1000316; Shaw J, 2004, AM J BOT, V91, P1557, DOI 10.3732/ajb.91.10.1557; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sloan DB, 2013, NEW PHYTOL, V200, P978, DOI 10.1111/nph.12395; Sloan DB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-274; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Swafford D. L., 2002, PAUP PHYLOGENETIC AN; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Thouvenot L, 2010, CRYPTOGAMIE BRYOL, V31, P163; Volkmar U, 2010, J MOL EVOL, V70, P506, DOI 10.1007/s00239-010-9348-9; Wahrmund U, 2010, MOL PHYLOGENET EVOL, V54, P417, DOI 10.1016/j.ympev.2009.09.031; Wahrmund U, 2009, PLANT SYST EVOL, V282, P241, DOI 10.1007/s00606-008-0043-x; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Xi ZX, 2014, SYST BIOL, V63, P919, DOI 10.1093/sysbio/syu055; Zwickl DJ., 2006, GENETIC ALGORITHM AP	51	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0137532	10.1371/journal.pone.0137532	http://dx.doi.org/10.1371/journal.pone.0137532			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618775	Green Published, gold			2022-12-26	WOS:000365889800001
J	Treaster, SB; Chaudhuri, AR; Austad, SN				Treaster, Stephen B.; Chaudhuri, Asish R.; Austad, Steven N.			Longevity and GAPDH Stability in Bivalves and Mammals: A Convenient Marker for Comparative Gerontology and Proteostasis	PLOS ONE			English	Article							QUAHOG ARCTICA-ISLANDICA; HEAT-SHOCK PROTEINS; LIFE-SPAN; DIETARY RESTRICTION; ALZHEIMERS-DISEASE; OXIDATIVE DAMAGE; RAT-BRAIN; AGE; STRESS; OSMOLYTES	Background Comparative aging studies, particularly those that include species of exceptional resistance to aging processes, can potentially illuminate novel senescence-retarding mechanisms. In recent years, protein homeostasis (proteostasis) has been implicated in fundamental aging processes. Here we further evaluate the relationship between proteostasis and longevity in a selection of bivalve mollusks and mammals with maximum longevities ranging from 3 to 507 years. Methods & Results We experimentally examined proteostasis using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a reporter, as it is ubiquitously expressed, highly conserved, and conveniently assayed. The ability to maintain this enzymatic function was tested with increasing concentrations of the chaotropic agent urea, revealing a robust relationship with longevity in bivalves and mice. While our shortest-lived mollusk and mouse lost all activity by 2.5 and 3.5 M urea respectively, the longest-lived mollusk species, Arctica islandica, still preserved 45% of its basal function even at 6 M urea. To confirm that GAPDH proteostasis has a broad association with longevity, we also investigated a selection of primate species ranging in maximum longevity from 22 to 122 years. They outperformed the mouse at all concentrations, but among the primates results were variable at low urea doses. Still, at 6 M urea baboon and human samples retained 10% of their activity while both mouse and marmoset samples had no activity. Mechanism of Exceptional Stress Resistance To explore possible mechanisms of the exceptional stress resistance of A. islandica GAPDH we enzymatically removed post-translational glycosylation, but observed no decrease in stability. We also removed molecules smaller than 30 kDa, which includes most small heat shock proteins, but again did not compromise the exceptional stress resistance of Arctica GAPDH. Conclusion While the mechanism underlying A. islandica's exceptional stress resistance remains elusive, this research identifies an experimental system that may reveal hitherto unknown mechanisms of protein homeostasis.	[Treaster, Stephen B.; Chaudhuri, Asish R.; Austad, Steven N.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Treaster, Stephen B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Austad, SN (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	austad@uab.edu		Treaster, Stephen/0000-0002-1651-4570	National Institutes of Health [P30 AG13319, R01 AG035327, T32 AG021890]; Barshop Institute for Longevity and Aging Studies; NATIONAL INSTITUTE ON AGING [R01AG035327, T32AG021890, P30AG013319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barshop Institute for Longevity and Aging Studies; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health (http://www.nia.nih.gov/) (grants P30 AG13319, [Center Grant, SNA Core Director, R01 AG035327 (SNA), and T32 AG021890 (SNA)]) and the Barshop Institute for Longevity and Aging Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2008, FREE RADICAL RES, V42, P474, DOI 10.1080/10715760802108849; [Anonymous], 1999, WALKERS MAMMALS WORL; [Anonymous], 1998, BIOL CHEM, V379, P245; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009; Bolen DW, 2004, METHODS, V34, P312, DOI 10.1016/j.ymeth.2004.03.022; Chong ZZ, 2012, PROG NEUROBIOL, V99, P128, DOI 10.1016/j.pneurobio.2012.08.001; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Doran P, 2009, PROTEOMICS, V9, P989, DOI 10.1002/pmic.200800365; Dubey A, 1996, ARCH BIOCHEM BIOPHYS, V333, P189, DOI 10.1006/abbi.1996.0380; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Graziotto JJ, 2012, AUTOPHAGY, V8, P147, DOI 10.4161/auto.8.1.18331; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Krebs E, 1955, METHOD ENZYMOL, P1; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; Moore SA, 1998, MECH AGEING DEV, V104, P59, DOI 10.1016/S0047-6374(98)00052-9; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Nishijima K, 2012, BIOGERONTOLOGY, V13, P439, DOI 10.1007/s10522-012-9388-1; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Oyama R, 2000, BBA-PROTEIN STRUCT M, V1479, P91, DOI 10.1016/S0167-4838(00)00057-1; Park J, 2009, BBA-PROTEINS PROTEOM, V1794, P254, DOI 10.1016/j.bbapap.2008.10.003; Philipp E, 2005, MECH AGEING DEV, V126, P598, DOI 10.1016/j.mad.2004.12.003; Ponurovskii SK, 2008, RUSS J MAR BIOL+, V34, P329, DOI 10.1134/S1063074008050106; POWELL EN, 1985, OECOLOGIA, V67, P177, DOI 10.1007/BF00384281; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Reis-Rodrigues P, 2012, AGING CELL, V11, P120, DOI 10.1111/j.1474-9726.2011.00765.x; Richardson CA, 2001, OCEANOGR MAR BIOL, V39, P103; RICHARDSON CA, 1991, ICES J MAR SCI, V48, P229, DOI 10.1093/icesjms/48.2.229; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P130, DOI 10.1016/j.palaeo.2005.03.049; SCHULZE H, 1993, J NEUROCHEM, V60, P1915, DOI 10.1111/j.1471-4159.1993.tb13420.x; Selsby JT, 2005, EXP GERONTOL, V40, P37, DOI 10.1016/j.exger.2004.08.012; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Strahl J, 2007, AQUAT BIOL, V1, P77, DOI 10.3354/ab00008; Treaster SB, 2014, AGE, V36, P1009, DOI 10.1007/s11357-013-9597-9; Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P741, DOI 10.1093/gerona/glr044; VEGARUD G, 1975, BIOTECHNOL BIOENG, V17, P1391, DOI 10.1002/bit.260170918; Velick S, 1955, METHOD ENZYMOL, P1; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Wanamaker AD, 2008, RADIOCARBON, V50, P399, DOI 10.1017/S0033822200053510; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yancey PH, 2001, AM ZOOL, V41, P699, DOI 10.1668/0003-1569(2001)041[0699:WSOAP]2.0.CO;2; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	58	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143680	10.1371/journal.pone.0143680	http://dx.doi.org/10.1371/journal.pone.0143680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619001	Green Published, gold			2022-12-26	WOS:000365889800057
J	Abecassis, M; Polovina, J; Baird, RW; Copeland, A; Drazen, JC; Domokos, R; Oleson, E; Jia, YL; Schorr, GS; Webster, DL; Andrews, RD				Abecassis, Melanie; Polovina, Jeffrey; Baird, Robin W.; Copeland, Adrienne; Drazen, Jeffrey C.; Domokos, Reka; Oleson, Erin; Jia, Yanli; Schorr, Gregory S.; Webster, Daniel L.; Andrews, Russel D.			Characterizing a Foraging Hotspot for Short-Finned Pilot Whales and Blainville's Beaked Whales Located off the West Side of Hawai'i Island by Using Tagging and Oceanographic Data	PLOS ONE			English	Article							CUVIERS ZIPHIUS-CAVIROSTRIS; KILLER WHALES; OCEAN; MICRONEKTON; MOVEMENTS; ABUNDANCE; BEHAVIOR; EDDIES; MODEL; SELECTION	Satellite tagging data for short-finned pilot whales (Globicephala macrorhynchus) and Blainville's beaked whales (Mesoplodon densirostris) were used to identify core insular foraging regions off the Kona (west) Coast of Hawai'i Island. Ship-based active acoustic surveys and oceanographic model output were used in generalized additive models (GAMs) and mixed models to characterize the oceanography of these regions and to examine relationships between whale density and the environment. The regions of highest density for pilot whales and Blainville's beaked whales were located between the 1000 and 2500 m isobaths and the 250 and 2000 m isobaths, respectively. Both species were associated with slope waters, but given the topography of the area, the horizontal distribution of beaked whales was narrower and located in shallower waters than that of pilot whales. The key oceanographic parameters characterizing the foraging regions were bathymetry, temperature at depth, and a high density of midwater micronekton scattering at 70 kHz in 400-650 m depths that likely represent the island-associated deep mesopelagic boundary community and serve as prey for the prey of the whales. Thus, our results suggest that off the Kona Coast, and potentially around other main Hawaiian Islands, the deep mesopelagic boundary community is key to a food web that supports insular cetacean populations.	[Abecassis, Melanie] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Polovina, Jeffrey; Domokos, Reka; Oleson, Erin] NOAA Fisheries, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Baird, Robin W.; Schorr, Gregory S.; Webster, Daniel L.] Cascadia Res Collect, Olympia, WA USA; [Copeland, Adrienne] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Drazen, Jeffrey C.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Jia, Yanli] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Andrews, Russel D.] Alaska SeaLife Ctr, Seward, AK USA; [Andrews, Russel D.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA	University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii System; University of Hawaii System; University of Alaska System; University of Alaska Fairbanks	Abecassis, M (corresponding author), Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	melanie.abecassis@noaa.gov	Domokos, Réka/H-5567-2019; Drazen, Jeffrey/C-1197-2013; Oleson, Erin/AAA-9681-2019; Baird, Robin/Y-8230-2019	Domokos, Réka/0000-0003-3297-4793; Drazen, Jeffrey/0000-0001-9613-3833; Oleson, Erin/0000-0002-4889-6059; Baird, Robin/0000-0002-9419-6336; Andrews, Russel/0000-0002-4545-137X; Copeland, Adrienne/0000-0002-7284-681X	NOAA Fisheries [13-11, AB133F07CN0220, AB133F08SE4534, AB133F09SE4843]; Office of Naval Research [N00140811203, N000141010686]; ONR [N000141110612, N000141210205]; Woods Hole Oceanographic Institution [D100115]	NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA); Office of Naval Research(Office of Naval Research); ONR(Office of Naval Research); Woods Hole Oceanographic Institution	This work was supported by Project 13-11 from the NOAA Fisheries and the Environment program: http://www.st.nmfs.noaa.gov/fate/Resources/Projects/index (MA), Grants No. N00140811203 and N000141010686 from Office of Naval Research, www.onr.navy.mil (RDA, RWB, GSS, DLW), Grant No. N000141110612 from ONR, www.onr.navy.mil (RWB, DLW), Grant No. N000141210205 from ONR, www.onr.navy.mil (AC), Sub-contract No. D100115 from Woods Hole Oceanographic Institution, www.whoi.edu (RWB, GSS, DLW) and Contracts AB133F07CN0220, AB133F08SE4534, AB133F09SE4843 from NOAA Fisheries to Cascadia Research Project (RWB, GSS, DLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073274; Abecassis M, 2012, MAR ECOL PROG SER, V452, P219, DOI 10.3354/meps09583; Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; Arranz P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028353; Baird RW, 2008, MAR MAMMAL SCI, V24, P630, DOI 10.1111/j.1748-7692.2008.00211.x; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; Baird RW, 2013, AQUAT MAMM, V39, P253, DOI 10.1578/AM.39.3.2013.253; Baird Robin W., 2012, Endangered Species Research, V18, P47, DOI 10.3354/esr00435; Baird RW, 2011, AQUAT MAMM, V37, P506, DOI 10.1578/AM.37.4.2011.506; Baird RW, 2013, NICHE PARTITIONING B; Baird RW, 2003, 15 BIENN C BIOL MAR, P14; Barlow J, 2006, MAR MAMMAL SCI, V22, P446, DOI 10.1111/j.1748-7692.2006.00032.x; Barlow Jay, 2005, Journal of Cetacean Research and Management, V7, P263; Benoit-Bird KJ, 2006, MAR ECOL PROG SER, V319, P1, DOI 10.3354/meps319001; Benoit-Bird KJ, 2004, DEEP-SEA RES PT I, V51, P707, DOI 10.1016/j.dsr.2004.01.004; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Benoit-Bird KJ, 2001, DIEL HORIZONTAL MIGR; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Bradford AL, 2013, WP13004 NOAA PIFSC; Chassignet EP, 2003, J PHYS OCEANOGR, V33, P2504, DOI 10.1175/1520-0485(2003)033<2504:NASWTH>2.0.CO;2; De Robertis A, 2007, ICES J MAR SCI, V64, P1282, DOI 10.1093/icesjms/fsm112; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Drazen JC, 2011, DEEP-SEA RES PT I, V58, P557, DOI 10.1016/j.dsr.2011.03.002; Foote KG, 1987, 114 ICES, V144, P69; Forney Karin A., 2012, Endangered Species Research, V16, P113, DOI 10.3354/esr00393; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Halliwell GR, 2004, OCEAN MODEL, V7, P285, DOI 10.1016/j.ocemod.2003.10.002; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hazen EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019269; Jia Y, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007305; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; MacLeod CD, 2006, MAR ECOL PROG SER, V326, P295, DOI 10.3354/meps326295; MacLeod CD, 2003, J MAR BIOL ASSOC UK, V83, P651, DOI 10.1017/S0025315403007616h; Mahaffy Sabre D., MAR MAMMAL IN PRESS; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; Oleson EM, 2013, WP13003 NOAA PIFSC; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; R Core Team, 2018, R LANG ENV STAT COMP; REID SB, 1991, MAR BIOL, V109, P427, DOI 10.1007/BF01313508; Rodhouse PG, 1996, PHILOS T ROY SOC B, V351, P1003, DOI 10.1098/rstb.1996.0090; Schorr Gregory S., 2010, Endangered Species Research, V10, P203, DOI 10.3354/esr00229; Seifert B, 1998, ENCY STAT SCI, V2, P367; Seifert Burkhardt, 2013, IPRIDGE LOCAL POLYNO; Seki MP, 2002, J OCEANOGR, V58, P739, DOI 10.1023/A:1022854609312; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Stevenson TC, 2011, ICES J MAR SCI, V68, P813, DOI 10.1093/icesjms/fsr020; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Venables WN., 2002, MODERN APPL STAT S 4; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodworth PA, 2012, MAR MAMMAL SCI, V28, P638, DOI 10.1111/j.1748-7692.2011.00509.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	56	30	32	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142628	10.1371/journal.pone.0142628	http://dx.doi.org/10.1371/journal.pone.0142628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605917	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300024
J	Cohen, R; Lata, JP; Lee, Y; Hernandez, JCC; Nishimura, N; Schaffer, CB; Mukai, C; Nelson, JL; Brangman, SA; Agrawal, Y; Travis, AJ				Cohen, Roy; Lata, James P.; Lee, Yurim; Hernandez, Jean C. Cruz; Nishimura, Nozomi; Schaffer, Chris B.; Mukai, Chinatsu; Nelson, Jacquelyn L.; Brangman, Sharon A.; Agrawal, Yash; Travis, Alexander J.			Use of Tethered Enzymes as a Platform Technology for Rapid Analyte Detection	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CEREBROSPINAL-FLUID; FIREFLY LUCIFERASE; MURINE SPERMATOZOA; HUMAN-SERUM; ASSAY; ATP; NUCLEOTIDES	Rapid diagnosis for time-sensitive illnesses such as stroke, cardiac arrest, and septic shock is essential for successful treatment. Much attention has therefore focused on new strategies for rapid and objective diagnosis, such as Point-of-Care Tests (PoCT) for blood biomarkers. Here we use a biomimicry-based approach to demonstrate a new diagnostic platform, based on enzymes tethered to nanoparticles (NPs). As proof of principle, we use oriented immobilization of pyruvate kinase (PK) and luciferase (Luc) on silica NPs to achieve rapid and sensitive detection of neuron-specific enolase (NSE), a clinically relevant biomarker for multiple diseases ranging from acute brain injuries to lung cancer. We hypothesize that an approach capitalizing on the speed and catalytic nature of enzymatic reactions would enable fast and sensitive biomarker detection, suitable for PoCT devices.	[Cohen, Roy; Lata, James P.; Mukai, Chinatsu; Nelson, Jacquelyn L.; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Lata, James P.; Lee, Yurim; Hernandez, Jean C. Cruz; Nishimura, Nozomi; Schaffer, Chris B.; Travis, Alexander J.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Brangman, Sharon A.] SUNY Upstate Med Univ, Cent New York ADAC, Syracuse, NY 13210 USA; [Agrawal, Yash] Cornell Univ, New York Presbyterian Hosp, Ithaca, NY 10065 USA; [Travis, Alexander J.] Cornell Univ, Atkinson Ctr Sustainable Future, Ithaca, NY 14853 USA	Cornell University; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cornell University; NewYork-Presbyterian Hospital; Cornell University	Travis, AJ (corresponding author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Hungerford Hill Rd, Ithaca, NY 14853 USA.	ajt32@cornell.edu	Nishimura, Nozomi/AAV-2425-2020; Nishimura, Nozomi/P-8908-2015; Schaffer, Chris B./A-7409-2008	Nishimura, Nozomi/0000-0003-4342-9416; Nishimura, Nozomi/0000-0003-4342-9416; Schaffer, Chris B./0000-0002-7800-9596; Mukai, Chinatsu/0000-0003-0080-9371	NIH [8DP1-EB016541, F32AG031620]; CTSC Seed Funding Program (NIH, Weill); SUNY Research Foundation; NATIONAL INSTITUTE ON AGING [F32AG031620] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSC Seed Funding Program (NIH, Weill); SUNY Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH, Pioneer Award 8DP1-EB016541 (originally 5DP1-OD-006431), "Nanoscale Energy Production for Implantable Medical Devices" (AJT); CTSC Seed Funding Program (NIH, Weill), Pilot Award, "Developing a Multiplexed Point-of-Care Platform to Detect Multiple Stroke Biomarkers" (AJT); NIH F32: F32AG031620 (NN); and the SUNY Research Foundation award, "Development of Hand-held Biosensors for Rapid Diagnosis and Study of Neural Disease & Neurotoxins" (AJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad O, 2012, CEREBROVASC DIS, V33, P47, DOI 10.1159/000332810; [Anonymous], GLOB BURD STROK; Brainin M, 2007, LANCET NEUROL, V6, P553, DOI 10.1016/S1474-4422(07)70005-4; Casmiro M, 2005, EUR J NEUROL, V12, P369, DOI 10.1111/j.1468-1331.2004.01021.x; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Chung JW, 2015, J STROKE, V17, P54, DOI 10.5853/jos.2015.17.1.54; Culler L, 2014, DIMENS CRIT CARE NUR, V33, P309, DOI [10.1097/DCC.0000000000000072, 10.1097/NCC.0000000000000185]; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Ford SR, 1996, J BIOLUM CHEMILUM, V11, P149, DOI 10.1002/(SICI)1099-1271(199605)11:3<149::AID-BIO411>3.0.CO;2-Q; FORD SR, 1994, ARCH BIOCHEM BIOPHYS, V314, P261, DOI 10.1006/abbi.1994.1440; Halliwell CM, 2001, ANAL BIOCHEM, V295, P257, DOI 10.1006/abio.2001.5182; Hasan N, 2012, BRIT J CLIN PHARMACO, V74, P230, DOI 10.1111/j.1365-2125.2012.04212.x; Hayashi T, 2001, BIOCHEM BIOPH RES CO, V287, P843, DOI 10.1006/bbrc.2001.5666; Kleindorfer D, 2013, STROKE, V44, pS129, DOI 10.1161/STROKEAHA.113.001457; Lata JP, 2015, BIOCONJUGATE CHEM, V26, P1931, DOI 10.1021/acs.bioconjchem.5b00354; Maiser SJ, 2011, INT J STROKE, V6, P25, DOI 10.1111/j.1747-4949.2010.00537.x; Marginean I C, 2011, J Med Life, V4, P148; Mukai C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061434; Mukai C, 2009, CHEM BIOL, V16, P1013, DOI 10.1016/j.chembiol.2009.08.009; Naik RR, 2002, J NANOSCI NANOTECHNO, V2, P95, DOI 10.1166/jnn.2002.074; Nakamura M, 2004, BIOTECHNOL LETT, V26, P1061, DOI 10.1023/B:BILE.0000032966.17759.08; Norrving B, 2013, NEUROLOGY, V80, pS5, DOI 10.1212/WNL.0b013e3182762397; Oren EE, 2010, LANGMUIR, V26, P11003, DOI 10.1021/la100049s; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Song YJ, 2014, TRENDS BIOTECHNOL, V32, P132, DOI 10.1016/j.tibtech.2014.01.003; Stippler M, 2007, J NEUROTRAUM, V24, P1347, DOI 10.1089/neu.2007.0277; Travis AJ, 1998, MOL BIOL CELL, V9, P263, DOI 10.1091/mbc.9.2.263; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; VIALLARD JL, 1985, NEUROCHEM RES, V10, P1555, DOI 10.1007/BF00988598; WEVERS RA, 1983, CLIN CHIM ACTA, V135, P159, DOI 10.1016/0009-8981(83)90131-6; WEVERS RA, 1988, CLIN CHIM ACTA, V178, P141, DOI 10.1016/0009-8981(88)90220-3; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006	33	3	3	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142326	10.1371/journal.pone.0142326	http://dx.doi.org/10.1371/journal.pone.0142326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605916	Green Published, gold			2022-12-26	WOS:000365865300014
J	Hu, JH; Gui, ST; Zhu, ZX; Wang, XL; Ke, WD; Ding, Y				Hu, Jihong; Gui, Songtao; Zhu, Zhixuan; Wang, Xiaolei; Ke, Weidong; Ding, Yi			Genome-Wide Identification of SSR and SNP Markers Based on Whole-Genome Re-Sequencing of a Thailand Wild Sacred Lotus (Nelumbo nucifera)	PLOS ONE			English	Article							GENETIC DIVERSITY; MICROSATELLITE MARKERS; EST-SSRS; CONSTRUCTION; L.	Genomic resources such as single nucleotide polymorphism (SNPs), insertions and deletions (InDels) and SSRs (simple sequence repeats) are essential for crop improvement and better utilization in genetic breeding. However, the resources for the sacred lotus (Nelumbo nucifera Gaertn.) are still limited. In the present study, to dissect large-scale genomic molecular marker resources for sacred lotus, we re-sequenced a Thailand sacred lotus cultivar 'Chiang Mai wild lotus' and compared with the reported lotus genome 'Middle lake wild lotus'. A total of 3,180,059 SNPs, 328, 251 InDels and 14,191 SVs were found between the two genomes. The functional impact analyses of these SNPs indicated that they may be involved in metabolic processes, binding, catalytic activity, etc. Mining the genome sequences for SSRs showed that 191,657 SSRs were identified with a frequency of one SSR per 4.23 kb and 103,656 SSR primer pairs were designed. Furthermore, 14, 502 EST-SSRs were also indentified using the available RNA-seq data in the NCBI. A subset of 150 SSRs (genomic and EST-SSRs) was randomly selected for validation and genetic diversity analysis. The genotypes could be easily distinguished using these SSR markers and the 'Chiang Mai wild lotus' was obviously differentiated from the other Chinese accessions. This study provides considerable amounts of genomic resources and markers for the quantitative trait locus (QTL) identification and molecular selection of the species, which could have a potential role in various applications in sacred lotus breeding.	[Hu, Jihong; Gui, Songtao; Zhu, Zhixuan; Wang, Xiaolei; Ding, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Ke, Weidong] Wuhan Natl Field Observat & Res Stn Aquat Vegetab, Wuhan Vegetable Sci Res Inst, Wuhan 430065, Peoples R China	Wuhan University	Ding, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	yiding@whu.edu.cn		Hu, Jihong/0000-0002-2512-4056; Gui, Songtao/0000-0001-6718-982X	National Natural Science Foundation of China [31271310]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is financially supported by National Natural Science Foundation of China (31271310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Duke J.A., 2002, HDB MED HERBS; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han YC, 2007, AQUAT BOT, V87, P141, DOI 10.1016/j.aquabot.2007.04.005; Hu JH, 2012, MOL BIOL REP, V39, P3637, DOI 10.1007/s11033-011-1138-y; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Kubo Nakao, 2009, Plant Genetic Resources Characterization and Utilization, V7, P260, DOI 10.1017/S1479262109356580; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Miller JS, 2002, AM J BOT, V89, P1907, DOI 10.3732/ajb.89.2.236; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Pan L, 2011, ANN APPL BIOL, V159, P428, DOI 10.1111/j.1744-7348.2011.00509.x; Pan L, 2007, MOL ECOL NOTES, V7, P1054, DOI 10.1111/j.1471-8286.2007.01774.x; Pan L, 2010, J HERED, V101, P71, DOI 10.1093/jhered/esp070; Rai KM, 2013, PLANT BIOTECHNOL J, V11, P953, DOI 10.1111/pbi.12088; Rohlf FJ, 2008, NTSYSPC NUMERICAL TA; Sahu J, 2012, BIOINFORMATION, V8, P260, DOI 10.6026/97320630008260; Sakai H, 2014, DNA RES, V21, P397, DOI 10.1093/dnares/dsu006; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Verma P, 2013, PLANT BIOTECHNOL J, V11, P894, DOI 10.1111/pbi.12082; Wang Y, 2013, PLANT J, V76, P557, DOI 10.1111/tpj.12313; Xiao SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124432; Xu J, 2013, DNA RES, V20, P497, DOI 10.1093/dnares/dst026; Xu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015952; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125702; Yang M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-653; Yang XH, 2011, GENETICA, V139, P1045, DOI 10.1007/s10709-011-9606-9; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yu H, 2008, J HERED, V99, P208, DOI 10.1093/jhered/esm124; Zhang Q, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-372; Zhang WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112223	40	14	17	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143765	10.1371/journal.pone.0143765	http://dx.doi.org/10.1371/journal.pone.0143765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606530	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300109
J	Leszczynska, AN; Majczynski, H; Wilczynski, GM; Slawinska, U; Cabaj, AM				Leszczynska, Anna N.; Majczynski, Henryk; Wilczynski, Grzegorz M.; Slawinska, Urszula; Cabaj, Anna M.			Thoracic Hemisection in Rats Results in Initial Recovery Followed by a Late Decrement in Locomotor Movements, with Changes in Coordination Correlated with Serotonergic Innervation of the Ventral Horn	PLOS ONE			English	Article							SPINAL-CORD-INJURY; OVERGROUND LOCOMOTION; IN-VITRO; FUNCTIONAL RECOVERY; COMMISSURAL INTERNEURONS; QUANTITATIVE ASSESSMENT; INTERLIMB COORDINATION; HINDLIMB COORDINATION; AXONAL PLASTICITY; 5-HT1A RECEPTORS	Lateral thoracic hemisection of the rodent spinal cord is a popular model of spinal cord injury, in which the effects of various treatments, designed to encourage locomotor recovery, are tested. Nevertheless, there are still inconsistencies in the literature concerning the details of spontaneous locomotor recovery after such lesions, and there is a lack of data concerning the quality of locomotion over a long time span after the lesion. In this study, we aimed to address some of these issues. In our experiments, locomotor recovery was assessed using EMG and CatWalk recordings and analysis. Our results showed that after hemisection there was paralysis in both hindlimbs, followed by a substantial recovery of locomotor movements, but even at the peak of recovery, which occurred about 4 weeks after the lesion, some deficits of locomotion remained present. The parameters that were abnormal included abduction, interlimb coordination and speed of locomotion. Locomotor performance was stable for several weeks, but about 3-4 months after hemisection secondary locomotor impairment was observed with changes in parameters, such as speed of locomotion, interlimb coordination, base of hindlimb support, hindlimb abduction and relative foot print distance. Histological analysis of serotonergic innervation at the lumbar ventral horn below hemisection revealed a limited restoration of serotonergic fibers on the ipsilateral side of the spinal cord, while on the contralateral side of the spinal cord it returned to normal. In addition, the length of these fibers on both sides of the spinal cord correlated with inter- and intralimb coordination. In contrast to data reported in the literature, our results show there is not full locomotor recovery after spinal cord hemisection. Secondary deterioration of certain locomotor functions occurs with time in hemisected rats, and locomotor recovery appears partly associated with reinnervation of spinal circuitry by serotonergic fibers.	[Leszczynska, Anna N.; Majczynski, Henryk; Wilczynski, Grzegorz M.; Slawinska, Urszula; Cabaj, Anna M.] PAS, Nencki Insitute Expt Biol, Warsaw, Poland; [Cabaj, Anna M.] PAS, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland	Polish Academy of Sciences; Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences	Majczynski, H (corresponding author), PAS, Nencki Insitute Expt Biol, Warsaw, Poland.	h.majczynski@nencki.gov.pl; a.cabaj@nencki.gov.pl	Slawinska, Urszula/R-4085-2016; Majczynski, Henryk/R-4119-2016; Slawinska, Urszula/AAV-9919-2021	Slawinska, Urszula/0000-0003-2856-2729; Majczynski, Henryk/0000-0003-1189-0363; Slawinska, Urszula/0000-0003-2856-2729; Wilczynski, Grzegorz/0000-0001-6667-0291	Polish Ministry of Science and High Education [N N404 584438]; European Union within the European Regional Development Fund [POIG 01.01.02-00-109/09]; Nencki Institute	Polish Ministry of Science and High Education(Ministry of Science and Higher Education, Poland); European Union within the European Regional Development Fund; Nencki Institute	This work was supported by the Nencki Institute statutory donation and grant nr. N N404 584438 from Polish Ministry of Science and High Education (www.nauka.gov.pl) and a grant from the European Union within the European Regional Development Fund, POIG 01.01.02-00-109/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antri M, 2003, EUR J NEUROSCI, V18, P1963, DOI 10.1046/j.1460-9568.2003.02916.x; Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Bannatyne BA, 2003, EUR J NEUROSCI, V18, P2273, DOI 10.1046/j.1460-9568.2003.02973.x; Barriere G, 2010, J NEUROPHYSIOL, V104, P1119, DOI 10.1152/jn.00255.2010; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Batschelet E, 1981, CIRCUKAR STAT BIOL; BEM T, 1995, EXP BRAIN RES, V104, P70, DOI 10.1007/BF00229856; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Brockett EG, 2013, NEUROSCIENCE, V240, P83, DOI 10.1016/j.neuroscience.2013.02.039; Camand E, 2004, EUR J NEUROSCI, V20, P1161, DOI 10.1111/j.1460-9568.2004.03558.x; Cloud BA, 2012, J NEUROSCI METH, V211, P179, DOI 10.1016/j.jneumeth.2012.08.024; Cowley KC, 2005, J NEUROPHYSIOL, V94, P3805, DOI 10.1152/jn.00016.2005; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; Deumens R, 2013, BEHAV BRAIN RES, V237, P185, DOI 10.1016/j.bbr.2012.09.036; Dietz V, 2012, EXP NEUROL, V235, P110, DOI 10.1016/j.expneurol.2011.04.007; Dietz V, 2010, NAT REV NEUROL, V6, P167, DOI 10.1038/nrneurol.2009.227; FeraboliLohnherr D, 1997, EXP BRAIN RES, V113, P443, DOI 10.1007/PL00005597; Filli L, 2014, J NEUROSCI, V34, P13399, DOI 10.1523/JNEUROSCI.0701-14.2014; FUNG SJ, 1989, NEUROSCI LETT, V103, P185, DOI 10.1016/0304-3940(89)90573-9; Garcia-Alias G, 2011, J NEUROSCI, V31, P17788, DOI 10.1523/JNEUROSCI.4308-11.2011; Gorska T, 2007, J NEUROTRAUM, V24, P1198, DOI 10.1089/neu.2006.0219; Gorska T, 2013, BEHAV BRAIN RES, V239, P121, DOI 10.1016/j.bbr.2012.10.054; Gorska T, 2009, BEHAV BRAIN RES, V196, P286, DOI 10.1016/j.bbr.2008.09.019; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Gulino R, 2007, NEUROSCI RES, V57, P148, DOI 10.1016/j.neures.2006.10.001; Hains BC, 2001, EXP NEUROL, V171, P361, DOI 10.1006/exnr.2001.7751; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hammar I, 2004, EUR J NEUROSCI, V19, P1305, DOI 10.1111/j.1460-9568.2004.03239.x; HRUSKA RE, 1979, LIFE SCI, V25, P181, DOI 10.1016/0024-3205(79)90390-4; Hunanyan AS, 2011, J NEUROPHYSIOL, V105, P1033, DOI 10.1152/jn.00810.2010; Hunanyan AS, 2010, J NEUROSCI, V30, P7761, DOI 10.1523/JNEUROSCI.4659-09.2010; Jordan LM, 2011, PROG BRAIN RES, V188, P181, DOI 10.1016/B978-0-444-53825-3.00017-6; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; Krutki P, 1997, ACTA NEUROBIOL EXP, V57, P1; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; Liu J, 2009, J NEUROPHYSIOL, V102, P337, DOI 10.1152/jn.91239.2008; Loy DN, 2002, EXP NEUROL, V177, P575, DOI 10.1006/exnr.2002.7959; Loy DN, 2002, J NEUROSCI, V22, P315, DOI 10.1523/JNEUROSCI.22-01-00315.2002; Madriaga MA, 2004, J NEUROPHYSIOL, V92, P1566, DOI 10.1152/jn.01181.2003; Majczynski H, 2005, J NEUROTRAUM, V22, P590, DOI 10.1089/neu.2005.22.590; Majczynski H, 2007, J NEUROSCI METH, V163, P197, DOI 10.1016/j.jneumeth.2007.02.023; Martinez M, 2011, J NEUROPHYSIOL, V106, P1969, DOI 10.1152/jn.00368.2011; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Noga BR, 2009, J NEUROPHYSIOL, V102, P1560, DOI 10.1152/jn.91179.2008; Pearlstein E, 2005, EUR J NEUROSCI, V21, P1338, DOI 10.1111/j.1460-9568.2005.03971.x; Petrosyan HA, 2013, J NEUROSCI, V33, P4032, DOI 10.1523/JNEUROSCI.4702-12.2013; Redondo-Castro E, 2013, J NEUROSCI METH, V213, P165, DOI 10.1016/j.jneumeth.2012.12.024; Ribotta MGY, 2000, J NEUROSCI, V20, P5144; Ribotta MGY, 1998, ANN NY ACAD SCI, V860, P393, DOI 10.1111/j.1749-6632.1998.tb09064.x; RIBOTTA MGY, 1995, J NEUROSCI RES, V41, P79, DOI 10.1002/jnr.490410110; Rossignol S, 2009, PHYSIOLOGY, V24, P127, DOI 10.1152/physiol.00042.2008; Saruhashi Y, 1996, EXP NEUROL, V139, P203, DOI 10.1006/exnr.1996.0094; Saruhashi Y, 2009, ARCH ORTHOP TRAUM SU, V129, P1279, DOI 10.1007/s00402-008-0754-z; Sathyanesan A, 2012, J NEUROSCI METH, V206, P165, DOI 10.1016/j.jneumeth.2012.02.019; Schnell L, 2011, EUR J NEUROSCI, V34, P1256, DOI 10.1111/j.1460-9568.2011.07862.x; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Shah PK, 2013, BRAIN, V136, P3362, DOI 10.1093/brain/awt265; Slawinska U, 2000, EXP BRAIN RES, V132, P27, DOI 10.1007/s002219900323; Slawinska U, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00095; Slawinska U, 2014, ACTA NEUROBIOL EXP, V74, P172; Slawinska U, 2013, EXP NEUROL, V247, P572, DOI 10.1016/j.expneurol.2013.02.008; Slawinska U, 2012, J PHYSIOL-LONDON, V590, P1721, DOI 10.1113/jphysiol.2011.224931; TAKAKUSAKI K, 1993, EXP BRAIN RES, V93, P471; Voda J, 2005, J NEUROTRAUM, V22, P1150, DOI 10.1089/neu.2005.22.1150; WANG MY, 1990, J PHYSIOL-LONDON, V430, P87, DOI 10.1113/jphysiol.1990.sp018283; Webb AA, 2002, J NEUROTRAUM, V19, P239, DOI 10.1089/08977150252806983; Wong JK, 2012, EXP NEUROL, V233, P693, DOI 10.1016/j.expneurol.2011.08.011; Yim PJ, 2000, IEEE T MED IMAGING, V19, P568, DOI 10.1109/42.870662; Zar JH, 1974, BIOSTATISTICAL ANAL, V22, P310; Zhang N, 2012, INDIAN J MED RES, V135, P287	74	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143602	10.1371/journal.pone.0143602	http://dx.doi.org/10.1371/journal.pone.0143602			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606275	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300087
J	Liu, L; Chen, L; Floehr, T; Xiao, HX; Bluhm, K; Hollert, H; Wu, LL				Liu, Li; Chen, Ling; Floehr, Tilman; Xiao, Hongxia; Bluhm, Kerstin; Hollert, Henner; Wu, Lingling			Assessment of the Mutagenicity of Sediments from Yangtze River Estuary Using Salmonella Typhimurium/Microsome Assay	PLOS ONE			English	Article							EFFECT-DIRECTED ANALYSIS; SUSPENDED PARTICULATE MATTER; POLYCYCLIC AROMATIC-HYDROCARBONS; AMES FLUCTUATION TEST; DIOXIN-LIKE COMPOUNDS; PERFLUORINATED COMPOUNDS; AQUATIC SEDIMENTS; SURFACE SEDIMENTS; HAMILTON HARBOR; FLOOD EVENTS	Sediments in estuaries are of important environmental concern because they may act as pollution sinks and sources to the overlying water body. These sediments can be accumulated by benthic organisms. This study assessed the mutagenic potential of sediment extracts from the Yangtze River estuary by using the Ames fluctuation assay with the Salmonella typhimurium his (-) strain TA98 (frameshift mutagen indicator) and TA100 (base-shift mutagen indicator). Most of the sediment samples were mutagenic to the strain TA98, regardless of the presence or absence of exogenous metabolic activation (S9 induction by beta-naphthoflavone/phenobarbital). However, none of the samples were mutagenic to the strain TA100. Thus, the mutagenicity pattern was mainly frameshift mutation, and the responsible toxicants were both direct (without S9 mix) and indirect (with S9 mix) mutagens. The mutagenicity of the sediment extracts increased when S9 was added. Chemical analysis showed a poor correlation between the content of priority polycyclic aromatic hydrocarbons and the detected mutagenicity in each sample. The concept of effect-directed analysis was used to analyze possible compounds responsible for the detected mutagenic effects. With regard to the mutagenicity of sediment fractions, non-polar compounds as well as weakly and moderately polar compounds played a main role. Further investigations should be conducted to identify the responsible components.	[Liu, Li; Chen, Ling; Hollert, Henner; Wu, Lingling] Tongji Univ, Coll Environm Sci & Engn, Key Lab Yangtze Water Environm, Minist Educ, Shanghai 200092, Peoples R China; [Floehr, Tilman; Xiao, Hongxia; Bluhm, Kerstin; Hollert, Henner] Rhein Westfal TH Aachen, Inst Environm Res Biol 5, Dept Ecosyst Anal, ABBt Aachen Biol & Biotechnol, Aachen, Germany; [Hollert, Henner] Chongqing Univ, Coll Resources & Environm Sci, Chongqing 630044, Peoples R China; [Hollert, Henner] Nanjing Univ, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China	Tongji University; RWTH Aachen University; Chongqing University; Nanjing University	Wu, LL (corresponding author), Tongji Univ, Coll Environm Sci & Engn, Key Lab Yangtze Water Environm, Minist Educ, Shanghai 200092, Peoples R China.	wulingling@tongji.edu.cn	Hollert, Henner/A-1027-2009; Wu, Ling/GZN-2235-2022	Hollert, Henner/0000-0001-5776-5619; 	National Natural Science Foundation of China [41101499]; Fundamental Research Funds for the Central Universities of China [0400219213]; National Key Technology RAMP;D Program of the Ministry of Science and Technology of China [2012BAJ24B01]; Chinese 111 Program; research cluster "Pollutants/Water/Sediment-Impacts of Transformation and Transportation Processes on the Yangtze Water Quality" - Federal Ministry of Education and Research, Germany (BMBF); BMBF DLR (DLR Project Management Agency-part of the German Aerospace Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Key Technology RAMP;D Program of the Ministry of Science and Technology of China; Chinese 111 Program(Ministry of Education, China - 111 Project); research cluster "Pollutants/Water/Sediment-Impacts of Transformation and Transportation Processes on the Yangtze Water Quality" - Federal Ministry of Education and Research, Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF DLR (DLR Project Management Agency-part of the German Aerospace Center	This work was supported by a grant from the National Natural Science Foundation of China (No. 41101499), the Fundamental Research Funds for the Central Universities of China (No. 0400219213), the National Key Technology R&D Program of the Ministry of Science and Technology of China (2012BAJ24B01) and Chinese 111 Program. The work was also supported by the research cluster "Pollutants/Water/Sediment-Impacts of Transformation and Transportation Processes on the Yangtze Water Quality" sponsored by the Federal Ministry of Education and Research, Germany (BMBF) and supported by a cooperation project with Chinese colleagues sponsored by the BMBF DLR (DLR Project Management Agency-part of the German Aerospace Center, which is a research funding organization supporting the Federal Ministry of Education and Research (BMBF)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ISO11350; Aouadene A, 2008, ENVIRON MOL MUTAGEN, V49, P283, DOI 10.1002/em.20384; Bao J, 2010, CHEMOSPHERE, V80, P123, DOI 10.1016/j.chemosphere.2010.04.008; Bols NC, 2005, BIOCH MOLEC, V6, P43; Bougeard C, 2011, CHEMOSPHERE, V83, P409, DOI 10.1016/j.chemosphere.2010.12.087; Brack W, 2000, ENVIRON TOXICOL CHEM, V19, P2493, DOI 10.1002/etc.5620191015; Brack W, 2003, ANAL BIOANAL CHEM, V377, P397, DOI 10.1007/s00216-003-2139-z; Brack W, 2005, ENVIRON TOXICOL CHEM, V24, P2445, DOI 10.1897/05-078R.1; Chen GS, 2004, MUTAT RES-REV MUTAT, V567, P151, DOI 10.1016/j.mrrev.2004.08.005; Chen SJ, 2006, ENVIRON POLLUT, V144, P951, DOI 10.1016/j.envpol.2006.01.044; Cheng Shu-bo, 2006, Huanjing Kexue, V27, P110; Dong Xiao-rong, 2010, China Environmental Science, V30, P263; Eastmond DA, 2009, MUTAGENESIS, V24, P341, DOI 10.1093/mutage/gep014; Faroon O., 2000, TOXICOLOGICAL PROFIL; Floehr T, 2013, ENVIRON SCI POLLUT R, V20, P6934, DOI 10.1007/s11356-013-1666-1; Hecker M, 2009, ENVIRON SCI POLLUT R, V16, P607, DOI 10.1007/s11356-009-0229-y; Higley E, 2012, ENVIRON TOXICOL CHEM, V31, P1053, DOI 10.1002/etc.1777; Hollert H, 2000, ENVIRON TOXICOL CHEM, V19, P528, DOI 10.1002/etc.5620190302; Hollert H, 2002, ECOTOXICOLOGY, V11, P323, DOI 10.1023/A:1020549103898; Houtman CJ, 2006, CHEMOSPHERE, V65, P2244, DOI 10.1016/j.chemosphere.2006.05.043; Hui YM, 2009, B ENVIRON CONTAM TOX, V83, P614, DOI 10.1007/s00128-009-9832-3; Jolibois B, 2003, CHEMOSPHERE, V51, P539, DOI 10.1016/S0045-6535(02)00867-6; Kosmehl Thomas, 2004, Journal of Soils and Sediments, V4, P84, DOI 10.1007/BF02991050; Li F, 2010, SCI TOTAL ENVIRON, V408, P617, DOI 10.1016/j.scitotenv.2009.10.032; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104748; Liu M, 2001, ENVIRON GEOL, V41, P90, DOI 10.1007/s002540100347; Lubcke-von Varel U, 2012, ENVIRON INT, V44, P31, DOI 10.1016/j.envint.2012.01.010; Lubcke-von Varel U, 2011, ENVIRON SCI TECHNOL, V45, P2384, DOI 10.1021/es103381y; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; MARVIN CH, 1993, ENVIRON MOL MUTAGEN, V22, P61, DOI 10.1002/em.2850220203; Marvin CH, 2000, CHEMOSPHERE, V41, P979, DOI 10.1016/S0045-6535(99)00494-4; Picer M, 2001, CHEMOSPHERE, V44, P1673, DOI 10.1016/S0045-6535(00)00576-2; Reifferscheid G, 2012, ENVIRON MOL MUTAGEN, V53, P185, DOI 10.1002/em.21677; Shen L, 2003, TOXICOLOGY, V191, P22; So MK, 2007, CHEMOSPHERE, V68, P2085, DOI 10.1016/j.chemosphere.2007.02.008; Srut M, 2011, TOXICOL IN VITRO, V25, P308, DOI 10.1016/j.tiv.2010.09.015; Stahl Thorsten, 2011, Environmental Sciences Europe, V23, P37, DOI 10.1186/2190-4715-23-37; Ubomba-Jaswa E, 2010, J WATER HEALTH, V8, P712, DOI 10.2166/wh.2010.136; Vahl HH, 1997, MUTAT RES-GEN TOX EN, V394, P81, DOI 10.1016/S1383-5718(97)00129-0; Weiqun S, 2002, ENV POLLUTION CONTRO, V24, P226; Wolz J, 2008, ENVIRON SCI POLLUT R, V15, P536, DOI 10.1007/s11356-008-0056-6; Wolz J, 2010, J SOIL SEDIMENT, V10, P1174, DOI 10.1007/s11368-010-0262-y; Wu JY, 2005, MAR POLLUT BULL, V50, P1661, DOI 10.1016/j.marpolbul.2005.07.001; Wu LL, 2010, ENVIRON TOXICOL, V25, P234, DOI 10.1002/tox.20501; ZEIGER E, 1984, ENVIRON MUTAGEN, V6, P683, DOI 10.1002/em.2860060506	45	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143522	10.1371/journal.pone.0143522	http://dx.doi.org/10.1371/journal.pone.0143522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606056	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300075
J	Perez-Osorio, J; Muller, HJ; Wiese, E; Wykowska, A				Perez-Osorio, Jairo; Mueller, Hermann J.; Wiese, Eva; Wykowska, Agnieszka			Gaze Following Is Modulated by Expectations Regarding Others' Action Goals	PLOS ONE			English	Article							HUMAN NEURAL SYSTEM; PREMOTOR CORTEX; REFLEXIVE; EYES; ACTIVATION	Humans attend to social cues in order to understand and predict others' behavior. Facial expressions and gaze direction provide valuable information to infer others' mental states and intentions. The present study examined the mechanism of gaze following in the context of participants' expectations about successive action steps of an observed actor. We embedded a gaze-cueing manipulation within an action scenario consisting of a sequence of naturalistic photographs. Gaze-induced orienting of attention (gaze following) was analyzed with respect to whether the gaze behavior of the observed actor was in line or not with the action-related expectations of participants (i.e., whether the actor gazed at an object that was congruent or incongruent with an overarching action goal). In Experiment 1, participants followed the gaze of the observed agent, though the gaze-cueing effect was larger when the actor looked at an action-congruent object relative to an incongruent object. Experiment 2 examined whether the pattern of effects observed in Experiment 1 was due to covert, rather than overt, attentional orienting, by requiring participants to maintain eye fixation throughout the sequence of critical photographs (corroborated by monitoring eye movements). The essential pattern of results of Experiment 1 was replicated, with the gazecueing effect being completely eliminated when the observed agent gazed at an action-incongruent object. Thus, our findings show that covert gaze following can be modulated by expectations that humans hold regarding successive steps of the action performed by an observed agent.	[Perez-Osorio, Jairo; Mueller, Hermann J.; Wiese, Eva; Wykowska, Agnieszka] Univ Munich, Dept Psychol, Munich, Germany; [Perez-Osorio, Jairo] Univ Munich, Dept Biol Neurobiol 2, Grad Sch Syst Neurosci, Planegg Martinsried, Germany; [Mueller, Hermann J.] Univ London, Birkbeck Coll, Dept Psychol Sci, London, England; [Wiese, Eva] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	University of Munich; University of Munich; University of London; Birkbeck University London; George Mason University	Perez-Osorio, J (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	jairo.perez@psy.lmu.de	Perez-Osorio, Jairo/X-9717-2019	Perez-Osorio, Jairo/0000-0003-0954-5704; Wykowska, Agnieszka/0000-0003-3323-7357	EXC142 grant (DFG-Excellence Cluster 'Cognition for Technical Systems) [435]; DFG [WY-122/1-1]	EXC142 grant (DFG-Excellence Cluster 'Cognition for Technical Systems); DFG(German Research Foundation (DFG))	This work was supported by EXC142 grant (DFG-Excellence Cluster 'Cognition for Technical Systems', sub-project #435: SocGaze) awarded to HM, and a DFG grant awarded to AW (WY-122/1-1) (http://www.dfg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron Cohen S, 1995, MINDBLINDNESS LEARNI, Vxxii; Baron-cohen S, 2005, ORIGINS SOCIAL MIND, P1; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bayliss AP, 2010, VIS COGN, V18, P1214, DOI 10.1080/13506285.2010.484657; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Friesen CK, 2003, NEUROREPORT, V14, P489, DOI 10.1097/01.wnr.0000058776.36017.5d; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Hamilton AF, 2007, ATTENTION PERFORM, P381, DOI DOI 10.1093/ACPR0F:0S0/9780199231447.003.0018; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Hietanen JK, 1999, NEUROREPORT; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; Kleiner M, 2007, PERCEPTION, V36, P14; Langton SRH, 1999, VIS COGN, V6, P541, DOI 10.1080/135062899394939; Mansfield EM, 2003, VIS COGN, V10, P7, DOI [10.1080/713756671, 10.1080/13506280143000647]; Manthey S, 2003, COGNITIVE BRAIN RES, V15, P296, DOI 10.1016/S0926-6410(02)00201-X; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Posner, 1984, ATTENTION PERFORM, V32, P531; Ricciardelli P, 2002, NEUROREPORT, V13, P2259, DOI 10.1097/00001756-200212030-00018; Ristic J, 2005, COGNITION, V94, pB55, DOI 10.1016/j.cognition.2004.04.005; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Saxe R, 2004, NEUROPSYCHOLOGIA, V42, P1435, DOI 10.1016/j.neuropsychologia.2004.04.015; Schubotz RI, 2002, NEUROIMAGE, V15, P787, DOI 10.1006/nimg.2001.1043; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Teufel C, 2010, TRENDS COGN SCI, V14, P376, DOI 10.1016/j.tics.2010.05.005; Teufel C, 2010, ATTEN PERCEPT PSYCHO, V72, P695, DOI 10.3758/APP.72.3.695; Townsend J. T., 1983, STOCHASTIC MODELING; Townsend JT, 1978, COGNITIVE THEORY, P199; Vuilleumier P, 2005, VIS COGN, V12, P85, DOI 10.1080/13506280444000120; Wiese E, 2014, PLOS ONE, V9; Wiese E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045391; Wurm MF, 2012, NEUROIMAGE, V59, P1551, DOI 10.1016/j.neuroimage.2011.08.038; Wykowska A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094339	44	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143614	10.1371/journal.pone.0143614	http://dx.doi.org/10.1371/journal.pone.0143614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7ES	26606534	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000365865300089
J	Bonnemains, L; Odille, F; Meyer, C; Hossu, G; Felblinger, J; Vuissoz, PA				Bonnemains, Laurent; Odille, Freddy; Meyer, Christophe; Hossu, Gabriella; Felblinger, Jacques; Vuissoz, Pierre-Andre			Is High Temporal Resolution Achievable for Paediatric Cardiac Acquisitions during Several Heart Beats? Illustration with Cardiac Phase Contrast Cine-MRI	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; TIME-RESOLVED MRI; RECONSTRUCTION; DOPPLER; ECHOCARDIOGRAPHY; MOTION; FIELD	Background During paediatric cardiac Cine-MRI, data acquired during cycles of different lengths must be combined. Most of the time, Feinstein's model is used to project multiple cardiac cycles of variable lengths into a mean cycle. Objective To assess the effect of Feinstein projection on temporal resolution of Cine-MRI. Methods 1/The temporal errors during Feinstein's projection were computed in 306 cardiac cycles fully characterized by tissue Doppler imaging with 6-phase analysis (from a population of 7 children and young adults). 2/The effects of these temporal errors on tissue velocities were assessed by simulating typical tissue phase mapping acquisitions and reconstructions. 3/Myocardial velocities curves, extracted from high-resolution phase-contrast cine images, were compared for the 6 volunteers with lowest and highest heart rate variability, within a population of 36 young adults. Results 1/The mean of temporal misalignments was 30 ms over the cardiac cycle but reached 60 ms during early diastole. 2/During phase contrast MRI simulation, early diastole velocity peaks were diminished by 6.1 cm/s leading to virtual disappearance of isovolumic relaxation peaks. 3/The smoothing and erasing of isovolumic relaxation peaks was confirmed on tissue phase mapping velocity curves, between subjects with low and high heart rate variability (p = 0.05). Conclusions Feinstein cardiac model creates temporal misalignments that impair high temporal resolution phase contrast cine imaging when beat-to-beat heart rate is changing.	[Bonnemains, Laurent] CHU Strasbourg, Dept Cardiol, F-67000 Strasbourg, France; [Bonnemains, Laurent] CHU Nancy, Dept Cardiol, Nancy, France; [Bonnemains, Laurent; Odille, Freddy; Meyer, Christophe; Hossu, Gabriella; Felblinger, Jacques; Vuissoz, Pierre-Andre] INSERM, U947, Nancy, France; [Bonnemains, Laurent; Odille, Freddy; Meyer, Christophe; Felblinger, Jacques; Vuissoz, Pierre-Andre] Univ Lorraine, IADI, Nancy, France; [Hossu, Gabriella; Felblinger, Jacques] CHU Nancy, Clin Invest Ctr, CIC IT 1433, Nancy, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; CHU de Nancy	Bonnemains, L (corresponding author), CHU Strasbourg, Dept Cardiol, F-67000 Strasbourg, France.	laurent.bonnemains@inserm.fr	Felblinger, Jacques/ABG-2033-2021; Hossu, Gabriela/ABG-2470-2021; Vuissoz, Pierre-André/Y-8259-2019; Odille, Freddy/H-7650-2019; bonnemains, laurent/A-3394-2013	Felblinger, Jacques/0000-0002-9245-6595; Hossu, Gabriela/0000-0003-1178-9097; Vuissoz, Pierre-André/0000-0003-3519-1743; Odille, Freddy/0000-0001-5260-8905; bonnemains, laurent/0000-0002-5194-1762				Bezanson J., 2012, ARXIV12095145CS; Biglino G, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-57; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Calcagno C, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-42; Espe EKS, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-82; Feinstein JA, 1997, JMRI-J MAGN RESON IM, V7, P794, DOI 10.1002/jmri.1880070505; Kellman P, 2009, MAGN RESON MED, V62, P1557, DOI 10.1002/mrm.22153; Kowalik GT, 2015, MAGN RESON MED, V73, P749, DOI 10.1002/mrm.25183; Larson AC, 2004, MAGN RESON MED, V51, P93, DOI 10.1002/mrm.10664; Lindqvist P, 2005, ECHOCARDIOGR-J CARD, V22, P305, DOI 10.1111/j.1540-8175.2005.04023.x; Meyer C, 2014, J CARDIOVASCULAR MAG, V16; Meyer C, 2014, MAGN RESON MATER PHY, V27, P211, DOI 10.1007/s10334-013-0405-4; Mistretta CA, 2006, MAGN RESON MED, V55, P30, DOI 10.1002/mrm.20772; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; R Core Team, 2020, R LANG ENV STAT COMP; Schaeffter T, 2001, MAGNET RESON MED, V46, P1238, DOI 10.1002/mrm.1322; Sengupta PP, 2007, J AM COLL CARDIOL, V49, P899, DOI 10.1016/j.jacc.2006.07.075; Siegel RJ, 1956, NONPARAMETRIC STAT B; Siest G, 1998, CLIN CHEM LAB MED, V36, P35, DOI 10.1515/CCLM.1998.007; Tsao J, 2012, J MAGN RESON IMAGING, V36, P543, DOI 10.1002/jmri.23640; Voss A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118308; WEISSLER AM, 1968, CIRCULATION, V37, P149, DOI 10.1161/01.CIR.37.2.149; Winkelmann S, 2007, IEEE T MED IMAGING, V26, P68, DOI 10.1109/TMI.2006.885337; Xue H, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-102; Zhang S, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-39	25	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143744	10.1371/journal.pone.0143744	http://dx.doi.org/10.1371/journal.pone.0143744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599755	gold, Green Published, Green Submitted			2022-12-26	WOS:000365862600116
J	Jozwiak, B; Orczykowska, M; Dziubinski, M				Jozwiak, Bertrand; Orczykowska, Magdalena; Dziubinski, Marek			Fractional Generalizations of Maxwell and Kelvin-Voigt Models for Biopolymer Characterization	PLOS ONE			English	Article							VISCOELASTIC MODELS; MOLECULAR-WEIGHT; CROSS-LINKS; CALCULUS; BEHAVIOR; RELAXATION; MODULUS; STARCH	The paper proposes a fractional generalization of the Maxwell and Kelvin-Voigt rheological models for a description of dynamic behavior of biopolymer materials. It was found that the rheological models of Maxwell-type do not work in the case of modeling of viscoelastic solids, and the model which significantly better describes the nature of changes in rheological properties of such media is the modified fractional Kelvin-Voigt model with two built-in springpots (MFKVM2). The proposed model was used to describe the experimental data from the oscillatory and creep tests of 3% (w/v) kuzu starch pastes, and to determine the values of their rheological parameters as a function of pasting time. These parameters provide a lot of additional information about structure and viscoelastic properties of the medium in comparison to the classical analysis of dynamic curves G' and G '' and shear creep compliance J(t). It allowed for a comprehensive description of a wide range of properties of kuzu starch pastes, depending on the conditions of pasting process.	[Jozwiak, Bertrand; Orczykowska, Magdalena; Dziubinski, Marek] Lodz Univ Technol, Fac Proc & Environm Engn, Lodz, Poland	Lodz University of Technology	Jozwiak, B (corresponding author), Lodz Univ Technol, Fac Proc & Environm Engn, Lodz, Poland.	bertrand.jozwiak@dokt.p.lodz.pl	Orczykowska, Magdalena/P-1472-2019; Dziubinski, Marek/P-4524-2019; Jóźwiak, Bertrand/AAW-3024-2021	Orczykowska, Magdalena/0000-0002-0109-2563; Dziubinski, Marek/0000-0002-7765-1106; Jozwiak, Bertrand/0000-0003-2977-5670				Alcoutlabi M, 1998, POLYMER, V39, P6269, DOI 10.1016/S0032-3861(98)00168-2; [Anonymous], 1980, VISCOELASTIC PROPERT; BAGLEY RL, 1986, J RHEOL, V30, P133, DOI 10.1122/1.549887; Cho K, 1996, POLYMER, V37, P813, DOI 10.1016/0032-3861(96)87258-2; Crawford R.J., 1998, PLASTICS ENG; Deshpande AP, 2010, RHEOLOGY OF COMPLEX FLUIDS, P87, DOI 10.1007/978-1-4419-6494-6_4; Dziubinski M, 2014, FUNDAMENTALS FLUID T; Dziubinski M, 2014, SOFT MATER, V12, P420, DOI 10.1080/1539445X.2014.957837; Fancey KS, 2005, J MATER SCI, V40, P4827, DOI 10.1007/s10853-005-2020-x; Friedrich C, 1999, RHEOL SER, V8, P429; HOLMES LA, 1966, J PHYS CHEM-US, V70, P2714, DOI 10.1021/j100881a002; Kilbas A.A., 2006, THEORY APPL FRACTION; Kilpimaa S, 2015, J IND ENG CHEM, V21, P1354, DOI 10.1016/j.jiec.2014.06.006; Lagaros ND., 2013, DESIGN OPTIMIZATION, DOI [10.4018/978-1-4666-2029-2, DOI 10.4018/978-1-4666-2029-2]; Lakes R, 2009, VISCOELASTIC MATERIALS, P1, DOI 10.1017/CBO9780511626722; Lakes R.S., 1998, CRC MEC ENG SER; Larson RG, 2003, J RHEOL, V47, P809, DOI 10.1122/1.1567750; Lefebvre J, 2003, J CEREAL SCI, V38, P257, DOI 10.1016/S0733-5210(03)00025-0; Lewandowski R, 2010, COMPUT STRUCT, V88, P1, DOI 10.1016/j.compstruc.2009.09.001; Liu CY, 2006, POLYMER, V47, P4461, DOI 10.1016/j.polymer.2006.04.054; Liu HZ, 2003, ULTRASON, P933; Ma HY, 2011, MACROMOL CHEM PHYS, V212, P252, DOI 10.1002/macp.201000503; Makris N, 2009, RHEOL ACTA, V48, P815, DOI 10.1007/s00397-009-0374-8; Orczykowska M, 2014, STARCH-STARKE, V66, P707, DOI 10.1002/star.201300265; Pritz T, 2003, J SOUND VIB, V265, P935, DOI 10.1016/S0022-460X(02)01530-4; Pruska-Kedzior A, 2006, APLICATION PHENOMENO; Schiessel H, 1995, J PHYS A-MATH GEN, V28, P6567, DOI 10.1088/0305-4470/28/23/012; Sen M, 1999, POLYMER, V40, P2969, DOI 10.1016/S0032-3861(98)00251-1; STEIN AD, 1992, J CHEM PHYS, V96, P3269, DOI 10.1063/1.461972; STIASSNIE M, 1979, APPL MATH MODEL, V3, P300, DOI 10.1016/S0307-904X(79)80063-3; Telis VRN, 2012, CONTEMP FOOD ENG, P1, DOI 10.1201/b12048; Tschoegl N.W., 1989, PHENOMENOLOGICAL THE; Ward I.M., 2012, MECH PROPERTIES SOLI; Worstell J., 2014, DIMENSIONAL ANAL PRA; Xu YJ, 2015, COMPOS STRUCT, V123, P35, DOI 10.1016/j.compstruct.2014.12.031; Yasar F, 2007, J FOOD ENG, V81, P187, DOI 10.1016/j.jfoodeng.2006.10.022	36	22	23	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143090	10.1371/journal.pone.0143090	http://dx.doi.org/10.1371/journal.pone.0143090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599756	gold, Green Published			2022-12-26	WOS:000365862600028
J	Aelvoet, SA; Pascual-Brazo, J; Libbrecht, S; Reumers, V; Gijsbers, R; Van den Haute, C; Baekelandt, V				Aelvoet, Sarah-Ann; Pascual-Brazo, Jesus; Libbrecht, Sarah; Reumers, Veerle; Gijsbers, Rik; Van den Haute, Chris; Baekelandt, Veerle			Long-Term Fate Mapping Using Conditional Lentiviral Vectors Reveals a Continuous Contribution of Radial Glia-Like Cells to Adult Hippocampal Neurogenesis in Mice	PLOS ONE			English	Article							NEURAL STEM-CELLS; REPORTER GENES; NEURONS; BRAIN; MULTIPOTENT; MIGRATION; MRI; PROGENITORS; ASTROCYTES; EXPRESSION	Newborn neurons are generated throughout life in two neurogenic regions, the subventricular zone and the hippocampal dentate gyrus. Stimulation of adult neurogenesis is considered as an attractive endogenous repair mechanism to treat different neurological disorders. Although tremendous progress has been made in our understanding of adult hippocampal neurogenesis, important questions remain unanswered, regarding the identity and the behavior of neural stem cells in the dentate gyrus. We previously showed that conditional Cre-Flex lentiviral vectors can be used to label neural stem cells in the subventricular zone and to track the migration of their progeny with non-invasive bioluminescence imaging. Here, we applied these Cre-Flex lentiviral vectors to study neurogenesis in the dentate gyrus with bioluminescence imaging and histological techniques. Stereotactic injection of the Cre-Flex vectors into the dentate gyrus of transgenic Nestin-Cre mice resulted in specific labeling of the nestin-positive neural stem cells. The labeled cell population could be detected with bioluminescence imaging until 9 months post injection, but no significant increase in the number of labeled cells over time was observed with this imaging technique. Nevertheless, the specific labeling of the nestin-positive neural stem cells, combined with histological analysis at different time points, allowed detailed analysis of their neurogenic potential. This long-term fate mapping revealed that a stable pool of labeled nestin-positive neural stem cells continuously contributes to the generation of newborn neurons in the mouse brain until 9 months post injection. In conclusion, the Cre-Flex technology is a valuable tool to address remaining questions regarding neural stem cell identity and behavior in the dentate gyrus.	[Aelvoet, Sarah-Ann; Pascual-Brazo, Jesus; Libbrecht, Sarah; Reumers, Veerle; Baekelandt, Veerle] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Dept Neurosci, Leuven, Flanders, Belgium; [Gijsbers, Rik; Van den Haute, Chris] Katholieke Univ Leuven, Leuven Viral Vector Core, Leuven, Flanders, Belgium	KU Leuven; KU Leuven	Baekelandt, V (corresponding author), Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Dept Neurosci, Leuven, Flanders, Belgium.	veerle.baekelandt@med.kuleuven.be	Baekelandt, Veerle/ABB-9736-2020	Baekelandt, Veerle/0000-0001-8966-2921; Libbrecht, Sarah/0000-0002-0612-0869	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen); European FP7 HEALTH-F2-278850 project (INMiND); FWO Research Foundation FWO [G.0484.08]; IWT [SBO/130065 MIRIAD]; KU Leuven (IMIR program financing) [PF/10/017]; KU Leuven (SCIL program financing) [PF/10/019]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European FP7 HEALTH-F2-278850 project (INMiND); FWO Research Foundation FWO; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven (IMIR program financing); KU Leuven (SCIL program financing)	SA was financially supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen, http://www.iwt.be). This work was financially supported by the European FP7 project HEALTH-F2-2011-278850 (INMiND, http://cordis.europa.eu/fp7), the FWO Research Foundation FWO (project G.0484.08 and PhD scholarship to SL, http://www.fwo.be), the IWT (SBO/130065 MIRIAD) and the KU Leuven (IMIR program financing PF/10/017 (http://www.kuleuven.be/imir) and SCIL program financing PF/10/019 (http://www.kuleuven.be/scil).	ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; Baekelandt V, 2003, GENE THER, V10, P1933, DOI 10.1038/sj.gt.3302094; BAYER SA, 1985, ANN NY ACAD SCI, V457, P163, DOI 10.1111/j.1749-6632.1985.tb20804.x; Bellenchi GC, 2013, J NEUROCHEM, V124, P159, DOI 10.1111/jnc.12084; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; Couillard-Despres S, 2011, EUR J NEUROSCI, V33, P1037, DOI 10.1111/j.1460-9568.2011.07601.x; DeCarolis NA, 2013, HIPPOCAMPUS, V23, P708, DOI 10.1002/hipo.22130; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deroose CM, 2006, MOL THER, V14, P423, DOI 10.1016/j.ymthe.2006.05.007; Deroose CM, 2009, CURR GENE THER, V9, P212, DOI 10.2174/156652309788488596; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Geraerts M, 2006, HUM GENE THER, V17, P635, DOI 10.1089/hum.2006.17.635; Guglielmetti C, 2014, NEUROIMAGE, V86, P99, DOI 10.1016/j.neuroimage.2013.07.080; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lemberger T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-4; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Massoud TF, 2008, AM J NEURORADIOL, V29, P409, DOI 10.3174/ajnr.A0863; Mezzanotte L, 2013, CONTRAST MEDIA MOL I, V8, P505, DOI 10.1002/cmmi.1549; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nieman BJ, 2010, NEUROIMAGE, V50, P456, DOI 10.1016/j.neuroimage.2009.12.107; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; Pascual-Brazo J, 2014, CURR PHARM DESIGN, V20, P3763, DOI 10.2174/13816128113196660739; Reumers V, 2008, STEM CELLS, V26, P2382, DOI 10.1634/stemcells.2007-1062; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rueger MA, 2010, J NEUROSCI, V30, P6454, DOI 10.1523/JNEUROSCI.6092-09.2010; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shapiro EM, 2006, NEUROIMAGE, V32, P1150, DOI 10.1016/j.neuroimage.2006.04.219; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sumner JP, 2009, NEUROIMAGE, V44, P671, DOI 10.1016/j.neuroimage.2008.07.050; Sun MY, 2014, J COMP NEUROL, V522, P1191, DOI 10.1002/cne.23497; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vande Velde G, 2012, NEUROIMAGE, V62, P367, DOI 10.1016/j.neuroimage.2012.04.040; Vandeputte C, 2014, NEUROBIOL DIS, V69, P144, DOI 10.1016/j.nbd.2014.05.014; Vreys R, 2010, NEUROIMAGE, V49, P2094, DOI 10.1016/j.neuroimage.2009.10.034	53	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143772	10.1371/journal.pone.0143772	http://dx.doi.org/10.1371/journal.pone.0143772			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600383	gold, Green Submitted, Green Published			2022-12-26	WOS:000365853900158
J	Idewaki, Y; Iwase, M; Fujii, H; Ohkuma, T; Ide, H; Kaizu, S; Jodai, T; Kikuchi, Y; Hirano, A; Nakamura, U; Kubo, M; Kitazono, T				Idewaki, Yasuhiro; Iwase, Masanori; Fujii, Hiroki; Ohkuma, Toshiaki; Ide, Hitoshi; Kaizu, Shinako; Jodai, Tamaki; Kikuchi, Yohei; Hirano, Atsushi; Nakamura, Udai; Kubo, Michiaki; Kitazono, Takanari			Association of Genetically Determined Aldehyde Dehydrogenase 2 Activity with Diabetic Complications in Relation to Alcohol Consumption in Japanese Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; CHRONIC KIDNEY-DISEASE; MICROVASCULAR COMPLICATIONS; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; RISK-FACTORS; POLYMORPHISM; MEN; RETINOPATHY	Aldehyde dehydrogenase 2 (ALDH2) detoxifies aldehyde produced during ethanol metabolism and oxidative stress. A genetic defect in this enzyme is common in East Asians and determines alcohol consumption behaviors. We investigated the impact of genetically determined ALDH2 activity on diabetic microvascular and macrovascular complications in relation to drinking habits in Japanese patients with type 2 diabetes mellitus. An ALDH2 single-nucleotide polymorphism (rs671) was genotyped in 4,400 patients. Additionally, the relationship of clinical characteristics with ALDH2 activity (ALDH2 *1/*1 active enzyme activity vs. *1/*2 or *2/*2 inactive enzyme activity) and drinking habits (lifetime abstainers vs. former or current drinkers) was investigated cross-sectionally (n = 691 in *1/*1 abstainers, n = 1,315 in abstainers with *2, n = 1,711 in *1/*1 drinkers, n = 683 in drinkers with *2). The multiple logistic regression analysis for diabetic complications was adjusted for age, sex, current smoking habits, leisure-time physical activity, depressive symptoms, diabetes duration, body mass index, hemoglobin A(1c), insulin use, high-density lipoprotein cholesterol, systolic blood pressure and renin-angiotensin system inhibitors use. Albuminuria prevalence was significantly lower in the drinkers with *2 than that of other groups (odds ratio [95% confidence interval (CI)]: *1/*1 abstainers as the referent, 0.94 [0.76-1.16] in abstainers with *2, 1.00 [0.80-1.26] in *1/*1 drinkers, 0.71 [0.54-0.93] in drinkers with *2). Retinal photocoagulation prevalence was also lower in drinkers with ALDH2 *2 than that of other groups. In contrast, myocardial infarction was significantly increased in ALDH2 *2 carriers compared with that in ALDH2 *1/*1 abstainers (odds ratio [95% CI]: *1/*1 abstainers as the referent, 2.63 [1.28-6.13] in abstainers with *2, 1.89 [0.89-4.51] in *1/*1 drinkers, 2.35 [1.06-5.79] in drinkers with *2). In summary, patients with type 2 diabetes and ALDH2 *2 displayed a lower microvascular complication prevalence associated with alcohol consumption but a higher macrovascular complication prevalence irrespective of alcohol consumption.	[Idewaki, Yasuhiro; Iwase, Masanori; Fujii, Hiroki; Ohkuma, Toshiaki; Ide, Hitoshi; Kaizu, Shinako; Jodai, Tamaki; Kikuchi, Yohei; Hirano, Atsushi; Nakamura, Udai; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Idewaki, Yasuhiro; Iwase, Masanori] Hakujyuji Hosp, Ctr Diabet, Fukuoka, Japan; [Fujii, Hiroki] Kyushu Dent Univ, Sch Oral Hlth Sci, Div Gen Internal Med, Kitakyushu, Fukuoka, Japan; [Ohkuma, Toshiaki] Kyushu Univ, Grad Sch Med Sci, Ctr Cohort Studies, Div Res Management, Fukuoka 812, Japan; [Hirano, Atsushi; Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan	Kyushu University; Kyushu Dental University; Kyushu University; RIKEN	Iwase, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan.	iwase@intmed2.med.kyushu-u.ac.jp	Kubo, Michiaki/N-7947-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan [23249037, 23659353]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23249037, 23659353]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by Grants-in-Aid for Scientific Research (no. 23249037 and no. 23659353) for M.I. from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Beulens JWJ, 2008, DIABETOLOGIA, V51, P1631, DOI 10.1007/s00125-008-1091-z; CAMARGO CA, 1989, STROKE, V20, P1611, DOI 10.1161/01.STR.20.12.1611; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Dunkler D, 2015, KIDNEY INT, V87, P784, DOI 10.1038/ki.2014.370; Evert AB, 2014, DIABETES CARE, V37, pS120, DOI 10.2337/dc14-S120; Guo JM, 2013, CELL RES, V23, P915, DOI 10.1038/cr.2013.69; Guo YJ, 2010, ATHEROSCLEROSIS, V211, P545, DOI 10.1016/j.atherosclerosis.2010.03.030; Harjutsalo V, 2014, DIABETIC MED, V31, P156, DOI 10.1111/dme.12307; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Jo SA, 2007, CLIN CHIM ACTA, V382, P43, DOI 10.1016/j.cca.2007.03.016; Kaizu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098768; Kato I, 2003, J CLIN EPIDEMIOL, V56, P196, DOI 10.1016/S0895-4356(02)00578-4; Kikuchi Y, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000063; Lee CC, 2010, DIABETIC MED, V27, P1130, DOI 10.1111/j.1464-5491.2010.03080.x; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Morita K, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-132; Nagasawa H, 2007, EUR J NEUROL, V14, P428, DOI 10.1111/j.1468-1331.2007.01700.x; Ohkuma T, 2013, DIABETOLOGIA, V56, P70, DOI 10.1007/s00125-012-2746-3; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; STOLINE MR, 1981, AM STAT, V35, P134, DOI 10.2307/2683979; Suzuki Y, 1996, DIABETOLOGIA, V39, P1115; Takagi S, 2002, HYPERTENS RES, V25, P677; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Tsuchihashi-Makaya M, 2009, HYPERTENS RES, V32, P207, DOI 10.1038/hr.2009.3; Wang Y, 2013, J HUM HYPERTENS, V27, P181, DOI 10.1038/jhh.2012.15; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yokoyama A, 1998, CARCINOGENESIS, V19, P1383, DOI 10.1093/carcin/19.8.1383; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258	34	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143288	10.1371/journal.pone.0143288	http://dx.doi.org/10.1371/journal.pone.0143288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599441	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900086
J	Mensah, LB; Davison, C; Fan, SJ; Morris, JF; Goberdhan, DCI; Wilson, C				Mensah, Lawrence B.; Davison, Claire; Fan, Shih-Jung; Morris, John F.; Goberdhan, Deborah C. I.; Wilson, Clive			Fine-Tuning of PI3K/AKT Signalling by the Tumour Suppressor PTEN Is Required for Maintenance of Flight Muscle Function and Mitochondrial Integrity in Ageing Adult Drosophila melanogaster	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; OXIDATIVE STRESS; PARKINSONS-DISEASE; ENERGY-METABOLISM; NERVOUS-SYSTEM; CELL-GROWTH; PROTEIN; PATHWAY; SIZE; NEURODEGENERATION	Insulin/insulin-like growth factor signalling (IIS), acting primarily through the PI3-kinase (PI3K)/AKT kinase signalling cassette, plays key evolutionarily conserved regulatory roles in nutrient homeostasis, growth, ageing and longevity. The dysfunction of this pathway has been linked to several age-related human diseases including cancer, Type 2 diabetes and neurodegenerative disorders. However, it remains unclear whether minor defects in IIS can independently induce the age-dependent functional decline in cells that accompany some of these diseases or whether IIS alters the sensitivity to other aberrant signalling. We identified a novel hypomorphic allele of PI3K's direct antagonist, Phosphatase and tensin homologue on chromosome 10 (Pten), in the fruit fly, Drosophila melanogaster. Adults carrying combinations of this allele, Pten(5), combined with strong loss-of-function Pten mutations exhibit subtle or no increase in mass, but are highly susceptible to a wide range of stresses. They also exhibit dramatic upregulation of the oxidative stress response gene, GstD1, and a progressive loss of motor function that ultimately leads to defects in climbing and flight ability. The latter phenotype is associated with mitochondrial disruption in indirect flight muscles, although overall muscle structure appears to be maintained. We show that the phenotype is partially rescued by muscle-specific expression of the Bcl-2 homologue Buffy, which in flies, maintains mitochondrial integrity, modulates energy homeostasis and suppresses cell death. The flightless phenotype is also suppressed by mutations in downstream IIS signalling components, including those in the mechanistic Target of Rapamycin Complex 1 (mTORC1) pathway, suggesting that elevated IIS is responsible for functional decline in flight muscle. Our data demonstrate that IIS levels must be precisely regulated by Pten in adults to maintain the function of the highly metabolically active indirect flight muscles, offering a new system to study the in vivo roles of IIS in the maintenance of mitochondrial integrity and adult ageing.	[Mensah, Lawrence B.; Davison, Claire; Fan, Shih-Jung; Morris, John F.; Goberdhan, Deborah C. I.; Wilson, Clive] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	University of Oxford	Wilson, C (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Le Gros Clark Bldg,South Parks Rd, Oxford OX1 3QX, England.	clive.wilson@dpag.ox.ac.uk			BBSRC [96/G10924, 43/C16865, BB-L007096-1]; BBSRC [BB/L007096/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L007096/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Some of the work was funded by BBSRC grants 96/G10924, 43/C16865, and and BB-L007096-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Alex Whitworth, Dept. of Biomedical Sciences, University of Sheffield, UK. Ernst Hafen, Universitat Zurich, currently at MIDATA COOP-Project, Switzerland, Hugo Stocker, ETH Zurich, Switzerland, Duojia D.J. Pan, Dept. of Molecular Biology and Genetics, Johns Hopkins University, USA, Judith Lengyel, Dept. of Molecular Biology, University of California, USA, Thomas Neufeld, College of Biological Sciences, University of Minnesota, USA and the Bloomington Stock Centre for fly stocks. We are also grateful to Chris Parkin, Mohan Masih and Lynne Scott for technical assistance. Some of the work was funded by BBSRC grants 96/G10924, 43/C16865 and BB-L007096-1.	Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bononi A, 2013, CELL DEATH DIFFER, V20, P1631, DOI 10.1038/cdd.2013.77; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Brown HLD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044888; Cauchi RJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000265; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Doumanis J, 2007, CELL DEATH DIFFER, V14, P907, DOI 10.1038/sj.cdd.4402082; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Goberdhan DCI, 2002, DEV GENES EVOL, V212, P196, DOI 10.1007/s00427-002-0226-3; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hatano T, 2012, MOVEMENT DISORD, V27, P1613, DOI 10.1002/mds.25241; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hosamani R, 2013, ARCH INSECT BIOCHEM, V83, P25, DOI 10.1002/arch.21094; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Kondo M, 2005, MECH AGEING DEV, V126, P642, DOI 10.1016/j.mad.2004.11.012; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Monserrate JP, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-63; Nepal O, 2011, Kathmandu Univ Med J (KUMJ), V9, P35; Oldham S, 2002, DEVELOPMENT, V129, P4103; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Patel PH, 2006, J CELL SCI, V119, P4285, DOI 10.1242/jcs.03199; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Quinn L, 2003, EMBO J, V22, P3568, DOI 10.1093/emboj/cdg355; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Rzezniczak TZ, 2011, ANAL BIOCHEM, V419, P345, DOI 10.1016/j.ab.2011.08.023; Shamoto-Nagai M, 2003, J NEUROSCI RES, V74, P589, DOI 10.1002/jnr.10777; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tsubouchi A, 2009, DEVELOPMENT, V136, P3757, DOI 10.1242/dev.042135; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Venderova K, 2009, HUM MOL GENET, V18, P4390, DOI 10.1093/hmg/ddp394; Vereshchagina N, 2008, J CELL SCI, V121, P3383, DOI 10.1242/jcs.035220; Vincent A, 2012, HUM MOL GENET, V21, P1760, DOI 10.1093/hmg/ddr609; Wang C, 2007, J NEUROSCI, V27, P8563, DOI 10.1523/JNEUROSCI.0218-07.2007; Wang LQ, 2011, J NEUROSCI, V31, P2868, DOI 10.1523/JNEUROSCI.3410-10.2011; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	59	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143818	10.1371/journal.pone.0143818	http://dx.doi.org/10.1371/journal.pone.0143818			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599788	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900163
J	Wei, SP; Roessler, BC; Icyuz, M; Chauvet, S; Tao, BL; Hartman, JL; Kirk, KL				Wei, Shipeng; Roessler, Bryan C.; Icyuz, Mert; Chauvet, Sylvain; Tao, Binli; Hartman, John L.; Kirk, Kevin L.			Long-range coupling between the extracellular gates and the intracellular ATP binding domains of multidrug resistance protein pumps and cystic fibrosis transmembrane conductance regulator channels	FASEB JOURNAL			English	Article						ABC transporter; ion channel; allostery; phosphorylation	CFTR CHLORIDE CHANNEL; NUCLEOTIDE-BINDING; ALLOSTERIC MODULATION; TRANSPORTER; MECHANISM; SITES; PORE; PHOSPHORYLATION; DIMERIZATION; HYDROLYSIS	The ABCC transporter subfamily includes pumps, the long and short multidrug resistance proteins (MRPs), and an ATP-gated anion channel, the cystic fibrosis transmembrane conductance regulator (CFTR). We show that despite their thermodynamic differences, these ABCC transporter subtypes use broadly similar mechanisms to couple their extracellular gates to the ATP occupancies of their cytosolic nucleotide binding domains. A conserved extracellular phenylalanine at this gate was a prime location for producing gain of function (GOF) mutants of a long MRP in yeast (Ycf1p cadmium transporter), a short yeast MRP (Yor1p oligomycin exporter), and human CFTR channels. Extracellular gate mutations rescued ATP binding mutants of the yeast MRPs and CFTR by increasing ATP sensitivity. Control ATPase-defective MRP mutants could not be rescued by this mechanism. A CFTR double mutant with an extracellular gate mutation plus a cytosolic GOF mutation was highly active (single-channel open probability >0.3) in the absence of ATP and protein kinase A, each normally required for CFTR activity. We conclude that all 3 ABCC transporter subtypes use similar mechanisms to couple their extracellular gates to ATP occupancy, and highly active CFTR channels that bypass defects in ATP binding or phosphorylation can be produced.	[Wei, Shipeng; Roessler, Bryan C.; Chauvet, Sylvain; Tao, Binli; Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Icyuz, Mert; Hartman, John L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Dept Genet, Birmingham, AL 35294 USA; [Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kirk, KL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1918 Univ Blvd, Birmingham, AL 35294 USA.	klkirk@uab.edu	Icyuz, Mert/J-6598-2013	Icyuz, Mert/0000-0003-1681-0115; Hartman, John/0000-0003-1176-6469	U.S. National Institutes of Health [RO1 DK056796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, R01DK056796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank John Rodgers and Sean Santos (both at the University of Alabama at Birmingham, Birmingham, AL, USA) for assistance with the yeast growth curve analysis. This study was supported by U.S. National Institutes of Health Grant RO1 DK056796.	Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Auerbach A, 2012, J PHYSIOL-LONDON, V590, P93, DOI 10.1113/jphysiol.2011.214684; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Burke D., 2000, METHODS YEAST GENETI; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Cui GY, 2012, PFLUG ARCH EUR J PHY, V463, P405, DOI 10.1007/s00424-011-1035-1; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; El-Sheikh AAK, 2008, MOL PHARMACOL, V74, P964, DOI 10.1124/mol.107.043661; Falcon-Perez JM, 2001, J BACTERIOL, V183, P4761, DOI 10.1128/JB.183.16.4761-4770.2001; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Gao XL, 2015, P NATL ACAD SCI USA, V112, P2461, DOI 10.1073/pnas.1420676112; Gentzsch M, 2007, J CELL SCI, V120, P447, DOI 10.1242/jcs.03350; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Herlitze S, 2001, P NATL ACAD SCI USA, V98, P4699, DOI 10.1073/pnas.051628998; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Kim IW, 2006, BIOCHEMISTRY-US, V45, P7605, DOI 10.1021/bi060308o; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Linsdell P, 2000, BIOPHYS J, V78, P2973, DOI 10.1016/S0006-3495(00)76836-6; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Norimatsu Y, 2012, MOL PHARMACOL, V82, P1042, DOI 10.1124/mol.112.080267; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; Okeyo G, 2013, J BIOL CHEM, V288, P17122, DOI 10.1074/jbc.M112.442582; Rodgers J, 2014, METHODS MOL BIOL, V1205, P187, DOI 10.1007/978-1-4939-1363-3_12; Sauna ZE, 2004, J BIOL CHEM, V279, P48855, DOI 10.1074/jbc.M408849200; Shah NA, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-3; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Szentpetery Z, 2004, ANTICANCER RES, V24, P449; Szollosi A, 2011, J GEN PHYSIOL, V137, P549, DOI 10.1085/jgp.201110608; Szollosi A, 2010, J GEN PHYSIOL, V136, P407, DOI 10.1085/jgp.201010434; Tsui LC, 1991, CURR OPIN GENET DEV, V1, P4, DOI 10.1016/0959-437X(91)80032-H; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wei SP, 2014, J BIOL CHEM, V289, P19942, DOI 10.1074/jbc.M114.562116; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yeh HI, 2015, J GEN PHYSIOL, V145, P47, DOI 10.1085/jgp.201411272; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	52	11	11	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1247	1262		10.1096/fj.15-278382	http://dx.doi.org/10.1096/fj.15-278382			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26606940	Green Published			2022-12-26	WOS:000370387800021
J	Lin, YB; Bogdanov, M; Tong, SL; Guan, ZQ; Zheng, L				Lin, Yibin; Bogdanov, Mikhail; Tong, Shuilong; Guan, Ziqiang; Zheng, Lei			Substrate Selectivity of Lysophospholipid Transporter LplT Involved in Membrane Phospholipid Remodeling in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOSE PERMEASE; 2-ACYL LYSOPHOSPHOLIPIDS; PROTEIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; HYDROLYSIS; CURVATURE; MECHANISM; PEPTIDES; LIPIDS	Lysophospholipid transporter (LplT) was previously found to be primarily involved in 2-acyl lysophosphatidylethanolamine (lyso-PE) recycling in Gram-negative bacteria. This work identifies the potent role of LplT in maintaining membrane stability and integrity in the Escherichia coli envelope. Here we demonstrate the involvement of LplT in the recycling of three major bacterial phospholipids using a combination of an in vitro lysophospholipid binding assay using purified protein and transport assays with E. coli spheroplasts. Our results show that lyso-PE and lysophosphatidylglycerol, but not lysophosphatidylcholine, are taken up by LplT for reacylation by acyltransferase/acyl-acyl carrier protein synthetase on the inner leaflet of the membrane. We also found a novel cardiolipin hydrolysis reaction by phospholipase A(2) to form diacylated cardiolipin progressing to the completely deacylated headgroup. These two distinct cardiolipin derivatives were both translocated with comparable efficiency to generate triacylated cardiolipin by acyltransferase/acyl-acyl carrier protein synthetase, demonstrating the first evidence of cardiolipin remodeling in bacteria. These findings support that a fatty acid chain is not required for LplT transport. We found that LplT cannot transport lysophosphatidic acid, and its substrate binding was not inhibited by either orthophosphate or glycerol 3-phosphate, indicating that either a glycerol or ethanolamine headgroup is the chemical determinant for substrate recognition. Diacyl forms of PE, phosphatidylglycerol, or the tetra-acylated form of cardiolipin could not serve as a competitive inhibitor in vitro. Based on an evolutionary structural model, we propose a "sideways sliding" mechanism to explain how a conserved membrane-embedded alpha-helical interface excludes diacylphospholipids from the LplT binding site to facilitate efficient flipping of lysophospholipid across the cell membrane.	[Lin, Yibin; Bogdanov, Mikhail; Tong, Shuilong; Zheng, Lei] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA; [Guan, Ziqiang] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27703 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Duke University	Zheng, L (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	lei.zheng@uth.tmc.edu	Crystal, Boy/Q-3005-2019; Bogdanov, Mikhail/J-3695-2017; Lin, B.Y./AAA-7774-2020; Guan, Ziqiang/AAE-5110-2019	Crystal, Boy/0000-0003-0608-7875; 	National Institutes of Health [R01GM098572]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM098572 (to L. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Buckland AG, 1998, BBA-LIPID LIPID MET, V1390, P65, DOI 10.1016/S0005-2760(97)00170-7; COLEMAN J, 1990, J BIOL CHEM, V265, P17215; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DENNIS EA, 1981, MOL CELL BIOCHEM, V36, P37, DOI 10.1007/BF02354830; DOI O, 1972, BIOCHIM BIOPHYS ACTA, V260, P244; DOI O, 1975, J BIOL CHEM, V250, P5208; Dowhan W, 2013, BBA-MOL CELL BIOL L, V1831, P471, DOI 10.1016/j.bbalip.2012.08.007; Dowhan W, 2008, N COMP BIOC, P1, DOI 10.1016/B978-044453219-0.50003-9; ELSBACH P, 1993, IMMUNOBIOLOGY, V187, P417, DOI 10.1016/S0171-2985(11)80354-2; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Guo DG, 2000, BBA-MOL CELL BIOL L, V1483, P263, DOI 10.1016/S1388-1981(99)00193-6; GUPTA SD, 1991, J BIOL CHEM, V266, P9983; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; HOMMA H, 1981, BIOCHIM BIOPHYS ACTA, V663, P1, DOI 10.1016/0005-2760(81)90189-2; HOMMA H, 1982, J BIOCHEM, V91, P1103, DOI 10.1093/oxfordjournals.jbchem.a133792; Hsu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059267; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; Koller D, 2014, BBA-BIOMEMBRANES, V1838, P2250, DOI 10.1016/j.bbamem.2014.05.013; Lin YB, 2013, BBA-BIOMEMBRANES, V1828, P1690, DOI 10.1016/j.bbamem.2013.03.003; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; Perez C, 2015, NATURE, V524, P433, DOI 10.1038/nature14953; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; Vitrac H, 2011, J BIOL CHEM, V286, P15182, DOI 10.1074/jbc.M110.214387; WRIGHT GC, 1990, J CLIN INVEST, V85, P1925, DOI 10.1172/JCI114655; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	43	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2136	2149		10.1074/jbc.M115.700419	http://dx.doi.org/10.1074/jbc.M115.700419			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26613781	Green Published, hybrid			2022-12-26	WOS:000369610400008
J	Guidotti, S; Minguzzi, M; Platano, D; Cattini, L; Trisolino, G; Mariani, E; Borzi, RM				Guidotti, Serena; Minguzzi, Manuela; Platano, Daniela; Cattini, Luca; Trisolino, Giovanni; Mariani, Erminia; Borzi, Rosa Maria			Lithium Chloride Dependent Glycogen Synthase Kinase 3 Inactivation Links Oxidative DNA Damage, Hypertrophy and Senescence in Human Articular Chondrocytes and Reproduces Chondrocyte Phenotype of Obese Osteoarthritis Patients	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; CELLULAR SENESCENCE; GENE-EXPRESSION; BETA-CATENIN; STEM-CELLS; IN-VITRO; CARTILAGE; DIFFERENTIATION; DEGRADATION; PROTEIN	Introduction Recent evidence suggests that GSK3 activity is chondroprotective in osteoarthritis (OA), but at the same time, its inactivation has been proposed as an anti-inflammatory therapeutic option. Here we evaluated the extent of GSK3 beta inactivation in vivo in OA knee cartilage and the molecular events downstream GSK3 beta inactivation in vitro to assess their contribution to cell senescence and hypertrophy. Methods In vivo level of phosphorylated GSK3 beta was analyzed in cartilage and oxidative damage was assessed by 8-oxo-deoxyguanosine staining. The in vitro effects of GSK3 beta inactivation (using either LiCl or SB216763) were evaluated on proliferating primary human chondrocytes by combined confocal microscopy analysis of Mitotracker staining and reactive oxygen species (ROS) production (2',7'-dichlorofluorescin diacetate staining). Downstream effects on DNA damage and senescence were investigated by western blot (gamma H2AX, GADD45 beta and p21), flow cytometric analysis of cell cycle and light scattering properties, quantitative assessment of senescence associated beta galactosidase activity, and PAS staining. Results In vivo chondrocytes from obese OA patients showed higher levels of phosphorylated GSK3 beta, oxidative damage and expression of GADD45 beta and p21, in comparison with chondrocytes of nonobese OA patients. LiCl mediated GSK3 beta inactivation in vitro resulted in increased mitochondrial ROS production, responsible for reduced cell proliferation, S phase transient arrest, and increase in cell senescence, size and granularity. Collectively, western blot data supported the occurrence of a DNA damage response leading to cellular senescence with increase in gamma H2AX, GADD45 beta and p21. Moreover, LiCl boosted 8-oxo-dG staining, expression of IKK alpha and MMP-10. Conclusions In articular chondrocytes, GSK3 beta activity is required for the maintenance of proliferative potential and phenotype. Conversely, GSK3 beta inactivation, although preserving chondrocyte survival, results in functional impairment via induction of hypertrophy and senescence. Indeed, GSK3 beta inactivation is responsible for ROS production, triggering oxidative stress and DNA damage response.	[Guidotti, Serena; Minguzzi, Manuela; Platano, Daniela; Cattini, Luca; Mariani, Erminia; Borzi, Rosa Maria] Ist Ortoped Rizzoli, Lab Immunoreumatol & Rigeneraz Tessutale, Bologna, Italy; [Guidotti, Serena; Minguzzi, Manuela; Platano, Daniela; Mariani, Erminia] Univ Bologna, Dipartimento Sci Med & Chirurg DIMEC, Bologna, Italy; [Platano, Daniela] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DIBINEM, Bologna, Italy; [Cattini, Luca; Mariani, Erminia; Borzi, Rosa Maria] Ist Ortoped Rizzoli, Lab RAMSES, Dipartimento RIT, Bologna, Italy; [Trisolino, Giovanni] Ist Ortoped Rizzoli, Chirurg Ricostruttiva Articolare Anca & Ginocchio, Bologna, Italy	IRCCS Istituto Ortopedico Rizzoli; University of Bologna; University of Bologna; IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli	Borzi, RM (corresponding author), Ist Ortoped Rizzoli, Lab Immunoreumatol & Rigeneraz Tessutale, Bologna, Italy.	rosamaria.borzi@ior.it	Mariani, Erminia/AAE-8110-2021; Minguzzi, Manuela/J-8172-2017; Borzì, Rosa Maria/ABI-2279-2020; Trisolino, Giovanni/I-3717-2019; Mariani, Erminia/C-6881-2019	Mariani, Erminia/0000-0002-4407-6707; Borzì, Rosa Maria/0000-0003-4133-4894; Trisolino, Giovanni/0000-0002-0361-9920; Mariani, Erminia/0000-0002-4407-6707	Ministero dell'Istruzione, dell'Universita e della Ricerca [RBAP10KCNS]; Fondi Cinque per mille (Ministero della Salute)	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondi Cinque per mille (Ministero della Salute)	This work was supported by RBAP10KCNS (Ministero dell'Istruzione, dell'Universita e della Ricerca, http://www.istruzione.it/) to Erminia Mariani; Fondi Cinque per mille (Ministero della Salute, http://www.salute.gov.it/) to Laboratorio di Immunoreumatologia e Rigenerazione Tissutale IOR, Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P1304, DOI 10.1002/1529-0131(200106)44:6<1304::AID-ART222>3.0.CO;2-T; Alvarez-Garcia O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034788; Anderson AS, 2010, BEST PRACT RES CL RH, V24, P15, DOI 10.1016/j.berh.2009.08.006; Bhattacharjee RN, 2005, FEBS LETT, V579, P6604, DOI 10.1016/j.febslet.2005.10.053; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Blumenfeld O, 2013, OSTEOARTHR CARTILAGE, V21, P923, DOI 10.1016/j.joca.2013.04.009; Borzi RM, 2010, ARTHRITIS RHEUM-US, V62, P2370, DOI 10.1002/art.27512; Byun HO, 2012, EXP CELL RES, V318, P1808, DOI 10.1016/j.yexcr.2012.04.012; Chiu CT, 2010, PHARMACOL THERAPEUT, V128, P281, DOI 10.1016/j.pharmthera.2010.07.006; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dai SM, 2006, ARTHRITIS RHEUM-US, V54, P818, DOI 10.1002/art.21639; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Gallo LI, 2011, J BIOL CHEM, V286, P30152, DOI 10.1074/jbc.M111.256610; Gavrilov B, 2006, BIOCHEM BIOPH RES CO, V347, P1048, DOI 10.1016/j.bbrc.2006.07.005; Gillespie JR, 2011, ENDOCRINOLOGY, V152, P1755, DOI 10.1210/en.2010-1412; Greenwood SK, 2004, ENVIRON MOL MUTAGEN, V43, P36, DOI 10.1002/em.10207; Guidotti S, 2013, STEM CELLS DEV, V22, P1588, DOI 10.1089/scd.2012.0399; Hojlund K, 2014, DAN MED J, V61; Hui W, 2010, RHEUMATOLOGY, V49, P2043, DOI 10.1093/rheumatology/keq217; Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200; Itoh S, 2012, J BIOL CHEM, V287, P29227, DOI 10.1074/jbc.M112.372086; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Litherland GJ, 2014, ARTHRITIS RHEUMATOL, V66, P2175, DOI 10.1002/art.38681; Liu KJ, 2011, J CELL PHYSIOL, V226, P424, DOI 10.1002/jcp.22348; Loeser RF, 2011, CURR OPIN RHEUMATOL, V23, P492, DOI 10.1097/BOR.0b013e3283494005; Lories RJ, 2013, NAT REV RHEUMATOL, V9, P328, DOI 10.1038/nrrheum.2013.25; Bonet ML, 2011, CURR DRUG TARGETS, V12, P2103; Manferdini C, 2013, ARTHRITIS RHEUM-US, V65, P1271, DOI 10.1002/art.37908; Markkanen E, 2012, CELL CYCLE, V11, P1070, DOI 10.4161/cc.11.6.19448; Minashima T, 2014, ARTHRITIS RHEUMATOL, V66, P1228, DOI 10.1002/art.38373; Nakanishi A, 2014, AGING DIS, V5, P203, DOI 10.14336/AD.2014.0500203; Nikoulina SE, 2002, DIABETES, V51, P2190, DOI 10.2337/diabetes.51.7.2190; Olivotto E, 2008, ARTHRITIS RHEUM-US, V58, P227, DOI 10.1002/art.23211; Philipot D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4494; Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Rabie ABM, 2004, ARCH ORAL BIOL, V49, P109, DOI 10.1016/j.archoralbio.2003.09.006; Redon CE, 2011, AGING-US, V3, P168, DOI 10.18632/aging.100284; Rose J, 2012, OSTEOARTHR CARTILAGE, V20, P1020, DOI 10.1016/j.joca.2012.05.009; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; Shimada H, 2011, PATHOL RES PRACT, V207, P225, DOI 10.1016/j.prp.2011.01.007; Stewart MC, 1997, CALCIFIED TISSUE INT, V61, P199, DOI 10.1007/s002239900323; Svetlova MP, 2010, MUTAT RES-FUND MOL M, V685, P54, DOI 10.1016/j.mrfmmm.2009.08.001; Takacs-Buia L, 2008, CYTOM PART B-CLIN CY, V74B, P356, DOI 10.1002/cyto.b.20428; Tsuchimochi K, 2010, J BIOL CHEM, V285, P8395, DOI 10.1074/jbc.M109.038638; van der Kraan PA, 2008, AGEING RES REV, V7, P106, DOI 10.1016/j.arr.2007.10.001; Wu QQ, 2008, ARTHRITIS RHEUM-US, V58, P3132, DOI 10.1002/art.23946; Wu QQ, 2009, EXP CELL RES, V315, P2386, DOI 10.1016/j.yexcr.2009.05.019; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yoshimura N, 2012, OSTEOARTHR CARTILAGE, V20, P1217, DOI 10.1016/j.joca.2012.06.006; Zhou HW, 2004, RHEUMATOLOGY, V43, P555, DOI 10.1093/rheumatology/keh127; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	56	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143865	10.1371/journal.pone.0143865	http://dx.doi.org/10.1371/journal.pone.0143865			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618897	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800083
J	Kwak, JH; Chang, SX; Naeth, MA; Schaaf, W				Kwak, Jin-Hyeob; Chang, Scott X.; Naeth, M. Anne; Schaaf, Wolfgang			Coarse Woody Debris Increases Microbial Community Functional Diversity but not Enzyme Activities in Reclaimed Oil Sands Soils	PLOS ONE			English	Article							ORGANIC AMENDMENTS; NITROGEN-MINERALIZATION; PLANT; RECLAMATION; BIOMASS; DECOMPOSITION; AVAILABILITY; DECREASES; PROFILES; RECOVERY	Forest floor mineral soil mix (FMM) and peat mineral soil mix (PMM) are cover soils commonly used for upland reclamation post open-pit oil sands mining in northern Alberta, Canada. Coarse woody debris (CWD) can be used to regulate soil temperature and water content, to increase organic matter content, and to create microsites for the establishment of microorganisms and vegetation in upland reclamation. We studied the effects of CWD on soil microbial community level physiological profile (CLPP) and soil enzyme activities in FMM and PMM in a reclaimed landscape in the oil sands. This experiment was conducted with a 2 (FMM vs PMM) x 2 (near CWD vs away from CWD) factorial design with 6 replications. The study plots were established with Populus tremuloides (trembling aspen) CWD placed on each plot between November 2007 and February 2008. Soil samples were collected within 5 cm from CWD and more than 100 cm away from CWD in July, August and September 2013 and 2014. Microbial biomass was greater (p<0.05) in FMM than in PMM, in July, and August 2013 and July 2014, and greater (p<0.05) near CWD than away from CWD in FMM in July and August samplings. Soil microbial CLPP differed between FMM and PMM (p<0.01) according to a principal component analysis and CWD changed microbial CLPP in FMM (p<0.05) but not in PMM. Coarse woody debris increased microbial community functional diversity (average well color development in Biolog Ecoplates) in both cover soils (p<0.05) in August and September 2014. Carbon degrading soil enzyme activities were greater in FMM than in PMM (p<0.05) regardless of distance from CWD but were not affected by CWD. Greater microbial biomass and enzyme activities in FMM than in PMM will increase organic matter decomposition and nutrient cycling, improving plant growth. Enhanced microbial community functional diversity by CWD application in upland reclamation has implications for accelerating upland reclamation after oil sands mining.	[Kwak, Jin-Hyeob; Chang, Scott X.; Naeth, M. Anne] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2E3, Canada; [Schaaf, Wolfgang] Brandenburg Univ Technol Cottbus Senftenberg, Soil Protect & Recultivat, D-03013 Cottbus, Germany	University of Alberta; Brandenburg University of Technology Cottbus	Chang, SX (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2E3, Canada.	scott.chang@ualberta.ca	Chang, Scott X/G-2029-2011	Chang, Scott/0000-0002-7624-439X; Schaaf, Wolfgang/0000-0003-3288-5539; Naeth, M Anne/0000-0002-9147-1638	Helmholtz-Alberta Initiative [HAI RES0006457]	Helmholtz-Alberta Initiative	This work was funded by Helmholtz-Alberta Initiative, HAI RES0006457, www.helmholtzalberta.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Government, 2014, ALB OIL SANDS; Alkorta Itziar, 2003, Rev Environ Health, V18, P65; Andersson M, 2004, SOIL BIOL BIOCHEM, V36, P1527, DOI 10.1016/j.soilbio.2004.07.018; Bach LH, 2008, CAN J FOREST RES, V38, P1504, DOI 10.1139/X07-232; Beasse ML, 2015, ECOL ENG, V75, P199, DOI 10.1016/j.ecoleng.2014.11.042; Brant JB, 2006, SOIL BIOL BIOCHEM, V38, P2219, DOI 10.1016/j.soilbio.2006.01.022; Brown RL, 2010, THESIS; Brown RL, 2014, RESTOR ECOL, V22, P40, DOI 10.1111/rec.12029; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Debeljak M, 2006, ECOL INDIC, V6, P733, DOI 10.1016/j.ecolind.2005.08.031; Degens BP, 2000, SOIL BIOL BIOCHEM, V32, P189, DOI 10.1016/S0038-0717(99)00141-8; Degens BP, 1998, SOIL BIOL BIOCHEM, V30, P1989, DOI 10.1016/S0038-0717(98)00071-6; DEPUIT EJ, 1984, MINER ENVIRON, V6, P115, DOI 10.1007/BF02043991; Dimitriu PA, 2010, SOIL BIOL BIOCHEM, V42, P2289, DOI 10.1016/j.soilbio.2010.09.001; Environment Canada, 2014, CAAND CLIM NORM 2014; Forsch KBC, 2014, THESIS; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Gonzalez-Polo M, 2013, ECOSYSTEMS, V16, P1025, DOI 10.1007/s10021-013-9665-0; Griffiths BS, 1999, SOIL BIOL BIOCHEM, V31, P145, DOI 10.1016/S0038-0717(98)00117-5; Hackett CA, 1997, J MICROBIOL METH, V30, P63, DOI 10.1016/S0167-7012(97)00045-6; Hahn AS, 2013, PLANT SOIL, V363, P331, DOI 10.1007/s11104-012-1306-4; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hernandez DL, 2010, PLANT SOIL, V335, P397, DOI 10.1007/s11104-010-0428-9; Jamro GM, 2014, ECOL ENG, V73, P92, DOI 10.1016/j.ecoleng.2014.09.005; Jenkinson DS, 1981, SOIL BIOCH, V5, P415; Jin VL, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001564; Kappes H, 2007, APPL SOIL ECOL, V36, P190, DOI 10.1016/j.apsoil.2007.02.003; Keeney D.R, 1982, AGRON MONOGR, P643; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; LADD JN, 1995, SOIL BIOL BIOCHEM, V27, P777, DOI 10.1016/0038-0717(94)00243-T; Lajtha K, 2005, BIOGEOCHEMISTRY, V76, P261, DOI 10.1007/s10533-005-5071-9; Mackenzie DD, 2010, RESTOR ECOL, V18, P418, DOI 10.1111/j.1526-100X.2008.00500.x; MacKenzie MD, 2010, APPL SOIL ECOL, V44, P32, DOI 10.1016/j.apsoil.2009.09.002; MCGILL WB, 1986, CAN J SOIL SCI, V66, P1, DOI 10.4141/cjss86-001; McMillan R, 2007, J ENVIRON QUAL, V36, P1470, DOI 10.2134/jeq2006.0530; Mielke PW, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-69813-7; Muruganandam S, 2009, SOIL SCI SOC AM J, V73, P751, DOI 10.2136/sssaj2008.0231; Preston-Mafham J, 2002, FEMS MICROBIOL ECOL, V42, P1, DOI 10.1111/j.1574-6941.2002.tb00990.x; Province of Alberta, 2014, CONS RECL REG ENV PR; Pyle C, 1999, FOREST ECOL MANAG, V114, P253, DOI 10.1016/S0378-1127(98)00356-9; R Development Core Team, 2012, LANG ENV STAT COMP V; SINSABAUGH RL, 1991, AGR ECOSYST ENVIRON, V34, P43, DOI 10.1016/0167-8809(91)90092-C; Sinsabaugh RL, 2003, APPL SOIL ECOL, V24, P263, DOI 10.1016/S0929-1393(03)00002-7; Stevens V., 1997, ECOLOGICAL ROLE COAR, P26; Sydnor MEW, 2002, J ENVIRON QUAL, V31, P1528, DOI 10.2134/jeq2002.1528; VANVEEN JA, 1990, BIOGEOCHEMISTRY, V11, P213, DOI 10.1007/BF00004497; Wagner GH., 2005, PRINCIPLES APPL SOIL, V2, P218; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Yang CH, 2000, APPL ENVIRON MICROB, V66, P345, DOI 10.1128/AEM.66.1.345-351.2000; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433	52	21	22	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143857	10.1371/journal.pone.0143857	http://dx.doi.org/10.1371/journal.pone.0143857			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618605	Green Submitted, gold, Green Published			2022-12-26	WOS:000365889800081
J	Pitarokoili, K; Ambrosius, B; Meyer, D; Schrewe, L; Gold, R				Pitarokoili, Kalliopi; Ambrosius, Bjoern; Meyer, Daniela; Schrewe, Lisa; Gold, Ralf			Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection	PLOS ONE			English	Article							PLACEBO-CONTROLLED PHASE-3; ACID ESTERS; ORAL BG-12; PSORIASIS; MECHANISMS	Background Dimethyl fumarate is an immunomodulatory and neuroprotective drug, approved recently for the treatment of relapsing-remitting multiple sclerosis. In view of the limited therapeutic options for human acute and chronic polyneuritis, we used the animal model of experimental autoimmune neuritis in the Lewis rat to study the effects of dimethyl fumarate on autoimmune inflammation and neuroprotection in the peripheral nervous system. Methods and Findings Experimental autoimmune neuritis was induced by immunization with the neuritogenic peptide (amino acids 53-78) of P2 myelin protein. Preventive treatment with dimethyl fumarate given at 45 mg/kg twice daily by oral gavage significantly ameliorated clinical neuritis by reducing demyelination and axonal degeneration in the nerve conduction studies. Histology revealed a significantly lower degree of inflammatory infiltrates in the sciatic nerves. In addition, we detected a reduction of early signs of axonal degeneration through a reduction of amyloid precursor protein expressed in axons of the peripheral nerves. This reduction correlated with an increase of nuclear factor (erythroid derived 2)-related factor 2 positive axons, supporting the neuroprotective potential of dimethyl fumarate. Furthermore, nuclear factor (erythroid derived 2)-related factor 2 expression in Schwann cells was only rarely detected and there was no increase of Schwann cells death during EAN. Conclusions We conclude that immunmodulatory and neuroprotective dimethyl fumarate may represent an innovative therapeutic option in human autoimmune neuropathies.	[Pitarokoili, Kalliopi; Ambrosius, Bjoern; Meyer, Daniela; Schrewe, Lisa; Gold, Ralf] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany	Ruhr University Bochum	Pitarokoili, K (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany.	kalliapit@yahoo.gr; ralf.gold@rub.de			Biogen idec [29.13.-92907]; Bayer Schering; Biogen Idec; Merck Serono; Novartis; Sanofi-Aventis; TEVA	Biogen idec(Biogen); Bayer Schering(Bayer AG); Biogen Idec(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); Sanofi-Aventis(Sanofi-Aventis); TEVA(Teva Pharmaceutical Industries)	Biogen idec (http://www.biogen.de/) supported the investigator initiated treatment study by an unrestricted grant (29.13.-92907) in the name of RG. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Kalliopi Pitarokoili, Bjorn Ambrosius, Lisa Schrewe and Daniela Meyer report no disclosures. R. Gold has received consultation fees and speakers honoraria from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi-Aventis and TEVA. He also acknowledges grant support from Bayer Schering, Biogen Idec, Merck-Serono, Sanofi-Aventis and TEVA.	Altmeyer P, 1996, HAUTARZT, V47, P190, DOI 10.1007/s001050050401; Benardais K, 2013, NEUROSCI LETT, V555, P165, DOI 10.1016/j.neulet.2013.09.038; Chen HW, 2014, TOXICOL APPL PHARM, V280, P1, DOI 10.1016/j.taap.2014.07.024; deJong P, 1996, EUR J IMMUNOL, V26, P2067, DOI 10.1002/eji.1830260916; Enders U, 1998, BRAIN, V121, P1257, DOI 10.1093/brain/121.7.1257; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Gold R, 2005, PERIPHERAL NEUROPATH; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Hadden RDM, 2003, J NEUROL NEUROSUR PS, V74, pII9, DOI 10.1136/jnnp.74.suppl_2.ii9; HARTUNG HP, 1988, ANN NEUROL, V23, P453, DOI 10.1002/ana.410230505; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Hughes RA, 2013, COCHRANE DATABASE SY; Hughes RAC, 2003, DRUGS, V63, P275, DOI 10.2165/00003495-200363030-00003; KADLUBOWSKI M, 1979, NATURE, V277, P140, DOI 10.1038/277140a0; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kieseier BC, 2002, NEUROLOGY, V59, pS7, DOI 10.1212/WNL.59.12_suppl_6.S7; Kieseier BC, 2004, MUSCLE NERVE, V30, P131, DOI 10.1002/mus.20076; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Mathey EK, 2015, J NEUROL NEUROSUR PS, V86, P973, DOI 10.1136/jnnp-2014-309697; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Pollard JD, 2011, J PERIPHER NERV SYST, V16, P15, DOI 10.1111/j.1529-8027.2011.00323.x; Reick C, 2014, EXP NEUROL, V257, P50, DOI 10.1016/j.expneurol.2014.04.003; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; Stoof TJ, 2001, BRIT J DERMATOL, V144, P1114, DOI 10.1046/j.1365-2133.2001.04220.x; Taylor JM, 2003, MUSCLE NERVE, V28, P344, DOI 10.1002/mus.10432; Treumer F, 2003, J INVEST DERMATOL, V121, P1383, DOI 10.1111/j.1523-1747.2003.12605.x; TUCK RR, 1982, J NEUROL SCI, V56, P173, DOI 10.1016/0022-510X(82)90140-X; WAKSMAN BH, 1955, J EXP MED, V102, P213, DOI 10.1084/jem.102.2.213; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; Yoon Min-Suk, 2011, Ther Adv Neurol Disord, V4, P193, DOI 10.1177/1756285611405564; Zhang HL, 2013, CYTOKINE GROWTH F R, V24, P443, DOI 10.1016/j.cytogfr.2013.05.005; Zhu KJ, 2001, J INVEST DERMATOL, V116, P203, DOI 10.1046/j.1523-1747.2001.01159.x	34	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143416	10.1371/journal.pone.0143416	http://dx.doi.org/10.1371/journal.pone.0143416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618510	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800035
J	Polin, S; Le Gallic, JF; Simon, JC; Tsuchida, T; Outreman, Y				Polin, Sarah; Le Gallic, Jean-Franois; Simon, Jean-Christophe; Tsuchida, Tsutomu; Outreman, Yannick			Conditional Reduction of Predation Risk Associated with a Facultative Symbiont in an Insect	PLOS ONE			English	Article							APHID ACYRTHOSIPHON-PISUM; PEA APHID; BACTERIAL ENDOSYMBIONTS; DEFENSIVE SYMBIOSIS; FORAGING BEHAVIOR; COLEOPTERA; SECRETIONS; INFECTION; RESPONSES; COLOR	Symbionts are widespread among eukaryotes and their impacts on the ecology and evolution of their hosts are meaningful. Most insects harbour obligate and facultative symbiotic bacteria that can influence their phenotype. In the pea aphid Acyrthosiphon pisum, an astounding symbiotic-mediated phenotype has been recently observed: when infected with the symbiotic bacteria Rickettsiella viridis, young red aphid larvae become greener at adulthood and even darker green when co-infected with Rickettsiella viridis and Hamiltonella defensa. As body colour affects the susceptibility towards natural enemies in aphids, the influence of the colour change due to these facultative symbionts on the host survival in presence of predators was tested. Our results suggested that the Rickettsiella viridis infection may impact positively host survival by reducing predation risk. Due to results from uninfected aphids (i.e., more green ones attacked), the main assumption is that this symbiotic infection would deter the predatory ladybird feeding by reducing the profitability of their hosts rather than decreasing host detection through body colour change. Aphids coinfected with Rickettsiella viridis and Hamiltonella defensa were, however, more exposed to predation suggesting an ecological cost associated with multiple infections. The underlying mechanisms and ecological consequences of these symbiotic effects are discussed.	[Polin, Sarah; Outreman, Yannick] Agrocampus Ouest, UMR IGEPP 1349, F-35042 Rennes, France; [Le Gallic, Jean-Franois; Simon, Jean-Christophe] INRA, UMR IGEPP 1349, F-35653 Le Rheu, France; [Tsuchida, Tsutomu] Toyama Univ, Frontier Res Core Life Sci, Toyama 9308555, Japan; [Outreman, Yannick] Univ Europeenne Bretagne, Rennes, France	Institut Agro; Agrocampus Ouest; INRAE; University of Toyama; Universite de Bretagne Occidentale	Outreman, Y (corresponding author), Agrocampus Ouest, UMR IGEPP 1349, F-35042 Rennes, France.	yannick.outreman@agrocampus-ouest.fr	Yannick, OUTREMAN/B-9309-2012	Yannick, OUTREMAN/0000-0002-7337-3049	Sigma-Xi; French 'Ministere de l'Enseignement Superieur et de la Recherche'; INRA-Department 'Sante des Plantes et Environnement'	Sigma-Xi; French 'Ministere de l'Enseignement Superieur et de la Recherche'; INRA-Department 'Sante des Plantes et Environnement'	This study was supported by a Sigma-Xi Grants-in-aid of Research, the French 'Ministere de l'Enseignement Superieur et de la Recherche', and the INRA-Department 'Sante des Plantes et Environnement'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker TCM, 1997, ECOLOGY, V78, P1098, DOI 10.1890/0012-9658(1997)078[1098:PICIBA]2.0.CO;2; Bilodeau E, 2013, EVOL ECOL, V27, P165, DOI 10.1007/s10682-012-9577-z; Bosch TCG, 2011, ZOOLOGY, V114, P185, DOI 10.1016/j.zool.2011.04.001; Chen DQ, 1996, CURR MICROBIOL, V33, P123, DOI 10.1007/s002849900086; Chen DQ, 1997, CURR MICROBIOL, V34, P220, DOI 10.1007/s002849900172; Clay K, 2014, FUNCT ECOL, V28, P293, DOI 10.1111/1365-2435.12258; Costopoulos K, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-5; Dion E, 2011, BIOL LETTERS, V7, P743, DOI 10.1098/rsbl.2011.0249; FERRAN A, 1993, EUR J ENTOMOL, V90, P383; FRAZER B D, 1976, Journal of the Entomological Society of British Columbia, V73, P33; Gauthier JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120664; Gehrer L, 2012, BIOL LETTERS, V8, P613, DOI 10.1098/rsbl.2012.0144; Gouin A, 2015, HEREDITY, V114, P494, DOI 10.1038/hdy.2014.85; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Harmon JP, 1998, OECOLOGIA, V115, P287, DOI 10.1007/s004420050518; Hemptinne JL, 2000, CHEMOECOLOGY, V10, P123, DOI 10.1007/PL00001813; Hussa EA, 2013, ANNU REV MICROBIOL, V67, P161, DOI 10.1146/annurev-micro-092412-155723; Janssens L, 2014, FRESHWATER BIOL, V59, P417, DOI 10.1111/fwb.12274; Jaquiery J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004838; Kunert G, 2010, ECOL ENTOMOL, V35, P147, DOI 10.1111/j.1365-2311.2009.01146.x; Libbrecht R, 2007, J INSECT BEHAV, V20, P25, DOI 10.1007/s10905-006-9055-y; Lopanik NB, 2014, FUNCT ECOL, V28, P328, DOI 10.1111/1365-2435.12160; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; Martin-Vivaldi M, 2010, P ROY SOC B-BIOL SCI, V277, P123, DOI 10.1098/rspb.2009.1377; Martin-Vivaldi M, 2009, J AVIAN BIOL, V40, P191, DOI 10.1111/j.1600-048X.2009.04393.x; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2006, P NATL ACAD SCI USA, V103, P12803, DOI 10.1073/pnas.0605772103; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Oliver KM, 2014, FUNCT ECOL, V28, P341, DOI 10.1111/1365-2435.12133; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Polin S, 2014, ECOL EVOL, V4, P826, DOI 10.1002/ece3.991; R Core Team, 2014, R FDN STAT COMP; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SENGONCA C, 1994, Z PFLANZENK PFLANZEN, V101, P173; STUBBS M, 1980, ECOL ENTOMOL, V5, P179, DOI 10.1111/j.1365-2311.1980.tb01139.x; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Tsuchida T, 2014, APPL ENVIRON MICROB, V80, P525, DOI 10.1128/AEM.03049-13; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463	43	29	29	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143728	10.1371/journal.pone.0143728	http://dx.doi.org/10.1371/journal.pone.0143728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618776	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800064
J	Wang, Y; Zeng, XQ; Ding, H				Wang, Yi; Zeng, XiaoQin; Ding, Han			Research on the Top-Down Parsing Method for Context-Sensitive Graph Grammars	PLOS ONE			English	Article								The parsing problem is one of the key problems of graph grammars. The typical parsing algorithm uses the bottom-up method. The time-complexity of this method is high, and it is difficult to apply. In order to reduce the time-complexity, this paper uses the top-down method for parsing. This method avoids the subgraph isomorphism judgment and selects the productions specifically, so that the time-complexity is greatly reduced.	[Wang, Yi; Zeng, XiaoQin] Hohai Univ, Inst Intelligence Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Wang, Yi; Ding, Han] Hubei Univ Arts & Sci, Sch Math & Comp Sci, Xiangyang, Peoples R China	Hohai University; Hubei University of Arts & Science	Wang, Y (corresponding author), Hubei Univ Arts & Sci, Sch Math & Comp Sci, Xiangyang, Peoples R China.	yiprince@126.com			National Natural Science Foundation of China [61170089]; Hubei Provinciale Natural Science Foundation of China [2014CFB634]; research and development projects of the Xiangyang plan of science and technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Provinciale Natural Science Foundation of China; research and development projects of the Xiangyang plan of science and technology	This work was supported (study design, data collection and analysis, decision to publish, and preparation of the manuscript) by the National Natural Science Foundation of China under grant No. 61170089, Hubei Provinciale Natural Science Foundation of China under grant NO. 2014CFB634, and the research and development projects of the Xiangyang plan of science and technology.	Adachi Y., 1999, Proceedings 1999 IEEE Symposium on Visual Languages, P228, DOI 10.1109/VL.1999.795908; COURCELLE B, 1987, THEOR COMPUT SCI, V55, P141, DOI 10.1016/0304-3975(87)90102-2; Daniel Le Metayer, 1997, IEEE T SOFTWARE ENG, V24, P521; Dong J, 2007, IEEE T SOFTWARE ENG, V33, P433, DOI 10.1109/TSE.2007.1012; ECONOMAKOS G, 1995, INFORM SOFTWARE TECH, V37, P493, DOI 10.1016/0950-5849(95)97293-H; Ghezzi C, 31 INT C SOFTW ENG I, P430; HAN X. Q., 2008, SURVEY GRAPH GRAMMAR, V35, P10; JANSSENS D, 1982, THEOR COMPUT SCI, V21, P55, DOI 10.1016/0304-3975(82)90088-3; Pfaltz J., P 1 INT JOINT C ART; Rekers J, 1997, J VISUAL LANG COMPUT, V8, P27, DOI 10.1006/jvlc.1996.0027; Rekers J, 9505 LEID U; Zeng Xiao-Qin, 2008, Journal of Software, V19, P1893, DOI 10.3724/SP.J.1001.2008.01893; Zeng XQ, 2005, 2005 IEEE SYMPOSIUM ON VISUAL LANGUAGE AND HUMAN-CENTRIC COMPUTING, PROCEEDINGS, P272; Zhang DQ, 2001, COMPUT J, V44, P186, DOI 10.1093/comjnl/44.3.186; Zhao C, 2007, J VISUAL LANG COMPUT, V18, P378, DOI 10.1016/j.jvlc.2007.07.004; Zhao CY, 2010, IEEE T SOFTWARE ENG, V36, P431, DOI 10.1109/TSE.2010.3	17	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0142776	10.1371/journal.pone.0142776	http://dx.doi.org/10.1371/journal.pone.0142776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618493	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800017
J	Connally, N; Anderson, CP; Bolton, JE; Bolton, EW; Buss, LW				Connally, Noah; Anderson, Christopher P.; Bolton, Jules E.; Bolton, Edward W.; Buss, Leo W.			The Selective Myosin II Inhibitor Blebbistatin Reversibly Eliminates Gastrovascular Flow and Stolon Tip Pulsations in the Colonial Hydroid Podocoryna carnea	PLOS ONE			English	Article							CELL MOVEMENTS; GROWTH; DYNAMICS; SHAPE	Blebbistatin reversibly disrupted both stolon tip pulsations and gastrovascular flow in the colonial hydroid Podocoryna carnea. Epithelial longitudinal muscles of polyps were unaffected by blebbistatin, as polyps contracted when challenged with a pulse of KCl. Latrunculin B, which sequesters G actin preventing F actin assembly, caused stolons to retract, exposing focal adhesions where the tip epithelial cells adhere to the substratum. These results are consistent with earlier suggestions that non-muscle myosin II provides the motive force for stolon tip pulsations and further suggest that tip oscillations are functionally coupled to hydrorhizal axial muscle contraction.	[Connally, Noah; Anderson, Christopher P.; Buss, Leo W.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Bolton, Edward W.] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Buss, Leo W.] Smithsonian Marine Stn, Ft Pierce, FL USA	Yale University; Yale University; Smithsonian Institution; Smithsonian National Museum of Natural History	Buss, LW (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	leo.buss@yale.edu						Beloussov L.V., 1973, Publications Seto Mar Biol Lab, V20, P315; BELOUSSOV LV, 1989, J EXP ZOOL, V249, P258, DOI 10.1002/jez.1402490304; BELOUSSOV LV, 1972, J EMBRYOL EXP MORPH, V27, P317; BERRILL NJ, 1949, Q J MICROSC SCI, V90, P235; BERRILL NJ, 1949, J MORPHOL, V84, P1, DOI 10.1002/jmor.1050840102; BERRILL NJ, 1949, J MORPHOL, V85, P297, DOI 10.1002/jmor.1050850203; Blackstone NW, 1996, BIOL BULL, V190, P56, DOI 10.2307/1542675; BLACKSTONE NW, 1991, BIOL BULL, V180, P394, DOI 10.2307/1542340; Braverman M., 1974, Oceanography mar Biol, V12, P129; Braverman M, 1966, CNIDARIA THEIR EVOLU, P169; BRAVERMAN MH, 1962, SCIENCE, V135, P310, DOI 10.1126/science.135.3500.310; Buss LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136814; Buss LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072221; Buss LW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048914; Buss LW, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P3; DONALDSON S, 1974, AM ZOOL, V14, P735; Dudgeon S, 1999, BIOL BULL, V196, P1, DOI 10.2307/1543161; Dudgeon SR, 2011, ADV MAR BIOL, V59, P107, DOI 10.1016/B978-0-12-385536-7.00003-0; Eddinger TJ, 2007, J PHARMACOL EXP THER, V320, P865, DOI 10.1124/jpet.106.109363; HALE LJ, 1964, J EMBRYOL EXP MORPH, V12, P517; HAMMETT FREDERICK S., 1935, PROTOPLASMA, V23, P81, DOI 10.1007/BF01603333; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kosevich I. A., 2006, Russian Journal of Developmental Biology, V37, P90, DOI 10.1134/S1062360406020056; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Lofgren M, 2003, J GEN PHYSIOL, V121, P301, DOI 10.1085/jgp.200208720; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Spector I, 1989, CELL MOTILITY CYTOSK, V13; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Thomas M.B., 1991, P91; VanWinkle DH, 1997, INVERTEBR BIOL, V116, P6; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; WYTTENBACH CR, 1973, J EXP ZOOL, V186, P79, DOI 10.1002/jez.1401860111; WYTTENBACH CR, 1973, J MORPHOL, V139, P363, DOI 10.1002/jmor.1051390306; WYTTENBACH CR, 1968, J EXP ZOOL, V167, P333, DOI 10.1002/jez.1401670306; WYTTENBACH CR, 1974, AM ZOOL, V14, P699	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143564	10.1371/journal.pone.0143564	http://dx.doi.org/10.1371/journal.pone.0143564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605798	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300083
J	Nishijima, T; Takano, M; Matsumoto, S; Koyama, M; Sugino, Y; Ogane, M; Ikeda, K; Kikuchi, Y; Oka, S; Gatanaga, H				Nishijima, Takeshi; Takano, Misao; Matsumoto, Shoko; Koyama, Miki; Sugino, Yuko; Ogane, Miwa; Ikeda, Kazuko; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki			What Triggers a Diagnosis of HIV Infection in the Tokyo Metropolitan Area? Implications for Preventing the Spread of HIV Infection in Japan	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ANTIRETROVIRAL THERAPY; INITIATION	Background Japan has not succeeded in reducing the annual number of new HIV-infected patients, although the prevalence of HIV infection is low (0.02%). Methods A single-center observational study was conducted at the largest HIV clinic in Tokyo, which treats 15% of the total patients in Japan, to determine the reasons for having diagnostic tests in newly infected individuals. HIV-infected patients who visited our clinic for the first time between 2011 and 2014 were analyzed. Results The 598 study patients comprised one-third of the total reported number of new patients in Tokyo during the study period. 76% were Japanese MSM. The reasons for being tested which led to the diagnosis was voluntary testing in 32%, existing diseases in 53% (AIDSdefining diseases in 22%, sexually transmitted infections (STI) in 8%, diseases other than AIDS or STIs in 23%) and routine pre-surgery or on admission screening in 15%. 52% and 74% of the study patients and patients presented with AIDS, respectively, had never been tested. The median CD4 count in patients with history of previous testing (315/mu L) was significantly higher than that of patients who had never been tested (203/ mu L, p< 0.001). Conclusions Only 32% of the newly HIV diagnosed patients were diagnosed because of voluntary testing, and 53% were diagnosed due to presence of other diseases. These results remain unchanged from our previous report 10 years earlier (2000-2004) on newly diagnosed patients at the same clinic. HIV testing has not been widely used by newly diagnosed patients in the Tokyo metropolitan area.	[Nishijima, Takeshi; Takano, Misao; Matsumoto, Shoko; Koyama, Miki; Sugino, Yuko; Ogane, Miwa; Ikeda, Kazuko; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Matsumoto, Shoko] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 173, Japan; [Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; Teikyo University; Kumamoto University	Nishijima, T (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	tnishiji@acc.ncgm.go.jp			Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001]	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in Aid for AIDS research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-56; [Anonymous], GUID TREATM HIV INF, V1-159; Brown LB, 2012, AIDS BEHAV, V16, P1148, DOI 10.1007/s10461-011-0094-9; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Gatanaga H, 2013, CLIN INFECT DIS, V56, P1812, DOI 10.1093/cid/cit145; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Komatsu H, 2014, WORLD J GASTROENTERO, V20, P8998, DOI 10.3748/wjg.v20.i27.8998; Laanani M, 2015, CLIN INFECT DIS, V60, P1715, DOI 10.1093/cid/civ171; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072310; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Nosyk B, 2015, LANCET HIV, V2, pE393, DOI 10.1016/S2352-3018(15)00127-7; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Ransome Y, 2015, AIDS, V29, P1369, DOI 10.1097/QAD.0000000000000684; Reports on the certification of disabilities due to immune deficiency by HIV, 1997, REP CERT DIS DUE IMM; Rodger A, 2014, C RETR OPP INF 2014; Seo J, 2010, 24 ANN M JAP SOC A 2; Statistics Bureau the Japanese Ministry of Internal Affairs and Communications, 2015, EST POP JAP 1 JAN; Takano M, 2012, INT J STD AIDS, V23, P262, DOI 10.1258/ijsa.2009.009493; Tanizaki R, 2015, CLIN INFECT DIS; World Health Organization, 2013, CONGUID UANT DRU	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143874	10.1371/journal.pone.0143874	http://dx.doi.org/10.1371/journal.pone.0143874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606382	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300118
J	Schmitz, P; Caspers, S; Warren, P; Witte, K				Schmitz, Philip; Caspers, Stephanie; Warren, Paige; Witte, Klaudia			First Steps into the Wild - Exploration Behavior of European Bison after the First Reintroduction in Western Europe	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; HOME-RANGE SIZE; CERVUS-ELAPHUS; ARABIAN ORYX; RANDOM-WALK; CONSERVATION; HABITAT; POPULATION; EXTINCTION; DYNAMICS	Biodiversity is rapidly declining globally. One strategy to help to conserve species is to breed species in captivity and release them into suitable habitats. The way that reintroduced animals explore new habitats and/or disperse from the release site is rarely studied in detail and represents key information for the success of reintroduction projects. The European bison (Bison bonasus L. 1758) was the largest surviving herbivore of the post-glacial mega-fauna in Europe before it became extinct in the wild, surviving only in captivity since 1919. We investigated the exploration behavior of a herd of European bison reintroduced into the Rothaargebirge, a commercial forest in low range mountain intensively used and densely populated by humans, in the first six months after release. We focused on three questions: (1) how did the European bison move and utilize the habitat on a daily basis, (2) how did the animals explore the new environment, and (3) did their habitat preferences change over time. The European bison dispersed away from their previous enclosure at an average rate of 539 m/month, with their areas of daily use ranging from 70 to 173 ha, their movement ranging from 3.6 km to 5.2 km per day, and their day-to-day use of areas ranged between 389 and 900 m. We could identify three major exploration bouts, when the animals entered and explored areas previously unknown to them. During the birthing phase, the European bison reduced daily walking distances, and the adult bull segregated from the herd for 58 days. Around rut, roaming behavior of the herd increased slightly. The animals preferred spruce forest, wind thrown areas and grassland, all of which are food abundant habitat types, and they avoided beech forest. Habitat preference differed slightly between phases of the study period, probably due to phenological cycles. After six months, the complete summer home range was 42.5 km(2). Our study shows that a small free-ranging herd of European bison can live in an area intensively used by humans and describes in detail the initial roaming behavior and habitat utilization of the animals.	[Schmitz, Philip; Caspers, Stephanie; Witte, Klaudia] Univ Siegen, Res Grp Ecol & Behav Biol, Inst Biol, D-57068 Siegen, Germany; [Warren, Paige] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA	Universitat Siegen; University of Massachusetts System; University of Massachusetts Amherst	Schmitz, P (corresponding author), Univ Siegen, Res Grp Ecol & Behav Biol, Inst Biol, D-57068 Siegen, Germany.	Schmitz.philip@gmail.com	; Caspers, Svenja/H-9346-2013	Warren, Paige/0000-0003-0787-4635; Caspers, Svenja/0000-0001-5083-4669	Federal Agency for Nature Conservation; Ministry for Climate Protection, Environment, Agriculture, Nature Conservation and Consumer Protection of North Rhine-Westphalia	Federal Agency for Nature Conservation; Ministry for Climate Protection, Environment, Agriculture, Nature Conservation and Consumer Protection of North Rhine-Westphalia	This study was funded by the Federal Agency for Nature Conservation, and the Ministry for Climate Protection, Environment, Agriculture, Nature Conservation and Consumer Protection of North Rhine-Westphalia.	[Anonymous], 2008, VERTEILUNGSFREIE MET; BAILEY BJR, 1980, TECHNOMETRICS, V22, P583, DOI 10.2307/1268196; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BOROWSKI STANISLAW, 1967, ACTA THERIOL, V12, P367; Bowkett AE, 2009, CONSERV BIOL, V23, P773, DOI 10.1111/j.1523-1739.2008.01157.x; Brandtberg NH, 2013, EUROPEAN BISON CONSE, V6, P73; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; CABONRACZYNSKA K, 1987, ACTA THERIOL, V32, P335, DOI 10.4098/AT.arch.87-24; Caspers S, 2013, THESIS; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chistopolova M., 2009, EUROPEAN BISON CONSE, V2, P40; Clevenger AP, 2002, CONSERV BIOL, V16, P503, DOI 10.1046/j.1523-1739.2002.00328.x; Cristescu B, 2013, J ETHOL, V31, P285, DOI 10.1007/s10164-013-0376-y; Cromsigt JPGM, 2012, DIVERS DISTRIB, V18, P1253, DOI 10.1111/j.1472-4642.2012.00927.x; Curie E, 1996, TRENDS ECOL EVOL, V11, P260, DOI 10.1016/0169-5347(96)20046-1; Daleszczyk K, 2007, CAN J ZOOL, V85, P261, DOI 10.1139/Z06-209; Daleszczyk K, 2005, FOLIA ZOOL, V54, P359; Daleszczyk K, 2004, ACTA THERIOL, V49, P555, DOI 10.1007/BF03192598; Daleszczyk K, 2001, FOLIA ZOOL, V50, P75; Daleszczyk K, 2010, EUROPEAN BISON CONSE, P5; Daleszczyk K, 2002, THESIS; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Diamond J., 1989, P37; Diamond J.M., 1984, P191; dlv Deutscher Landwirtschaftsverlag GmbH, 2013, WIDL WIS SCHW; dlv Deutscher Landwirtschaftsverlag GmbH, 2014, VERS STEIGT; dlv Deutscher Landwirtschaftsverlag GmbH, 2014, BETR WILDR AUSG; dlv Deutscher Landwirtschaftsverlag GmbH, 2014, WIS DOCH NOCH NICHT; dlv Deutscher Landwirtschaftsverlag GmbH, 2014, WIS JETZT HERR; EBENHARD T, 1995, TRENDS ECOL EVOL, V10, P438, DOI 10.1016/S0169-5347(00)89176-4; Eggermann J, 2009, THESIS, P115; Etienne R, 2002, ECOL MODEL, V148, P153, DOI 10.1016/S0304-3800(01)00417-3; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Fuller W, 1960, ARCTIC, V13, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrer B, 2006, WIRTSCHAFTLICHE EFFE; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2007, AFR J ECOL, V45, P103, DOI 10.1111/j.1365-2028.2006.00673.x; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Hirzel AH, 2004, J APPL ECOL, V41, P1103, DOI 10.1111/j.0021-8901.2004.00980.x; Hofmann G, 2008, EBERSWALDER FORSTLIC; Hubbard B, 2004, IUCN OTTER SPEC GROU, V21, P60; Hucht-Ciorga Ingrid, 2012, Saeugetierkundliche Informationen, V8, P463; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Kalden N, 2013, BFN SCHRIFTENREIHE N, V133, P56; Kamler JF, 2007, ACTA THERIOL, V52, P113, DOI 10.1007/BF03194206; Kareiva P., 2011, BREAKTHROUGH J, VFall 2011, P29; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x; KOMERS PE, 1992, BEHAV ECOL SOCIOBIOL, V31, P195; KRASINSKA M, 1987, ACTA THERIOL, V32, P147, DOI 10.4098/AT.arch.87-14; KRASINSKA M, 1995, ACTA THERIOL, V40, P1; Krasinska M, 2000, ACTA THERIOL, V45, P321, DOI 10.4098/AT.arch.00-32; Krasinska M., 2007, EUROPEAN BISON NATUR; KRASINSKI ZA, 1978, ACTA THERIOL, V23, P3, DOI 10.4098/AT.arch.78-1; Krone O, 2009, J ORNITHOL, V150, P273, DOI 10.1007/s10336-008-0347-1; Kuemmerle T, 2012, DIVERS DISTRIB, V18, P1258, DOI 10.1111/ddi.12013; Kuemmerle T, 2012, DIVERS DISTRIB, V18, P47, DOI 10.1111/j.1472-4642.2011.00849.x; Kuemmerle T, 2011, J APPL ECOL, V48, P317, DOI 10.1111/j.1365-2664.2010.01954.x; Kuemmerle T, 2010, BIOL CONSERV, V143, P908, DOI 10.1016/j.biocon.2009.12.038; Larter NC, 2000, ANIM CONSERV, V3, P299, DOI 10.1111/j.1469-1795.2000.tb00115.x; Lindner U, 2006, TAURUS NATURENTWICKL; Marttila O, 1997, ANN ZOOL FENN, V34, P177; Mohr E., 1952, DER WISENT, V74; Musiani M, 1998, ACTA THERIOL, V43, P409, DOI 10.4098/AT.arch.98-51; Mysterud A, 1999, CAN J ZOOL, V77, P776, DOI 10.1139/cjz-77-5-776; Olech W., 2004, STATUS SURVEY CONSER; Osborne Patrick E., 2012, P73; Ostrowski S, 1998, ORYX, V32, P209, DOI 10.1017/S0030605300029975; Parnikoza I, 2009, EUROPEAN BISON CONSE, V2, P47; Perzanowski K, 2004, BIOL CONSERV, V120, P345, DOI 10.1016/j.biocon.2004.03.006; Perzanowski K., 2010, EUROPEAN BISON CONSE, V3, P45; Perzanowski KA, 2013, STUDIA MAT CEPLW ROG, V36, P11; Perzanowski KA, 2008, ANN ZOOL FENN, V45, P347, DOI 10.5735/086.045.0417; Petrak M, 1999, NATUR KULTURLANDSCHA, V3, P289; Piroznikow B., 2008, EUROPEAN BISON CONSE, V1, P14; Raczynski J, 2013, EUROPEAN BISON PEDIG; Rduch V, 2013, THESIS; Saltz D, 1998, ANIM CONSERV, V1, P245, DOI 10.1111/j.1469-1795.1998.tb00035.x; Sanz V, 1998, CONSERV BIOL, V12, P430, DOI 10.1046/j.1523-1739.1998.96261.x; Schippers P, 1996, ECOGRAPHY, V19, P97, DOI 10.1111/j.1600-0587.1996.tb00160.x; Schmitz P, 2013, BFN SCHRIFTENREIHE N, V133, P44; Schmitz P, 2013, BFN SKRIPTENREIHE, V370, P89; Schmitz P, 2015, THESIS; Schmitz P, 2013, NATURSCHUTZ BIOL VIE, V133, P51; Schmitz P, 2013, NATURSCHUTZ BIOL VIE, V133, P37; SCHMITZ P, 2012, BFN-SKR, V309, P107; Schmitz P, 2013, NATURSCHUTZ BIOL VIE, V133, P66; Schmitz P, 2014, 19 GRAD M EV BIOL GR, P15; Schneider TC, 2013, MAMM BIOL, V78, P438, DOI 10.1016/j.mambio.2013.06.002; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x; SMITH K.G., 1991, E WORKSH BLACK BEAR, V10, P5; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; STUWE M, 1991, APPL ANIM BEHAV SCI, V29, P379, DOI 10.1016/0168-1591(91)90262-V; Swihart Robert K., 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P48, DOI 10.2307/1400640; Tillmann J, 2013, NATURSCHUTZ BIOL VIE, V133; Tillmann Joerg, 2012, Naturschutz und Landschaftsplanung, V44, P267; van de Vlasakker J, 2014, REWILDING EUROPE 201; Wakefield Simon, 2002, P82; Wu H, 2000, ECOL MODEL, V132, P115, DOI 10.1016/S0304-3800(00)00309-4; Yott A, 2011, RESTOR ECOL, V19, P70, DOI 10.1111/j.1526-100X.2009.00639.x	104	12	12	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143046	10.1371/journal.pone.0143046	http://dx.doi.org/10.1371/journal.pone.0143046			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605549	gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300042
J	Straub, MH; Kelly, TR; Rideout, BA; Eng, C; Wynne, J; Braun, J; Johnson, CK				Straub, Mary H.; Kelly, Terra R.; Rideout, Bruce A.; Eng, Curtis; Wynne, Janna; Braun, Josephine; Johnson, Christine K.			Seroepidemiologic Survey of Potential Pathogens in Obligate and Facultative Scavenging Avian Species in California	PLOS ONE			English	Article							WEST-NILE-VIRUS; NEWCASTLE-DISEASE VIRUS; POLYMERASE-CHAIN-REACTION; VULTURE GYPS-BENGALENSIS; LOUIS-ENCEPHALITIS-VIRUS; WILD BIRDS; GYMNOGYPS-CALIFORNIANUS; INFECTIOUS-BRONCHITIS; POPULATION DECLINES; LEAD-EXPOSURE	Throughout the world, populations of scavenger birds are declining rapidly with some populations already on the brink of extinction. Much of the current research into the factors contributing to these declines has focused on exposure to drug residues, lead, and other toxins. Despite increased monitoring of these declining populations, little is known about infectious diseases affecting scavenger bird species. To assess potential infectious disease risks to both obligate and facultative scavenger bird species, we performed a serosurvey for eleven potential pathogens in three species of scavenging birds in California: the California condor (Gymnogyps californianus), turkey vulture (Cathartes aura) and golden eagle (Aquila chrysaetos). California condors were seropositive for avian adenovirus, infectious bronchitis virus, Mycoplasma gallisepticum, avian paramyxovirus-2, West Nile virus (WNV) and Toxoplasma gondii. Golden eagles were seropositive for avian adenovirus, Chlamydophila psittaci and Toxoplasma gondii, and turkey vultures were seropositive for avian adenovirus, Chlamydophila psittaci, avian paramyxovirus-1, Toxoplasma gondii and WNV. Risk factor analyses indicated that rearing site and original release location were significantly associated with a positive serologic titer to WNV among free-flying condors. This study provides preliminary baseline data on infectious disease exposure in these populations for aiding in early disease detection and provides potentially critical information for conservation of the endangered California condor as it continues to expand its range and encounter new infectious disease threats.	[Straub, Mary H.; Kelly, Terra R.; Johnson, Christine K.] Univ Calif Davis, Sch Vet Med, Wildlife Hlth Ctr, Davis, CA 95616 USA; [Rideout, Bruce A.; Braun, Josephine] San Diego Zoo Inst Conservat Res, Wildlife Dis Labs, Escondido, CA USA; [Eng, Curtis] Los Angeles Zoo & Bot Gardens, Los Angeles, CA USA; [Wynne, Janna] Calif Sci Ctr Fdn, Los Angeles, CA USA	University of California System; University of California Davis; Zoological Society of San Diego	Johnson, CK (corresponding author), Univ Calif Davis, Sch Vet Med, Wildlife Hlth Ctr, Davis, CA 95616 USA.	ckjohnson@ucdavis.edu			Morris Animal Foundation [D08ZO-155]; California State Wildlife [T-12-1]	Morris Animal Foundation; California State Wildlife	1. This work was funded by a Morris Animal Foundation Grant #D08ZO-155 (CKJ TRK) http://www.morrisanimalfoundation.org/ and supported by a California State Wildlife Grant #T-12-1 (CKJ TRK) https://www.wildlife.ca.gov/. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D. J., 1986, Acute virus infections of poultry, P52; Alexander DJ, 2008, POULTRY DIS, P75; Jimenez-Clavero MA, 2008, EMERG INFECT DIS, V14, P1489, DOI 10.3201/eid1409.080190; Bloom Peter H., 2001, North American Bird Bander, V26, P97; Boyce WM, 2011, VECTOR-BORNE ZOONOT, V11, P1063, DOI 10.1089/vbz.2010.0171; Cade TJ, 2007, J WILDLIFE MANAGE, V71, P2125, DOI 10.2193/2007-084; Cavanagh D, 2005, AVIAN PATHOL, V34, P439, DOI 10.1080/03079450500367682; Cavanagh D., 2008, DIS POULTRY, P117; Chang GJJ, 2007, VACCINE, V25, P2325, DOI 10.1016/j.vaccine.2006.11.056; Chemnick L. G., 2000, International Zoo Yearbook, V37, P330, DOI 10.1111/j.1748-1090.2000.tb00738.x; Chiles RE, 1998, J VECTOR ECOL, V23, P123; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; DOCHERTY DE, 1994, AVIAN DIS, V38, P899, DOI 10.2307/1592132; Dubey JP, 2002, VET PARASITOL, V106, P121, DOI 10.1016/S0304-4017(02)00034-1; Ebel GD, 2002, EMERG INFECT DIS, V8, P979, DOI 10.3201/eid0809.020152; Fang Y, 2006, AM J TROP MED HYG, V75, P480, DOI 10.4269/ajtmh.2006.75.480; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Forbes NA, 1997, J AVIAN MED SURG, V11, P31; Frolich K, 2002, J WILDLIFE DIS, V38, P633, DOI 10.7589/0090-3558-38.3.633; Gilbert M, 2002, BIRD CONSERV INT, V12, P311, DOI 10.1017/S0959270902002198; Gilbert M, 2006, ORYX, V40, P388, DOI 10.1017/S0030605306001347; GOODMAN BB, 1988, AVIAN DIS, V32, P713, DOI 10.2307/1590989; Grantham J., 2007, SERIES ORNITHOLOGY, V2, P123; Hale KA, 2007, ANIM CONSERV, V10, P2, DOI 10.1111/j.1469-1795.2006.00059.x; Henckel E, 1981, N AM BIRD BANDER, V6, P106; Hofle U, 2002, ANN NY ACAD SCI, V969, P213; Hollmen T, 2008, INFECTIOUS DIS BIRDS, P177; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hughes LA, 2009, EMERG INFECT DIS, V15, P1091, DOI 10.3201/eid1507.090067; Ismail MM, 2001, AVIAN DIS, V45, P157, DOI 10.2307/1593023; IUCN, 2015, GYMN CAL IUCN 2015; Jindal N, 2010, AVIAN PATHOL, V39, P441, DOI 10.1080/03079457.2010.517249; Kauffman EB, 2003, J CLIN MICROBIOL, V41, P3661, DOI 10.1128/JCM.41.8.3661-3667.2003; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kelly TR, 2014, CONSERV BIOL, V28, P1721, DOI 10.1111/cobi.12342; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017656; Kelly TR, 2011, PLOS ONE, V6; Kirk DA, 1998, TURKEY VULTURE CATHA; Kochert M. N., 2002, GOLDEN EAGLE AQUILA; Koenig R, 2006, SCIENCE, V312, P1591, DOI 10.1126/science.312.5780.1591; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lapointe JM, 1999, ARCH VIROL, V144, P393, DOI 10.1007/s007050050512; Leighton FA, 2008, INFECTIOUS DIS WILD, P1; Ley DH, 2006, J WILDLIFE DIS, V42, P429, DOI 10.7589/0090-3558-42.2.429; LIPKIND M, 1982, VET REC, V110, P15, DOI 10.1136/vr.110.1.15; LIPKIND MA, 1979, VET REC, V105, P577; Lublin A, 2001, AVIAN DIS, V45, P741, DOI 10.2307/1592921; Luttrell P, 2008, MYCOPLASMOSIS INFECT, P317; Mace M, 2011, CALIFORNIA CONDOR IN; Margalida A, 2014, SCIENCE, V346, P1296, DOI 10.1126/science.1260260; Margalida A, 2012, SCIENCE, V335, P284, DOI 10.1126/science.335.6066.284-a; Markandya A, 2008, ECOL ECON, V67, P194, DOI 10.1016/j.ecolecon.2008.04.020; McFerran JB, 2000, REV SCI TECH OIE, V19, P589, DOI 10.20506/rst.19.2.1238; MCMARTIN DA, 1968, BRIT VET J, V124, P576, DOI 10.1016/S0007-1935(17)39033-4; Moleon M, 2014, BIOSCIENCE; Muradrasoli S, 2009, J VIROL METHODS, V159, P277, DOI 10.1016/j.jviromet.2009.04.022; Nam DH, 2009, ECOTOXICOLOGY, V18, P225, DOI 10.1007/s10646-008-0275-0; Nemeth N, 2006, J WILDLIFE DIS, V42, P1, DOI 10.7589/0090-3558-42.1.1; Oaks JL, 2004, J CLIN MICROBIOL, V42, P5909, DOI 10.1128/JCM.42.12.5909-5912.2004; Ogada DL, 2012, CONSERV BIOL, V26, P453, DOI 10.1111/j.1523-1739.2012.01827.x; Ogada D, 2016, CONSERV LETT, V9, P89, DOI 10.1111/conl.12182; Ogada DL, 2012, ANN NY ACAD SCI, V1249, P57, DOI 10.1111/j.1749-6632.2011.06293.x; Pain DJ, 2003, CONSERV BIOL, V17, P661, DOI 10.1046/j.1523-1739.2003.01740.x; Pennycott TW, 2009, VET REC, V164, P157, DOI 10.1136/vr.164.5.157-b; POVEDA JB, 1990, AVIAN PATHOL, V19, P627, DOI 10.1080/03079459008418718; Prakash V, 2003, BIOL CONSERV, V109, P381, DOI 10.1016/S0006-3207(02)00164-7; Prakash V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049118; Ralls K, 2004, CONDOR, V106, P215, DOI 10.1650/7348; Reidarson TH, 1998, J WILDLIFE DIS, V34, P771, DOI 10.7589/0090-3558-34.4.771; Reisen WK, 2008, J MED ENTOMOL, V45, P494, DOI 10.1603/0022-2585(2008)45[494:PWNVTA]2.0.CO;2; Rideout BA, 2012, J WILDLIFE DIS, V48, P95, DOI 10.7589/0090-3558-48.1.95; Salant H, 2013, VET PARASITOL, V191, P23, DOI 10.1016/j.vetpar.2012.07.029; Schettler E, 2003, J WILDLIFE DIS, V39, P57, DOI 10.7589/0090-3558-39.1.57; Schrenzel M, 2005, J CLIN MICROBIOL, V43, P3402, DOI 10.1128/JCM.43.7.3402-3413.2005; Shihmanter E, 1998, AVIAN DIS, V42, P418, DOI 10.2307/1592497; Shultz S, 2004, P ROY SOC B-BIOL SCI, V271, pS458, DOI 10.1098/rsbl.2004.0223; Snyder NFR., 2000, CALIFORNIA CONDOR SA; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; STAUBER N, 1995, VACCINE, V13, P360, DOI 10.1016/0264-410X(95)98257-B; Stephensen CB, 1999, VIRUS RES, V60, P181, DOI 10.1016/S0168-1702(99)00017-9; Szabo KA, 2004, J PARASITOL, V90, P907, DOI 10.1645/GE-270R; Tarnagda Z, 2011, J INFECT DEV COUNTR, V5, P565, DOI 10.3855/jidc.1441; Thiaucourt F, 2000, VET MICROBIOL, V72, P251, DOI 10.1016/S0378-1135(99)00204-7; Thiollay JM, 2006, BIRD CONSERV INT, V16, P353, DOI 10.1017/S0959270906000487; Turell MJ, 2003, EMERG INFECT DIS, V9, P1077, DOI 10.3201/eid0909.030025; van den Brand JMA, 2007, AVIAN PATHOL, V36, P293, DOI 10.1080/03079450701447309; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; Vojdani A, 1998, FEMS IMMUNOL MED MIC, V22, P355; Walters JR, 2010, AUK, V127, P969, DOI 10.1525/auk.2010.127.4.969; Warke A, 2008, AVIAN DIS, V52, P694, DOI 10.1637/8390-070308-RESNOTE.1; Wheeler SS, 2011, VECTOR-BORNE ZOONOT, V25, P25; Zhang GZ, 2007, AVIAN DIS, V51, P137, DOI 10.1637/0005-2086(2007)051[0137:SSOPOA]2.0.CO;2	94	11	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143018	10.1371/journal.pone.0143018	http://dx.doi.org/10.1371/journal.pone.0143018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606755	Green Published, gold			2022-12-26	WOS:000365865300041
J	Tian, FW; Xiao, Y; Li, XX; Zhai, QX; Wang, G; Zhang, QX; Zhang, H; Chen, W				Tian, Fengwei; Xiao, Yue; Li, Xiaoxiao; Zhai, Qixiao; Wang, Gang; Zhang, Qiuxiang; Zhang, Hao; Chen, Wei			Protective Effects of Lactobacillus plantarum CCFM8246 against Copper Toxicity in Mice	PLOS ONE			English	Article							CADMIUM-BINDING; WILSON DISEASE; LEAD; METALS; NANOPARTICLES; BIOSORPTION; REMOVAL; WATER; FISH	Lactobacillus plantarum CCFM8246, which has a relatively strong copper binding capacity and tolerance to copper ions, was obtained by screening from 16 lactic acid bacteria in vitro. The selected strain was then applied to a mouse model to evaluate its protective function against copper intoxication in vivo. The experimental mice were divided into an intervention group and a therapy group; mice in the intervention group received co-administration of CCFM8246 and a copper ion solution by gavage, while mice in the therapy group were treated with CCFM8246 after 4 weeks of copper exposure. In both two groups, mice treated with copper alone and that treated with neither CCFM8246 nor copper served as positive and negative controls, respectively. At the end of the experimental period, the copper content in feces and tissues, the activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum, and oxidation stress indices in liver and kidney tissue were determined. Learning and memory ability was evaluated by Morris water maze experiments. The results indicated that treatment with CCFM8246 significantly increased the copper content in feces to promote copper excretion, reduce the accumulation of copper in tissues, reverse oxidative stress induced by copper exposure, recover the ALT and AST in serum and improve the spatial memory of mice.	[Tian, Fengwei; Xiao, Yue; Li, Xiaoxiao; Zhai, Qixiao; Wang, Gang; Zhang, Qiuxiang; Zhang, Hao; Chen, Wei] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Chen, Wei] Beijing Technol & Business Univ, Beijing Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China	Jiangnan University; Beijing Technology & Business University	Chen, W (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.	chenwei66@jiangnan.edu.cn	Chen, Wei/GZK-7348-2022; Zhang, Hao/HHM-1940-2022	Wang, Gang/0000-0003-2007-2143	National Natural Science Foundation of China [31530056, 31470161]; National Science Fund for Distinguished Young Scholars [31125021]; Science and Nature Foundation of Jiangsu Province [BK 20131102]; key projects in the national science & technology pillar program during the twelfth five-year plan period [2012BAD12B02, 2012BAD28B08]; National Basic Research Program of China (973 Program) [2012CB720802]; 111 Project [B07019]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1249]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Science and Nature Foundation of Jiangsu Province; key projects in the national science & technology pillar program during the twelfth five-year plan period; National Basic Research Program of China (973 Program)(National Basic Research Program of China); 111 Project(Ministry of Education, China - 111 Project); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China Key Program (No. 31530056, WC), the National Science Fund for Distinguished Young Scholars (No. 31125021, WC), the National Natural Science Foundation of China General Program (No. 31470161, WC), the Science and Nature Foundation of Jiangsu Province (No. BK 20131102, WC), the key projects in the national science & technology pillar program during the twelfth five-year plan period (No. 2012BAD12B02, 2012BAD28B08, WC), the National Basic Research Program of China (973 Program No. 2012CB720802, WC), the 111 Project B07019, and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1249, WC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu Z, 2001, J ENVIRON SCI HEAL A, V36, P367, DOI 10.1081/ESE-100102928; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Chakravarty R, 2012, BIORESOURCE TECHNOL, V108, P176, DOI 10.1016/j.biortech.2011.12.100; Chen Z, 2006, TOXICOL LETT, V163, P109, DOI 10.1016/j.toxlet.2005.10.003; Chen Z, 2007, J RADIOANAL NUCL CH, V272, P599, DOI 10.1007/s10967-007-0631-1; CHISOLM JJ, 1968, J PEDIATR-US, V73, P1, DOI 10.1016/S0022-3476(68)80036-8; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; Gerbino E, 2014, J DAIRY RES, V81, P280, DOI 10.1017/S0022029914000314; Gratz S, 2006, APPL ENVIRON MICROB, V72, P7398, DOI 10.1128/AEM.01348-06; Halttunen T, 2007, INT J FOOD MICROBIOL, V114, P30, DOI 10.1016/j.ijfoodmicro.2006.10.040; Imperiale TF, 2000, AM J GASTROENTEROL, V95, P2328, DOI 10.1111/j.1572-0241.2000.02322.x; Kim SY, 2015, J BIOSCI BIOENG, V119, P433, DOI 10.1016/j.jbiosc.2014.09.022; Li L, 2011, BEHAV BRAIN RES, V217, P244, DOI 10.1016/j.bbr.2010.10.032; Matos RC, 2010, ENVIRON RES, V110, P424, DOI 10.1016/j.envres.2010.03.001; Matovic V, 2015, FOOD CHEM TOXICOL, V78, P130, DOI [10.1016/j.fct.2015.02.011, 10.1016/jict.2015.02.011]; Montazer-Rahmati MM, 2011, J HAZARD MATER, V185, P401, DOI 10.1016/j.jhazmat.2010.09.047; PLAYLE RC, 1993, CAN J FISH AQUAT SCI, V50, P2678, DOI 10.1139/f93-291; Romera E, 2007, BIORESOURCE TECHNOL, V98, P3344, DOI 10.1016/j.biortech.2006.09.026; Sakhaee E, 2012, VET RES FORUM, V2, P232; Sayre LM, 1999, CURR OPIN CHEM BIOL, V3, P220, DOI 10.1016/S1367-5931(99)80035-0; Schilsky ML, 1996, SEMIN LIVER DIS, V16, P83, DOI 10.1055/s-2007-1007221; Schut S, 2011, INT J FOOD MICROBIOL, V145, P126, DOI 10.1016/j.ijfoodmicro.2010.11.039; Tian FW, 2012, BIOL TRACE ELEM RES, V150, P264, DOI 10.1007/s12011-012-9462-1; Volpe MG, 2009, FOOD CHEM, V117, P553, DOI 10.1016/j.foodchem.2009.04.033; Wang XP, 2003, FUNCT NEUROL, V18, P149; Yu AS, 2003, AM J GASTROENTEROL, V98, P955; Zaza S, 2015, J FOOD COMPOS ANAL, V40, P148, DOI 10.1016/j.jfca.2015.01.007; Zhai QX, 2013, APPL ENVIRON MICROB, V79, P1508, DOI 10.1128/AEM.03417-12; Zhang Y, 2010, EUR FOOD RES TECHNOL, V231, P151, DOI 10.1007/s00217-010-1255-1	30	30	31	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143318	10.1371/journal.pone.0143318	http://dx.doi.org/10.1371/journal.pone.0143318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605944	Green Submitted, gold, Green Published			2022-12-26	WOS:000365865300054
J	van Adrichem, EJ; Siebelink, MJ; Rottier, BL; Dilling, JM; Kuiken, G; van der Schans, CP; Verschuuren, EAM				van Adrichem, Edwin J.; Siebelink, Marion J.; Rottier, Bart L.; Dilling, Janneke M.; Kuiken, Greetje; van der Schans, Cees P.; Verschuuren, Erik A. M.			Tolerance of Organ Transplant Recipients to Physical Activity during a High-Altitude Expedition: Climbing Mount Kilimanjaro	PLOS ONE			English	Article							HAND-HELD DYNAMOMETRY; SUCCESS; VALUES	Background It is generally unknown to what extent organ transplant recipients can be physically challenged. During an expedition to Mount Kilimanjaro, the tolerance for strenuous physical activity and high-altitude of organ transplant recipients after various types of transplantation was compared to non-transplanted controls. Methods Twelve organ transplant recipients were selected to participate (2 heart-, 2 lung-, 2 kidney-, 4 liver-, 1 allogeneic stem cell-and 1 small bowel-transplantation). Controls comprised the members of the medical team and accompanying family members (n = 14). During the climb, cardiopulmonary parameters and symptoms of acute mountain sickness were recorded twice daily. Capillary blood analyses were performed three times during the climb and once following return. Results Eleven of the transplant participants and all controls began the final ascent from 4700 meters and reached over 5000 meters. Eight transplant participants (73%) and thirteen controls (93%) reached the summit (5895m). Cardiopulmonary parameters and altitude sickness scores demonstrated no differences between transplant participants and controls. Signs of hyperventilation were more pronounced in transplant participants and adaptation to high-altitude was less effective, which was related to a decreased renal function. This resulted in reduced metabolic compensation. Conclusion Overall, tolerance to strenuous physical activity and feasibility of a high-altitude expedition in carefully selected organ transplant recipients is comparable to non-transplanted controls.	[van Adrichem, Edwin J.; van der Schans, Cees P.] Hanze Univ Appl Sci, Res & Innovat Grp Hlth Care & Nursing, Groningen, Netherlands; [van Adrichem, Edwin J.; van der Schans, Cees P.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Rottier, Bart L.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Allergy, Groningen Res Inst Asthma & COPD, Groningen, Netherlands; [Verschuuren, Erik A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands; [Dilling, Janneke M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands; [van Adrichem, Edwin J.; Siebelink, Marion J.; Rottier, Bart L.; Kuiken, Greetje; Verschuuren, Erik A. M.] Univ Groningen, Univ Med Ctr Groningen, Groningen Transplant Ctr, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	van Adrichem, EJ (corresponding author), Hanze Univ Appl Sci, Res & Innovat Grp Hlth Care & Nursing, Groningen, Netherlands.	e.j.van.adrichem@pl.hanze.nl	van Adrichem, Edwin J./AAS-1271-2020	Siebelink, Marion/0000-0001-5366-1732; van der Schans, Cees P/0000-0003-4728-4082; Rottier, Bart/0000-0002-2437-8070; Verschuuren, Erik/0000-0002-6807-6744	TEVA pharma; Stichting Sport en Transplantatie; Astellas Pharmaceuticals; 'Verosol' solar shading; 'Rabobank' cooperative banking; 'Medlon' medical diagnostics; 'Ambulance care' University Medical Center Groningen; 'Hago care' cleaning services; 'De Sprong' pharmacy; 'Fru Amundsen' travel agency; 'Snow Leopard' travel agency; 'GasTerra' natural gas trade company; 'Siesling BV' industrial cleaning; Zetacom' business communication; 'Cofely GDF Suiz' technical service provider; Dutch Transplant Foundation	TEVA pharma(Teva Pharmaceutical Industries); Stichting Sport en Transplantatie; Astellas Pharmaceuticals(Astellas Pharmaceuticals); 'Verosol' solar shading; 'Rabobank' cooperative banking; 'Medlon' medical diagnostics; 'Ambulance care' University Medical Center Groningen; 'Hago care' cleaning services; 'De Sprong' pharmacy; 'Fru Amundsen' travel agency; 'Snow Leopard' travel agency; 'GasTerra' natural gas trade company; 'Siesling BV' industrial cleaning; Zetacom' business communication; 'Cofely GDF Suiz' technical service provider; Dutch Transplant Foundation	The expedition was partially sponsored by TEVA pharma, 'Stichting Sport en Transplantatie', Astellas Pharmaceuticals, 'Verosol' solar shading, 'Rabobank' cooperative banking, 'Medlon' medical diagnostics, 'Ambulance care' University Medical Center Groningen, 'Hago care' cleaning services, 'De Sprong' pharmacy, 'Fru Amundsen' travel agency, 'Snow Leopard' travel agency, 'GasTerra' natural gas trade company, 'Siesling BV' industrial cleaning, Zetacom' business communication, 'Cofely GDF Suiz' technical service provider, and the Dutch Transplant Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Andrews AW, 1996, PHYS THER, V76, P248, DOI 10.1093/ptj/76.3.248; [Anonymous], 2013, ACSMS GUIDELINES EXE; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Bohannon RW, 2006, PERCEPT MOTOR SKILL, V103, P3, DOI 10.2466/PMS.103.1.3-4; Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Daniels R, 2012, WILD ENVIRON MED, V23, P95, DOI 10.1016/j.wem.2011.09.009; Davies AJ, 2009, WILD ENVIRON MED, V20, P311, DOI 10.1580/1080-6032-020.004.0311; Evangelista Lorraine S, 2005, J Cardiovasc Nurs, V20, P334; Fess EE., 1992, CLIN ASSESSMENT RECO, P41; Langer D, 2009, J HEART LUNG TRANSPL, V28, P572, DOI 10.1016/j.healun.2009.03.007; Masala D, 2012, TRANSPL P, V44, P1346, DOI 10.1016/j.transproceed.2012.01.123; Myers Jonathan, 2003, J Cardiopulm Rehabil, V23, P100; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pirenne J, 2004, AM J TRANSPLANT, V4, P554, DOI 10.1111/j.1600-6143.2004.00363.x; Pollard AJ., 2003, HIGH ALTITUDE MED HD; van Adrichem EJ, 2014, PHYS THER; West JB, 2012, AM J RESP CRIT CARE, V186, P1229, DOI 10.1164/rccm.201207-1323CI; Williams TJ, 2012, COMPR PHYSIOL, V2, P1937, DOI 10.1002/cphy.c110021; Zelle DM, 2010, AM J TRANSPLANT, V10, P106, DOI 10.1111/j.1600-6143.2009.02876.x	21	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142641	10.1371/journal.pone.0142641	http://dx.doi.org/10.1371/journal.pone.0142641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606048	Green Published, gold			2022-12-26	WOS:000365865300025
J	Jang, SJ; Hsieh, CA; Huang, HL; Juang, JMJ; Chou, HH; Tsao, CY; Wu, TY; Ko, YL				Jang, Shih-Jung; Hsieh, Chien-An; Huang, Hsuan-Li; Juang, Jyh-Ming Jimmy; Chou, Hsin-Hua; Tsao, Chueh-Yung; Wu, Tien-Yu; Ko, Yu-Lin			Feasibility and Clinical Outcomes of Peripheral Drug-Coated Balloon in High-Risk Patients with Femoropopliteal Disease	PLOS ONE			English	Article							IN-STENT RESTENOSIS; PROXIMAL POPLITEAL ARTERIES; PACLITAXEL-ELUTING BALLOON; SUBINTIMAL ANGIOPLASTY; TASC C; LONG; LESIONS; IMPLANTATION; IMPACT; CLASSIFICATION	Background Clinical outcomes of the drug-coated balloon (DCB) procedure in high-risk patients with femoropopliteal (FP) disease have not been investigated sufficiently. Methods This retrospective, single-center study analyzed 87 patients (39% dialysis) and 97 affected legs (64% critical limb ischemia [CLI]) that underwent DCB for symptomatic FP disease from March 2013 to September 2014. Risk stratification was based on FeDCLIP (female, diabetes, dialysis, CLI, lesion length >150 mm and poor runoff) score. The DCB outcomes among the different risk groups were compared and factors predicting restenosis were analyzed during follow-up. Results Most of study participants (84%) were moderate to high-risk patients. The procedural success rate was 100% and the 30-day major adverse vascular event rate was 2.1%. The mean lesion length was 178 +/- 106 mm and the mean follow-up time was 428 +/- 145 (range 50-782) days. The binary restenosis-free and clinically driven target lesion revascularization (CD-TLR)-free rates at 12 months were 77.5% and 84.3%, respectively, for all participants. No significant differences were observed in 1-year binary restenosis and CD-TLR rates in the low-, moderate-, and high-risk groups (60%, 84%, and 73%: p = 0.396; 78%, 89%, and 80%: p = 0.635, respectively). In multivariate analysis, lesion length > 150 mm (Hazard ratio [HR]: 8.00, 95% confidence interval (CI) 1.12 to 55.6, p = 0.038) and Rutherford class 6 (HR: 7.09, 95% CI, 1.15 to 43.5, p = 0.034) were identified as independent predictors of binary restenosis. Conclusions Despite general comorbidities and advanced limb ischemia, 1-year outcomes of DCB in high-risk patients with FP disease were effective. The DCB procedure holds promise to improve vessel patency; however, lesion length >150 mm and major tissue loss were independent predictors for binary restenosis after the treatment.	[Jang, Shih-Jung; Hsieh, Chien-An; Huang, Hsuan-Li; Chou, Hsin-Hua; Wu, Tien-Yu; Ko, Yu-Lin] Taipei Tzuchi Hosp, Buddhist Tzuchi Med Fdn, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Chou, Hsin-Hua; Ko, Yu-Lin] Tzuchi Univ, Sch Med, Hualien, Taiwan; [Juang, Jyh-Ming Jimmy] Natl Taiwan Univ Hosp, Dept Internal Med, Cardiovasc Ctr, Taipei 100, Taiwan; [Juang, Jyh-Ming Jimmy] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Juang, Jyh-Ming Jimmy] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Tsao, Chueh-Yung] Chang Gang Univ, Dept Ind & Business Management, Taoyuan, Taiwan	Tzu Chi University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung University	Huang, HL (corresponding author), Taipei Tzuchi Hosp, Buddhist Tzuchi Med Fdn, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	huang304@gmail.com	Huang, Hsuan-Li/AAS-9530-2021; Chou, Hsin Hua/AAU-8756-2021; Huang, Hsuan Li/ABD-2244-2020	Huang, Hsuan-Li/0000-0001-7640-7702; Chou, Hsin Hua/0000-0001-5871-555X; Juang, Jyh-Ming Jimmy/0000-0003-4767-7636				Armstrong EJ, 2014, J ENDOVASC THER, V21, P34, DOI 10.1583/13-4399MR.1; Ban DT, 2010, J VASC SURG, V51, P1406, DOI 10.1016/j.jvs.2010.01.062; Bosiers M, 2011, J VASC SURG, V54, P1042, DOI 10.1016/j.jvs.2011.03.272; Chalmers N, 2013, CARDIOVASC INTER RAD, V36, P353, DOI 10.1007/s00270-012-0492-z; Davaine JM, 2012, EUR J VASC ENDOVASC, V44, P432, DOI 10.1016/j.ejvs.2012.07.015; Fanelli F, 2014, CARDIOVASC INTER RAD, V37, P898, DOI 10.1007/s00270-014-0904-3; Iida O, 2009, CIRC J, V73, P2143, DOI 10.1253/circj.CJ-09-0166; Laird JR, 2012, J ENDOVASC THER, V19, P1, DOI 10.1583/11-3627.1; Laird JR, 2012, J AM COLL CARDIOL, V59, P24, DOI 10.1016/j.jacc.2011.09.037; Laird JR, 2012, CATHETER CARDIO INTE, V80, P852, DOI 10.1002/ccd.23475; Laxdal E, 2003, EUR J VASC ENDOVASC, V25, P578, DOI 10.1053/ejvs.2002.1899; Liistro F, 2014, J ENDOVASC THER, V21, P1, DOI 10.1583/13-4420R.1; Mewissen MW, 2009, J ENDOVASC THER, V16, P63, DOI 10.1583/08-2658.1; Micari A, 2012, JACC-CARDIOVASC INTE, V5, P331, DOI 10.1016/j.jcin.2011.11.010; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026; Scheinert D, 2014, JACC-CARDIOVASC INTE, V7, P11, DOI 10.1016/j.jcin.2013.05.022; Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303; Sidhu R, 2010, VASC ENDOVASC SURG, V44, P633, DOI 10.1177/1538574410376453; Soga Y, 2011, J VASC SURG, V54, P1058, DOI 10.1016/j.jvs.2011.03.286; Soga Y, 2010, J VASC SURG, V52, P608, DOI 10.1016/j.jvs.2010.03.050; Tepe G, 2015, CIRCULATION, V131, P495, DOI 10.1161/CIRCULATIONAHA.114.011004; Tosaka A, 2012, J AM COLL CARDIOL, V59, P16, DOI 10.1016/j.jacc.2011.09.036; Virga V, 2014, JACC-CARDIOVASC INTE, V7, P411, DOI 10.1016/j.jcin.2013.11.020; Werk M, 2012, CIRC-CARDIOVASC INTE, V5, P831, DOI 10.1161/CIRCINTERVENTIONS.112.971630; Zeller T, 2014, J ENDOVASC THER, V21, P359, DOI 10.1583/13-4630MR.1	26	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143658	10.1371/journal.pone.0143658	http://dx.doi.org/10.1371/journal.pone.0143658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599128	gold, Green Submitted, Green Published			2022-12-26	WOS:000365862600101
J	Karimian, G; Kirschbaum, M; Veldhuis, ZJ; Bomfati, F; Porte, RJ; Lisman, T				Karimian, Golnar; Kirschbaum, Marc; Veldhuis, Zwanida J.; Bomfati, Fernanda; Porte, Robert J.; Lisman, Ton			Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice	PLOS ONE			English	Article							NF-KAPPA-B; LIPID-PEROXIDATION; HEPATOCYTE APOPTOSIS; HEPATIC STEATOSIS; DOWN-REGULATION; RISK-FACTOR; STEATOHEPATITIS; REGENERATION; INFLAMMATION; EXPRESSION	Background and Aim The progression of non-alcoholic fatty liver disease (NAFLD) likely involves a 'multiple hit' mechanism. We hypothesized that partial hepatectomy, a procedure performed frequently in patients with NAFLD, would accelerate the progression of disease. Methods C57BL/6JolaHsd mice were fed a choline-deficient L-amino acid-defined diet (CD-AA) or a choline-sufficient L-amino acid-defined control diet (CS-AA). Part of the mice in the CD-AA group received a diet enriched in vitamin E (similar to 20 mg /day). Two weeks after the start of the diet, mice underwent a partial hepatectomy or a sham operation. Results In the CD-AA group, NAFLD activity scores were significantly higher at 7 days after partial hepatectomy compared to the sham operated mice (3.7 +/- 1.3 vs. 1.8 +/- 0.7; P<0.05). In addition, TBARS, a measure for oxidative stress, in liver tissue of the CD-AA group were significantly higher at day 1, 3 and 7 after partial hepatectomy compared to the sham operated mice (P<0.05). Vitamin E therapy significantly reduced TBARS level at day 7 after partial hepatectomy compared to the CD-AA diet group (P<0.05). Vitamin E suppletion reduced NAFLD activity score at day 7 after partial hepatectomy compared to the CD-AA group (2.3 +/- 0.8 vs. 3.8 +/- 1.0; P<0.05). Conclusion Partial hepatectomy accelerates the progression of NAFLD. Disease progression induced by partial hepatectomy is substantially attenuated by vitamin E.	[Karimian, Golnar; Kirschbaum, Marc; Veldhuis, Zwanida J.; Bomfati, Fernanda] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Surg Res Lab, Groningen, Netherlands; [Porte, Robert J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands; [Lisman, Ton] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Surg Res Lab, Groningen, Netherlands; [Lisman, Ton] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Karimian, G (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Surg Res Lab, Groningen, Netherlands.	golnar.karimian@gmail.com		Lisman, Ton/0000-0002-3503-7140	Netherlands Organization for scientific research (VIDI) [917.11.304]	Netherlands Organization for scientific research (VIDI)(Netherlands Organization for Scientific Research (NWO))	This project was supported by the Netherlands Organization for scientific research (VIDI, 917.11.304; T.L.).	Albano E, 2005, ALIMENT PHARM THER, V22, P71, DOI 10.1111/j.1365-2036.2005.02601.x; Albano E, 2005, GUT, V54, P987, DOI 10.1136/gut.2004.057968; Cho JY, 2006, SURGERY, V139, P508, DOI 10.1016/j.surg.2005.09.007; Cho SW, 2008, ANN SURG ONCOL, V15, P2795, DOI 10.1245/s10434-008-0090-0; Day CP, 2012, DIGEST DIS, V30, P69, DOI 10.1159/000341128; de Meijer VE, 2010, BRIT J SURG, V97, P1331, DOI 10.1002/bjs.7194; DeAngelis RA, 2005, HEPATOLOGY, V42, P1148, DOI 10.1002/hep.20879; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; FRAGA CG, 1988, FREE RADICAL BIO MED, V4, P155, DOI 10.1016/0891-5849(88)90023-8; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Hardwick RN, 2010, DRUG METAB DISPOS, V38, P2293, DOI 10.1124/dmd.110.035006; Hsieh HF, 2008, AM J SURG, V196, P346, DOI 10.1016/j.amjsurg.2007.09.051; Hugenholtz GCG, 2013, THROMB HAEMOSTASIS, V109, P948, DOI 10.1160/TH12-12-0930; Iwai M, 2001, CYTOKINE, V13, P60, DOI 10.1006/cyto.2000.0797; Kamada Y, 2007, J HEPATOL, V47, P556, DOI 10.1016/j.jhep.2007.03.020; Kele PG, 2013, LIVER INT, V33, P469, DOI 10.1111/liv.12089; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Lo Sasso G, 2010, HEPATOLOGY, V51, P1334, DOI 10.1002/hep.23436; Morris EM, 2011, ANTIOXID REDOX SIGN, V15, P485, DOI 10.1089/ars.2010.3795; Oliveira CPMS, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-9; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Ronco MT, 2002, MOL MED, V8, P808, DOI 10.1007/BF03402085; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schattenberg JM, 2010, DIGEST DIS, V28, P247, DOI 10.1159/000282097; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; Sydor S, 2013, LAB INVEST, V93, P20, DOI 10.1038/labinvest.2012.142; Tevar AD, 2010, J AM COLL SURGEONS, V210, P515, DOI 10.1016/j.jamcollsurg.2010.01.020; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tilg H, 2010, DIGEST DIS, V28, P179, DOI 10.1159/000282083; Zhang YKJ, 2010, TOXICOL APPL PHARM, V245, P326, DOI 10.1016/j.taap.2010.03.016	32	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143121	10.1371/journal.pone.0143121	http://dx.doi.org/10.1371/journal.pone.0143121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600128	gold, Green Submitted, Green Published			2022-12-26	WOS:000365862600029
J	Luo, XM; Xu, B; Zhou, ML; Bao, YY; Zhou, SH; Fan, J; Lu, ZJ				Luo, Xing-Mei; Xu, Bin; Zhou, Min-Li; Bao, Yang-Yang; Zhou, Shui-Hong; Fan, Jun; Lu, Zhong-Jie			Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GLUCOSE-UPTAKE; CANCER CELLS; GLOTTIC CANCER; HEP-2 CELLS; NECK-CANCER; GLUCOSE-TRANSPORTER-1; AKT; HEAD; ACTIVATION	In the present study, we investigated the role of GLUT-1 and PI3K/Akt signaling in radioresistance of laryngeal carcinoma xenografts. Volume, weight, radiosensitization, and the rate of inhibition of tumor growth in the xenografts were evaluated in different groups. Apoptosis was evaluated by TUNEL assay. In addition, mRNA and protein levels of GLUT-1, p-Akt, and PI3K in the xenografts were measured. Treatment with LY294002, wortmannin, wortmannin plus GLUT-1 AS-ODN, and LY294002 plus GLUT-1 AS-ODN after X-ray irradiation significantly reduced the size and weight of the tumors, rate of tumor growth, and apoptosis in tumors compared to that observed in the 10-Gy group (p<0.05). In addition, mRNA and protein expression of GLUT-1, p-Akt, and PI3K was downregulated. The E/O values of LY294002, LY294002 plus GLUT-1 AS-ODN, wortmannin, and wortmannin plus GLUT-1 AS-ODN were 2.7, 1.1, 1.8, and 1.8, respectively. Taken together, these data indicate that GLUT-1 AS-ODN as well as the inhibitors of PI3K/Akt signaling may act as radiosensitizers of laryngeal carcinoma in vivo.	[Luo, Xing-Mei; Xu, Bin; Zhou, Min-Li; Bao, Yang-Yang; Zhou, Shui-Hong] Zhejiang Univ, Affiliated Hosp 1, Dept Otolaryngol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Fan, Jun] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Zhong-Jie] Zhejiang Univ, Affiliated Hosp 1, Dept Radiotherapy, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhou, SH (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Otolaryngol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	zhouyunzhoush@163.com			National Natural Science Foundation of China [81172562, 81372903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81172562 and 81372903).	Bao YY, 2015, ONCOL REP, V34, P1805, DOI 10.3892/or.2015.4158; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Chang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.407; Chen XH, 2013, MOL MED REP, V8, P1695, DOI 10.3892/mmr.2013.1740; Doki Y, 2005, SURGERY, V137, P536, DOI 10.1016/j.surg.2005.01.008; Eckert AW, 2012, ORAL MAXILLOFAC SURG, V16, P189, DOI 10.1007/s10006-012-0335-8; Fan JA, 2010, CANCER BIOTHER RADIO, V25, P521, DOI 10.1089/cbr.2010.0784; Han MW, 2012, HEAD NECK-J SCI SPEC, V34, P1395, DOI 10.1002/hed.21945; Heavey S, 2014, CANCER TREAT REV, V40, P445, DOI 10.1016/j.ctrv.2013.08.006; Huang XQ, 2014, INT J CLIN EXP PATHO, V7, P1651; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Ke CC, 2013, EUR J NUCL MED MOL I, V40, P61, DOI 10.1007/s00259-012-2242-5; Kim JH, 2013, INT J MOL SCI, V14, P17304, DOI 10.3390/ijms140917304; Koukourakis MI, 2010, INT J RADIAT ONCOL, V77, P9, DOI 10.1016/j.ijrobp.2009.04.060; Lei Y, 2013, INT J RADIAT BIOL, V89, P1079, DOI 10.3109/09553002.2013.825058; Luna-Ortiz K, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-101; Luo XM, 2010, J INT MED RES, V38, P1885, DOI 10.1177/147323001003800601; Melstrom LG, 2008, PANCREAS, V37, P426, DOI 10.1097/MPA.0b013e3181735ccb; Pedersen MWB, 2001, NEOPLASIA, V3, P80, DOI 10.1038/sj.neo.7900133; Pellini R, 2008, HEAD NECK-J SCI SPEC, V30, P372, DOI 10.1002/hed.20709; Perri F, 2015, HEAD NECK-J SCI SPEC, V37, P763, DOI 10.1002/hed.23837; Rashmi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092948; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Santoro R, 2014, EUR ARCH OTO-RHINO-L, V271, P777, DOI 10.1007/s00405-013-2583-0; Shimanishi M, 2013, J ORAL PATHOL MED, V42, P382, DOI 10.1111/jop.12028; Shin SJ, 2014, EUR J PHARMACOL, V743, P17, DOI 10.1016/j.ejphar.2014.09.013; SKORSKI T, 1995, BLOOD, V86, P726, DOI 10.1182/blood.V86.2.726.bloodjournal862726; Tateya I, 2006, EUR ARCH OTO-RHINO-L, V263, P144, DOI 10.1007/s00405-005-0978-2; van der Molen L, 2013, RADIOTHER ONCOL, V106, P364, DOI 10.1016/j.radonc.2013.03.005; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Volker HU, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-18; Wang KR, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-294; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xia Y, 1996, AIZHENG, V15, P8; Xu YY, 2014, INT J CLIN EXP PATHO, V7, P3938; Yan SX, 2013, INT J MED SCI, V10, P1375, DOI 10.7150/ijms.6855; Yang X, 2015, TUMOR BIOL, V36, P383, DOI 10.1007/s13277-014-2617-2; Zhou SH, 2009, HEAD NECK-J SCI SPEC, V31, P1624, DOI 10.1002/hed.21137	38	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143306	10.1371/journal.pone.0143306	http://dx.doi.org/10.1371/journal.pone.0143306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600164	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600047
J	Pellegrin, M; Aubert, JF; Bouzourene, K; Amstutz, C; Mazzolai, L				Pellegrin, Maxime; Aubert, Jean-Francois; Bouzourene, Karima; Amstutz, Catherine; Mazzolai, Lucia			Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects	PLOS ONE			English	Article							E-DEFICIENT MICE; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; HYPERCHOLESTEROLEMIC MICE; CARDIAC REHABILITATION; INFLAMMATORY MARKERS; PRIMARY PREVENTION; KNOCKOUT MICE; T-CELLS; PLAQUE	We have previously demonstrated that exercise training prevents the development of Angiotensin (Ang) II-induced atherosclerosis and vulnerable plaques in Apolipoprotein E-deficient (ApoE(-/-)) mice. In this report, we investigated whether exercise attenuates progression and promotes stability in pre-established vulnerable lesions. To this end, ApoE(-/-) mice with already established Ang II-mediated advanced and vulnerable lesions (2-kidney, 1-clip [2K1C] renovascular hypertension model), were subjected to sedentary (SED) or voluntary wheel running training (EXE) regimens for 4 weeks. Mean blood pressure and plasma renin activity did not significantly differ between the two groups, while total plasma cholesterol significantly decreased in 2K1C EXE mice. Aortic plaque size was significantly reduced by 63% in 2K1C EXE compared to SED mice. Plaque stability score was significantly higher in 2K1C EXE mice than in SED ones. Aortic ICAM-1 mRNA expression was significantly down-regulated following EXE. Moreover, EXE significantly down-regulated splenic proinflammatory cytokines IL-18, and IL-1 beta mRNA expression while increasing that of antiinflammatory cytokine IL-4. Reduction in plasma IL-18 levels was also observed in response to EXE. There was no significant difference in aortic and splenic Th1/Th2 and M1/M2 polarization markers mRNA expression between the two groups. Our results indicate that voluntary EXE is effective in slowing progression and promoting stabilization of preexisting Ang II-dependent vulnerable lesions by ameliorating systemic inflammatory state. Our findings support a therapeutic role for voluntary EXE in patients with established atherosclerosis.	[Pellegrin, Maxime; Aubert, Jean-Francois; Bouzourene, Karima; Amstutz, Catherine; Mazzolai, Lucia] Univ Lausanne Hosp, Div Angiol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Pellegrin, M (corresponding author), Univ Lausanne Hosp, Div Angiol, Lausanne, Switzerland.	maxime.pellegrin@chuv.ch						Ajijola OA, 2009, ANTIOXID REDOX SIGN, V11, P15, DOI 10.1089/ars.2008.2092; Apostolakis Stavros, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P150, DOI 10.2174/187152508783955006; Fukao K, 2010, J ATHEROSCLER THROMB, V17, P1226, DOI 10.5551/jat.4788; Goldhammer E, 2005, INT J CARDIOL, V100, P93, DOI 10.1016/j.ijcard.2004.08.073; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Kadoglou NPE, 2011, J VASC RES, V48, P347, DOI 10.1159/000321174; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Kyaw T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060430; Lavie CJ, 2011, PROG CARDIOVASC DIS, V53, P397, DOI 10.1016/j.pcad.2011.02.008; Lawler PR, 2011, AM HEART J, V162, P571, DOI 10.1016/j.ahj.2011.07.017; Li NL, 2013, THROMB HAEMOSTASIS, V109, P980, DOI 10.1160/TH12-11-0819; Liu Z, 2013, BRIT J PHARMACOL, V169, P1795, DOI 10.1111/bph.12246; Mazzolai L, 2004, HYPERTENSION, V44, P277, DOI 10.1161/01.HYP.0000140269.55873.7b; Meissner M, 2011, ATHEROSCLEROSIS, V218, P323, DOI 10.1016/j.atherosclerosis.2011.06.040; Napoli C, 2006, P NATL ACAD SCI USA, V103, P10479, DOI 10.1073/pnas.0602774103; Nussberger J, 2008, HYPERTENSION, V51, P1306, DOI 10.1161/HYPERTENSIONAHA.108.110932; Okabe T, 2007, CARDIOVASC RES, V74, P537, DOI 10.1016/j.cardiores.2007.02.019; Pedersen BK, 2006, ESSAYS BIOCHEM, V42, P105, DOI 10.1042/bse0420105; Pellegrin M, 2013, J CLIN EXP CARDIOLOG; Pellegrin M, 2007, ATHEROSCLEROSIS, V190, P35, DOI 10.1016/j.atherosclerosis.2006.02.001; Pellegrin M, 2009, MED SCI SPORT EXER, V41, P2128, DOI 10.1249/MSS.0b013e3181a8d530; Pellegrin M, 2009, HYPERTENSION, V53, P782, DOI 10.1161/HYPERTENSIONAHA.108.128165; Pello OM, 2011, IMMUNOBIOLOGY, V216, P1172, DOI 10.1016/j.imbio.2011.05.010; Perez-Terzic CM, 2012, PM&R, V4, P867, DOI 10.1016/j.pmrj.2012.10.003; Pinto A, 2012, CURR PHARM DESIGN, V18, P4326, DOI 10.2174/138161212802481192; Qamar A, 2012, CURR OPIN LIPIDOL, V23, P548, DOI 10.1097/MOL.0b013e328359b0a6; Ramachandran S, 2005, ATHEROSCLEROSIS, V178, P33, DOI 10.1016/j.atherosclerosis.2004.08.010; Ribeiro F, 2012, INT J SPORTS MED, V33, P192, DOI 10.1055/s-0031-1297959; She ZG, 2009, CIRC RES, V104, P1160, DOI 10.1161/CIRCRESAHA.108.192229; Shin HS, 2014, J ETHNOPHARMACOL, V153, P142, DOI 10.1016/j.jep.2014.01.039; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Spence AL, 2013, J PHYSIOL-LONDON, V591, P1265, DOI 10.1113/jphysiol.2012.247387; Thijssen DHJ, 2012, CLIN SCI, V122, P311, DOI 10.1042/CS20110469; Tse K, 2013, INT IMMUNOL, V25, P615, DOI 10.1093/intimm/dxt043; Walther C, 2008, EUR J CARDIOV PREV R, V15, P107, DOI 10.1097/HJR.0b013e3282f29aa6; Xu SW, 2011, ARCH BIOCHEM BIOPHYS, V515, P72, DOI 10.1016/j.abb.2011.08.006	37	10	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143536	10.1371/journal.pone.0143536	http://dx.doi.org/10.1371/journal.pone.0143536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600018	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600080
J	Pisani, F; Settanni, P; Rosito, S; Mola, MG; Iorio, R; Tortorella, C; Ruggieri, M; Trojano, M; Svelto, M; Frigeri, A; Nicchia, GP				Pisani, Francesco; Settanni, Paolo; Rosito, Stefania; Mola, Maria Grazia; Iorio, Raffaele; Tortorella, Carla; Ruggieri, Maddalena; Trojano, Maria; Svelto, Maria; Frigeri, Antonio; Nicchia, Grazia Paola			Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection	PLOS ONE			English	Article							ANTI-AQUAPORIN-4 ANTIBODIES; DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; BINDING; MARKER; IGG; NMO; SPECIFICITY; MUSCLE; ASSAYS	Serological markers of Nuromyelitis Optica (NMO), an autoimmune disorder of the central nervous system, are autoantibodies targeting the astrocytic water channel aquaporin-4 (AQP4). We have previously demonstrated that the main epitopes for these autoantibodies (AQP4-IgG) are generated by the supramolecular arrangement of AQP4 tetramers into an Orthogonal Array of Particles (OAPs). Many tests have been developed to detect AQP4-IgG in patient sera but several procedural issues affect OAP assembly and consequently test sensitivity. To date, the protein based ELISA test shows the lowest sensitivity while representing a valid alternative to the more sensitive cell based assay (CBA), which, however, shows economic, technical and interpretation problems. Here we have developed a high perfomance ELISA in which native OAPs are used as the molecular target. To this aim a native size exclusion chromatography method has been developed to isolate integral, highly pure and AQP4-IgG-recognized OAPs from rat brain. These OAPs were immobilized and oriented on a plastic plate by a sandwich approach and 139 human sera were tested, including 67 sera from NMO patients. The OAP-ELISA showed a 99% specificity and a higher sensitivity (91%) compared to the CBA test. A comparative analysis revealed an end-point titer three orders of magnitude higher than the commercial ELISA and six times higher than our in-house CBA test. We show that CNS-extracted OAPs are crucial elements in order to perform an efficient AQP4-IgG test and the OAP-ELISA developed represents a valid alternative to the CBA currently used.	[Pisani, Francesco; Settanni, Paolo; Rosito, Stefania; Mola, Maria Grazia; Svelto, Maria; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy; [Pisani, Francesco; Settanni, Paolo; Rosito, Stefania; Mola, Maria Grazia; Svelto, Maria; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Ctr Excellence Comparat Genom, I-70126 Bari, Italy; [Tortorella, Carla; Ruggieri, Maddalena; Trojano, Maria; Frigeri, Antonio] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, I-70126 Bari, Italy; [Iorio, Raffaele] Univ Cattolica Sacro Cuore, Inst Neurol, Dept Geriatr Neurosci & Orthoped, I-00168 Rome, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Frigeri, A (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, I-70126 Bari, Italy.	antonio.frigeri@uniba.it	Iorio, Raffaele/E-1236-2014; PISANI, Francesco/AAC-1749-2019; Mola, Maria Grazia/I-3507-2019; Iorio, Raffaele/HDN-3072-2022; frigeri, Antonio/AAC-6336-2022; tortorella, carla/J-2557-2012	Iorio, Raffaele/0000-0002-6270-0956; PISANI, Francesco/0000-0001-8511-117X; Mola, Maria Grazia/0000-0002-4421-9237; Iorio, Raffaele/0000-0002-6270-0956; Trojano, Maria/0000-0002-6329-8946; tortorella, carla/0000-0001-9037-7300	Italian Ministry of University and Research MIUR, FIRB [RBFR12SJA8]; Apulian Region funding PON [01_01297]	Italian Ministry of University and Research MIUR, FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Apulian Region funding PON	This work was financially supported by: Italian Ministry of University and Research MIUR, FIRB project RBFR12SJA8 to GPN and Apulian Region funding PON project 01_01297 to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apiwattanakul M, 2012, J NEUROL SCI, V320, P118, DOI 10.1016/j.jns.2012.07.014; Bergamaschi R, 2004, NEUROL SCI, V25, pS364, DOI 10.1007/s10072-004-0342-0; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Fazio R, 2009, MULT SCLER J, V15, P1153, DOI 10.1177/1352458509106851; Frigeri A, 2004, FASEB J, V18, P905, DOI 10.1096/fj.03-0987fje; Fryer JP, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000011; Hayakawa S, 2008, J NEUROIMMUNOL, V196, P181, DOI 10.1016/j.jneuroim.2008.03.009; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Isobe N, 2012, MULT SCLER J, V18, P1541, DOI 10.1177/1352458512443917; Jarius S, 2012, J NEUROL SCI, V320, P32, DOI 10.1016/j.jns.2012.06.002; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Jarius S, 2013, BRAIN PATHOL, V23, P661, DOI 10.1111/bpa.12084; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; Kampylafka EI, 2011, J AUTOIMMUN, V36, P221, DOI 10.1016/j.jaut.2011.01.004; Kim W, 2012, MULT SCLER J, V18, P578, DOI 10.1177/1352458511424590; Kim YJ, 2012, J CLIN LAB ANAL, V26, P184, DOI 10.1002/jcla.21508; Kimbrough DJ, 2012, MULT SCLER RELAT DIS, V1, P180, DOI 10.1016/j.msard.2012.06.002; Kremer L, 2014, MULT SCLER J, V20, P843, DOI 10.1177/1352458513507822; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Nicchia GP, 2008, J NEUROCHEM, V105, P2156, DOI 10.1111/j.1471-4159.2008.05302.x; Nicchia GP, 2010, NEUROSCIENCE, V168, P903, DOI 10.1016/j.neuroscience.2010.02.008; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Pisani F, 2014, J BIOL CHEM, V289, P30578, DOI 10.1074/jbc.M114.582221; Pisani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079185; Pisani F, 2011, GLIA, V59, P1923, DOI 10.1002/glia.21234; Pisani F, 2011, J BIOL CHEM, V286, P9216, DOI 10.1074/jbc.M110.123000; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rossi A, 2010, J BIOL CHEM, V285, P4562, DOI 10.1074/jbc.M109.069245; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Waters P, 2008, Int MS J, V15, P99; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729	39	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143679	10.1371/journal.pone.0143679	http://dx.doi.org/10.1371/journal.pone.0143679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599905	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600104
J	Shin, SJ; Ko, KJ; Kim, TS; Ryoo, HS; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Choi, HY; Jeon, SS				Shin, Seung Jea; Ko, Kwang Jin; Kim, Tae Sun; Ryoo, Hyun Soo; Sung, Hyun Hwan; Jeon, Hwang Gyun; Jeong, Byong Chang; Seo, Seong Il; Lee, Hyun Moo; Choi, Han Yong; Jeon, Seong Soo			Trends in the Use of Nephron-Sparing Surgery over 7 Years: An Analysis Using the RENAL Nephrometry Scoring System	PLOS ONE			English	Article							RADICAL NEPHRECTOMY; IMPACT	Objective To analyze trends in the use of partial nephrectomy, we evaluated which individual factors of renal nephrometry score (RNS) influenced the operative approach bi-annually from 2008 to 2014. Materials and Methods We performed a retrospective review of renal cell carcinoma treated by surgery in 2008, 2010, 2012, and 2014. The complexity of renal masses was measured using the R.E.N.A.L. nephrometry scoring system with CT or MRI. Group comparison in terms of operation year and surgical type (partial nephrectomy versus radical nephrectomy) was performed. We developed a nomogram to quantitate the likelihood of selecting partial nephrectomy over radical nephrectomy. Results A total of 1106 cases (237 in 2008, 225 in 2010, 292 in 2012, and 352 in 2014) were available for the study. Over the study period, the proportion of partial nephrectomies performed increased steadily from 21.5% in 2008 to 66.5% in 2014 (p < 0.05). Furthermore, use of partial nephrectomy increased steadily in all RNS complexity groups (low, moderate, and high) (p < 0.05). In the analysis of individual components of RNS, values of the R and N components increased statistically by year in the partial nephrectomy group (p < 0.05). Average AUC was 0.920. Conclusions The proportion of partial nephrectomies performed sharply increased over the study period. Additionally, over the study period, more partial nephrectomies were performed for renal masses of larger size and closer to the collecting system and main renal vessels. A nomogram developed based on this recent data set provides significant predictive value for surgical decision making.	[Shin, Seung Jea; Ko, Kwang Jin; Kim, Tae Sun; Ryoo, Hyun Soo; Sung, Hyun Hwan; Jeon, Hwang Gyun; Jeong, Byong Chang; Seo, Seong Il; Lee, Hyun Moo; Choi, Han Yong; Jeon, Seong Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, SS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea.	seongsoo.jeon@samsung.com	Ko, Kwang/AFO-2587-2022; sung, hh/O-6246-2014; Ko, Kwang Jin/AAH-7455-2019	Ko, Kwang/0000-0003-1085-1266; 	Korean Urologic Oncology Society [12-02]	Korean Urologic Oncology Society	The research was supported in part by the Korean Urologic Oncology Society Grant 12-02.	Becker F, 2006, EUR UROL, V49, P1058, DOI 10.1016/j.eururo.2006.03.003; Dulabon LM, 2010, CANCER-AM CANCER SOC, V116, P2316, DOI 10.1002/cncr.24965; Heuer R, 2010, EUR UROL, V57, P223, DOI 10.1016/j.eururo.2009.10.023; Hwang EC, 2013, KOREAN J UROL, V54, P283, DOI 10.4111/kju.2013.54.5.283; Kim SP, 2011, J UROLOGY, V186, P1779, DOI 10.1016/j.juro.2011.07.041; Kim SP, 2012, J UROL IN PRESS; Krebs RK, 2014, UROL INT, V92, P449, DOI 10.1159/000355609; Kutikov A, 2011, EUR UROL, V60, P241, DOI 10.1016/j.eururo.2011.03.029; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Lane BR, 2011, J UROLOGY, V186, P1229, DOI 10.1016/j.juro.2011.05.081; Lane BR, 2010, J UROLOGY, V184, P1286, DOI 10.1016/j.juro.2010.06.011; Leslie S, 2014, EUR UROL, V66, P884, DOI 10.1016/j.eururo.2014.03.010; Monn MF, 2014, J ENDOUROL, V28, P1006, DOI 10.1089/end.2014.0166; Montag S, 2011, J ENDOUROL, V25, P1925, DOI 10.1089/end.2011.0217; Poon SA, 2013, J UROLOGY, V190, P464, DOI 10.1016/j.juro.2013.02.094; ROBSON CJ, 1969, J UROLOGY, V101, P297, DOI 10.1016/S0022-5347(17)62331-0; Rosevear HM, 2012, BJU INT, V109, P700, DOI 10.1111/j.1464-410X.2011.10452.x; Satasivam P, 2012, BJU INT, V109, P1341, DOI 10.1111/j.1464-410X.2011.10595.x; Thompson RH, 2009, J UROLOGY, V181, P993, DOI 10.1016/j.juro.2008.11.017; Touijer K, 2010, EUR UROL, V57, P214, DOI 10.1016/j.eururo.2009.10.019; Weight CJ, 2011, J UROLOGY, V186, P1223, DOI 10.1016/j.juro.2011.05.052	21	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0141709	10.1371/journal.pone.0141709	http://dx.doi.org/10.1371/journal.pone.0141709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599436	gold, Green Published, Green Submitted			2022-12-26	WOS:000365862600005
J	Wiecek, M; Maciejczyk, M; Szymura, J; Szygula, Z; Kantorowicz, M				Wiecek, Magdalena; Maciejczyk, Marcin; Szymura, Jadwiga; Szygula, Zbigniew; Kantorowicz, Malgorzata			Changes in Non-Enzymatic Antioxidants in the Blood Following Anaerobic Exercise in Men and Women	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; VASTUS LATERALIS MUSCLE; HUMAN SKELETAL-MUSCLE; SPRINT EXERCISE; FIBER-TYPE; ENZYME-ACTIVITIES; FREE-RADICALS; WINGATE TEST; VITAMIN-E; PLASMA	Purpose The aim of this study was to compare changes in total oxidative status (TOS), total antioxidative capacity (TAC) and the concentration of VitA, VitE, VitC, uric acid (UA), reduced (GSH) and oxidized glutathione (GSSG) in blood within 24 hours following anaerobic exercise (AnEx) among men and women. Methods 10 women and 10 men performed a 20-second bicycle sprint (AnEx). Concentrations of oxidative stress indicators were measured before AnEx and 3, 15 and 30 minutes and 1 hour afterwards. UA, GSH and GSSH were also measured 24 hours after AnEx. Lactate and H+ concentrations were measured before and 3 minutes after AnEx. Results The increase in lactate and H+ concentrations following AnEx was similar in both sexes. Changes in the concentrations of all oxidative stress indicators were significant and did not differ between men and women. In both sexes, TOS, TAC, TOS/ TAC and VitA and VitE concentrations were the highest 3 minutes, VitC concentration was the highest 30 minutes, and UA concentration was the highest 1 hour after AnEx. GSH concentration was significantly lower than the initial concentration from 15 minutes to 24 hour after AnEx. GSSG concentration was significantly higher, while the GSH/ GSSG ratio was significantly lower than the initial values 1 hour and 24 hour after AnEx. Conclusions With similar changes in lactate and H+ concentrations, AnEx induces the same changes in TAC, TOS, TOS/ TAC and non-enzymatic antioxidants of low molecular weight in men and women. Oxidative stress lasted at least 24 hours after AnEx.	[Wiecek, Magdalena; Maciejczyk, Marcin] Univ Phys Educ, Fac Phys Educ & Sport, Dept Physiol & Biochem, Krakow, Poland; [Szymura, Jadwiga] Univ Phys Educ, Dept Clin Rehabil, Fac Motor Rehabil, Krakow, Poland; [Szygula, Zbigniew] Univ Phys Educ, Fac Phys Educ & Sport, Dept Sports Med & Human Nutr, Krakow, Poland; [Kantorowicz, Malgorzata] Univ Phys Educ, Fac Phys Educ & Sport, Krakow, Poland		Wiecek, M (corresponding author), Univ Phys Educ, Fac Phys Educ & Sport, Dept Physiol & Biochem, Krakow, Poland.	magdalena.wiecek@awf.krakow.pl	Więcek, Magdalena/P-8276-2018; Magdalena, Wiecek/U-2339-2019; Maciejczyk, Marcin/E-1211-2017; Szymura, Jadwiga/V-6413-2018	Więcek, Magdalena/0000-0002-5390-3049; Magdalena, Wiecek/0000-0002-5390-3049; Maciejczyk, Marcin/0000-0002-9505-4081; Szymura, Jadwiga/0000-0003-4594-7954; Szygula, Zbigniew/0000-0002-6685-6579; Kantorowicz, Malgorzata/0000-0002-4913-9930	Faculty of Physical Education and Sport, University of Physical Education in Krakow, Poland [21/BS/IFC/2011]	Faculty of Physical Education and Sport, University of Physical Education in Krakow, Poland	The research was carried out under a statutory research of the Faculty of Physical Education and Sport, University of Physical Education in Krakow, Poland (grant 21/BS/IFC/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MED SCI SPORT EXER S, V29, P89, DOI DOI 10.1097/00005768-199706001-00018; Baker JS, 2004, EUR J APPL PHYSIOL, V92, P321, DOI 10.1007/s00421-004-1090-9; Berzosa C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/540458; Bloomer RJ, 2009, RES SPORTS MED, V17, P1, DOI 10.1080/15438620802678289; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; Cuevas MJ, 2005, FREE RADICAL RES, V39, P431, DOI 10.1080/10715760500072149; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Durackova Z, 2010, PHYSIOL RES, V59, P459, DOI 10.33549/physiolres.931844; Dybek T, 2012, BIOL SPORT, V29, P39, DOI 10.5604/20831862.979854; ESBJORNSSON M, 1993, INT J SPORTS MED, V14, P257, DOI 10.1055/s-2007-1021174; Esbjornsson-Liljedahl M, 2002, J APPL PHYSIOL, V93, P1075, DOI 10.1152/japplphysiol.00732.1999; Esbjornsson-Liljedahl M, 1999, J APPL PHYSIOL, V87, P1326, DOI 10.1152/jappl.1999.87.4.1326; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Fuentes T, 2012, EUR J APPL PHYSIOL, V112, P1917, DOI 10.1007/s00421-011-2164-0; GREEN HJ, 1984, J NEUROL SCI, V65, P323, DOI 10.1016/0022-510X(84)90095-9; Groussard C, 2003, EUR J APPL PHYSIOL, V89, P14, DOI 10.1007/s00421-002-0767-1; Groussard C, 2003, CAN J APPL PHYSIOL, V28, P79, DOI 10.1139/h03-007; Ilhan N, 2004, ARCH MED RES, V35, P294, DOI 10.1016/j.arcmed.2004.03.006; Inbar O, 1996, WINGATE ANAEROBIC TE, P35; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Karabulut A., 2011, J US CHINA MEDICAL S, V8, P150; Kurkcu R, 2010, BIOL SPORT, V27, P177, DOI 10.5604/20831862.919350; Laurent CM, 2007, EUR J APPL PHYSIOL, V100, P645, DOI 10.1007/s00421-007-0454-3; Michailidis Y, 2007, MED SCI SPORT EXER, V39, P1107, DOI 10.1249/01.mss.0b013e318053e7ba; Morales-Alamo D, 2014, FREE RADICAL RES, V48, P30, DOI 10.3109/10715762.2013.825043; Morales-Alamo D, 2013, J APPL PHYSIOL, V114, P566, DOI 10.1152/japplphysiol.01246.2012; Morales-Alamo D, 2012, J APPL PHYSIOL, V113, P917, DOI 10.1152/japplphysiol.00415.2012; Podgorski T, 2006, POLISH J SPORT MED, V22, P215; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Quindry J, 2011, INT J SPORT NUTR EXE, V21, P462, DOI 10.1123/ijsnem.21.6.462; Rutkowski M, 2012, INT J OCCUP MED ENV, V25, P105, DOI 10.2478/S13382-012-0022-x; Sacheck JM, 2001, NUTRITION, V17, P809, DOI 10.1016/S0899-9007(01)00639-6; Sakano N, 2009, J CLIN BIOCHEM NUTR, V44, P185, DOI 10.3164/jcbn.08-252; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Szponar L, 2012, ALBUM PHOTOGRAPHS FO; Taito S, 2013, CLIN PHYSIOL FUNCT I, V33, P241, DOI 10.1111/cpf.12007; Toft I, 2003, MUSCLE NERVE, V28, P101, DOI 10.1002/mus.10373; Vincent S, 2004, EUR J APPL PHYSIOL, V91, P15, DOI 10.1007/s00421-003-0957-5; WAYNER DDM, 1987, BIOCHIM BIOPHYS ACTA, V924, P408, DOI 10.1016/0304-4165(87)90155-3; Weber GL, 2000, EUR J APPL PHYSIOL, V82, P255, DOI 10.1007/s004210000214; Wiecek M, 2015, PHYSIOL RES, V64, P93, DOI 10.33549/physiolres.932744	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143499	10.1371/journal.pone.0143499	http://dx.doi.org/10.1371/journal.pone.0143499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600020	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600072
J	Field, MA; Cho, V; Andrews, TD; Goodnow, CC				Field, Matthew A.; Cho, Vicky; Andrews, T. Daniel; Goodnow, Chris C.			Reliably Detecting Clinically Important Variants Requires Both Combined Variant Calls and Optimized Filtering Strategies	PLOS ONE			English	Article							READ ALIGNMENT; WHOLE-GENOME; GENERATION; EXOME; BIOINFORMATICS; PERFORMANCE; FRAMEWORK; MUTATIONS; DISCOVERY; PIPELINES	A diversity of tools is available for identification of variants from genome sequence data. Given the current complexity of incorporating external software into a genome analysis infrastructure, a tendency exists to rely on the results from a single tool alone. The quality of the output variant calls is highly variable however, depending on factors such as sequence library quality as well as the choice of short-read aligner, variant caller, and variant caller filtering strategy. Here we present a two-part study first using the high quality 'genome in a bottle' reference set to demonstrate the significant impact the choice of aligner, variant caller, and variant caller filtering strategy has on overall variant call quality and further how certain variant callers outperform others with increased sample contamination, an important consideration when analyzing sequenced cancer samples. This analysis confirms previous work showing that combining variant calls of multiple tools results in the best quality resultant variant set, for either specificity or sensitivity, depending on whether the intersection or union, of all variant calls is used respectively. Second, we analyze a melanoma cell line derived from a control lymphocyte sample to determine whether software choices affect the detection of clinically important melanoma risk-factor variants finding that only one of the three such variants is unanimously detected under all conditions. Finally, we describe a cogent strategy for implementing a clinical variant detection pipeline; a strategy that requires careful software selection, variant caller filtering optimizing, and combined variant calls in order to effectively minimize false negative variants. While implementing such features represents an increase in complexity and computation the results offer indisputable improvements in data quality.	[Field, Matthew A.; Cho, Vicky; Andrews, T. Daniel; Goodnow, Chris C.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia; [Cho, Vicky] Australian Natl Univ, Australian Phen Facil, Canberra, ACT, Australia; [Field, Matthew A.; Andrews, T. Daniel] Australian Natl Univ, Natl Computat Infrastruct, Canberra, ACT, Australia; [Goodnow, Chris C.] St Vincents Hosp, Garvan Inst Med Res, Immunol Res Program, Immunogen Grp, Darlinghurst, NSW 2010, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; Australian National University; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Field, MA (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia.	matt.field@anu.edu.au	Goodnow, Christopher C/V-8108-2018; Andrews, Dan/ABG-4815-2020	Goodnow, Christopher C/0000-0001-5296-6155; Field, Matthew/0000-0003-0788-6513; Andrews, Dan/0000-0003-3922-6376	National Institutes of Health [U19 AII00627]; National Health and Medical Research Council [585490]; National Collaborative Research Infrastructure Strategy (Australia); Melanoma Institute of Australia; Bioplatforms Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Collaborative Research Infrastructure Strategy (Australia)(Australian GovernmentDepartment of Industry, Innovation and Science); Melanoma Institute of Australia; Bioplatforms Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been in part funded by grants from the National Institutes of Health (Author: CCG; URL: www.nih.gov; Grant ID: U19 AII00627), the National Health and Medical Research Council (Author: CCG; URL: https://www.nhmrc.gov.au/; Grant ID: Australia Fellowship 585490), the National Collaborative Research Infrastructure Strategy (Australia), the Melanoma Institute of Australia (Author: MAF; URL: www.melanoma.org.au/), and Bioplatforms Australia (Author: MAF; URL: www.bioplatforms.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; Brownstein CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r53; BURNET M, 1965, BRIT MED J, V1, P338, DOI 10.1136/bmj.1.5431.338; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cantarel BL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-104; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0089-z; Field MA, 2015, BIOINFORMATICS, V31, P2377, DOI 10.1093/bioinformatics/btv135; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guan YF, 2012, CHIN J CANCER, V31, P463, DOI 10.5732/cjc.012.10216; Highnam G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7275; Jeck WR, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12238; Jia PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038470; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Liu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075619; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mose LE, 2014, BIOINFORMATICS, V30, P2813, DOI 10.1093/bioinformatics/btu376; Nagy R, 2004, ONCOGENE, V23, P6445, DOI 10.1038/sj.onc.1207714; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Oinn T, 2004, BIOINFORMATICS, V20, P3045, DOI 10.1093/bioinformatics/bth361; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Parla JS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r97; Pirooznia M, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-14; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Ramos EM, 2014, AM J MED GENET C, V166, P93, DOI 10.1002/ajmg.c.31386; Ratan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055089; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sadedin SP, 2012, BIOINFORMATICS, V28, P1525, DOI 10.1093/bioinformatics/bts167; Shang J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/309650; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Thomas A, 2013, ANN ONCOL, V24, P577, DOI 10.1093/annonc/mds478; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wilmott JS, 2015, PATHOLOGY, V47, P683, DOI 10.1097/PAT.0000000000000324; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Yi M, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku392; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	53	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143199	10.1371/journal.pone.0143199	http://dx.doi.org/10.1371/journal.pone.0143199			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600436	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000365853900075
J	Mensen, A; Poryazova, R; Huegli, G; Baumann, CR; Schwartz, S; Khatami, R				Mensen, Armand; Poryazova, Rositsa; Huegli, Gordana; Baumann, Christian R.; Schwartz, Sophie; Khatami, Ramin			The Roles of Dopamine and Hypocretin in Reward: A Electroencephalographic Study	PLOS ONE			English	Article							FEEDBACK-RELATED NEGATIVITY; MEDIAL PREFRONTAL CORTEX; PARKINSONS-DISEASE; PREDICTION ERRORS; NARCOLEPSY; CATAPLEXY; MODULATION; BRAIN; EEG; ANTICIPATION	The proper functioning of the mesolimbic reward system is largely dependent on the neurotransmitter dopamine. Recent evidence suggests that the hypocretin system has significant projections to this reward system. We examined the distinct effects of reduced dopamine or reduced hypocretin levels on reward activity in patients with Parkinson's disease, dopamine deficient, as well as patients with narcolepsy-cataplexy, hypocretin depleted, and healthy controls. Participants performed a simple game-like task while high-density electroencephalography was recorded. Topography and timing of event-related potentials for both reward cue, and reward feedback was examined across the entire dataset. While response to reward cue was similar in all groups, two distinct time points were found to distinguish patients and controls for reward feedback. Around 160ms both patient groups had reduced ERP amplitude compared to controls. Later at 250ms, both patient groups also showed a clear event-related potential (ERP), which was absent in controls. The initial differences show that both patient groups show a similar, blunted response to reward delivery. The second potential corresponds to the classic feedback-related negativity (FRN) potential which relies on dopamine activity and reflects reward prediction-error signaling. In particular the mismatch between predicted reward and reward subsequently received was significantly higher in PD compared to NC, independent of reward magnitude and valence. The intermediate FRN response in NC highlights the contribution of hypocretin in reward processing, yet also shows that this is not as detrimental to the reward system as in Parkinson's. Furthermore, the inability to generate accurate predictions in NC may explain why hypocretin deficiency mediates cataplexy triggered by both positive and negative emotions.	[Mensen, Armand; Huegli, Gordana; Khatami, Ramin] Clin Barmelweid, Dept Sleep Med, CH-5017 Aargau, Switzerland; [Poryazova, Rositsa; Baumann, Christian R.] Univ Zurich Hosp, Dept Neurol, CH-8006 Zurich, Switzerland; [Schwartz, Sophie] Univ Geneva, Dept Neurosci, CH-1211 Geneva, Switzerland	University of Zurich; University Zurich Hospital; University of Geneva	Khatami, R (corresponding author), Clin Barmelweid, Dept Sleep Med, CH-5017 Aargau, Switzerland.	Ramin.Khatami@Barmelweid.ch		Baumann, Christian/0000-0003-3417-1978; Schwartz, Sophie/0000-0001-7718-4053	Swiss National Science Foundation [32003B_124763/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation. Grant ID: 32003B_124763/1.	Aarts E, 2012, NEUROIMAGE, V59, P3339, DOI 10.1016/j.neuroimage.2011.11.073; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Baker TE, 2009, CEREB CORTEX, V19, P1708, DOI 10.1093/cercor/bhn223; Bassetti C, 1997, SLEEP, V20, P630, DOI 10.1093/sleep/20.8.630; Biehl SC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-107; Bismark AW, 2013, PSYCHOPHYSIOLOGY, V50, P125, DOI 10.1111/j.1469-8986.2012.01490.x; Bortoletto M, 2011, INT J PSYCHOPHYSIOL, V81, P312, DOI 10.1016/j.ijpsycho.2011.07.017; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Calipari ES, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00054; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Delazer M, 2011, NEUROPSYCHOLOGY, V25, P477, DOI 10.1037/a0022357; Donamayor N, 2012, NEUROIMAGE, V62, P17, DOI 10.1016/j.neuroimage.2012.04.038; Donamayor N, 2011, HUM BRAIN MAPP, V32, P2228, DOI 10.1002/hbm.21184; Eckart C, 2012, NEUROIMAGE; Ferdinand NK, 2012, J NEUROSCI, V32, P12087, DOI 10.1523/JNEUROSCI.1410-12.2012; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GOTHAM AM, 1986, LANCET, V2, P970; Hauser TU, 2014, NEUROIMAGE, V84, P159, DOI 10.1016/j.neuroimage.2013.08.028; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Holroyd CB, 2009, COGN AFFECT BEHAV NE, V9, P59, DOI 10.3758/CABN.9.1.59; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Korotkova TM, 2003, J NEUROSCI, V23, P7; MacDonald PA, 2011, BRAIN, V134, P1447, DOI 10.1093/brain/awr075; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Mantini D, 2010, BRAIN TOPOGR, V23, P150, DOI 10.1007/s10548-009-0132-3; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Mensen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085978; Mensen A, 2013, NEUROIMAGE, V67, P111, DOI 10.1016/j.neuroimage.2012.10.027; Mensen Armand, 2015, EEG PERMUTATION TEST, DOI [10.5281/zenodo.14787, DOI 10.5281/ZENODO.14787]; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Narita M, 2006, J NEUROSCI, V26, P398, DOI 10.1523/JNEUROSCI.2761-05.2006; Oishi Y, 2013, J NEUROSCI, V33, P9743, DOI 10.1523/JNEUROSCI.0499-13.2013; Overeem S, 2011, SLEEP MED, V12, P12, DOI 10.1016/j.sleep.2010.05.010; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Ponz A, 2010, ANN NEUROL, V67, P190, DOI 10.1002/ana.21825; Rossion B, VISION RES IN PRESS; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sato JR, 2010, NEUROIMAGE, V50, P1416, DOI 10.1016/j.neuroimage.2010.01.075; Schultz A, 2004, ACTA ANAESTH SCAND, V48, P27, DOI 10.1111/j.1399-6576.2004.00258.x; Talmi D, 2013, J NEUROSCI, V33, P8264, DOI 10.1523/JNEUROSCI.5695-12.2013; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; van der Vegt JPM, 2013, BRAIN, V136, P1192, DOI 10.1093/brain/awt027; van Wouwe NC, 2012, NEUROPSYCHOLOGIA, V50, P583, DOI 10.1016/j.neuropsychologia.2011.12.012; Voon V, 2010, NEURON, V65, P135, DOI 10.1016/j.neuron.2009.12.027; Walsh MM, 2011, P NATL ACAD SCI USA, V108, P19048, DOI 10.1073/pnas.1117189108; Zinbarg RE, 2010, J ABNORM PSYCHOL, V119, P307, DOI 10.1037/a0017552	49	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142432	10.1371/journal.pone.0142432	http://dx.doi.org/10.1371/journal.pone.0142432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599765	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000365853900025
J	Sola-Gines, M; Cameron-Veas, K; Badiola, I; Dolz, R; Majo, N; Dahbi, G; Viso, S; Mora, A; Blanco, J; Piedra-Carrasco, N; Gonzalez-Lopez, JJ; Migura-Garcia, L				Sola-Gines, Marc; Cameron-Veas, Karla; Badiola, Ignacio; Dolz, Roser; Majo, Natalia; Dahbi, Ghizlane; Viso, Susana; Mora, Azucena; Blanco, Jorge; Piedra-Carrasco, Nuria; Gonzalez-Lopez, Juan Jose; Migura-Garcia, Lourdes			Diversity of Multi-Drug Resistant Avian Pathogenic Escherichia coli (APEC) Causing Outbreaks of Colibacillosis in Broilers during 2012 in Spain	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; MOLECULAR EPIDEMIOLOGY; POULTRY PRODUCTS; PUBLIC-HEALTH; RISK-FACTORS; O78 STRAINS; VIRULENCE; PLASMIDS; ANIMALS; SPREAD	Avian pathogenic Escherichia coli (APEC) are the major cause of colibacillosis in poultry production. In this study, a total of 22 E. coli isolated from colibacillosis field cases and 10 avian faecal E. coli (AFEC) were analysed. All strains were characterised phenotypically by susceptibility testing and molecular typing methods such as pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST). The presence of 29 virulence genes associated to APEC and human extraintestinal pathogenic E. coli (ExPEC) was also evaluated. For cephalosporin resistant isolates, cephalosporin resistance genes, plasmid location and replicon typing was assessed. Avian isolates belonged to 26 O:H serotypes and 24 sequence types. Out of 22 APEC isolates, 91% contained the virulence genes predictors of APEC; iutA, hlyF, iss, iroN and ompT. Of all strains, 34% were considered ExPEC. PFGE analysis demonstrated a high degree of genetic polymorphism. All strains were multi-resistant, including those isolated from healthy animals. Eleven strains were resistant to cephalosporins; six contained bla(CTX-M-14), two bla(SHV-12), two bla(CMY-2) and one bla(SHV-2). Two strains harboured qnrA, and two qnrA together with aac(6')-Ib-cr. Additionally, the emergent clone O25b:H4-B2-ST131 was isolated from a healthy animal which harboured bla(CMY-2) and qnrS genes. Cephalosporin resistant genes were mainly associated to the presence of IncK replicons. This study demonstrates a very diverse population of multi-drug resistant E. coli containing a high number of virulent genes. The E. coli population among broilers is a reservoir of resistance and virulence-associated genes that could be transmitted into the community through the food chain. More epidemiological studies are necessary to identify clonal groups and resistance mechanisms with potential relevance to public health.	[Sola-Gines, Marc; Cameron-Veas, Karla; Badiola, Ignacio; Dolz, Roser; Majo, Natalia; Migura-Garcia, Lourdes] IRTA, CReSA, Barcelona, Spain; [Majo, Natalia] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Cerdanyola Del, Spain; [Dahbi, Ghizlane; Viso, Susana; Mora, Azucena; Blanco, Jorge] Univ Santiago de Compostela, Fac Vet, Dept Microbiol & Parasitol, Lab Referencia E Coli, Lugo, Spain; [Piedra-Carrasco, Nuria; Gonzalez-Lopez, Juan Jose] Univ Autonoma Barcelona, Hosp Vall Hebron, Microbiol Serv, E-08193 Barcelona, Spain	IRTA; Autonomous University of Barcelona; Universidade de Santiago de Compostela; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Migura-Garcia, L (corresponding author), IRTA, CReSA, Campus UAB, Barcelona, Spain.	lourdes.migura@irta.cat	Masferrer, Natàlia Majó/AAV-3696-2021; Migura-Garcia, Lourdes/E-3560-2016; González-López, Juanjo/C-5366-2014; Gutiérrez, Azucena Mora/F-4612-2016; ALVAREZ, JORGE BLANCO/C-7161-2013	Migura-Garcia, Lourdes/0000-0003-2935-928X; González-López, Juanjo/0000-0003-2419-5909; Gutiérrez, Azucena Mora/0000-0002-0785-5795; ALVAREZ, JORGE BLANCO/0000-0003-0264-4136; Viso, Susana/0000-0003-2530-1961	Ministerio de Economia y Competitividad (Espana) [AGL2011-28836, AGL2013-47852-R]; Conselleria de Cultura, Educacion e Ordenacion Universitaria [CN2012/303, EM2014/001]; Xunta de Galicia [CN2012/303, EM2014/001]; European Regional Development Fund, ERDF [CN2012/303, EM2014/001]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA); European Social Fund; Ministerio de Economia y Competitividad (Gobierno de Espana) [AGL2013-47852-R, AGL2011- 28836]	Ministerio de Economia y Competitividad (Espana); Conselleria de Cultura, Educacion e Ordenacion Universitaria; Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Regional Development Fund, ERDF(European Commission); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Social Fund(European Social Fund (ESF)); Ministerio de Economia y Competitividad (Gobierno de Espana)	This work was partially supported by the grants AGL2011-28836 and AGL2013-47852-R from the Ministerio de Economia y Competitividad (Espana) and grants CN2012/303 and EM2014/001 (Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia and the European Regional Development Fund, ERDF). Work from LMG is supported by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the grants AGL2011- 28836 and AGL2013-47852-R from the Ministerio de Economia y Competitividad (Gobierno de Espana) and grants CN2012/303 and EM2014/001 (Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia and the European Regional Development Fund, ERDF).; MSG is a Ph.D. student registered with the Universidad Autonoma de Barcelona. Work from LMG is supported by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) and the European Social Fund.	BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Blanco JE, 1998, VET MICROBIOL, V61, P229, DOI 10.1016/S0378-1135(98)00182-5; Blanco M, 2009, J ANTIMICROB CHEMOTH, V63, P1135, DOI 10.1093/jac/dkp122; Bortolaia V, 2010, ANTIMICROB AGENTS CH, V54, P1623, DOI 10.1128/AAC.01361-09; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chen X, 2012, ANTIMICROB AGENTS CH, V56, P3423, DOI 10.1128/AAC.06191-11; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clinical and Laboratory Standards Institute (CLSI), 2008, AUSTRALIA; Coelho A, 2011, J ANTIMICROB CHEMOTH, V66, P517, DOI 10.1093/jac/dkq491; Coelho A, 2009, J ANTIMICROB CHEMOTH, V64, P862, DOI 10.1093/jac/dkp264; CollignOn P, 2013, EMERG INFECT DIS, V19, P1339, DOI [10.3201/eid1908.120681, 10.3201/eid.1908.120681]; Coque T M, 2008, Euro Surveill, V13; Cortes P, 2010, APPL ENVIRON MICROB, V76, P2799, DOI 10.1128/AEM.02421-09; de Campos TA, 2008, PESQUI VET BRASIL, V28, P533, DOI 10.1590/S0100-736X2008001000015; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dziva F, 2013, INFECT IMMUN, V81, P838, DOI 10.1128/IAI.00585-12; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Gross WB, 1991, DIS POULTRY, P138; Guinee P. A. M., 1981, Laboratory diagnosis in neonatal calf and pig diarrhoea, P126; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Heininger A, 1999, J CLIN MICROBIOL, V37, P2479, DOI 10.1128/JCM.37.8.2479-2482.1999; Johnson JR, 2007, EMERG INFECT DIS, V13, P838, DOI 10.3201/eid1306.061576; Johnson JR, 2003, ANTIMICROB AGENTS CH, V47, P2161, DOI 10.1128/AAC.47.7.2161-2168.2003; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Lopez-Cerero L, 2014, J ANTIMICROB CHEMOTH, V69, P809, DOI 10.1093/jac/dkt405; Maluta RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105016; Manges AR, 2012, CLIN INFECT DIS, V55, P712, DOI 10.1093/cid/cis502; Mora Azucena, 2013, Vet Microbiol, V167, P506, DOI 10.1016/j.vetmic.2013.08.007; Mora A, 2010, APPL ENVIRON MICROB, V76, P6991, DOI 10.1128/AEM.01112-10; MORLEY AJ, 1984, AVIAN DIS, V28, P238, DOI 10.2307/1590147; Nakazato G, 2009, PESQUI VET BRASIL, V29, P479, DOI 10.1590/S0100-736X2009000700001; Novais A, 2012, ANTIMICROB AGENTS CH, V56, P3973, DOI 10.1128/AAC.00475-12; Ozawa M, 2010, J VET MED SCI, V72, P1517, DOI 10.1292/jvms.10-0174; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pires-dos-Santos T, 2013, VET MICROBIOL, V162, P873, DOI 10.1016/j.vetmic.2012.11.008; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Schouler C, 2012, J CLIN MICROBIOL, V50, P1673, DOI 10.1128/JCM.05057-11; Sola-Gines M, 2015, APPL ENVIRON MICROB, V81, P3604, DOI 10.1128/AEM.04252-14; Wang Y, 2010, AVIAN PATHOL, V39, P297, DOI 10.1080/03079457.2010.495742; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	51	60	63	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143191	10.1371/journal.pone.0143191	http://dx.doi.org/10.1371/journal.pone.0143191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600205	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900074
J	Zahawi, RA; Duran, G; Kormann, U				Zahawi, Rakan A.; Duran, Guillermo; Kormann, Urs			Sixty-Seven Years of Land-Use Change in Southern Costa Rica	PLOS ONE			English	Article							RAIN-FOREST VEGETATION; LOS-TUXTLAS; COUNTRYSIDE BIOGEOGRAPHY; LANDSCAPE CHANGES; SPECIES RICHNESS; NATURAL-HISTORY; BIRD ABUNDANCE; LIVE FENCES; DEFORESTATION; FRAGMENTATION	Habitat loss and fragmentation of forests are among the biggest threats to biodiversity and associated ecosystem services in tropical landscapes. We use the vicinity of the Las Cruces Biological Station in southern Costa Rica as a regional case study to document seven decades of land-use change in one of the most intensively studied sites in the Neotropics. Though the premontane wet forest was largely intact in 1947, a wave of immigration in 1952 initiated rapid changes over a short period. Overall forest cover was reduced during each time interval analyzed (1947-1960, 1960-1980, 1980-1997, 1997-2014), although the vast majority of forest loss (> 90%) occurred during the first two time intervals (1947-1960, 1960-1980) with an annual deforestation rate of 2.14% and 3.86%, respectively. The rate dropped to < 2% thereafter and has been offset by forest recovery in fallow areas more recently, but overall forest cover has continued to decline. Approximately 27.9% of the study area is forested currently. Concomitantly, the region shifted from a single contiguous forest to a series of progressively smaller forest fragments with each successive survey. A strong reduction in the amount of core habitat was paralleled by an increased proportion of edge habitat, due to the irregular shape of many forest fragments. Structural connectivity, however, remains high, with an expansive network of > 100 km of linear strips of vegetation within a 3 km radius of the station, which may facilitate landscape-level movement for some species. Despite the extent of forest loss, a substantial number of regional landscape-level studies over the past two decades have demonstrated the persistence of many groups of organisms such as birds and mammals. Nonetheless, the continued decline in the quantity and quality of remaining habitat (similar to 30% of remaining forest is secondary), as well as the threat of an extinction debt (or time lag in species loss), may result in the extirpation of additional species if more proactive conservation measures are not taken to reverse current trends-a pattern that reflects many other tropical regions the world over.	[Zahawi, Rakan A.] Org Trop Studies, Las Cruces Biol Stn, San Vito De Coto Brus, Costa Rica; [Duran, Guillermo] Univ Nacl Costa Rica, Ctr Recursos Hidr Ctr Amer & Caribe, Sede Chorotega, Liberia, Costa Rica; [Kormann, Urs] Univ Gottingen, Dept Agroecol, D-37077 Gottingen, Germany	Universidad Nacional Costa Rica; University of Gottingen	Zahawi, RA (corresponding author), Org Trop Studies, Las Cruces Biol Stn, Apartado 73-8257, San Vito De Coto Brus, Costa Rica.	zahawi@ots.ac.cr	; Zahawi, Rakan/N-1028-2014	Duran Sanabria, Guillermo A./0000-0002-1944-9524; Zahawi, Rakan/0000-0002-5678-2967	Deutsche Forschungsgemeinschaft; Organization for Tropical Studies	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Organization for Tropical Studies	The Organization for Tropical Studies provided funds for data analysis and data acquisition (RZ). The Deutsche Forschungsgemeinschaft provided financial assistance for data analysis (UK).	Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; Aldrich PR, 1998, SCIENCE, V281, P103, DOI 10.1126/science.281.5373.103; Anchukaitis KJ, 2005, PALAEOGEOGR PALAEOCL, V221, P35, DOI 10.1016/j.palaeo.2005.02.003; Austin George T., 1996, Tropical Lepidoptera, V7, P21; Babin N, 2015, AGROECOL SUST FOOD, V39, P99, DOI 10.1080/21683565.2014.960549; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Barnett JR, 2008, CONSERV GENET, V9, P1403, DOI 10.1007/s10592-007-9463-3; Borgella R, 2005, ECOL APPL, V15, P1062, DOI 10.1890/04-0352; Brockett CD, 2002, LAT AM RES REV, V37, P7; Brosi BJ, 2007, ECOL APPL, V17, P418, DOI 10.1890/06-0029; Brosi BJ, 2009, BIOL CONSERV, V142, P414, DOI 10.1016/j.biocon.2008.11.003; Calvo-Alvarado J, 2009, FOREST ECOL MANAG, V258, P931, DOI 10.1016/j.foreco.2008.10.035; Cayuela L, 2006, FOREST ECOL MANAG, V226, P208, DOI 10.1016/j.foreco.2006.01.047; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Clement RM, 2001, HOLOCENE, V11, P419, DOI 10.1191/095968301678302850; Cole-Christensen D, 1997, PLACE RAIN FOREST; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Diaz A, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8101; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; EDELMAN M, 1994, HISPANIC AM HIST REV, V74, P445, DOI 10.2307/2517892; Estrada A, 2000, BIODIVERS CONSERV, V9, P1399, DOI 10.1023/A:1008935016046; Estrada A, 1997, BIODIVERS CONSERV, V6, P19, DOI 10.1023/A:1018328930981; Estrada A, 2001, ECOGRAPHY, V24, P94, DOI 10.1034/j.1600-0587.2001.240111.x; Ewers RM, 2007, CONSERV BIOL, V21, P926, DOI 10.1111/j.1523-1739.2007.00720.x; Ewers RM, 2013, ECOL LETT, V16, P1221, DOI 10.1111/ele.12160; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAO, 2020, GLOBAL FOREST RESOUR; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Frishkoff LO, 2014, SCIENCE, V345, P1343, DOI 10.1126/science.1254610; Fuchs EJ, 2003, CONSERV BIOL, V17, P149, DOI 10.1046/j.1523-1739.2003.01140.x; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gloor M, 2012, BIOGEOSCIENCES, V9, P5407, DOI 10.5194/bg-9-5407-2012; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hadley AS, 2014, ECOLOGY, V95, P2202, DOI 10.1890/13-0929.1; Hadley AS, 2009, BIOL LETTERS, V5, P207, DOI 10.1098/rsbl.2008.0691; HARRISON S, 1991, INTERCIENCIA, V16, P83; Holdridge L.R., 1971, FOREST ENV TROPICAL; Hughes JB, 2002, ECOL LETT, V5, P121, DOI 10.1046/j.1461-0248.2002.00294.x; Huth T, 2012, BIOTROPICA, V44, P661, DOI 10.1111/j.1744-7429.2012.00863.x; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Killeen TJ, 2008, ECOL SOC, V13; Laurance SGW, 2004, CONSERV BIOL, V18, P1099, DOI 10.1111/j.1523-1739.2004.00268.x; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Leon MC, 2006, AGROFOREST SYST, V68, P15, DOI 10.1007/s10457-005-5831-5; Lindell CA, 2006, ANIM CONSERV, V9, P445, DOI 10.1111/j.1469-1795.2006.00060.x; Lindquist E. J., 2012, Global forest land-use change 1990-2005; Manger WF, 1992, COLONIZATION SO FRON; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Mendenhall CD, 2014, ECOLOGY, V95, P856, DOI 10.1890/12-2017.1; Mendenhall CD, 2011, P NATL ACAD SCI USA, V108, P16313, DOI 10.1073/pnas.1111687108; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Meyfroidt P, 2013, CURR OPIN ENV SUST, V5, P438, DOI 10.1016/j.cosust.2013.04.003; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pacheco J, 2006, REV BIOL TROP, V54, P219; Pulido-Santacruz P, 2011, AGROFOREST SYST, V81, P15, DOI 10.1007/s10457-010-9331-x; Reid JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090573; Rickert E., 2005, THESIS; Rosero-Bixby L, 1998, POPUL ENVIRON, V20, P149, DOI 10.1023/A:1023319327838; Ruiz-Gutierrez V, 2008, ECOL APPL, V18, P838, DOI 10.1890/07-1090.1; Ryan MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098351; SADER SA, 1988, BIOTROPICA, V20, P11, DOI 10.2307/2388421; Sanchez- Azofeifa G. A., 2000, QUANTIFYING SUSTAINA, P473; Santos BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012625; Santos-Barrera G, 2008, REV BIOL TROP, V56, P755; SAUER JD, 1979, TURRIALBA, V29, P255; Schlaepfer MA, 2001, CONSERV BIOL, V15, P1079, DOI 10.1046/j.1523-1739.2001.0150041079.x; Sekercioglu CH, 2007, CONSERV BIOL, V21, P482, DOI 10.1111/j.1523-1739.2007.00655.x; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Volpe NL, 2014, ECOL APPL, V24, P2122, DOI 10.1890/13-2168.1; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]	74	56	56	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143554	10.1371/journal.pone.0143554	http://dx.doi.org/10.1371/journal.pone.0143554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599325	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900144
J	Comba, A; Ainnada, LL; Tolosa, EJ; Iguchi, E; Marks, DL; Messler, MV; Silva, R; Fernandez-Barrena, MG; Enriquez-Hesles, E; Vrabel, AL; Botta, B; Di Marcotulio, L; Ellenrieder, V; Eynard, AR; Pasqualini, ME; Fernandez-Zapico, ME				Comba, Andrea; Ainnada, Luciana L.; Tolosa, Ezequiel J.; Iguchi, Eriko; Marks, David L.; Messler, Marianela Vara; Silva, Renata; Fernandez-Barrena, Maite G.; Enriquez-Hesles, Elisa; Vrabel, Anne L.; Botta, Bruno; Di Marcotulio, Lucia; Ellenrieder, Volker; Eynard, Aldo R.; Pasqualini, Maria E.; Fernandez-Zapico, Martin E.			Nuclear Factor of Activated T Cells-dependent Down-regulation of the Transcription Factor Glioma-associated Protein 1 (GLI1) Underlies the Growth Inhibitory Properties of Arachidonic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; GAMMA-LINOLENIC ACID; INDUCED GENE-EXPRESSION; IN-VITRO; CANCER CELLS; MOLECULAR PATHWAYS; SIGNALING PATHWAY; FACTOR-BETA; CYCLIN D1; APOPTOSIS	Numerous reports have demonstrated a tumor inhibitory effect of polyunsaturated fatty acids (PUFAs). However, the molecular mechanisms modulating this phenomenon are in part poorly understood. Here, we provide evidence of a novel antitumoral mechanism of the PUFA arachidonic acid (AA). In vivo and in vitro experiments showed that AA treatment decreased tumor growth and metastasis and increased apoptosis. Molecular analysis of this effect showed significantly reduced expression of a subset of antiapoptotic proteins, including BCL2, BFL1/A1, and 4-1BB, in AA-treated cells. We demonstrated that down-regulation of the transcription factor glioma-associated protein 1 (GLI1) in AA-treated cells is the underlying mechanism controlling BCL2, BFL1/A1, and 4-1BB expression. Using luciferase reporters, chromatin immunoprecipitation, and expression studies, we found that GLI1 binds to the promoter of these antiapoptotic molecules and regulates their expression and promoter activity. We provide evidence that AA-induced apoptosis and down-regulation of antiapoptotic genes can be inhibited by overexpressing GLI1 in AA-sensitive cells. Conversely, inhibition of GLI1 mimics AA treatments, leading to decreased tumor growth, cell viability, and expression of antiapoptotic molecules. Further characterization showed that AA represses GLI1 expression by stimulating nuclear translocation of NFATc1, which then binds the GLI1 promoter and represses its transcription. AA was shown to increase reactive oxygen species. Treatment with antioxidants impaired the AA-induced apoptosis and down-regulation of GLI1 and NFATc1 activation, indicating that NFATc1 activation and GLI1 repression require the generation of reactive oxygen species. Collectively, these results define a novel mechanism underlying AA antitumoral functions that may serve as a foundation for future PUFA-based therapeutic approaches.	[Comba, Andrea; Ainnada, Luciana L.; Tolosa, Ezequiel J.; Iguchi, Eriko; Marks, David L.; Fernandez-Barrena, Maite G.; Enriquez-Hesles, Elisa; Vrabel, Anne L.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA; [Comba, Andrea; Messler, Marianela Vara; Silva, Renata; Eynard, Aldo R.; Pasqualini, Maria E.] Univ Nacl Cordoba, Inst lnvest Ciencias Salud, Consejo Nacl lnvest Cient & Tecn, Ciudad Univ, RA-5000 Cordoba, Argentina; [Comba, Andrea; Messler, Marianela Vara; Silva, Renata; Eynard, Aldo R.; Pasqualini, Maria E.] Univ Nacl Cordoba, Fac Ciencias, Ciudad Univ, RA-5000 Cordoba, Argentina; [Botta, Bruno] Univ Roma La Sapienza, Ctr Life Nano Sci Sapienza, Ist Italiano Tecnol, Dipartimento Chim & Tecnol Farmaco, Rome, Italy; [Di Marcotulio, Lucia] Univ Roma La Sapienza, Dept Mol Med, Pasteur lnst, Cenci Bolognetti Fdn, I-00161 Rome, Italy; [Ellenrieder, Volker] Univ Med Ctr Gottingen, Gastroenterol & Gastrointestinal Oncol, D-37075 Gottingen, Germany; [Comba, Andrea] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	Mayo Clinic; National University of Cordoba; National University of Cordoba; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Gottingen; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu	Fernandez-Barrena, Maite G/J-8040-2014; Tolosa, Ezequiel J/AAD-9799-2019; Messler, Marianela Vara/AAB-7729-2020	Fernandez-Barrena, Maite G/0000-0003-0375-6236; Tolosa, Ezequiel J/0000-0001-5167-0782; Messler, Marianela Vara/0000-0003-0493-7071; Botta, Bruno/0000-0001-8707-4333	National Institutes of Health from the NCI [CA136526]; National Institutes of Health through the Mayo Clinic Pancreatic Specialized Program of Research Excellence [P50 CA102701]; National Institutes of Health through the Mayo Clinic Center for Cell Signaling in Gastroenterology [P30 DK84567]; Consejo Nacional de Investigaciones Cientificas y Tecnicas-Argentina (CONICET)-PIP [11220080103014, 11220110101010]; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba-Argentina (SECYT-UNC) [214/10]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA136526, P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM075148, R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health through the Mayo Clinic Pancreatic Specialized Program of Research Excellence; National Institutes of Health through the Mayo Clinic Center for Cell Signaling in Gastroenterology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones Cientificas y Tecnicas-Argentina (CONICET)-PIP; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba-Argentina (SECYT-UNC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health Grants CA136526 from the NCI, P50 CA102701 through the Mayo Clinic Pancreatic Specialized Program of Research Excellence, and P30 DK84567 through the Mayo Clinic Center for Cell Signaling in Gastroenterology (to M. E. F.-Z.), Consejo Nacional de Investigaciones Cientificas y Tecnicas-Argentina (CONICET)-PIP 2009-2011 Grant 11220080103014 and (CONICET)-PIP 2012-2014 Grant 11220110101010 (to A. R. E.), and Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba-Argentina (SECYT-UNC) Grants 214/10 (to M. E. P.). The authors have declared that no conflict of interest exists. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arita K, 2001, BIOCHEM PHARMACOL, V62, P821, DOI 10.1016/S0006-2952(01)00723-7; Azrad M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00224; Bakshi A, 2003, NUTRITION, V19, P305, DOI 10.1016/S0899-9007(02)00862-6; Baumgart S, 2014, CANCER DISCOV, V4, P688, DOI 10.1158/2159-8290.CD-13-0593; Baumgart S, 2012, GASTROENTEROLOGY, V142, P388, DOI 10.1053/j.gastro.2011.11.001; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Bocca C, 2008, BRIT J NUTR, V100, P739, DOI 10.1017/S0007114508942161; Comba A, 2009, PANCREATOLOGY, V9, P724, DOI 10.1159/000235623; Comba A, 2011, CANCER METAST REV, V30, P325, DOI 10.1007/s10555-011-9308-x; Dahm CC, 2012, AM J CLIN NUTR, V96, P1354, DOI 10.3945/ajcn.112.034157; Dai JF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-71; DAS UN, 1995, CANCER LETT, V94, P147, DOI 10.1016/0304-3835(95)03844-M; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Das UN, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-159; de Lorgeril M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-50; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dymkowska D, 2009, ACTA BIOCHIM POL, V56, P711; Elsawa SF, 2011, J BIOL CHEM, V286, P21524, DOI 10.1074/jbc.M111.234146; Eynard AR, 2013, NUTRITION, V29, P930, DOI 10.1016/j.nut.2012.12.014; FALCONER JS, 1994, BRIT J CANCER, V69, P826, DOI 10.1038/bjc.1994.161; Farago N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-173; Fenton JI, 2013, PROSTAG LEUKOTR ESS, V89, P379, DOI 10.1016/j.plefa.2013.09.011; Foy KC, 2012, ONCOIMMUNOLOGY, V1, P1004, DOI 10.4161/onci.21057; Fukui M, 2013, J CELL BIOCHEM, V114, P192, DOI 10.1002/jcb.24354; GARDELL SJ, 1983, J BIOL CHEM, V258, P6198; Giamarellos-Bourboulis EJ, 2002, PROSTAG LEUKOTR ESS, V67, P57, DOI 10.1054/plef.2002.0382; Gleissman H, 2010, EXP CELL RES, V316, P1365, DOI 10.1016/j.yexcr.2010.02.039; Gong PF, 2006, J BIOL CHEM, V281, P14573, DOI 10.1074/jbc.M600613200; Gurda GT, 2008, MOL BIOL CELL, V19, P198, DOI 10.1091/mbc.E07-05-0430; Hammamieh R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-138; HICKS M, 1979, ANAL BIOCHEM, V99, P249, DOI 10.1016/S0003-2697(79)80003-2; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Hughes-Fulford M, 2006, CANCER RES, V66, P1427, DOI 10.1158/0008-5472.CAN-05-0914; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Konig A, 2010, PANCREATOLOGY, V10, P416, DOI 10.1159/000315035; Kundumani-Sridharan V, 2012, J BIOL CHEM, V287, P22463, DOI 10.1074/jbc.M112.362996; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Leaver HA, 2002, PROSTAG LEUKOTR ESS, V67, P283, DOI 10.1054/plef.2002.0431; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Liu WH, 2009, TOXICOL LETT, V191, P140, DOI 10.1016/j.toxlet.2009.08.016; Lo Re AE, 2012, J BIOL CHEM, V287, P25325, DOI 10.1074/jbc.M112.370809; Lu J, 2008, AM J PHYSIOL-GASTR L, V294, pG1181, DOI 10.1152/ajpgi.00343.2007; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Miyake JA, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-8; Monjazeb AM, 2006, CARCINOGENESIS, V27, P1950, DOI 10.1093/carcin/bgl023; NARIAI T, 1993, CLIN EXP METASTAS, V11, P141, DOI 10.1007/BF00114972; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Nye MD, 2014, J BIOL CHEM, V289, P15495, DOI 10.1074/jbc.M113.545194; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; Oraldi M, 2009, J ONCOL, V2009, DOI 10.1155/2009/867915; Pasqualini ME, 2008, CURR NUTR FOOD SCI, V4, P161, DOI 10.2174/157340108785133356; Prasad A, 2010, J CELL PHYSIOL, V225, P829, DOI 10.1002/jcp.22290; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Salem ML, 2005, INT IMMUNOPHARMACOL, V5, P947, DOI 10.1016/j.intimp.2004.12.013; Sandrone SS, 2014, NUTRITION, V30, P1104, DOI 10.1016/j.nut.2014.01.009; Schonfeld P, 2011, J NEUROCHEM, V118, P69, DOI 10.1111/j.1471-4159.2011.07286.x; Senft D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030821; Shaikh IAA, 2010, NUTR CANCER, V62, P284, DOI 10.1080/01635580903407189; SIEGEL I, 1987, J NATL CANCER I, V78, P271; Soria EA, 2007, LIFE SCI, V81, P1397, DOI 10.1016/j.lfs.2007.09.008; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Urtreger AJ, 1997, INT J ONCOL, V11, P489; Wang WC, 2014, PROSTAG OTH LIPID M, V113, P13, DOI 10.1016/j.prostaglandins.2014.07.002; Yang X, 2014, J PHARM SCI-US, V103, P305, DOI 10.1002/jps.23800; Yin HY, 2013, MITOCHONDRION, V13, P209, DOI 10.1016/j.mito.2012.10.003; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030	73	14	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1933	1947		10.1074/jbc.M115.691972	http://dx.doi.org/10.1074/jbc.M115.691972			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26601952	Green Published, hybrid			2022-12-26	WOS:000368620700031
J	Kwon, MJ; Park, J; Jang, S; Eom, CY; Oh, ES				Kwon, Mi-Jung; Park, Jisu; Jang, Sinae; Eom, Chi-Yong; Oh, Eok-Soo			The Conserved Phenylalanine in the Transmembrane Domain Enhances Heteromeric Interactions of Syndecans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; GROWTH-FACTOR; HETEROTYPIC INTERACTIONS; TYROSINE KINASES; RECEPTOR; CANCER; OLIGOMERIZATION; DIMERIZATION; HELICES; PROTEIN	The transmembrane domain (TMD) of the syndecans, a family of transmembrane heparin sulfate proteoglycans, is involved in forming homo-and heterodimers and oligomers that transmit signaling events. Recently, we reported that the unique phenylalanine in TMD positively regulates intramolecular interactions of syndecan-2. Besides the unique phenylalanine, syndecan-2 contains a conserved phenylalanine (SDC2-Phe-169) that is present in all syndecan TMDs, but its function has not been determined. We therefore investigated the structural role of SDC2-Phe-169 in syndecan TMDs. Replacement of SDC2-Phe-169 by tyrosine (S2F169Y) did not affect SDS-resistant homodimer formation but significantly reduced SDS-resistant heterodimer formation between syndecan-2 and -4, suggesting that SDC2-Phe-169 is involved in the heterodimerization/oligomerization of syndecans. Similarly, in an in vitro binding assay, a syndecan-2 mutant (S2(F169Y)) showed a significantly reduced interaction with syndecan-4. FRET assays showed that heteromolecular interactions between syndecan-2 and -4 were reduced in HEK293T cells transfected with S2(F169Y) compared with syndecan-2. Moreover, S2(F169Y) reduced downstream reactions mediated by the heterodimerization of syndecan-2 and -4, including Rac activity, cell migration, membrane localization of PKC alpha, and focal adhesion formation. The conserved phenylalanine in syndecan-1 and -3 also showed heterodimeric interaction with syndecan-2 and -4. Taken together, these findings suggest that the conserved phenylalanine in the TMD of syndecans is crucial in regulating heteromeric interactions of syndecans.	[Kwon, Mi-Jung; Park, Jisu; Oh, Eok-Soo] Ewha Womans Univ, Res Ctr Cellular Homeostasis, Dept Life Sci, Seoul 120750, South Korea; [Jang, Sinae; Eom, Chi-Yong] Korea Basic Sci Inst, Seoul Ctr, Seoul 136075, South Korea	Ewha Womans University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 120750, South Korea.	OhES@ewha.ac.kr			National Research Foundation of Korea - Korean government (MSIP) [2012R1A5A1048236, 2013R1A2A2A01013565]	National Research Foundation of Korea - Korean government (MSIP)	This work was supported by National Research Foundation of Korea grants 2012R1A5A1048236 and 2013R1A2A2A01013565 funded by the Korean government (MSIP). The authors declare that they have no conflicts of interest with the contents of this article.	Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Campbell K S, 1994, Semin Immunol, V6, P393, DOI 10.1006/smim.1994.1049; Carey DJ, 1997, BIOCHEM J, V327, P1; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Choi Y, 2015, J BIOL CHEM, V290, P16943, DOI 10.1074/jbc.M114.611798; Choi Y, 2010, BIOCHEM BIOPH RES CO, V391, P921, DOI 10.1016/j.bbrc.2009.11.165; Cymer F, 2010, CELL ADHES MIGR, V4, P299, DOI 10.4161/cam.4.2.11191; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Escher C, 2009, J MOL BIOL, V389, P10, DOI 10.1016/j.jmb.2009.04.002; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Hecker TP, 2002, CANCER RES, V62, P2699; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HELDIN CH, 1992, KIDNEY INT, V41, P571, DOI 10.1038/ki.1992.84; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; Johnson RM, 2007, BIOCHEMISTRY-US, V46, P9208, DOI 10.1021/bi7008773; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kwon MJ, 2015, J BIOL CHEM, V290, P5772, DOI 10.1074/jbc.M114.599845; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; Lee H, 2011, BIOCHEM BIOPH RES CO, V409, P148, DOI 10.1016/j.bbrc.2011.04.135; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Okolicsanyi RK, 2014, J CELL BIOCHEM, V115, P967, DOI 10.1002/jcb.24746; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ortega DR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3881; Pallitto MM, 1999, BIOCHEMISTRY-US, V38, P3570, DOI 10.1021/bi982119e; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Ryu HY, 2009, J BIOL CHEM, V284, P35692, DOI 10.1074/jbc.M109.054254; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; Sawma P, 2014, J MOL BIOL, V426, P4099, DOI 10.1016/j.jmb.2014.10.007; Schlesinger TK, 1999, BIOCHEM J, V344, P519, DOI 10.1042/0264-6021:3440519; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Yamashita H, 2015, BBA-BIOMEMBRANES, V1848, P1359, DOI 10.1016/j.bbamem.2015.03.004; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121513	39	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					872	881		10.1074/jbc.M115.685040	http://dx.doi.org/10.1074/jbc.M115.685040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26601939	Green Published, hybrid			2022-12-26	WOS:000367830500033
J	Simon, K; Hennen, S; Merten, N; Blattermann, S; Gillard, M; Kostenis, E; Gomeza, J				Simon, Katharina; Hennen, Stephanie; Merten, Nicole; Blaettermann, Stefanie; Gillard, Michel; Kostenis, Evi; Gomeza, Jesus			The Orphan G Protein-coupled Receptor GPR17 Negatively Regulates Oligodendrocyte Differentiation via G alpha(i/o) and Its Downstream Effector Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; NUCLEOTIDE-EXCHANGE FACTOR; ELEMENT-BINDING PROTEIN; CYCLIC-AMP; KINASE-C; PRECURSOR DIFFERENTIATION; CELL-DIFFERENTIATION; SIGNALING PATHWAYS; AXON GROWTH; MAP KINASE	Recent studies have recognized G protein-coupled receptors as important regulators of oligodendrocyte development. GPR17, in particular, is an orphan G protein-coupled receptor that has been identified as oligodendroglial maturation inhibitor because its stimulation arrests primary mouse oligodendrocytes at a less differentiated stage. However, the intracellular signaling effectors transducing its activation remain poorly understood. Here, we use Oli-neu cells, an immortalized cell line derived from primary murine oligodendrocytes, and primary rat oligodendrocyte cultures as model systems to identify molecular targets that link cell surface GPR17 to oligodendrocyte maturation blockade. We demonstrate that stimulation of GPR17 by the small molecule agonist MDL29,951 (2-carboxy-4,6-dichloro-1H-indole-3-propionic acid) decreases myelin basic protein expression levels mainly by triggering the G alpha(i/o) signaling pathway, which in turn leads to reduced activity of the downstream cascade adenylyl cyclase-cAMP-PKA-cAMP response element-binding protein (CREB). In addition, we show that GPR17 activation also diminishes myelin basic protein abundance by lessening stimulation of the exchange protein directly activated by cAMP (EPAC), thus uncovering a previously unrecognized role for EPAC to regulate oligodendrocyte differentiation. Together, our data establish PKA and EPAC as key downstream effectors of GPR17 that inhibit oligodendrocyte maturation. We envisage that treatments augmenting PKA and/or EPAC activity represent a beneficial approach for therapeutic enhancement of remyelination in those demyelinating diseases where GPR17 is highly expressed, such as multiple sclerosis.	[Simon, Katharina; Hennen, Stephanie; Merten, Nicole; Blaettermann, Stefanie; Kostenis, Evi; Gomeza, Jesus] Univ Bonn, Inst Pharmaceut Biol, Sect Mol Cellular & Pharmacobiol, D-53115 Bonn, Germany; [Gillard, Michel] CNS Res, UCB Pharma, B-1420 Braine Lalleud, Belgium	University of Bonn; UCB Pharma SA	Kostenis, E (corresponding author), Univ Bonn, Inst Pharmaceut Biol, Sect Mol Cellular & Pharmacobiol, D-53115 Bonn, Germany.	kostenis@uni-bonn.de; jgomeza@uni-bonn.de			German Federal Ministry for Education and Research (BMBF) within the BioPharma Initiative "Neuroallianz" [1615609B]; German Research Foundation (DFG) [RTG1873]	German Federal Ministry for Education and Research (BMBF) within the BioPharma Initiative "Neuroallianz"(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the German Federal Ministry for Education and Research (BMBF) within the BioPharma Initiative "Neuroallianz" (Grant 1615609B; to E. K.). K. S. is a member of the German Research Foundation (DFG)-funded Research Training Group RTG1873. The authors declare that they have no conflicts of interest with the contents of this article.; K. S. is a member of the German Research Foundation (DFG)-funded Research Training Group RTG1873.	Ackerman SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7122; Afshari FS, 2001, J NEUROSCI RES, V66, P37, DOI 10.1002/jnr.1195; Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; Baron W, 2000, J NEUROSCI RES, V59, P74, DOI 10.1002/(SICI)1097-4547(20000101)59:1<74::AID-JNR9>3.0.CO;2-P; Bhat NR, 2007, NEUROCHEM RES, V32, P293, DOI 10.1007/s11064-006-9274-9; Bhat NR, 1996, J NEUROCHEM, V66, P1986; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Chepurny OG, 2013, MOL ENDOCRINOL, V27, P1267, DOI 10.1210/me.2013-1029; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Corredor RG, 2012, J NEUROSCI, V32, P7734, DOI 10.1523/JNEUROSCI.5288-11.2012; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fratangeli A, 2013, J BIOL CHEM, V288, P5241, DOI 10.1074/jbc.M112.404996; Fyffe-Maricich SL, 2011, J NEUROSCI, V31, P843, DOI 10.1523/JNEUROSCI.3239-10.2011; Gobert RP, 2009, MOL CELL BIOL, V29, P1538, DOI 10.1128/MCB.01375-08; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Hedegaard ER, 2014, EUR J PHARMACOL, V723, P216, DOI 10.1016/j.ejphar.2013.11.029; Hennen S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004350; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; JENSEN NA, 1993, J NEUROSCI RES, V35, P288, DOI 10.1002/jnr.490350308; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kankaanranta H, 2011, PULM PHARMACOL THER, V24, P394, DOI 10.1016/j.pupt.2011.03.002; Kremer D, 2011, ANN NEUROL, V69, P602, DOI 10.1002/ana.22415; Kwak HJ, 2008, CELL SIGNAL, V20, P803, DOI 10.1016/j.cellsig.2007.12.011; Laursen LS, 2007, NEURON GLIA BIOL, V3, P367, DOI 10.1017/S1740925X08000161; McNulty S, 2001, NEUROSCI RES, V41, P217, DOI 10.1016/S0168-0102(01)00280-2; Medina-Rodriguez EM, 2013, CELL MOL LIFE SCI, V70, P3449, DOI 10.1007/s00018-013-1340-2; Meffre D, 2015, NEUROSCIENCE, V284, P962, DOI 10.1016/j.neuroscience.2014.10.064; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Mir F, 2008, MOL CELL BIOL, V28, P6329, DOI 10.1128/MCB.00482-08; Mironov SL, 2011, J NEUROCHEM, V117, P295, DOI 10.1111/j.1471-4159.2011.07202.x; Murray AJ, 2008, MOL CELL NEUROSCI, V38, P578, DOI 10.1016/j.mcn.2008.05.006; Murray AJ, 2009, J NEUROSCI, V29, P15434, DOI 10.1523/JNEUROSCI.3071-09.2009; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Parnell E, 2015, TRENDS PHARMACOL SCI, V36, P203, DOI 10.1016/j.tips.2015.02.003; Pende M, 1997, J NEUROSCI, V17, P1291; PLEASURE D, 1986, J NEUROCHEM, V46, P300, DOI 10.1111/j.1471-4159.1986.tb12963.x; Qi AD, 2013, J PHARMACOL EXP THER, V347, P38, DOI 10.1124/jpet.113.207647; RAIBLE DW, 1990, J NEUROSCI RES, V27, P43, DOI 10.1002/jnr.490270107; Roberts OL, 2014, BIOCHEM SOC T, V42, P89, DOI 10.1042/BST20130253; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; SatoBigbee C, 1996, J NEUROSCI RES, V46, P98, DOI 10.1002/(SICI)1097-4547(19961001)46:1<98::AID-JNR12>3.0.CO;2-8; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Syed YA, 2013, EMBO MOL MED, V5, P1918, DOI 10.1002/emmm.201303123; VARTANIAN T, 1986, SCIENCE, V234, P1395, DOI 10.1126/science.2431483; Wiemelt AP, 1997, J BIOL CHEM, V272, P31489, DOI 10.1074/jbc.272.50.31489; Xiao L, 2012, GLIA, V60, P1037, DOI 10.1002/glia.22333; Zieba BJ, 2011, J BIOL CHEM, V286, P16681, DOI 10.1074/jbc.M110.205062	60	52	55	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					705	718		10.1074/jbc.M115.683953	http://dx.doi.org/10.1074/jbc.M115.683953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26620557	Green Published, hybrid			2022-12-26	WOS:000367830500019
J	Boag, AM; Christie, MR; McLaughlin, KA; Syme, HM; Graham, P; Catchpole, B				Boag, Alisdair M.; Christie, Michael R.; McLaughlin, Kerry A.; Syme, Harriet M.; Graham, Peter; Catchpole, Brian			Autoantibodies against Cytochrome P450 Side-Chain Cleavage Enzyme in Dogs (Canis lupus familiaris) Affected with Hypoadrenocorticism (Addison's Disease)	PLOS ONE			English	Article							AUTOIMMUNE POLYGLANDULAR SYNDROME; ADRENAL-CORTEX AUTOANTIBODIES; MHC CLASS-II; STEROID 21-HYDROXYLASE; THYROID PEROXIDASE; CANDIDATE GENES; APS-I; THYROGLOBULIN; AUTOANTIGENS; ASSOCIATION	Canine hypoadrenocorticism likely arises from immune-mediated destruction of adrenocortical tissue, leading to glucocorticoid and mineralocorticoid deficiency. In humans with autoimmune Addison's disease (AAD) or autoimmune polyendocrine syndrome (APS), circulating autoantibodies have been demonstrated against enzymes associated with adrenal steroid synthesis. The current study investigates autoantibodies against steroid synthesis enzymes in dogs with spontaneous hypoadrenocorticism. Coding regions of canine CYP21A2 (21-hydroxylase; 21-OH), CYP17A1 (17-hydroxylase; 17-OH), CYP11A1 (P450 side-chain cleavage enzyme; P450scc) and HSD3B2 (3 beta hydroxysteroid dehydrogenase; 3 beta HSD) were amplified, cloned and expressed as S-35-methionine radiolabelled recombinant protein. In a pilot study, serum samples from 20 dogs with hypoadrenocorticism and four unaffected control dogs were screened by radio-immunoprecipitation assay. There was no evidence of reactivity against 21-OH, 17-OH or 3 beta HSD, but five dogs with hypoadrenocorticism showed immunoreactivity to P450scc compared with controls. Serum samples were subsequently obtained from 213 dogs diagnosed with hypoadrenocorticism and 110 dogs from a hospital control population. Thirty control dogs were randomly selected to establish a threshold for antibody positivity (mean + 3 x standard deviation). Dogs with hypoadrenocorticism were more likely to be P450scc autoantibody positive than hospital controls (24% vs. 1.2%, respectively; p = 0.0016). Sex was significantly associated with the presence of P450scc autoantibodies in the case population, with 30% of females testing positive compared with 17% of males (p = 0.037). Significant associations with breed (p = 0.015) and DLA-type (DQA1*006: 01 allele; p = 0.017) were also found. This cross-sectional study indicates that P450scc autoantibodies are present in a proportion of dogs affected with hypoadrenocorticism.	[Boag, Alisdair M.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland; [Christie, Michael R.; McLaughlin, Kerry A.] Kings Coll London, Div Diabet & Nutr Sci, London WC2R 2LS, England; [Christie, Michael R.] Lincoln Univ, Sch Life Sci, Lincoln, England; [Syme, Harriet M.] Univ London Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Graham, Peter] Univ Nottingham, Fac Med & Hlth Sci, Loughborough, Leics, England; [Catchpole, Brian] Univ London Royal Vet Coll, Dept Pathol & Pathogen Biol, Hatfield, Herts, England	University of Edinburgh; University of London; King's College London; University of Lincoln; University of London; University of London Royal Veterinary College; University of Nottingham; University of London; University of London Royal Veterinary College	Catchpole, B (corresponding author), Univ London Royal Vet Coll, Dept Pathol & Pathogen Biol, Hawkshead Lane, Hatfield, Herts, England.	bcatchpole@rvc.ac.uk	Graham, Peter/AAG-2950-2019; McLaughlin, Kerry/H-4173-2016	Graham, Peter/0000-0001-7133-1358; McLaughlin, Kerry/0000-0002-5909-2160; Boag, Alisdair/0000-0002-3819-1821; Syme, Harriet/0000-0002-0967-4031	Biotechnology and Biological Sciences Research Council as an industrial CASE PhD studentship [BB/G0169921]; Dechra Ltd.; Petplan Charitable Trust [09-04]	Biotechnology and Biological Sciences Research Council as an industrial CASE PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dechra Ltd.; Petplan Charitable Trust	This study was supported by the Biotechnology and Biological Sciences Research Council as an industrial CASE PhD studentship (Grant number: BB/G0169921), with Dechra Ltd. as the industrial partner. Co-funding was generously provided by the Petplan Charitable Trust (Grant number: 09-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adissu HA, 2010, VET PATHOL, V47, P1082, DOI 10.1177/0300985810382520; Adler JA, 2007, J VET INTERN MED, V21, P1168, DOI 10.1892/06-270.1; ANDERSON JR, 1957, LANCET, V1, P1123; [Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Arase M, 2006, BIOCHEM BIOPH RES CO, V344, P400, DOI 10.1016/j.bbrc.2006.03.067; Baker PR, 2011, J CLIN ENDOCR METAB, V96, P2154, DOI 10.1210/jc.2010-2964; BEDNAREK J, 1992, FEBS LETT, V309, P51, DOI 10.1016/0014-5793(92)80737-2; Bellumori TP, 2013, JAVMA-J AM VET MED A, V242, P1549, DOI 10.2460/javma.242.11.1549; Betterle C, 2005, BEST PRACT RES CL EN, V19, P85, DOI 10.1016/j.beem.2004.11.008; Betterle C, 1999, J CLIN ENDOCR METAB, V84, P618, DOI 10.1210/jc.84.2.618; Betterle C, 2002, ENDOCR REV, V23, P327, DOI 10.1210/er.23.3.327; BLIZZARD RM, 1963, J CLIN INVEST, V42, P1653, DOI 10.1172/JCI104851; Boag AM, 2014, TOP COMPANION ANIM M, V29, P96, DOI 10.1053/j.tcam.2015.01.001; BOUJON CE, 1994, J COMP PATHOL, V111, P287, DOI 10.1016/S0021-9975(05)80007-6; BOWEN D, 1986, J AM ANIM HOSP ASSOC, V22, P649; Chase K, 2006, INT J IMMUNOGENET, V33, P179, DOI 10.1111/j.1744-313X.2006.00593.x; Cihakova D, 2001, HUM MUTAT, V18, P225, DOI 10.1002/humu.1178; Dal Pra C, 2003, EUR J ENDOCRINOL, V148, P565, DOI 10.1530/eje.0.1480565; Davison LJ, 2008, VET IMMUNOL IMMUNOP, V126, P83, DOI 10.1016/j.vetimm.2008.06.016; Davison LJ, 2004, CANINE DIABETES MELL; Davison LJ, 2011, RES VET SCI, V91, P58, DOI 10.1016/j.rvsc.2010.08.007; Devendra D, 2004, CLIN LAB MED, V24, P275, DOI 10.1016/j.cll.2004.01.012; Dixon RM, 1999, RES VET SCI, V66, P243, DOI 10.1053/rvsc.1998.0268; Erichsen MM, 2009, J CLIN ENDOCR METAB, V94, P4882, DOI 10.1210/jc.2009-1368; Falorni A, 2002, FERTIL STERIL, V78, P270, DOI 10.1016/S0015-0282(02)03205-3; Falorni A, 2011, CLIN IMMUNOL, V140, P291, DOI 10.1016/j.clim.2011.04.012; Famula TR, 2003, J SMALL ANIM PRACT, V44, P8, DOI 10.1111/j.1748-5827.2003.tb00096.x; Frank CB, 2013, J COMP PATHOL, V149, P268, DOI 10.1016/j.jcpa.2012.11.242; Graham PA, 2007, VET CLIN N AM-SMALL, V37, P617, DOI 10.1016/j.cvsm.2007.05.002; HADLOW WJ, 1953, AM J PATHOL, V29, P353; Hughes AM, 2010, TISSUE ANTIGENS, V75, P684, DOI 10.1111/j.1399-0039.2010.01440.x; Hughes AM, 2007, JAVMA-J AM VET MED A, V231, P407, DOI 10.2460/javma.231.3.407; Hughes AM, 2011, VET J, V187, P212, DOI 10.1016/j.tvjl.2009.10.012; Husebye E, 2009, BEST PRACT RES CL EN, V23, P147, DOI 10.1016/j.beem.2008.09.004; Kelch WJ., 1996, CANINE HYPOADRENOCOR; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P82, DOI 10.1111/j.1399-0039.2006.00614.x; Kennedy LJ, 2002, TISSUE ANTIGENS, V59, P194, DOI 10.1034/j.1399-0039.2002.590303.x; Kooistra HS, 2012, TOP COMPANION ANIM M, V27, P21, DOI 10.1053/j.tcam.2012.06.001; Labelle P, 2005, VET PATHOL, V42, P52, DOI 10.1354/vp.42-1-52; Lleo A, 2010, AUTOIMMUN REV, V9, pA259, DOI 10.1016/j.autrev.2009.12.002; Luu-The V, 2005, J STEROID BIOCHEM, V93, P269, DOI 10.1016/j.jsbmb.2005.01.003; Massey J, 2013, IMMUNOGENETICS, V65, P291, DOI 10.1007/s00251-013-0680-2; McLachlan SM, 2007, THYROID, V17, P939, DOI 10.1089/thy.2007.0169; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mitchell AL, 2012, NAT REV ENDOCRINOL, V8, P306, DOI [10.1038/nrendo.2012.74, 10.1038/nrendo.2012.200, 10.1038/nrendo.2012.56, 10.1038/nrendo.2012.127, 10.1038/nrendo.2012.186, 10.1038/nrendo.2011.245]; Myhre AG, 2001, CLIN ENDOCRINOL, V54, P211, DOI 10.1046/j.1365-2265.2001.01201.x; Nachreiner RF, 1998, AM J VET RES, V59, P951; Nachreiner RMF, 2002, J AM VET MED ASSOC, V220, P466, DOI 10.2460/javma.2002.220.466; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; Oberbauer A M, 2006, BMC Vet Res, V2, P15, DOI 10.1186/1746-6148-2-15; PATNAIK AK, 1989, J AM ANIM HOSP ASSOC, V25, P103; Patzl M, 2003, J VET MED A, V50, P72, DOI 10.1046/j.1439-0442.2003.00491.x; Perniola R, 2000, EUR J ENDOCRINOL, V143, P497, DOI 10.1530/eje.0.1430497; Peterson ME, 1996, J AM VET MED ASSOC, V208, P85; Peterson P, 1997, CLIN EXP IMMUNOL, V107, P335, DOI 10.1111/j.1365-2249.1997.282-ce1175.x; Piechotta M, 2010, J VET SCI, V11, P191, DOI 10.4142/jvs.2010.11.3.191; Reimand K, 2000, J CLIN ENDOCR METAB, V85, P2324, DOI 10.1210/jc.85.6.2324; Rick M, 2013, THE MEASUREMENT OF 2; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; SCHAER M, 1986, J AM ANIM HOSP ASSOC, V22, P789; Scott EE, 2001, ARCH BIOCHEM BIOPHYS, V395, P57, DOI 10.1006/abbi.2001.2574; Scott-Moncrieff JC, 2015, CANINE FELINE ENDOCR, V4th, P485; Short AD, 2014, VET REC, V175, DOI 10.1136/vr.102160; Short AD, 2013, J HERED, V104, P807, DOI 10.1093/jhered/est051; Silva RD, 2000, EUR J ENDOCRINOL, V142, P187, DOI 10.1530/eje.0.1420187; Skopek E, 2006, AM J VET RES, V67, P809, DOI 10.2460/ajvr.67.5.809; Summers JF, 2010, VET J, V183, P39, DOI 10.1016/j.tvjl.2009.11.002; Thompson AL, 2007, JAVMA-J AM VET MED A, V230, P1190, DOI 10.2460/javma.230.8.1190; UIBO R, 1994, J AUTOIMMUN, V7, P399, DOI 10.1006/jaut.1994.1029; Van LT, 2013, J STEROID BIOCHEM, V137, P176, DOI 10.1016/j.jsbmb.2013.05.017; Watson ADJ, 1998, AUST VET J, V76, P255, DOI 10.1111/j.1751-0813.1998.tb10153.x; Wilbe M, 2012, REPROD DOMEST ANIM, V47, P27, DOI 10.1111/j.1439-0531.2011.01962.x	73	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143458	10.1371/journal.pone.0143458	http://dx.doi.org/10.1371/journal.pone.0143458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618927	Green Published, Green Accepted, gold			2022-12-26	WOS:000365889800038
J	Steffani, N; Sedick, S; Rogers, J; Gibbons, MJ				Steffani, Nina; Sedick, Safiyya; Rogers, John; Gibbons, Mark John			Infaunal Benthic Communities from the Inner Shelf off Southwestern Africa Are Characterised by Generalist Species	PLOS ONE			English	Article							OXYGEN MINIMUM ZONE; BENGUELA ECOSYSTEM; WEST-COAST; SEDIMENT RELATIONSHIPS; CALLIANASSA-KRAUSSI; SOUTHERN AFRICA; BIODIVERSITY; RICHNESS; DIVERSITY; PATTERNS	Infaunal communities of benthic macro-organisms (> 1mm length) were studied from 81 samples collected across nine sites to the north and south of the Orange River in the Benguela upwelling ecosystem in 2003, with a view to describing communities and understanding the drivers of regional community structure, as well as to document diversity and to examine geographic affinities. Although the fauna was dominated by polychaetes and peracarid crustaceans, patterns in community structure could only weakly be explained by the measured environment (similar to 35%). This is attributed to the generalist nature of the species recovered, which were widely distributed amongst different sediments, water-depths and latitudes. The fauna is dominated by species that enjoy a widespread regional and global distribution and is characterised by relatively low diversity, which is discussed.	[Sedick, Safiyya; Gibbons, Mark John] Univ Western Cape, Dept Biodivers & Conservat Biol, ZA-7535 Bellville, South Africa	University of the Western Cape	Gibbons, MJ (corresponding author), Univ Western Cape, Dept Biodivers & Conservat Biol, ZA-7535 Bellville, South Africa.	mgibbons@uwc.ac.za			National Research Foundation (ZA); University of the Western Cape (ZA); De Beers Marine Namibia, Namdeb and De Beers Marine (Pty) Ltd	National Research Foundation (ZA); University of the Western Cape (ZA); De Beers Marine Namibia, Namdeb and De Beers Marine (Pty) Ltd	The National Research Foundation (ZA) provided funding support for SS and MJG, whilst the University of the Western Cape (ZA) provided additional financial support for MJG. De Beers Marine Namibia, Namdeb and De Beers Marine (Pty) Ltd provided funding for NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arntz W. E., 2006, ADV GEOSCI, V6, P243, DOI DOI 10.5194/ADGE0-6-243-2006; Arrighetti F, 2010, J MAR BIOL ASSOC UK, V90, P933, DOI 10.1017/S0025315409991524; Atkinson LJ, 2011, MAR ECOL PROG SER, V430, P241, DOI 10.3354/meps08956; Awad AA, 2002, DIVERS DISTRIB, V8, P129, DOI 10.1046/j.1472-4642.2002.00132.x; Bakun A, 1996, PATTERNS OCEAN OCEAN; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; BRANCH GM, 1987, J EXP MAR BIOL ECOL, V107, P219, DOI 10.1016/0022-0981(87)90039-6; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CHAPMAN P, 1985, OCEANOGR MAR BIOL, V23, P183; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colwell RK, 2013, ESTIMATES STAT ESTIM; Ellingsen KE, 2001, MAR ECOL PROG SER, V218, P1, DOI 10.3354/meps218001; EMANUEL BP, 1992, S AFR J MARINE SCI, V12, P341; Emeis KC, 2004, CONT SHELF RES, V24, P627, DOI 10.1016/j.csr.2004.01.007; Foggo A, 2003, MAR ECOL PROG SER, V248, P15, DOI 10.3354/meps248015; Folk R. L., 1957, J SEDIMENT PETROL, V27, P3, DOI [10.1306/74d70646-2b21-11d7-8648000102c1865, 10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D]; FOLK RL, 1954, J GEOL, V62, P344, DOI 10.1086/626171; Freon P, 2009, PROG OCEANOGR, V83, P97, DOI 10.1016/j.pocean.2009.07.034; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gallardo VA, 2004, DEEP-SEA RES PT II, V51, P2475, DOI 10.1016/j.dsr2.2004.07.028; Gallego I, 2012, ECOL INDIC, V18, P575, DOI 10.1016/j.ecolind.2012.01.002; Gibbons MJ, 2010, J BIOGEOGR, V37, P606, DOI 10.1111/j.1365-2699.2009.02237.x; Gorley C.K., 2006, GETTING STARTED PRIM; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; Gray CED, 2000, S AFR GEOGR J, V82, P137, DOI DOI 10.1080/03736245.2000.9713705; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Hyams D.G., 2010, CURVEEXPERT SOFTWARE; Jarre A, 2015, FISH OCEANOGR, V24, P56, DOI 10.1111/fog.12076; Josefson AB, 2008, MAR POLLUT BULL, V56, P1265, DOI 10.1016/j.marpolbul.2008.04.028; Lange G, 2014, AFR J MAR SCI, V36, P313, DOI 10.2989/1814232X.2014.948913; Larsen K, 2001, ZOOL J LINN SOC-LOND, V131, P353, DOI 10.1111/j.1096-3642.2001.tb02241.x; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; Magurran A.E, 2003, MEASURING BIOL DIVER; Newell RC, 2001, J MAR BIOL ASSOC UK, V81, P1, DOI 10.1017/S0025315401003344; Olsgard F, 2000, J AQUAT ECOSYS STRES, V7, P24; Pacheco AS, 2012, OIKOS, V121, P2097, DOI 10.1111/j.1600-0706.2012.20257.x; Pacheco AS, 2011, HELGOLAND MAR RES, V65, P413, DOI 10.1007/s10152-010-0238-8; PAYNE AIL, 1987, S AFR J MARINE SCI, V5, P471, DOI 10.2989/025776187784522667; Pillay D, 2007, MAR ECOL PROG SER, V347, P1, DOI 10.3354/meps07054; Reiss H, 2005, ESTUAR COAST SHELF S, V65, P253, DOI 10.1016/j.ecss.2005.06.008; Rogers AD, 2000, DEEP-SEA RES PT II, V47, P119, DOI 10.1016/S0967-0645(99)00107-1; Rogers J, 2006, AFR J MAR SCI, V28, P511, DOI 10.2989/18142320609504202; Rogers J, 2002, QUATERN INT, V92, P101, DOI 10.1016/S1040-6182(01)00118-5; ROGERS J, 1991, OCEANOGR MAR BIOL, V29, P1; Rogers J., 1977, THESIS; Salvanes AGV, 2015, FISH OCEANOGR, V24, P102; Scott RJ, 2012, AFR J MAR SCI, V34, P341, DOI 10.2989/1814232X.2012.725284; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; Shannon V, 2006, LAR MAR ECOSYST, V14, P1; TARAZONA J, 1988, OECOLOGIA, V76, P184, DOI 10.1007/BF00379951; Tjorve E, 2003, J BIOGEOGR, V30, P827, DOI 10.1046/j.1365-2699.2003.00877.x; Utne-Palm AC, 2010, SCIENCE, V329, P333, DOI 10.1126/science.1190708; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Waite IR, 2000, J N AM BENTHOL SOC, V19, P429, DOI 10.2307/1468105; Weeks SJ, 2004, DEEP-SEA RES PT I, V51, P153, DOI 10.1016/j.dsr.2003.10.004; Widdicombe S, 2001, LIMNOL OCEANOGR, V46, P1720, DOI 10.4319/lo.2001.46.7.1720; Zettler ML, 2013, AFR J MAR SCI, V35, P283, DOI 10.2989/1814232X.2013.798592; Zettler ML, 2009, MAR BIOL, V156, P1949, DOI 10.1007/s00227-009-1227-9	65	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143637	10.1371/journal.pone.0143637	http://dx.doi.org/10.1371/journal.pone.0143637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618477	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800053
J	Yason, JA; Tan, KSW				Yason, John Anthony; Tan, Kevin Shyong Wei			Seeing the Whole Elephant: Imaging Flow Cytometry Reveals Extensive Morphological Diversity within Blastocystis Isolates	PLOS ONE			English	Article							MULTIPLE REPRODUCTIVE PROCESSES; STOOL SAMPLES; HOMINIS; INFECTION; FORMS; SPP.; IDENTIFICATION; PREDOMINANCE; SUBTYPES; CULTURE	Blastocystis is a common protist isolated in humans and many animals. The parasite is a species complex composed of 19 subtypes, 9 of which have been found in humans. There are biological and molecular differences between Blastocystis subtypes although microscopy alone is unable to distinguish between these subtypes. Blastocystis isolates also display various morphological forms. Several of these forms, however, have not been properly evaluated on whether or not these play significant functions in the organism's biology. In this study, we used imaging flow cytometry to analyze morphological features of Blastocystis isolates representing 3 subtypes (ST1, ST4 and ST7). We also employed fluorescence dyes to discover new cellular features. The profiles from each of the subtypes exhibit considerable differences with the others in terms of shape, size and granularity. We confirmed that the classical vacuolar form comprises the majority in all three subtypes. We have also evaluated other morphotypes on whether these represent distinct life stages in the parasite. Irregularly-shaped cells were identified but all of them were found to be dying cells in one isolate. Granular forms were present as a continuum in both viable and non-viable populations, with non-viable forms displaying higher granularity. By analyzing the images, rare morphotypes such as multinucleated cells could be easily observed and quantified. These cells had low granularity and lower DNA content. Small structures containing nucleic acid were also identified. We discuss the possible biological implications of these unusual forms.	[Yason, John Anthony; Tan, Kevin Shyong Wei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore	National University of Singapore	Tan, KSW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore.	kevin_tan@nuhs.edu.sg			National University of Singapore [R-182-000-710-733]; National University of Singapore	National University of Singapore(National University of Singapore); National University of Singapore(National University of Singapore)	The work was generously funded by a grant from the National University of Singapore (R-182-000-710-733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JAY acknowledges the generous research scholarship from the National University of Singapore.	Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; Anuar TS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-40; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Chen XQ, 1997, PARASITOL RES, V83, P313, DOI 10.1007/s004360050255; Clark CG, 2013, ADV PARASIT, V82, P1, DOI 10.1016/B978-0-12-407706-5.00001-0; Casero RD, 2015, ACTA TROP, V148, P156, DOI 10.1016/j.actatropica.2015.05.004; Ramirez JD, 2014, INFECT GENET EVOL, V22, P223, DOI 10.1016/j.meegid.2013.07.020; Govind SK, 2003, TRENDS PARASITOL, V19, P291, DOI 10.1016/S1471-4922(03)00140-5; Govind SK, 2002, TRENDS PARASITOL, V18, P528, DOI 10.1016/S1471-4922(02)02402-9; HO LC, 1993, PARASITOL RES, V79, P614, DOI 10.1007/BF00932249; MACPHERSON DW, 1994, J CLIN MICROBIOL, V32, P267, DOI 10.1128/JCM.32.1.267-268.1994; Mirza H, 2009, PARASITOL RES, V104, P355, DOI 10.1007/s00436-008-1203-1; Mirza H, 2011, INFECT IMMUN, V79, P5019, DOI 10.1128/IAI.05632-11; Moe KT, 1997, PARASITOL RES, V83, P319, DOI 10.1007/s004360050256; Noel C, 2005, J CLIN MICROBIOL, V43, P348, DOI 10.1128/JCM.43.1.348-355.2005; Poirier P, 2014, PARASITOLOGY, V141, P670, DOI 10.1017/S0031182013001996; Rajamanikam A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-295; Roberts T, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-17; Roberts T, 2014, J MED MICROBIOL, V63, P252, DOI 10.1099/jmm.0.065508-0; Santos HJ, 2013, ASIAN PAC J TROP MED, V6, P780, DOI 10.1016/S1995-7645(13)60138-8; Scanlan PD, 2014, FEMS MICROBIOL ECOL, V90, P326, DOI 10.1111/1574-6941.12396; Stensvold Christen Rune, 2013, Trop Parasitol, V3, P26, DOI 10.4103/2229-5070.113896; SURESH K, 1994, PARASITOL RES, V80, P523, DOI 10.1007/BF00932701; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan KSW, 2003, TRENDS PARASITOL, V19, P290, DOI 10.1016/S1471-4922(03)00119-3; Tan TC, 2006, PARASITOL RES, V98, P189, DOI 10.1007/s00436-005-0033-7; Teo JDW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089036; Vdovenko AA, 2000, PARASITOL RES, V86, P8, DOI 10.1007/PL00008506; Windsor JJ, 2003, TRENDS PARASITOL, V19, P289, DOI 10.1016/S1471-4922(03)00118-1; Wong KHS, 2008, PARASITOL RES, V102, P663, DOI 10.1007/s00436-007-0808-0; Wu ZN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002885; Yoshikawa H., 2012, BLASTOCYSTIS PATHOGE, P9; Zhang X, 2012, PARASITOL RES, V110, P1165, DOI 10.1007/s00436-011-2607-x	33	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143974	10.1371/journal.pone.0143974	http://dx.doi.org/10.1371/journal.pone.0143974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618361	Green Submitted, gold, Green Published			2022-12-26	WOS:000365889800097
J	Araujo, LH; Timmers, C; Shilo, K; Zhao, WQ; Zhang, JY; Yu, LB; Natarajan, TG; Miller, CJ; Yilmaz, AS; Liu, T; Amann, J; Silva, JRLE; Ferreira, CG; Carbone, DP				Araujo, Luiz H.; Timmers, Cynthia; Shilo, Konstantin; Zhao, Weiqiang; Zhang, Jianying; Yu, Lianbo; Natarajan, Thanemozhi G.; Miller, Clinton J.; Yilmaz, Ayse Selen; Liu, Tom; Amann, Joseph; Lapa e Silva, Jose Roberto; Ferreira, Carlos Gil; Carbone, David P.			Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency	PLOS ONE			English	Article							CLINICAL TUMOR SAMPLES; GENOME; MUTATIONS; FORMALDEHYDE; VALIDATION; SPECIMENS; INTEGRITY; CAPTURE; SUCCESS; PCR	Tumor specimens are often preserved as formalin-fixed paraffin-embedded (FFPE) tissue blocks, the most common clinical source for DNA sequencing. Herein, we evaluated the effect of pre-sequencing parameters to guide proper sample selection for targeted gene sequencing. Data from 113 FFPE lung tumor specimens were collected, and targeted gene sequencing was performed. Libraries were constructed using customprobes and were paired-end sequenced on a next generation sequencing platform. A PCR-based quality control (QC) assay was utilized to determine DNA quality, and a ratio was generated in comparison to control DNA. We observed that FFPE storage time, PCR/QC ratio, and DNA input in the library preparation were significantly correlated to most parameters of sequencing efficiency including depth of coverage, alignment rate, insert size, and read quality. A combined score using the three parameters was generated and proved highly accurate to predict sequencing metrics. We also showed wide read count variability within the genome, with worse coverage in regions of low GC content like in KRAS. Sample quality and GC content had independent effects on sequencing depth, and the worst results were observed in regions of low GC content in samples with poor quality. Our data confirm that FFPE samples are a reliable source for targeted gene sequencing in cancer, provided adequate sample quality controls are exercised. Tissue quality should be routinely assessed for pre-analytical factors, and sequencing depthmay be limited in genomic regions of low GC content if suboptimal samples are utilized.	[Araujo, Luiz H.; Timmers, Cynthia; Shilo, Konstantin; Zhao, Weiqiang; Yilmaz, Ayse Selen; Liu, Tom; Amann, Joseph; Carbone, David P.] Ohio State Univ, James Thorac Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Zhang, Jianying; Yu, Lianbo; Yilmaz, Ayse Selen] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Natarajan, Thanemozhi G.; Miller, Clinton J.] GenomOncology, Cleveland, OH 44145 USA; [Yilmaz, Ayse Selen] Ohio State Univ, Biomed Informat Shared Resource, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Lapa e Silva, Jose Roberto] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Ferreira, Carlos Gil] Brazilian Natl Canc Inst, Rio De Janeiro, Brazil	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca)	Carbone, DP (corresponding author), Ohio State Univ, James Thorac Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA.	david.carbone@osumc.edu	yu, lianbo/B-3472-2010; Ferreira, Carlos Gil/AAD-4104-2020; Zhao, Weiqiang/E-4368-2011; Lapa e Silva, Jose R./AAS-4793-2020; Shilo, K/AAV-2360-2020; Shilo, Konstantin/E-4084-2011	Ferreira, Carlos Gil/0000-0002-7228-7018; Lapa e Silva, Jose R./0000-0003-3116-0253; Shilo, K/0000-0002-6702-3130; Natarajan, Thanemozhi/0000-0002-0598-9693	Conquer Cancer Foundation of ASCO Long-Term International Fellowship (LIFe); Landon Foundation-AACR INNOVATOR Award for International Collaboration in Cancer Research; NIH/NCI [1RC1 CA146260-01]; NCI [R01CA60691, R01CA87895, P30CA022453]; Ohio State Cancer Center Support Grant (CCSG) [NCI CA16058]; NATIONAL CANCER INSTITUTE [P30CA016058, RC1CA146260, P30CA022453, R01CA087895, R01CA060691] Funding Source: NIH RePORTER	Conquer Cancer Foundation of ASCO Long-Term International Fellowship (LIFe); Landon Foundation-AACR INNOVATOR Award for International Collaboration in Cancer Research; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ohio State Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	L.H.A. is supported by a Conquer Cancer Foundation of ASCO Long-Term International Fellowship (LIFe) and a Landon Foundation-AACR INNOVATOR Award for International Collaboration in Cancer Research. This work was funded by a NIH/NCI 1RC1 CA146260-01, NCI R01CA60691, NCI R01CA87895, NCI P30CA022453, and the Ohio State Cancer Center Support Grant (CCSG), NCI CA16058. T.G.N and C.J.M. are employed by GenomOncology. This funder provided support in the form of salaries for authors (T.G.N and C.J.M), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Agilent T., 2013, FFPE DERIVED D UNPUB; AUERBACH C, 1977, MUTAT RES, V39, P317, DOI 10.1016/0165-1110(77)90011-2; Chen K, 2015, CLIN CHEM, V61, P544, DOI 10.1373/clinchem.2014.231100; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Didelot A, 2013, CLIN CHEM, V59, P815, DOI 10.1373/clinchem.2012.193409; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; KARLSEN F, 1994, LAB INVEST, V71, P604; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacConaill LE, 2010, J CLIN ONCOL, V28, P5219, DOI 10.1200/JCO.2009.27.4944; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sah S, 2013, GENOME MED, V5, DOI 10.1186/gm481; Samorodnitsky E, 2015, J MOL DIAGN, V17, P64, DOI 10.1016/j.jmoldx.2014.09.009; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wang FF, 2007, J MOL DIAGN, V9, P441, DOI 10.2353/jmoldx.2007.070004	41	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143092	10.1371/journal.pone.0143092	http://dx.doi.org/10.1371/journal.pone.0143092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605948	gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300044
J	Mwangala, S; Moland, KM; Nkamba, HC; Musonda, KG; Monze, M; Musukwa, KK; Fylkesnes, K				Mwangala, Sheila; Moland, Karen M.; Nkamba, Hope C.; Musonda, Kunda G.; Monze, Mwaka; Musukwa, Katoba K.; Fylkesnes, Knut			Task-Shifting and Quality of HIV Testing Services: Experiences from a National Reference Hospital in Zambia	PLOS ONE			English	Article							RANDOMIZED-TRIAL; HEALTH; ACCEPTABILITY; TANZANIA; CARE; SENSITIVITY; ACCEPTANCE; COUNSELORS; FACILITIES; SETTINGS	Background With new testing technologies, task-shifting and rapid scale-up of HIV testing services in high HIV prevalence countries, assuring quality of HIV testing is paramount. This study aimed to explore various cadres of providers' experiences in providing HIV testing services and their understanding of elements that impact on quality of service in Zambia. Methods Sixteen in-depth interviews and two focus group discussions were conducted with HIV testing service providers including lay counselors, nurses and laboratory personnel at purposively selected HIV testing sites at a national reference hospital in Lusaka. Qualitative content analysis was adopted for data analysis. Results Lay counselors and nurses reported confidentiality and privacy to be greatly compromised due to limited space in both in-and out-patient settings. Difficulties in upholding consent were reported in provider-initiated testing in in-patient settings. The providers identified nonadherence to testing procedures, high workload and inadequate training and supervision as key elements impacting on quality of testing. Difficulties related to testing varied by subgroups of providers: lay counselors, in finger pricking and obtaining adequate volumes of specimen; non-laboratory providers in general, in interpreting invalid, false-negative and false-positive results. The providers had been participating in a recently established national HIV quality assurance program, i. e. proficiency testing, but rarely received site supervisory visits. Conclusion Task-shifting coupled with policy shifts in service provision has seriously challenged HIV testing quality, protection of confidentiality and the process of informed consent. Ways to better protect confidentiality and informed consent need careful attention. Training, supervision and quality assurance need strengthening tailored to the needs of the different cadres of providers.	[Mwangala, Sheila; Nkamba, Hope C.; Musonda, Kunda G.; Monze, Mwaka; Musukwa, Katoba K.] Univ Teaching Hosp, Dept Pathol & Microbiol, Virol Lab, Lusaka, Zambia; [Mwangala, Sheila; Moland, Karen M.; Fylkesnes, Knut] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Musonda, Kunda G.] Univ London, London Sch Hyg & Trop Med, Pathogen Mol Biol Dept, London, England; [Fylkesnes, Knut] Univ Zambia, Sch Med, Dept Publ Hlth, Lusaka, Zambia	University of Zambia; University of Bergen; University of London; London School of Hygiene & Tropical Medicine; University of Zambia	Mwangala, S (corresponding author), Univ Teaching Hosp, Dept Pathol & Microbiol, Virol Lab, Lusaka, Zambia.	sheilamwangala@yahoo.com			Norwegian government quota program; Centre for International Health, University of Bergen (Uib)	Norwegian government quota program; Centre for International Health, University of Bergen (Uib)	The authors would like to acknowledge the Norwegian government quota program and the Centre for International Health, University of Bergen (Uib) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, 2013 UNAIDS REP GLOB; [Anonymous], 2008, CLEARV COMPL HIV 1 2; [Anonymous], 2005, GUID ASS ACC REL HIV; Astles JR, 1998, ARCH PATHOL LAB MED, V122, P700; Babalola S, 2007, AIDS BEHAV, V11, P759, DOI 10.1007/s10461-006-9189-0; Bateganya MH, 2007, COCHRANE DB SYST REV, P4; Beardsell S, 1996, SOC SCI MED, V42, P733, DOI 10.1016/0277-9536(95)00145-X; Chang Denison, 2006, Expert Rev Anti Infect Ther, V4, P565, DOI 10.1586/14787210.4.4.565; Chippindale S, 2001, BRIT MED J, V322, P1533, DOI 10.1136/bmj.322.7301.1533; Chiu YH, 2011, PLOS ONE, V6, P3; Evans C, 2011, AIDS CARE, V23, P1291, DOI 10.1080/09540121.2011.555751; Foster PH, 2008, J HEALTH CARE POOR U, V19, P10, DOI 10.1353/hpu.2008.0004; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Fylkesnes K, 1999, AIDS, V13, P2469, DOI 10.1097/00002030-199912030-00019; Fylkesnes K, 2013, SOC SCI MED, V86, P9, DOI 10.1016/j.socscimed.2013.02.036; George P, 1997, 14 ABT ASS INC; Gillet P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-215; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grinstead OA, 2000, AIDS CARE, V12, P625, DOI 10.1080/095401200750003806; Gruskin S, 2008, DEV WORLD BIOETH, V8, P23, DOI 10.1111/j.1471-8847.2007.00222.x; Joo E, 2000, AM J PUBLIC HEALTH, V90, P273, DOI 10.2105/AJPH.90.2.273; Jurgensen M, 2013, SOC SCI MED, V97, P210, DOI 10.1016/j.socscimed.2013.07.033; Koblavi-Deme S, 2001, J CLIN MICROBIOL, V39, P1808, DOI 10.1128/JCM.39.5.1808-1812.2001; Kruse GR, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-55; Learmonth KM, 2008, J CLIN MICROBIOL, V46, P1692, DOI 10.1128/JCM.01761-07; Lehmann U, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-49; LIE GT, 1994, AIDS CARE, V6, P139, DOI 10.1080/09540129408258625; Maman S, 2008, J MIDWIFERY WOM HEAL, V53, P195, DOI 10.1016/j.jmwh.2007.11.001; Matovu JKB, 2002, TROP MED INT HEALTH, V7, P1064, DOI 10.1046/j.1365-3156.2002.00964.x; Mbilinyi D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-266; Ministry of Health, 2006, ESS COMP ART PMTCT C; Ministry of Health, 2009, 1 PROF TEST TRIAL PR; Ministry of Health, 2007, NAT QUAL ASS STRAT H; Ministry of Health, 2010, AD AD ANT THER PROT; Ministry of Health National HIV/AIDS/STI/TB council, 2007, NAT HIV RAP TEST TRA; Ministry of Health Zambia, 2006, ZAMB NAT GUID HIV CO; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Msisuka C, 2011, SAHARA J-J SOC ASP H, V8, P204, DOI 10.1080/17290376.2011.9725005; Myers T, 2003, AIDS EDUC PREV, V15, P309, DOI 10.1521/aeap.15.5.309.23821; Njeru MK, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-87; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Parekh BS, 2010, AM J CLIN PATHOL, V134, P573, DOI 10.1309/AJCPTDIMFR00IKYX; Sanjana P, 2009, HUM RESOUR HEALTH, V7, P44, DOI [10.1186/1478-4491-7-44, DOI 10.1186/1478-4491-7-44]; SCHALLA WO, 1990, PUBLIC HEALTH REP, V105, P167; SEELEY J, 1991, AIDS Care, V3, P207, DOI 10.1080/09540129108253064; Sutton M, 2010, J RURAL HEALTH, V26, P240, DOI 10.1111/j.1748-0361.2010.00284.x; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; Tuturu, 2020, COMM CONS HLTH ED; UNAIDS, 2002, HIV VOL COUNS TEST G; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; WHO, 2009, 16 WHO; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wolpaw BJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-73; World Health Organization, 2012, STAT HIV TEST COUNS; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2008, TASK SHIFT RAT RED T; World Health Organization, 2010, HDB IMPR HIV TEST CO; World Health Organization, 1990, GUID COUNS HIV INF D; World Health Organization Deutsche Gesellschaft fur Technische Zusammenarbeit Joint United Nations Programme on HIV/AIDS International HIV/AIDS Alliance, 2005, SCAL HIV TEST COUNS; Worthington C, 2002, AIDS PATIENT CARE ST, V16, P537, DOI 10.1089/108729102761041092; Yao K, 2010, AM J CLIN PATHOL, V134, P568, DOI 10.1309/AJCPOPXR8MNTZ5PY; Yeatman SE, 2007, STUD FAMILY PLANN, V38, P271, DOI 10.1111/j.1728-4465.2007.00139.x	63	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143075	10.1371/journal.pone.0143075	http://dx.doi.org/10.1371/journal.pone.0143075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7ES	26605800	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300043
J	Bongers, MN; Schabel, C; Thomas, C; Raupach, R; Notohamiprodjo, M; Nikolaou, K; Bamberg, F				Bongers, Malte N.; Schabel, Christoph; Thomas, Christoph; Raupach, Rainer; Notohamiprodjo, Mike; Nikolaou, Konstantin; Bamberg, Fabian			Comparison and Combination of Dual-Energy- and Iterative-Based Metal Artefact Reduction on Hip Prosthesis and Dental Implants	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ORTHOPEDIC IMPLANTS; CT; RECONSTRUCTIONS; IMAGES	Purpose To compare and combine dual-energy based and iterative metal artefact reduction on hip prosthesis and dental implants in CT. Material and Methods A total of 46 patients (women: 50%, mean age: 63+/-15years) with dental implants or hip prostheses (n = 30/20) were included and examined with a second-generation Dual Source Scanner. 120kV equivalent mixed-images were derived from reconstructions of the 100/Sn140kV source images using no metal artefact reduction (NOMAR) and iterative metal artefact reduction (IMAR). We then generated monoenergetic extrapolations at 130keV from source images without IMAR (DEMAR) or from source images with IMAR, (IMAR + DEMAR). The degree of metal artefact was quantified for NOMAR, IMAR, DEMAR and IMAR+DEMAR using a Fourier-based method and subjectively rated on a five point Likert scale by two independent readers. Results In subjects with hip prosthesis, DEMAR and IMAR resulted in significantly reduced artefacts compared to standard reconstructions (33% vs. 56%; for DEMAR and IMAR; respectively, p<0.005), but the degree of artefact reduction was significantly higher for IMAR (all p<0.005). In contrast, in subjects with dental implants only IMAR showed a significant reduction of artefacts whereas DEMAR did not (71%, vs. 8% p<0.01 and p = 0.1; respectively). Furthermore, the combination of IMAR with DEMAR resulted in additionally reduced artefacts (Hip prosthesis: 47%, dental implants 18%; both p<0.0001). Conclusion IMAR allows for significantly higher reduction of metal artefacts caused by hip prostheses and dental implants, compared to a dual energy based method. The combination of DE-source images with IMAR and subsequent monoenergetic extrapolation provides an incremental benefit compared to both single methods.	[Bongers, Malte N.; Schabel, Christoph; Notohamiprodjo, Mike; Nikolaou, Konstantin; Bamberg, Fabian] Univ Hosp Tubingen, Dept Diagnost & Intervent Radiol, D-72076 Tubingen, Germany; [Thomas, Christoph] Univ Hosp Dusseldorf, Dept Diagnost & Intervent Radiol, D-40225 Dusseldorf, Germany; [Raupach, Rainer] Siemens AG, Healthcare Sect, D-91301 Forchheim, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Siemens AG; Siemens Germany	Bongers, MN (corresponding author), Univ Hosp Tubingen, Dept Diagnost & Intervent Radiol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	malte.bongers@med.uni-tuebingen.de	Artzner, Christoph/GLS-9305-2022		Siemens Healthcare, Germany; Siemens AG	Siemens Healthcare, Germany(Siemens AG); Siemens AG(Siemens AG)	The study was supported by a research grant from Siemens Healthcare, Germany. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis or decision to publish. Coauthor Rainer Raupach (RR) is employed by Siemens AG. Siemens AG provided support in the form of salary for author RR, but did not have any additional role in the study design, data collection and analysis or decision to publish. The specific role of this author is articulated in the 'author contributions' section.	Bamberg F, 2011, EUR RADIOL, V21, P1424, DOI 10.1007/s00330-011-2062-1; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Dong Y, 2016, EUR SPINE J, V25, P1754, DOI 10.1007/s00586-015-4053-4; Filograna L, 2015, SKELETAL RADIOL, V44, P1287, DOI 10.1007/s00256-015-2155-z; Grant KL, 2014, INVEST RADIOL, V49, P586, DOI 10.1097/RLI.0000000000000060; Han SC, 2014, AM J ROENTGENOL, V203, P788, DOI 10.2214/AJR.13.10980; Kuchenbecker S, 2015, MED PHYS, V42, P1023, DOI 10.1118/1.4905106; Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087; Mangold S, 2014, INVEST RADIOL, V49, P788, DOI 10.1097/RLI.0000000000000083; Meyer E, 2012, MED PHYS, V39, P1904, DOI 10.1118/1.3691902; Meyer E, 2010, MED PHYS, V37, P5482, DOI 10.1118/1.3484090; Morsbach F, 2013, EUR RADIOL, V23, P2687, DOI 10.1007/s00330-013-2885-z; Morsbach F, 2013, RADIOLOGY, V268, P237, DOI 10.1148/radiol.13122089; Mouton A, 2013, J X-RAY SCI TECHNOL, V21, P193, DOI 10.3233/XST-130372; Subhas N, 2014, SKELETAL RADIOL, V43, P1729, DOI 10.1007/s00256-014-1987-2; Taljanovic MS, 2003, RADIOGRAPHICS, V23, P1295, DOI 10.1148/rg.235035059; Teixeira PAG, 2014, SKELETAL RADIOL, V43, P1237, DOI 10.1007/s00256-014-1923-5; White Lawrence M, 2002, Semin Musculoskelet Radiol, V6, P5, DOI 10.1055/s-2002-23160; Zhou CS, 2011, ACAD RADIOL, V18, P1252, DOI 10.1016/j.acra.2011.05.009	19	60	60	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143584	10.1371/journal.pone.0143584	http://dx.doi.org/10.1371/journal.pone.0143584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600188	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600089
J	Floren, A; Kruger, D; Muller, T; Dittrich, M; Rudloff, R; Hoppe, B; Linsenmair, KE				Floren, Andreas; Krueger, Dirk; Mueller, Tobias; Dittrich, Marcus; Rudloff, Renate; Hoppe, Bjoern; Linsenmair, Karl Eduard			Diversity and Interactions of Wood-Inhabiting Fungi and Beetles after Deadwood Enrichment	PLOS ONE			English	Article							FOREST MANAGEMENT; NORWAY SPRUCE; BARK BEETLES; SPECIES RICHNESS; ECOLOGY; RARE; ESTABLISHMENT; METAANALYSIS; COMMUNITIES; ASSEMBLAGES	Freshly cut beech deadwood was enriched in the canopy and on the ground in three cultural landscapes in Germany (Swabian Alb, Hainich-Dun, Schorfheide-Chorin) in order to analyse the diversity, distribution and interaction of wood-inhabiting fungi and beetles. After two years of wood decay 83 MOTUs (Molecular Operational Taxonomic Units) from 28 wood samples were identified. Flight Interception Traps (FITs) installed adjacent to the deadwood enrichments captured 29.465 beetles which were sorted to 566 species. Geographical 'region' was the main factor determining both beetle and fungal assemblages. The proportions of species occurring in all regions were low. Statistic models suggest that assemblages of both taxa differed between stratum and management praxis but their strength varied among regions. Fungal assemblages in Hainich-Dun, for which the data was most comprehensive, discriminated unmanaged from extensively managed and age-class forests (even-aged timber management) while canopy communities differed not from those near the ground. In contrast, the beetle assemblages at the same sites showed the opposite pattern. We pursued an approach in the search for fungus-beetle associations by computing cross correlations and visualize significant links in a network graph. These correlations can be used to formulate hypotheses on mutualistic relationships for example in respect to beetles acting as vectors of fungal spores.	[Floren, Andreas; Linsenmair, Karl Eduard] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97074 Wurzburg, Germany; [Krueger, Dirk; Rudloff, Renate; Hoppe, Bjoern] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, D-06120 Halle, Saale, Germany; [Mueller, Tobias; Dittrich, Marcus] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97074 Wurzburg, Germany	University of Wurzburg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Wurzburg	Floren, A (corresponding author), Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97074 Wurzburg, Germany.	floren@biozentrum.uni-wuerzburg.de; bjoern.hoppe@ufz.de	Linsenmair, Karl Eduard/Q-2268-2018; Müller, Tobias/A-8952-2008; Kruger, Dirk/C-3316-2012	Linsenmair, Karl Eduard/0000-0002-2132-8721; Kruger, Dirk/0000-0002-7305-5104; Hoppe, Bjorn/0000-0001-8689-4911	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" [LI 150/22-1, KR 3587/3-2]; Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"; Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (grants LI 150/22-1 and KR 3587/3-2) and also supported through the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103416; Bassler C, 2014, J APPL ECOL, V51, P939, DOI 10.1111/1365-2664.12267; Bassler C, 2010, FUNGAL BIOL-UK, V114, P129, DOI 10.1016/j.funbio.2009.11.001; Baum Sebastian, 2003, Mycological Progress, V2, P141, DOI 10.1007/s11557-006-0052-5; Biedermann PHW, 2013, FEMS MICROBIOL ECOL, V83, P711, DOI 10.1111/1574-6941.12026; Blaser S, 2013, FOREST ECOL MANAG, V304, P42, DOI 10.1016/j.foreco.2013.04.043; Chessel D., 2012, PACKAGE ADE4 ANAL EC; Doyle J. J., 1987, PHYTOCHEM B, P11; Dray S, 2014, COMP SCI DATA ANAL S, P289; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Floren A, 2014, FOREST ECOL MANAG, V323, P57, DOI 10.1016/j.foreco.2014.03.028; Garbelotto M, 2013, ANNU REV PHYTOPATHOL, V51, P39, DOI 10.1146/annurev-phyto-082712-102225; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Giordano L, 2013, MYCOL PROG, V12, P127, DOI 10.1007/s11557-012-0822-1; Gossner MM, 2013, FOREST ECOL MANAG, V302, P404, DOI 10.1016/j.foreco.2013.03.039; Gruppe Axel, 2008, P383; Halme P, 2013, BIOL CONSERV, V168, P24, DOI 10.1016/j.biocon.2013.08.034; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hiscox J, 2015, ISME J, V9, P2246, DOI 10.1038/ismej.2015.38; Hoppe B, 2016, FUNGAL DIVERS, V77, P367, DOI 10.1007/s13225-015-0341-x; Hoppe B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088141; Jonsson MT, 2008, J ECOL, V96, P1065, DOI 10.1111/j.1365-2745.2008.01411.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Klausnitzer Bernhard, 2011, Berichte der Naturforschenden Gesellschaft Oberlausitz, V19, P47; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Kohler F, 2000, LOBF SCHRIFTENREIH B, P1; Lachat T, 2012, ECOL INDIC, V23, P323, DOI 10.1016/j.ecolind.2012.04.013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassauce A, 2011, ECOL INDIC, V11, P1027, DOI 10.1016/j.ecolind.2011.02.004; Leach JG, 1937, J AGRIC RES, V55, P0129; Leather SR, 2014, INSECT CONSERV DIVER, V7, P314, DOI 10.1111/icad.12055; Lindblad I, 1998, NORD J BOT, V18, P243, DOI 10.1111/j.1756-1051.1998.tb01877.x; Lonsdale D, 2008, EUR J FOREST RES, V127, P1, DOI 10.1007/s10342-007-0182-6; Molina R, 2008, MYCOL RES, V112, P613, DOI 10.1016/j.mycres.2007.12.005; Moller G, 2009, THESIS; Muller J, 2007, EUR J FOREST RES, V126, P513, DOI 10.1007/s10342-007-0173-7; Oksanen J, 2013, MULTIVARIATE ANAL EC; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Pazoutova S, 2010, FUNGAL ECOL, V3, P392, DOI 10.1016/j.funeco.2010.07.002; Persson Y, 2011, FUNGAL ECOL, V4, P262, DOI 10.1016/j.funeco.2011.01.005; Persson Y, 2009, MICROB ECOL, V58, P651, DOI 10.1007/s00248-009-9520-1; Poos MS, 2012, ECOL INDIC, V18, P82, DOI 10.1016/j.ecolind.2011.10.008; Purahong W, 2015, FUNG ECOL UNPUB; Purahong W, 2014, J ENVIRON MANAGE, V139, P109, DOI 10.1016/j.jenvman.2014.02.031; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Schauer F, 1999, MYCOSES, V42, P12, DOI 10.1111/j.1439-0507.1999.tb04521.x; Schigel D. S., 2012, Mycology - An International Journal on Fungal Biology, V3, P258; Schmidl Juergen, 2004, Naturschutz und Landschaftsplanung, V36, P202; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Six DL, 2003, CAN J FOREST RES, V33, P1815, DOI 10.1139/X03-107; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Strid Y, 2014, FUNGAL ECOL, V7, P47, DOI 10.1016/j.funeco.2013.09.003; Ulyshen MD, 2016, BIOL REV, V91, P70, DOI 10.1111/brv.12158; Ulyshen MD, 2013, METHODS ECOL EVOL, V4, P345, DOI 10.1111/2041-210x.12012; Unterseher M, 2006, MYCOL RES, V110, P169, DOI 10.1016/j.mycres.2005.08.002; van der Wal A, 2015, ECOLOGY, V96, P124, DOI 10.1890/14-0242.1; Vindstad OPL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099624; Weslien J, 2011, J ANIM ECOL, V80, P1155, DOI 10.1111/j.1365-2656.2011.01860.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yousuf F, 2014, AUSTRAL ENTOMOL, V53, P298, DOI 10.1111/aen.12077; Zanzot JW, 2010, ENVIRON ENTOMOL, V39, P415, DOI 10.1603/EN09261	64	16	19	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143566	10.1371/journal.pone.0143566	http://dx.doi.org/10.1371/journal.pone.0143566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599572	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600085
J	Liang, WH; Fang, L; Xiang, D; Hu, Y; Feng, H; Chang, LJ; Zhang, TZ				Liang, Wenhua; Fang, Lei; Xiang, Dan; Hu, Yan; Feng, Hao; Chang, Lijing; Zhang, Tianzhen			Transcriptome Analysis of Short Fiber Mutant Ligon lintless-1 (Li-1) Reveals Critical Genes and Key Pathways in Cotton Fiber Elongation and Leaf Development	PLOS ONE			English	Article							CELL ELONGATION; MOLECULAR CHARACTERIZATION; IN-VITRO; EXPRESSION; WALL; GROWTH; TEMPERATURE; GENOMICS; KINETICS; ETHYLENE	For efficient spinning and superior fabric production, long fiber length is a desired trait for cotton production. To unveil the molecular basis of the cotton fiber length regulation, a short fiber mutant, Ligon lintless-1 (Li-1), is selected to compare with its corresponding wild type (WT). Li-1 is a monogenic dominant cotton mutant causing extremely short fibers (<6mm) on mature seeds with visible pleiotropic effects on vegetative growth and development. In this research, we compared the transcriptome of fiber bearing ovules at 1 DPA, 3 DPA, 8 DPA and leaf between Li1 mutant and WT. A total of 7,852 differentially expressed genes (DEGs) were detected in ovules and leaves, which mainly participated in sugar, secondary metabolite and lipid metabolism pathways based on KEGG analysis. The common DEGs at 1 DPA and 3 DPA were involved in the responses to endogenous stimulus, signal transduction and long-chain fatty acid biosynthesis. For 3 DPA, 8 DPA and leaf, the common DEGs were involved in the responses to auxin and receptor kinases related pathway. Further analysis showed that 37 genes involved in very-long-chain fatty acid biosynthesis were suppressed in Li1 mutant during fiber fast elongation development. Most of the DEGs involved in cell wall metabolism, such cellulose synthase, expansin family, and glycosyl hydrolase were differentially expressed at 3 DPA and 8 DPA. Our results provide new insights into the mechanisms of fiber elongation, and offer novel genes as potential objects for fiber length improvement.	[Liang, Wenhua; Fang, Lei; Xiang, Dan; Hu, Yan; Feng, Hao; Chang, Lijing; Zhang, Tianzhen] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Cotton Hybrid R&D Engn Ctr, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, TZ (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Cotton Hybrid R&D Engn Ctr, Nanjing 210095, Jiangsu, Peoples R China.	cotton@njau.edu.cn			Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 program; JCIC-MCP project	Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 program(Ministry of Education, China - 111 Project); JCIC-MCP project	This work was financially supported in part by grants from the Priority Academic Program Development of Jiangsu Higher Education Institutions, the 111 program, and the JCIC-MCP project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CF, 2007, MOL GENET GENOMICS, V278, P539, DOI 10.1007/s00438-007-0270-9; Andrews S., 2010, FASTQC QUALITY CONTR; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Basra AS, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P47; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Bolton JJ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/659301; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Davidonis GH, 2004, AGRON J, V96, P42, DOI 10.2134/agronj2004.0042; Ding MQ, 2014, GENE, V535, P273, DOI 10.1016/j.gene.2013.11.017; Gilbert MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095554; Gilbert MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-403; GORDON A., 2011, FASTX TOOLKIT COMPUT; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Hamann T, 2009, PLANT J, V57, P1015, DOI 10.1111/j.1365-313X.2008.03744.x; He XC, 2008, J EXP BOT, V59, P2687, DOI 10.1093/jxb/ern127; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Hinchliffe DJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-445; Hinchliffe DJ, 2011, CROP SCI, V51, P1683, DOI 10.2135/cropsci2010.10.0569; Hovav R, 2008, PLANTA, V227, P319, DOI 10.1007/s00425-007-0619-7; JENSEN WA, 1968, PLANTA, V79, P346, DOI 10.1007/BF00386917; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karaca M, 2002, J HERED, V93, P221, DOI 10.1093/jhered/93.3.221; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; KOHEL RJ, 1992, CROP SCI, V32, P733, DOI 10.2135/cropsci1992.0011183X003200030031x; KOHEL RJ, 1972, CROP SCI, V12, P66, DOI 10.2135/cropsci1972.0011183X001200010022x; KOHEL RJ, 1974, CROP SCI, V14, P471, DOI 10.2135/cropsci1974.0011183X001400030040x; KOHEL RJ, 1993, CROP SCI, V33, P1036, DOI 10.2135/cropsci1993.0011183X003300050032x; Kunst L, 2000, BIOCHEM SOC T, V28, P651, DOI 10.1042/BST0280651; Lassner MW, 1996, PLANT CELL, V8, P281, DOI 10.1105/tpc.8.2.281; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lee J, 2010, PLANTA, V232, P1191, DOI 10.1007/s00425-010-1246-2; Li L, 2007, J EXP BOT, V58, P3227, DOI 10.1093/jxb/erm167; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Li YL, 2003, SCI CHINA SER C, V46, P235, DOI 10.1360/03yc9025; Liakatas A, 1998, J AGR SCI-CAMBRIDGE, V130, P463, DOI 10.1017/S0021859698005413; Liu K, 2012, GENOMICS, V100, P42, DOI 10.1016/j.ygeno.2012.04.007; Ma JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049244; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; NAITHANI SC, 1982, PHYSIOL PLANTARUM, V54, P225, DOI 10.1111/j.1399-3054.1982.tb06330.x; Naoumkina M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-155; NARBUTH EV, 1990, J HERED, V81, P131; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Rong JK, 2005, THEOR APPL GENET, V111, P1137, DOI 10.1007/s00122-005-0041-0; SCHUBERT AM, 1973, CROP SCI, V13, P704, DOI 10.2135/cropsci1973.0011183X001300060035x; SCHUBERT AM, 1976, CROP SCI, V16, P539, DOI 10.2135/cropsci1976.0011183X001600040026x; SEAGULL RW, 1986, CAN J BOT, V64, P1373, DOI 10.1139/b86-188; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; THAKER VS, 1989, FIELD CROP RES, V22, P129, DOI 10.1016/0378-4290(89)90063-4; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thyssen GN, 2014, THEOR APPL GENET, V127, P2183, DOI 10.1007/s00122-014-2372-1; TIWARI SC, 1995, CAN J BOT, V73, P746, DOI 10.1139/b95-081; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; WILLISON JHM, 1977, PROTOPLASMA, V92, P21, DOI 10.1007/BF01280198; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhao PM, 2010, J PROTEOME RES, V9, P1076, DOI 10.1021/pr900975t	60	13	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143503	10.1371/journal.pone.0143503	http://dx.doi.org/10.1371/journal.pone.0143503			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600249	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600074
J	Lyons, C; Raustad, N; Bustos, MA; Shiaris, M				Lyons, Casandra; Raustad, Nicole; Bustos, Mario A.; Shiaris, Michael			Incidence of Type II CRISPR1-Cas Systems in Enterococcus Is Species-Dependent	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COMPLETE GENOME SEQUENCE; CAS SYSTEMS; PATHOGENICITY ISLAND; IMMUNE-SYSTEM; FAECALIS; FAECIUM; CASSELIFLAVUS; RESISTANCE; VIRULENCE	CRISPR-Cas systems, which obstruct both viral infection and incorporation of mobile genetic elements by horizontal transfer, are a specific immune response common to prokaryotes. Antiviral protection by CRISPR-Cas comes at a cost, as horizontally-acquired genes may increase fitness and provide rapid adaptation to habitat change. To date, investigations into the prevalence of CRISPR have primarily focused on pathogenic and clinical bacteria, while less is known about CRISPR dynamics in commensal and environmental species. We designed PCR primers and coupled these with DNA sequencing of products to detect and characterize the presence of cas1, a universal CRISPR-associated gene and proxy for the Type II CRISPR1-Cas system, in environmental and non-clinical Enterococcus isolates. CRISPR1-cas1 was detected in approximately 33% of the 275 strains examined, and differences in CRISPR1 carriage between species was significant. Incidence of cas1 in E. hirae was 73%, nearly three times that of E. faecalis (23.6%) and 10 times more frequent than in E. durans (7.1%). Also, this is the first report of CRISPR1 presence in E. durans, as well as in the plant-associated species E. casseliflavus and E. sulfureus. Significant differences in CRISPR1-cas1 incidence among Enterococcus species support the hypothesis that there is a tradeoff between protection and adaptability. The differences in the habitats of enterococcal species may exert varying selective pressure that results in a species-dependent distribution of CRISPR-Cas systems.	[Lyons, Casandra; Raustad, Nicole; Bustos, Mario A.; Shiaris, Michael] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston	Shiaris, M (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	michael.shiaris@umb.edu		Lyons, Casandra/0000-0002-6900-0311	National Science Foundation [IOS -0847691 8]; National Science Foundation Research Experiences for Undergraduates [DBI-1062748]; National Institutes of Health Bridges to Baccalaureate Program [2R25GM075306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM075306] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Research Experiences for Undergraduates(National Science Foundation (NSF)); National Institutes of Health Bridges to Baccalaureate Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (IOS -0847691 8) (http://www.nsf.gov), the National Science Foundation Research Experiences for Undergraduates (DBI-1062748) (http://www.nsf.gov), and the National Institutes of Health Bridges to the Baccalaureate Program (2R25GM075306) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; BLAIMONT B, 1995, MICROB ECOL HEALTH D, V8, P87, DOI 10.3109/08910609509140084; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Burley KM, 2012, J ENDODONT, V38, P1511, DOI 10.1016/j.joen.2012.07.004; Devriese LA, 2002, J APPL MICROBIOL, V92, P821, DOI 10.1046/j.1365-2672.2002.01586.x; Duerkop B.A., 2014, ENTEROCOCCI COMMENSA; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garcia-Gutierrez E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131935; Gilmore MS, 2013, CURR OPIN MICROBIOL, V16, P10, DOI 10.1016/j.mib.2013.01.006; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Halliday E, 2011, ENVIRON SCI TECHNOL, V45, P370, DOI 10.1021/es102747s; Holzel C, 2014, MICROB DRUG RESIST, V20, P177, DOI 10.1089/mdr.2013.0108; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Katyal I, 2013, MICROB ECOL, V66, P182, DOI 10.1007/s00248-013-0217-0; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Lebreton F, 2013, MBIO, V4, DOI 10.1128/mBio.00534-13; Levin BR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001171; Lindenstrauss AG, 2011, SYST APPL MICROBIOL, V34, P553, DOI 10.1016/j.syapm.2011.05.002; Liu Y, 2014, VET MICROBIOL, V170, P352, DOI 10.1016/j.vetmic.2014.02.037; Low JR, 2015, EYE; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Magni C, 2012, J BACTERIOL, V194, P550, DOI 10.1128/JB.06415-11; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MARTINEZMURCIA AJ, 1991, FEMS MICROBIOL LETT, V80, P69; MUNDT JO, 1968, J BACTERIOL, V95, P2005, DOI 10.1128/JB.95.6.2005-2009.1968; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Narciso-Schiavon JL, 2015, ANN HEPATOL, V14, P270, DOI 10.1016/S1665-2681(19)30791-4; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Palmer KL, 2010, CURR OPIN MICROBIOL, V13, P632, DOI 10.1016/j.mib.2010.08.004; Parte AC, 2014, NUCLEIC ACIDS RES, V42, pD613, DOI 10.1093/nar/gkt1111; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pieniz S, 2015, FOOD CONTROL, V51, P49, DOI 10.1016/j.foodcont.2014.11.012; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Rozen S, 2000, Methods Mol Biol, V132, P365; Santagati M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00095; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shiwa Y, 2014, DNA RES, V21, P369, DOI 10.1093/dnares/dsu003; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; VAUGHAN DH, 1979, INT J SYST BACTERIOL, V29, P204, DOI 10.1099/00207713-29-3-204; Yasuda M, 2010, WATER RES, V44, P3982, DOI 10.1016/j.watres.2010.05.007	47	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143544	10.1371/journal.pone.0143544	http://dx.doi.org/10.1371/journal.pone.0143544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600384	gold, Green Published, Green Submitted			2022-12-26	WOS:000365862600081
J	Tsai, CC; Wu, SB; Chang, PC; Wei, YH				Tsai, Chieh-Chih; Wu, Shi-Bei; Chang, Pei-Chen; Wei, Yau-Huei			Alteration of Connective Tissue Growth Factor (CTGF) Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy	PLOS ONE			English	Article							THYROID-ASSOCIATED OPHTHALMOPATHY; OXIDATIVE STRESS; FIBROSIS; CELLS; PATHOGENESIS; INDUCTION; INSIGHTS; COLLAGEN; INDUCER	Graves' ophthalmopathy (GO) is a disfiguring and sometimes blinding disease, which is characterized by inflammation and swelling of orbital tissues, with fibrosis and adipogenesis being predominant features. The aim of this study is to investigate whether the expression levels of fibrosis-related genes, especially that of connective tissue growth factor (CTGF), are altered in orbital fibroblasts of patients with GO. The role of oxidative stress in the regulation of CTGF expression in GO orbital fibroblasts is also examined. By a SYBR Green-based real time quantitative PCR (RT-QPCR), we demonstrated that the mRNA expression levels of fibronectin, apolipoprotein J, and CTGF in cultured orbital fibroblasts from patients with GO were significantly higher than those of age-matched normal controls (p = 0.007, 0.037, and 0.002, respectively). In addition, the protein expression levels of fibronectin, apolipoprotein J, and CTGF analyzed by Western blot were also significantly higher in GO orbital fibroblasts (p = 0.046, 0.032, and 0.008, respectively) as compared with the control. Furthermore, after treatment of orbital fibroblasts with a sub-lethal dose of hydrogen peroxide (200 mu M H2O2), we found that the H2O2-induced increase of CTGF expression was more pronounced in the GO orbital fibroblasts as compared with those in normal controls (20% vs. 7%, p = 0.007). Importantly, pre-incubation with antioxidants including N-acetylcysteine (NAC) and vitamin C, respectively, resulted in significant attenuation of the induction of CTGF in GO orbital fibroblasts in response to H2O2 (p = 0.004 and 0.015, respectively). Taken together, we suggest that oxidative stress plays a role in the alteration of the expression of CTGF in GO orbital fibroblasts that may contribute to the pathogenesis and progression of GO. Antioxidants may be used in combination with the therapeutic agents for effective treatment of GO.	[Tsai, Chieh-Chih] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei 112, Taiwan; [Tsai, Chieh-Chih] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Wu, Shi-Bei; Wei, Yau-Huei] Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan; [Chang, Pei-Chen] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wei, Yau-Huei] Mackay Med Coll, Dept Med, New Taipei 252, Taiwan; [Wei, Yau-Huei] Mackay Med Coll, Inst Biomed Sci, New Taipei 252, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Medical College	Wei, YH (corresponding author), Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan.	joeman@ym.edu.tw	Wei, Yau-Huei/ABA-6841-2021; Tsai, Chieh-Chih/ABE-6364-2021; TMU, barry0110/AAV-4030-2021	Wei, Yau-Huei/0000-0002-6429-2546; Tsai, Chieh-Chih/0000-0002-4411-3387; 	Ministry of Science and Technology (MOST), Executive Yuan, Taiwan [MOST 103-2314-B-075-074, MOST 103-2321-B-715-001, MOST 104-2314-B-075 -056 -MY2]; Taipei Veterans General Hospital, Taiwan [V103-C-194]	Ministry of Science and Technology (MOST), Executive Yuan, Taiwan; Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This study was supported by grants (MOST 103-2314-B-075-074, MOST 103-2321-B-715-001, and MOST 104-2314-B-075 -056 -MY2) from the Ministry of Science and Technology (MOST), Executive Yuan, Taiwan to authors CCT and YHW. This study was also supported by grant (V103-C-194) from Taipei Veterans General Hospital, Taiwan to author CCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shady M, 2000, LIVER, V20, P296, DOI 10.1034/j.1600-0676.2000.020004296.x; Aragno M, 2008, ENDOCRINOLOGY, V149, P380, DOI 10.1210/en.2007-0877; Bartley GB, 1996, OPHTHALMOLOGY, V103, P958, DOI 10.1016/S0161-6420(96)30579-4; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Dammeier J, 1998, J BIOL CHEM, V273, P18185, DOI 10.1074/jbc.273.29.18185; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Folger PA, 2001, INVEST OPHTH VIS SCI, V42, P2534; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Guo P, 2006, J HYPERTENS, V24, P1097, DOI 10.1097/01.hjh.0000226200.73065.5d; Han R, 2005, J IMMUNOL, V174, P3072, DOI 10.4049/jimmunol.174.5.3072; He SK, 2008, INVEST OPHTH VIS SCI, V49, P4078, DOI 10.1167/iovs.07-1302; Hondur A, 2008, CURR EYE RES, V33, P421, DOI 10.1080/02713680802123532; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Iyer P, 2012, INVEST OPHTH VIS SCI, V53, P4952, DOI 10.1167/iovs.12-9681; Kazim M, 2002, ARCH OPHTHALMOL-CHIC, V120, P380; Kim H, 2010, INVEST OPHTH VIS SCI, V51, P3061, DOI 10.1167/iovs.09-4257; Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8; LAWRENCE DA, 1995, KIDNEY INT, V47, pS19; Lin CS, 2012, INT J MOL SCI, V13, P11228, DOI 10.3390/ijms130911228; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Ma B, 2014, BIOCHEM BIOPH RES CO, V447, P689, DOI 10.1016/j.bbrc.2014.04.068; Marcocci C, 2011, NEW ENGL J MED, V364, P1920, DOI 10.1056/NEJMoa1012985; Matsuda S, 2006, JPN J OPHTHALMOL, V50, P229, DOI 10.1007/s10384-005-0317-6; Naik V, 2008, THYROID, V18, P967, DOI 10.1089/thy.2007.0403; Park SK, 2001, BIOCHEM BIOPH RES CO, V284, P966, DOI 10.1006/bbrc.2001.5058; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; Shih MJ, 2006, J CLIN ENDOCR METAB, V91, P1159, DOI 10.1210/jc.2005-1877; Sisco M, 2008, WOUND REPAIR REGEN, V16, P661, DOI 10.1111/j.1524-475X.2008.00416.x; Smith TJ, 2005, CLIN EXP IMMUNOL, V141, P388, DOI 10.1111/j.1365-2249.2005.02824.x; Smith TJ, 2002, THYROID, V12, P197, DOI 10.1089/105072502753600133; Sobral LM, 2011, J PERIODONTOL, V82, P642, DOI 10.1902/jop.2010.100510; Tall EG, 2010, INVEST OPHTH VIS SCI, V51, P5002, DOI 10.1167/iovs.09-5110; Tsai CC, 2010, EYE, V24, P1520, DOI 10.1038/eye.2010.31; Tsai CC, 2009, EYE, V23, P1725, DOI 10.1038/eye.2008.310; Tsai CC, 2013, MOL VIS, V19, P927; Tsai CC, 2011, MOL VIS, V17, P2782; Yokoi H, 2001, AM J KIDNEY DIS, V38, pS134, DOI 10.1053/ajkd.2001.27422; Yoon JS, 2012, INVEST OPHTH VIS SCI, V53, P5921, DOI 10.1167/iovs.12-9646; Zarkovic M, 2012, J THROID RES, V2012, DOI 10.1155/2012/302537; Zhang JY, 2014, CURR EYE RES, V39, P53, DOI 10.3109/02713683.2013.833245; Zhao SX, 2011, J ENDOCRINOL, V210, P369, DOI 10.1530/JOE-11-0162	42	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143514	10.1371/journal.pone.0143514	http://dx.doi.org/10.1371/journal.pone.0143514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599235	Green Submitted, gold, Green Published			2022-12-26	WOS:000365862600078
J	Hall, CM; Busch, JD; Shippy, K; Allender, CJ; Kaestli, M; Mayo, M; Sahl, JW; Schupp, JM; Colman, RE; Keim, P; Currie, BJ; Wagner, DM				Hall, Carina M.; Busch, Joseph D.; Shippy, Kenzie; Allender, Christopher J.; Kaestli, Mirjam; Mayo, Mark; Sahl, Jason W.; Schupp, James M.; Colman, Rebecca E.; Keim, Paul; Currie, Bart J.; Wagner, David M.			Diverse Burkholderia Species Isolated from Soils in the Southern United States with No Evidence of B. pseudomallei	PLOS ONE			English	Article							CEPACIA COMPLEX; GENETIC DIVERSITY; MELIOIDOSIS; EPIDEMIOLOGY; IDENTIFICATION; AMPLIFICATION; THAILANDENSIS; SURVEILLANCE; CENOCEPACIA; INFECTION	The global distribution of the soil-dwelling bacterium Burkholderia pseudomallei, causative agent of melioidosis, is poorly understood. We used established culturing methods developed for B. pseudomallei to isolate Burkholderia species from soil collected at 18 sampling sites in three states in the southern United States (Arizona (n = 4), Florida (n = 7), and Louisiana (n = 7)). Using multi-locus sequence typing (MLST) of seven genes, we identified 35 Burkholderia isolates from these soil samples. All species belonged to the B. cepacia complex (Bcc), including B. cenocepacia, B. cepacia, B. contaminans, B. diffusa, B. metallica, B. seminalis, B. vietnamiensis and two unnamed members of the Bcc. The MLST analysis provided a high level of resolution among and within these species. Despite previous clinical cases within the U.S. involving B. pseudomallei and its close phylogenetic relatives, we did not isolate any of these taxa. The Bcc contains a number of opportunistic pathogens that cause infections in cystic fibrosis patients. Interestingly, we found that B. vietnamiensis was present in soil from all three states, suggesting it may be a common component in southern U.S. soils. Most of the Burkholderia isolates collected in this study were from Florida (30/35; 86%), which may be due to the combination of relatively moist, sandy, and acidic soils found there compared to the other two states. We also investigated one MLST gene, recA, for its ability to identify species within Burkholderia. A 365bp fragment of recA recovered nearly the same species-level identification as MLST, thus demonstrating its cost effective utility when conducting environmental surveys for Burkholderia. Although we did not find B. pseudomallei, our findings document that other diverse Burkholderia species are present in soils in the southern United States.	[Hall, Carina M.; Busch, Joseph D.; Shippy, Kenzie; Allender, Christopher J.; Sahl, Jason W.; Keim, Paul; Wagner, David M.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Kaestli, Mirjam; Mayo, Mark; Currie, Bart J.] Menzies Sch Hlth Res, Casuarina, NT, Australia; [Schupp, James M.; Colman, Rebecca E.; Keim, Paul] Translat Genom Res Inst, Flagstaff, AZ 86001 USA	Northern Arizona University; Charles Darwin University; Menzies School of Health Research; Translational Genomics Research Institute	Wagner, DM (corresponding author), No Arizona Univ, Ctr Microbial Genet & Genom, 1395 S Knoles Dr, Flagstaff, AZ 86011 USA.	Dave.Wagner@nau.edu	Colman, Rebecca/AAI-2112-2019	Colman, Rebecca/0000-0002-6854-2100; , Jason/0000-0002-2497-0138; Wagner, David/0000-0003-2684-6007; , Mirjam/0000-0002-6053-5141	Chemical Biological Technologies Directorate from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency [HDTRA1-12-C-0066]	Chemical Biological Technologies Directorate from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency	This work was supported by the Chemical Biological Technologies Directorate contract HDTRA1-12-C-0066 to DMW from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency (www.dtra.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; [Anonymous], 1998, SOILDATA V 0 PROGR C; ASHDOWN LR, 1979, PATHOLOGY, V11, P293, DOI 10.3109/00313027909061954; Bachmann HS, 2003, PHARMACOGENETICS, V13, P759, DOI 10.1097/00008571-200312000-00006; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Baldwin A, 2005, J CLIN MICROBIOL, V43, P4665, DOI 10.1128/JCM.43.9.4665-4673.2005; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Biggins JB, 2012, J AM CHEM SOC, V134, P13192, DOI 10.1021/ja3052156; Birnie E, 2015, FUTURE MICROBIOL, V10, P275, DOI [10.2217/FMB.14.113, 10.2217/fmb.14.113]; Cesarini S, 2009, LETT APPL MICROBIOL, V49, P580, DOI 10.1111/j.1472-765X.2009.02709.x; Chantratita N, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000182; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; DELAMBALLERIE X, 1992, RES MICROBIOL, V143, P785, DOI 10.1016/0923-2508(92)90107-Y; Doker TJ, 2014, AM J TROP MED HYG, V91, P743, DOI 10.4269/ajtmh.14-0172; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Engelthaler DM, 2014, MBIO, V5, DOI 10.1128/mBio.01464-14; Engelthaler DM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001347; Environmental Systems Research Institute, 2013, ESRI ARCMAP; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; Gee JE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-54; GILLIS M, 1995, INT J SYST BACTERIOL, V45, P274, DOI 10.1099/00207713-45-2-274; Ginther JL, 2015, PLOS NEGLEC IN RPESS; Glass MB, 2009, AM J TROP MED HYG, V80, P1023, DOI 10.4269/ajtmh.2009.80.1023; Glass MB, 2006, INT J SYST EVOL MICR, V56, P2171, DOI 10.1099/ijs.0.63991-0; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Inglis TJJ, 2004, EPIDEMIOL INFECT, V132, P813, DOI 10.1017/s0950268804002663; Jacobs JL, 2008, APPL ENVIRON MICROB, V74, P3121, DOI 10.1128/AEM.01941-07; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kaestli M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000364; Lee YA, 2007, PHYTOPATHOLOGY, V97, P195, DOI 10.1094/PHYTO-97-2-0195; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002105; LiPuma JJ, 2001, AM J RESP CRIT CARE, V164, P92, DOI 10.1164/ajrccm.164.1.2011153; LiPuma JJ, 2003, SEMIN RESP CRIT CARE, V24, P681, DOI 10.1055/s-2004-815664; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Martina P, 2013, J CLIN MICROBIOL, V51, P339, DOI 10.1128/JCM.02500-12; Nei M, 2000, MOL EVOLUTION PHYLOG, Vxiv; NELSON MJK, 1986, APPL ENVIRON MICROB, V52, P383, DOI 10.1128/AEM.52.2.383-384.1986; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; O'Sullivan LA, 2005, LETT APPL MICROBIOL, V41, P8, DOI 10.1111/j.1472-765X.2005.01758.x; Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005; Price EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071647; Sarovich DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030789; Stewart T, 2011, EMERG INFECT DIS, V17, P1286, DOI 10.3201/eid1707.100661; Stopnisek N, 2014, ENVIRON MICROBIOL, V16, P1503, DOI 10.1111/1462-2920.12211; TABLAN OC, 1993, INFECT CONT HOSP EP, V14, P124, DOI 10.2307/30148474; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trung TT, 2011, T ROY SOC TROP MED H, V105, P346, DOI 10.1016/j.trstmh.2011.03.004; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Weisskopf L, 2011, APPL ENVIRON MICROB, V77, P7715, DOI 10.1128/AEM.05845-11; Wiersinga WJ, 2015, EMERG INFECT DIS, V21, P40, DOI 10.3201/eid2101.140762	56	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143254	10.1371/journal.pone.0143254	http://dx.doi.org/10.1371/journal.pone.0143254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600238	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900082
J	Li, RH; Jiang, XT; Jin, DH; Dhaubhadel, S; Bian, SM; Li, XY				Li, Ruihua; Jiang, Xiaotong; Jin, Donghao; Dhaubhadel, Sangeeta; Bian, Shaomin; Li, Xuyan			Identification of 14-3-3 Family in Common Bean and Their Response to Abiotic Stress	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; GENE FAMILY; COMPREHENSIVE ANALYSIS; ISOFORM SPECIFICITY; ARABIDOPSIS HOMOLOG; SIGNAL-TRANSDUCTION; DROUGHT TOLERANCE; ROOT-GROWTH; PROTEIN; RICE	14-3-3s are a class of conserved regulatory proteins ubiquitously found in eukaryotes, which play important roles in a variety of cellular processes including response to diverse stresses. Although much has been learned about 14-3-3s in several plant species, it remains unknown in common bean. In this study, 9 common bean 14-3-3s (PvGF14s) were identified by exhaustive data mining against the publicly available common bean genomic database. A phylogenetic analysis revealed that each predicted PvGF14 was clustered with two GmSGF14 paralogs from soybean. Both epsilon-like and non-epsilon classes of PvGF14s were found in common bean, and the PvGF14s belonging to each class exhibited similar gene structure. Among 9 PvGF14s, only 8 are transcribed in common bean. Expression patterns of PvGF14s varied depending on tissue type, developmental stage and exposure of plants to stress. A protein-protein interaction study revealed that PvGF14a forms dimer with itself and with other PvGF14 isoforms. This study provides a first comprehensive look at common bean 14-3-3 proteins, a family of proteins with diverse functions in many cellular processes, especially in response to stresses.	[Li, Ruihua; Jiang, Xiaotong; Jin, Donghao; Bian, Shaomin; Li, Xuyan] Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China; [Dhaubhadel, Sangeeta] Agr & Agri Food Canada, Southern Crop Protect & Food Res Ctr, London, ON, Canada	Jilin University; Agriculture & Agri Food Canada	Bian, SM (corresponding author), Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China.	shmbian@jlu.edu.cn; xuyanli@jlu.edu.cn			National Natural Science Foundation of China [31300253]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 31300253), http://www.nsfc.gov.cn/.	Aksamit A, 2005, PLANT CELL PHYSIOL, V46, P1635, DOI 10.1093/pcp/pci179; Alsterfjord M, 2004, PLANT CELL PHYSIOL, V45, P1202, DOI 10.1093/pcp/pch136; Andrews RK, 1998, BIOCHEMISTRY-US, V37, P638, DOI 10.1021/bi970893g; BRANDT J, 1992, PLANT J, V2, P815, DOI 10.1046/j.1365-313X.1992.t01-18-00999.x; Campo S, 2012, J EXP BOT, V63, P983, DOI 10.1093/jxb/err328; Catala R, 2014, PLANT CELL, V26, P3326, DOI 10.1105/tpc.114.127605; Chang IF, 2009, PROTEOMICS, V9, P2967, DOI 10.1002/pmic.200800445; Chen F, 2006, DNA RES, V13, P53, DOI 10.1093/dnares/dsl001; Chen Q, 2015, PLANT CELL PHYSIOL, V56, P1144, DOI 10.1093/pcp/pcv038; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; DEVETTEN NC, 1994, PLANT PHYSIOL, V106, P1593, DOI 10.1104/pp.106.4.1593; Dobra J, 2015, PLANT SCI, V231, P52, DOI 10.1016/j.plantsci.2014.11.005; Ferl RJ, 2002, GENOME BIOL, V3; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Gokirmak T, 2010, CURR OPIN PLANT BIOL, V13, P527, DOI 10.1016/j.pbi.2010.06.001; HIRSCH S, 1992, FEBS LETT, V296, P222, DOI 10.1016/0014-5793(92)80384-S; Ho SL, 2013, PLANT MOL BIOL, V81, P347, DOI 10.1007/s11103-012-0006-z; JARILLO JA, 1994, PLANT MOL BIOL, V25, P693, DOI 10.1007/BF00029607; Jaspert N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00096; Kinoshita T, 2002, PLANT CELL PHYSIOL, V43, P1359, DOI 10.1093/pcp/pcf167; Kumar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123236; LAUGHNER B, 1994, PLANT PHYSIOL, V105, P1457, DOI 10.1104/pp.105.4.1457; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Li MY, 2012, PLANT CELL REP, V31, P369, DOI 10.1007/s00299-011-1172-1; Li XY, 2012, PLANT J, V71, P239, DOI 10.1111/j.1365-313X.2012.04986.x; Li XY, 2011, PLANTA, V233, P569, DOI 10.1007/s00425-010-1315-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LU GH, 1992, P NATL ACAD SCI USA, V89, P11490, DOI 10.1073/pnas.89.23.11490; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Paul AL, 2005, MOL BIOL CELL, V16, P1735, DOI 10.1091/mbc.E04-09-0839; Paul AL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00190; Pedrosa A, 2003, THEOR APPL GENET, V106, P205, DOI 10.1007/s00122-002-1138-3; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Porcel R, 2006, MICROB ECOL, V52, P575, DOI 10.1007/s00248-006-9015-2; Rosenquist M, 2001, PLANT PHYSIOL, V127, P142, DOI 10.1104/pp.127.1.142; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Sehnke PC, 2002, PLANT MOL BIOL, V50, P1011, DOI 10.1023/A:1021289127519; Sehnke PC, 2002, PLANT CELL, V14, pS339, DOI 10.1105/tpc.010430; Shanko AV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1320, DOI 10.1023/B:BIRY.0000011653.46422.c3; Sun GL, 2011, FUNCT INTEGR GENOMIC, V11, P627, DOI 10.1007/s10142-011-0242-3; Sun XL, 2014, PLANT CELL PHYSIOL, V55, P99, DOI 10.1093/pcp/pct161; Swatek KN, 2011, J PROTEOME RES, V10, P4076, DOI 10.1021/pr200263m; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Tian FX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123225; van Kleeff PJM, 2014, J EXP BOT, V65, P5877, DOI 10.1093/jxb/eru338; Vysotskii DA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22672; Wang XQ, 2009, PROTEOMICS, V9, P4529, DOI 10.1002/pmic.200900062; Xu WF, 2006, ANN BOT-LONDON, V98, P965, DOI 10.1093/aob/mcl189; Xu WF, 2013, PLANT PHYSIOL, V163, P1817, DOI 10.1104/pp.113.224758; Xu WF, 2012, PLANT CELL ENVIRON, V35, P1393, DOI 10.1111/j.1365-3040.2012.02497.x; Yan JQ, 2004, PLANT CELL PHYSIOL, V45, P1007, DOI 10.1093/pcp/pch115; Yang XH, 2006, PLANT PHYSIOL, V142, P820, DOI 10.1104/pp.106.083642; Yang ZP, 2014, PLANT PHYSIOL BIOCH, V80, P121, DOI 10.1016/j.plaphy.2014.03.034; Yao Y, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1003, DOI 10.1134/S000629790709012X; Yao Y, 2007, J BIOCHEM MOL BIOL, V40, P349; Yuan SX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1328-4; Zhang ZT, 2010, J EXP BOT, V61, P3331, DOI 10.1093/jxb/erq155; Zhou HP, 2014, PLANT CELL, V26, P1166, DOI 10.1105/tpc.113.117069	62	19	23	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143280	10.1371/journal.pone.0143280	http://dx.doi.org/10.1371/journal.pone.0143280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599110	Green Published, gold			2022-12-26	WOS:000365853900084
J	McInnes, AM; Khoosal, A; Murrell, B; Merkle, D; Lacerda, M; Nyengera, R; Coetzee, JC; Edwards, LC; Ryan, PG; Rademan, J; van der Westhuizen, JJ; Pichegru, L				McInnes, Alistair M.; Khoosal, Arjun; Murrell, Ben; Merkle, Dagmar; Lacerda, Miguel; Nyengera, Reason; Coetzee, Janet C.; Edwards, Loyd C.; Ryan, Peter G.; Rademan, Johan; van der Westhuizen, Jan J.; Pichegru, Lorien			Recreational Fish-Finders-An Inexpensive Alternative to Scientific Echo-Sounders for Unravelling the Links between Marine Top Predators and Their Prey	PLOS ONE			English	Article							PENGUINS SPHENISCUS-DEMERSUS; SOUTH-AFRICA; ROBBEN ISLAND; SEABIRDS; SCHOOLS; INDICATORS; FISHERIES; ZONE	Studies investigating how mobile marine predators respond to their prey are limited due to the challenging nature of the environment. While marine top predators are increasingly easy to study thanks to developments in bio-logging technology, typically there is scant information on the distribution and abundance of their prey, largely due to the specialised nature of acquiring this information. We explore the potential of using single-beam recreational fish-finders (RFF) to quantify relative forage fish abundance and draw inferences of the prey distribution at a fine spatial scale. We compared fish school characteristics as inferred from the RFF with that of a calibrated scientific split-beam echo-sounder (SES) by simultaneously operating both systems from the same vessel in Algoa Bay, South Africa. Customized open-source software was developed to extract fish school information from the echo returns of the RFF. For schools insonified by both systems, there was close correspondence between estimates of mean school depth (R-2 = 0.98) and school area (R-2 = 0.70). Estimates of relative school density (mean volume backscattering strength; S-v) measured by the RFF were negatively biased through saturation of this system given its smaller dynamic range. A correction factor applied to the RFF-derived density estimates improved the comparability between the two systems. Relative abundance estimates using all schools from both systems were congruent at scales from 0.5 km to 18 km with a strong positive linear trend in model fit estimates with increasing scale. Although absolute estimates of fish abundance cannot be derived from these systems, they are effective at describing prey school characteristics and have good potential for mapping forage fish distribution and relative abundance. Using such relatively inexpensive systems could greatly enhance our understanding of predator-prey interactions.	[McInnes, Alistair M.; Ryan, Peter G.] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa; [Khoosal, Arjun] Univ Cape Town, Inst Infect Dis & Mol Med, Computat Biol Grp, ZA-7925 Cape Town, South Africa; [Murrell, Ben] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Merkle, Dagmar; Coetzee, Janet C.; Rademan, Johan; van der Westhuizen, Jan J.] Dept Agr Forestry & Fisheries, Branch Fisheries Management, Cape Town, South Africa; [Lacerda, Miguel] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Nyengera, Reason; Pichegru, Lorien] Nelson Mandela Metropolitan Univ, Dept Zool, DST NRF Ctr Excellence, Percy Fitzpatrick Inst African Ornithol, Port Elizabeth, South Africa; [Edwards, Loyd C.] Raggy Charters, Port Elizabeth, South Africa	National Research Foundation - South Africa; University of Cape Town; University of Cape Town; University of California System; University of California San Diego; University of Cape Town; National Research Foundation - South Africa; Nelson Mandela University	McInnes, AM (corresponding author), Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa.	amcinnes3@gmail.com	Murrell, Ben/AAM-1188-2021	Coetzee, Janet/0000-0002-2382-7815; Pichegru, Lorien/0000-0003-3815-9845; Murrell, Ben/0000-0002-0393-4445	Department of Science and Technology-National Research Foundation Centre of Excellence; African Penguin Species Champion project of the Charl van der Merwe Trust; Responsible Fisheries Alliance; Raggy Charters	Department of Science and Technology-National Research Foundation Centre of Excellence; African Penguin Species Champion project of the Charl van der Merwe Trust; Responsible Fisheries Alliance; Raggy Charters	This work was supported by the Department of Science and Technology-National Research Foundation Centre of Excellence grant to the Percy FitzPatrick Institute of African Ornithology at the University of Cape Town http://www.fitzpatrick.uct.ac.za/: AMM; The African Penguin Species Champion project of the Charl van der Merwe Trust: LP; and The Responsible Fisheries Alliance http://www.rfalliance.org.za/: LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Loyd C. Edwards is employed by Raggy Charters. Raggy Charters provided support in the form of salary for author LCE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707; Brierley AS, 2015, CURR BIOL, V25, P75, DOI 10.1016/j.cub.2014.10.062; CAIRNS D K, 1987, Biological Oceanography, V5, P261; Coetzee J, 2000, AQUAT LIVING RESOUR, V13, P1, DOI 10.1016/S0990-7440(00)00139-X; Coetzee JC, 2008, AFR J MAR SCI, V30, P205, DOI 10.2989/AJMS.2008.30.2.1.551; Coetzee JC, 2010, CLAIM PICHEGRU MARIN; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Crawford RJM, 2011, AFR J MAR SCI, V33, P139, DOI 10.2989/1814232X.2011.572377; Crawford RJM, 2006, BIOL CONSERV, V132, P119, DOI 10.1016/j.biocon.2006.03.019; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Foote KG, 1981, FISH RES, V1, P129, DOI [10.1016/0165-7836(81)90015-1, DOI 10.1016/0165-7836(81)90015-1]; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Harding AMA, 2007, ECOLOGY, V88, P2024, DOI 10.1890/06-1695.1; IUCN, IUCN RED LIST THREAT; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Korneliussen RJ, 2008, ICES J MAR SCI, V65, P982, DOI 10.1093/icesjms/fsn052; Lawson GL, 2001, ICES J MAR SCI, V58, P275, DOI 10.1006/jmsc.2000.1009; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Montevecchi WA, 1993, BIRDS MONITORS ENV C; Mori Y, 1998, J ZOOL, V245, P279, DOI 10.1111/j.1469-7998.1998.tb00102.x; PIATT JF, 1990, STUD AVIAN BIOL, V14, P36; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; Pichegru L, 2012, BIOL CONSERV, V156, P117, DOI 10.1016/j.biocon.2011.12.013; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; PIVORUNAS A, 1979, AM SCI, V67, P432; R Development Core Team, 2014, R LANG ENV STAT COMP; RICKLEFS RE, 1985, J ANIM ECOL, V54, P883, DOI 10.2307/4385; ROEL BA, 1991, S AFR J MARINE SCI, V11, P267, DOI 10.2989/025776191784287655; Ropert-Coudert Yan, 2000, Polar Bioscience, V13, P101; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Weill A, 1993, AQUAT LIVING RESOUR, V6, P255, DOI 10.1051/alr:1993026; Weller F, 2014, ECOL MODEL, V277, P38, DOI 10.1016/j.ecolmodel.2014.01.013; Wilson R.P., 1990, P181; Wilson RP, 2010, AQUAT BIOL, V8, P193, DOI 10.3354/ab00230; WILSON RP, 1986, ARDEA, V74, P211; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241; WILSON RP, 1985, MAR ECOL PROG SER, V25, P219, DOI 10.3354/meps025219; Zeileis A, 2014, R PACKAGE ZOO	45	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0140936	10.1371/journal.pone.0140936	http://dx.doi.org/10.1371/journal.pone.0140936			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600300	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900010
J	Peng, M; Ding, YL; Yu, L; Deng, YL; Lai, WS; Hu, Y; Zhang, HW; Wu, XQ; Fan, H; Ding, H; Wu, YL; Tao, GS				Peng, Mei; Ding, Yiling; Yu, Ling; Deng, Yali; Lai, Weisi; Hu, Yun; Zhang, Hongwen; Wu, Xianqing; Fan, Hong; Ding, Hui; Wu, Yilin; Tao, Guangshi			Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm	PLOS ONE			English	Article							HYDATIDIFORM MOLE; MANAGEMENT; DIAGNOSIS; DISEASE; S-1; UFT	Although 5-fluorouracil (5-Fu) combination chemotherapy provides a satisfactory therapeutic response in patients with gestational trophoblastic neoplasms (GTNs), it has severe side effects. The current study analyzed the therapeutic effects and side effects of tegafur plus actinomycin D (Act-D) vs. 5-Fu plus Act-D for the treatment of GTNs based on controlled historical records. A total of 427 GTN cases that received tegafur and Act-D combination chemotherapy at the Second Xiangya Hospital of XiangYa Medical School between August 2003 and July 2013 were analyzed based on historical data. A total of 393 GTN cases that received 5-Fu plus Act-D between August 1993 and July 2003 at the same hospital were also analyzed, which constituted the control group. The therapeutic effects, toxicity and side effects after chemotherapy were compared between the groups. The overall response rate was 90.63% in the tegafur+Act-D group (tegafur group) and 92.37% in the 5-Fu+Act-D group (5-Fu group); these rates were not significantly different (P > 0.05). However, the incidence rates of myelosuppression (white blood cell decline), gastrointestinal reactions (nausea, vomiting, dental ulcer, and diarrhea), skin lesions and phlebitis were lower in the tegafur group than in the 5-Fu group (P < 0.05). The results of this study may provide useful data for the clinical application of tegafur in GTN treatment.	[Peng, Mei; Ding, Yiling; Yu, Ling; Deng, Yali; Lai, Weisi; Hu, Yun; Zhang, Hongwen; Wu, Xianqing; Fan, Hong; Ding, Hui; Wu, Yilin; Tao, Guangshi] Cent S Univ, Dept Obstet & Gynaecol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China	Central South University	Ding, YL (corresponding author), Cent S Univ, Dept Obstet & Gynaecol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.	dingylcn@yeah.net						Ajani JA, 2005, J CLIN ONCOL, V24, P663; Berkowitz RS, 2002, NOVAKS GYNECOLOGY, P1353; Cao J, 2007, WORLD PHARM NEWSLETT, P38; Chalouhi GE, 2009, AM J OBSTET GYNECOL, P643; Chen XQ, 2003, NEW PHARM, P673; Eiriksson L, 2012, GYNECOL ONCOL, V124, P553, DOI 10.1016/j.ygyno.2011.10.036; Feng YJ, 2010, OBSTET GYNECOLOGY 8; Goldstein DP, 2012, HEMATOL ONCOL CLIN N, V26, P111, DOI 10.1016/j.hoc.2011.10.007; Komatsu T, 2001, CLIN CANCER RES, V7, P675; LI MC, 1971, ANN INTERN MED, V74, P102, DOI 10.7326/0003-4819-74-1-102; LI MC, 1956, P SOC EXP BIOL MED, V93, P361; Li ZY, 2009, CLIN ONCOLOGY, Vl14, P1022; Malet-Martino M, 2002, ONCOLOGIST, V7, P288, DOI 10.1634/theoncologist.7-4-288; Manopunya M, 2012, ASIAN PAC J CANCER P, V13, P387, DOI 10.7314/APJCP.2012.13.1.387; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Ngan HYS, 2002, INT J GYNECOL OBSTET, V77, P285; Ngan S, 2007, CURR OPIN ONCOL, V19, P486, DOI 10.1097/CCO.0b013e3282dc94e5; Organization W.H, 1979, WHO HDB REP RES CANC; Rodriguez N, 2010, EXPERT OPIN PHARMACO, V11, P3027, DOI 10.1517/14656566.2010.512288; Shi YF, 2006, HYDATID MOLE CHORIOC; Shi YF, 2000, CHINESE J CLIN OBSTE, V1, P29; Song HZ, 2004, DIAGNOSIS TREATMENT; Soper JT, 2004, GYNECOL ONCOL, V93, P575, DOI 10.1016/j.ygyno.2004.05.013; Sun Y, 2001, ONCOLOGY INTERNAL ME, P523; Takayama K, 2008, RESPIROLOGY, V13, P103, DOI 10.1111/j.1440-1843.2007.01190.x; Tsuburaya A, 2014, LANCET ONCOL, V15, P886, DOI 10.1016/S1470-2045(14)70025-7; Wan XR, 2002, CHINESE J PRACTICAL, V17, P398; Wang CM, 2009, J MED GENET, V46, P569, DOI 10.1136/jmg.2008.064196; Wang FM, 2007, PRACTICAL J CANC, P77; WANG SL, 1991, CHINESE MED J-PEKING, V104, P156; Zhao YF, 2007, CHINESE CLIN ONCOLOG, V12, P699; Zhou JC, 2003, PRACTICAL TUMOR INTE; Zhou JC, CLIN APPL ANTITUMOR; Zhou X, 2012, ONCOL LETT, V3, P659, DOI 10.3892/ol.2011.542	34	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143531	10.1371/journal.pone.0143531	http://dx.doi.org/10.1371/journal.pone.0143531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599757	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900138
J	Silva, DF; de Almeida, MM; Chaves, CG; Braz, AL; Gomes, MA; Pinho-da-Silva, L; Pesquero, JL; Andrade, VA; Leite, MD; de Albuquerque, JGF; Araujo, IGA; Nunes, XP; Barbosa, JM; Cruz, JD; Correia, ND; de Medeiros, IA				Silva, Darizy Flavia; de Almeida, Monica Moura; Chaves, Cinthia Guedes; Braz, Ana Leticia; Gomes, Maria Aparecida; Pinho-da-Silva, Leidiane; Pesquero, Jorge Luiz; Andrade, Viviane Aguiar; Leite, Maria de Fatima; Ferreira de Albuquerque, Jose George; Albuquerque Araujo, Islania Giselia; Nunes, Xirley Pereira; Barbosa-Filho, Jose Maria; Cruz, Jader dos Santos; Correia, Nadja de Azevedo; de Medeiros, Isac Almeida			TRPM8 Channel Activation Induced by Monoterpenoid Rotundifolone Underlies Mesenteric Artery Relaxation	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; PIPERITENONE OXIDE; VASCULAR-TONE; SMOOTH-MUSCLE; ION-CHANNEL; MENTHOL; COLD; CALCIUM; THERMOSENSATION; LOCALIZATION	In this study, our aims were to investigate transient receptor potential melastatin-8 channels (TRPM8) involvement in rotundifolone induced relaxation in the mesenteric artery and to increase the understanding of the role of these thermosensitive TRP channels in vascular tissue. Thus, message and protein levels of TRPM8 were measured by semi-quantitative PCR and western blotting in superior mesenteric arteries from 12 week-old Spague-Dawley (SD) rats. Isometric tension recordings evaluated the relaxant response in mesenteric rings were also performed. Additionally, the intracellular Ca2+ changes in mesenteric artery myocytes were measured using confocal microscopy. Using PCR and western blotting, both TRPM8 channel mRNA and protein expression was measured in SD rat mesenteric artery. Rotundifolone and menthol induced relaxation in the isolated superior mesenteric artery from SD rats and improved the relaxant response induced by cool temperatures. Also, this monoterpene induced an increase in transient intracellular Ca2+. These responses were significantly attenuated by pretreatment with capsazepine or BCTC, both TRPM8 channels blockers. The response induced by rotundifolone was not significantly attenuated by ruthenium red, a non-selective TRP channels blocker, or following capsaicin-mediated desensitization of TRPV1. Our findings suggest that rotundifolone induces relaxation by activating TRPM8 channels in rat superior mesenteric artery, more selectively than menthol, the classic TRPM8 agonist, and TRPM8 channels participates in vasodilatory pathways in isolated rat mesenteric arteries.	[Silva, Darizy Flavia] Univ Fed Bahia UFBA, Dept Bioregulacao, BR-40110902 Salvador, BA, Brazil; [de Almeida, Monica Moura; Chaves, Cinthia Guedes; Braz, Ana Leticia; Ferreira de Albuquerque, Jose George; Albuquerque Araujo, Islania Giselia; Barbosa-Filho, Jose Maria; Correia, Nadja de Azevedo; de Medeiros, Isac Almeida] Univ Fed Paraiba UFPB, Dept Ciencias Farmaceut, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Gomes, Maria Aparecida; Pinho-da-Silva, Leidiane; Pesquero, Jorge Luiz; Andrade, Viviane Aguiar; Leite, Maria de Fatima; Cruz, Jader dos Santos] Univ Fed Minas Gerais, Dept Fisiol & Biofis, BR-31270901 Belo Horizonte, MG, Brazil; [Nunes, Xirley Pereira] Univ Fed Vale Sao Francisco, Nucleo Estudos & Pesquisas Plantas Med, BR-56304205 Petrolina, PE, Brazil	Universidade Federal da Paraiba; Universidade Federal de Minas Gerais; Universidade Federal do Vale do Sao Francisco	Silva, DF (corresponding author), Univ Fed Bahia UFBA, Dept Bioregulacao, BR-40110902 Salvador, BA, Brazil.	darizy@gmail.com	Cruz, Jader/AAO-5284-2020; de Medeiros, Isac Almeida/C-5784-2013; Silva, Darizy Flávia/AAV-9772-2020; Filho, Jose Maria Barbosa/B-3951-2010; de Fatima Leite, Maria/AAK-2555-2021; Nunes, Xirley/F-6272-2014	Cruz, Jader/0000-0003-1365-2318; de Medeiros, Isac Almeida/0000-0001-8783-4806; Filho, Jose Maria Barbosa/0000-0002-9567-4096; Pesquero, Jorge/0000-0002-1460-9226; Braz de Sousa, Ana Leticia/0000-0003-0576-1047; Nunes, Xirley/0000-0002-9714-8575; Giselia Albuquerque Araujo, Islania/0000-0002-3584-898X	Fundacao de Amparo a pesquisa do estado da Bahia (FAPESB); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a pesquisa do estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DFS was supported by Fundacao de Amparo a pesquisa do estado da Bahia (FAPESB-http://www.fapesb.ba.gov.br). JSC was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - www.fapemig.br). IAM and MFL were supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R. N., 1996, Fitoterapia, V67, P334; Amato A, 2014, EUR J PHARMACOL, V745, P129, DOI 10.1016/j.ejphar.2014.10.012; Bai VU, 2010, INT J ONCOL, V36, P443, DOI 10.3892/ijo_00000518; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Calixto JB, 2005, PHARMACOL THERAPEUT, V106, P179, DOI 10.1016/j.pharmthera.2004.11.008; Cheang WS, 2013, EUR J PHARMACOL, V702, P79, DOI 10.1016/j.ejphar.2013.01.028; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Filosa JA, 2013, J CARDIOVASC PHARM, V61, P113, DOI 10.1097/FJC.0b013e318279ba42; Guedes DN, 2004, BRAZ J MED BIOL RES, V37, P1881, DOI 10.1590/S0100-879X2004001200014; Guedes DN, 2002, PLANTA MED, V68, P700, DOI 10.1055/s-2002-33795; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Lahlou S, 2001, PLANTA MED, V67, P638, DOI 10.1055/s-2001-17352; Leite MF, 2003, P NATL ACAD SCI USA, V100, P2975, DOI 10.1073/pnas.0536590100; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Reading SA, 2005, AM J PHYSIOL-HEART C, V288, pH2055, DOI 10.1152/ajpheart.00861.2004; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Silva DF, 2011, BASIC CLIN PHARMACOL, V109, P465, DOI 10.1111/j.1742-7843.2011.00749.x; Sokabe Takaaki, 2009, Communicative & Integrative Biology, V2, P170; Sousa PJC, 1997, BRAZ J MED BIOL RES, V30, P787, DOI 10.1590/S0100-879X1997000600014; Tanaka Y, 1999, BRIT J PHARMACOL, V128, P1602, DOI 10.1038/sj.bjp.0702954; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Zholos A, 2010, BRIT J PHARMACOL, V159, P1559, DOI 10.1111/j.1476-5381.2010.00649.x; Zuker CS, 2002, NATURE, V416, P27, DOI 10.1038/416027a	50	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143171	10.1371/journal.pone.0143171	http://dx.doi.org/10.1371/journal.pone.0143171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599698	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900072
J	Singh, GKS; Balzer, BWR; Kelly, PJ; Paxton, K; Hawke, CI; Handelsman, DJ; Steinbeck, KS				Singh, Gurmeet K. S.; Balzer, Ben W. R.; Kelly, Patrick J.; Paxton, Karen; Hawke, Catherine I.; Handelsman, David J.; Steinbeck, Katharine S.			Urinary Sex Steroids and Anthropometric Markers of Puberty - A Novel Approach to Characterising Within-Person Changes of Puberty Hormones	PLOS ONE			English	Article							MASS-SPECTROMETRY ASSAY; SELF-ASSESSMENT; REFERENCE INTERVALS; TESTOSTERONE LEVELS; CHINESE BOYS; GIRLS; ADOLESCENTS; CHILDREN; ESTRADIOL; PATTERN	Background/Aims The longitudinal relationships of within-individual hormone and anthropometric changes during puberty have not ever been fully described. The objectives of this study were to demonstrate that 3 monthly urine collection was feasible in young adolescents and to utilise liquid chromatography-tandem mass spectrometry assay methods for serum and urine testosterone (T), estradiol (E2) and luteinizing hormone (LH) in adolescents by relating temporal changes in urine and serum hormones over 12 months to standard measures of pubertal development. Methods A community sample of 104 adolescents (57 female) was studied over 12 months with annual anthropometric assessment, blood sampling and self-rated Tanner staging and urine collected every 3 months. Serum and urine sex steroids (T, E2) were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and LH by immunoassay. Results A high proportion (92%) of scheduled samples were obtained with low attrition rate of 6.7% over the 12 months. Urine hormone measurements correlated cross-sectionally and longitudinally with age, anthropometry and Tanner stage. Conclusion We have developed a feasible and valid sampling methodology and measurements for puberty hormones in urine, which allows a sampling frequency by which individual pubertal progression in adolescents can be described in depth.	[Singh, Gurmeet K. S.; Handelsman, David J.] Univ Sydney, ANZAC Res Inst, Camperdown, NSW, Australia; [Singh, Gurmeet K. S.] Univ Teknol MARA, Fac Pharm, Selangor, Malaysia; [Balzer, Ben W. R.; Steinbeck, Katharine S.] Childrens Hosp Westmead, Acad Dept Adolescent Med, Westmead, NSW, Australia; [Balzer, Ben W. R.; Steinbeck, Katharine S.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney Med Sch, Camperdown, NSW, Australia; [Kelly, Patrick J.] Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Camperdown, NSW, Australia; [Paxton, Karen; Hawke, Catherine I.] Univ Sydney, Sch Rural Hlth, Sydney Med Sch, Camperdown, NSW, Australia	University of Sydney; ANZAC Research Institute; Universiti Teknologi MARA; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Steinbeck, KS (corresponding author), Childrens Hosp Westmead, Acad Dept Adolescent Med, Westmead, NSW, Australia.	kate.steinbeck@health.nsw.gov.au	Research Institute, ANZAC/CAE-9030-2022; Surindar Singh, Gurmeet Kaur/ABA-7801-2020; Handelsman, David/AAR-9580-2021; Steinbeck, Kate/AAX-6197-2020; Ekanayake, Kanchana/P-8817-2016	Surindar Singh, Gurmeet Kaur/0000-0003-4223-9557; Kelly, Patrick/0000-0002-5015-0977; Handelsman, David/0000-0002-4200-7476; Paxton, Karen/0000-0001-7537-3731; Balzer, Ben/0000-0001-7116-2339	Australian National Health and Medical Research Council (NHMRC) Project [1003312]	Australian National Health and Medical Research Council (NHMRC) Project(National Health and Medical Research Council (NHMRC) of Australia)	The ARCHER study is supported by the Australian National Health and Medical Research Council (NHMRC) Project Grant #1003312. (KSS, CIH, DJH) www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Balzer BWR, 2015, EUR J PEDIATR, V174, P289, DOI 10.1007/s00431-014-2475-3; BIRO FM, 1995, J PEDIATR-US, V127, P100, DOI 10.1016/S0022-3476(95)70265-2; Biro FM, 2014, J CLIN ENDOCR METAB, V99, P3829, DOI 10.1210/jc.2013-4528; Bonat S, 2002, PEDIATRICS, V110, P743, DOI 10.1542/peds.110.4.743; Bordini B, 2011, PEDIATR REV, V32, P281, DOI 10.1542/pir.32-7-281; BREMNER WJ, 1983, J CLIN ENDOCR METAB, V56, P1278, DOI 10.1210/jcem-56-6-1278; Courant F, 2010, J CLIN ENDOCR METAB, V95, P82, DOI 10.1210/jc.2009-1140; Desmangles JC, 2006, J PEDIATR ENDOCR MET, V19, P213; Dorn L. D., 2006, APPL DEV SCI, V10, P30, DOI [10.1207/s1532480xads1001_3, DOI 10.1207/S1532480XADS1001_3]; Duke SA, 2014, J ADOLESCENT HEALTH, V55, P315, DOI 10.1016/j.jadohealth.2014.05.007; Handelsman DJ, 2013, J CLIN ENDOCR METAB, V98, P3971, DOI 10.1210/jc.2013-3375; Harwood DT, 2009, CLIN CHIM ACTA, V409, P78, DOI 10.1016/j.cca.2009.09.003; Hergenroeder AC, 1999, J ADOLESCENT HEALTH, V24, P201, DOI 10.1016/S1054-139X(98)00110-4; Ji CY, 2001, AM J HUM BIOL, V13, P35, DOI 10.1002/1520-6300(200101/02)13:1<35::AID-AJHB1005>3.0.CO;2-E; Kaitz M, 2012, DEV PSYCHOBIOL, V54, P113, DOI 10.1002/dev.20580; Kettaneh A, 2005, DIABETES METAB, V31, P534, DOI 10.1016/S1262-3636(07)70228-8; Konforte D, 2013, CLIN CHEM, V59, P1215, DOI 10.1373/clinchem.2013.204123; Kushnir MM, 2008, AM J CLIN PATHOL, V129, P530, DOI 10.1309/LC03BHQ5XJPJYEKG; Kushnir MM, 2010, MASS SPECTROM REV, V29, P480, DOI 10.1002/mas.20264; Laron Zvi, 2010, Pediatr Endocrinol Rev, V7, P256; Lee PA, 2006, PEDIAT ENDOCRINOLOGY, P273; Marceau K, 2011, DEV PSYCHOL, V47, P1389, DOI 10.1037/a0023838; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Mouritsen A, 2014, HORM RES PAEDIAT, V82, P12, DOI 10.1159/000358560; NIELSEN CT, 1986, ACTA ENDOCRINOL-COP, V113, P98; Rasmussen AR, 2015, PEDIATRICS, V135, P86, DOI 10.1542/peds.2014-0793; Rosner W, 2013, J CLIN ENDOCR METAB, V98, P1376, DOI 10.1210/jc.2012-3780; Sikaris K, 2005, J CLIN ENDOCR METAB, V90, P5928, DOI 10.1210/jc.2005-0962; Singh GKS, 2015, ANN CLIN BIOCHEM, V52, P665, DOI 10.1177/0004563215580385; Singh GKS, 2014, DRUG TEST ANAL, V6, P336, DOI 10.1002/dta.1481; Sivananthan T, 2012, ASIAN J ANDROL, V14, P476, DOI 10.1038/aja.2012.2; Steinbeck K, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-143; Sun Y, 2012, ANN HUM BIOL, V39, P461, DOI 10.3109/03014460.2012.712156; Taieb J, 2003, CLIN CHEM, V49, P1381, DOI 10.1373/49.8.1381	37	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143555	10.1371/journal.pone.0143555	http://dx.doi.org/10.1371/journal.pone.0143555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599397	gold, Green Submitted, Green Published			2022-12-26	WOS:000365853900145
J	Adams, JB; Bollens, SM; Bishop, JG				Adams, Jesse B.; Bollens, Stephen M.; Bishop, John G.			Predation on the Invasive Copepod, Pseudodiaptomus forbesi, and Native Zooplankton in the Lower Columbia River: An Experimental Approach to Quantify Differences in Prey-Specific Feeding Rates	PLOS ONE			English	Article							JUVENILE CHINOOK SALMON; DIEL VERTICAL MIGRATION; SELECTIVE PREDATION; FRESH-WATER; PLANKTIVOROUS FISH; BODY-SIZE; PTYCHOCHEILUS-OREGONENSIS; ONCORHYNCHUS-TSHAWYTSCHA; NORTHERN PIKEMINNOW; CALANUS-PACIFICUS	Invasive planktonic crustaceans have become a prominent feature of aquatic communities worldwide, yet their effects on food webs are not well known. The Asian calanoid copepod, Pseudodiaptomus forbesi, introduced to the Columbia River Estuary approximately 15 years ago, now dominates the late-summer zooplankton community, but its use by native aquatic predators is unknown. We investigated whether three species of planktivorous fishes (chinook salmon, three-spined stickleback, and northern pikeminnow) and one species of mysid exhibited higher feeding rates on native copepods and cladocerans relative to P. forbesi by conducting 'single-prey' feeding experiments and, additionally, examined selectivity for prey types with 'two-prey' feeding experiments. In single-prey experiments individual predator species showed no difference in feeding rates on native cyclopoid copepods (Cyclopidae spp.) relative to invasive P. forbesi, though wild-collected predators exhibited higher feeding rates on cyclopoids when considered in aggregate. In two-prey experiments, chinook salmon and northern pikeminnow both strongly selected native cladocerans (Daphnia retrocurva) over P. forbesi, and moreover, northern pikeminnow selected native Cyclopidae spp. over P. forbesi. On the other hand, in two-prey experiments, chinook salmon, three-spined stickleback and mysids were non-selective with respect to feeding on native cyclopoid copepods versus P. forbesi. Our results indicate that all four native predators in the Columbia River Estuary can consume the invasive copepod, P. forbesi, but that some predators select for native zooplankton over P. forbesi, most likely due to one (or both) of two possible underlying casual mechanisms: 1) differential taxon-specific prey motility and escape responses (calanoids > cyclopoids > daphnids) or 2) the invasive status of the zooplankton prey resulting in naivety, and thus lower feeding rates, of native predators feeding on invasive prey.	[Adams, Jesse B.; Bollens, Stephen M.] Washington State Univ, Sch Environm, Vancouver, WA 99164 USA; [Bollens, Stephen M.; Bishop, John G.] Washington State Univ, Sch Biol Sci, Vancouver, WA USA	Washington State University; Washington State University	Adams, JB (corresponding author), Washington State Univ, Sch Environm, Vancouver, WA 99164 USA.	jesse.b.adams@wsu.edu		Adams, Jesse/0000-0002-0739-8782	National Science Foundation [DGE-0742561]; Washington State University	National Science Foundation(National Science Foundation (NSF)); Washington State University	This research was funded through a grant from the National Science Foundation to SB et al. (DGE-0742561) and Washington State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avent SR, 2001, DEEP-SEA RES PT II, V48, P673, DOI 10.1016/S0967-0645(00)00093-X; Balestrieri A, 2013, FRESHWATER BIOL, V58, P995, DOI 10.1111/fwb.12102; Barber NA, 2008, ECOLOGY, V89, P2678, DOI 10.1890/08-0395.1; BEAMESDERFER RC, 1992, ENVIRON BIOL FISH, V35, P231, DOI 10.1007/BF00001888; Beckman BR, 2007, CAN J FISH AQUAT SCI, V64, P256, DOI 10.1139/F07-001; Bersine K, 2008, BIOL INVASIONS, V10, P1381, DOI 10.1007/s10530-007-9213-y; Bollache L, 2006, ANIM BEHAV, V72, P627, DOI 10.1016/j.anbehav.2005.11.020; BOLLENS SM, 1989, LIMNOL OCEANOGR, V34, P1072, DOI 10.4319/lo.1989.34.6.1072; BOLLENS SM, 1993, LIMNOL OCEANOGR, V38, P1827, DOI 10.4319/lo.1993.38.8.1827; Bollens SM, 2002, HYDROBIOLOGIA, V480, P87, DOI 10.1023/A:1021233018533; BOLLENS SM, 1991, OECOLOGIA, V87, P155, DOI 10.1007/BF00325252; Bollens SM, 2010, J PLANKTON RES; Bollens SM, 2012, AQUAT INVASIONS, V7, P101, DOI 10.3391/ai.2012.7.1.011; Bollens SM, 2010, FISH B-NOAA, V108, P393; BOTTOM DL, 1990, PROG OCEANOGR, V25, P243, DOI 10.1016/0079-6611(90)90009-Q; Boxshall GA, 2008, HYDROBIOLOGIA, V595, P195, DOI 10.1007/s10750-007-9014-4; Breckenridge JK, 2015, ESTUAR COAST, V38, P93, DOI 10.1007/s12237-014-9820-7; BRETT JR, 1971, J FISH RES BOARD CAN, V28, P409, DOI 10.1139/f71-053; Brooks J. L., 1968, Systematic Zoology, V17, P273; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carlsson NOL, 2009, FRONT ECOL ENVIRON, V7, P525, DOI 10.1890/080093; Carlton JT, 1991, CHEM PHYS LETT, V179, P53, DOI DOI 10.1016/0009-2614(91)90290-P; Cattau CE, 2010, BIOL CONSERV, V143, P513, DOI 10.1016/j.biocon.2009.11.022; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Collis Ken, 1995, North American Journal of Fisheries Management, V15, P346, DOI 10.1577/1548-8675(1995)015<0346:CICRAD>2.3.CO;2; Cordell JR, 2008, ICES J MAR SCI, V65, P753, DOI 10.1093/icesjms/fsm195; Cordell JR, 2007, MAR ECOL PROG SER, V333, P213, DOI 10.3354/meps333213; CRADDOCK DR, 1976, T AM FISH SOC, V105, P72, DOI 10.1577/1548-8659(1976)105<72:OAUOZB>2.0.CO;2; DALY KL, 1986, J CRUSTACEAN BIOL, V6, P840, DOI 10.2307/1548396; Dermott R, 2001, J GREAT LAKES RES, V27, P423, DOI 10.1016/S0380-1330(01)70657-0; Dexter E, 2015, LIMNOL OCEANOGR, V60, P527, DOI 10.1002/lno.10034; Dick JTA, 2002, CAN J FISH AQUAT SCI, V59, P1078, DOI 10.1139/F02-074; DRENNER RW, 1978, J FISH RES BOARD CAN, V35, P1370, DOI 10.1139/f78-215; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; EKLOV P, 1989, OIKOS, V56, P149, DOI 10.2307/3565330; EKLOV P, 1994, OECOLOGIA, V98, P344, DOI 10.1007/BF00324223; Emerson JE, 2015, AQUAT INVASIONS, V10, P25, DOI 10.3391/ai.2015.10.1.03; EVEREST FH, 1972, J FISH RES BOARD CAN, V29, P91, DOI 10.1139/f72-012; FENDERSO.OC, 1968, J FISH RES BOARD CAN, V25, P1, DOI 10.1139/f68-001; Fink P, 2012, AQUAT SCI, V74, P191, DOI 10.1007/s00027-011-0210-y; Fitzgerald G.J., 1986, P409; Gorokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071385; HARTLEB CF, 1995, FISH RES, V24, P261, DOI 10.1016/0165-7836(95)00390-V; Haskell CA, 2006, RIVER RES APPL, V22, P739, DOI 10.1002/rra.927; HOLLING C. S., 1966, Memoirs of the Entomology Society of Canada; Jaworski CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082231; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Koehler ME, 2006, T AM FISH SOC, V135, P1580, DOI 10.1577/T05-178.1; Lawrence DJ, 2010, BIOL CONSERV, V143, P700, DOI 10.1016/j.biocon.2009.12.008; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lopez MS, 2010, MAR ECOL PROG SER, V403, P101, DOI 10.3354/meps08409; Lovell S. J., 2006, Agricultural and Resource Economics Review, V35, P195; Lundvall D, 1999, CAN J FISH AQUAT SCI, V56, P1285, DOI 10.1139/cjfas-56-7-1285; Maerz JC, 2005, DIVERS DISTRIB, V11, P83, DOI 10.1111/j.1366-9516.2005.00125.x; MANLY BFJ, 1974, BIOMETRICS, V30, P281, DOI 10.2307/2529649; Maszczyk P, 2014, LIMNOL OCEANOGR, V59, P68, DOI 10.4319/lo.2014.59.1.0068; MENG L, 1991, T AM FISH SOC, V120, P187, DOI 10.1577/1548-8659(1991)120<0187:SPBLSB>2.3.CO;2; MILLS EL, 1986, T AM FISH SOC, V115, P716, DOI 10.1577/1548-8659(1986)115<716:ZSBYYP>2.0.CO;2; MOLLES MC, 1983, OECOLOGIA, V57, P25, DOI 10.1007/BF00379557; MURTAUGH PA, 1981, ECOLOGY, V62, P894, DOI 10.2307/1936986; Nobriga ML, 2002, CALIF FISH GAME, V88, P149; OBRIEN WJ, 1979, AM SCI, V67, P572; Orsi JJ, 1990, B PLANKTON SOC JPN, V553-562; PAINE RT, 1976, ECOLOGY, V57, P858, DOI 10.2307/1941053; PALMER AR, 1984, OECOLOGIA, V62, P162, DOI 10.1007/BF00379009; Petersen JH, 2001, CAN J FISH AQUAT SCI, V58, P1831, DOI 10.1139/cjfas-58-9-1831; Petersen JH, 2001, J FISH BIOL, V58, P1137, DOI 10.1111/j.1095-8649.2001.tb00561.x; Phillips BL, 2006, P ROY SOC B-BIOL SCI, V273, P1545, DOI 10.1098/rspb.2006.3479; Pichlova-Ptacnikova R, 2011, BIOL INVASIONS, V13, P2595, DOI 10.1007/s10530-011-0076-x; Pothoven SA, 2001, N AM J FISH MANAGE, V21, P876, DOI 10.1577/1548-8675(2001)021<0876:CIDABC>2.0.CO;2; Pothoven SA, 2008, N AM J FISH MANAGE, V28, P308, DOI 10.1577/M07-022.1; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; REIMERS PE, 1968, J FISH RES BOARD CAN, V25, P2005, DOI 10.1139/f68-179; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; Rilov G, 2002, MAR ENVIRON RES, V54, P85, DOI 10.1016/S0141-1136(02)00096-X; Rothlisberger JD, 2012, ECOSYSTEMS, V15, P462, DOI 10.1007/s10021-012-9522-6; ROTHSCHILD BJ, 1988, J PLANKTON RES, V10, P465, DOI 10.1093/plankt/10.3.465; SHERRATT TN, 1993, BIOL J LINN SOC, V48, P167, DOI 10.1111/j.1095-8312.1993.tb00885.x; SIMENSTAD CA, 1990, PROG OCEANOGR, V25, P1, DOI 10.1016/0079-6611(90)90002-J; SOSIAK AJ, 1979, J FISH RES BOARD CAN, V36, P1408, DOI 10.1139/f79-202; Strayer DL, 1999, J N AM BENTHOL SOC, V18, P74, DOI 10.2307/1468010; Suarez AV, 2000, ECOL APPL, V10, P711; Sytsma M, 2004, US COAST GUARD US FI, V1, P1; Twardochleb LA, 2012, ECOL APPL, V22, P1162, DOI 10.1890/11-0871.1; Underwood AJ, 2005, J EXP MAR BIOL ECOL, V318, P227, DOI [10.1016/j.jembe.2004.12.014, 10.1016/j.jembre.2004.12.014]; VIGG S, 1991, CAN J FISH AQUAT SCI, V48, P2491, DOI 10.1139/f91-290; VISSER M, 1982, OECOLOGIA, V55, P395, DOI 10.1007/BF00376928; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Wanger TC, 2011, P ROY SOC B-BIOL SCI, V278, P690, DOI 10.1098/rspb.2010.1512; WERNER EE, 1974, ECOLOGY, V55, P1042, DOI 10.2307/1940354; ZARET TM, 1975, ECOLOGY, V56, P232, DOI 10.2307/1935317; Zimmerman MP, 1999, T AM FISH SOC, V128, P1036, DOI 10.1577/1548-8659(1999)128<1036:FHOSBW>2.0.CO;2	93	4	4	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0144095	10.1371/journal.pone.0144095	http://dx.doi.org/10.1371/journal.pone.0144095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618851	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800101
J	Cavalieri, V; Spinelli, G				Cavalieri, Vincenzo; Spinelli, Giovanni			Ectopic hbox12 Expression Evoked by Histone Deacetylase Inhibition Disrupts Axial Specification of the Sea Urchin Embryo	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; HOMEOBOX-CONTAINING GENE; ECTODERM CELLS AFFECTS; ORAL-ABORAL AXIS; TRICHOSTATIN-A; TRANSCRIPTIONAL NETWORKS; VALPROIC ACID; ACETYLATION; POTENT; METHYLATION	Dorsal/ventral patterning of the sea urchin embryo depends upon the establishment of a Nodal-expressing ventral organizer. Recently, we showed that spatial positioning of this organizer relies on the dorsal-specific transcription of the Hbox12 repressor. Building on these findings, we determined the influence of the epigenetic milieu on the expression of hbox12 and nodal genes. We find that Trichostatin-A, a potent and selective histone-deacetylases inhibitor, induces histone hyperacetylation in hbox12 chromatin, evoking broad ectopic expression of the gene. Transcription of nodal concomitantly drops, prejudicing dorsal/ventral polarity of the resulting larvae. Remarkably, impairing hbox12 function, either in a spatially-restricted sector or in the whole embryo, specifically rescues nodal transcription in Trichostatin-A-treated larvae. Beyond strengthen the notion that nodal expression is not allowed in the presence of functional Hbox12 in the same cells, these results highlight a critical role of histone deacetylases in regulating the spatial expression of hbox12.	[Cavalieri, Vincenzo; Spinelli, Giovanni] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, I-90133 Palermo, Italy; [Cavalieri, Vincenzo] Univ Palermo, Mediterranean Ctr Human Hlth Adv Biotechnol CHAB, I-90133 Palermo, Italy	University of Palermo; University of Palermo	Cavalieri, V (corresponding author), Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, I-90133 Palermo, Italy.	vincenzo.cavalieri@unipa.it; giovanni.spinelli@unipa.it		SPINELLI, Giovanni/0000-0002-2785-2014; CAVALIERI, Vincenzo/0000-0003-0906-9963	Universita degli studi di Palermo - STEMBIO Award; Universita degli studi di Palermo - FFR ex60%; Assessorato Regionale della Salute; Regione Siciliana - PO F.E.S.R. 4.1.1.1 RIMEDRI	Universita degli studi di Palermo - STEMBIO Award; Universita degli studi di Palermo - FFR ex60%; Assessorato Regionale della Salute; Regione Siciliana - PO F.E.S.R. 4.1.1.1 RIMEDRI	This work was supported by the Universita degli studi di Palermo - STEMBIO Award to VC, Universita degli studi di Palermo - FFR ex60% to VC, Assessorato Regionale della Salute, Regione Siciliana - PO F.E.S.R. 4.1.1.1 RIMEDRI to VC and Assessorato Regionale della Salute, Regione Siciliana - PO F.E.S.R. 4.1.1.1 RIMEDRI to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOUZNI G, 1994, DEV BIOL, V165, P654, DOI 10.1006/dbio.1994.1283; Angerer LM, 2003, CURR TOP DEV BIOL, V53, P159, DOI 10.1016/S0070-2153(03)53005-8; Angerer LM, 2000, DEVELOPMENT, V127, P1105; Bolouri H, 2010, DEV BIOL, V340, P170, DOI 10.1016/j.ydbio.2009.06.007; Bradham CA, 2009, DEV BIOL, V328, P221, DOI 10.1016/j.ydbio.2009.01.027; Cavalieri V, 2003, DEV BIOL, V262, P107, DOI 10.1016/S0012-1606(03)00317-8; Cavalieri V, 2008, DEV BIOL, V321, P455, DOI 10.1016/j.ydbio.2008.06.006; Cavalieri V, 2014, ELIFE, V3, DOI 10.7554/eLife.04664; Cavalieri V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003847; Cavalieri V, 2011, DEVELOPMENT, V138, P4279, DOI 10.1242/dev.066480; Cavalieri V, 2009, NUCLEIC ACIDS RES, V37, P7407, DOI 10.1093/nar/gkp859; Cavalieri Vincenzo, 2009, V518, P175, DOI 10.1007/978-1-59745-202-1_13; Cavalieri V, 2007, GENE EXPR PATTERNS, V7, P124, DOI 10.1016/j.modgep.2006.06.001; Chen JH, 2011, DEV DYNAM, V240, P250, DOI 10.1002/dvdy.22514; Chiba T, 2004, ONCOLOGY-BASEL, V66, P481, DOI 10.1159/000079503; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Davidson EH, 2006, REG GEN GEN REG; Di Caro V, 2007, J MOL BIOL, V365, P1285, DOI 10.1016/j.jmb.2006.10.098; DIBERNARDO M, 1995, P NATL ACAD SCI USA, V92, P8180, DOI 10.1073/pnas.92.18.8180; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; Duboc V, 2008, DEV BIOL, V320, P49, DOI 10.1016/j.ydbio.2008.04.012; El-Osta A, 2002, MOL CELL BIOL, V22, P1844, DOI 10.1128/MCB.22.6.1844-1857.2002; Emanuele M, 2011, INT J DEV BIOL, V55, P591, DOI 10.1387/ijdb.103264me; Ettensohn CA, 2013, GENESIS, V51, P383, DOI 10.1002/dvg.22380; Flowers VL, 2004, DEV DYNAM, V231, P727, DOI 10.1002/dvdy.20194; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gray SG, 2004, INT J ONCOL, V24, P773; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; IKEGAMI S, 1993, ROUX ARCH DEV BIOL, V202, P144, DOI 10.1007/BF00365304; Jasinskas A, 1997, BBA-GENE STRUCT EXPR, V1351, P168, DOI 10.1016/S0167-4781(96)00193-5; Jee BC, 2012, ZYGOTE, V20, P27, DOI 10.1017/S0967199410000547; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Khan DH, 2013, FEBS LETT, V587, P1510, DOI 10.1016/j.febslet.2013.03.029; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lapraz F, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000248; Li EH, 2013, DEV BIOL, V382, P268, DOI 10.1016/j.ydbio.2013.07.027; Li EH, 2012, DEV BIOL, V369, P377, DOI 10.1016/j.ydbio.2012.06.022; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Molina MD, 2013, CURR OPIN GENET DEV, V23, P445, DOI 10.1016/j.gde.2013.04.010; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Nam J, 2007, DEV BIOL, V306, P860, DOI 10.1016/j.ydbio.2007.03.033; Nemer M, 1998, DEV GROWTH DIFFER, V40, P583; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Range R, 2007, DEVELOPMENT, V134, P3649, DOI 10.1242/dev.007799; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Saudemont A, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1001259, DOI 10.1371/J0URNAL.PGEN.1001259]; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Su YH, 2009, DEV BIOL, V329, P410, DOI 10.1016/j.ydbio.2009.02.029; Van Nostrand EL, 2011, CURR OPIN GENET DEV, V21, P776, DOI 10.1016/j.gde.2011.08.007; WANGH L, 1972, ARCH BIOCHEM BIOPHYS, V150, P44, DOI 10.1016/0003-9861(72)90008-2; Wunderlich Z, 2011, CURR OPIN GENET DEV, V21, P711, DOI 10.1016/j.gde.2011.07.005; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yaguchi S, 2010, DEV BIOL, V347, P71, DOI 10.1016/j.ydbio.2010.08.009; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang Y, 2005, MOL CELL BIOL, V25, P7929, DOI 10.1128/MCB.25.18.7929-7939.2005; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	70	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143860	10.1371/journal.pone.0143860	http://dx.doi.org/10.1371/journal.pone.0143860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618749	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800082
J	Huh, JH; Ahn, SV; Koh, SB; Choi, E; Kim, JY; Sung, KC; Kim, EJ; Park, JB				Huh, Ji Hye; Ahn, Song Vogue; Koh, Sang Baek; Choi, Eunhee; Kim, Jang Young; Sung, Ki-Chul; Kim, Eung Ju; Park, Jeong Bae			A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; SERUM ADIPONECTIN; RECEPTOR BLOCKER; RISK-FACTORS; OBESITY; ASSOCIATION	Background Although non-alcoholic fatty liver disease is the hepatic manifestation of metabolic syndrome, its influence on hypertension development is poorly understood. We investigated whether fatty liver disease, as assessed by the fatty liver index, could predict the development of hypertension independently of systemic insulin resistance, inflammatory status and adipokine levels. Methods Prospective cohort study of 1,521 adults (484 men and 1037 women) aged 40 to 70 years without baseline hypertension examined. An equation was used to calculate fatty liver index and classify patients as follows: fatty liver index <30, no non-alcoholic fatty liver disease; fatty liver index >= 60, non-alcoholic fatty liver disease; and 30 <= fatty liver index <60, intermediate fatty liver index. Results During an average of 2.6 years of follow-up, 153 subjects (10.06%) developed hypertension. Fatty liver index was positively associated with baseline blood pressure, homeostasis model assessment of insulin resistance, urinary albumin/creatinine excretion, and high sensitivity C-reactive protein. After adjustment for confounding factors, including markers of insulin resistance, systemic inflammation and adiponectin levels, the odds ratio [95% confidence interval] for the incident hypertension increased in a graded manner with fatty liver index (<30 vs. 30-59 vs. >= 60 = 1 vs. 1.83 [1.16 similar to 2.88] vs. 2.09 [1.08 similar to 4.055], respectively). Conclusions Non-alcoholic fatty liver disease assessed by fatty liver index was an independent risk factor for hypertension. Our findings suggest that fatty liver index, a simple surrogate indicator of fatty liver disease, might be useful for identifying subjects at high risk for incident hypertension in clinical practice.	[Huh, Ji Hye] Wonju Coll Med, Div Endocrinol & Metab, Dept Internal Med, Wonju, South Korea; [Ahn, Song Vogue; Koh, Sang Baek] Wonju Coll Med, Inst Genom Cohort, Dept Prevent Med, Wonju, South Korea; [Choi, Eunhee] Wonju Coll Med, Inst Life Style Med, Wonju, South Korea; [Kim, Jang Young] Yonsei Univ, Wonju Coll Med, Div Cardiol, Dept Internal Med, Wonju, South Korea; [Sung, Ki-Chul] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Med, Seoul, South Korea; [Kim, Eung Ju] Korea Univ, Coll Med, Guro Hosp, Div Cardiol,Dept Med, Seoul 136705, South Korea; [Park, Jeong Bae] Kwandong Univ, Coll Med, Cheil Gen Hosp, Div Cardiol,Dept Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine); Catholic Kwandong University	Choi, E (corresponding author), Wonju Coll Med, Inst Life Style Med, Wonju, South Korea.	eunhee_choi@yonsei.ac.kr; kimjy@yonsei.ac.kr	Ahn, Song Vogue/AAK-2900-2021	Kim, Eung Ju/0000-0003-2322-6267; Choi, Eunhee/0000-0002-3449-0672				Aizawa-Abe M, 2000, J CLIN INVEST, V105, P1243, DOI 10.1172/JCI8341; Aneni EC, 2015, J HYPERTENS, V33, P1207, DOI 10.1097/HJH.0000000000000532; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Beltowski J, 2006, J HYPERTENS, V24, P789; BHAGAT B, 1981, BRIT J PHARMACOL, V74, P325, DOI 10.1111/j.1476-5381.1981.tb09975.x; Bidani AK, 2004, HYPERTENSION, V44, P595, DOI 10.1161/01.HYP.0000145180.38707.84; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Souza Mônica Rodrigues de Araújo, 2012, Arq. Gastroenterol., V49, P89, DOI 10.1590/S0004-28032012000100015; Fan JG, 2007, J GASTROEN HEPATOL, V22, P1086, DOI 10.1111/j.1440-1746.2006.04781.x; GILMORE IT, 1995, GUT, V36, P437, DOI 10.1136/gut.36.3.437; Harrison W, 2006, J HUM HYPERTENS, V20, P97, DOI 10.1038/sj.jhh.1001958; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jung CH, 2013, DIABETIC MED, V30, P428, DOI 10.1111/dme.12104; Jung DH, 2014, DIABETES RES CLIN PR, V103, P51, DOI 10.1016/j.diabres.2013.09.018; Kato J, 2012, INT J MOL MED, V30, P107, DOI 10.3892/ijmm.2012.958; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kim JY, 2013, DIABETES CARE, V36, P1547, DOI 10.2337/dc12-0223; Kim JH, 2011, LIVER INT, V31, P1600, DOI 10.1111/j.1478-3231.2011.02580.x; Kozakova M, 2012, HEPATOLOGY, V55, P1406, DOI 10.1002/hep.25555; Lau K, 2010, J HYPERTENS, V28, P1829, DOI 10.1097/HJH.0b013e32833c211b; Lee YH, 2015, J HEPATOL, V63, P486, DOI 10.1016/j.jhep.2015.02.051; Lopez-Suarez A, 2011, EUR J GASTROEN HEPAT, V23, P1011, DOI 10.1097/MEG.0b013e32834b8d52; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Munshi MK, 2011, EXP BIOL MED, V236, P557, DOI 10.1258/ebm.2011.010375; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Oni ET, 2013, ATHEROSCLEROSIS, V230, P258, DOI 10.1016/j.atherosclerosis.2013.07.052; Osawa H, 1996, J CLIN ULTRASOUND, V24, P25, DOI 10.1002/(SICI)1097-0096(199601)24:1<25::AID-JCU4>3.0.CO;2-N; Paschos P, 2012, WORLD J HEPATOL, V4, P327, DOI 10.4254/wjh.v4.i12.327; Perseghin G, 2003, INT J OBESITY, V27, pS6, DOI 10.1038/sj.ijo.0802491; Rojas E, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0463-7; Ryoo JH, 2014, J GASTROEN HEPATOL, V29, P1926, DOI 10.1111/jgh.12643; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Yoo HJ, 2015, DIABETES METAB J, V39, P10, DOI 10.4093/dmj.2015.39.1.10; Zelber-Sagi S, 2013, WORLD J GASTROENTERO, V19, P57, DOI 10.3748/wjg.v19.i1.57	38	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143560	10.1371/journal.pone.0143560	http://dx.doi.org/10.1371/journal.pone.0143560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618774	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800046
J	Jue, DW; Sang, XL; Lu, SQ; Dong, C; Zhao, QF; Chen, HL; Jia, LQ				Jue, Dengwei; Sang, Xuelian; Lu, Shengqiao; Dong, Chen; Zhao, Qiufang; Chen, Hongliang; Jia, Liqiang			Genome-Wide Identification, Phylogenetic and Expression Analyses of the Ubiquitin-Conjugating Enzyme Gene Family in Maize	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS COP10; E2; EXTENSION; PROMOTES; REVEALS; VARIANT; UBC13; RICE; E3	Background Ubiquitination is a post-translation modification where ubiquitin is attached to a substrate. Ubiquitin-conjugating enzymes (E2s) play a major role in the ubiquitin transfer pathway, as well as a variety of functions in plant biological processes. To date, no genome-wide characterization of this gene family has been conducted in maize (Zea mays). Methodology/Principal Findings In the present study, a total of 75 putative ZmUBC genes have been identified and located in the maize genome. Phylogenetic analysis revealed that ZmUBC proteins could be divided into 15 subfamilies, which include 13 ubiquitin-conjugating enzymes (ZmE2s) and two independent ubiquitin-conjugating enzyme variant (UEV) groups. The predicted ZmUBC genes were distributed across 10 chromosomes at different densities. In addition, analysis of exon-intron junctions and sequence motifs in each candidate gene has revealed high levels of conservation within and between phylogenetic groups. Tissue expression analysis indicated that most ZmUBC genes were expressed in at least one of the tissues, indicating that these are involved in various physiological and developmental processes in maize. Moreover, expression profile analyses of ZmUBC genes under different stress treatments (4 degrees C, 20% PEG6000, and 200 mM NaCl) and various expression patterns indicated that these may play crucial roles in the response of plants to stress. Conclusions Genome-wide identification, chromosome organization, gene structure, evolutionary and expression analyses of ZmUBC genes have facilitated in the characterization of this gene family, as well as determined its potential involvement in growth, development, and stress responses. This study provides valuable information for better understanding the classification and putative functions of the UBC-encoding genes of maize.	[Jue, Dengwei; Sang, Xuelian; Dong, Chen; Zhao, Qiufang; Chen, Hongliang; Jia, Liqiang] Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Key Lab Trop Fruit Biol, Minist Agr, Zhanjiang 524091, Peoples R China; [Lu, Shengqiao] Guangxi Acad Agr Sci, Maize Res Inst, Nanning 530227, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Guangxi Academy of Agricultural Sciences	Jia, LQ (corresponding author), Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Key Lab Trop Fruit Biol, Minist Agr, Zhanjiang 524091, Peoples R China.	lqjia@mail.zaas.ac.cn			National Natural Science Foundation of China [30900784]; Fundamental Research Funds of the National Nonprofit Research Institute for South Subtropical crops Research Institute, Chinese Academy of Tropical Agricultural Sciences [1630062015003, 1630062013001, 1630062015017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of the National Nonprofit Research Institute for South Subtropical crops Research Institute, Chinese Academy of Tropical Agricultural Sciences	This research was supported by the grants from the National Natural Science Foundation of China (Grant No. 30900784) and supported by the Fundamental Research Funds of the National Nonprofit Research Institute for South Subtropical crops Research Institute, Chinese Academy of Tropical Agricultural Sciences (No. 1630062015003, 1630062013001, 1630062015017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN S, 1993, P NATL ACAD SCI USA, V90, P7980, DOI 10.1073/pnas.90.17.7980; Bachmair A, 2001, TRENDS PLANT SCI, V6, P463, DOI 10.1016/S1360-1385(01)02080-5; Bae H, 2013, BIOCHEM BIOPH RES CO, V433, P266, DOI 10.1016/j.bbrc.2013.03.005; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bruggmann R, 2006, GENOME RES, V16, P1241, DOI 10.1101/gr.5338906; Callis Judy, 2014, Arabidopsis Book, V12, pe0174, DOI 10.1199/tab.0174; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Criqui MC, 2002, PLANT PHYSIOL, V130, P1230, DOI 10.1104/pp.011353; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; E ZG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122621; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hou HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059358; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jeon EH, 2012, BIOCHEM BIOPH RES CO, V427, P309, DOI 10.1016/j.bbrc.2012.09.048; Jones D, 2002, GENOME BIOL, V3; Knobbe AR, 2015, PLANT PHYSIOL, V167, DOI 10.1104/pp.114.256081; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Lau OS, 2009, BIOCHEM J, V418, P683, DOI 10.1042/BJ20081943; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li WF, 2010, PLANT J, V62, P330, DOI 10.1111/j.1365-313X.2010.04150.x; Lin YX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-76; Lin YQ, 2002, J BIOL CHEM, V277, P21913, DOI 10.1074/jbc.M109398200; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Mergner J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00103; Michelle C, 2009, J MOL EVOL, V68, P616, DOI 10.1007/s00239-009-9225-6; Miura K, 2011, PLANTA, V234, P1191, DOI 10.1007/s00425-011-1476-y; Mural RV, 2013, PLANT CELL, V25, P3615, DOI 10.1105/tpc.113.117093; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Papaleo E, 2012, PLOS ONE, V7, P398; Park BS, 2014, PLANT CELL, V26, P454, DOI 10.1105/tpc.113.120311; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Ptak C, 2001, MOL CELL BIOL, V21, P6537, DOI 10.1128/MCB.21.19.6537-6548.2001; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schumacher FR, 2013, J MOL BIOL, V425, P4099, DOI 10.1016/j.jmb.2013.06.039; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Shen J, 2015, PROTOPLASMA, V252, P173, DOI 10.1007/s00709-014-0669-1; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Suzuki G, 2002, GENE DEV, V16, P554, DOI 10.1101/gad.964602; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang Y, 2015, GENE, V566, P95, DOI 10.1016/j.gene.2015.04.041; Wang YY, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0548-2; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Wen R, 2008, PLANT CELL, V20, P213, DOI 10.1105/tpc.107.051862; Wen R, 2006, PLANT MOL BIOL, V61, P241, DOI 10.1007/s11103-006-0007-x; Winn PJ, 2004, STRUCTURE, V12, P1563, DOI 10.1016/j.str.2004.06.017; Xia ZL, 2012, GENE, V495, P146, DOI 10.1016/j.gene.2011.12.028; Xu L, 2009, PLANT J, V57, P279, DOI 10.1111/j.1365-313X.2008.03684.x; Yanagawa Y, 2004, GENE DEV, V18, P2172, DOI 10.1101/gad.1229504; Yang SA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040003; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488; Zhou GA, 2010, PLANT MOL BIOL, V72, P357, DOI 10.1007/s11103-009-9575-x; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	65	28	43	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143488	10.1371/journal.pone.0143488	http://dx.doi.org/10.1371/journal.pone.0143488			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606743	Green Submitted, gold, Green Published			2022-12-26	WOS:000365865300071
J	Starha, P; Hanouskova, L; Travnicek, Z				Starha, Pavel; Hanouskova, Lucie; Travnicek, Zdenek			Organometallic Half-Sandwich Dichloridoruthenium(II) Complexes with 7-Azaindoles: Synthesis, Characterization and Elucidation of Their Anticancer Inactivity against A2780 Cell Line	PLOS ONE			English	Article							IN-VITRO; RUTHENIUM; METALS; DERIVATIVES; DRUG	A series of organometallic half-sandwich dichloridoruthenium(II) complexes of the general formula [Ru(eta(6)-p-cym)(naza)Cl-2] (1-8; p-cym = p-cymene; naza = 7-azaindole or its derivatives) was synthesised and fully characterized by elemental analysis, mass spectrometry, and infrared and multinuclear NMR spectroscopy. A single-crystal X-ray structural analysis of [Ru(eta(6)-p-cym)(2Me4Claza)Cl-2] (6) revealed a typical piano-stool geometry with an N7-coordination mode of 2-methyl-4-chloro-7-azaindole (2Me4Claza). The complexes have been found to be inactive against human ovarian cancer cell line A2780 up to the highest applied concentration (IC50 > 50.0 mu M). An inactivity of the complexes is caused by their instability in water-containing solvents connected with a release of the naza N-donor ligand, as proved by the detailed H-1 NMR, mass spectrometry and fluorescence experiments.	[Starha, Pavel; Hanouskova, Lucie; Travnicek, Zdenek] Palacky Univ, Fac Sci, Dept Inorgan Chem, Reg Ctr Adv Technol & Mat, Olomouc 77146, Czech Republic	Palacky University Olomouc	Travnicek, Z (corresponding author), Palacky Univ, Fac Sci, Dept Inorgan Chem, Reg Ctr Adv Technol & Mat, 17 Listopadu 12, Olomouc 77146, Czech Republic.	zdenek.travnicek@upol.cz	Starha, Pavel/H-3902-2016	Travnicek, Zdenek/0000-0002-5890-7874	National Program of Sustainability I of the Ministry of Education, Youth and Sports of the Czech Republic [LO1305]; Palacky University in Olomouc [IGA_PrF_2015_019]; X-ray Diffraction and BioSAXS Core Facility of CEITEC-Central European Institute of Technology under CEITEC-open access project - Ministry of Education, Youth and Sports of the Czech Republic [LM2011020]	National Program of Sustainability I of the Ministry of Education, Youth and Sports of the Czech Republic; Palacky University in Olomouc; X-ray Diffraction and BioSAXS Core Facility of CEITEC-Central European Institute of Technology under CEITEC-open access project - Ministry of Education, Youth and Sports of the Czech Republic	This work was supported by the National Program of Sustainability I (LO1305) of the Ministry of Education, Youth and Sports of the Czech Republic (www.msmt.cz), the Palacky University in Olomouc (IGA_PrF_2015_019, www.upol.cz) and the X-ray Diffraction and BioSAXS Core Facility of CEITEC-Central European Institute of Technology under CEITEC-open access project, ID number LM2011020, funded by the Ministry of Education, Youth and Sports of the Czech Republic (www.msmt.cz).	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Barry NPE, 2013, CHEM COMMUN, V49, P5106, DOI 10.1039/c3cc41143e; Betanzos-Lara S, 2011, EUR J INORG CHEM, P3257, DOI 10.1002/ejic.201100250; Bland BRA, 2005, INORG CHIM ACTA, V358, P3927, DOI 10.1016/j.ica.2005.06.023; Brandenburg K., 2015, DIAMOND VERSION 4 0; CHEN Y, 1993, J PHYS CHEM-US, V97, P1770, DOI 10.1021/j100111a011; Clarke MJ, 2003, COORDIN CHEM REV, V236, P207, DOI 10.1016/S0010-8545(02)00311-9; Corazza A, 1996, EUR J BIOCHEM, V236, P697, DOI 10.1111/j.1432-1033.1996.0697d.x; Cutillas N, 2013, COORDIN CHEM REV, V257, P2784, DOI 10.1016/j.ccr.2013.03.024; Desoize B, 2002, CRIT REV ONCOL HEMAT, V42, P317, DOI 10.1016/S1040-8428(01)00219-0; Diaz-Torres R, 2011, DALTON T, V40, P10742, DOI 10.1039/c1dt11000d; Ganeshpandian M, 2014, DALTON T, V43, P1203, DOI 10.1039/c3dt51641e; Grau J, 2012, J INORG BIOCHEM, V109, P72, DOI 10.1016/j.jinorgbio.2012.01.003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Khan FA, 2013, J ORGANOMET CHEM, V730, P49, DOI 10.1016/j.jorganchem.2012.10.016; Kilpin KJ, 2012, ORGANOMETALLICS, V31, P7031, DOI 10.1021/om3007079; Kosaka W, 2013, INORG CHEM, V52, P9908, DOI 10.1021/ic401030r; Levina A, 2009, METALLOMICS, V1, P458, DOI 10.1039/b904071d; Liu KG, 2012, INORG CHIM ACTA, V388, P78, DOI 10.1016/j.ica.2012.02.046; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Medici S, 2015, COORDIN CHEM REV, V284, P329, DOI 10.1016/j.ccr.2014.08.002; Nazarov AA, 2013, DALTON T, V42, P2347, DOI 10.1039/c2dt31936e; New EJ, 2009, J INORG BIOCHEM, V103, P1120, DOI 10.1016/j.jinorgbio.2009.05.005; Patra M, 2013, CHEM-EUR J, V19, P14768, DOI 10.1002/chem.201303341; Romero-Canelon I, 2013, J MED CHEM, V56, P1291, DOI 10.1021/jm3017442; Saez R, 2014, J INORG BIOCHEM, V136, P1, DOI 10.1016/j.jinorgbio.2014.03.002; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soldevila-Barreda JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7582; Starha P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136338; Starha P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123595; Starha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090341; Starha P, 2012, J INORG BIOCHEM, V115, P57, DOI 10.1016/j.jinorgbio.2012.05.006; Tonnemann J, 2013, EUR J INORG CHEM, V2013, P4558, DOI 10.1002/ejic.201300600; TOKUMURA K, 1987, J AM CHEM SOC, V109, P1346, DOI 10.1021/ja00239a010; Travnicek Z, 2011, J INORG BIOCHEM, V105, P937, DOI 10.1016/j.jinorgbio.2011.04.002; Trondl R, 2014, CHEM SCI, V5, P2925, DOI 10.1039/c3sc53243g; Vacca A, 2002, BRIT J CANCER, V86, P993, DOI 10.1038/sj.bjc.6600176; Wang ZG, 2014, J INORG BIOCHEM, V131, P47, DOI 10.1016/j.jinorgbio.2013.10.017; Weiss A, 2014, CHEM SCI, V5, P4742, DOI 10.1039/c4sc01255k	40	9	9	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143871	10.1371/journal.pone.0143871	http://dx.doi.org/10.1371/journal.pone.0143871			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606245	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300117
J	Chang, HT; Mishra, N; Lin, CC				Chang, Hsien-Tsung; Mishra, Nilamadhab; Lin, Chung-Chih			IoT Big-Data Centred Knowledge Granule Analytic and Cluster Framework for BI Applications: A Case Base Analysis	PLOS ONE			English	Article							INTERVAL TYPE-2; FUZZY; INTELLIGENCE; SYSTEMS; MODEL	The current rapid growth of Internet of Things (IoT) in various commercial and non-commercial sectors has led to the deposition of large-scale IoT data, of which the time-critical analytic and clustering of knowledge granules represent highly thought-provoking application possibilities. The objective of the present work is to inspect the structural analysis and clustering of complex knowledge granules in an IoT big-data environment. In this work, we propose a knowledge granule analytic and clustering (KGAC) framework that explores and assembles knowledge granules from IoT big-data arrays for a business intelligence (BI) application. Our work implements neuro-fuzzy analytic architecture rather than a standard fuzzified approach to discover the complex knowledge granules. Furthermore, we implement an enhanced knowledge granule clustering (e-KGC) mechanism that is more elastic than previous techniques when assembling the tactical and explicit complex knowledge granules from IoT big-data arrays. The analysis and discussion presented here show that the proposed framework and mechanism can be implemented to extract knowledge granules from an IoT big-data array in such a way as to present knowledge of strategic value to executives and enable knowledge users to perform further BI actions.	[Chang, Hsien-Tsung; Mishra, Nilamadhab; Lin, Chung-Chih] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan	Chang Gung University	Lin, CC (corresponding author), Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan.	cclin@mail.cgu.edu.tw	Mishra, Dr. Nilamadhab/I-3515-2014; Chang, Hsien-Tsung/E-7511-2012	Mishra, Dr. Nilamadhab/0000-0002-1330-4869; Chang, Hsien-Tsung/0000-0003-4987-5943	Ministry of Science and Technology, Taiwan [MOST 104-2218-E-182-005 -MY3, MOST 104-2221-E-182-069]; Chang Gung University [CMRPD3E0061]; Chang Gung Memorial Hospital of Chang Gung University [CMRPD3E0061]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung University; Chang Gung Memorial Hospital of Chang Gung University(Chang Gung Memorial Hospital)	Financial support was provided by the Ministry of Science and Technology, Taiwan, through Grants MOST 104-2218-E-182-005 -MY3, MOST 104-2221-E-182-069, and CMRPD3E0061 of Chang Gung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support provided by the Ministry of Science and Technology, through Grant MOST 104-2218-E-182-005 -MY3, MOST 104-2221-E-182-069 and the Chang Gung Memorial Hospital through CMRPD3E0061 of Chang Gung University is gratefully acknowledged. The authors also would like to express their deep appreciation to all anonymous reviewers for their kind comments.	Aggarwal C.C., 2012, MINING TEXT DATA, P77, DOI [DOI 10.1007/978-1-4614-3223-44, 10.1007/978-1-4614-3223-4, 10.1007/978-1-4614-3223-4_4, DOI 10.1007/978-1-4614-3223-4_4]; Al-Shayea Q. K., 2012, P 11 WSEAS INT C ART, P22; Al-Shayea Q. K., 2014, P WORLD C ENG, V1; Alelyani S, 2014, CH CRC DATA MIN KNOW, P29; [Anonymous], 2013, ARXIV13010159; Asemi A., 2014, P 3 INT C COMP ENG M; Bouveyron C, 2014, COMPUT STAT DATA AN, V71, P52, DOI 10.1016/j.csda.2012.12.008; Cai X., P 23 INT JOINT C ART, P2598; Cattelani L, 2014, COMP MED SY, P38, DOI 10.1109/CBMS.2014.35; Chen CLP, 2014, INFORM SCIENCES, V275, P314, DOI 10.1016/j.ins.2014.01.015; Chen Y., 2014, UNCERTAIN SUPPLY CHA, V2, P229; Comas DS, 2014, SOFT COMPUTING BUSIN, P267, DOI DOI 10.1007/978-3-642-53737-0_18; Davenport T., 2013, BIG DATA BIG COMPANI; Davenport T. H., 2013, MIT SLOAN MANAGEMENT, V54; Gaxiola F, 2014, INFORM SCIENCES, V260, P1, DOI 10.1016/j.ins.2013.11.006; Gayathri K. S., P 3 INT C SOFT COMP, P833; George G, 2014, ACAD MANAGE J, V57, P321, DOI 10.5465/amj.2014.4002; Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128; Kalaichelvi V, 2013, J INTELL FUZZY SYST, V25, P429, DOI 10.3233/IFS-120650; Kannan D, 2013, J CLEAN PROD, V47, P355, DOI 10.1016/j.jclepro.2013.02.010; Kar S, 2014, APPL SOFT COMPUT, V15, P243, DOI 10.1016/j.asoc.2013.10.014; Krishna Anand S., 2014, International Journal of Artificial Intelligence and Soft Computing, V4, P249, DOI 10.1504/IJAISC.2014.062822; Kuznetsov Sergei O., 2013, Formal Concept Analysis. 11th International Conference, ICFCA 2013. Proceedings, P254, DOI 10.1007/978-3-642-38317-5_17; Lemos A, 2011, IEEE T FUZZY SYST, V19, P91, DOI 10.1109/TFUZZ.2010.2087381; Lin YY, 2014, IEEE T IND ELECTRON, V61, P447, DOI 10.1109/TIE.2013.2248332; Lucia, 2013, MIL COMM INF SYST C, P1; Makridou G., 2013, INT J FINANCIAL ENG, V1, P35, DOI DOI 10.1504/IJFERM.2013.053707; Marquez-Chamorro A. E., EV COMP CEC 2013 IEE, P592; Mehta A., 2011, BIG DATA POWERING NE; Mishra N., 2014, SCI WORLD J; Mishra N., COMM PROBL SOLV ICCP, P124; Mishra N, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/172186; Ozkan G, 2014, APPL SOFT COMPUT, V24, P232, DOI 10.1016/j.asoc.2014.06.032; Park K., 2014, INT J DISTRIBUTED SE; Ren Q, 2014, INFORM SCIENCES, V255, P121, DOI 10.1016/j.ins.2013.06.010; Roostaee Razieh, 2012, International Journal of Fuzzy Systems Applications, V2, P1, DOI 10.4018/ijfsa.2012010101; Rouhani S, 2012, EXPERT SYST APPL, V39, P3764, DOI 10.1016/j.eswa.2011.09.074; Sheta AF, 2013, BUSINESS INTELLIGENC, P191, DOI DOI 10.1007/978-1-4471-4866-1_13; Silva AM, 2014, APPL SOFT COMPUT, V14, P194, DOI 10.1016/j.asoc.2013.03.022; Stefik M, 2014, PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON COLLABORATION TECHNOLOGIES AND SYSTEMS (CTS), P474, DOI 10.1109/CTS.2014.6867609; Subramanian K, 2013, IEEE CONF EVOL ADAPT, P48, DOI 10.1109/EAIS.2013.6604104; Wu DR, 2012, IEEE T FUZZY SYST, V20, P832, DOI 10.1109/TFUZZ.2012.2186818; Wu XD, 2014, IEEE T KNOWL DATA EN, V26, P97, DOI 10.1109/TKDE.2013.109; Yu MC, 2011, EXPERT SYST APPL, V38, P3416, DOI 10.1016/j.eswa.2010.08.127; Yuksel M. E., 2013, COMPUTATIONAL INTELL, P3; Zhang X., 2014, TRANSPORTATION RES C	46	5	5	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0141980	10.1371/journal.pone.0141980	http://dx.doi.org/10.1371/journal.pone.0141980			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600156	gold, Green Published			2022-12-26	WOS:000365862600006
J	Gutierrez, S; Tardaguila, J; Fernandez-Novales, J; Diago, MP				Gutierrez, Salvador; Tardaguila, Javier; Fernandez-Novales, Juan; Diago, Maria P.			Support Vector Machine and Artificial Neural Network Models for the Classification of Grapevine Varieties Using a Portable NIR Spectrophotometer	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; DISCRIMINATION; IDENTIFICATION; SPECTROSCOPY; WATER	The identification of different grapevine varieties, currently attended using visual ampelometry, DNA analysis and very recently, by hyperspectral analysis under laboratory conditions, is an issue of great importance in the wine industry. This work presents support vector machine and artificial neural network's modelling for grapevine varietal classification from in-field leaf spectroscopy. Modelling was attempted at two scales: site-specific and a global scale. Spectral measurements were obtained on the near-infrared (NIR) spectral range between 1600 to 2400 nm under field conditions in a non-destructive way using a portable spectrophotometer. For the site specific approach, spectra were collected from the adaxial side of 400 individual leaves of 20 grapevine (Vitis vinifera L.) varieties one week after veraison. For the global model, two additional sets of spectra were collected one week before harvest from two different vineyards in another vintage, each one consisting on 48 measurement from individual leaves of six varieties. Several combinations of spectra scatter correction and smoothing filtering were studied. For the training of the models, support vector machines and artificial neural networks were employed using the pre-processed spectra as input and the varieties as the classes of the models. The results from the pre-processing study showed that there was no influence whether using scatter correction or not. Also, a second-degree derivative with a window size of 5 Savitzky-Golay filtering yielded the highest outcomes. For the site-specific model, with 20 classes, the best results from the classifiers thrown an overall score of 87.25% of correctly classified samples. These results were compared under the same conditions with a model trained using partial least squares discriminant analysis, which showed a worse performance in every case. For the global model, a 6-class dataset involving samples from three different vineyards, two years and leaves monitored at post-veraison and harvest was also built up, reaching a 77.08% of correctly classified samples. The outcomes obtained demonstrate the capability of using a reliable method for fast, in-field, non-destructive grapevine varietal classification that could be very useful in viticulture and wine industry, either global or site-specific.	[Gutierrez, Salvador; Tardaguila, Javier; Fernandez-Novales, Juan; Diago, Maria P.] Univ La Rioja, CSIC, Inst Ciencias Vid & Vino, Logrono 26007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja	Diago, MP (corresponding author), Univ La Rioja, CSIC, Inst Ciencias Vid & Vino, Ctra Burgos Km 6, Logrono 26007, Spain.	mpaz.diago.santamaria@gmail.com	Fernández-Novales, Juan/K-7123-2015; Novales, Juan Fernández/ABG-2333-2021; Gutiérrez, Salvador/GLV-0302-2022; Tardaguila, Javier/K-3512-2012; Gutiérrez, Salvador/T-7637-2019; Diago, Maria P/R-9547-2018	Fernández-Novales, Juan/0000-0001-9973-2604; Novales, Juan Fernández/0000-0001-9973-2604; Tardaguila, Javier/0000-0002-6639-8723; Gutiérrez, Salvador/0000-0002-8205-9772; Diago, Maria P/0000-0003-4049-0879	Spanish Ministry of Economy and Competitiveness (MINECO) under INNGRAPE project [RTC-2014-3058-2]	Spanish Ministry of Economy and Competitiveness (MINECO) under INNGRAPE project	This work has received funding from the Spanish Ministry of Economy and Competitiveness (MINECO) under the INNGRAPE project (RTC-2014-3058-2).	ALTUBE H, 1991, VITIS, V30, P203; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Borchers H. W., 2015, PRACMA PRACTICAL NUM; Borrego J, 2002, AM J ENOL VITICULT, V53, P125; Canaza-Cayo AW, 2012, COMPUT ELECTRON AGR, V88, P141, DOI 10.1016/j.compag.2012.07.013; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Delwiche SR, 2004, J NEAR INFRARED SPEC, V12, P177, DOI 10.1255/jnirs.424; DHANOA MS, 1995, APPL SPECTROSC, V49, P765, DOI 10.1366/0003702953964615; Diago MP, 2013, COMPUT ELECTRON AGR, V99, P7, DOI 10.1016/j.compag.2013.08.021; Fernandes AM, 2015, J AGR SCI-CAMBRIDGE, V153, P455, DOI 10.1017/S0021859614000252; Fernandez-Cabanas VM, 2006, APPL SPECTROSC, V60, P17, DOI 10.1366/000370206775382839; Fernandez-Novales J, 2009, INT J FOOD SCI NUTR, V60, P265, DOI 10.1080/09637480903093116; Fu X, 2007, T ASABE, V50, P1355, DOI 10.13031/2013.23613; Galet P, 1979, PRACTICAL AMPELOGRAP; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Ivorra E, 2013, J FOOD ENG, V117, P342, DOI 10.1016/j.jfoodeng.2013.02.022; Jacquemoud S, 2001, P 8 INT S PHYS MEASU, P223; Kong WW, 2013, SENSORS-BASEL, V13, P8916, DOI 10.3390/s130708916; Li XL, 2008, BIOSYST ENG, V99, P313, DOI 10.1016/j.biosystemseng.2007.11.007; Li XL, 2007, J FOOD ENG, V81, P357, DOI 10.1016/j.jfoodeng.2006.10.033; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Pelabon C, 2013, ANN BOT-LONDON, V111, P935, DOI 10.1093/aob/mct050; Pelsy F, 2010, THEOR APPL GENET, V120, P1219, DOI 10.1007/s00122-009-1250-8; Perez-Marin D, 2010, J FOOD ENG, V99, P294, DOI 10.1016/j.jfoodeng.2010.03.002; Platt J., 1998, TECH REP; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sanchez MT, 2012, J FOOD ENG, V110, P102, DOI 10.1016/j.jfoodeng.2011.12.003; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sefc KM, 2001, MOLECULAR BIOLOGY & BIOTECHNOLOGY OF THE GRAPEVINE, P433; Stevens A., 2020, R PACKAG, P1; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Talens P, 2013, J FOOD ENG, V117, P272, DOI 10.1016/j.jfoodeng.2013.03.014; Vanloot P, 2014, COMPUT ELECTRON AGR, V102, P98, DOI 10.1016/j.compag.2014.01.009; Wang W, 2006, T ASABE, V49, P1607, DOI 10.13031/2013.22035; Werbos P., 1974, THESIS; Xie CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098522; Xu HR, 2009, J ZHEJIANG UNIV-SC B, V10, P126, DOI 10.1631/jzus.B0820200; Yang CW, 2011, J FOOD DRUG ANAL, V19, P9; Yang XL, 2015, SENSORS-BASEL, V15, P15578, DOI 10.3390/s150715578	42	34	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143197	10.1371/journal.pone.0143197	http://dx.doi.org/10.1371/journal.pone.0143197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600316	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600036
J	Ortega-Andrade, HM; Rojas-Soto, OR; Valencia, JH; de Los Monteros, AE; Morrone, JJ; Ron, SR; Cannatella, DC				Mauricio Ortega-Andrade, H.; Rojas-Soto, Octavio R.; Valencia, Jorge H.; Espinosa de los Monteros, Alejandro; Morrone, Juan J.; Ron, Santiago R.; Cannatella, David C.			Insights from Integrative Systematics Reveal Cryptic Diversity in Pristimantis Frogs (Anura: Craugastoridae) from the Upper Amazon Basin	PLOS ONE			English	Article							SPECIES DELIMITATION; HISTORICAL BIOGEOGRAPHY; PHYLOGENETIC ANALYSIS; CENTRAL-AMERICA; FOREST CANOPY; ELEUTHERODACTYLUS; LEPTODACTYLIDAE; EVOLUTION; DIVERSIFICATION; MITOCHONDRIAL	Pluralistic approaches to taxonomy facilitate a more complete appraisal of biodiversity, especially the diversification of cryptic species. Although species delimitation has traditionally been based primarily on morphological differences, the integration of new methods allows diverse lines of evidence to solve the problem. Robber frogs (Pristimantis) are exemplary, as many of the species show high morphological variation within populations, but few traits that are diagnostic of species. We used a combination of DNA sequences from three mitochondrial genes, morphometric data, and comparisons of ecological niche models (ENMs) to infer a phylogenetic hypothesis for the Pristimantis acuminatus complex. Molecular phylogenetic analyses revealed a close relationship between three new species-Pristimantis enigmaticus sp. nov., P. limoncochensis sp. nov. and P. omeviridis sp. nov.-originally confused with Pristimantis acuminatus. In combination with morphometric data and geographic distributions, several morphological characters such as degree of tympanum exposure, skin texture, ulnar/tarsal tubercles and sexual secondary characters (vocal slits and nuptial pads in males) were found to be useful for diagnosing species in the complex. Multivariate discriminant analyses provided a successful classification rate for 83-100% of specimens. Discriminant analysis of localities in environmental niche space showed a successful classification rate of 75-98%. Identity tests of ENMs rejected hypotheses of niche equivalency, although not strongly because the high values on niche overlap. Pristimantis acuminatus and P. enigmaticus sp. nov. are distributed along the lowlands of central-southern Ecuador and northern Peru, in contrast with P. limoncochensis sp. nov. and P. omeviridis sp. nov., which are found in northern Ecuador and southern Colombia, up to 1200 m in the upper Amazon Basin. The methods used herein provide an integrated framework for inventorying the greatly underestimated biodiversity in Amazonia.	[Mauricio Ortega-Andrade, H.; Rojas-Soto, Octavio R.] Inst Ecol AC, Lab Biogeog, Red Biol Evolutiva, Xalapa, Veracruz, Mexico; [Mauricio Ortega-Andrade, H.] Museo Ecuatoriano Ciencias Nat, Div Herpetol, Secc Vertebrados, Quito, Ecuador; [Mauricio Ortega-Andrade, H.] Fdn EcoCiencia, Programa Conservac Especies & Ecosistemas Amenaza, Quito, Ecuador; [Valencia, Jorge H.] Fdn Herpetol Gustavo Orces, Quito, Ecuador; [Espinosa de los Monteros, Alejandro] Inst Ecol AC, Red Biol Evolutiva, Xalapa, Veracruz, Mexico; [Morrone, Juan J.] Univ Nacl Autonoma Mexico, Fac Ciencias, Museo Zool Alfonso L Herrera, Dept Biol Evolutiva, Mexico City 04510, DF, Mexico; [Ron, Santiago R.] Pontificia Univ Catolica Ecuador, Museo Zool, Dept Ciencias Biol, Quito, Ecuador; [Cannatella, David C.] Univ Texas Austin, Dept Integrat Biol & Biodivers Collect, Austin, TX 78712 USA	Instituto de Ecologia - Mexico; Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico; Pontificia Universidad Catolica del Ecuador; University of Texas System; University of Texas Austin	Ortega-Andrade, HM (corresponding author), Inst Ecol AC, Lab Biogeog, Red Biol Evolutiva, Xalapa, Veracruz, Mexico.	biomauro@hotmail.com	Rojas-Soto, Octavio/Q-6252-2018; Espinosa de los Monteros, Alejandro/Q-6207-2018; Andrade, H. Mauricio Ortega/G-8245-2016; Morrone, Juan J./AAH-4325-2021; Ron, Santiago/J-4203-2019	Rojas-Soto, Octavio/0000-0002-0201-1454; Espinosa de los Monteros, Alejandro/0000-0002-7742-5977; Andrade, H. Mauricio Ortega/0000-0001-9464-3688; Ron, Santiago/0000-0001-6300-9350	Consejo Nacional de Ciencia y Tecnologia [275448/224620]; Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion; Richard Gilder Graduate School; Pontificia Universidad Catolica del Ecuador	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion; Richard Gilder Graduate School; Pontificia Universidad Catolica del Ecuador	Support was provided by Consejo Nacional de Ciencia y Tecnologia, No. 275448/224620 [http://www.conacyt.mx/] to HMOA; Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion [http://programasbecas.educacionsuperior.gob.ec/] to HMOA; Richard Gilder Graduate School [http://www.amnh.org/our-research/richard-gilder-graduate-school] to HMOA; Pontificia Universidad Catolica del Ecuador. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; Almendariz A, 2005, REV POLITECNICA, V26, P20; Barker MG, 2001, PLANT ECOL, V153, P23, DOI 10.1023/A:1017584130692; Barley AJ, 2013, EVOLUTION, V67, P3556, DOI 10.1111/evo.12219; BARVE N, 2008, TOOL PARTIAL ROC VER; Beirne D, 2011, FROGS YACHANA RESERV; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BOLT JR, 1985, BIOL J LINN SOC, V24, P83, DOI 10.1111/j.1095-8312.1985.tb00162.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Chessel D., 2004, R NEWS, V4, P5; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Christensen-Dalsgaard J, 2008, BRAIN RES BULL, V75, P365, DOI 10.1016/j.brainresbull.2007.10.044; Crawford AJ, 2003, MOL ECOL, V12, P2525, DOI 10.1046/j.1365-294X.2003.01910.x; Crawford AJ, 2005, MOL PHYLOGENET EVOL, V35, P536, DOI 10.1016/j.ympev.2005.03.006; Crawford AJ, 2013, MOL ECOL RESOUR, V13, P1005, DOI 10.1111/1755-0998.12054; Crawford AJ, 2010, HERPETOLOGICA, V66, P192, DOI 10.1655/09-018R1.1; Crump M.L., 1994, MEASURING MONITORING, P84, DOI DOI 10.1007/S10682-018-9929-4; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dixon J, 1975, MILLWAKEE PUBLIC MUS, V1975, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Duellman W.E., 2005, CUSCO AMAZONICO THE; Duellman W.E., 2009, TERRESTRIAL BREEDING; Duellman WE, 1999, PATTERNS OF DISTRIBU; Duellman William E., 1995, University of Kansas Science Bulletin, V55, P329; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Elmer KR, 2008, ZOOTAXA, P11, DOI 10.11646/zootaxa.1784.1.2; ESRI, 2010, ARCMAP 10 0; Florio AM, 2012, J EVOLUTION BIOL, V25, P1399, DOI 10.1111/j.1420-9101.2012.02528.x; Fouquet A, 2014, J BIOGEOGR, V41, P855, DOI 10.1111/jbi.12250; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046077; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guayasamin JM, 2006, HERPETOLOGICA, V62, P191, DOI 10.1655/05-40.1; Hedges SB, 2008, ZOOTAXA, P1; Heinicke MP, 2009, ZOOTAXA, P1; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hetherington TE, 1999, J COMP PHYSIOL A, V184, P395, DOI 10.1007/s003590050338; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, WORLDCLIM VERSION 1; Hooghiemstra H, 2001, INTRO BIOGEOGRAFIA L; Hu JH, 2012, NATURWISSENSCHAFTEN, V99, P553, DOI 10.1007/s00114-012-0933-1; IUCN, 2003, DIR EMPL CRIT LIST R; Jansen M, 2011, ZOOL SCR, V40, P567, DOI 10.1111/j.1463-6409.2011.00498.x; Jaramillo C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P317; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kohler J, 1998, STUD NEOTROP FAUNA E, V33, P93, DOI 10.1076/snfe.33.2.93.2158; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Lehr E, 2007, HERPETOLOGICA, V63, P94, DOI 10.1655/0018-0831(2007)63[94:ANSOAE]2.0.CO;2; Lehr E, 2007, ZOOL J LINN SOC-LOND, V149, P583, DOI 10.1111/j.1096-3642.2007.00270.x; Liao JC, 2008, ITAL J ZOOL, V75, P125, DOI 10.1080/11250000701878773; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; LYNCH J D, 1980, American Museum Novitates, P1; Lynch JD, 1997, U KANSAS NATURAL HIS, V23, P1, DOI DOI 10.5962/BHL.TITLE.7951; Lynch John D., 1997, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V21, P237; Lynch John D., 2005, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V29, P581; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; McCracken Shawn F., 2007, Phyllomedusa, V6, P23; McDiarmid R. W., 1994, MEASURING MONITORING; Miller M.A., 2010, P GAT COMP ENV WORKS; Moravec J, 2010, VERTEBRATE ZOOLOGY, V60, P10; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ortega-Andrade H Mauricio, 2013, PLoS One, V8, pe81837, DOI 10.1371/journal.pone.0081837; Ortega-Andrade HM, 2010, THESIS; OVASKA K, 1992, COPEIA, P569; Padial JM, 2008, ZOOL J LINN SOC-LOND, V152, P353, DOI 10.1111/j.1096-3642.2007.00341.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Padial JM, 2009, ZOOL J LINN SOC-LOND, V155, P97, DOI 10.1111/j.1096-3642.2008.00424.x; Paez-Moscoso DJ, 2012, MOL PHYLOGENET EVOL, V65, P805, DOI 10.1016/j.ympev.2012.08.001; Pearman PB, 1997, CONSERV BIOL, V11, P1211, DOI 10.1046/j.1523-1739.1997.96202.x; PEARMAN PB, 1995, HERPETOLOGICA, V51, P325; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 1999, CONSERV BIOL, V13, P427, DOI 10.1046/j.1523-1739.1999.013002427.x; Peterson AT, 2011, MONOGRAPHS POPULATIO, P328, DOI [DOI 10.5860/CHOICE.49-6266, 10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rambaut A, 2013, TRACER VERSION 1 6; ROBERTSON JGM, 1986, ANIM BEHAV, V34, P773, DOI 10.1016/S0003-3472(86)80061-6; Pinto-Sanchez NR, 2012, MOL PHYLOGENET EVOL, V62, P954, DOI 10.1016/j.ympev.2011.11.022; Rojas-Soto O, 2008, J FIELD ORNITHOLOGY, V79, P245; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Santos JC, 2009, PLOS BIOL, V7, P448, DOI 10.1371/journal.pbio.1000056; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SHREVE BENJAMIN, 1935, OCCAS PAPERS BOSTON SOC NAT HIST, V8, P209; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Smith SA, 2010, SYST BIOL, V59, P322, DOI 10.1093/sysbio/syq011; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; UICN [Union Internacional de Conservacion de la Naturaleza], 2012, CAT CRIT LIST ROJ UN; Urbina-C. Jose Nicolas, 2003, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V27, P105; Vigle Gregory O., 2008, Breviora, V514, P1, DOI 10.3099/0006-9698-514.1.1; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Williams RAJ, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-47; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zink RM, 1995, AUK, V112, P701; Zwickl D, 2006, THESIS	119	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143392	10.1371/journal.pone.0143392	http://dx.doi.org/10.1371/journal.pone.0143392			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600198	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600061
J	Carrillo, P; Medina-Sanchez, JM; Herrera, G; Duran, C; Segovia, M; Cortes, D; Salles, S; Korbee, N; Figueroa, FL; Mercado, JM				Carrillo, Presentacion; Medina-Sanchez, Juan M.; Herrera, Guillermo; Duran, Cristina; Segovia, Maria; Cortes, Dolores; Salles, Soluna; Korbee, Nathalie; Figueroa, Felix L.; Mercado, Jesus M.			Interactive Effect of UVR and Phosphorus on the Coastal Phytoplankton Community of the Western Mediterranean Sea: Unravelling Eco-Physiological Mechanisms	PLOS ONE			English	Article							DIATOM THALASSIOSIRA-PSEUDONANA; ULTRAVIOLET-RADIATION; MARINE-PHYTOPLANKTON; PRIMARY PRODUCTIVITY; SOLAR-RADIATION; ALBORAN SEA; TAXONOMIC COMPOSITION; NUTRIENT LIMITATION; AMINO-ACIDS; LIGHT	Some of the most important effects of global change on coastal marine systems include increasing nutrient inputs and higher levels of ultraviolet radiation (UVR, 280-400 nm), which could affect primary producers, a key trophic link to the functioning of marine food webs. However, interactive effects of both factors on the phytoplankton community have not been assessed for the Mediterranean Sea. An in situ factorial experiment, with two levels of ultraviolet solar radiation (UVR+PAR vs. PAR) and nutrients (control vs. P-enriched), was performed to evaluate single and UVRxP effects on metabolic, enzymatic, stoichiometric and structural phytoplanktonic variables. While most phytoplankton variables were not affected by UVR, dissolved phosphatase (APA(EX)) and algal P content increased in the presence of UVR, which was interpreted as an acclimation mechanism of algae to oligotrophic marine waters. Synergistic UVRxP interactive effects were positive on photosynthetic variables (i.e., maximal electron transport rate, ETRmax), but negative on primary production and phytoplankton biomass because the pulse of P unmasked the inhibitory effect of UVR. This unmasking effect might be related to greater photodamage caused by an excess of electron flux after a P pulse (higher ETRmax) without an efficient release of carbon as the mechanism to dissipate the reducing power of photosynthetic electron transport.	[Carrillo, Presentacion; Medina-Sanchez, Juan M.; Herrera, Guillermo; Duran, Cristina] Univ Granada, Inst Agua, Granada, Spain; [Carrillo, Presentacion; Medina-Sanchez, Juan M.] Univ Granada, Fac Ciencias, Dept Ecol, Granada, Spain; [Segovia, Maria; Korbee, Nathalie; Figueroa, Felix L.] Univ Malaga, Fac Ciencias, Dept Ecol, E-29071 Malaga, Spain; [Cortes, Dolores; Salles, Soluna; Mercado, Jesus M.] Inst Espanol Oceanog Fuengirola, Ctr Oceanog Malaga, Malaga, Spain	University of Granada; University of Granada; Universidad de Malaga; Spanish Institute of Oceanography	Carrillo, P (corresponding author), Univ Granada, Inst Agua, Granada, Spain.	pcl@ugr.es	Mercado, Jesús M./B-1011-2008; Medina-Sánchez, Juan Manuel/A-4703-2013; Korbee, Nathalie/K-5995-2014; /ABH-3083-2020; Carrillo, Presentación/I-1601-2015; Lopez Figueroa, Felix Diego/K-7720-2014	Mercado, Jesús M./0000-0003-3291-1493; Medina-Sánchez, Juan Manuel/0000-0003-0991-9331; Korbee, Nathalie/0000-0002-9780-4915; Carrillo, Presentación/0000-0003-3794-4294; Duran Romero, Cristina/0000-0003-2382-4056; Lopez Figueroa, Felix Diego/0000-0003-3580-4693	Spanish Ministries of Science and Innovation [CGL2011-23681/BOS]; Consejeria de Innovacion, Ciencia y Empresa - Junta de Andalucia [CVI-02598]; Spanish government 'Formacion de Profesorado Universitario fellowship; Ministerio Ciencia e Innovacion [CGL2011-23681/BOS]; Spanish Government - Formacion de Profesorado Universitario Grant; Consejeria de Innovacion, Ciencia y Empresa-Junta de Andalucia [CVI-02598]	Spanish Ministries of Science and Innovation(Spanish Government); Consejeria de Innovacion, Ciencia y Empresa - Junta de Andalucia(Junta de Andalucia); Spanish government 'Formacion de Profesorado Universitario fellowship; Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Government - Formacion de Profesorado Universitario Grant; Consejeria de Innovacion, Ciencia y Empresa-Junta de Andalucia(Junta de Andalucia)	This research was supported by the Spanish Ministries of Science and Innovation (CGL2011-23681/BOS), Consejeria de Innovacion, Ciencia y Empresa - Junta de Andalucia' (Excelencia CVI-02598) and Spanish government 'Formacion de Profesorado Universitario fellowship to G. Herrera and C Duran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Ministerio Ciencia e Innovacion (CGL2011-23681/BOS), Consejeria de Innovacion, Ciencia y Empresa-Junta de Andalucia (Excelencia CVI-02598). GH and CD were supported by the Spanish Government - Formacion de Profesorado Universitario Grant. We thank the crew of the B/O F. de P.	Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bader MR, 2000, PHILOS T R SOC B, V355, P1433, DOI 10.1098/rstb.2000.0704; BADGER MR, 1985, ANNU REV PLANT PHYS, V36, P27, DOI 10.1146/annurev.arplant.36.1.27; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Beardall J, 2009, PHOTOCH PHOTOBIO SCI, V8, P1257, DOI 10.1039/b9pp00034h; Bouchard JN, 2013, MAR BIOL, V160, P2547, DOI 10.1007/s00227-013-2247-z; Carrillo P, 2008, GLOBAL CHANGE BIOL, V14, P423, DOI 10.1111/j.1365-2486.2007.01496.x; Carrillo P, 2008, MICROB ECOL, V56, P350, DOI 10.1007/s00248-007-9353-8; Cloern JE, 2014, BIOGEOSCIENCES, V11, P2477, DOI 10.5194/bg-11-2477-2014; Cloern JE, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000397; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; Doyle SA, 2005, LIMNOL OCEANOGR, V50, P1362, DOI 10.4319/lo.2005.50.5.1362; Duran C, 2014, MULTIPLE STRESSORS A; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Findlay S., 2003, AQUATIC ECOSYSTEMS I; Gallisai R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110762; Gao KS, 2007, PLANT PHYSIOL, V144, P54, DOI 10.1104/pp.107.098491; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Garcia-Gomez C, 2014, PHOTOCH PHOTOBIO SCI, V13, P1347, DOI 10.1039/c4pp00044g; Goyal A, 1996, P NATL ACAD SCI USA, V93, P3319, DOI 10.1073/pnas.93.8.3319; Grasshoff K, 1999, METHODS SEAWATER ANA; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hader DP, 2015, PHOTOCH PHOTOBIO SCI, V14, P108, DOI 10.1039/c4pp90035a; HELBLING EW, 1992, MAR ECOL PROG SER, V80, P89, DOI 10.3354/meps080089; Heraud P, 2005, J PHYCOL, V41, P1212, DOI 10.1111/j.1529-8817.2005.00149.x; Hessen DO, 2012, J EXP MAR BIOL ECOL, V411, P45, DOI 10.1016/j.jembe.2011.10.028; Hessen DO, 2008, DEEP-SEA RES PT II, V55, P2169, DOI 10.1016/j.dsr2.2008.05.013; Hudson JJ, 2000, NATURE, V406, P54, DOI 10.1038/35017531; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jahid IK, 2006, APPL ENVIRON MICROB, V72, P7043, DOI 10.1128/AEM.00924-06; JANSSON M, 1988, HYDROBIOLOGIA, V170, P157, DOI 10.1007/BF00024903; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; KANA TM, 1987, DEEP-SEA RES, V34, P497, DOI 10.1016/0198-0149(87)90002-1; KARENTZ D, 1991, J PHYCOL, V27, P326, DOI 10.1111/j.0022-3646.1991.00326.x; Korbee N, 2005, MAR BIOL, V146, P645, DOI 10.1007/s00227-004-1484-6; Korbee N, 2012, PHOTOCH PHOTOBIO SCI, V11, P1087, DOI 10.1039/c2pp05336e; Korbee N, 2010, LIMNOL OCEANOGR, V55, P899, DOI 10.4319/lo.2009.55.2.0899; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Krom MD, 2004, LIMNOL OCEANOGR, V49, P1582, DOI 10.4319/lo.2004.49.5.1582; Kulk G, 2011, J EXP MAR BIOL ECOL, V398, P63, DOI 10.1016/j.jembe.2010.12.011; Lawrenz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058137; Leu E, 2007, LIMNOL OCEANOGR, V52, P787, DOI 10.4319/lo.2007.52.2.0787; LIGNELL R, 1992, LIMNOL OCEANOGR, V37, P172, DOI 10.4319/lo.1992.37.1.0172; Llabres M, 2010, MAR ECOL PROG SER, V399, P27, DOI 10.3354/meps08332; Llebot C, 2010, J MARINE SYST, V83, P192, DOI 10.1016/j.jmarsys.2010.06.009; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; Lubian LM, 1998, PHYCOLOGIA, V37, P16, DOI 10.2216/i0031-8884-37-1-16.1; LUDWIG LJ, 1971, PLANT PHYSIOL, V48, P712, DOI 10.1104/pp.48.6.712; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; Marcoval MA, 2008, J PHOTOCH PHOTOBIO B, V91, P157, DOI 10.1016/j.jphotobiol.2008.03.002; Martinez-Lozano JA, 2011, INT J CLIMATOL, V31, P1554, DOI 10.1002/joc.2173; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; Medina-Sanchez JM, 2006, LIMNOL OCEANOGR, V51, P913; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Mercado JM, 2014, AQUAT BIOL, V22, P43, DOI 10.3354/ab00606; Mercado JM, 2008, J MARINE SYST, V71, P31, DOI 10.1016/j.jmarsys.2007.05.009; Mercado JM, 2007, PROG OCEANOGR, V74, P273, DOI 10.1016/j.pocean.2007.04.013; Mercado JM, 2006, ESTUAR COAST SHELF S, V69, P459, DOI 10.1016/j.ecss.2006.05.019; Mercado JM, 2005, SCI MAR, V69, P451, DOI 10.3989/scimar.2005.69n4451; Morales-Baquero R, 2006, LIMNOL OCEANOGR, V51, P830, DOI 10.4319/lo.2006.51.2.0830; MOREL A, 1993, J MAR RES, V51, P617, DOI 10.1357/0022240933223963; Neale PJ, 2014, AQUAT BIOL, V22, P25, DOI 10.3354/ab00587; Neale PJ, 2014, BIOGEOSCIENCES, V11, P2883, DOI 10.5194/bg-11-2883-2014; Olenina I., 2006, HELCON BALTIC SEA EN, P144; Peinado NK, 2004, J PHYCOL, V40, P248, DOI 10.1046/j.1529-8817.2004.03013.x; Petterson K, 1978, VERH INT VEREIN LIMN, V20, P226; Philippart CJM, 2011, J EXP MAR BIOL ECOL, V400, P52, DOI 10.1016/j.jembe.2011.02.023; Pinhassi J, 2006, AQUAT MICROB ECOL, V44, P241, DOI 10.3354/ame044241; Querol X, 2009, ATMOS CHEM PHYS, V9, P4575, DOI 10.5194/acp-9-4575-2009; Ramirez T, 2005, ESTUAR COAST SHELF S, V65, P654, DOI 10.1016/j.ecss.2005.07.012; RAVEN JA, 1981, CAN B FISH AQUAT SCI, P55; Ribes M, 1999, J PLANKTON RES, V21, P1077, DOI 10.1093/plankt/21.6.1077; Rijstenbil JW, 2002, J PLANKTON RES, V24, P1277, DOI 10.1093/plankt/24.12.1277; Segovia M, 2009, J PHYCOL, V45, P1116, DOI 10.1111/j.1529-8817.2009.00733.x; Sereda JM, 2011, HYDROBIOLOGIA, V665, P205, DOI 10.1007/s10750-011-0623-6; Shanklin J, 2010, NATURE, V465, P34, DOI 10.1038/465034a; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Sola Y, 2011, INT J CLIMATOL, V31, P1724, DOI 10.1002/joc.2194; SOMERVILLE CR, 1982, TRENDS BIOCHEM SCI, V7, P171, DOI 10.1016/0968-0004(82)90130-X; Sommaruga R, 2005, APPL ENVIRON MICROB, V71, P2154, DOI 10.1128/AEM.71.4.2154-2157.2005; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Tanaka T, 2004, LIMNOL OCEANOGR, V49, P1063, DOI 10.4319/lo.2004.49.4.1063; Tanaka T, 2011, BIOGEOSCIENCES, V8, P525, DOI 10.5194/bg-8-525-2011; Tanaka T, 2009, AQUAT MICROB ECOL, V56, P81, DOI 10.3354/ame01314; Tank SE, 2005, LIMNOL OCEANOGR, V50, P1345, DOI 10.4319/lo.2005.50.5.1345; Vadrucci M.R., 2007, TRANSITIONAL WATERS, V2, P83, DOI [10.1285/i1825229Xv1n2p83, DOI 10.1285/I1825229XV1N2P83]; van de Poll WH, 2009, PHOTOCH PHOTOBIO SCI, V8, P1295, DOI 10.1039/b904501e; Veen A, 1997, PLANT ECOL, V128, P28; VERITY PG, 1992, LIMNOL OCEANOGR, V37, P1434, DOI 10.4319/lo.1992.37.7.1434; Villafane VE, 2004, MAR ECOL PROG SER, V284, P23, DOI 10.3354/meps284023; Villafane VE, 2003, COMP SER PHOTOCHEM, V1, P357; Villafane VE, 2014, J EXP MAR BIOL ECOL, V459, P199, DOI 10.1016/j.jembe.2014.05.027; Xenopoulos MA, 2003, J PHYCOL, V39, P291, DOI 10.1046/j.1529-8817.2003.02125.x; Xenopoulos MA, 2002, ECOLOGY, V83, P423, DOI 10.1890/0012-9658(2002)083[0423:JEOURA]2.0.CO;2; Xu ZG, 2009, FUNCT PLANT BIOL, V36, P1057, DOI 10.1071/FP09092; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002; Zudaire L, 2001, J PHOTOCH PHOTOBIO B, V62, P26, DOI 10.1016/S1011-1344(01)00150-6	99	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142987	10.1371/journal.pone.0142987	http://dx.doi.org/10.1371/journal.pone.0142987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599583	gold, Green Submitted, Green Published			2022-12-26	WOS:000365853900053
J	Larsen, ME; Curry, L; Mastellos, N; Robb, C; Car, J; Middleton, LT				Larsen, Mark E.; Curry, Lisa; Mastellos, Nikolaos; Robb, Catherine; Car, Josip; Middleton, Lefkos T.			Development of the CHARIOT Research Register for the Prevention of Alzheimer's Dementia and Other Late Onset Neurodegenerative Diseases	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MILD COGNITIVE IMPAIRMENT; CROSS-SECTIONAL ANALYSIS; PRIMARY-CARE; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; HEALTH RESEARCH; RECRUITMENT; RECOMMENDATIONS	Background Identifying cognitively healthy people at high risk of developing dementia is an ever-increasing focus. These individuals are essential for inclusion in observational studies into the natural history of the prodromal and early disease stages and for interventional studies aimed at prevention or disease modification. The success of this research is dependent on having access to a well characterised, representative and sufficiently large population of individuals. Access to such a population remains challenging as clinical research has, historically, focussed on patients with dementia referred to secondary and tertiary services. The primary care system in the United Kingdom allows access to a true prodromal population prior to symptoms emerging and specialist referral. We report the development and recruitment rates of the CHARIOT register, a primary care-based recruitment register for research into the prevention of dementia. The CHARIOT register was designed specifically to support recruitment into observational natural history studies of pre-symptomatic or prodromal dementia stages, and primary or secondary prevention pharmaceutical trials or other prevention strategies for dementia and other cognitive problems associated with ageing. Methods Participants were recruited through searches of general practice lists across the west and central London regions. Invitations were posted to individuals aged between 60 and 85 years, without a diagnosis of dementia. Upon consent, a minimum data set of demographic and contact details was extracted from the patient's electronic health record. Results To date, 123 surgeries participated in the register, recruiting a total of 24,509 participants-a response rate of 22.3%. The age, gender and ethnicity profiles of participants closely match that of the overall eligible population. Higher response rates tended to be associated with larger practices (r = 0.34), practices with a larger older population (r = 0.27), less socioeconomically disadvantaged practices ( r = 0.68), and practices with a higher proportion of White patients (r = 0.82). Discussion Response rates are comparable to other registers reported in the literature, and indicate good interest and support for a research register and for participation in research for the prevention of age-related neurodegenerative diseases and dementia. We consider that the simplicity of the approach means that this system is easily scalable and replicable across the UK and internationally.	[Larsen, Mark E.; Mastellos, Nikolaos; Car, Josip] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Global eHlth Unit, London, England; [Curry, Lisa; Robb, Catherine; Middleton, Lefkos T.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Neuroepidemiol & Ageing Res Unit, London, England; [Car, Josip] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Imperial College London; Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Car, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Global eHlth Unit, London, England.	josip.car@imperial.ac.uk	Car, Josip/H-6755-2015	Car, Josip/0000-0001-8969-371X; Middleton, Lefkos/0000-0002-8615-3723	Janssen Pharmaceuticals; AstraZeneca; Zinfandel Pharmaceuticals; Takeda	Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); AstraZeneca(AstraZeneca); Zinfandel Pharmaceuticals; Takeda(Takeda Pharmaceutical Company Ltd)	The CHARIOT register was made possible with funding from Janssen Pharmaceuticals, AstraZeneca, Zinfandel Pharmaceuticals and Takeda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Beaton SJ, 2010, CONTEMP CLIN TRIALS, V31, P549, DOI 10.1016/j.cct.2010.08.005; Bell-Syer SEM, 2000, FAM PRACT, V17, P187, DOI 10.1093/fampra/17.2.187; Bower P, 2007, FAM PRACT, V24, P601, DOI 10.1093/fampra/cmm051; Bower P, 2009, FAM PRACT, V26, P391, DOI 10.1093/fampra/cmp037; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Department of Health, DEM CHALL AR ACT IMP; Douglas L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-546; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Gill TM, 2001, J AM GERIATR SOC, V49, P1039, DOI 10.1046/j.1532-5415.2001.49206.x; Health & Social Care Information Centre, QUAL OUTC FRAM; Hetherton J, 2004, PRIM HEALTH CARE RES, V5, P5, DOI DOI 10.1191/1463423604PC1680A]; Iliffe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-9; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; Khadjesari Z, 2013, BRIT J GEN PRACT, V63, pE706, DOI 10.3399/bjgp13X673720; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lyketsos CG, 2007, NEUROLOGY, V68, P1800; Mason VL, 2007, FAM PRACT, V24, P518, DOI 10.1093/fampra/cmm047; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; Olsson T, 2015, AD PD C 18 22 MARCH; Ousset P-J, 2014, J Prev Alzheimers Dis, V1, P40, DOI 10.14283/jpad.2014.19; Patel M.X., 2003, ADV PSYCHIAT TREAT, V9, P229, DOI [10.1192/apt.9.3.229, DOI 10.1192/APT.9.3.229]; Public Health England, NAT GEN PRACT PROF; Sano M, 2008, CLIN TRIALS, V5, P523, DOI 10.1177/1740774508096313; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sullivan F.M., 2011, TRIALS S1, V12, pA115, DOI DOI 10.1186/1745-6215-12-S1-A115; Vellas B, 2012, J NUTR HEALTH AGING, V16, P339, DOI 10.1007/s12603-012-0044-x; Wang YY, 2006, BRIT J GEN PRACT, V56, P830; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; World Health Organization, DEM CAS SET TRIPL 20	35	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141806	10.1371/journal.pone.0141806	http://dx.doi.org/10.1371/journal.pone.0141806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599631	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900015
J	Spencer, MD; Tyndall, AV; Davenport, MH; Argourd, L; Anderson, TJ; Eskes, GA; Friedenreich, CM; Hogan, DB; Leigh, R; Meshi, B; Smith, EE; Wilson, BJ; Wilton, SB; Poulin, MJ				Spencer, Matthew D.; Tyndall, Amanda V.; Davenport, Margie H.; Argourd, Laurie; Anderson, Todd J.; Eskes, Gail A.; Friedenreich, Christine M.; Hogan, David B.; Leigh, Richard; Meshi, Bernard; Smith, Eric E.; Wilson, Ben J.; Wilton, Stephen B.; Poulin, Marc J.			Cerebrovascular Responsiveness to Hypercapnia Is Stable over Six Months in Older Adults	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; TRANSCRANIAL DOPPLER ULTRASOUND; COGNITIVE FUNCTION; AEROBIC EXERCISE; CARBON-DIOXIDE; REACTIVITY; FITNESS; PERFORMANCE; POPULATION; VELOCITY	The primary purpose of this Brain in Motion (BIM) sub-study was to determine the 6-month stability of resting blood flow velocity and cerebrovascular responsiveness to a euoxic hypercapnic challenge in a group of physically inactive community dwelling men and men aged >= 55 yrs (range 55-92 yrs). At baseline and 6 months later 88 women (65 +/- 6 yr) and 78 men (67 +/- 7 yr) completed a hypercapnic challenge (step changes from resting end-tidal PCO2 ((PETCO2) to +1, +5 and +8 mmHg above rest) while cerebral blood flow velocity was assessed using transcranial Doppler ultrasound. Peak velocity of the middle cerebral artery (MCAv) was increased (p<0.05) at the second visit during rest (51 +/- 2 vs. 52 +/- 4); however, these differences were abolished (p>0.05) when MCAv was normalized to PETCO2. During hypercapnia, MCAv tended to be increased at follow-up, but this finding was absent when MCAv/PETCO2 was compared across time. Cerebrovascular reactivity (i.e., Delta MCAv/Delta PETCO2) was similar (p>0.05) between testing occasions regardless of the approach taken (i.e., considering only the lower step [from +1 to +5 mmHg]; the upper step [+5 to +8 mmHg]; or the complete test taken together). In conclusion, this study has shown that cerebral blood flow and cerebrovascular responsiveness to acute euoxic hypercapnia are stable in older, healthy adults over a 6-month period. Modest changes in MCAv over time must be viewed in the context of underlying differences in PETCO2, an important finding with implications for future studies considering cerebral blood flow velocity.	[Spencer, Matthew D.; Tyndall, Amanda V.; Davenport, Margie H.; Argourd, Laurie; Eskes, Gail A.; Leigh, Richard; Poulin, Marc J.] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Tyndall, Amanda V.; Davenport, Margie H.; Argourd, Laurie; Hogan, David B.; Smith, Eric E.; Poulin, Marc J.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Anderson, Todd J.; Wilton, Stephen B.; Poulin, Marc J.] Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Anderson, Todd J.] Univ Calgary, Cumming Sch Med, Dept Cardiac Sci, Calgary, AB T2N 4N1, Canada; [Eskes, Gail A.] Dalhousie Univ, Fac Med, Dept Psychiat, Halifax, NS B3H 2E2, Canada; [Friedenreich, Christine M.] Canc Control Alberta, Alberta Hlth Serv, Dept Canc Epidemiol & Prevent Res, Calgary, AB T2S 3C3, Canada; [Friedenreich, Christine M.; Hogan, David B.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB T2N 4N1, Canada; [Friedenreich, Christine M.] Univ Calgary, Cumming Sch Med, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Hogan, David B.; Leigh, Richard; Meshi, Bernard; Wilson, Ben J.] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB T2N 4N1, Canada; [Hogan, David B.; Smith, Eric E.; Poulin, Marc J.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Leigh, Richard] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada; [Poulin, Marc J.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; Dalhousie University; Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Poulin, MJ (corresponding author), Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada.	poulin@ucalgary.ca	Smith, Eric E/C-5443-2012; Hogan, David Bryan/I-4360-2013	Smith, Eric E/0000-0003-3956-1668; Hogan, David Bryan/0000-0002-9462-5460; Eskes, Gail/0000-0001-5867-9616; Friedenreich, Christine/0000-0002-4783-1966	Eyes High Postdoctoral Fellowship - University of Calgary; Alberta Innovates - Health Solutions (AIHS) Postdoctoral Fellowship; Alzheimer Society of Canada Research Program doctoral award; Canadian Institutes for Health Research/Heart and Stroke Foundation of Canada - Focus on Stroke Postdoctoral Fellowship; Canadian Institutes for Health Research Operating Grant [MOP-93717]	Eyes High Postdoctoral Fellowship - University of Calgary; Alberta Innovates - Health Solutions (AIHS) Postdoctoral Fellowship; Alzheimer Society of Canada Research Program doctoral award; Canadian Institutes for Health Research/Heart and Stroke Foundation of Canada - Focus on Stroke Postdoctoral Fellowship; Canadian Institutes for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	MD Spencer was supported by an Eyes High Postdoctoral Fellowship awarded by the University of Calgary and an Alberta Innovates - Health Solutions (AIHS) Postdoctoral Fellowship. AV Tyndall was supported by an Alzheimer Society of Canada Research Program doctoral award. MH Davenport was supported by a Canadian Institutes for Health Research/Heart and Stroke Foundation of Canada - Focus on Stroke Postdoctoral Fellowship. CM Friedenreich holds an Alberta Innovates-Health Solutions Health Senior Scholar Award and the ACF Weekend to End Women's Cancers Breast Cancer Chair. EE Smith holds the Katthy Taylor Chair in Vascular Dementia. DB Hogan holds The Brenda Strafford Foundation Chair in Geriatric Medicine. MJP Holds The Brenda Strafford Foundation Chair in Alzheimer Research. This research was supported by a Canadian Institutes for Health Research Operating Grant (MOP-93717; PI, MJ Poulin; Co-Applicants and Collaborators, TJ Anderson, GA Eskes, CM Friedenreich, DB Hogan; R Leigh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to the participants in this study and to acknowledge the assistance provided by Brad Hanson, Grazyna Burek, Jacqueline Harrison, Tona Pitt and Kristin Sabourin. MD Spencer was supported by an Eyes High Postdoctoral Fellowship awarded by the University of Calgary and an Alberta Innovates-Health Solutions (AIHS) Postdoctoral Fellowship. AV Tyndall was supported by an Alzheimer Society of Canada Research Program doctoral award. MH Davenport was supported by a Canadian Institutes for Health Research/Heart and Stroke Foundation of Canada-Focus on Stroke Postdoctoral Fellowship. CM Friedenreich holds an Alberta Innovates-Health Solutions Health Senior Scholar Award and the ACF Weekend to End Women's Cancers Breast Cancer Chair. EE Smith holds the Katthy Taylor Chair in Vascular Dementia. DB Hogan holds The Brenda Strafford Foundation Chair in Geriatric Medicine. MJP Holds The Brenda Strafford Foundation Chair in Alzheimer Research. This research was supported by a Canadian Institutes for Health Research Operating Grant (MOP-93717; PI, MJ Poulin; Co-Applicants and Collaborators, TJ Anderson, GA Eskes, CM Friedenreich, DB Hogan; R Leigh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Ainslie PN, 2014, J APPL PHYSIOL, V117, P1081, DOI 10.1152/japplphysiol.00854.2014; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; ARTS MGJ, 1972, MED BIOL ENG, V10, P23, DOI 10.1007/BF02474565; Baker AB, 2003, EXP AGING RES, V29, P47, DOI 10.1080/03610730303706; Battisti-Charbonney A, 2011, J PHYSIOL-LONDON, V589, P3039, DOI 10.1113/jphysiol.2011.206052; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown AD, 2010, NEUROBIOL AGING, V31, P2047, DOI 10.1016/j.neurobiolaging.2008.11.002; Canadian Society for Exercise Physiology, 1996, PROF FITN LIF CONS R; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Coverdale NS, 2014, J APPL PHYSIOL, V117, P1090, DOI 10.1152/japplphysiol.00285.2014; Davenport MH, 2012, EXERC SPORT SCI REV, V40, P153, DOI 10.1097/JES.0b013e3182553430; Donald AE, 2008, J AM COLL CARDIOL, V51, P1959, DOI 10.1016/j.jacc.2008.02.044; Fierstra J, 2010, J NEUROL NEUROSUR PS, V81, P290, DOI 10.1136/jnnp.2009.188078; Galvin SD, 2010, ANAESTH INTENS CARE, V38, P710, DOI 10.1177/0310057X1003800415; Halani S, 2015, NEUROIMAGE, V110, P110, DOI 10.1016/j.neuroimage.2015.01.050; Hatab MR, 1997, ULTRASOUND MED BIOL, V23, P1025, DOI 10.1016/S0301-5629(97)00030-6; Ide Kojiro, 2003, Journal of Applied Physiology, V95, P129; Lambertsen CJ, 1998, J APPL PHYSIOL, V85, P386, DOI 10.1152/jappl.1998.85.2.386; LAUTT WW, 1989, MICROVASC RES, V37, P230, DOI 10.1016/0026-2862(89)90040-X; Mitsis GD, 2002, P ANN INT IEEE EMBS, P1341, DOI 10.1109/IEMBS.2002.1106418; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Paterson DH, 1999, MED SCI SPORT EXER, V31, P1813, DOI 10.1097/00005768-199912000-00018; Poulin MJ, 1996, J APPL PHYSIOL, V81, P1084, DOI 10.1152/jappl.1996.81.3.1084; Poulin MJ, 1996, STROKE, V27, P2244, DOI 10.1161/01.STR.27.12.2244; Poulin MJ, 1998, J APPL PHYSIOL, V85, P388, DOI 10.1152/jappl.1998.85.2.388; Przybylowski T, 2003, J PHYSIOL-LONDON, V548, P323, DOI 10.1113/jphysiol.2002.029678; Regan RE, 2014, BRAIN BEHAV, V4, P775, DOI 10.1002/brb3.275; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Schwertfeger N, 2006, J NEUROL SCI, V249, P135, DOI 10.1016/j.jns.2006.06.009; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Sobczyk O, 2014, NEUROIMAGE, V92, P56, DOI 10.1016/j.neuroimage.2014.01.051; Sobczyk O, 2015, J CEREBR BLOOD F MET, V35, P213, DOI 10.1038/jcbfm.2014.184; Stoquart-ElSankari S, 2007, J CEREBR BLOOD F MET, V27, P1563, DOI 10.1038/sj.jcbfm.9600462; Strohm J, 2014, RESP PHYSIOL NEUROBI, V197, P15, DOI 10.1016/j.resp.2014.03.003; Thomas BP, 2014, J CEREBR BLOOD F MET, V34, P242, DOI 10.1038/jcbfm.2013.194; Tyndall AV, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-21; Verbree J, 2014, J APPL PHYSIOL, V117, P1084, DOI 10.1152/japplphysiol.00651.2014; Viticchi G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.027; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Wilson MH, 2011, J CEREBR BLOOD F MET, V31, P2019, DOI 10.1038/jcbfm.2011.81	42	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143059	10.1371/journal.pone.0143059	http://dx.doi.org/10.1371/journal.pone.0143059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599343	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900060
J	Yu, HF; Sui, YJ; Wang, YC; Sato, N; Frey, B; Xia, Z; Waldmann, TA; Berzofsky, J				Yu, Huifeng; Sui, Yongjun; Wang, Yichuan; Sato, Noriko; Frey, Blake; Xia, Zheng; Waldmann, Thomas A.; Berzofsky, Jay			Interleukin-15 Constrains Mucosal T Helper 17 Cell Generation: Influence of Mononuclear Phagocytes	PLOS ONE			English	Article							INTESTINAL DENDRITIC CELLS; IN-VITRO; IMMUNE-RESPONSES; IL-15; EXPRESSION; DIFFERENTIATION; SUBSETS; TH17; PATHWAYS; DISTINCT	Interleukin (IL)-15 has multiple roles in innate and adaptive immunity, especially regarding CD8(+) T cells and natural killer cells. However, the role of IL-15 in regulating differentiation of T helper cell subsets and mononuclear phagocytes (MPs) in different tissues in vivo is unknown. Here we report that IL-15 indirectly regulates Th17 but not other Th subsets in the intestinal lamina propria (LP), apparently through effects on MPs. Th17 cells in the LP were more prevalent in IL-15 KO mice than their wild-type counterparts, and less prevalent in IL-15 transgenic mice than their wild-type littermates, even co-caged. MPs from the LP of these mice were sufficient to mimic the in vivo finding in vitro by skewing of cocultured wild type OVA-specific CD4(+) T cells. However, production of IL-15 or lack thereof by these MPs was not sufficient to explain the skewing, as addition or blockade of IL- 15 in the cultures had no effect. Rather, a skewing of the relative proportion of CD11b(+), CD103(+) and double positive LP MP subsets in transgenic and KO could explain the differences in Th17 cells. Thus, IL-15 may influence MP subsets in the gut in a novel way that alters the frequency of LP Th17 cells.	[Yu, Huifeng; Sui, Yongjun; Wang, Yichuan; Frey, Blake; Xia, Zheng; Berzofsky, Jay] NIH, Vaccine Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Sato, Noriko] NCI, Mol Imaging Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Waldmann, Thomas A.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sui, YJ (corresponding author), NIH, Vaccine Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA.	suiy@niaid.nih.gov; berzofsj@mail.nih.gov	Sui, Yongjun/AAA-3228-2019; Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660; Sato, Noriko/0000-0002-9372-1725; Sui, Yongjun/0000-0002-1568-4607	National Cancer Institute (NCI) [ZO1 SC 004020]; NATIONAL CANCER INSTITUTE [Z01SC004020, ZIBBC010906] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Cancer Institute (NCI) intramural funding ZO1 SC 004020.	Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Becker M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00326; Borger P, 1999, IMMUNOLOGY, V96, P207; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Cerovic V, 2014, TRENDS IMMUNOL, V35, P270, DOI 10.1016/j.it.2014.04.003; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Fehniger TA, 2002, CYTOKINE GROWTH F R, V13, P169, DOI 10.1016/S1359-6101(01)00021-1; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Gross M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00254; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Imamichi H, 2008, EUR J IMMUNOL, V38, P1621, DOI 10.1002/eji.200737607; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jaensson-Gyllenback E, 2011, MUCOSAL IMMUNOL, V4, P438, DOI 10.1038/mi.2010.91; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim JJ, 1998, EUR J IMMUNOL, V28, P1089, DOI 10.1002/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lu J, 2002, CLIN CANCER RES, V8, P3877; Malamut G, 2010, J CLIN INVEST, V120, P2131, DOI 10.1172/JCI41344; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Mann ER, 2013, IMMUNOL LETT, V150, P30, DOI 10.1016/j.imlet.2013.01.007; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Masuda A, 2000, J BIOL CHEM, V275, P29331, DOI 10.1074/jbc.M910290199; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mishra A, 2014, CLIN CANCER RES, V20, P2044, DOI 10.1158/1078-0432.CCR-12-3603; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Oh S, 2004, P NATL ACAD SCI USA, V101, P15154, DOI 10.1073/pnas.0406649101; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Pandiyan P, 2012, J IMMUNOL, V189, P4237, DOI 10.4049/jimmunol.1201476; Persson EK, 2013, EUR J IMMUNOL, V43, P3098, DOI 10.1002/eji.201343740; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Raki M, 2006, GASTROENTEROLOGY, V131, P428, DOI 10.1053/j.gastro.2006.06.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Scott CL, 2015, MUCOSAL IMMUNOL, V8, P327, DOI 10.1038/mi.2014.70; Seder RA, 1996, J IMMUNOL, V156, P2413; Sin JI, 1998, EUR J IMMUNOL, V28, P3530, DOI 10.1002/(SICI)1521-4141(199811)28:11<3530::AID-IMMU3530>3.0.CO;2-C; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Terabe M, 2008, J IMMUNOL, V180, P7276, DOI 10.4049/jimmunol.180.11.7276; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Umemura M, 2001, J IMMUNOL, V167, P946, DOI 10.4049/jimmunol.167.2.946; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	74	133	135	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143001	10.1371/journal.pone.0143001	http://dx.doi.org/10.1371/journal.pone.0143001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600079	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900055
J	Spencer, B; Potkar, R; Metcalf, J; Thrin, I; Adame, A; Rockenstein, E; Masliah, E				Spencer, Brian; Potkar, Rewati; Metcalf, Jeff; Thrin, Ivy; Adame, Anthony; Rockenstein, Edward; Masliah, Eliezer			Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN ACCUMULATION; APP TRANSGENIC MODEL; CEREBROSPINAL-FLUID; SUBVENTRICULAR ZONE; ALTERED EXPRESSION; LENTIVIRAL VECTORS; FUSION PROTEIN; WEIGHT-LOSS; IN-VIVO; DEMENTIA	Neuropeptide Y (NPY) is one of the most abundant protein transmitters in the central nervous system with roles in a variety of biological functions including: food intake, cardiovascular regulation, cognition, seizure activity, circadian rhythms, and neurogenesis. Reduced NPY and NPY receptor expression is associated with numerous neurodegenerative disorders including Alzheimer disease (AD). To determine whether replacement of NPY could ameliorate some of the neurodegenerative and behavioral pathology associated with AD, we generated a lentiviral vector expressing NPY fused to a brain transport peptide (apoB) for widespread CNS delivery in an APP-transgenic (tg) mouse model of AD. The recombinant NPY-apoB effectively reversed neurodegenerative pathology and behavioral deficits although it had no effect on accumulation of A beta. The subgranular zone of the hippocampus showed a significant increase in proliferation of neural precursor cells without further differentiation into neurons. The neuroprotective and neurogenic effects of NPY-apoB appeared to involve signaling via ERK and Akt through the NPY R1 and NPY R2 receptors. Thus, widespread CNS-targeted delivery of NPY appears to be effective at reversing the neuronal and glial pathology associated with A beta accumulation while also increasing NPC proliferation. Overall, increased delivery of NPY to the CNS for AD might be an effective therapy especially if combined with an anti-A beta therapeutic.	[Spencer, Brian; Potkar, Rewati; Metcalf, Jeff; Thrin, Ivy; Adame, Anthony; Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92102 USA; [Metcalf, Jeff; Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, San Diego, CA 92102 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Masliah, E (corresponding author), 9500 Gilman Dr,0624, La Jolla, CA 92093 USA.	emasliah@ucsd.edu			National Institutes of Health [AG022074, AG018440, AG010435]; NATIONAL INSTITUTE ON AGING [P01AG022074, P01AG010435, R37AG018440, R01AG018440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG022074, AG018440, and AG010435. The authors declare they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; ALOM J, 1990, EUR NEUROL, V30, P207; Angelucci F, 2014, CAN J PHYSIOL PHARM, V92, P621, DOI 10.1139/cjpp-2014-0099; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Baptista S, 2012, NEUROPHARMACOLOGY, V62, P2413, DOI 10.1016/j.neuropharm.2012.02.015; BarrettConnor E, 1996, J AM GERIATR SOC, V44, P1147, DOI 10.1111/j.1532-5415.1996.tb01362.x; BEAL MF, 1986, ANN NEUROL, V20, P282, DOI 10.1002/ana.410200303; Buchman AS, 2005, NEUROLOGY, V65, P892, DOI 10.1212/01.wnl.0000176061.33817.90; CHANPALAY V, 1985, J COMP NEUROL, V238, P390, DOI 10.1002/cne.902380404; CHANPALAY V, 1986, J COMP NEUROL, V248, P376, DOI 10.1002/cne.902480307; Corvino V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088294; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Croce N, 2012, ACS CHEM NEUROSCI, V3, P312, DOI 10.1021/cn200127e; Croce N, 2011, NEURODEGENER DIS, V8, P300, DOI 10.1159/000323468; DAVIES CA, 1990, J NEUROL SCI, V96, P59, DOI 10.1016/0022-510X(90)90057-T; Decressac M, 2012, EXP NEUROL, V238, P265, DOI 10.1016/j.expneurol.2012.09.004; Diez M, 2003, NEUROBIOL DIS, V14, P579, DOI 10.1016/j.nbd.2003.08.003; EDVINSSON L, 1993, DEMENTIA, V4, P167, DOI 10.1159/000107318; Ferreira R, 2010, J BIOL CHEM, V285, P41921, DOI 10.1074/jbc.M110.164020; Goncalves J, 2012, J NEUROCHEM, V123, P1041, DOI 10.1111/jnc.12052; Goncalves J, 2012, EUR J NEUROSCI, V36, P3173, DOI 10.1111/j.1460-9568.2012.08232.x; Hernandez S, 2012, NEUROPEPTIDES, V46, P29, DOI 10.1016/j.npep.2011.10.002; Howell OW, 2005, J NEUROCHEM, V93, P560, DOI 10.1111/j.1471-4159.2005.03057.x; Howell OW, 2003, J NEUROCHEM, V86, P646, DOI 10.1046/j.1471-4159.2003.01895.x; Howell OW, 2007, NEUROBIOL DIS, V26, P174, DOI 10.1016/j.nbd.2006.12.014; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Jin HK, 2009, CELL PROLIFERAT, V42, P571, DOI 10.1111/j.1365-2184.2009.00625.x; Johnson DK, 2006, ARCH NEUROL-CHICAGO, V63, P1312, DOI 10.1001/archneur.63.9.1312; KOIDE S, 1995, NEUROSCI LETT, V198, P149, DOI 10.1016/0304-3940(95)11973-Z; KOWALL NW, 1988, ANN NEUROL, V23, P105, DOI 10.1002/ana.410230202; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; MARTEL JC, 1990, BRAIN RES, V519, P228, DOI 10.1016/0006-8993(90)90082-M; MARTIGNONI E, 1992, J NEURAL TRANSM-PARK, V4, P191, DOI 10.1007/BF02260903; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Minthon L, 1990, J Neural Transm Suppl, V30, P57; Minthon L, 1996, ALZ DIS ASSOC DIS, V10, P197, DOI 10.1097/00002093-199601040-00005; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Musiek ES, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00029; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pfeifer A, 2001, MOL THER, V3, P319, DOI 10.1006/mthe.2001.0276; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Ray J, 1997, P NATL ACAD SCI USA, V94, P7047, DOI 10.1073/pnas.94.13.7047; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rose JB, 2009, J NEUROSCI, V29, P1115, DOI 10.1523/JNEUROSCI.4220-08.2009; Shaw JL, 2003, J CHEM NEUROANAT, V26, P179, DOI 10.1016/j.jchemneu.2003.07.003; Silva AP, 2002, CLIN CHIM ACTA, V326, P3, DOI 10.1016/S0009-8981(02)00301-7; Spencer B, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0043-6; Spencer B, 2014, MOL THER, V22, P1753, DOI 10.1038/mt.2014.129; Spencer B, 2014, J BIOL CHEM, V289, P17917, DOI 10.1074/jbc.M114.557439; Spencer B, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00114; Spencer B, 2013, MOL THER, V21, P31, DOI 10.1038/mt.2012.66; Spencer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016575; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; St-Pierre JA, 2000, GLIA, V30, P82, DOI 10.1002/(SICI)1098-1136(200003)30:1<82::AID-GLIA9>3.3.CO;2-#; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Terry Robert D., 1994, P179; Thiriet N, 2011, J NEUROCHEM, V116, P1018, DOI 10.1111/j.1471-4159.2010.07154.x; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tsigelny IF, 2014, J ALZHEIMERS DIS, V39, P583, DOI 10.3233/JAD-131589; Ubhi K, 2010, J NEUROSCI, V30, P6236, DOI 10.1523/JNEUROSCI.0567-10.2010; van Wamelen DJ, 2013, J NEUROENDOCRINOL, V25, P198, DOI 10.1111/j.1365-2826.2012.02379.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; White H, 1998, J AM GERIATR SOC, V46, P1223, DOI 10.1111/j.1532-5415.1998.tb04537.x; Winner B, 2008, NEUROBIOL AGING, V29, P913, DOI 10.1016/j.neurobiolaging.2006.12.016; Xapelli S, 2007, PEPTIDES, V28, P288, DOI 10.1016/j.peptides.2006.09.031; Xapelli Sara, 2006, Recent Pat CNS Drug Discov, V1, P315, DOI 10.2174/157488906778773689	72	37	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1905	1920		10.1074/jbc.M115.678185	http://dx.doi.org/10.1074/jbc.M115.678185			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26620558	hybrid, Green Published			2022-12-26	WOS:000368620700029
J	Xue, JH; Xu, GF; Gu, TP; Chen, GD; Han, BB; Xu, ZM; Bjoras, M; Krokan, HE; Xu, GL; Du, YR				Xue, Jian-Huang; Xu, Gui-Fang; Gu, Tian-Peng; Chen, Guo-Dong; Han, Bin-Bin; Xu, Zhi-Mei; Bjoras, Magnar; Krokan, Hans E.; Xu, Guo-Liang; Du, Ya-Rui			Uracil-DNA Glycosylase UNG Promotes Tet-mediated DNA Demethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-DEMETHYLATION; CRYSTAL-STRUCTURE; TDG; 5-CARBOXYLCYTOSINE; 5-FORMYLCYTOSINE; 5-METHYLCYTOSINE; METHYLATION; OXIDATION; EXCISION; 5-HYDROXYMETHYLCYTOSINE	In mammals, active DNA demethylation involves oxidation of 5-methylcytosine (5mC) into 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) by Tet dioxygenases and excision of these two oxidized bases by thymine DNA glycosylase (TDG). Although TDG is essential for active demethylation in embryonic stem cells and induced pluripotent stem cells, it is hardly expressed in mouse zygotes and dispensable in pronuclear DNA demethylation. To search for other factors that might contribute to demethylation in mammalian cells, we performed a functional genomics screen based on a methylated luciferase reporter assay. UNG2, one of the glycosylases known to excise uracil residues from DNA, was found to reduce DNA methylation, thus activating transcription of a methylation-silenced reporter gene when co-transfected with Tet2 into HEK293T cells. Interestingly, UNG2 could decrease 5caC from the genomic DNA and a reporter plasmid in transfected cells, like TDG. Furthermore, deficiency in Ung partially impaired DNA demethylation in mouse zygotes. Our results suggest that UNG might be involved in Tet-mediated DNA demethylation.	[Xue, Jian-Huang; Xu, Gui-Fang; Gu, Tian-Peng; Chen, Guo-Dong; Han, Bin-Bin; Xu, Zhi-Mei; Xu, Guo-Liang; Du, Ya-Rui] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Xu, Gui-Fang] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Bjoras, Magnar] Natl Hosp Norway, Oslo Univ Hosp, Clin Diagnost & Intervent, Dept Microbiol, N-0424 Oslo, Norway; [Krokan, Hans E.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, NO-7491 Trondheim, Norway; [Xu, Guo-Liang] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; University of Oslo; National Hospital Norway; Norwegian University of Science & Technology (NTNU); ShanghaiTech University	Du, YR (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	yrdu@sibcb.ac.cn	Xue, Jianhuang/AAE-3589-2021; Bjørås, Magnar/N-9286-2017	Xue, Jianhuang/0000-0003-0623-2200	National Natural Science Foundation of China [31430049, 31230039, 31471213]; National Basic Research Program of China [2014CB965200]; Breakthrough Project of Strategic Priority Program of the Chinese Academy of Sciences [XDB13000000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Breakthrough Project of Strategic Priority Program of the Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China Grants 31430049 and 31230039 (to G.-L. X.) and 31471213 (to Y.-R. D.), National Basic Research Program of China Grant 2014CB965200 (to Y.-R. D.), and the Breakthrough Project of Strategic Priority Program of the Chinese Academy of Sciences Grant XDB13000000. The authors declare that they have no conflicts of interest with the contents of this article.	Bestor TH, 2015, P NATL ACAD SCI USA, V112, P6796, DOI 10.1073/pnas.1415301111; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krokeide SZ, 2009, PROTEIN EXPRES PURIF, V65, P160, DOI 10.1016/j.pep.2008.11.014; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Li Z, 2015, NUCLEIC ACIDS RES, V43, P3986, DOI 10.1093/nar/gkv283; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; Muller U, 2014, NUCLEIC ACIDS RES, V42, P8592, DOI 10.1093/nar/gku552; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Wheldon LM, 2014, CELL REP, V7, P1353, DOI 10.1016/j.celrep.2014.05.003; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu D, 2014, J BIOL CHEM, V289, P15463, DOI 10.1074/jbc.M114.561019; Xu GL, 2015, NATL SCI REV, V2, P318, DOI 10.1093/nsr/nwv029; Xu GL, 2014, BMB REP, V47, P609, DOI 10.5483/BMBRep.2014.47.11.223; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006	38	26	29	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					731	738		10.1074/jbc.M115.693861	http://dx.doi.org/10.1074/jbc.M115.693861			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26620559	hybrid, Green Published			2022-12-26	WOS:000367830500021
J	Bergstrom, JJE; Heyman, B				Bergstrom, Joakim J. E.; Heyman, Birgitta			IgG Suppresses Antibody Responses in Mice Lacking C1q, C3, Complement Receptors 1 and 2, or IgG Fc-Receptors	PLOS ONE			English	Article							MEDIATED IMMUNE SUPPRESSION; RII-DEFICIENT MICE; HEMOLYTIC-DISEASE; GAMMA-RIIB; IN-VIVO; EPITOPE MASKING; T-CELLS; ANTIGEN; ERYTHROCYTES; ACTIVATION	Antigen-specific IgG antibodies, passively administered to mice or humans together with large particulate antigens like erythrocytes, can completely suppress the antibody response against the antigen. This is used clinically in Rhesus prophylaxis, where administration of IgG anti-RhD prevents RhD-negative women from becoming immunized against RhD-positive fetal erythrocytes aquired transplacentally. The mechanisms by which IgG suppresses antibody responses are poorly understood. We have here addressed whether complement or Fc-receptors for IgG (Fc gamma Rs) are required for IgG-mediated suppression. IgG, specific for sheep red blood cells (SRBC), was administered to mice together with SRBC and the antibody responses analyzed. IgG was able to suppress early IgM- as well as longterm IgG-responses in wildtype mice equally well as in mice lacking Fc gamma RIIB (Fc gamma RIIB knockout mice) or Fc gamma RI, III, and IV (FcR gamma knockout mice). Moreover, IgG was able to suppress early IgM responses equally well in mice lacking C1q (C1qA knockout mice), C3 (C3 knockout mice), or complement receptors 1 and 2 (Cr2 knockout mice) as in wildtype mice. Owing to the previously described severely impaired IgG responses in the complement deficient mice, it was difficult to assess whether passively administered IgG further decreased their IgG response. In conclusion, Fc-receptor binding or complement-activation by IgG does not seem to be required for its ability to suppress antibody responses to xenogeneic erythrocytes.	[Bergstrom, Joakim J. E.; Heyman, Birgitta] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University	Heyman, B (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	birgitta.heyman@imbim.uu.se		Heyman, Birgitta/0000-0003-0869-0483	Swedish Research Council [K2012-57X-07492-25-6]; Hans von Kantzow's Foundation; King Gustaf V:s 80 Years Foundation; Ollie and Elof Ericsson's Foundation; Agnes and Mac Rudberg's Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Hans von Kantzow's Foundation; King Gustaf V:s 80 Years Foundation; Ollie and Elof Ericsson's Foundation; Agnes and Mac Rudberg's Foundation	This work was supported by the Swedish Research Council, grant K2012-57X-07492-25-6, http://www.vr.se/ (BH); Hans von Kantzow's Foundation (no grant number) (BH); King Gustaf V:s 80 Years Foundation (no grant number, http://ams.orbelon.com/gv80/) (BH) Ollie and Elof Ericsson's Foundation (no grant number or web page) (BH); and Agnes and Mac Rudberg's Foundation (no grant number, http://www.uu.se/) (JJEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo L, 2015, J IMMUNOL, V195, P2224, DOI 10.4049/jimmunol.1500790; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Carlsson F, 2009, SCAND J IMMUNOL, V70, P77, DOI 10.1111/j.1365-3083.2009.02274.x; CLARKE CA, 1963, BRIT MED J, P979; Cutler AJ, 1998, J EXP MED, V187, P1789, DOI 10.1084/jem.187.11.1789; da Silveira SA, 2002, J EXP MED, V195, P665, DOI 10.1084/jem.20012024; Daeron M, 2006, ADV IMMUNOL, V89, P39, DOI 10.1016/S0065-2776(05)89002-9; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Fischer MB, 1996, J IMMUNOL, V157, P549; Getahun A, 2009, SCAND J IMMUNOL, V70, P277, DOI 10.1111/j.1365-3083.2009.02298.x; HENRY C, 1968, J EXP MED, V128, P133, DOI 10.1084/jem.128.1.133; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; Heyman B, 2001, SCAND J IMMUNOL, V53, P331, DOI 10.1046/j.1365-3083.2001.00890.x; Heyman B, 1999, IMMUNOL LETT, V68, P41, DOI 10.1016/S0165-2478(99)00028-0; HEYMAN B, 1988, EUR J IMMUNOL, V18, P1739, DOI 10.1002/eji.1830181113; Heyman B, 2014, CURR TOP MICROBIOL, V382, P201, DOI 10.1007/978-3-319-07911-0_9; JERNE NK, 1963, SCIENCE, V140, P405, DOI 10.1126/science.140.3565.405; Karlsson MCI, 2001, SCAND J IMMUNOL, V53, P381, DOI 10.1046/j.1365-3083.2001.00886.x; Karlsson MCI, 2001, J IMMUNOL, V167, P5558, DOI 10.4049/jimmunol.167.10.5558; Karlsson MCI, 1999, P NATL ACAD SCI USA, V96, P2244, DOI 10.1073/pnas.96.5.2244; KLAUS GGB, 1979, IMMUNOLOGY, V37, P345; Kumpel BM, 2008, CLIN EXP IMMUNOL, V154, P1, DOI 10.1111/j.1365-2249.2008.03735.x; Kumpel BM, 2001, TRENDS IMMUNOL, V22, P26, DOI 10.1016/S1471-4906(00)01801-9; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; Na D, 2006, J THEOR BIOL, V241, P830, DOI 10.1016/j.jtbi.2006.01.019; NOSE M, 1983, P NATL ACAD SCI-BIOL, V80, P6632, DOI 10.1073/pnas.80.21.6632; Rutemark C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041968; Rutemark C, 2011, P NATL ACAD SCI USA, V108, pE934, DOI 10.1073/pnas.1109831108; Sinclair NRS, 2001, SCAND J IMMUNOL, V53, P322, DOI 10.1046/j.1365-3083.2001.00889.x; Sorman A, 2014, MOL IMMUNOL, V61, P79, DOI 10.1016/j.molimm.2014.06.010; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Urbaniak SJ, 2000, BLOOD REV, V14, P44, DOI 10.1054/blre.1999.0123; Wernersson S, 1999, J IMMUNOL, V163, P618; Yu HH, 2014, J IMMUNOL, V193, P2902, DOI 10.4049/jimmunol.1302287	37	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143841	10.1371/journal.pone.0143841	http://dx.doi.org/10.1371/journal.pone.0143841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619292	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800078
J	Bernardi, G				Bernardi, Giorgio			Chromosome Architecture and Genome Organization	PLOS ONE			English	Article							HUMAN TRANSCRIPTOME MAP; GC-CONTENT; INTERSPERSED REPEATS; EUKARYOTIC GENOMES; ISOCHORE PATTERNS; GENE DENSITY; REVEALS; BANDS; EVOLUTION; DOMAINS	How the same DNA sequences can function in the three-dimensional architecture of interphase nucleus, fold in the very compact structure of metaphase chromosomes and go precisely back to the original interphase architecture in the following cell cycle remains an unresolved question to this day. The strategy used to address this issue was to analyze the correlations between chromosome architecture and the compositional patterns of DNA sequences spanning a size range from a few hundreds to a few thousands Kilobases. This is a critical range that encompasses isochores, interphase chromatin domains and boundaries, and chromosomal bands. The solution rests on the following key points: 1) the transition from the looped domains and sub-domains of interphase chromatin to the 30-nm fiber loops of early prophase chromosomes goes through the unfolding into an extended chromatin structure (probably a 10-nm "beads-on-a-string" structure); 2) the architectural proteins of interphase chromatin, such as CTCF and cohesin sub-units, are retained in mitosis and are part of the discontinuous protein scaffold of mitotic chromosomes; 3) the conservation of the link between architectural proteins and their binding sites on DNA through the cell cycle explains the "mitotic memory" of interphase architecture and the reversibility of the interphase to mitosis process. The results presented here also lead to a general conclusion which concerns the existence of correlations between the isochore organization of the genome and the architecture of chromosomes from interphase to metaphase.	[Bernardi, Giorgio] Univ Rome Tre, Dept Sci, I-00146 Rome, Italy; [Bernardi, Giorgio] Stn Zool Anton Dohrn, Naples, Italy	Italfarmaco; Roma Tre University; Stazione Zoologica Anton Dohrn di Napoli	Bernardi, G (corresponding author), Univ Rome Tre, Dept Sci, I-00146 Rome, Italy.	gbernardi@uniroma3.it						Alberts B., 1983, MOL BIOL CELL, V4; Arhondakis S, 2011, GENOME BIOL EVOL, V3, P1080, DOI 10.1093/gbe/evr017; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; BERNARDI G, 1990, BIOFUTUR, P43; BERNARDI G, 1993, J MOL EVOL, V37, P331, DOI 10.1007/BF00178863; Bernardi G., 2004, STRUCTURAL EVOLUTION; Berthelot C, 2015, CELL REP, V10, P1913, DOI 10.1016/j.celrep.2015.02.046; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; Cammarano R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-538; Carels N, 2000, GENETICS, V154, P1819; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; CASPERSSON T, 1968, EXP CELL RES, V49, P219, DOI 10.1016/0014-4827(68)90538-7; Chandra T, 2015, CELL REP, V10, P471, DOI 10.1016/j.celrep.2014.12.055; COMINGS DE, 1978, ANNU REV GENET, V12, P25, DOI 10.1146/annurev.ge.12.120178.000325; CORNEO G, 1968, BIOCHEMISTRY-US, V7, P4373, DOI 10.1021/bi00852a033; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Costantini M, 2008, P NATL ACAD SCI USA, V105, P13971, DOI 10.1073/pnas.0803916105; Costantini M, 2008, P NATL ACAD SCI USA, V105, P3433, DOI 10.1073/pnas.0710587105; Costantini M, 2007, CHROMOSOMA, V116, P29, DOI 10.1007/s00412-006-0078-0; Costantini M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-755; Costantini M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005972; Costantini M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-146; Cozzi P, EVOLUTIONAR IN PRESS; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Cruveiller S, 2004, GENOME RES, V14, P886, DOI 10.1101/gr.2246704; D'Onofrio G, 2002, GENE, V300, P179, DOI 10.1016/S0378-1119(02)01045-4; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Devillers-Thiery A., 1974, THESIS; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; DURET L, 1995, J MOL EVOL, V40, P308, DOI 10.1007/BF00163235; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; FILIPSKI J, 1973, J MOL BIOL, V80, P177, DOI 10.1016/0022-2836(73)90240-4; Fisher AM, 2005, GENE CHROMOSOME CANC, V43, P383, DOI 10.1002/gcc.20196; Follmer NE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003135; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; Frenkel ZM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-203; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hodgkinson A, 2012, HUM MUTAT, V33, P136, DOI 10.1002/humu.21616; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Houlard M, 2015, NAT CELL BIOL, V17, P771, DOI 10.1038/ncb3167; Jabbari K, GENOMICS IN PRESS; Julienne H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003233; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kleckner N, 2013, SCIENCE, V342, P940, DOI 10.1126/science.1247514; Konu O, 2002, J MOL EVOL, V54, P35, DOI 10.1007/s00239-001-0015-z; Lemaitre C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-335; Lewin B., 2008, GENES 9; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; MACAYA G, 1976, J MOL BIOL, V108, P237, DOI 10.1016/S0022-2836(76)80105-2; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; MEUNIERROTIVAL M, 1982, P NATL ACAD SCI-BIOL, V79, P355, DOI 10.1073/pnas.79.2.355; MOUCHIROUD D, 1991, GENE, V100, P181, DOI 10.1016/0378-1119(91)90364-H; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pavlicek A, 2002, FEBS LETT, V511, P175, DOI 10.1016/S0014-5793(01)03282-3; Poirier MG, 2002, P NATL ACAD SCI USA, V99, P15393, DOI 10.1073/pnas.232442599; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Rabl C, 1885, MORPHOL JB, V10, P214; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Rynditch AV, 1998, GENE, V222, P1, DOI 10.1016/S0378-1119(98)00451-X; Saccone S, 2002, GENE, V300, P169, DOI 10.1016/S0378-1119(02)01038-7; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; Saccone S, 2001, CHROMOSOME RES, V9, P533, DOI 10.1023/A:1012443217627; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Schmegner C, 2007, GENETICS, V175, P421, DOI 10.1534/genetics.106.064386; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; THIERY JP, 1976, J MOL BIOL, V108, P219, DOI 10.1016/S0022-2836(76)80104-0; Varriale A, 2010, GENOMICS, V95, P25, DOI 10.1016/j.ygeno.2009.09.006; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Watanabe Y, 2002, HUM MOL GENET, V11, P13, DOI 10.1093/hmg/11.1.13; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712; YUNIS JJ, 1981, HUM GENET, V56, P293, DOI 10.1007/BF00274682; Zaret KS, 2014, DEV CELL, V29, P132, DOI 10.1016/j.devcel.2014.04.019; Zoubak S, 1996, GENE, V174, P95, DOI 10.1016/0378-1119(96)00393-9	92	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143739	10.1371/journal.pone.0143739	http://dx.doi.org/10.1371/journal.pone.0143739			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619076	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800066
J	Gomes, JMM; Ribeiro, HJ; Procopio, MS; Alvarenga, BM; Castro, ACS; Dutra, WO; da Silva, JBB; Correa, JD				Gomes, Juliana M. M.; Ribeiro, Heder J.; Procopio, Marcela S.; Alvarenga, Betania M.; Castro, Antonio C. S.; Dutra, Walderez O.; da Silva, Jose B. B.; Correa Junior, Jose D.			What the Erythrocytic Nuclear Alteration Frequencies Could Tell Us about Genotoxicity and Macrophage Iron Storage?	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; INDUCED LIPID-PEROXIDATION; NILE TILAPIA; MELANOMACROPHAGE CENTERS; MICRONUCLEUS TEST; HEAD-KIDNEY; IN-VIVO; OXIDATIVE STRESS; CADMIUM CHLORIDE; EMBRYONIC STAGES	Erythrocytic nuclear alterations have been considered as an indicative of organism's exposure to genotoxic agents. Due to their close relationship among their frequencies and DNA damages, they are considered excellent markers of exposure in eukaryotes. However, poor data has been found in literature concerning their genesis, differential occurrence and their life span. In this study, we use markers of cell viability; genotoxicity and cellular turn over in order to shed light to these events. Tilapia and their blood were exposed to cadmium in acute exposure and in vitro assays. They were analyzed using flow cytometry for oxidative stress and membrane disruption, optical microscopy for erythrocytic nuclear alteration, graphite furnace atomic absorption spectrometry for cadmium content in aquaria water, blood and cytochemical and analytical electron microscopy techniques for the hemocateretic aspects. The results showed a close relationship among the total nuclear alterations and cadmium content in the total blood and melanomacrophage centres area, mismatching reactive oxygen species and membrane damages. Moreover, nuclear alterations frequencies (vacuolated, condensed and blebbed) showed to be associated to cadmium exposure whereas others (lobed and bud) were associated to depuration period. Decrease on nuclear alterations frequencies was also associated with hemosiderin increase inside spleen and head kidney macrophages mainly during depurative processes. These data disclosure in temporal fashion the main processes that drive the nuclear alterations frequencies and their relationship with some cellular and systemic biomarkers.	[Gomes, Juliana M. M.; Procopio, Marcela S.; Alvarenga, Betania M.; Dutra, Walderez O.; Correa Junior, Jose D.] Univ Fed Minas Gerais, Dept Morfol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil; [Ribeiro, Heder J.] Univ Fed Juiz de Fora, Dept Med, Fac Med, BR-35010177 Governador Valadares, MG, Brazil; [Castro, Antonio C. S.] Univ Fed Juiz de Fora, Dept Med Vet, Fac Med, BR-36036900 Juiz De Fora, MG, Brazil; [da Silva, Jose B. B.] Univ Fed Minas Gerais, Dept Quim, Inst Ciencias Exatas, BR-31270901 Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Universidade Federal de Minas Gerais	Correa, JD (corresponding author), Univ Fed Minas Gerais, Dept Morfol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil.	correajr@ufmg.br	Procópio, Marcela/P-9640-2018; Corrêa, José Dias/G-3858-2012; Corrêa, José Dias/P-3815-2019; Gomes, Juliana Moreira Mendonça/AAG-8391-2019; Dutra, Walderez Ornelas/CAH-1502-2022	Corrêa, José Dias/0000-0002-8623-8524; Corrêa, José Dias/0000-0002-8623-8524; Dutra, Walderez Ornelas/0000-0002-7586-9996; Moreira Mendonca Gomes, Juliana/0000-0002-5444-5764	CAPES; CTIT-UFMG; FAPEMIG; PRPq-UFMG; PG Biologia Celular-UFMG (Brazilian Agencies for Science and Technology)	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CTIT-UFMG; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); PRPq-UFMG; PG Biologia Celular-UFMG (Brazilian Agencies for Science and Technology)	This study was funded by CAPES, CTIT-UFMG, FAPEMIG, PRPq-UFMG and PG Biologia Celular-UFMG (Brazilian Agencies for Science and Technology). No additional funding was received for this study.	Agius C, 2003, J FISH DIS, V26, P499, DOI 10.1046/j.1365-2761.2003.00485.x; Agius C., 1985, P85; Almeida JA, 2002, ENVIRON INT, V27, P673, DOI 10.1016/S0160-4120(01)00127-1; ALSABTI K, 1995, MUTAT RES-GENET TOX, V343, P121, DOI 10.1016/0165-1218(95)90078-0; Aramphongphan A, 2009, TOXICOL IN VITRO, V23, P963, DOI 10.1016/j.tiv.2009.04.010; Authman MMN, 2012, ECOTOX ENVIRON SAFE, V84, P163, DOI 10.1016/j.ecoenv.2012.07.005; Ayllon F, 2000, MUTAT RES-GEN TOX EN, V467, P177, DOI 10.1016/S1383-5718(00)00033-4; Barbosa JS, 2010, ECOTOX ENVIRON SAFE, V73, P320, DOI 10.1016/j.ecoenv.2009.10.008; Bentsen HB, 1998, AQUACULTURE, V160, P145, DOI 10.1016/S0044-8486(97)00230-5; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Blazer VS, 2002, FISH PHYSIOL BIOCHEM, V26, P85, DOI 10.1023/A:1023332216713; Bolognesi C, 2003, MUTAT RES-REV MUTAT, V543, P251, DOI 10.1016/S1383-5742(03)00015-2; Bork U, 2010, AM J PHYSIOL-RENAL, V298, pF255, DOI 10.1152/ajprenal.00273.2009; BUCKE D, 1992, MAR ECOL PROG SER, V91, P193, DOI 10.3354/meps091193; Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4; Canonico B, 2004, J IMMUNOL METHODS, V295, P67, DOI 10.1016/j.jim.2004.09.013; CARRASCO KR, 1990, CAN J FISH AQUAT SCI, V47, P2123, DOI 10.1139/f90-237; Castano A, 1998, ECOTOX ENVIRON SAFE, V41, P29, DOI 10.1006/eesa.1998.1663; Cavas T, 2005, AQUAT TOXICOL, V74, P264, DOI 10.1016/j.aquatox.2005.06.001; Cavas T, 2005, FOOD CHEM TOXICOL, V43, P569, DOI 10.1016/j.fct.2004.12.014; Cavas T, 2003, MUTAT RES-GEN TOX EN, V538, P81, DOI 10.1016/S1383-5718(03)00091-3; Cavas T, 2008, AQUAT TOXICOL, V90, P154, DOI 10.1016/j.aquatox.2008.08.011; da Silva JBB, 2003, TALANTA, V60, P977, DOI 10.1016/S0039-9140(03)00182-6; Dang F, 2009, AQUAT TOXICOL, V95, P248, DOI 10.1016/j.aquatox.2009.09.013; Diaz-Satizabal L, 2015, DEV COMP IMMUNOL, V48, P221, DOI 10.1016/j.dci.2014.10.003; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fishelson L, 2006, J MORPHOL, V267, P57, DOI 10.1002/jmor.10385; Fournie JW, 2001, J AQUAT ANIM HEALTH, V13, P105, DOI 10.1577/1548-8667(2001)013<0105:UOSMAA>2.0.CO;2; Grant KR, 2015, CLIN LAB MED, V35, P681, DOI [10.1016/j.cll.2015.05.015, 10.1016/j.cvex.2014.09.007]; Grisolia CK, 2009, GENET MOL BIOL, V32, P138, DOI 10.1590/S1415-47572009005000009; Guardiola EA, 2013, FISH SHELLFISH IMMUN, V35, P792, DOI 10.1016/j.fsi.2013.06.011; Gutierrez-Praena D, 2012, ECOTOX ENVIRON SAFE, V76, P102, DOI 10.1016/j.ecoenv.2011.10.008; Harabawy ASA, 2014, ECOTOX ENVIRON SAFE, V104, P28, DOI 10.1016/j.ecoenv.2014.02.015; HEDDLE JA, 1991, ENVIRON MOL MUTAGEN, V18, P277, DOI 10.1002/em.2850180414; Hoshina MM, 2008, MUTAT RES-GEN TOX EN, V656, P44, DOI 10.1016/j.mrgentox.2008.07.004; HUSSAIN T, 1987, PHARMACOL TOXICOL, V60, P355, DOI 10.1111/j.1600-0773.1987.tb01526.x; Inoue T, 2002, FISH SHELLFISH IMMUN, V13, P379, DOI 10.1006/fsim.2002.0413; Jiraungkoorskul W, 2008, J FISH BIOL, V73, P355, DOI 10.1111/j.1095-8649.2008.01873.x; Langenau DM, 2005, NAT REV IMMUNOL, V5, P307, DOI 10.1038/nri1590; Le MT, 2013, CHEM PHYS LIPIDS, V170, P46, DOI 10.1016/j.chemphyslip.2013.03.001; Leknes IL, 2007, ACTA HISTOCHEM, V109, P164, DOI 10.1016/j.acthis.2006.10.003; Lim C., 2006, TILAPIA BIOL CULTURE; Linde-Arias AR, 2008, SCI TOTAL ENVIRON, V399, P186, DOI 10.1016/j.scitotenv.2008.03.028; Mai WJ, 2010, AQUAT TOXICOL, V100, P271, DOI 10.1016/j.aquatox.2010.07.025; MESEGUER J, 1991, ARCH HISTOL CYTOL, V54, P299, DOI 10.1679/aohc.54.299; Misra UK, 2002, CELL SIGNAL, V14, P327, DOI 10.1016/S0898-6568(01)00268-6; Muranli FDG, 2011, MUTAT RES-GEN TOX EN, V726, P104, DOI 10.1016/j.mrgentox.2011.05.004; Nigam S, 2000, BBA-MOL CELL BIOL L, V1488, P167, DOI 10.1016/S1388-1981(00)00119-0; Nusse M, 1997, MUTAT RES-GEN TOX EN, V392, P109, DOI 10.1016/S0165-1218(97)00049-9; Osman A, 2010, ECOTOX ENVIRON SAFE, V73, P24, DOI 10.1016/j.ecoenv.2009.08.021; Ozkan F, 2011, TURK J ZOOL, V35, P585, DOI 10.3906/zoo-0907-77; Pacheco M, 1998, ECOTOX ENVIRON SAFE, V40, P71, DOI 10.1006/eesa.1998.1644; Palhares Dario, 2002, Genet. Mol. Biol., V25, P281, DOI 10.1590/S1415-47572002000300005; Palic D, 2006, AQUACULTURE, V254, P675, DOI 10.1016/j.aquaculture.2005.11.004; PELGROM SMGJ, 1995, ENVIRON POLLUT, V90, P415, DOI 10.1016/0269-7491(95)00022-J; Pettersen EF, 2000, FISH SHELLFISH IMMUN, V10, P695, DOI 10.1006/fsim.2000.0284; Praskova E, 2011, POL J VET SCI, V14, P545, DOI 10.2478/v10181-011-0081-0; Praskova E, 2012, NEUROENDOCRINOL LETT, V33, P72; Rabitto IS, 2005, ECOTOX ENVIRON SAFE, V60, P147, DOI 10.1016/j.ecoenv.2004.03.002; Ribeiro HJ, 2011, CELL TISSUE RES, V346, P417, DOI 10.1007/s00441-011-1286-3; Ronneseth A, 2006, FISH SHELLFISH IMMUN, V20, P610, DOI 10.1016/j.fsi.2005.08.004; Russo C, 2004, ECOTOX ENVIRON SAFE, V57, P168, DOI 10.1016/S0147-6513(03)00027-7; Saraiva AM, 2013, HUM IMMUNOL, V74, P207, DOI 10.1016/j.humimm.2012.10.026; SARKAR S, 1994, TOXICOL IN VITRO, V8, P1239, DOI 10.1016/0887-2333(94)90115-5; SARKAR S, 1995, J TRACE ELEM MED BIO, V9, P144, DOI 10.1016/S0946-672X(11)80038-6; Sayed AEH, 2014, MUTAT RES-GEN TOX EN, V771, P64, DOI 10.1016/j.mrgentox.2014.01.013; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; Souza TD, 2006, MUTAT RES-GEN TOX EN, V605, P87, DOI 10.1016/j.mrgentox.2006.02.010; Summak S, 2010, FOOD CHEM TOXICOL, V48, P2443, DOI 10.1016/j.fct.2010.06.007; Suwalsky M, 2004, J INORG BIOCHEM, V98, P1061, DOI 10.1016/j.jinorgbio.2004.02.027; Svobodova Z., 1991, MANUAL INT TRAINING; Tang S, 2013, TOXICOL APPL PHARM, V272, P443, DOI 10.1016/j.taap.2013.06.004; Tappel AL, 1973, LIPID PEROXIDATION F; Templeton DM, 2010, CHEM-BIOL INTERACT, V188, P267, DOI 10.1016/j.cbi.2010.03.040; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Utani K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027233; Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089; Vazzana M, 2014, ECOTOX ENVIRON SAFE, V102, P113, DOI 10.1016/j.ecoenv.2014.01.018; Viana KF, 2013, VET PARASITOL, V198, P62, DOI 10.1016/j.vetpar.2013.08.014; Vijayan MM, 1996, J EXP BIOL, V199, P2467; Wang L, 2012, AQUAT TOXICOL, V114, P134, DOI 10.1016/j.aquatox.2012.02.025; Witten PE, 1998, CAN J ZOOL, V76, P310, DOI 10.1139/cjz-76-2-310; Wolke R. E., 1992, Annual Review of Fish Diseases, V2, P91, DOI 10.1016/0959-8030(92)90058-6; Xiao X, 2011, PHYS CHEM EARTH, V36, P424, DOI 10.1016/j.pce.2010.03.028; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Yano CL, 2005, FREE RADICAL BIO MED, V39, P1378, DOI 10.1016/j.freeradbiomed.2005.07.001	86	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143029	10.1371/journal.pone.0143029	http://dx.doi.org/10.1371/journal.pone.0143029			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619141	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800022
J	Rizk, M; Lalanne, C; Berthoz, S; Kern, L; Godart, N				Rizk, Melissa; Lalanne, Christophe; Berthoz, Sylvie; Kern, Laurence; Godart, Nathalie		EVHAN Grp	Problematic Exercise in Anorexia Nervosa: Testing Potential Risk Factors against Different Definitions	PLOS ONE			English	Article							EATING-DISORDER EXAMINATION; QUALITY-OF-LIFE; QUESTIONNAIRE EDE-Q; PHYSICAL-ACTIVITY; EXCESSIVE EXERCISE; INDUCED HYPERACTIVITY; ADOLESCENTS; DEPENDENCE; FEATURES; ANXIETY	"Hyperactivity" has a wide prevalence range of 31% to 80% in the anorexia nervosa literature that could be partly due to the plethora of definitions provided by researchers in this field. The purpose of this study was two-fold: 1) To assess the variance across prevalence rates of problematic exercise encountered in patients with anorexia nervosa, in relation to seven different definitions found in the literature. 2) To examine how core eating disorder symptoms and the dimensions of emotional profile are associated with these different definitions and the impact of these definitions on the assessment of patients' quality of life. Exercise was evaluated in terms of duration, intensity, type and compulsion using a semistructured questionnaire administered to 180 women suffering from severe anorexia nervosa. Seven different definitions of problematic exercise were identified in the literature: three entailing a single dimension of problematic exercise (duration, compulsion or intensity) and four combining these different dimensions. Emotional profile scores, obsessive-compulsive symptoms, eating disorder symptomatology, worries and concerns about body shape, self-esteem and quality of life were assessed using several established questionnaires. The prevalence of problematic exercise varied considerably from, 5% to 54%, depending on the number of criteria used for its definition. The type and level of eating disorder symptomatology was found to be associated with several definitions of problematic exercise. Surprisingly, a better self-reported quality of life was found among problematic exercisers compared to non-problematic exercisers in three of the definitions. The different definitions of problematic exercise explain the broad prevalence ranges and the conflicting associations generally reported in the literature between problematic exercise and eating disorder-related psychological parameters. There is an urgent need for a valid consensus on the definition of problematic exercise in anorexia nervosa. This will support the development of further research on the etiology and treatment of problematic exercise.	[Rizk, Melissa] Univ Paris 05, USPC, INSERM, CESP, Paris, France; [Lalanne, Christophe] Univ Paris Diderot, Sorbonne Paris Cite, Patient Centered Outcomes Res, EA REMES 7334, Paris, France; [Berthoz, Sylvie; Godart, Nathalie] Univ Paris Saclay, Univ Paris 11, UVSQ, CESP,INSERM, Paris, France; [Berthoz, Sylvie; Godart, Nathalie] Inst Mutualiste Montsouris, Psychiat Unit, Paris, France; [Kern, Laurence] CERSM, UFR STAPS, Lab EA 2931, Nanterre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite	Rizk, M (corresponding author), Univ Paris 05, USPC, INSERM, CESP, Paris, France.	melissarizk@hotmail.com	Zamora, Cristina Cuesta/E-2864-2016; Berthoz Landron, Sylvie/M-4517-2018	Zamora, Cristina Cuesta/0000-0003-1121-9561; Berthoz, Sylvie/0000-0002-6862-2362; Duclos - Lavagne d'Ortigue, Jeanne/0000-0002-7454-0021; Rousselet, Morgane/0000-0003-4027-7963; bioulac, stephanie/0000-0003-2618-4234	French Ministry of Health [PHRCN 2007, 2011 AOM11197]; CNAM-TS; Fondation de France; Fondation MGEN; EHESP; AP-HP; CIFRE; Contrats d'interface INSERM	French Ministry of Health; CNAM-TS; Fondation de France(Fondation de France); Fondation MGEN; EHESP; AP-HP; CIFRE; Contrats d'interface INSERM	The authors received no specific funding for this work. EVHAN study was supported by grants from the French Ministry of Health (PHRCN 2007, 2011 AOM11197; ANR Jeunechercheur, Bourse de these Eiffel) and from CNAM-TS, Fondation de France, Fondation MGEN, EHESP, AP-HP, CIFRE, and Contrats d'interface INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan RAH, 2011, CURR TOP BEHAV NEURO, V6, P229, DOI 10.1007/7854_2010_77; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Alberti M, 2013, MED SCI SPORT EXER, V45, P1643, DOI 10.1249/MSS.0b013e31828e8f07; [Anonymous], 1997, COMP INT DIAGN INT C; Bewell-Weiss CV, 2010, COMPR PSYCHIAT, V51, P566, DOI 10.1016/j.comppsych.2010.03.002; Bratland-Sanda S, 2010, INT J EAT DISORDER, V43, P88, DOI 10.1002/eat.20753; Bratland-Sanda S, 2011, EUR EAT DISORD REV, V19, P249, DOI 10.1002/erv.971; Bratland-Sanda S, 2010, INT J EAT DISORDER, V43, P266, DOI 10.1002/eat.20769; BREWERTON TD, 1995, INT J EAT DISORDER, V17, P413, DOI 10.1002/1098-108X(199505)17:4<413::AID-EAT2260170414>3.0.CO;2-0; Brownstone LM, 2013, EAT BEHAV, V14, P413, DOI 10.1016/j.eatbeh.2013.07.004; Carrera O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041851; Carruth B, 2000, J ADOLESCENT HEALTH, V26, P8; Casper R.C., 1996, J YOUTH ADOLESCENCE, V25, P466; CASPER RC, 1991, AM J CLIN NUTR, V53, P1143, DOI 10.1093/ajcn/53.5.1143; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cook B, 2014, INT J EAT DISORDER, V47, P268, DOI 10.1002/eat.22198; COOPER Z, 1989, BRIT J PSYCHIAT, V154, P807, DOI 10.1192/bjp.154.6.807; Courty A, 2015, COMPR PSYCHIAT, V56, P217, DOI 10.1016/j.comppsych.2014.09.011; Couturier JL, 2006, INT J EAT DISORDER, V39, P212, DOI 10.1002/eat.20241; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dalle Grave R, 2008, COMPR PSYCHIAT, V49, P346, DOI 10.1016/j.comppsych.2007.12.007; DAVIS C, 1993, ADDICT BEHAV, V18, P201, DOI 10.1016/0306-4603(93)90050-J; Davis C, 1998, ADDICT BEHAV, V23, P463, DOI 10.1016/S0306-4603(98)00009-4; Davis C, 1998, PSYCHOSOM MED, V60, P192, DOI 10.1097/00006842-199803000-00015; Davis C, 2006, PSYCHIAT RES, V142, P209, DOI 10.1016/j.psychres.2005.11.006; Davis C, 1997, COMPR PSYCHIAT, V38, P321, DOI 10.1016/S0010-440X(97)90927-5; Davis C, 1995, J PSYCHOSOM RES, V39, P967, DOI 10.1016/0022-3999(95)00064-X; DAVIS C, 1994, PSYCHOL MED, V24, P957, DOI 10.1017/S0033291700029044; Davis C, 2002, COMPR PSYCHIAT, V43, P189, DOI 10.1053/comp.2002.32356; Davis C, 1999, J NERV MENT DIS, V187, P336, DOI 10.1097/00005053-199906000-00002; Deborde AS, 2004, ENCEPHALE, V30, P464; Dorard G, 2014, ENCEPHALE, V40, P255, DOI 10.1016/j.encep.2013.04.014; El Ghoch M, 2013, INT J EAT DISORDER, V46, P709, DOI 10.1002/eat.22140; Engel SG, 2006, INT J EAT DISORDER, V39, P62, DOI 10.1002/eat.20200; Exner C, 2000, MOL PSYCHIATR, V5, P476, DOI 10.1038/sj.mp.4000771; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Favaro A, 2000, PSYCHOSOM MED, V62, P535, DOI 10.1097/00006842-200007000-00012; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Goncalves SF, 2012, EAT BEHAV, V13, P127, DOI 10.1016/j.eatbeh.2011.11.011; Gummer R, 2015, EUR EAT DISORD REV, V23, P333, DOI 10.1002/erv.2377; Gull W W, 1874, Br Med J, V2, P425; Hale BS, 2002, J SPORT MED PHYS FIT, V42, P108; Hebebrand J, 2003, PHYSIOL BEHAV, V79, P25, DOI 10.1016/S0031-9384(03)00102-1; HODGSON RJ, 1977, BEHAV RES THER, V15, P389, DOI 10.1016/0005-7967(77)90042-0; Holmen TL, 2002, EUR RESPIR J, V19, P8, DOI 10.1183/09031936.02.00203502; Holtkamp K, 2004, INT J EAT DISORDER, V36, P163, DOI 10.1002/eat.20035; Keshaviah A, 2014, COMPR PSYCHIAT, V55, P1773, DOI 10.1016/j.comppsych.2014.07.017; Keyes A, 2015, INT J EAT DISORDER, V48, P46, DOI 10.1002/eat.22354; Klein DA, 2004, CNS SPECTRUMS, V9, P531, DOI 10.1017/S1092852900009627; Klein DA, 2007, PSYCHONEUROENDOCRINO, V32, P539, DOI 10.1016/j.psyneuen.2007.03.007; Kohl M, 2004, ENCEPHALE, V30, P492; Kostrzewa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078251; Long C., 1993, J MENTAL HLTH, V2, P321, DOI DOI 10.3109/09638239309016967; Luce KH, 2008, INT J EAT DISORDER, V41, P273, DOI 10.1002/eat.20504; Mangerud WL, 2014, CHILD ADOL PSYCH MEN, V8, DOI 10.1186/1753-2000-8-2; Markland D, 1997, BRIT J HEALTH PSYCH, V2, P361, DOI 10.1111/j.2044-8287.1997.tb00549.x; Meyer C, 2011, EUR EAT DISORD REV, V19, P169, DOI 10.1002/erv.1121; Mond JM, 2004, EUR EAT DISORD REV, V12, P265, DOI 10.1002/erv.579; Mond JM, 2006, BEHAV RES THER, V44, P53, DOI 10.1016/j.brat.2004.12.003; Mond JM, 2009, AUST NZ J PSYCHIAT, V43, P227, DOI 10.1080/00048670802653323; Ng LWC, 2013, PHYSIOTHERAPY, V99, P1, DOI 10.1016/j.physio.2012.05.006; Penas-Lledo E, 2002, INT J EAT DISORDER, V31, P370, DOI 10.1002/eat.10042; PIRKE KM, 1993, NEUROSCI BIOBEHAV R, V17, P287, DOI 10.1016/S0149-7634(05)80012-0; Rizk M., 2015, THESIS; Rousseau A, 2005, ENCEPHALE, V31, P162; Roux H, 2013, ENCEPHALE, V39, P85, DOI 10.1016/j.encep.2012.06.001; Shroff H, 2006, INT J EAT DISORDER, V39, P454, DOI 10.1002/eat.20247; Smith AR, 2013, PSYCHIAT RES, V206, P246, DOI 10.1016/j.psychres.2012.11.004; Solenberger S E, 2001, Eat Behav, V2, P151, DOI 10.1016/S1471-0153(01)00026-5; Steinhausen HC, 2009, CHILD ADOL PSYCH CL, V18, P225, DOI 10.1016/j.chc.2008.07.013; Sternheim L, 2015, INT J EAT DISORDER, V48, P42, DOI 10.1002/eat.22272; Stiles-Shields EC, 2011, EAT BEHAV, V12, P328, DOI 10.1016/j.eatbeh.2011.09.002; Strober M, 2004, INT J EAT DISORDER, V36, P245, DOI 10.1002/eat.20054; Sy R, 2013, EAT DISORD, V21, P206, DOI 10.1080/10640266.2013.779176; Taylor G.J., 1997, DISORDERS AFFECT REG; Treasure J, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-13; US Department of Health & Human Services, 2008, PHYS ACT GUID AM, DOI DOI 10.4085/1062-6050-44.1.5; van Elburg AA, 2007, EUR EAT DISORD REV, V15, P425, DOI 10.1002/erv.803; Vancampfort D, 2014, DISABIL REHABIL, V36, P628, DOI 10.3109/09638288.2013.808271; Vandereycken W, 1983, INT J EAT DISORDER, V2, P7; WHO (World Health Organization), 2009, GLOB DAT BOD MASS IN; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zipfel S, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-37	85	29	29	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143352	10.1371/journal.pone.0143352	http://dx.doi.org/10.1371/journal.pone.0143352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7NW	26618359	gold, Green Published, Green Submitted			2022-12-26	WOS:000365889800034
J	Harris, S; Croft, J; O'Flynn, C; Deusch, O; Colyer, A; Allsopp, J; Milella, L; Davis, IJ				Harris, Stephen; Croft, Julie; O'Flynn, Ciaran; Deusch, Oliver; Colyer, Alison; Allsopp, Judi; Milella, Lisa; Davis, Ian J.			A Pyrosequencing Investigation of Differences in the Feline Subgingival Microbiota in Health, Gingivitis and Mild Periodontitis	PLOS ONE			English	Article							INTERACTIVE TREE; CATS; GENERATION; OBLIGATE; DISPLAY; SEARCH; TOOL	Periodontitis is the most frequently diagnosed health problem in cats yet little is known about the bacterial species important for the disease. The objective of this study was to identify bacterial species associated with health, gingivitis or mild periodontitis (<25% attachment loss) in feline plaque. Knowledge of these species is a first step in understanding the potential for improving oral health of cats via dietary interventions that alter the proportions of influential species. Subgingival plaque samples were collected from 92 cats with healthy gingiva, gingivitis or mild periodontitis. Pyrosequencing of the V1-V3 region of the 16S rDNA from these plaque samples generated more than one million reads and identified a total of 267 operational taxonomic units after bioinformatic and statistical analysis. Porphyromonas was the most abundant genus in all gingival health categories, particularly in health along with Moraxella and Fusobacteria. The Peptostreptococcaceae were the most abundant family in gingivitis and mild periodontitis. Logistic regression analysis identified species from various genera that were significantly associated with health, gingivitis or mild periodontitis. The species identified were very similar to those observed in canine plaque in the corresponding health and disease states. Such similarities were not observed between cat and human at the bacterial species level but with disease progression similarities did emerge at the phylum level. This suggests that interventions targeted at human pathogenic species will not be effective for use in cats but there is more potential for commonalities in interventions for cats and dogs.	[Harris, Stephen; Croft, Julie; O'Flynn, Ciaran; Deusch, Oliver; Colyer, Alison; Allsopp, Judi; Davis, Ian J.] Mars Petcare UK, WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England; [Milella, Lisa] Vet Dent Surg, Surrey, England	Mars; WALTHAM Petcare Science Institute	Davis, IJ (corresponding author), Mars Petcare UK, WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England.	ian.davis@effem.com		Deusch, Oliver/0000-0003-3378-6129; Harris, Stephen/0000-0002-4422-612X	Mars Petcare UK	Mars Petcare UK	This work was funded by Mars Petcare UK. The WALTHAM Centre for Pet Nutrition is the fundamental research centre for Mars Petcare. Authors from the WALTHAM Centre for Pet Nutrition were involved at all levels of this research including study design, data collection and analysis, decision to publish and preparation of the manuscript. The author LM (owner of The Veterinary Dental Surgery) did not provide any financial support and was employed by WALTHAM on a consultancy basis as a veterinary periodontal expert. LM was involved in the study design, sample collection, training of scorers and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The oligonucleotide primers used and the parameters used in subsequent analysis were chosen on guidance from external academic experts & used in non-commercial funded research. No additional funding sources for this study.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booij-Vrieling HE, 2010, VET MICROBIOL, V144, P147, DOI 10.1016/j.vetmic.2009.12.046; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Davis IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083158; Dewhirst FE, 2015, VET MICROBIOL, V175, P294, DOI 10.1016/j.vetmic.2014.11.019; Dewhirst FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036067; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Girard N, 2009, J VET DENT, V26, P147, DOI 10.1177/089875640902600301; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Lavy E, 2012, ISR J VET MED, V67, P244; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li Y, 2014, ISME J, V8, P1879, DOI 10.1038/ismej.2014.28; Lommer MJ, 2001, J AM VET MED ASSOC, V218, P230, DOI 10.2460/javma.2001.218.230; LOVE DN, 1994, INT J SYST BACTERIOL, V44, P204, DOI 10.1099/00207713-44-2-204; LOVE DN, 1990, VET MICROBIOL, V22, P267, DOI 10.1016/0378-1135(90)90114-B; MALLONEE DH, 1988, ARCH ORAL BIOL, V33, P677, DOI 10.1016/0003-9969(88)90123-9; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; O'Flynn C, 2015, GENOME BIOL EVOL, V7, P3397, DOI 10.1093/gbe/evv220; O'Neill DG, 2014, VET J, V202, P286, DOI 10.1016/j.tvjl.2014.08.004; Perez-Salcedo L, 2013, J VET DENT, V30, P208, DOI 10.1177/089875641303000402; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Sturgeon A, 2014, VET J, V201, P223, DOI 10.1016/j.tvjl.2014.01.024; UEMATSU H, 1992, J PERIODONTAL RES, V27, P15, DOI 10.1111/j.1600-0765.1992.tb02080.x; Wallis C, 2015, LONGUTUDUBAL ANAL CH; Wiggs R, 1997, PERIODONTOLOGY VET D	33	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0136986	10.1371/journal.pone.0136986	http://dx.doi.org/10.1371/journal.pone.0136986			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605793	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300003
J	Kohda, M; Jordan, LA; Hotta, T; Kosaka, N; Karino, K; Tanaka, H; Taniyama, M; Takeyama, T				Kohda, Masanori; Jordan, Lyndon Alexander; Hotta, Takashi; Kosaka, Naoya; Karino, Kenji; Tanaka, Hirokazu; Taniyama, Masami; Takeyama, Tomohiro			Facial Recognition in a Group-Living Cichlid Fish	PLOS ONE			English	Article							INDIVIDUAL RECOGNITION; SEXUAL SELECTION; FACE RECOGNITION; VIDEO PLAYBACK; EVOLUTION; IDENTITY; COGNITION; PATTERNS; QUALITY; SIGNALS	The theoretical underpinnings of the mechanisms of sociality, e.g. territoriality, hierarchy, and reciprocity, are based on assumptions of individual recognition. While behavioural evidence suggests individual recognition is widespread, the cues that animals use to recognise individuals are established in only a handful of systems. Here, we use digital models to demonstrate that facial features are the visual cue used for individual recognition in the social fish Neolamprologus pulcher. Focal fish were exposed to digital images showing four different combinations of familiar and unfamiliar face and body colorations. Focal fish attended to digital models with unfamiliar faces longer and from a further distance to the model than to models with familiar faces. These results strongly suggest that fish can distinguish individuals accurately using facial colour patterns. Our observations also suggest that fish are able to rapidly (<= 0.5 sec) discriminate between familiar and unfamiliar individuals, a speed of recognition comparable to primates including humans.	[Kohda, Masanori; Jordan, Lyndon Alexander; Hotta, Takashi; Kosaka, Naoya; Tanaka, Hirokazu; Taniyama, Masami; Takeyama, Tomohiro] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Lab Anim Sociol, Osaka 5588585, Japan; [Karino, Kenji] Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo 1848501, Japan	Osaka Metropolitan University; Tokyo Gakugei University	Kohda, M (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Lab Anim Sociol, Osaka 5588585, Japan.	kohda.tanganyika@gmail.com	; Jordan, Alex/D-8243-2011	Takeyama, Tomohiro/0000-0001-5983-3611; Jordan, Alex/0000-0001-6131-9734	JSPS (Japan Society for Promotion of Science) [26118511, 26540070, 25304017]	JSPS (Japan Society for Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was financially supported by Grand in Aid from JSPS (Japan Society for Promotion of Science) (Nos. 26118511, 26540070 & 25304017) to MK.	ALCOCK J, 2005, ANIMAL BEHAV EVOLUTI; Alen GR, 1975, DAMSELFISHES S SEAS; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Balshine-Earn S, 1998, BEHAVIOUR, V135, P369, DOI 10.1163/156853998793066221; Brown C, 2015, ANIM COGN, V18, P1, DOI 10.1007/s10071-014-0761-0; BROWN SD, 1993, J COMP PSYCHOL, V107, P48, DOI 10.1037/0735-7036.107.1.48; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Bshary R, 2011, FISH COGNITION BEHAV, P223, DOI DOI 10.1002/9781444342536.CH13; Bshary R, 2014, TRENDS COGN SCI, V18, P465, DOI 10.1016/j.tics.2014.04.005; Candolin U, 1999, ANIM BEHAV, V58, P1261, DOI 10.1006/anbe.1999.1259; Douglas R.H., 1990, P373; Duftner N, 2007, MOL PHYLOGENET EVOL, V45, P706, DOI 10.1016/j.ympev.2007.08.001; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Frostman P, 2004, ICHTHYOL RES, V51, P283, DOI 10.1007/s10228-004-0223-9; Griffiths S.W., 2011, FISH COGNITION BEHAV, P186, DOI [DOI 10.1002/9781444342536.CH9, 10.1002/9781444342536.ch9]; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Heg D, 2006, ENVIRON BIOL FISH, V76, P265, DOI 10.1007/s10641-006-9032-5; HERT E, 1985, Z TIERPSYCHOL, V68, P313; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; KENDRICK KM, 1995, ANIM BEHAV, V49, P1665, DOI 10.1016/0003-3472(95)90088-8; Koning A, 1992, TANGANYIKA SECRETS; Krause J, 2002, LIVING GROUPS; Lorenz K, 1962, P ROY INST, V39, P282; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; Pollard KA, 2011, CURR BIOL, V21, P413, DOI 10.1016/j.cub.2011.01.051; ROSENFELD SA, 1979, NEUROPSYCHOLOGIA, V17, P503, DOI 10.1016/0028-3932(79)90057-5; Rosenthal GG, 1999, ENVIRON BIOL FISH, V56, P307, DOI 10.1023/A:1007597604793; RYAN MJ, 1993, EVOLUTION, V47, P647, DOI 10.1111/j.1558-5646.1993.tb02118.x; Ryan MJ, 2015, APA HDB COMP PSYCHOL; Sheehan MJ, 2010, J EVOLUTION BIOL, V23, P570, DOI 10.1111/j.1420-9101.2009.01923.x; Sheehan MJ, 2011, SCIENCE, V334, P1272, DOI 10.1126/science.1211334; Siebeck UE, 2004, ANIM BEHAV, V68, P273, DOI 10.1016/j.anbehav.2003.11.010; Siebeck UE, 2010, CURR BIOL, V20, P407, DOI 10.1016/j.cub.2009.12.047; Sopinka NM, 2009, J FISH BIOL, V75, P1, DOI 10.1111/j.1095-8649.2009.02234.x; TABORSKY M, 1981, BEHAV ECOL SOCIOBIOL, V8, P143, DOI 10.1007/BF00300826; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; WARNER RR, 1992, EVOLUTION, V46, P1421, DOI 10.1111/j.1558-5646.1992.tb01134.x; Wong M, 2011, BIOL REV, V86, P511, DOI 10.1111/j.1469-185X.2010.00158.x; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	42	40	41	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142552	10.1371/journal.pone.0142552	http://dx.doi.org/10.1371/journal.pone.0142552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605789	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300023
J	Parodi, EM; Roesner, JM; Huang, LS				Parodi, Emily M.; Roesner, Joseph M.; Huang, Linda S.			SPO73 and SPO71 Function Cooperatively in Prospore Membrane Elongation During Sporulation in Saccharomyces cerevisiae	PLOS ONE			English	Article							SPORE FORMATION; MEIOSIS; YEAST; PROTEIN; PATHWAY; WALL; LOCALIZATION; PHOSPHATIDYLSERINE; IDENTIFICATION; MORPHOGENESIS	In the yeast Saccharomyces cerevisiae, cells undergoing sporulation form prospore membranes to surround their meiotic nuclei. The prospore membranes ultimately become the plasma membranes of the new cells. The putative phospholipase Spo1 and the tandem Pleckstrin Homology domain protein Spo71 have previously been shown to be required for prospore membrane development, along with the constitutively expressed Vps13 involved in vacuolar sorting. Here, we utilize genetic analysis, and find that SPO73 is required for proper prospore membrane shape and, like SPO71, is necessary for prospore membrane elongation. Additionally, similar to SPO71, loss of SPO73 partially suppresses spo1 Delta. Spo73 localizes to prospore membranes and complexes with Spo71. We also find that phosphatidylserine localizes to the prospore membrane. Our results suggest a model where SPO71 and SPO73 act in opposition to SPO1 to form and elongate prospore membranes, while VPS13 plays a distinct role in prospore membrane development.	[Parodi, Emily M.; Roesner, Joseph M.; Huang, Linda S.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston	Huang, LS (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	Linda.Huang@umb.edu	Huang, Linda/C-9903-2014	Huang, Linda/0000-0002-9033-4391	National Institutes of Health [GM086805]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM086805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an R15 award GM086805 from the National Institutes of Health to LSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; BRIZA P, 1986, J BIOL CHEM, V261, P4288; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Coluccio A, 2004, EUKARYOT CELL, V3, P1464, DOI 10.1128/EC.3.6.1464-1475.2004; de Seynes MJ, 1868, CR HEBD ACAD SCI, V67, P105; Dougherty R., 2005, 11 AIAA CEAS AER C, P2961; Enyenihi AH, 2003, GENETICS, V163, P47; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Felder T, 2002, EUKARYOT CELL, V1, P799, DOI 10.1128/EC.1.5.799-810.2002; Horchani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113484; Huang LS, 2005, P NATL ACAD SCI USA, V102, P12431, DOI 10.1073/pnas.0502324102; Kruis K, 1918, NAKL C AKAD PRAHA, P67; Lin CPC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003700; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maier P, 2008, EMBO J, V27, P2363, DOI 10.1038/emboj.2008.168; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Nakanishi H, 2007, J CELL SCI, V120, P908, DOI 10.1242/jcs.03405; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Park JS, 2013, EUKARYOT CELL, V12, P1530, DOI 10.1128/EC.00239-13; Park JS, 2012, J CELL SCI, V125, P3004, DOI 10.1242/jcs.105114; Parodi EM, 2012, EUKARYOT CELL, V11, P1191, DOI 10.1128/EC.00076-12; Philips J, 1998, J CELL BIOL, V143, P375, DOI 10.1083/jcb.143.2.375; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rose K, 1995, P NATL ACAD SCI USA, V92, P12151, DOI 10.1073/pnas.92.26.12151; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; Rudge SA, 1998, J CELL BIOL, V140, P81, DOI 10.1083/jcb.140.1.81; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Slubowski CJ, 2015, YEAST, V32, P379, DOI 10.1002/yea.3065; Slubowski CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113528; Suda Y, 2007, EUKARYOT CELL, V6, P2009, DOI 10.1128/EC.00238-07; Sun YD, 2012, J CELL SCI, V125, P6157, DOI 10.1242/jcs.115741; Tevzadze GG, 2007, GENETICS, V175, P1213, DOI 10.1534/genetics.106.069252; Tevzadze GG, 2000, CHROMOSOMA, V109, P72, DOI 10.1007/s004120050414; Winge O, 1935, COMPT REND TRAV LA P, V21, P77; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143571	10.1371/journal.pone.0143571	http://dx.doi.org/10.1371/journal.pone.0143571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605945	Green Submitted, gold, Green Published			2022-12-26	WOS:000365865300084
J	Yap, HYY; Chooi, YH; Fung, SY; Ng, ST; Tan, CS; Tan, NH				Yap, Hui-Yeng Y.; Chooi, Yit-Heng; Fung, Shin-Yee; Ng, Szu-Ting; Tan, Chon-Seng; Tan, Nget-Hong			Transcriptome Analysis Revealed Highly Expressed Genes Encoding Secondary Metabolite Pathways and Small Cysteine-Rich Proteins in the Sclerotium of Lignosus rhinocerotis	PLOS ONE			English	Article							TIGER MILK MUSHROOM; MEDICINAL MUSHROOM; GRIFOLA-FRONDOSA; CERATO-PLATANIN; PROTEOMIC ANALYSIS; FUNGAL; LECTINS; IDENTIFICATION; HYDROPHOBINS; ABUNDANCE	Lignosus rhinocerotis (Cooke) Ryvarden (tiger milk mushroom) has long been known for its nutritional and medicinal benefits among the local communities in Southeast Asia. However, the molecular and genetic basis of its medicinal and nutraceutical properties at transcriptional level have not been investigated. In this study, the transcriptome of L. rhinocerotis sclerotium, the part with medicinal value, was analyzed using high-throughput Illumina HiSeq (TM) platform with good sequencing quality and alignment results. A total of 3,673, 117, and 59,649 events of alternative splicing, novel transcripts, and SNP variation were found to enrich its current genome database. A large number of transcripts were expressed and involved in the processing of gene information and carbohydrate metabolism. A few highly expressed genes encoding the cysteine-rich cerato-platanin, hydrophobins, and sugar-binding lectins were identified and their possible roles in L. rhinocerotis were discussed. Genes encoding enzymes involved in the biosynthesis of glucans, six gene clusters encoding four terpene synthases and one each of non-ribosomal peptide synthetase and polyketide synthase, and 109 transcribed cytochrome P450 sequences were also identified in the transcriptome. The data from this study forms a valuable foundation for future research in the exploitation of this mushroom in pharmacological and industrial applications.	[Yap, Hui-Yeng Y.; Fung, Shin-Yee; Tan, Nget-Hong] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Chooi, Yit-Heng] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Ng, Szu-Ting] Ligno Biotech Sdn Bhd, Balakong Jaya, Selangor, Malaysia; [Tan, Chon-Seng] MARDI, Serdang, Selangor, Malaysia	Universiti Malaya; University of Western Australia; Institute Penyelidikan Dan Kemajuan Pertanian	Yap, HYY (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	yean_ny_nie@yahoo.com	TAN, NGET HONG/B-9914-2010; Chooi, Yit Heng/D-4338-2013; FUNG, SHIN YEE/AAJ-3690-2020; Fung, Shin Yee/B-5393-2010; Hui Yeng, Yeannie Yap/K-3685-2015	Chooi, Yit Heng/0000-0001-7719-7524; FUNG, SHIN YEE/0000-0002-9288-7328; Fung, Shin Yee/0000-0002-9288-7328; Hui Yeng, Yeannie Yap/0000-0003-0739-8667	High Impact Research Grant [UM.C/625/1/HIR/MoE/E00040-20001]; Fundamental Research Grant Scheme (FRGS) from the University of Malaya/Ministry of Education, Malaysia [FP029-2014A]	High Impact Research Grant; Fundamental Research Grant Scheme (FRGS) from the University of Malaya/Ministry of Education, Malaysia	This research is supported by High Impact Research Grant UM.C/625/1/HIR/MoE/E00040-20001 and Fundamental Research Grant Scheme (FRGS) FP029-2014A from the University of Malaya/Ministry of Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abdul Razak MS, 2009, RES REPORT; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baccelli I, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00769; Barsottini MRD, 2013, MOL PLANT MICROBE IN, V26, P1281, DOI 10.1094/MPMI-05-13-0148-R; Bayes T., 1997, A M F R S PHILOS T R, V53, P370, DOI DOI 10.1098/RSTL.1763.0053; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Burkill IH, 1930, GARD B STRAITS SETTL, V6, P165; Burkill IH, 1966, DICT EC PRODUCTS MAL, V1; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chan GG., 1953, MALAYAN FORESTER, V2, P103; Chang YS, 2004, FUNGAL DIVERS, V15, P15; Chen H, 2015, SEM FOR PATH 2015 AP; Chen HX, 2013, MYCOLOGIA, V105, P1479, DOI 10.3852/13-115; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; Cui BK, 2011, MYCOL PROG, V10, P267, DOI 10.1007/s11557-010-0697-y; Douglas CM, 2001, MED MYCOL, V39, P55, DOI 10.1080/mmy.39.1.55.66; Ebbole DJ, 1997, TRENDS MICROBIOL, V5, P405, DOI 10.1016/S0966-842X(97)01130-X; Eik LF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/320308; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guillot J, 1997, BIOCHEM SYST ECOL, V25, P203, DOI 10.1016/S0305-1978(96)00110-X; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hamby Stephen E., 2011, Human Genomics, V5, P241; Hassan MAA, 2015, INT J MOL SCI, V16, P7802, DOI 10.3390/ijms16047802; Hektor HJ, 2005, CURR OPIN BIOTECH, V16, P434, DOI 10.1016/j.copbio.2005.05.004; Hj Che Fauzi S, 2013, OPEN C P J TOCPR, V4, P65, DOI DOI 10.2174/2210289201304020065; Huang NL, 1999, ACTA EDULIS FUNGI, V6, P32; Ide M, 2012, ARCH MICROBIOL, V194, P243, DOI 10.1007/s00203-011-0753-2; Jeong JS, 2007, FEMS MICROBIOL LETT, V273, P157, DOI 10.1111/j.1574-6968.2007.00796.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KAWAGISHI H, 1990, BIOCHIM BIOPHYS ACTA, V1034, P247, DOI 10.1016/0304-4165(90)90045-X; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Khan F, 2011, AM J BIOCH MOL BIOL, V1, P375; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kurita T, 2012, J BIOL CHEM, V287, P17415, DOI 10.1074/jbc.M111.321018; Lai CKM, 2008, INT J MED MUSHROOMS, V10, P255, DOI 10.1615/IntJMedMushr.v10.i3.60; Lau BF, 2013, J ETHNOPHARMACOL, V150, P252, DOI 10.1016/j.jep.2013.08.034; Lee M L, 2012, Evid Based Complement Alternat Med, V2012, P697603, DOI 10.1155/2012/697603; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030987; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Mankel A, 2002, APPL ENVIRON MICROB, V68, P1408, DOI 10.1128/AEM.68.3.1408-1413.2002; Mohanarji S., 2012, J PHARM BIOMED SCI, V18, P1, DOI DOI 10.1111/j.1365-2095.2011.00866.x; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagata Y, 2005, BIOSCI BIOTECH BIOCH, V69, P2374, DOI 10.1271/bbb.69.2374; Novak R, 2010, CURR OPIN INVEST DR, V11, P182; Nunez M., 2001, SYNOP FUNG, V14, P170; Ooi V. E. C., 1999, International Journal of Medicinal Mushrooms, V1, P195; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Phan CW, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-261; Rementeria Aitor, 2005, Revista Iberoamericana de Micologia, V22, P1, DOI 10.1016/S1130-1406(05)70001-2; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Schimoler-O'Rourke R, 2003, CURR MICROBIOL, V46, P408, DOI 10.1007/s00284-002-3884-5; Schobert R, 2011, CURR MED CHEM, V18, P790, DOI 10.2174/092986711794927766; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Sheu F, 2009, J AGR FOOD CHEM, V57, P4130, DOI 10.1021/jf900469a; Syed K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086683; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan CS, 2010, ACTA HORTIC, V859, P161, DOI 10.17660/ActaHortic.2010.859.19; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tisserant E, 2011, NEW PHYTOL, V189, P883, DOI 10.1111/j.1469-8137.2010.03597.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Varrot A, 2013, CURR OPIN STRUC BIOL, V23, P678, DOI 10.1016/j.sbi.2013.07.007; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang HX, 1998, MYCOL RES, V102, P897, DOI 10.1017/S0953756298006200; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Wong KH, 2011, FOOD HYDROCOLLOID, V25, P150, DOI 10.1016/j.foodhyd.2010.04.008; Wong KH, 2009, INT J MED MUSHROOMS, V11, P215, DOI 10.1615/IntJMedMushr.v11.i3.10; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Wosten HAB, 2000, BBA-REV BIOMEMBRANES, V1469, P79, DOI 10.1016/S0304-4157(00)00002-2; Xu XF, 2011, BIOTECHNOL ADV, V29, P667, DOI 10.1016/j.biotechadv.2011.05.003; Yap HYY, 2015, J ETHNOPHARMACOL, V174, P437, DOI 10.1016/j.jep.2015.08.042; Yap HYY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-635; Yap HYY, 2015, INT J MED SCI, V12, P23, DOI 10.7150/ijms.10019; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038381, 10.1371/journal.pone.0051853]; Yu HY, 2014, GENET MOL BIOL, V37, P423, DOI 10.1590/S1415-47572014000300015; Yu L, 2008, MICROBIOL-SGM, V154, P1677, DOI 10.1099/mic.0.2007/015263-0; Zhong MT, 2013, BIOCHEM BIOPH RES CO, V431, P111, DOI 10.1016/j.bbrc.2012.12.065	84	12	13	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143549	10.1371/journal.pone.0143549	http://dx.doi.org/10.1371/journal.pone.0143549			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606395	Green Published, gold			2022-12-26	WOS:000365865300078
J	Hart, ML; Meyer, A; Johnson, PJ; Ericsson, AC				Hart, Marcia L.; Meyer, Alexandra; Johnson, Philip J.; Ericsson, Aaron C.			Comparative Evaluation of DNA Extraction Methods from Feces of Multiple Host Species for Downstream Next-Generation Sequencing	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL-DNA; DATABASE	The gastrointestinal tract contains a vast community of microbes that to this day remain largely unculturable, making studies in this area challenging. With the newly affordable advanced sequencing technology, important breakthroughs in this exciting field are now possible. However, standardized methods of sample collection, handling, and DNA extraction have yet to be determined. To help address this, we investigated the use of 5 common DNA extraction methods on fecal samples from 5 different species. Our data show that the method of DNA extraction impacts DNA concentration and purity, successful NGS amplification, and influences microbial communities seen in NGS output dependent on the species of fecal sample and the DNA extraction method used. These data highlight the importance of careful consideration of DNA extraction method used when designing and interpreting data from cross species studies.	[Hart, Marcia L.; Ericsson, Aaron C.] Univ Missouri, Dept Vet Pathobiol, Comparat Med Program, Columbia, MO 65211 USA; [Meyer, Alexandra] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Johnson, Philip J.] Univ Missouri, Dept Vet Med & Surg, Columbia, MO USA; [Ericsson, Aaron C.] Univ Missouri, Metagen Ctr, Columbia, MO USA; [Ericsson, Aaron C.] Univ Missouri, Mutant Mouse Resource & Res Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ericsson, AC (corresponding author), Univ Missouri, Dept Vet Pathobiol, Comparat Med Program, Columbia, MO 65211 USA.	ericssona@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021	Ericsson, Aaron C./0000-0002-3053-7269	National Institutes of Health [NIH U42 OD010918-13, NIH T32 OD011126]; Mizzou Advantage, One Health Initiative; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011126, U42OD010918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizzou Advantage, One Health Initiative; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Studies were funded by grants from the National Institutes of Health (NIH U42 OD010918-13 and NIH T32 OD011126) to the University of Missouri Mutant Mouse Resource and Research Center (www.mmrrc.org) and a T32 training grant to the University of Missouri Comparative Medicine Program (cmp.missouri.edu). Funding was also provided by the Mizzou Advantage, One Health Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Ferrand J, 2014, J MICROBIOL METH, V105, P180, DOI 10.1016/j.mimet.2014.07.029; Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hugenholtz P, 2002, GENOME BIOL, V3; Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li M, 2003, J MICROBIOL METH, V54, P13, DOI 10.1016/S0167-7012(02)00260-9; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Strober W, 2013, TRENDS IMMUNOL, V34, P423, DOI 10.1016/j.it.2013.07.001; Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865	24	84	89	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143334	10.1371/journal.pone.0143334	http://dx.doi.org/10.1371/journal.pone.0143334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599606	gold, Green Submitted, Green Published			2022-12-26	WOS:000365862600052
J	Isdory, A; Mureithi, EW; Sumpter, DJT				Isdory, Augustino; Mureithi, Eunice W.; Sumpter, David J. T.			The Impact of Human Mobility on HIV Transmission in Kenya	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EPIDEMIC MODEL; RISK-FACTORS; INFECTION; MIGRATION; SPREAD; HIV/AIDS; DYNAMICS; HETEROGENEITY; ABSTINENCE	Disease spreads as a result of people moving and coming in contact with each other. Thus the mobility patterns of individuals are crucial in understanding disease dynamics. Here we study the impact of human mobility on HIV transmission in different parts of Kenya. We build an SIR metapopulation model that incorporates the different regions within the country. We parameterise the model using census data, HIV data and mobile phone data adopted to track human mobility. We found that movement between different regions appears to have a relatively small overall effect on the total increase in HIV cases in Kenya. However, the most important consequence of movement patterns was transmission of the disease from high infection to low prevalence areas. Mobility slightly increases HIV incidence rates in regions with initially low HIV prevalences and slightly decreases incidences in regions with initially high HIV prevalence. We discuss how regional HIV models could be used in public-health planning. This paper is a first attempt to model spread of HIV using mobile phone data, and we also discuss limitations to the approach.	[Isdory, Augustino; Mureithi, Eunice W.] Univ Dar Es Salaam, Dept Math, Dar Es Salaam, Tanzania; [Sumpter, David J. T.] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden	University of Dar es Salaam; Uppsala University	Isdory, A (corresponding author), Univ Dar Es Salaam, Dept Math, Dar Es Salaam, Tanzania.	lukwea@yahoo.com	Isdory, Augustino/ABC-6031-2020; Mureithi, Eunice/ABB-6114-2020		International Science Programme (ISP); International Science Programme (ISP) in Sweden	International Science Programme (ISP); International Science Programme (ISP) in Sweden	The authors received no specific funding for this work. However, the International Science Programme (ISP) sponsored the corresponding author in his visits from Tanzania to Uppsala University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the International Science Programme (ISP) in Sweden for the financial support. We also thank the PLOS One reviewers for their critical review and many useful suggestions on an earlier version of this Manuscript.	Abdulkarim UM, 2007, RES J APPL SCI, V2, P595; Amundsen EJ, 2004, EPIDEMIOL INFECT, V132, P1139, DOI 10.1017/S0950268804002997; ANDERSON RM, 1988, J ROY STAT SOC A STA, V151, P66, DOI 10.2307/2982185; Arino J, 2005, MATH MED BIOL, V22, P129, DOI 10.1093/imammb/dqi003; Arino J, 2007, MATH BIOSCI, V206, P46, DOI 10.1016/j.mbs.2005.09.002; Arino J, 2006, FIELDS I COMMUN, V48, P1; Barnett T, 2005, LANCET INFECT DIS, V5, P590, DOI 10.1016/S1473-3099(05)70219-X; BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; Baryarama F, 2006, Comput Math Methods Med, V7, P27, DOI 10.1080/10273660600890057; Berman A., 1979, NONNEGATIVE MATRICES; Brewer TH, 1998, AIDS, V12, P1879, DOI 10.1097/00002030-199814000-00020; BWAYO J, 1994, ARCH INTERN MED, V154, P1391, DOI 10.1001/archinte.154.12.1391; Bygrave H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013198; CARSWELL JW, 1989, AIDS, V3, P759, DOI 10.1097/00002030-198911000-00013; Coast E, 2006, SOC SCI MED, V63, P1000, DOI 10.1016/j.socscimed.2006.03.009; Coffee M, 2007, AIDS, V21, P343, DOI 10.1097/QAD.0b013e328011dac9; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; David Z, 2015, DATABANK HOME CORPOR; Deane KD, 2010, TROP MED INT HEALTH, V15, P1458, DOI 10.1111/j.1365-3156.2010.02647.x; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Farina L., 2000, PUR AP M-WI; FLINT JJ, 1974, WATER RESOUR RES, V10, P969, DOI 10.1029/WR010i005p00969; Goufo EFD, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/781028; Gualtieri AF, 2011, J LIFE SCI, V5, P503; Hargrove J, 2008, S AFR J SCI, V104, P53; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; HETHCOTE HW, 1987, MATH BIOSCI, V84, P85, DOI 10.1016/0025-5564(87)90044-7; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; HUANG WZ, 1992, SIAM J APPL MATH, V52, P835, DOI 10.1137/0152047; Kamwanga J, 2006, CORRIDORS HOPE SO AF; Keeling MJ, 2009, BRIT MED BULL, V92, P33, DOI 10.1093/bmb/ldp038; Keeling MJ, 2008, MODELING INFECT DIES; Kenya A.I.D.S., 2008, IND SURV 2007 NAIR K; Kenya S, 2013, COUNTRY COUNTIES KEN; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Korobeinikov A, 2006, B MATH BIOL, V68, P615, DOI 10.1007/s11538-005-9037-9; Lagarde E, 2003, INT J EPIDEMIOL, V32, P744, DOI 10.1093/ije/dyg111; Lima V, 2009, SOC SCI MED, V68, P1044, DOI 10.1016/j.socscimed.2008.12.043; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lu ZH, 2002, MATH COMPUT MODEL, V36, P1039, DOI 10.1016/S0895-7177(02)00257-1; LUI KJ, 1986, P NATL ACAD SCI USA, V83, P3051, DOI 10.1073/pnas.83.10.3051; Lurie M, 1997, HLTH TRANSITION R S3, V7, P17; Lurie MN, 2002, SEXUALLY TRANSMITTED, V30, P149, DOI [10.1097/00007435-200302000-00011, DOI 10.1097/00007435-200302000-00011]; Makinde OD, 2007, APPL MATH COMPUT, V184, P842, DOI 10.1016/j.amc.2006.06.074; Margevicius R., 2013, INVOLVE, V6, P127, DOI DOI 10.2140/INV0LVE.2013.6.127; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Mmbaga EJ, 2008, INT J INFECT DIS, V12, P519, DOI 10.1016/j.ijid.2008.02.007; Naresh R., 2011, WORLD J MODEL SIMUL, V7, P230; Nishiura H, 2010, INT J ENV RES PUB HE, V7, P291, DOI 10.3390/ijerph7010291; Ramjee G, 2002, SEX TRANSM DIS, V29, P44, DOI 10.1097/00007435-200201000-00008; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; Singh S, 2004, REPROD HEALTH MATTER, V12, P129, DOI 10.1016/S0968-8080(04)23118-4; Smith RJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S15; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287; Tizzoni M, 2014, USE HUMAN MOBILITY P, DOI [10.1371/journal.pcbi.1003716, DOI 10.1371/JOURNAL.PCBI.1003716]; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vergu E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009371; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Williams B, ARXIV13043720; WILSON ME, 1995, EMERG INFECT DIS, V1, P39, DOI 10.3201/eid0102.950201; Xiao YN, 2013, J THEOR BIOL, V317, P271, DOI 10.1016/j.jtbi.2012.09.037; Zuma K, 2005, EPIDEMIOL INFECT, V133, P421, DOI 10.1017/S0950268804003607	66	22	23	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142805	10.1371/journal.pone.0142805	http://dx.doi.org/10.1371/journal.pone.0142805			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599277	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600019
J	Sarfo, FS; Eberhardt, KA; Dompreh, A; Kuffour, EO; Soltau, M; Schachscheider, M; Drexler, JF; Eis-Hubinger, AM; Haussinger, D; Oteng-Seifah, EE; Bedu-Addo, G; Phillips, RO; Norman, B; Burchard, G; Feldt, T				Sarfo, Fred Stephen; Eberhardt, Kirsten Alexandra; Dompreh, Albert; Kuffour, Edmund Osei; Soltau, Mareike; Schachscheider, Marei; Drexler, Jan Felix; Eis-Hubinger, Anna Maria; Haeussinger, Dieter; Oteng-Seifah, Emelia Efua; Bedu-Addo, George; Phillips, Richard Odame; Norman, Betty; Burchard, Gerd; Feldt, Torsten			Helicobacter pylori Infection Is Associated with Higher CD4 T Cell Counts and Lower HIV-1 Viral Loads in ART-Naive HIV-Positive Patients in Ghana	PLOS ONE			English	Article							CD4/CD8 RATIO; IMMUNE-RESPONSE; THERAPY; COHORT; RISK; TUBERCULOSIS; INFLAMMATION; INDIVIDUALS; ERADICATION; PERSPECTIVE	Background Worldwide, there is a high co-endemicity of HIV and H. pylori infection and there is growing evidence that H. pylori co-infection is associated with parameters of HIV disease progression. The objective of this study was to investigate the prevalence of H. pylori infection, and the association with clinical, immunological and virological parameters in a large cohort of HIV-infected individuals and uninfected controls in a West African country. Methods HIV-patients (n = 1,095) and HIV-negative individuals (n = 107) were recruited at a university hospital in Ghana. H. pylori status was determined using stool antigen testing. HIV-related, clinical and socio-demographic parameters were recorded and analyzed according to H. pylori status. Results The prevalence of H. pylori infection was significantly lower in HIV-positive compared to HIV-negative individuals (51.5 vs. 88%, p<0.0001). In HIV patients, H. pylori prevalence decreased in parallel with CD4+ T cell counts. In ART-naive HIV-infected individuals, but not in those taking ART, H. pylori infection was associated with higher CD4 cell counts (312 vs. 189 cells/mu L, p<0.0001) and lower HIV-1 viral loads (4.92 vs. 5.21 log10 copies/mL, p = 0.006). The findings could not be explained by socio-demographic confounders or reported use of antibiotics. Having no access to tap water and higher CD4+ T cell counts were identified as risk factors for H. pylori infection. Conclusions H. pylori prevalence was inversely correlated with the degree of immunosuppression. In ART-naive individuals, H. pylori infection is associated with favorable immunological and virological parameters. The underlying mechanisms for this association are unclear and warrant investigation.	[Sarfo, Fred Stephen; Bedu-Addo, George; Phillips, Richard Odame; Norman, Betty] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Sarfo, Fred Stephen; Dompreh, Albert; Bedu-Addo, George; Phillips, Richard Odame; Norman, Betty] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Eberhardt, Kirsten Alexandra; Soltau, Mareike; Schachscheider, Marei; Burchard, Gerd; Feldt, Torsten] Bernhard Nocht Inst Trop Med, Clin Res Unit, Hamburg, Germany; [Kuffour, Edmund Osei; Haeussinger, Dieter] Univ Hosp Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Drexler, Jan Felix; Eis-Hubinger, Anna Maria] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Oteng-Seifah, Emelia Efua] Kumasi Ctr Collaborat Res, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Bernhard Nocht Institut fur Tropenmedizin; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Bonn; Kumasi Center for Collaborative Research	Feldt, T (corresponding author), Bernhard Nocht Inst Trop Med, Clin Res Unit, Hamburg, Germany.	Torsten.Feldt@med.uni-duesseldorf.de	Phillips, Richard Odame/ABD-5394-2021; Drexler, Jan Felix/GMW-5098-2022; Feldt, Torsten/ABF-5894-2021; Eberhardt, Kirsten/AAP-8440-2021	Phillips, Richard Odame/0000-0001-8992-0222; Eberhardt, Kirsten/0000-0002-1002-0326; Drexler, Jan Felix/0000-0002-3509-0232	German Federal Ministry of Education and Research [01KA1102]; MRC [MR/J01477X/1] Funding Source: UKRI; Medical Research Council [MR/J01477X/1] Funding Source: researchfish	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the German Federal Ministry of Education and Research [grant number 01KA1102]. The funders had no role in the design of the study and decision to publish these findings.	Aebischer T, 2010, HELICOBACTER, V15, P21, DOI 10.1111/j.1523-5378.2010.00777.x; Ahmed K. S., 2007, SMJ Singapore Medical Journal, V48, P543; Angin M, 2014, J INFECT DIS, V210, P899, DOI 10.1093/infdis/jiu188; Arnold IC, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00010; Assimakopoulos SF, 2014, INFECTION; Bhan MK, 2002, J INFECT DIS, V186, P1857, DOI 10.1086/345762; Boyanova L, 2014, DIAGN MICR INFEC DIS, V79, P358, DOI 10.1016/j.diagmicrobio.2014.03.028; Bravo LE, 2003, J PEDIATR GASTR NUTR, V37, P614, DOI 10.1097/00005176-200311000-00021; Buggert M, 2014, J IMMUNOL, V192, P2099, DOI 10.4049/jimmunol.1302596; Burkey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P41, DOI 10.1097/QAI.0000000000000094; CHIBA N, 1992, AM J GASTROENTEROL, V87, P1716; DuBois S, 2005, AM J GASTROENTEROL, V100, P453, DOI 10.1111/j.1572-0241.2005.30252.x; Eberhardt KA, 2015, CLIN INFECT DIS, V61, P1615, DOI 10.1093/cid/civ577; EDWARDS PD, 1991, AM J GASTROENTEROL, V86, P1761; Erzin Y, 2004, HELICOBACTER, V9, P657, DOI 10.1111/j.1083-4389.2004.00280.x; Fabris P, 1997, DIGEST DIS SCI, V42, P289, DOI 10.1023/A:1018801532136; Gao L, 2009, EUR J CANCER, V45, P2860, DOI 10.1016/j.ejca.2009.04.015; Gisbert JP, 2007, HELICOBACTER, V12, P50, DOI 10.1111/j.1523-5378.2007.00576.x; Goll R, 2007, HELICOBACTER, V12, P185, DOI 10.1111/j.1523-5378.2007.00495.x; Goodwin CS, 1997, LANCET, V349, P265, DOI 10.1016/S0140-6736(96)07023-7; Khamri W, 2010, INFECT IMMUN, V78, P845, DOI 10.1128/IAI.00524-09; Khan A, 2012, J INFECT DEV COUNTR, V6, P251, DOI 10.3855/jidc.2312; Makristathis A, 2000, J CLIN MICROBIOL, V38, P3710, DOI 10.1128/JCM.38.10.3710-3714.2000; Mitchell P, 2007, INFECT IMMUN, V75, P810, DOI 10.1128/IAI.00228-06; Muller A, 2011, HELICOBACTER, V16, P26, DOI 10.1111/j.1523-5378.2011.00877.x; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Nevin DT, 2014, HELICOBACTER, V19, P323, DOI 10.1111/hel.12131; Panos GZ, 2007, AIDS RES HUM RETROV, V23, P709, DOI 10.1089/aid.2006.0174; Perry S, 2013, EPIDEMIOL INFECT, V141, P1232, DOI 10.1017/S0950268812001823; Perry S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008804; Romanelli F, 2007, AIDS PATIENT CARE ST, V21, P908, DOI 10.1089/apc.2006.0215; Rothenbacher D, 2000, J PEDIATR-US, V136, P744, DOI 10.1016/S0022-3476(00)77103-4; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Sayi A, 2009, J IMMUNOL, V182, P7085, DOI 10.4049/jimmunol.0803293; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Stevenson TH, 2000, APPL ENVIRON MICROB, V66, P723, DOI 10.1128/AEM.66.2.723-727.2000; Thomas JE, 2004, ARCH DIS CHILD, V89, P1149, DOI 10.1136/adc.2002.015313; UNAIDS, 2014, THE GAP REP	39	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143388	10.1371/journal.pone.0143388	http://dx.doi.org/10.1371/journal.pone.0143388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599971	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600060
J	Bernard, H; Desseyn, JL; Gottrand, F; Stahl, B; Bartke, N; Husson, MO				Bernard, Henry; Desseyn, Jean-Luc; Gottrand, Frederic; Stahl, Bernd; Bartke, Nana; Husson, Marie-Odile			Pectin- Derived Acidic Oligosaccharides Improve the Outcome of Pseudomonas aeruginosa Lung Infection in C57BL/6 Mice	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; IMMUNE-RESPONSE; GALACTO-OLIGOSACCHARIDES; BUTYRATE; CELLS; BIFIDOBACTERIA; POLARIZATION; ACTIVATION; MICROBIOTA; MONOCYTES	The administration of prebiotics as oligosaccharides (OS), by acting on intestinal microbiota, could modulate the immune and inflammatory response and represent a new strategy to improve the outcome of bacterial infection. The aim of this study was to determine whether pectin-derived acidic oligosaccharides (pAOS) could modulate the outcome of pulmonary P. aeruginosa (PA) infection in C57BL/6 mice, which develop a Th1 response to PA lung infection. Mice were randomized for 5 weeks to consume a control or a 5% pAOS diet and chronically infected by PA. Resistance to a second PA infection was also analyzed by reinfecting the surviving mice 2 weeks after the first infection. Compared with control mice, mice fed pAOS had reduced mortality (P<0.05). This improvement correlated with a better control of the inflammatory response with a lower neutrophil count on day 1 (P<0.05), a sustained neutrophil and macrophage recruitment on days 2 and 3 (P<0.01) a greater and sustained IL-10 release in lung (P<0.05) and a reduction of the Th1 response and M1 activation with a lower IFN-./IL-4 (P<0.01) and nos2/arg1 (P<0.05) ratios. These results coincided with a modulation of the intestinal microbiota as shown by an increased butyric acid concentration in feces (P<0.05). Moreover, pAOS decreased the bacterial load (P<0.01) in mice reinfected 2 weeks after the first infection, suggesting that pAOS could reduce pulmonary exacerbations. In conclusion, pAOS improved the outcome of PA infection in C57BL/6 mice by modulating the intestinal microbiota and the inflammatory and immune responses.	[Bernard, Henry; Desseyn, Jean-Luc; Gottrand, Frederic; Husson, Marie-Odile] Univ Lille, LIRIC UMR 995, INSERM, CHRU Lille,Fac Med, F-59045 Lille, France; [Stahl, Bernd; Bartke, Nana] Nutricia Res, NL-3584 CT Utrecht, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Danone Nutricia	Husson, MO (corresponding author), Univ Lille, LIRIC UMR 995, INSERM, CHRU Lille,Fac Med, Pl Verdun, F-59045 Lille, France.	mo.husson@orange.fr	Desseyn, Jean-Luc/M-5070-2018; gottrand, frederic/G-7370-2015	Desseyn, Jean-Luc/0000-0001-6876-8049; gottrand, frederic/0000-0002-5290-0436	French Association "Vaincre la Mucoviscidose" [2009/IC0916, 2010/IC1018]; Funder Nutritia Research	French Association "Vaincre la Mucoviscidose"; Funder Nutritia Research	The study was funded by grants from the French Association "Vaincre la Mucoviscidose": grant number 2009/IC0916, 2010/IC1018) for purchasing mice and materials, and Nutricia Research for providing the experimental diets. The Funder Nutritia Research provided also support in the form of the salary of H. B., but did not have any additional role in the study design, data collection and other analysis, decision to publish, or preparation of the manuscript. The specific roles of the two authors (N.B. and B.S.) of Nutritia Research are articulated in the 'author contributions' section.	Arslanoglu S, 2012, J Biol Regul Homeost Agents, V26, P49; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bernard H, 2015, J INFECT DIS, V211, P156, DOI 10.1093/infdis/jiu391; Brazova J, 2005, CLIN IMMUNOL, V115, P210, DOI 10.1016/j.clim.2005.01.013; Capitan-Canadas F, 2014, MOL NUTR FOOD RES, V58, P1098, DOI 10.1002/mnfr.201300497; Chuang L, 2007, J AGR FOOD CHEM, V55, P11080, DOI 10.1021/jf071786o; Duytschaever G, 2013, J CYST FIBROS, V12, P206, DOI 10.1016/j.jcf.2012.10.003; Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x; Perez-Cobas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080201; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Ghadimi D, 2008, IMMUNOBIOLOGY, V213, P677, DOI 10.1016/j.imbio.2008.02.001; Giovannini M, 2014, J AM COLL NUTR, V10, P1; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Jensen PO, 2010, FEMS IMMUNOL MED MIC, V59, P292, DOI 10.1111/j.1574-695X.2010.00706.x; Kondratieva TK, 2000, CLIN EXP IMMUNOL, V121, P275, DOI 10.1046/j.1365-2249.2000.01222.x; Livingston M, 2010, IMMUNOL CELL BIOL, V88, P99, DOI 10.1038/icb.2009.71; Lohner S, 2014, NUTR REV, V72, P523, DOI 10.1111/nure.12117; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Moser C, 2005, APMIS, V113, P400, DOI 10.1111/j.1600-0463.2005.apm_142.x; Moser C, 1999, APMIS, V107, P1093, DOI 10.1111/j.1699-0463.1999.tb01514.x; Ni YF, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-33; Ortega-Gonzalez M, 2014, MOL NUTR FOOD RES, V58, P384, DOI 10.1002/mnfr.201300296; Pierre M, 2007, AM J PHYSIOL-LUNG C, V292, pL1422, DOI 10.1152/ajplung.00337.2006; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Saemann MD, 2000, FASEB J, V14, P2380; Schippa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061176; Scott KP, 2014, FEMS MICROBIOL ECOL, V87, P30, DOI 10.1111/1574-6941.12186; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; van Hoffen E, 2009, ALLERGY, V64, P484, DOI 10.1111/j.1398-9995.2008.01765.x; van't Land B, 2010, VACCINE, V28, P5711, DOI 10.1016/j.vaccine.2010.06.046; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vos AP, 2007, PEDIAT ALLERG IMM-UK, V18, P304, DOI 10.1111/j.1399-3038.2007.00515.x; Walton GE, 2012, BRIT J NUTR, V107, P1466, DOI 10.1017/S0007114511004697; Yang JY, 2013, ANAEROBE, V23, P74, DOI 10.1016/j.anaerobe.2013.06.012	38	14	15	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0139686	10.1371/journal.pone.0139686	http://dx.doi.org/10.1371/journal.pone.0139686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599638	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900006
J	De Franceschi, N; Peuhu, E; Parsons, M; Rissanen, S; Vattulainen, I; Salmi, M; Ivaska, J; Pouwels, J				De Franceschi, Nicola; Peuhu, Emilia; Parsons, Maddy; Rissanen, Sami; Vattulainen, Ilpo; Salmi, Marko; Ivaska, Johanna; Pouwels, Jeroen			Mutually Exclusive Roles of SHARPIN in Integrin Inactivation and NF-kappa B Signaling	PLOS ONE			English	Article							UBIQUITIN LIGASE; ACTIVATION; COMPLEX; PROTEIN; CANCER; CELLS; PTEN; CONTRIBUTES	SHANK-associated RH domain interactor (SHARPIN) inhibits integrins through interaction with the integrin alpha-subunit. In addition, SHARPIN enhances nuclear factor-kappaB (NF-kappa B) activity as a component of the linear ubiquitin chain assembly complex (LUBAC). However, it is currently unclear how regulation of these seemingly different roles is coordinated. Here, we show that SHARPIN binds integrin and LUBAC in a mutually exclusive manner. We map the integrin binding site on SHARPIN to the ubiquitin-like (UBL) domain, the same domain implicated in SHARPIN interaction with LUBAC component RNF31 (ring finger protein 31), and identify two SHARPIN residues (V267, L276) required for both integrin and RNF31 regulation. Accordingly, the integrin alpha-tail is capable of competing with RNF31 for SHARPIN binding in vitro. Importantly, the full SHARPIN RNF31-binding site contains residues (F263A/I272A) that are dispensable for SHARPIN-integrin interaction. Importantly, disrupting SHARPIN interaction with integrin or RNF31 abolishes SHARPIN-mediated regulation of integrin or NF-kappa B activity, respectively. Altogether these data suggest that the roles of SHARPIN in inhibiting integrin activity and supporting linear ubiquitination are (molecularly) distinct.	[De Franceschi, Nicola; Peuhu, Emilia; Ivaska, Johanna; Pouwels, Jeroen] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [De Franceschi, Nicola; Peuhu, Emilia; Ivaska, Johanna] VTT Tech Res Ctr Finland, Med Biotechnol, Turku, Finland; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Rissanen, Sami; Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Vattulainen, Ilpo] Univ Southern Denmark, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Salmi, Marko] Univ Turku, MediCity Res Lab, Turku, Finland; [Salmi, Marko] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Ivaska, Johanna] Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland	University of Turku; VTT Technical Research Center Finland; University of London; King's College London; Tampere University; University of Southern Denmark; University of Turku; University of Turku; University of Turku	Ivaska, J (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.	johanna.ivaska@utu.fi; jpouwels@btk.fi	Vattulainen, Ilpo T/G-4224-2014; De Franceschi, Nicola/S-8194-2016; Parsons, Maddy/B-2203-2013	Vattulainen, Ilpo/0000-0001-7408-3214; De Franceschi, Nicola/0000-0002-7221-613X; Ivaska, Johanna/0000-0002-6295-6556; Peuhu, Emilia/0000-0003-4945-3046; Pouwels, Jeroen/0000-0002-5388-6103; Parsons, Maddy/0000-0002-2021-8379	FinPharma Doctoral Programme; Intrumentarium Foundation; Orion Research Foundation; Finsk-Norska Medicinska Stiftelsen; Magnus Ehrnrooth Foundation; Royal Society; Academy of Finland; Sigrid Juselius Foundation; European Research Council; Finnish Heart Foundation; Finnish Cancer Organizations; Finnish Cancer Institute; Instrumentarium Foundation	FinPharma Doctoral Programme; Intrumentarium Foundation; Orion Research Foundation; Finsk-Norska Medicinska Stiftelsen; Magnus Ehrnrooth Foundation; Royal Society(Royal Society of London); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Research Council(European Research Council (ERC)European Commission); Finnish Heart Foundation; Finnish Cancer Organizations; Finnish Cancer Institute; Instrumentarium Foundation	This work was supported by N.d.F. FinPharma Doctoral Programme (http://www.fpdp.fi/), Intrumentarium Foundation (http://www.instrufoundation.fi/), Orion Research Foundation (http://www.orion.fi/tutkimus/orionin-tutkimussaatio/), Finsk-Norska Medicinska Stiftelsen (http://www.foundationweb.net/finsknorska/), and the Magnus Ehrnrooth Foundation (http://pro.tsv.fi/magnusehrnrooth/English/); E.P. Academy of Finland Postdoc Grant (www.aka.fi); M.P. Royal Society (https://royalsociety.org/); M.S. Academy of Finland, the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation); J.I. Academy of Finland, European Research Council Starting Grant (http://erc.europa.eu/), The Finnish Heart Foundation (http://www.sydanliitto.fi/finnish-heart-association#.VdV8Z5fUPhU) and Finnish Cancer Organizations (www.cancer.fi); J.P. Finnish Cancer Institute (www.cancer.fi), Academy of Finland, Instrumentarium Foundation.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; De Franceschi N, 2014, TRAFFIC, V15, P104, DOI 10.1111/tra.12124; De Melo J, 2014, CELL SIGNAL, V26, P2749, DOI 10.1016/j.cellsig.2014.08.013; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Dubois SM, 2014, BLOOD, V123, P2199, DOI 10.1182/blood-2013-05-504019; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; He LZ, 2010, J CLIN INVEST, V120, P2094, DOI 10.1172/JCI40778; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Jung J, 2010, MOL CELL BIOCHEM, V340, P161, DOI 10.1007/s11010-010-0413-x; Landgraf K, 2010, MOL CELL BIOL, V30, P5764, DOI 10.1128/MCB.01645-09; Li J, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0444-3; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Liu JM, 2015, NAT STRUCT MOL BIOL, V22, P383, DOI 10.1038/nsmb.2999; Mameza MG, 2013, J BIOL CHEM, V288, P26697, DOI 10.1074/jbc.M112.424747; Milella M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00024; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pouwels J, 2013, CELL REP, V5, P619, DOI 10.1016/j.celrep.2013.10.011; QWARNSTROM EE, 1994, J BIOL CHEM, V269, P30765; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Rosales C, 1996, CANCER RES, V56, P2302; Sieber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029993; Stieglitz B, 2012, J BIOL CHEM, V287, P20823, DOI 10.1074/jbc.M112.359547; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Zhang YM, 2014, CANCER-AM CANCER SOC, V120, P3208, DOI 10.1002/cncr.28796	32	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143423	10.1371/journal.pone.0143423	http://dx.doi.org/10.1371/journal.pone.0143423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600301	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900116
J	Park, BY; Lee, H; Woo, S; Yoon, M; Kim, J; Hong, Y; Lee, HS; Park, EK; Hahm, JC; Kim, JW; Shin, SS; Kim, MY; Yoon, M				Park, Byung Young; Lee, Hyunghee; Woo, Sangee; Yoon, Miso; Kim, Jeongjun; Hong, Yeonhee; Lee, Hee Suk; Park, Eun Kyu; Hahm, Jong Cheon; Kim, Jin Woo; Shin, Soon Shik; Kim, Min-Young; Yoon, Michung			Reduction of Adipose Tissue Mass by the Angiogenesis Inhibitor ALS-L1023 from Melissa officinalis	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITION; COMPOSITION OB-X; INSULIN-RESISTANCE; GELATINASE-A; PPAR-ALPHA; MORUS-ALBA; OBESITY; GROWTH; EXPRESSION; ADIPOGENESIS	It has been suggested that angiogenesis modulates adipogenesis and obesity. This study was undertaken to determine whether ALS-L1023 (ALS) prepared by a two-step organic solvent fractionation from Melissa leaves, which exhibits antiangiogenic activity, can regulate adipose tissue growth. The effects of ALS on angiogenesis and extracellular matrix remodeling were measured using in vitro assays. The effects of ALS on adipose tissue growth were investigated in high fat diet-induced obese mice. ALS inhibited VEGF-and bFGF-induced endothelial cell proliferation and suppressed matrix metalloproteinase (MMP) activity in vitro. Compared to obese control mice, administration of ALS to obese mice reduced body weight gain, adipose tissue mass and adipocyte size without affecting appetite. ALS treatment decreased blood vessel density and MMP activity in adipose tissues. ALS reduced the mRNA levels of angiogenic factors (VEGF-A and FGF-2) and MMPs (MMP-2 and MMP-9), whereas ALS increased the mRNA levels of angiogenic inhibitors (TSP-1, TIMP-1, and TIMP-2) in adipose tissues. The protein levels of VEGF, MMP-2 and MMP-9 were also decreased by ALS in adipose tissue. Metabolic changes in plasma lipids, liver triglycerides, and hepatic expression of fatty acid oxidation genes occurred during ALS-induced weight loss. These results suggest that ALS, which has antiangiogenic and MMP inhibitory activities, reduces adipose tissue mass in nutritionally obese mice, demonstrating that adipose tissue growth can be regulated by angiogenesis inhibitors.	[Park, Byung Young; Kim, Jin Woo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Park, Byung Young; Lee, Hee Suk; Park, Eun Kyu; Hahm, Jong Cheon; Kim, Min-Young] AngioLab Inc, Daejeon, South Korea; [Lee, Hyunghee; Woo, Sangee; Yoon, Miso; Kim, Jeongjun; Hong, Yeonhee; Yoon, Michung] Mokwon Univ, Dept Biomed Engn, Daejeon, South Korea; [Shin, Soon Shik] Dong Eui Univ, Dept Formula Sci, Coll Oriental Med, Busan, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Mokwon University; Dong-Eui University	Kim, MY (corresponding author), AngioLab Inc, Daejeon, South Korea.	mykim@angiolab.co.kr; yoon60@mokwon.ac.kr	KIM, JIN WOO/C-1655-2011	KIM, JIN WOO/0000-0003-0767-1918	National Research Foundation of Korea Grant - Korea Government (MEST), Korea [2012R1A1A3002100, 2012R1A2A2A01004508, 2015R1A1A3A04001016]; AngioLab Inc	National Research Foundation of Korea Grant - Korea Government (MEST), Korea; AngioLab Inc	This work was supported by the National Research Foundation of Korea [http://www.nrf.re.kr/] Grants funded by the Korea Government (MEST) (2012R1A1A3002100, 2012R1A2A2A01004508, and 2015R1A1A3A04001016), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder AngioLab Inc provided support in the form of salaries for authors [HL SW MY JK] and reagent materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondzadeh S, 2003, J NEUROL NEUROSUR PS, V6, P625; [Anonymous], [No title captured]; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Blumenthal M, 2000, HERBAL MED EXPANDED, V123, P230; Bouloumie A, 2002, ANN ENDOCRINOL-PARIS, V63, P91; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Brakenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Celletti FL, 2001, NAT MED, V7, P425, DOI 10.1038/86490; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Croissandeau G, 2002, BIOCHEM J, V364, P739, DOI 10.1042/BJ20011158; Demeulemeester D, 2005, BIOCHEM BIOPH RES CO, V329, P105, DOI 10.1016/j.bbrc.2005.01.103; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; GALARDY RE, 1994, CANCER RES, V54, P4715; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hong Y, 2011, PHARM BIOL, V49, P775, DOI 10.3109/13880209.2010.547208; Itoh T, 1998, CANCER RES, V58, P1048; Jeong S, 2009, EXP MOL MED, V41, P397, DOI 10.3858/emm.2009.41.6.045; Kim MY, 2010, INT J OBESITY, V34, P820, DOI 10.1038/ijo.2010.13; Kim YM, 2007, J MOL ENDOCRINOL, V38, P455, DOI 10.1677/jme.1.02165; Lee H, 2013, FOOD CHEM TOXICOL, V53, P402, DOI 10.1016/j.fct.2012.11.052; Li JP, 2002, AM J PHYSIOL-ENDOC M, V282, pE1334, DOI 10.1152/ajpendo.00516.2001; Lijnen HR, 2002, ARTERIOSCL THROM VAS, V22, P374, DOI 10.1161/hq0302.104522; Lijnen HR, 2001, THROMB HAEMOSTASIS, V85, P1111; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Miksztowicz V, 2014, NUTR METAB CARDIOVAS, V24, P294, DOI 10.1016/j.numecd.2013.08.007; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Rundhaug JE, 2003, CLIN CANCER RES, V9, P551; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987; SILVERMAN KJ, 1988, BIOCHEM BIOPH RES CO, V153, P347, DOI 10.1016/S0006-291X(88)81229-4; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Valentino MA, 2010, CLIN PHARMACOL THER, V87, P652, DOI 10.1038/clpt.2010.57; Van Hul M, 2008, J THROMB HAEMOST, V6, P1198, DOI 10.1111/j.1538-7836.2008.02988.x; Van Hul M, 2011, ENDOCR J, V58, P101, DOI 10.1507/endocrj.K10E-267; Yoon M, 2011, PHARM BIOL, V49, P614, DOI 10.3109/13880209.2010.539617; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004	46	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141612	10.1371/journal.pone.0141612	http://dx.doi.org/10.1371/journal.pone.0141612			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599360	Green Published, gold			2022-12-26	WOS:000365853900013
J	Jain, N; Morgan, CE; Rife, BD; Salemi, M; Tolbert, BS				Jain, Niyati; Morgan, Christopher E.; Rife, Brittany D.; Salemi, Marco; Tolbert, Blanton S.			Solution Structure of the HIV-1 Intron Splicing Silencer and Its Interactions with the UP1 Domain of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RNA STRUCTURE; BIOLOGICAL MACROMOLECULES; STRUCTURE PREDICTION; SECONDARY STRUCTURE; SOLUTION SCATTERING; EXON; BINDING; NMR; TAT	Splicing patterns in human immunodeficiency virus type 1 (HIV-1) are maintained through cis regulatory elements that recruit antagonistic host RNA-binding proteins. The activity of the 3' acceptor site A7 is tightly regulated through a complex network of an intronic splicing silencer (ISS), a bipartite exonic splicing silencer (ESS3a/b), and an exonic splicing enhancer (ESE3). Because HIV-1 splicing depends on protein-RNA interactions, it is important to know the tertiary structures surrounding the splice sites. Herein, we present the NMR solution structure of the phylogenetically conserved ISS stem loop. ISS adopts a stable structure consisting of conserved UG wobble pairs, a folded 2X2 (GU/UA) internal loop, a UU bulge, and a flexible AGUGA apical loop. Calorimetric and biochemical titrations indicate that the UP1 domain of heterogeneous nuclear ribonucleoprotein A1 binds the ISS apical loop site-specifically and with nanomolar affinity. Collectively, this work provides additional insights into how HIV-1 uses a conserved RNA structure to commandeer a host RNA-binding protein.	[Jain, Niyati; Morgan, Christopher E.; Tolbert, Blanton S.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Rife, Brittany D.; Salemi, Marco] Univ Florida, Dept Pathol Immunol, Gainesville, FL 32610 USA; [Rife, Brittany D.; Salemi, Marco] Univ Florida, Lab Med, Coll Med, Gainesville, FL 32610 USA; [Rife, Brittany D.; Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA	Case Western Reserve University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tolbert, BS (corresponding author), Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA.	bst18@case.edu		Rife Magalis, Brittany/0000-0001-6088-4651	National Science Foundation [1334048]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; National Institute of General Medical Sciences of the National Institutes of Health [P41 GM103622]; National Institutes of Health [1S10OD018090-1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101979, P50GM103297, P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Bruker Avance III HD (500-MHz) spectrometer and Prodigy broadband cryoprobe were purchased using funds provided by National Science Foundation Grant 1334048. This research also used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. This project was also supported by Grant P41 GM103622 from the National Institute of General Medical Sciences of the National Institutes of Health. Use of the Pilatus 3 1M detector was provided by National Institutes of Health Grant 1S10OD018090-1.	Al-Hashimi HM, 2002, J MOL BIOL, V315, P95, DOI 10.1006/jmbi.2001.5235; AMENDT BA, 1995, MOL CELL BIOL, V15, P4606; Asai K, 2003, VIROLOGY, V314, P229, DOI 10.1016/S0042-6822(03)00400-8; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clore GM, 2003, J AM CHEM SOC, V125, P1518, DOI 10.1021/ja028383j; Damgaard CK, 2002, RNA, V8, P1401, DOI 10.1017/S1355838202023075; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fang XY, 2013, CELL, V155, P594, DOI 10.1016/j.cell.2013.10.008; Fischer W, 2012, J VIROL, V86, P13217, DOI 10.1128/JVI.01862-12; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lavender CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004230; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Levengood JD, 2012, J MOL BIOL, V415, P680, DOI 10.1016/j.jmb.2011.11.034; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Marchand V, 2002, J MOL BIOL, V323, P629, DOI 10.1016/S0022-2836(02)00967-1; Morgan CE, 2015, J MOL BIOL, V427, P3241, DOI 10.1016/j.jmb.2015.05.009; Mueller N, 2015, J GEN VIROL, V96, P1906, DOI 10.1099/vir.0.000122; Mueller N, 2014, VIROLOGY, V468, P609, DOI 10.1016/j.virol.2014.09.018; Ocwieja KE, 2012, NUCLEIC ACIDS RES, V40, P10345, DOI 10.1093/nar/gks753; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rollins C, 2014, BIOCHEMISTRY-US, V53, P2172, DOI 10.1021/bi500180p; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/nmeth.3029, 10.1038/NMETH.3029]; STAFFA A, 1994, J VIROL, V68, P3071, DOI 10.1128/JVI.68.5.3071-3079.1994; Stoltzfus CM, 2009, ADV VIRUS RES, V74, P1, DOI 10.1016/S0065-3527(09)74001-1; Stoltzfus CM, 2006, CURR HIV RES, V4, P43, DOI 10.2174/157016206775197655; Sukosd Z, 2015, NUCLEIC ACIDS RES, V43, P10168, DOI 10.1093/nar/gkv1039; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tange TO, 2001, J MOL BIOL, V312, P649, DOI 10.1006/jmbi.2001.4971; Tange TO, 2001, EMBO J, V20, P5748; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolbert BS, 2010, J BIOMOL NMR, V47, P205, DOI 10.1007/s10858-010-9424-x; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wu XW, 2013, J STRUCT BIOL, V183, P429, DOI 10.1016/j.jsb.2013.07.006	51	21	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2331	2344		10.1074/jbc.M115.674564	http://dx.doi.org/10.1074/jbc.M115.674564			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26607354	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000369610400023
J	Abbadi, A; Lauer, M; Swaidani, S; Wang, AM; Hascall, V				Abbadi, Amina; Lauer, Mark; Swaidani, Shadi; Wang, Aimin; Hascall, Vincent			Hyaluronan Rafts on Airway Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; FACTOR-STIMULATED GENE-6; SMOOTH-MUSCLE-CELLS; ENDOPLASMIC-RETICULUM STRESS; HEAVY-CHAIN TRANSFER; TRYPSIN INHIBITOR; LEUKOCYTE ADHESION; PROTEIN TSG-6; GLYCOSAMINOGLYCANS; SYNTHESIZE	Many cells, including murine airway epithelial cells, respond to a variety of inflammatory stimuli by synthesizing leukocyteadhesive hyaluronan (HA) cables that remain attached to their cell surfaces. This study shows that air-liquid interface cultures of murine airway epithelial cells (AECs) also actively synthesize and release a majority of their HA onto their ciliated apical surfaces to form a heavy chain hyaluronan (HC-HA) matrix in the absence of inflammatory stimuli. These matrices do not resemble the rope-like HA cables but occur in distinct sheets or rafts that can capture and embed leukocytes from cell suspensions. The HC-HA modification involves the transfer of heavy chains from the inter-alpha-inhibitor (I alpha I) proteoglycan, which has two heavy chains (HC1 and HC2) on its chondroitin sulfate chain. The transesterification transfer of HCs from chondroitin sulfate to HA is mediated by tumor necrosis factor-induced gene 6 (TSG-6), which is up-regulated in inflammatory reactions. Because the AEC cultures do not have TSG-6 nor serum, the source of I alpha I, assays for HCs and TSG-6 were done. The results show that AECs synthesize TSG-6 and their own heavy chain donor (pre-I alpha I) with a single heavy chain 3 (HC3), which are also constitutively expressed by human renal proximal tubular epithelial cells. These leukocyte adhesive HC3-HA structures were also found in the bronchoalveolar lavage of naive mice and were observed on their apical ciliated surfaces. Thus, these leukocyte-adhesive HA rafts are now identified as HC3-HA complexes that could be part of a host defense mechanism filling some important gaps in our current understanding of murine airway epithelial biology and secretions.	[Abbadi, Amina; Lauer, Mark; Wang, Aimin; Hascall, Vincent] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Swaidani, Shadi] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Abbadi, Amina] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Hascall, V (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA.	hascalv@ccf.org		Swaidani, Shadi/0000-0003-1506-4472	National Institutes of Health [P01HL107147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, R01HL113325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL107147 (NHLBI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHLBI of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Colon E, 2009, J BIOL CHEM, V284, P2320, DOI 10.1074/jbc.M807183200; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Janssen U, 2001, KIDNEY INT, V60, P126, DOI 10.1046/j.1523-1755.2001.00779.x; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lauer ME, 2014, J BIOL CHEM, V289, P6791, DOI 10.1074/jbc.M113.512491; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lilly CM, 2005, AM J RESP CRIT CARE, V171, P579, DOI 10.1164/rccm.200404-532OC; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Maier R, 1996, ARTHRITIS RHEUM, V39, P552, DOI 10.1002/art.1780390403; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; Papakonstantinou E, 2009, BRIT J PHARMACOL, V157, P1111, DOI 10.1111/j.1476-5381.2009.00279.x; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2010, J BIOL CHEM, V285, P21988, DOI 10.1074/jbc.M109.041046; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Wang AM, 2014, J BIOL CHEM, V289, P11410, DOI 10.1074/jbc.M113.541458; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Yoshihara Y, 2008, OSTEOARTHR CARTILAGE, V16, P1343, DOI 10.1016/j.joca.2008.04.004; Zhang XL, 2004, AM J PATHOL, V165, P763, DOI 10.1016/S0002-9440(10)63339-1; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	40	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1448	1455		10.1074/jbc.M115.704288	http://dx.doi.org/10.1074/jbc.M115.704288			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26601955	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000368068300035
J	Ohashi, K; Komada, H; Uda, S; Kubota, H; Iwaki, T; Fukuzawa, H; Komori, Y; Fujii, M; Toyoshima, Y; Sakaguchi, K; Ogawa, W; Kuroda, S				Ohashi, Kaoru; Komada, Hisako; Uda, Shinsuke; Kubota, Hiroyuki; Iwaki, Toshinao; Fukuzawa, Hiroki; Komori, Yasunori; Fujii, Masashi; Toyoshima, Yu; Sakaguchi, Kazuhiko; Ogawa, Wataru; Kuroda, Shinya			Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans	PLOS ONE			English	Article							BETA-CELL FUNCTION; TYPE-2 DIABETIC-PATIENTS; TOLERANCE TEST DATA; MINIMAL MODEL; C-PEPTIDE; INTRAVENOUS GLUCOSE; HEALTHY-VOLUNTEERS; OBESE SUBJECTS; AKT PATHWAY; ORAL-TEST	Homeostatic control of blood glucose is regulated by a complex feedback loop between glucose and insulin, of which failure leads to diabetes mellitus. However, physiological and pathological nature of the feedback loop is not fully understood. We made a mathematical model of the feedback loop between glucose and insulin using time course of blood glucose and insulin during consecutive hyperglycemic and hyperinsulinemic-euglycemic clamps in 113 subjects with variety of glucose tolerance including normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM). We analyzed the correlation of the parameters in the model with the progression of glucose intolerance and the conserved relationship between parameters. The model parameters of insulin sensitivity and insulin secretion significantly declined from NGT to IGT, and from IGT to T2DM, respectively, consistent with previous clinical observations. Importantly, insulin clearance, an insulin degradation rate, significantly declined from NGT, IGT to T2DM along the progression of glucose intolerance in the mathematical model. Insulin clearance was positively correlated with a product of insulin sensitivity and secretion assessed by the clamp analysis or determined with the mathematical model. Insulin clearance was correlated negatively with postprandial glucose at 2h after oral glucose tolerance test. We also inferred a square-law between the rate constant of insulin clearance and a product of rate constants of insulin sensitivity and secretion in the model, which is also conserved among NGT, IGT and T2DM subjects. Insulin clearance shows a conserved relationship with the capacity of glucose disposal among the NGT, IGT and T2DM subjects. The decrease of insulin clearance predicts the progression of glucose intolerance.	[Ohashi, Kaoru; Uda, Shinsuke; Kubota, Hiroyuki; Komori, Yasunori; Fujii, Masashi; Toyoshima, Yu; Kuroda, Shinya] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Komada, Hisako; Sakaguchi, Kazuhiko; Ogawa, Wataru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol,Chuo Ku, Kobe, Hyogo 657, Japan; [Iwaki, Toshinao; Kuroda, Shinya] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Bunkyo Ku, Tokyo, Japan; [Fukuzawa, Hiroki] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; Kobe University; University of Tokyo; University of Tokyo	Ogawa, W (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	ogawa@med.kobe-u.ac.jp; skuroda@bs.s.u-tokyo.ac.jp	Toyoshima, Yu/G-5005-2014; Fujii, Masashi/S-1516-2019; OGAWA, Wataru/AAQ-9586-2020	Toyoshima, Yu/0000-0001-5239-2235; Fujii, Masashi/0000-0002-1586-6435; 	Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST, of the Japan Science and Technology Agency (JST); Kakenhi Scientific Research grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [21240025]; Human Frontier Science Project (HFSP) grant [RGP0061/2011]	Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST, of the Japan Science and Technology Agency (JST); Kakenhi Scientific Research grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Human Frontier Science Project (HFSP) grant	This work was supported by Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST, of the Japan Science and Technology Agency (JST), http://www.jst.go.jp/kisoken/crest/en/; Kakenhi Scientific Research grant (A) (#21240025) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, https://www.jsps.go.jp/english/e-grants/; and Human Frontier Science Project (HFSP) grant (RGP0061/2011), http://www.hfsp.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader M, 2014, OBESITY, V22, P1238, DOI 10.1002/oby.20625; Ajmera I, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.30; Antuna-Puente B, 2011, DIABETES METAB, V37, P179, DOI 10.1016/j.diabet.2011.01.002; BENZI L, 1994, DIABETES, V43, P297, DOI 10.2337/diabetes.43.2.297; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; BOLIE VW, 1961, J APPL PHYSIOL, V16, P783, DOI 10.1152/jappl.1961.16.5.783; BONORA E, 1983, METABOLISM, V32, P438, DOI 10.1016/0026-0495(83)90004-5; Breda E, 2001, DIABETES, V50, P150, DOI 10.2337/diabetes.50.1.150; Brys G, 2004, J COMPUT GRAPH STAT, V13, P996, DOI 10.1198/106186004X12632; Campioni M, 2009, AM J PHYSIOL-ENDOC M, V297, pE941, DOI 10.1152/ajpendo.90842.2008; CASTILLO MJ, 1994, DIABETES METAB REV, V10, P119, DOI 10.1002/dmr.5610100205; Choi E, 2011, KOREAN J ANESTHESIOL, V60, P226, DOI 10.4097/kjae.2011.60.3.226; COBELLI C, 1988, DIABETES, V37, P223, DOI 10.2337/diabetes.37.2.223; Dalla Man C, 2004, AM J PHYSIOL-ENDOC M, V287, pE637, DOI 10.1152/ajpendo.00319.2003; Dalla Man C, 2002, IEEE T BIO-MED ENG, V49, P419, DOI 10.1109/10.995680; De Gaetano A, 2000, J MATH BIOL, V40, P136, DOI 10.1007/s002850050007; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Denti P, 2010, AM J PHYSIOL-ENDOC M, V298, pE950, DOI 10.1152/ajpendo.00656.2009; EATON RP, 1980, J CLIN ENDOCR METAB, V51, P520, DOI 10.1210/jcem-51-3-520; Fujita KA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000810; Hovorka R, 1996, COMPUT METH PROG BIO, V50, P253, DOI 10.1016/0169-2607(96)01755-5; Hovorka R, 1998, J CLIN ENDOCR METAB, V83, P744, DOI 10.1210/jc.83.3.744; Hubert M, 2008, J CHEMOMETR, V22, P235, DOI 10.1002/cem.1123; Jauslin PM, 2007, J CLIN PHARMACOL, V47, P1244, DOI 10.1177/0091270007302168; Jones CNO, 1997, J CLIN ENDOCR METAB, V82, P1834, DOI 10.1210/jc.82.6.1834; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Komada H, 2011, J DIABETES INVEST, V2, P293, DOI 10.1111/j.2040-1124.2010.00099.x; Kubota H, 2012, MOL CELL, V46, P820, DOI 10.1016/j.molcel.2012.04.018; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lee CC, 2013, DIABETES CARE, V36, P901, DOI 10.2337/dc12-1316; Mari A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1159, DOI 10.1152/ajpendo.00093.2002; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Marini MA, 2014, ACTA DIABETOL, V51, P257, DOI 10.1007/s00592-013-0511-9; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matveyenko AV, 2006, DIABETES, V55, P2347, DOI 10.2337/db06-0345; Neuhauser M, 2001, BIOMETRICAL J, V43, P571, DOI 10.1002/1521-4036(200109)43:5<571::AID-BIMJ571>3.0.CO;2-N; Noguchi R, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.19; Okuno Y, 2013, METABOLISM, V62, P1470, DOI 10.1016/j.metabol.2013.05.022; Pedersen MG, 2010, AM J PHYSIOL-ENDOC M, V298, pE597, DOI 10.1152/ajpendo.00670.2009; POLONSKY KS, 1986, J CLIN INVEST, V77, P98, DOI 10.1172/JCI112308; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; Retnakaran R, 2008, OBESITY, V16, P1901, DOI 10.1038/oby.2008.307; Rudovich NN, 2004, DIABETES, V53, P2359, DOI 10.2337/diabetes.53.9.2359; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schofield CJ, 2012, DIABETIC MED, V29, P972, DOI 10.1111/j.1464-5491.2012.03655.x; Silber HE, 2007, J CLIN PHARMACOL, V47, P1159, DOI 10.1177/0091270007304457; Silber HE, 2010, J CLIN PHARMACOL, V50, P246, DOI 10.1177/0091270009341185; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; Thomaseth K, 1996, AM J PHYSIOL-ENDOC M, V270, pE522, DOI 10.1152/ajpendo.1996.270.3.E522; Toffolo G, 2006, AM J PHYSIOL-ENDOC M, V290, pE169, DOI 10.1152/ajpendo.00473.2004; TOFFOLO G, 1995, DIABETES, V44, P845, DOI 10.2337/diabetes.44.7.845; Toffolo G, 2001, AM J PHYSIOL-ENDOC M, V280, pE2, DOI 10.1152/ajpendo.2001.280.1.E2; Toyoshima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1745; VOLUND A, 1987, DIABETES, V36, P1195, DOI 10.2337/diabetes.36.10.1195; Watanabe RM, 1998, AM J PHYSIOL-ENDOC M, V274, pE172, DOI 10.1152/ajpendo.1998.274.1.E172	56	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143880	10.1371/journal.pone.0143880	http://dx.doi.org/10.1371/journal.pone.0143880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26623647	gold, Green Published, Green Submitted			2022-12-26	WOS:000365891600063
J	Drotz, MK; Brodin, T; Nilsson, AN				Drotz, Marcus K.; Brodin, Tomas; Nilsson, Anders N.			Changing Names with Changed Address: Integrated Taxonomy and Species Delimitation in the Holarctic Colymbetes paykulli Group (Coleoptera: Dytiscidae)	PLOS ONE			English	Article							DIVING BEETLES; AGABUS-BIPUSTULATUS; SPECIATION; DISPERSAL; PATTERNS; COMPLEX; DIVERSIFICATION; EVOLUTION	Species delimitation of geographically isolated forms is a long-standing problem in less studied insect groups. Often taxonomic decisions are based directly on morphologic variation, and lack a discussion regarding sample size and the efficiency of migration barriers or dispersal/migration capacity of the studied species. These problems are here exemplified in a water beetle complex from the Bering Sea region that separates North America from Eurasia. Only a few sampled specimens occur from this particular area and they are mostly found in museum and private collections. Here we utilize the theory of integrated taxonomy to discuss the speciation of the Holarctic Colymbetes paykulli water beetle complex, which historically has included up to five species of which today only two are recognized. Three delimitation methods are used; landmark based morphometry of body shape, variation in reticulation patterns of the pronotum exo-skeleton and sequence variation of the partial mitochondrial gene Cyt b. Our conclusion is that the Palearctic and Nearctic populations of C. paykulli are given the status of separate species, based on the fact that all methods showed significant separation between populations. As a consequence the name of the Palearctic species is C. paykulli Erichson and the Nearctic species should be known as C. longulus LeConte. There is no clear support for delineation between Palearctic and Nearctic populations of C. dahuricus based on mtDNA. However, significant difference in size and reticulation patterns from the two regions is shown. The combined conclusion is that the C. dahuricus complex needs a more thorough investigation to fully disentangle its taxonomic status. Therefore it is here still regarded as a Holarctic species. This study highlights the importance to study several diagnosable characters that has the potential to discriminate evolutionary lineage during speciation.	[Drotz, Marcus K.] Lake Vanern Museum Nat & Cultural Hist, Lidkoping, Vastra Gotaland, Sweden; [Brodin, Tomas; Nilsson, Anders N.] Umea Univ, Dept Ecol & Environm Sci, Umea, Vasterbotten, Sweden	Umea University	Drotz, MK (corresponding author), Lake Vanern Museum Nat & Cultural Hist, Lidkoping, Vastra Gotaland, Sweden.	marcus.drotz@lidkoping.se		Brodin, Tomas/0000-0003-1086-7567	Kungl. Fysiografiska Sallskapet; Nilson Ehle Fond	Kungl. Fysiografiska Sallskapet; Nilson Ehle Fond	This research project was partially sponsored by the Kungl. Fysiografiska Sallskapet (http://www.fysiografen.se/default.asp) and Nilson Ehle Fond (material and analysis costs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Andersson J, 2005, BIOL J LINN SOC, V85, P341, DOI 10.1111/j.1095-8312.2005.00501.x; Arnqvist G, 1998, ACTA ZOOL ACAD SCI H, V44, P73; Aube C., 1836, ICONOGRAPHIE HIST NA, V5, P1836; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1983, MOL BIOL EVOL, V1, P38; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; BILTON DT, 1992, HEREDITY, V69, P503, DOI 10.1038/hdy.1992.165; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; COOPER SJB, 1995, MOL ECOL, V4, P49, DOI 10.1111/j.1365-294X.1995.tb00191.x; Crotch GR, 1873, T AM ENTOMOL SOC, V4, P383; Davy-Bowker John, 2002, Aquatic Ecology, V36, P435, DOI 10.1023/A:1016550127986; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Cock R, 2000, BELG J ZOOL, V130, P93; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; deQueiroz K, 1997, Q REV BIOL, V72, P3, DOI 10.1086/419656; Derycke S, 2008, ZOOL J LINN SOC-LOND, V152, P1, DOI 10.1111/j.1096-3642.2007.00365.x; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Drotz MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031381; Drotz MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009034; Drotz MK, 2003, BIOL J LINN SOC, V79, P653, DOI 10.1046/j.1095-8312.2003.00214.x; Drotz MK, 2001, BIOL J LINN SOC, V73, P11, DOI 10.1006/bijl.2001.0491; Drovetski SV, 2004, P ROY SOC B-BIOL SCI, V271, P545, DOI 10.1098/rspb.2003.2638; Eldredge N., 1980, P1; Enghoff H, 1995, CLADISTICS, V11, P223, DOI 10.1016/0748-3007(95)90014-4; Erichson WF, 1837, KAFER MARK BRANDENBU; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gemminger M, 1868, CATALOGUE COLEOPTERO, VII; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Johansson F, 2006, ICHTHYOL RES, V53, P63, DOI 10.1007/s10228-005-0316-0; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koehler AVA, 2007, J PARASITOL, V93, P1070, DOI 10.1645/GE-1182R.1; LARSON D J, 1975, Quaestiones Entomologicae, V11, P245; Larson D. J., 2000, PREDACEOUS DIVING BE; LeConte JL, 1862, P ACAD NAT SCI PHILA, V14, P521; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Lundkvist E, 2002, ANN ZOOL FENN, V39, P109; Lundmark M, 2001, INSECT SYST EVOL, V32, P241, DOI 10.1163/187631201X00182; Maklin F. G., 1853, B SOC IMPERIALE NATU, V26, P95; Manley WF, 2002, POSTGLACIAL FLOODING; Mayden R. L., 1997, V54, P381; Mayr E., 1942, P1; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Moriniere J, 2015, CLADISTICS, V31, P166, DOI 10.1111/cla.12074; NILSSON A N, 1985, Notulae Entomologicae, V65, P137; Nilsson AN, 2007, AQUAT INSECT, V29, P159, DOI 10.1080/01650420701383136; Nixon K, 1999, WINCLADA VER 0 9 99M; Preacher JK, 2001, CALCULATION CHI SQUA; Ribera I, 1995, CAN J ZOOL, V73, P2343, DOI 10.1139/z95-275; Ribera I, 2004, MOL ECOL, V13, P179, DOI 10.1046/j.1365-294X.2003.02035.x; Rohlf FJ, 2003, SYST BIOL, V52, P66, DOI 10.1080/10635150390132759; Rohlf JF, 1998, RELATIVE WARPS VERSI; Rohlf JF, 1993, CONTRIBUTIONS MORPHO; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Sharp D., 1882, Transactions Dublin Soc, V(2), P179; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stow DA, 2004, REMOTE SENS ENVIRON, V89, P281, DOI 10.1016/j.rse.2003.10.018; Suselbeck G., 1987, THESIS; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; von Dohlen CD, 2002, MOL PHYLOGENET EVOL, V23, P257, DOI 10.1016/S1055-7903(02)00025-8; von Paykull G, 1798, FAUNA SUECICA INSECT; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; ZIMMERMAN J R, 1981, Coleopterists Bulletin, V35, P1; ZIMMERMANN A, 1920, COLEOPTERORUM CATALO, V4; Zimmermann A, 1919, ARCH NATURGESCH, V83A, P68	76	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143577	10.1371/journal.pone.0143577	http://dx.doi.org/10.1371/journal.pone.0143577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619278	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800050
J	Martin, V; Pascual, E; Avia, M; Pena, L; Valcarcel, F; Sevilla, N				Martin, Veronica; Pascual, Elena; Avia, Miguel; Pena, Lourdes; Valcarcel, Felix; Sevilla, Noemi			Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses	PLOS ONE			English	Article							IMMUNE-RESPONSE; SEROTYPE 8; CAPSID PROTEIN; I IFN; VP2; EXPRESSION; NEUTRALIZATION; PURIFICATION; GENERATION; DETERMINES	Bluetongue virus (BTV) is an economically important Orbivirus of the Reoviridae family that causes a hemorrhagic disease in ruminants. Its control has been achieved by inactivated-vaccines that have proven to protect against homologous BTV challenge although unable to induce long-term immunity. Therefore, a more efficient control strategy needs to be developed. Recombinant adenovirus vectors are lead vaccine candidates for protection of several diseases, mainly because of their potency to induce potent T cell immunity. Here we report the induction of humoral and T-cell mediated responses able to protect animals against BTV challenge by recombinant replication-defective human adenovirus serotype 5 (Ad5) expressing either VP7, VP2 or NS3 BTV proteins. First we used the IFNAR((-/-)) mouse model system to establish a proof of principle, and afterwards we assayed the protective efficacy in sheep, the natural host of BTV. Mice were completely protected against BTV challenge, developing humoral and BTV-specific CD8(+)- and CD4(+)-T cell responses by vaccination with the different rAd5. Sheep vaccinated with Ad5-BTV-VP2 and Ad5-BTV-VP7 or only with Ad5-BTV-VP7 and challenged with BTV showed mild disease symptoms and reduced viremia. This partial protection was achieved in the absence of neutralizing antibodies but strong BTV-specific CD8(+) T cell responses in those sheep vaccinated with Ad5-BTV-VP7. These data indicate that rAd5 is a suitable vaccine vector to induce T cell immunity during BTV vaccination and provide new data regarding the relevance of T cell responses in protection during BTV infection.	[Martin, Veronica; Pascual, Elena; Avia, Miguel; Pena, Lourdes; Valcarcel, Felix; Sevilla, Noemi] Inst Nacl Invest Agr & Alimentaria, Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Sevilla, N (corresponding author), Inst Nacl Invest Agr & Alimentaria, Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain.	sevilla@inia.es	Martin, Veronica/M-9641-2019; Martín, Verónica/H-2776-2015; Sevilla, Noemi/K-8648-2014; Valcarcel, Felix/Y-3386-2019	Martin, Veronica/0000-0003-1486-1656; Martín, Verónica/0000-0003-1486-1656; Sevilla, Noemi/0000-0003-0118-0376; Valcarcel, Felix/0000-0001-5609-0496	Ministerio de Economia y Competitividad [AGL212-33289, AGL2011-25025]; PLATESA from Comunidad Automoma de Madrid [S2013/ABI-2906]; Ministerio de Ciencia e Innovacion [RyC2010-06516]	Ministerio de Economia y Competitividad(Spanish Government); PLATESA from Comunidad Automoma de Madrid; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by AGL212-33289 (NS) and AGL2011-25025 (VM) from Ministerio de Economia y Competitividad. PLATESA (S2013/ABI-2906) from Comunidad Automoma de Madrid (NS). RyC2010-06516 from Ministerio de Ciencia e Innovacion (VM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2014, CLIN VACCINE IMMUNOL, V21, P443, DOI 10.1128/CVI.00776-13; ANDREW M, 1995, VET IMMUNOL IMMUNOP, V47, P311, DOI 10.1016/0165-2427(94)05410-T; Batten CA, 2008, VIRUS RES, V137, P56, DOI 10.1016/j.virusres.2008.05.016; Boone JD, 2007, VACCINE, V25, P672, DOI 10.1016/j.vaccine.2006.08.025; Bouet-Cararo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111605; Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027; Calvo-Pinilla E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005171; Caporale M, 2014, J VIROL, V88, P10399, DOI 10.1128/JVI.01641-14; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Frenz T, 2010, EUR J IMMUNOL, V40, P2769, DOI 10.1002/eji.201040453; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hamers C, 2009, VET REC, V165, P369, DOI 10.1136/vr.165.13.369; HUISMANS H, 1987, VIROLOGY, V157, P172, DOI 10.1016/0042-6822(87)90326-6; INUMARU S, 1987, VIROLOGY, V157, P472, DOI 10.1016/0042-6822(87)90289-3; Jabbar TK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060574; Janardhana V, 1999, RES VET SCI, V67, P213, DOI 10.1053/rvsc.1999.0306; JEGGO MH, 1984, RES VET SCI, V36, P81, DOI 10.1016/S0034-5288(18)32007-1; JEGGO MH, 1984, IMMUNOLOGY, V52, P403; Jones LD, 1996, J GEN VIROL, V77, P997, DOI 10.1099/0022-1317-77-5-997; Kastenmuller K, 2011, J CLIN INVEST, V121, P1782, DOI 10.1172/JCI45416; Kochinger S, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-64; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lobato ZIP, 1997, VET IMMUNOL IMMUNOP, V59, P293, DOI 10.1016/S0165-2427(97)00084-6; Ma GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034425; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; MACLACHLAN N J, 1985, P79; Maclachlan NJ, 2014, VIRUS RES, V182, P71, DOI 10.1016/j.virusres.2013.09.040; Matsuo E, 2011, J VIROL, V85, P10213, DOI 10.1128/JVI.05412-11; Mellor PS, 2009, BIOL ANIM INFECT, P1; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Quinn KM, 2015, J CLIN INVEST, V125, P1129, DOI 10.1172/JCI78280; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Rojas JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101226; Rojas JM, 2014, VACCINE, V32, P393, DOI 10.1016/j.vaccine.2013.11.033; Rojas JM, 2011, VACCINE, V29, P6848, DOI 10.1016/j.vaccine.2011.07.061; Roy P, 2005, ADV VIRUS RES, V64, P69, DOI 10.1016/S0065-3527(05)64004-3; Sambrook J., 2001, MOL CLONING LAB MANU; Savini G, 2008, COMP IMMUNOL MICROB, V31, P101, DOI 10.1016/j.cimid.2007.07.006; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Stott J L, 1979, Proc Annu Meet U S Anim Health Assoc, P55; STOTT JL, 1985, AM J VET RES, V46, P1043; Szmaragd C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009353; TAKAMATSU H, 1989, IMMUNOLOGY, V66, P258; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Umeshappa CS, 2010, VACCINE, V28, P2522, DOI 10.1016/j.vaccine.2010.01.039; van Rijn PA, 2012, J VET DIAGN INVEST, V24, P469, DOI 10.1177/1040638712440986; WadeEvans AM, 1996, VIROLOGY, V220, P227, DOI 10.1006/viro.1996.0306; WHITE JR, 1990, J GEN VIROL, V71, P1325, DOI 10.1099/0022-1317-71-6-1325; Wilson WC, 2000, VIRUS RES, V67, P141, DOI 10.1016/S0168-1702(00)00138-6; Zhang X, 2010, P NATL ACAD SCI USA, V107, P6292, DOI 10.1073/pnas.0913403107	52	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143273	10.1371/journal.pone.0143273	http://dx.doi.org/10.1371/journal.pone.0143273			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619062	Green Submitted, gold, Green Published			2022-12-26	WOS:000365889800030
J	Sun, HL; Pei, D; Lue, KH; Chen, YL				Sun, Hai-Lun; Pei, Dee; Lue, Ko-Huang; Chen, Yen-Lin			Uric Acid Levels Can Predict Metabolic Syndrome and Hypertension in Adolescents: A 10-Year Longitudinal Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; NEW-ONSET; CHILDREN; HYPERURICEMIA; RISK; OBESITY	The relationships between uric acid and chronic disease risk factors such as metabolic syndrome, type 2 diabetes mellitus, and hypertension have been studied in adults. However, whether these relationships exist in adolescents is unknown. We randomly selected 8,005 subjects who were between 10 to 15 years old at baseline. Measurements of uric acid were used to predict the future occurrence of metabolic syndrome, hypertension, and type 2 diabetes. In total, 5,748 adolescents were enrolled and followed for a median of 7.2 years. Using cutoff points of uric acid for males and females (7.3 and 6.2 mg/dl, respectively), a high level of uric acid was either the second or third best predictor for hypertension in both genders (hazard ratio: 2.920 for males, 5.222 for females; p<0.05). However, uric acid levels failed to predict type 2 diabetes mellitus, and only predicted metabolic syndrome in males (hazard ratio: 1.658; p<0.05). The same results were found in multivariate adjusted analysis. In conclusion, a high level of uric acid indicated a higher likelihood of developing hypertension in both genders and metabolic syndrome in males after 10 years of follow-up. However, uric acid levels did not affect the occurrence of type 2 diabetes in both genders.	[Sun, Hai-Lun; Lue, Ko-Huang] Chung Shan Med Univ, Sch Med, Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Pei, Dee] Fu Jen Catholic Univ, Sch Med, Cardinal Tien Hosp, Dept Internal Med, New Taipei, Taiwan; [Chen, Yen-Lin] Fu Jen Catholic Univ, Sch Med, Cardinal Tien Hosp, Dept Pathol, New Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Fu Jen Catholic University; Fu Jen Catholic University	Sun, HL (corresponding author), Chung Shan Med Univ, Sch Med, Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan.	sunhailun@yahoo.com.tw; anthonypatho@gmail.com						Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Bombelli M, 2014, J HYPERTENS, V32, P1237, DOI 10.1097/HJH.0000000000000161; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Fu YH, 2015, AGING MALE, V18, P38, DOI 10.3109/13685538.2014.913562; GARBAGNATI E, 1994, METABOLISM, V43, P819, DOI 10.1016/0026-0495(94)90260-7; Garbagnati E, 1996, METABOLISM, V45, P203, DOI 10.1016/S0026-0495(96)90054-2; Ishiro M, 2013, ANN NUTR METAB, V62, P169, DOI 10.1159/000346227; Jiang Y., 2009, Plant Biology (Rockville), V2009, P111; Jolliffe CJ, 2007, J AM COLL CARDIOL, V49, P891, DOI 10.1016/j.jacc.2006.08.065; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Lee K, 2013, METAB SYNDR RELAT D, V11, P229, DOI 10.1089/met.2012.0153; Lee MS, 2007, ASIA PAC J CLIN NUTR, V16, P594; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Loeffler LF, 2012, HYPERTENSION, V59, P811, DOI 10.1161/HYPERTENSIONAHA.111.183244; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; Richette P, 2013, CURR MED RES OPIN, V29, P9, DOI 10.1185/03007995.2013.790801; Sung RYT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-324; Surani SR, 2014, WORLD J DIABETES, V5, P381, DOI 10.4239/wjd.v5.i3.381; Takase H, 2014, J HUM HYPERTENS, V28, P529, DOI 10.1038/jhh.2013.143; Tang L, 2010, PEDIATRIC REP, V2, P38, DOI 10.4081/pr.2010.e12; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wang JY, 2012, J PEDIATR-US, V161, P753, DOI 10.1016/j.jpeds.2012.03.036; Wilcox WD, 1996, J PEDIATR-US, V128, P731, DOI 10.1016/S0022-3476(96)70322-0; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	30	59	68	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143786	10.1371/journal.pone.0143786	http://dx.doi.org/10.1371/journal.pone.0143786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618358	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800070
J	Furtado, MM; Gennari, SM; Ikuta, CY; Jacomo, ATD; de Morais, ZM; Pena, HFD; Porfirio, GED; Silveira, L; Sollmann, R; de Souza, GO; Torres, NM; Neto, JSF				Furtado, Mariana Malzoni; Gennari, Solange Maria; Ikuta, Cassia Yumi; de Almeida Jacomo, Anah Tereza; de Morais, Zenaide Maria; de Jesus Pena, Hilda Fatima; de Oliveira Porfirio, Grasiela Edith; Silveira, Leandro; Sollmann, Rahel; de Souza, Gisele Oliveira; Torres, Natalia Mundim; Ferreira Neto, Jose Soares			Serosurvey of Smooth Brucella, Leptospira spp. and Toxoplasma gondii in Free-Ranging Jaguars (Panthera onca) and Domestic Animals from Brazil	PLOS ONE			English	Article							FREE-LIVING JAGUARS; NEOSPORA-CANINUM; MATO-GROSSO; DAIRY-CATTLE; ANTIBODIES; SEROPREVALENCE; ZOO; PREVALENCE; INFECTION; ABORTUS	This study investigated the exposure of jaguar populations and domestic animals to smooth Brucella, Leptospira spp. and Toxoplasma gondii in the Cerrado, Pantanal and Amazon biomes of Brazil. Between February 2000 and January 2010, serum samples from 31 jaguars (Panthera onca), 1,245 cattle (Bos taurus), 168 domestic dogs (Canis lupus familiaris) and 29 domestic cats (Felis catus) were collected and analysed by rose bengal test for smooth Brucella, microscopic agglutination test for Leptospira spp. and modified agglutination test for T. gondii. Cattle populations from all sites (9.88%) were exposed to smooth Brucella, but only one jaguar from Cerrado was exposed to this agent. Jaguars captured in the Cerrado (60.0%) and in the Pantanal (45.5%) were seropositive for different serovars of Leptospira spp., cattle (72.18%) and domestic dogs (13.1%) from the three sites and one domestic cat from Pantanal were also seropositive for the agent. The most prevalent serotype of Leptospira spp. identified in jaguars from the Cerrado (Grippotyphosa) and the Pantanal (Pomona) biomes were distinct from those found in the domestic animals sampled. Jaguars (100%), domestic dogs (38.28%) and domestic cats (82.76%) from the three areas were exposed to T. gondii. Our results show that brucellosis and leptospirosis could have been transmitted to jaguars by domestic animals; and jaguars probably play an important role in the maintenance of T. gondii in nature.	[Furtado, Mariana Malzoni; de Almeida Jacomo, Anah Tereza; Silveira, Leandro; Sollmann, Rahel; Torres, Natalia Mundim] Inst Onca Pintada, Jaguar Conservat Fund, Mineiros, Go, Brazil; [Furtado, Mariana Malzoni; Gennari, Solange Maria; Ikuta, Cassia Yumi; de Morais, Zenaide Maria; de Jesus Pena, Hilda Fatima; de Souza, Gisele Oliveira; Ferreira Neto, Jose Soares] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, Sao Paulo, Brazil; [de Oliveira Porfirio, Grasiela Edith] Univ Catolica Dom Bosco, Programa Posgrad Ciencias Ambientais & Sustentabi, Campo Grande, MS, Brazil; [Torres, Natalia Mundim] Univ Fed Uberlandia, Inst Ciencias Biomed, Inst Biol, BR-38400 Uberlandia, MG, Brazil	Universidade de Sao Paulo; Universidade Catolica Dom Bosco (UCDB); Universidade Federal de Uberlandia	Furtado, MM (corresponding author), Inst Onca Pintada, Jaguar Conservat Fund, Mineiros, Go, Brazil.	marianafurtado@jaguar.org.br	Furtado, Mariana/ABH-2648-2021; Ikuta, Cassia Y/I-3797-2012; Neto, José Soares Ferreira/H-5082-2017; Porfirio, Grasiela/F-3353-2019	Ikuta, Cassia Y/0000-0002-8543-5219; Neto, José Soares Ferreira/0000-0002-1286-6245; Porfirio, Grasiela/0000-0003-0837-7489; Furtado, Mariana Malzoni/0000-0001-5147-7202; Torres, Natalia Mundim/0000-0001-7123-5112; Gennari, Solange/0000-0001-7500-5277	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2007/50941-5, 2007/50942-1]; Fundacao Monsanto; Earthwatch Institute; Memphis Zoo; FAPESP	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Monsanto; Earthwatch Institute; Memphis Zoo; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study received financial support from the following: 1) FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo): Process no 2007/50941-5; www.fapesp.br; financial support to data collection and analysis (JSFN). 2) Fundacao Monsanto: www.monsanto.com/global/br/quemsomos/pages/fundacao-monsanto.aspx; financial support to data collection (LS). 3) Earthwatch Institute: www.earthwatch.org; financial support to data collection (LS). 4) The Memphis Zoo: www.memphiszoo.org; financial support to data collection (LS). 5) FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Process no 2007/50942-1): MF received a scholarship from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha PN, 1986, ZOONOSIS ENFERMIDADE; Acha PN, 2001, ZOONOSES COMMUNICABL; Almeida A. B. P. F., 2013, International Zoo Yearbook, V47, P204, DOI 10.1111/j.1748-1090.2012.00188.x; Alvarado-Esquivel C, 2013, J ZOO WILDLIFE MED, V44, P803, DOI 10.1638/2013-0032.1; Bengis RG, 2002, REV SCI TECH OIE, V21, P53; Brasil. Ministerio da Agricultura Pecuaria e Abastecimento, 2006, PROGR NAC CONTR ERR; CamargO M. E., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P117; Carletti R. T., 2002, 29 C BRAS MED VET GR, P60; Cavalcante GT, 2006, J PARASITOL, V92, P863, DOI 10.1645/GE-830R.1; Correa SHR, 2000, THESIS; Correa SHR, 2006, TRATADO ANIMALS SELV, P358; Davis D. S., 1990, Animal brucellosis., P321; de Camps S, 2008, J PARASITOL, V94, P648, DOI 10.1645/GE-1453.1; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Demar M, 2008, AM J TROP MED HYG, V78, P195, DOI 10.4269/ajtmh.2008.78.195; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; DUBEY JP, 1995, J PARASITOL, V81, P723, DOI 10.2307/3283961; DUBEY JP, 1986, FELINE PRACT, V16, P12; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Faine S., 1982, GUIDELINES CONTROL L; FERNANDES W. J., 1972, Revista de Patologia Tropical, V1, P259; Figueiredo AD, 2009, PESQUI VET BRASIL, V29, P375, DOI 10.1590/S0100-736X2009000500003; FORBES LB, 1990, J AM VET MED ASSOC, V196, P911; Furtado Mariana M., 2008, Cat News, P41; Guerra Neto G, 2004, ARS VET, V20, P75; Hill NJ, 2008, VET PARASITOL, V152, P202, DOI 10.1016/j.vetpar.2008.01.002; Innes EA, 2010, ZOONOSES PUBLIC HLTH, V57, P1, DOI 10.1111/j.1863-2378.2009.01276.x; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Kamga-Waladjo AR, 2009, ASIAN J ANIM VET ADV, V4, P346, DOI 10.3923/ajava.2009.346.349; LANGONI H., 1999, REV ED CONT CRMV SP, V2, P52; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lilenbaum W, 2004, VET J, V168, P191, DOI 10.1016/S1090-0233(03)00139-4; Lindsay DS, 1997, COMP CONT EDUC PRACT, V19, P448; Marques JM, 2009, SEMIN-CIENC AGRAR, V30, P889; Onuma SSM, 2014, REV BRAS PARASITOL V, V23, P547, DOI [10.1590/S1984-29612014077, 10.1590/s1984-29612014077]; Munoz PM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-46; Murray DL, 1999, ANIM CONSERV, V2, P241, DOI 10.1111/j.1469-1795.1999.tb00070.x; Nava AFD, 2008, THESIS; Ogawa L, 2005, ARQ BRAS MED VET ZOO, V57, P312, DOI 10.1590/S0102-09352005000300006; OLIVARES R, 1993, ARCH MED VET, V25, P101; Onuma SSM, 2015, REV INST MED TROP SP, V57, P177, DOI 10.1590/S0036-46652015000200014; Paterson S, 2003, TRENDS PARASITOL, V19, P370, DOI 10.1016/S1471-4922(03)00149-1; Paulin LM, 2003, COMBATE BRUCELOSE BO; Pimentel JS, 2009, PESQUISA VET BRASIL, V29, P1009, DOI 10.1590/S0100-736X2009001200010; Jorge RSP, 2011, MEM I OSWALDO CRUZ, V106, P441, DOI 10.1590/S0074-02762011000400009; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rivetti AV, 2008, ARQ BRAS MED VET ZOO, V60, P1281, DOI 10.1590/S0102-09352008000500038; Santos SL, 2010, PARASITOL RES, V106, P457, DOI 10.1007/s00436-009-1686-4; Santos TR, 2009, VET PARASITOL, V161, P324, DOI 10.1016/j.vetpar.2009.01.017; SCOTT M E, 1988, Conservation Biology, V2, P40, DOI 10.1111/j.1523-1739.1988.tb00334.x; SHOPHET R, 1980, BRIT VET J, V136, P265, DOI 10.1016/S0007-1935(17)32291-1; Silva JCR, 2001, VET PARASITOL, V102, P217, DOI 10.1016/S0304-4017(01)00523-4; Smith KF, 2009, ECOHEALTH, V6, P287, DOI 10.1007/s10393-009-0254-9; Soule ME, CONTINENTAL CONSERVA, P17; Spagnol FH, 2009, REV BRAS PARASITOL V, V18, P42, DOI 10.4322/rbpv.01802009; Spencer JA, 2003, J ZOO WILDLIFE MED, V34, P246, DOI 10.1638/02-046; Thorne E. Tom, 2001, P372, DOI 10.1002/9780470344880.ch22; Vijayachari P, 2008, J BIOSCIENCES, V33, P557, DOI 10.1007/s12038-008-0074-z	59	21	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143816	10.1371/journal.pone.0143816	http://dx.doi.org/10.1371/journal.pone.0143816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605787	gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300113
J	LeJeune, TM; Tsui, HY; Parsons, LB; Miller, GE; Whitted, C; Lynch, KE; Ramsauer, RE; Patel, JU; Wyatt, JE; Street, DS; Adams, CB; McPherson, B; Tsui, HM; Evans, JA; Livesay, C; Torrenegra, RD; Palau, VE				LeJeune, Timothy M.; Tsui, Hei Yin; Parsons, Laura B.; Miller, Gerald E.; Whitted, Crystal; Lynch, Kayla E.; Ramsauer, Robert E.; Patel, Jasmine U.; Wyatt, Jarrett E.; Street, Doris S.; Adams, Carolyn B.; McPherson, Brian; Tsui, Hei Man; Evans, Julie A.; Livesay, Christopher; Torrenegra, Ruben D.; Palau, Victoria E.			Mechanism of Action of Two Flavone Isomers Targeting Cancer Cells with Varying Cell Differentiation Status	PLOS ONE			English	Article							MITOCHONDRIAL DAMAGE; CURCUMIN ANALOG; STEM-CELLS; C-JUN; DEATH; PHOSPHORYLATION; ACTIVATION; BAD; GEMCITABINE; CASPASES	Apoptosis can be triggered in two different ways, through the intrinsic or the extrinsic pathway. The intrinsic pathway is mediated by the mitochondria via the release of cytochrome C while the extrinsic pathway is prompted by death receptor signals and bypasses the mitochondria. These two pathways are closely related to cell proliferation and survival signaling cascades, which thereby constitute possible targets for cancer therapy. In previous studies we introduced two plant derived isomeric flavonoids, flavone A and flavone B which induce apoptosis in highly tumorigenic cancer cells of the breast, colon, pancreas, and the prostate. Flavone A displayed potent cytotoxic activity against more differentiated carcinomas of the colon (CaCo-2) and the pancreas (Panc28), whereas flavone B cytotoxic action is observed on poorly differentiated carcinomas of the colon (HCT 116) and pancreas (MIA PaCa). Apoptosis is induced by flavone A in better differentiated colon cancer CaCo-2 and pancreatic cancer Panc 28 cells via the intrinsic pathway by the inhibition of the activated forms of extracellular signal-regulated kinase (ERK) and pS6, and subsequent loss of phosphorylation of Bcl-2 associated death promoter (BAD) protein, while apoptosis is triggered by flavone B in poorly differentiated colon cancer HCT 116 and MIA PaCa pancreatic cancer cells through the extrinsic pathway with the concomitant upregulation of the phosphorylated forms of ERK and c-JUN at serine 73. These changes in protein levels ultimately lead to activation of apoptosis, without the involvement of AKT.	[LeJeune, Timothy M.; Tsui, Hei Yin; Parsons, Laura B.; Miller, Gerald E.; Whitted, Crystal; Lynch, Kayla E.; Ramsauer, Robert E.; Patel, Jasmine U.; Wyatt, Jarrett E.; Street, Doris S.; Adams, Carolyn B.; McPherson, Brian; Tsui, Hei Man; Evans, Julie A.; Livesay, Christopher] E Tennessee State Univ, Bill Gatton Coll Pharm, Johnson City, TN 37614 USA; [Torrenegra, Ruben D.] Univ Ciencias Aplicadas & Ambientales, Bogota, Colombia; [Palau, Victoria E.] E Tennessee State Univ, Div Hematol Oncol, Dept Internal Med, James Quillen Coll Med, Johnson City, TN 37614 USA; [Palau, Victoria E.] E Tennessee State Univ, Dept Pharmaceut Sci, Bill Gatton Coll Pharm, Johnson City, TN 37614 USA	East Tennessee State University; East Tennessee State University; East Tennessee State University	Palau, VE (corresponding author), E Tennessee State Univ, Div Hematol Oncol, Dept Internal Med, James Quillen Coll Med, Johnson City, TN 37614 USA.	palauv@etsu.edu	GUERRERO, RUBEN D TORRENEGRA/W-9018-2019; Palau, Victoria/F-3520-2012	Palau, Victoria/0000-0003-2761-7003; U.D.C.A, Universidad de Ciencias Aplicadas y Ambientales/0000-0002-2291-5354	Department of Pharmaceutical Sciences at East Tennessee State University Gatton College of Pharmacy; East Tennessee State University Research Development Committee Major Grants Program [82171]; Chemistry Department at Universidad de Ciencias Aplicadas y Ambientales	Department of Pharmaceutical Sciences at East Tennessee State University Gatton College of Pharmacy; East Tennessee State University Research Development Committee Major Grants Program; Chemistry Department at Universidad de Ciencias Aplicadas y Ambientales	This work was funded by the Department of Pharmaceutical Sciences at East Tennessee State University Gatton College of Pharmacy (http://www.etsu.edu/pharmacy/), grant 82171 from the East Tennessee State University Research Development Committee Major Grants Program (http://www.etsu.edu/research/rdc/) and the Chemistry Department at Universidad de Ciencias Aplicadas y Ambientales (http://www.udca.edu.co/).	Chiang LC, 2006, CANCER LETT, V237, P207, DOI 10.1016/j.canlet.2005.06.002; Choudhary MI, 2008, PHYTOCHEMISTRY, V69, P1880, DOI 10.1016/j.phytochem.2008.03.011; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Dandawate PR, 2012, PHARM RES-DORDR, V29, P1775, DOI 10.1007/s11095-012-0700-1; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Garcia-Barriga H., 1975, FLORA MED COLOMBIA B; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Gonzalez-Vallinas M, 2013, PHARMACOL RES, V72, P61, DOI 10.1016/j.phrs.2013.03.010; Hansel R, PHYTOCHEMISTRY; Javed H, 2012, NEUROSCIENCE, V210, P340, DOI 10.1016/j.neuroscience.2012.02.046; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kale A, 2008, PHYTOTHER RES, V22, P567, DOI 10.1002/ptr.2283; Kanadaswami C, 2005, IN VIVO, V19, P895; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lin L, 2011, BRIT J CANCER, V105, P212, DOI 10.1038/bjc.2011.200; Lopez-Lazaro M, 2002, Curr Med Chem Anticancer Agents, V2, P691; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Madeo A, 2010, ONCOGENE, V29, P978, DOI 10.1038/onc.2009.400; Neumeister V, 2010, AM J PATHOL, V176, P2131, DOI 10.2353/ajpath.2010.090712; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Pfister AB, 2010, J CELL BIOCHEM, V111, P643, DOI 10.1002/jcb.22754; Philchenkov A, 2004, EXP ONCOL, V26, P82; Rathos MJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-161; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Suzgec S, 2005, FITOTERAPIA, V76, P269, DOI 10.1016/j.fitote.2004.12.006; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039806; TOMASLORENTE F, 1989, PHYTOCHEMISTRY, V28, P1613, DOI 10.1016/S0031-9422(00)97809-9; TORRENEGRA RD, 1980, PHYTOCHEMISTRY, V19, P2795, DOI 10.1016/S0031-9422(00)83978-3; Torrenegra RD, 1982, REV LATINOAM QUIM, V13, P75; Torrenegra RD, 1987, REV LATINOAMERICANA, V18, P116; Tseng Tsui-Hwa, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P347, DOI 10.2174/187152006777698150; van Delft MF, 2010, CELL DEATH DIFFER, V17, P821, DOI 10.1038/cdd.2009.166; VANPUYVELDE L, 1989, J NAT PROD, V52, P629, DOI 10.1021/np50063a025; Vinciguerr M, 2008, INT J BIOCHEM CELL B, V40, P307, DOI 10.1016/j.biocel.2007.08.001; Jaime MFV, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-245; Visus C, 2011, CLIN CANCER RES, V17, P6174, DOI 10.1158/1078-0432.CCR-11-1111; Wachmann K, 2010, BIOCHEMISTRY-US, V49, P8307, DOI 10.1021/bi100968m; Wang HK, 2000, EXPERT OPIN INV DRUG, V9, P2103, DOI 10.1517/13543784.9.9.2103; Xiong HP, 2009, ACTA CRYSTALLOGR E, V65, pO3277, DOI 10.1107/S1600536809050715; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yeo D, 2014, CANCER LETT, V346, P264, DOI 10.1016/j.canlet.2014.01.001; Zandi K, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-214	45	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142928	10.1371/journal.pone.0142928	http://dx.doi.org/10.1371/journal.pone.0142928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606169	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300036
J	Nozako, M; Koyama, T; Nagano, C; Sato, M; Matsumoto, S; Mitani, K; Yasufuku, R; Kohashi, M; Yoshikawa, T				Nozako, Masanori; Koyama, Takashi; Nagano, Chifumi; Sato, Makoto; Matsumoto, Satoshi; Mitani, Kiminobu; Yasufuku, Reiko; Kohashi, Masayuki; Yoshikawa, Tomohiro			An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF Rats	PLOS ONE			English	Article							INJURY MOLECULE-1 EXPRESSION; ACUTE KIDNEY INJURY; OXIDATIVE STRESS; RENAL INJURY; ATHEROSCLEROSIS; CHOLESTEROL; MURINE; LIVER; RISK; PATHOPHYSIOLOGY	Diabetic nephropathy develops in association with hyperglycemia, is aggravated by atherogenic factors such as dyslipidemia, and is sometimes initiated before obvious hyperglycemia is seen. However, the precise mechanisms of progression are still unclear. In this study, we investigated the influence of an atherogenic Paigen diet (PD) on the progression of nephropathy in spontaneous type 2 diabetic OLETF rats. Feeding PD to male OLETF rats for 12 weeks caused an extensive increase in excretion of urinary albumin and markers of tubular injury such as KIM-1 and L-FABP, accompanied by mesangial expansion and tubular atrophy. PD significantly increased plasma total cholesterol concentration, which correlates well with increases in urine albumin excretion and mesangial expansion. Conversely, PD did not change plasma glucose and free fatty acid concentrations. PD enhanced renal levels of mRNA for inflammatory molecules such as KIM-1, MCP-1, TLR4 and TNF-alpha and promoted macrophage infiltration and lipid accumulation in the tubulointerstitium and glomeruli in OLETF rats. Intriguingly, PD had little effect on urine albumin excretion and renal morphology in normal control LETO rats. This model may be useful in studying the complex mechanisms that aggravate diabetic nephropathy in an atherogenic environment.	[Nozako, Masanori; Koyama, Takashi; Nagano, Chifumi; Mitani, Kiminobu; Yasufuku, Reiko; Kohashi, Masayuki; Yoshikawa, Tomohiro] Otsuka Pharmaceut Co Ltd, Free Rad Res Project, Tokushima, Tokushima 77101, Japan; [Nozako, Masanori; Koyama, Takashi; Nagano, Chifumi; Sato, Makoto; Matsumoto, Satoshi] Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Drug Safety Res Ctr, Dept Toxicol, Tokushima, Tokushima 77101, Japan	Otsuka Pharmaceutical; Otsuka Pharmaceutical	Yoshikawa, T (corresponding author), Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 1, Tokushima, Tokushima 77101, Japan.	yoshikawa.tomohiro.a@otsuka.jp			Otsuka Pharmaceutical Co., Ltd.	Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical)	The authors MN, TK, CN, MS, SM, KM, RY, MK, and TY received funding from Otsuka Pharmaceutical Co., Ltd. The authors have carefully reviewed their statements relating to the author contributions, and ensured that they have specifically and accurately indicated the roles that these authors had in the study. The funder provided support in the form of salaries for authors MN, TK, CN, MS, SM, KM, RY, MK, TY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author contributions" section of the online submission form.	Appel GB, 2003, DIABETES CARE, V26, P1402, DOI 10.2337/diacare.26.5.1402; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Desai MS, 2008, J LEUKOCYTE BIOL, V83, P1336, DOI 10.1189/jlb.0607390; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Gorin Y, 2015, MOL CELLS, V38, P285, DOI 10.14348/molcells.2015.0010; Gunaratnam L, 2009, J AM SOC NEPHROL, V20, P1877, DOI 10.1681/ASN.2008070804; Hashimoto S, 2009, AM J PHYSIOL-RENAL, V296, pF598, DOI 10.1152/ajprenal.00074.2008; Hatamizadeh P, 2013, NAT REV NEPHROL, V9, P99, DOI 10.1038/nrneph.2012.279; Humphreys BD, 2013, J CLIN INVEST, V123, P4023, DOI 10.1172/JCI45361; Ichikawa D, 2014, AM J PHYSIOL-RENAL, V306, pF655, DOI 10.1152/ajprenal.00460.2013; Kamijo A, 2002, KIDNEY INT, V62, P1628, DOI 10.1046/j.1523-1755.2002.00618.x; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Kawano K, 1999, J VET MED SCI, V61, P1219, DOI 10.1292/jvms.61.1219; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; KEESFOLTS D, 1994, KIDNEY INT, V45, P1697, DOI 10.1038/ki.1994.222; Koike T, 2005, ACTA PHYSIOL SCAND, V184, P73, DOI 10.1111/j.1365-201X.2005.01418.x; KROLEWSKI AS, 1994, KIDNEY INT, V45, pS125; Kuwabara T, 2014, CLIN EXP NEPHROL, V18, P584, DOI 10.1007/s10157-013-0922-5; Kuwabara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088942; Lin QZ, 2014, AM J PHYSIOL-RENAL, V306, pF885, DOI 10.1152/ajprenal.00331.2013; Martinez-Castelao A, 2015, J CLIN MED, V4, P1207, DOI 10.3390/jcm4061207; Martini S, 2008, REV ENDOCR METAB DIS, V9, P267, DOI 10.1007/s11154-008-9103-3; Mima A, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/248563; Miyamoto S, 2012, DIABETES, V61, P897, DOI 10.2337/db11-0402; Moore E, 2010, MINERVA ANESTESIOL, V76, P425; Mora-Fernandez C, 2014, J PHYSIOL-LONDON, V592, P3997, DOI 10.1113/jphysiol.2014.272328; Moran TH, 2008, PHYSIOL BEHAV, V94, P71, DOI 10.1016/j.physbeh.2007.11.035; MULEC H, 1993, AM J KIDNEY DIS, V22, P196, DOI 10.1016/S0272-6386(12)70186-5; Nagai Y, 2005, J AM SOC NEPHROL, V16, P703, DOI 10.1681/ASN.2004080649; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nicholas SB, 2010, KIDNEY INT, V77, P588, DOI 10.1038/ki.2009.518; Niimi M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-166; Nosadini R, 2011, NUTR METAB CARDIOVAS, V21, P79, DOI 10.1016/j.numecd.2010.10.002; Okuno S, 2002, DIABETES OBES METAB, V4, P309, DOI 10.1046/j.1463-1326.2002.00217.x; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; Patrakka J, 2007, TRENDS MOL MED, V13, P396, DOI 10.1016/j.molmed.2007.06.006; Qin P, 2005, AM J PHYSIOL-GASTR L, V289, pG267, DOI 10.1152/ajpgi.00043.2005; Rajendran S, 1996, ATHEROSCLEROSIS, V123, P235, DOI 10.1016/0021-9150(96)05813-3; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Shimada M, 1996, P NATL ACAD SCI USA, V93, P7242, DOI 10.1073/pnas.93.14.7242; Tachibana H, 2012, J AM SOC NEPHROL, V23, P1835, DOI 10.1681/ASN.2012010022; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang GQ, 2005, HEPATOLOGY, V42, P871, DOI 10.1002/hep.20857; Wolf G, 2004, EUR J CLIN INVEST, V34, P785, DOI 10.1111/j.1365-2362.2004.01429.x; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yamada T, 2012, EXP DIABETES RES, DOI 10.1155/2012/582546; Yoshida M, 2006, EUR J PHARMACOL, V548, P174, DOI 10.1016/j.ejphar.2006.07.053; Yoshikawa T, 2001, HORM METAB RES, V33, P472, DOI 10.1055/s-2001-16940	52	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143979	10.1371/journal.pone.0143979	http://dx.doi.org/10.1371/journal.pone.0143979			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606054	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300125
J	Sheng, Z; Sun, Y; Zhu, RX; Jiao, N; Tang, KL; Cao, ZW; Ma, C				Sheng, Zhen; Sun, Yi; Zhu, Ruixin; Jiao, Na; Tang, Kailin; Cao, Zhiwei; Ma, Chao			Functional Cross-Talking between Differentially Expressed and Alternatively Spliced Genes in Human Liver Cancer Cells Treated with Berberine	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SEMANTIC SIMILARITY; CYCLE ARREST; R PACKAGE; P53 GENE; APOPTOSIS; PHOSPHORYLATION; ACTIVATION; INDUCTION; PATHWAY	Berberine has been identified with anti-proliferative effects on various cancer cells. Many researchers have been trying to elucidate the anti-cancer mechanisms of berberine based on differentially expressed genes. However, differentially alternative splicing genes induced by berberine might also contribute to its pharmacological actions and have not been reported yet. Moreover, the potential functional cross-talking between the two sets of genes deserves further exploration. In this study, RNA-seq technology was used to detect the differentially expressed genes and differentially alternative spliced genes in BEL-7402 cancer cells induced by berberine. Functional enrichment analysis indicated that these genes were mainly enriched in the p53 and cell cycle signalling pathway. In addition, it was statistically proven that the two sets of genes were locally co-enriched along chromosomes, closely connected to each other based on protein-protein interaction and functionally similar on Gene Ontology tree. These results suggested that the two sets of genes regulated by berberine might be functionally cross-talked and jointly contribute to its cell cycle arresting effect. It has provided new clues for further researches on the pharmacological mechanisms of berberine as well as the other botanical drugs.	[Sheng, Zhen; Sun, Yi; Zhu, Ruixin; Jiao, Na; Tang, Kailin; Cao, Zhiwei; Ma, Chao] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Ma, Chao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cao, ZW (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	zwcao@tongji.edu.cn; silentma@hotmail.com	, 金石为开/AFU-9737-2022; Sheng, Zhen/AAQ-6562-2020	Zhu, Ruixin/0000-0002-5070-6453; Tang, KaiLin/0000-0002-0508-6056	National High Technology Research and Development Program ("863" Program) of China [2012AA020405]; Funding of Ministry of Health [2012ZX10005001]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); Funding of Ministry of Health	This work was supported partially by the National High Technology Research and Development Program ("863" Program) of China (2012AA020405), and the Funding of Ministry of Health (2012ZX10005001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2000, Altern Med Rev, V5, P175; Aschoff M, 2013, BIOINFORMATICS, V29, P1141, DOI 10.1093/bioinformatics/btt101; Attardi LD, 2000, GENE DEV, V14, P704; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Chen JM, ACTA BIOL EXPT SINIC, V11, P37; Choi MS, 2009, INT J ONCOL, V34, P1221, DOI 10.3892/ijo_00000250; Choi MS, 2008, ANTICANCER RES, V28, P3777; De Preter K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn114; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Diamant G, 2013, BBA-GENE REGUL MECH, V1829, P937, DOI 10.1016/j.bbagrm.2013.04.007; Dutertre M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4395; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; ENCODE, 2011, STAND GUID BEST PRAC; Gutierrez-Mariscal FM, 2014, J GERONTOL A-BIOL, V69, P886, DOI 10.1093/gerona/glt174; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hernandez-Vargas H, 2007, BREAST CANCER RES TR, V102, P157, DOI 10.1007/s10549-006-9322-9; Hooper JE, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-3; Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Liu LX, 2003, HEPATO-GASTROENTEROL, V50, P1496; Liu Y, 2010, CELL CYCLE, V9, P3423, DOI 10.4161/cc.9.17.12946; Liu ZJ, 2009, MUTAT RES-FUND MOL M, V662, P75, DOI 10.1016/j.mrfmmm.2008.12.009; Ma C, 2013, CHEM BIOL DRUG DES, V81, P775, DOI 10.1111/cbdd.12124; Mao GY, 2013, J APPL MATH, DOI 10.1155/2013/865643; Montes M, 2012, GENE, V501, P104, DOI 10.1016/j.gene.2012.04.006; Ortiz LMG, 2014, MOLECULES, V19, P12349, DOI 10.3390/molecules190812349; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Ozes ON, 1999, NATURE, V401, P82; Ren Y, 2003, CLIN CANCER RES, V9, P5996; Rigo F, 2008, MOL CELL BIOL, V28, P849, DOI 10.1128/MCB.01410-07; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Shkreta L, 2008, MOL CANCER THER, V7, P1398, DOI 10.1158/1535-7163.MCT-08-0192; Singh RK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-57; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tang JY, 2013, SCI WORLD J, DOI 10.1155/2013/703568; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tillhon M, 2012, BIOCHEM PHARMACOL, V84, P1260, DOI 10.1016/j.bcp.2012.07.018; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Yi HJLH, 2010, SELECTIVE EFFECT BER; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Yang XL, 2013, MOL MED REP, V8, P505, DOI 10.3892/mmr.2013.1506; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zeng YX, 1997, INT J ONCOL, V11, P221	57	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143742	10.1371/journal.pone.0143742	http://dx.doi.org/10.1371/journal.pone.0143742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606055	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300105
J	Terasaki, M; Hiromura, M; Mori, Y; Kohashi, K; Nagashima, M; Kushima, H; Watanabe, T; Hirano, T				Terasaki, Michishige; Hiromura, Munenori; Mori, Yusaku; Kohashi, Kyoko; Nagashima, Masaharu; Kushima, Hideki; Watanabe, Takuya; Hirano, Tsutomu			Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; SMOOTH-MUSCLE; EXPRESSION; ABCG1; RISK; DAPAGLIFLOZIN; TRANSPORTERS; PATHWAY; LESIONS	Direct associations between hyperglycemia and atherosclerosis remain unclear. We investigated the association between the amelioration of glycemia by sodium-glucose cotransporter 2 inhibitors (SGLT2is) and macrophage-driven atherosclerosis in diabetic mice. We administered dapagliflozin or ipragliflozin (1.0 mg/kg/day) for 4-weeks to apolipoprotein E-null (Apoe(-/-)) mice, streptozotocin-induced diabetic Apoe(-/-) mice, and diabetic db/db mice. We then determined aortic atherosclerosis, oxidized low-density lipoprotein (LDL)-induced foam cell formation, and related gene expression in exudate peritoneal macrophages. Dapagliflozin substantially decreased glycated hemoglobin (HbA1c) and glucose tolerance without affecting body weight, blood pressure, plasma insulin, and lipids in diabetic Apoe(-/-) mice. Aortic atherosclerotic lesions, atheromatous plaque size, and macrophage infiltration in the aortic root increased in diabetic Apoe(-/-) mice; dapagliflozin attenuated these changes by 33%, 27%, and 20%, respectively. Atherosclerotic lesions or foam cell formation highly correlated with HbA1c. Dapagliflozin did not affect atherosclerosis or plasma parameters in non-diabetic Apoe(-/-) mice. In db/db mice, foam cell formation increased by 4-fold compared with C57/BL6 mice, whereas ipragliflozin decreased it by 31%. Foam cell formation exhibited a strong correlation with HbA1c. Gene expression of lectin-like ox-LDL receptor-1 and acyl-coenzyme A: cholesterol acyltransferase 1 was upregulated, whereas that of ATP-binding cassette transporter A1 was downregulated in the peritoneal macrophages of both types of diabetic mice. SGLT2i normalized these gene expressions. Our study is the first to demonstrate that SGLT2i exerts anti-atherogenic effects by pure glucose lowering independent of insulin action in diabetic mice through suppressing macrophage foam cell formation, suggesting that foam cell formation is highly sensitive to glycemia ex vivo.	[Terasaki, Michishige; Hiromura, Munenori; Mori, Yusaku; Kohashi, Kyoko; Nagashima, Masaharu; Kushima, Hideki; Hirano, Tsutomu] Showa Univ, Sch Med, Dept Med, Div Diabet Metab & Endocrinol,Shinagawa Ku, Tokyo 142, Japan; [Watanabe, Takuya] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Hachioji, Tokyo 19203, Japan	Showa University; Tokyo University of Pharmacy & Life Sciences	Hirano, T (corresponding author), Showa Univ, Sch Med, Dept Med, Div Diabet Metab & Endocrinol,Shinagawa Ku, Tokyo 142, Japan.	hirano@med.showa-u.ac.jp	Terasaki, Michishige/I-1659-2016	Terasaki, Michishige/0000-0002-7405-7419	AstraZeneca; Astellas Pharma Inc.	AstraZeneca(AstraZeneca); Astellas Pharma Inc.(Astellas Pharmaceuticals)	This study was financially supported from AstraZeneca and Astellas Pharma Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdian S, 2012, CARDIOVASC RES, V95, P165, DOI 10.1093/cvr/cvs094; [Anonymous], 2009, GLO J PHARM, V3, P81; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chait A, 2009, J LIPID RES, V50, pS335, DOI 10.1194/jlr.R800059-JLR200; Chang YC, 2013, J CELL BIOCHEM, V114, P1364, DOI 10.1002/jcb.24478; Chen GP, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/379287; DeFronzo RA, 2013, DIABETES CARE, V36, P3169, DOI 10.2337/dc13-0387; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Ferrannini E, 2012, NAT REV ENDOCRINOL, V8, P495, DOI 10.1038/nrendo.2011.243; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Fujita Y, 2014, J DIABETES INVEST, V5, P265, DOI 10.1111/jdi.12214; Fukuhara T, 2005, J BIO CHEM, V280, P3355; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Graham ML, 2011, COMPARATIVE MED, V61, P356; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Hamuro M, 2002, ATHEROSCLEROSIS, V162, P277, DOI 10.1016/S0021-9150(01)00719-5; Hayek T, 2005, ATHEROSCLEROSIS, V183, P25, DOI 10.1016/j.atherosclerosis.2005.02.018; Kaplan M, 2008, J CARDIOVASC PHARM, V52, P324, DOI 10.1097/FJC.0b013e3181879d98; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Li L, 2004, CIRC RES, V94, P892, DOI 10.1161/01.RES.0000124920.09738.26; Lin CS, 2012, CARDIOVASC RES, V95, P346, DOI 10.1093/cvr/cvs189; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Machado-Lima A, 2015, J CELL PHYSIOL, V230, P1250, DOI 10.1002/jcp.24860; Mauerer R, 2009, EXP MOL MED, V41, P126, DOI 10.3858/emm.2009.41.2.015; Mauldin JP, 2006, J BIOL CHEM, V281, P21216, DOI 10.1074/jbc.M510952200; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Moheimani F, 2011, EXP DIABETES RES, DOI 10.1155/2011/851280; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Mudaliar H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108844; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; Nagashima M, 2010, ATHEROSCLEROSIS, V212, P70, DOI 10.1016/j.atherosclerosis.2010.04.027; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nauck MA, 2014, DRUG DES DEV THER, V8, P1335, DOI 10.2147/DDDT.S50773; Nogi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035683; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Passarelli M, 2005, DIABETES, V54, P2198, DOI 10.2337/diabetes.54.7.2198; Patel DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022142; Piarulli F, 2013, ACTA DIABETOL, V50, P101, DOI 10.1007/s00592-012-0412-3; Sekiya M, 2011, J ATHEROSCLER THROMB, V18, P359, DOI 10.5551/jat.7013; Takeda Y, 2012, DIABETOLOGIA, V55, P404, DOI 10.1007/s00125-011-2365-4; Terasaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070933; Terasaki M, 2012, METABOLISM, V61, P974, DOI 10.1016/j.metabol.2011.11.011; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Yvan-Chravet L, 2010, ATHEROSCLER THROMB V, V30, P139	46	64	67	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143396	10.1371/journal.pone.0143396	http://dx.doi.org/10.1371/journal.pone.0143396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606676	Green Submitted, gold, Green Published			2022-12-26	WOS:000365865300060
J	Doetterl, S; Kearsley, E; Bauters, M; Hufkens, K; Lisingo, J; Baert, G; Verbeeck, H; Boeckx, P				Doetterl, Sebastian; Kearsley, Elizabeth; Bauters, Marijn; Hufkens, Koen; Lisingo, Janvier; Baert, Geert; Verbeeck, Hans; Boeckx, Pascal			Aboveground vs. Belowground Carbon Stocks in African Tropical Lowland Rainforest: Drivers and Implications	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; NUTRIENT LIMITATION; AMAZONIAN FORESTS; MATTER; NITROGEN; BIOMASS; STABILIZATION; PHOSPHORUS; GROWTH; FRACTIONATION	Background African tropical rainforests are one of the most important hotspots to look for changes in the upcoming decades when it comes to C storage and release. The focus of studying C dynamics in these systems lies traditionally on living aboveground biomass. Belowground soil organic carbon stocks have received little attention and estimates of the size, controls and distribution of soil organic carbon stocks are highly uncertain. In our study on lowland rainforest in the central Congo basin, we combine both an assessment of the aboveground C stock with an assessment of the belowground C stock and analyze the latter in terms of functional pools and controlling factors. Principal Findings Our study shows that despite similar vegetation, soil and climatic conditions, soil organic carbon stocks in an area with greater tree height (=larger aboveground carbon stock) were only half compared to an area with lower tree height (=smaller aboveground carbon stock). This suggests that substantial variability in the aboveground vs. belowground C allocation strategy and/or C turnover in two similar tropical forest systems can lead to significant differences in total soil organic C content and C fractions with important consequences for the assessment of the total C stock of the system. Conclusions/Significance We suggest nutrient limitation, especially potassium, as the driver for aboveground versus belowground C allocation. However, other drivers such as C turnover, tree functional traits or demographic considerations cannot be excluded. We argue that large and unaccounted variability in C stocks is to be expected in African tropical rain-forests. Currently, these differences in aboveground and belowground C stocks are not adequately verified and implemented mechanistically into Earth System Models. This will, hence, introduce additional uncertainty to models and predictions of the response of C storage of the Congo basin forest to climate change and its contribution to the terrestrial C budget.	[Doetterl, Sebastian; Kearsley, Elizabeth; Bauters, Marijn; Boeckx, Pascal] Univ Ghent, Isotope Biosci Lab ISOFYS, B-9000 Ghent, Belgium; [Hufkens, Koen] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Lisingo, Janvier] Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; [Baert, Geert] Univ Ghent, Dept Appl Biosci, B-9000 Ghent, Belgium; [Kearsley, Elizabeth; Bauters, Marijn; Verbeeck, Hans] Univ Ghent, Computat & Appl Vegetat Ecol CAVElab, B-9000 Ghent, Belgium; [Doetterl, Sebastian] Univ Augsburg, Dept Geog, D-86159 Augsburg, Germany	Ghent University; Harvard University; Ghent University; Ghent University; University of Augsburg	Doetterl, S (corresponding author), Univ Ghent, Isotope Biosci Lab ISOFYS, B-9000 Ghent, Belgium.	Sebastian.Doetterl@Ugent.be		Bauters, Marijn/0000-0003-0978-6639; Hufkens, Koen/0000-0002-5070-8109; Doetterl, Sebastian/0000-0002-0986-891X; Verbeeck, Hans/0000-0003-1490-0168	Belgian Science Policy Office (BELSPO) [SD/AR/01A]; BELSPO Interuniversity Attraction Poles Programme IUAP project "SOGLO-Soils under Global change"	Belgian Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); BELSPO Interuniversity Attraction Poles Programme IUAP project "SOGLO-Soils under Global change"	This research is part of the COBIMFO project (Congo Basin integrated monitoring for forest carbon mitigation and biodiversity; contract no. SD/AR/01A) and was funded by the Belgian Science Policy Office (BELSPO). Further funding was given by the BELSPO Interuniversity Attraction Poles Programme IUAP project "SOGLO-Soils under Global change."	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; Aragao LEOC, 2009, BIOGEOSCIENCES, V6, P2759, DOI 10.5194/bg-6-2759-2009; Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Banin L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1179, DOI 10.1111/j.1466-8238.2012.00778.x; Batjes NH, 2008, GEODERMA, V146, P58, DOI 10.1016/j.geoderma.2008.05.006; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; Don A, 2009, J PLANT NUTR SOIL SC, V172, P53, DOI 10.1002/jpln.200700158; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Espeleta JF, 2007, ECOL MONOGR, V77, P377, DOI 10.1890/06-1257.1; Fanin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049990; Fanin N, 2011, SOIL BIOL BIOCHEM, V43, P1014, DOI 10.1016/j.soilbio.2011.01.018; Fernandez-Martinez M, 2015, NATURE CLIM CHANG, V4, P471; Field C. B., 2003, GLOBAL CARBON CYCLE, P1; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; Fisher JB, 2013, OECOLOGIA, V172, P889, DOI 10.1007/s00442-012-2522-6; Gilson P, 1956, NOTICE EXPLICATIVE C; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; IUSS Working Group WRB, 2014, WORLD SOIL RES REP, V106; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; John B, 2005, GEODERMA, V128, P63, DOI 10.1016/j.geoderma.2004.12.013; Kearsley E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3269; Kong AYY, 2010, SOIL SCI SOC AM J, V74, P1201, DOI 10.2136/sssaj2009.0346; Laudelout H, 1954, T 5 INT C SOIL SCI, V2, P267; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Malhi Y, 2002, J VEG SCI, V13, P439, DOI 10.1111/j.1654-1103.2002.tb02068.x; Malhi Y, 2009, GLOBAL CHANGE BIOL, V15, P1255, DOI 10.1111/j.1365-2486.2008.01780.x; McCormack ML, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00205; NADELHOFFER KJ, 1985, ECOLOGY, V66, P1377, DOI 10.2307/1939190; Nottingham AT, 2015, SOIL BIOL BIOCHEM, V80, P26, DOI 10.1016/j.soilbio.2014.09.012; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pansu M, 2006, HDB SOIL ANAL, DOI 10.1007/978-3-540-31211-6; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pichancourt JB, 2014, GLOBAL CHANGE BIOL, V20, P382, DOI 10.1111/gcb.12345; Priess J, 1999, PLANT ECOL, V143, P171, DOI 10.1023/A:1009844226078; Reyer CPO, 2015, J ECOL, V103, P5, DOI 10.1111/1365-2745.12337; Saiz G, 2012, GLOBAL CHANGE BIOL, V18, P1670, DOI 10.1111/j.1365-2486.2012.02657.x; Santiago LS, 2012, J ECOL, V100, P309, DOI 10.1111/j.1365-2745.2011.01904.x; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schulp CJE, 2008, FOREST ECOL MANAG, V256, P482, DOI 10.1016/j.foreco.2008.05.007; Silver WL, 2001, OECOLOGIA, V129, P407, DOI 10.1007/s004420100740; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Six J, 2014, SOIL BIOL BIOCHEM, V68, pA4, DOI 10.1016/j.soilbio.2013.06.014; United Nations, 2011, UN COLL PROGR RED EM; Verbeeck H, 2014, J TROP FOR SCI, V26, P409; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Wurzburger N, 2015, ECOLOGY, V96, P2137, DOI 10.1890/14-1362.1; Zanne AE, 2009, DRYAD DIGITAL REPOSI, V2009, DOI [10.5061/dryad.234, DOI 10.5061/DRYAD.234]	59	22	22	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143209	10.1371/journal.pone.0143209	http://dx.doi.org/10.1371/journal.pone.0143209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599231	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600038
J	Hu, LS; Ning, SL; Eschbacher, JM; Gaw, N; Dueck, AC; Smith, KA; Nakaji, P; Plasencia, J; Ranjbar, S; Price, SJ; Tran, N; Loftus, J; Jenkins, R; O'Neill, BP; Elmquist, W; Baxter, LC; Gao, F; Frakes, D; Karis, JP; Zwart, C; Swanson, KR; Sarkaria, J; Wu, T; Mitchell, JR; Li, J				Hu, Leland S.; Ning, Shuluo; Eschbacher, Jennifer M.; Gaw, Nathan; Dueck, Amylou C.; Smith, Kris A.; Nakaji, Peter; Plasencia, Jonathan; Ranjbar, Sara; Price, Stephen J.; Nhan Tran; Loftus, Joseph; Jenkins, Robert; O'Neill, Brian P.; Elmquist, William; Baxter, Leslie C.; Gao, Fei; Frakes, David; Karis, John P.; Zwart, Christine; Swanson, Kristin R.; Sarkaria, Jann; Wu, Teresa; Mitchell, J. Ross; Li, Jing			Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma	PLOS ONE			English	Article							DIFFUSION; GLIOMAS; VALIDATION; CLASSIFICATION; DELINEATION; NECROSIS; REGIONS	Background Genetic profiling represents the future of neuro-oncology but suffers from inadequate biopsies in heterogeneous tumors like Glioblastoma (GBM). Contrast-enhanced MRI (CE-MRI) targets enhancing core (ENH) but yields adequate tumor in only similar to 60% of cases. Further, CE-MRI poorly localizes infiltrative tumor within surrounding non-enhancing parenchyma, or brain-around-tumor (BAT), despite the importance of characterizing this tumor segment, which universally recurs. In this study, we use multiple texture analysis and machine learning (ML) algorithms to analyze multi-parametric MRI, and produce new images indicating tumor-rich targets in GBM. Methods We recruited primary GBM patients undergoing image-guided biopsies and acquired preoperative MRI: CE-MRI, Dynamic-Susceptibility-weighted-Contrast-enhanced-MRI, and Diffusion Tensor Imaging. Following image coregistration and region of interest placement at biopsy locations, we compared MRI metrics and regional texture with histologic diagnoses of high-vs low-tumor content (>= 80% vs <80% tumor nuclei) for corresponding samples. In a training set, we used three texture analysis algorithms and three ML methods to identify MRI-texture features that optimized model accuracy to distinguish tumor content. We confirmed model accuracy in a separate validation set. Results We collected 82 biopsies from 18 GBMs throughout ENH and BAT. The MRI-based model achieved 85% cross-validated accuracy to diagnose high-vs low-tumor in the training set (60 biopsies, 11 patients). The model achieved 81.8% accuracy in the validation set (22 biopsies, 7 patients). Conclusion Multi-parametric MRI and texture analysis can help characterize and visualize GBM's spatial histologic heterogeneity to identify regional tumor-rich biopsy targets.	[Hu, Leland S.; Ranjbar, Sara; Zwart, Christine; Wu, Teresa; Mitchell, J. Ross; Li, Jing] Mayo Clin, Dept Radiol, Phoenix, AZ 85054 USA; [Dueck, Amylou C.] Mayo Clin, Dept Biostat, Phoenix, AZ USA; [Swanson, Kristin R.] Mayo Clin, Dept Neurosurg, Phoenix, AZ USA; [Loftus, Joseph] Mayo Clin, Dept Canc & Cell Biol, Scottsdale, AZ USA; [Jenkins, Robert] Mayo Clin, Dept Pathol, Rochester, MN USA; [O'Neill, Brian P.] Mayo Clin, Dept Neurooncol, Rochester, MN USA; [Sarkaria, Jann] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Elmquist, William] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Nhan Tran] Translat Genom Res Inst, Dept Canc & Cell Biol, Phoenix, AZ USA; [Ning, Shuluo; Gaw, Nathan; Gao, Fei; Wu, Teresa; Li, Jing] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ USA; [Plasencia, Jonathan; Frakes, David] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA; [Eschbacher, Jennifer M.] Barrow Neurol Inst, Dept Pathol, Phoenix, AZ 85013 USA; [Smith, Kris A.; Nakaji, Peter] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Hu, Leland S.; Baxter, Leslie C.; Karis, John P.] Barrow Neurol Inst, Dept Radiol, Phoenix, AZ 85013 USA; [Price, Stephen J.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Translational Genomics Research Institute; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Barrow Neurological Institute; Barrow Neurological Institute; Barrow Neurological Institute; University of Cambridge	Hu, LS (corresponding author), Mayo Clin, Dept Radiol, Phoenix, AZ 85054 USA.	Hu.leland@mayo.edu	Ning, Shuluo/AAD-2426-2020; Ranjbar, Sara/AAA-4550-2020; Price, Stephen J/B-1068-2011	Price, Stephen J/0000-0002-7535-3009; Ranjbar, Sara/0000-0002-4344-1282; Baxter, Leslie/0000-0002-3971-863X	NATIONAL INSTITUTES OF HEALTH (NIH) - National Institute of Neurological Disorders and Stroke (NINDS) [NS082609]; Mayo Clinic Foundation; National Institute for Health Research [NIHR/CS/009/011] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS082609] Funding Source: NIH RePORTER	NATIONAL INSTITUTES OF HEALTH (NIH) - National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NATIONAL INSTITUTES OF HEALTH (NIH) - National Institute of Neurological Disorders and Stroke (NINDS) NS082609 (LSH): provided support for study design, data collection and analysis, preparation of the manuscript. Mayo Clinic Foundation (LSH): provided support for study design, data collection and analysis, preparation of the manuscript. National Science Foundation (NSF) DGE-1311230 (JP): provided support for data collection and analysis.	Agarwal S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001888; Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Berens Michael E., 1999, Neoplasia (New York), V1, P208, DOI 10.1038/sj.neo.7900034; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Brown R, 2008, CLIN CANCER RES, V14, P2357, DOI 10.1158/1078-0432.CCR-07-1964; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dixon SJ, 2009, CHEMOMETR INTELL LAB, V95, P1, DOI 10.1016/j.chemolab.2008.07.010; Drabycz S, 2010, NEUROIMAGE, V49, P1398, DOI 10.1016/j.neuroimage.2009.09.049; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Eyal E, 2010, INVEST RADIOL, V45, P174, DOI 10.1097/RLI.0b013e3181d0a02f; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hu LS, 2012, AM J NEURORADIOL, V33, P69, DOI 10.3174/ajnr.A2743; Hu LS, 2010, AM J NEURORADIOL, V31, P40, DOI 10.3174/ajnr.A1787; Hu LS, 2012, NEURO-ONCOLOGY, V14, P919, DOI 10.1093/neuonc/nos112; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; LaViolette PS, 2014, NEURO-ONCOLOGY, V16, P1599, DOI 10.1093/neuonc/nou142; Lin GC, 2010, COMPUT MED IMAG GRAP, V34, P251, DOI 10.1016/j.compmedimag.2009.11.001; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pafundi DH, 2013, NEURO-ONCOLOGY, V15, P1058, DOI 10.1093/neuonc/not002; Price SJ, 2006, AM J NEURORADIOL, V27, P1969; Roberts DW, 2011, J NEUROSURG, V114, P595, DOI 10.3171/2010.2.JNS091322; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Semmineh NB, 2015, MAGN RESON MED, V74, P772, DOI 10.1002/mrm.25435; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stadlbauer A, 2006, RADIOLOGY, V240, P803, DOI 10.1148/radiol.2403050937; Valdes PA, 2012, J NEUROPATH EXP NEUR, V71, P806, DOI 10.1097/NEN.0b013e31826775a1; Weber MA, 2010, INVEST RADIOL, V45, P755, DOI 10.1097/RLI.0b013e3181ec9db0; Yeung TPC, 2014, ACAD RADIOL, V21, P624, DOI 10.1016/j.acra.2014.01.015; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147	30	64	68	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0141506	10.1371/journal.pone.0141506	http://dx.doi.org/10.1371/journal.pone.0141506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599106	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600004
J	Camara, ACL; Gadelha, ICN; Borges, PAC; de Paiva, SA; Melo, MM; Soto-Blanco, B				Lopes Camara, Antonio Carlos; Nunes Gadelha, Ivana Cristina; Cordeiro Borges, Pedro Augusto; de Paiva, Silvano Alves; Melo, Marilia Martins; Soto-Blanco, Benito			Toxicity of Gossypol from Cottonseed Cake to Sheep Ovarian Follicles	PLOS ONE			English	Article							EXPELLED COTTONSEED; EMBRYO DEVELOPMENT; DIETS; IMPLANTATION; FERTILITY; OOCYTES	Gossypol, a polyphenol compound produced by cotton plant, has proven reproductive toxicity, but the effects of gossypol on sheep ovaries are unknown. This study was aimed to determine the in vitro and in vivo effects of gossypol on the ovarian follicles of sheep. This trial was divided into two experiments. In the first one, we used twelve non-pregnant, nulliparous, Santa Ines crossbred ewes, which were randomly distributed into two equal groups and fed diets with and without cottonseed cake. Feed was offered at 1.5% of the animal's body weight for 63 days. The concentrations of total and free gossypol in the cottonseed cake were 3.28 mg/g and 0.11 mg/g, respectively. Throughout the trial period, no animal showed clinical signs of toxicity and no effects on body weight were observed. However, there was a significantly lower number of viable ovarian follicles (20.6%) and higher number of atretic follicles (79.4%) in the gossypol-fed sheep compared to the control (85.1 and 34.9%, respectively). These findings were observed at all stages of follicular development. In the second experiment, eight ovaries from slaughterhouse were cultured with different concentrations of gossypol acetic acid (0, 5, 10 and 20 mu g/mL) for 24 hours or seven days. The in vitro action of gossypol resulted in a significant decrease in viable ovarian follicles, especially the primary and transition follicles, and a significant increase in the number of atretic follicles after 24 hours of culture. These follicles were greatly affected when cultured with gossypol for seven days. It is concluded that gossypol present in cotton seeds directly acts on ovarian follicles in sheep to increase atresia.	[Lopes Camara, Antonio Carlos; Nunes Gadelha, Ivana Cristina; Cordeiro Borges, Pedro Augusto; de Paiva, Silvano Alves] Univ Fed Rural Semiarido UFERSA, Hosp Vet, BR-59625900 Mossoro, RN, Brazil; [Melo, Marilia Martins; Soto-Blanco, Benito] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, BR-30123970 Belo Horizonte, MG, Brazil	Universidade Federal Rural do Semi-Arido (UFERSA); Universidade Federal de Minas Gerais	Soto-Blanco, B (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Ave Antonio Carlos 6627, BR-30123970 Belo Horizonte, MG, Brazil.	benito.blanco@pq.cnpq.br	Borges, Pedro/GNP-7493-2022; Melo, Marilia/I-8283-2018; Maracaja, Patricio Borges B/Q-6300-2018; Soto-Blanco, Benito/A-5817-2010	Melo, Marilia/0000-0003-3630-6776; Maracaja, Patricio Borges B/0000-0003-4812-0389; Soto-Blanco, Benito/0000-0003-3861-1838	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [474432/2012-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a grant of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (project #474432/2012-2).	Basini G, 2009, DOMEST ANIM ENDOCRIN, V37, P30, DOI 10.1016/j.domaniend.2009.01.005; Guedes FCB, 2010, ACTA SCI VET, V38, P415; Braga AP, 2012, REV MED VET-TOULOUSE, V163, P147; BREITBART H, 1984, INT J ANDROL, V7, P439, DOI 10.1111/j.1365-2605.1984.tb00801.x; BREITBART H, 1989, INT J BIOCHEM, V21, P1097, DOI 10.1016/0020-711X(89)90049-9; Brocas C, 1997, BIOL REPROD, V57, P901, DOI 10.1095/biolreprod57.4.901; Camboni A, 2005, FERTIL STERIL, V84, pS104, DOI 10.1016/j.fertnstert.2005.07.251; Cengiz E, 2010, MOL BIOL REP, V37, P1269, DOI 10.1007/s11033-009-9501-y; Cheng JS, 2003, CHINESE J PHYSIOL, V46, P117; Chenoweth PJ, 2000, THERIOGENOLOGY, V53, P1193, DOI 10.1016/S0093-691X(00)00264-8; El-Sharaky AS, 2010, FOOD CHEM TOXICOL, V48, P3354, DOI 10.1016/j.fct.2010.09.004; FORNES MW, 1993, BIOCHEM BIOPH RES CO, V195, P1289, DOI 10.1006/bbrc.1993.2183; GAMBILL MD, 1993, THERIOGENOLOGY, V40, P585, DOI 10.1016/0093-691X(93)90411-W; Hassan ME, 2004, THERIOGENOLOGY, V61, P1171, DOI 10.1016/j.theriogenology.2003.07.007; Hernandez-Ceron J, 2005, J DAIRY SCI, V88, P922, DOI 10.3168/jds.S0022-0302(05)72759-4; Herve JC, 1996, EUR J PHARMACOL, V313, P243, DOI 10.1016/0014-2999(96)00476-1; Hirshfield AN, 1997, ENVIRON MOL MUTAGEN, V29, P10; Hron RJ, 1999, J AM OIL CHEM SOC, V76, P1351, DOI 10.1007/s11746-999-0149-5; HRON RJ, 1990, J AM OIL CHEM SOC, V67, P182, DOI 10.1007/BF02539622; Israely T, 2003, BIOL REPROD, V68, P2055, DOI 10.1095/biolreprod.102.011734; Kovacic P, 2003, CURR MED CHEM, V10, P2711, DOI 10.2174/0929867033456369; LIN YC, 1985, LIFE SCI, V37, P39, DOI 10.1016/0024-3205(85)90623-X; LIN YC, 1991, THERIOGENOLOGY, V35, P769, DOI 10.1016/0093-691X(91)90418-D; Moon D-O, 2008, CANC LETT, P192; Noftsger SM, 2000, J DAIRY SCI, V83, P2539, DOI 10.3168/jds.S0022-0302(00)75146-0; Gadelha ICN, 2014, SCI WORLD J, DOI 10.1155/2014/986184; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; R Core Team, 2018, R LANG ENV STAT COMP; RANDEL RD, 1992, J ANIM SCI, V70, P1628, DOI 10.2527/1992.7051628x; Randel RD, 1996, THERIOGENOLOGY, V45, P911, DOI 10.1016/0093-691X(96)00021-0; Rodrigues MC, 2012, REV PORT CIENCIAS VE, V111, P165; Nunes FDR, 2010, J ANIM VET ADV, V9, P75; Romualdo GS, 2002, J ANDROL, V23, P220; Santos JEP, 2003, J DAIRY SCI, V86, P892, DOI 10.3168/jds.S0022-0302(03)73672-8; Soto-Blanco B., 2008, TOXICOLOGIA APLICADA, P531; UENO H, 1988, CONTRACEPTION, V37, P333, DOI 10.1016/0010-7824(88)90033-9; Velasquez-Pereira J, 2003, J DAIRY SCI, V86, P240; Villasenor M, 2008, J DAIRY SCI, V91, P3015, DOI 10.3168/jds.2007-0939; ZIRKLE SM, 1988, THERIOGENOLOGY, V30, P575, DOI 10.1016/0093-691X(88)90207-5	39	16	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143708	10.1371/journal.pone.0143708	http://dx.doi.org/10.1371/journal.pone.0143708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600470	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600108
J	Pappalardo, AM; Federico, C; Sabella, G; Saccone, S; Ferrito, V				Pappalardo, Anna Maria; Federico, Concetta; Sabella, Giorgio; Saccone, Salvatore; Ferrito, Venera			A COI Nonsynonymous Mutation as Diagnostic Tool for Intraspecific Discrimination in the European Anchovy Engraulis encrasicolus (Linnaeus)	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; APHANIUS-FASCIATUS; SELECTION; VARIABILITY; NUCLEOTIDE; STRAIT; NORTH; TELEOSTEI	The European anchovy, Engraulis encrasicolus, is currently one of the principal target species for commercial fisheries in Europe. In this study, the mitochondrial Control Region (CR) and the Cytochrome Oxidase I (COI) mitochondrial gene were analyzed in 74 specimens of E. encrasicolus from four localities in the central Mediterranean. In both populations, the two markers revealed the presence of two main haplogroups, A and B, already detected in previous investigations of different classes of molecular markers. Both CR and COI markers consistently identified two haplogroups. The COI sequence analysis identified a non-synonymous transversion (T to G) at position 116 of the translated sequence, resulting in an amino acid change. All COI sequences of haplogroup A had an amino acid sequence with alanine in this position, while serine was present in the same position in haplogroup B. The two haplogroups A and B were also discriminated by the variable number of TACA elements at the 5'-end of the mitochondrial CR. The selection tests applied to the COI dataset revealed that codon 116 was not under positive selection, that seven amino acid changes were under purifying selection, and that two amino acids were under episodic positive selection.	[Pappalardo, Anna Maria; Federico, Concetta; Sabella, Giorgio; Saccone, Salvatore; Ferrito, Venera] Univ Catania, Dept Biol Geol & Environm Sci, Sec Anim Biol M La Greca, Catania, Italy	University of Catania	Ferrito, V (corresponding author), Univ Catania, Dept Biol Geol & Environm Sci, Sec Anim Biol M La Greca, Catania, Italy.	vferrito@unict.it	Sabella, Giorgio/R-9487-2019; Pappalardo, Anna Maria/AAD-3410-2019; Saccone, Salvatore/H-1548-2012; FEDERICO, Concetta/M-5553-2015	Saccone, Salvatore/0000-0001-7568-5823; Ferrito, Venera/0000-0001-5069-546X; FEDERICO, Concetta/0000-0002-0160-9040; SABELLA, Giorgio/0000-0002-2234-1901				Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Basilone G, 2006, FISH OCEANOGR, V15, P271, DOI 10.1111/j.1365-2419.2005.00391.x; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Bonanno A, 2014, OCEAN SCI, V10, P759, DOI 10.5194/os-10-759-2014; Borrell YJ, 2012, ICES J MAR SCI, V69, P1357, DOI 10.1093/icesjms/fss129; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Castellana S, 2011, GENOME BIOL EVOL, V3, P1067, DOI 10.1093/gbe/evr040; Cuttitta A, 2015, FISH OCEANOGR, V24, P135, DOI 10.1111/fog.12098; Dalziel AC, 2006, J MOL EVOL, V62, P319, DOI 10.1007/s00239-005-0110-7; Erdogan Z, 2009, ACTA ADRIAT, V50, P77; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falcini F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123213; Ferrito V, 2013, MAR BIOL, V160, P3193, DOI 10.1007/s00227-013-2307-4; Fruciano C, 2014, BIOL J LINN SOC, V112, P387, DOI 10.1111/bij.12279; Grant WS, 2006, J HERED, V97, P571, DOI 10.1093/jhered/esl033; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Grant WS, 2005, GENETICA, V125, P293, DOI 10.1007/s10709-005-0717-z; Grueber CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089632; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova Petya P., 2006, Acta Adriatica, V47, P13; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kristoffersen JB, 2008, FISH RES, V91, P187, DOI 10.1016/j.fishres.2007.11.024; Lafuente JG, 2002, FISH OCEANOGR, V11, P31, DOI 10.1046/j.1365-2419.2002.00186.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Magoulas A, 1996, MOL BIOL EVOL, V13, P178, DOI 10.1093/oxfordjournals.molbev.a025554; Magoulas A, 2006, MOL PHYLOGENET EVOL, V39, P734, DOI 10.1016/j.ympev.2006.01.016; Mhlongo N, 2015, FISH OCEANOGR, V24, P1, DOI 10.1111/fog.12061; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pappalardo AM, 2008, J FISH BIOL, V72, P1154, DOI 10.1111/j.1095-8649.2007.01748.x; Pappalardo AM, 2015, J FISH BIOL, V87, P69, DOI 10.1111/jfb.12693; Pappalardo AM, 2015, HYDROBIOLOGIA, V749, P155, DOI 10.1007/s10750-014-2161-5; Pappalardo AM, 2015, FISH RES, V164, P153, DOI 10.1016/j.fishres.2014.11.004; Pappalardo AM, 2015, FOOD CONTROL, V57, P385, DOI 10.1016/j.foodcont.2015.03.038; Pappalardo AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025516; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Raab K, 2013, MAR ECOL PROG SER, V488, P233, DOI 10.3354/meps10408; Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109; Robalo JI, 2012, ECOL EVOL, V2, P153, DOI 10.1002/ece3.77; Sanz N, 2008, ICES J MAR SCI, V65, P1635, DOI 10.1093/icesjms/fsn128; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Shaltout M, 2014, OCEANOLOGIA, V56, P411, DOI 10.5697/oc.56-3.411; Silva G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1093; Silva G, 2014, J BIOGEOGR, V41, P1171, DOI 10.1111/jbi.12275; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tomasco IH, 2014, GENE, V534, P371, DOI 10.1016/j.gene.2013.09.097; Tudela S, 2002, J MAR BIOL ASSOC UK, V82, P349, DOI 10.1017/S0025315402005568; Vinas J, 2014, ICES J MAR SCI, V71, P391, DOI 10.1093/icesjms/fst132; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2007, MOL ECOL NOTES, V7, P899, DOI 10.1111/j.1471-8286.2007.01886.x; Whitehead P.J.P., 1990, CHECKLIST FISHES E T, V1, P228; Whitehead PJP, 1988, FAO FISHERIES SYNOPS, V7; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Zardoya R, 2004, MOL ECOL, V13, P1785, DOI 10.1111/j.1365-294X.2004.02198.x; Zarraonaindia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042201; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	60	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143297	10.1371/journal.pone.0143297	http://dx.doi.org/10.1371/journal.pone.0143297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599908	gold, Green Published, Green Submitted			2022-12-26	WOS:000365862600046
J	Rabinovich-Toidman, P; Rabinovich-Nikitin, I; Ezra, A; Barbiro, B; Fogel, H; Slutsky, I; Solomon, B				Rabinovich-Toidman, Polina; Rabinovich-Nikitin, Inna; Ezra, Assaf; Barbiro, Beka; Fogel, Hilla; Slutsky, Inna; Solomon, Beka			Mutant SOD1 Increases APP Expression and Phosphorylation in Cellular and Animal Models of ALS	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; SOD1(G93A) MOUSE MODEL; INTRACELLULAR DOMAIN; DISEASE PROGRESSION; RELEASE PROBABILITY; FAMILIAL ALS; A-BETA; NEURONS; DYSFUNCTION	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease and it is the most common adult onset neurodegenerative disorder affecting motor neurons. There is currently no effective treatment for ALS and our understanding of the pathological mechanism is still far away from prevention and/or treatment of this devastating disease. Amyloid precursor protein (APP) is a transmembrane protein that undergoes processing either by beta-secretase or a-secretase, followed by gamma-secretase. In the present study, we show that APP levels, and aberrant phosphorylation, which is associated with enhanced beta-secretase cleavage, are increased in SOD1(G93A) ALS mouse model. Fluorescence resonance energy transfer (FRET) analysis suggests a close interaction between SOD1 and APP at hippocampal synapses. Notably, SOD1(G93A) mutation induces APP-SOD1 conformational changes, indicating a crosstalk between these two signaling proteins. Inhibition of APP processing via monoclonal antibody called BBS that blocks APP beta-secretase cleavage site, resulted in reduction of mutant SOD1(G93A) levels in animal and cellular models of ALS, significantly prolonged life span of SOD1(G93A) mice and diminished inflammation. Beyond its effect on toxic mutant SOD1(G93A), BBS treatment resulted in a reduction in the levels of APP, its processing product soluble APP beta and pro-apoptotic p53. This study demonstrates that APP and its processing products contribute to ALS pathology through several different pathways; thus BBS antibody could be a promising neuroprotective strategy for treatment of this disease.	[Rabinovich-Toidman, Polina; Rabinovich-Nikitin, Inna; Ezra, Assaf; Barbiro, Beka; Solomon, Beka] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Fogel, Hilla; Slutsky, Inna] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Solomon, B (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	beka@post.tau.ac.il		Rabinovich-Nikitin, Inna/0000-0001-5067-8803; Slutsky, Inna/0000-0002-0700-2266	NasVax Ltd.; Tel Aviv University	NasVax Ltd.; Tel Aviv University	Partial support was provided by NasVax Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funding source was internal Tel Aviv University funding.	Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Arbel M, 2005, P NATL ACAD SCI USA, V102, P7718, DOI 10.1073/pnas.0502427102; Bros-Facer V, 2014, HUM MOL GENET, V23, P4187, DOI 10.1093/hmg/ddu136; Bryson JB, 2012, HUM MOL GENET, V21, P3871, DOI 10.1093/hmg/dds215; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Coan G, 2015, NEURODEGENER DIS, V15, P301, DOI 10.1159/000433581; Fogel H, 2014, CELL REP, V7, P1560, DOI 10.1016/j.celrep.2014.04.024; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Koistinen H, 2006, MUSCLE NERVE, V34, P444, DOI 10.1002/mus.20612; Laviv T, 2010, NEURON, V67, P253, DOI 10.1016/j.neuron.2010.06.022; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Leigh P Nigel, 2007, Handb Clin Neurol, V82, P249, DOI 10.1016/S0072-9752(07)80016-9; Li QX, 2006, AGING CELL, V5, P153, DOI 10.1111/j.1474-9726.2006.00200.x; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; Mali Y, 2009, J MED CHEM, V52, P5442, DOI 10.1021/jm900631m; Martin LJ, 2000, NEUROBIOL DIS, V7, P613, DOI 10.1006/nbdi.2000.0314; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Ozaki T, 2006, BIOCHEM BIOPH RES CO, V351, P57, DOI 10.1016/j.bbrc.2006.09.162; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Rabinovich-Nikitin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046650; Rabinovich-Toidman P, 2012, NEURODEGENER DIS, V10, P30, DOI 10.1159/000334774; Ranganathan Srikanth, 2010, Open Pathol J, V4, P11; Sasaki S, 1999, ACTA NEUROPATHOL, V97, P463, DOI 10.1007/s004010051015; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Woolley SC, 2010, AMYOTROPH LATERAL SC, V11, P303, DOI 10.3109/17482961003727954; Xie YY, 2000, NEUROREPORT, V11, P697, DOI 10.1097/00001756-200003200-00009; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143420	10.1371/journal.pone.0143420	http://dx.doi.org/10.1371/journal.pone.0143420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600047	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600064
J	Bosse, JB; Tanneti, NS; Hogue, IB; Enquist, LW				Bosse, Jens B.; Tanneti, Nikhila S.; Hogue, Ian B.; Enquist, Lynn W.			Open LED Illuminator: A Simple and Inexpensive LED Illuminator for Fast Multicolor Particle Tracking in Neurons	PLOS ONE			English	Article							LIGHT-EMITTING-DIODES; MICROSCOPY	Dual-color live cell fluorescence microscopy of fast intracellular trafficking processes, such as axonal transport, requires rapid switching of illumination channels. Typical broad-spectrum sources necessitate the use of mechanical filter switching, which introduces delays between acquisition of different fluorescence channels, impeding the interpretation and quantification of highly dynamic processes. Light Emitting Diodes (LEDs), however, allow modulation of excitation light in microseconds. Here we provide a step-by-step protocol to enable any scientist to build a research-grade LED illuminator for live cell microscopy, even without prior experience with electronics or optics. We quantify and compare components, discuss our design considerations, and demonstrate the performance of our LED illuminator by imaging axonal transport of herpes virus particles with high temporal resolution.	[Bosse, Jens B.; Tanneti, Nikhila S.; Hogue, Ian B.; Enquist, Lynn W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Bosse, Jens B.; Tanneti, Nikhila S.; Hogue, Ian B.; Enquist, Lynn W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University	Enquist, LW (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	lenquist@princeton.edu	Bosse, Jens Bernhard/D-7336-2011	Bosse, Jens Bernhard/0000-0001-7252-5541; Hogue, Ian/0000-0002-1977-5573	National Institutes of Health [NS033506, NS060699]; Deutsche Forschungsgesellschaft [BO 4158/1-1]; American Cancer Society [PF-13-050-01-MPC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060699, R01NS033506, R37NS033506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (www.NIH.gov) grants NS033506 and NS060699 to LWE. JBB was supported by a Fellowship from the Deutsche Forschungsgesellschaft (www.dg.de) (BO 4158/1-1). IBH was supported by a fellowship from the American Cancer Society (www.cancer.org) (PF-13-050-01-MPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeanu DF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002146; [Anonymous], 2007, NAT PHOTONICS, V1, P23; Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Baird T Regan, 2014, J Biomol Tech, V25, P48, DOI 10.7171/jbt.14-2502-001; Ball T., OPTICS IMAGING; Benavides JM, 2005, APPL OPTICS, V44, P4000, DOI 10.1364/AO.44.004000; Cole RW, 2008, MICROSC MICROANAL, V14, P243, DOI 10.1017/S1431927608080288; Curanovic Dusica, 2009, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2604s43; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diaz E, PROTOTYPING ILLUMINA; Edelstein Arthur D, 2014, J Biol Methods, V1; Hogue IB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004535; Moser C, 2006, J MICROSC-OXFORD, V222, P135, DOI 10.1111/j.1365-2818.2006.01581.x; Nishigaki T, 2006, BIOTECHNIQUES, V41, P191, DOI 10.2144/000112220; Pitrone PG, 2013, NAT METHODS, V10, P598, DOI 10.1038/nmeth.2507; Sato T, 2012, COLD SPRING HARB PRO, V2012; Schek H., 2015, BIOOPTICS WORLD; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Thorlabs, LED OUTP COMP SCAL M; thorlabs, MCPCB LED SPECTR; Wessels JT, 2012, CYTOM PART A, DOI [10.1002/cyto.a.22023/pdf, DOI 10.1002/CYTO.A.22023/PDF]	21	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143547	10.1371/journal.pone.0143547	http://dx.doi.org/10.1371/journal.pone.0143547			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600461	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900142
J	de Oliveira, AP; Bernardo, CR; Camargo, AVD; Ronchi, LS; Borim, AA; de Mattos, CCB; de Campos, E; Castiglioni, L; Netinho, JG; Cavasini, CE; Bestetti, RB; de Mattos, LC				de Oliveira, Amanda Priscila; Bernardo, Cassia Rubia; da Silveira Camargo, Ana Vitoria; Ronchi, Luiz Sergio; Borim, Aldenis Albaneze; Brandao de Mattos, Cinara Cassia; de Campos Junior, Eumildo; Castiglioni, Lilian; Netinho, Joao Gomes; Cavasini, Carlos Eugonio; Bestetti, Reinaldo Bulgarelli; de Mattos, Luiz Carlos			Genetic Susceptibility to Cardiac and Digestive Clinical Forms of Chronic Chagas Disease: Involvement of the CCR5 59029 A/G Polymorphism	PLOS ONE			English	Article							CRUZI-ELICITED MYOCARDITIS; CHEMOKINE RECEPTOR EXPRESSION; HARDY-WEINBERG EQUILIBRIUM; TRYPANOSOMA-CRUZI; MONONUCLEAR-CELLS; IMMUNE-RESPONSES; T-CELLS; CARDIOMYOPATHY; HIV-1; INFECTION	The clinical manifestations of chronic Chagas disease include the cardiac form of the disease and the digestive form. Not all the factors that act in the variable clinical course of this disease are known. This study investigated whether the CCR5 Delta 32 (rs333) and CCR5 59029 A/G (promoter region-rs1799987) polymorphisms of the CCR5 gene are associated with different clinical forms of chronic Chagas disease and with the severity of left ventricular systolic dysfunction in patients with chronic Chagas heart disease (CCHD). The antibodies anti-T. cruzi were identified by ELISA. PCR and PCR-RFLP were used to identify the CCR5.32 and CCR5 59029 A/G polymorphisms. The chi-square test was used to compare variables between groups. There was a higher frequency of the AA genotype in patients with CCHD compared with patients with the digestive form of the disease and the control group. The results also showed a high frequency of the AG genotype in patients with the digestive form of the disease compared to the other groups. The results of this study show that the CCR5.32 polymorphism does not seem to influence the different clinical manifestations of Chagas disease but there is involvement of the CCR5 59029 A/G polymorphism in susceptibility to the different forms of chronic Chagas disease. Besides, these polymorphisms do not influence left ventricular systolic dysfunction in patients with CCHD.	[de Oliveira, Amanda Priscila; Bernardo, Cassia Rubia; da Silveira Camargo, Ana Vitoria; Brandao de Mattos, Cinara Cassia; de Mattos, Luiz Carlos] Fac Med Sao Jose do Rio Preto, Dept Biol Mol, Lab Imunogenet, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Ronchi, Luiz Sergio; Borim, Aldenis Albaneze; de Campos Junior, Eumildo; Netinho, Joao Gomes] Fac Med Sao Jose do Rio Preto, Dept Cirugia, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Borim, Aldenis Albaneze; de Campos Junior, Eumildo; Netinho, Joao Gomes] Hosp Base, Fundacao Fac Reg Med, Dept Cirurgia Geral, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Castiglioni, Lilian] Fac Med Sao Jose do Rio Preto, Dept Epidemiol & Saude Colet, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Cavasini, Carlos Eugonio] Fac Med Sao Jose do Rio Preto, Ctr Invest Microrganismos, Dept Doencas Dermatol Infecciosas & Parasitarias, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil; [Bestetti, Reinaldo Bulgarelli] Fac Med Sao Jose do Rio Preto, Dept Cardiol & Cirurgia Cardiovasc, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil		de Mattos, LC (corresponding author), Fac Med Sao Jose do Rio Preto, Dept Biol Mol, Lab Imunogenet, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.	luiz.demattos@famerp.br	BRANDÃO, CINARA/B-3650-2008; de Mattos, Luiz Carlos/P-4005-2019; DE MATTOS, LUIZ CARLOS/F-6739-2010; de Mattos, Luiz Carlos/P-3574-2019; Bestetti, Reinaldo B./AAH-4658-2019; Castiglioni, Lilian/C-2687-2014	BRANDÃO, CINARA/0000-0002-4836-3113; de Mattos, Luiz Carlos/0000-0002-8572-8177; DE MATTOS, LUIZ CARLOS/0000-0002-8572-8177; Castiglioni, Lilian/0000-0002-9999-2673	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP] [2011/08075-4, 2011/19439-7, 2012/20735-2, 2012/05580-2]; Brazilian Ministry of Education Scholarship - Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior; Institutional Research Grant BAP-FAMERP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP](Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Ministry of Education Scholarship - Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior; Institutional Research Grant BAP-FAMERP	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP grant numbers #2011/08075-4 to LCM; #2011/19439-7 to AVSC; #2012/20735-2 to AVSC; #2012/05580-2 to CRB]; Brazilian Ministry of Education Scholarship - Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (to APO; AVSC; CRB) and Institutional Research Grant BAP-FAMERP to LC. The opinions, assumptions, and conclusions or recommendations expressed in this material are the responsibility of the authors and do not necessarily reflect the views of FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Machuca MA, 2014, HUM IMMUNOL, V75, P1210, DOI 10.1016/j.humimm.2014.09.023; Ayo CM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/284729; Bestetti RB, 2014, INT J CARDIOL, V176, P309, DOI 10.1016/j.ijcard.2014.07.112; Bestetti RB, 2011, INT J CARDIOL, V151, P205, DOI 10.1016/j.ijcard.2010.05.033; Bestetti RB, 2008, INT J CARDIOL, V131, P9, DOI 10.1016/j.ijcard.2008.05.024; Bonney KM, 2014, PARASITE, V21, DOI 10.1051/parasite/2014012; Brener Z, 1997, INT ARCH ALLERGY IMM, V114, P103, DOI 10.1159/000237653; Calzada JE, 2001, TISSUE ANTIGENS, V58, P154, DOI 10.1034/j.1399-0039.2001.580302.x; Corbett CEP, 2001, DIS COLON RECTUM, V44, P993, DOI 10.1007/BF02235488; Correa-Oliveira R, 1999, MEM I OSWALDO CRUZ, V94, P253, DOI 10.1590/S0074-02761999000700042; Coura JR, 2014, MEM I OSWALDO CRUZ, V109, P856, DOI 10.1590/0074-0276140236; Cunha-Neto E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/683230; Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032; da Silveira ABM, 2007, PARASITOLOGY, V134, P789, DOI 10.1017/S0031182007002296; da Silveira ABM, 2005, PARASITOLOGY, V131, P627, DOI 10.1017/S0031182005008061; dos Santos PVA, 2001, MICROBES INFECT, V3, P971, DOI 10.1016/S1286-4579(01)01461-7; Dutra Oscar P., 2006, Arq. Bras. Cardiol., V87, P223, DOI 10.1590/S0066-782X2006001500024; Dutra WO, 2009, MEM I OSWALDO CRUZ, V104, P208, DOI 10.1590/S0074-02762009000900027; Esper L, 2015, CURR OPIN INFECT DIS, V28, P246, DOI 10.1097/QCO.0000000000000157; Fernandez-Mestre MT, 2004, HUM IMMUNOL, V65, P725, DOI 10.1016/j.humimm.2004.05.002; Florez O, 2012, HUM IMMUNOL, V73, P852, DOI 10.1016/j.humimm.2012.04.005; Frade AF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-587; Gomes JAS, 2005, INFECT IMMUN, V73, P7960, DOI 10.1128/IAI.73.12.7960-7966.2005; Guedes PMM, 2010, VET IMMUNOL IMMUNOP, V138, P106, DOI 10.1016/j.vetimm.2010.06.010; Gutierrez FRS, 2009, PARASITE IMMUNOL, V31, P673, DOI 10.1111/j.1365-3024.2009.01108.x; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kimura A, 2014, GENE, V537, P357, DOI 10.1016/j.gene.2014.01.005; Li MY, 2008, GENET EPIDEMIOL, V32, P589, DOI 10.1002/gepi.20335; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Llorca Javier, 2005, Gac Sanit, V19, P321, DOI 10.1157/13078032; Lopes MP, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/678246; Machado Fabiana S, 2012, Front Biosci (Elite Ed), V4, P1743; Mack M, 1999, ARTHRITIS RHEUM, V42, P981, DOI 10.1002/1529-0131(199905)42:5<981::AID-ANR17>3.0.CO;2-4; Mangano A, 2001, TISSUE ANTIGENS, V58, P99, DOI 10.1034/j.1399-0039.2001.580207.x; Marino APMP, 2005, MEM I OSWALDO CRUZ, V100, P93, DOI 10.1590/S0074-02762005000900015; Marino APMP, 2004, CIRCULATION, V110, P1443, DOI 10.1161/01.CIR.0000141561.15939.EC; Martins Paulo Roberto Juliano, 2013, Rev. Bras. Hematol. Hemoter., V35, P180, DOI 10.5581/1516-8484.20130040; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Medeiros GA, 2009, MICROBES INFECT, V11, P264, DOI 10.1016/j.micinf.2008.11.012; Nogueira LG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001867; Oliveira AP, 2011, J VENOM ANIM TOXINS, V17, P264, DOI 10.1590/S1678-91992011000300005; Oliveira AP, 2014, INT J CARDIOL, V176, P520, DOI 10.1016/j.ijcard.2014.07.043; Pinazo MJ, 2015, ACTA TROP, V151, P16, DOI 10.1016/j.actatropica.2015.06.013; Ferreira LRP, 2014, WORLD J CARDIOL, V6, P782, DOI 10.4330/wjc.v6.i8.782; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Shieh B, 2000, INT IMMUNOL, V12, P1311, DOI 10.1093/intimm/12.9.1311; Steverding D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-317; Strasen J, 2014, CLIN RES CARDIOL, V103, P1, DOI 10.1007/s00392-013-0613-y; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; Talvani A, 2004, J INFECT DIS, V189, P214, DOI 10.1086/380803; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337; Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3; Vargas AE, 2006, BRAZ J MED BIOL RES, V39, P321, DOI 10.1590/S0100-879X2006000300002; World Health Organization (WHO), CHAG DIS AM TRYP; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y	60	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141847	10.1371/journal.pone.0141847	http://dx.doi.org/10.1371/journal.pone.0141847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599761	Green Published, gold			2022-12-26	WOS:000365853900016
J	Martin, L; De Santis, R; Koczera, P; Simons, N; Haase, H; Heinbockel, L; Brandenburg, K; Marx, G; Schuerholz, T				Martin, Lukas; De Santis, Rebecca; Koczera, Patrick; Simons, Nadine; Haase, Hajo; Heinbockel, Lena; Brandenburg, Klaus; Marx, Gernot; Schuerholz, Tobias			The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis	PLOS ONE			English	Article							EXPRESSION; FAILURE; MODEL	Heparanase is an endo-beta-glucuronidase that cleaves heparan sulfate side chains from their proteoglycans. Thereby, heparanase liberates highly potent circulating heparan sulfate-fragments (HS-fragments) and triggers the fatal and excessive inflammatory response in sepsis. As a potential anti-inflammatory agent for sepsis therapy, peptide 19-2.5 belongs to the class of synthetic anti-lipopolysaccharide peptides; however, its activity is not restricted to Gram-negative bacterial infection. We hypothesized that peptide 19-2.5 interacts with heparanase and/or HS, thereby reducing the levels of circulating HS-fragments in murine and human sepsis. Our data indicate that the treatment of septic mice with peptide 19-2.5 compared to untreated control animals lowers levels of plasma heparanase and circulating HS-fragments and reduces heparanase activity. Additionally, mRNA levels of heparanase in heart, liver, lung, kidney and spleen are downregulated in septic mice treated with peptide 19-2.5 compared to untreated control animals. In humans, plasma heparanase level and activity are elevated in septic shock. The ex vivo addition of peptide 19-2.5 to plasma of septic shock patients decreases heparanase activity but not heparanase level. Isothermal titration calorimetry revealed a strong exothermic reaction between peptide 19-2.5 and heparanase and HS-fragments. However, a saturation character has been identified only in the peptide 19-2.5 and HS interaction. In conclusion, the findings of our current study indicate that peptide 19-2.5 interacts with heparanase, which is elevated in murine and human sepsis and consecutively attenuates the generation of circulating HS-fragments in systemic inflammation. Thus, peptide 19-2.5 seems to be a potential anti-inflammatory agent in sepsis.	[Martin, Lukas; De Santis, Rebecca; Koczera, Patrick; Simons, Nadine; Marx, Gernot; Schuerholz, Tobias] Univ Hosp RWTH, Dept Intens Care & Intermediate Care, Aachen, Germany; [Haase, Hajo] Berlin Inst Technol, Dept Food Chem & Toxicol, Berlin, Germany; [Heinbockel, Lena; Brandenburg, Klaus] Forschungszentrum Borstel, Div Biophys, Borstel, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Technical University of Berlin; Forschungszentrum Borstel	Schuerholz, T (corresponding author), Univ Hosp RWTH, Dept Intens Care & Intermediate Care, Aachen, Germany.	tschuerholz@ukaachen.de	Haase, Hajo/B-9280-2009; Martin, Lukas/Q-8917-2019; Schuerholz, Tobias/E-8071-2011	Haase, Hajo/0000-0002-1622-8718; Martin, Lukas/0000-0001-8650-5090; Schuerholz, Tobias/0000-0003-3830-3499	Astellas Pharma; Bayer Vital; Astra-Zeneca; B. Braun Melsungen; BBraun; Edwards Life Sciences; Serumwerke Bernburg; Hutchinson Technology; Baxter	Astellas Pharma(Astellas Pharmaceuticals); Bayer Vital(Bayer AG); Astra-Zeneca(AstraZeneca); B. Braun Melsungen; BBraun; Edwards Life Sciences; Serumwerke Bernburg; Hutchinson Technology; Baxter	KB has a patent for the structure of the synthetic antimicrobial peptide 19-2.5 (Aspidasept, Brandenburg Antiinfektiva, Borstel, Germany): Patent-No: PCT/EP2009/002565, and is chief scientific officer of Brandenburg Antiinfektiva GmbH. TS received travel grants and lecture fees from Astellas Pharma, and lecture fees from Bayer Vital, Astra-Zeneca and B. Braun Melsungen, and is chief medical officer of Brandenburg Antiinfektiva GmbH. GM has received honoraria for consulting or lecturing and restricted research grants from the following companies: BBraun, Edwards Life Sciences, Serumwerke Bernburg, Hutchinson Technology, and Baxter. The competing interests do not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chen GP, 2004, BIOCHEMISTRY-US, V43, P4971, DOI 10.1021/bi0356552; Edovitsky E, 2006, BLOOD, V107, P3609, DOI 10.1182/blood-2005-08-3301; Goode KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109596; Gutsmann T, 2010, ANTIMICROB AGENTS CH, V54, P3817, DOI 10.1128/AAC.00534-10; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Heinbockel L, 2015, INNATE IMMUN-LONDON, V21, P305, DOI 10.1177/1753425914535957; Heinbockel L, 2013, ANTIMICROB AGENTS CH, V57, P1480, DOI 10.1128/AAC.02066-12; Hu ZS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085765; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Johnson GB, 2004, J IMMUNOL, V172, P20, DOI 10.4049/jimmunol.172.1.20; Kaconis Y, 2011, BIOPHYS J, V100, P2652, DOI 10.1016/j.bpj.2011.04.041; Krepstakies M, 2012, J INFECT DIS, V205, P1654, DOI 10.1093/infdis/jis273; Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972; Lerner I, 2008, CLIN CANCER RES, V14, P668, DOI 10.1158/1078-0432.CCR-07-1866; Lygizos MI, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.153; Martin L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127584; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Nelson A, 2014, ACTA ANAESTH SCAND, V58, P36, DOI 10.1111/aas.12223; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Reinhart K, 2012, CLIN MICROBIOL REV, V25, P609, DOI 10.1128/CMR.00016-12; Schmidt EP, 2014, J BIOL CHEM, V289, P8194, DOI 10.1074/jbc.M113.539452; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Schuerholz T, 2013, CRIT CARE, V17, DOI 10.1186/cc11920; Shafat I, 2007, NEOPLASIA, V9, P909, DOI 10.1593/neo.07673; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; van Griensven M, 2002, SHOCK, V18, P445, DOI 10.1097/00024382-200211000-00010; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Zanotti S, 2002, EXPERT OPIN INV DRUG, V11, P1061, DOI 10.1517/13543784.11.8.1061; Zhang LJ, 2006, EXPERT OPIN PHARMACO, V7, P653, DOI 10.1517/14656566.7.6.653	31	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143583	10.1371/journal.pone.0143583	http://dx.doi.org/10.1371/journal.pone.0143583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600070	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900146
J	Fischer, K; Ruttgers, D; Muller, HP; Jacobs, G; Kassubek, J; Lieb, W; Nothlings, U				Fischer, Karina; Ruettgers, Daniela; Mueller, Hans-Peter; Jacobs, Gunnar; Kassubek, Jan; Lieb, Wolfgang; Noethlings, Ute			Association of Habitual Patterns and Types of Physical Activity and Inactivity with MRI-Determined Total Volumes of Visceral and Subcutaneous Abdominal Adipose Tissue in a General White Population	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; INSULIN SENSITIVITY; FAT ACCUMULATION; BODY-COMPOSITION; SLEEP DURATION; VIEWING TIME; WEIGHT-LOSS; OBESITY; EXERCISE; RISK	Population-based evidence for the role of habitual physical activity (PA) in the accumulation of visceral (VAT) and subcutaneous (SAAT) abdominal adipose tissue is limited. We investigated if usual patterns and types of self-reported PA and inactivity were associated with VAT and SAAT in a general white population. Total volumes of VAT and SAAT were quantified by magnetic resonance imaging in 583 men and women (61 +/- 11.9 y; BMI 27.2 +/- 4.4 kg/m(2)). Past-year PA and inactivity were self-reported by questionnaire. Exploratory activity patterns (APAT) were derived by principal components analysis. Cross-sectional associations between individual activities, total PA in terms of metabolic equivalents (PA MET), or overall APAT and either VAT or SAAT were analyzed by multivariable-adjusted robust or generalized linear regression models. Whereas vigorous-intensity PA (VPA) was negatively associated with both VAT and SAAT, associations between total PA MET, moderate-intensity PA (MPA), or inactivity and VAT and/or SAAT depended on sex. There was also evidence of a threshold effect in some of these relationships. Total PA MET was more strongly associated with VAT in men (B = -3.3 +/- 1.4; P = 0.02) than women (B = -2.1 +/- 1.1; P = 0.07), but was more strongly associated with SAAT in women (B = -5.7 +/- 2.5; P = 0.05) than men (B = -1.7 +/- 1.6; P = 0.3). Men (-1.52 dm(3) or -1.89 dm(3)) and women (-1.15 dm(3) or -2.61 dm(3)) in the highest (> 6.8 h/wk VPA) or second (4.0-6.8 h/wk VPA) tertile of an APAT rich in VPA, had lower VAT and SAAT, respectively, than those in the lowest (< 4.0 h/wk VPA) tertile (P <= 0.016; P-trend <= 0.0005). They also had lower VAT and SAAT than those with APAT rich in MPA and/or inactivity only. In conclusion, our results suggest that in white populations, habitual APAT rich inMPA might be insufficient to impact on accumulation of VAT or SAAT. APAT including >= 4.0-6.8 h/wk VPA, by contrast, are more strongly associated with lower VAT and SAAT.	[Fischer, Karina; Ruettgers, Daniela; Noethlings, Ute] Univ Bonn, Dept Nutr & Food Sci, Bonn, Germany; [Mueller, Hans-Peter; Kassubek, Jan] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Jacobs, Gunnar; Lieb, Wolfgang] Univ Hosp Schleswig Holstein, PopGen Biobank, Kiel, Germany; [Lieb, Wolfgang] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Fischer, Karina] Univ Zurich Hosp, Dept Geriatr, CH-8091 Zurich, Switzerland; [Fischer, Karina] Univ Zurich, Ctr Aging & Mobil, Zurich, Switzerland	University of Bonn; Ulm University; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Zurich; University Zurich Hospital; University of Zurich	Fischer, K (corresponding author), Univ Bonn, Dept Nutr & Food Sci, Bonn, Germany.	karina.fischer@uzh.ch	Lieb, Wolfgang/AAC-7650-2022; Kassubek, Jan/F-2774-2015; Nöthlings, Ute/B-2713-2010; Kassubek, Jan/O-1740-2019; Kassubek, Jan/GPX-0910-2022	Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270	Deutsche Forschungsgemeinschaft [EXC306, EXC306/2]; German Federal Ministry of Education and Research [01GR0468]; German Federal Ministry for Education and Research [01EY1103]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	The work was supported by grants (EXC306, EXC306/2) from the Deutsche Forschungsgemeinschaft (http://www.dfg.de) Excellence Cluster "Inflammation at Interfaces" and through grants (01GR0468) from the German Federal Ministry of Education and Research (http://bmbf.de). The PopGen 2.0 network is supported by a grant (01EY1103) from the German Federal Ministry for Education and Research (http://bmbf.de). (Note to editors: All these grants were not recieved by a single author, but by the PopGen biobank). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2012, METAB SYNDR RELAT D, V10, P319, DOI 10.1089/met.2012.1502; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Arsenault BJ, 2010, INT J OBESITY, V34, P340, DOI 10.1038/ijo.2009.229; Ayabe M, 2013, INT J SPORTS MED, V34, P62, DOI 10.1055/s-0032-1314814; Benjamini Y, 2001, ANN STAT, V29, P1165; Bisschop CNS, 2013, MATURITAS, V76, P139, DOI 10.1016/j.maturitas.2013.06.015; Bosy-Westphal A, 2010, OBESITY, V18, P2111, DOI 10.1038/oby.2010.49; Browning LM, 2011, OBESITY FACTS, V4, P9, DOI 10.1159/000324546; Chaput JP, 2014, OBESITY, V22, pE9, DOI 10.1002/oby.20701; Chaston TB, 2008, INT J OBESITY, V32, P619, DOI 10.1038/sj.ijo.0803761; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; Coker RH, 2009, METAB SYNDR RELAT D, V7, P363, DOI 10.1089/met.2008.0060; Czernichow S, 2004, DIABETES METAB, V30, P153, DOI 10.1016/S1262-3636(07)70101-5; Dugan SA, 2010, OBESITY, V18, P1260, DOI 10.1038/oby.2009.396; Ekelund U, 2011, AM J CLIN NUTR, V93, P826, DOI 10.3945/ajcn.110.006593; Fischer K, 2015, AM J CLIN NUTR, V101, P794, DOI 10.3945/ajcn.114.101626; Greenfield JR, 2003, DIABETES CARE, V26, P2734, DOI 10.2337/diacare.26.10.2734; Hairston KG, 2010, SLEEP, V33, P289, DOI 10.1093/sleep/33.3.289; Hayes L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-723; Herzig KH, 2014, INT J OBESITY, V38, P1089, DOI 10.1038/ijo.2013.224; Hunter GR, 1996, INT J OBESITY, V20, P860; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Imamura F, 2009, AM J CLIN NUTR, V90, P1075, DOI 10.3945/ajcn.2009.28009; Kanaley JA, 2001, METABOLISM, V50, P976, DOI 10.1053/meta.2001.24931; Kay SJ, 2006, OBES REV, V7, P183, DOI 10.1111/j.1467-789X.2006.00250.x; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Labayen I, 2014, CLIN NUTR, V33, P859, DOI 10.1016/j.clnu.2013.10.008; Lakerveld J, 2011, PREV MED, V53, P299, DOI 10.1016/j.ypmed.2011.07.012; Lesser IA, 2012, J OBES, V2012, DOI 10.1155/2012/703941; Lindauer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067783; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; McGuire KA, 2012, OBESITY, V20, P576, DOI 10.1038/oby.2011.278; McKeown NM, 2010, AM J CLIN NUTR, V92, P1165, DOI 10.3945/ajcn.2009.29106; Molenaar EA, 2009, DIABETES CARE, V32, P505, DOI 10.2337/dc08-1382; Muller HP, 2011, NMR BIOMED, V24, P17, DOI 10.1002/nbm.1549; Nothlings U, 2012, BUNDESGESUNDHEITSBLA, V55, P831, DOI 10.1007/s00103-012-1487-2; Ocke MC, 2013, P NUTR SOC, V72, P191, DOI 10.1017/S0029665113000013; Ohkawara K, 2008, INT J OBESITY, V32, P395, DOI 10.1038/sj.ijo.0803749; Ohkawara K, 2007, INT J OBESITY, V31, P1786, DOI 10.1038/sj.ijo.0803683; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Riechman SE, 2002, OBES RES, V10, P1065, DOI 10.1038/oby.2002.144; Roemmich JN, 2000, AM J PHYSIOL-ENDOC M, V279, pE1426, DOI 10.1152/ajpendo.2000.279.6.E1426; Ruttgers D, 2015, BRIT J NUTR, V114, P1929, DOI 10.1017/S0007114515003682; Saelens BE, 2007, AM J CLIN NUTR, V85, P46, DOI 10.1093/ajcn/85.1.46; Samaras K, 1999, ANN INTERN MED, V130, P873, DOI 10.7326/0003-4819-130-11-199906010-00002; Sasai H, 2010, DIABETES RES CLIN PR, V88, P34, DOI 10.1016/j.diabres.2009.12.018; Pitanga CPS, 2012, ARQ BRAS ENDOCRINOL, V56, P358, DOI 10.1590/S0004-27302012000600003; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Smith SR, 1999, INT J OBESITY, V23, P329, DOI 10.1038/sj.ijo.0800834; So R, 2012, EUR J CLIN NUTR, V66, P1351, DOI 10.1038/ejcn.2012.147; Steeves JA, 2012, INT J OBESITY, V36, P100, DOI 10.1038/ijo.2011.50; Suijkerbuijk KPM, 2006, CANCER EPIDEM BIOMAR, V15, P456, DOI 10.1158/1055-9965.EPI-05-0569; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Trichopoulou A, 2001, AM J CLIN NUTR, V74, P574; Tripette Julien, 2014, BMC Res Notes, V7, P567, DOI 10.1186/1756-0500-7-567; Vissers D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056415; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366	61	2	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143925	10.1371/journal.pone.0143925	http://dx.doi.org/10.1371/journal.pone.0143925			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618489	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000365889800089
J	Lobo, V; Rao, P; Gajbhiye, R; Kulkarni, V; Parte, P				Lobo, Vivian; Rao, Parimala; Gajbhiye, Rahul; Kulkarni, Vijay; Parte, Priyanka			Glucose Regulated Protein 78 Phosphorylation in Sperm Undergoes Dynamic Changes during Maturation	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; GRP78; EXPRESSION; ASTHENOZOOSPERMIA; SPERMATOGENESIS; IDENTIFICATION; CHROMATOGRAPHY; PHOSPHATASES	GRP78, a resident endoplasmic reticulum (ER) chaperone involved in protein transport, folding and assembly, has been reported in sperm. It is shown to be localized in the neck region of human sperm. We have previously reported GRP78 to be less phosphorylated in asthenozoosperm. The present study aimed to determine whether sperm GRP78 undergoes phosphorylation changes during epididymal maturation and whether there are any differences in GRP78 phosphoforms in asthenozoosperm vis-alpha-vis normozoosperm. Testicular- and cauda epididymal-sperm from adult male Holtzman rats, and semen ejaculates collected from normal and asthenozoospermic individuals were investigated. DIGE carried out to determine phosphorylation of GRP78 in asthenozoosperm and normal sperm reveals a shift in the location of GRP78 of asthenozoosperm towards the alkaline pH, indicative of reduced GRP78 phosphorylation. Immunoprecipitation studies using antibodies specific to GRP78, serine-, threonine-, and tyrosine phosphorylation and Pan phospho antibody demonstrates GRP78 to be phosphorylated at all three residues in rat spermatozoa. Phosphatase assays using Calf intestinal alkaline phosphatase and Lambda protein phosphatase followed by nanofluidic proteomic immunoassay (NIA) show that in rat, GP(4.96), GP(4.94) and GP(4.85) are the three phosphoforms in mature (caudal) sperm as against two phosphoforms GP(4.96)and GP(4.94)in immature (testicular) sperm. In mature human sperm GP(5.04), GP(4.96), and GP(4.94)were the 3 phosphoforms observed. GP(4.94)[P = 0.014] andGP(5.04) [P = 0.02] are significantly reduced in asthenozoosperm. Ours is the first report indicating GRP78 in sperm to be phosphorylated at serine, threonine and tyrosine residues contrary to published literature reporting GRP78 not to be tyrosine phosphorylated. We report the presence of GRP78 phosphoforms in rat-and human-sperm and our data suggest that GRP78 phosphorylation in sperm undergoes spatial reorganization during epididymal maturation. Significant differences observed in 2 out of 3 phosphoforms in asthenozoosperm suggest that GRP78 phosphorylation may have functional relevance in sperm with consequent clinical implications.	[Lobo, Vivian; Rao, Parimala; Parte, Priyanka] Natl Inst Res Reprod Hlth ICMR, Dept Gamete Immunobiol, Bombay 400012, Maharashtra, India; [Gajbhiye, Rahul; Kulkarni, Vijay] Natl Inst Res Reprod Hlth ICMR, Dept Reprod Endocrinol & Infertil, Bombay 400012, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Parte, P (corresponding author), Natl Inst Res Reprod Hlth ICMR, Dept Gamete Immunobiol, Bombay 400012, Maharashtra, India.	partep@nirrh.res.in	Parte, Priyanka/L-5775-2019; Gajbhiye, Rahul/AAE-6889-2022	Parte, Priyanka/0000-0002-3800-4053; Gajbhiye, Rahul/0000-0003-3864-1818	Indian Council of Medical Research and Department of Biotechnology (DBT), India [RA/181/09-2014]; University Grants Commission (UGC); DBT, India	Indian Council of Medical Research and Department of Biotechnology (DBT), India; University Grants Commission (UGC)(University Grants Commission, India); DBT, India(Department of Biotechnology (DBT) India)	This work (RA/181/09-2014) was carried out with the financial support from the Indian Council of Medical Research and Department of Biotechnology (DBT), India and their support is gratefully acknowledged. The authors also thank the University Grants Commission (UGC) for the 'Maulana Azad Fellowship' provided to V. L. and DBT, India for Junior Research Fellowship (JRF) and Senior Research Fellowship (SRF) to P. R.	Aguilar-Mahecha A, 2001, BIOL REPROD, V65, P119, DOI 10.1095/biolreprod65.1.119; Bedu-Addo K, 2008, INT J DEV BIOL, V52, P615, DOI 10.1387/ijdb.072535kb; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLINO A, 1992, P NATL ACAD SCI USA, V89, P2081, DOI 10.1073/pnas.89.6.2081; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huo R, 2004, CELL TISSUE RES, V316, P359, DOI 10.1007/s00441-004-0885-7; Khan SA, 2009, REPRODUCTION, V138, P81, DOI 10.1530/REP-09-0052; Lachance C, 2007, HUM REPROD, V22, P2606, DOI 10.1093/humrep/dem242; Lachance C, 2010, INT J ANDROL, V33, P33, DOI 10.1111/j.1365-2605.2008.00948.x; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; MOSSNER E, 1980, H-S Z PHYSIOL CHEM, V361, P543, DOI 10.1515/bchm2.1980.361.1.543; Naaby-Hansen S, 2010, J REPROD IMMUNOL, V84, P32, DOI 10.1016/j.jri.2009.09.006; Organization WH, 2010, WHO LABORATORY MANUA; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Parte PP, 2012, J PROTEOMICS, V75, P5861, DOI 10.1016/j.jprot.2012.07.003; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Shen SL, 2013, WORLD J UROL, V31, P1395, DOI 10.1007/s00345-013-1023-5; Suryawanshi AR, 2011, J ANDROL, V32, P240, DOI 10.2164/jandrol.110.010967; Yan JX, 2002, PROTEOMICS, V2, P1682, DOI 10.1002/1615-9861(200212)2:12<1682::AID-PROT1682>3.0.CO;2-Y	24	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0141858	10.1371/journal.pone.0141858	http://dx.doi.org/10.1371/journal.pone.0141858			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618558	Green Submitted, gold, Green Published			2022-12-26	WOS:000365889800009
J	Nakashima, A; Ohkido, I; Yokoyama, K; Mafune, A; Urashima, M; Yokoo, T				Nakashima, Akio; Ohkido, Ichiro; Yokoyama, Keitaro; Mafune, Aki; Urashima, Mitsuyoshi; Yokoo, Takashi			Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; LOW SERUM MAGNESIUM; RESIDUAL RENAL-FUNCTION; BONE-MINERAL DENSITY; VASCULAR CALCIFICATION; ATRIAL-FIBRILLATION; HYPOMAGNESEMIA; RISK; DIALYSIS; EXPRESSION	Magnesium concentration is a proven predictor of mortality in hemodialysis patients. Recent reports have indicated that proton pump inhibitor (PPI) use affects serum magnesium levels, however few studies have investigated the relationship between PPI use and magnesium levels in hemodialysis patients. This study aimed to clarify the association between PPI use and serum magnesium levels in hemodialysis patients. We designed this cross sectional study and included 1189 hemodialysis patients in stable condition. Associations between PPI and magnesium-related factors, as well as other possible confounders, were evaluated using a multiple regression model. We defined hypomagnesemia as a value <2.0 mg/dL, and created comparable logistic regression models to assess the association between PPI use and hypomagnesemia. PPI use is associated with a significantly lower mean serum magnesium level than histamine 2 (H2) receptor antagonists or no acid-suppressive medications (mean [SD] PPI: 2.52 [0.45] mg/dL; H2 receptor antagonist: 2.68 [0.41] mg/dL; no acid suppressive medications: 2.68 [0.46] mg/dL; P = 0.001). Hypomagnesemia remained significantly associated with PPI (adjusted OR, OR: 2.05; 95% CI: 1.14-3.69; P = 0.017). PPI use is associated with an increased risk of hypomagnesemia in hemodialysis patients. Future prospective studies are needed to explore magnesium replacement in PPI users on hemodialysis.	[Nakashima, Akio; Ohkido, Ichiro; Yokoyama, Keitaro; Mafune, Aki; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan; [Nakashima, Akio; Mafune, Aki; Urashima, Mitsuyoshi] Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan	Jikei University; Jikei University	Nakashima, A (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan.	a-nakashima@jikei.ac.jp	Mafune, Aki/AAL-2293-2021	Mafune, Aki/0000-0002-6160-2879; Nakashima, Akio/0000-0002-3730-0301				Agus ZS, 1999, J AM SOC NEPHROL, V10, P1616; Alhosaini M, 2014, AM J NEPHROL, V39, P204, DOI 10.1159/000360011; Bai JPF, 2012, MOL PHARMACEUT, V9, P3495, DOI 10.1021/mp300323q; Bailie George R, 2006, Hemodial Int, V10, P180, DOI 10.1111/j.1542-4758.2006.00092.x; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Broeren MAC, 2009, ANN INTERN MED, V151, P755, DOI 10.7326/0003-4819-151-10-200911170-00016; Cano AE, 2007, AM J GASTROENTEROL, V102, P1990, DOI 10.1111/j.1572-0241.2007.01321.x; Castiglioni S, 2013, NUTRIENTS, V5, P3022, DOI 10.3390/nu5083022; Cundy T, 2008, CLIN ENDOCRINOL, V69, P338, DOI 10.1111/j.1365-2265.2008.03194.x; Cundy T, 2011, CURR OPIN GASTROEN, V27, P180, DOI 10.1097/MOG.0b013e32833ff5d6; Danziger J, 2008, CLIN J AM SOC NEPHRO, V3, P1504, DOI 10.2215/CJN.00770208; Danziger J, 2013, KIDNEY INT, V83, P692, DOI 10.1038/ki.2012.452; Epstein M, 2006, NEW ENGL J MED, V355, P1834, DOI 10.1056/NEJMc066308; Ethier J, 2007, AM J KIDNEY DIS, V50, P602, DOI 10.1053/j.ajkd.2007.07.007; Fusaro M, 2013, DRUG SAFETY, V36, P635, DOI 10.1007/s40264-013-0062-6; Hess MW, 2012, ALIMENT PHARM THER, V36, P405, DOI 10.1111/j.1365-2036.2012.05201.x; Hou JH, 2008, J CLIN INVEST, V118, P619, DOI 10.1172/JCI33970; Joosten MM, 2013, HYPERTENSION, V61, P1161, DOI 10.1161/HYPERTENSIONAHA.113.01333; Khan AM, 2013, CIRCULATION, V127, P33, DOI 10.1161/CIRCULATIONAHA.111.082511; Kirkpantur A, 2009, INT J CLIN PRACT, V63, P261, DOI 10.1111/j.1742-1241.2008.01883.x; Lameris ALL, 2013, PFLUG ARCH EUR J PHY, V465, P1613, DOI 10.1007/s00424-013-1306-0; Lau AN, 2015, ENDOCRINE, V49, P606, DOI 10.1007/s12020-015-0576-z; Lemes HP, 2011, CLIN EXP NEPHROL, V15, P554, DOI 10.1007/s10157-011-0427-z; Liao JN, 2015, KIDNEY INT, V87, P1209, DOI 10.1038/ki.2014.393; Lim H, 2015, J GASTROEN HEPATOL, V30, P478, DOI 10.1111/jgh.12780; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; Louvet L, 2013, NEPHROL DIAL TRANSPL, V28, P869, DOI 10.1093/ndt/gfs520; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mehrotra R, 1997, AM J KIDNEY DIS, V29, P106, DOI 10.1016/S0272-6386(97)90016-0; Navarro-Gonzalez JF, 2009, SEMIN DIALYSIS, V22, P37, DOI 10.1111/j.1525-139X.2008.00530.x; Okuno S, 2007, NEW PERSPECTIVES IN MAGNESIUM RESEARCH: NUTRITION AND HEALTH, P316, DOI 10.1007/978-1-84628-483-0_26; Orchard TS, 2014, AM J CLIN NUTR, V99, P926, DOI 10.3945/ajcn.113.067488; Paloian NJ, 2014, AM J PHYSIOL-RENAL, V307, pF891, DOI 10.1152/ajprenal.00163.2014; Pilkey RM, 2007, AM J KIDNEY DIS, V49, P432, DOI 10.1053/j.ajkd.2006.11.041; Quamme GA, 2008, CURR OPIN GASTROEN, V24, P230, DOI 10.1097/MOG.0b013e3282f37b59; Reffelmann T, 2011, ATHEROSCLEROSIS, V219, P280, DOI 10.1016/j.atherosclerosis.2011.05.038; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Rondon LJ, 2008, AM J PHYSIOL-REG I, V294, pR2001, DOI 10.1152/ajpregu.00153.2007; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Shabajee N, 2008, BMJ-BRIT MED J, DOI [10.1136/j.bmj.2008.39505.738981, DOI 10.1136/J.BMJ.2008.39505.738981]; Strid H, 2009, EUR J GASTROEN HEPAT, V21, P137, DOI 10.1097/MEG.0b013e3283200047; Van Laecke S, 2012, NEPHROL DIAL TRANSPL, V27, P4003, DOI 10.1093/ndt/gfs126; Wang AYM, 2006, KIDNEY INT, V69, P1726, DOI 10.1038/sj.ki.5000382; William JH, 2014, NEPHROLOGY, V19, P798, DOI 10.1111/nep.12330; Wu LL, 2014, ACTA BIOMATER, V10, P2843, DOI 10.1016/j.actbio.2014.02.010; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Zipursky J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001736	49	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143656	10.1371/journal.pone.0143656	http://dx.doi.org/10.1371/journal.pone.0143656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618538	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800054
J	Fornari, TA; Donate, PB; Assis, AF; Macedo, C; Sakamoto-Hojo, ET; Donadi, EA; Passos, GA				Fornari, Thais A.; Donate, Paula B.; Assis, Amanda F.; Macedo, Claudia; Sakamoto-Hojo, Elza T.; Donadi, Eduardo A.; Passos, Geraldo A.			Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice	PLOS ONE			English	Article							GENETIC-CONTROL; MOUSE MODEL; TYPE-1; CELLS; MECHANISMS; TOLERANCE; PREDICTION; INITIATION; INSULITIS; SEQUENCE	In autoimmune type 1 diabetes mellitus (T1D), auto-reactive clones of CD4(+) and CD8(+) T lymphocytes in the periphery evolve into pancreas-infiltrating T lymphocytes (PILs), which destroy insulin-producing beta-cells through inflammatory insulitis. Previously, we demonstrated that, during the development of T1D in non-obese diabetic (NOD) mice, a set of immune/inflammatory reactivity genes were differentially expressed in T lymphocytes. However, the posttranscriptional control involving miRNA interactions that occur during the evolution of thymocytes into PILs remains unknown. In this study, we postulated that miRNAs are differentially expressed during this period and that these miRNAs can interact with mRNAs involved in auto-reactivity during the progression of insulitis. To test this hypothesis, we used NOD mice to perform, for the first time, a comprehensive survey of miRNA and mRNA expression as thymocytes mature into peripheral CD3(+) T lymphocytes and, subsequently, into PILs. Reconstruction of miRNA-mRNA interaction networks for target prediction revealed the participation of a large set of miRNAs that regulate mRNA targets related to apoptosis, cell adhesion, cellular regulation, cellular component organization, cellular processes, development and the immune system, among others. The interactions between miR-202-3p and the Ccr7 chemokine receptor mRNA or Cd247 (Cd3 zeta chain) mRNA found in PILs are highlighted because these interactions can contribute to a better understanding of how the lack of immune homeostasis and the emergence of autoimmunity (e.g., T1D) can be associated with the decreased activity of Ccr7 or Cd247, as previously observed in NOD mice. We demonstrate that these mRNAs are controlled at the posttranscriptional level in PILs.	[Fornari, Thais A.; Donate, Paula B.; Assis, Amanda F.; Macedo, Claudia; Sakamoto-Hojo, Elza T.; Donadi, Eduardo A.; Passos, Geraldo A.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Mol Immunogenet Grp, BR-14049900 Ribeirao Preto, SP, Brazil; [Sakamoto-Hojo, Elza T.] Univ Sao Paulo, Dept Biol, Fac Philosophy Sci & Letters Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil; [Donadi, Eduardo A.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Med, Div Clin Immunol, BR-14049900 Ribeirao Preto, SP, Brazil; [Passos, Geraldo A.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Discipline Genet, BR-14040904 Ribeirao Preto, SP, Brazil; [Passos, Geraldo A.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Discipline Mol Biol, BR-14040904 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Passos, GA (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Mol Immunogenet Grp, BR-14049900 Ribeirao Preto, SP, Brazil.	passos@usp.br	Passos, Geraldo Aleixo/ABE-3251-2020; Sakamoto-Hojo, Elza Tiemi/C-3959-2012; Passos, Geraldo A/A-2899-2008; donadi, eduardo A/H-7080-2013	Passos, Geraldo Aleixo/0000-0002-4408-140X; Sakamoto-Hojo, Elza Tiemi/0000-0002-1383-3314; Passos, Geraldo A/0000-0002-4408-140X; donadi, eduardo A/0000-0002-9457-9601; Freire Assis, Amanda/0000-0003-4738-8260	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo, Brazil) [08/56594-8]; FAPESP-CEPID Inflammatory Diseases [13/08216-2]; University of Sao Paulo NAP-Inflammatory Diseases (NAP-DIN); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brasilia, Brazil)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP-CEPID Inflammatory Diseases; University of Sao Paulo NAP-Inflammatory Diseases (NAP-DIN); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brasilia, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo, Brazil) through Thematic Project (08/56594-8), FAPESP-CEPID Inflammatory Diseases (13/08216-2), University of Sao Paulo NAP-Inflammatory Diseases (NAP-DIN), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, Brazil) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brasilia, Brazil).	Acharjee S, 2013, CAN J DIABETES, V37, P269, DOI 10.1016/j.jcjd.2013.05.001; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Anderson G, 2014, CURR TOP MICROBIOL, V373, P19, DOI 10.1007/82_2013_320; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; BERGMAN B, 1994, DIABETES, V43, P197, DOI 10.2337/diabetes.43.2.197; Bettini M, 2011, CURR OPIN IMMUNOL, V23, P754, DOI 10.1016/j.coi.2011.10.002; Bluestone J. A., 2012, COLD SPRING HARBOR P, V4; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Boitard C, 2012, PRESSE MED, V41, pE636, DOI 10.1016/j.lpm.2012.10.003; Burt TD, 2013, AM J REPROD IMMUNOL, V69, P346, DOI 10.1111/aji.12083; Chentoufi AA, 2008, SCAND J IMMUNOL, V68, P1, DOI 10.1111/j.1365-3083.2008.02120.x; Donate PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054803; Driver JP, 2011, SEMIN IMMUNOPATHOL, V33, P67, DOI 10.1007/s00281-010-0204-1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fornari TA, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/158735; Fousteri G, 2013, CLIN IMMUNOL, V149, P556, DOI 10.1016/j.clim.2013.10.006; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Gonzalez A, 1997, IMMUNITY, V7, P873, DOI 10.1016/S1074-7613(00)80405-7; Groop L, 2014, MOL CELL ENDOCRINOL, V382, P726, DOI 10.1016/j.mce.2013.04.002; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; IKEGAMI H, 1995, J CLIN INVEST, V96, P1936, DOI 10.1172/JCI118239; Jayasimhan A, 2014, CLIN SCI, V126, P1, DOI 10.1042/CS20120627; Kanagawa O, 2002, J IMMUNOL, V168, P6159, DOI 10.4049/jimmunol.168.12.6159; KATZ J, 1993, EUR J IMMUNOL, V23, P3358, DOI 10.1002/eji.1830231244; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Knip M, 2008, AUTOIMMUN REV, V7, P550, DOI 10.1016/j.autrev.2008.04.008; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; LEITER EH, 1987, AM J PATHOL, V128, P380; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lundholm M, 2010, J IMMUNOL, V184, P5537, DOI 10.4049/jimmunol.0904012; Ma DY, 2013, DEV COMP IMMUNOL, V39, P91, DOI 10.1016/j.dci.2011.12.013; Magnuson AM, 2015, P NATL ACAD SCI USA, V112, P1511, DOI 10.1073/pnas.1423769112; Martin AP, 2009, J IMMUNOL, V183, P3073, DOI 10.4049/jimmunol.0900275; Martinic MM, 2008, IMMUNOL REV, V221, P200, DOI 10.1111/j.1600-065X.2008.00581.x; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Morahan G, 2012, CURR OPIN ENDOCRINOL, V19, P263, DOI 10.1097/MED.0b013e328355b7fe; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Nokoff NJ, 2012, DISCOV MED, V13, P115; Notkins AL, 2001, J CLIN INVEST, V108, P1247, DOI 10.1172/JCI200114257; Palmero EI, 2011, GENET MOL BIOL, V34, P363, DOI 10.1590/S1415-47572011000300001; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reyes-Garcia MG, 2013, BIOMED RES INT, V2013; Ridgway WM, 2008, ADV IMMUNOL, V100, P151, DOI 10.1016/S0065-2776(08)00806-7; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; SHIZURU JA, 1988, SCIENCE, V240, P659, DOI 10.1126/science.2966437; Stadinski B, 2010, IMMUNITY, V32, P446, DOI 10.1016/j.immuni.2010.04.008; Taniguchi RT, 2011, IMMUNOL CELL BIOL, V89, P40, DOI 10.1038/icb.2010.132; Thayer TC, 2010, ENDOCRIN METAB CLIN, V39, P541, DOI 10.1016/j.ecl.2010.05.001; Tsirogianni A, 2009, AUTOIMMUN REV, V8, P687, DOI 10.1016/j.autrev.2009.02.019; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Zucchelli S, 2005, IMMUNITY, V22, P385, DOI 10.1016/j.immuni.2005.01.015	58	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142688	10.1371/journal.pone.0142688	http://dx.doi.org/10.1371/journal.pone.0142688			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606254	Green Submitted, gold, Green Published			2022-12-26	WOS:000365865300027
J	Smith, AM; Njanpop-Lafourcade, BM; Mengel, MA; Gessner, BD; Sauvageot, D; Bidjada, B; Miwanda, BN; Saliou, DM; N'Douba, AK; Langa, JP; Ismail, H; Tau, N; Sooka, A; Keddy, KH				Smith, Anthony M.; Njanpop-Lafourcade, Berthe-Marie; Mengel, Martin A.; Gessner, Bradford D.; Sauvageot, Delphine; Bidjada, Bawimodom; Miwanda, Berthe N.; Saliou, Diallo M.; N'Douba, Adele Kacou; Langa, Jose P.; Ismail, Husna; Tau, Nomsa; Sooka, Arvinda; Keddy, Karen. H.			Comparative Characterization of Vibrio cholerae O1 from Five Sub-Saharan African Countries Using Various Phenotypic and Genotypic Techniques	PLOS ONE			English	Article							SOUTH-AFRICA; GENETIC-CHARACTERIZATION; MULTIDRUG-RESISTANT; STRAINS; OUTBREAK; EPIDEMIC; MOZAMBIQUE; TRANSMISSION; INTEGRON; SEQUENCE	We used standardized methodologies to characterize Vibrio cholerae O1 isolates from Guinea, Democratic Republic of the Congo (DRC), Togo, Cote d'Ivoire and Mozambique. We investigated 257 human isolates collected in 2010 to 2013. DRC isolates serotyped O1 Inaba, while isolates from other countries serotyped O1 Ogawa. All isolates were biotype El Tor and positive for cholera toxin. All isolates showed multidrug resistance but lacked ciprofloxacin resistance. Antimicrobial susceptibility profiles of isolates varied between countries. In particular, the susceptibility profile of isolates from Mozambique (East-Africa) included resistance to ceftriaxone and was distinctly different to the susceptibility profiles of isolates from countries located in West-and Central-Africa. Molecular subtyping of isolates using pulsed-field gel electrophoresis (PFGE) analysis showed a complex relationship among isolates. Some PFGE patterns were unique to particular countries and clustered by country; while other PFGE patterns were shared by isolates from multiple countries, indicating that the same genetic lineage is present in multiple countries. Our data add to a better understanding of cholera epidemiology in Africa.	[Smith, Anthony M.; Ismail, Husna; Tau, Nomsa; Sooka, Arvinda; Keddy, Karen. H.] Div Natl Hlth Lab Serv NHLS, Natl Inst Communicable Dis, Ctr Enter Dis, Johannesburg, South Africa; [Smith, Anthony M.; Ismail, Husna; Tau, Nomsa; Keddy, Karen. H.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Njanpop-Lafourcade, Berthe-Marie; Mengel, Martin A.; Gessner, Bradford D.; Sauvageot, Delphine] AMP, Paris, France; [Sauvageot, Delphine; Bidjada, Bawimodom] Natl Inst Hyg, Lome, Togo; [Miwanda, Berthe N.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Saliou, Diallo M.] Inst Natl Sante Publ, Conakry, Guinea; [N'Douba, Adele Kacou] Inst Pasteur Cote dIvoire, Abidjan, Cote Ivoire; [Langa, Jose P.] Natl Inst Hlth, Maputo, Mozambique	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Agence de Medecine Preventive; Institute Nacional de Recherche Biomedical	Smith, AM (corresponding author), Div Natl Hlth Lab Serv NHLS, Natl Inst Communicable Dis, Ctr Enter Dis, Johannesburg, South Africa.	anthonys@nicd.ac.za	Keddy, Karen Helena/AAZ-2189-2020	Keddy, Karen Helena/0000-0001-8640-2235	Bill & Melinda Gates Foundation [OPPGH5233]; Centers for Disease Control and Prevention, USA [5U19GH000571-02]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Centers for Disease Control and Prevention, USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Africhol is a project fully funded by the Bill & Melinda Gates Foundation (grant number OPPGH5233). Parts of the laboratory analysis of isolates were funded by a Cooperative Agreement (5U19GH000571-02) from the Centers for Disease Control and Prevention, USA. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.	Akoachere JFTK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-366; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; [Anonymous], 2014, AGENCE MED PREVENTIV; [Anonymous], 2014, M100S24 CLSI; [Anonymous], 2014, WEEKLY EPIDEMIOLOGIC, V89, P345; Ansaruzzaman M, 2004, EMERG INFECT DIS, V10, P2057, DOI 10.3201/eid1011.040682; Bhuiyan NA, 2012, EPIDEMIOL INFECT, V140, P510, DOI 10.1017/S0950268811000926; Cooper KLF, 2006, FOODBORNE PATHOG DIS, V3, P51, DOI 10.1089/fpd.2006.3.51; Dalsgaard A, 2001, J ANTIMICROB CHEMOTH, V48, P827, DOI 10.1093/jac/48.6.827; Dalsgaard A, 2000, J CLIN MICROBIOL, V38, P3774, DOI 10.1128/JCM.38.10.3774-3779.2000; De R, 2013, J INFECT DIS, V208, pS32, DOI 10.1093/infdis/jit199; Folgosa E, 2001, EPIDEMIOL INFECT, V127, P17, DOI 10.1017/S0950268801005623; Grim CJ, 2010, J BACTERIOL, V192, P3524, DOI 10.1128/JB.00040-10; Islam MS, 2011, J CLIN MICROBIOL, V49, P2325, DOI 10.1128/JCM.00432-11; Ismail H, 2013, J INFECT DIS, V208, pS39, DOI 10.1093/infdis/jit200; Ismail H, 2012, J INFECT DEV COUNTR, V6, P897, DOI 10.3855/jidc.2448; Ismail H, 2011, J CLIN MICROBIOL, V49, P2976, DOI 10.1128/JCM.00293-11; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KEASLER SP, 1993, LANCET, V341, P1661, DOI 10.1016/0140-6736(93)90792-F; Kiiru J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074829; Lee JH, 2006, J MED MICROBIOL, V55, P165, DOI 10.1099/jmm.0.46287-0; Lunguya Octavie, 2012, PLoS Negl Trop Dis, V6, pe1921, DOI 10.1371/journal.pntd.0001921; Mengel MA, 2014, CURR TOP MICROBIOL, V379, P117, DOI 10.1007/82_2014_369; Miwanda B, 2015, EMERG INFECT DIS, V21, P847, DOI 10.3201/eid2105.141233; Mohamed AA, 2012, EMERG INFECT DIS, V18, P925, DOI 10.3201/eid1806.111774; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Mwansa JCL, 2007, EPIDEMIOL INFECT, V135, P847, DOI 10.1017/S0950268806007254; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Ng LK, 2003, ANTIMICROB AGENTS CH, V47, P1479, DOI 10.1128/AAC.47.4.1479-1480.2003; Opintan JA, 2008, J ANTIMICROB CHEMOTH, V62, P929, DOI 10.1093/jac/dkn334; Oyedeji KS, 2013, J HEALTH POPUL NUTR, V31, P178; Pugliese N, 2009, J ANTIMICROB CHEMOTH, V63, P438, DOI 10.1093/jac/dkn542; Rebaudet S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002898; Rebaudet S, 2013, J INFECT DIS, V208, pS98, DOI 10.1093/infdis/jit202; Rebaudet S, 2013, J INFECT DIS, V208, pS46, DOI 10.1093/infdis/jit195; Saidi SM, 2014, J MED MICROBIOL, V63, P415, DOI 10.1099/jmm.0.068999-0; Smith AM, 2008, EPIDEMIOL INFECT, V136, P1207, DOI 10.1017/S0950268807009685; Smith AM, 2011, J MED MICROBIOL, V60, P1405, DOI 10.1099/jmm.0.030700-0; Talkington D, 2011, EMERG INFECT DIS, V17, P2122, DOI 10.3201/eid1711.110805; Thompson CC, 2011, INFECT GENET EVOL, V11, P1951, DOI 10.1016/j.meegid.2011.08.020; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	42	7	7	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142989	10.1371/journal.pone.0142989	http://dx.doi.org/10.1371/journal.pone.0142989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606536	gold, Green Submitted, Green Published			2022-12-26	WOS:000365865300039
J	Xu, CCY; Yen, IJ; Bowman, D; Turner, CR				Xu, Charles C. Y.; Yen, Ivy J.; Bowman, Dean; Turner, Cameron R.			Spider Web DNA: A New Spin on Noninvasive Genetics of Predator and Prey	PLOS ONE			English	Article							ARANEAE THERIDIIDAE; SAMPLING METHODS; WIDOW; IDENTIFICATION; BIODIVERSITY; DIVERSITY	Noninvasive genetic sampling enables biomonitoring without the need to directly observe or disturb target organisms. This paper describes a novel and promising source of noninvasive spider and insect DNA from spider webs. Using black widow spiders (Latrodectus spp.) fed with house crickets (Acheta domesticus), we successfully extracted, amplified, and sequenced mitochondrial DNA from spider web samples that identified both spider and prey to species. Detectability of spider DNA did not differ between assays with amplicon sizes from 135 to 497 base pairs. Spider and prey DNA remained detectable at least 88 days after living organisms were no longer present on the web. Spider web DNA as a proof-of-concept may open doors to other practical applications in conservation research, pest management, biogeography studies, and biodiversity assessments.	[Xu, Charles C. Y.; Yen, Ivy J.; Turner, Cameron R.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Bowman, Dean] Potawatomi Zoo, South Bend, IN USA	University of Notre Dame	Xu, CCY (corresponding author), Uppsala Univ, Dept Ecol & Genet, Anim Ecol Res Grp, Evolutionary Biol Ctr, Uppsala, Sweden.	charles.cong.xu@gmail.com	Xu, Cong/O-6143-2014	Xu, Cong/0000-0001-6779-8879	NSF IGERT [0504495]	NSF IGERT(National Science Foundation (NSF))	Funding for this work came from the University of Notre Dame through the laboratory of Dr. David Lodge to support CCYX's independent undergraduate research. CRT was supported by NSF IGERT grant award #0504495 to the GLOBES graduate training program at the University of Notre Dame. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti N, 2003, MOL ECOL, V12, P3467, DOI 10.1046/j.1365-294X.2003.02014.x; Agusti N, 2003, B ENTOMOL RES, V93, P179, DOI 10.1079/BER2003236; [Anonymous], WORLD SPID CAT VERS; Arnedo MA, 2004, MOL PHYLOGENET EVOL, V31, P225, DOI 10.1016/S1055-7903(03)00261-6; Astrin JJ, 2006, ZOOL SCR, V35, P441, DOI 10.1111/j.1463-6409.2006.00239.x; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blagoev GA, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-44; Brennan Karl E. C., 2004, Pacific Conservation Biology, V10, P241; Calvignac-Spencer S, 2013, MOL ECOL, V22, P915, DOI 10.1111/mec.12183; Chen Y, 2000, MOL ECOL, V9, P1887, DOI 10.1046/j.1365-294x.2000.01100.x; Churchill TB, 1999, J INSECT CONSERV, V3, P287, DOI 10.1023/A:1009638706789; Churchill Tracey B., 1997, Memoirs of Museum Victoria, V56, P331; Clausen I.H.S., 1986, Bulletin of the British Arachnological Society, V7, P83; Dondale Charles D., 2002, Biodiversity (Ottawa), V3, P17; Doran NE, 1999, J INSECT CONSERV, V3, P257, DOI 10.1023/A:1009677531343; Eggs B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082637; Feinstein J, 2004, CONSERV GENET, V5, P103, DOI 10.1023/B:COGE.0000014058.34840.94; Fetzner JW, 1999, BIOTECHNIQUES, V26, P1052, DOI 10.2144/99266bm09; Garb JE, 2004, MOL PHYLOGENET EVOL, V31, P1127, DOI 10.1016/j.ympev.2003.10.012; Gariepy TD, 2012, MOL ECOL RESOUR, V12, P646, DOI 10.1111/j.1755-0998.2012.03140.x; Gollan JR, 2010, BIODIVERS CONSERV, V19, P3141, DOI 10.1007/s10531-010-9882-1; Green J, 1999, J ARACHNOL, V27, P176; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoy MA, 1994, INSECT MOL GENETICS; Huber B, 2004, BIOSEMIOTIK PRAKTISC, P89; Huber BA, 2001, J ZOOL, V255, P301, DOI 10.1017/S095283690100139X; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Krell B, 2015, LIMNOLOGICA, V51, P1, DOI 10.1016/j.limno.2014.10.001; KREMEN C, 1993, CONSERV BIOL, V7, P796, DOI 10.1046/j.1523-1739.1993.740796.x; Lewitus V, 1935, AM J NURS, V35, P751, DOI 10.2307/3412883; Maelfait Jean-Pierre, 1998, P293; MOULDER BC, 1972, ECOL MONOGR, V42, P473, DOI 10.2307/1942168; Nattier R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048047; Nielsen Ebbe S., 2000, P213; Pearce JL, 2006, ECOL INDIC, V6, P780, DOI 10.1016/j.ecolind.2005.03.005; Petersen SD, 2007, CONSERV GENET, V8, P497, DOI 10.1007/s10592-006-9173-2; Riecken U, 1999, J ARACHNOL, V27, P189; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; ROSENBERG DM, 1986, ENVIRON MANAGE, V10, P773, DOI 10.1007/BF01867730; Salomon M, 2011, J ARACHNOL, V39, P154, DOI 10.1636/P10-25.1; SAMU F, 1992, PESTIC SCI, V36, P47, DOI 10.1002/ps.2780360108; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; Scott AG, 2006, BIOL CONSERV, V127, P420, DOI 10.1016/j.biocon.2005.09.001; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Sint D, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0096-y; Sint D, 2011, MOL ECOL RESOUR, V11, P795, DOI 10.1111/j.1755-0998.2011.03018.x; Sirvid PJ, 2012, NZ ENTOMOL, V35, P85, DOI 10.1080/00779962.2012.686310; Sorensen LL, 2002, ENVIRON ENTOMOL, V31, P319, DOI 10.1603/0046-225X-31.2.319; SUNDERLAND KD, 1986, J APPL ECOL, V23, P433, DOI 10.2307/2404027; Townzen JS, 2008, MED VET ENTOMOL, V22, P386, DOI 10.1111/j.1365-2915.2008.00760.x; Vetter RS, 2012, J MED ENTOMOL, V49, P947, DOI 10.1603/ME11285; Vink CJ, 2011, BIOL INVASIONS, V13, P1003, DOI 10.1007/s10530-010-9885-6; Winkler S, 2000, J Biotechnol, V74, P85; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zevenbergen JM, 2008, ANIM BEHAV, V76, P823, DOI 10.1016/j.anbehav.2008.05.008	57	22	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142503	10.1371/journal.pone.0142503	http://dx.doi.org/10.1371/journal.pone.0142503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606730	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300021
J	Fried, P; Iber, D				Fried, Patrick; Iber, Dagmar			Read-Out of Dynamic Morphogen Gradients on Growing Domains	PLOS ONE			English	Article							DPP MORPHOGEN; DROSOPHILA; PATTERN; CELL; MECHANISMS	Quantitative data from the Drosophila wing imaginal disc reveals that the amplitude of the Decapentaplegic (Dpp) morphogen gradient increases continuously. It is an open question how cells can determine their relative position within a domain based on a continuously increasing gradient. Here we show that pre-steady state diffusion-based dispersal of morphogens results in a zone within the growing domain where the concentration remains constant over the patterning period. The position of the zone that is predicted based on quantitative data for the Dpp morphogen corresponds to where the Dpp-dependent gene expression boundaries of spalt (sal) and daughters against dpp (dad) emerge. The model also suggests that genes that are scaling and are expressed at lateral positions are either under the control of a different read-out mechanism or under the control of a different morphogen. The patterning mechanism explains the extraordinary robustness that is observed for variations in Dpp production, and offers an explanation for the dual role of Dpp in controlling patterning and growth. Pre-steady-state dynamics are pervasive in morphogen-controlled systems, thus making this a probable general mechanism for the scaled read-out of morphogen gradients in growing developmental systems.	[Fried, Patrick; Iber, Dagmar] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Fried, Patrick; Iber, Dagmar] SIB Swiss Inst Bioinformat, Basel, Switzerland	ETH Zurich; Swiss Institute of Bioinformatics	Iber, D (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	dagmar.iber@bsse.ethz.ch	Iber, Dagmar/V-2846-2019	Iber, Dagmar/0000-0001-8051-1035				Aegerter-Wilmsen T, 2012, DEVELOPMENT, V139, P3221, DOI 10.1242/dev.082800; Averbukh I, 2014, DEVELOPMENT, V141, P2150, DOI 10.1242/dev.107011; Bai LG, 2013, PROC SPIE, V8654, DOI 10.1117/12.2008497; Bangi E, 2006, DEV BIOL, V295, P178, DOI 10.1016/j.ydbio.2006.03.021; Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Cook O, 2004, DEVELOPMENT, V131, P2113, DOI 10.1242/dev.01100; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Fried P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6077; Funakoshi Y, 2001, DEVELOPMENT, V128, P67; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; He F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7679; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Kuntz SG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004293; Lander AD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002022; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Schwank G, 2012, SCIENCE, V335, DOI 10.1126/science.1210997; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	34	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143226	10.1371/journal.pone.0143226	http://dx.doi.org/10.1371/journal.pone.0143226			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599604	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600040
J	Paletta, D; Fichtner, AS; Starick, L; Porcelli, SA; Savage, PB; Herrmann, T				Paletta, Daniel; Fichtner, Alina Suzann; Starick, Lisa; Porcelli, Steven A.; Savage, Paul B.; Herrmann, Thomas			Species Specific Differences of CD1d Oligomer Loading In Vitro	PLOS ONE			English	Article							T-CELL-RECEPTOR; COMPLEMENTARITY-DETERMINING REGION-2; TRIGLYCERIDE TRANSFER PROTEIN; ANTIGEN PRESENTATION; ALPHA-CHAIN; RECOGNITION; NKT; TETRAMERS; TCR; BINDING	CD1d molecules are MHC class I-like molecules that present glycolipids to iNKT cells. The highly conserved interaction between CD1d:alpha-Galactosylceramide (alpha GC) complexes and the iNKT TCR not only defines this population of alpha beta T cells but can also be used for its direct identification. Therefore, CD1d oligomers are a widely used tool for iNKT cell related investigations. To this end, the lipid chains of the antigen have to be inserted into the hydrophobic pockets of the CD1d binding cleft, often with help of surfactants. In this study, we investigated the influence of different surfactants (Triton X-100, Tween 20, Tyloxapol) on in vitro loading of CD1d molecules derived from four different species (human, mouse, rat and cotton rat) with aGC and derivatives carrying modifications of the acyl-chain (DB01-1, PBS44) and a 6-acetamido-6-deoxy-addition at the galactosyl head group (PBS57). We also compared rat CD1d dimers with tetramers and staining of an iNKT TCR transductant was used as readout for loading efficacy. The results underlined the importance of CD1d loading efficacy for proper analysis of iNKT TCR binding and demonstrated the necessity to adjust loading conditions for each oligomer/glycolipid combination. The efficient usage of surfactants as a tool for CD1d loading was revealed to be species-specific and depending on the origin of the CD1d producing cells. Additional variation of surfactant-dependent loading efficacy between tested glycolipids was influenced by the acyl-chain length and the modification of the galactosyl head group with PBS57 showing the least dependence on surfactants and the lowest degree of species-dependent differences.	[Paletta, Daniel; Fichtner, Alina Suzann; Starick, Lisa; Herrmann, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Savage, Paul B.] Brigham Young Univ, Dept Chem, Provo, UT 84602 USA	University of Wurzburg; Yeshiva University; Albert Einstein College of Medicine; Brigham Young University	Herrmann, T (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany.	herrmann-t@vim.uni-wuerzburg.de	Savage, Paul B/E-1448-2011; Savage, Paul B/HGB-3414-2022; Herrmann, Thomas/J-4943-2012	Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109; Herrmann, Thomas/0000-0002-1093-0194; Fichtner, Alina Suzann/0000-0003-4772-9352	Deutsche Forschungsgemeinschaft DFG [HE 2346/6-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft DFG HE 2346/6-1 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; DALPORTO J, 1993, P NATL ACAD SCI USA, V90, P6671, DOI 10.1073/pnas.90.14.6671; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Facciotti F, 2011, P NATL ACAD SCI USA, V108, P14228, DOI 10.1073/pnas.1108809108; Fichtner AS, 2015, IMMUNOLOGY, V146, P618, DOI 10.1111/imm.12532; Freigang S, 2012, J CLIN INVEST, V122, P3943, DOI 10.1172/JCI62267; Gadola SD, 2003, PHILOS T ROY SOC B, V358, P875, DOI 10.1098/rstb.2003.1267; Greenaway HY, 2013, IMMUNOBIOLOGY, V218, P213, DOI 10.1016/j.imbio.2012.04.003; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Kasmar A, 2009, CURR OPIN IMMUNOL, V21, P397, DOI 10.1016/j.coi.2009.05.022; KOSEKI H, 1990, P NATL ACAD SCI USA, V87, P5248, DOI 10.1073/pnas.87.14.5248; Kreiss M, 2004, INT IMMUNOL, V16, P655, DOI 10.1093/intimm/dxh068; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; Ly D, 2014, CELL MOL LIFE SCI, V71, P3069, DOI 10.1007/s00018-014-1603-6; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; MCMICHAEL AJ, 1979, EUR J IMMUNOL, V9, P205, DOI 10.1002/eji.1830090307; Monzon-Casanova E, 2010, RAT INKT CELLS PHENO, pp51; Monzon-Casanova E, 2013, EUR J IMMUNOL, V43, P404, DOI 10.1002/eji.201242565; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; Paletta D, 2015, EUR J IMMUNOL, V45, P2122, DOI 10.1002/eji.201545534; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Pyz E, 2006, J IMMUNOL, V176, P7447, DOI 10.4049/jimmunol.176.12.7447; Schneck Jonathan P., 2000, Immunological Investigations, V29, P163, DOI 10.3109/08820130009062300; Sidobre S, 2002, J IMMUNOL METHODS, V268, P107, DOI 10.1016/S0022-1759(02)00204-1; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; Van Rhijn I, 2006, J IMMUNOL, V176, P4888, DOI 10.4049/jimmunol.176.8.4888; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	42	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143449	10.1371/journal.pone.0143449	http://dx.doi.org/10.1371/journal.pone.0143449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599805	gold, Green Submitted, Green Published			2022-12-26	WOS:000365862600067
J	Wang, J; Kato, F; Oyama-Manabe, N; Li, RJ; Cui, Y; Tha, KK; Yamashita, H; Kudo, K; Shirato, H				Wang, Jeff; Kato, Fumi; Oyama-Manabe, Noriko; Li, Ruijiang; Cui, Yi; Tha, Khin Khin; Yamashita, Hiroko; Kudo, Kohsuke; Shirato, Hiroki			Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study	PLOS ONE			English	Article							COMPUTER-AIDED-DIAGNOSIS; MAMMOGRAPHIC DENSITY; SIGNAL ENHANCEMENT; MENSTRUAL-CYCLE; IMAGE-ANALYSIS; RISK; ASSOCIATION; FEATURES; LESIONS; TUMORS	Objectives To determine the added discriminative value of detailed quantitative characterization of background parenchymal enhancement in addition to the tumor itself on dynamic contrast-enhanced (DCE) MRI at 3.0 Tesla in identifying "triple-negative" breast cancers. Materials and Methods In this Institutional Review Board-approved retrospective study, DCE-MRI of 84 women presenting 88 invasive carcinomas were evaluated by a radiologist and analyzed using quantitative computer-aided techniques. Each tumor and its surrounding parenchyma were segmented semi-automatically in 3-D. A total of 85 imaging features were extracted from the two regions, including morphologic, densitometric, and statistical texture measures of enhancement. A small subset of optimal features was selected using an efficient sequential forward floating search algorithm. To distinguish triple-negative cancers from other sub-types, we built predictive models based on support vector machines. Their classification performance was assessed with the area under receiver operating characteristic curve (AUC) using cross-validation. Results Imaging features based on the tumor region achieved an AUC of 0.782 in differentiating triple-negative cancers from others, in line with the current state of the art. When background parenchymal enhancement features were included, the AUC increased significantly to 0.878 (p<0.01). Similar improvements were seen in nearly all subtype classification tasks undertaken. Notably, amongst the most discriminating features for predicting triple-negative cancers were textures of background parenchymal enhancement. Conclusions Considering the tumor as well as its surrounding parenchyma on DCE-MRI for radiomic image phenotyping provides useful information for identifying triple-negative breast cancers. Heterogeneity of background parenchymal enhancement, characterized by quantitative texture features on DCE-MRI, adds value to such differentiation models as they are strongly associated with the triple-negative subtype. Prospective validation studies are warranted to confirm these findings and determine potential implications.	[Wang, Jeff; Tha, Khin Khin; Shirato, Hiroki] Hokkaido Univ, Dept Radiat Med, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kato, Fumi; Oyama-Manabe, Noriko; Kudo, Kohsuke] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Li, Ruijiang] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Wang, Jeff; Oyama-Manabe, Noriko; Li, Ruijiang; Cui, Yi; Tha, Khin Khin; Kudo, Kohsuke; Shirato, Hiroki] Hokkaido Univ, Proton Beam Therapy Ctr, Global Stn Quantum Med Sci & Engn, Global Inst Collaborat Res & Educ GI CoRE,Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Yamashita, Hiroko] Hokkaido Univ Hosp, Dept Breast Surg, Kita Ku, Sapporo, Hokkaido 0608648, Japan	Hokkaido University; Hokkaido University; Stanford University; Hokkaido University; Hokkaido University	Kato, F (corresponding author), Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Kita Ku, North 14 West 5, Sapporo, Hokkaido 0608648, Japan.	fumikato@med.hokudai.ac.jp	Tha, Khin/AAN-7345-2020; Yamashita, Hiroko/D-5102-2012; Kudo, Kohsuke/AAK-9938-2021; Tha, Khin Khin/A-4762-2012; Cui, Yi/L-5804-2013	Yamashita, Hiroko/0000-0003-4281-8727; Kudo, Kohsuke/0000-0001-5351-9242; Tha, Khin Khin/0000-0002-9072-4509; Cui, Yi/0000-0002-6103-6352; Li, Ruijiang/0000-0002-0232-5998	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Agliozzo S, 2012, MED PHYS, V39, P1704, DOI 10.1118/1.3691178; Agner SC, 2014, RADIOLOGY, V272, P91, DOI 10.1148/radiol.14121031; Ahn HS, 2013, QUANTITATIVE ANAL BR; Alic L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110300; American College of Radiology, 2013, ACR BREAST IM REP DA; American Concrete Institute, 2010, ACI522R, P1; Arasu VA, 2011, ACAD RADIOL, V18, P716, DOI 10.1016/j.acra.2011.02.008; Meinel LA, 2007, J MAGN RESON IMAGING, V25, P89, DOI 10.1002/jmri.20794; Bertrand KA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3570; Bhatelia K, 2014, CELL SIGNAL, V26, P2350, DOI 10.1016/j.cellsig.2014.07.035; Bhooshan N, 2010, RADIOLOGY, V254, P680, DOI 10.1148/radiol.09090838; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Chaudhuri O, 2014, NAT MAT; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Delille JP, 2005, BREAST J, V11, P236, DOI 10.1111/j.1075-122X.2005.21499.x; DeMartini WB, 2012, AM J ROENTGENOL, V198, pW373, DOI 10.2214/AJR.10.6272; Deurloo EE, 2005, RADIOLOGY, V234, P693, DOI 10.1148/radiol.2343031580; Dontchos BN, 2015, RADIOLOGY, V276, P371, DOI 10.1148/radiol.2015142304; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eng A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0439-1; Ercan G, 2007, DIGITAL IMAGE PROCES; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Giger Maryellen L., 2014, Breast Imaging. 12th International Workshop, IWDM 2014. Proceedings: LNCS 8539, P195, DOI 10.1007/978-3-319-07887-8_28; Giger ML, 2013, ANNU REV BIOMED ENG, V15, P327, DOI 10.1146/annurev-bioeng-071812-152416; Gillies RJ, 2010, CLIN RADIOL, V65, P517, DOI 10.1016/j.crad.2010.04.005; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goto M, 2007, J MAGN RESON IMAGING, V25, P104, DOI 10.1002/jmri.20812; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hambly NM, 2011, AM J ROENTGENOL, V196, P218, DOI 10.2214/AJR.10.4550; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harris JR, 2014, DISEASES OF THE BREA; Hylton NM, 2012, RADIOLOGY, V263, P663, DOI 10.1148/radiol.12110748; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jones EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061969; King V, 2011, RADIOLOGY, V260, P50, DOI 10.1148/radiol.11102156; Klifa C, 2004, C P IEEE ENG MED BIO; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kohavi R., 1995, IJCAI; Kuhl CK, 1997, RADIOLOGY, V203, P137, DOI 10.1148/radiology.203.1.9122382; Lambin P, 2012, EUR J; Lee SH, 2010, MED PHYS, V37, P3940, DOI 10.1118/1.3446799; Lee SH, 2008, KOREAN J RADIOL, V9, P10, DOI 10.3348/kjr.2008.9.1.10; Liu H, 1995, PROC INT C TOOLS ART, P388, DOI 10.1109/TAI.1995.479783; Mandelson MT, 2000, J NATL CANC I; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Mazurowski MA, 2014, RADIOLOGY, V273, P365, DOI 10.1148/radiol.14132641; Meeuwis C, 2010, EUR RADIOL, V20, P522, DOI 10.1007/s00330-009-1573-5; MullerSchimpfle M, 1997, RADIOLOGY, V203, P145; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Pathak AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063146; Pearl J, 1985, HEURISTICS INTELLIGE; Pediconi F, 2009, INVEST RADIOL, V44, P412, DOI 10.1097/RLI.0b013e3181a53654; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Platt J., 1999, ADV KERNEL METHODS S, P41; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schmitz AMT, 2014, BREAST CANCER RES TR, V148, P541, DOI 10.1007/s10549-014-3170-9; Shepherd JA, 2011, CANCER EPIDEM BIOMAR, V20, P1473, DOI 10.1158/1055-9965.EPI-10-1150; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081653; Williams TC, 2007, RADIOLOGY, V244, P94, DOI 10.1148/radiol.2441060634; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yoshioka T, 2013, BREAST CANC; Youk JH, 2012, EUR RADIOL, V22, P1724, DOI 10.1007/s00330-012-2425-2	72	95	108	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143308	10.1371/journal.pone.0143308	http://dx.doi.org/10.1371/journal.pone.0143308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600392	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600048
J	Karweina, D; Kreuzer-Redmer, S; Muller, U; Franken, T; Pieper, R; Baron, U; Olek, S; Zentek, J; Brockmann, GA				Karweina, Diana; Kreuzer-Redmer, Susanne; Mueller, Uwe; Franken, Tobias; Pieper, Robert; Baron, Udo; Olek, Sven; Zentek, Juergen; Brockmann, Gudrun A.			The Zinc Concentration in the Diet and the Length of the Feeding Period Affect the Methylation Status of the ZIP4 Zinc Transporter Gene in Piglets	PLOS ONE			English	Article							ANTIBIOTIC GROWTH PROMOTERS; MESSENGER-RNA; WEANLING PIGS; REDUCED USE; EXPRESSION; TRANSCRIPTION; PROTEIN; OXIDE; WEB; METALLOTHIONEIN	High doses of zinc oxide are commonly used in weaned pig diets to improve performance and health. Recent reports show that this may also lead to an imbalanced zinc homeostasis in the animal. For a better understanding of the regulatory mechanisms of different zinc intakes, we performed a feeding experiment to assess potential epigenetic regulation of the ZIP4 gene expression via DNA methylation in the small intestine of piglets. Fifty-four piglets were fed diets with 57 (LZn), 164 (NZn) or 2,425 (HZn) mg Zn/kg feed for one or four weeks. The ZIP4 expression data provided significant evidence for counter-regulation of zinc absorption with higher dietary zinc concentrations. The CpG + 735 in the second exon had a 56% higher methylation in the HZn group compared to the others after one week of feeding (8.0.10(-4) < p < 0.035); the methylation of this CpG was strongly negatively associated with the expression of the long ZIP4 transcripts (p < 0.007). In the LZn and NZn diets, the expression of the long ZIP4 transcripts were lower after four vs. one week of feeding (2.9.10(-4) < p < 0.017). The strongest switch leading to high DNA methylation in nearly all analysed regions was dependent on feeding duration or age in all diet groups (3.7.10(-10) < p < 0.099). The data suggest that DNA methylation serves as a fine-tuning mechanism of ZIP4 gene regulation to maintain zinc homeostasis. Methylation of the ZIP4 gene may play a minor role in the response to very high dietary zinc concentration, but may affect binding of alternate zinc-responsive transcription factors.	[Karweina, Diana; Kreuzer-Redmer, Susanne; Mueller, Uwe; Franken, Tobias; Brockmann, Gudrun A.] Humboldt Univ, Fac Life Sci, Albrecht Daniel Thaer Inst Agri & Hort, Breeding Biol & Mol Genet, D-10099 Berlin, Germany; [Pieper, Robert; Zentek, Juergen] Free Univ Berlin, Dept Vet Med, Inst Anim Nutr, Berlin, Germany; [Baron, Udo; Olek, Sven] Epiontis GmbH, Berlin, Germany	Humboldt University of Berlin; Free University of Berlin; Epiontis GmbH	Brockmann, GA (corresponding author), Humboldt Univ, Fac Life Sci, Albrecht Daniel Thaer Inst Agri & Hort, Breeding Biol & Mol Genet, D-10099 Berlin, Germany.	gudrun.brockmann@hu-berlin.de	Kreuzer-Redmer, Susanne/AAV-4840-2020	Kreuzer-Redmer, Susanne/0000-0001-9425-3356; Baron, Udo/0000-0001-7432-3601; Pieper, Robert/0000-0002-0292-1482; Zentek, Jurgen/0000-0003-2864-9250	Deutsche Forschungsgemeinschaft (DFG) [SFB 852]; Epiontis GmbH	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Epiontis GmbH	The study was funded by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/en/) through grant SFB 852 (http://www.sfb852.de/en/) with JZ as the Speaker of the SFB 852. The DFG had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Epiontis GmbH provided support in the form of salaries for authors [UB, SO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Andrews GK, 2001, BIOMETALS, V14, P223, DOI 10.1023/A:1012932712483; Andrews GK, 2008, BIOCHEM SOC T, V36, P1242, DOI 10.1042/BST0361242; Antala S, 2012, BIOCHEMISTRY-US, V51, P963, DOI 10.1021/bi201553p; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bondzio Angelika, 2013, PLoS One, V8, pe81202, DOI 10.1371/journal.pone.0081202; Brugger D, 2014, ARCH ANIM NUTR, V68, P73, DOI 10.1080/1745039X.2014.898392; Chowanadisai W, 2013, P NATL ACAD SCI USA, V110, P9903, DOI 10.1073/pnas.1222142110; Coneyworth LJ, 2009, P NUTR SOC, V68, P142, DOI 10.1017/S0029665109001104; Dasgupta C, 2012, HYPERTENSION, V60, P697, DOI 10.1161/HYPERTENSIONAHA.112.198242; Davin R, 2013, J ANIM PHYSIOL AN N, V97, P6, DOI 10.1111/jpn.12046; DIXON WJ, 1950, ANN MATH STAT, V21, P488, DOI 10.1214/aoms/1177729747; Dong G, 2015, MOL MED REP, V11, P1582, DOI 10.3892/mmr.2014.2969; Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Penny ME, 2013, ANN NUTR METAB, V62, P31, DOI 10.1159/000348263; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Esteller M, 2008, LANCET, pS90; Fairweather-Tait SJ, 2008, EXP GERONTOL, V43, P382, DOI 10.1016/j.exger.2007.10.015; Feng L, 2007, BIOCHEM GENET, V45, P131, DOI 10.1007/s10528-006-9059-5; Fujimura T, 2012, BRIT J NUTR, V107, P1655, DOI 10.1017/S0007114511004867; Fujishiro H, 2009, TOXICOL APPL PHARM, V241, P195, DOI 10.1016/j.taap.2009.08.015; GfE, 2006, EMPF EN NAHRST BEI S; GOODING JM, 1995, BIOCHEM SOC T, V23, pS332, DOI 10.1042/bst023332s; Han YK, 2011, J SWINE HEALTH PROD, V19, P34; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Jackson KA, 2008, BIOCHEM SOC T, V36, P1262, DOI 10.1042/BST0361262; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Krebs NF, 2000, J NUTR, V130, p1374S, DOI 10.1093/jn/130.5.1374S; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu J, 2008, NUTR NEUROSCI, V11, P96, DOI 10.1179/147683008X301432; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Liuzzi JP, 2009, AM J PHYSIOL-GASTR L, V296, pG517, DOI 10.1152/ajpgi.90568.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maret W, 2008, EXP GERONTOL, V43, P378, DOI 10.1016/j.exger.2007.10.005; Martin L, 2013, J NUTR, V143, P1205, DOI 10.3945/jn.113.177881; Martin L, 2013, ARCH ANIM NUTR, V67, P248, DOI 10.1080/1745039X.2013.801138; Meurens F, 2009, MOL IMMUNOL, V46, P927, DOI 10.1016/j.molimm.2008.09.036; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Nielsen FH, 2012, ADV NUTR, V3, P783, DOI 10.3945/an.112.002881; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Owusu-Asiedu A, 2003, J ANIM SCI, V81, P1790; Pettigrew JE, 2006, ANIM BIOTECHNOL, V17, P207, DOI 10.1080/10495390600956946; Pieper R, 2015, J TRACE ELEM MED BIO, V30, P30, DOI 10.1016/j.jtemb.2015.01.008; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Qiao H, 2011, BIOCHEM J, V440, P73, DOI 10.1042/BJ20110392; Romero-Tlalolini MA, 2013, BIOCHEM BIOPH RES CO, V438, P54, DOI 10.1016/j.bbrc.2013.07.023; Sales J, 2013, BIOL TRACE ELEM RES, V152, P343, DOI 10.1007/s12011-013-9638-3; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Seal BS, 2013, ANIM HEALTH RES REV, V14, P78, DOI 10.1017/S1466252313000030; Sharif R, 2012, MUTAT RES-FUND MOL M, V733, P111, DOI 10.1016/j.mrfmmm.2011.08.009; Sharma A, 2013, PHYSIOL MOL BIOL PLA, V19, P11, DOI 10.1007/s12298-012-0139-1; Smit AFA, 2015, REPEATMASKER WEB SER; Solomons NW, 2013, ANN NUTR METAB, V62, P8, DOI 10.1159/000348547; Starke Ingo C, 2014, Mol Biol Int, V2014, P548683, DOI 10.1155/2014/548683; Stein HH, 2006, ANIM BIOTECHNOL, V17, P217, DOI 10.1080/10495390600957191; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P426, DOI 10.1079/9781845934729.0426; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VANBEERSSCHREURS HMG, 1992, VET QUART, V14, P29, DOI 10.1080/01652176.1992.9694322; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Weaver BP, 2007, BIOL CHEM, V388, P1301, DOI 10.1515/BC.2007.149; Wong CP, 2013, J NUTR BIOCHEM, V24, P353, DOI 10.1016/j.jnutbio.2012.07.005; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang YQ, 2013, EMBO MOL MED, V5, P1322, DOI 10.1002/emmm.201302507; Zhang YQ, 2010, CLIN CANCER RES, V16, P1423, DOI 10.1158/1078-0432.CCR-09-2405	68	11	12	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143098	10.1371/journal.pone.0143098	http://dx.doi.org/10.1371/journal.pone.0143098			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599865	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900064
J	Luk, KC; Berg, MG; Naccache, SN; Kabre, B; Federman, S; Mbanya, D; Kaptue, L; Chiu, CY; Brennan, CA; Hackett, J				Luk, Ka-Cheung; Berg, Michael G.; Naccache, Samia N.; Kabre, Beniwende; Federman, Scot; Mbanya, Dora; Kaptue, Lazare; Chiu, Charles Y.; Brennan, Catherine A.; Hackett, John, Jr.			Utility of Metagenomic Next-Generation Sequencing for Characterization of HIV and Human Pegivirus Diversity	PLOS ONE			English	Article							CIRCULATING RECOMBINANT FORM; GB-VIRUS-C; VIRAL GENETIC DIVERSITY; SUBTYPE-A; GENOME CHARACTERIZATION; PATHOGEN DISCOVERY; CLINICAL-SAMPLES; TYPE-1; IDENTIFICATION; CAMEROON	Given the dynamic changes in HIV-1 complexity and diversity, next-generation sequencing (NGS) has the potential to revolutionize strategies for effective HIV global surveillance. In this study, we explore the utility of metagenomic NGS to characterize divergent strains of HIV-1 and to simultaneously screen for other co-infecting viruses. Thirty-five HIV-1-infected Cameroonian blood donor specimens with viral loads of >4.4 log(10) copies/ml were selected to include a diverse representation of group M strains. Random-primed NGS libraries, prepared from plasma specimens, resulted in greater than 90% genome coverage for 88% of specimens. Correct subtype designations based on NGS were concordant with sub-region PCR data in 31 of 35 (89%) cases. Complete genomes were assembled for 25 strains, including circulating recombinant forms with relatively limited data available (7 CRF11_cpx, 2 CRF13_cpx, 1 CRF18_cpx, and 1 CRF37_cpx), as well as 9 unique recombinant forms. HPgV (formerly designated GBV-C) co-infection was detected in 9 of 35 (25%) specimens, of which eight specimens yielded complete genomes. The recovered HPgV genomes formed a diverse cluster with genotype 1 sequences previously reported from Ghana, Uganda, and Japan. The extensive genome coverage obtained by NGS improved accuracy and confidence in phylogenetic classification of the HIV-1 strains present in the study population relative to conventional sub-region PCR. In addition, these data demonstrate the potential for metagenomic analysis to be used for routine characterization of HIV-1 and identification of other viral co-infections.	[Luk, Ka-Cheung; Berg, Michael G.; Brennan, Catherine A.; Hackett, John, Jr.] Abbott Diagnost, Infect Dis Res, Abbott Pk, IL 60064 USA; [Naccache, Samia N.; Kabre, Beniwende; Federman, Scot; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Naccache, Samia N.; Kabre, Beniwende; Federman, Scot; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA; [Mbanya, Dora] Univ Yaounde I, Yaounde, Cameroon; [Kaptue, Lazare] Univ Montagnes, Bangangte, Cameroon; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA	University of California System; University of California San Francisco; University of Yaounde I; University of California System; University of California San Francisco	Hackett, J (corresponding author), Abbott Diagnost, Infect Dis Res, Abbott Pk, IL 60064 USA.	john.hackett@abbott.com			National Institutes of Health [R01-HL105704]; UCSF-Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF-Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by the National Institutes of Health, R01-HL105704 (to CYC) and UCSF-Abbott Viral Discovery Award (to CYC). The funder provided support in the form of salaries for authors KCL, MGB, CAB, JH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Archer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049602; Archer J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000178; Barin F, 1996, AIDS RES HUM RETROV, V12, P1279, DOI 10.1089/aid.1996.12.1279; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bobkov AF, 2004, J MED VIROL, V74, P191, DOI 10.1002/jmv.20177; Brennan CA, 2008, JAIDS-J ACQ IMM DEF, V49, P432, DOI 10.1097/QAI.0b013e31818a6561; Brennan CA, 2006, J MED VIROL, V78, pS24, DOI 10.1002/jmv.20603; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; Chius CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/j.mib.2013.05.001; de Oliveira CF, 2000, TRANSFUSION, V40, P1399, DOI 10.1046/j.1537-2995.2000.40111399.x; Delaugerre C, 2011, LANCET, V378, P1894, DOI 10.1016/S0140-6736(11)61457-8; Delwart E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003146; Firth C, 2013, ANNU REV GENOM HUM G, V14, P281, DOI 10.1146/annurev-genom-091212-153446; Ghai RR, 2013, J GEN VIROL, V94, P2670, DOI 10.1099/vir.0.055509-0; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hemelaar J, 2013, J INFECTION, V66, P391, DOI 10.1016/j.jinf.2012.10.026; Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Konings FAJ, 2006, JAIDS-J ACQ IMM DEF, V42, P331, DOI 10.1097/01.qai.0000219784.81163.2e; Law J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060595; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Lihana RW, 2012, AIDS REV, V14, P83; Liitsola K, 1998, AIDS, V12, P1907, DOI 10.1097/00002030-199814000-00023; Luk KC, 2007, AIDS RES HUM RETROV, V23, P297, DOI 10.1089/aid.2006.0177; Magiorkinis G, 2003, J GEN VIROL, V84, P2715, DOI 10.1099/vir.0.19180-0; Giret MTM, 2012, CURR HIV-AIDS REP, V9, P26, DOI 10.1007/s11904-011-0109-1; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Montavon C, 2002, AIDS RES HUM RETROV, V18, P231, DOI 10.1089/08892220252781301; Mourez T, 2013, CLIN MICROBIOL REV, V26, P448, DOI 10.1128/CMR.00012-13; Muerhoff AS, 2006, J MED VIROL, V78, P105, DOI 10.1002/jmv.20510; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Peeters M, 2014, AIDS REV, V16, P23; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Powell RLR, 2008, AIDS RES HUM RETROV, V24, P100, DOI 10.1089/aid.2007.0162; Powell RLR, 2007, AIDS RES HUM RETROV, V23, P923, DOI 10.1089/aid.2007.0040; Pyne MT, 2013, J CLIN MICROBIOL, V51, P2662, DOI 10.1128/JCM.00880-13; Redd AD, 2011, J CLIN MICROBIOL, V49, P2859, DOI 10.1128/JCM.00804-11; Sahni H, 2014, J MED VIROL, V86, P426, DOI 10.1002/jmv.23845; Schwarze-Zander C, 2012, EXPERT REV ANTI-INFE, V10, P563, DOI [10.1586/eri.12.37, 10.1586/ERI.12.37]; Semaille C, 2007, J INFECT DIS, V196, P377, DOI 10.1086/519387; Simen BB, 2014, J VIROL METHODS, V204, P31, DOI 10.1016/j.jviromet.2014.04.007; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; Swei A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062083; Thomson MA, 2005, AIDS, V19, P1155, DOI 10.1097/01.aids.0000176215.95119.1d; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; Van Heuverswyn F, 2007, VIROLOGY, V368, P155, DOI 10.1016/j.virol.2007.06.018; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Wilbe K, 2002, AIDS RES HUM RETROV, V18, P849, DOI 10.1089/08892220260190326; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; World Health Organization, 2010, CAM HLTH STAT PROF; Yang J, 2011, J CLIN MICROBIOL, V49, P3463, DOI 10.1128/JCM.00273-11; Yin L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-108	60	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141723	10.1371/journal.pone.0141723	http://dx.doi.org/10.1371/journal.pone.0141723			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599538	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900014
J	Stach, CS; Vu, BG; Schlievert, PM				Stach, Christopher S.; Vu, Bao G.; Schlievert, Patrick M.			Determining the Presence of Superantigens in Coagulase Negative Staphylococci from Humans	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; BLOOD-STREAM INFECTIONS; ENTEROTOXIN-F; AUREUS; HOSPITALS; EXOTOXINS	Superantigens (SAgs) are important virulence factors in S. aureus. Recent studies identified their presence in animal coagulase-negative staphylococci (CNS). The emergence of human-associated SAg+ CNS would mark a prodigious shift in virulence capabilities. We examined CNS isolates from healthy human nares and diseased individuals, and determined that no known SAgs were present.	[Stach, Christopher S.; Vu, Bao G.; Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Schlievert, PM (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	patrick-schlievert@uiowa.edu		Schlievert, Patrick/0000-0001-8314-9369	University of Iowa Start-up funds	University of Iowa Start-up funds	This research was supported by the University of Iowa Start-up funds for PMS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, J DERMATOL SCI, V24, P142, DOI 10.1016/S0923-1811(00)00122-5; BERGDOLL MS, 1981, LANCET, V1, P1017; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; BONVENTRE PF, 1983, INFECT IMMUN, V40, P1023, DOI 10.1128/IAI.40.3.1023-1029.1983; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; CRASS BA, 1986, J CLIN MICROBIOL, V23, P43, DOI 10.1128/JCM.23.1.43-45.1986; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; KREISWIRTH BN, 1987, J CLIN MICROBIOL, V25, P2028, DOI 10.1128/JCM.25.10.2028-2029.1987; Madhusoodanan J, 2011, J BACTERIOL, V193, P1854, DOI 10.1128/JB.00162-10; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Park JY, 2011, VET MICROBIOL, V147, P142, DOI 10.1016/j.vetmic.2010.06.020; Park JY, 2011, VET MICROBIOL, V147, P149, DOI 10.1016/j.vetmic.2010.06.021; Salgado-Pabon W, 2013, METHODS MOL BIOL, V185, P169, DOI 10.1007/978-1-62703-664-1_10; Schlievert PA, 2007, J CLIN MICROBIOL, V45, P2704, DOI 10.1128/JCM.02295-06; SCHLIEVERT PM, 1988, METHOD ENZYMOL, V165, P339; SCHLIEVERT PM, 1991, J INFECT DIS, V164, P1245, DOI 10.1093/infdis/164.6.1245; SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509, DOI 10.1093/infdis/143.4.509; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Vu BG, 2014, J INFECT DIS, V210, P1920, DOI 10.1093/infdis/jiu350; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zell C, 2008, INT J FOOD MICROBIOL, V127, P246, DOI 10.1016/j.ijfoodmicro.2008.07.016	22	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143341	10.1371/journal.pone.0143341	http://dx.doi.org/10.1371/journal.pone.0143341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599862	Green Published, gold			2022-12-26	WOS:000365853900096
J	Ahrens, MM; Veniero, D; Gross, J; Harvey, M; Thut, G				Ahrens, Merle-Marie; Veniero, Domenica; Gross, Joachim; Harvey, Monika; Thut, Gregor			Visual Benefits in Apparent Motion Displays: Automatically Driven Spatial and Temporal Anticipation Are Partially Dissociated	PLOS ONE			English	Article							AUDITORY LOOMING PERCEPTION; LOW-FREQUENCY OSCILLATIONS; NEURONAL OSCILLATIONS; ALPHA OSCILLATIONS; ORIENTING DEFICIT; ATTENTION; ENTRAINMENT; TRACKING; EXTRAPOLATION; EXPECTATIONS	Many behaviourally relevant sensory events such as motion stimuli and speech have an intrinsic spatio-temporal structure. This will engage intentional and most likely unintentional (automatic) prediction mechanisms enhancing the perception of upcoming stimuli in the event stream. Here we sought to probe the anticipatory processes that are automatically driven by rhythmic input streams in terms of their spatial and temporal components. To this end, we employed an apparent visual motion paradigm testing the effects of pre-target motion on lateralized visual target discrimination. The motion stimuli either moved towards or away from peripheral target positions (valid vs. invalid spatial motion cueing) at a rhythmic or arrhythmic pace (valid vs. invalid temporal motion cueing). Crucially, we emphasized automatic motion-induced anticipatory processes by rendering the motion stimuli non-predictive of upcoming target position (by design) and task-irrelevant (by instruction), and by creating instead endogenous (orthogonal) expectations using symbolic cueing. Our data revealed that the apparent motion cues automatically engaged both spatial and temporal anticipatory processes, but that these processes were dissociated. We further found evidence for lateralisation of anticipatory temporal but not spatial processes. This indicates that distinct mechanisms may drive automatic spatial and temporal extrapolation of upcoming events from rhythmic event streams. This contrasts with previous findings that instead suggest an interaction between spatial and temporal attention processes when endogenously driven. Our results further highlight the need for isolating intentional from unintentional processes for better understanding the various anticipatory mechanisms engaged in processing behaviourally relevant stimuli with predictable spatio-temporal structure such as motion and speech.	[Ahrens, Merle-Marie; Harvey, Monika] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland; [Ahrens, Merle-Marie; Veniero, Domenica; Gross, Joachim; Thut, Gregor] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Ahrens, MM (corresponding author), Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland.	m.ahrens.1@research.gla.ac.uk; gregor.thut@glasgow.ac.uk	Gross, Joachim/C-5886-2009; Thut, Gregor/A-4374-2009	Gross, Joachim/0000-0002-3994-1006; Thut, Gregor/0000-0003-1313-4262	College of Science and Engineering at the University of Glasgow; Wellcome Trust Joint Investigator Award [098433, 098434]	College of Science and Engineering at the University of Glasgow; Wellcome Trust Joint Investigator Award(Wellcome Trust)	This research was supported by a PhD studentship from the College of Science and Engineering at the University of Glasgow (received by MMA) and a Wellcome Trust Joint Investigator Award to GTand JG [grant numbers 098433, 098434]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Al-Aidroos N, 2010, VIS COGN, V18, P859, DOI 10.1080/13506280903343085; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; BRADSHAW JL, 1981, BEHAV BRAIN SCI, V4, P51, DOI 10.1017/S0140525X00007548; Breska A, 2014, J COGNITIVE NEUROSCI, V26, P1555, DOI 10.1162/jocn_a_00564; Calderone DJ, 2014, TRENDS COGN SCI, V18, P300, DOI 10.1016/j.tics.2014.02.005; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Coull JT, 1998, J NEUROSCI, V18, P7426; Cravo AM, 2013, J NEUROSCI, V33, P4002, DOI 10.1523/JNEUROSCI.4675-12.2013; de Graaf TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060035; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; Golumbic EMZ, 2012, BRAIN LANG, V122, P151, DOI 10.1016/j.bandl.2011.12.010; Gross J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001752; HALPERN AR, 1993, J EXP PSYCHOL LEARN, V19, P471, DOI 10.1037/0278-7393.19.2.471; Hammond G, 1982, BRAIN COGN; Hogendoorn H, 2008, VISION RES, V48, P872, DOI 10.1016/j.visres.2007.12.019; Jones A, 2015, FRONT INTEGR NEUROSC, V8, DOI [10.3389/fnint.2014.00096, 10.3389/tnint.2014.00096]; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Kerzel D, 2003, COGNITION, V88, P109, DOI 10.1016/S0010-0277(03)00018-0; Khoei MA, 2013, J PHYSIOL-PARIS, V107, P409, DOI 10.1016/j.jphysparis.2013.08.001; Khurana B, 1995, NATURE, P378; Kinsbourne M, 1977, Adv Neurol, V18, P41; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Mathewson KE, 2012, J COGNITIVE NEUROSCI, V24, P2321, DOI 10.1162/jocn_a_00288; Mathewson KE, 2010, COGNITION, V115, P186, DOI 10.1016/j.cognition.2009.11.010; Muller HJ, 1996, PERCEPT PSYCHOPHYS, V58, P224, DOI 10.3758/BF03211877; NACHSHON I, 1985, INT J NEUROSCI, V25, P161, DOI 10.3109/00207458508985369; Nicholls M E, 1996, Laterality, V1, P97; Nijhawan R, 1994, NATURE, P370; Olk B, 2014, EXP BRAIN RES, V232, P3623, DOI 10.1007/s00221-014-4033-7; Park H, 2015, CURR BIOL, V25, P1649, DOI 10.1016/j.cub.2015.04.049; POLLATSEK A, 1981, BRAIN LANG, V14, P174, DOI 10.1016/0093-934X(81)90073-0; RAYNER K, 1980, PERCEPT PSYCHOPHYS, V27, P537, DOI 10.3758/BF03198682; Roach NW, 2011, CURR BIOL, V21, P740, DOI 10.1016/j.cub.2011.03.031; Rohenkohl G, 2014, J VISION, V14, DOI 10.1167/14.4.8; Rohenkohl G, 2012, J NEUROSCI, V32, P8424, DOI 10.1523/JNEUROSCI.0804-12.2012; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Rohenkohl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014620; ROSENBLUM LD, 1993, PERCEPTION, V22, P1467, DOI 10.1068/p221467; Rushworth MFS, 2001, J COGNITIVE NEUROSCI, V13, P698, DOI 10.1162/089892901750363244; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schwiedrzik CM, 2007, VISION RES, V47, P3424, DOI 10.1016/j.visres.2007.10.004; Shioiri S, 2002, VISION RES, V42, P2811, DOI 10.1016/S0042-6989(02)00405-4; Shioiri S, 2000, VISION RES, V40, P1365, DOI 10.1016/S0042-6989(99)00249-7; Spaak E, 2014, J NEUROSCI, V34, P3536, DOI 10.1523/JNEUROSCI.4385-13.2014; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Trivino M, 2011, NEUROPSYCHOLOGIA, V49, P3917, DOI 10.1016/j.neuropsychologia.2011.10.009; Trivino M, 2010, BRAIN, V133, P1173, DOI 10.1093/brain/awp346; Verghese P, 2002, J VISION, V2, P413, DOI 10.1167/2.5.5; Yantis S, 1998, NAT NEUROSCI, V1, P508, DOI 10.1038/2226	55	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0144082	10.1371/journal.pone.0144082	http://dx.doi.org/10.1371/journal.pone.0144082			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7OL	26623650	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000365891600090
J	Yanagida, N; Imai, T; Sato, S; Ebisawa, M				Yanagida, Noriyuki; Imai, Takanori; Sato, Sakura; Ebisawa, Motohiro			Do Longer Intervals between Challenges Reduce the Risk of Adverse Reactions in Oral Wheat Challenges?	PLOS ONE			English	Article							FOOD ALLERGY; EUROPEAN ACADEMY; POSITION PAPER; GUIDELINES; ANAPHYLAXIS; MANAGEMENT; DIAGNOSIS; CHILDREN	Background The use of oral food challenges (OFCs) in clinics is limited because they are complicated and associated with anaphylactic symptoms. To increase their use, it is necessary to develop novel, effective, and safe methods. However, the effectiveness of different OFCs has not been compared. Objective To investigate the effect of ingestion methods on wheat allergy symptoms and treatment during OFCs. Method Without changing the total challenge dose, we changed the administration method from a 5-installment dose titration every 15 min (15-min interval method) to 3 installments every 30 min (30-min interval method). We retrospectively reviewed and compared the results of 65 positive 15-min interval wheat challenge tests conducted between July 2005 and February 2008 and 87 positive 30-min interval tests conducted between March 2008 and December 2009. Results A history of immediate symptoms was more common for the 30-min interval method; however, no difference between methods was observed in other background parameters. Switching from the 15-min to the 30-min interval method did not increase symptoms or require treatment. The rate of cardiovascular symptoms (p = 0.032), and adrenaline use (p = 0.017) was significantly lower with the 30-min interval method. The results did not change after adjusting for the effects of immediate symptom history in multivariate analysis. Conclusion This study suggests that the 30-min interval method reduces the risk of adverse events, compared to the 15-min interval method.	[Yanagida, Noriyuki; Imai, Takanori] Sagamihara Natl Hosp, Dept Pediat, Kanagawa, Japan; [Sato, Sakura; Ebisawa, Motohiro] Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Kanagawa, Japan		Yanagida, N (corresponding author), Sagamihara Natl Hosp, Dept Pediat, Kanagawa, Japan.	n-yanagida@sagamihara-hosp.gr.jp	Yanagida, Noriyuki/ABF-3471-2021	Yanagida, Noriyuki/0000-0001-9643-744X; Ebisawa, Motohiro/0000-0003-4117-558X	Ministry of Health, Labour and Welfare;  [201414009A]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); 	This study was supported by the Scientific Research Fund of the Ministry of Health, Labour and Welfare in 2014. Motohiro Ebisawa received the funding. Grant number is 201414009A. https://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=201414009A.	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Bindslev-Jensen C, 2004, ALLERGY, V59, P690, DOI 10.1111/j.1398-9995.2004.00466.x; Burks AW, 2011, PEDIATRICS, V128, P955, DOI 10.1542/peds.2011-0539; Ebisawa Motohiro, 2009, Allergology International, V58, P475, DOI 10.2332/allergolint.09-RAI-0143; Imai T, 2014, ALLERGOL INT, V63, P205, DOI 10.2332/allergolint.12-OA-0513; Keet CA, 2009, ANN ALLERG ASTHMA IM, V102, P410, DOI 10.1016/S1081-1206(10)60513-3; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Pettersson ME, 2014, PEDIAT ALLERG IMM-UK, V25, P615, DOI 10.1111/pai.12256; Rance F, 2009, EUR ANN ALLERGY CLIN, V41, P35; Rolinck-Werninghaus C, 2012, ALLERGY, V67, P951, DOI 10.1111/j.1398-9995.2012.02838.x; Sampson HA, 2003, PEDIATRICS, V111, P1601; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Simons FER, 2012, CURR OPIN ALLERGY CL, V12, P389, DOI 10.1097/ACI.0b013e328355b7e4; Simons FER, 2011, J ALLERGY CLIN IMMUN, V127, P587, DOI 10.1016/j.jaci.2011.01.038; Urisu A, 2014, ALLERGOL INT, V63, P399, DOI 10.2332/allergolint.14-RAI-0770; Zhu YD, 2014, J NUTR, V144, P114, DOI 10.3945/jn.113.184663	17	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143717	10.1371/journal.pone.0143717	http://dx.doi.org/10.1371/journal.pone.0143717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624006	Green Published, gold			2022-12-26	WOS:000365891600046
J	Lara-Gonzalez, S; Estrella, P; Portillo, C; Cruces, ME; Jimenez-Sandoval, P; Fattori, J; Migliorini-Figueira, AC; Lopez-Hidalgo, M; Diaz-Quezada, C; Lopez-Castillo, M; Trasvina-Arenas, CH; Sanchez-Sandoval, E; Gomez-Puyou, A; Ortega-Lopez, J; Arroyo, R; Benitez-Cardoza, CG; Brieba, LG				Lara-Gonzalez, Samuel; Estrella, Priscilla; Portillo, Carmen; Cruces, Maria E.; Jimenez-Sandoval, Pedro; Fattori, Juliana; Migliorini-Figueira, Ana C.; Lopez-Hidalgo, Marisol; Diaz-Quezada, Corina; Lopez-Castillo, Margarita; Trasvina-Arenas, Carlos H.; Sanchez-Sandoval, Eugenia; Gomez-Puyou, Armando; Ortega-Lopez, Jaime; Arroyo, Rossana; Benitez-Cardoza, Claudia G.; Brieba, Luis G.			Substrate-Induced Dimerization of Engineered Monomeric Variants of Triosephosphate Isomerase from Trichomonas vaginalis	PLOS ONE			English	Article							ACTIVE-SITE LOOP; DIMER INTERFACE; POINT MUTATION; DESIGN; DEFICIENCY; STRATEGIES; EVOLUTION; INSIGHTS; MONOTIM; MUSCLE	The dimeric nature of triosephosphate isomerases (TIMs) is maintained by an extensive surface area interface of more than 1600 angstrom 2. TIMs from Trichomonas vaginalis (TvTIM) are held in their dimeric state by two mechanisms: a ball and socket interaction of residue 45 of one subunit that fits into the hydrophobic pocket of the complementary subunit and by swapping of loop 3 between subunits. TvTIMs differ from other TIMs in their unfolding energetics. In TvTIMs the energy necessary to unfold a monomer is greater than the energy necessary to dissociate the dimer. Herein we found that the character of residue I45 controls the dimer-monomer equilibrium in TvTIMs. Unfolding experiments employing monomeric and dimeric mutants led us to conclude that dimeric TvTIMs unfold following a four state model denaturation process whereas monomeric TvTIMs follow a three state model. In contrast to other monomeric TIMs, monomeric variants of TvTIM1 are stable and unexpectedly one of them (I45A) is only 29-fold less active than wild-type TvTIM1. The high enzymatic activity of monomeric TvTIMs contrast with the marginal catalytic activity of diverse monomeric TIMs variants. The stability of the monomeric variants of TvTIM1 and the use of cross-linking and analytical ultracentrifugation experiments permit us to understand the differences between the catalytic activities of TvTIMs and other marginally active monomeric TIMs. As TvTIMs do not unfold upon dimer dissociation, herein we found that the high enzymatic activity of monomeric TvTIM variants is explained by the formation of catalytic dimeric competent species assisted by substrate binding.	[Lara-Gonzalez, Samuel] IPICYT, Div Biol Mol, San Luis Potosi 78216, San Luis Potosi, Mexico; [Estrella, Priscilla; Portillo, Carmen; Diaz-Quezada, Corina; Lopez-Castillo, Margarita; Trasvina-Arenas, Carlos H.; Sanchez-Sandoval, Eugenia; Brieba, Luis G.] IPN, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato 36500, Mexico; [Cruces, Maria E.; Jimenez-Sandoval, Pedro; Lopez-Hidalgo, Marisol; Benitez-Cardoza, Claudia G.] ENMyH IPN, Lab Invest Bioquim, Programa Inst Biomed Mol, La Escalera Ticoman 07320, DF, Mexico; [Fattori, Juliana; Migliorini-Figueira, Ana C.] Ctr Nacl Pesquisa Energia Mat, Lab Nacl Biociencias, Campinas, SP, Brazil; [Gomez-Puyou, Armando] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim & Biol Estruct, Mexico City 04510, DF, Mexico; [Ortega-Lopez, Jaime] IPN, Ctr Invest & Estudios Avanzados, Dept Biotecnol & Bioingn, La Escalera Ticoman 07360, DF, Mexico; [Arroyo, Rossana] IPN, Ctr Invest & Estudios Avanzados, Dept Infect & Patogenesis Mol, La Escalera Ticoman 07360, DF, Mexico	Instituto Potosino Investigacion Cientifica y Tecnologica; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Benitez-Cardoza, CG (corresponding author), ENMyH IPN, Lab Invest Bioquim, Programa Inst Biomed Mol, La Escalera Ticoman 07320, DF, Mexico.	beni1972uk@gmail.com; lgbrieba@langebio.cinvestav.mx	Ortega-Lopez, Jaime/A-1364-2008; Fattori, Juliana/M-4021-2019; Trasvina, CH/AAJ-9838-2020; Verástegui, Rossana Arroyo/ABF-7739-2021; Brieba, Luis/I-8447-2016; Fattori, Juliana/B-7702-2012; Jimenez-Sandoval, Pedro/A-2965-2019; Lopez-Castillo, Laura Margarita/O-6296-2016	Ortega-Lopez, Jaime/0000-0001-9136-9994; Fattori, Juliana/0000-0002-5865-0183; Verástegui, Rossana Arroyo/0000-0002-8193-9700; Brieba, Luis/0000-0002-6073-5207; Fattori, Juliana/0000-0002-5865-0183; Jimenez-Sandoval, Pedro/0000-0002-8982-5070; Trasvina-Arenas, Carlos H./0000-0002-9881-375X; Lopez-Castillo, Laura Margarita/0000-0002-6738-9554; sanchez-sandoval, maria eugenia/0000-0002-6083-4651; Lara-Gonzalez, Samuel/0000-0002-3313-0165; Benitez Cardoza, Claudia Guadalupe/0000-0002-7841-5711	National Polytechnic Institute (SIP-IPN grant) [20140317]; Secretary of Economy - Mexican National Council of Science (SE-CONACYT grant) [216767]	National Polytechnic Institute (SIP-IPN grant); Secretary of Economy - Mexican National Council of Science (SE-CONACYT grant)	Support was provided by funding from research and graduate studies coordination from the National Polytechnic Institute [http://www.sip.ipn.mx/Paginas/Principal.aspx] (SIP-IPN grant 20140317) and the Secretary of Economy - Mexican National Council of Science [www.conacyt.mx/] (SE-CONACYT grant 216767) to CGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahuhta M, 2008, PROTEIN ENG DES SEL, V21, P257, DOI 10.1093/protein/gzn002; Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Alvarez G, 2010, EUR J MED CHEM, V45, P5767, DOI 10.1016/j.ejmech.2010.09.034; Aparicio R, 2003, J MOL BIOL, V334, P1023, DOI 10.1016/j.jmb.2003.10.022; Auclair JR, 2010, P NATL ACAD SCI USA, V107, P21394, DOI 10.1073/pnas.1015463107; Banerjee M, 2009, FEBS J, V276, P4169, DOI 10.1111/j.1742-4658.2009.07126.x; BORCHERT TV, 1995, STRUCTURE, V3, P669, DOI 10.1016/S0969-2126(01)00202-7; BORCHERT TV, 1994, P NATL ACAD SCI USA, V91, P1515, DOI 10.1073/pnas.91.4.1515; Chanez-Cardenas ME, 2005, BIOCHEMISTRY-US, V44, P10883, DOI 10.1021/bi047687a; Coffin SR, 2009, BIOCHEMISTRY-US, V48, P7399, DOI 10.1021/bi9008006; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datta D, 2013, J BIOL CHEM, V288, P9971, DOI 10.1074/jbc.M112.426460; DAVENPORT RC, 1991, BIOCHEMISTRY-US, V30, P5821, DOI 10.1021/bi00238a002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enriquez-Flores S, 2008, MOL BIOCHEM PARASIT, V157, P179, DOI 10.1016/j.molbiopara.2007.10.013; Figueroa-Angulo EE, 2012, PARASITOLOGY, V139, P1729, DOI 10.1017/S003118201200114X; Hayes D, 1995, PROGRAM SEDNTERP SED; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Ivanov I, 2012, PROTEINS, V80, P703, DOI 10.1002/prot.23227; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Lara-Gonzalez S, 2014, PROTEINS, V82, P22, DOI 10.1002/prot.24333; LeFevre KR, 2003, P NATL ACAD SCI USA, V100, P2345, DOI 10.1073/pnas.0537925100; Lindwall G, 2000, PROTEIN ENG, V13, P67, DOI 10.1093/protein/13.1.67; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lukatsky DB, 2007, J MOL BIOL, V365, P1596, DOI 10.1016/j.jmb.2006.11.020; Mainfroid V, 1996, J MOL BIOL, V257, P441, DOI 10.1006/jmbi.1996.0174; Olivares-Illana V, 2006, BIOCHEMISTRY-US, V45, P2556, DOI 10.1021/bi0522293; Peimbert M, 2008, BIOCHEMISTRY-US, V47, P5556, DOI 10.1021/bi702502k; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; PLAUT B, 1972, BIOCHEM J, V129, P311, DOI 10.1042/bj1290311; Ralser M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000030; Rodriguez-Almazan C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000497; Rodriguez-Almazan C, 2008, J BIOL CHEM, V283, P23254, DOI 10.1074/jbc.M802145200; Rozovsky S, 2001, J MOL BIOL, V310, P271, DOI 10.1006/jmbi.2001.4673; Saab-Rincon G, 2001, PROTEIN ENG, V14, P149, DOI 10.1093/protein/14.3.149; Salin M, 2010, ACTA CRYSTALLOGR D, V66, P934, DOI 10.1107/S0907444910025710; Schliebs W, 1996, PROTEIN SCI, V5, P229; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sullivan BJ, 2011, J MOL BIOL, V413, P195, DOI 10.1016/j.jmb.2011.08.001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tellez LA, 2008, BIOCHEMISTRY-US, V47, P11665, DOI 10.1021/bi801360k; Velanker SS, 1997, STRUCTURE, V5, P751, DOI 10.1016/S0969-2126(97)00230-X; Wongsantichon J, 2006, BIOCHEM J, V394, P135, DOI 10.1042/BJ20050915; Zarate-Perez F, 2009, BIOCHEM BIOPH RES CO, V382, P626, DOI 10.1016/j.bbrc.2009.03.085; Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331	45	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0141747	10.1371/journal.pone.0141747	http://dx.doi.org/10.1371/journal.pone.0141747			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618356	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800007
J	Miller, KJ; Raulefs, S; Kong, B; Steiger, K; Regel, I; Gewies, A; Kleeff, J; Michalski, CW				Miller, Katharina J.; Raulefs, Susanne; Kong, Bo; Steiger, Katja; Regel, Ivonne; Gewies, Andreas; Kleeff, Joerg; Michalski, Christoph W.			Loss of Ifnar1 in Pancreatic Acinar Cells Ameliorates the Disease Course of Acute Pancreatitis	PLOS ONE			English	Article							INTERFERON-ALPHA; CYTOKINE PRODUCTION; MACROPHAGES; EXPRESSION; REGENERATION; STIMULATION; CHEMOKINES; MONOCYTES; THERAPY; RESPOND	Type I interferon constitutes an essential component of the combinational therapy against viral disease. Acute pancreatitis is one side effect of type I interferon-based therapy, implying that activation of type I interferon signaling affects the homeostasis and integrity of pancreatic acinar cells. Here, we investigated the role of type I interferon signaling in pancreatic acinar cells using a caerulein-induced murine model of acute pancreatitis. Pancreas-specific ablation of interferon (alpha and beta) receptor 1 (Ifnar1) partially protected animals from caerulein-induced pancreatitis, as demonstrated by reduced tissue damage. Profiling of infiltrating immune cells revealed that this dampened tissue damage response correlated with the number of macrophages in the pancreas. Pharmacologic depletion of macrophages reversed the protective effect of Ifnar1 deficiency. Furthermore, expression of chemokine (C-C motif) ligand 2 (Ccl2), a potent factor for macrophage recruitment, was significantly increased in the Ifnar1-deficient pancreas. Thus, type I interferon signaling in pancreatic acinar cells controls pancreatic homeostasis by affecting the macrophage-mediated inflammatory response in the pancreas.	[Miller, Katharina J.; Raulefs, Susanne; Kong, Bo; Regel, Ivonne; Kleeff, Joerg] Tech Univ Munich, Dept Surg, D-80290 Munich, Germany; [Steiger, Katja] Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany; [Gewies, Andreas] Tech Univ Munich, Inst Klin Chem & Pathobiochem, D-80290 Munich, Germany; [Michalski, Christoph W.] Univ Heidelberg Hosp, Dept Surg, Heidelberg, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Ruprecht Karls University Heidelberg	Michalski, CW (corresponding author), Univ Heidelberg Hosp, Dept Surg, Heidelberg, Germany.	cwmichalski@googlemail.com	Michalski, Christoph/U-9167-2019; Kleeff, Jorg/B-2124-2009; Regel, Ivonne/AFS-1831-2022	Kleeff, Jorg/0000-0003-3432-6669; Steiger, Katja/0000-0002-7269-5433; Gewies, Andreas/0000-0002-7606-6482				Abdulmahdi W, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12357; Ando Kenji, 2009, Case Rep Gastroenterol, V3, P372; Billiau A, 2006, ANTIVIR RES, V71, P108, DOI 10.1016/j.antiviral.2006.03.006; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; Chaudhari S, 2004, DIGEST DIS SCI, V49, P1000, DOI 10.1023/B:DDAS.0000034562.17003.50; Conrady CD, 2013, MUCOSAL IMMUNOL, V6, P45, DOI 10.1038/mi.2012.46; Criscimanna A, 2014, GASTROENTEROLOGY, V147, P1106, DOI 10.1053/j.gastro.2014.08.008; De Palma M, 2008, CANCER CELL, V14, P299, DOI 10.1016/j.ccr.2008.09.004; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Devitt A, 2011, J LEUKOCYTE BIOL, V90, P447, DOI 10.1189/jlb.0211095; Drechsler M, 2015, ARTERIOSCL THROM VAS, V35, P1050, DOI 10.1161/ATVBAHA.114.304649; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fink GW, 1997, CYTOKINE, V9, P1023, DOI 10.1006/cyto.1997.0260; Folias AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102125; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grady T, 1997, GASTROENTEROLOGY, V113, P1966, DOI 10.1016/S0016-5085(97)70017-9; Gregory CD, 2004, IMMUNOLOGY, V113, P1, DOI 10.1111/j.1365-2567.2004.01959.x; Gukovskaya AS, 1997, J CLIN INVEST, V100, P1853, DOI 10.1172/JCI119714; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Lee PY, 2009, AM J PATHOL, V175, P2023, DOI 10.2353/ajpath.2009.090328; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Makhija Rohit, 2002, J Hepatobiliary Pancreat Surg, V9, P401, DOI 10.1007/s005340200049; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murtaugh LC, 2015, ANNU REV PHYSIOL, V77, P229, DOI 10.1146/annurev-physiol-021014-071727; Naing A, 2011, J CANCER, V2, P81, DOI 10.7150/jca.2.81; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Norman JG, 1997, DIGEST DIS SCI, V42, P1783, DOI 10.1023/A:1018886120711; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Saeki K, 2012, GASTROENTEROLOGY, V142, P1010, DOI 10.1053/j.gastro.2011.12.054; SALUJA A, 1985, AM J PHYSIOL, V249, pG702, DOI 10.1152/ajpgi.1985.249.6.G702; Saurer L, 2000, GASTROENTEROLOGY, V118, P356, DOI 10.1016/S0016-5085(00)70218-6; Schaar CG, 2005, ANN ONCOL, V16, P634, DOI 10.1093/annonc/mdi125; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun LK, 2007, AM J PHYSIOL-GASTR L, V293, pG1196, DOI 10.1152/ajpgi.00330.2007; Trivedi CD, 2005, J CLIN GASTROENTEROL, V39, P709, DOI 10.1097/01.mcg.0000173929.60115.b4; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; WATANABE O, 1984, AM J PHYSIOL, V246, pG457, DOI 10.1152/ajpgi.1984.246.4.G457; Yoshimura A, 2003, CURR OPIN IMMUNOL, V15, P704, DOI 10.1016/j.coi.2003.09.004	43	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143735	10.1371/journal.pone.0143735	http://dx.doi.org/10.1371/journal.pone.0143735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618925	Green Published, gold			2022-12-26	WOS:000365889800065
J	Paskulin, DD; Giacomazzi, J; Achatz, MI; Costa, S; Reis, RM; Hainaut, P; dos Santos, SEB; Ashton-Prolla, P				Paskulin, Diego Davila; Giacomazzi, Juliana; Achatz, Maria Isabel; Costa, Sandra; Reis, Rui Manoel; Hainaut, Pierre; Batista dos Santos, Sidney Emanuel; Ashton-Prolla, Patricia			Ancestry of the Brazilian TP53 c.1010G > A (p.Arg337His, R337H) Founder Mutation: Clues from Haplotyping of Short Tandem Repeats on Chromosome 17p	PLOS ONE			English	Article							LI-FRAUMENI; LINKAGE DISEQUILIBRIUM; COMMON FOUNDER; BREAST-CANCER; POPULATION; P.R337H; CHILDREN; IMPACT; FRENCH; TUMORS	Rare germline mutations in TP53 (17p13.1) cause a highly penetrant predisposition to a specific spectrum of early cancers, defining the Li-Fraumeni Syndrome (LFS). A germline mutation at codon 337 (p.Arg337His, c1010G>A) is found in about 0.3% of the population of Southern Brazil. This mutation is associated with partially penetrant LFS traits and is found in the germline of patients with early cancers of the LFS spectrum unselected for familial history. To characterize the extended haplotypes carrying the mutation, we have genotyped 9 short tandem repeats on chromosome 17p in 12 trios of Brazilian p.Arg337His carriers. Results confirm that all share a common ancestor haplotype of Caucasian/Portuguese-Iberic origin, distant in about 72-84 generations (2000 years assuming a 25 years intergenerational distance) and thus pre-dating European migration to Brazil. So far, the founder p. Arg337His haplotype has not been detected outside Brazil, with the exception of two residents of Portugal, one of them of Brazilian origin. On the other hand, increased meiotic recombination in p. Arg337His carriers may account for higher than expected haplotype diversity. Further studies comparing haplotypes in populations of Brazil and of other areas of Portuguese migration are needed to understand the historical context of this mutation in Brazil.	[Paskulin, Diego Davila; Giacomazzi, Juliana; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Postgrad Program, Genet & Mol Biol, Porto Alegre, RS, Brazil; [Paskulin, Diego Davila; Giacomazzi, Juliana; Ashton-Prolla, Patricia] Hosp Clin Porto Alegre, Expt Res Ctr, Genom Med Lab, Porto Alegre, RS, Brazil; [Achatz, Maria Isabel] AC Camargo Canc Ctr, Dept Oncogenet, Sao Paulo, Brazil; [Costa, Sandra; Reis, Rui Manoel] Univ Minho, Life & Hlth Sci Res Inst, Braga, Portugal; [Costa, Sandra; Reis, Rui Manoel] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Reis, Rui Manoel] Barretos Canc Hosp, Mol Oncol Res Ctr, Sao Paulo, Brazil; [Hainaut, Pierre] Int Prevent Res Inst, Lyon, France; [Hainaut, Pierre] Inst Albert Bonniot, INSERM 823, Grenoble, France; [Batista dos Santos, Sidney Emanuel] Fed Univ Para, Biosci Inst, Human & Med Genet Lab, BR-66059 Belem, Para, Brazil; [Ashton-Prolla, Patricia] Hosp Clin Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; A.C.Camargo Cancer Center; Universidade do Minho; Hospital de Cancer de Barretos; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universidade Federal do Para	Paskulin, DD (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program, Genet & Mol Biol, Porto Alegre, RS, Brazil.	diegopaskulin@gmail.com	Reis, Rui Manuel/B-1744-2018; Achatz, Maria Isabel/C-5751-2013; Hainaut, Pierre/B-6018-2012; Reis, Rui M/C-2859-2009; Costa, Sandra/AAV-7175-2020; Reis, Rui Manuel/AAD-6470-2020; Ashton-Prolla, Patricia/T-3515-2019; Ashton-Prolla, Patricia/H-2927-2012; Costa, Sandra/B-4253-2011; Giacomazzi, Juliana/F-6629-2015	Reis, Rui Manuel/0000-0002-9639-7940; Achatz, Maria Isabel/0000-0001-6894-1219; Hainaut, Pierre/0000-0002-1303-1610; Reis, Rui M/0000-0002-9639-7940; Costa, Sandra/0000-0001-6795-4245; Reis, Rui Manuel/0000-0002-9639-7940; Costa, Sandra/0000-0001-6795-4245; Giacomazzi, Juliana/0000-0001-5811-5140	CNPq (RFA MCT/CNPq; Universal), Brazil [478430/2012-4, 14/2012]; UFRGS; UFPA; AC Camargo; HC Barretos; University of Minho	CNPq (RFA MCT/CNPq; Universal), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UFRGS; UFPA; AC Camargo; HC Barretos; University of Minho	This study was funded by grant # 478430/2012-4 from CNPq (RFA MCT/CNPq - No 14/2012; Universal), Brazil.; We would like to thank UFRGS, UFPA, AC Camargo, HC Barretos and University of Minho for their support during this work.	Alves C, 2004, FORENSIC SCI INT, V139, P201, DOI 10.1016/j.forsciint.2003.11.002; Ariffin H, 2014, P NATL ACAD SCI USA, V111, P15497, DOI 10.1073/pnas.1417322111; Assumpcao JG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-357; Bougeard G, 2008, J MED GENET, V45, P535, DOI 10.1136/jmg.2008.057570; Campanella NC, 2014, EUR J HUM GENET, V22, P875, DOI 10.1038/ejhg.2013.256; Chompret A, 2001, J MED GENET, V38, P43, DOI 10.1136/jmg.38.1.43; Costa BM, 2007, CLIN CANCER RES, V13, P2621, DOI 10.1158/1078-0432.CCR-06-2606; Custodio G, 2013, J CLIN ONCOL, V31, P2619, DOI 10.1200/JCO.2012.46.3711; Custodio G, 2012, MOL CELL ENDOCRINOL, V351, P44, DOI 10.1016/j.mce.2011.10.019; Custodio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018015; de Mello RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072373; Dominguez-Valentin M, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-18; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Figueiredo BC, 2006, J MED GENET, V43, P91, DOI 10.1136/jmg.2004.030551; Garritano S, 2010, HUM MUTAT, V31, P143, DOI 10.1002/humu.21151; Gaspar C, 2001, AM J HUM GENET, V68, P523, DOI 10.1086/318184; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Giacomazzi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099893; Giacomazzi J, 2013, CANCER-AM CANCER SOC, V119, P4341, DOI 10.1002/cncr.28346; Giacomazzi J, 2013, VIRCHOWS ARCH, V463, P17, DOI 10.1007/s00428-013-1439-8; Giacomazzi J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-187; Herrmann LJM, 2012, J CLIN ENDOCR METAB, V97, pE476, DOI 10.1210/jc.2011-1982; Levy M S, 1974, Rev Saude Publica, VSuppl, P49; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1969, J NATL CANCER I, V43, P1365; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Palmero EI, 2008, CANCER LETT, V261, P21, DOI 10.1016/j.canlet.2007.10.044; Peixoto A, 2011, BREAST CANCER RES TR, V127, P671, DOI 10.1007/s10549-010-1036-3; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pinheiro M, 2013, CLIN GENET, V84, P244, DOI 10.1111/cge.12062; Pinto C, 2009, FAM CANCER, V8, P383, DOI 10.1007/s10689-009-9251-y; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Santos SEB, 1996, ANN HUM GENET, V60, P305, DOI 10.1111/j.1469-1809.1996.tb01194.x; Seidinger AL, 2011, CANCER-AM CANCER SOC, V117, P2228, DOI 10.1002/cncr.25826; Silva WA, 2006, HUM BIOL, V78, P29, DOI 10.1353/hub.2006.0028; STEVANIN G, 1995, AM J HUM GENET, V57, P1247; Achatz MIW, 2007, CANCER LETT, V245, P96, DOI 10.1016/j.canlet.2005.12.039	44	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143262	10.1371/journal.pone.0143262	http://dx.doi.org/10.1371/journal.pone.0143262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618902	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800029
J	Xie, LZ; Hu, YN; Yan, B; Wang, L; Yang, BQ; Liu, WY; Zhang, LB; Luo, LM; Shu, HZ; Chen, Y				Xie, Lizhe; Hu, Yining; Yan, Bin; Wang, Lin; Yang, Benqiang; Liu, Wenyuan; Zhang, Libo; Luo, Limin; Shu, Huazhong; Chen, Yang			An Effective CUDA Parallelization of Projection in Iterative Tomography Reconstruction	PLOS ONE			English	Article							IMAGE-RECONSTRUCTION; COMPUTED-TOMOGRAPHY	Projection and back-projection are the most computationally intensive parts in Computed Tomography (CT) reconstruction, and are essential to acceleration of CT reconstruction algorithms. Compared to back-projection, parallelization efficiency in projection is highly limited by racing condition and thread unsynchronization. In this paper, a strategy of Fixed Sampling Number Projection (FSNP) is proposed to ensure the operation synchronization in the ray-driven projection with Graphical Processing Unit (GPU). Texture fetching is also used utilized to further accelerate the interpolations in both projection and back-projection. We validate the performance of this FSNP approach using both simulated and real conebeam CT data. Experimental results show that compare to the conventional approach, the proposed FSNP method together with texture fetching is 10 similar to 16 times faster than the conventional approach based on global memory, and thus leads to more efficient iterative algorithm in CT reconstruction.	[Xie, Lizhe; Yan, Bin; Wang, Lin] Nanjing Med Univ, Oral Hosp Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Hu, Yining; Luo, Limin; Shu, Huazhong; Chen, Yang] Ctr Rech Informat Biomed Sinofrancais LIA CRIBs, Rennes, France; [Hu, Yining; Luo, Limin; Shu, Huazhong; Chen, Yang] Southeast Univ, Lab Image Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Hu, Yining; Luo, Limin; Shu, Huazhong; Chen, Yang] Southeast Univ, Minist Educ, Key Lab Comp Network & Informat Integrat, Beijing, Peoples R China; [Yang, Benqiang; Liu, Wenyuan; Zhang, Libo] Shenyang Mil Area Command, Gen Hosp, Dept Radiol, Shenyang, Peoples R China	Nanjing Medical University; Southeast University - China; Southeast University - China	Yang, BQ (corresponding author), Shenyang Mil Area Command, Gen Hosp, Dept Radiol, Shenyang, Peoples R China.	bqyang_syjqzyy@sina.com; sy_liuwenyuan@sina.com	liu, wen/HGE-3071-2022		National Natural Science Foundation [81370040, 81530060, 61405033, 31100713]; Natural Science Foundation of Jiangsu Province [BK20130629]; Qing Lan Project in Jiangsu Province	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Qing Lan Project in Jiangsu Province	This research was supported by National Natural Science Foundation under grants (81370040, 81530060, 61405033, 31100713). This work was also supported by the grant of Natural Science Foundation of Jiangsu Province under grant BK20130629, and the Qing Lan Project in Jiangsu Province.	Bian JG, 2014, PHYS MED BIOL, V59, P2659, DOI 10.1088/0031-9155/59/11/2659; Bruno D., 2002, NUCL SCI S 2002 IEEE, V3; Chen Y, 2008, J MATH IMAGING VIS, V30, P133, DOI 10.1007/s10851-007-0042-5; Chen Y, 2011, MULTISCALE MODEL SIM, V9, P1399, DOI 10.1137/100814184; Chen Y, 2009, COMPUT MED IMAG GRAP, V33, P495, DOI 10.1016/j.compmedimag.2008.12.007; Chou CY, 2011, MED PHYS, V38, P4052, DOI 10.1118/1.3591994; De Man B, 2004, PHYS MED BIOL, V49, P2463, DOI 10.1088/0031-9155/49/11/024; De Witte Y, 2010, IEEE T IMAGE PROCESS, V19, P2419, DOI 10.1109/TIP.2010.2046960; Flores LA, 2014, RADIAT PHYS CHEM, V95, P247, DOI 10.1016/j.radphyschem.2013.03.011; Flores LA, 2013, PROCEDIA COMPUT SCI, V18, P1412, DOI 10.1016/j.procs.2013.05.308; Gao H., 2012, MED PHYS, V39; HU Y, 2012, C IEEE INT S BIOM IM, P804; Hu YN, 2011, PHYS MED BIOL, V56, P1173, DOI 10.1088/0031-9155/56/4/018; Hu Z, 2007, IEEE NUCL SCI CONF R, P4415, DOI 10.1109/NSSMIC.2007.4437091; Jia X., 2011, PHYS MED BIOL, V56; Knaup M., 2008, IEEE NUCL SCI S, P5153; LEWITT RM, 1990, J OPT SOC AM A, V7, P1834, DOI 10.1364/JOSAA.7.001834; Ma JH, 2012, PHYS MED BIOL, V57, P7519, DOI 10.1088/0031-9155/57/22/7519; Ma JH, 2011, MED PHYS, V38, P5713, DOI 10.1118/1.3638125; Noel PB, 2010, COMPUT METH PROG BIO, V98, P271, DOI 10.1016/j.cmpb.2009.08.006; Okitsu Y, 2010, PARALLEL COMPUT, V36, P129, DOI 10.1016/j.parco.2010.01.004; Pratx G, 2009, IEEE T MED IMAGING, V28, P435, DOI 10.1109/TMI.2008.2006518; Siddon R. L., 1985, MED PHYS, V12, P52; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Wang J, 2009, MED PHYS, V36, P252, DOI 10.1118/1.3036112; Wang L., 2013, SENSORS TRANSDUCERS, V21, P128; Xu Jingyan, 2009, J Am Coll Radiol, V6, P274, DOI 10.1016/j.jacr.2008.12.014; Zeng GSL, 2000, IEEE T MED IMAGING, V19, P548, DOI 10.1109/42.870265; Zhang B, 2006, IEEE NUCL SCI CONF R, P2900, DOI 10.1109/NSSMIC.2006.356483; Zhao X, 2013, J X-RAY SCI TECHNOL, V21, P53, DOI 10.3233/XST-130366; ZHUANG W, 1994, IEEE T NUCL SCI, V41, P1660, DOI 10.1109/23.322963	31	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0142184	10.1371/journal.pone.0142184	http://dx.doi.org/10.1371/journal.pone.0142184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618857	gold, Green Published, Green Submitted			2022-12-26	WOS:000365889800011
J	Mochizuki-Kawai, H; Niki, T; Shibuya, K; Ichimura, K				Mochizuki-Kawai, Hiroko; Niki, Tomoko; Shibuya, Kenichi; Ichimura, Kazuo			Programmed Cell Death Progresses Differentially in Epidermal and Mesophyll Cells of Lily Petals	PLOS ONE			English	Article							SENESCENCE-ASSOCIATED GENES; CYSTEINE PROTEASE; PROTEOLYTIC ACTIVITY; FLOWER SENESCENCE; UP-REGULATION; EXPRESSION; IDENTIFICATION; LEAF; ARABIDOPSIS; VACUOLES	In the petals of some species of flowers, programmed cell death (PCD) begins earlier in mesophyll cells than in epidermal cells. However, PCD progression in each cell type has not been characterized in detail. We separately constructed a time course of biochemical signs and expression patterns of PCD-associated genes in epidermal and mesophyll cells in Lilium cv. Yelloween petals. Before visible signs of senescence could be observed, we found signs of PCD, including DNA degradation and decreased protein content in mesophyll cells only. In these cells, the total proteinase activity increased on the day after anthesis. Within 3 days after anthesis, the protein content decreased by 61.8%, and 22.8% of mesophyll cells was lost. A second peak of proteinase activity was observed on day 6, and the number of mesophyll cells decreased again from days 4 to 7. These biochemical and morphological results suggest that PCD progressed in steps during flower life in the mesophyll cells. PCD began in epidermal cells on day 5, in temporal synchrony with the time course of visible senescence. In the mesophyll cells, the KDEL-tailed cysteine proteinase (LoCYP) and S1/P1 nuclease (LoNUC) genes were upregulated before petal wilting, earlier than in epidermal cells. In contrast, relative to that in the mesophyll cells, the expression of the SAG12 cysteine proteinase homolog (LoSAG12) drastically increased in epidermal cells in the final stage of senescence. These results suggest that multiple PCD-associated genes differentially contribute to the time lag of PCD progression between epidermal and mesophyll cells of lily petals.	[Mochizuki-Kawai, Hiroko; Niki, Tomoko; Shibuya, Kenichi; Ichimura, Kazuo] NARO Inst Floricultural Sci, Tsukuba, Ibaraki 3058519, Japan		Mochizuki-Kawai, H (corresponding author), NARO Inst Floricultural Sci, Tsukuba, Ibaraki 3058519, Japan.	hirokom@affrc.go.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT/KAKENHI) [25660032]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT/KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for scientific research to HM from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT/KAKENHI) (25660032).	Battelli R, 2010, THESIS; Battelli R, 2014, PLANT SCI, V214, P38, DOI 10.1016/j.plantsci.2013.09.011; Battelli R, 2011, PLANT SCI, V180, P716, DOI 10.1016/j.plantsci.2011.01.024; Beyene G, 2006, J EXP BOT, V57, P1431, DOI 10.1093/jxb/erj123; Gruis D, 2002, PLANT CELL, V14, P2863, DOI 10.1105/tpc.005009; Hara-Nishimura I, 1998, J PLANT PHYSIOL, V152, P668, DOI 10.1016/S0176-1617(98)80028-X; Helm M, 2008, AM J BOT, V95, P1049, DOI 10.3732/ajb.2007404; Hoeberichts FA, 2007, J EXP BOT, V58, P2873, DOI 10.1093/jxb/erm076; Hunter DA, 2002, PLANT SCI, V163, P13, DOI 10.1016/S0168-9452(02)00068-7; Jones ML, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt023; Jones ML, 2005, J EXP BOT, V56, P2733, DOI 10.1093/jxb/eri266; Lesniewicz K, 2013, PLANT CELL PHYSIOL, V54, P1064, DOI 10.1093/pcp/pct061; LOHMAN KN, 1994, PHYSIOL PLANTARUM, V92, P322, DOI 10.1111/j.1399-3054.1994.tb05343.x; Makino A, 1997, PLANTA, V203, P390, DOI 10.1007/s004250050205; Mochizuki-Kawai H, 2013, POSTHARVEST BIOL TEC, V79, P9, DOI 10.1016/j.postharvbio.2012.12.010; Mochizuki-Kawai H, 2012, J JPN SOC HORTIC SCI, V81, P350, DOI 10.2503/jjshs1.81.350; Otegui MS, 2005, PLANT J, V41, P831, DOI 10.1111/j.1365-313X.2005.02346.x; Pak C, 2005, NEW PHYTOL, V165, P473, DOI 10.1111/j.1469-8137.2004.01226.x; Panavas T, 1999, PLANT MOL BIOL, V40, P237, DOI 10.1023/A:1006146230602; Perez-Amador MA, 2000, PLANT PHYSIOL, V122, P169, DOI 10.1104/pp.122.1.169; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Richau KH, 2012, PLANT PHYSIOL, V158, P1583, DOI 10.1104/pp.112.194001; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; VALPUESTA V, 1995, PLANT MOL BIOL, V28, P575, DOI 10.1007/BF00020403; van Doorn WG, 2003, PLANT MOL BIOL, V53, P845, DOI 10.1023/B:PLAN.0000023670.61059.1d; van Doorn WG, 2008, J EXP BOT, V59, P453, DOI 10.1093/jxb/erm356; Wagstaff C, 2003, NEW PHYTOL, V160, P49, DOI 10.1046/j.1469-8137.2003.00853.x; Wagstaff C, 2002, J EXP BOT, V53, P233, DOI 10.1093/jexbot/53.367.233; Wan LL, 2002, PLANT J, V30, P1, DOI 10.1046/j.1365-313X.2002.01262.x; Yamada T, 2003, PLANT SCI, V164, P213, DOI 10.1016/S0168-9452(02)00403-X; Yamada T, 2007, PLANTA, V226, P1195, DOI 10.1007/s00425-007-0566-3; Yamada T, 2009, PLANT CELL PHYSIOL, V50, P610, DOI 10.1093/pcp/pcp019	32	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143502	10.1371/journal.pone.0143502	http://dx.doi.org/10.1371/journal.pone.0143502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605547	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300072
J	Chiba, K; Tsuchiya, M; Koide, M; Hagiwara, Y; Sasaki, K; Hattori, Y; Watanabe, M; Sugawara, S; Kanzaki, M; Endo, Y				Chiba, Ko; Tsuchiya, Masahiro; Koide, Masashi; Hagiwara, Yoshihiro; Sasaki, Keiichi; Hattori, Yoshinori; Watanabe, Makoto; Sugawara, Shunji; Kanzaki, Makoto; Endo, Yasuo			Involvement of IL-1 in the Maintenance of Masseter Muscle Activity and Glucose Homeostasis	PLOS ONE			English	Article							SKELETAL-MUSCLE; TEMPOROMANDIBULAR DISORDERS; HISTIDINE-DECARBOXYLASE; OLDER-ADULTS; EXERCISE; MICE; INTERLEUKIN-1; FATIGUE; FATIGABILITY; CELLS	Physical exercise reportedly stimulates IL-1 production within working skeletal muscles, but its physiological significance remains unknown due to the existence of two distinct IL-1 isoforms, IL-1 alpha and IL-1 beta. The regulatory complexities of these two isoforms, in terms of which cells in muscles produce them and their distinct/redundant biological actions, have yet to be elucidated. Taking advantage of our masticatory behavior (Restrained/Gnawing) model, we herein show that IL-1 alpha/1 beta-double-knockout (IL-1-KO) mice exhibit compromised masseter muscle (MM) activity which is at least partially attributable to abnormalities of glucose handling (rapid glycogen depletion along with impaired glucose uptake) and dysfunction of IL-6 upregulation in working MMs. In wild-type mice, masticatory behavior clearly increased IL-1 beta mRNA expression but no incremental protein abundance was detectable in whole MM homogenates, whereas immunohistochemical staining analysis revealed that both IL-1 alpha- and IL-1 beta-immunopositive cells were recruited around blood vessels in the perimysium of MMs after masticatory behavior. In addition to the aforementioned phenotype of IL-1-KO mice, we found the IL-6 mRNA and protein levels in MMs after masticatory behavior to be significantly lower in IL-1-KO than in WT. Thus, our findings confirm that the locally-increased IL-1 elicited by masticatory behavior, although present small in amounts, contributes to supporting MM activity by maintaining normal glucose homeostasis in these muscles. Our data also underscore the importance of IL-1-mediated local interplay between autocrine myokines including IL-6 and paracrine cytokines in active skeletal muscles. This interplay is directly involved in MM performance and fatigability, perhaps mediated through maintaining muscular glucose homeostasis.	[Chiba, Ko; Hattori, Yoshinori; Watanabe, Makoto] Tohoku Univ, Grad Sch Dent, Div Aging & Geriatr Dent, Sendai, Miyagi 980, Japan; [Chiba, Ko; Sugawara, Shunji; Endo, Yasuo] Tohoku Univ, Grad Sch Dent, Div Oral Mol Regulat, Sendai, Miyagi 980, Japan; [Tsuchiya, Masahiro; Watanabe, Makoto] Tohoku Fukushi Univ, Kansei Fukushi Res Inst, Sendai, Miyagi, Japan; [Tsuchiya, Masahiro] Tohoku Univ, Grad Sch Dent, Div Oral Diag, Sendai, Miyagi 980, Japan; [Koide, Masashi; Hagiwara, Yoshihiro] Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 980, Japan; [Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 980, Japan; [Kanzaki, Makoto] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Tsuchiya, M (corresponding author), Tohoku Fukushi Univ, Kansei Fukushi Res Inst, Sendai, Miyagi, Japan.	mtsuchiya@tfu-mail.tfu.ac.jp	Tsuchiya, Masahiro/C-5553-2018; Hattori, Yoshinori/AAE-1393-2019; Kanzaki, Makoto/H-6680-2017	Tsuchiya, Masahiro/0000-0002-7000-4547; Hattori, Yoshinori/0000-0002-9076-4359; Kanzaki, Makoto/0000-0002-6884-2955	Japan Society for the Promotion of Science [23390439, 24390429, 25670813]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the following grants from the Japan Society for the Promotion of Science: 23390439 (to M. Watanabe), and 24390429 and 25670813 (both to M. Tsuchiya). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NB, 2010, J AM GERIATR SOC, V58, P967, DOI 10.1111/j.1532-5415.2010.02811.x; Angelini Corrado, 2014, Acta Myol, V33, P119; Armijo-Olivo S, 2012, CLIN J PAIN, V28, P55, DOI 10.1097/AJP.0b013e31822019f2; Ayada K, 2002, PHYSIOL BEHAV, V77, P161, DOI 10.1016/S0031-9384(02)00844-2; Ayada K, 2000, AM J PHYSIOL-REG I, V279, pR2042, DOI 10.1152/ajpregu.2000.279.6.R2042; Bender SD, 2012, HEADACHE, V52, P22, DOI 10.1111/j.1526-4610.2012.02134.x; CANNON JG, 1986, J APPL PHYSIOL, V61, P1869, DOI 10.1152/jappl.1986.61.5.1869; CANNON JG, 1983, SCIENCE, V220, P617, DOI 10.1126/science.6836306; DELREY A, 1987, AM J PHYSIOL, V253, pR794, DOI 10.1152/ajpregu.1987.253.5.R794; Deng X, 2006, TOXICOL APPL PHARM, V213, P64, DOI 10.1016/j.taap.2005.09.005; Deng X, 2012, INT IMMUNOPHARMACOL, V14, P658, DOI 10.1016/j.intimp.2012.10.001; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1991, BLOOD, V77, P1627; DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI [10.1016/s0065-2776(08)60642-2, 10.1016/S0065-2776(08)60642-2, DOI 10.1016/S0065-2776(08)60642-2]; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Eldadah BA, 2010, PM&R, V2, P406, DOI 10.1016/j.pmrj.2010.03.022; ENDO Y, 1985, BIOCHIM BIOPHYS ACTA, V840, P37, DOI 10.1016/0304-4165(85)90159-X; ENDO Y, 1991, IMMUNOL LETT, V27, P75, DOI 10.1016/0165-2478(91)90248-9; EVANS WJ, 1986, J APPL PHYSIOL, V61, P1864, DOI 10.1152/jappl.1986.61.5.1864; FEINGOLD KR, 1992, DIABETES, V41, P97, DOI 10.2337/diab.41.2.S97; FERRE P, 1985, BIOCHEM J, V228, P103, DOI 10.1042/bj2280103; Fricton James, 2007, Dent Clin North Am, V51, P61, DOI 10.1016/j.cden.2006.10.002; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Glund S, 2008, ACTA PHYSIOL, V192, P37, DOI 10.1111/j.1748-1716.2007.01779.x; Gore AC, 2013, ENDOCRINOLOGY, V154, P579, DOI 10.1210/en.2012-2222; Gorselink M, 2002, AM J PHYSIOL-ENDOC M, V282, pE348, DOI 10.1152/ajpendo.00085.2001; Grzelkowska-Kowalczyk K, 2006, POL J VET SCI, V9, P1; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Isanejad A, 2015, CYTOKINE, V73, P302, DOI 10.1016/j.cyto.2015.03.013; Jemima EA, 2014, MOL IMMUNOL, V62, P19, DOI 10.1016/j.molimm.2014.05.007; Justice JN, 2014, EXP GERONTOL, V55, P92, DOI 10.1016/j.exger.2014.03.018; Kadotani A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1291, DOI 10.1152/ajpendo.00293.2009; Kitaoka Yu, 2014, Biology (Basel), V3, P157, DOI 10.3390/biology3010157; Kubo K, 2006, ARCH ORAL BIOL, V51, P146, DOI 10.1016/j.archoralbio.2005.06.009; LEE MD, 1987, P NATL ACAD SCI USA, V84, P2590, DOI 10.1073/pnas.84.9.2590; Moreh E, 2010, J GERONTOL A-BIOL, V65, P884, DOI 10.1093/gerona/glq064; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Neu D, 2014, EUR J APPL PHYSIOL, V114, P1841, DOI 10.1007/s00421-014-2910-1; Oguri S, 2002, CLIN DIAGN LAB IMMUN, V9, P1307, DOI 10.1128/CDLI.9.6.1307-1312.2002; Peake JM, 2015, EXERC IMMUNOL REV, V21, P8; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Pedersen BK, 2000, IMMUNOL CELL BIOL, V78, P532, DOI 10.1046/j.1440-1711.2000.00962.x; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reddy K, 2008, MOL CANCER RES, V6, P929, DOI 10.1158/1541-7786.MCR-07-2189; Ruano-Rodriguez C, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00101; Rudroff T, 2014, NEUROREHABILITATION, V35, P813, DOI 10.3233/NRE-141179; Sato S, 2009, HISTOCHEM CELL BIOL, V131, P583, DOI 10.1007/s00418-009-0556-6; Tanaka Y, 2012, J LEUKOCYTE BIOL, V91, P485, DOI 10.1189/jlb.1210697; Tsuchiya M, 2012, TOHOKU J EXP MED, V227, P109, DOI 10.1620/tjem.227.109; VANHANDEL E, 1965, ANAL BIOCHEM, V11, P256, DOI 10.1016/0003-2697(65)90013-8; Vedsted P, 2003, ACTA PHYSIOL SCAND, V178, P175, DOI 10.1046/j.1365-201X.2003.01123.x	53	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143635	10.1371/journal.pone.0143635	http://dx.doi.org/10.1371/journal.pone.0143635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599867	Green Published, gold			2022-12-26	WOS:000365862600097
J	Leiser, OP; Merkley, ED; Clowers, BH; Kaiser, BLD; Lin, A; Hutchison, JR; Melville, AM; Wagner, DM; Keim, PS; Foster, JT; Kreuzer, HW				Leiser, Owen P.; Merkley, Eric D.; Clowers, Brian H.; Kaiser, Brooke L. Deatherage; Lin, Andy; Hutchison, Janine R.; Melville, Angela M.; Wagner, David M.; Keim, Paul S.; Foster, Jeffrey T.; Kreuzer, Helen W.			Investigation of Yersinia pestis Laboratory Adaptation through a Combined Genomics and Proteomics Approach	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; NITROGEN ASSIMILATION; MUTATIONAL ANALYSIS; PROLYL ISOMERASE; PLAGUE; PEPA; METABOLISM; EXPRESSION; SEQUENCE	The bacterial pathogen Yersinia pestis, the cause of plague in humans and animals, normally has a sylvatic lifestyle, cycling between fleas and mammals. In contrast, laboratory-grown Y. pestis experiences a more constant environment and conditions that it would not normally encounter. The transition from the natural environment to the laboratory results in a vastly different set of selective pressures, and represents what could be considered domestication. Understanding the kinds of adaptations Y. pestis undergoes as it becomes domesticated will contribute to understanding the basic biology of this important pathogen. In this study, we performed a parallel serial passage experiment (PSPE) to explore the mechanisms by which Y. pestis adapts to laboratory conditions, hypothesizing that cells would undergo significant changes in virulence and nutrient acquisition systems. Two wild strains were serially passaged in 12 independent populations each for similar to 750 generations, after which each population was analyzed using whole-genome sequencing, LC-MS/MS proteomic analysis, and GC/MS metabolomics. We observed considerable parallel evolution in the endpoint populations, detecting multiple independent mutations in ail, pepA, and zwf, suggesting that specific selective pressures are shaping evolutionary responses. Complementary LC-MS/MS proteomic data provide physiological context to the observed mutations, and reveal regulatory changes not necessarily associated with specific mutations, including changes in amino acid metabolism and cell envelope biogenesis. Proteomic data support hypotheses generated by genomic data in addition to suggesting future mechanistic studies, indicating that future whole-genome sequencing studies be designed to leverage proteomics as a critical complement.	[Leiser, Owen P.; Wagner, David M.; Keim, Paul S.; Foster, Jeffrey T.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86001 USA; [Merkley, Eric D.; Kaiser, Brooke L. Deatherage; Lin, Andy; Hutchison, Janine R.; Melville, Angela M.; Foster, Jeffrey T.; Kreuzer, Helen W.] Pacific NW Natl Lab, Chem & Biol Signature Sci, Richland, WA 99352 USA; [Clowers, Brian H.] Washington State Univ, Dept Chem, Pullman, WA 99354 USA	Northern Arizona University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington State University	Kreuzer, HW (corresponding author), Pacific NW Natl Lab, Chem & Biol Signature Sci, Richland, WA 99352 USA.	helen.kreuzer@pnnl.gov	Clowers, Brian/GLQ-6772-2022; Leiser, Owen/ABA-8089-2021	Clowers, Brian/0000-0002-5809-9379; Foster, Jeffrey/0000-0001-8235-8564; Lin, Andy/0000-0003-0072-612X; Wagner, David/0000-0003-2684-6007; Leiser, Owen/0000-0003-1190-5596; Merkley, Eric/0000-0002-5486-4723	Defense Threat Reduction Agency Basic Research Award [DTRA10027IA-2129]; Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory; U.S. DOE [DE-AC06-76RLO]	Defense Threat Reduction Agency Basic Research Award(United States Department of DefenseDefense Threat Reduction Agency); Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory; U.S. DOE(United States Department of Energy (DOE))	This work was supported by Defense Threat Reduction Agency Basic Research Award DTRA10027IA-2129 and by the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory, a multiprogram national laboratory operated by Battelle for the U.S. Department of Energy. Battelle Memorial Institute operates Pacific Northwest National Laboratory for the U.S. DOE under Contract DE-AC06-76RLO. The funders authorized publication, but had no role in study design, data collection and analysis, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansong C, 2013, MOL BIOSYST, V9, P44, DOI 10.1039/c2mb25287b; Arie JP, 2001, MOL MICROBIOL, V39, P199, DOI 10.1046/j.1365-2958.2001.02250.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; Bender RA, 2010, J BACTERIOL, V192, P4801, DOI 10.1128/JB.00266-10; Brookes P., 2001, MICROBES ENVIRON, V16, P131, DOI [10.1264/jsme2.2001.131, DOI 10.1264/JSME2.2001.131]; Buetow L, 2007, P NATL ACAD SCI USA, V104, P4321, DOI 10.1073/pnas.0606356104; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; CHARLIER D, 1995, J MOL BIOL, V250, P392, DOI 10.1006/jmbi.1995.0385; Charlier D, 2000, J MOL BIOL, V302, P411, DOI 10.1006/jmbi.2000.4067; Charusanti P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-163; Chauvaux S, 2007, MICROBIOL-SGM, V153, P3112, DOI 10.1099/mic.0.2007/006213-0; Chauvaux S, 2011, INT J MED MICROBIOL, V301, P105, DOI 10.1016/j.ijmm.2010.08.013; Cox Jr, 2014, MOL CELLULLAR PROTEO; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Devroede N, 2006, J BACTERIOL, V188, P3236, DOI 10.1128/JB.188.9.3236-3245.2006; Eisen RJ, 2007, J MED ENTOMOL, V44, P530, DOI 10.1603/0022-2585(2007)44[530:HPITSU]2.0.CO;2; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Eydallin G, 2014, ENVIRON MICROBIOL, V16, P813, DOI 10.1111/1462-2920.12208; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; Flores S, 2004, BIOTECHNOL BIOENG, V87, P485, DOI 10.1002/bit.20137; Fox A, 1988, ANAL CARBOHYDRATES G, P87; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Gourlay SC, 2004, MOL MICROBIOL, V52, P53, DOI 10.1111/j.1365-2958.2003.03962.x; Harley WM, 2002, J MICROBIOL METH, V51, P95, DOI 10.1016/S0167-7012(02)00064-7; HINNEBUSCH J, 1993, J CLIN MICROBIOL, V31, P1511, DOI 10.1128/JCM.31.6.1511-1514.1993; Hixson KK, 2006, J PROTEOME RES, V5, P3008, DOI 10.1021/pr060179y; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; Jabbour RE, 2010, J PROTEOME RES, V9, P3647, DOI 10.1021/pr100402y; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kolodkin-Gal A, 2008, J BACTERIOL, V190, P3169, DOI 10.1128/JB.01918-07; Kolodziejek AM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00103; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Leal-Balbino TC, 2004, MEM I OSWALDO CRUZ, V99, P727, DOI 10.1590/S0074-02762004000700011; Lin A, 2015, J MICROBIOL METH, V112, P3, DOI 10.1016/j.mimet.2015.01.015; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Maddamsetti R, 2015, GENETICS, V200, P619, DOI 10.1534/genetics.115.176677; MAKOFF AJ, 1978, MICROBIOL REV, V42, P307, DOI 10.1128/MMBR.42.2.307-328.1978; McGovern TW, 1997, MED ASPECTS CHEM BIO, P479; MIKKOLA R, 1992, MOL BIOL EVOL, V9, P394; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Nicolas C, 2007, FEBS LETT, V581, P3771, DOI 10.1016/j.febslet.2007.06.066; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Paul S, 2004, PLASMID, V52, P63, DOI 10.1016/j.plasmid.2004.04.003; Perry RD, 1998, INFECT IMMUN, V66, P4611, DOI 10.1128/IAI.66.10.4611-4623.1998; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pieper R, 2009, MICROBIOL-SGM, V155, P498, DOI 10.1099/mic.0.022160-0; Pieper R, 2008, PROTEOMICS, V8, P1442, DOI 10.1002/pmic.200700923; Pieper R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-30; Pieper R, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-5; Plesniak LA, 2011, BBA-BIOMEMBRANES, V1808, P482, DOI 10.1016/j.bbamem.2010.09.017; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Ponnusamy D, 2011, VET MICROBIOL, V150, P146, DOI 10.1016/j.vetmic.2010.12.025; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Reijns M, 2005, MOL MICROBIOL, V57, P927, DOI 10.1111/j.1365-2958.2005.04716.x; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Sarovich DS, 2010, J MICROBIOL METH, V82, P95, DOI 10.1016/j.mimet.2010.03.019; Sawa J, 2010, CURR OPIN STRUC BIOL, V20, P253, DOI 10.1016/j.sbi.2010.01.014; Saxer G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004872; Scholz C, 2006, BIOCHEMISTRY-US, V45, P20, DOI 10.1021/bi051922n; Sebbane F, 2001, INFECT IMMUN, V69, P170, DOI 10.1128/IAI.69.1.170-176.2001; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sjodin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011556; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Stevenson HL, 2003, J MED ENTOMOL, V40, P329, DOI 10.1603/0022-2585-40.3.329; STRALEY SC, 1988, REV INFECT DIS, V10, pS323; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Strater N, 1999, EMBO J, V18, P4513, DOI 10.1093/emboj/18.16.4513; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Tanaka K, 2001, J BACTERIOL, V183, P6538, DOI 10.1128/JB.183.22.6538-6542.2001; Tolker-Nielsen T, 2000, MICROB ECOL, V40, P75; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vogler AJ, 2007, MUTAT RES-FUND MOL M, V616, P145, DOI 10.1016/j.mrfmmm.2006.11.007; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2; Wang YP, 2010, BIOGEOSCIENCES, V7, P2261, DOI 10.5194/bg-7-2261-2010; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; WUNSCHEL D, 1995, SYST APPL MICROBIOL, V17, P625, DOI 10.1016/S0723-2020(11)80085-8; Zhao J, 2004, METAB ENG, V6, P164, DOI 10.1016/j.ymben.2004.02.004	92	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142997	10.1371/journal.pone.0142997	http://dx.doi.org/10.1371/journal.pone.0142997			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599979	Green Submitted, gold, Green Published			2022-12-26	WOS:000365862600025
J	Li, MY; Huang, R; Jiang, X; Chen, YX; Zhang, Z; Zhang, XY; Liang, PP; Zhan, SQ; Cao, SB; Zhou, SY; Huang, JJ				Li, Minyan; Huang, Rui; Jiang, Xue; Chen, Yuxi; Zhang, Zhen; Zhang, Xiya; Liang, Puping; Zhan, Shaoquan; Cao, Shanbo; Zhou Songyang; Huang, Junjiu			CRISPR/Cas9 Promotes Functional Study of Testis Specific X-Linked Gene In Vivo	PLOS ONE			English	Article								Mammalian spermatogenesis is a highly regulated multistage process of sperm generation. It is hard to uncover the real function of a testis specific gene in vitro since the in vitro model is not yet mature. With the development of the CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated 9) system, we can now rapidly generate knockout mouse models of testis specific genes to study the process of spermatogenesis in vivo. SYCP3-like X-linked 2 (SLX2) is a germ cell specific component, which contains a Cor1 domain and belongs to the XLR (X-linked, lymphocyte regulated) family. Previous studies suggested that SLX2 might play an important role in mouse spermatogenesis based on its subcellular localization and interacting proteins. However, the function of SLX2 in vivo is still elusive. Here, to investigate the functions of SLX2 in spermatogenesis, we disrupted the Slx2 gene by using the CRISPR/Cas9 system. Since Slx2 is a testis specific X-linked gene, we obtained knockout male mice in the first generation and accelerated the study process. Compared with wild-type mice, Slx2 knockout mice have normal testis and epididymis. Histological observation of testes sections showed that Slx2 knockout affected none of the three main stages of spermatogenesis: mitosis, meiosis and spermiogenesis. In addition, we further confirmed that disruption of Slx2 did not affect the number of spermatogonial stem cells, meiosis progression or XY body formation by immunofluorescence analysis. As spermatogenesis was normal in Slx2 knockout mice, these mice were fertile. Taken together, we showed that Slx2 itself is not an essential gene for mouse spermatogenesis and CRISPR/Cas9 technique could speed up the functional study of testis specific X-linked gene in vivo.	[Li, Minyan; Huang, Rui; Jiang, Xue; Chen, Yuxi; Zhang, Zhen; Zhang, Xiya; Liang, Puping; Zhan, Shaoquan; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Reprod Med, Guangzhou 510275, Guangdong, Peoples R China; [Li, Minyan; Huang, Rui; Jiang, Xue; Chen, Yuxi; Zhang, Zhen; Zhang, Xiya; Liang, Puping; Zhan, Shaoquan; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Li, Minyan; Huang, Rui; Jiang, Xue; Chen, Yuxi; Zhang, Zhen; Zhang, Xiya; Liang, Puping; Zhan, Shaoquan; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Sch Life Sci, Inst Hlth Aging Res, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Minyan; Huang, Rui; Jiang, Xue; Chen, Yuxi; Zhang, Zhen; Zhang, Xiya; Liang, Puping; Zhan, Shaoquan; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Sch Life Sci, SYSU BCM Joint Res Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhan, Shaoquan; Cao, Shanbo] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Reprod Med Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Zhou, SY (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Reprod Med, Guangzhou 510275, Guangdong, Peoples R China.	songyanz@mail.sysu.edu.cn; hjunjiu@mail.sysu.edu.cn		Liang, Puping/0000-0003-3593-2599; Li, Minyan/0000-0002-1944-5881	Natural Science Foundation of Guangdong Province [2014A030312011]; National Natural Science Foundation [81330055, 31371508, 31301178, 31401223, J131002]; Science and Technology Planning Project of Guangdong Province [2015B020228002]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province	This study was supported by the Natural Science Foundation of Guangdong Province (2014A030312011), the National Natural Science Foundation (81330055, 31371508, 31301178, 31401223 and J131002) and the Science and Technology Planning Project of Guangdong Province (2015B020228002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank Dr. Yuwen Qiu and Zhini Zhang for their helpful suggestions in animal experimental design; Professor Jian Ren for providing GPS CNN1.0 software for cell counting.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cloutier JM, 2010, CURR BIOL, V20, pR962, DOI 10.1016/j.cub.2010.09.041; Cocquet J, 2010, MOL BIOL CELL, V21, P3497, DOI 10.1091/mbc.E10-07-0601; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; Cohen DI, 1985, NATURE, V314; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Escalier D, 1999, J IMMUNOL, V162, P292; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; Fernandez- Capetillo O, 2003, DEV CELL, V4; Fietz D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062638; Garchon HJ, 1989, NUCL ACIDS RES, V17; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kolas NK, 2004, CYTOGENET GENOME RES, V105, P182, DOI 10.1159/000078188; Kotaja N, 2014, FERTIL STERIL, V101, P1552, DOI 10.1016/j.fertnstert.2014.04.025; Kouznetsova A, 2005, J CELL SCI 10, V118; Kubota H, 2008, METHOD CELL BIOL, V86, P00016, DOI [10.1016/S0091-679X, DOI 10.1016/S0091-679X(08)00016-2]; Lu LY, 2013, NAT COMMUN, P4; Maeda Y, 2002, CELL DEATH DIFFERENT, V9; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meikar O, 2011, REPRODUCTION, V142, P195, DOI 10.1530/REP-11-0057; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pearson H, 2002, NATURE, V415, P8, DOI 10.1038/415008a; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Reynard LN, 2009, BIOL REPROD, V81, DOI [10.1095/biolreprod.109.076117, DOI 10.1095/BIOLREPROD.109.076117]; Sander JD, 2014, NAT BIOTECHNOL, V32; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Shi YQ, 2013, GENE, V527, P352, DOI 10.1016/j.gene.2013.06.033; Shukla KK, 2012, FRONT BIOSCI, P4; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Tsutsumi M, 2011, BIOL REPROD, V85; Turner JM, 2007, DEVELOPMENT, V134; Turner JM, 2005, NAT GENET, V37; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zhuang XJ, 2014, CELL CYCLE, V13, P2230, DOI 10.4161/cc.29265; Zhuang XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020866	49	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143148	10.1371/journal.pone.0143148	http://dx.doi.org/10.1371/journal.pone.0143148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599493	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600033
J	Lisein, J; Michez, A; Claessens, H; Lejeune, P				Lisein, Jonathan; Michez, Adrien; Claessens, Hugues; Lejeune, Philippe			Discrimination of Deciduous Tree Species from Time Series of Unmanned Aerial System Imagery	PLOS ONE			English	Article							CLASSIFICATION; FOREST	Technology advances can revolutionize Precision Forestry by providing accurate and fine forest information at tree level. This paper addresses the question of how and particularly when Unmanned Aerial System (UAS) should be used in order to efficiently discriminate deciduous tree species. The goal of this research is to determine when is the best time window to achieve an optimal species discrimination. A time series of high resolution UAS imagery was collected to cover the growing season from leaf flush to leaf fall. Full benefit was taken of the temporal resolution of UAS acquisition, one of the most promising features of small drones. The disparity in forest tree phenology is at the maximum during early spring and late autumn. But the phenology state that optimized the classification result is the one that minimizes the spectral variation within tree species groups and, at the same time, maximizes the phenologic differences between species. Sunlit tree crowns (5 deciduous species groups) were classified using a Random Forest approach for monotemporal, two-date and three-date combinations. The end of leaf flushing was the most efficient single-date time window. Multitemporal datasets definitely improve the overall classification accuracy. But single-date high resolution orthophotomosaics, acquired on optimal time-windows, result in a very good classification accuracy (overall out of bag error of 16%).	[Lisein, Jonathan; Michez, Adrien; Claessens, Hugues; Lejeune, Philippe] Univ Liege, Gembloux Agrobio Tech 2, Dept Biosyt Engn, Lab Forest Resources Management, B-5030 Gembloux, Belgium; [Lisein, Jonathan] Ecole Natl Sci Geog, F-77455 Marne La Vallee, France	University of Liege; Universite Gustave-Eiffel	Lisein, J (corresponding author), Univ Liege, Gembloux Agrobio Tech 2, Dept Biosyt Engn, Lab Forest Resources Management, B-5030 Gembloux, Belgium.	jo.lisein@ulg.ac.be	Michez, Adrien/AAB-3241-2019	Michez, Adrien/0000-0003-4329-6422				Aber JS, 2010, SMALL-FORMAT AERIAL PHOTOGRAPHY: PRINCIPLES, TECHNIQUES AND GEOSCIENCE APPLICATIONS, P1; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Baltsavias E, 2008, INT J REMOTE SENS, V29, P1243, DOI 10.1080/01431160701736513; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burkholder A, 2011, PHOTOGRAMM ENG REM S, V77, P793, DOI 10.14358/PERS.77.8.793; Cole B, 2014, ISPRS J PHOTOGRAMM, V90, P49, DOI 10.1016/j.isprsjprs.2014.01.010; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Drauschke M, 2014, P WORKSH UAV BAS REM, P21; Etten RJHJv, 2014, RASTER GEOGRAPHIC AN; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gini R, 2014, EUR J REMOTE SENS, V47, P251, DOI 10.5721/EuJRS20144716; Heinzel JN, 2008, P SILVILASER 2008; Hill RA, 2010, APPL VEG SCI, V13, P86, DOI 10.1111/j.1654-109X.2009.01053.x; Honkavaara E, 2009, REMOTE SENS-BASEL, V1, P577, DOI 10.3390/rs1030577; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; Husson C, 2011, EUR J PLANT PATHOL, V130, P311, DOI 10.1007/s10658-011-9755-9; Immitzer M, 2012, REMOTE SENS-BASEL, V4, P2661, DOI 10.3390/rs4092661; Kempeneers P, 2013, IEEE GEOSCI REMOTE S, V10, P1459, DOI 10.1109/LGRS.2013.2260129; Kempeneers P, 2011, IEEE T GEOSCI REMOTE, V49, P4977, DOI 10.1109/TGRS.2011.2158548; Key T, 2001, REMOTE SENS ENVIRON, V75, P100, DOI 10.1016/S0034-4257(00)00159-0; Lisein J, 2013, FORESTS, V4, P922, DOI 10.3390/f4040922; Masaitis G, 2013, RES RURAL DEV, P20; Motohka T, 2010, REMOTE SENS-BASEL, V2, P2369, DOI 10.3390/rs2102369; Pierrot-Deseilligny M, 2006, INT ARCHIVES OF PHOT, V36; Somers B, 2013, REMOTE SENS ENVIRON, V136, P14, DOI 10.1016/j.rse.2013.04.006; Sripada RP, 2006, AGRON J, V98, P968, DOI 10.2134/agronj2005.0200; Stumpf A, 2011, REMOTE SENS ENVIRON, V115, P2564, DOI 10.1016/j.rse.2011.05.013; Triggs B., 2000, Vision Algorithms: Theory and Practice. International Workshop on Vision Algorithms. Proceedings (Lecture Notes in Computer Science Vol. 1883), P298; Waser LT, 2011, REMOTE SENS ENVIRON, V115, P76, DOI 10.1016/j.rse.2010.08.006; Wu C.-H., 2014, P IEEE PES INN SMART, P1; Zhu XL, 2014, ISPRS J PHOTOGRAMM, V96, P1, DOI 10.1016/j.isprsjprs.2014.06.012; Zhu Z, 2014, REMOTE SENS ENVIRON, V144, P152, DOI 10.1016/j.rse.2014.01.011	33	64	65	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0141006	10.1371/journal.pone.0141006	http://dx.doi.org/10.1371/journal.pone.0141006			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600422	Green Published, gold			2022-12-26	WOS:000365862600003
J	Infusini, G; Smith, JM; Yuan, H; Pizzolla, A; Ng, WC; Londrigan, SL; Haque, A; Reading, PC; Villadangos, JA; Wakim, LM				Infusini, Giuseppe; Smith, Jeffrey M.; Yuan, He; Pizzolla, Angela; Ng, Wy Ching; Londrigan, Sarah L.; Haque, Ashraful; Reading, Patrick C.; Villadangos, Jose A.; Wakim, Linda M.			Respiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8(+) T Cell Priming	PLOS ONE			English	Article							DENDRITIC CELLS; INFLUENZA-VIRUS; CUTTING EDGE; INFLAMMATION; RESPONSES; PROTEINS; EXPRESSION; SUBSETS; ANTIGEN	Respiratory dendritic cells (DC) play a pivotal role in the initiation of adaptive immune responses to influenza virus. To do this, respiratory DCs must ferry viral antigen from the lung to the draining lymph node without becoming infected and perishing en route. We show that respiratory DCs up-regulate the expression of the antiviral molecule, interferon-induced transmembrane protein 3 (IFITM3) in response to influenza virus infection, in a manner dependent on type I interferon signaling and the transcription factors IRF7 and IRF3. Failure of respiratory DCs to up-regulate IFITM3 following influenza virus infection resulted in impaired trafficking to the draining LN and consequently in impaired priming of an influenza-specific CD8+ T cell response. The impaired trafficking of IFITM3-deficient DC correlated with an increased susceptibility of these DC to influenza virus infection. This work shows that the expression of IFITM3 protects respiratory DCs from influenza virus infection, permitting migration from lung to LN and optimal priming of a virus specific T-cell response.	[Infusini, Giuseppe] Walter & Eliza Hall Inst Med Res, Div Syst Biol & Personalised Med, Parkville, Vic 3052, Australia; [Smith, Jeffrey M.; Yuan, He; Pizzolla, Angela; Ng, Wy Ching; Londrigan, Sarah L.; Reading, Patrick C.; Villadangos, Jose A.; Wakim, Linda M.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Haque, Ashraful] QIMR Berghofer Med Res Inst, Malaria Immunol Lab, Brisbane, Qld, Australia; [Reading, Patrick C.] Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza, Victorian Infect Dis Reference Lab, Melbourne, Vic 3000, Australia; [Villadangos, Jose A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; QIMR Berghofer Medical Research Institute; Victorian Infectious Diseases Reference Laboratory; World Health Organization; University of Melbourne	Villadangos, JA (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.	j.villadangos@unimelb.edu.au; wakiml@unimelb.edu.au	Villadangos, Jose A/AAU-1404-2020; Ng, Wy Ching/GQT-0056-2022; Pizzolla, Angela/AAN-1566-2021; Haque, Ashraful/H-8697-2014	Villadangos, Jose A/0000-0001-6771-8891; Pizzolla, Angela/0000-0003-2024-4144; Smith, Jeffrey/0000-0003-3630-4068; Londrigan, Sarah/0000-0003-0989-4971; Reading, Patrick/0000-0002-8860-5308; Wakim, Linda/0000-0003-1752-9579; Haque, Ashraful/0000-0003-2260-0026	National Health and Medical Research Council (NHMRC) of Australia; University of Melbourne (Early Career Establishment Grant); Bio21 Institute/CSL Ltd.; Australian Government Department of Health	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne (Early Career Establishment Grant); Bio21 Institute/CSL Ltd.; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This work was funded by the National Health and Medical Research Council (NHMRC) of Australia, with additional support from the University of Melbourne (Early Career Establishment Grant) and Bio21 Institute/CSL Ltd. J. A. Villadangos is a NHMRC Principal Research Fellow and L. Wakim is a NHMRC Career Development Fellow. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ingulli E, 2009, J IMMUNOL, V182, P29, DOI 10.4049/jimmunol.182.1.29; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Short KR, 2013, INFECT IMMUN, V81, P645, DOI 10.1128/IAI.01278-12; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Topham DJ, 1997, J IMMUNOL, V159, P5197; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	21	25	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143539	10.1371/journal.pone.0143539	http://dx.doi.org/10.1371/journal.pone.0143539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600246	gold, Green Published			2022-12-26	WOS:000365853900141
J	Kramer, J; Bijnens, B; Stork, S; Ritter, CO; Liu, D; Ertl, G; Wanner, C; Weidemann, F				Kraemer, Johannes; Bijnens, Bart; Stoerk, Stefan; Ritter, Christian O.; Liu, Dan; Ertl, Georg; Wanner, Christoph; Weidemann, Frank			Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; 2-DIMENSIONAL SPECKLE TRACKING; CLINICAL MANIFESTATIONS; MYOCARDIAL-INFARCTION; DISEASE; THERAPY; IDENTIFICATION; DIAGNOSIS; FIBROSIS; IMPACT	Background In spite of several research studies help to describe the heart in Fabry disease (FD), the cardiomyopathy is not entirely understood. In addition, the impact of blood pressure and alterations in geometry have not been systematically evaluated. Methods In 74 FD patients (mean age 36 +/- 12 years; 45 females) the extent of myocardial fibrosis and its progression were quantified using cardiac magnetic-resonance-imaging with late enhancement technique (LE). Results were compared to standard echocardiography complemented by 2D-speckle-tracking, 3D-sphericity-index (SI) and standardized blood pressure measurement. At baseline, no patient received enzyme replacement therapy (ERT). After 51 +/- 24 months, a follow-up examination was performed. Results Systolic blood pressure (SBP) was higher in patients with vs. without LE: 123 +/- 17 mmHg vs. 115 +/- 13 mmHg; P = 0.04. A positive correlation was found between SI and the amount of LE-positive myocardium (r = 0.51; P< 0.001) indicating an association of higher SI in more advanced stages of the cardiomyopathy. SI at baseline was positively associated with the increase of LE-positive myocardium during follow-up. The highest SBP (125 +/- 19 mmHg) and also the highest SI (0.32 +/- 0.05) was found in the subgroup with a rapidly increasing LE (ie, >= 0.2% per year; n = 16; P = 0.04). Multivariate logistic regression analysis including SI, SBP, EF, left ventricular volumes, wall thickness and NT-proBNP adjusted for age and sex showed SI as the most powerful parameter to detect rapid progression of LE (AUC = 0.785; P<0.05). Conclusions LV geometry as assessed by the sphericity index is altered in relation to the stage of the Fabry cardiomyopathy. Although patients with FD are not hypertensive, the SBP has a clear impact on the progression of the cardiomyopathy.	[Kraemer, Johannes; Stoerk, Stefan; Liu, Dan; Ertl, Georg] Univ Wurzburg, Dept Med 1, Cardiol Unit, D-97070 Wurzburg, Germany; [Kraemer, Johannes] Univ Ulm, Dept Pediat & Adolescent Med, D-89069 Ulm, Germany; [Wanner, Christoph] Univ Wurzburg, Nephrol Unit, Dept Med 1, D-97070 Wurzburg, Germany; [Bijnens, Bart] Univ Pompeu Fabra, ICREA, Barcelona, Spain; [Bijnens, Bart] Katholieke Univ Leuven, Leuven, Belgium; [Kraemer, Johannes; Stoerk, Stefan; Ritter, Christian O.; Liu, Dan; Ertl, Georg; Wanner, Christoph; Weidemann, Frank] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany; [Ritter, Christian O.] Univ Wurzburg, Dept Radiol, D-97070 Wurzburg, Germany; [Weidemann, Frank] Katharinen Hosp Unna, Dept Internal Med 2, D-59423 Unna, Germany	University of Wurzburg; Ulm University; University of Wurzburg; ICREA; Pompeu Fabra University; KU Leuven; University of Wurzburg; University of Wurzburg	Weidemann, F (corresponding author), Katharinen Hosp Unna, Innere Klin 2, Obere Husemannstr 2, D-59423 Unna, Germany.	f.weidemann@katharinen-hospital.de	Stork, Stefan/AAR-4182-2020; Bijnens, Bart/AAE-7186-2021; Bijnens, Bart H/C-2955-2008	Stork, Stefan/0000-0002-1771-7249; Bijnens, Bart/0000-0003-3130-6937; Bijnens, Bart H/0000-0003-3130-6937	Bundesministerium fur Bildung und Forschung [BMFBF01 EO1004]; Genzyme Corporation (Cambridge, MA, USA); Genzyme; Shire Corporation; ICREA Funding Source: Custom	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Genzyme Corporation (Cambridge, MA, USA)(Sanofi-AventisGenzyme Corporation); Genzyme(Sanofi-AventisGenzyme Corporation); Shire Corporation; ICREA(ICREA)	This study was supported by Bundesministerium fur Bildung und Forschung (BMFBF01 EO1004).; This work was supported by grants from the Bundesministerium fur Bildung und Forschung (BMFBF01 EO1004). CW and FW are members of the Fabry Registry European Board of Advisors which is sponsored by Genzyme Corporation (Cambridge, MA, USA). JK, MN, FW and CW have received speakers honoraria and FW and CW has received research support (grant to the institution) from Genzyme and Shire Corporation.	Boyd AC, 2013, J AM SOC ECHOCARDIOG, V26, P1415, DOI 10.1016/j.echo.2013.08.024; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; Coats CJ, 2013, AM J CARDIOL, V111, P111, DOI 10.1016/j.amjcard.2012.08.055; Desnick RJ., 1995, METABOLIC MOL BASES, P2741; Duann JR, 1999, COMPUT MED IMAG GRAP, V23, P89, DOI 10.1016/S0895-6111(98)00065-2; FARAGGIANA T, 1981, AM J PATHOL, V103, P247; Goodfriend TL, 1996, NEW ENGL J MED, V334, P1649, DOI 10.1056/NEJM199606203342507; Jain G, 2011, NEPHRON CLIN PRACT, V118, pC43, DOI 10.1159/000320903; Kleinert J, 2006, AM J HYPERTENS, V19, P782, DOI 10.1016/j.amjhyper.2006.01.011; Kosmala W, 2008, J AM SOC ECHOCARDIOG, V21, P1309, DOI 10.1016/j.echo.2008.10.006; Kramer J, 2014, AM J CARDIOL, V114, P895, DOI 10.1016/j.amjcard.2014.06.019; Kramer J, 2013, EUR HEART J, V34, P1587, DOI 10.1093/eurheartj/eht098; LAMAS GA, 1989, AM J CARDIOL, V63, P1167, DOI 10.1016/0002-9149(89)90173-2; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Mannaerts HFJ, 2004, EUR HEART J, V25, P680, DOI 10.1016/j.ehj.2004.02.030; Marchal P, 2013, EUR HEART J-CARD IMG, V14, P914, DOI 10.1093/ehjci/jet064; Moon JC, 2006, J CARDIOVASC MAGN R, V8, P479, DOI 10.1080/10976640600605002; Moon JCC, 2003, EUR HEART J, V24, P2151, DOI 10.1016/j.ehj.2003.09.017; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Niemann M, 2011, JACC-CARDIOVASC IMAG, V4, P592, DOI 10.1016/j.jcmg.2011.01.020; Nouri M, 2013, J CARDIAC SURG, V28, P359, DOI 10.1111/jocs.12145; Rombach SM, 2010, MOL GENET METAB, V99, P99, DOI 10.1016/j.ymgme.2009.10.004; Shanks M, 2013, J AM SOC ECHOCARDIOG, V26, P1407, DOI 10.1016/j.echo.2013.09.005; Tahir H, 2007, J AM SOC NEPHROL, V18, P2609, DOI 10.1681/ASN.2006121400; Takenaka T, 2008, J CARDIOL, V51, P50, DOI 10.1016/j.jjcc.2007.12.001; Teraguchi Hiroyuki, 2004, J Cardiol, V43, P98; Torralba-Cabeza MA, 2011, MOL GENET METAB, V104, P301, DOI 10.1016/j.ymgme.2011.06.021; Weidemann F, 2005, EUR HEART J, V26, P1221, DOI 10.1093/eurheartj/ehi143; Weidemann F, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-116; Yoon Jae Yong, 2013, J Cardiovasc Ultrasound, V21, P26, DOI 10.4250/jcu.2013.21.1.26; Yousef Z, 2013, EUR HEART J, V34, P802, DOI 10.1093/eurheartj/ehs166	32	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0140627	10.1371/journal.pone.0140627	http://dx.doi.org/10.1371/journal.pone.0140627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600044	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900008
J	Mendez-Lorenzo, L; Porras-Dominguez, JR; Raga-Carbajal, E; Olvera, C; Rodriguez-Alegria, ME; Carrillo-Nava, E; Costas, M; Munguia, AL				Mendez-Lorenzo, Luz; Porras-Dominguez, Jaime R.; Raga-Carbajal, Enrique; Olvera, Clarita; Elena Rodriguez-Alegria, Maria; Carrillo-Nava, Ernesto; Costas, Miguel; Lopez Munguia, Agustin			Intrinsic Levanase Activity of Bacillus subtilis 168 Levansucrase (SacB)	PLOS ONE			English	Article							LACTOBACILLUS-REUTERI; MOLECULAR-WEIGHT	Levansucrase catalyzes the synthesis of fructose polymers through the transfer of fructosyl units from sucrose to a growing fructan chain. Levanase activity of Bacillus subtilis levansucrase has been described since the very first publications dealing with the mechanism of levan synthesis. However, there is a lack of qualitative and quantitative evidence regarding the importance of the intrinsic levan hydrolysis of B. subtilis levansucrase and its role in the levan synthesis process. Particularly, little attention has been paid to the long-term hydrolysis products, including its participation in the final levan molecules distribution. Here, we explored the hydrolytic and transferase activity of the B. subtilis levansucrase (SacB) when levans produced by the same enzyme are used as substrate. We found that levan is hydrolyzed through a first order exo-type mechanism, which is limited to a conversion extent of around 30% when all polymer molecules reach a structure no longer suitable to SacB hydrolysis. To characterize the reaction, Isothermal Titration Calorimetry (ITC) was employed and the evolution of the hydrolysis products profile followed by HPLC, GPC and HPAEC-PAD. The ITC measurements revealed a second step, taking place at the end of the reaction, most probably resulting from disproportionation of accumulated fructo-oligosaccharides. As levanase, levansucrase may use levan as substrate and, through a fructosyl-enzyme complex, behave as a hydrolytic enzyme or as a transferase, as demonstrated when glucose and fructose are added as acceptors. These reactions result in a wide variety of oligosaccharides that are also suitable acceptors for fructo-oligosaccharide synthesis. Moreover, we demonstrate that SacB in the presence of levan and glucose, through blastose and sucrose synthesis, results in the same fructooligosaccharides profile as that observed in sucrose reactions. We conclude that SacB has an intrinsic levanase activity that contributes to the final levan profile in reactions with sucrose as substrate.	[Mendez-Lorenzo, Luz; Porras-Dominguez, Jaime R.; Raga-Carbajal, Enrique; Olvera, Clarita; Elena Rodriguez-Alegria, Maria; Lopez Munguia, Agustin] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico; [Carrillo-Nava, Ernesto; Costas, Miguel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Quim Fis, Lab Biofis Quim, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Munguia, AL (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico.	agustin@ibt.unam.mx		Raga-Carbajal, Enrique/0000-0002-7598-0520; Costas, Miguel/0000-0001-8604-6381; Rodriguez Alegria, Maria Elena/0000-0001-6789-705X; Olvera-Carranza, Clarita/0000-0002-8364-5845; Lopez Munguia, Agustin/0000-0003-4204-4936	MC Direccion General de Asuntos del Personal Academico-Universidad Navidad Autonoma de Mexico (PAPIIT grant) [IN112813]; Consejo Nacional de Ciencia y Tecnologia (CB-SEP-CONACyT) [219728]; DGAPA-UNAM (PAPIIT grant) [IN112813]	MC Direccion General de Asuntos del Personal Academico-Universidad Navidad Autonoma de Mexico (PAPIIT grant); Consejo Nacional de Ciencia y Tecnologia (CB-SEP-CONACyT); DGAPA-UNAM (PAPIIT grant)	This work is supported by MC Direccion General de Asuntos del Personal Academico-Universidad Navidad Autonoma de Mexico (PAPIIT grant number IN112813 to M.C.) and by Consejo Nacional de Ciencia y Tecnologia (CB-SEP-CONACyT No. 219728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Alma Jessica Diaz Salazar and Fernando Gonzalez for their competent technical assistance, as well as Mario Trejo and Martin Patino for administrative support. This work was supported by DGAPA-UNAM (PAPIIT grant number IN112813 to M.C.) and by Consejo Nacional de Ciencia y Tecnologia (CB-SEP-CONACyT) No. 219728.	Albenne C, 2002, FEBS LETT, V527, P67, DOI 10.1016/S0014-5793(02)03168-X; CHAMBERT R, 1974, EUR J BIOCHEM, V41, P285, DOI 10.1111/j.1432-1033.1974.tb03269.x; Dedonder R., 1966, COMPLEX CARBOHYDRATE, P500; HESTRIN S, 1958, BIOCHEM J, V69, P388, DOI 10.1042/bj0690388; Jang KH, 2007, FOOD SCI BIOTECHNOL, V16, P482; Martinez C, 2015, ANAL BIOCH IN PRESS; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Ortiz-Soto ME, 2008, PROTEIN ENG DES SEL, V21, P589, DOI 10.1093/protein/gzn036; Ozimek LK, 2006, MICROBIOL-SGM, V152, P1187, DOI 10.1099/mic.0.28484-0; Porras-Dominguez JR, 2015, CARBOHYD POLYM, V132, P338, DOI 10.1016/j.carbpol.2015.06.056; Porras-Dominguez JR, 2014, PROCESS BIOCHEM, V49, P783, DOI 10.1016/j.procbio.2014.02.005; RAPOPORT G, 1963, B SOC CHIM BIOL, V45, P493; Santos-Moriano P, 2015, J MOL CATAL B-ENZYM, V119, P18, DOI 10.1016/j.molcatb.2015.05.011; SIMMS PJ, 1990, CARBOHYD RES, V208, P193, DOI 10.1016/0008-6215(90)80099-O; TANAKA T, 1981, J BIOCHEM-TOKYO, V90, P521, DOI 10.1093/oxfordjournals.jbchem.a133500; TANAKA T, 1980, J BIOCHEM, V87, P297, DOI 10.1093/oxfordjournals.jbchem.a132737; TANAKA T, 1979, J BIOCHEM-TOKYO, V85, P287, DOI 10.1093/oxfordjournals.jbchem.a132322; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; van Hijum SAFT, 2004, MICROBIOL-SGM, V150, P621, DOI 10.1099/mic.0.26671-0; YAMAMOTO S, 1985, AGR BIOL CHEM TOKYO, V49, P343, DOI 10.1080/00021369.1985.10866727; Yoon EJ, 2004, INT J BIOL MACROMOL, V34, P191, DOI 10.1016/j.ijbiomac.2004.04.001	21	27	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143394	10.1371/journal.pone.0143394	http://dx.doi.org/10.1371/journal.pone.0143394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600431	Green Published, gold			2022-12-26	WOS:000365853900106
J	Mrozek-Wilczkiewicz, A; Spaczynska, E; Malarz, K; Cieslik, W; Rams-Baron, M; Krystof, V; Musiol, R				Mrozek-Wilczkiewicz, Anna; Spaczynska, Ewelina; Malarz, Katarzyna; Cieslik, Wioleta; Rams-Baron, Marzena; Krystof, Vladimir; Musiol, Robert			Design, Synthesis and In Vitro Activity of Anticancer Styrylquinolines. The p53 Independent Mechanism of Action	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITY SPECTRUM; INTEGRASE INHIBITORS; MITOCHONDRIAL-DNA; CP-31398; ANALOGS; APOPTOSIS; REACTIVATION; DERIVATIVES; SERIES; AGENTS	A group of styrylquinolines were synthesized and tested for their anti-proliferative activity. Anti-proliferative activity was evaluated against the human colon carcinoma cell lines that had a normal expression of the p53 protein (HCT116 p53(+/+)) and mutants with a disabled TP53 gene (HCT116 p53(-/-)) and against the GM 07492 normal human fibroblast cell line. A SAR study revealed the importance of Cl and OH as substituents in the styryl moiety. Several of the compounds that were tested were found to have a marked anti-proliferative activity that was similar to or better than doxorubicin and were more active against the p53 null than the wild type cells. The cellular localization tests and caspase activity assays suggest a mechanism of action through the mitochondrial pathway of apoptosis in a p53-independent manner. The activity of the styrylquinoline compounds may be associated with their DNA intercalating ability.	[Mrozek-Wilczkiewicz, Anna; Rams-Baron, Marzena] Univ Silesia, A Chelkowski Inst Phys, Katowice, Poland; [Mrozek-Wilczkiewicz, Anna; Rams-Baron, Marzena] Univ Silesia, Silesian Ctr Educ & Interdisciplinary Res, Chorzow, Poland; [Spaczynska, Ewelina; Malarz, Katarzyna; Cieslik, Wioleta; Musiol, Robert] Univ Silesia, Inst Chem, Katowice, Poland; [Krystof, Vladimir] Palacky Univ, Lab Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic; [Krystof, Vladimir] Inst Expt Bot AS CR, Olomouc, Czech Republic	University of Silesia in Katowice; University of Silesia in Katowice; University of Silesia in Katowice; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Musiol, R (corresponding author), Univ Silesia, Inst Chem, Katowice, Poland.	robert.musiol@us.edu.pl	Malarz, Katarzyna/AAA-2689-2020; Krystof, Vladimir/B-9499-2009; Musioł, Robert/J-4790-2019; Cieślik, Wioleta/AAH-6820-2021	Malarz, Katarzyna/0000-0003-4283-3126; Krystof, Vladimir/0000-0001-5838-2118; Cieślik, Wioleta/0000-0001-6371-9061; Musiol, Robert/0000-0002-6219-7369; Mrozek-Wilczkiewicz, Anna/0000-0003-2228-1475	NCN grant from RM [2013/09/B/NZ7/00423, 2014/13/D/NZ7/00322, 2012/07/N/NZ7/02110]; DoktoRIS; CITTRFUS; National Program for Sustainability I [LO1204]; Polish National Center for Science NCN grants from the R.M. [2013/09/B/NZ7/00423, 2014/13/D/NZ7/00322, WC 2012/07/N/NZ7/02110]	NCN grant from RM; DoktoRIS; CITTRFUS; National Program for Sustainability I; Polish National Center for Science NCN grants from the R.M.	This study is supported by an NCN grant from RM (2013/09/B/NZ7/00423); AM-W (2014/13/D/NZ7/00322); and WC (2012/07/N/NZ7/02110). The authors also appreciate the financial support of the DoktoRIS and CITTRFUS PhD scholarships and the National Program for Sustainability I (grant no. LO1204).; This study is supported by Polish National Center for Science NCN grants from the R.M. (2013/09/B/NZ7/00423) AM-W. (2014/13/D/NZ7/00322) and WC 2012/07/N/NZ7/02110. We also appreciate the financial support of the DoktoRIS and CITTRFUS PhD scholarships and the National Program for Sustainability I (grant no. LO1204).	Ashley N, 2009, ONCOGENE, V28, P3880, DOI 10.1038/onc.2009.242; Ashley N, 2009, BIOCHEM BIOPH RES CO, V378, P450, DOI 10.1016/j.bbrc.2008.11.059; Behforouz M, 2007, BIOORGAN MED CHEM, V15, P495, DOI 10.1016/j.bmc.2006.09.039; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bonnenfant S, 2004, J VIROL, V78, P5728, DOI 10.1128/JVI.78.11.5728-5736.2004; Brown CJ, 2011, TRENDS PHARMACOL SCI, V32, P53, DOI 10.1016/j.tips.2010.11.004; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; Chan SH, 2013, ACS MED CHEM LETT, V4, P170, DOI 10.1021/ml300238z; CIESLIK W, 2012, INT B PHARM SCI, V1, P3; Cieslik W, 2012, BIOORGAN MED CHEM, V20, P6960, DOI 10.1016/j.bmc.2012.10.027; Demma MJ, 2004, J BIOL CHEM, V279, P45887, DOI 10.1074/jbc.M401854200; Fang YA, 2003, MOL CANCER THER, V2, P517; Hassani M, 2005, J MED CHEM, V48, P7733, DOI 10.1021/jm050758z; Jampilek J, 2009, MOLECULES, V14, P4246, DOI 10.3390/molecules14104246; JIANG JB, 1990, J MED CHEM, V33, P1721, DOI 10.1021/jm00168a029; Lain S, 2010, SEMIN CANCER BIOL, V20, P1, DOI 10.1016/j.semcancer.2010.03.003; Lukin DJ, 2015, MOL CANCER RES, V13, P16, DOI 10.1158/1541-7786.MCR-14-0177; Luu Y, 2002, EXP CELL RES, V276, P214, DOI 10.1006/excr.2002.5526; Mekouar K, 1998, J MED CHEM, V41, P2846, DOI 10.1021/jm980043e; Mrozek-Wilczkiewicz A, 2010, BIOORGAN MED CHEM, V18, P2664, DOI 10.1016/j.bmc.2010.02.025; Mukhopadhyay A, 2007, ADV DRUG DELIVER REV, V59, P729, DOI 10.1016/j.addr.2007.06.004; Musiol R, 2006, BIOORGAN MED CHEM, V14, P3592, DOI 10.1016/j.bmc.2006.01.016; Musiol R, 2010, CURR MED CHEM, V17, P1960, DOI 10.2174/092986710791163966; Musiol R., 2011, SCI MICROBIAL PATHOG, P72; Musiol R, 2008, BIOORGAN MED CHEM, V16, P4490, DOI 10.1016/j.bmc.2008.02.065; Musiol R, 2007, BIOORGAN MED CHEM, V15, P1280, DOI 10.1016/j.bmc.2006.11.020; Musiol R, 2010, MOLECULES, V15, P288, DOI 10.3390/molecules15010288; Musiol R, 2009, CENT EUR J CHEM, V7, P586, DOI 10.2478/s11532-009-0059-2; Nycz JE, 2011, J MOL STRUCT, V986, P39, DOI 10.1016/j.molstruc.2010.11.032; Podeszwa B, 2007, BIOORG MED CHEM LETT, V17, P6138, DOI 10.1016/j.bmcl.2007.09.040; Polanski J, 2004, Acta Pol Pharm, V61 Suppl, P3; Polanski J, 2012, CURR MED CHEM, V19, P1921, DOI 10.2174/092986712800167356; Rams-Baron M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131210; Roh JL, 2011, ORAL ONCOL, V47, P8, DOI 10.1016/j.oraloncology.2010.10.011; Sahu U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066430; Selivanova G, 2010, SEMIN CANCER BIOL, V20, P46, DOI 10.1016/j.semcancer.2010.02.006; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Solomon VR, 2011, CURR MED CHEM, V18, P1488; Staples OD, 2008, SURG-J R COLL SURG E, V6, P240, DOI 10.1016/S1479-666X(08)80034-0; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Sutherland HS, 2012, INVEST NEW DRUG, V30, P2035, DOI 10.1007/s10637-011-9744-z; Takimoto R, 2002, CANCER BIOL THER, V1, P47, DOI 10.4161/cbt.1.1.41; Wang WG, 2003, MOL CELL BIOL, V23, P2171, DOI 10.1128/MCB.23.6.2171-2181.2003; Wischhusen J, 2003, ONCOGENE, V22, P8233, DOI 10.1038/sj.onc.1207198	44	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142678	10.1371/journal.pone.0142678	http://dx.doi.org/10.1371/journal.pone.0142678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599982	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900037
J	Philippe, J; Derhourhi, M; Durand, E; Vaillant, E; Dechaume, A; Rabearivelo, I; Dhennin, V; Vaxillaire, M; De Graeve, F; Sand, O; Froguel, P; Bonnefond, A				Philippe, Julien; Derhourhi, Mehdi; Durand, Emmanuelle; Vaillant, Emmanuel; Dechaume, Aurelie; Rabearivelo, Iandry; Dhennin, Veronique; Vaxillaire, Martine; De Graeve, Franck; Sand, Olivier; Froguel, Philippe; Bonnefond, Amelie			What Is the Best NGS Enrichment Method for the Molecular Diagnosis of Monogenic Diabetes and Obesity?	PLOS ONE			English	Article							EXOME; MUTATIONS; LEPTIN; GENOME; PANEL	Molecular diagnosis of monogenic diabetes and obesity is of paramount importance for both the patient and society, as it can result in personalized medicine associated with a better life and it eventually saves health care spending. Genetic clinical laboratories are currently switching from Sanger sequencing to next-generation sequencing (NGS) approaches but choosing the optimal protocols is not easy. Here, we compared the sequencing coverage of 43 genes involved in monogenic forms of diabetes and obesity, and variant detection rates, resulting from four enrichment methods based on the sonication of DNA (Agilent Sure-Select, RainDance technologies), or using enzymes for DNA fragmentation (Illumina Nextera, Agilent HaloPlex). We analyzed coding exons and untranslated regions of the 43 genes involved in monogenic diabetes and obesity. We found that none of the methods achieves yet full sequencing of the gene targets. Nonetheless, the RainDance, SureSelect and HaloPlex enrichment methods led to the best sequencing coverage of the targets; while the Nextera method resulted in the poorest sequencing coverage. Although the sequencing coverage was high, we unexpectedly found that the HaloPlex method missed 20% of variants detected by the three other methods and Nextera missed 10%. The question of which NGS technique for genetic diagnosis yields the highest diagnosis rate is frequently discussed in the literature and the response is still unclear. Here, we showed that the RainDance enrichment method as well as SureSelect, which are both based on the sonication of DNA, resulted in a good sequencing quality and variant detection, while the use of enzymes to fragment DNA (HaloPlex or Nextera) might not be the best strategy to get an accurate sequencing.	[Philippe, Julien; Derhourhi, Mehdi; Durand, Emmanuelle; Vaillant, Emmanuel; Dechaume, Aurelie; Rabearivelo, Iandry; Dhennin, Veronique; Vaxillaire, Martine; De Graeve, Franck; Sand, Olivier; Froguel, Philippe; Bonnefond, Amelie] Lille Pasteur Inst, CNRS, UMR8199, Lille, France; [Philippe, Julien; Derhourhi, Mehdi; Durand, Emmanuelle; Vaillant, Emmanuel; Dechaume, Aurelie; Rabearivelo, Iandry; Dhennin, Veronique; Vaxillaire, Martine; De Graeve, Franck; Sand, Olivier; Froguel, Philippe; Bonnefond, Amelie] Univ Lille, Lille, France; [Philippe, Julien; Derhourhi, Mehdi; Durand, Emmanuelle; Vaillant, Emmanuel; Dechaume, Aurelie; Rabearivelo, Iandry; Dhennin, Veronique; Vaxillaire, Martine; De Graeve, Franck; Sand, Olivier; Froguel, Philippe; Bonnefond, Amelie] EGID, FR 3508, Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Imperial College London	Froguel, P (corresponding author), Lille Pasteur Inst, CNRS, UMR8199, Lille, France.	froguel@good.ibl.fr; amelie.bonnefond@inserm.fr	Bonnefond, Amélie/O-2784-2017; FROGUEL, Philippe/O-6799-2017; Philippe, Julien/R-5183-2019	Bonnefond, Amélie/0000-0001-9976-3005; FROGUEL, Philippe/0000-0003-2972-0784; Philippe, Julien/0000-0003-1906-7259; Sand, Olivier/0000-0003-1465-1640	French National Research Agency [European Genomics Institute for Diabetes] [ANR-10-LABX-46]; French National Research Agency [LIGAN-PM] [ANR-10-EQPX-07-01]; European Research Council (ERC GEPIDIAB) [294785]; FEDER; Region Nord Pas-de-Calais; Inserm	French National Research Agency [European Genomics Institute for Diabetes](French National Research Agency (ANR)); French National Research Agency [LIGAN-PM](French National Research Agency (ANR)); European Research Council (ERC GEPIDIAB)(European Research Council (ERC)); FEDER(European Commission); Region Nord Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from the French National Research Agency	Bonnefond A, 2014, DIABETES CARE, V37, P460, DOI 10.2337/dc13-0698; Bonnefond A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037423; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Consugar MB, 2015, GENET MED, V17, P253, DOI 10.1038/gim.2014.172; Coonrod EM, 2014, BIOTECHNIQUES, V57, P204, DOI 10.2144/000114217; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Greeley SAW, 2011, DIABETES CARE, V34, P622, DOI 10.2337/dc10-1616; Miya F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09331; Naylor RN, 2014, DIABETES CARE, V37, P202, DOI 10.2337/dc13-0410; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Saeed S, 2012, MOL GENET METAB, V106, P121, DOI 10.1016/j.ymgme.2012.03.001; Sun Y, 2015, HUM MUTAT, V36, P648, DOI 10.1002/humu.22783; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601	15	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143373	10.1371/journal.pone.0143373	http://dx.doi.org/10.1371/journal.pone.0143373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599467	Green Published, gold, Green Submitted			2022-12-26	WOS:000365853900102
J	Sambri, I; Crespo, J; Aguilo, S; Ingrosso, D; Rodriguez, C; Gonzalez, JM				Sambri, Irene; Crespo, Javier; Aguilo, Silvia; Ingrosso, Diego; Rodriguez, Cristina; Gonzalez, Jose Martinez			miR-17 and-20a Target the Neuron-Derived Orphan Receptor-1 (NOR-1) in Vascular Endothelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KAPPA-B ACTIVATION; NUCLEAR RECEPTORS; GENE-EXPRESSION; GROWTH-FACTOR; TRANSCRIPTIONAL REGULATORS; MICRORNA-17-92 CLUSTER; MESSENGER-RNA; BREAST-CANCER; PROLIFERATION	Neuron-derived orphan receptor-1 (NOR-1) plays a major role in vascular biology by controlling fibroproliferative and inflammatory responses. Because microRNAs (miRNAs) have recently emerged as key players in the regulation of gene expression in the vasculature, here we have investigated the regulation of NOR-1 by miRNAs in endothelial cells. Computational algorithms suggest that NOR-1 could be targeted by members of the miR-17 family. Accordingly, ectopic over-expression of miR-17 or miR-20a in endothelial cells using synthetic premiRNAs attenuated the up-regulation of NOR-1 expression induced by VEGF (as evidenced by real time PCR, Western blot and immunocitochemistry). Conversely, the antagonism of these miRNAs by specific antagomirs prevented the down-regulation of NOR-1 promoted by miR-17 or miR-20a in VEGF-stimulated cells. Disruption of the miRNA-NOR- 1 mRNA interaction using a custom designed target protector evidenced the selectivity of these responses. Further, luciferase reporter assays and seed-sequence mutagenesis confirmed that miR-17 and -20a bind to NOR-1 3'-UTR. Finally, miR-17 and -20a ameliorated the up-regulation of VCAM-1 mediated by NOR-1 in VEGF-stimulated cells. Therefore, miR-17 and -20a target NOR-1 thereby regulating NOR-1-dependent gene expression.	[Sambri, Irene; Crespo, Javier; Aguilo, Silvia; Rodriguez, Cristina; Gonzalez, Jose Martinez] Ctr Invest Cardiovasc CSIC ICCC, IIB St Pau, Barcelona, Spain; [Sambri, Irene; Ingrosso, Diego] Univ Naples 2, Sch Med & Surg, Dept Biochem Biophys & Gen Pathol, Naples, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Universita della Campania Vanvitelli	Gonzalez, JM (corresponding author), Ctr Invest Cardiovasc CSIC ICCC, IIB St Pau, Barcelona, Spain.	jmartinez@csic-iccc.org	Ingrosso, Diego/AHE-4980-2022; Rodriguez, Cristina/D-3099-2011	Rodriguez, Cristina/0000-0002-6472-5647; Crespo, Javier/0000-0001-8248-0172; Martinez-Gonzalez, Jose/0000-0002-3894-7166; Sambri, Irene/0000-0003-3500-6958	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [SAF2012-40127, RD12/0042/0053, PI12/01952]; EMBO fellowship (ASTF) [211-2010]; Fondo Europeo de Desarrollo Regional (FEDER)	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII); EMBO fellowship (ASTF); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [SAF2012-40127 (JMG), RD12/0042/0053 (JMG) and PI12/01952 (CR]. IS was a recipient of an EMBO fellowship (ASTF number: 211- 2010). The study was co-funded by Fondo Europeo de Desarrollo Regional (FEDER)-The way to build Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [SAF2012-40127, RD12/0042/0053 and PI12/01952]. I Sambri was a recipient of an EMBO fellowship (ASTF number: 211-2010). The study was co-funded by Fondo Europeo de Desarrollo Regional (FEDER)-The way to build Europe. We are grateful to Dr. Giulio Piluso, Dept. of General Pathology and Oncology, S.U.N.) for kindly providing us with the construct of TK promoter in pGL3.	Aitken S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004217; Arkenbout EK, 2003, ARTERIOSCL THROM VAS, V23, P1535, DOI 10.1161/01.ATV.0000084639.16462.7A; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Boon RA, 2015, NAT REV CARDIOL, V12, P135, DOI 10.1038/nrcardio.2014.207; Calvayrac O, 2015, J MOL CELL CARDIOL, V80, P34, DOI 10.1016/j.yjmcc.2014.12.015; Crespo J, 2005, CARDIOVASC RES, V67, P333, DOI 10.1016/j.cardiores.2005.03.016; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Duan XD, 2015, CELL SIGNAL, V27, P61, DOI 10.1016/j.cellsig.2014.10.006; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Kaluza D, 2013, ARTERIOSCL THROM VAS, V33, P533, DOI 10.1161/ATVBAHA.112.300415; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kumar S, 2014, ARTERIOSCL THROM VAS, V34, P2206, DOI 10.1161/ATVBAHA.114.303425; Li P, 2013, CARDIOVASC RES, V99, P185, DOI 10.1093/cvr/cvt082; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; Luo T, 2014, MOL CELL BIOCHEM, V389, P169, DOI 10.1007/s11010-013-1938-6; Marques FZ, 2011, HYPERTENSION, V58, P1093, DOI 10.1161/HYPERTENSIONAHA.111.180729; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; Martorell L, 2007, J THROMB HAEMOST, V5, P1766, DOI 10.1111/j.1538-7836.2007.02627.x; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; Medunjanin S, 2015, CARDIOVASC RES, V106, P488, DOI 10.1093/cvr/cvv126; Mohan HM, 2012, CLIN CANCER RES, V18, P3223, DOI 10.1158/1078-0432.CCR-11-2953; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pin AL, 2012, ANGIOGENESIS, V15, P593, DOI 10.1007/s10456-012-9283-z; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; Rius J, 2006, ATHEROSCLEROSIS, V184, P276, DOI 10.1016/j.atherosclerosis.2005.04.008; Rius J, 2004, ARTERIOSCL THROM VAS, V24, P697, DOI 10.1161/01.ATV.0000121570.00515.dc; Rodriguez-Calvo R, 2015, THROMB HAEMOSTASIS, V113, P1323, DOI 10.1160/TH14-07-0645; Rodriguez-Calvo R, 2013, HUM MOL GENET, V22, P1949, DOI 10.1093/hmg/ddt042; Sambri I, 2011, J BIOL CHEM, V286, P43690, DOI 10.1074/jbc.M111.290437; Schroen B, 2012, CARDIOVASC RES, V93, P605, DOI 10.1093/cvr/cvr268; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Witkos TM, 2011, CURR MOL MED, V11, P93; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhao Y, 2010, CIRC RES, V107, P501, DOI 10.1161/CIRCRESAHA.110.222083; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	48	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141932	10.1371/journal.pone.0141932	http://dx.doi.org/10.1371/journal.pone.0141932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600038	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900018
J	Stenfeldt, C; Eschbaumer, M; Pacheco, JM; Rekant, SI; Rodriguez, LL; Arzt, J				Stenfeldt, Carolina; Eschbaumer, Michael; Pacheco, Juan M.; Rekant, Steven I.; Rodriguez, Luis L.; Arzt, Jonathan			Pathogenesis of Primary Foot-and-Mouth Disease Virus Infection in the Nasopharynx of Vaccinated and Non-Vaccinated Cattle	PLOS ONE			English	Article							DIRECT-CONTACT CHALLENGE; KIDNEY-CELL LINE; CARRIER STATE; SECRETORY IGA; SEROTYPE O; IN-VITRO; REPLICATION; INOCULATION; PERSISTENCE; INTERFERON	A time-course pathogenesis study was performed to compare and contrast primary foot-and-mouth disease virus (FMDV) infection following simulated-natural (intra-nasopharyngeal) virus exposure of cattle that were non-vaccinated or vaccinated using a recombinant adenovirus-vectored FMDV vaccine. FMDV genome and infectious virus were detected during the initial phase of infection in both categories of animals with consistent predilection for the nasopharyngeal mucosa. A rapid progression of infection with viremia and widespread dissemination of virus occurred in non-vaccinated animals whilst vaccinated cattle were protected from viremia and clinical FMD. Analysis of micro-anatomic distribution of virus during early infection by lasercapture microdissection localized FMDV RNA to follicle-associated epithelium of the nasopharyngeal mucosa in both groups of animals, with concurrent detection of viral genome in nasopharyngeal MALT follicles in vaccinated cattle only. FMDV structural and non-structural proteins were detected in epithelial cells of the nasopharyngeal mucosa by immunomicroscopy 24 hours after inoculation in both non-vaccinated and vaccinated steers. Co-localization of CD11c(+)/MHC II+ cells with viral protein occurred early at primary infection sites in vaccinated steers while similar host-virus interactions were observed at later time points in non-vaccinated steers. Additionally, numerous CD8(+)/CD3(-) host cells, representing presumptive natural killer cells, were observed in association with foci of primary FMDV infection in the nasopharyngeal mucosa of vaccinated steers but were absent in non-vaccinated steers. Immunomicroscopic evidence of an activated antiviral response at primary infection sites of vaccinated cattle was corroborated by a relative induction of interferon -alpha, -beta, -gamma and -lambda mRNA in micro-dissected samples of nasopharyngeal mucosa. Although vaccination protected cattle from viremia and clinical FMD, there was subclinical infection of epithelial cells of the nasopharyngeal mucosa that could enable shedding and long-term persistence of infectious virus. Additionally, these data indicate different mechanisms within the immediate host response to infection between non-vaccinated and vaccinated cattle.	[Stenfeldt, Carolina; Eschbaumer, Michael; Pacheco, Juan M.; Rekant, Steven I.; Rodriguez, Luis L.; Arzt, Jonathan] ARS, Plum Isl Anim Dis Ctr, Foreign Anim Dis Res Unit, USDA, Greenport, NY 11944 USA; [Stenfeldt, Carolina; Eschbaumer, Michael; Rekant, Steven I.] PIADC Res Participat Program, Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Arzt, J (corresponding author), ARS, Plum Isl Anim Dis Ctr, Foreign Anim Dis Res Unit, USDA, Greenport, NY 11944 USA.	Jonathan.Arzt@ars.usda.gov	Stenfeldt, Carolina/AAG-7940-2021; Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Arzt, Jonathan/0000-0002-7517-7893; Stenfeldt, Carolina/0000-0002-2074-3886; Pacheco, Juan/0000-0001-5477-0201	Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQPM-13-X-00131]; US Department of Agriculture - Agricultural Research Service, Current Research Information System Project [1940-32000-057-00D]; Plum Island Animal Disease Center Research Participation Program fellowship	Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); US Department of Agriculture - Agricultural Research Service, Current Research Information System Project; Plum Island Animal Disease Center Research Participation Program fellowship	This research was funded by an interagency agreement with the Science and Technology Directorate of the U.S. Department of Homeland Security (award number HSHQPM-13-X-00131). Additional funding came from US Department of Agriculture - Agricultural Research Service, Current Research Information System Project 1940-32000-057-00D. CS, ME and SIR are recipients of a Plum Island Animal Disease Center Research Participation Program fellowship, administered by the Oak Ridge Institute for Science and Education (ORISE, www.orau.org) through an interagency agreement with the US Department of Energy. None of the funding sources had influence upon design or performance of experimental studies, interpretation of results or writing of the manuscript.	Aggarwal N, 2002, VACCINE, V20, P2508, DOI 10.1016/S0264-410X(02)00178-0; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, MICROBES INFECT, V4, P1099, DOI 10.1016/S1286-4579(02)01634-9; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Arzt J, 2014, VIROLOGY, V452, P12, DOI 10.1016/j.virol.2014.01.001; Arzt J, 2009, J VET DIAGN INVEST, V21, P779, DOI 10.1177/104063870902100604; BAXT B, 1989, J VIROL, V63, P2143, DOI 10.1128/JVI.63.5.2143-2151.1989; Boysen P, 2009, VET IMMUNOL IMMUNOP, V130, P163, DOI 10.1016/j.vetimm.2009.02.017; Brake DA, 2012, DEV BIOLOGICALS, V134, P123; Brito BP, 2011, TRANSBOUND EMERG DIS, V58, P387, DOI 10.1111/j.1865-1682.2011.01217.x; BROWN CC, 1992, CAN J VET RES, V56, P189; BURROWS R, 1981, J COMP PATHOL, V91, P599, DOI 10.1016/0021-9975(81)90089-X; BURROWS R, 1966, J HYG-CAMB, V64, P81, DOI 10.1017/S0022172400040365; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Cox SJ, 2006, VACCINE, V24, P3184, DOI 10.1016/j.vaccine.2006.01.037; Cox SJ, 2005, VACCINE, V23, P1106, DOI 10.1016/j.vaccine.2004.08.034; DOEL TR, 1994, VACCINE, V12, P592, DOI 10.1016/0264-410X(94)90262-3; Fray MD, 2001, J IMMUNOL METHODS, V249, P235, DOI 10.1016/S0022-1759(00)00359-8; Grubman MJ, 2010, FUTURE VIROL, V5, P51, DOI 10.2217/FVL.09.68; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Guzylack-Piriou L, 2006, EUR J IMMUNOL, V36, P1674, DOI 10.1002/eji.200635866; HEDGER RS, 1970, J HYG-CAMB, V68, P53, DOI 10.1017/S0022172400028497; Ilott MC, 1997, EPIDEMIOL INFECT, V118, P181, DOI 10.1017/S0950268896007376; Juleff N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003434; LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12; Liebler-Tenorio EM, 2006, VET RES, V37, P257, DOI 10.1051/vetres:2006001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCULLOUGH KC, 1988, IMMUNOLOGY, V65, P187; MCVICAR JW, 1976, J HYG-CAMBRIDGE, V76, P467, DOI 10.1017/S0022172400055406; Moonen P, 2004, VET MICROBIOL, V103, P151, DOI 10.1016/j.vetmic.2004.07.005; Pacheco JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125698; Pacheco JM, 2010, VET J, V183, P46, DOI 10.1016/j.tvjl.2008.08.023; Parida S, 2006, VACCINE, V24, P1107, DOI 10.1016/j.vaccine.2005.09.006; Parthiban ABR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128815; Patch JR, 2014, COMP IMMUNOL MICROB, V37, P249, DOI 10.1016/j.cimid.2014.07.004; Perez-Martin E, 2012, J VIROL, V86, P4477, DOI 10.1128/JVI.06683-11; Rasmussen TB, 2003, ARCH VIROL, V148, P2005, DOI 10.1007/s00705-003-0145-2; Reimer JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041451; Rieder E, 2005, J VIROL, V79, P12989, DOI 10.1128/JVI.79.20.12989-12998.2005; Sei JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109273; Stenfeldt C, 2012, J COMP PATHOL, V146, P243, DOI 10.1016/j.jcpa.2011.06.005; Stenfeldt C, 2014, TRANSBOUND IN PRESS; Stenfeldt C, 2015, VET MICROBIOL, V178, P50, DOI 10.1016/j.vetmic.2015.04.004; Stenfeldt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106859; Stenfeldt C, 2012, VET MICROBIOL, V154, P230, DOI 10.1016/j.vetmic.2011.07.007; Stenfeldt C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-66; Summerfield A, 2009, VET IMMUNOL IMMUNOP, V128, P205, DOI 10.1016/j.vetimm.2008.10.296; SWANEY LM, 1988, VET MICROBIOL, V18, P1, DOI 10.1016/0378-1135(88)90111-3; Yang M, 2007, J IMMUNOL METHODS, V321, P174, DOI 10.1016/j.jim.2007.01.016; Zhang ZD, 2001, J COMP PATHOL, V124, P89, DOI 10.1053/jcpa.2000.0431	51	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143666	10.1371/journal.pone.0143666	http://dx.doi.org/10.1371/journal.pone.0143666			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599543	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900155
J	Torres, LM; Rivera-Espinosa, L; Chavez-Pacheco, JL; Navas, CF; Demetrio, JA; Alemon-Medina, R; Trujillo, F; Perez, M; Zapata, MM; Cardenas, R; Salinas, C; Aquino, A; Velazquez-Cruz, R; Castillejos, MD				Torres, Luz-Maria; Rivera-Espinosa, Liliana; Chavez-Pacheco, Juan L.; Navas, Carlos F.; Demetrio, Joel A.; Alemon-Medina, Radames; Trujillo, Francisca; Perez, Martin; Zapata, Martha M.; Cardenas, Rocio; Salinas, Citlaltepetl; Aquino, Arnoldo; Velazquez-Cruz, Rafael; Castillejos, Manuel-de-Jesus			A New Method to Quantify Ifosfamide Blood Levels Using Dried Blood Spots and UPLC-MS/MS in Paediatric Patients with Embryonic Solid Tumours	PLOS ONE			English	Article							MASS-SPECTROMETRY; PHARMACOKINETICS; METABOLISM; OXAZAPHOSPHORINES; CHROMATOGRAPHY; CHILDREN; PLASMA; CYCLOPHOSPHAMIDE; INFUSION; DRUGS	Ifosfamide blood concentrations are necessary to monitor its therapeutic response, avoiding any adverse effect. We developed and validated an analytical method by UPLC-MS/MS to quantify ifosfamide in dried blood spots (DBS). Blood samples were collected on Whatman 9031 (R) filter paper cards. Five 3 mm disks were punched out from each dried blood spot. Acetonitrile and ethyl acetate were used for drug extraction. Chromatographic separation was carried out in an Acquity UPLC equipment with a BEH-C18 column, 2.1 x 100 mm, 1.7 mu m (Waters (R)). The mobile phase consisted in 5 mM ammonium formate and methanol: acetonitrile (40:48:12 v/v/v) at 0.2 mL/min. LC-MS/MS detection was done by ESI+ and multiple reaction mode monitoring, ionic transitions were m/z(1+) 260.99 > 91.63 for ifosfamide and 261.00 > 139.90 for cyclophosphamide (internal standard). This method was linear within a 100-10000 ng/mL range and it was accurate, precise and selective. Ifosfamide samples in DBS were stable for up to 52 days at -80 degrees C. The procedure was tested in 14 patients, ages 1 month to 17 years (9 males and 5 females), with embryonic tumours treated with ifosfamide, alone or combined, at a public tertiary referral hospital. Ifosfamide blood levels ranged from 11.1 to 39.7 mu mol/L at 12 hours after the last infusion, while 24-hour levels ranged from 0.7-19.7 mu mol/L. The median at 12 hours was 19.5 mu mol/L (Q(25) 14.4-Q(75) 29.0) and 3.8 mu mol/L (Q(25) 1.5-Q(75) 9.9) at 24 hours, p<0.001. This method is feasible to determine ifosfamide plasma levels in paediatric patients.	[Torres, Luz-Maria; Rivera-Espinosa, Liliana; Chavez-Pacheco, Juan L.; Navas, Carlos F.; Demetrio, Joel A.; Alemon-Medina, Radames; Trujillo, Francisca] Inst Nacl Pediat, Lab Farmacol, Mexico City, DF, Mexico; [Navas, Carlos F.] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Mexico City 04510, DF, Mexico; [Salinas, Citlaltepetl] Inst Nacl Neurol & Neurocirug, Lab Neuropatol, Mexico City, DF, Mexico; [Aquino, Arnoldo] Inst Nacl Enfermedades Resp, Lab Genom Canc, Mexico City, DF, Mexico; [Velazquez-Cruz, Rafael] Inst Nacl Med Genom, Lab Genom Metab Oseo, Mexico City, DF, Mexico; [Castillejos, Manuel-de-Jesus] Inst Nacl Enfermedades Resp, Unidad Vigilancia Epidemiol, Mexico City, DF, Mexico; [Perez, Martin; Zapata, Martha M.; Cardenas, Rocio] Inst Nacl Pediat, Serv Oncol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica	Chavez-Pacheco, JL (corresponding author), Natl Inst Paediat, Pharmacol Lab, Mexico City, DF, Mexico.	jchavez_pacheco@hotmail.com; mcastillejos@gmail.com	SALINAS, CITLALTEPETL/AAG-4810-2020; Velazquez-Cruz, Rafael/AAC-3710-2021	Velazquez-Cruz, Rafael/0000-0003-4515-0777; RIVERA ESPINOSA, LILIANA/0000-0002-1334-0026; Castillejos-Lopez, Manuel de Jesus/0000-0001-8689-9755; Torres-Espindola, Luz-Maria/0000-0001-9929-9361	Fondo Sectorial Salud [SSA-2012-179406]; Fondo Federal, Instituto Nacional de Pediatria [068-2013]; Consejo Nacional de Ciencia y Tecnologia	Fondo Sectorial Salud; Fondo Federal, Instituto Nacional de Pediatria; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank Consejo Nacional de Ciencia y Tecnologia, Fondo Sectorial Salud SSA-2012-179406 (JLCP), and Fondo Federal, Instituto Nacional de Pediatria 068-2013 (LMT). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aleksa K, 2009, CHIRALITY, V21, P674, DOI 10.1002/chir.20662; [Anonymous], 2015, GUID BIOAN METH VAL; [Anonymous], NOM177SSA12013 MEX H; Boddy AV, 1996, CANCER CHEMOTH PHARM, V38, P147, DOI 10.1007/s002800050463; BODDY AV, 1993, CANCER RES, V53, P3758; Boddy AV, 2000, CLIN PHARMACOKINET, V38, P291, DOI 10.2165/00003088-200038040-00001; Code EL, 1997, DRUG METAB DISPOS, V25, P985; Deroussent A, 2011, J CHROMATOGR B, V879, P743, DOI 10.1016/j.jchromb.2011.02.012; Giraud B, 2010, EXPERT OPIN DRUG MET, V6, P919, DOI 10.1517/17425255.2010.487861; Guidance for Industry, 2015, BIOAN METH VAL DRAFT; Kerbusch T, 1998, J CHROMATOGR B, V716, P275, DOI 10.1016/S0378-4347(98)00298-9; Kerbusch T, 2001, DRUG METAB DISPOS, V29, P967; Kerbusch T, 2000, THER DRUG MONIT, V22, P613, DOI 10.1097/00007691-200010000-00018; Klastersky J, 2003, ONCOLOGY-BASEL, V65, P7, DOI 10.1159/000073351; Larson Rodney R, 2003, Appl Occup Environ Hyg, V18, P109; Li F, 2010, BIOCHEM PHARMACOL, V80, P1063, DOI 10.1016/j.bcp.2010.06.002; Martins I, 2009, LAT AM J PHARM, V28, P41; Rivera R, 2010, PROTOCOLOS TECNICOS; Rivera-Luna R, 2013, INT J CANCER, V132, P1646, DOI 10.1002/ijc.27771; Sanson AL, 2011, BRAZ J PHARM SCI, V47, P363, DOI 10.1590/S1984-82502011000200017; Storme T, 2005, J CHROMATOGR B, V820, P251, DOI 10.1016/j.jchromb.2005.03.023; WAGNER T, 1994, CLIN PHARMACOKINET, V26, P439, DOI 10.2165/00003088-199426060-00003; Yin JE, 2010, J CHROMATOGR SCI, V48, P781, DOI 10.1093/chromsci/48.10.781; Zhang J, 2005, DRUG METAB REV, V37, P611, DOI 10.1080/03602530500364023; Zolezzi C, 1999, J CHEMOTHERAPY, V11, P69, DOI 10.1179/joc.1999.11.1.69	25	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143421	10.1371/journal.pone.0143421	http://dx.doi.org/10.1371/journal.pone.0143421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600181	Green Published, gold			2022-12-26	WOS:000365853900115
J	Willsey, GG; Wargo, MJ				Willsey, Graham G.; Wargo, Matthew J.			Extracellular Lipase and Protease Production from a Model Drinking Water Bacterial Community Is Functionally Robust to Absence of Individual Members	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PHOSPHOLIPASE-C; BURKHOLDERIA-CEPACIA; ENZYME-ACTIVITIES; INTERSPECIES COMMUNICATION; MICROBIAL COMMUNITIES; WASTE-WATER; BIOFILMS; BIODIVERSITY; SEA	Bacteria secrete enzymes into the extracellular space to hydrolyze macromolecules into constituents that can be imported for microbial nutrition. In bacterial communities, these enzymes and their resultant products can be modeled as community property. Our goal was to investigate the impact of individual community member absence on the resulting community production of exoenzymes (extracellular enzymes) involved in lipid and protein hydrolysis. Our model community contained nine bacteria isolated from the potable water system of the International Space Station. Bacteria were grown in static conditions individually, all together, or in all combinations of eight species and exoproduct production was measured by colorimetric or fluorometric reagents to assess short chain and long chain lipases, choline-specific phospholipases C, and proteases. The exoenzyme production of each species grown alone varied widely, however, the enzyme activity levels of the mixed communities were functionally robust to absence of any single species, with the exception of phospholipase C production in one community. For phospholipase C, absence of Chryseobacterium gleum led to increased choline-specific phospholipase C production, correlated with increased growth of Burkholderia cepacia and Sphingomonas sanguinis. Because each individual species produced different enzyme activity levels in isolation, we calculated an expected activity value for each bacterial mixture using input levels or known final composition. This analysis suggested that robustness of each exoenzyme activity is not solely mediated by community composition, but possibly influenced by bacterial communication, which is known to regulate such pathways in many bacteria. We conclude that in this simplified model of a drinking water bacterial community, community structure imposes constraints on production and/or secretion of exoenzymes to generate a level appropriate to exploit a given nutrient environment.	[Willsey, Graham G.; Wargo, Matthew J.] Univ Vermont, Dept Microbiol & Mol Genet, Coll Med, Burlington, VT 05405 USA	University of Vermont	Wargo, MJ (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Coll Med, Burlington, VT 05405 USA.	mwargo@uvm.edu		Wargo, Matthew/0000-0001-5659-749X; Willsey, Graham/0000-0001-7595-5854	National Aeronautics and Space Administration [EPSCoR NNX13AD40A]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This project was supported by a grant from the National Aeronautics and Space Administration EPSCoR NNX13AD40A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begon M, 1990, ECOLOGY INDIVIDUALS, Vxii; Bramucci M, 2003, APPL MICROBIOL BIOT, V62, P594, DOI 10.1007/s00253-003-1372-x; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Busse HJ, 1999, J IND MICROBIOL BIOT, V23, P242, DOI 10.1038/sj.jim.2900745; Castro VA, 2004, MICROB ECOL, V47, P119, DOI 10.1007/s00248-003-1030-y; Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4; Dong YH, 2005, MOL MICROBIOL, V56, P1287, DOI 10.1111/j.1365-2958.2005.04612.x; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Fitzsimmons LF, 2012, J BACTERIOL, V194, P4718, DOI 10.1128/JB.00596-12; Flagan S, 2003, APPL ENVIRON MICROB, V69, P909, DOI 10.1128/AEM.69.2.909-916.2003; Flieger A, 2000, ENZYME MICROB TECH, V26, P451, DOI 10.1016/S0141-0229(99)00190-8; FRANKENBERGER WT, 1983, SOIL SCI SOC AM J, V47, P945, DOI 10.2136/sssaj1983.03615995004700050021x; FRIEDMAN BE, 1977, J MOL BIOL, V111, P27; Harrington Kyle I, 2014, Commun Integr Biol, V7, pe28230, DOI 10.4161/cib.28230; Hobley L, 2006, APPL ENVIRON MICROB, V72, P6757, DOI 10.1128/AEM.00844-06; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HOPPE HG, 1988, APPL ENVIRON MICROB, V54, P784, DOI 10.1128/AEM.54.3.784-790.1988; Huang KL, 2014, ECOTOX ENVIRON SAFE, V109, P15, DOI 10.1016/j.ecoenv.2014.07.029; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hutchison ML, 1998, INFECT IMMUN, V66, P2033, DOI 10.1128/IAI.66.5.2033-2039.1998; Korbsrisate S, 2007, MICROBIOL-SGM, V153, P1907, DOI 10.1099/mic.0.2006/003004-0; Lee KWK, 2014, ISME J, V8, P894, DOI 10.1038/ismej.2013.194; Lehman RM, 2002, APPL ENVIRON MICROB, V68, P1569, DOI 10.1128/AEM.68.4.1569-1575.2002; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; Martinez J, 1996, AQUAT MICROB ECOL, V10, P223, DOI 10.3354/ame010223; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; McCoy ST, 2012, J ENVIRON ENG, V138, P786, DOI 10.1061/(ASCE)EE.1943-7870.0000539; MCKENNEY D, 1995, J BACTERIOL, V177, P6989, DOI 10.1128/jb.177.23.6989-6992.1995; MEISS HK, 1969, J BIOL CHEM, V244, P5382; Misic C, 2008, J MARINE SYST, V73, P123, DOI 10.1016/j.jmarsys.2007.10.003; Mongkolthanaruk W, 2002, INT BIODETER BIODEGR, V50, P101, DOI 10.1016/S0964-8305(02)00057-4; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Pai A, 2012, P NATL ACAD SCI USA, V109, P19810, DOI 10.1073/pnas.1211072109; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Raghavan V, 2014, MOL MICROBIOL, V93, P1010, DOI 10.1111/mmi.12714; Rao D, 2005, APPL ENVIRON MICROB, V71, P1729, DOI 10.1128/AEM.71.4.1729-1736.2005; RATH J, 1993, MAR ECOL PROG SER, V102, P89, DOI 10.3354/meps102089; Reed DP, 2001, HARVARD BUS REV, V79, P23; Reed DP, 2001, HARVARD BUS REV, V79, P154; Riedel K, 2001, MICROBIOL-SGM, V147, P3249, DOI 10.1099/00221287-147-12-3249; Simoes LC, 2007, APPL ENVIRON MICROB, V73, P6192, DOI 10.1128/AEM.00837-07; SINSABAUGH RL, 1988, FRESHWATER BIOL, V20, P249, DOI 10.1111/j.1365-2427.1988.tb00449.x; STEAD D, 1987, J DAIRY RES, V54, P535, DOI 10.1017/S0022029900025735; Stonehouse MJ, 2002, MOL MICROBIOL, V46, P661, DOI 10.1046/j.1365-2958.2002.03194.x; Sutherland IW, 2004, FEMS MICROBIOL LETT, V232, P1, DOI 10.1016/S0378-1097(04)00041-2; Teh KH, 2013, INT J FOOD MICROBIOL, V163, P129, DOI 10.1016/j.ijfoodmicro.2013.02.009; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Wargo MJ, 2011, AM J RESP CRIT CARE, V184, P345, DOI 10.1164/rccm.201103-0374OC; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Williams CJ, 2006, HYDROBIOLOGIA, V569, P113, DOI 10.1007/s10750-006-0126-z; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Woodcock S, 2007, FEMS MICROBIOL ECOL, V62, P171, DOI 10.1111/j.1574-6941.2007.00379.x; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zhang LF, 2006, NANO LETT, V6, P694, DOI 10.1021/nl052455y	59	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143617	10.1371/journal.pone.0143617	http://dx.doi.org/10.1371/journal.pone.0143617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599415	gold, Green Submitted, Green Published			2022-12-26	WOS:000365853900149
J	Yang, MY; Du, LM; Li, WJ; Shen, FJ; Fan, ZX; Jian, ZY; Hou, R; Shen, YM; Yue, BS; Zhang, XY				Yang, Mingyu; Du, Lianming; Li, Wujiao; Shen, Fujun; Fan, Zhenxin; Jian, Zuoyi; Hou, Rong; Shen, Yongmei; Yue, Bisong; Zhang, Xiuyue			Profile of microRNA in Giant Panda Blood: A Resource for Immune-Related and Novel microRNAs	PLOS ONE			English	Article							CANCER; PATHWAY; PROTEIN; GENOME; RECONSTRUCTION; ACTIVATION; APOPTOSIS; SURVIVAL; SYSTEM; MAPK	The giant panda (Ailuropoda melanoleuca) is one of the world's most beloved endangered mammals. Although the draft genome of this species had been assembled, little was known about the composition of its microRNAs (miRNAs) or their functional profiles. Recent studies demonstrated that changes in the expression of miRNAs are associated with immunity. In this study, miRNAs were extracted from the blood of four healthy giant pandas and sequenced by Illumina next generation sequencing technology. As determined by miRNA screening, a total of 276 conserved miRNAs and 51 novel putative miRNAs candidates were detected. After differential expression analysis, we noticed that the expressions of 7 miRNAs were significantly up-regulated in young giant pandas compared with that of adults. Moreover, 2 miRNAs were up-regulated in female giant pandas and 1 in the male individuals. Target gene prediction suggested that the miRNAs of giant panda might be relevant to the expressions of 4,602 downstream genes. Subseuqently, the predicted target genes were conducted to KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis and we found that these genes were mainly involved in host immunity, including the Ras signaling pathway, the PI3K-Akt signaling pathway, and the MAPK signaling pathway. In conclusion, our results provide the first miRNA profiles of giant panda blood, and the predicted functional analyses may open an avenue for further study of giant panda immunity.	[Yang, Mingyu; Du, Lianming; Li, Wujiao; Fan, Zhenxin; Jian, Zuoyi; Yue, Bisong; Zhang, Xiuyue] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China; [Shen, Fujun; Hou, Rong] Chengdu Res Base Giant Panda Breeding, Key Lab Conservat Biol Endangered Wildlife, Chengdu 610081, Sichuan, Peoples R China; [Shen, Yongmei] Gooddoctor Pharmaceut Grp, Chengdu 610000, Sichuan, Peoples R China	Sichuan University	Zhang, XY (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China.	zhangxy317@126.com		Yue, Bisong/0000-0001-6731-538X	Chengdu Panda Breeding Research Foundation [CPF-2012-14]; National Basic Research Program of China (973 Project) [2012CB722207]	Chengdu Panda Breeding Research Foundation; National Basic Research Program of China (973 Project)(National Basic Research Program of China)	The authors thank the Chengdu Research Base of Giant Panda Breeding for their help in collecting the samples for this study. This work was supported by the Chengdu Panda Breeding Research Foundation (CPF-2012-14) and the National Basic Research Program of China (973 Project: 2012CB722207). Gooddoctor pharmaceutical group employee YMS provided data analysis, but the company did not have any additional role in the study design, data collection and decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bates DJ, 2009, BBA-GEN SUBJECTS, V1790, P970, DOI 10.1016/j.bbagen.2009.03.028; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; CLARK GJ, 1995, BREAST CANCER RES TR, V35, P133, DOI 10.1007/BF00694753; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Du LM, 2015, MOL ECOL RESOUR, V15, P1001, DOI 10.1111/1755-0998.12367; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gorospe M, 2011, TRENDS GENET, V27, P233, DOI 10.1016/j.tig.2011.03.005; Gunda V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.78; He WY, 2012, AUTOPHAGY, V8, P1811, DOI 10.4161/auto.22145; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kozomara A., 2013, NUCLEIC ACIDS RES; Kozomara A., 2010, NUCLEIC ACIDS RES; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li CJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-16; Li N, 2011, NEUROBIOL AGING, V32, P944, DOI 10.1016/j.neurobiolaging.2009.04.020; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044906; Morais ATS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-205; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; NARANDA T, 1994, J BIOL CHEM, V269, P32286; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; WATSON MA, 1979, LANCET, V2, P1323; Wei FW, 2000, J MAMMAL, V81, P448, DOI 10.1644/1545-1542(2000)081<0448:HUASBT>2.0.CO;2; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Wynendaele E, 2015, PEPTIDES, V64, P40, DOI 10.1016/j.peptides.2014.12.009; Xie Y, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0629-9; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhang X.-D., 2013, NUCLEIC ACIDS RES, V14, P157	45	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143242	10.1371/journal.pone.0143242	http://dx.doi.org/10.1371/journal.pone.0143242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599861	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900080
J	Sato, M; Takahashi, G; Shibata, S; Onodera, M; Suzuki, Y; Inoue, Y; Endo, S				Sato, Masayuki; Takahashi, Gaku; Shibata, Shigehiro; Onodera, Makoto; Suzuki, Yasushi; Inoue, Yoshihiro; Endo, Shigeatsu			Clinical Performance of a New Soluble CD14-Subtype Immunochromatographic Test for Whole Blood Compared with Chemiluminescent Enzyme Immunoassay: Use of Quantitative Soluble CD14-Subtype Immunochromatographic Tests for the Diagnosis of Sepsis	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; PRESEPSIN; PREDICTION; SEVERITY; PROCALCITONIN; SCORE	We previously reported that a soluble CD14-subtype (sCD14-ST) immunochromatographic test (ICT) for plasma is more convenient than chemiluminescent enzyme immunoassay (CLEIA), but plasma separation makes bedside measurements difficult. We developed a new sCD14-ST ICT for whole blood and investigated whether quantitative determinations of sCD14-ST by ICT were useful for diagnosing sepsis and severe sepsis/septic shock. We studied 20 patients who fulfilled two or more systemic inflammatory response syndrome (SIRS) criteria and 32 patients who had been diagnosed with sepsis or severe sepsis/septic shock. Whole blood was collected on day 0 (on admission) and day 7, and the sCD14-ST concentration was quantitatively measured by CLEIA and ICT for whole blood. The patients' Acute Physiology and Chronic Health Evaluation (APACHE) II, Sequential Organ Failure Assessment (SOFA), and Mortality in Emergency Department Sepsis (MEDS) scores were also calculated. The cut-off values obtained by the quantitative measurements made by ICT were 464.5 pg/mL for sepsis and 762.7 pg/mL for severe sepsis/septic shock (P < 0.0001). A Bland-Altman plot showed that no fixed bias or proportional bias was detected between CLEIA and quantitative ICT for whole blood. sCD14-ST concentrations were significantly correlated with APACHE II, SOFA, and MEDS scores (P < 0.0001). These results suggest that the new sCD14-ST ICT for whole blood may be a useful tool for the convenient, rapid bedside diagnosis and treatment of sepsis.	[Sato, Masayuki; Takahashi, Gaku; Shibata, Shigehiro; Onodera, Makoto; Suzuki, Yasushi; Inoue, Yoshihiro; Endo, Shigeatsu] Iwate Med Univ, Dept Crit Care Med, Morioka, Iwate 020, Japan	Iwate Medical University	Sato, M (corresponding author), Iwate Med Univ, Dept Crit Care Med, Morioka, Iwate 020, Japan.	masato@iwate-med.ac.jp						Aikawa Naoki, 2005, Journal of Infection and Chemotherapy, V11, P152, DOI 10.1007/s10156-005-0388-9; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Ammori BJ, 2003, BRIT J SURG, V90, P197, DOI 10.1002/bjs.4036; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Endo S, 2012, J INFECT CHEMOTHER, V18, P891, DOI 10.1007/s10156-012-0435-2; Ishikura H, 2014, CRIT CARE, V18, DOI 10.1186/cc13700; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kweon OJ, 2014, J CRIT CARE, V29, P965, DOI 10.1016/j.jcrc.2014.06.014; Liu B, 2013, CRIT CARE, V17, DOI 10.1186/cc13070; Madenci OC, 2014, BURNS, V40, P664, DOI 10.1016/j.burns.2013.08.024; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Miyata M, 2007, J IWATE MED ASS, V59, P325; NYLEN ES, 1992, HORM METAB RES, V24, P439, DOI 10.1055/s-2007-1003354; Nylen ES, 1997, CRIT CARE MED, V25, P1362, DOI 10.1097/00003246-199708000-00024; Rudiger A, 2008, SWISS MED WKLY, V138, P629, DOI 2008/43/smw-12319; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Shozushima T, 2010, J IWATE MED ASS, V62, P411; Shozushima T, 2011, J INFECT CHEMOTHER, V17, P764, DOI 10.1007/s10156-011-0254-x; Takahashi G, 2010, MED POSTGRAD, V48, P25; Takahashi G, 2010, MED POSTGRAD, V48, P15; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Ulla M, 2013, CRIT CARE, V17, DOI 10.1186/cc12847; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vodnik T, 2013, CLIN CHEM LAB MED, V51, P2053, DOI 10.1515/cclm-2013-0061; Yaegashi Yasunori, 2005, Journal of Infection and Chemotherapy, V11, P234, DOI 10.1007/s10156-005-0400-4	28	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143971	10.1371/journal.pone.0143971	http://dx.doi.org/10.1371/journal.pone.0143971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26623644	gold, Green Published, Green Submitted			2022-12-26	WOS:000365891600081
J	Tanigaki, Y; Higashi, T; Takayama, K; Nagano, AJ; Honjo, MN; Fukuda, H				Tanigaki, Yusuke; Higashi, Takanobu; Takayama, Kotaro; Nagano, Atsushi J.; Honjo, Mie N.; Fukuda, Hirokazu			Transcriptome Analysis of Plant Hormone-Related Tomato (Solanum lycopersicum) Genes in a Sunlight-Type Plant Factory	PLOS ONE			English	Article							SALICYLIC-ACID; ARABIDOPSIS-THALIANA; CELL-DEATH; ETHYLENE; STRESS; RESISTANCE; GROWTH; BIOSYNTHESIS; REGULATORS; JASMONATE	In plant factories, measurements of plant conditions are necessary at an early stage of growth to predict harvest times of high value-added crops. Moreover, harvest qualities depend largely on environmental stresses that elicit plant hormone responses. However, the complexities of plant hormone networks have not been characterized under nonstress conditions. In the present study, we determined temporal expression profiles of all genes and then focused on plant hormone pathways using RNA-Seq analyses of gene expression in tomato leaves every 2 h for 48 h. In these experiments, temporally expressed genes were found in the hormone synthesis pathways for salicylic acid, abscisic acid, ethylene, and jasmonic acid. The timing of CAB expression 1 (TOC1) and abscisic acid insensitive 1 (ABA1) and open stomata 1 (OST1) control gating stomata. In this study, compare with tomato and Arabidopsis thaliana, expression patterns of TOC1 have similarity. In contrast, expression patterns of tomato ABI1 and OST1 had expression peak at different time. These findings suggest that the regulation of gating stomata does not depend predominantly on TOC1 and significantly reflects the extracellular environment. The present data provide new insights into relationships between temporally expressed plant hormone-related genes and clock genes under normal sunlight conditions.	[Tanigaki, Yusuke; Fukuda, Hirokazu] Osaka Prefecture Univ, Grad Sch Engn, Dept Mech Engn, Sakai, Osaka 591, Japan; [Higashi, Takanobu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Appl Life Sci, Sakai, Osaka 591, Japan; [Takayama, Kotaro] Ehime Univ, Fac Agr, Natl Univ Corp, Matsuyama, Ehime 790, Japan; [Nagano, Atsushi J.] Ryukoku Univ, Fac Agr, Otsu, Shiga, Japan; [Nagano, Atsushi J.] JST PRESTO, Kawaguchi, Saitama, Japan; [Nagano, Atsushi J.; Honjo, Mie N.] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Ehime University; Ryukoku University; Japan Science & Technology Agency (JST); Kyoto University	Fukuda, H (corresponding author), Osaka Prefecture Univ, Grad Sch Engn, Dept Mech Engn, Sakai, Osaka 591, Japan.	fukuda@bioinfo.osakafu-u.ac.jp	Nagano, Atsushi J./A-2957-2019	Nagano, Atsushi J./0000-0001-7891-5049	Canon Foundation; Joint Usage /Research program of Center for Ecological Research, Kyoto University;  [25712029];  [25119721]; Grants-in-Aid for Scientific Research [15J12133, 26292134] Funding Source: KAKEN	Canon Foundation(Canon Foundation); Joint Usage /Research program of Center for Ecological Research, Kyoto University; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by Grants-in-Aid for Scientific Research, https://www.jsps.go.jp/english/e-grants/, No. 25712029 and 25119721 to HF (the funders had role in data analysis); the Canon Foundation, http://www.canon-foundation.jp/index.html, to HF (the funders had role in data collection); and the Joint Usage /Research program of Center for Ecological Research, Kyoto University (the funders had roles in data analysis).	Barak S, 2000, TRENDS PLANT SCI, V5, P517, DOI 10.1016/S1360-1385(00)01785-4; BURG SP, 1973, P NATL ACAD SCI USA, V70, P591, DOI 10.1073/pnas.70.2.591; Coquoz JL, 1998, PLANT PHYSIOL, V117, P1095, DOI 10.1104/pp.117.3.1095; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; De Vleesschauwer D, 2010, PLANT PHYSIOL, V152, P2036, DOI 10.1104/pp.109.152702; Dempsey DA, 2012, TRENDS PLANT SCI, V17, P538, DOI 10.1016/j.tplants.2012.05.011; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Higashi Takanobu, 2015, Environmental Control in Biology, V53, P7, DOI 10.2525/ecb.53.7; HIGHKIN HR, 1954, PLANT PHYSIOL, V29, P301, DOI 10.1104/pp.29.3.301; Jia CG, 2013, J EXP BOT, V64, P637, DOI 10.1093/jxb/ers360; Kozai T, 2013, P JPN ACAD B-PHYS, V89, P447, DOI 10.2183/pjab.89.447; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Moldau H, 2011, PLANT SIGNAL BEHAV, V6, P311, DOI 10.4161/psb.6.2.15044; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Nagano AJ, 2015, METHODS MOL BIOL, V1236, P89, DOI 10.1007/978-1-4939-1743-3_8; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Nemchenko A, 2006, J EXP BOT, V57, P3767, DOI 10.1093/jxb/erl137; O'Donnell PJ, 2001, PLANT J, V25, P315, DOI 10.1046/j.1365-313x.2001.00968.x; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Rico A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008977; Rodrigues A, 2013, PLANT CELL, V25, P3871, DOI 10.1105/tpc.113.114066; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Takayama Kotaro, 2007, Environmental Control in Biology, V45, P241; Tang DZ, 2005, PLANT PHYSIOL, V138, P1018, DOI 10.1104/pp.105.060400; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296	34	5	6	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143412	10.1371/journal.pone.0143412	http://dx.doi.org/10.1371/journal.pone.0143412			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624004	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600028
J	Biehle, LR; Cottreau, JM; Thompson, DJ; Filipek, RL; O'Donnell, JN; Lasco, TM; Mahoney, MV; Hirsch, EB				Biehle, Lauren R.; Cottreau, Jessica M.; Thompson, David J.; Filipek, Rachel L.; O'Donnell, J. Nicholas; Lasco, Todd M.; Mahoney, Monica V.; Hirsch, Elizabeth B.			Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia	PLOS ONE			English	Article							ESCHERICHIA-COLI; PNEUMONIAE; INFECTIONS; THERAPY; MULTICENTER; OPTIONS	Background Extensive dissemination of carbapenemase-producing Enterobacteriaceae has led to increased resistance among Klebsiella species. Carbapenems are used as a last resort against resistant pathogens, but carbapenemase production can lead to therapy failure. Identification of risk factors for mortality and assessment of current susceptibility breakpoints are valuable for improving patient outcomes. Aim The objective of this study was to evaluate outcomes and risk factors for mortality among patients treated with carbapenems for Klebsiella spp. bacteremia. Methods Patients hospitalized between 2006 and 2012 with blood cultures positive for Klebsiella spp. who received >= 48 hours of carbapenem treatment within 72 hours of positive culture were included in this retrospective study. Patient data were retrieved from electronic medical records. Multivariate logistic regression was used to identify risk factors for 30-day hospital mortality. Results One hundred seven patients were included. The mean patient age was 61.5 years and the median APACHE II score was 13 +/- 6.2. Overall, 30-day hospital mortality was 9.3%. After adjusting for confounding variables, 30-day mortality was associated with baseline APACHE II score (OR, 1.17; 95% CI, 1.01-1.35; P = 0.03), length of stay prior to index culture (OR, 1.03; 95% CI, 1.00-1.06; P = 0.04), and carbapenem non-susceptible (imipenem or meropenem MIC > 1 mg/L) infection (OR, 9.08; 95% CI, 1.17-70.51; P = 0.04). Conclusions Baseline severity of illness and length of stay prior to culture were associated with 30-day mortality and should be considered when treating patients with Klebsiella bacteremia. These data support the change in carbapenem breakpoints for Klebsiella species.	[Biehle, Lauren R.; Cottreau, Jessica M.] Univ Houston, Houston, TX USA; [Biehle, Lauren R.; Cottreau, Jessica M.; Lasco, Todd M.] Baylor St Lukes Med Ctr, Catholic Hlth Initiat St Lukes Hlth, Houston, TX USA; [Thompson, David J.; Filipek, Rachel L.; O'Donnell, J. Nicholas; Hirsch, Elizabeth B.] Northeastern Univ, Boston, MA 02115 USA; [O'Donnell, J. Nicholas; Mahoney, Monica V.; Hirsch, Elizabeth B.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	University of Houston System; University of Houston; Northeastern University; Harvard University; Beth Israel Deaconess Medical Center	Hirsch, EB (corresponding author), Northeastern Univ, Boston, MA 02115 USA.	e.hirsch@neu.edu	O'Donnell, J Nicholas/H-7084-2019	O'Donnell, J Nicholas/0000-0001-5184-1385; Lasco, Todd/0000-0002-5405-7067; Mahoney, Monica/0000-0002-5071-2159				Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, 2012, M100S22 CLIN LAB S S M100S22 CLIN LAB S S; Daikos GL, 2014, ANTIMICROB AGENTS CH, V58, P2322, DOI 10.1128/AAC.02166-13; Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004; Hirsch EB, 2011, DIAGN MICR INFEC DIS, V69, P234, DOI 10.1016/j.diagmicrobio.2010.09.003; Hirsch EB, 2010, J ANTIMICROB CHEMOTH, V65, P1119, DOI 10.1093/jac/dkq108; Kontopidou F, 2014, CLIN MICROBIOL INFEC, V20, pO117, DOI 10.1111/1469-0691.12341; Lee NY, 2012, ANTIMICROB AGENTS CH, V56, P2888, DOI 10.1128/AAC.06301-11; Lee NY, 2011, DIAGN MICR INFEC DIS, V70, P150, DOI 10.1016/j.diagmicrobio.2010.12.008; Luzzaro F, 2011, DIAGN MICR INFEC DIS, V69, P363, DOI 10.1016/j.diagmicrobio.2010.10.016; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Michalopoulos A, 2011, AM J INFECT CONTROL, V39, P396, DOI 10.1016/j.ajic.2010.06.017; Nguyen M, 2010, DIAGN MICR INFEC DIS, V67, P180, DOI 10.1016/j.diagmicrobio.2010.02.001; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; Tam VH, 2012, ANN PHARMACOTHER, V46, P1120, DOI 10.1345/aph.1R021; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Zarkotou O, 2011, CLIN MICROBIOL INFEC	17	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143845	10.1371/journal.pone.0143845	http://dx.doi.org/10.1371/journal.pone.0143845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618357	gold, Green Published			2022-12-26	WOS:000365889800079
J	Chen, H; Babino, D; Schoenbichler, SA; Arkhipova, V; Tochterle, S; Martin, F; Huck, CW; von Lintig, J; Meyer, D				Chen, Hao; Babino, Darwin; Schoenbichler, Stefan A.; Arkhipova, Valeryia; Toechterle, Sonja; Martin, Fabian; Huck, Christian W.; von Lintig, Johannes; Meyer, Dirk			Nmnat1-Rbp7 Is a Conserved Fusion-Protein That Combines NAD plus Catalysis of Nmnat1 with Subcellular Localization of Rbp7	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; LEBER CONGENITAL AMAUROSIS; ZEBRAFISH DANIO-RERIO; SHORT-CHAIN DEHYDROGENASES/REDUCTASES; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; ACID RECEPTORS; MUTATIONS; TRANSCRIPTION; BIOSYNTHESIS	Retinol binding proteins (Rbps) are known as carriers for transport and targeting of retinoids to their metabolizing enzymes. Rbps are also reported to function in regulating the homeostatic balance of retinoid metabolism, as their level of retinoid occupancy impacts the activities of retinoid metabolizing enzymes. Here we used zebrafish as a model to study rbp7a function and regulation. We find that early embryonic rbp7a expression is negatively regulated by the Nodal/FoxH1-signaling pathway and we show that Nodal/FoxH1 activity has the opposite effect on aldh1a2, which encodes the major enzyme for early embryonic retinoic acid production. The data are consistent with a Nodal-dependent coordination of the allocation of retinoid precursors to processing enzymes with the catalysis of retinoic acid formation. Further, we describe a novel nmnat1-rbp7 transcript encoding a fusion of Rbp7 and the NAD(+) (Nicotinamide adenine dinucleotide) synthesizing enzyme Nmnat1. We show that nmnat1-rbp7 is conserved in fish, mouse and chicken, and that in zebrafish regulation of nmnat1-rbp7a is distinct from that of rbp7a and nmnat1. Injection experiments in zebrafish further revealed that Nmnat1-Rbp7a and Nmnat1 have similar NAD(+) catalyzing activities but a different subcellular localization. HPLC measurements and protein localization analysis highlight Nmnat1-Rbp7a as the only known cytoplasmic and presumably endoplasmic reticulum (ER) specific NAD(+) catalyzing enzyme. These studies, taken together with previously documented NAD(+) dependent interaction of RBPs with ER-associated enzymes of retinal catalysis, implicate functions of this newly described NMNAT1-Rbp7 fusion protein in retinol oxidation.	[Chen, Hao; Arkhipova, Valeryia; Toechterle, Sonja; Martin, Fabian; Meyer, Dirk] Univ Innsbruck, CMBI, Inst Mol Biol, A-6020 Innsbruck, Austria; [Schoenbichler, Stefan A.; Huck, Christian W.] Univ Innsbruck, CCB, Inst Analyt Chem & Radiochem, A-6020 Innsbruck, Austria; [Babino, Darwin; von Lintig, Johannes] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA	University of Innsbruck; University of Innsbruck; Case Western Reserve University	Meyer, D (corresponding author), Univ Innsbruck, CMBI, Inst Mol Biol, Technikerstr 25, A-6020 Innsbruck, Austria.	dirk.meyer@uibk.ac.at		Huck, Christian/0000-0002-6272-3242; Meyer, Dirk/0000-0002-4020-4484	Austrian Science Foundation (FWF) [P20492]; University of Innsbruck; Austrian Science Fund (FWF) [P 20492] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Foundation (FWF) Grant P20492 to DM (https://www.fwf.ac.at/). This work was further supported by the University of Innsbruck (http://www.uibk.ac.at/).	Arkhipova V, 2012, DEV BIOL, V365, P290, DOI 10.1016/j.ydbio.2012.03.001; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Begemann G, 2001, DEVELOPMENT, V128, P3081; Belliveau DJ, 2010, GENE EXPR PATTERNS, V10, P167, DOI 10.1016/j.gep.2010.04.003; Bennett JT, 2007, DEV BIOL, V304, P525, DOI 10.1016/j.ydbio.2007.01.012; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Cai K, 2009, INT J BIOCHEM CELL B, V41, P546, DOI 10.1016/j.biocel.2008.06.007; Cameron MC, 2002, EUR J BIOCHEM, V269, P4685, DOI 10.1046/j.1432-1033.2002.03170.x; Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370; Chiu WT, 2014, DEVELOPMENT, V141, P4537, DOI 10.1242/dev.107227; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Clugston RD, 2014, ZOO BIOL, V33, P527, DOI 10.1002/zoo.21140; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Epting D, 2007, GENE EXPR PATTERNS, V7, P389, DOI 10.1016/j.modgep.2006.11.010; Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361; Folli C, 2002, J BIOL CHEM, V277, P41970, DOI 10.1074/jbc.M207124200; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hauptmann G, 2000, METH MOL B, V137, P139; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Isken A, 2007, J BIOL CHEM, V282, P1144, DOI 10.1074/jbc.M609109200; Izzi L, 2007, EMBO J, V26, P3132, DOI 10.1038/sj.emboj.7601753; Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356; Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Lhor M, 2014, BIOCHEM CELL BIOL, V92, P510, DOI 10.1139/bcb-2014-0082; Li Z, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-117; Liu RZ, 2004, EUR J BIOCHEM, V271, P339, DOI 10.1046/j.1432-1033.2003.03932.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nash D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131514; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nikiforov A., 2015, CRIT REV BIOCHEM MOL, P1, DOI DOI 10.3109/10409238.2015.1028612; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; Parmar MB, 2013, MAR GENOM, V11, P1, DOI 10.1016/j.margen.2013.04.001; Perrault I, 2012, NAT GENET, V44, P975, DOI 10.1038/ng.2357; Piantedosi R, 2005, J BIOL CHEM, V280, P24286, DOI 10.1074/jbc.M503906200; Pierzchalski K, 2013, FASEB J, V27, P1904, DOI 10.1096/fj.12-219410; Pogoda HM, 2000, CURR BIOL, V10, P1041, DOI 10.1016/S0960-9822(00)00669-2; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Samarut E, 2015, BBA-GENE REGUL MECH, V1849, P73, DOI 10.1016/j.bbagrm.2014.05.030; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Slagle CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002072; Tarter M, 2008, PROTEINS, V70, P1626, DOI 10.1002/prot.21848; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028	59	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143825	10.1371/journal.pone.0143825	http://dx.doi.org/10.1371/journal.pone.0143825			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26618989	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800075
J	Kuo, HC; Chang, JC; Guo, MMH; Hsieh, KS; Yeter, D; Li, SC; Yang, KD				Kuo, Ho-Chang; Chang, Jen-Chieh; Guo, Mindy Ming-Huey; Hsieh, Kai-Sheng; Yeter, Deniz; Li, Sung-Chou; Yang, Kuender D.			Gene-Gene Associations with the Susceptibility of Kawasaki Disease and Coronary Artery Lesions	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTIFACTOR DIMENSIONALITY REDUCTION; ENVIRONMENT INTERACTIONS; TAIWANESE CHILDREN; POLYMORPHISMS; DIAGNOSIS; PHOSPHODIESTERASE-2; MANAGEMENT; PROMOTER; RISK	Kawasaki disease (KD) is a systemic vasculitis primarily affecting children < 5 years old. Genes significantly associated with KD mostly involve cardiovascular, immune, and inflammatory responses. Recent studies have observed stronger associations for KD risk with multiple genes compared to individual genes. Therefore, we investigated whether gene combinations influenced KD susceptibility or coronary artery lesion (CAL) formation. We examined 384 single-nucleotide polymorphisms (SNPs) for 159 immune-related candidate genes in DNA samples from KD patients with CAL (n = 73), KD patients without CAL (n = 153), and cohort controls (n = 575). Individual SNPs were first assessed by univariate analysis (UVA) and multivariate analysis (MVA). We used multifactor dimensionality reduction (MDR) to examine individual SNPs in one-, two-, and three-locus best fit models. UVA identified 53 individual SNPs that were significantly associated with KD risk or CAL formation (p < 0.10), while 35 individual SNPs were significantly associated using MVA (p <= 0.05). Significant associations in MDR analysis were only observed for the two-locus models after permutation testing (p <= 0.05). In logistic regression, combined possession of PDE2A (rs341058) and CYFIP2 (rs767007) significantly increased KD susceptibility (OR = 3.54; p = 4.14 x 10(-7)), while combinations of LOC100133214 (rs2517892) and IL2RA (rs3118470) significantly increased the risk of CAL in KD patients (OR = 5.35; p = 7.46 x 10(-5)). Our results suggest varying gene-gene associations respectively predispose individuals to KD risk or its complications of CAL.	[Kuo, Ho-Chang; Guo, Mindy Ming-Huey; Hsieh, Kai-Sheng] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Kuo, Ho-Chang; Guo, Mindy Ming-Huey; Hsieh, Kai-Sheng; Yeter, Deniz] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan; [Chang, Jen-Chieh; Li, Sung-Chou] Kaohsiung Chang Gung Mem Hosp, Genom & Prote Core Lab, Dept Med Res, Kaohsiung, Taiwan; [Yang, Kuender D.] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Yang, Kuender D.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Mackay Memorial Hospital; National Yang Ming Chiao Tung University	Kuo, HC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.	erickuo48@yahoo.com.tw; yangkd.yeh@hotmail.com	Li, Sung-Chou/AGZ-8626-2022; Kuo, Ho-Chang/AAQ-6644-2020	Li, Sung-Chou/0000-0002-3016-9718; Kuo, Ho-Chang/0000-0002-3295-2984; Hsieh, Kai-Sheng/0000-0002-0294-9872	Ministry of Science and Technology, Taiwan [MOST 102-2314-B-182-053-MY3, MOST103-2410-H-264-004, 104-2314-B-758-002-MY3]; Chang Gung Memorial Hospital [CMRPG8C1082, CMRPG8B0212, CMRPG8D1561, CMRPG8D0521]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The work was supported by Ministry of Science and Technology, Taiwan (MOST 102-2314-B-182-053-MY3, MOST103-2410-H-264-004 and 104-2314-B-758-002-MY3) and Chang Gung Memorial Hospital (CMRPG8C1082, CMRPG8B0212, CMRPG8D1561 and CMRPG8D0521). This work was carried out as a cooperative project of the institutes of all authors. None of the institutes had an influence on the collection, analysis, and interpretation of data or on the preparation of the manuscript.	[Anonymous], 2010, CIRC J, V74, P1989; BROSIUS CL, 1988, PEDIATR INFECT DIS J, V7, P863; Burns JC, 2005, GENES IMMUN, V6, P438, DOI 10.1038/sj.gene.6364225; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Chang JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070362; Gao XY, 2011, GENET EPIDEMIOL, V35, P154, DOI 10.1002/gepi.20563; Gui JA, 2011, HUM GENET, V129, P101, DOI 10.1007/s00439-010-0905-5; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Holman RC, 2005, PEDIATR INFECT DIS J, V24, P429, DOI 10.1097/01.inf.0000160946.05295.91; Huang FY, 2008, HUM IMMUNOL, V69, P52, DOI 10.1016/j.humimm.2007.11.002; Julia A, 2007, GENOMICS, V90, P6, DOI 10.1016/j.ygeno.2007.03.011; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105236; Kuo HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069685; Kuo HC, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-38; Kuo HC, 2012, PEDIATR NEONATOL, V53, P4, DOI 10.1016/j.pedneo.2011.11.003; Kuo HC, 2011, ACTA PHARMACOL SIN, V32, P1193, DOI 10.1038/aps.2011.93; Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Mehel H, 2013, J AM COLL CARDIOL, V62, P1596, DOI 10.1016/j.jacc.2013.05.057; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Nishimura S, 2003, J PEDIATR-US, V143, P357, DOI 10.1067/S0022-3476(03)00330-5; Onouchi Y, 2013, PHARMACOGENOMICS J, V13, P52, DOI 10.1038/tpj.2011.45; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, CIRC J, V76, P1581, DOI 10.1253/circj.CJ-12-0568; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Portman MA, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-32; Ritchie Marylyn D, 2005, Neurosurg Focus, V19, pE2; Rowley AH, 2011, ANNU REV MED, V62, P69, DOI 10.1146/annurev-med-042409-151944; Seybold J, 2005, BLOOD, V105, P3569, DOI 10.1182/blood-2004-07-2729; Wang CL, 2005, PEDIATR INFECT DIS J, V24, P998, DOI 10.1097/01.inf.0000183786.70519.fa; Weng KP, 2010, CIRC J, V74, P2726, DOI 10.1253/circj.CJ-10-0542; Wu H, 2010, J ALLERGY CLIN IMMUN, V125, P321, DOI 10.1016/j.jaci.2009.09.007; Yang KD, 2010, ALLERGY, V65, P731, DOI 10.1111/j.1398-9995.2009.02260.x; Yeter D, 2012, AUTOIMMUN REV, V11, P903, DOI 10.1016/j.autrev.2012.03.006	37	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143056	10.1371/journal.pone.0143056	http://dx.doi.org/10.1371/journal.pone.0143056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619243	Green Submitted, Green Published, gold			2022-12-26	WOS:000365889800023
J	Paget, J; Aangenend, H; Kuhn, M; Hautvast, J; van Oorschot, D; Loohuis, AO; van der Velden, K; Friedrich, AW; Voss, A; Kock, R				Paget, John; Aangenend, Helen; Kuhn, Malte; Hautvast, Jeannine; van Oorschot, Desiree; Loohuis, Alphons Olde; van der Velden, Koos; Friedrich, Alexander W.; Voss, Andreas; Kock, Robin			MRSA Carriage in Community Outpatients: A Cross-Sectional Prevalence Study in a High-Density Livestock Farming Area along the Dutch-German Border	PLOS ONE			English	Article							RESISTANT-STAPHYLOCOCCUS-AUREUS; NETHERLANDS; METAANALYSIS; ADMISSION; RISK	Objectives MRSA poses a considerable public health threat to the community. The objectives of this study were to assess the prevalence of MRSA carriage and determine factors that were associated with MRSA carriage among outpatients who had used antibiotics in the previous three months and who lived in a high-density livestock farming area along the Dutch-German border. Methods Cross-sectional prevalence study carried out between November 2011 and June 2012. Nasal swabs and questionnaires were collected in patients (>4 years) who had used antibiotics in the previous three months from twelve Dutch General Practitioners (GPs), seven German GPs and two German outpatient urologists. To assess nasal carriage, swabs were analyzed using selective MRSA agars after broth enrichment. MRSA positive samples were spa typed. Results Data were collected from 513 GP outpatients in the Netherlands, 261 GP outpatients in Germany and 200 urologist outpatients in Germany. The overall prevalence of MRSA carriage was 0.8%, 1.1% and 2.0%, respectively. In the GP outpatient populations, the prevalence was similar in both countries (0.8% and 1.1%, respectively, p = 0.879), all spa types were indicative for livestock-associated MRSA (4xt011 in the Netherlands; 2xt034 and t011 in Germany) and being a farmer, living on or near (<5km) to a farm were associated with MRSA carriage. In the urologist outpatient population, the prevalence was higher (2.0%), all spa types were indicative for healthcare-associated MRSA (t068, t032, t003, t10231) and being a farmer, living on or near to a farm were factors not associated with MRSA carriage. Conclusions The prevalence of MRSA carriage in these community outpatient populations along the Dutch-German border was low. There were striking similarities in livestock-associated MRSA carriage and clonal spread in the outpatient populations seeing their GP in both countries. In contrast, urologist outpatients in Germany were colonized with spa types indicative of healthcare-associated MRSA.	[Paget, John; Aangenend, Helen; Hautvast, Jeannine; van Oorschot, Desiree; Loohuis, Alphons Olde; van der Velden, Koos] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Paget, John] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Aangenend, Helen; Hautvast, Jeannine] GGD Gelderland Zuid Municipal Hlth Serv Gelderlan, Nijmegen, Netherlands; [Kuhn, Malte; Kock, Robin] Univ Hosp Munster, Inst Hyg, Munster, Germany; [Friedrich, Alexander W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Voss, Andreas] Canisius Wilhelmina Hosp, Dept Clin Microbiol & Infect Dis, Nijmegen, Netherlands; [Voss, Andreas] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Netherlands Institute for Health Services Research; University of Munster; University of Groningen; Canisius-Wilhelmina Hospital; Radboud University Nijmegen	Paget, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands.	j.paget@nivel.nl	Friedrich, Alex/ABG-9823-2020; van der Velden, J./H-8101-2014; Köck, Robin/AAC-1552-2019; Voss, A./H-8111-2014; Hautvast, J.L.A./L-4352-2015		INTERREG IVa program of the European Union (SafeGuard "MRSA-MedVetnet") [III-2-03=025]; INTERREG IVa program of the European Union (EurSafety Health-net/EUREGIO MRSAnet) [III-1-02=73]	INTERREG IVa program of the European Union (SafeGuard "MRSA-MedVetnet"); INTERREG IVa program of the European Union (EurSafety Health-net/EUREGIO MRSAnet)	The study was supported by grants from the INTERREG IVa program of the European Union (SafeGuard "MRSA-MedVetnet" (III-2-03=025)) and EurSafety Health-net/EUREGIO MRSAnet (III-1-02=73). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Dalhoff A, 2010, INT J ANTIMICROB AG, V36, P216, DOI 10.1016/j.ijantimicag.2010.04.014; den Heijer CDJ, 2013, LANCET INFECT DIS, V13, P409, DOI 10.1016/S1473-3099(13)70036-7; Destatis Statistisches Bundesamt, 2013, GES NACH BER 2011; European Centre for Disease Prevention and Control, ANT RES INT DAT EARS; Friedrich AW, 2008, EUROSURVEILLANCE, V28, P13; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kock R, 2009, J HOSP INFECT, V71, P320, DOI 10.1016/j.jhin.2008.12.001; Layer F, 2012, BUNDESGESUNDHEITSBLA, V55, P1377, DOI 10.1007/s00103-012-1560-x; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Monnet DL, 1998, INFECT CONT HOSP EP, V19, P552; Mulders MN, 2010, EPIDEMIOL INFECT, V138, P743, DOI 10.1017/S0950268810000075; Statline Centraal Bureau voor de Statistiek, 2008, BER NAAR BEDR PERS 2; Tacconelli E, 2008, J ANTIMICROB CHEMOTH, V61, P26, DOI 10.1093/jac/dkm416; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042787; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wassenberg WM, 2010, NED TIJDSCHRIFT GENE, V154; Wulf M, 2008, CLIN MICROBIOL INFEC, V14, P519, DOI 10.1111/j.1469-0691.2008.01970.x; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z	26	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0139589	10.1371/journal.pone.0139589	http://dx.doi.org/10.1371/journal.pone.0139589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619190	Green Published, gold, Green Submitted			2022-12-26	WOS:000365889800004
J	Stetz, G; Verkhivker, GM				Stetz, Gabrielle; Verkhivker, Gennady M.			Dancing through Life: Molecular Dynamics Simulations and Network-Centric Modeling of Allosteric Mechanisms in Hsp70 and Hsp110 Chaperone Proteins	PLOS ONE			English	Article							SUBSTRATE-BINDING DOMAIN; CONFORMATIONAL TRANSITION PATHWAYS; DNAK CHAPERONE; STRUCTURAL BASIS; MITOCHONDRIAL HSP70; HYDROGEN-EXCHANGE; CRYSTAL-STRUCTURE; LIGAND-BINDING; RESIDUE DEPTH; ACTIVE-SITE	Hsp70 and Hsp110 chaperones play an important role in regulating cellular processes that involve protein folding and stabilization, which are essential for the integrity of signaling networks. Although many aspects of allosteric regulatory mechanisms in Hsp70 and Hsp110 chaperones have been extensively studied and significantly advanced in recent experimental studies, the atomistic picture of signal propagation and energetics of dynamics-based communication still remain unresolved. In this work, we have combined molecular dynamics simulations and protein stability analysis of the chaperone structures with the network modeling of residue interaction networks to characterize molecular determinants of allosteric mechanisms. We have shown that allosteric mechanisms of Hsp70 and Hsp110 chaperones may be primarily determined by nucleotide-induced redistribution of local conformational ensembles in the inter-domain regions and the substrate binding domain. Conformational dynamics and energetics of the peptide substrate binding with the Hsp70 structures has been analyzed using free energy calculations, revealing allosteric hotspots that control negative cooperativity between regulatory sites. The results have indicated that cooperative interactions may promote a population-shift mechanism in Hsp70, in which functional residues are organized in a broad and robust allosteric network that can link the nucleotide-binding site and the substrate-binding regions. A smaller allosteric network in Hsp110 structures may elicit an entropy-driven allostery that occurs in the absence of global structural changes. We have found that global mediating residues with high network centrality may be organized in stable local communities that are indispensable for structural stability and efficient allosteric communications. The network-centric analysis of allosteric interactions has also established that centrality of functional residues could correlate with their sensitivity to mutations across diverse chaperone functions. This study reconciles a wide spectrum of structural and functional experiments by demonstrating how integration of molecular simulations and network-centric modeling may explain thermodynamic and mechanistic aspects of allosteric regulation in chaperones.	[Stetz, Gabrielle; Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Grad Program Computat & Data Sci, Orange, CA 92866 USA; [Verkhivker, Gennady M.] Chapman Univ, Sch Pharm, Irvine, CA USA	Chapman University System; Chapman University; Chapman University System; Chapman University	Verkhivker, GM (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Grad Program Computat & Data Sci, Orange, CA 92866 USA.	verkhivk@chapman.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	Chapman University	Chapman University	This work is supported by funding from Chapman University. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Bahar I, 1998, BIOCHEMISTRY-US, V37, P1067, DOI 10.1021/bi9720641; Bello-Rivas JM, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4913399; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Besker N, 2012, METHODS MOL BIOL, V819, P501, DOI 10.1007/978-1-61779-465-0_29; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; Blacklock K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003679; Blacklock K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071936; Bracher Andreas, 2015, Subcell Biochem, V78, P1, DOI 10.1007/978-3-319-11731-7_1; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Burkholder WF, 1996, P NATL ACAD SCI USA, V93, P10632, DOI 10.1073/pnas.93.20.10632; Cavalli A, 2015, ACCOUNTS CHEM RES, V48, P277, DOI 10.1021/ar500356n; Chakravarty S, 1999, STRUCT FOLD DES, V7, P723, DOI 10.1016/S0969-2126(99)80097-5; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; Christensen NJ, 2013, J CHEM THEORY COMPUT, V9, P3210, DOI 10.1021/ct4002152; Christensen NJ, 2012, J CHEM INF MODEL, V52, P3028, DOI 10.1021/ci300398z; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Csermely P, 2012, CURR PROTEIN PEPT SC, V13, P19, DOI 10.2174/138920312799277992; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Daily MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000293; Dam TK, 2002, BIOCHEMISTRY-US, V41, P1351, DOI 10.1021/bi015830j; Das A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003521; del Sol A, 2005, BIOINFORMATICS, V21, P1311, DOI 10.1093/bioinformatics/bti167; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dixit A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037605; Duncan Emma J, 2015, Subcell Biochem, V78, P243, DOI 10.1007/978-3-319-11731-7_12; Emperador A, 2008, BIOPHYS J, V95, P2127, DOI 10.1529/biophysj.107.119115; Emperador A, 2010, PROTEINS, V78, P83, DOI 10.1002/prot.22563; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Fenley AT, 2012, P NATL ACAD SCI USA, V109, P20006, DOI 10.1073/pnas.1213180109; Fernandez-Fuentes N, 2006, NUCLEIC ACIDS RES, V34, pW173, DOI 10.1093/nar/gkl113; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FLAHERTY KM, 1994, J BIOL CHEM, V269, P12899; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Gaspar ME, 2012, BRIEF FUNCT GENOMICS, V11, P443, DOI 10.1093/bfgp/els023; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; General IJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003624; Golas E, 2012, J CHEM THEORY COMPUT, V8, P1750, DOI 10.1021/ct200680g; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Han WJ, 2001, FEBS LETT, V497, P55, DOI 10.1016/S0014-5793(01)02435-8; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hilser VJ, 2015, P NATL ACAD SCI USA, V112, P11430, DOI 10.1073/pnas.1515239112; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Hu ZJ, 2007, PLOS COMPUT BIOL, V3, P1097, DOI 10.1371/journal.pcbi.0030117; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Garzon JI, 2007, BIOINFORMATICS, V23, P901, DOI 10.1093/bioinformatics/btm014; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jacobs DJ, 2012, METHODS MOL BIOL, V796, P279, DOI 10.1007/978-1-61779-334-9_15; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kalodimos CG, 2012, ANN NY ACAD SCI, V1260, P81, DOI 10.1111/j.1749-6632.2011.06319.x; Karshikoff A, 2015, FEBS J, V282, P3899, DOI 10.1111/febs.13343; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kityk R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9308; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; Kovacs JA, 2004, PROTEINS, V56, P661, DOI 10.1002/prot.20151; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Leone V, 2010, CURR OPIN STRUC BIOL, V20, P148, DOI 10.1016/j.sbi.2010.01.011; Li CQ, 2014, J PHYS CHEM B, V118, P1273, DOI 10.1021/jp411111g; Li TJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0082499, 10.1371/journal.pone.0092870]; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Liu Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000931; Livesay DR, 2004, FEBS LETT, V576, P468, DOI 10.1016/j.febslet.2004.09.057; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Ma W, 2015, J AM CHEM SOC, V137, P3031, DOI 10.1021/ja512605w; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Mayer MP, 2000, BIOL CHEM, V381, P877, DOI 10.1515/BC.2000.109; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moran C, 2013, G3-GENES GENOM GENET, V3, P1409, DOI 10.1534/g3.113.007112; Moro F, 2006, PROTEIN SCI, V15, P223, DOI 10.1110/ps.051732706; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Motlagh HN, 2012, P NATL ACAD SCI USA, V109, P4134, DOI 10.1073/pnas.1120519109; Navizet I, 2004, BIOPHYS J, V87, P1426, DOI 10.1529/biophysj.104.042085; Nesmelova IV, 2010, J MOL BIOL, V397, P1209, DOI 10.1016/j.jmb.2010.02.033; Nicolai A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003379; Nicolai A, 2013, J BIOMOL STRUCT DYN, V31, P1111, DOI 10.1080/07391102.2012.726190; Nussinov R, 2013, STRUCTURE, V21, P1509, DOI 10.1016/j.str.2013.06.002; Nussinov R, 2013, ANNU REV BIOPHYS, V42, P169, DOI 10.1146/annurev-biophys-083012-130257; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Nussinov R, 2012, MOL BIOSYST, V8, P22, DOI 10.1039/c1mb05205e; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pan AC, 2008, J PHYS CHEM B, V112, P3432, DOI 10.1021/jp0777059; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pintar A, 2003, TRENDS BIOCHEM SCI, V28, P593, DOI 10.1016/j.tibs.2003.09.004; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Polier S, 2010, J MOL BIOL, V401, P696, DOI 10.1016/j.jmb.2010.07.004; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Rader AJ, 2011, MOL BIOSYST, V7, P464, DOI 10.1039/c0mb00054j; Lopez-Blanco JR, 2014, NUCLEIC ACIDS RES, V42, pW271, DOI 10.1093/nar/gku339; Rampelt H, 2011, METHODS MOL BIOL, V787, P83, DOI 10.1007/978-1-61779-295-3_7; Revington M, 2005, J MOL BIOL, V349, P163, DOI 10.1016/j.jmb.2005.03.033; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Rodina A, 2013, CHEM BIOL, V20, P1469, DOI 10.1016/j.chembiol.2013.10.008; Sacquin-Mora S, 2006, BIOPHYS J, V90, P2706, DOI 10.1529/biophysj.105.074997; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Sfriso P, 2013, BIOINFORMATICS, V29, P1980, DOI 10.1093/bioinformatics/btt324; Sfriso P, 2012, J CHEM THEORY COMPUT, V8, P4707, DOI 10.1021/ct300494q; Shukla D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4397; Sikor M, 2013, EMBO J, V32, P1639, DOI 10.1038/emboj.2013.89; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Song JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007072; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Stevens SY, 2003, PROTEIN SCI, V12, P2588, DOI 10.1110/ps.03269103; Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947; Sutto L, 2013, P NATL ACAD SCI USA, V110, P10616, DOI 10.1073/pnas.1221953110; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Szilagyi A, 2013, CURR TOP MED CHEM, V13, P64, DOI 10.2174/1568026611313010007; Tan KP, 2013, NUCLEIC ACIDS RES, V41, pW314, DOI 10.1093/nar/gkt503; Taneva SG, 2010, BIOCHEMISTRY-US, V49, P1338, DOI 10.1021/bi901847q; Taylor D, 2014, BIOINFORMATICS, V30, P3189, DOI 10.1093/bioinformatics/btu506; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Ung PMU, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003279; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; Woo HJ, 2009, BIOCHEMISTRY-US, V48, P11470, DOI 10.1021/bi901256y; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057; Yuan Z, 2008, PROTEINS, V70, P509, DOI 10.1002/prot.21545; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2015, P NATL ACAD SCI USA, V112, pE2865, DOI 10.1073/pnas.1506692112; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108	168	38	38	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143752	10.1371/journal.pone.0143752	http://dx.doi.org/10.1371/journal.pone.0143752			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619280	Green Published, Green Submitted, gold			2022-12-26	WOS:000365889800068
J	Buchacher, T; Ohradanova-Repic, A; Stockinger, H; Fischer, MB; Weber, V				Buchacher, Tanja; Ohradanova-Repic, Anna; Stockinger, Hannes; Fischer, Michael B.; Weber, Viktoria			M2 Polarization of Human Macrophages Favors Survival of the Intracellular Pathogen Chlamydia pneumoniae	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS REPLICATION; HUMAN BLOOD MONOCYTES; IFN-GAMMA; IN-VITRO; M-CSF; INFECTION; CELLS; TRACHOMATIS; ACTIVATION; PERSISTENCE	Intracellular pathogens have developed various strategies to escape immunity to enable their survival in host cells, and many bacterial pathogens preferentially reside inside macrophages, using diverse mechanisms to penetrate their defenses and to exploit their high degree of metabolic diversity and plasticity. Here, we characterized the interactions of the intracellular pathogen Chlamydia pneumoniae with polarized human macrophages. Primary human monocytes were pre-differentiated with granulocyte macrophage colony-stimulating factor or macrophage colony-stimulating factor for 7 days to yield M1-like and M2-like macrophages, which were further treated with interferon-gamma and lipopolysaccharide or with interleukin-4 for 48 h to obtain fully polarized M1 and M2 macrophages. M1 and M2 cells exhibited distinct morphology with round or spindle-shaped appearance for M1 and M2, respectively, distinct surface marker profiles, as well as different cytokine and chemokine secretion. Macrophage polarization did not influence uptake of C. pneumoniae, since comparable copy numbers of chlamydial DNA were detected in M1 and M2 at 6 h post infection, but an increase in chlamydial DNA over time indicating proliferation was only observed in M2. Accordingly, 72 +/- 5% of M2 vs. 48 +/- 7% of M1 stained positive for chlamydial lipopolysaccharide, with large perinuclear inclusions in M2 and less clearly bordered inclusions for M1. Viable C. pneumoniae was present in lysates from M2, but not from M1 macrophages. The ability of M1 to restrict chlamydial replication was not observed in M1-like macrophages, since chlamydial load showed an equal increase over time for M1-like and M2-like macrophages. Our findings support the importance of macrophage polarization for the control of intracellular infection, and show that M2 are the preferred survival niche for C. pneumoniae. M1 did not allow for chlamydial proliferation, but failed to completely eliminate chlamydial infection, giving further evidence for the ability of C. pneumoniae to evade cellular defense and to persist in human macrophages.	[Buchacher, Tanja; Weber, Viktoria] Danube Univ Krems, Christian Doppler Lab Innovat Therapy Approaches, Krems, Austria; [Ohradanova-Repic, Anna; Stockinger, Hannes] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Mol Immunol Unit, Vienna, Austria; [Fischer, Michael B.] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria; [Fischer, Michael B.; Weber, Viktoria] Danube Univ Krems, Dept Hlth Sci & Biomed, Krems, Austria	Danube University Krems; Medical University of Vienna; Medical University of Vienna; Danube University Krems	Weber, V (corresponding author), Danube Univ Krems, Christian Doppler Lab Innovat Therapy Approaches, Krems, Austria.	viktoria.weber@donau-uni.ac.at	Fischer, Michael/AAU-5579-2020; Ohradanova-Repic, Anna/ABG-3709-2020; Stockinger, Hannes/E-5173-2011	Fischer, Michael/0000-0002-5876-0243; Ohradanova-Repic, Anna/0000-0002-8005-8522; Stockinger, Hannes/0000-0001-6404-4430; weber, viktoria/0000-0002-3963-9077; Buchacher, Tanja/0000-0003-1937-2202	Christian Doppler Forschungsgesellschaft, grant: Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis	Christian Doppler Forschungsgesellschaft, grant: Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis	This work was supported by Christian Doppler Forschungsgesellschaft (www.cdg.ac.at), grant: Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis.	Abdullah Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037349; Airenne S, 1999, INFECT IMMUN, V67, P1445, DOI 10.1128/IAI.67.3.1445-1449.1999; Balin BJ, 2008, J ALZHEIMERS DIS, V13, P371; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Buchacher T, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0060-1; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Datta B, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0209-3; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Goldschmidt P, 2006, BRIT J OPHTHALMOL, V90, P1425, DOI 10.1136/bjo.2006.096420; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gracey E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069421; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Jupelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077447; Kern JM, 2009, CLIN MICROBIOL INFEC, V15, P36, DOI 10.1111/j.1469-0691.2008.02631.x; Ketavarapu JM, 2008, P NATL ACAD SCI USA, V105, P9313, DOI 10.1073/pnas.0707636105; Lenzo JC, 2012, IMMUNOL CELL BIOL, V90, P429, DOI 10.1038/icb.2011.58; Lopez-Castejon G, 2011, CELL MOL LIFE SCI, V68, P3095, DOI 10.1007/s00018-010-0609-y; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Marangoni Antonella, 2014, BMC Res Notes, V7, P230, DOI 10.1186/1756-0500-7-230; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mia S, 2014, SCAND J IMMUNOL, V79, P305, DOI 10.1111/sji.12162; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muraille E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00603; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Price JV, 2014, IMMUNITY, V41, P685, DOI 10.1016/j.immuni.2014.10.015; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Rodriguez AR, 2011, MUCOSAL IMMUNOL, V4, P217, DOI 10.1038/mi.2010.59; Rottenberg ME, 2000, J IMMUNOL, V164, P4812, DOI 10.4049/jimmunol.164.9.4812; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Rupp J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006020; Saikku P, 2002, EUR HEART J, V23, P263, DOI 10.1053/euhj.2001.2913; Sommer K, 2009, FEMS IMMUNOL MED MIC, V55, P206, DOI 10.1111/j.1574-695X.2008.00503.x; Thi EP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002551; von Hertzen LC, 2002, EUR RESPIR J, V19, P546, DOI 10.1183/09031936.02.00254402; Wolf K, 2005, INFECT IMMUN, V73, P4560, DOI 10.1128/IAI.73.8.4560-4570.2005; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394	42	63	67	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143593	10.1371/journal.pone.0143593	http://dx.doi.org/10.1371/journal.pone.0143593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606059	Green Published, gold, Green Submitted			2022-12-26	WOS:000365865300085
J	Dahms, C; Hubner, NO; Kossow, A; Mellmann, A; Dittmann, K; Kramer, A				Dahms, Carmen; Huebner, Nils-Olaf; Kossow, Annelene; Mellmann, Alexander; Dittmann, Kathleen; Kramer, Axel			Occurrence of ESBL-Producing Escherichia coli in Livestock and Farm Workers in Mecklenburg-Western Pomerania, Germany	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; EXTENDED-SPECTRUM; PUBLIC-HEALTH; RISK-FACTORS; E. COLI; PREVALENCE; CATTLE; GENES; TRANSMISSION; BROILERS	In recent years, extended-spectrum beta-lactamases (ESBL) producing bacteria have been found in livestock, mainly as asymptomatic colonizers. The zoonotic risk for people working in close contact to animal husbandry has still not been completely assessed. Therefore, we investigated the prevalence of ESBL-producing Escherichia spp. in livestock animals and workers to determine the potential risk for an animal-human cross-transmission. In Mecklenburg-Western Pomerania, northeast Germany, inguinal swabs of 73 individuals with livestock contact from 23 different farms were tested for ESBL-producing Escherichia spp. Two pooled fecal samples per farm of animal origin from 34 different farms (17 pig farms, 11 cattle farms, 6 poultry farms) as well as cloacal swabs of 10 randomly selected broilers or turkeys were taken at each poultry farm. For identification, selective chromogenic agar was used after an enrichment step. Phenotypically ESBL-producing isolates (n = 99) were tested for CTX-M, OXA, SHV and TEM using PCR, and isolates were further characterized using multilocus sequence typing (MLST). In total, 61 diverse isolates from different sources and/ or different MLST/PCR results were acquired. Five farm workers (three from cattle farms and two from pig farms) harbored ESBL-producing E. coli. All human isolates harbored the CTX-M a-lactamase; TEM and OXA a-lactamases were additionally detected in two, resp. one, isolates. ESBL-producing Escherichia spp. were found in fecal samples at pig (15/17), cattle (6/11) and poultry farms (3/6). In total, 70.6% (24/36) of the tested farms were ESBL positive. Furthermore, 9 out of 60 cloacal swabs turned out to be ESBL positive. All isolated ESBL-producing bacteria from animal sources were E. coli, except for one E. hermanii isolate. CTX-M was the most prevalent beta-lactamase at cattle and pig farms, while SHV predominated in poultry. One human isolate shared an identical MLST sequence type (ST) 3891 and CTX-M allele to the isolate found in the cattle fecal sample from the same farm, indicating a zoonotic transfer. Two other pairs of human-pig and human-cattle E. coli isolates encoded the same ESBL genes but did not share the same MLST ST, which may indicate horizontal resistance gene transfer. In summary, the study shows the high prevalence of ESBL-producing E. coli in livestock in Mecklenburg-Western Pomerania and provides the risk of transfer between livestock and farm workers.	[Dahms, Carmen; Huebner, Nils-Olaf; Dittmann, Kathleen; Kramer, Axel] Univ Med Greifswald, Inst Hyg & Environm Med, Greifswald, Germany; [Huebner, Nils-Olaf] IMD, Greifswald, Germany; [Kossow, Annelene; Mellmann, Alexander] Univ Hosp Munster, Inst Hyg, Munster, Germany	Greifswald Medical School; University of Munster	Hubner, NO (corresponding author), Univ Med Greifswald, Inst Hyg & Environm Med, Greifswald, Germany.	nhuebner@uni-greifswald.de			Federal Ministry of Education and Research [01KQ1001E]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Federal Ministry of Education and Research (Grant Number 01KQ1001E).	Andreoletti O, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2322; Brasme L, 2007, J ANTIMICROB CHEMOTH, V60, P956, DOI 10.1093/jac/dkm319; Brinas L, 2003, ANTIMICROB AGENTS CH, V47, P2056, DOI 10.1128/AAC.47.6.2056-2058.2003; Buchter B., 2010, THESIS; Burt SA, 2012, VET MICROBIOL, V160, P256, DOI 10.1016/j.vetmic.2012.05.014; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Chong Y, 2011, INFECT GENET EVOL, V11, P1499, DOI 10.1016/j.meegid.2011.06.001; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dierikx CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079005; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Ewers C GM, 2011, EXTENDED SPECTRUM BE; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Fang H, 2008, J CLIN MICROBIOL, V46, P707, DOI 10.1128/JCM.01943-07; Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175; Guenther S, 2010, VET MICROBIOL, V144, P219, DOI 10.1016/j.vetmic.2009.12.016; Guenther S, 2010, J ANTIMICROB CHEMOTH, V65, P582, DOI 10.1093/jac/dkp496; Hammerum AM, 2014, J ANTIMICROB CHEMOTH; Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; Laube H, 2014, VET MICROBIOL, V172, P519, DOI 10.1016/j.vetmic.2014.06.008; Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13; Leistner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074323; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Literak I, 2010, J APPL MICROBIOL, V108, P1702, DOI 10.1111/j.1365-2672.2009.04572.x; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Marathe NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077310; Mendonca N, 2009, INT J ANTIMICROB AG, V34, P29, DOI 10.1016/j.ijantimicag.2008.11.014; Moodley A, 2009, ANTIMICROB AGENTS CH, V53, P1709, DOI 10.1128/AAC.01014-08; Nemoy LL, 2005, J CLIN MICROBIOL, V43, P1776, DOI 10.1128/JCM.43.4.1776-1781.2005; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pena C, 2006, CLIN MICROBIOL INFEC, V12, P279, DOI 10.1111/j.1469-0691.2005.01358.x; Persoons D, 2011, MICROB DRUG RESIST, V17, P513, DOI 10.1089/mdr.2011.0048; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Schauss T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119791; Schmid A, 2013, APPL ENVIRON MICROB, V79, P3027, DOI 10.1128/AEM.00204-13; Schwaber MJ, 2005, ANTIMICROB AGENTS CH, V49, P2137, DOI 10.1128/AAC.49.5.2137-2139.2005; Teshager T, 2000, ANTIMICROB AGENTS CH, V44, P3483, DOI 10.1128/AAC.44.12.3483-3484.2000; Timofte D, 2014, ANTIMICROB AGENTS CH, V58, P789, DOI 10.1128/AAC.00752-13; Valentin L., 2014, INT J MED MICROBIOL; Valenza G, 2014, ANTIMICROB AGENTS CH, V58, P1228, DOI 10.1128/AAC.01993-13; Wallensten Anders, 2011, Infect Ecol Epidemiol, V1, DOI 10.3402/iee.v1i0.7030; Wang Y, 2012, VET MICROBIOL, V159, P53, DOI 10.1016/j.vetmic.2012.03.009; Wieler LH, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-17; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075392	45	107	109	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143326	10.1371/journal.pone.0143326	http://dx.doi.org/10.1371/journal.pone.0143326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606146	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300056
J	Hadjichristodoulou, C; Pournaras, S; Mavrouli, M; Marka, A; Tserkezou, P; Baka, A; Billinis, C; Katsioulis, A; Psaroulaki, A; Papa, A; Papadopoulos, N; Mamuris, Z; Tsakris, A; Kremastinou, J				Hadjichristodoulou, Christos; Pournaras, Spyros; Mavrouli, Maria; Marka, Andriani; Tserkezou, Persefoni; Baka, Agoritsa; Billinis, Charalambos; Katsioulis, Antonios; Psaroulaki, Anna; Papa, Anna; Papadopoulos, Nikos; Mamuris, Zissis; Tsakris, Athanasios; Kremastinou, Jenny		MALWEST Project	West Nile Virus Seroprevalence in the Greek Population in 2013: A Nationwide Cross-Sectional Survey	PLOS ONE			English	Article							INFECTION; EPIDEMIC; ROMANIA; ENCEPHALITIS; RISK	Cases of West Nile Virus (WNV) disease were recorded for three consecutive years in Greece following the year 2010 outbreak. A cross-sectional serologic survey was conducted to estimate the WNV seroprevalence and assess the ratio of infection to neuroinvasive disease. A stratified left-over sampling methodology was used including age and residence strata. A total of 3,962 serum samples was collected and tested for WNV Immunoglobulin G (IgG) antibodies by Enzyme-Linked Immunosorbent Assay (ELISA). All positive samples were further tested by Plaque Reduction Neutralization Test (PRNT) and WNV Immunoglobulin M (IgM) antibodies. WNV IgG antibodies were detected in 82 samples and 61 were also positive in PRNT representing a weighted seroprevalence of 2.1% (95% C.I.: 1.7-2.6) and 1.5% (95% C.I.: 1.2-2.0), respectively. Multivariable analysis showed that seroprevalence was associated with age and residence. The overall ratio of neuroinvasive disease to infected persons was estimated at 1: 376 (95% C.I.: 1: 421-1: 338), while the elderly people had the highest ratio. This nationwide study provided valuable data regarding the epidemiology of WNV in Greece based on the fact that elderly people have higher risk of being both infected and having severe disease.	[Hadjichristodoulou, Christos; Marka, Andriani; Tserkezou, Persefoni; Katsioulis, Antonios] Univ Thessaly, Fac Med, Dept Hyg & Epidemiol, Larisa, Greece; [Pournaras, Spyros; Mavrouli, Maria; Tsakris, Athanasios] Univ Athens, Fac Med, Dept Microbiol, Athens 11528, Greece; [Baka, Agoritsa; Kremastinou, Jenny] Hellen Ctr Dis Control & Prevent KEELPNO, Athens, Greece; [Billinis, Charalambos] Univ Thessaly, Fac Vet Med, Lab Microbiol & Parasitol, Kardhitsa, Greece; [Psaroulaki, Anna] Univ Crete, Sch Med, Lab Bacteriol Parasitol Zoonoses & Geogrph Med, Iraklion, Greece; [Papa, Anna] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, Natl Reference Ctr Arboviruses, GR-54006 Thessaloniki, Greece; [Papadopoulos, Nikos] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Sch Agr Sci, Lab Entomol & Agr Zool, Volos, Greece; [Mamuris, Zissis] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece	University of Thessaly; National & Kapodistrian University of Athens; University of Thessaly; University of Crete; Aristotle University of Thessaloniki; University of Thessaly; University of Thessaly	Hadjichristodoulou, C (corresponding author), Univ Thessaly, Fac Med, Dept Hyg & Epidemiol, Larisa, Greece.	xhatzi@med.uth.gr	Papadopoulos, Nikos/AAJ-1721-2020; TSIODRAS, SOTIRIOS/AAD-8273-2019; Dovas, Chrysostomos/AAF-9663-2019; Mamuris, Zissis/AAN-2576-2021	Papadopoulos, Nikos/0000-0003-2480-8189; TSIODRAS, SOTIRIOS/0000-0002-0463-4321; Dovas, Chrysostomos/0000-0003-2947-1765; Kremastinou-Kourea, Konstantina/0000-0002-0098-181X; Hadjichristodoulou, Christos/0000-0002-4769-8376; Photis, Yorgos/0000-0003-2382-5526	European Union-European Regional Development Fund	European Union-European Regional Development Fund	The study was conducted in the context of the integrated surveillance and control program for West Nile Virus and malaria in Greece (MALWEST Project) which is implemented through the Operational Program entitled "Human Resources Development of National Strategic Reference Framework" (NSRF) 2007-2013. The program is co-funded by Greece and the European Union-European Regional Development Fund.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Antoniadis A., 1990, Archives of Virology, Supplementum, P277; Barzon L, 2009, EUROSURVEILLANCE, V14, P24; Bernabeu-Wittel M, 2007, ENFERM INFEC MICR CL, V25, P561, DOI 10.1157/13111181; Bunning ML, 2002, EMERG INFECT DIS, V8, P380; Carson PJ, 2012, EMERG INFECT DIS, V18, P684, DOI 10.3201/eid1804.111313; Center for Disease Control and Prevention (CDC), W NIL VIR SURV CONTR; Chaintoutis SC, 2014, COMP IMMUNOL MICROB, V37, P131, DOI 10.1016/j.cimid.2014.01.004; Charrel RN, 2001, TRANSFUSION, V41, P1320, DOI 10.1046/j.1537-2995.2001.41101320.x; Chowers MY, 2005, EUR J CLIN MICROBIOL, V24, P851, DOI 10.1007/s10096-005-0061-3; Han LL, 1999, J INFECT DIS, V179, P230, DOI 10.1086/314566; HCDCP, 2011, ANN EP REP W NIL VIR; HCDCP, 2012, ANN EP REP W NIL VIR; Hellenic Centre for Disease Control and Prevention (HCDCP), 2010, W NIL VIR REV EP REP; Ladbury GAF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080432; Marka A, 2013, INT J ENV RES PUB HE, V10, P6534, DOI 10.3390/ijerph10126534; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Nardone A, 2004, EURO SURVEILL, V9; PEZZOTTI P, 2009, EURO SURVEILL, V16; Pierro A, 2013, CLIN MICROBIOL INFEC, V19, pE451, DOI 10.1111/1469-0691.12241; Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712; Sirbu A, 2011, EUROSURVEILLANCE, V16, P2; Soliman Atef, 2010, J Infect Public Health, V3, P54, DOI 10.1016/j.jiph.2009.11.002; Tezcan S, 2014, MIKROBIYOL BUL, V48, P606, DOI 10.5578/mb.8301; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Uluer Biceroglu S, 2015, TURK J MED SCI, V45, P84, DOI 10.3906/sag-1312-50; Valiakos G, 2011, EUROSURVEILLANCE, V16, P5; Valiakos G, 2012, EUR J WILDLIFE RES, V58, P749, DOI 10.1007/s10344-011-0603-1	29	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143803	10.1371/journal.pone.0143803	http://dx.doi.org/10.1371/journal.pone.0143803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605539	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300112
J	Makshakov, G; Nazarov, V; Kochetova, O; Surkova, E; Lapin, S; Evdoshenko, E				Makshakov, Gleb; Nazarov, Vladimir; Kochetova, Olga; Surkova, Elena; Lapin, Sergey; Evdoshenko, Evgeniy			Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis	PLOS ONE			English	Article							FREE KAPPA-CHAINS; OLIGOCLONAL IGG; CSF	Background and objective In this study, we evaluated the diagnostic and prognostic significance of cerebrospinal fluid free light chains (CSF FLC) at the time of clinically isolated syndrome (CIS). Methods We compared FLC-parameters at the moment of CIS in patients with conversion to multiple sclerosis (MS) after 2 years (CIS-MS), patients who remained stable both clinically and radiologically after 2 years (CIS-nonMS), patients with non-inflammatory neurologic diseases (NIND) as a comparison group and patients with other inflammatory neurologic diseases (IND) with intrathecal oligoclonal bands (OCB) synthesis. ROC-analysis was conducted to define FLC-assay characteristics and cut-off values. We also compared FLC-concentrations in CIS patients to determine their OCB-status. A correlation analysis was performed between FLC-concentrations and the expanded disability scale score (EDSS), annualized relapse rate (ARR) and MRI-activity (i.e., number of new and gadolinium-enhancing (Gd+) lesions) in patients. Results The levels of kappa-FLC (k-FLCCSF) and lambda-FLC (lambda-FLCCSF) as well as kappa- and lambda-quotients (Q-k and Q-lambda) were elevated in CIS-MS compared to the CIS-nonMS and NIND groups. These levels did not differ significantly when compared with the IND group. We identified several patients with high k-FLCCSF and lambda-FLCCSF in OCB-negative CIS and IND groups. The level of k-FLCCSF production was significantly higher in OCB-positive patients in the CIS-MS group compared to the CIS-nonMS group. The concentrations of k-FLCCSF and Q-k in the CIS-MS group showed significant correlation with the level of EDSS after 2 years (k-FLC: r = 0.4477, p = 0.0016; Q-k: r = 0.4621, p = 0.0016). lambda-FLCCSF and Q-lambda inversely correlated with the number of Gd+ lesions (CSF lambda-FLC: r = -0.3698, p = 0.0223; Q-lambda: r = -0.4527, p = 0.0056). Conclusion The concentration of CSF FLC predicts conversion to MS within 2 years following CIS. OCB-positive patients with an early conversion have a higher concentration of CSF-FLC. We have also shown a prognostic significance of k-FLCCSF for future EDSS-progression.	[Makshakov, Gleb; Kochetova, Olga; Evdoshenko, Evgeniy] Municipal Clin Hosp 31, City Ctr Multiple Sclerosis & Autoimmune Dis, St Petersburg, Russia; [Nazarov, Vladimir; Surkova, Elena; Lapin, Sergey] First Pavlov State St Petersburg Med Univ, Ctr Mol Med, Lab Autoimmune Diagnost, St Petersburg, Russia		Evdoshenko, E (corresponding author), Municipal Clin Hosp 31, City Ctr Multiple Sclerosis & Autoimmune Dis, St Petersburg, Russia.	e.evdoshenko@gmail.com	nazarov, vladimir/AAL-3359-2020; Kochetova, Olga/A-2035-2014	Kochetova, Olga/0000-0002-2944-4428; Surkova, Elena/0000-0001-5191-0221; Makshakov, Gleb/0000-0001-6831-0441; Kochetova, Olga/0000-0003-2740-1288				Awad A, 2010, J NEUROIMMUNOL, V219, P1, DOI 10.1016/j.jneuroim.2009.09.002; Dobson R, 2013, J NEUROL NEUROSUR PS, V84, P909, DOI 10.1136/jnnp-2012-304695; Duranti F, 2013, J NEUROIMMUNOL, V263, P116, DOI 10.1016/j.jneuroim.2013.07.006; Goffette S, 2004, J NEUROL NEUROSUR PS, V75, P308, DOI 10.1136/jnnp.2003.010710; Hassan-Smith G, 2014, J NEUROIMMUNOL, V276, P175, DOI 10.1016/j.jneuroim.2014.08.003; Kuhle J, 2015, MULT SCLER J, V4, P1; Nazarov V, 2014, MULT SCLER S, V20, P67; Polman CH, 2011, JS ANN NEUROL, V69, P92; Presslauer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089945; Presslauer S, 2008, J NEUROL, V255, P1508, DOI 10.1007/s00415-008-0954-z; Rinker John R 2nd, 2006, Neurology, V67, P1288, DOI 10.1212/01.wnl.0000238107.31364.21; Rudick R A, 1995, Mult Scler, V1, P150; Rudick RA, 1999, J NEUROIMMUNOL, V93, P8, DOI 10.1016/S0165-5728(98)00174-X; Senel M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088680; Villar LM, 2012, CLIN CHIM ACTA, V413, P1813, DOI 10.1016/j.cca.2012.07.007; Zeman D, 2015, BIOMED PAP, V159, P104, DOI 10.5507/bp.2014.058	16	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143375	10.1371/journal.pone.0143375	http://dx.doi.org/10.1371/journal.pone.0143375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606531	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300059
J	Mendez, MF; Joshi, A; Daianu, M; Jimenez, E; Thompson, P				Mendez, Mario F.; Joshi, Aditi; Daianu, Madelaine; Jimenez, Elvira; Thompson, Paul			White Matter Changes Associated with Resting Sympathetic Tone in Frontotemporal Dementia vs. Alzheimer's Disease	PLOS ONE			English	Article							SKIN-CONDUCTANCE RESPONSES; HUMAN CEREBRAL-CORTEX; BEHAVIORAL VARIANT; LOBAR DEGENERATION; INTEROCEPTIVE AWARENESS; PHYSIOLOGICAL CONDITION; AUTONOMIC AROUSAL; WATER DIFFUSION; APATHY; BRAIN	Background Resting sympathetic tone, a measure of physiological arousal, is decreased in patients with apathy and inertia, such as those with behavioral variant frontotemporal dementia (bvFTD) and other frontally-predominant disorders. Objective To identify the neuroanatomical correlates of skin conductance levels (SCLs), an index of resting sympathetic tone and apathy, among patients with bvFTD, where SCLs is decreased, compared to those with Alzheimer's disease (AD), where it is not. Methods This study analyzed bvFTD (n = 14) patients and a comparison group with early-onset AD (n = 19). We compared their resting SCLs with gray matter and white matter regions of interest and white matter measures of fiber integrity on magnetic resonance imaging and diffusion tensor imaging. Results As expected, bvFTD patients, compared to AD patients, had lower SCLs, which correlated with an apathy measure, and more gray matter loss and abnormalities of fiber integrity (fractional anisotropy and mean diffusivity) in frontal-anterior temporal regions. After controlling for group membership, the SCLs were significantly correlated with white matter volumes in the cingulum and inferior parietal region in the right hemisphere. Conclusion Among dementia patients, SCLs, and resting sympathetic tone, may correlate with quantity of white matter, rather than with gray matter or with white matter fiber integrity. Loss of white matter volumes, especially involving a right frontoparietal network, may reflect chronic loss of cortical axons that mediate frontal control of resting sympathetic tone, changes that could contribute to the apathy and inertia of bvFTD and related disorders.	[Mendez, Mario F.; Joshi, Aditi; Daianu, Madelaine; Jimenez, Elvira] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Mendez, Mario F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Thompson, Paul] Univ So Calif, Inst Neuroimaging & Informat, Imaging Genet Ctr, Los Angeles, CA 90033 USA; [Thompson, Paul] Univ So Calif, Dept Neurol, Los Angeles, CA 90033 USA; [Thompson, Paul] Univ So Calif, Dept Psychiat, Los Angeles, CA 90033 USA; [Thompson, Paul] Univ So Calif, Dept Radiol, Los Angeles, CA 90033 USA; [Thompson, Paul] Univ So Calif, Dept Radiol, Los Angeles, CA 90033 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Mendez, MF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	mmendez@ucla.edu	Thompson, Paul M/C-4194-2018; Joshi, Aditi/O-6979-2015	Thompson, Paul M/0000-0002-4720-8867; 	National Institutes of Health (NIH) [R01 AG034499-05];  [R01 AG040060,];  [R01 EB008432];  [R01 MH097268]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034499, R01AG040060, RF1AG041915] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funding from National Institutes of Health (NIH) grant R01 AG034499-05, and M.D. is also supported by R01 AG040060, R01 EB008432, and R01 MH097268.; This work was supported by funding from NIH grant R01 AG034499-05 and M.D. is also supported by R01 AG040060, R01 EB008432, and R01 MH097268.	ABRAMS R, 1978, AM J PSYCHIAT, V135, P226; Avants BB, 2010, NEUROIMAGE, V50, P1004, DOI 10.1016/j.neuroimage.2010.01.041; Barry RJ, 2004, CLIN NEUROPHYSIOL, V115, P402, DOI 10.1016/S1388-2457(03)00343-2; BARRY RJ, 1993, INT J PSYCHOPHYSIOL, V15, P39, DOI 10.1016/0167-8760(93)90093-5; Borroni B, 2007, ARCH NEUROL-CHICAGO, V64, P246, DOI 10.1001/archneur.64.2.246; Chow TW, 2009, ARCH NEUROL-CHICAGO, V66, P888, DOI 10.1001/archneurol.2009.92; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Critchley HD, 2000, J NEUROSCI, V20, P3033; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; Deco G, 2011, NEUROSCIENTIST, V17, P107, DOI 10.1177/1073858409354384; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fan J, 2012, J NEUROSCI, V32, P11176, DOI 10.1523/JNEUROSCI.1172-12.2012; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRITH CD, 1983, BIOL PSYCHOL, V17, P27, DOI 10.1016/0301-0511(83)90064-9; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Hilz MJ, 2001, ANN NEUROL, V49, P575, DOI 10.1002/ana.1006; Hoefer M, 2008, BRAIN, V131, P1646, DOI 10.1093/brain/awn082; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Hyam JA, 2012, NAT REV NEUROL, V8, P391, DOI 10.1038/nrneurol.2012.100; Joshi A, 2014, J NEUROPSYCH CLIN N, V26, P227, DOI 10.1176/appi.neuropsych.12110332; Kimmerly DS, 2005, J PHYSIOL-LONDON, V569, P331, DOI 10.1113/jphysiol.2005.091637; Kumfor F, 2012, NEUROPSYCHOL REV, V22, P280, DOI 10.1007/s11065-012-9201-6; Lee GJ, 2014, J ALZHEIMERS DIS, V41, P793, DOI 10.3233/JAD-132219; Leow AD, 2007, IEEE T MED IMAGING, V26, P822, DOI 10.1109/TMI.2007.892646; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Linnman C, 2012, BIOL PSYCHOL, V89, P450, DOI 10.1016/j.biopsycho.2011.12.012; MALMO R B, 1959, Rass Giuliana Med, VNo 11, P86; Marin, 1996, Semin Clin Neuropsychiatry, V1, P304; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Massimo L, 2009, DEMENT GERIATR COGN, V27, P96, DOI 10.1159/000194658; Mathersul D, 2013, INT J PSYCHOPHYSIOL, V89, P475, DOI 10.1016/j.ijpsycho.2013.04.014; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mendez MF, 2008, J NEUROPSYCH CLIN N, V20, P130, DOI 10.1176/appi.neuropsych.20.2.130; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Naqvi NH, 2006, INT J PSYCHOPHYSIOL, V61, P77, DOI 10.1016/j.ijpsycho.2005.10.018; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; Peters F, 2006, DEMENT GERIATR COGN, V21, P373, DOI 10.1159/000091898; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pollatos O, 2007, HUM BRAIN MAPP, V28, P9, DOI 10.1002/hbm.20258; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Powers JP, 2014, COGN BEHAV NEUROL, V27, P206, DOI 10.1097/WNN.0000000000000044; Quaranta Davide, 2012, Curr Gerontol Geriatr Res, V2012, P719250, DOI 10.1155/2012/719250; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Santillo AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066932; Seeley WW, 2012, NEUROSCIENTIST, V18, P373, DOI 10.1177/1073858411410354; Srikanth S, 2005, J NEUROL SCI, V236, P43, DOI 10.1016/j.jns.2005.04.014; Sturm VE, 2006, BRAIN, V129, P2508, DOI 10.1093/brain/awl145; TRANEL D, 1994, PSYCHOPHYSIOLOGY, V31, P427, DOI 10.1111/j.1469-8986.1994.tb01046.x; VaezMousavi SM, 2007, ACTA NEUROBIOL EXP, V67, P461; Westerhaus MJ, 2001, BRAIN RES, V903, P117, DOI 10.1016/S0006-8993(01)02453-2; Whitwell JL, 2010, NEUROLOGY, V74, P1279, DOI 10.1212/WNL.0b013e3181d9edde; Zamboni G, 2008, NEUROLOGY, V71, P736, DOI 10.1212/01.wnl.0000324920.96835.95; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408; Zhang S, 2013, SOC COGN AFFECT NEUR	63	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							0142445	10.1371/journal.pone.0142445	http://dx.doi.org/10.1371/journal.pone.0142445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606247	Green Published, Green Submitted, gold			2022-12-26	WOS:000365865300017
J	Nunes, MA; Schowe, NM; Monteiro-Silva, KC; Baraldi-Tornisielo, T; Souza, SIG; Balthazar, J; Albuquerque, MS; Caetano, AL; Viel, TA; Buck, HS				Nunes, Marielza Andrade; Schoewe, Natalia Mendes; Monteiro-Silva, Karla Cristina; Baraldi-Tornisielo, Ticiana; Goncalves Souza, Suzzanna Ingryd; Balthazar, Janaina; Albuquerque, Marilia Silva; Caetano, Ariadiny Lima; Viel, Tania Araujo; Buck, Hudson Sousa			Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							CEREBRAL CORTICAL-NEURONS; AMYLOID PRECURSOR PROTEIN; ANXIETY-LIKE BEHAVIOR; SPATIAL MEMORY; EXPRESSION; MICE; INCREASES; RECEPTOR; CORTEX; RAT	The use of lithium is well established in bipolar disorders and the benefits are being demonstrated in neurodegenerative disorders. Recently, our group showed that treatment with microdose lithium stabilized the cognitive deficits observed in Alzheimer's disease (AD) patients. In order to verify the lithium microdose potential in preventing the disease development, the aim of this work was to verify the effects of chronic treatment with microdose lithium given before and after the appearance of symptoms in a mouse model of a disease similar to AD. Transgenic mice (Cg-Tg(PDGFB-APPSwInd) 20Lms/2J) and their non-transgenic litter mate genetic controls were treated with lithium carbonate (1.2 mg/Kg/day in drinking water) for 16 or 8 months starting at two and ten months of age, respectively. Similar groups were treated with water. At the end of treatments, both lithium treated transgenic groups and non-transgenic mice showed no memory disruption, different from what was observed in the water treated transgenic group. Transgenic mice treated with lithium since two months of age showed decreased number of senile plaques, no neuronal loss in cortex and hippocampus and increased BDNF density in cortex, when compared to non-treated transgenic mice. It is suitable to conclude that these data support the use of microdose lithium in the prevention and treatment of Alzheimer's disease, once the neurohistopathological characteristics of the disease were modified and the memory of transgenic animals was maintained.	[Nunes, Marielza Andrade; Monteiro-Silva, Karla Cristina; Baraldi-Tornisielo, Ticiana; Goncalves Souza, Suzzanna Ingryd; Albuquerque, Marilia Silva; Caetano, Ariadiny Lima; Buck, Hudson Sousa] Santa Casa de Sao Paulo Sch Med Sci, Dept Physiol Sci, BR-01221020 Sao Paulo, SP, Brazil; [Schoewe, Natalia Mendes; Balthazar, Janaina; Viel, Tania Araujo] Univ Sao Paulo, Inst Biomed Sci, Graduat Course Pharmacol, BR-05508900 Sao Paulo, Brazil; [Viel, Tania Araujo] Univ Sao Paulo, Sch Arts Sci & Humanities, BR-03828080 Sao Paulo, SP, Brazil; [Nunes, Marielza Andrade; Schoewe, Natalia Mendes; Baraldi-Tornisielo, Ticiana; Albuquerque, Marilia Silva; Caetano, Ariadiny Lima; Viel, Tania Araujo; Buck, Hudson Sousa] Res Grp Neuropharmacol Aging ReGNA, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Buck, HS (corresponding author), Santa Casa de Sao Paulo Sch Med Sci, Dept Physiol Sci, R Dr Cesario Motta Jr 61,11 Andar, BR-01221020 Sao Paulo, SP, Brazil.	hudson.buck@fcmsantacasasp.edu.br	Buck, Hudson/E-7664-2013; Caetano, Ariadiny Lima/B-4225-2013; Viel, Tania/K-2909-2016; Caetano, Ariadiny L/H-9375-2016	Buck, Hudson/0000-0002-1867-2441; Viel, Tania/0000-0002-4015-785X; CAETANO, ARIADINY de LIMA/0000-0002-3619-6485	FAP-Santa Casa; Fundacao de Amparo a Pesquisa no Estado de Sao Paulo [FAPESP 2012/12917-3]; CAPES-PROSUP; PIBIC/CNPq; CAPES; FAPESP [2013/19999-8]; CNPq [303283/2014-9]; Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP) [2012/12917-3]; Schowe	FAP-Santa Casa; Fundacao de Amparo a Pesquisa no Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES-PROSUP(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PIBIC/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Schowe	This work was supported by grants from FAP-Santa Casa/2011, Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP 2012/12917-3). Nunes, M.A, Baraldi-Tornisielo, T., were fellowship recipients from CAPES-PROSUP; Monteiro-Silva, K. and Sousa, S.I.G. were fellowship recipients from PIBIC/CNPq; Balthazar, J. and Albuquerque, M.S. were fellowship recipients from CAPES; and Schowe, N.M. was fellowship recipient from FAPESP (2013/19999-8). Buck, H.S. is a fellowship recipient from CNPq (303283/2014-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors want to thank Dr. Wagner Montor for English review. This work was supported by grants from FAP-Santa Casa/2011, Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP 2012/12917-3). Nunes, M.A, Baraldi-Tornisielo, T., were fellowship recipients from CAPES-PROSUP; Monteiro-Silva, K. and Sousa, S.I.G. were fellowship recipients from PIBIC/CNPq; Balthazar, J. and Albuquerque, M.S. were fellowship recipients from CAPES and Schowe, N.M. was fellowship recipient from FAPESP (2013/19999-8). Buck HS is a fellowship recipient from CNPq (303283/2014-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Amaral FA, 2010, NEUROPEPTIDES, V44, P93, DOI 10.1016/j.npep.2009.10.006; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Asplund CL, 2010, NAT NEUROSCI, V13, P507, DOI 10.1038/nn.2509; Baraldi T, 2013, EXP GERONTOL, V48, P831, DOI 10.1016/j.exger.2013.05.055; Barnes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003248; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Boncristiano S, 2005, NEUROBIOL AGING, V26, P607, DOI 10.1016/j.neurobiolaging.2004.06.010; BRAAK H, 1993, HIPPOCAMPUS, V3, P239; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Burnouf S, 2012, CURR ALZHEIMER RES, V9, P406, DOI 10.2174/156720512800492468; Caetano AL, 2015, NEUROPEPTIDES, V53, P51, DOI 10.1016/j.npep.2015.09.001; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; Couch BA, 2013, J COMP NEUROL, V521, P1395, DOI 10.1002/cne.23239; de Oliveira JL, 2010, REV ASSOC MED BRAS, V56, P600, DOI 10.1590/S0104-42302010000500025; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Espana J, 2010, BIOL PSYCHIAT, V67, P513, DOI 10.1016/j.biopsych.2009.06.015; Ferreira FR, 2009, BIOSCI J, V25, P131; Ferretti L, 2001, J GERIATR PSYCH NEUR, V14, P52, DOI 10.1177/089198870101400111; Fiorentini A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014382; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; Forlenza OV, 2014, ACS CHEM NEUROSCI, V5, P443, DOI 10.1021/cn5000309; Forlenza OV, 2014, ACS CHEM NEUROSCI, V5, P484, DOI 10.1021/cn5000315; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fukumoto T, 2001, PSYCHOPHARMACOLOGY, V158, P100, DOI 10.1007/s002130100871; Gerlai R, 2002, BEHAV BRAIN RES, V136, P503, DOI 10.1016/S0166-4328(02)00198-5; Gil-Bea FJ, 2007, BEHAV NEUROSCI, V121, P340, DOI 10.1037/0735-7044.121.2.340; Gilbert PE, 1998, J NEUROSCI, V18, P804; Goldsbury C, 2008, AGING CELL, V7, P771, DOI 10.1111/j.1474-9726.2008.00423.x; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; Hiroi T, 2005, PHARMACOGENOMICS J, V5, P102, DOI 10.1038/sj.tpj.6500296; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jope R. S., 2006, GLYCOGEN SYNTHASE KI, P223; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Khairova R, 2012, MOL MED REP, V5, P680, DOI 10.3892/mmr.2011.732; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kubie JL, 1999, PSYCHOBIOLOGY, V27, P313; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Liechti FD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113607; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Ly S, 2013, J BIOL CHEM, V288, P11628, DOI 10.1074/jbc.M112.411900; Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Nunes MA, 2013, CURR ALZHEIMER RES, V10, P104; OKUSA MD, 1994, AM J MED, V97, P383, DOI 10.1016/0002-9343(94)90308-5; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pilly PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060599; Pompl PN, 1999, J NEUROSCI METH, V87, P87, DOI 10.1016/S0165-0270(98)00169-1; Raji CA, 2009, NEUROLOGY, V73, P1899, DOI 10.1212/WNL.0b013e3181c3f293; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Rouaud JL, 1993, PSYCHOL MED, V25, P561; SALINOVICH O, 1986, ANAL BIOCHEM, V156, P341, DOI 10.1016/0003-2697(86)90263-0; Sarkar S, 2006, AUTOPHAGY, V2, P132, DOI 10.4161/auto.2387; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Small SA, 2000, MICROSC RES TECHNIQ, V51, P101, DOI 10.1002/1097-0029(20001001)51:1<101::AID-JEMT11>3.0.CO;2-H; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Tsetsenis T, 2007, NAT NEUROSCI, V10, P896, DOI 10.1038/nn1919; Viel TA, 2008, NEUROBIOL AGING, V29, P1805, DOI 10.1016/j.neurobiolaging.2007.04.019; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WOOD AJ, 1986, NEUROPHARMACOLOGY, V25, P1285, DOI 10.1016/0028-3908(86)90149-8; Wright AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059586; Wu D, 2010, NEUROSCI LETT, V485, P157, DOI 10.1016/j.neulet.2010.08.086; Yan XB, 2007, NEUROPHARMACOLOGY, V53, P487, DOI 10.1016/j.neuropharm.2007.06.020; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301	88	39	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0142267	10.1371/journal.pone.0142267	http://dx.doi.org/10.1371/journal.pone.0142267			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605788	gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300013
J	Oladimeji, KE; Tsoka-Gwegweni, JM; Igbodekwe, FC; Twomey, M; Akolo, C; Balarabe, HS; Atilola, O; Jegede, O; Oladimeji, O				Oladimeji, Kelechi Elizabeth; Tsoka-Gwegweni, Joyce M.; Igbodekwe, Franklin C.; Twomey, Mary; Akolo, Christopher; Balarabe, Hadiza Sabuwa; Atilola, Olayinka; Jegede, Oluwole; Oladimeji, Olanrewaju			Knowledge and Beliefs of Breast Self-Examination and Breast Cancer among Market Women in Ibadan, South West, Nigeria	PLOS ONE			English	Article							BENIN-CITY; ATTITUDE	Background In most resource constrained settings like Nigeria, breast self-examination self-breast examination (BSE) is culturally acceptable, religious friendly and attracts no cost. Women's knowledge and beliefs about breast cancer and its management may contribute significantly to medical help-seeking behaviours. This study aimed to assess knowledge and beliefs of BSE among market women. Methods A descriptive cross-sectional study was conducted among 603 market women in Ibadan, Nigeria. Data was collected using semi-structured interviews and analyzed using descriptive and analytic statistical methods. Results The mean age of the respondents was 34.6 +/- 9.3 years with 40% of the women aged between 30-39years. The proportion of married women was 339 (68.5%) with 425 (70.8%) respondents reporting that they do not know how to perform BSE. However, 372 (61.7%) women strongly agreed that BSE is a method of screening for breast cancer. Highest proportion 219 (36.3%) reported that the best time for a woman to perform BSE was 'anytime'. Most of the respondents believed breast cancer is a dangerous disease that kills fast and requires a lot of money for treatment. Conclusion More efforts are needed in creating awareness and advocacy campaigns in the grassroots in order to detect early breast cancer and enhance prevention strategies that would reduce the burden of breast cancer in Nigeria.	[Oladimeji, Kelechi Elizabeth; Tsoka-Gwegweni, Joyce M.; Oladimeji, Olanrewaju] Univ KwaZulu Natal, Coll Hlth Sci, Discipline Publ Hlth Med, Durban, South Africa; [Oladimeji, Kelechi Elizabeth; Igbodekwe, Franklin C.; Atilola, Olayinka; Oladimeji, Olanrewaju] Ctr Community Healthcare Res & Dev, Abuja, Nigeria; [Twomey, Mary] Open Univ, Hlth & Social Care Dept, London MK7 6BJ, England; [Akolo, Christopher] Populat Serv Int, Washington, DC 20036 USA; [Balarabe, Hadiza Sabuwa] Fed Capital Terr, Dept Publ Hlth & Human Serv, Abuja, Nigeria; [Atilola, Olayinka] Lagos State Univ, Dept Psychiat, Lagos, Nigeria; [Jegede, Oluwole] George Washington Univ, Milken Inst Publ Hlth, Washington, DC 20052 USA	University of Kwazulu Natal; Open University - UK; Lagos State University; George Washington University	Oladimeji, KE (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Discipline Publ Hlth Med, Howard Coll Campus, Durban, South Africa.	oladimejikelechi@yahoo.com	Jegede, Oluwole/AAB-6172-2021; Oladimeji, Olanrewaju/AAE-9633-2019; Oladimeji, Kelechi Elizabeth/AAF-2155-2019	Jegede, Oluwole/0000-0001-6772-7149; Oladimeji, Olanrewaju/0000-0002-5356-901X; Oladimeji, Kelechi Elizabeth/0000-0002-0246-5595; Atilola, Olayinka/0000-0001-9835-6432	Center for Community Health Care, Research and Development, Nigeria (CCHARD)	Center for Community Health Care, Research and Development, Nigeria (CCHARD)	This study was supported by Center for Community Health Care, Research and Development, Nigeria (CCHARD), www.cchrad.org. Ms. Kelechi Elizabeth Oladimeji is currently a Public Health doctorate Scholar in College of Health Science, Howard College Campus, University of KwaZulu-Natal, Durban, South Africa. Kelechi is also a co-lead at the Center for Community Health Care, Research and Development, Nigeria (cchrad.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesunkanmi ARK, 2006, BREAST, V15, P399, DOI 10.1016/j.breast.2005.06.008; Agwu UM, 2007, EMJ, V6, P44; Akhigbe AO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-203; American Cancer Society, 2014, BREAST CANC PREV EAR; [Anonymous], 2006, NATL POPULATION COMM; Anyanwu SNC, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-17; Azubuike SO, 2013, ANN MED HEALTH SCI R, V3, P155, DOI 10.4103/2141-9248.113653; Balogun MO, 2005, ANN IBADAN POSTGRADU, V3, P52; Banjo AAF, 2004, INT WORKSH NEW TREND; Banning B, 2013, J CANC THERAPY RES, V1; Bellgam HI., 2012, NIGERIAN HLTH J, V12, P16; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Ertem G., 2009, Indian Journal of Cancer, V46, P208, DOI 10.4103/0019-509X.52955; Faronbi JO, 2012, OPEN J NURS, V02, P111, DOI DOI 10.4236/OJN.2012.22017; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Gueye S M K, 2009, Rev Med Brux, V30, P77; Gwarzo UMD, 2009, ANN AFR MED, V8, P55, DOI 10.4103/1596-3519.55766; Hadi Muhammad A., 2010, Pharmacy Pract (Granada), V8, P29; Harirchi I, 2011, ANN ONCOL, V22, P93, DOI 10.1093/annonc/mdq303; Ibrahim NA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-76; Jebbin N J, 2004, Niger J Med, V13, P166; Jedy-Agba E, 2012, CANCER EPIDEMIOL, V36, pE271, DOI 10.1016/j.canep.2012.04.007; Kayode F, 2005, EUROPEAN J SCI RES, V10, P42; Okobia Michael N, 2006, World J Surg Oncol, V4, P11, DOI 10.1186/1477-7819-4-11; Oluwatosin OA, 2010, CANCER EPIDEMIOL, V34, P425, DOI 10.1016/j.canep.2010.04.005; Oluwole OC, 2008, SUDAN J MED SCI, V3, P99; Omotara B, 2012, J COMMUNITY MED HLTH, V2, P148, DOI DOI 10.4172/2161-0711.1000148; Osime OC, 2008, ANN AFR MED, V7, P192, DOI 10.4103/1596-3519.55654; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Ramasamy, 2013, AM J PUBLIC HLTH RES, V1, P135, DOI [10.12691/ajphr-1-6-2, DOI 10.12691/AJPHR-1-6-2]; Sadjadi A, 2009, East Mediterr Health J, V15, P1426; Sambanje Martha Nyanungo, 2012, Pan Afr Med J, V11, P70; Secginli S, 2006, INT J NURS STUD, V43, P161, DOI 10.1016/j.ijnurstu.2005.02.004; Soyer MT, 2007, J CLIN NURS, V16, P707, DOI 10.1111/j.1365-2702.2006.01644.x; WHO, 2013, BREAST CANC PREV CON; Wilson CM, 2004, INT J GYNECOL CANCER, V14, P1, DOI 10.1111/j.1048-891x.2004.14178.x	40	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0140904	10.1371/journal.pone.0140904	http://dx.doi.org/10.1371/journal.pone.0140904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606137	gold, Green Submitted, Green Published			2022-12-26	WOS:000365865300006
J	Prescott, J; Setiawan, VW; Wentzensen, N; Schumacher, F; Yu, H; Delahanty, R; Bernstein, L; Chanock, SJ; Chen, C; Cook, LS; Friedenreich, C; Garcia-Closas, M; Haiman, CA; Le Marchand, L; Liang, XL; Lissowska, J; Lu, LG; Magliocco, AM; Olson, SH; Risch, HA; Shu, XO; Ursin, G; Yang, HP; Kraft, P; De Vivo, I				Prescott, Jennifer; Setiawan, Veronica W.; Wentzensen, Nicolas; Schumacher, Fredrick; Yu, Herbert; Delahanty, Ryan; Bernstein, Leslie; Chanock, Stephen J.; Chen, Chu; Cook, Linda S.; Friedenreich, Christine; Garcia-Closas, Monserrat; Haiman, Christopher A.; Le Marchand, Loic; Liang, Xiaolin; Lissowska, Jolanta; Lu, Lingeng; Magliocco, Anthony M.; Olson, Sara H.; Risch, Harvey A.; Shu, Xiao-Ou; Ursin, Giske; Yang, Hannah P.; Kraft, Peter; De Vivo, Immaculata			Body Mass Index Genetic Risk Score and Endometrial Cancer Risk	PLOS ONE			English	Article							POSTMENOPAUSAL HORMONE-THERAPY; GENOME-WIDE ASSOCIATION; REPLACEMENT THERAPY; VARIANTS; ESTROGEN	Genome-wide association studies (GWAS) have identified common variants that predispose individuals to a higher body mass index (BMI), an independent risk factor for endometrial cancer. Composite genotype risk scores (GRS) based on the joint effect of published BMI risk loci were used to explore whether endometrial cancer shares a genetic background with obesity. Genotype and risk factor data were available on 3,376 endometrial cancer case and 3,867 control participants of European ancestry from the Epidemiology of Endometrial Cancer Consortium GWAS. A BMI GRS was calculated by summing the number of BMI risk alleles at 97 independent loci. For exploratory analyses, additional GRSs were based on subsets of risk loci within putative etiologic BMI pathways. The BMI GRS was statistically significantly associated with endometrial cancer risk (P = 0.002). For every 10 BMI risk alleles a woman had a 13% increased endometrial cancer risk (95% CI: 4%, 22%). However, after adjusting for BMI, the BMI GRS was no longer associated with risk (per 10 BMI risk alleles OR = 0.99, 95% CI: 0.91, 1.07; P = 0.78). Heterogeneity by BMI did not reach statistical significance (P = 0.06), and no effect modification was noted by age, GWAS Stage, study design or between studies (P >= 0.58). In exploratory analyses, the GRS defined by variants at loci containing monogenic obesity syndrome genes was associated with reduced endometrial cancer risk independent of BMI (per BMI risk allele OR = 0.92, 95% CI: 0.88, 0.96; P = 2.1 x 10(-5)). Possessing a large number of BMI risk alleles does not increase endometrial cancer risk above that conferred by excess body weight among women of European descent. Thus, the GRS based on all current established BMI loci does not provide added value independent of BMI. Future studies are required to validate the unexpected observed relation between monogenic obesity syndrome genetic variants and endometrial cancer risk.	[Prescott, Jennifer; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Prescott, Jennifer; Kraft, Peter; De Vivo, Immaculata] Harvard Univ, Sch Med, Boston, MA USA; [Prescott, Jennifer; De Vivo, Immaculata] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Program Genet Epidemiol & Stat Genet, Boston, MA USA; [Setiawan, Veronica W.; Schumacher, Fredrick; Haiman, Christopher A.; Ursin, Giske] Univ Calif Los Angeles, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [Wentzensen, Nicolas; Chanock, Stephen J.; Yang, Hannah P.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Yu, Herbert] Univ Hawaii, Program Epidemiol, Ctr Canc, Honolulu, HI 96822 USA; [Yu, Herbert] Yale Univ, Dept Epidemiol & Publ Hlth, Yale Canc Ctr, Yale Sch Publ Hlth, New Haven, CT 06520 USA; [Delahanty, Ryan; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med, Nashville, TN 37212 USA; [Delahanty, Ryan; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA; [Chen, Chu] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98195 USA; [Chen, Chu] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Cook, Linda S.] Univ New Mexico, Albuquerque, NM 87131 USA; [Friedenreich, Christine] Alberta Hlth Serv Canc Control Alberta, Dept Populat Hlth Res, Div Canc Care, Calgary, AB, Canada; [Garcia-Closas, Monserrat] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Liang, Xiaolin; Olson, Sara H.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Lissowska, Jolanta] Ctr Canc, Dept Epidemiol & Canc Prevent, Warsaw, Poland; [Lissowska, Jolanta] M Sklodowska Curie Inst Oncol, Warsaw, Poland; [Magliocco, Anthony M.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Ursin, Giske] Canc Registry Norway, Oslo, Norway; [Ursin, Giske] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cancer Research Center of Hawaii; University of Hawaii System; Yale University; Vanderbilt University; Vanderbilt University; City of Hope; Beckman Research Institute of City of Hope; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of New Mexico; Alberta Health Services (AHS); University of London; Institute of Cancer Research - UK; Memorial Sloan Kettering Cancer Center; Maria Sklodowska-Curie National Research Institute of Oncology; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Oslo; University of Oslo	Prescott, J (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	jennifer.prescott@channing.harvard.edu	Schumacher, Fredrick/R-6043-2019; Lissowska, Jolanta/AAH-3252-2020; Ursin, Giske/U-6637-2017; Wentzensen, Nicolas/AAG-8522-2019; Kraft, Peter/GQH-8448-2022; Garcia-Closas, Montserrat/F-3871-2015	Schumacher, Fredrick/0000-0002-3073-7463; Lissowska, Jolanta/0000-0003-2695-5799; Ursin, Giske/0000-0002-0835-9507; De Vivo, Immaculata/0000-0002-7185-7402; Garcia-Closas, Montserrat/0000-0003-1033-2650; Kraft, Peter/0000-0002-4472-8103; Friedenreich, Christine/0000-0002-4783-1966; Olson, Sara/0000-0003-0182-2754; Setiawan, Veronica/0000-0001-9239-5692	National Institutes of Health [R01 CA134958, U54 CA155626, R01 CA83918, P30 CA008748, R35 CA39779, R01 CA75977, R03 CA80636, N01 HD23166, N01 CN05230, N01 CN67009, R01 CA105212, R01 CA87538, P01 CA87969, R01 CA49449, R01 CA77398, CA091019, K05 CA136967]; Canadian Cancer Society; Canadian Institutes for Health Research; Health Senior Scholar, Alberta Innovates-Health Solutions; National Cancer Institute at the National Institutes of Health [R01 CA098346]; National Cancer Institute [R37 CA054281, R01 CA063464]; Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN005230] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD023166] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA091019, ZIACP010126, R01CA049449, P01CA087969, R01CA087538, P30CA008748, R01CA105212, R01CA063464, R01CA077398, R01CA075977, U54CA155626, R01CA098346, R37CA054281, K05CA136967, R01CA083918, U01CA164973, R03CA080636, R35CA039779, R01CA134958, P30CA015704, R35CA197449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Health Senior Scholar, Alberta Innovates-Health Solutions; National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [grant R01 CA134958 (IDV)]. JP was supported by the National Institutes of Health [grant U54 CA155626]. The Alberta Health Services Study was funded by research grants from the Canadian Cancer Society and the Canadian Institutes for Health Research. CF was supported as a Health Senior Scholar by Alberta Innovates-Health Solutions. The Connecticut Endometrial Cancer Study was supported by the National Cancer Institute at the National Institutes of Health [grant R01 CA098346 (HY)]. The Estrogen, Diet, Genetics, and Endometrial Cancer study was supported by the National Institutes of Health [grants R01 CA83918 (SHO), P30 CA008748]. The Fred Hutchinson Cancer Research Center studies were supported by the National Institute of Health [grants R35 CA39779, R01 CA75977, R03 CA80636 (CC), N01 HD23166, N01 CN05230, N01 CN67009, R01 CA105212 (CC) and R01 CA87538]. The Multiethnic Cohort was supported by the National Cancer Institute [grants R37 CA054281, R01 CA063464]. The Nurses' Health Study was supported by the National Institutes of Health [grants P01 CA87969, R01 CA49449]. The California Teachers Study was supported by the National Institutes of Health [grants R01 CA77398 (LB), CA091019, and K05 CA136967 (LB)]. The Polish Endometrial Case-Control Study was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedkhanov A, 2001, ANN NY ACAD SCI, V943, P296, DOI 10.1111/j.1749-6632.2001.tb03811.x; BELANGER CF, 1978, AM J NURS, V78, P1039, DOI 10.2307/3462013; Bernstein L, 2002, CANCER CAUSE CONTROL, V13, P625, DOI 10.1023/A:1019552126105; Bodelon C, 2009, AM J EPIDEMIOL, V170, P1512, DOI 10.1093/aje/kwp321; Brinton LA, 2007, BRIT J CANCER, V96, P1450, DOI 10.1038/sj.bjc.6603731; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Crosbie EJ, 2010, CANCER EPIDEM BIOMAR, V19, P3119, DOI 10.1158/1055-9965.EPI-10-0832; Cust AE, 2007, ENDOCR-RELAT CANCER, V14, P755, DOI 10.1677/ERC-07-0132; De Vivo I, 2014, HUM GENET, V133, P211, DOI 10.1007/s00439-013-1369-1; Delahanty RJ, 2011, AM J EPIDEMIOL, V174, P1115, DOI 10.1093/aje/kwr233; Friedenreich CM, 2010, CANCER CAUSE CONTROL, V21, P1105, DOI 10.1007/s10552-010-9538-1; Gaudet MM, 2010, CANCER EPIDEM BIOMAR, V19, P2106, DOI 10.1158/1055-9965.EPI-10-0515; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Long JR, 2012, CANCER EPIDEM BIOMAR, V21, P980, DOI 10.1158/1055-9965.EPI-11-1160; Lu LG, 2011, INT J CANCER, V129, P1237, DOI 10.1002/ijc.26046; Lurie G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016756; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Nead KT, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv178; Olson SH, 2008, CANCER CAUSE CONTROL, V19, P955, DOI 10.1007/s10552-008-9160-7; Paynter RA, 2004, PHARMACOGENETICS, V14, P851, DOI 10.1097/00008571-200412000-00008; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ranadive SA, 2008, ENDOCRIN METAB CLIN, V37, P733, DOI 10.1016/j.ecl.2008.07.003; Razavi P, 2012, INT J CANCER, V130, P1629, DOI 10.1002/ijc.26163; Razavi P, 2010, CANCER EPIDEM BIOMAR, V19, P475, DOI 10.1158/1055-9965.EPI-09-0712; Rebbeck TR, 2006, J NATL CANCER I, V98, P1311, DOI 10.1093/jnci/djj360; Setiawan VW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030390; Setiawan VW, 2009, CANCER EPIDEM BIOMAR, V18, P242, DOI 10.1158/1055-9965.EPI-08-0689; Shoff SM, 1998, AM J EPIDEMIOL, V148, P234, DOI 10.1093/oxfordjournals.aje.a009630; Smith WM, 2001, HUM GENET, V109, P146, DOI 10.1007/s004390100563; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spurdle AB, 2011, NAT GENET, V43, P451, DOI 10.1038/ng.812	35	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143256	10.1371/journal.pone.0143256	http://dx.doi.org/10.1371/journal.pone.0143256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26606540	Green Submitted, Green Published, gold			2022-12-26	WOS:000365865300049
J	Rastinehad, AR; Waingankar, N; Turkbey, B; Yaskiv, O; Sonstegard, AM; Fakhoury, M; Olsson, CA; Siegel, DN; Choyke, PL; Ben-Levi, E; Villani, R				Rastinehad, Ardeshir R.; Waingankar, Nikhil; Turkbey, Baris; Yaskiv, Oksana; Sonstegard, Anna M.; Fakhoury, Mathew; Olsson, Carl A.; Siegel, David N.; Choyke, Peter L.; Ben-Levi, Eran; Villani, Robert			Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies	PLOS ONE			English	Article							TRANSRECTAL ULTRASOUND BIOPSY; ACTIVE SURVEILLANCE; RISK; STRATIFICATION	Introduction Multiple scoring systems have been proposed for prostate MRI reporting. We sought to review the clinical impact of the new Prostate Imaging Reporting and Data System v2 (PI- RADS) and compare those results to our proposed Simplified Qualitative System (SQS) score with respect to detection of prostate cancers and clinically significant prostate cancers. Methods All patients who underwent multiparametric prostate MRI (mpMRI) had their images interpreted using PI-RADS v1 and SQS score. PI-RADS v2 was calculated from prospectively collected data points. Patients with positive mpMRIs were then referred by their urologists for enrollment in an IRB-approved prospective phase III trial of mpMRI-Ultrasound (MR/TRUS) fusion biopsy of suspicious lesions. Standard 12-core biopsy was performed at the same setting. Clinical data were collected prospectively. Results 1060 patients were imaged using mpMRI at our institution during the study period. 341 participants were then referred to the trial. 312 participants underwent MR/TRUS fusion biopsy of 452 lesions and were included in the analysis. 202 participants had biopsy-proven cancer (64.7%) and 206 (45.6%) lesions were positive for cancer. Distribution of cancer detected at each score produced a Gaussian distribution for SQS while PI-RADS demonstrates a negatively skewed curve with 82.1% of cases being scored as a 4 or 5. Patient-level data demonstrated AUC of 0.702 (95% CI 0.65 to 0.73) for PI-RADS and 0.762 (95% CI 0.72 to 0.81) for SQS (p< 0.0001) with respect to the detection of prostate cancer. The analysis for clinically significant prostate cancer at a per lesion level resulted in an AUC of 0.725 (95% CI 0.69 to 0.76) and 0.829 (95% CI 0.79 to 0.87) for the PI-RADS and SQS score, respectively (p< 0.0001). Conclusions mpMRI is a useful tool in the workup of patients at risk for prostate cancer, and serves as a platform to guide further evaluation with MR/TRUS fusion biopsy. SQS score provided a more normal distribution of scores and yielded a higher AUC than PI-RADS v2. However until our findings are validated, we recommend reporting of detailed sequence-specific findings. This will allow for prospectively collected data to be utilized in determining the impact of ongoing changes to these scoring systems as our understanding of mpMRI interpretation evolves.	[Rastinehad, Ardeshir R.; Olsson, Carl A.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Waingankar, Nikhil] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Turkbey, Baris; Choyke, Peter L.] NIH, Mol Imaging Program, Bethesda, MD 20892 USA; [Yaskiv, Oksana; Sonstegard, Anna M.; Fakhoury, Mathew; Siegel, David N.; Ben-Levi, Eran; Villani, Robert] Hofstra North Shore LIJ Sch Med, New Hyde Pk, NY USA	Icahn School of Medicine at Mount Sinai; Fox Chase Cancer Center; National Institutes of Health (NIH) - USA; Hofstra University; Northwell Health	Rastinehad, AR (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	art.rastinehad@mountsinai.org			NATIONAL CANCER INSTITUTE [ZIABC010655] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abd-Alazeez M, 2014, UROL ONCOL, V32, P45, DOI DOI 10.1016/J.UR0L0NC.2013.06.007; Abd-Alazeez M, 2014, UROL ONCOL-SEMIN ORI, V32, P741, DOI 10.1016/j.urolonc.2014.01.008; Ankerst DP, 2014, UROLOGY, V83, P1362, DOI 10.1016/j.urology.2014.02.035; Auprich M, 2011, EUR UROL, V60, P1045, DOI 10.1016/j.eururo.2011.08.003; Balleyguier C, 2007, EUR J RADIOL, V61, P192, DOI 10.1016/j.ejrad.2006.08.033; Busetto GM, 2013, UROLOGY, V82, P1355, DOI 10.1016/j.urology.2013.06.078; Cooperberg MR, 2013, J CLIN ONCOL, V31, P1428, DOI 10.1200/JCO.2012.46.4396; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; Leyten GHJM, 2014, EUR UROL, V65, P534, DOI 10.1016/j.eururo.2012.11.014; Moore CM, 2013, EUR UROL, V63, P125, DOI 10.1016/j.eururo.2012.06.004; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Pinto PA, 2011, J UROLOGY, V186, P1281, DOI 10.1016/j.juro.2011.05.078; Puech P, 2015, CURR OPIN UROL, V25, P522, DOI 10.1097/MOU.0000000000000217; Rastinehad AR, 2011, J UROLOGY, V185, P815, DOI 10.1016/j.juro.2010.10.076; Salami SS, 2014, CANCER-AM CANCER SOC, V120, P2876, DOI 10.1002/cncr.28790; Stamatakis L, 2013, CANCER-AM CANCER SOC, V119, P3359, DOI 10.1002/cncr.28216; Turkbey B, 2013, RADIOLOGY, V268, P144, DOI 10.1148/radiol.13121325; Turkbey B, 2011, J UROLOGY, V186, P1818, DOI 10.1016/j.juro.2011.07.013; Vourganti S, 2012, J UROLOGY, V188, P2152, DOI 10.1016/j.juro.2012.08.025	20	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2015	10	11							e0143404	10.1371/journal.pone.0143404	http://dx.doi.org/10.1371/journal.pone.0143404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7ES	26605548	gold, Green Published, Green Submitted			2022-12-26	WOS:000365865300062
J	Matsubayashi, Y; Takeshita, K; Sumitani, M; Oshima, Y; Tonosu, J; Kato, S; Ohya, J; Oichi, T; Okamoto, N; Tanaka, S				Matsubayashi, Yoshitaka; Takeshita, Katsushi; Sumitani, Masahiko; Oshima, Yasushi; Tonosu, Juichi; Kato, So; Ohya, Junichi; Oichi, Takeshi; Okamoto, Naoki; Tanaka, Sakae			Psychometric Validation of the Japanese Version of the Neuropathic Pain Symptom Inventory	PLOS ONE			English	Article							CLINICAL-TESTS; IDENTIFY; VALIDITY; SYSTEM; SF-36	Objective This study aimed to evaluate the validity and reliability of the Japanese version of the Neuropathic Pain Symptom Inventory (NPSI-J). Design Cross-sectional study design. Subjects and Methods The original Neuropathic Pain Symptom Inventory (NPSI) was translated into Japanese according to published guidelines. Subsequently, an observational study of 60 Japanese patients suffering from neuropathic pain was performed to evaluate the validity and reliability of the NPSI-J. Results The NPSI-J exhibited a statistically significant correlation with pain intensity (Numerical Rating Scale). The Cronbach alpha value for Likert items was 0.86. Using the test-retest analysis method, the intraclass correlation coefficient between the two scores was 0.81. Factor analysis revealed that the main component of NPSI-J comprised three determinative factors. Conclusions The NPSI-J is a reliable and valid pain assessment tool.	[Matsubayashi, Yoshitaka; Oshima, Yasushi; Tonosu, Juichi; Kato, So; Ohya, Junichi; Oichi, Takeshi; Okamoto, Naoki; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Takeshita, Katsushi] Jichi Med Univ, Dept Orthopaed Surg, Shimotsuke, Tochigi, Japan; [Sumitani, Masahiko] Univ Tokyo, Dept Pain & Palliat Med, Tokyo, Japan	University of Tokyo; Jichi Medical University; University of Tokyo	Matsubayashi, Y (corresponding author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan.	ymatsubayashi-tky@umin.ac.jp	Ohya, Junichi/L-5987-2019; Tanaka, Sakae/Y-3061-2019; Ohya, Junichi/AAV-8524-2020	Tanaka, Sakae/0000-0001-9210-9414; Ohya, Junichi/0000-0002-1299-2508; Matsubayashi, Yoshitaka/0000-0002-2087-5774	Japan Agency for Medical Research and Development [H27-itami-shitei-001]; Ministry of Health, Labor, and Welfare [H23-itami-ippan-002]; Grants-in-Aid for Scientific Research [25293316] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by Japan Agency for Medical Research and Development Grant (H27-itami-shitei-001) to MS (URL: http://www.amed.go.jp) and Ministry of Health, Labor, and Welfare Science Research Grant (H23-itami-ippan-002) to KT and MS (URL: http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre-Obadia N, 2008, NEUROLOGY, V71, P833, DOI 10.1212/01.wnl.0000325481.61471.f0; Attal N, 2008, PAIN, V138, P343, DOI 10.1016/j.pain.2008.01.006; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Bouhassira D, 2014, PAIN, V155, P2171, DOI 10.1016/j.pain.2014.08.020; BOUREAU F, 1990, PAIN, V42, P145, DOI 10.1016/0304-3959(90)91158-F; de Andrade DC, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-107; DUBUISSON D, 1976, EXP NEUROL, V51, P480, DOI 10.1016/0014-4886(76)90271-5; Feise RJ, 2001, SPINE, V26, P78, DOI 10.1097/00007632-200101010-00015; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Matsubayashi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068013; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; O'Connor AB, 2009, PHARMACOECONOMICS, V27, P95, DOI 10.2165/00019053-200927020-00002; Padua L, 2009, NEUROL SCI, V30, P99, DOI 10.1007/s10072-009-0025-y; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sommer C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-104; Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170; Sumitani M, 2015, J PAIN PALLIAT CARE; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Villoria J, 2011, J PAIN SYMPTOM MANAG, V42, P134, DOI 10.1016/j.jpainsymman.2010.09.018	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143350	10.1371/journal.pone.0143350	http://dx.doi.org/10.1371/journal.pone.0143350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26600240	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600054
J	Doddala, PRC; Minor, MA; Rogers, DJ; Trewick, SA				Doddala, Prasad R. C.; Minor, Maria A.; Rogers, David J.; Trewick, Steven A.			Fifteen into Three Does Go: Morphology, Genetics and Genitalia Confirm Taxonomic Inflation of New Zealand Beetles (Chrysomelidae: Eucolaspis)	PLOS ONE			English	Article							BRONZE BEETLE; COLEOPTERA-CHRYSOMELIDAE; DNA; SEQUENCES; GRASSHOPPERS; ORTHOPTERA; EVOLUTION; INFERENCE; MRBAYES	Eucolaspis Sharp 1886 is a New Zealand native leaf beetle genus (Coleoptera: Chrysomelidae: Eumolpinae) with poorly described species and a complex taxonomy. Many economically important fruit crops are severely damaged by these beetles. Uncertain species taxonomy of Eucolaspis is leaving any biological research, as well as pest management, tenuous. We used morphometrics, mitochondrial DNA and male genitalia to study phylogenetic and geographic diversity of Eucolaspis in New Zealand. Freshly collected beetles from several locations across their distribution range, as well as identified voucher specimens from major museum collections were examined to test the current classification. We also considered phylogenetic relationships among New Zealand and global Eumolpinae (Coleoptera: Chyrosomelidae). We demonstrate that most of the morphological information used previously to define New Zealand Eucolaspis species is insufficient. At the same time, we show that a combination of morphological and genetic evidence supports the existence of just 3 mainland Eucolaspis lineages (putative species), and not 5 or 15, as previously reported. In addition, there may be another closely related lineage (putative species) on an offshore location (Three Kings Islands, NZ). The cladistic structure among the lineages, conferred through mitochondrial DNA data, was well supported by differences in male genitalia. We found that only a single species (lineage) infests fruit orchards in Hawke's Bay region of New Zealand. Species-host plant associations vary among different regions.	[Doddala, Prasad R. C.; Minor, Maria A.; Trewick, Steven A.] Massey Univ, Inst Agr & Environm, Ecol Grp, Palmerston North, New Zealand; [Rogers, David J.] Plant & Food Res Ltd, Havelock North, New Zealand	Massey University; New Zealand Institute for Plant & Food Research Ltd	Doddala, PRC (corresponding author), Swedish Univ Agr Sci, Dept Plant Protect Biol, Div Chem Ecol, Alnarp, Sweden.	prasad.doddala@slu.se	Rogers, Dave/J-4235-2018	Rogers, Dave/0000-0003-1976-6930; Trewick, Steven/0000-0002-4680-8457	Plant and Food Research Ltd.	Plant and Food Research Ltd.	The funder (Plant and Food Research Ltd.) provided support in the form of salaries for authors (DJR), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber HS, 1937, P ENTOMOLOGICAL SOC, V38; Broun T, 1893, J NATURAL HIST 6, V6, P374; Broun T, 1880, MANUAL NZ COLEOPTERA; Broun T, 1909, J NATURAL HIST 8, V8, P275; Broun T, 1893, MANUAL NZ COLEOPTERA; Bryant GE, 1957, PAC SCI, V11, P2; Crosby TK, 1998, NEW ZEAL J ZOOL, V25, P175, DOI 10.1080/03014223.1998.9518148; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Doddala P. R. C., 2010, New Zealand Plant Protection, V63, P195; Doddala PRC, 2015, J APPL ENTOMOLOGY; Doddala PRC, 2012, THESIS; Drummond A. J., 2011, GENEIOUS V5 4; Fabricius J.C., 1781, SPECIES INSECTORUM, V1; Ferro D. N, 1977, Bulletin ent Soc NZ, VNo. 4, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gomez-Zurita J, 2010, J NAT HIST, V44, P2557, DOI 10.1080/00222933.2010.499575; GURNEY ASHLEY B., 1964, ANN ENTOMOL SOC AMER, V57, P240; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kawakami Y, 2010, ANN ENTOMOL SOC AM, V103, P327, DOI 10.1603/AN09074; Kubisz D, 2012, CENT EUR J BIOL, V7, P69, DOI 10.2478/s11535-011-0099-4; Kuschel G., 1990, 3 DSIR; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lysaght AM, 1930, NZ DEP SCI IND RES W, V25; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; McGlone M, 2011, ECOREGIONS TE ARA EN; Montagna M, 2013, PACHYBRACHIS HOLEROR, V3741, P11; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Peterson MA, 2007, CHEMOECOLOGY, V17, P87, DOI 10.1007/s00049-007-0366-z; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rogers D. J., 2007, New Zealand Plant Protection, V60, P1; Rogers D. J., 2006, New Zealand Plant Protection, V59, P57; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Sharp D, 1886, NZ COLEOPTERA DESCRI, P445; Shaw S., 1957, ANN MAGAZINE NATURAL, V12, P641, DOI DOI 10.1080/00222935708656008; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tosevski I, 2011, SYST ENTOMOL, V36, P741, DOI 10.1111/j.1365-3113.2011.00593.x; Trewick SA, 2000, MOL ECOL, V9, P269, DOI 10.1046/j.1365-294x.2000.00873.x; Trewick SA, 2008, CLADISTICS, V24, P240, DOI 10.1111/j.1096-0031.2007.00174.x; Trewick Steven A., 2011, Insects, V2, P297, DOI 10.3390/insects2030297; Vaux F, 2015, BIOL J LINNEAN SOC; Vawter L, 1991, EVOLUTION BLATTOID I; White A, 1846, ZOOLOGY VOYAGE HMS E, P23; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x	50	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143258	10.1371/journal.pone.0143258	http://dx.doi.org/10.1371/journal.pone.0143258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26600380	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900083
J	Fang, F; Luo, ZC; Dejemli, A; Delvin, E; Zhang, J				Fang, Fang; Luo, Zhong-Cheng; Dejemli, Anissa; Delvin, Edgard; Zhang, Jun			Maternal Smoking and Metabolic Health Biomarkers in Newborns	PLOS ONE			English	Article							GROWTH-FACTOR-I; NICOTINE EXPOSURE; BIRTH-WEIGHT; CIGARETTE-SMOKING; PREGNANT-WOMEN; FETAL-GROWTH; LEPTIN; RISK; CESSATION; PROTEINS	Background Maternal smoking has been associated with elevated risk of type 2 diabetes among the offspring in adulthood. The mechanisms underlying this fetal "programming" effect remain unclear. The present study sought to explore whether maternal smoking affects metabolic health biomarkers in fetuses/newborns. Methods In a prospective singleton pregnancy cohort (n = 248), we compared metabolic health biomarkers in the newborns of smoking and non-smoking mothers. Outcomes included cord plasma insulin, proinsulin, insulin-like growth factor I (IGF-I), IGF-II, leptin and adiponectin concentrations, glucose-to-insulin ratio (an indicator of insulin sensitivity) and proinsulin-to-insulin ratio (an indicator of beta-cell function). Results Independent of maternal (glucose tolerance, age, ethnicity, parity, education, body mass index, alcohol use) and infant (sex, gestational age, birth weight z score, mode of delivery, cord blood glucose concentration) characteristics, the newborns of smoking mothers had lower IGF-I concentrations (mean: 6.7 vs. 8.4 nmol/L, adjusted p = 0.006), and marginally higher proinsulin-to-insulin ratios (0.94 vs. 0.72, adjusted p = 0.06) than the newborns of non-smoking mothers. Cord plasma insulin, proinsulin, IGF-II, leptin and adiponectin concentrations and glucose-to-insulin ratios were similar in the newborns of smoking and nonsmoking mothers. Conclusions Maternal smoking was associated with decreased fetal IGF-I levels, and borderline lower fetal beta-cell function. Larger cohort studies are required to confirm the latter finding. The preliminary findings prompt the hypothesis that these early life metabolic changes may be involved in the impact of maternal smoking on future risk of metabolic syndrome related disorders in the offspring.	[Fang, Fang; Luo, Zhong-Cheng; Zhang, Jun] Shanghai Jiao Tong Univ, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp, Minist Educ,Sch Med, Shanghai 200092, Peoples R China; [Luo, Zhong-Cheng] Univ Montreal, Res Ctr, Dept Obstet & Gynecol, St Justine Hosp, Montreal, PQ H3T 1C5, Canada; [Dejemli, Anissa; Delvin, Edgard] Univ Montreal, Res Ctr, Dept Clin Biochem, St Justine Hosp, Montreal, PQ H3T 1C5, Canada	Shanghai Jiao Tong University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Luo, ZC (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp, Minist Educ,Sch Med, Shanghai 200092, Peoples R China.	zhongcheng_luo3@163.com	Luo, Zhong-Cheng/T-3882-2017	Luo, Zhong-Cheng/0000-0002-1794-1312	Canadian Institutes of Health Research (CIHR grant) [79896]; National Natural Science Foundation of China [81370742]	Canadian Institutes of Health Research (CIHR grant)(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the Canadian Institutes of Health Research (CIHR grant # 79896) and National Natural Science Foundation of China (grant # 81370742). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 1997, BRIT MED BULL, V53, P96; Bruin JE, 2007, J ENDOCRINOL, V194, P171, DOI 10.1677/JOE-07-0050; Burks DJ, 2001, DIABETES, V50, pS140, DOI 10.2337/diabetes.50.2007.S140; Chelchowska Magdalena, 2014, Przegl Lek, V71, P567; Chelchowska Magdalena, 2013, Przegl Lek, V70, P800; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027260; Dempsey D, 2002, J PHARMACOL EXP THER, V301, P594, DOI 10.1124/jpet.301.2.594; Dukic VM, 2009, INT J ENV RES PUB HE, V6, P1744, DOI 10.3390/ijerph6061744; Elghazi L, 2009, TRENDS ENDOCRIN MET, V20, P243, DOI 10.1016/j.tem.2009.03.002; Ermis B, 2004, HORM RES, V62, P288, DOI 10.1159/000081974; Gluckman PD, 2003, J NUTR, V133, p1741S, DOI 10.1093/jn/133.5.1741S; Helland IB, 2001, ACTA PAEDIATR, V90, P282, DOI 10.1080/080352501300067578; Ingvarsson RF, 2007, ACTA PAEDIATR, V96, P383, DOI 10.1111/j.1651-2227.2007.00103.x; Jaddoe VWV, 2014, DIABETES CARE, V37, P2966, DOI 10.2337/dc13-1679; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; La Merrill MA, 2015, J DEV ORIG HLTH DIS, V6, P242, DOI 10.1017/S2040174415000045; Luo ZC, 2013, OBESITY, V21, P210, DOI 10.1002/oby.20250; Luo ZC, 2012, J CLIN ENDOCR METAB, V97, P1720, DOI 10.1210/jc.2011-3296; Luo ZC, 2010, DIABETES CARE, V33, P2055, DOI 10.2337/dc10-0819; Mantzoros CS, 1997, J CLIN ENDOCR METAB, V82, P2856, DOI 10.1210/jc.82.9.2856; Mathews T J, 2001, Natl Vital Stat Rep, V49, P1; Ozkan B, 2005, ENDOCR RES, V31, P177, DOI 10.1080/07435800500371748; Pickett KE, 2009, NICOTINE TOB RES, V11, P1166, DOI 10.1093/ntr/ntp117; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Pringle PJ, 2005, J CLIN ENDOCR METAB, V90, P2556, DOI 10.1210/jc.2004-1674; REECE EA, 1994, OBSTET GYNECOL, V84, P88; Rogers John M., 2008, Birth Defects Research, V84, P1, DOI 10.1002/bdrc.20119; Russell TV, 2004, NICOTINE TOB RES, V6, pS141, DOI 10.1080/14622200410001669141; Sargeant LA, 2001, INT J EPIDEMIOL, V30, P547, DOI 10.1093/ije/30.3.547; Somm E, 2008, ENDOCRINOLOGY, V149, P6289, DOI 10.1210/en.2008-0361; Vardavas CI, 2010, EUR J PEDIATR, V169, P741, DOI 10.1007/s00431-009-1107-9; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826; Xu D, 2013, ACTA PHARMACOL SIN, V34, P1526, DOI 10.1038/aps.2013.171; Zhang HR, 2010, OBESITY, V18, P2071, DOI 10.1038/oby.2010.91; Zhao JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085054, 10.1371/journal.pone.0108005]	36	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143660	10.1371/journal.pone.0143660	http://dx.doi.org/10.1371/journal.pone.0143660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599278	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900153
J	van Hulst, BM; de Zeeuw, P; Lupas, K; Bos, DJ; Neggers, SFW; Durston, S				van Hulst, Branko M.; de Zeeuw, Patrick; Lupas, Kellina; Bos, Dienke J.; Neggers, Sebastiaan F. W.; Durston, Sarah			Reward Anticipation in Ventral Striatum and Individual Sensitivity to Reward: A Pilot Study of a Child-Friendly fMRI Task	PLOS ONE			English	Article							DISORDER; ADHD; ADOLESCENCE; RELIABILITY; IMPULSIVITY	Reward processing has been implicated in developmental disorders. However, the classic task to probe reward anticipation, the monetary incentive delay task, has an abstract coding of reward and no storyline and may therefore be less appropriate for use with developmental populations. We modified the task to create a version appropriate for use with children. We investigated whether this child-friendly version could elicit ventral striatal activation during reward anticipation in typically developing children and young adolescents (aged 9.5-14.5). In addition, we tested whether our performance-based measure of reward sensitivity was associated with anticipatory activity in ventral striatum. Reward anticipation was related to activity in bilateral ventral striatum. Moreover, we found an association between individual reward sensitivity and activity in ventral striatum. We conclude that this task assesses ventral striatal activity in a child-friendly paradigm. The combination with a performance-based measure of reward sensitivity potentially makes the task a powerful tool for developmental imaging studies of reward processing.	[van Hulst, Branko M.; de Zeeuw, Patrick; Lupas, Kellina; Bos, Dienke J.; Neggers, Sebastiaan F. W.; Durston, Sarah] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, NICHE Lab, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van Hulst, BM (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, NICHE Lab, Utrecht, Netherlands.	b.vanhulst@umcutrecht.nl	Lupas, Kellina/ABG-3448-2020	Lupas, Kellina/0000-0003-4293-5923	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) [Vici-453-10-005]	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) (S.D., grant number Vici-453-10-005). The funding source had no influence on study design, data analysis or the written report.	de Zeeuw P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051416; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Helfinstein SM, 2013, SOC COGN AFFECT NEUR, V8, P720, DOI 10.1093/scan/nss057; Hoogman M, 2011, AM J PSYCHIAT, V168, P1099, DOI 10.1176/appi.ajp.2011.10101446; Kappel V, 2013, J NEURAL TRANSM, V120, P1259, DOI 10.1007/s00702-012-0962-0; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Lamm C, 2014, BRAIN COGNITION, V89, P51, DOI 10.1016/j.bandc.2013.12.003; Lorenz RC, 2015, NEUROIMAGE, V117, P250, DOI 10.1016/j.neuroimage.2015.05.024; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Matthys W, 2013, DEV PSYCHOPATHOL, V25, P193, DOI 10.1017/S0954579412000272; Mazaika P., 2009, NEUROIMAGE, V47, pS58, DOI DOI 10.1016/S1053-8119(09)70238-1; Mir P, 2011, EXP BRAIN RES, V209, P551, DOI 10.1007/s00221-011-2583-5; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Plichta MM, 2012, NEUROIMAGE, V60, P1746, DOI 10.1016/j.neuroimage.2012.01.129; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Stoppel CM, 2011, BRAIN RES, V1383, P218, DOI 10.1016/j.brainres.2011.01.095; Stringaris A, 2015, AM J PSYCHIAT, V172, P1215, DOI 10.1176/appi.ajp.2015.14101298; Vaidya JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058708; van Hulst BM, 2015, PSYCHOL MED, V45, P735, DOI 10.1017/S0033291714001792	22	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142413	10.1371/journal.pone.0142413	http://dx.doi.org/10.1371/journal.pone.0142413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599542	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900023
J	Santos, SB; Carvalho, C; Azeredo, J; Ferreira, EC				Santos, Silvio B.; Carvalho, Carla; Azeredo, Joana; Ferreira, Eugenio C.			Population Dynamics of a Salmonella Lytic Phage and Its Host: Implications of the Host Bacterial Growth Rate in Modelling (vol 9, e102507, 2014)	PLOS ONE			English	Correction													Santos, Silvio/O-5491-2015; Vale, Mariana M./I-9408-2012; Carvalho, Bruno/G-9558-2013; Ferreira, Eugénio Campos/B-5417-2009	Santos, Silvio/0000-0003-0801-8080; Vale, Mariana M./0000-0003-0734-4925; Carvalho, Bruno/0000-0002-0009-5770; Ferreira, Eugénio Campos/0000-0002-5400-3333; Carvalho, Carla/0000-0002-9345-6546; Rangel, Elizabeth/0000-0002-9584-1202; Azeredo, Joana/0000-0002-5180-7133				Santos SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102507	1	62	64	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2015	10	8							e0136007	10.1371/journal.pone.0136007	http://dx.doi.org/10.1371/journal.pone.0136007			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6KK	26619186	gold, Green Published			2022-12-26	WOS:000359995500042
J	Carvalho, BM; Rangel, EF; Ready, PD; Vale, MM				Carvalho, Bruno M.; Rangel, Elizabeth F.; Ready, Paul D.; Vale, Mariana M.			Ecological Niche Modelling Predicts Southward Expansion of Lutzomyia (Nyssomyia) flaviscutellata (Diptera: Psychodidae: Phlebotominae), Vector of Leishmania (Leishmania) amazonensis in South America, under Climate Change	PLOS ONE			English	Article							SAND FLIES DIPTERA; ENZOOTIC RODENT LEISHMANIASIS; SPECIES DISTRIBUTION MODELS; DE-JANEIRO STATE; CUTANEOUS LEISHMANIASIS; MATO-GROSSO; ENVIRONMENTAL VARIABLES; VISCERAL LEISHMANIASIS; SELECTING THRESHOLDS; POTENTIAL VECTORS	Vector borne diseases are susceptible to climate change because distributions and densities of many vectors are climate driven. The Amazon region is endemic for cutaneous leishmaniasis and is predicted to be severely impacted by climate change. Recent records suggest that the distributions of Lutzomyia (Nyssomyia) flaviscutellata and the parasite it transmits, Leishmania (Leishmania) amazonensis, are expanding southward, possibly due to climate change, and sometimes associated with new human infection cases. We define the vector's climatic niche and explore future projections under climate change scenarios. Vector occurrence records were compiled from the literature, museum collections and Brazilian Health Departments. Six bioclimatic variables were used as predictors in six ecological niche model algorithms (BIOCLIM, DOMAIN, MaxEnt, GARP, logistic regression and Random Forest). Projections for 2050 used 17 general circulation models in two greenhouse gas representative concentration pathways: "stabilization" and "high increase". Ensemble models and consensus maps were produced by overlapping binary predictions. Final model outputs showed good performance and significance. The use of species absence data substantially improved model performance. Currently, L. flaviscutellata is widely distributed in the Amazon region, with records in the Atlantic Forest and savannah regions of Central Brazil. Future projections indicate expansion of the climatically suitable area for the vector in both scenarios, towards higher latitudes and elevations. L. flaviscutellata is likely to find increasingly suitable conditions for its expansion into areas where human population size and density are much larger than they are in its current locations. If environmental conditions change as predicted, the range of the vector is likely to expand to southeastern and central-southern Brazil, eastern Paraguay and further into the Amazonian areas of Bolivia, Peru, Ecuador, Colombia and Venezuela. These areas will only become endemic for L. amazonensis, however, if they have competent reservoir hosts and transmission dynamics matching those in the Amazon region.	[Carvalho, Bruno M.; Vale, Mariana M.] Univ Fed Rio de Janeiro, Inst Biol, Lab Vertebrados, Rio De Janeiro, Brazil; [Carvalho, Bruno M.; Rangel, Elizabeth F.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Vigilancia Entomol Diptera, Rio De Janeiro, Brazil; [Carvalho, Bruno M.; Ready, Paul D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1, England; [Carvalho, Bruno M.] Univ Estado Rio de Janeiro, Posgrad Ecol & Evolucao, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; University of London; London School of Hygiene & Tropical Medicine; Universidade do Estado do Rio de Janeiro	Carvalho, BM (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Lab Vertebrados, Rio De Janeiro, Brazil.	brunomc.eco@gmail.com	Santos, Silvio/O-5491-2015; Vale, Mariana M./I-9408-2012; Carvalho, Bruno/G-9558-2013; Ferreira, Eugénio Campos/B-5417-2009	Santos, Silvio/0000-0003-0801-8080; Vale, Mariana M./0000-0003-0734-4925; Carvalho, Bruno/0000-0002-0009-5770; Ferreira, Eugénio Campos/0000-0002-5400-3333; Carvalho, Carla/0000-0002-9345-6546; Rangel, Elizabeth/0000-0002-9584-1202; Azeredo, Joana/0000-0002-5180-7133	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ [E-26/101.450/2012, E-26/111.618/2011, E-26/111.577/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq [203165/2014-4, 400113/2011-2, 34/2012, 477524/2012-2, 444704/2014, 550022/2014-7]; Financiadora de Estudos e Projetos, FINEP [01.13.0353.00]; Instituto Oswaldo Cruz, IOC/FIOCRUZ; National Science Foundation [DBI-1300426]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos, FINEP(Financiadora de Inovacao e Pesquisa (Finep)); Instituto Oswaldo Cruz, IOC/FIOCRUZ; National Science Foundation(National Science Foundation (NSF))	This research was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ (http://www.faperj.br; Grants E-26/101.450/2012, BMC; E-26/111.618/2011, EFR; E-26/111.577/2014, MMV); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (http://www.cnpq.br; Grants 203165/2014-4, BMC; 400113/2011-2, EFR; 34/2012, MMV; 477524/2012-2, MMV; 444704/2014, MMV; 550022/2014-7, MMV); Financiadora de Estudos e Projetos, FINEP (http://www.finep.gov.br; Grant 01.13.0353.00, MMV); Instituto Oswaldo Cruz, IOC/FIOCRUZ (http://www.ioc.fiocruz.br; EFR), and National Science Foundation (http://www.nsf.gov; Grants # DBI-1300426, PDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Alves VR, 2012, REV BRAS ENTOMOL, V56, P220, DOI 10.1590/S0085-56262012005000020; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Azeredo-Coutinho RBG, 2007, T ROY SOC TROP MED H, V101, P735, DOI 10.1016/j.trstmh.2007.01.005; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Bates PA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0712-x; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Nunes VL, 2008, REV BRAS ENTOMOL, V52, P446, DOI 10.1590/S0085-56262008000300019; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2007, MAN VIG LEISHM TEG A; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cardenas R, 2008, ANN NY ACAD SCI, V1149, P326, DOI 10.1196/annals.1428.094; Cardenas R, 2006, AM J TROP MED HYG, V75, P273, DOI 10.4269/ajtmh.2006.75.273; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Carvalho BM, 2014, REV BRAS ENTOMOL, V58, P77, DOI 10.1590/S0085-56262014000100013; Carvalho BM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-325; Dorval MEC, 2010, REV SOC BRAS MED TRO, V43, P491, DOI 10.1590/S0037-86822010000500003; Chaves LF, 2006, PLOS MED, V3, P1320, DOI 10.1371/journal.pmed.0030295; Chiang JM, 2008, J INTEGR PLANT BIOL, V50, P1426, DOI 10.1111/j.1744-7909.2008.00749.x; Costa JM, 2009, GAZ MED BAHIA, V79, P16; de Brito VN, 2014, MEM I OSWALDO CRUZ, V109, P899, DOI 10.1590/0074-0276140112; de Oliveira Alessandra Gutierrez, 2003, Cad Saude Publica, V19, P933; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; Dias ES, 2011, VET PARASITOL, V176, P101, DOI 10.1016/j.vetpar.2010.11.014; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dorval MEC, 2007, MEM I OSWALDO CRUZ, V102, P877, DOI 10.1590/S0074-02762007005000111; Dorval MEC, 2009, MEM I OSWALDO CRUZ, V104, P695, DOI 10.1590/S0074-02762009000500005; Edenhofer O., 2014, CONTRIBUTION WORKING; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ELITH J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI [DOI 10.1146/ANNUREV.EC0LSYS.110308.120159, 10.1146/annurev.ecolsys.110308.120159, DOI 10.1146/ANNUREV.ECOLSYS.110308.120159]; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Perez JE, 2007, MEM I OSWALDO CRUZ, V102, P655, DOI 10.1590/S0074-02762007005000077; FAIRCHILD GB, 1971, J MED ENTOMOL, V8, P153, DOI 10.1093/jmedent/8.2.153; Fischer Dominik, 2011, PLoS Negl Trop Dis, V5, pe1407, DOI 10.1371/journal.pntd.0001407; Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008; Forattini OP, 1973, ENTOMOLOGIA MEDICA 4, V4; Franke CR, 2002, EMERG INFECT DIS, V8, P914, DOI 10.3201/eid0809.010523; Franklin J., 2010, MAPPING SPECIES DIST, DOI DOI 10.1017/CBO9780511810602; Fuller DO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-264; Galati EAB, 2006, MEM I OSWALDO CRUZ, V101, P175, DOI 10.1590/S0074-02762006000200010; Galati EAB, 2003, FLEBOTOMINEOS BRASIL, P53, DOI DOI 10.1590/S0085-56262003000200017; Galvez R, 2010, ACTA TROP, V115, P95, DOI 10.1016/j.actatropica.2010.02.009; Galvez R, 2011, VECTOR-BORNE ZOONOT, V11, P799, DOI 10.1089/vbz.2010.0109; Gomes Almerio de Castro, 2012, Revista de Patologia Tropical, V41, P215, DOI 10.5216/rpt.v41i2.19323; Gomez EA, 2014, ACTA TROP, V137, P118, DOI 10.1016/j.actatropica.2014.05.006; Gonzalez C, 2014, ACTA TROP, V129, P83, DOI 10.1016/j.actatropica.2013.08.014; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HASHIGUCHI Y, 1992, ANN TROP MED PARASIT, V86, P175, DOI 10.1080/00034983.1992.11812649; Hijmans R.J., 2014, DISMO SPECIES DISTRI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IBGE, 2010, I BRAS GEOGR EST CEN; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Joetzjer E, 2013, CLIM DYNAM, V41, P2921, DOI 10.1007/s00382-012-1644-1; Kato H, 2013, ACTA TROP, V128, P710, DOI 10.1016/j.actatropica.2013.09.001; Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; LAINSON R, 1968, T ROY SOC TROP MED H, V62, P385, DOI 10.1016/0035-9203(68)90090-4; LAINSON R, 1994, MEM I OSWALDO CRUZ, V89, P435, DOI 10.1590/S0074-02761994000300027; Lainson R, 2005, TOPLEY WILSONS MICRO, V5, P313; LEWIS DJ, 1975, J MED ENTOMOL, V12, P363, DOI 10.1093/jmedent/12.3.363; Li XH, 2013, INTEGR ZOOL, V8, P124, DOI 10.1111/1749-4877.12000; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Marengo J.A., 2007, MUDANCAS CLIMATICAS; Queiroz MFM, 2012, REV SOC BRAS MED TRO, V45, P313, DOI 10.1590/S0037-86822012000300007; Moo-Llanes D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002421; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011; Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peters J, 2011, PREV VET MED, V100, P15, DOI 10.1016/j.prevetmed.2011.03.004; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2011, MONOGRAPHS POPULATIO, P328, DOI [DOI 10.5860/CHOICE.49-6266, 10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pinto IS, 2010, J VECTOR ECOL, V35, P325, DOI 10.1111/j.1948-7134.2010.00090.x; Porretta D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-271; Qiao H, METHODS ECOL EVOL; R Core Team, 2021, R LANGUAGE ENV STAT; Rado Covarrubias CD, 2011, THESIS; Rangel EF, 2014, LEISHMANIASIS - TRENDS IN EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT, P3, DOI 10.5772/57207; Rangel EF, 2009, MEM I OSWALDO CRUZ, V104, P937, DOI 10.1590/S0074-02762009000700001; Ready PD, 2008, REV SCI TECH OIE, V27, P399, DOI 10.20506/rst.27.2.1803; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; READY PD, 1983, T ROY SOC TROP MED H, V77, P775, DOI 10.1016/0035-9203(83)90288-2; Rosenthal J, 2009, ECOHEALTH, V6, P489, DOI 10.1007/s10393-010-0314-1; SHAW JJ, 1968, T ROY SOC TROP MED H, V62, P396, DOI 10.1016/0035-9203(68)90091-6; SHAW JJ, 1972, T ROY SOC TROP MED H, V66, P709, DOI 10.1016/0035-9203(72)90084-3; Silva Ferreira Joao Victor, 2014, Revista Pan-Amazonica de Saude, V5, P29; Rodrigues EDS, 2011, REV INST MED TROP SP, V53, P255, DOI 10.1590/S0036-46652011000500003; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tolezano JE, 2007, VET PARASITOL, V149, P280, DOI 10.1016/j.vetpar.2007.07.008; Vale MM, 2012, J BIOGEOGR, V39, P1744, DOI 10.1111/j.1365-2699.2012.02750.x; Vilela ML, 2013, MEM I OSWALDO CRUZ, V108, P578, DOI 10.1590/S0074-02762013000500007; Vilela ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027721; Wei T., 2013, CORRPLOT VISUALIZATI, V230, P11; WHO, 2010, WHO TECH REP SER, V949, P1; Woodward A, 2014, LANCET, V383, P1185, DOI 10.1016/S0140-6736(14)60576-6; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1; Zerpa O, 2009, GAZETA MED BAHIA S3, V79, P30	109	62	64	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2015	10	11							e0143282	10.1371/journal.pone.0143282	http://dx.doi.org/10.1371/journal.pone.0143282			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7NW	26619186	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000365889800031
